Citrus Sinensis ID: 001226
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1119 | 2.2.26 [Sep-21-2011] | |||||||
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.929 | 0.937 | 0.389 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | yes | no | 0.899 | 0.912 | 0.371 | 1e-177 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.921 | 0.918 | 0.360 | 1e-177 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.922 | 0.948 | 0.361 | 1e-176 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.950 | 0.849 | 0.339 | 1e-173 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.878 | 0.892 | 0.370 | 1e-171 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.930 | 0.833 | 0.355 | 1e-169 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.876 | 0.872 | 0.367 | 1e-166 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.822 | 0.806 | 0.350 | 1e-148 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.923 | 0.922 | 0.341 | 1e-147 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 656 bits (1693), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/1141 (38%), Positives = 623/1141 (54%), Gaps = 101/1141 (8%)
Query: 6 SYYVLFSLNQFLALSVSSPPSAISLVQFLDSLPKQ-SQSHLPWNQSVSTSAPCKWSGVSC 64
S Y F+LN S + +SL + S+P +QS WN S ST PC W GV C
Sbjct: 17 SIYAAFALN-------SDGAALLSLTRHWTSIPSDITQS---WNASDST--PCSWLGVEC 64
Query: 65 YNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKT 124
+ + LNLS +G+SG IS++ +HL + LSGN F GSIP QLGNC L+
Sbjct: 65 -DRRQFVDTLNLSSYGISGEFGPEISHL---KHLKKVVLSGNGFFGSIPSQLGNCSLLEH 120
Query: 125 LLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGEL 184
+ L+ N F G+IP + L+ L L L +NSL G P + LE++ F N LNG +
Sbjct: 121 IDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSI 180
Query: 185 PNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEF 244
P++I ++ +L +L+L+ +N F G +P+SL N L E
Sbjct: 181 PSNIGNMSELTTLWLD-----------------------DNQFSGPVPSSLGNITTLQEL 217
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTI 304
+ NN G + P L L L + +N+L G IP + + + LS N+ G +
Sbjct: 218 YLNDNNLVGTL-PVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGL 276
Query: 305 SGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVD 364
+ +C L+ L G IP G L+ L++L L N G +PPELG C S++D
Sbjct: 277 PPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMID 336
Query: 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRI 424
L+LQ N + G IP E+ L++L+ L+L+ N + G +P I ++ L L LY N L+G +
Sbjct: 337 LQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGEL 396
Query: 425 PPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLF 484
P D+T L+ L L+L NH TG + +LG + L LDLT N F G IP N+C L
Sbjct: 397 PVDMTELKQLVSLALYENHFTGVIPQDLGAN-SSLEVLDLTRNMFTGHIPPNLCSQKKLK 455
Query: 485 VLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS 544
L+LG N GS P ++G CS+L R+IL N L+G LP +E+ + F D+ GN G
Sbjct: 456 RLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFVEKQ-NLLFFDLSGNNFTGP 514
Query: 545 IPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMI 604
IPP G N+T + S N+LSGSIP ELG+L L+ L LS N L G +P EL C K+
Sbjct: 515 IPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLS 574
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664
+LD S N L GSIPS + SL ++ LSL EN+ SG IP + L LQLG N+ G
Sbjct: 575 ELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGD 634
Query: 665 IPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL 724
IP + L S LN+S+NKL+G++P LG L L+ LD+S N+ SG + ++ + SL
Sbjct: 635 IP-PVGALQALRS-LNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTLRV-LSTIQSL 691
Query: 725 YFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC--------------------RQGN 764
F+NIS N FSG +P S T + S P SF GNS+LC Q N
Sbjct: 692 TFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSN 751
Query: 765 CGKNGRGHTRGRLAGIIIGVLLSVALLCALIYIM---------VVRVLRSKCFSDPSLLQ 815
GK G T G +A I++G LL + +C ++ V + S D SLL
Sbjct: 752 TGKGGLS-TLG-IAMIVLGALLFI--ICLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLN 807
Query: 816 DVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR-TLSNNSRKHWAVKKL-----NR 869
V +E+L + +IGKG HGT+Y+ TLS + K +AVKKL
Sbjct: 808 KVLEATENL------------NDKYVIGKGAHGTIYKATLSPD--KVYAVKKLVFTGIKN 853
Query: 870 SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDW 929
+ EI T+ VRHRN++++ + E+G I+ YM G+L ++LH+ P LDW
Sbjct: 854 GSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDW 913
Query: 930 NTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989
+TR++IA+G A GL+YLH+DC P I+HRDIK NILLDS+LEP I DFG++KL+ S +S
Sbjct: 914 STRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATS 973
Query: 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT 1049
+ + G++GY+APENA++T + +SDVYSYGV+L EL+ RK +DPSF +TDIV W
Sbjct: 974 IPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWV 1033
Query: 1050 RWKLQENHECICFLDREI--SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107
R + E +D + DS + L LAL C + D RP+MR+VV L
Sbjct: 1034 RSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQLT 1093
Query: 1108 K 1108
+
Sbjct: 1094 R 1094
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1608), Expect = e-177, Method: Compositional matrix adjust.
Identities = 408/1099 (37%), Positives = 600/1099 (54%), Gaps = 93/1099 (8%)
Query: 47 WNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGN 106
WN + S PC W+GV C N SS + +LSL+LS
Sbjct: 51 WNSN--DSVPCGWTGVMCSNYSS-------------------------DPEVLSLNLS-- 81
Query: 107 EFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSL 166
+++L+ G + P I L L LDL YN LSGKIP ++
Sbjct: 82 -----------------SMVLS-----GKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGN 119
Query: 167 CYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLP-EFPNSCAILHLLIHEN 225
C SLE + +NN +GE+P +I L L++L + N ++G LP E N ++ L+ + N
Sbjct: 120 CSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSN 179
Query: 226 DFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLW 285
+ G LP S+ N + L F A N G++ P G L +L L N L G++P+ +
Sbjct: 180 NISGQLPRSIGNLKRLTSFRAGQNMISGSL-PSEIGGCESLVMLGLAQNQLSGELPKEIG 238
Query: 286 GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN 345
L+ L +++L N+ +G I +IS+C L+ +AL +N LVG IP+ +G+L SL L L+
Sbjct: 239 MLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYR 298
Query: 346 NRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIG 405
N L GT+P E+GN +++ N + G IP E+ N+ LE+LYLF N++ G IP ++
Sbjct: 299 NGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELS 358
Query: 406 RMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLT 465
+ L +L L N LTG IP LR L L L N L+G + +LG + L LD++
Sbjct: 359 TLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLG-WYSDLWVLDMS 417
Query: 466 GNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATL 525
N G IP+ +C+ +N+ +L LG N +G+ P I C +L ++ L+ N L G P+ L
Sbjct: 418 DNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNL 477
Query: 526 ERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLS 585
+ V+ +++ N +GSIP G S L L ++N +G +P E+G L L L +S
Sbjct: 478 CKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNIS 537
Query: 586 ANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAF 645
+NKL G +P E+ C + +LD+ N +G++PSEV SL +++ L L NNLSG IP A
Sbjct: 538 SNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVAL 597
Query: 646 SSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDL 705
++ L ELQ+G N+F+GSIP L L LN+S NKL+G+IP L NL L+ L L
Sbjct: 598 GNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLL 657
Query: 706 SSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC----- 760
++N+ SGEIP+ N+ SL N S+N +G +P M SF+GN LC
Sbjct: 658 NNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISM----SSFIGNEGLCGPPLN 713
Query: 761 ----RQGNCGKNGRGHTRGRLAGIIIGVLLSVALLCALIYI-MVVRVLRSKCFSDPSLLQ 815
Q G G + II + +V +L+ I ++V ++R + S Q
Sbjct: 714 QCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQ 773
Query: 816 DVQSRSEDL-----PRD-LRYEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVK 865
D Q L P++ ++D++ AT E ++G+G GTVY+ + + AVK
Sbjct: 774 DGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVL-PAGYTLAVK 832
Query: 866 KL---------NRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916
KL N + +F EI TL +RHRNI+++ G C ++ EYMP G+L
Sbjct: 833 KLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGE 892
Query: 917 VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976
+LH +P LDW+ R+ IALG AQGL+YLH+DC P+I HRDIKS+NILLD + E +GD
Sbjct: 893 ILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 950
Query: 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
FG++K+I HS S SAI GS GYIAPE AY+ ++TEKSD+YSYGV+L ELL K PV
Sbjct: 951 FGLAKVIDMPHSKSM-SAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQ 1009
Query: 1037 PSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMR 1096
P + D+V W R ++ + LD ++ D L +L++AL CT R
Sbjct: 1010 P-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVAR 1068
Query: 1097 PSMREVVGFLIKLNDKNEG 1115
PSMR+VV LI+ ++++EG
Sbjct: 1069 PSMRQVVLMLIE-SERSEG 1086
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1604), Expect = e-177, Method: Compositional matrix adjust.
Identities = 398/1105 (36%), Positives = 605/1105 (54%), Gaps = 74/1105 (6%)
Query: 35 DSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICK 94
D +P Q S W + S + PC W G++C ++
Sbjct: 44 DRVPPQVTST--WKINASEATPCNWFGITCDDS--------------------------- 74
Query: 95 NQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYN 154
+++ SL+ + + +G + ++G L+ L L+ N F G+IP + +L+ LDL N
Sbjct: 75 -KNVASLNFTRSRVSGQLGPEIGELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSEN 133
Query: 155 SLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPE-FPN 213
S KIP + LE + + NFL GELP + +PKL+ LYL+ NNLTG +P+ +
Sbjct: 134 GFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGD 193
Query: 214 SCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDD 273
+ ++ L ++ N F G++P S+ N +L N G++ P L L L++ +
Sbjct: 194 AKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVGSL-PESLNLLGNLTTLFVGN 252
Query: 274 NNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVG 333
N+L+G + +NL L LS N+ G + + +C+ L + + NL G IP S+G
Sbjct: 253 NSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLG 312
Query: 334 NLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN 393
L +L L L NRL G++P ELGNC SL L+L N + G IP + L KLE L LF
Sbjct: 313 MLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFE 372
Query: 394 NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG 453
NR G IP +I + L +L +Y N LTG +P ++T ++ L+ +L +N G + LG
Sbjct: 373 NRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLG 432
Query: 454 KHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILS 513
+ L +D GN G IP N+C G L +L LG+N +G+ P IG C ++RR IL
Sbjct: 433 VN-SSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILR 491
Query: 514 NNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL 573
N L G LP ++ +SFLD N +G IP G NL+ ++ S NR +G IP +L
Sbjct: 492 ENNLSGLLPE-FSQDHSLSFLDFNSNNFEGPIPGSLGSCKNLSSINLSRNRFTGQIPPQL 550
Query: 574 GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQ 633
GNL+NL + LS N L+G +P +L C + + D+ N L GS+PS + + + +L L
Sbjct: 551 GNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLS 610
Query: 634 ENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693
EN SG IP ++ L LQ+ N F G IP S+ + L++S N L+G+IP
Sbjct: 611 ENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAK 670
Query: 694 LGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSF 753
LG+L KL L++S+N+ +G + + + + SL V++S N F+G +P + ++S P SF
Sbjct: 671 LGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEPSSF 729
Query: 754 LGNSELC--RQGNCGKNGRG-------HTRGRLAG------IIIGVLLSVALLCALIYIM 798
GN LC + N R ++ R +G ++I VL S+ +L ++ ++
Sbjct: 730 SGNPNLCIPHSFSASNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALV 789
Query: 799 VVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRAT----EGRIIGKGKHGTVYRTL 854
+ + R K + +D +++ L V+ AT E IG+G HG VYR
Sbjct: 790 FICLRRRKGRPE----KDAYVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRA- 844
Query: 855 SNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909
S S K +AVK+L R+ + EI T+ VRHRN++++ G + + G ++ YM
Sbjct: 845 SLGSGKVYAVKRLVFASHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYM 904
Query: 910 PGGTLFNVLHQNEPRL-VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968
P G+L++VLH P+ VLDW+ RY++ALG+A GL+YLHYDC P I+HRDIK +NIL+DS
Sbjct: 905 PKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDS 964
Query: 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
+LEP IGDFG+++L+ DS S+ + + G+ GYIAPENA+ T +SDVYSYGV+L EL
Sbjct: 965 DLEPHIGDFGLARLLDDSTVST--ATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLEL 1022
Query: 1029 LFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI-------SFWDSDDQLKALRL 1081
+ RK VD SF E TDIV+W R L ++ + + I DS + + +++
Sbjct: 1023 VTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQV 1082
Query: 1082 LELALECTRQVADMRPSMREVVGFL 1106
ELAL CT+Q MRP+MR+ V L
Sbjct: 1083 TELALSCTQQDPAMRPTMRDAVKLL 1107
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 618 bits (1594), Expect = e-176, Method: Compositional matrix adjust.
Identities = 412/1141 (36%), Positives = 634/1141 (55%), Gaps = 109/1141 (9%)
Query: 3 LLISYYVLFSLNQFLALSVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCK--WS 60
LL S +V F ++ +L+ S + +SL++ D +P + S W ++ S + PC W
Sbjct: 11 LLCSLFVYFRIDSVSSLN-SDGLALLSLLKHFDKVPLEVAS--TWKENTSETTPCNNNWF 67
Query: 61 GVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCG 120
GV C DLSGN
Sbjct: 68 GVIC-------------------------------------DLSGN-------------- 76
Query: 121 QLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFL 180
++TL L+ + G + EI +LK L LDL NS SG +P + C SLE + NN
Sbjct: 77 VVETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDF 136
Query: 181 NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNS-CAILHLLIHENDFVGSLPTSLSNCR 239
+GE+P+ SL L LYL+ NNL+GL+P ++ L + N+ G++P L NC
Sbjct: 137 SGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNCS 196
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLV---LS 296
L + ++N G++ P L L L++ +N+L G++ +G N +KLV LS
Sbjct: 197 KLEYLALNNNKLNGSL-PASLYLLENLGELFVSNNSLGGRLH---FGSSNCKKLVSLDLS 252
Query: 297 ANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPEL 356
N G + +I +C+ L + + + NL G IP S+G L ++ + L +NRL G +P EL
Sbjct: 253 FNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQEL 312
Query: 357 GNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416
GNC SL L+L N + G IPP + L KL+ L LF N++ G IP I ++ L ++ +Y
Sbjct: 313 GNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVY 372
Query: 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPAN 476
NN LTG +P ++T+L++L+ L+L +N G++ + LG + L +DL GN F G IP +
Sbjct: 373 NNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRS-LEEVDLLGNRFTGEIPPH 431
Query: 477 ICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDV 536
+C G L + +LG+N+ +G P I +C +L RV L +N L G LP E + +S++++
Sbjct: 432 LCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVLPEFPE-SLSLSYVNL 490
Query: 537 RGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYE 596
N +GSIP G NL +D S+N+L+G IP ELGNL++L +L LS N L+G +P +
Sbjct: 491 GSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQ 550
Query: 597 LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQL 656
L C +++ D+ N L GSIPS S + + +L L +NN GAIP + + L +L++
Sbjct: 551 LSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDRLSDLRI 610
Query: 657 GSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPT 716
N F G IP S+ L L++S N +G+IP LG L L+ L++S+N +G +
Sbjct: 611 ARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINLERLNISNNKLTGPLSV 670
Query: 717 EVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQGNCG---------K 767
+ ++ SL V++S+N F+G +P + ++S F GN +LC Q + K
Sbjct: 671 -LQSLKSLNQVDVSYNQFTGPIPVN----LLSNSSKFSGNPDLCIQASYSVSAIIRKEFK 725
Query: 768 NGRGHTR---GRLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDL 824
+ +G + ++A I G LSV L +++++ R R D ++L + E L
Sbjct: 726 SCKGQVKLSTWKIALIAAGSSLSVLALLFALFLVLCRCKRGTKTEDANILAE-----EGL 780
Query: 825 PRDLRYEDVIRATEG----RIIGKGKHGTVYRTLSNNSRKHWAVKKL-----NRSETNFD 875
L V+ AT+ IIG+G HG VYR S S + +AVKKL R+ N
Sbjct: 781 --SLLLNKVLAATDNLDDKYIIGRGAHGVVYRA-SLGSGEEYAVKKLIFAEHIRANQNMK 837
Query: 876 VEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ-NEPRLVLDWNTRYH 934
EI T+ LVRHRN++R+ + E G ++ +YMP G+L +VLH+ N+ VLDW+ R++
Sbjct: 838 REIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFN 897
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
IALGI+ GL+YLH+DC P IIHRDIK +NIL+DS++EP IGDFG+++++ DS S+ +
Sbjct: 898 IALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDDSTVST--AT 955
Query: 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL- 1053
+ G+ GYIAPENAY T +++SDVYSYGV+L EL+ K +D SF ED +IV+W R L
Sbjct: 956 VTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDINIVSWVRSVLS 1015
Query: 1054 ---QENHECICFLDREI--SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108
E+ +D ++ D+ + +A+++ +LAL CT + + RPSMR+VV L
Sbjct: 1016 SYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDVVKDLTD 1075
Query: 1109 L 1109
L
Sbjct: 1076 L 1076
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 609 bits (1570), Expect = e-173, Method: Compositional matrix adjust.
Identities = 414/1218 (33%), Positives = 629/1218 (51%), Gaps = 154/1218 (12%)
Query: 38 PKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQH 97
PK+ WN + + C W+GV+C + LNLSG GL+G ++ SI + +
Sbjct: 44 PKEEDVLRDWNSG--SPSYCNWTGVTC--GGREIIGLNLSGLGLTGSISPSIG---RFNN 96
Query: 98 LLSLDLSGNEF-------------------------TGSIPKQLGNCGQLKTLLLNDNRF 132
L+ +DLS N +G IP QLG+ LK+L L DN
Sbjct: 97 LIHIDLSSNRLVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNEL 156
Query: 133 QGSIP-----------------------PEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCY 168
G+IP P F +L +L L L N L G IP ++ C
Sbjct: 157 NGTIPETFGNLVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCT 216
Query: 169 SLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLP-EFPNSCAILHLLIHENDF 227
SL N LNG LP ++ L L++L L N+ +G +P + + +I +L + N
Sbjct: 217 SLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQL 276
Query: 228 VGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGL 287
G +P L+ NL SSNN G I ++ + QLE L L N L G +P+T+
Sbjct: 277 QGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWR-MNQLEFLVLAKNRLSGSLPKTICSN 335
Query: 288 E-NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346
+L++L LS +L+G I +IS+C L+++ LS N L GQIP S+ L L +L L NN
Sbjct: 336 NTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNN 395
Query: 347 RLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGR 406
L+GTL + N +L + L HN + G +P EI L KLE++YL+ NR G +P +IG
Sbjct: 396 SLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGN 455
Query: 407 MSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG------------- 453
++L E+ Y NRL+G IP I RL++L L L N L G + LG
Sbjct: 456 CTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADN 515
Query: 454 -------KHFPYLSRLDL---TGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF------ 497
F +L+ L+L NS G +P ++ NL + +N+FNGS
Sbjct: 516 QLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGS 575
Query: 498 -----------------PIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
P+E+GK ++L R+ L N G +P T + +S LD+ N
Sbjct: 576 SSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNS 635
Query: 541 LQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC 600
L G IP G LT +D + N LSG IP+ LG L L L+LS+NK G +P E+
Sbjct: 636 LSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSL 695
Query: 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNI 660
T ++ L L N L GSIP E+ +L+ + +L+L+EN LSG +P + LFEL+L N
Sbjct: 696 TNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNA 755
Query: 661 FDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNN 720
G IP + +L S L++S N +G+IP + L KL+ LDLS N GE+P ++ +
Sbjct: 756 LTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGD 815
Query: 721 MVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQ--GNCGKNGRGHTRGRLA 778
M SL ++N+S+N+ GKL ++ +F+GN+ LC +C + G + R L+
Sbjct: 816 MKSLGYLNLSYNNLEGKLKKQFSRWQAD---AFVGNAGLCGSPLSHCNRAGSKNQRS-LS 871
Query: 779 GIIIGVLLSVALLCALIYIMVVRVLRSKCFSDPSLLQDVQS-----------------RS 821
+ ++ +++ L A+ +++V +L K D L + V+ +
Sbjct: 872 PKTVVIISAISSLAAIALMVLVIILFFKQNHD--LFKKVRGGNSAFSSNSSSSQAPLFSN 929
Query: 822 EDLPRDLRYEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKL-----NRSET 872
D++++D++ AT E +IG G G VY+ N + AVKK+ S
Sbjct: 930 GGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNG-ETIAVKKILWKDDLMSNK 988
Query: 873 NFDVEIRTLSLVRHRNILRIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNE---PRLVL 927
+F+ E++TL +RHR++++++G C+ G ++ EYM G++++ LH NE + VL
Sbjct: 989 SFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVL 1048
Query: 928 DWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987
W TR IALG+AQG+ YLHYDCVP I+HRDIKS N+LLDS +E +GDFG++K+++ ++
Sbjct: 1049 GWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNY 1108
Query: 988 SSSTRS--AIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
++T S GS GYIAPE AYS + TEKSDVYS G++L E++ KMP + F E+TD+
Sbjct: 1109 DTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDM 1168
Query: 1046 VTWTRWKLQ-----ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMR 1100
V W L E E + +D E+ ++ A ++LE+AL+CT+ RPS R
Sbjct: 1169 VRWVETVLDTPPGSEAREKL--IDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSR 1226
Query: 1101 EVVGFLIKLNDKNEGGMR 1118
+ +L+ + + R
Sbjct: 1227 QASEYLLNVFNNRAASYR 1244
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 602 bits (1552), Expect = e-171, Method: Compositional matrix adjust.
Identities = 378/1019 (37%), Positives = 559/1019 (54%), Gaps = 36/1019 (3%)
Query: 119 CGQLKTLL---LNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGF 175
C L+T+ LN G++ P I KL L L++ N +SG IP +SLC SLE +
Sbjct: 63 CTHLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDL 122
Query: 176 HNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLP-EFPNSCAILHLLIHENDFVGSLPTS 234
N +G +P + + LK LYL N L G +P + N ++ L+I+ N+ G +P S
Sbjct: 123 CTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPS 182
Query: 235 LSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLV 294
++ R L A N F G I P G L+VL L +N LEG +P+ L L+NL L+
Sbjct: 183 MAKLRQLRIIRAGRNGFSGVI-PSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLI 241
Query: 295 LSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPP 354
L N+L+G I + + ++L+V+AL N G IPR +G L+ + L L+ N+L G +P
Sbjct: 242 LWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPR 301
Query: 355 ELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414
E+GN ++ N + G IP E ++ L++L+LF N + G IP ++G ++ L +L
Sbjct: 302 EIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLD 361
Query: 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIP 474
L NRL G IP ++ L L L L N L G++ +G + S LD++ NS GPIP
Sbjct: 362 LSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIG-FYSNFSVLDMSANSLSGPIP 420
Query: 475 ANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFL 534
A+ C L +L LG+N+ +G+ P ++ C SL +++L +N L GSLP L ++ L
Sbjct: 421 AHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTAL 480
Query: 535 DVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIP 594
++ N L G+I G NL L + N +G IP E+GNL + +S+N+L G IP
Sbjct: 481 ELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIP 540
Query: 595 YELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFEL 654
ELG C + +LDLS N +G I E+ L ++ L L +N L+G IP +F + L EL
Sbjct: 541 KELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMEL 600
Query: 655 QLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEI 714
QLG N+ +IP L KL LN+S+N LSG IP+ LGNL L+IL L+ N SGEI
Sbjct: 601 QLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEI 660
Query: 715 PTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC--RQGNCGKNGRGH 772
P + N++SL NIS N+ G +P + +F GN LC ++ +C + H
Sbjct: 661 PASIGNLMSLLICNISNNNLVGTVPDT-AVFQRMDSSNFAGNHGLCNSQRSHC-QPLVPH 718
Query: 773 TRGRLAGIIIGVLLS--VALLCALIYIMVVRVLRSKCFS----DPSLLQ-------DVQS 819
+ +L +I G + + C +I + + C++ +P+ + DV
Sbjct: 719 SDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMD 778
Query: 820 RSEDLPRDLRYEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN------R 869
+ Y+ ++ AT E ++G+G GTVY+ + + AVKKLN
Sbjct: 779 SYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKA-EMSGGEVIAVKKLNSRGEGAS 837
Query: 870 SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDW 929
S+ +F EI TL +RHRNI+++ G C ++ EYM G+L L + E +LDW
Sbjct: 838 SDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDW 897
Query: 930 NTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989
N RY IALG A+GL YLH+DC PQI+HRDIKS+NILLD + +GDFG++KLI S+S
Sbjct: 898 NARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK 957
Query: 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT 1049
S SA+ GS GYIAPE AY+ ++TEK D+YS+GV+L EL+ K PV P + D+V W
Sbjct: 958 SM-SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWV 1015
Query: 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108
R ++ I D + D + +L++AL CT RP+MREVV + +
Sbjct: 1016 RRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 596 bits (1537), Expect = e-169, Method: Compositional matrix adjust.
Identities = 389/1094 (35%), Positives = 589/1094 (53%), Gaps = 53/1094 (4%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLL 126
N +L+ L L+ L+G + + + + + Q L+ L N G IP +LGNC L
Sbjct: 165 NLVNLQMLALASCRLTGPIPSQLGRLVRVQSLI---LQDNYLEGPIPAELGNCSDLTVFT 221
Query: 127 LNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPN 186
+N G+IP E+ +L+ L L+L NSL+G+IP Q+ L+ + N L G +P
Sbjct: 222 AAENMLNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPK 281
Query: 187 DICSLPKLKSLYLNTNNLTGLLPE-FPNSCAILHLLIHENDFVGSLPTSL-SNCRNLVEF 244
+ L L++L L+ NNLTG +PE F N +L L++ N GSLP S+ SN NL +
Sbjct: 282 SLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQL 341
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTI 304
S G I P L+ L L +N+L G IPE L+ L L L L N L GT+
Sbjct: 342 VLSGTQLSGEI-PVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTL 400
Query: 305 SGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVD 364
S IS+ LQ + L NNL G++P+ + L L L L+ NR G +P E+GNC SL
Sbjct: 401 SPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKM 460
Query: 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRI 424
+ + N G IPP I L +L +L+L N + G +P +G +L L L +N+L+G I
Sbjct: 461 IDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSI 520
Query: 425 PPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLF 484
P L+ L+ L L +N L G + L L+R++L+ N G I +C ++
Sbjct: 521 PSSFGFLKGLEQLMLYNNSLQGNLPDSL-ISLRNLTRINLSHNRLNGTIHP-LCGSSSYL 578
Query: 485 VLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS 544
+ NN F P+E+G +L R+ L N L G +P TL + +S LD+ N L G+
Sbjct: 579 SFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGT 638
Query: 545 IPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMI 604
IP LT +D + N LSG IP LG L L L+LS+N+ +P EL CTK++
Sbjct: 639 IPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLL 698
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664
L L N L GSIP E+ +L + L+L +N SG++P A + L+EL+L N G
Sbjct: 699 VLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGE 758
Query: 665 IPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL 724
IP + +L S L++S N +G IP +G L KL+ LDLS N +GE+P V +M SL
Sbjct: 759 IPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSL 818
Query: 725 YFVNISFNHFSGKLPASWTTLMVSYPG-SFLGNSELCRQ--GNCGKNGRGHTRGRLAGII 781
++N+SFN+ GKL ++ +P SFLGN+ LC C + + + L+
Sbjct: 819 GYLNVSFNNLGGKLKKQFS----RWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARS 874
Query: 782 IGVLLSVALLCALIYIMVVRVLRSKCFSD------------PSLLQDVQSRSEDLPR--- 826
+ ++ +++ L A+ +++V L K D S Q+ + L R
Sbjct: 875 VVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGA 934
Query: 827 ---DLRYEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKL-----NRSETNF 874
D+R+ED++ AT E +IG G G VY+ N AVKK+ S +F
Sbjct: 935 SKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGET-VAVKKILWKDDLMSNKSF 993
Query: 875 DVEIRTLSLVRHRNILRIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRL-----VL 927
E++TL +RHR++++++G C+ G ++ EYM G++++ LH+++P L +L
Sbjct: 994 SREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLL 1053
Query: 928 DWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987
DW R IA+G+AQG+ YLH+DCVP I+HRDIKS N+LLDS +E +GDFG++K+++++
Sbjct: 1054 DWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENC 1113
Query: 988 SSSTRSA--IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
++T S S GYIAPE AYS + TEKSDVYS G++L E++ KMP D FG + D+
Sbjct: 1114 DTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDM 1173
Query: 1046 VTWTRWKLQ-ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104
V W L+ +D ++ ++ A ++LE+AL+CT+ RPS R+
Sbjct: 1174 VRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACD 1233
Query: 1105 FLIKLNDKNEGGMR 1118
L+ + + G +
Sbjct: 1234 SLLHVYNNRTAGYK 1247
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 585 bits (1507), Expect = e-166, Method: Compositional matrix adjust.
Identities = 378/1029 (36%), Positives = 570/1029 (55%), Gaps = 48/1029 (4%)
Query: 122 LKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
+ +L L+ G + P I L L +L+L YN+L+G IP ++ C LE + +NN
Sbjct: 87 VTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFG 146
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPE-FPNSCAILHLLIHENDFVGSLPTSLSNCRN 240
G +P +I L +L+S + N L+G LPE + + L+ + N+ G LP SL N
Sbjct: 147 GSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNK 206
Query: 241 LVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKL 300
L F A N+F G I I K L L++L L N + G++P+ + L LQ+++L NK
Sbjct: 207 LTTFRAGQNDFSGNIPTEIGK-CLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKF 265
Query: 301 NGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG 360
+G I I + L+ +AL N+LVG IP +GN+ SL L L+ N+L GT+P ELG
Sbjct: 266 SGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLS 325
Query: 361 SLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRL 420
++++ N + G IP E+ +++L +LYLF N++ G IP+++ ++ L +L L N L
Sbjct: 326 KVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSL 385
Query: 421 TGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG 480
TG IPP L +++ L L HN L+G + LG + P L +D + N G IP IC
Sbjct: 386 TGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSP-LWVVDFSENQLSGKIPPFICQQ 444
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
+NL +L LG+NR G+ P + +C SL ++ + N L G P L + +S +++ N
Sbjct: 445 SNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNR 504
Query: 541 LQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC 600
G +PP G L L + N+ S ++P+E+ L NL +S+N L G IP E+ C
Sbjct: 505 FSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANC 564
Query: 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNI 660
+ +LDLS N GS+P E+ SL +++ L L EN SG IP ++ L ELQ+G N+
Sbjct: 565 KMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNL 624
Query: 661 FDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNN 720
F GSIP L L +N+S N SG+IP +GNL L L L++N SGEIPT N
Sbjct: 625 FSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFEN 684
Query: 721 MVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC----RQGNCGKNGRGHT--- 773
+ SL N S+N+ +G+LP + ++ SFLGN LC R + + H
Sbjct: 685 LSSLLGCNFSYNNLTGQLPHTQIFQNMTL-TSFLGNKGLCGGHLRSCDPSHSSWPHISSL 743
Query: 774 ------RGRLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSED---- 823
RGR+ I+ V+ ++LL I VV LR+ + D + ++
Sbjct: 744 KAGSARRGRIIIIVSSVIGGISLLLIAI---VVHFLRNPVEPTAPYVHDKEPFFQESDIY 800
Query: 824 -LPRD-LRYEDVIRATEG----RIIGKGKHGTVYRTLSNNSRKHWAVKKLN--------- 868
+P++ +D++ AT+G I+G+G GTVY+ + S K AVKKL
Sbjct: 801 FVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVM-PSGKTIAVKKLESNREGNNNN 859
Query: 869 --RSETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIVTEYMPGGTLFNVLHQNEPR 924
++ +F EI TL +RHRNI+R+ C ++ EYM G+L +LH +
Sbjct: 860 SNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSH 919
Query: 925 LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984
+DW TR+ IALG A+GL+YLH+DC P+IIHRDIKS+NIL+D E +GDFG++K+I
Sbjct: 920 -SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVI- 977
Query: 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
D S + SA+ GS GYIAPE AY+ ++TEK D+YS+GV+L ELL K PV P + D
Sbjct: 978 DMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGD 1036
Query: 1045 IVTWTRWKLQENHECICFLDREISFWDSDDQL-KALRLLELALECTRQVADMRPSMREVV 1103
+ TWTR ++++ LD ++ + D L + + ++A+ CT+ RP+MREVV
Sbjct: 1037 LATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVV 1096
Query: 1104 GFLIKLNDK 1112
LI+ ++
Sbjct: 1097 LMLIESGER 1105
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1352), Expect = e-148, Method: Compositional matrix adjust.
Identities = 346/986 (35%), Positives = 520/986 (52%), Gaps = 66/986 (6%)
Query: 184 LPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLL-IHENDFVGSLPTSLSNCRNLV 242
LP ++ + L+ L ++ NLTG LPE C L +L + N VG +P SLS RNL
Sbjct: 97 LPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLE 156
Query: 243 EFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK-LN 301
+SN G I P I K +L+ L L DN L G IP L L L+ + + NK ++
Sbjct: 157 TLILNSNQLTGKIPPDISK-CSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEIS 215
Query: 302 GTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGS 361
G I +I C+ L V+ L+ ++ G +P S+G L L +L ++ + G +P +LGNC
Sbjct: 216 GQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSE 275
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
LVDL L N + G+IP EI L KLE L+L+ N + G IP +IG S L + L N L+
Sbjct: 276 LVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLS 335
Query: 422 GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT 481
G IP I RL L+ ++ N +G + + + L +L L N G IP+ + T
Sbjct: 336 GSIPSSIGRLSFLEEFMISDNKFSGSIPTTI-SNCSSLVQLQLDKNQISGLIPSELGTLT 394
Query: 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLL 541
L + +N+ GS P + C+ L+ + LS N L G++P+ L ++ L + N L
Sbjct: 395 KLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSL 454
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCT 601
G IP G S+L L NR++G IPS +G+L+ + L S+N+L G++P E+G C+
Sbjct: 455 SGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCS 514
Query: 602 KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIF 661
++ +DLS+N L GS+P+ V SL +Q L + N SG IP + + SL +L L N+F
Sbjct: 515 ELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLF 574
Query: 662 DGSIPCSLS------------------------KLHHFSSILNVSNNKLSGKIPECLGNL 697
GSIP SL + + LN+S+N+L+GKIP + +L
Sbjct: 575 SGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASL 634
Query: 698 DKLQILDLSSNSFSGEIP--TEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLG 755
+KL ILDLS N G++ + N+VSL NIS+N FSG LP + +S P G
Sbjct: 635 NKLSILDLSHNMLEGDLAPLANIENLVSL---NISYNSFSGYLPDNKLFRQLS-PQDLEG 690
Query: 756 NSELC-----------RQGN-CGKNGRGHTRGRLAGIIIGVLLSVALLCALIYIMVVRVL 803
N +LC R+GN G +G +L + ++ +L L + V+R
Sbjct: 691 NKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRAR 750
Query: 804 RSKCFSDPSLLQDVQSRSEDLPRDLRY--EDVIRA-TEGRIIGKGKHGTVYRTLSNNS-- 858
R+ S L + + L + + +IR E +IGKG G VYR +N
Sbjct: 751 RNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEV 810
Query: 859 ---RKHWAV-------KKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908
+K W +K +F E++TL +RH+NI+R +G C ++ +Y
Sbjct: 811 IAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDY 870
Query: 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968
MP G+L ++LH+ LDW+ RY I LG AQGL+YLH+DC+P I+HRDIK++NIL+
Sbjct: 871 MPNGSLGSLLHERRGS-SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGL 929
Query: 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
+ EP I DFG++KL+ + + + GS GYIAPE YS ++TEKSDVYSYGV++ E+
Sbjct: 930 DFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEV 989
Query: 1029 LFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALEC 1088
L K P+DP+ E +V W R +N + LD + + + +++L AL C
Sbjct: 990 LTGKQPIDPTVPEGIHLVDWVR----QNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLC 1045
Query: 1089 TRQVADMRPSMREVVGFLIKLNDKNE 1114
D RP+M++V L ++ + E
Sbjct: 1046 VNSSPDERPTMKDVAAMLKEIKQERE 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 524 bits (1349), Expect = e-147, Method: Compositional matrix adjust.
Identities = 370/1082 (34%), Positives = 556/1082 (51%), Gaps = 49/1082 (4%)
Query: 48 NQSVSTSAPC-KWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGN 106
+ + +TS C W GVSC N+ S++ LNL+ G+ G + +I + +L +DLS N
Sbjct: 56 DANTNTSFSCTSWYGVSC-NSRGSIEELNLTNTGIEGTFQD-FPFISLS-NLAYVDLSMN 112
Query: 107 EFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSL 166
+G+IP Q GN +L L+ N G I P + LK L+ L L N L+ IP ++
Sbjct: 113 LLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGN 172
Query: 167 CYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLL-PEFPNSCAILHLLIHEN 225
S+ + N L G +P+ + +L L LYL N LTG++ PE N ++ L + +N
Sbjct: 173 MESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQN 232
Query: 226 DFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLW 285
GS+P++L N +NL+ N G I P I + + L L N L G IP +L
Sbjct: 233 KLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEI-GNMESMTNLALSQNKLTGSIPSSLG 291
Query: 286 GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN 345
L+NL L L N L G I ++ + + + LS N L G IP S+GNL +L L L+
Sbjct: 292 NLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYE 351
Query: 346 NRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIG 405
N L G +PPELGN S++DL+L +N + G+IP NL L LYL+ N + G IP ++G
Sbjct: 352 NYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELG 411
Query: 406 RMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLT 465
M ++ L L N+LTG +P L+ L L NHL+G + + +L+ L L
Sbjct: 412 NMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANS-SHLTTLILD 470
Query: 466 GNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATL 525
N+F G P +C G L + L N G P + C SL R N G +
Sbjct: 471 TNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAF 530
Query: 526 ERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLS 585
P ++F+D N G I + L L S N ++G+IP+E+ N+ L L LS
Sbjct: 531 GIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLS 590
Query: 586 ANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAF 645
N L G +P +G T + +L L+ N L+G +P+ + L ++SL L NN S IP F
Sbjct: 591 TNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTF 650
Query: 646 SSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDL 705
S L ++ L N FDGSIP LSKL + L++S+N+L G+IP L +L L LDL
Sbjct: 651 DSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQ-LDLSHNQLDGEIPSQLSSLQSLDKLDL 708
Query: 706 SSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC----- 760
S N+ SG IPT M++L V+IS N G LP + T + + N LC
Sbjct: 709 SHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDT-PTFRKATADALEENIGLCSNIPK 767
Query: 761 -RQGNCGKNGRGHTRGRLAGIIIGVLLSVAL---LCA--LIYIMVVRVLRSKCFSDPSLL 814
R C + + G L I+ +L V + +CA Y + R L++ +DP
Sbjct: 768 QRLKPCRELKKPKKNGNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNGRNTDPETG 827
Query: 815 QDVQSRSEDLPRDLRYEDVIRATE----GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS 870
+++ S D +Y+D+I +T +IG G + VYR +N AVK+L+ +
Sbjct: 828 ENMSIFSVD--GKFKYQDIIESTNEFDPTHLIGTGGYSKVYR--ANLQDTIIAVKRLHDT 883
Query: 871 ----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ 920
+ F E++ L+ +RHRN++++ G C+ H F++ EYM G+L +L
Sbjct: 884 IDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLAN 943
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980
+E L W R ++ G+A LSY+H+D + I+HRDI S NILLD++ KI DFG +
Sbjct: 944 DEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTA 1003
Query: 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFG 1040
KL+ SS SA+ G+ GY+APE AY+ ++TEK DVYS+GV++ EL+ K P
Sbjct: 1004 KLLKT--DSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHP------ 1055
Query: 1041 EDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMR 1100
D+V+ E D + ++ K L+++E+AL C + + RP+M
Sbjct: 1056 --GDLVSSLSSSPGEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTML 1113
Query: 1101 EV 1102
+
Sbjct: 1114 SI 1115
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1119 | ||||||
| 224118404 | 1145 | predicted protein [Populus trichocarpa] | 0.995 | 0.972 | 0.684 | 0.0 | |
| 225455244 | 1137 | PREDICTED: leucine-rich repeat receptor- | 0.997 | 0.981 | 0.651 | 0.0 | |
| 302143967 | 1060 | unnamed protein product [Vitis vinifera] | 0.869 | 0.917 | 0.608 | 0.0 | |
| 18542898 | 1130 | Putative receptor-like protein kinase [O | 0.967 | 0.958 | 0.465 | 0.0 | |
| 297727333 | 1155 | Os10g0155733 [Oryza sativa Japonica Grou | 0.978 | 0.948 | 0.468 | 0.0 | |
| 125531177 | 1155 | hypothetical protein OsI_32785 [Oryza sa | 0.978 | 0.948 | 0.467 | 0.0 | |
| 357140190 | 1146 | PREDICTED: leucine-rich repeat receptor- | 0.961 | 0.938 | 0.459 | 0.0 | |
| 222612458 | 1131 | hypothetical protein OsJ_30765 [Oryza sa | 0.957 | 0.946 | 0.464 | 0.0 | |
| 242034683 | 1157 | hypothetical protein SORBIDRAFT_01g02595 | 0.939 | 0.908 | 0.449 | 0.0 | |
| 414869380 | 1088 | TPA: putative leucine-rich repeat recept | 0.850 | 0.875 | 0.476 | 0.0 |
| >gi|224118404|ref|XP_002317810.1| predicted protein [Populus trichocarpa] gi|222858483|gb|EEE96030.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1462 bits (3784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 772/1128 (68%), Positives = 907/1128 (80%), Gaps = 14/1128 (1%)
Query: 1 MLLLISYYVLFSLNQF-LALSVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKW 59
M LL +VL SL F + S P SAI L++F DSLP SQ LPWNQS S+S+PC+W
Sbjct: 1 MFLLCQCFVLISLTLFQASSPASLPSSAIDLLKFQDSLPLLSQKLLPWNQSSSSSSPCQW 60
Query: 60 SGVSCYNNSS-SLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGN 118
GVSCY N S +KALNLSG+GLSGVLNNSISY+C+++HL+ LDLSGN FTG IP L N
Sbjct: 61 PGVSCYPNKSFQVKALNLSGYGLSGVLNNSISYLCRHKHLVLLDLSGNHFTGVIPHLLVN 120
Query: 119 CGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN 178
CGQL T+LLNDN +GSIP ++FK K+L LD GYNSLSG IPP+VS C +LE +G +NN
Sbjct: 121 CGQLNTILLNDNGLEGSIPADVFKSKKLVQLDFGYNSLSGNIPPEVSFCTNLEYLGLYNN 180
Query: 179 FLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNC 238
+L+G +P++I SLPKL +YLNTNNLTGLLP F SCAI LLIHEN F GSLP++LSNC
Sbjct: 181 YLSGAVPSEIFSLPKLNFMYLNTNNLTGLLPNFLPSCAISDLLIHENAFSGSLPSTLSNC 240
Query: 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSAN 298
+NL F AS NNF G I+P IFKGLLQLEVLYLD N LEG+IPETLWGLENLQ+LVLS N
Sbjct: 241 QNLTVFIASQNNFEGVIAPEIFKGLLQLEVLYLDGNKLEGEIPETLWGLENLQELVLSGN 300
Query: 299 KLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGN 358
KLNGTIS +IS C QL IALS NNLVG IPR VG L L +L+LF+N+L G+LP ELGN
Sbjct: 301 KLNGTISERISQCPQLMTIALSGNNLVGHIPRLVGTLQYLTNLILFDNKLDGSLPAELGN 360
Query: 359 CGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNN 418
C SLV+ RLQ+N IGG IPPEICNL LEVL+L NN +EG IP QIGR+S L LALY+N
Sbjct: 361 CSSLVEFRLQNNLIGGNIPPEICNLENLEVLFLSNNFVEGHIPRQIGRLSNLKILALYSN 420
Query: 419 RLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANIC 478
L+G IP +IT L +LS AHN LTGEV +LGK+ P L RLDLT N YGPIP N+C
Sbjct: 421 NLSGIIPSEITNFTKLTYLSFAHNDLTGEVPFDLGKNSPDLDRLDLTSNHLYGPIPPNVC 480
Query: 479 VGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRG 538
G NL VL LG+NRFNG FP+EIGKC SLRRVILSNNLL+GS+P LERN G+S+L+VRG
Sbjct: 481 NGNNLRVLTLGDNRFNGIFPVEIGKCLSLRRVILSNNLLEGSIPTDLERNSGISYLEVRG 540
Query: 539 NLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELG 598
NL++G IP VFG WSNL+M+DFS N+ SGSIP ELG L NLQ LRLS+N L G IP +L
Sbjct: 541 NLIEGKIPAVFGSWSNLSMIDFSGNKFSGSIPPELGKLANLQALRLSSNNLTGSIPSDLS 600
Query: 599 KCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658
C K IK+DLS N L+G IPSE+ SLEK++SL LQEN LSGAIPD+FS +Q LFELQL S
Sbjct: 601 HCRKFIKIDLSKNQLSGKIPSEITSLEKLESLLLQENKLSGAIPDSFSPLQGLFELQLSS 660
Query: 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718
N+ +G IPCSLSK++HFSS+LN+S NKLSGKIP CLGNLDKLQILDLS NSF GE+PTE+
Sbjct: 661 NMLEGPIPCSLSKINHFSSVLNLSYNKLSGKIPGCLGNLDKLQILDLSCNSFYGEMPTEL 720
Query: 719 NNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQGN----CGKNGRGHT- 773
NNM+SLYFVNISFN SGKLP SW +M SYPGSFLGN ELC GN C GHT
Sbjct: 721 NNMISLYFVNISFNQLSGKLPTSWIRIMASYPGSFLGNPELCLPGNDARDCKNVREGHTR 780
Query: 774 ---RGRLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRY 830
R LAG+II V++S+ALLC+++YI+VVRVL+ K D SLL++ +S +EDLP DL++
Sbjct: 781 RLDRHALAGVIICVVISMALLCSVVYIIVVRVLQHKYHRDQSLLRECRSHTEDLPEDLQF 840
Query: 831 EDVIRATEGR----IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH 886
ED++RATEGR +IG+GKHGTVYRT S NSRKHWAVKK++ S NF +E+RTLS+VRH
Sbjct: 841 EDIMRATEGRSEEYVIGRGKHGTVYRTESANSRKHWAVKKVSLSGDNFSLEMRTLSVVRH 900
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
RNI+R+ G C KD +GFIVTE+MPGGTLF+VLH++EPR+ LDW+TRY IALG+AQGLSYL
Sbjct: 901 RNIVRMGGYCIKDGYGFIVTEFMPGGTLFDVLHRHEPRMALDWDTRYRIALGVAQGLSYL 960
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H+DCVPQIIHRD+KSDNIL+DSELEPK+GDFGMSK++ DS SSSTRS IVG+LGY+APEN
Sbjct: 961 HHDCVPQIIHRDVKSDNILMDSELEPKVGDFGMSKMLLDSDSSSTRSRIVGTLGYMAPEN 1020
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066
AYS RLTEK DVYSYGVIL E++ RK PVDPSF E DIV+WTR KLQEN EC+CFLDRE
Sbjct: 1021 AYSIRLTEKVDVYSYGVILLEIVCRKFPVDPSFEEGLDIVSWTRKKLQENDECVCFLDRE 1080
Query: 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
ISFWD D+Q KAL+LLELALECT VAD RPSMR+VVG LIKL+DK+E
Sbjct: 1081 ISFWDRDEQQKALKLLELALECTESVADKRPSMRDVVGSLIKLHDKHE 1128
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455244|ref|XP_002271388.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PEPR1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1385 bits (3586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 739/1134 (65%), Positives = 884/1134 (77%), Gaps = 18/1134 (1%)
Query: 1 MLLLISYYVLFSLNQFLALSVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWS 60
M LL+ VL SL LA S S P+A L+QF SLPK SQ LPWN+S S S C+W
Sbjct: 1 MFLLLPCCVLLSLPFLLASSASISPAASYLLQFRSSLPKSSQHLLPWNKSDSPSH-CQWP 59
Query: 61 GVSCY-NNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNC 119
GVSCY N+ +K+LNLSG+GLSG+L NSIS++C ++HLLSLDLS N FTG IP+ LGNC
Sbjct: 60 GVSCYSNDDPEVKSLNLSGYGLSGILANSISHVCSHKHLLSLDLSINNFTGGIPQLLGNC 119
Query: 120 GQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNF 179
+L T+LLNDN QGSIP +IF K+L L+LG N L G IP +V LC +LE +G +NNF
Sbjct: 120 SRLSTILLNDNGLQGSIPAQIFS-KQLLELNLGTNLLWGTIPSEVRLCRNLEYLGLYNNF 178
Query: 180 LNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCR 239
L+GE+P ++ SLPKLK LYLNTNNLTG LP FP SCAI L IHEN GSLP SL NCR
Sbjct: 179 LSGEIPRELFSLPKLKFLYLNTNNLTGTLPNFPPSCAISDLWIHENALSGSLPHSLGNCR 238
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK 299
NL F AS NNFGG I P IFKGL+QLE LYLD N LEGQIPETLWGL L++LVLS N
Sbjct: 239 NLTMFFASYNNFGGIIPPEIFKGLVQLEFLYLDSNKLEGQIPETLWGLGELKELVLSGNM 298
Query: 300 LNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC 359
LNG I +I+ C+QL V++LS NNLVGQIP S+G+L L + L +N LQG+LPPE+GNC
Sbjct: 299 LNGRIPERIAQCHQLAVLSLSTNNLVGQIPPSIGSLKDLYFVSLSDNMLQGSLPPEVGNC 358
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNR 419
SLV+LRLQ+N I G IP E+C L LEV +LFNN I+G IP QIGRMS LVELALYNN
Sbjct: 359 SSLVELRLQNNLIEGRIPSEVCKLENLEVFHLFNNHIKGRIPQQIGRMSNLVELALYNNS 418
Query: 420 LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKH-FPYLSRLDLTGNSFYGPIPANIC 478
LTGRIP IT L+ L FLSLA N+LTGEV E+G++ P L +LDLTGN YG IP+ IC
Sbjct: 419 LTGRIPSGITHLKKLTFLSLADNNLTGEVPSEIGRNNSPGLVKLDLTGNRLYGLIPSYIC 478
Query: 479 VGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRG 538
G +L VL LGNN FNG+FP+E+GKCSSLRRVILS NLLQGS+PA L++NPG+SFLD RG
Sbjct: 479 SGNSLSVLALGNNSFNGTFPVELGKCSSLRRVILSYNLLQGSIPAELDKNPGISFLDARG 538
Query: 539 NLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELG 598
NLL+GSIPPV G WSNL+MLD SENRLSGSIP ELG L NLQ+L LS+N+L+G IP ELG
Sbjct: 539 NLLEGSIPPVVGSWSNLSMLDLSENRLSGSIPPELGMLGNLQMLLLSSNRLNGSIPPELG 598
Query: 599 KCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658
C++MIK+DLS N L G+IPSE+ S +Q+L LQ+NNLSG IPD+FSS++SLF+LQLG+
Sbjct: 599 YCSQMIKMDLSKNSLRGNIPSEITSFVALQNLLLQDNNLSGVIPDSFSSLESLFDLQLGN 658
Query: 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718
N+ +GSIPCSL KLH +S+LN+S+N LSG+IP CL LDKLQILDLSSN+FSG IP E+
Sbjct: 659 NMLEGSIPCSLGKLHQLNSVLNLSHNMLSGEIPRCLSGLDKLQILDLSSNNFSGTIPPEL 718
Query: 719 NNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQGN------CGKNGRGH 772
N+MVSL FVNISFNH SGK+P +W M S PGS+LGN ELC QGN CG+ H
Sbjct: 719 NSMVSLSFVNISFNHLSGKIPDAWMKSMASSPGSYLGNPELCLQGNADRDSYCGEAKNSH 778
Query: 773 TRG-RLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFSDP-SLLQDVQSRSEDLPRDLRY 830
T+G L GII+ V +ALLCA IYI + LR + S S L + +S++EDLP DL+
Sbjct: 779 TKGLVLVGIILTVAFFIALLCAAIYITLDHRLRQQLSSQTRSPLHECRSKTEDLPEDLKL 838
Query: 831 EDVIRATEG----RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH 886
ED+I+ATEG +IG+GKHGTVYRT + NSR++WAVKK++ SETNF +E+RTLSLVRH
Sbjct: 839 EDIIKATEGWNDRYVIGRGKHGTVYRTETENSRRNWAVKKVDLSETNFSIEMRTLSLVRH 898
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
RN++R+ G C KD +GFIVTEYM GGTLF+VLH +P LVL+W++RY IALGIAQGLSYL
Sbjct: 899 RNVVRMAGYCIKDGYGFIVTEYMEGGTLFDVLHWRKP-LVLNWDSRYRIALGIAQGLSYL 957
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS-DSHSSSTRSAIVGSLGYIAPE 1005
H+DCVPQIIHRD+KSDNIL+DSELEPKIGDFG++KL+S DS +SST SAIVG+LGYIAPE
Sbjct: 958 HHDCVPQIIHRDVKSDNILMDSELEPKIGDFGLAKLVSDDSDASSTMSAIVGTLGYIAPE 1017
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065
N +STRLTEK DVYSYGVIL ELL RK+PVDPSF E DI +WTR LQEN+EC FLD
Sbjct: 1018 NGHSTRLTEKCDVYSYGVILLELLCRKLPVDPSFEEGLDIASWTRKNLQENNECCSFLDV 1077
Query: 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGMRT 1119
EI W+ D+Q KAL+LLELAL+CT +RPSMR+VVG+LIKLNDK EG + T
Sbjct: 1078 EIGSWNVDEQWKALKLLELALDCTELEPGIRPSMRDVVGYLIKLNDKQEGTVHT 1131
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143967|emb|CBI23072.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1160 bits (3001), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/1038 (60%), Positives = 760/1038 (73%), Gaps = 65/1038 (6%)
Query: 95 NQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYN 154
++HLLSLDLS N FTG IP+ LGNC +L T+LLNDN QGSIP +IF K+L L+LG N
Sbjct: 69 HKHLLSLDLSINNFTGGIPQLLGNCSRLSTILLNDNGLQGSIPAQIFS-KQLLELNLGTN 127
Query: 155 SLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNS 214
L G IP +V LC +LE +G +NNFL+GE+P ++ SLPKLK LYLNTNNLTG LP FP S
Sbjct: 128 LLWGTIPSEVRLCRNLEYLGLYNNFLSGEIPRELFSLPKLKFLYLNTNNLTGTLPNFPPS 187
Query: 215 CAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
CAI L IHEN GSLP SL NCRNL F AS NNFGG I P IFKGL+QLE LYLD N
Sbjct: 188 CAISDLWIHENALSGSLPHSLGNCRNLTMFFASYNNFGGIIPPEIFKGLVQLEFLYLDSN 247
Query: 275 NLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN 334
LEGQIPETLWGL L++LVLS N LNG I +I+ C+QL V++LS NNLVGQIP S+G+
Sbjct: 248 KLEGQIPETLWGLGELKELVLSGNMLNGRIPERIAQCHQLAVLSLSTNNLVGQIPPSIGS 307
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394
L L + L +N LQG+LPPE+GNC SLV+LRLQ+N I G IP E+C L LEV +LFNN
Sbjct: 308 LKDLYFVSLSDNMLQGSLPPEVGNCSSLVELRLQNNLIEGRIPSEVCKLENLEVFHLFNN 367
Query: 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK 454
I+G IP QIGRMS LVELALYNN LTGRIP IT L+ L FLSLA N+LTGEV E+G+
Sbjct: 368 HIKGRIPQQIGRMSNLVELALYNNSLTGRIPSGITHLKKLTFLSLADNNLTGEVPSEIGR 427
Query: 455 H-FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILS 513
+ P L +LDLTGN YG IP+ IC G +L VL LGNN FNG+FP+E+GKCSSLRRVILS
Sbjct: 428 NNSPGLVKLDLTGNRLYGLIPSYICSGNSLSVLALGNNSFNGTFPVELGKCSSLRRVILS 487
Query: 514 NNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL 573
NLLQGS+PA L++NPG+SFLD RGNLL+GSIPPV G WSNL+MLD SENRLSGSIP EL
Sbjct: 488 YNLLQGSIPAELDKNPGISFLDARGNLLEGSIPPVVGSWSNLSMLDLSENRLSGSIPPEL 547
Query: 574 GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQ 633
G L NLQ+L LS+N+L+G IP ELG C++MIK+DLS N L G+IPSE+ S +Q+L LQ
Sbjct: 548 GMLGNLQMLLLSSNRLNGSIPPELGYCSQMIKMDLSKNSLRGNIPSEITSFVALQNLLLQ 607
Query: 634 ENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693
+NNLSG IPD+FSS++SLF+LQLG+N+ +GSIPCSL KLH +S+LN+S+N LSG+IP C
Sbjct: 608 DNNLSGVIPDSFSSLESLFDLQLGNNMLEGSIPCSLGKLHQLNSVLNLSHNMLSGEIPRC 667
Query: 694 LGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSF 753
L LDKLQILDLSSN+FSG IP E+N+MVSL FVNISFNH SGK+P +W M S PGS+
Sbjct: 668 LSGLDKLQILDLSSNNFSGTIPPELNSMVSLSFVNISFNHLSGKIPDAWMKSMASSPGSY 727
Query: 754 LGNSELCRQGN------CGKNGRGHTRG-RLAGIIIGVLLSVALLCALIYIMVVRVLRSK 806
LGN ELC QGN CG+ HT+G L GII+ V +ALLCA IYI + LR +
Sbjct: 728 LGNPELCLQGNADRDSYCGEAKNSHTKGLVLVGIILTVAFFIALLCAAIYITLDHRLRQQ 787
Query: 807 CFSDP-SLLQDVQSRSEDLPRDLRYEDVIRATEG----RIIGKGKHGTVYRTLSNNSRKH 861
S S L + +S++EDLP DL+ ED+I+ATEG +IG+GKHGTVYRT + NSR++
Sbjct: 788 LSSQTRSPLHECRSKTEDLPEDLKLEDIIKATEGWNDRYVIGRGKHGTVYRTETENSRRN 847
Query: 862 WAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN 921
WAVKK++ SETNF +E+RTLSLVRHRN++R+ G C KD +GFIVTEYM GGTLF+VLH
Sbjct: 848 WAVKKVDLSETNFSIEMRTLSLVRHRNVVRMAGYCIKDGYGFIVTEYMEGGTLFDVLHWR 907
Query: 922 EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981
+P LH + +I+ K+D+ K
Sbjct: 908 KP----------------------LHTNFPTPLIY---KTDH----------------QK 926
Query: 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
L S + SS R PEN +STRLTEK DVYSYGVIL ELL RK+PVDPSF E
Sbjct: 927 LTSLNSLSSPR----------VPENGHSTRLTEKCDVYSYGVILLELLCRKLPVDPSFEE 976
Query: 1042 DTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMRE 1101
DI +WTR LQEN+EC FLD EI W+ D+Q KAL+LLELAL+CT +RPSMR+
Sbjct: 977 GLDIASWTRKNLQENNECCSFLDVEIGSWNVDEQWKALKLLELALDCTELEPGIRPSMRD 1036
Query: 1102 VVGFLIKLNDKNEGGMRT 1119
VVG+LIKLNDK EG + T
Sbjct: 1037 VVGYLIKLNDKQEGTVHT 1054
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18542898|gb|AAL75740.1|AC091724_13 Putative receptor-like protein kinase [Oryza sativa Japonica Group] gi|110288629|gb|ABB46782.2| Leucine Rich Repeat family protein, expressed [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 947 bits (2448), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/1117 (46%), Positives = 710/1117 (63%), Gaps = 34/1117 (3%)
Query: 21 VSSPP------SAISLVQFLDSLPKQSQSHL--PWNQSVSTSAP-CKWSGVSCYNNSSSL 71
V+ PP SA L FL SLP S+ L W + AP C + GV+C + + ++
Sbjct: 20 VARPPPPERADSAAVLRSFLASLPPPSRRVLRPSWRRGGGGGAPHCAFLGVTC-DAAGAV 78
Query: 72 KALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNR 131
ALNLSG GL+G L S +C L +LDLS N FTGS+P L C + TL+L+ N
Sbjct: 79 AALNLSGAGLAGELAASAPRLCALPALAALDLSRNGFTGSVPAALAACSCIATLVLSFNS 138
Query: 132 FQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYS--LESIGFHNNFLNGELPNDIC 189
G++PPEI +RL +DL N+L+G+IP S LE + N L+G +P ++
Sbjct: 139 LSGAVPPEILSSRRLRKVDLNSNALTGEIPTTGLAAGSSVLEYLDLCVNSLSGAIPPELA 198
Query: 190 S-LPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
+ LP+L L L++NNL+G +PEFP C +++L ++ N G LP SL+NC NL S
Sbjct: 199 AALPELTYLDLSSNNLSGPMPEFPPRCGLVYLSLYSNQLAGELPRSLTNCGNLTVLYLSY 258
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N GG + P F + L+ LYLDDN G++P ++ L NL++LV+S N GTI I
Sbjct: 259 NKIGGEV-PDFFASMANLQTLYLDDNAFVGELPASIGELVNLEELVVSENAFTGTIPEAI 317
Query: 309 SHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ 368
C L ++ L+ N G IP+ +G+L+ L + +N + G +PPE+G C LV++ LQ
Sbjct: 318 GRCRSLTMLYLNGNRFTGSIPKFIGDLTRLQLFSIADNGITGEIPPEIGKCRGLVEIALQ 377
Query: 369 HNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI 428
+N + G IPP+I L +L+ L LF+N + G +P + R+S + L L NN +G I DI
Sbjct: 378 NNSLSGMIPPDIAELNQLQKLSLFDNILRGPVPLALWRLSNMAVLQLNNNSFSGEIHSDI 437
Query: 429 TRLRNLQFLSLAHNHLTGEVALELG-KHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLV 487
T++RNL ++L +N+ TGE+ ELG P L +DLT N F G IP +C G L VL
Sbjct: 438 TQMRNLTNITLYNNNFTGELPQELGLNTTPGLLHIDLTRNHFRGAIPPGLCTGGQLAVLD 497
Query: 488 LGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
LG N+F+G FP EI KC SL RV L+NN + GSLPA N G+S++D+ NLL+G IP
Sbjct: 498 LGYNQFDGGFPSEIAKCQSLYRVNLNNNQINGSLPADFGTNWGLSYIDMSSNLLEGIIPS 557
Query: 548 VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLD 607
G WSNLT LD S N SG IP ELGNL NL LR+S+N+L G IP+ELG C K+ LD
Sbjct: 558 ALGSWSNLTKLDLSSNSFSGPIPRELGNLSNLGTLRMSSNRLTGPIPHELGNCKKLALLD 617
Query: 608 LSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPC 667
L +N+L+GSIP+E+ +L +Q+L L NNL+G IPD+F++ Q+L ELQLG N +G+IP
Sbjct: 618 LGNNFLSGSIPAEITTLGSLQNLLLAGNNLTGTIPDSFTATQALLELQLGDNSLEGAIPH 677
Query: 668 SLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFV 727
SL L + S LN+SNN+LSG+IP LGNL L++LDLS+NS SG IP+++ NM+SL V
Sbjct: 678 SLGSLQYISKALNISNNQLSGQIPSSLGNLQDLEVLDLSNNSLSGIIPSQLINMISLSVV 737
Query: 728 NISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQGN---CGKNGRGHTRGRLAGIIIGV 784
N+SFN SG+LPA W L P SFLGN +LC + C K+ R I++G+
Sbjct: 738 NLSFNKLSGELPAGWAKLAAQSPESFLGNPQLCVHSSDAPCLKSQSAKNRTWKTRIVVGL 797
Query: 785 LLS-----VALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRAT-- 837
++S VA L A+ YI+ RS+ S + +E+LP +L YED++R T
Sbjct: 798 VISSFSVMVASLFAIRYILK----RSQRLSTNRVSVRNMDSTEELPEELTYEDILRGTDN 853
Query: 838 --EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGS 895
E +IG+G+HGTVYRT K WAVK ++ S+ +E++ L+ V+HRNI+R+ G
Sbjct: 854 WSEKYVIGRGRHGTVYRT-ECKLGKQWAVKTVDLSQCKLPIEMKILNTVKHRNIVRMAGY 912
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
C + G I+ EYMP GTLF +LH+ +P LDW R+ IA G+AQGLSYLH+DCVP I+
Sbjct: 913 CIRGSVGLILYEYMPEGTLFELLHRRKPHAALDWTVRHQIAFGVAQGLSYLHHDCVPMIV 972
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRD+KS NIL+D+EL PK+ DFGM K++ D +T S +VG+LGYIAPE+ Y TRLTEK
Sbjct: 973 HRDVKSSNILMDTELVPKLTDFGMGKIVEDDDLDATVSVVVGTLGYIAPEHGYYTRLTEK 1032
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF--LDREISFWDSD 1073
SDVYSYGV+L ELL RKMPVDP+FG+ DIVTW R L + + LD EI +W D
Sbjct: 1033 SDVYSYGVVLLELLCRKMPVDPAFGDSVDIVTWMRSNLTQADRRVIMECLDEEIMYWPED 1092
Query: 1074 DQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110
+Q KAL LL+LA+ CT+ RPSMREVV L++++
Sbjct: 1093 EQAKALDLLDLAMYCTQLACQSRPSMREVVNNLMRMD 1129
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297727333|ref|NP_001176030.1| Os10g0155733 [Oryza sativa Japonica Group] gi|18542897|gb|AAL75739.1|AC091724_12 Putative receptor-like protein kinase [Oryza sativa Japonica Group] gi|31430260|gb|AAP52200.1| Leucine Rich Repeat family protein, expressed [Oryza sativa Japonica Group] gi|255679221|dbj|BAH94758.1| Os10g0155733 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2440), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/1131 (46%), Positives = 717/1131 (63%), Gaps = 36/1131 (3%)
Query: 17 LALSVSSPP---------SAISLVQFLDSLPKQSQSHL-PWNQSV--------STSAP-- 56
LA S PP +A L+ FLDSLP SQ L P + +T+ P
Sbjct: 20 LATSAQPPPPSNTSASTSAAAVLLSFLDSLPPASQRLLLPSWRQSRSSSSSGNATAPPPH 79
Query: 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICK--NQHLLSLDLSGNEFTGSIPK 114
C + GV+C +++ ++ ALNLSG GL+G L+ S +C L LDLSGN FTG++P
Sbjct: 80 CAFLGVTC-SDTGAVAALNLSGVGLTGALSASAPRLCALPASALPVLDLSGNGFTGAVPA 138
Query: 115 QLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIG 174
L C + TLLL N G +PPE+ ++L +DL N+L+G+IP LE +
Sbjct: 139 ALAACAGVATLLLGGNNLSGGVPPELLSSRQLVEVDLNGNALTGEIPAPAGSPVVLEYLD 198
Query: 175 FHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTS 234
N L+G +P ++ +LP L+ L L+ N LTG +PEFP C + L ++ N G LP S
Sbjct: 199 LSGNSLSGAVPPELAALPDLRYLDLSINRLTGPMPEFPVHCRLKFLGLYRNQIAGELPKS 258
Query: 235 LSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLV 294
L NC NL S NN G + P F + L+ LYLDDN+ G++P ++ L +L+KLV
Sbjct: 259 LGNCGNLTVLFLSYNNLTGEV-PDFFASMPNLQKLYLDDNHFAGELPASIGELVSLEKLV 317
Query: 295 LSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPP 354
++AN+ GTI I +C L ++ L+ NN G IP +GNLS L + N + G++PP
Sbjct: 318 VTANRFTGTIPETIGNCRCLIMLYLNSNNFTGSIPAFIGNLSRLEMFSMAENGITGSIPP 377
Query: 355 ELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414
E+G C LVDL+L N + GTIPPEI L++L+ LYL+NN + G +P + R+ +VEL
Sbjct: 378 EIGKCRQLVDLQLHKNSLTGTIPPEIGELSRLQKLYLYNNLLHGPVPQALWRLVDMVELF 437
Query: 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPY-LSRLDLTGNSFYGPI 473
L +NRL+G + DIT++ NL+ ++L +N+ TGE+ LG + L R+D T N F G I
Sbjct: 438 LNDNRLSGEVHEDITQMSNLREITLYNNNFTGELPQALGMNTTSGLLRVDFTRNRFRGAI 497
Query: 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSF 533
P +C L VL LGNN+F+G F I KC SL RV L+NN L GSLPA L N GV+
Sbjct: 498 PPGLCTRGQLAVLDLGNNQFDGGFSSGIAKCESLYRVNLNNNKLSGSLPADLSTNRGVTH 557
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
LD+ GNLL+G IP G W NLT LD S N+ SG IP ELG L L L +S+N+L G I
Sbjct: 558 LDISGNLLKGRIPGALGLWHNLTRLDVSGNKFSGPIPHELGALSILDTLLMSSNRLTGAI 617
Query: 594 PYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFE 653
P+ELG C ++ LDL +N L GSIP+E+ +L +Q+L L N L+G IPD+F++ QSL E
Sbjct: 618 PHELGNCKRLAHLDLGNNLLNGSIPAEITTLSGLQNLLLGGNKLAGPIPDSFTATQSLLE 677
Query: 654 LQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713
LQLGSN +G IP S+ L + S LN+SNN+LSG IP LGNL KL++LDLS+NS SG
Sbjct: 678 LQLGSNNLEGGIPQSVGNLQYISQGLNISNNRLSGPIPHSLGNLQKLEVLDLSNNSLSGP 737
Query: 714 IPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC-RQGN--CGKNGR 770
IP++++NM+SL VNISFN SG+LP W + P FLGN +LC GN C K
Sbjct: 738 IPSQLSNMISLSVVNISFNELSGQLPDGWDKIATRLPQGFLGNPQLCVPSGNAPCTKYQS 797
Query: 771 GHTRGRLAGIIIGVLLS-VALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLR 829
+ R II+ +L+S +AL+ A + I+ V RS+ S + +E+LP DL
Sbjct: 798 AKNKRRNTQIIVALLVSTLALMIASLVIIHFIVKRSQRLSANRVSMRNLDSTEELPEDLT 857
Query: 830 YEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR 885
YED++RAT E +IG+G+HGTVYRT K WAVK ++ S+ F +E++ L+ V+
Sbjct: 858 YEDILRATDNWSEKYVIGRGRHGTVYRT-ELAVGKQWAVKTVDLSQCKFPIEMKILNTVK 916
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
HRNI+R+ G C + G I+ EYMP GTLF +LH+ P++ LDWN R+ IALG+A+ LSY
Sbjct: 917 HRNIVRMAGYCIRSNIGLILYEYMPEGTLFELLHERTPQVSLDWNVRHQIALGVAESLSY 976
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH+DCVP IIHRD+KS NIL+D+EL PK+ DFGM K+I D + +T S +VG+LGYIAPE
Sbjct: 977 LHHDCVPMIIHRDVKSSNILMDAELVPKLTDFGMGKIIDDDDADATVSVVVGTLGYIAPE 1036
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-QENHECIC-FL 1063
+ YSTRL+EKSDVYSYGV+L ELL RKMPVDP+FG+ DIVTW L Q +H I FL
Sbjct: 1037 HGYSTRLSEKSDVYSYGVVLLELLCRKMPVDPAFGDGVDIVTWMGSNLNQADHSNIMRFL 1096
Query: 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
D EI +W ++ K L LL+LA+ CT+ +RPSMREVV L+++ N
Sbjct: 1097 DEEIIYWPEHEKAKVLDLLDLAMTCTQVSCQLRPSMREVVSILMRIERSNH 1147
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125531177|gb|EAY77742.1| hypothetical protein OsI_32785 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2431), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/1131 (46%), Positives = 716/1131 (63%), Gaps = 36/1131 (3%)
Query: 17 LALSVSSPP---------SAISLVQFLDSLPKQSQSHL-PWNQSV--------STSAP-- 56
LA S PP +A L+ FLDSLP SQ L P + +T+ P
Sbjct: 20 LATSAQPPPPSNTSASTSAAAVLLSFLDSLPPASQRLLLPSWRQSRSSSSSGNATAPPPH 79
Query: 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICK--NQHLLSLDLSGNEFTGSIPK 114
C + GV+C +++ ++ ALNLSG GL+G L+ S +C L LDLSGN FTG++P
Sbjct: 80 CAFLGVTC-SDTGAVAALNLSGVGLTGALSASAPRLCALPASALPVLDLSGNGFTGAVPA 138
Query: 115 QLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIG 174
L C + TLLL N G +PPE+ ++L +DL N+L+G+IP LE +
Sbjct: 139 ALAACAGVATLLLGGNNLSGGVPPELLSSRQLVEVDLNGNALTGEIPAPAGSPVVLEYLD 198
Query: 175 FHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTS 234
N L+G +P ++ +LP L+ L L+ N LTG +PEFP C + L ++ N G LP S
Sbjct: 199 LSGNSLSGAVPPELAALPDLRYLDLSINRLTGPMPEFPVHCRLKFLGLYRNQIAGELPKS 258
Query: 235 LSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLV 294
L NC NL S NN G + P F + L+ LYLDDN+ G++P ++ L +L+KLV
Sbjct: 259 LGNCGNLTVLFLSYNNLTGEV-PDFFASMPNLQKLYLDDNHFAGELPASIGELVSLEKLV 317
Query: 295 LSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPP 354
++AN+ GTI I +C L ++ L+ NN G IP +GNLS L + N + G++PP
Sbjct: 318 VTANRFTGTIPETIGNCRCLIMLYLNSNNFTGSIPAFIGNLSRLEMFSMAENGITGSIPP 377
Query: 355 ELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414
E+G C LVDL+L N + GTIPPEI L++L+ LYL+NN + G +P + R+ +VEL
Sbjct: 378 EIGKCRQLVDLQLHKNSLTGTIPPEIGELSRLQKLYLYNNLLHGPVPQALWRLVDMVELF 437
Query: 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPY-LSRLDLTGNSFYGPI 473
L +NRL+G + DIT++ NL+ ++L +N+ TGE+ LG + L R+D T N F G I
Sbjct: 438 LNDNRLSGEVHEDITQMSNLREITLYNNNFTGELPQALGMNTTSGLLRVDFTRNRFRGAI 497
Query: 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSF 533
P +C L VL LGNN+F+G F I KC SL RV L+NN L GSLPA L N GV+
Sbjct: 498 PPGLCTRGQLAVLDLGNNQFDGGFSSGIAKCESLYRVNLNNNKLSGSLPADLSTNRGVTH 557
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
LD+ GNLL+ IP G W NLT LD S N+ SG IP ELG L L L +S+N+L G I
Sbjct: 558 LDISGNLLKRRIPGALGLWHNLTRLDVSGNKFSGPIPHELGALSILDTLLMSSNRLTGAI 617
Query: 594 PYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFE 653
P+ELG C ++ LDL +N L GSIP+E+ +L +Q+L L N L+G IPD+F++ QSL E
Sbjct: 618 PHELGNCKRLAHLDLGNNLLNGSIPAEITTLSGLQNLLLGGNKLAGPIPDSFTATQSLLE 677
Query: 654 LQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713
LQLGSN +G IP S+ L + S LN+SNN+LSG IP LGNL KL++LDLS+NS SG
Sbjct: 678 LQLGSNNLEGGIPQSVGNLQYISQGLNISNNRLSGPIPHSLGNLQKLEVLDLSNNSLSGP 737
Query: 714 IPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC-RQGN--CGKNGR 770
IP++++NM+SL VNISFN SG+LP W + P FLGN +LC GN C K
Sbjct: 738 IPSQLSNMISLSVVNISFNELSGQLPDGWDKIATRLPQGFLGNPQLCVPSGNAPCTKYQS 797
Query: 771 GHTRGRLAGIIIGVLLS-VALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLR 829
+ R II+ +L+S +AL+ A + I+ V RS+ S + +E+LP DL
Sbjct: 798 AKNKRRNTQIIVALLVSTLALMIASLVIIHFIVKRSQRLSANRVSMRNLDSTEELPEDLT 857
Query: 830 YEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR 885
YED++RAT E +IG+G+HGTVYRT K WAVK ++ S+ F +E++ L+ V+
Sbjct: 858 YEDILRATDNWSEKYVIGRGRHGTVYRT-ELAVGKQWAVKTVDLSQCKFPIEMKILNTVK 916
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
HRNI+R+ G C + G I+ EYMP GTLF +LH+ P++ LDWN R+ IALG+A+ LSY
Sbjct: 917 HRNIVRMAGYCIRSNIGLILYEYMPEGTLFELLHERTPQVSLDWNVRHQIALGVAESLSY 976
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH+DCVP IIHRD+KS NIL+D+EL PK+ DFGM K+I D + +T S +VG+LGYIAPE
Sbjct: 977 LHHDCVPMIIHRDVKSSNILMDAELVPKLTDFGMGKIIDDDDADATVSVVVGTLGYIAPE 1036
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-QENHECIC-FL 1063
+ YSTRL+EKSDVYSYGV+L ELL RKMPVDP+FG+ DIVTW L Q +H I FL
Sbjct: 1037 HGYSTRLSEKSDVYSYGVVLLELLCRKMPVDPAFGDGVDIVTWMGSNLNQADHSNIMRFL 1096
Query: 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
D EI +W ++ K L LL+LA+ CT+ +RPSMREVV L+++ N
Sbjct: 1097 DEEIIYWPEHEKAKVLDLLDLAMTCTQVSCQLRPSMREVVSILMRIERSNH 1147
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357140190|ref|XP_003571653.1| PREDICTED: leucine-rich repeat receptor-like protein kinase PEPR2-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 921 bits (2380), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/1111 (45%), Positives = 695/1111 (62%), Gaps = 35/1111 (3%)
Query: 30 LVQFLDSLPKQSQSHL--PWNQSV--STSAP---------CKWSGVSC-YNNSSSLKALN 75
L+ FL +LP +Q L W ++ TS+P C + GV+C + + A+N
Sbjct: 40 LLSFLAALPPAAQRFLLPTWLRTGVNHTSSPASKRHHHHHCAFLGVTCSAATTGEVSAVN 99
Query: 76 LSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGS 135
LSG GLSG L +S +C L +LDLS N TG +P L C L L+L N G+
Sbjct: 100 LSGSGLSGALASSAPRLCALPALAALDLSRNSLTGPVPAALAACSALTELVLAFNLLSGT 159
Query: 136 IPPEIFKLKRL-SWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKL 194
+P E+ + L LDL N+L+G IPP S+ LE + N +GE+P + +LP+L
Sbjct: 160 VPAELLSSRSLLRKLDLNTNALTGDIPPSPSMI--LEYLDLSANSFSGEIPPEFSALPRL 217
Query: 195 KSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGA 254
L L+ NNL+G +PEF C +L+L + N G LP SL+NC NL N G
Sbjct: 218 TYLDLSNNNLSGPIPEFSAPCRLLYLSLFSNKLAGELPQSLANCVNLTVLYLPDNEISGE 277
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQL 314
+ P F + L+ LYL DN G++P ++ L +L++LV+S N G++ G I C L
Sbjct: 278 V-PDFFAAMPNLQKLYLGDNAFTGELPASIGELVSLEELVVSNNWFTGSVPGAIGRCQSL 336
Query: 315 QVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGG 374
++ L+ N G IP +GNLS L +N G +PPE+ NC LVDL LQ+N + G
Sbjct: 337 TMLYLNGNRFTGSIPLFIGNLSQLQMFSAADNGFTGRIPPEVRNCRGLVDLELQNNSLSG 396
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNL 434
TIPPEI L++L+ LYLFNN + G +P + R++ +VEL L NN L+G I +IT +RNL
Sbjct: 397 TIPPEIAELSQLQKLYLFNNLLHGPVPPALWRLADMVELYLNNNSLSGEIHSEITHMRNL 456
Query: 435 QFLSLAHNHLTGEVALELG-KHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRF 493
+ ++L N TGE+ +LG P + R+DLTGN F+G IP +C G L +L LG+N F
Sbjct: 457 REITLYSNSFTGELPQDLGFNTTPGIVRVDLTGNRFHGAIPPGLCTGGQLAILDLGDNLF 516
Query: 494 NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWS 553
+G FP EI KC SL R+ L+NN + GSLPA L N G+S++D+ GN L+G IP V G WS
Sbjct: 517 DGGFPSEIAKCQSLYRLKLNNNQISGSLPADLGTNRGLSYVDMSGNRLEGRIPAVIGSWS 576
Query: 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613
NLTMLD S N L G IP ELG L NL LR+S+N L G IP++LG C ++ LDL +N L
Sbjct: 577 NLTMLDLSGNNLLGPIPGELGALSNLVTLRMSSNMLTGLIPHQLGNCKILVCLDLGNNLL 636
Query: 614 AGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLH 673
GS+P+EV +L +Q+L L NN + AIPD+F++ Q+L ELQLG N F+G+IP SL L
Sbjct: 637 NGSLPAEVTTLGSLQNLLLDRNNFTSAIPDSFTATQALLELQLGDNYFEGAIPHSLGNLQ 696
Query: 674 HFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNH 733
+ S LN+SNN+LS +IP LGNL L++LDLS NS G IP +V+NM+SL VN+SFN
Sbjct: 697 YLSKTLNISNNRLSSQIPSSLGNLQDLEVLDLSENSLYGPIPPQVSNMISLLVVNLSFNE 756
Query: 734 FSGKLPASWTTLMVSYPGSFLGNSELCRQGNCG------KNGRGHTRGRLAGII--IGVL 785
SG+LPASW P F GN LC + + K + R + II + +
Sbjct: 757 LSGQLPASWVKFAARSPEGFSGNPHLCVRSDIDAPCSSKKQSVKNRTSRNSWIIVALVLP 816
Query: 786 LSVALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRAT----EGRI 841
V L+ AL I + + + + L+ + S +E+LP D+ YED++RAT E +
Sbjct: 817 TVVVLVAALFAIHYIVKMPGRLSAKRVSLRSLDS-TEELPEDMTYEDILRATDNWSEKYV 875
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEH 901
IGKG+HGTVYRT K WAVK ++ S+ F +E++ L+ V+HRNI+R+ G +
Sbjct: 876 IGKGRHGTVYRT-DCKLGKQWAVKTVDLSQCKFPIEMKILNTVKHRNIVRMAGYYIRGNV 934
Query: 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKS 961
G I+ EYMP GTLF +LH+ +P++ L W R+ IALG+AQGLSYLH DCVP I+HRD+KS
Sbjct: 935 GLILYEYMPEGTLFELLHERKPQVALGWMARHQIALGVAQGLSYLHQDCVPMIVHRDVKS 994
Query: 962 DNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSY 1021
NIL+D EL PK+ DFGM K++ D S +T S IVG+LGYIAPE+ YSTRL+EKSDVYSY
Sbjct: 995 SNILMDVELVPKLTDFGMGKIVGDEDSDATVSVIVGTLGYIAPEHGYSTRLSEKSDVYSY 1054
Query: 1022 GVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC--ICFLDREISFWDSDDQLKAL 1079
GV+L ELL RKMPVD +FG+ DIVTW R L++ C + LD EI +W D+Q KAL
Sbjct: 1055 GVVLLELLCRKMPVDSAFGDGVDIVTWMRSNLKQADHCSVMSCLDEEIVYWPEDEQAKAL 1114
Query: 1080 RLLELALECTRQVADMRPSMREVVGFLIKLN 1110
LL+LA+ CT +RPSMREVV L++++
Sbjct: 1115 HLLDLAISCTEVACQLRPSMREVVNVLVRMD 1145
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|222612458|gb|EEE50590.1| hypothetical protein OsJ_30765 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2373), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 525/1131 (46%), Positives = 704/1131 (62%), Gaps = 60/1131 (5%)
Query: 17 LALSVSSPP---------SAISLVQFLDSLPKQSQSHL-PWNQSV--------STSAP-- 56
LA S PP +A L+ FLDSLP SQ L P + +T+ P
Sbjct: 20 LATSAQPPPPSNTSASTSAAAVLLSFLDSLPPASQRLLLPSWRQSRSSSSSGNATAPPPH 79
Query: 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICK--NQHLLSLDLSGNEFTGSIPK 114
C + GV+C +++ ++ ALNLSG GL+G L+ S +C L LDLSGN FTG++P
Sbjct: 80 CAFLGVTC-SDTGAVAALNLSGVGLTGALSASAPRLCALPASALPVLDLSGNGFTGAVPA 138
Query: 115 QLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIG 174
L C L + LN N G IP L +LDL NSLSG +PP+++
Sbjct: 139 ALAACAGLVEVDLNGNALTGEIPAPAGSPVVLEYLDLSGNSLSGAVPPELA--------- 189
Query: 175 FHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTS 234
+LP L+ L L+ N LTG +PEFP C + L ++ N G LP S
Sbjct: 190 ---------------ALPDLRYLDLSINRLTGPMPEFPVHCRLKFLGLYRNQIAGELPKS 234
Query: 235 LSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLV 294
L NC NL S NN G + P F + L+ LYLDDN+ G++P ++ L +L+KLV
Sbjct: 235 LGNCGNLTVLFLSYNNLTGEV-PDFFASMPNLQKLYLDDNHFAGELPASIGELVSLEKLV 293
Query: 295 LSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPP 354
++AN+ GTI I +C L ++ L+ NN G IP +GNLS L + N + G++PP
Sbjct: 294 VTANRFTGTIPETIGNCRCLIMLYLNSNNFTGSIPAFIGNLSRLEMFSMAENGITGSIPP 353
Query: 355 ELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414
E+G C LVDL+L N + GTIPPEI L++L+ LYL+NN + G +P + R+ +VEL
Sbjct: 354 EIGKCRQLVDLQLHKNSLTGTIPPEIGELSRLQKLYLYNNLLHGPVPQALWRLVDMVELF 413
Query: 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPY-LSRLDLTGNSFYGPI 473
L +NRL+G + DIT++ NL+ ++L +N+ TGE+ LG + L R+D T N F G I
Sbjct: 414 LNDNRLSGEVHEDITQMSNLREITLYNNNFTGELPQALGMNTTSGLLRVDFTRNRFRGAI 473
Query: 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSF 533
P +C L VL LGNN+F+G F I KC SL RV L+NN L GSLPA L N GV+
Sbjct: 474 PPGLCTRGQLAVLDLGNNQFDGGFSSGIAKCESLYRVNLNNNKLSGSLPADLSTNRGVTH 533
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
LD+ GNLL+G IP G W NLT LD S N+ SG IP ELG L L L +S+N+L G I
Sbjct: 534 LDISGNLLKGRIPGALGLWHNLTRLDVSGNKFSGPIPHELGALSILDTLLMSSNRLTGAI 593
Query: 594 PYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFE 653
P+ELG C ++ LDL +N L GSIP+E+ +L +Q+L L N L+G IPD+F++ QSL E
Sbjct: 594 PHELGNCKRLAHLDLGNNLLNGSIPAEITTLSGLQNLLLGGNKLAGPIPDSFTATQSLLE 653
Query: 654 LQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713
LQLGSN +G IP S+ L + S LN+SNN+LSG IP LGNL KL++LDLS+NS SG
Sbjct: 654 LQLGSNNLEGGIPQSVGNLQYISQGLNISNNRLSGPIPHSLGNLQKLEVLDLSNNSLSGP 713
Query: 714 IPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELC-RQGN--CGKNGR 770
IP++++NM+SL VNISFN SG+LP W + P FLGN +LC GN C K
Sbjct: 714 IPSQLSNMISLSVVNISFNELSGQLPDGWDKIATRLPQGFLGNPQLCVPSGNAPCTKYQS 773
Query: 771 GHTRGRLAGIIIGVLLS-VALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLR 829
+ R II+ +L+S +AL+ A + I+ V RS+ S + +E+LP DL
Sbjct: 774 AKNKRRNTQIIVALLVSTLALMIASLVIIHFIVKRSQRLSANRVSMRNLDSTEELPEDLT 833
Query: 830 YEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR 885
YED++RAT E +IG+G+HGTVYRT K WAVK ++ S+ F +E++ L+ V+
Sbjct: 834 YEDILRATDNWSEKYVIGRGRHGTVYRT-ELAVGKQWAVKTVDLSQCKFPIEMKILNTVK 892
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
HRNI+R+ G C + G I+ EYMP GTLF +LH+ P++ LDWN R+ IALG+A+ LSY
Sbjct: 893 HRNIVRMAGYCIRSNIGLILYEYMPEGTLFELLHERTPQVSLDWNVRHQIALGVAESLSY 952
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH+DCVP IIHRD+KS NIL+D+EL PK+ DFGM K+I D + +T S +VG+LGYIAPE
Sbjct: 953 LHHDCVPMIIHRDVKSSNILMDAELVPKLTDFGMGKIIDDDDADATVSVVVGTLGYIAPE 1012
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-QENHECIC-FL 1063
+ YSTRL+EKSDVYSYGV+L ELL RKMPVDP+FG+ DIVTW L Q +H I FL
Sbjct: 1013 HGYSTRLSEKSDVYSYGVVLLELLCRKMPVDPAFGDGVDIVTWMGSNLNQADHSNIMRFL 1072
Query: 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
D EI +W ++ K L LL+LA+ CT+ +RPSMREVV L+++ N
Sbjct: 1073 DEEIIYWPEHEKAKVLDLLDLAMTCTQVSCQLRPSMREVVSILMRIERSNH 1123
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242034683|ref|XP_002464736.1| hypothetical protein SORBIDRAFT_01g025950 [Sorghum bicolor] gi|241918590|gb|EER91734.1| hypothetical protein SORBIDRAFT_01g025950 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 891 bits (2302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 512/1139 (44%), Positives = 693/1139 (60%), Gaps = 88/1139 (7%)
Query: 27 AISLVQFLDSLPKQSQSHL--PWNQS-VSTSA-----PCKWSGVSCYNNSSSLKALNLSG 78
A L F+ SLP S+ L W + STS C + GV C + ++ A+NLSG
Sbjct: 34 AAVLRAFIASLPPVSRRVLRPSWRATNASTSGGRSRTHCAFLGVQC-TATGAVAAVNLSG 92
Query: 79 FGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPP 138
GLSG L + +C L +LDLS N FTG++P L C + TLLL N G++P
Sbjct: 93 AGLSGDLAATAPRLCALPALAALDLSRNRFTGAVPAALTACSVVATLLLGGNLLTGAVPL 152
Query: 139 EIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLY 198
E+ +L +DL YN+L+G I S LE + N L+G +P ++ +LP L +
Sbjct: 153 ELLSSPQLRKVDLSYNTLAGDISGSSSPV--LEYLDLSVNMLSGTVPLELAALPSLIYMD 210
Query: 199 LNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258
L+ NNL+G +PEFP C +++L + N G +P SL+NC NL S N GG + P
Sbjct: 211 LSGNNLSGPVPEFPAPCRLVYLSLFSNQLSGGIPRSLANCHNLTTLYLSYNVIGGKV-PD 269
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318
F L +L+ LYLDDN G++P+++ L +L++LV+S N GT+ I C L ++
Sbjct: 270 FFASLPKLQKLYLDDNKFVGELPQSIGTLVSLEQLVVSNNGFTGTVPDAIGKCQSLTMLY 329
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
L RNN G IP V N S L L + +NR+ G +PPE+G C LV+L+LQ+N + GTIP
Sbjct: 330 LDRNNFSGSIPVFVSNFSRLQKLSMAHNRISGRIPPEIGKCQELVELQLQNNSLSGTIPL 389
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438
EIC L++L+ YL NN + G +P +I ++ KL E++L++N TG +P Q L
Sbjct: 390 EICKLSQLQNFYLHNNSLRGELPAEITQIRKLREISLFDNNFTGVLP---------QALG 440
Query: 439 LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP 498
L P L ++DLTGN F+G IP +C G L VL LG N+F+GS P
Sbjct: 441 L--------------NTTPGLVQVDLTGNHFHGEIPPGLCTGGQLSVLDLGYNQFSGSLP 486
Query: 499 IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTML 558
I I KC SL+R+IL+NNL+ G++PA L N G+S++D+ GNLL G IP V G W NLTML
Sbjct: 487 IGILKCESLQRLILNNNLITGNIPANLGTNIGLSYMDISGNLLHGVIPAVLGSWRNLTML 546
Query: 559 DFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618
D S N SG IP EL L L+ LR+S+N+L G IP+ELG C ++ LDL N L GSIP
Sbjct: 547 DISNNLFSGPIPRELSALTKLETLRMSSNRLTGPIPHELGNCKDLLCLDLGKNLLNGSIP 606
Query: 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSI 678
+E+ +L +QSL L NNL+G IPD+F++ Q L ELQLG N +G+IP SL L + S
Sbjct: 607 AEITTLNSLQSLVLGANNLTGRIPDSFTAAQDLIELQLGDNRLEGAIPDSLGNLQYLSKA 666
Query: 679 LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKL 738
LN+S+N+LSG+IP LG L L++LDLS NS SG IP++++NMVSL VNISFN SG L
Sbjct: 667 LNISHNRLSGQIPNSLGKLQDLELLDLSMNSLSGPIPSQLSNMVSLLVVNISFNELSGLL 726
Query: 739 PASWTTLMVSYPGSFLGNSELCRQGNCGKNGRGHTRGRL----AGIIIGVLLS-----VA 789
P +W L P FLGN +LC Q +C +L II+ +L+S VA
Sbjct: 727 PGNWPKLATKSPDGFLGNPQLCIQSDCLHRSNNQLARKLHYSKTRIIVALLVSTLAIIVA 786
Query: 790 LLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRAT----EGRIIGKG 845
LC + YI V RS+ S +E+LP DL YED++RAT E +IG+G
Sbjct: 787 GLCVVYYI----VKRSQHLSASHASVRSLDTTEELPEDLTYEDILRATDNWSEKYVIGRG 842
Query: 846 KHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905
+HGTVYRT K WAVK ++ S+ F +E++ L+ V+HRNI+R+ G C + G I+
Sbjct: 843 RHGTVYRT-ECKLGKDWAVKTVDLSKCKFPIEMKILNTVKHRNIVRMEGYCIRGSVGLIL 901
Query: 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNIL 965
EYMP GTLF++LH+ +PR+ LD R+ IALG+AQ LSYLH+DCVP I+HRD+KS NIL
Sbjct: 902 YEYMPEGTLFDLLHERKPRVPLDCMARWQIALGVAQALSYLHHDCVPMIVHRDVKSSNIL 961
Query: 966 LDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA---------------------- 1003
+D+EL PK+ DFGM K++ D ++ +T SAI+G+LGYIA
Sbjct: 962 MDAELVPKLTDFGMGKIVCDENADATVSAIIGTLGYIAPGRFFHNLYHNLFDHITMATCT 1021
Query: 1004 -----------PENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK 1052
PE+ YSTRLTEKSDVYSYGV+L ELL RK P+D SFG+ TDIVTW R
Sbjct: 1022 SGLTRSVLYVYPEHGYSTRLTEKSDVYSYGVVLLELLCRKTPLDSSFGDGTDIVTWMRTN 1081
Query: 1053 LQENHEC--ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
L+ C I +D E+++W D+Q KAL LL+LA+ CT+ RPSMREVV L+K+
Sbjct: 1082 LEHEDRCSIISLMDEEMTYWPEDEQEKALSLLDLAVSCTQVACQSRPSMREVVKMLLKI 1140
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|414869380|tpg|DAA47937.1| TPA: putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 869 bits (2246), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/977 (47%), Positives = 633/977 (64%), Gaps = 25/977 (2%)
Query: 154 NSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPN 213
NS +G +P ++ C +L ++ NN L+G +P ++ +LP L L L+ N LTG +PEFP
Sbjct: 117 NSFTGAVPAALAACSALATLDLSNNSLSGAVPRELAALPALTDLRLSGNGLTGPVPEFPA 176
Query: 214 SCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDD 273
C + +L ++ N G+LP SL NC NL SSN GGA+ P +F L L+ LYLD
Sbjct: 177 RCGLRYLSLYGNRISGALPRSLGNCVNLTVLFLSSNRIGGAL-PDVFGSLPMLQKLYLDS 235
Query: 274 NNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVG 333
N G +PE++ L +L++ V S N NG+I I C L + L N G IP S+G
Sbjct: 236 NLFAGALPESVGELGSLERFVASTNCFNGSIPASIGRCGSLTTLLLHNNQFTGPIPASIG 295
Query: 334 NLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN 393
NLS L L + + + G +PPE+G C LV L LQ+N + GTIPPE+ L KL L L+
Sbjct: 296 NLSRLQWLTIKDTFVTGAIPPEIGRCQELVILDLQNNNLTGTIPPELAELKKLRSLSLYR 355
Query: 394 NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG 453
N + G +P + +M +L +LALYNN L+G IP +I +RNL+ L LA N+ TGE+ LG
Sbjct: 356 NMLHGPVPAALWQMPELEKLALYNNSLSGEIPEEINHMRNLRELLLAFNNFTGELPQGLG 415
Query: 454 KHFPY-LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVIL 512
+ + L +D+ GN F+G IP +C G L +L L NRF+G P EI KC SL R L
Sbjct: 416 SNTTHGLVWVDVMGNHFHGAIPPGLCTGGQLAILDLALNRFSGGIPSEIIKCQSLWRARL 475
Query: 513 SNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSE 572
+NNL GS P+ L N G S++++ GN G IP V G W NLT+LD S N SG IP E
Sbjct: 476 ANNLFSGSFPSDLGINTGWSYVELGGNRFDGRIPSVLGSWRNLTVLDLSRNSFSGPIPPE 535
Query: 573 LGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSL 632
LG L +L L LS+NKL GRIP+ELG C +++LDL +N L GSIP+E++SL +Q L L
Sbjct: 536 LGALAHLGDLNLSSNKLSGRIPHELGNCRGLVRLDLENNLLNGSIPAEIVSLGSLQHLVL 595
Query: 633 QENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPE 692
N LSG IPDAF+S Q L ELQLG N +G++P SL KL S I+N+S+N LSG IP
Sbjct: 596 GGNKLSGEIPDAFTSTQGLLELQLGGNSLEGAVPWSLGKLQFISQIINMSSNMLSGTIPS 655
Query: 693 CLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGS 752
LGNL L++LDLS NS SG IP++++NMVSL N+SFN SG LP W + +
Sbjct: 656 SLGNLRMLEMLDLSENSLSGPIPSQLSNMVSLSAANVSFNRLSGPLPVGWANKLPA--DG 713
Query: 753 FLGNSELC---RQGNCGKNG-RGHTRGRLAGIIIGVLLS-----VALLCALIYIMVVRVL 803
FLGN +LC C KN R TR R II+ +LLS + LCA+ Y V+
Sbjct: 714 FLGNPQLCVRPEDAACSKNQYRSRTR-RNTRIIVALLLSSLAVMASGLCAVRY--AVKTS 770
Query: 804 RSKCFSDPSLLQDVQS-RSEDLPRDLRYEDVIRAT----EGRIIGKGKHGTVYRTLSNNS 858
R + + ++ + + +E+LP DL Y+D+IRAT E +IG+G+HGTVYRT
Sbjct: 771 RRRLLAKRVSVRGLDATTTEELPEDLSYDDIIRATDNWSEKYVIGRGRHGTVYRTELAPG 830
Query: 859 RKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVL 918
R+ WAVK ++ S F +E++ L++VRHRNI+++ G C + G I++EYMP GTLF +L
Sbjct: 831 RR-WAVKTVDLSRVKFPIEMKILNMVRHRNIVKMEGYCIRGNFGVILSEYMPRGTLFELL 889
Query: 919 HQNEPRLV-LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
H +P++V LDW R+ IALG AQGLSYLH+DCVP ++HRD+KS NIL+D++L PKI DF
Sbjct: 890 HGRKPQVVALDWKARHQIALGAAQGLSYLHHDCVPMVVHRDVKSSNILMDADLVPKIADF 949
Query: 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
GM K++ D + +T S +VG+LGYIAPE+ Y+TRLTEKSDVYSYGV+L ELL R+MPVDP
Sbjct: 950 GMGKIVGDEDADATVSVVVGTLGYIAPEHGYNTRLTEKSDVYSYGVVLLELLCRRMPVDP 1009
Query: 1038 SFGEDTDIVTWTRWKLQENHEC--ICFLDREISFWDSDDQLKALRLLELALECTRQVADM 1095
+FG+ DIV W R L+ C + FLD EI +W D++ KAL +L++A+ CT+ +
Sbjct: 1010 AFGDGVDIVAWMRLNLKHADCCSVMTFLDEEIMYWPEDEKAKALDVLDMAISCTQVAFES 1069
Query: 1096 RPSMREVVGFLIKLNDK 1112
RPSMREVVG L++++D+
Sbjct: 1070 RPSMREVVGALMRIDDQ 1086
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1119 | ||||||
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.907 | 0.915 | 0.370 | 7.9e-165 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.880 | 0.905 | 0.360 | 2.9e-158 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.637 | 0.569 | 0.327 | 1.7e-154 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.634 | 0.568 | 0.340 | 8.1e-153 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.958 | 0.955 | 0.335 | 6.8e-143 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.647 | 0.608 | 0.335 | 4.6e-135 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.897 | 0.911 | 0.338 | 1e-130 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.584 | 0.645 | 0.316 | 4.2e-130 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.856 | 0.839 | 0.322 | 9.3e-130 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.880 | 0.894 | 0.337 | 9.3e-130 |
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 1604 (569.7 bits), Expect = 7.9e-165, P = 7.9e-165
Identities = 405/1093 (37%), Positives = 585/1093 (53%)
Query: 43 SHLPWNQSVSTSAPCKWSGVSCYXXXXXXXXXXXXGFGLSGVLNNSISYICKNQHLLSLD 102
S + + + S S PC W GV C +G+SG IS++ +HL +
Sbjct: 43 SDITQSWNASDSTPCSWLGVEC-DRRQFVDTLNLSSYGISGEFGPEISHL---KHLKKVV 98
Query: 103 LSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPP 162
LSGN F GSIP QLGNC L+ + L+ N F G+IP + L+ L L L +NSL G P
Sbjct: 99 LSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPE 158
Query: 163 QVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSXXXXXXXXXXXXPE-FPNSCAILHLL 221
+ LE++ F N LNG +P++I ++ +L + P N + L
Sbjct: 159 SLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELY 218
Query: 222 IHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIP 281
+++N+ VG+LP +L+N NLV +N+ GAI P F Q++ + L +N G +P
Sbjct: 219 LNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAI-PLDFVSCKQIDTISLSNNQFTGGLP 277
Query: 282 ETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGXXXXXXXX 341
L +L++ + L+G I +L + L+ N+ G+IP
Sbjct: 278 PGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIP------------ 325
Query: 342 XXXXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401
PELG C S++DL+LQ N + G IP E+ L++L+ L+L+ N + G +P
Sbjct: 326 ------------PELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVP 373
Query: 402 HQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR 461
I ++ L L LY N L+G +P D+T L+ L L+L NH TG + +LG + L
Sbjct: 374 LSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSS-LEV 432
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSL 521
LDLT N F G IP N+C L L+LG N GS P ++G CS+L R+IL N L+G L
Sbjct: 433 LDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGL 492
Query: 522 PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQI 581
P +E+ + F D+ GN G IPP G N+T + S N+LSGSIP ELG+L L+
Sbjct: 493 PDFVEKQ-NLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEH 551
Query: 582 LRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641
L LS N L G +P EL C K+ +LD S N L GSIPS + SL ++ LSL EN+ SG I
Sbjct: 552 LNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGI 611
Query: 642 PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQ 701
P + L LQLG N+ G IP + L S LN+S+NKL+G++P LG L L+
Sbjct: 612 PTSLFQSNKLLNLQLGGNLLAGDIP-PVGALQALRS-LNLSSNKLNGQLPIDLGKLKMLE 669
Query: 702 ILDLSSNSFSGEIP--------TEVNNMVSLYF--VNISFNHFSGKLPASWT---TLMVS 748
LD+S N+ SG + T +N +L+ V S F P S++ L ++
Sbjct: 670 ELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCIN 729
Query: 749 YPGSFLG--NSELCR----QGNCGKNGRGHTRGRLAGIIIGVLLSVALLCALIYIMVVRV 802
P L S + R Q N GK G T G +A I++G LL + +C ++ +
Sbjct: 730 CPADGLACPESSILRPCNMQSNTGKGGLS-TLG-IAMIVLGALLFI--ICLFLFSAFL-F 784
Query: 803 LRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGR----IIGKGKHGTVYR-TLSNN 857
L K +Q++ +++ L V+ ATE +IGKG HGT+Y+ TLS +
Sbjct: 785 LHCK-----KSVQEIAISAQEGDGSL-LNKVLEATENLNDKYVIGKGAHGTIYKATLSPD 838
Query: 858 SRKHWAVKKL-----NRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912
K +AVKKL + EI T+ VRHRN++++ + E+G I+ YM G
Sbjct: 839 --KVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENG 896
Query: 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972
+L ++LH+ P LDW+TR++IA+G A GL+YLH+DC P I+HRDIK NILLDS+LEP
Sbjct: 897 SLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEP 956
Query: 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK 1032
I DFG++KL+ S +S + + G++GY+APENA++T + +SDVYSYGV+L EL+ RK
Sbjct: 957 HISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRK 1016
Query: 1033 MPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI--SFWDSDDQXXXXXXXXXXXXCTR 1090
+DPSF +TDIV W R + E +D + DS C
Sbjct: 1017 KALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAE 1076
Query: 1091 QVADMRPSMREVV 1103
+ D RP+MR+VV
Sbjct: 1077 KEVDKRPTMRDVV 1089
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1542 (547.9 bits), Expect = 2.9e-158, P = 2.9e-158
Identities = 372/1032 (36%), Positives = 574/1032 (55%)
Query: 106 NEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVS 165
N + G I GN ++TL L+ + G + EI +LK L LDL NS SG +P +
Sbjct: 64 NNWFGVICDLSGNV--VETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLG 121
Query: 166 LCYSLESIGFHNNFLNGELPNDICSLPKLKSXXXXXXXXXXXXPEFPNSCA-ILHLLIHE 224
C SLE + NN +GE+P+ SL L P ++ L +
Sbjct: 122 NCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSY 181
Query: 225 NDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETL 284
N+ G++P L NC L + ++N G++ ++ L L L++ +N+L G++
Sbjct: 182 NNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYL-LENLGELFVSNNSLGGRLH--- 237
Query: 285 WGLENLQKLV---LSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGXXXXXXXX 341
+G N +KLV LS N G + +I +C+ L + + + NL G IP S+G
Sbjct: 238 FGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVI 297
Query: 342 XXXXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401
G +P ELGNC SL L+L N + G IPP + L KL+ L LF N++ G IP
Sbjct: 298 DLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIP 357
Query: 402 HQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR 461
I ++ L ++ +YNN LTG +P ++T+L++L+ L+L +N G++ + LG + L
Sbjct: 358 IGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRS-LEE 416
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSL 521
+DL GN F G IP ++C G L + +LG+N+ +G P I +C +L RV L +N L G L
Sbjct: 417 VDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVL 476
Query: 522 PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQI 581
P E + +S++++ N +GSIP G NL +D S+N+L+G IP ELGNL++L +
Sbjct: 477 PEFPE-SLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGL 535
Query: 582 LRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641
L LS N L+G +P +L C +++ D+ N L GSIPS S + + +L L +NN GAI
Sbjct: 536 LNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAI 595
Query: 642 PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQ 701
P + + L +L++ N F G IP S+ L L++S N +G+IP LG L L+
Sbjct: 596 PQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINLE 655
Query: 702 ILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCR 761
L++S+N +G + + ++ SL V++S+N F+G +P + ++S F GN +LC
Sbjct: 656 RLNISNNKLTGPLSV-LQSLKSLNQVDVSYNQFTGPIPVN----LLSNSSKFSGNPDLCI 710
Query: 762 QGNCG---------KNGRGHTR---GRLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFS 809
Q + K+ +G + ++A I G LSV L +++++ R R
Sbjct: 711 QASYSVSAIIRKEFKSCKGQVKLSTWKIALIAAGSSLSVLALLFALFLVLCRCKRGTKTE 770
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN- 868
D ++L + + S L + L D + + IIG+G HG VYR S S + +AVKKL
Sbjct: 771 DANILAE-EGLSLLLNKVLAATDNL--DDKYIIGRGAHGVVYRA-SLGSGEEYAVKKLIF 826
Query: 869 ----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ-NEP 923
R+ N EI T+ LVRHRN++R+ + E G ++ +YMP G+L +VLH+ N+
Sbjct: 827 AEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQG 886
Query: 924 RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983
VLDW+ R++IALGI+ GL+YLH+DC P IIHRDIK +NIL+DS++EP IGDFG+++++
Sbjct: 887 EAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARIL 946
Query: 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
DS S+ + + G+ GYIAPENAY T +++SDVYSYGV+L EL+ K +D SF ED
Sbjct: 947 DDSTVST--ATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDI 1004
Query: 1044 DIVTWTRWKLQ--ENHECIC--FLDREI--SFWDSDDQXXXXXXXXXXXXCTRQVADMRP 1097
+IV+W R L E+ + +D ++ D+ + CT + + RP
Sbjct: 1005 NIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRP 1064
Query: 1098 SMREVVGFLIKL 1109
SMR+VV L L
Sbjct: 1065 SMRDVVKDLTDL 1076
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 1.7e-154, Sum P(2) = 1.7e-154
Identities = 238/727 (32%), Positives = 374/727 (51%)
Query: 81 LSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEI 140
L+G++ + + + Q L+ L NE G IP ++GNC L NR GS+P E+
Sbjct: 180 LTGLIPSRFGRLVQLQTLI---LQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAEL 236
Query: 141 FKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSXXXX 200
+LK L L+LG NS SG+IP Q+ S++ + N L G +P + L L++
Sbjct: 237 NRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLS 296
Query: 201 XXXXXXXX-PEFPNSCAILHLLIHENDFVGSLPTSL-SNCRNLVEFSASSNNFGGAISPW 258
EF + L++ +N GSLP ++ SN +L + S G I P
Sbjct: 297 SNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEI-PA 355
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318
L++L L +N L GQIP++L+ L L L L+ N L GT+S IS+ LQ
Sbjct: 356 EISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFT 415
Query: 319 LSRNNLVGQIPRSVGXXXXXXXXXXXXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
L NNL G++P+ +G G +P E+GNC L ++ N + G IP
Sbjct: 416 LYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPS 475
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438
I L L L+L N + G IP +G ++ + L +N+L+G IP L L+
Sbjct: 476 SIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFM 535
Query: 439 LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP 498
+ +N L G + L + L+R++ + N F G I + +C ++ + N F G P
Sbjct: 536 IYNNSLQGNLPDSL-INLKNLTRINFSSNKFNGSI-SPLCGSSSYLSFDVTENGFEGDIP 593
Query: 499 IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTML 558
+E+GK ++L R+ L N G +P T + +S LD+ N L G IP G LT +
Sbjct: 594 LELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHI 653
Query: 559 DFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618
D + N LSG IP+ LG L L L+LS+NK G +P E+ T ++ L L N L GSIP
Sbjct: 654 DLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIP 713
Query: 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSI 678
E+ +L+ + +L+L+EN LSG +P + LFEL+L N G IP + +L S
Sbjct: 714 QEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSA 773
Query: 679 LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKL 738
L++S N +G+IP + L KL+ LDLS N GE+P ++ +M SL ++N+S+N+ GKL
Sbjct: 774 LDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL 833
Query: 739 PASWTTLMVSYPGSFLGNSELCRQ--GNCGKNGRGHTRGRLAGIIIGVLLSVALLCALIY 796
++ +F+GN+ LC +C + G + R L+ + ++ +++ L A+
Sbjct: 834 KKQFSRWQAD---AFVGNAGLCGSPLSHCNRAGSKNQRS-LSPKTVVIISAISSLAAIAL 889
Query: 797 IMVVRVL 803
+++V +L
Sbjct: 890 MVLVIIL 896
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 8.1e-153, Sum P(2) = 8.1e-153
Identities = 247/726 (34%), Positives = 372/726 (51%)
Query: 81 LSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEI 140
L+G + + + + + Q L+ L N G IP +LGNC L +N G+IP E+
Sbjct: 179 LTGPIPSQLGRLVRVQSLI---LQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAEL 235
Query: 141 FKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSXXXX 200
+L+ L L+L NSL+G+IP Q+ L+ + N L G +P + L L++
Sbjct: 236 GRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLS 295
Query: 201 XXXXXXXXPE-FPNSCAILHLLIHENDFVGSLPTSL-SNCRNLVEFSASSNNFGGAISPW 258
PE F N +L L++ N GSLP S+ SN NL + S G I
Sbjct: 296 ANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVE 355
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318
+ K L+ L L +N+L G IPE L+ L L L L N L GT+S IS+ LQ +
Sbjct: 356 LSK-CQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLV 414
Query: 319 LSRNNLVGQIPRSVGXXXXXXXXXXXXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
L NNL G++P+ + G +P E+GNC SL + + N G IPP
Sbjct: 415 LYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPP 474
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438
I L +L +L+L N + G +P +G +L L L +N+L+G IP L+ L+ L
Sbjct: 475 SIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLM 534
Query: 439 LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP 498
L +N L G + L L+R++L+ N G I +C ++ + NN F P
Sbjct: 535 LYNNSLQGNLPDSLIS-LRNLTRINLSHNRLNGTIHP-LCGSSSYLSFDVTNNGFEDEIP 592
Query: 499 IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTML 558
+E+G +L R+ L N L G +P TL + +S LD+ N L G+IP LT +
Sbjct: 593 LELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHI 652
Query: 559 DFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618
D + N LSG IP LG L L L+LS+N+ +P EL CTK++ L L N L GSIP
Sbjct: 653 DLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIP 712
Query: 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSI 678
E+ +L + L+L +N SG++P A + L+EL+L N G IP + +L S
Sbjct: 713 QEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSA 772
Query: 679 LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKL 738
L++S N +G IP +G L KL+ LDLS N +GE+P V +M SL ++N+SFN+ GKL
Sbjct: 773 LDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL 832
Query: 739 PASWTTLMVSYPG-SFLGNSELCRQ--GNCGKNGRGHTRGRLAGIIIGVLLSVALLCAL- 794
++ +P SFLGN+ LC C + + + L+ + ++ +++ L A+
Sbjct: 833 KKQFSR----WPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIG 888
Query: 795 IYIMVV 800
+ I+V+
Sbjct: 889 LMILVI 894
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1397 (496.8 bits), Expect = 6.8e-143, P = 6.8e-143
Identities = 379/1129 (33%), Positives = 562/1129 (49%)
Query: 3 LLISYYVLFSLNQFLALSV--SSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWS 60
+L+ ++ LF +++S S + +SL++ LD +P Q S W + S + PC W
Sbjct: 10 ILLLFFCLFLSTHIISVSCLNSDGLTLLSLLKHLDRVPPQVTS--TWKINASEATPCNWF 67
Query: 61 GVSCYXXXXXXXXXXXXGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCG 120
G++C +SG L I + + L LDLS N F+G+IP LGNC
Sbjct: 68 GITCDDSKNVASLNFTRS-RVSGQLGPEIGEL---KSLQILDLSTNNFSGTIPSTLGNCT 123
Query: 121 QLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFL 180
+L TL L++N F IP + LKRL L L N L+G++P + L+ + N L
Sbjct: 124 KLATLDLSENGFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYLDYNNL 183
Query: 181 NGELPNDICSLPKLKSXXXXXXXXXXXXPE-FPNSCAILHLLIHENDFVGSLPTSLSNCR 239
G +P I +L PE NS ++ L +H N VGSLP SL+
Sbjct: 184 TGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNKLVGSLPESLNLLG 243
Query: 240 NLVEFSASSNNFGGAI---SPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLS 296
NL +N+ G + SP K LL L++ Y N EG +P L +L LV+
Sbjct: 244 NLTTLFVGNNSLQGPVRFGSPNC-KNLLTLDLSY---NEFEGGVPPALGNCSSLDALVIV 299
Query: 297 ANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGXXXXXXXXXXXXXXXQGTLPPEL 356
+ L+GTI + L ++ LS N L G IP +G G +P L
Sbjct: 300 SGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSAL 359
Query: 357 GNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416
G L L L N G IP EI L L ++ N + G +P ++ M KL L+
Sbjct: 360 GKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLF 419
Query: 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPAN 476
NN G IPP + +L+ + N LTGE+ L H L L+L N +G IPA+
Sbjct: 420 NNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLC-HGRKLRILNLGSNLLHGTIPAS 478
Query: 477 ICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDV 536
I + +L N +G P E + SL + ++N +G +P +L +S +++
Sbjct: 479 IGHCKTIRRFILRENNLSGLLP-EFSQDHSLSFLDFNSNNFEGPIPGSLGSCKNLSSINL 537
Query: 537 RGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYE 596
N G IPP G NL ++ S N L GS+P++L N +L+ + N L+G +P
Sbjct: 538 SRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSN 597
Query: 597 LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSL-FELQ 655
+ L LS+N +G IP + L+K+ +L + N G IP + ++ L ++L
Sbjct: 598 FSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLD 657
Query: 656 LGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715
L N G IP L L + LN+SNN L+G + L L L +D+S+N F+G IP
Sbjct: 658 LSGNGLTGEIPAKLGDLIKLTR-LNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFTGPIP 715
Query: 716 TEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNS----ELCR-QGNCGKNGR 770
+N+ S FSG P L + + S NS + C+ Q K+G
Sbjct: 716 ---DNLEGQLLSEPS--SFSGN-P----NLCIPHSFSASNNSRSALKYCKDQSKSRKSGL 765
Query: 771 GHTRGRLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRY 830
+ L ++ +L+ V +L AL++I + R + + D + + S L + L
Sbjct: 766 STWQIVLIAVLSSLLVLVVVL-ALVFICLRR-RKGRPEKDAYVFTQEEGPSLLLNKVLAA 823
Query: 831 EDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVR 885
D + E IG+G HG VYR S S K +AVK+L R+ + EI T+ VR
Sbjct: 824 TDNLN--EKYTIGRGAHGIVYRA-SLGSGKVYAVKRLVFASHIRANQSMMREIDTIGKVR 880
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL-VLDWNTRYHIALGIAQGLS 944
HRN++++ G + + G ++ YMP G+L++VLH P+ VLDW+ RY++ALG+A GL+
Sbjct: 881 HRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLA 940
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
YLHYDC P I+HRDIK +NIL+DS+LEP IGDFG+++L+ DS S+ + + G+ GYIAP
Sbjct: 941 YLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVST--ATVTGTTGYIAP 998
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI---- 1060
ENA+ T +SDVYSYGV+L EL+ RK VD SF E TDIV+W R L ++ +
Sbjct: 999 ENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMV 1058
Query: 1061 -CFLDREI--SFWDSDDQXXXXXXXXXXXXCTRQVADMRPSMREVVGFL 1106
+D + DS + CT+Q MRP+MR+ V L
Sbjct: 1059 TTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLL 1107
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 894 (319.8 bits), Expect = 4.6e-135, Sum P(2) = 4.6e-135
Identities = 253/753 (33%), Positives = 368/753 (48%)
Query: 2 LLLISYYVLFSLNQFLALSVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSG 61
L + ++ FS + + +SS + SL+ F SL S WN S S+++ C W G
Sbjct: 4 LTALFLFLFFSFSSSAIVDLSSETT--SLISFKRSLENPSLLS-SWNVS-SSASHCDWVG 59
Query: 62 VSCYXXXXXXXXXXXXGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQ 121
V+C L G + IS + KN L L L+GN+F+G IP ++ N
Sbjct: 60 VTCLLGRVNSLSLPS--LSLRGQIPKEISSL-KN--LRELCLAGNQFSGKIPPEIWNLKH 114
Query: 122 LKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCY-SLESIGFHNNFL 180
L+TL L+ N G +P + +L +L +LDL N SG +PP + +L S+ NN L
Sbjct: 115 LQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSL 174
Query: 181 NGELPNDICSLPKLKSXXXXXXXXXXXXP-EFPNSCAILHLLIHENDFVGSLPTSLSNCR 239
+GE+P +I L L + P E N + + F G LP +S +
Sbjct: 175 SGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLK 234
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK 299
+L + S N +I P F L L +L L L G IP L ++L+ L+LS N
Sbjct: 235 HLAKLDLSYNPLKCSI-PKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNS 293
Query: 300 LNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGXXXXXXXXXXXXXXXQGTLPPELGNC 359
L+G + ++S L + RN L G +P +G G +P E+ +C
Sbjct: 294 LSGPLPLELSEI-PLLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDC 352
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNR 419
L L L N + G+IP E+C LE + L N + G I S L EL L NN+
Sbjct: 353 PMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQ 412
Query: 420 LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICV 479
+ G IP D+ +L L L L N+ TGE+ L K L + N G +PA I
Sbjct: 413 INGSIPEDLWKLP-LMALDLDSNNFTGEIPKSLWKS-TNLMEFTASYNRLEGYLPAEIGN 470
Query: 480 GTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGN 539
+L LVL +N+ G P EIGK +SL + L+ N+ QG +P L ++ LD+ N
Sbjct: 471 AASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSN 530
Query: 540 LLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS---------ELGNLENLQ---ILRLSAN 587
LQG IP + L L S N LSGSIPS E+ +L LQ I LS N
Sbjct: 531 NLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYN 590
Query: 588 KLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSS 647
+L G IP ELG+C ++++ LS+N+L+G IP+ + L + L L N L+G+IP +
Sbjct: 591 RLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGN 650
Query: 648 VQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSS 707
L L L +N +G IP S L LN++ NKL G +P LGNL +L +DLS
Sbjct: 651 SLKLQGLNLANNQLNGHIPESFGLLGSLVK-LNLTKNKLDGPVPASLGNLKELTHMDLSF 709
Query: 708 NSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPA 740
N+ SGE+ +E++ M L + I N F+G++P+
Sbjct: 710 NNLSGELSSELSTMEKLVGLYIEQNKFTGEIPS 742
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 358/1059 (33%), Positives = 516/1059 (48%)
Query: 80 GLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPE 139
G +GV+ ++ S + +LSL+LS +G + +G LK L L+ N G IP E
Sbjct: 60 GWTGVMCSNYS---SDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKE 116
Query: 140 IFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSXXX 199
I L L L N G+IP ++ SLE++ +NN ++G LP +I +L L
Sbjct: 117 IGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVT 176
Query: 200 XXXXXXXXXPE-FPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258
P N + +N GSLP+ + C +LV + N G +
Sbjct: 177 YSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKE 236
Query: 259 IFKGLLQ-LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVI 317
I G+L+ L + L +N G IP + +L+ L L N+L G I ++ L+ +
Sbjct: 237 I--GMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFL 294
Query: 318 ALSRNNLVGQIPRSVGXXXXXXXXXXXXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIP 377
L RN L G IPR +G G +P ELGN L L L N + GTIP
Sbjct: 295 YLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIP 354
Query: 378 PEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFL 437
E+ L L L L N + G IP + L L L+ N L+G IPP + +L L
Sbjct: 355 VELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVL 414
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF 497
++ NHL+G + L H + L+L N+ G IP I L L L N G F
Sbjct: 415 DMSDNHLSGRIPSYLCLHSNMII-LNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRF 473
Query: 498 PIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTM 557
P + K ++ + L N +GS+P + + L + N G +P G S L
Sbjct: 474 PSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGT 533
Query: 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617
L+ S N+L+G +PSE+ N + LQ L + N G +P E+G ++ L LS+N L+G+I
Sbjct: 534 LNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTI 593
Query: 618 PSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSL-FELQLGSNIFDGSIPCSLSKLHHFS 676
P + +L ++ L + N +G+IP S+ L L L N G IP LS L
Sbjct: 594 PVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLE 653
Query: 677 SILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736
+L ++NN LSG+IP NL L + S NS +G IP NIS + F G
Sbjct: 654 FLL-LNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPL---------LRNISMSSFIG 703
Query: 737 KLPASWTTLMVSYPGSFLGNSELCRQGNCGKNGRGHTRGRLAGIIIGVLLSVAL-LCALI 795
L + + GK G G ++ I V+ V+L L ALI
Sbjct: 704 NEGLCGPPL-----NQCIQTQPFAPSQSTGKPG-GMRSSKIIAITAAVIGGVSLMLIALI 757
Query: 796 YIMVVRVLRSKCFSDPSLLQDVQ--SRSEDL---PRD-LRYEDVIRAT----EGRIIGKG 845
++ R +R+ S QD Q S D+ P++ ++D++ AT E ++G+G
Sbjct: 758 VYLMRRPVRTVASS----AQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRG 813
Query: 846 KHGTVYRTLSNNSRKHWAVKKL---------NRSETNFDVEIRTLSLVRHRNILRIVGSC 896
GTVY+ + AVKKL N + +F EI TL +RHRNI+++ G C
Sbjct: 814 ACGTVYKAVLPAGYT-LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC 872
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
++ EYMP G+L +LH +P LDW+ R+ IALG AQGL+YLH+DC P+I H
Sbjct: 873 NHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFH 930
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RDIKS+NILLD + E +GDFG++K+I HS S SAI GS GYIAPE AY+ ++TEKS
Sbjct: 931 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSM-SAIAGSYGYIAPEYAYTMKVTEKS 989
Query: 1017 DVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQX 1076
D+YSYGV+L ELL K PV P + D+V W R ++ + LD ++ D
Sbjct: 990 DIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVS 1048
Query: 1077 XXXXXXXXXXXCTRQVADMRPSMREVVGFLIKLNDKNEG 1115
CT RPSMR+VV LI+ ++++EG
Sbjct: 1049 HMLTVLKIALLCTSVSPVARPSMRQVVLMLIE-SERSEG 1086
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 768 (275.4 bits), Expect = 4.2e-130, Sum P(2) = 4.2e-130
Identities = 216/682 (31%), Positives = 330/682 (48%)
Query: 226 DFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLW 285
+ G + S+S +LV F+ S N F + P K + L+ + + N+ G + L+
Sbjct: 82 NLTGKISDSISQLSSLVSFNISCNGFESLL-P---KSIPPLKSIDISQNSFSGSL--FLF 135
Query: 286 GLENLQKLVLSA--NKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGXXXXXXXXXX 343
E+L + L+A N L+G ++ + + L+V+ L N G +P S
Sbjct: 136 SNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGL 195
Query: 344 XXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQ 403
G LP LG SL L +N G IPPE N+ L+ L L ++ G IP +
Sbjct: 196 SGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSE 255
Query: 404 IGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLD 463
+G++ L L LY N TG IP +I + L+ L + N LTGE+ +E+ K L L+
Sbjct: 256 LGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITK-LKNLQLLN 314
Query: 464 LTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPA 523
L N G IP I L VL L NN +G P ++GK S L+ + +S+N G +P+
Sbjct: 315 LMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPS 374
Query: 524 TLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILR 583
TL ++ L + N G IP +L + N L+GSIP G LE LQ L
Sbjct: 375 TLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLE 434
Query: 584 LSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPD 643
L+ N+L G IP ++ + +D S N + S+PS ++S+ +Q+ + +N +SG +PD
Sbjct: 435 LAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPD 494
Query: 644 AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQIL 703
F SL L L SN G+IP S++ S LN+ NN L+G+IP + + L +L
Sbjct: 495 QFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVS-LNLRNNNLTGEIPRQITTMSALAVL 553
Query: 704 DLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQ- 762
DLS+NS +G +P + +L +N+S+N +G +P + ++ P GNS LC
Sbjct: 554 DLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTIN-PDDLRGNSGLCGGV 612
Query: 763 -GNCGKNGRG-HTRGRLAG--IIIGVLLSVALLCAL-IYIMVVRVLRSKCFSDPSLLQDV 817
C K R + L G I+ G L+ +A + AL I +V R L K +S+ +
Sbjct: 613 LPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDET 672
Query: 818 QSRSEDLPRDLRYE-------DVIRAT-EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR 869
S+ E R + + D++ E +IG G G VY+ + S AVKKL R
Sbjct: 673 ASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWR 732
Query: 870 SETNFDVEIRTLS-LVRHRNIL 890
S D+E T V N+L
Sbjct: 733 SAA--DIEDGTTGDFVGEVNLL 752
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1273 (453.2 bits), Expect = 9.3e-130, P = 9.3e-130
Identities = 323/1002 (32%), Positives = 500/1002 (49%)
Query: 133 QGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLP 192
Q S+P + + L L + +L+G +P + C L+ + +N L G++P + L
Sbjct: 94 QLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLR 153
Query: 193 KLKSXXXXXXXXXXXXPEFPNSCAILH-LLIHENDFVGSLPTSLSNCRNLVEFSASSNN- 250
L++ P + C+ L L++ +N GS+PT L L N
Sbjct: 154 NLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKE 213
Query: 251 FGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISH 310
G I P L VL L + ++ G +P +L L+ L+ L + ++G I + +
Sbjct: 214 ISGQI-PSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGN 272
Query: 311 CNQLQVIALSRNNLVGQIPRSVGXXXXXXXXXXXXXXXQGTLPPELGNCGSLVDLRLQHN 370
C++L + L N+L G IPR +G G +P E+GNC +L + L N
Sbjct: 273 CSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLN 332
Query: 371 FIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITR 430
+ G+IP I L+ LE + +N+ G+IP I S LV+L L N+++G IP ++
Sbjct: 333 LLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGT 392
Query: 431 LRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGN 490
L L N L G + L L LDL+ NS G IP+ + + NL L+L +
Sbjct: 393 LTKLTLFFAWSNQLEGSIPPGLADCTD-LQALDLSRNSLTGTIPSGLFMLRNLTKLLLIS 451
Query: 491 NRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFG 550
N +G P EIG CSSL R+ L N + G +P+ + ++FLD N L G +P G
Sbjct: 452 NSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIG 511
Query: 551 FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD 610
S L M+D S N L GS+P+ + +L LQ+L +SAN+ G+IP LG+ + KL LS
Sbjct: 512 SCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSK 571
Query: 611 NYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSL-FELQLGSNIFDGSIPCSL 669
N +GSIP+ + +Q L L N LSG IP +++L L L SN G IP +
Sbjct: 572 NLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKI 631
Query: 670 SKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNI 729
+ L+ S IL++S+N L G + L N++ L L++S NSFSG +P N + F +
Sbjct: 632 ASLNKLS-ILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPD--NKL----FRQL 683
Query: 730 SFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQGN-CGKNGRGHTRGRLAGIIIGVLLSV 788
S G +T FL R+GN G +G +R R + + +L+++
Sbjct: 684 SPQDLEGNKKLCSST----QDSCFL----TYRKGNGLGDDGDA-SRTRKLRLTLALLITL 734
Query: 789 ALLCALI-YIMVVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRY--EDVIRA-TEGRIIGK 844
++ ++ + V+R R+ S L + + L + + +IR E +IGK
Sbjct: 735 TVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGK 794
Query: 845 GKHGTVYRTLSNNS-----RKHWAV-------KKLNRSETNFDVEIRTLSLVRHRNILRI 892
G G VYR +N +K W +K +F E++TL +RH+NI+R
Sbjct: 795 GCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRF 854
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+G C ++ +YMP G+L ++LH+ LDW+ RY I LG AQGL+YLH+DC+P
Sbjct: 855 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLP 913
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
I+HRDIK++NIL+ + EP I DFG++KL+ + + + GS GYIAPE YS ++
Sbjct: 914 PIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKI 973
Query: 1013 TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072
TEKSDVYSYGV++ E+L K P+DP+ E +V W R +N + LD +
Sbjct: 974 TEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVR----QNRGSLEVLDSTLRSRTE 1029
Query: 1073 DDQXXXXXXXXXXXXCTRQVADMRPSMREVVGFLIKLNDKNE 1114
+ C D RP+M++V L ++ + E
Sbjct: 1030 AEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQERE 1071
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1273 (453.2 bits), Expect = 9.3e-130, P = 9.3e-130
Identities = 346/1024 (33%), Positives = 505/1024 (49%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGK 159
S+DL+G +G++ + L+ L ++ N G IP ++ + L LDL N G
Sbjct: 71 SVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGV 130
Query: 160 IPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSXXXXXXXXXXXXPEFPNSCAILH 219
IP Q+++ +L+ + N+L G +P I +L L+ P P+ +
Sbjct: 131 IPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIP--PSMAKLRQ 188
Query: 220 LLI---HENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNL 276
L I N F G +P+ +S C +L + N G++ + K L L L L N L
Sbjct: 189 LRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEK-LQNLTDLILWQNRL 247
Query: 277 EGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGXXX 336
G+IP ++ + L+ L L N G+I +I +++ + L N L G+IPR +G
Sbjct: 248 SGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLI 307
Query: 337 XXXXXXXXXXXXQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRI 396
G +P E G+ +L L L N + G IP E+ L LE L L NR+
Sbjct: 308 DAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRL 367
Query: 397 EGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHF 456
G IP ++ + LV+L L++N+L G+IPP I N L ++ N L+G + + F
Sbjct: 368 NGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCR-F 426
Query: 457 PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNL 516
L L L N G IP ++ +L L+LG+N+ GS PIE+ +L + L N
Sbjct: 427 QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486
Query: 517 LQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNL 576
L G++ A L + + L + N G IPP G + + + S N+L+G IP ELG+
Sbjct: 487 LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546
Query: 577 ENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENN 636
+Q L LS NK G I ELG+ + L LSDN L G IP L ++ L L N
Sbjct: 547 VTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNL 606
Query: 637 LSGAIPDAFSSVQSL-FELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG 695
LS IP + SL L + N G+IP SL L IL +++NKLSG+IP +G
Sbjct: 607 LSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLE-ILYLNDNKLSGEIPASIG 665
Query: 696 NLDKLQILDLSSNSFSGEIP-TEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFL 754
NL L I ++S+N+ G +P T V + N + NH G + + P S
Sbjct: 666 NLMSLLICNISNNNLVGTVPDTAVFQRMDSS--NFAGNH--GLCNSQRSHCQPLVPHS-- 719
Query: 755 GNSELCRQGNCGKNGRGHTRGRLAGIIIGVLLSVALLCALIYIMVVRVLRSKCFS--DPS 812
+S+L N NG R ++ I V+ SV L+ L ++ R F +
Sbjct: 720 -DSKL----NWLINGS--QRQKILTITCIVIGSVFLITFLGLCWTIK-RREPAFVALEDQ 771
Query: 813 LLQDVQSRSEDLPRDLRYEDVIRAT----EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN 868
DV + Y+ ++ AT E ++G+G GTVY+ + AVKKLN
Sbjct: 772 TKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVI-AVKKLN 830
Query: 869 R------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE 922
S+ +F EI TL +RHRNI+++ G C ++ EYM G+L L + E
Sbjct: 831 SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGE 890
Query: 923 PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982
+LDWN RY IALG A+GL YLH+DC PQI+HRDIKS+NILLD + +GDFG++KL
Sbjct: 891 KNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKL 950
Query: 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042
I S+S S SA+ GS GYIAPE AY+ ++TEK D+YS+GV+L EL+ K PV P +
Sbjct: 951 IDLSYSKSM-SAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQG 1008
Query: 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQXXXXXXXXXXXXCTRQVADMRPSMREV 1102
D+V W R ++ I D + D CT RP+MREV
Sbjct: 1009 GDLVNWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
Query: 1103 VGFL 1106
V +
Sbjct: 1069 VAMI 1072
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LVP0 | Y5639_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.3712 | 0.8990 | 0.9128 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00120279 | hypothetical protein (1145 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1119 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-137 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-49 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-27 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-18 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-17 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-16 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-13 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 438 bits (1128), Expect = e-137
Identities = 328/1082 (30%), Positives = 496/1082 (45%), Gaps = 180/1082 (16%)
Query: 30 LVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSI 89
L+ F S+ + WN S C W G++C NNSS + +++LSG +SG ++++I
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSADV---CLWQGITC-NNSSRVVSIDLSGKNISGKISSAI 89
Query: 90 SYICKNQHLLSLDLSGNEFTGSIPKQL-GNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSW 148
+ ++ +++LS N+ +G IP + L+ L L++N F GSIP
Sbjct: 90 FRL---PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP----------- 135
Query: 149 LDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLL 208
G IP +LE++ NN L+GE+PNDI S LK L L N L
Sbjct: 136 --------RGSIP-------NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL---- 176
Query: 209 PEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEV 268
VG +P SL+N L LE
Sbjct: 177 -------------------VGKIPNSLTN-------------------------LTSLEF 192
Query: 269 LYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQI 328
L L N L GQIP L +++L+ + L N L+G I +I L + L NNL G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 329 PRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV 388
P S+GNL +L L L+ N+L G +PP + + L+ L L N + G IP + L LE+
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 389 LYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEV 448
L+LF +N TG+IP +T L LQ L L N +GE+
Sbjct: 313 LHLF------------------------SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 449 ALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLR 508
LGKH L+ LDL+ N+ G IP +C NLF L+L +N G P +G C SLR
Sbjct: 349 PKNLGKH-NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR 407
Query: 509 RVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGS 568
RV L +N G LP+ + P V FLD+ N LQG I +L ML + N+ G
Sbjct: 408 RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467
Query: 569 IPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQ 628
+P G+ + L+ L LS N+ G +P +LG +++++L LS+N L+G IP E+ S +K+
Sbjct: 468 LPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526
Query: 629 SLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSG 688
SL L N LSG IP +FS + L +
Sbjct: 527 SLDLSHNQLSGQIPASFSEMPVLSQ----------------------------------- 551
Query: 689 KIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVS 748
LDLS N SGEIP + N+ SL VNIS NH G LP++ L ++
Sbjct: 552 --------------LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAIN 597
Query: 749 YPGSFLGNSELCRQGN------CGKNGRGHTRGRLAGIIIGVLLSVALLC-ALIYIMVVR 801
+ GN +LC C + + + +G L +AL+ ++I
Sbjct: 598 -ASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRN 656
Query: 802 VLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRA-TEGRIIGKGKHGTVYRTLSNNSRK 860
L K + ++Q + + + D++ + E +I +GK G Y+ S +
Sbjct: 657 NLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGM 716
Query: 861 HWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ 920
+ VK++N + EI + ++H NI++++G C ++ +++ EY+ G L VL
Sbjct: 717 QFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980
L W R IA+GIA+ L +LH C P ++ ++ + I++D + EP + +
Sbjct: 777 ------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLP 829
Query: 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFG 1040
L+ SA Y+APE + +TEKSD+Y +G+IL ELL K P D FG
Sbjct: 830 GLLCTDTKCFISSA------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG 883
Query: 1041 EDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMR 1100
IV W R+ + H ++D I S +Q + + ++ LAL CT RP
Sbjct: 884 VHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 1101 EV 1102
+V
Sbjct: 943 DV 944
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 77/204 (37%), Positives = 114/204 (55%), Gaps = 19/204 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIVGSC 896
+G+G GTVY + K A+K + + +++ + EI L + H NI+++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
+ H ++V EY GG+L ++L +NE + L + I L I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH-SN--GIIH 115
Query: 957 RDIKSDNILLDS-ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-NAYSTRLTE 1014
RD+K +NILLDS + K+ DFG+SKL++ S IVG+ Y+APE +E
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 1015 KSDVYSYGVILFEL-----LFRKM 1033
KSD++S GVIL+EL L RKM
Sbjct: 174 KSDIWSLGVILYELPELKDLIRKM 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 75/271 (27%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIV 893
+G+G G VY + K A+K + + + D EI+ L ++H NI+R+
Sbjct: 4 LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLY 63
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
++ ++V EY GG LF++L + RL D R+ I L YLH
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDE-ARF-YLRQILSALEYLHSK---G 117
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
I+HRD+K +NILLD + K+ DFG+++ + +T VG+ Y+APE
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLGKGYG 174
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073
+ D++S GVIL+ELL K P F D ++ + + WD
Sbjct: 175 KAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPF------PPPEWDIS 224
Query: 1074 DQLKAL--RLLELALECTRQVADMRPSMREV 1102
+ K L +LL + R + E
Sbjct: 225 PEAKDLIRKLLVK-------DPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 5e-49
Identities = 90/278 (32%), Positives = 129/278 (46%), Gaps = 35/278 (12%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNIL 890
R +G G GTVY+ + K AVK L + EIR L + H NI+
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
R++ + +H ++V EY GG LF+ L + P L + IAL I +GL YLH +
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN- 117
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
IIHRD+K +NILLD KI DFG++K + SSS+ + VG+ Y+APE
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065
N Y K DV+S GVIL+ELL K P D ++ L+
Sbjct: 174 NGYGP----KVDVWSLGVILYELLTGKPPFSGENILD------QLQLIRRILGPP--LEF 221
Query: 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103
+ W S + +L +C + RP+ E++
Sbjct: 222 DEPKWSSGSE----EAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 5e-44
Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 52/289 (17%)
Query: 837 TEGRIIGKGKHGTVYR-TLSNNSRKHW---AVKKLNRSETN-----FDVEIRTLSLVRHR 887
T G+ +G+G G VY+ L K AVK L + F E R + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
N+++++G CT++E +IV EYM GG L + L +N P+ L + AL IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS---HSSSTRSAIVGSLGYIAP 1004
IHRD+ + N L+ L KI DFG+S+ + D + I ++AP
Sbjct: 120 -SK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI----RWMAP 172
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE-------DTDIVTWTRWKLQENH 1057
E+ + T KSDV+S+GV+L+E+ + GE + +++ + L+ +
Sbjct: 173 ESLKEGKFTSKSDVWSFGVLLWEIF--------TLGEQPYPGMSNEEVLEY----LKNGY 220
Query: 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
L + + + L +L L+C + + RP+ E+V L
Sbjct: 221 ----RLPQPPN--CPPE------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 84/289 (29%), Positives = 137/289 (47%), Gaps = 51/289 (17%)
Query: 837 TEGRIIGKGKHGTVYR-TLSNNSRKHW---AVKKLNRSET-----NFDVEIRTLSLVRHR 887
T G+ +G+G G VY+ TL AVK L + F E R + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
NI++++G CT++E IV EYMPGG L + L +N P+ L + AL IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE 120
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS---HSSSTRSAIVGSLGYIAP 1004
IHRD+ + N L+ L KI DFG+S+ + D + I ++AP
Sbjct: 121 -SK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI----RWMAP 173
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE-------DTDIVTWTRWKLQENH 1057
E+ + T KSDV+S+GV+L+E+ + GE + +++ + L++ +
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIF--------TLGEEPYPGMSNAEVLEY----LKKGY 221
Query: 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
L + + + L +L L+C + + RP+ E+V L
Sbjct: 222 ----RLPKPPN--CPPE------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 41/284 (14%)
Query: 837 TEGRIIGKGKHGTVYR----TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHR 887
G+ +G+G G VY+ + AVK L F E + + H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
NI+R++G CT+ E +IVTEYMPGG L + L ++ +L L +AL IA+G+ YL
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE 119
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
+HRD+ + N L+ L KI DFG+S+ I + R + ++APE+
Sbjct: 120 -SK--NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067
+ T KSDV+S+GV+L+E+ + GE + N E + L+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIF--------TLGEQP-------YPGMSNEEVLELLED-- 219
Query: 1068 SFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFL 1106
+L L EL L+C + RP+ E+V L
Sbjct: 220 -----GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 75/287 (26%), Positives = 129/287 (44%), Gaps = 46/287 (16%)
Query: 840 RIIGKGKHGTVYR---TLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILR 891
+ +G+G G VY+ + AVK L + + E R + + H N++R
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL------VLDWNTRYHIALGIAQGLSY 945
++G CT++E ++V EYM GG L + L ++ P L A+ IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
L + +HRD+ + N L+ +L KI DFG+S+ + D ++ + ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGED--TDIVTWTRWKLQENHECICFL 1063
+ T KSDV+S+GV+L+E+ + G + N E + +L
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIF--------TLGATPYPGLS---------NEEVLEYL 220
Query: 1064 DR----EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
+ + D+ L EL L C + + RP+ E+V L
Sbjct: 221 RKGYRLPKPEYCPDE------LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 68/198 (34%), Positives = 103/198 (52%), Gaps = 14/198 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSC 896
IGKG G VY+ + K A+K + + E EI+ L +H NI++ GS
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII-NEIQILKKCKHPNIVKYYGSY 66
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
K + +IV E+ GG+L ++L L Y + + +GL YLH + IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLHSN---GIIH 121
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RDIK+ NILL S+ E K+ DFG+S +SD+ + +T +VG+ ++APE K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDYKA 178
Query: 1017 DVYSYGVILFELLFRKMP 1034
D++S G+ EL K P
Sbjct: 179 DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 6e-37
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNIL 890
T G ++G+G G+VY L ++ + AVK + S + + EIR LS ++H NI+
Sbjct: 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 891 RIVGSCTKDEHGF--IVTEYMPGGTLFNVLHQNEPRLVLDWNT--RYHIALGIAQGLSYL 946
R GS +E I EY+ GG+L ++L + L +Y I +GL+YL
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK---LPEPVIRKY--TRQILEGLAYL 117
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H + I+HRDIK NIL+DS+ K+ DFG +K + D + ++ G+ ++APE
Sbjct: 118 HSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 1007 AYSTRLTEKSDVYSYGVILFELL 1029
+D++S G + E+
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMA 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 7e-34
Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 27/223 (12%)
Query: 814 LQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN----R 869
L+D+ S E PR+L Y+++ + IG+G G VY+ + K A+KK+
Sbjct: 8 LKDIVS--EGDPREL-YKNLEK------IGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58
Query: 870 SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDW 929
E + EI + +H NI+ S + ++V EYM GG+L +++ QN R+
Sbjct: 59 KELIIN-EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRM---- 113
Query: 930 NTRYHIA---LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986
IA + QGL YLH +IHRDIKSDNILL + K+ DFG + ++
Sbjct: 114 -NEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169
Query: 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
S R+++VG+ ++APE K D++S G++ E+
Sbjct: 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 34/208 (16%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIV 893
+ IGKG G VY + K + +K+++ S + E++ L + H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQ----NEP---RLVLDWNTRYHIALGIAQGLSYL 946
S + IV EY GG L + + +P +LDW + + L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKYL 119
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPE 1005
H +I+HRDIK NI L S K+GDFG+SK L S + T +VG+ Y++PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT---VVGTPYYLSPE 173
Query: 1006 ----NAYSTRLTEKSDVYSYGVILFELL 1029
Y+ KSD++S G +L+EL
Sbjct: 174 LCQNKPYN----YKSDIWSLGCVLYELC 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 28/210 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNF----DVEIRTLSLVRHRNILRIVGSC 896
+G+G G VY+ + K +A+KK++ + F E++TL +++ G+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
K+ IV EYM GG+L ++L + EP L IA I +GL YLH
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQILKGLDYLHTK--R 119
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAY 1008
IIHRDIK N+L++S+ E KI DFG+SK++ + + + VG++ Y++PE +Y
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN--TLDQCNTFVGTVTYMSPERIQGESY 177
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPS 1038
S +D++S G+ L E K P P
Sbjct: 178 SY----AADIWSLGLTLLECALGKFPFLPP 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 2e-29
Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 23/257 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-------EIRTLSLVRH-RNIL 890
R +G+G G VY K A+K L + + EI+ L+ + H NI+
Sbjct: 5 LRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
++ + ++V EY+ GG+L ++L + + L + I I L YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 951 VPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSSST----RSAIVGSLGYIAPE 1005
IIHRDIK +NILLD + K+ DFG++KL+ D S+S+ S VG+ GY+APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 1006 NAYSTRL---TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062
L + SD++S G+ L+ELL P + + L+ +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPF-EGEKNSSATSQTLKIILELPTPSLAS 237
Query: 1063 LDREISFWDSDDQLKAL 1079
+ L
Sbjct: 238 PLSPSNPELISKAASDL 254
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 61/201 (30%), Positives = 106/201 (52%), Gaps = 12/201 (5%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET----NFDVEIRTLSLVRHRNILRIVG 894
R +G G G V+ L N + A+K L + +F E++ L +RH++++ +
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
C+ E +I+TE M G+L L E + VL + +A +A+G++YL
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ---NS 125
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
IHRD+ + NIL+ +L K+ DFG+++LI + S+ I + APE A +
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFST 183
Query: 1015 KSDVYSYGVILFELLFR-KMP 1034
KSDV+S+G++L+E+ ++P
Sbjct: 184 KSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 27/207 (13%)
Query: 840 RIIGKGKHGTV----YRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNIL 890
+ +G+G G V Y L +N+ + AVK LN S ++F+ EI L + H NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 891 RIVGSCTKDEHGF---IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
+ G C K G ++ EY+P G+L + L ++ ++ L + + I +G+ YL
Sbjct: 70 KYKGVCEKP-GGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLG 126
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG-----YI 1002
+ IHRD+ + NIL++SE KI DFG++K++ + V G +
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY----VKEPGESPIFWY 179
Query: 1003 APENAYSTRLTEKSDVYSYGVILFELL 1029
APE +++ + SDV+S+GV L+EL
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 67/196 (34%), Positives = 105/196 (53%), Gaps = 15/196 (7%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGS 895
R +G G+ G V+ N + K AVK L S F E + + +RH ++++
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
C+++E +IVTEYM G+L + L E + L +A IA+G++YL +Y
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRNY---- 124
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
IHRD+ + NIL+ L KI DFG+++LI D ++ A + + APE A R
Sbjct: 125 --IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-PIKWTAPEAANYGRF 181
Query: 1013 TEKSDVYSYGVILFEL 1028
T KSDV+S+G++L E+
Sbjct: 182 TIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 842 IGKGKHGTVYRT--LSNNSRKHWAVKKLN--RSETNFDV---EIRTLSLVRHRNILRIVG 894
IG G VY L NN + A+K+++ + +T+ D E++ +S H N+++
Sbjct: 9 IGVGATAVVYAAICLPNNEKV--AIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
S + ++V Y+ GG+L +++ + PR LD + + +GL YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDS--HSSSTRSAIVGSLGYIAPE-----NA 1007
IHRDIK+ NILL + KI DFG+S ++D + R VG+ ++APE +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 1008 YSTRLTEKSDVYSYGVILFEL 1028
Y K+D++S+G+ EL
Sbjct: 184 Y----DFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 17/201 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVG 894
+GKG G V ++ K +A+K L + + + E LS + H I+++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH-YDCVPQ 953
+ +E ++V EY PGG LF+ L E R + R++ A I L YLH
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEER-ARFYAA-EIVLALEYLHSLG---- 113
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
II+RD+K +NILLD++ K+ DFG++K S S T + G+ Y+APE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNT-FCGTPEYLAPEVLLGKGYG 171
Query: 1014 EKSDVYSYGVILFELLFRKMP 1034
+ D +S GV+L+E+L K P
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 65/197 (32%), Positives = 102/197 (51%), Gaps = 14/197 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIV 893
R++G+G G V+ +K +K++ E + L L+ H NI+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ +D+ IV EY PGGTL + Q +LD +T H + I L ++H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVH---TKL 121
Query: 954 IIHRDIKSDNILLDS-ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
I+HRD+K+ NILLD ++ KIGDFG+SK++S S S +VG+ YI+PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPY 178
Query: 1013 TEKSDVYSYGVILFELL 1029
+KSD+++ G +L+EL
Sbjct: 179 NQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 28/204 (13%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRI 892
G +IG+G G VY+ L+ + A+K+++ + + EI L ++H NI++
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP---RLVLDWNTRYHIALGIAQ---GLSYL 946
+GS + +I+ EY G+L ++ + P LV Y + Q GL+YL
Sbjct: 65 IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV----AVY-----VYQVLQGLAYL 115
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDSHSSSTRSAIVGSLGYIAPE 1005
H +IHRDIK+ NIL + K+ DFG++ KL S ++ +VG+ ++APE
Sbjct: 116 HEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPE 169
Query: 1006 NAYSTRLTEKSDVYSYGVILFELL 1029
+ + SD++S G + ELL
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN--RSETNFDV----EIRTLSLVRHRNILRIV 893
IG+G +G VY+ + + + A+KK+ + F + EI+ L +RH NI+R+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 894 GSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
T G ++V EYM L +L E + + + +GL YLH +
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES-QIK-CYMKQLLEGLQYLHSN-- 119
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-ST 1010
I+HRDIK NIL++++ K+ DFG+++ + +S+ + ++ +L Y PE +T
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGAT 177
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
R + D++S G IL EL K
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 71/202 (35%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDV-EIRTLSLVRHRNILRIVGS 895
IGKG G V++ + ++ +A+K K+NR E + E R L+ + I+R S
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLH-QNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
IV EY G L +L Q L D R+ I + + GL++LH +I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL--GLAHLHSK---KI 122
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
+HRDIKS N+ LD+ KIGD G++KL+SD +++ + IVG+ Y++PE E
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 1015 KSDVYSYGVILFELLFRKMPVD 1036
KSDV++ GV+L+E K P D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-------NFDVEIRTLSLVRHRNILRIVG 894
I KG +G V+ ++ +A+K + +++ E LS + ++++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
S ++ ++V EY+PGG L ++L LD + I L YLH + I
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GI 114
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSK--LISDSHSSSTRSA----IVGSLGYIAPENAY 1008
IHRD+K DNIL+DS K+ DFG+SK L+ + + IVG+ YIAPE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
++ D +S G IL+E L P F +T
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGI----PPFHGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGSC 896
R +G G+ G V+ L NN+ AVK L +F E + + +RH ++++ C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQ 953
T +E +IVTE M G+L L R L +A +A G++YL +Y
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNY----- 124
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRD+ + N+L+ K+ DFG++++I + + R + + APE A R +
Sbjct: 125 -IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFS 182
Query: 1014 EKSDVYSYGVILFELL-FRKMP 1034
KSDV+S+G++L E++ + +MP
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 62/294 (21%)
Query: 840 RIIGKGKHGTVYR-TLSNNSRKHW--AVKKLNRSET-----NFDVEIRTLSLVRHRNILR 891
++IG G+ G V R L +K A+K L + +F E + H NI+R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ G TK I+TEYM G+L L +N+ + + GIA G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGMLRGIASGMKYLSEMNY 127
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
+HRD+ + NIL++S L K+ DFG+S+ + DS ++ T + + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071
T SDV+S+G++++E++ S+GE +WD
Sbjct: 185 FTSASDVWSFGIVMWEVM--------SYGER-------------------------PYWD 211
Query: 1072 SDDQ--LKALR--------------LLELALECTRQVADMRPSMREVVGFLIKL 1109
+Q +KA+ L +L L+C ++ + RP+ ++V L K+
Sbjct: 212 MSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 56/193 (29%), Positives = 100/193 (51%), Gaps = 15/193 (7%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV--EIRTLSLVRHRNILRIVGSCTK 898
+G+G +G+VY+ + + + A+K + E ++ EI L I++ GS K
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL---GIAQGLSYLHYDCVPQII 955
+ +IV EY G++ +++ L T IA +GL YLH + + I
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTL-----TEEEIAAILYQTLKGLEYLHSN---KKI 121
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRDIK+ NILL+ E + K+ DFG+S ++D+ + R+ ++G+ ++APE K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNK 179
Query: 1016 SDVYSYGVILFEL 1028
+D++S G+ E+
Sbjct: 180 ADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
G IGKG+ G V + AVK L T F E ++ +RH N+++++G
Sbjct: 11 GATIGKGEFGDVMLGDYRG--QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ +IVTEYM G+L + L R V+ + AL + +G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL--GYIAPENAYSTRLT 1013
HRD+ + N+L+ +L K+ DFG++K S S G L + APE + +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-------GKLPVKWTAPEALREKKFS 177
Query: 1014 EKSDVYSYGVILFEL 1028
KSDV+S+G++L+E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN--------RSETN-FDVEIRTLSLVRHRNI 889
G+++G+G G VY ++ + AVK++ + E N + EI+ L ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
++ G DE I EYMPGG++ + L L I +G+ YLH +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSN 123
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST-RSAIVGSLGYIAPENAY 1008
I+HRDIK NIL DS K+GDFG SK + SS T ++ G+ +++PE
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMP 1034
K+DV+S G + E+L K P
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 68/215 (31%), Positives = 113/215 (52%), Gaps = 28/215 (13%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETN------------FDVEIRTLSLV 884
G +IGKG +G VY L+ + + AVK+ L + EI TL +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 885 RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---EPRLVLDWNTRYHIALGIAQ 941
H NI++ +G T +E+ I EY+PGG++ + L E +LV + +
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV------RFFTEQVLE 119
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
GL+YLH I+HRD+K+DN+L+D++ KI DFG+SK D + + ++ GS+ +
Sbjct: 120 GLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 1002 IAPE--NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+APE ++YS + K D++S G ++ E+ + P
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 81/287 (28%), Positives = 137/287 (47%), Gaps = 41/287 (14%)
Query: 837 TEGRIIGKGKHGTVYR---TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRN 888
T+ ++IG G+ G V+R + A+K L + +F E + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL--GIAQGLSYL 946
I+R+ G TK + I+TEYM G L L ++ ++++ + + GIA G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL 123
Query: 947 ---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS-HSSSTRSAIVGSLGYI 1002
+Y +HRD+ + NIL++S LE K+ DFG+S+++ D + T S + +
Sbjct: 124 SDMNY------VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 1003 APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062
APE + T SDV+S+G++++E++ SFGE W + NHE +
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVM--------SFGER------PYWDMS-NHEVMKA 222
Query: 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
++ D A+ +L L+C +Q RP ++V L KL
Sbjct: 223 INDGFRLPAPMDCPSAVY--QLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 16/198 (8%)
Query: 842 IGKGKHGTV----YRTLSNNSRKHWAVKKLNRSET----NFDVEIRTLSLVRHRNILRIV 893
+GKG G+V Y L +N+ + AVKKL S +F+ EI L ++H NI++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 894 GSC-TKDEHGF-IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
G C + +V EY+P G+L + L ++ RL D A I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLLYASQICKGMEYLG---S 126
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLI-SDSHSSSTRSAIVGSLGYIAPENAYST 1010
+ +HRD+ + NIL++SE KIGDFG++K++ D R + + APE+ +
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 1011 RLTEKSDVYSYGVILFEL 1028
+ + SDV+S+GV+L+EL
Sbjct: 187 KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 33/261 (12%)
Query: 863 AVKKLNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNV 917
AVK L + +F E++ LS + NI R++G CT D ++ EYM G L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 918 LHQNEPR--------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969
L ++ L ++T ++A IA G+ YL +HRD+ + N L+
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKN 166
Query: 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL- 1028
KI DFGMS+ + S + + ++A E+ + T KSDV+++GV L+E+
Sbjct: 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEIL 226
Query: 1029 -LFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALR--LLELA 1085
L R+ P + TD + ++ R+I + + EL
Sbjct: 227 TLCREQP----YEHLTD-----QQVIENAGHFFRDDGRQIYL----PRPPNCPKDIYELM 273
Query: 1086 LECTRQVADMRPSMREVVGFL 1106
LEC R+ + RP+ RE+ FL
Sbjct: 274 LECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEI----RTLSLVRHRNILRIVG 894
+G G G V + + +A+K + + ET I L H I+++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ ++ +++ EY GG L+ +L L ++ R++IA + YLH I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIA-CVVLAFEYLHNR---GI 114
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
I+RD+K +N+LLDS K+ DFG +K + + T G+ Y+APE +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYDF 171
Query: 1015 KSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
D +S G++L+ELL + P FGED +
Sbjct: 172 SVDYWSLGILLYELLTGRPP----FGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 64/220 (29%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 840 RIIGKGKHGTVYR-TLSN----NSRKHWAVKKL-----NRSETNFDVEIRTLSLVRHRNI 889
R +G+G G V+ + N ++ AVK L N + +F+ E L+ +H NI
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV-----------LDWNTRYHIALG 938
++ G CT+ + +V EYM G L L + P L + IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 939 IAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995
IA G+ YL H+ +HRD+ + N L+ +L KIGDFGMS+ + +
Sbjct: 131 IASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
+ + ++ PE+ + T +SDV+S+GV+L+E+ + K P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 63/196 (32%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 840 RIIGKGKHGTVYR-TLSNNSRKHWAVKKLNRSET-----NFDVEIRTLSLVRHRNILRIV 893
IGKG G VY+ L N+ AVK + F E L H NI++++
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV--AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G C + + +IV E +PGG+L L + + RL + ++L A G+ YL
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNC-- 114
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDS--HSSSTRSAIVGSLGYIAPENAYSTR 1011
IHRD+ + N L+ KI DFGMS+ S I + + APE R
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGR 171
Query: 1012 LTEKSDVYSYGVILFE 1027
T +SDV+SYG++L+E
Sbjct: 172 YTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/197 (32%), Positives = 100/197 (50%), Gaps = 22/197 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIVGSC 896
IGKG G VY+ + + + A+K ++ E ++ EI+ LS R I + GS
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
K +I+ EY GG+ ++L +P LD I + GL YLH + IH
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL---KPG-KLDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAYSTRL 1012
RDIK+ NILL E + K+ DFG+S ++ + S R+ VG+ ++APE + Y
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTS--TMSKRNTFVGTPFWMAPEVIKQSGYD--- 176
Query: 1013 TEKSDVYSYGVILFELL 1029
EK+D++S G+ EL
Sbjct: 177 -EKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/217 (33%), Positives = 119/217 (54%), Gaps = 29/217 (13%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKL----------NRSETNFDVEIRTLSLVR-- 885
+G +IG G G+VY ++ +S + AVK++ +R + D R ++L++
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 886 -HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---EPRLVLDWNTRYHIALGIAQ 941
H NI++ +GS +H I EY+PGG++ +L+ E LV ++ + I +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILK 117
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST----RSAIVG 997
GL+YLH IIHRDIK NIL+D++ KI DFG+SK + + S+ R ++ G
Sbjct: 118 GLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
S+ ++APE T T K+D++S G ++ E+L K P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 58/197 (29%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-NFDV---EIRTLSLVRHRNILRIVGSCT 897
IG G +G VY+ + + A+K + +F++ EI L RH NI+ GS
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ + +IV EY GG+L ++ L + + R L +GL+YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE--TL---KGLAYLHET---GK 122
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE---NAYSTR 1011
IHRDIK NILL + + K+ DFG+S + + + + R + +G+ ++APE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 1012 LTEKSDVYSYGVILFEL 1028
K D+++ G+ EL
Sbjct: 181 YDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 5e-23
Identities = 80/285 (28%), Positives = 134/285 (47%), Gaps = 43/285 (15%)
Query: 841 IIGKGKHGTVYR-TLSNNSRKHW--AVKKL-----NRSETNFDVEIRTLSLVRHRNILRI 892
+IG G+ G V R L ++ A+K L + +F E + H NI+ +
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL-----GIAQGLSYLH 947
G TK I+TE+M G L + L QN+ + + I L GIA G+ YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-------IQLVGMLRGIAAGMKYL- 122
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS---LGYIAP 1004
+HRD+ + NIL++S L K+ DFG+S+ + D S T ++ +G + + AP
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E + T SDV+SYG++++E++ S+GE W + N + I ++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVM--------SYGER------PYWDMS-NQDVINAIE 225
Query: 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
++ D AL +L L+C ++ + RP ++V L K+
Sbjct: 226 QDYRLPPPMDCPTALH--QLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 68/201 (33%), Positives = 102/201 (50%), Gaps = 22/201 (10%)
Query: 840 RIIGKGKHG--TVYRTLSNNSRKHWAVKKLNR-SETNFDV---EIRTLSLVRHRNILRIV 893
R++GKG G T+YR ++S W L R SE EI LSL++H NI+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 894 GSCTKDEHGFIVTEYMPGGTLFN-VLHQN----EPRLVLDWNTRYHIALGIAQGLSYLHY 948
D I EY GGTL++ ++ Q E +VL + I +SY+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSAVSYIHK 119
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
I+HRDIK+ NI L K+GDFG+SK++ +S + +VG+ Y++PE
Sbjct: 120 A---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQ 174
Query: 1009 STRLTEKSDVYSYGVILFELL 1029
+ KSD+++ G +L+ELL
Sbjct: 175 GVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 65/205 (31%), Positives = 113/205 (55%), Gaps = 22/205 (10%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGSC 896
+ +G G+ G V+ NNS K AVK L S F E + ++H ++R+
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNE------PRLVLDWNTRYHIALGIAQGLSYLHYDC 950
TK+E +I+TEYM G+L + L +E P+L+ D++ + IA+G++Y+
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-DFSAQ------IAEGMAYIERK- 122
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
IHRD+++ N+L+ L KI DFG++++I D+ ++ A + + APE
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 179
Query: 1011 RLTEKSDVYSYGVILFELL-FRKMP 1034
T KSDV+S+G++L+E++ + K+P
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 65/214 (30%), Positives = 112/214 (52%), Gaps = 25/214 (11%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV----------EIRTLSLVRH 886
T+G ++GKG +GTVY L+N + AVK++ +N E+ L ++H
Sbjct: 3 TKGEVLGKGAYGTVYCGLTNQG-QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ--NEPRLVLDWNTRYHIALGIAQGLS 944
NI++ +G+C D I E++PGG++ ++L++ P V T+ I G++
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVA 116
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG---- 1000
YLH +CV +HRDIK +N++L K+ DFG ++ ++ T S ++ S+
Sbjct: 117 YLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
++APE + KSD++S G +FE+ K P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSET----NFDVEIRTLSLVRHRNILRI 892
G IG G G VY ++ ++ + AVK ++ ++ E++ L L++H N+++
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLH--QNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
G E +I EY GGTL +L + V+ Y L + +GL+YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVY--TLQLLEGLAYLHSH- 118
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG---YIAPENA 1007
I+HRDIK NI LD K+GDFG + + +++++ + G Y+APE
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 1008 YSTRLTEK---SDVYSYGVILFELLFRKMP 1034
+ +D++S G ++ E+ K P
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIV 893
T + +G G+ G V+ A+K + SE +F E + + + H N++++
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKI-DVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G CTK FIVTEYM G L N L + + +L +W + + + + YL +
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGF-- 121
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
IHRD+ + N L+ + K+ DFG+++ ++ D ++SS + + + PE +R
Sbjct: 122 -IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRF 178
Query: 1013 TEKSDVYSYGVILFELLFR-KMPVD 1036
+ KSDV+S+GV+++E+ KMP +
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 33/222 (14%)
Query: 837 TEGRIIGKGKHGTVYRTL-----SNNSRKHWAVKKL-----NRSETNFDVEIRTLSLVRH 886
T R +G G G VY L + AVK L + E++F +E +S H
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV----LDWNTRYHIALGIAQG 942
+NI+R++G + FI+ E M GG L + L +N PR L A +A+G
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 943 LSYL---HYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLI--SDSHSSSTRS 993
YL H+ IHRDI + N LL + P KI DFGM++ I + + R+
Sbjct: 129 CKYLEENHF------IHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRA 181
Query: 994 AIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
+ + ++ PE T K+DV+S+GV+L+E+ MP
Sbjct: 182 ML--PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-22
Identities = 71/236 (30%), Positives = 120/236 (50%), Gaps = 26/236 (11%)
Query: 824 LPRDLRYE-DVIRATEGRIIGKGKHG-----TVYRTLSNNSRKHWAVKKL----NRSETN 873
LP DL++E + G+ +G G G T Y +++ AVK L + SE
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 874 -FDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNT 931
E++ +S L H NI+ ++G+CT ++TEY G L N L + L
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR-ESFLTLED 142
Query: 932 RYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI-SDSHSS 989
+ +A+G+++L +C IHRD+ + N+LL KI DFG+++ I +DS+
Sbjct: 143 LLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL------FRKMPVDPSF 1039
+A + + ++APE+ ++ T +SDV+SYG++L+E+ + MPVD F
Sbjct: 199 VKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF 253
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 59/199 (29%), Positives = 108/199 (54%), Gaps = 15/199 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN--FDVEIRTLSLVRHRNILRIVGSCT 897
+ IGKG+ G V L + AVK + T F E ++ +RH N+++++G
Sbjct: 12 QTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 898 KDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
+++ G +IVTEYM G+L + L ++ R VL + +L + + + YL + +H
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RD+ + N+L+ + K+ DFG++K +SST+ + + APE + + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 1017 DVYSYGVILFELL-FRKMP 1034
DV+S+G++L+E+ F ++P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 55/194 (28%), Positives = 103/194 (53%), Gaps = 16/194 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSET----NFDVEIRTLSLVRHRNILRIVGSCT 897
+G G++G VY + AVK L + +T F E + ++H N+++++G CT
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957
++ +I+TE+M G L + L + R ++ ++A I+ + YL IHR
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHR 128
Query: 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS---LGYIAPENAYSTRLTE 1014
D+ + N L+ K+ DFG+S+L++ T +A G+ + + APE+ + +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 1015 KSDVYSYGVILFEL 1028
KSDV+++GV+L+E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTLS-LVRHRNIL 890
G+IIG+G TV + K +A+K L++ + +E L+ L H I+
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
++ + +E+ + V EY P G L + + L TR++ A I L YLH
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKC-TRFYAAE-ILLALEYLH-SK 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS------------------TR 992
IIHRD+K +NILLD ++ KI DFG +K++ + S
Sbjct: 122 --GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
++ VG+ Y++PE + SD+++ G I++++L K P
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------EIRTLSLVRHRNI 889
G ++G G G+VY L+ + +AVK+++ ++ EI LS ++H NI
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVL--HQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
++ +G+ ++++ +I E +PGG+L +L + + P V+ TR I GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLEYLH 119
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
+HRDIK NIL+D+ K+ DFGM+K + S + GS ++APE
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEVI 173
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
Y +D++S G + E+ K P
Sbjct: 174 AQQGGYGL----AADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 85/278 (30%), Positives = 131/278 (47%), Gaps = 37/278 (13%)
Query: 840 RIIGKGKHGTVYR-TL--SNNSRKHWAVKKLNRSETNFDVE--IRTLSLVR---HRNILR 891
R+IGKG G VY TL S+ + H AVK LNR +VE ++ +++ H N+L
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 892 IVGSCTKDEHG-FIVTEYMPGGTLFNVLHQNEPR--LVLDWNTRYHIALGIAQGLSYLHY 948
++G C E +V YM G L N + ++E V D L +A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI-RSETHNPTVKDL---IGFGLQVAKGMEYL-- 114
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL--GYIAPEN 1006
+ +HRD+ + N +LD K+ DFG+++ I D S + L ++A E+
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066
+ + T KSDV+S+GV+L+EL+ R P P D D T + LQ R
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVDSFDITVYLLQ---------GRR 220
Query: 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104
+ + L E+ L C +MRP+ E+V
Sbjct: 221 L----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-21
Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 61/274 (22%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIV 893
+IG+G G V+ ++ + +A+K L +S + E L+ I+++
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH---YDC 950
S +EH ++V EYMPGG L N+L + + R++IA + L +H +
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEET-ARFYIA-ELVLALDSVHKLGF-- 122
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST------------------- 991
IHRDIK DNIL+D++ K+ DFG+ K ++ +
Sbjct: 123 ----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 992 --------RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
++ VG+ YIAPE T + D +S GVIL+E+L+ P F DT
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG----FPPFYSDT 234
Query: 1044 DIVTW---TRWKLQENHECICF-LDREIS--FWD 1071
T+ WK E + F D +S D
Sbjct: 235 LQETYNKIINWK-----ESLRFPPDPPVSPEAID 263
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVRHRNILRIV---GSC 896
+G G G V + L + K AVK +L +E +R L ++ N IV G+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ I EYM GG+L +L + + P +L IA+ + +GL+YLH +
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKH--K 121
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IIHRD+K NIL++S + K+ DFG+S + +S + VG+ Y+APE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYS 177
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPS 1038
KSD++S G+ L EL + P P
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPE 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 38/207 (18%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRH---RNILRI 892
+IG+G +G VYR + + A+K +N + DV E+ LS +R NI +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQ---NEPRLVLDWNTRYHIALGIA---QGLSYL 946
GS K +I+ EY GG++ ++ E +I++ I L Y+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEK----------YISVIIREVLVALKYI 117
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE- 1005
H +IHRDIK+ NIL+ + K+ DFG++ L+ + +SS RS VG+ ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEV 172
Query: 1006 ----NAYSTRLTEKSDVYSYGVILFEL 1028
Y T K+D++S G+ ++E+
Sbjct: 173 ITEGKYYDT----KADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN-------RSETNFDVEIRTLSLVRHRNILRI 892
R+IGKG G V +++K +A+K +N S N E R L + H ++ +
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 893 VGSCTKDEHGFIVTEYMPGGTL-FNVLHQ---NEPRLVLDWNTRYHIALGIAQGLSYLHY 948
S +E+ ++V + + GG L +++ + +E + ++ I I L YLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ------VKFWIC-EIVLALEYLHS 118
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
IIHRDIK DNILLD + I DF ++ ++ +++ S G+ GY+APE
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLC 172
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMP 1034
+ D +S GV +E L K P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 38/219 (17%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----------AVKKLNRSE-----TNFDVEIRTLS 882
+++G G GTVY+ W A+K L E ++
Sbjct: 12 IKVLGSGAFGTVYKG-------VWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMA 64
Query: 883 LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE----PRLVLDWNTRYHIALG 938
V H +++R++G C + ++T+ MP G L + + ++ + +L+W +
Sbjct: 65 SVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------ 117
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998
IA+G+SYL +++HRD+ + N+L+ + KI DFG++KL+
Sbjct: 118 IAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMPVD 1036
+ ++A E+ T KSDV+SYGV ++EL+ F P +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 62/200 (31%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK-----LNRSETNFDV-EIRTLSLVRHRNILRIVGS 895
+GKG +G+VY+ + + +A+K+ +++ E V EIR L+ V H NI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
IV EY P G L + + + R ++ + I + + +GL LH +I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
+HRD+KS NILL + KIGD G+SK++ + ++ I G+ Y+APE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAPEVWKGRPYSY 180
Query: 1015 KSDVYSYGVILFELLFRKMP 1034
KSD++S G +L+E+ P
Sbjct: 181 KSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 75/219 (34%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNILRI 892
+++GKG G V + + +AVK L + D E R L+L L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 893 VGSC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYL 946
+ SC TKD F V EY+ GG L + + +EPR R++ A I GL +L
Sbjct: 61 LHSCFQTKD-RLFFVMEYVNGGDLMFHIQRSGRFDEPR------ARFY-AAEIVLGLQFL 112
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPE 1005
H II+RD+K DN+LLDSE KI DFGM K I ++ST G+ YIAPE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST---FCGTPDYIAPE 166
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
D ++ GV+L+E+L + P + G+D D
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE---GDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 72/215 (33%), Positives = 107/215 (49%), Gaps = 32/215 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKL----NRSETNFDV-----EIRTLSLVRHRNI 889
G+++G+G G VY ++ + AVK++ + ET+ +V EI+ L +RH I
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 890 LRIVGSCTKDEHG---FIVTEYMPGGTL------FNVLHQNEPRLVLDWNTRYHIALGIA 940
++ G C +D I EYMPGG++ + L +N R RY I
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-------RY--TRQIL 116
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR-SAIVGSL 999
QG+SYLH + I+HRDIK NIL DS K+GDFG SK I S T ++ G+
Sbjct: 117 QGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+++PE K+DV+S + E+L K P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-21
Identities = 69/232 (29%), Positives = 102/232 (43%), Gaps = 56/232 (24%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-FDV-----EIRTLS 882
RYE + + IG G +G V + + + A+KK++ + D EI+ L
Sbjct: 1 RYELL------KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLR 54
Query: 883 LVRHRNILRIV-----GSCTKDEHGFIVTEYMPGGT-LFNVLHQNEPRLVLDWNTRYHIA 936
+RH NI+ ++ S +IVTE M T L V+ +P L D HI
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQP-LTDD-----HIQ 106
Query: 937 LGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS--- 990
+ Q GL YLH +IHRD+K NIL++S + KI DFG+++ +
Sbjct: 107 YFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 991 -----TRSAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRK 1032
TR Y APE + Y+ + D++S G I ELL RK
Sbjct: 164 TEYVVTRW-------YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 4e-21
Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 43/285 (15%)
Query: 840 RIIGKGKHGTV-YRTLSNNSRKHW--AVKKL-----NRSETNFDVEIRTLSLVRHRNILR 891
++IG G+ G V L ++ A+K L + +F E + H NI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL-----GIAQGLSYL 946
+ G TK + IVTEYM G+L L +++ + + I L GIA G+ YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV-------IQLVGMLRGIASGMKYL 122
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--STRSAIVGSLGYIAP 1004
D +HRD+ + NIL++S L K+ DFG+S+++ D + +TR + + + AP
Sbjct: 123 S-DM--GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTAP 178
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E + T SDV+SYG++++E++ S+GE W++ N + I ++
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVM--------SYGER------PYWEMS-NQDVIKAIE 223
Query: 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
D AL +L L+C ++ + RP ++V L KL
Sbjct: 224 EGYRLPAPMDCPAALH--QLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 9e-21
Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 27/268 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGSCTK 898
+G G+ G V+ N + K AVK L S +F E + + +RH ++++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLY-AVVS 71
Query: 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRD 958
+E +IVTEYM G+L + L E R L +A +A G++Y+ IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 959 IKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDV 1018
++S NIL+ L KI DFG+++LI D+ ++ + A + + APE A R T KSDV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDV 186
Query: 1019 YSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKA 1078
+S+G++L EL+ + P + +++ +++ + C D IS
Sbjct: 187 WSFGILLTELVTKGRVPYPGM-NNREVLE----QVERGYRMPCPQDCPIS---------- 231
Query: 1079 LRLLELALECTRQVADMRPSMREVVGFL 1106
L EL L+C ++ + RP+ + FL
Sbjct: 232 --LHELMLQCWKKDPEERPTFEYLQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------EIRTLSLVRHRNIL 890
IG G +G V + S K A+KK+ + FDV E++ L +H NI+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVPTLAKRTLRELKILRHFKHDNII 67
Query: 891 RIVGSC-TKDEHG---FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ---GL 943
I ++V + M L +++H ++P L + HI + Q GL
Sbjct: 68 AIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP-LTEE-----HIRYFLYQLLRGL 120
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR--SAIVGSLGY 1001
Y+H V IHRD+K N+L++ + E +IGDFGM++ +S S + + V + Y
Sbjct: 121 KYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177
Query: 1002 IAPENAYST-RLTEKSDVYSYGVILFELLFRK 1032
APE S T D++S G I E+L R+
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL----NRSETNFDV------EIRTLSLVRH 886
+G+ +G G + Y+ + AVK++ N S +V EIR ++ + H
Sbjct: 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
+I+R++G+ +D H + E+M GG++ ++L + + + +GLSYL
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYL 119
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEP-KIGDFGMS-KLISD-SHSSSTRSAIVGSLGYIA 1003
H + QIIHRD+K N+L+DS + +I DFG + +L + + + + ++G++ ++A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 1004 PENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
PE + DV+S G ++ E+ K P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 71/221 (32%), Positives = 108/221 (48%), Gaps = 25/221 (11%)
Query: 828 LRYEDVIRATEGRII-GKGKHGTVY--RTLSNNSRKHWAVKKL----NRSETNFDVEIRT 880
L YE R++ GKG +G VY R LS R A+K++ +R EI
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVR--IAIKEIPERDSRYVQPLHEEIAL 58
Query: 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA 940
S ++HRNI++ +GS +++ I E +PGG+L +L L + T I
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGMSKLISDSHSSSTRSAIVGSL 999
+GL YLH + QI+HRDIK DN+L+++ KI DFG SK ++ + + G+L
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT--ETFTGTL 173
Query: 1000 GYIAPE------NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
Y+APE Y +D++S G + E+ K P
Sbjct: 174 QYMAPEVIDKGPRGYGA----PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 27/221 (12%)
Query: 828 LRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRK-----HWAVKKLNRSET-----NFDVE 877
L E + E +G+G G VY L+ K A+K +N + + F E
Sbjct: 3 LPREKITLIRE---LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 878 IRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH-------QNEPRLVLDWN 930
+ +++R++G + + +V E M G L + L N
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 931 TRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHS 988
+A IA G++YL + +HRD+ + N ++ +L KIGDFGM++ I +D +
Sbjct: 120 KFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ + + ++APE+ T KSDV+S+GV+L+E+
Sbjct: 177 KGGKGLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 31/262 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGSCTK 898
+G G+ G V+ N K A+K L + S F E + ++H ++R+ T+
Sbjct: 14 LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRD 958
E +I+TEYM G+L + L E + L N +A IA+G++++ IHRD
Sbjct: 73 -EPIYIITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127
Query: 959 IKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDV 1018
+++ NIL+ L KI DFG+++LI D+ ++ A + + APE T KSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDV 186
Query: 1019 YSYGVILFELLFRKMPVDPSFGEDTDIVTWTR--WKLQENHECICFLDREISFWDSDDQL 1076
+S+G++L T+IVT+ R + N E I L+R D+
Sbjct: 187 WSFGILL-----------------TEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229
Query: 1077 KALRLLELALECTRQVADMRPS 1098
+ L EL C ++ + RP+
Sbjct: 230 EE--LYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 55/181 (30%), Positives = 98/181 (54%), Gaps = 21/181 (11%)
Query: 864 VKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVL----H 919
+K+ + SE F E + + + H ++++ G CTK +IVTEYM G L N L
Sbjct: 36 IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK 95
Query: 920 QNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979
+ +P +L+ + + +G++YL Q IHRD+ + N L+D + K+ DFG+
Sbjct: 96 RFQPSQLLE------MCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGL 146
Query: 980 SKLISDSHSSSTRSAIVGS---LGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMPV 1035
S+ + D +S+ VGS + + PE ++ + KSDV+++GV+++E+ KMP
Sbjct: 147 SRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202
Query: 1036 D 1036
+
Sbjct: 203 E 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHW--AVKKLNR---SETNFDVEIRTLSLVRHRNILRIVG 894
+ +G G+ G V+ R A+K +N SE +F E + + + H ++++ G
Sbjct: 10 KELGSGQFGVVHL---GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
CT+ + +IVTE+M G L N L Q + +L D + + +G+ YL +
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN---SF 121
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
IHRD+ + N L+ S K+ DFGM++ + D +S+ A + + PE ++ +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSS 180
Query: 1015 KSDVYSYGVILFELLFR-KMP 1034
KSDV+S+GV+++E+ KMP
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 74/245 (30%), Positives = 112/245 (45%), Gaps = 29/245 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLV-RHRNILR 891
+++GKG G V + + +A+K L + D VE R L+L H +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ + EH F V EY+ GG L + H + R++ A I GL +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFY-AAEIICGLQFLHKK-- 115
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K DN+LLD + KI DFGM K + + S G+ YIAPE +
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT---------RWKLQENHEC-IC 1061
E D +S+GV+L+E+L + P GED D + + RW +E +C
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFH---GEDEDELFDSILNDRPHFPRWISKEAKDCLSK 229
Query: 1062 FLDRE 1066
+R+
Sbjct: 230 LFERD 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 81/312 (25%), Positives = 139/312 (44%), Gaps = 59/312 (18%)
Query: 824 LPRDLRYE-DVIRATEGRIIGKGKHGTV----YRTLSN-NSRKHWAVKKLNRSETNFDV- 876
LP D +E R T G+ +G+G G V L N N AVK L T D+
Sbjct: 1 LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS 60
Query: 877 ----EIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP-------- 923
E+ + ++ +H+NI+ ++G CT++ ++V EY G L + L P
Sbjct: 61 DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120
Query: 924 --RLVLDWNTRYHI---ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978
R + T+ + A +A+G+ +L + IHRD+ + N+L+ + KI DFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 979 MSKLIS--DSHSSSTRSAIVGSLGY--IAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+++ I D + +T G L +APE + T +SDV+S+GV+L+E+
Sbjct: 178 LARDIHHIDYYRKTTN----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----- 228
Query: 1035 VDPSFGED--TDIVTWTRWK-LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQ 1091
+ G I +K L+E + +++ Q L L +C +
Sbjct: 229 ---TLGGSPYPGIPVEELFKLLKEGYR----MEKP--------QNCTQELYHLMRDCWHE 273
Query: 1092 VADMRPSMREVV 1103
V RP+ +++V
Sbjct: 274 VPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 840 RIIGKGKHGTV----YRTLSNNSRKHWAVKKL---NRSETNFDV--EIRTLSLVRHRNIL 890
R +G+G G V Y +N+ + AVK L + D+ EI L + H NI+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 891 RIVGSCTKDEHGFI--VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
+ G CT+D I + E++P G+L L +N+ ++ L +Y A+ I +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY--AVQICKGMDYLGS 127
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST-RSAIVGSLGYIAPENA 1007
Q +HRD+ + N+L++SE + KIGDFG++K I T + + + + APE
Sbjct: 128 R---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 1008 YSTRLTEKSDVYSYGVILFELL 1029
++ SDV+S+GV L+ELL
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 842 IGKGKHGTVYR--TLSNNSRKHW---AVKKLNRS-----ETNFDVEIRTLSLVRHRNILR 891
+G+G G VY+ N R A+K L + + F E +S ++H NI+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALG 938
++G CTK++ ++ EY+ G L L +N P + LD + HIA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 939 IAQGLSYL--HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
IA G+ YL H+ +HRD+ + N L+ L KI DFG+S+ I + +S +
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
+ ++ PE + T +SD++S+GV+L+E+
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDV-EIRTLSLVRHRNIL---- 890
IGKG GTV + + K K+++ E V E+ L ++H NI+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ-NEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
RI+ + + IV EY GG L ++ + + R ++ + I + L H
Sbjct: 67 RIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 950 CVP--QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
P ++HRD+K NI LD+ K+GDFG++K++ H SS VG+ Y++PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPEQL 182
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMP 1034
EKSD++S G +++EL P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 6e-20
Identities = 63/192 (32%), Positives = 101/192 (52%), Gaps = 14/192 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVE-----IRTLSLVRHRNILRIVGSC 896
IGKG G V++ + N ++K A+K ++ E ++E I LS + + GS
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
KD +I+ EY+ GG+ ++L EP LD I I +GL YLH + + IH
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL---EPG-PLDETQIATILREILKGLDYLHSE---KKIH 124
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RDIK+ N+LL E K+ DFG++ ++D+ R+ VG+ ++APE + K+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 1017 DVYSYGVILFEL 1028
D++S G+ EL
Sbjct: 183 DIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-20
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 29/232 (12%)
Query: 828 LRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVK--KLNRSET---NFDVEIR 879
++ ED+ T GR IG+G+ G VY+ N + AVK K S + F E
Sbjct: 3 IQREDI---TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 880 TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
+ H +I++++G T + +IV E P G L + L N+ L L Y + +
Sbjct: 60 IMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY--SYQL 116
Query: 940 AQGLSYLH-YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS---HSSSTRSAI 995
+ L+YL V HRDI + N+L+ S K+GDFG+S+ + D +S + I
Sbjct: 117 STALAYLESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFG-EDTDIV 1046
++APE+ R T SDV+ +GV ++E+L V P G ++ D++
Sbjct: 173 ----KWMAPESINFRRFTSASDVWMFGVCMWEILMLG--VKPFQGVKNNDVI 218
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 60/195 (30%), Positives = 98/195 (50%), Gaps = 19/195 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-------NFDVEIRTLSLVRHRNILRIVG 894
IG+G GTVY + + + A+K++N + N EI + +H NI+ +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN---EILVMRENKHPNIVNYLD 83
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
S + ++V EY+ GG+L +V+ + +D + Q L +LH + Q+
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QV 136
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
IHRDIKSDNILL + K+ DFG I+ S RS +VG+ ++APE
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 1015 KSDVYSYGVILFELL 1029
K D++S G++ E++
Sbjct: 195 KVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 71/269 (26%), Positives = 126/269 (46%), Gaps = 29/269 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGSCTK 898
+G+G G V+ N + + A+K L S F E + + +RH ++++ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY-AVVS 71
Query: 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRD 958
+E +IVTEYM G+L + L + E L +A IA G++Y+ +HRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 959 IKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDV 1018
+++ NIL+ L K+ DFG+++LI D+ ++ + A + + APE A R T KSDV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDV 186
Query: 1019 YSYGVILFELLFR-KMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLK 1077
+S+G++L EL + ++P + +++ EC
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC------------------ 228
Query: 1078 ALRLLELALECTRQVADMRPSMREVVGFL 1106
L +L +C R+ + RP+ + FL
Sbjct: 229 PESLHDLMCQCWRKEPEERPTFEYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 18/218 (8%)
Query: 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRN 888
R IG+G HG V++ + + A+KK+ + EI+ L +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
+++++ +V EYMP L VL +E R + + + + +G++Y+H
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVK-SYMRMLLKGVAYMHA 117
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
+ I+HRD+K N+L+ ++ KI DFG+++L S+ V + Y APE Y
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLY 173
Query: 1009 -STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ + D+++ G I ELL P+ F + DI
Sbjct: 174 GARKYDPGVDLWAVGCIFAELL-NGSPL---FPGENDI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 64/196 (32%), Positives = 103/196 (52%), Gaps = 20/196 (10%)
Query: 841 IIGKGKHGTVYR-TLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR------HRNILRIV 893
++GKG G V++ TL K K + + +++I+ LS R H NI++++
Sbjct: 2 LLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVP 952
G CT+ + +IV E +PGG + L + + L ++ AL A G++YL +C
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKNC-- 114
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS-HSSSTRSAIVGSLGYIAPENAYSTR 1011
IHRD+ + N L+ KI DFGMS+ D +SSS I + + APE R
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGR 170
Query: 1012 LTEKSDVYSYGVILFE 1027
+ +SDV+SYG++L+E
Sbjct: 171 YSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-19
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 22/206 (10%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLV-RHRNILR 891
+++GKG G V+ + + +A+K L + D VE R LSL H +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ + E+ F V EY+ GG L F++ Q+ + L T Y A I GL +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFY--AAEIICGLQFLHSK- 115
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSK--LISDSHSSSTRSAIVGSLGYIAPENAY 1008
I++RD+K DNILLD++ KI DFGM K ++ D+ + + G+ YIAPE
Sbjct: 116 --GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT----FCGTPDYIAPEILL 169
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMP 1034
+ D +S+GV+L+E+L + P
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRT-----LSLVRHRNILRIVG 894
R++G+G G NS + +A+K++ +++ VE L+ ++H NI+
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL-----VLDWNTRYHIALGIAQGLSYLHYD 949
S D H +IV EY GG L + +L +L W + + G+ ++H
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
+++HRDIKS NI L + K+GDFG ++L+ + + VG+ Y+ PE +
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWEN 174
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMP 1034
KSD++S G IL+EL K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHW---AVK-----KLNRSETNFDVEIRTLSLVRHRNILRIV 893
+G G G V R + S AVK KL+ +F E + + H N++R+
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G +VTE P G+L + L ++ L +T A+ IA G+ YL +
Sbjct: 63 G-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLE---SKR 117
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSK--LISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
IHRD+ + NILL S+ + KIGDFG+ + ++ H V + APE+ +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRT 176
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042
+ SDV+ +GV L+E+ ++GE+
Sbjct: 177 FSHASDVWMFGVTLWEMF--------TYGEE 199
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVGS 895
IG+G +G VY+ + + A+KK+ + + EI+ L + H NI++++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
++V E+M L+ ++ + L + + QGL++ H I+
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRLTE 1014
HRD+K +N+L+++E K+ DFG+++ T V + Y APE +
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY--VVTRWYRAPELLLGDKGYST 178
Query: 1015 KSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR 1050
D++S G I ELL R+ P F ++I +
Sbjct: 179 PVDIWSVGCIFAELLSRR----PLFPGKSEIDQLFK 210
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-19
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVE--------IRTLSLVRHRNIL 890
++G+G G V + + +A+K L + + +VE T + RH ++
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---EPRLVLDWNTRYHIALGIAQGLSYLH 947
+ ++H V EY GG L +H + EPR ++ A + GL YLH
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR------AVFYAAC-VVLGLQYLH 118
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
+ +I++RD+K DN+LLD+E KI DFG+ K S G+ ++APE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVL 173
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046
T T D + GV+++E+L + P G+D + V
Sbjct: 174 TETSYTRAVDWWGLGVLIYEMLVGESPFP---GDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 842 IGKGKHGTVY--RTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVG 894
IG+G G V+ R ++N+ AVK + + F E R L H NI+R++G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPV--AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
CT+ + +IV E + GG L PRL + + A G+ YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KELIQMVENAAAGMEYLESKHC--- 115
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
IHRD+ + N L+ + KI DFGMS+ D +ST + + APE R +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 1015 KSDVYSYGVILFE 1027
+SDV+S+G++L+E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 14/192 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVE-----IRTLSLVRHRNILRIVGSC 896
IGKG G VY+ + N +++ A+K ++ E ++E I LS I R GS
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
K +I+ EY+ GG+ ++L L+ I I +GL YLH + + IH
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLHSE---RKIH 124
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RDIK+ N+LL + + K+ DFG++ ++D+ R+ VG+ ++APE + K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 1017 DVYSYGVILFEL 1028
D++S G+ EL
Sbjct: 183 DIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 9e-19
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 18/197 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN-------RSETNFDVEIRTLSLVRHRNILRI 892
+ +G G G V S K++A+K L+ + + E R L +RH ++ +
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
GS D + ++V EY+PGG LF+ + R Y A + L YLH
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFY--AAQVVLALEYLHSL--- 120
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
I++RD+K +N+LLDS+ KI DFG +K + + + G+ Y+APE S
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLAPEIILSKGY 175
Query: 1013 TEKSDVYSYGVILFELL 1029
+ D ++ G++++E+L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 20/197 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHR-NILRIV 893
I KG G+VY ++ ++A+K L +S+ TN E + + + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
S ++ ++V EY+ GG +++ L DW +Y + G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQY--IAEVVLGVEDLHQR---G 117
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IIHRDIK +N+L+D K+ DFG+S+ ++ VG+ Y+APE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGDD 171
Query: 1014 EKSDVYSYGVILFELLF 1030
+ SD +S G ++FE LF
Sbjct: 172 KMSDWWSLGCVIFEFLF 188
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 72/217 (33%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNILRIV 893
++GKG G V + + +A+K L + D VE R L+L L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 894 GSC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLH 947
SC T D + V EY+ GG L + Q EP V A IA GL +LH
Sbjct: 67 HSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGKFKEPHAVF-------YAAEIAIGLFFLH 118
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
II+RD+K DN++LD+E KI DFGM K + T G+ YIAPE
Sbjct: 119 SK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEII 173
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ D +++GV+L+E+L + P D GED D
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFD---GEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-18
Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKL----NRSETNFDV-----EIRTLSLVRHRNI 889
G+++G+G G VY ++ + A K++ ET+ +V EI+ L ++H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 890 LRIVGSCTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
++ G C +D I EYMPGG+ V Q + L + I +G+SY
Sbjct: 67 VQYYG-CLRD-RAEKTLTIFMEYMPGGS---VKDQLKAYGALTESVTRKYTRQILEGMSY 121
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAP 1004
LH + I+HRDIK NIL DS K+GDFG SK L + S + ++ G+ +++P
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
E K+DV+S G + E+L K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-18
Identities = 71/214 (33%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNIL-R 891
+++GKG G V +++AVK L + D VE R L+L L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ + EH F V E++ GG L F++ Q++ R L T Y A I GL +LH
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFY--AAEIVCGLQFLHSK- 115
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
II+RD+K DN++LD + KI DFGM K + + S G+ YIAPE
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGL 171
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ T D +S+GV+L+E+L + P G+D D
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFH---GDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVE---IRTLSLVR---HRNIL 890
E +G+G G+V + N+ +A+K + N D++ +R L + + I+
Sbjct: 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIV 62
Query: 891 RIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQG 942
+ G+ + I EY GG+L ++ + V R IA + +G
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-----VKKRGGRIGEKVLGKIAESVLKG 117
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDSHSSSTRSAIVGSLGY 1001
LSYLH +IIHRDIK NILL + + K+ DFG+S +L+ +S G+ Y
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV-----NSLAGTFTGTSFY 169
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038
+APE + SDV+S G+ L E+ + P P
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 32/213 (15%)
Query: 842 IGKGKHGTV----YRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRI 892
+G G G+V Y + AVK L + + F E ++ + H I+R+
Sbjct: 3 LGHGNFGSVVKGVYLM-KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLD---WNTRYHIALGIAQGLSYLHYD 949
+G C K E +V E P G L L + V D A +A G++YL
Sbjct: 62 IGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI-SDSHSSSTRSAIVGSLGYIAPENAY 1008
+HRD+ + N+LL + + KI DFGMS+ + + S +A L + APE
Sbjct: 115 ---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
+ + KSDV+SYGV L+E S+G
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAF--------SYGA 196
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 35/220 (15%)
Query: 842 IGKGKHGTVY-----RTLSNNSRKHWAVKKLNRSETN----FDVEIRTLSLVRHRNILRI 892
+G+G G V+ L + AVK L + + F E L++++H++I+R
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP--RLV----------LDWNTRYHIALGIA 940
G CT+ +V EYM G L L + P +++ L IA IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 941 QGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHSSSTRSAI 995
G+ YL H+ +HRD+ + N L+ L KIGDFGMS+ I +D + R+ +
Sbjct: 133 SGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
+ ++ PE+ + T +SD++S+GV+L+E+ + K P
Sbjct: 187 --PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 840 RIIGKGKHGTV--YRTLSNN--SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNIL 890
R++G+G G V Y N + + AVK L R + + EI L + H NI+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 891 RIVGSCTK--DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
+ G C++ + ++ EY+P G+L + L P+ L+ A I +G++YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS-SSTRSAIVGSLGYIAPENA 1007
IHRD+ + N+LLD++ KIGDFG++K + + H R + + A E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 1008 YSTRLTEKSDVYSYGVILFELLFR 1031
+ + SDV+S+GV L+ELL
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 29/200 (14%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSC 896
IG+G G V ++ + AVKK++ R E F+ E+ + +H NI+ + S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSY 85
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQ---NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ ++V E++ GG L +++ NE ++ + L + + LS+LH V
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-------VCLAVLKALSFLHAQGV-- 136
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAYS 1009
IHRDIKSD+ILL S+ K+ DFG +S R ++VG+ ++APE Y
Sbjct: 137 -IHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 1010 TRLTEKSDVYSYGVILFELL 1029
T + D++S G+++ E++
Sbjct: 194 TEV----DIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (211), Expect = 6e-18
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVG 894
+G+G +G VY+ + + A+KK L+ E EI L ++H NI++++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ ++V EY L L + L N I + +GL+Y H +I
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCHSH---RI 119
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAYS 1009
+HRD+K NIL++ + K+ DFG+++ T + V +L Y APE YS
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKHYS 177
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
T + D++S G I E++ K P F D++I
Sbjct: 178 TAV----DIWSVGCIFAEMITGK----PLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILR 891
++ + T G IIG+G+ G V + + K + + F E ++ + H+N++R
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVR 63
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
++G + +IV E M G L N L + R ++ +L +A+G+ YL
Sbjct: 64 LLGVILHNGL-YIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK-- 119
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
+++HRD+ + NIL+ + K+ DFG++++ S +S + + APE +
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-----VKWTAPEALKHKK 173
Query: 1012 LTEKSDVYSYGVILFELL 1029
+ KSDV+SYGV+L+E+
Sbjct: 174 FSSKSDVWSYGVLLWEVF 191
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 7e-18
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL---NRSET----NFDV--EIRTLSLVR 885
R +G+ +G+G + VY+ + + A+KK+ R E NF EI+ L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHI---ALGIAQG 942
H NI+ ++ + +V E+M L V+ L T I L +G
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVL-----TPADIKSYMLMTLRG 114
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
L YLH I+HRD+K +N+L+ S+ K+ DFG+++ + T + + Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYR 169
Query: 1003 APE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
APE Y + D++S G I ELL R P D+DI
Sbjct: 170 APELLFGARHYGVGV----DMWSVGCIFAELLLRV----PFLPGDSDI 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 22/197 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGSCTK 898
+G+G G V+ N + K A+K L F E + + +RH ++ + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLY-AVVS 71
Query: 899 DEHGFIVTEYMPGGTLFNVLHQNE------PRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+E +IVTE+M G+L + L + + P+LV +A IA G++Y+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV-------DMAAQIADGMAYIER---M 121
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
IHRD+++ NIL+ L KI DFG+++LI D+ ++ + A + + APE A R
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRF 180
Query: 1013 TEKSDVYSYGVILFELL 1029
T KSDV+S+G++L EL+
Sbjct: 181 TIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-------RSETNFDVEIRTLSLVRHRNILRIVG 894
+G G G V+ S ++A+K + + E + E R L V H I+R+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ +++ EY+PGG LF+ L +N R +T A I L YLH +I
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYL-RNSGRF--SNSTGLFYASEIVCALEYLHSK---EI 122
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS-AIVGSLGYIAPENAYSTRLT 1013
++RD+K +NILLD E K+ DFG +K + D R+ + G+ Y+APE S
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQSKGHN 176
Query: 1014 EKSDVYSYGVILFELLFRKMP 1034
+ D ++ G++++E+L P
Sbjct: 177 KAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGSCTK 898
IG G+ G V+ RK A+K + SE +F E + + + H ++++ G CT+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRD 958
+V E+M G L + L R T + L + +G++YL V IHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSNV---IHRD 125
Query: 959 IKSDNILLDSELEPKIGDFGMSKLI-SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSD 1017
+ + N L+ K+ DFGM++ + D ++SST + + + +PE ++ + KSD
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSD 183
Query: 1018 VYSYGVILFELLFR-KMPVD 1036
V+S+GV+++E+ K P +
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 20/195 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVE-----IRTLSLVRHRNILRIVGSC 896
IGKG G V++ + N +++ A+K ++ E ++E I LS + + GS
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL---GIAQGLSYLHYDCVPQ 953
K +I+ EY+ GG+ ++L D + IA I +GL YLH + +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGP----FD---EFQIATMLKEILKGLDYLHSE---K 121
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRDIK+ N+LL + + K+ DFG++ ++D+ R+ VG+ ++APE +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYD 179
Query: 1014 EKSDVYSYGVILFEL 1028
K+D++S G+ EL
Sbjct: 180 SKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-17
Identities = 71/216 (32%), Positives = 100/216 (46%), Gaps = 27/216 (12%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNILRIV 893
++GKG G V + + +A+K L + D VE R L+L L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 894 GSCTKD-EHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLHY 948
SC + + + V EY+ GG L + Q EP+ V A I+ GL +LH
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-------YAAEISVGLFFLHR 119
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
II+RD+K DN++LDSE KI DFGM K T G+ YIAPE
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ D ++YGV+L+E+L + P D GED D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 25/208 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN---RSETNFDVEIRTL-SLVRHRNILRIVG 894
+IG+G +G VY+ + + A+K ++ E E L H NI G
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 895 SCTKDEHG------FIVTEYMPGGT---LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
+ K ++V E GG+ L L + RL +W +I +GL+Y
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAY 128
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH + ++IHRDIK NILL E K+ DFG+S + + R+ +G+ ++APE
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL--DSTLGRRNTFIGTPYWMAPE 183
Query: 1006 -----NAYSTRLTEKSDVYSYGVILFEL 1028
+SDV+S G+ EL
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 50/204 (24%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 841 IIGKGKHGTVY-----RTLSNNSRKHWAVKKLNRSETN-----FDVEIRTLSLVRHRNIL 890
+G+G+ G V+ VK L +++ F E+ + H+N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV------LDWNTRYHIALGIAQGLS 944
R++G C + E +++ EY G L L + + L + + IA G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
+L + +HRD+ + N L+ S+ E K+ +SK + +S R+A++ L ++AP
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 1005 ENAYSTRLTEKSDVYSYGVILFEL 1028
E + KSDV+S+GV+++E+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 22/199 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVRHRNILRIVGSC 896
+ +G G+ G V+ N K AVK + + S F E + ++H ++++
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNE------PRLVLDWNTRYHIALGIAQGLSYLHYDC 950
TK E +I+TE+M G+L + L +E P+L+ D++ + IA+G++++
Sbjct: 71 TK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-DFSAQ------IAEGMAFIEQR- 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
IHRD+++ NIL+ + L KI DFG++++I D+ ++ A + + APE
Sbjct: 122 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFG 178
Query: 1011 RLTEKSDVYSYGVILFELL 1029
T KSDV+S+G++L E++
Sbjct: 179 SFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVE---IRTLSL 883
DLR ED+ ++ +G G G+V + + A KK+ V +R L +
Sbjct: 1 DLRNEDLETISD---LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQI 56
Query: 884 VRHRNILRIV---GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA 940
+ IV G+ + + + E+M G+L + + P + IA+ +
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVV 113
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDSHSSSTRSAIVGSL 999
+GL+YL+ V +I+HRDIK NIL++S + K+ DFG+S +LI +S VG+
Sbjct: 114 EGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-----NSIADTFVGTS 166
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042
Y++PE + T KSDV+S G+ + EL K P S +D
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDD 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-17
Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 43/266 (16%)
Query: 829 RYEDVIRATEG-----------RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSE 871
RYE ++R ++IG+G G V +S+K +A+K L+ RS+
Sbjct: 27 RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD 86
Query: 872 TNFDVEIR-TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN 930
+ F E R ++ ++++ + D++ ++V EYMPGG L N++ + + W
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWA 144
Query: 931 TRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990
Y + +A L +H +IHRD+K DN+LLD K+ DFG + ++
Sbjct: 145 KFYTAEVVLA--LDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR 199
Query: 991 TRSAIVGSLGYIAPE-------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
+A VG+ YI+PE + Y R + D +S GV LFE+L P F D+
Sbjct: 200 CDTA-VGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLFEMLVGDTP----FYADS 251
Query: 1044 DIVTWTRWKLQENHECICF-LDREIS 1068
+ T++ K+ ++ + F D EIS
Sbjct: 252 LVGTYS--KIMDHKNSLNFPEDVEIS 275
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 73/217 (33%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNILRIV 893
++GKG G V + + +A+K L + D VE R L+L L +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 894 GSC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLH 947
SC T D F V EY+ GG L + Q EP V A IA GL +LH
Sbjct: 67 HSCFQTMDRLYF-VMEYVNGGDLMYQIQQVGRFKEPHAVF-------YAAEIAIGLFFLH 118
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
II+RD+K DN++LDSE KI DFGM K + T G+ YIAPE
Sbjct: 119 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEII 173
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ D +++GV+L+E+L + P + GED D
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 76/235 (32%), Positives = 116/235 (49%), Gaps = 38/235 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILR---------I 892
IGKG G VY+ ++R+ +A+K L++ E E+ + RNIL I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA--HTIGERNILVRTLLDESPFI 58
Query: 893 VG---SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH-Y 948
VG S D ++VT+YM GG LF L Q E R D +++IA + L +LH Y
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFSED-RAKFYIA-ELVLALEHLHKY 115
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
D I++RD+K +NILLD+ + DFG+SK ++ + T + G+ Y+APE
Sbjct: 116 D----IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 1009 STR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062
+ T+ D +S GV++FE+ P + EDT Q+ + I F
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMC---CGWSPFYAEDT----------QQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDV--EIRTLSLVRHRNILRI 892
R IG G G VY + + A+KK++ S E D+ E+R L +RH N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 893 VGSCTKDEHGFIVTEYMPGGT--LFNV----LHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
G ++ ++V EY G + V L + E I G QGL+YL
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---------ICHGALQGLAYL 131
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H IHRDIK+ NILL K+ DFG + L+S ++S VG+ ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEV 182
Query: 1007 AYST---RLTEKSDVYSYGVILFELLFRKMP 1034
+ + K DV+S G+ EL RK P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIV 893
+ IG+G G +Y + + +H +K+++ + + E+ L+ ++H NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL-----VLDWNTRYHIALGIAQGLSYLHY 948
S ++ FIV EY GG L +++ L +L W + I+ GL ++H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIHD 119
Query: 949 DCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
+I+HRDIKS NI L + K+GDFG+++ ++DS + VG+ Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA--YTCVGTPYYLSPEIC 174
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
+ K+D++S G +L+EL K P +
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-17
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 31/223 (13%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRK-------HWAVKKLNRSETNFDVEIR 879
+L+ +D R +E +G G G V + S H +K R++ IR
Sbjct: 1 ELKDDDFERISE---LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-----IR 52
Query: 880 TLSLVRHRN---ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE--PRLVLDWNTRYH 934
L ++ N I+ G+ D I E+M GG+L VL + + P +L
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----K 107
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
+++ + +GL+YL QI+HRD+K NIL++S E K+ DFG+S + DS ++S
Sbjct: 108 VSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 161
Query: 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
VG+ Y++PE T + +SD++S G+ L EL + P+ P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-17
Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDVEIRTLSLVRHR---NILRIVGSCT 897
IG+G GTVY + + + A+K++N + + ++ I + ++R NI+ + S
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957
+ ++V EY+ GG+L +V+ + +D + Q L +LH + Q+IHR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHR 139
Query: 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSD 1017
DIKSDNILL + K+ DFG I+ S RS +VG+ ++APE K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVD 197
Query: 1018 VYSYGVILFELLFRKMP 1034
++S G++ E++ + P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIV 893
R++GKG +G V K + +KKLN R + E + LS ++H NI+
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 894 GSCT-KDEHGFIVTEYMPGGTLFNVLHQNEPRL-----VLDWNTRYHIALGIAQGLSYLH 947
S +D +IV + GG L++ L + + +L V++W + IA L YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLH 119
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
I+HRD+K+ N+ L K+GD G+++++ + + S ++G+ Y++PE
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA--STLIGTPYYMSPELF 174
Query: 1008 YSTRLTEKSDVYSYGVILFEL 1028
+ KSDV++ G ++E+
Sbjct: 175 SNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 6e-17
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 24/211 (11%)
Query: 840 RIIGKGKHGTVYRTL----SNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNIL 890
+++G G GTVY+ + + A+K LN ++ F E ++ + H +++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE----PRLVLDWNTRYHIALGIAQGLSYL 946
R++G C +VT+ MP G L + +H+++ +L+L+W + IA+G+ YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
+++HRD+ + N+L+ S KI DFG+++L+ + ++A E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 1007 AYSTRLTEKSDVYSYGVILFELL-FRKMPVD 1036
+ + T +SDV+SYGV ++EL+ F P D
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 6e-17
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSC 896
IG+G GTV+ + + + A+K++N + E + EI + +++ NI+ + S
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLDSF 85
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
+ F+V EY+ GG+L +V+ + +D + Q L +LH + Q+IH
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RDIKSDN+LL + K+ DFG I+ S RS +VG+ ++APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1017 DVYSYGVILFELLFRKMP 1034
D++S G++ E++ + P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 34/211 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSE--TNFDVEIRTLSLVRHRNILRIVGSCT 897
+G G G VY+ + A K ++ E +F VEI LS +H NI+ + +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQ-----NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ +I+ E+ GG L +++ + EP++ RY + + + L++LH
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQI------RY-VCRQMLEALNFLHSH--- 122
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE------- 1005
++IHRD+K+ NILL + + K+ DFG+S + + R +G+ ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
N Y K+D++S G+ L EL + P
Sbjct: 181 KDNPYDY----KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 840 RIIGKGKHGTV-----YRTLSNNSRKHWAVKKLN----RSETNFDVEIRTLSLVRHRNIL 890
R +G+G G V Y + AVK L + +F E L+ ++H +I+
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP--RLVLDWNTR-----------YHIAL 937
+ G C + +V EYM G L L + P +++D R HIA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
IA G+ YL +HRD+ + N L+ + L KIGDFGMS+ + + +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
+ ++ PE+ + T +SDV+S+GVIL+E+ + K P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 840 RIIGKGKHGTVYR-TLSN-----NSRKHWAVKKLNRSETN-----FDVEIRTLSLVRHRN 888
+G G G VY T ++ + AVK L + T+ F E +S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH----QNEPRLVLDWNTRYHIALGIAQGLS 944
I++++G C +E +I+ E M GG L + L + +L I L +A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 945 YL---HYDCVPQIIHRDIKSDNILL-----DSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
YL H+ IHRD+ + N L+ D++ KIGDFG+++ I S +
Sbjct: 121 YLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ ++APE+ + T +SDV+S+GV+++E+L
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDVEIRTLSLVRHR---NILRIVGSCT 897
IG+G GTVY + + + A++++N + + ++ I + ++R NI+ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957
+ ++V EY+ GG+L +V+ + +D + Q L +LH + Q+IHR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSD 1017
DIKSDNILL + K+ DFG I+ S RS +VG+ ++APE K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 1018 VYSYGVILFELLFRKMP 1034
++S G++ E++ + P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 53/181 (29%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 863 AVKKLNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNV 917
AVK L T +F EI+ +S +++ NI+R++G C D+ ++TEYM G L
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 918 LHQNEPRLVL---------DWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968
L Q E ++A+ IA G+ YL +HRD+ + N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGN 164
Query: 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
KI DFGMS+ + + V + ++A E+ + T SDV+++GV L+E+
Sbjct: 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
Query: 1029 L 1029
Sbjct: 225 F 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 21/196 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDVEIRTLSLVRHRNILRIVGSC 896
IG+G G V +S + AVK K R E F+ E+ + +H+N++ + S
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVEMYKSY 87
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQ---NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
E +++ E++ GG L +++ Q NE ++ + + Q L YLH V
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT-------VCESVLQALCYLHSQGV-- 138
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRDIKSD+ILL + K+ DFG IS R ++VG+ ++APE T
Sbjct: 139 -IHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 1014 EKSDVYSYGVILFELL 1029
+ D++S G+++ E++
Sbjct: 196 TEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 26/204 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN--------RSETNFDVEIRTLSLVRHRNILRIV 893
IG+G G S K + +K++N R E+ +V + LS ++H NI++
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAV--LSNMKHPNIVQYQ 65
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL-----VLDWNTRYHIALGIAQGLSYLHY 948
S ++ + +IV +Y GG L+ ++ L +LDW + I L ++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ------ICLALKHVHD 119
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
+I+HRDIKS NI L + K+GDFG+++++ +S R+ I G+ Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCI-GTPYYLSPEICE 174
Query: 1009 STRLTEKSDVYSYGVILFELLFRK 1032
+ KSD+++ G +L+E+ K
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 57/213 (26%), Positives = 113/213 (53%), Gaps = 26/213 (12%)
Query: 833 VIRATE---GRIIGKGKHGTVYRTL----SNNSRKHWAVKKL-NRS--ETNFDVEIRTLS 882
+++ TE +++G G GTV++ + ++ + A+K + +RS +T ++ L+
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 883 L--VRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE----PRLVLDWNTRYHIA 936
+ + H I+R++G C +VT+ P G+L + + Q+ P+ +L+W +
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ---- 117
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
IA+G+ YL ++HR++ + NILL S+ +I DFG++ L+ S
Sbjct: 118 --IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ ++A E+ R T +SDV+SYGV ++E++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKL----NRSETNFDV-----EIRTLSLVRHRNI 889
G+++G+G G VY ++ + AVK++ ET+ +V EI+ L + H I
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 890 LRIVGSCTKDEHG---FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
++ G C +D I E+MPGG++ + Q + L N I +G+SYL
Sbjct: 67 VQYYG-CLRDPMERTLSIFMEHMPGGSIKD---QLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPE 1005
H + I+HRDIK NIL DS K+GDFG SK L + S + ++ G+ +++PE
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
K+D++S G + E+L K P
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 56/211 (26%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 840 RIIGKGKHGTVYRTLSN----NSRKHWAVKKLNRS---ETNFDV--EIRTLSLVRHRNIL 890
+++G G GTVY+ L + A+K+L + + N ++ E ++ V + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL----VLDWNTRYHIALGIAQGLSYL 946
R++G C I T+ MP G L + + +++ + +L+W + IA+G++YL
Sbjct: 73 RLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
+++HRD+ + N+L+ + KI DFG++KL+ + ++A E+
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 1007 AYSTRLTEKSDVYSYGVILFELL-FRKMPVD 1036
T +SDV+SYGV ++EL+ F P D
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 70/262 (26%), Positives = 115/262 (43%), Gaps = 46/262 (17%)
Query: 870 SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH---------- 919
+ +F E++ LS ++ NI+R++G C ++ ++TEYM G L L
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 920 ------QNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973
+ +++ H+AL IA G+ YL +HRD+ + N L+ L K
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIK 178
Query: 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF--R 1031
I DFGMS+ + + V + ++A E + T SDV+++GV L+E+L +
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
Query: 1032 KMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALR-------LLEL 1084
+ P +GE TD ++ EN F D Q+ R L EL
Sbjct: 239 EQP----YGELTD------EQVIENAGEF--------FRDQGRQVYLFRPPPCPQGLYEL 280
Query: 1085 ALECTRQVADMRPSMREVVGFL 1106
L+C + RPS ++ FL
Sbjct: 281 MLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 38/247 (15%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRN---IL 890
++IG+G G V +S++ +A+K L+ RS++ F E R ++ H N I+
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEER--DIMAHANSEWIV 106
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYD 949
++ + D++ ++V EYMPGG L N++ + P W R++ A + L +H
Sbjct: 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KW-ARFYTA-EVVLALDAIHS- 160
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDS--HSSSTRSAIVGSLGYIAPEN 1006
IHRD+K DN+LLD K+ DFG K+ ++ + VG+ YI+PE
Sbjct: 161 --MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDYISPEV 214
Query: 1007 AYSTRLT----EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062
S + D +S GV L+E+L D F D+ + T++ K+ ++ + F
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLVGTYS--KIMDHKNSLTF 268
Query: 1063 LDR-EIS 1068
D EIS
Sbjct: 269 PDDIEIS 275
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 840 RIIGKGKHGTV-----YRTLSNNSRKHWAVKKLNRSETN----FDVEIRTLSLVRHRNIL 890
R +G+G G V Y + AVK L + N F E L+ ++H +I+
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL----------DWNTRYHIALGIA 940
+ G C + + +V EYM G L L + P VL + HIA IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
G+ YL +HRD+ + N L+ L KIGDFGMS+ + + + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
++ PE+ + T +SDV+S GV+L+E+ + K P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH-----RNILRIVG 894
R+IG+G + V + + +A+K + + N D +I + +H N +VG
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 895 --SCTKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
SC + E F V EY+ GG L + H R + + + R++ A I+ L+YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNYLHER-- 115
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K DN+LLDSE K+ D+GM K T S G+ YIAPE
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVD 1036
D ++ GV++FE++ + P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-16
Identities = 50/131 (38%), Positives = 66/131 (50%), Gaps = 17/131 (12%)
Query: 43 SHLPWNQSVSTSAPC-----KWSGVSCYNNSSSLK----ALNLSGFGLSGVLNNSISYIC 93
WN PC WSG C +S+ K L L GL G + N IS
Sbjct: 388 LRFGWNGD-----PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDIS--- 439
Query: 94 KNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGY 153
K +HL S++LSGN G+IP LG+ L+ L L+ N F GSIP + +L L L+L
Sbjct: 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
Query: 154 NSLSGKIPPQV 164
NSLSG++P +
Sbjct: 500 NSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 73/235 (31%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEI-----RTLSLVRHRNILRI 892
R++GKG G V S + +AVK L + + DVE R LSL R+ L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 893 VGSCTKD-EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ C + + F V E++ GG L + H + R + R++ A I L +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAA-EITSALMFLHDK-- 115
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K DN+LLD E K+ DFGM K + T S G+ YIAPE
Sbjct: 116 -GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGED------TDIVTWTRWKLQENHECI 1060
D ++ GV+L+E+L P + +D D V + W L ++ I
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW-LSQDAVDI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 38/228 (16%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVE---IRTLSLVR------HRN 888
E IG+G +GTVY+ N+ + A+KK+ + + +R ++L++ H N
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ-------NEPRLVLDWNTRYHIALGIAQ 941
I+R++ C HG + +F + Q P+ L T + + +
Sbjct: 63 IVRLLDVC----HGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
G+ +LH I+HRD+K NIL+ S+ + KI DFG+++ I + T ++V +L Y
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALT--SVVVTLWY 172
Query: 1002 IAPE----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
APE ++Y+T + D++S G I EL R+ P F ++
Sbjct: 173 RAPEVLLQSSYATPV----DMWSVGCIFAELFRRR----PLFRGTSEA 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 35/213 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTL----SLVRHRN---ILRIVG 894
IG+G GTV + L S AVK++ RS + + R L ++R + I++ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 895 SCTKDEHGFIVTEYMPGG------TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
+ ++ +I E M ++ VL P +L IA+ + L+YL
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKALNYLKE 125
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE--- 1005
+ +IIHRD+K NILLD K+ DFG+S + DS + TR A G Y+APE
Sbjct: 126 EL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDA--GCRPYMAPERID 180
Query: 1006 ----NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+ Y R SDV+S G+ L+E+ K P
Sbjct: 181 PSARDGYDVR----SDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 842 IGKGKHGTVYRTLSNNS-----RK--HWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVG 894
+G G G V + L S RK H +K R++ IR L ++ N IVG
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI-----IRELKVLHECNSPYIVG 63
Query: 895 ---SCTKDEHGFIVTEYMPGGTLFNVLHQNE--PRLVLDWNTRYHIALGIAQGLSYLHYD 949
+ D I E+M GG+L VL + P +L I++ + +GL+YL
Sbjct: 64 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE- 117
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
+I+HRD+K NIL++S E K+ DFG+S + DS ++S VG+ Y++PE
Sbjct: 118 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQG 172
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVDP 1037
T T +SD++S G+ L E+ + P+ P
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKL--NRSET---NFDVEIRTLSLVRHRNILRIV 893
IG G GTVY+ + + + +A+K + N +T EI L V H N+++
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ ++ E+M GG+L +E L +A I G++YLH
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVARQILSGIAYLHRR---H 188
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
I+HRDIK N+L++S KI DFG+S++++ + S VG++ Y++PE +T L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERI-NTDLN 245
Query: 1014 E------KSDVYSYGVILFELLFRKMP 1034
D++S GV + E + P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 62/215 (28%), Positives = 113/215 (52%), Gaps = 32/215 (14%)
Query: 840 RIIGKGKHGTVYRTL----SNNSRKHWAVKKLNRS---ETNFDV--EIRTLSLVRHRNIL 890
+++G G GTVY+ + N + A+K L + + N ++ E ++ V +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL----VLDWNTRYHIALGIAQGLSYL 946
R++G C +VT+ MP G L + + +N+ R+ +L+W + IA+G+SYL
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI----SDSHSSSTRSAIVGSLGYI 1002
+++HRD+ + N+L+ S KI DFG+++L+ ++ H+ + I ++
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI----KWM 178
Query: 1003 APENAYSTRLTEKSDVYSYGVILFELL-FRKMPVD 1036
A E+ R T +SDV+SYGV ++EL+ F P D
Sbjct: 179 ALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 25/201 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----------EIRTLSLVRHRNIL 890
IGKG+ VY+ + + A+KK+ F++ EI L + H N++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQI----FEMMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
+ + S ++ IV E G L ++ H + + ++ T + + + L ++H
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK 125
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA--IVGSLGYIAPENA 1007
+I+HRDIK N+ + + K+GD G+ + SS T +A +VG+ Y++PE
Sbjct: 126 ---RIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMSPERI 178
Query: 1008 YSTRLTEKSDVYSYGVILFEL 1028
+ KSD++S G +L+E+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH-----RNILRIVG 894
R+IG+G + V +R+ +A+K + + N D +I + +H N +VG
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 895 --SCTKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
SC + E F V E++ GG L + H R + + + R++ A I+ L++LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSA-EISLALNFLHER-- 115
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K DN+LLD+E K+ D+GM K T S G+ YIAPE
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVD 1036
D ++ GV++FE++ + P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIR-------TLSLVRHRNILRIVG 894
+G+G +G V+ ++ + A+K++ +S E+R L+ + +++++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 895 SCTKDEHGFIVTEYMPGG---TLFN---VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
+ DE+ ++ EY+PGG TL N VL ++ R+++A + LH
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH--------ARFYMAEMFE-AVDALHE 119
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPENA 1007
IHRD+K +N L+D+ K+ DFG+SK +++ ++S +VGS Y+APE
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPEVL 170
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT---RWK 1052
D +S G +L+E L P S + TW WK
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE----TWENLKYWK 214
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-15
Identities = 52/137 (37%), Positives = 74/137 (54%), Gaps = 4/137 (2%)
Query: 663 GSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMV 722
G IP +SKL H SI N+S N + G IP LG++ L++LDLS NSF+G IP + +
Sbjct: 432 GFIPNDISKLRHLQSI-NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 723 SLYFVNISFNHFSGKLPASWTTLMVSYPG-SFLGNSELCRQGNCGKNGRGHTRGRLAGII 781
SL +N++ N SG++PA+ ++ +F N+ LC G G G A I
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC--GIPGLRACGPHLSVGAKIG 548
Query: 782 IGVLLSVALLCALIYIM 798
I +SVA L +I M
Sbjct: 549 IAFGVSVAFLFLVICAM 565
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 78/315 (24%), Positives = 140/315 (44%), Gaps = 63/315 (20%)
Query: 824 LPRDLRYE-DVIRATEGRIIGKGKHGTVYRTLS-------NNSRKHWAVKKLNRSETNFD 875
LP D ++E R T G+ +G+G G V + N AVK L T+ D
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 876 V-----EIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP------ 923
+ E+ + ++ +H+NI+ ++G+CT+D +++ EY G L L P
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 924 ----RL---VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976
+L L + A +A+G+ YL + IHRD+ + N+L+ + KI D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIAD 177
Query: 977 FGMSKLIS--DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL----- 1029
FG+++ + D + +T + + ++APE + T +SDV+S+GV+L+E+
Sbjct: 178 FGLARDVHNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
Query: 1030 -FRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALEC 1088
+ +PV+ F L+E H +D+ + L + EC
Sbjct: 236 PYPGIPVEELFK-----------LLKEGHR----MDKPANC--------THELYMIMREC 272
Query: 1089 TRQVADMRPSMREVV 1103
V RP+ +++V
Sbjct: 273 WHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 67/232 (28%), Positives = 117/232 (50%), Gaps = 31/232 (13%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNS-----RK--HWAVKKLNRSETNFDVEIR 879
+L+ +D + +E +G G G V++ S RK H +K R++ IR
Sbjct: 1 ELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI-----IR 52
Query: 880 TLSLVRHRNILRIVG---SCTKDEHGFIVTEYMPGGTLFNVLHQ--NEPRLVLDWNTRYH 934
L ++ N IVG + D I E+M GG+L VL + P +L
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----K 107
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
+++ + +GL+YL +I+HRD+K NIL++S E K+ DFG+S + DS ++S
Sbjct: 108 VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---- 161
Query: 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046
VG+ Y++PE T + +SD++S G+ L E+ + P+ P ++ +++
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 64/236 (27%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 823 DLPRDLRYE-DVIRATEGRIIGKGKHGTVYRTLS-------NNSRKHWAVKKLNRSETNF 874
+LP D R+E R G+ +G+G G V + N AVK L T
Sbjct: 6 ELPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK 65
Query: 875 DV-----EIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV-- 926
D+ E+ + ++ +H+NI+ ++G+CT+D +++ EY G L L P +
Sbjct: 66 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 927 -----------LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975
L + A +A+G+ YL + IHRD+ + N+L+ + KI
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 182
Query: 976 DFGMSKLIS--DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
DFG+++ I D + +T + + ++APE + T +SDV+S+GV+L+E+
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 21/196 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSC 896
IG+G G V ++ K AVKK++ R E F+ E+ + H N++ + S
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFN-EVVIMRDYHHENVVDMYNSY 88
Query: 897 TKDEHGFIVTEYMPGGTLFNVL---HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ ++V E++ GG L +++ NE ++ + L + + LSYLH V
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-------VCLSVLRALSYLHNQGV-- 139
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRDIKSD+ILL S+ K+ DFG +S R ++VG+ ++APE
Sbjct: 140 -IHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 1014 EKSDVYSYGVILFELL 1029
+ D++S G+++ E++
Sbjct: 197 TEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 36/233 (15%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHW-------AVKKLNRSETNFD 875
+ PRD R G+ +G+G G V R + K AVK L + T+ D
Sbjct: 8 EFPRD-------RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKD 60
Query: 876 V-----EIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP------ 923
+ E+ + L+ +H+NI+ ++G CT++ +++ EY G L L P
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT 120
Query: 924 -------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976
L + A +A+G+ YL + IHRD+ + N+L+ + KI D
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIAD 177
Query: 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
FG+++ + D S + ++APE + T +SDV+S+G++++E+
Sbjct: 178 FGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVRHRNILRIV---GSC 896
+GKG +G+VY+ L + A+K +L E+ F+ I L ++ IV G+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
+ ++ EYM G+L + + + I + +GL +L + IIH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIH 126
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE-- 1014
RD+K N+L++ + K+ DFG+S + S + + +G Y+APE S +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGGPNQNP 182
Query: 1015 ----KSDVYSYGVILFELLFRKMPVDP 1037
+SDV+S G+ + E+ + P P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 35/224 (15%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTL--SNNSRKHWAVKKLNR--SETN---FDVEIR 879
D+++EDVI G+G G V R + + + + A+K L SE + F E+
Sbjct: 3 DIKFEDVI--------GEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE 54
Query: 880 TL-SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALG 938
L L H NI+ ++G+C + +I EY P G L + L ++ VL+ + + G
Sbjct: 55 VLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSR---VLETDPAFAKEHG 111
Query: 939 IAQGLSY-------------LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985
A L+ + Y Q IHRD+ + N+L+ L KI DFG+S+ +
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG-EE 170
Query: 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ T + + ++A E+ + T KSDV+S+GV+L+E++
Sbjct: 171 VYVKKTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 22/204 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDV--EIRTLSLVRHRNILRIVG 894
IG G G VY ++++ + AVKK++ S E D+ E++ L ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
K+ ++V EY G + +P ++ H AL QGL+YLH +
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHN---M 142
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST---R 1011
IHRDIK+ NILL + K+ DFG + S ++S VG+ ++APE + +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEGQ 196
Query: 1012 LTEKSDVYSYGVILFELLFRKMPV 1035
K DV+S G+ EL RK P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 45/236 (19%)
Query: 825 PRD-LRYEDVIRATEGRIIGKGKHGTVYRT-----LSNNSRKHWAVKKLN-----RSETN 873
PR+ + Y R IG+G G V++ L AVK L + +
Sbjct: 3 PRNNIEYV--------RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 54
Query: 874 FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPR--------- 924
F E ++ H NI++++G C + ++ EYM G L L PR
Sbjct: 55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114
Query: 925 ----------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI 974
L L + IA +A G++YL + +HRD+ + N L+ + KI
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKI 171
Query: 975 GDFGMSKLI--SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
DFG+S+ I +D + +S AI + ++ PE+ + R T +SDV++YGV+L+E+
Sbjct: 172 ADFGLSRNIYSADYYKASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/195 (31%), Positives = 98/195 (50%), Gaps = 17/195 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDV---EIRTLSLVRHRNILRIVGSC 896
IG G +G VY+ + N+ + A+K KL E +F V EI + +H NI+ GS
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
+ + +I E+ GG+L ++ H P L + +++ QGL YLH +H
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSK---GKMH 129
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR---LT 1013
RDIK NILL K+ DFG+S I + + + R + +G+ ++APE A R
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQI--TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 1014 EKSDVYSYGVILFEL 1028
+ D+++ G+ EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 36/211 (17%)
Query: 842 IGKGKHGTVYRT-LSNNSRKHWAVKKLN-----------RSETNFDVEIRTLSLV----R 885
+G G G VY+ NN + A+K++N + + + ++++ R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPG---GTLFNVL---HQN--EPRLVLDWNTRYHIAL 937
H NI+R + +++ +IV + + G G FN L Q E R+ WN I +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WN----IFV 120
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
+ L YLH + +I+HRD+ +NI+L + + I DFG++K S +++VG
Sbjct: 121 QMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
++ Y PE + EK+DV+++G IL+++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 63/199 (31%), Positives = 96/199 (48%), Gaps = 20/199 (10%)
Query: 842 IGKGKHGTVYRTLSNNSR--------KHWAVKKLNRSET-NFDVEIRTLSLVRHRNILRI 892
+GKG GTVY + K V +LN +ET + E + LS + H I++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 893 VGSCTKDEHGFIVTEYMPGGTL---FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
S + + I+TEY G L L L + + I L + G+ Y+H
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--GVHYMH-- 123
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
+I+HRD+K+ NI L + L KIGDFG+S+L+ S +T G+ Y++PE
Sbjct: 124 -QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLAT--TFTGTPYYMSPEALKH 179
Query: 1010 TRLTEKSDVYSYGVILFEL 1028
KSD++S G IL+E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 66/255 (25%), Positives = 118/255 (46%), Gaps = 46/255 (18%)
Query: 823 DLPRDLRYE-DVIRATEGRIIGKGKHGTVYRTLSNNSRKH-------WAVKKLNRSETNF 874
+LP D R+E + T G+ +G+G G V + K AVK L T
Sbjct: 3 ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62
Query: 875 DV-----EIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLD 928
D+ E+ + ++ +H+NI+ ++G+CT+D +++ EY G L L P
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP---PG 119
Query: 929 WNTRYHIA----------------LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972
Y IA +A+G+ YL + IHRD+ + N+L+
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVM 176
Query: 973 KIGDFGMSKLIS--DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL- 1029
KI DFG+++ ++ D + +T + + ++APE + T +SDV+S+GV+++E+
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
Query: 1030 -----FRKMPVDPSF 1039
+ +PV+ F
Sbjct: 235 LGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH----RNILR---- 891
++IGKG G V K +AVK L + I +H RN+L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA------ILKKKEQKHIMAERNVLLKNVK 54
Query: 892 ---IVG---SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
+VG S + + V +Y+ GG LF H R + R++ A IA L Y
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGY 111
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH II+RD+K +NILLDS+ + DFG+ K S T S G+ Y+APE
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPE 166
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLF 1030
D + G +L+E+L+
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 55/223 (24%), Positives = 107/223 (47%), Gaps = 41/223 (18%)
Query: 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHR 887
V++AT R+ G+ + TV AVK L + ++ ++ E L V H
Sbjct: 16 VVKATAFRLKGRAGYTTV------------AVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---EPRLVLDWNTRYH---------- 934
+++++ G+C++D ++ EY G+L + L ++ P + R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 935 --------IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986
A I++G+ YL +++HRD+ + N+L+ + KI DFG+S+ + +
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
S RS + ++A E+ + T +SDV+S+GV+L+E++
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 6e-15
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 840 RIIGKGKHGTVY--RTLSNNS-----RKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRI 892
R IG G G VY R + N+ + ++ K+ N + E+R L +RH N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
G ++ ++V EY G + +P ++ H AL QGL+YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH--- 134
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-- 1010
+IHRD+K+ NILL K+GDFG + +++ ++ VG+ ++APE +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDE 188
Query: 1011 -RLTEKSDVYSYGVILFELLFRKMPV 1035
+ K DV+S G+ EL RK P+
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-15
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEI-------RTLSLVRHRNILRI 892
+++GKG G V S K++A+K L + E+ R L RH + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 893 VGSC-TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
S TKD F++ EY+ GG LF H + R+ + TR++ A I L YLH
Sbjct: 61 KYSFQTKDRLCFVM-EYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG-- 114
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+I++RD+K +N++LD + KI DFG+ K I+D ++T G+ Y+APE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---AATMKTFCGTPEYLAPEVLEDN 170
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
D + GV+++E++ ++P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-15
Identities = 85/313 (27%), Positives = 146/313 (46%), Gaps = 50/313 (15%)
Query: 814 LQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN----- 868
++D++ ++ED YE V ++IG+G G V ++RK +A+K L+
Sbjct: 35 IRDLRMKAED------YEVV------KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82
Query: 869 -RSETNFDVEIR-TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV 926
RS++ F E R ++ ++++ + D + ++V EYMPGG L N++ + +
Sbjct: 83 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VP 140
Query: 927 LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986
W R++ A + L +H IHRD+K DN+LLD K+ DFG ++
Sbjct: 141 EKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195
Query: 987 HSSSTRSAIVGSLGYIAPE-------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF 1039
+A VG+ YI+PE + Y R + D +S GV L+E+L P F
Sbjct: 196 GMVRCDTA-VGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTP----F 247
Query: 1040 GEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSM 1099
D+ + T+++ NH+ ++F D +D K + L A R+V R +
Sbjct: 248 YADSLVGTYSKIM---NHK------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGV 298
Query: 1100 REVVGFLIKLNDK 1112
E+ L ND+
Sbjct: 299 EEIKRHLFFKNDQ 311
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVY--RTLSNNSRKHWAVKKLNRSET-----NFDVEIR 879
D++++DVI G+G G V R + R A+K++ + +F E+
Sbjct: 8 DIKFQDVI--------GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 59
Query: 880 TL-SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN-----EPRLVLDWNTR- 932
L L H NI+ ++G+C + ++ EY P G L + L ++ +P + +T
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 933 -------YHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985
H A +A+G+ YL Q IHRD+ + NIL+ KI DFG+S+ +
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-QE 175
Query: 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ T + + ++A E+ + T SDV+SYGV+L+E++
Sbjct: 176 VYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVGS 895
+G+G +G V + + + + A+KK SE + DV E++ L +RH NI+ + +
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ ++V EY+ TL +L + L D Y L Q ++Y H II
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL--LQAIAYCHSH---NII 122
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRDIK +NIL+ K+ DFG ++ + +S + V + Y APE K
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 1016 S-DVYSYGVILFELL 1029
DV++ G I+ ELL
Sbjct: 182 PVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 30/213 (14%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCT-- 897
++IG+G G V ++ + +A+K LN+ E E T RN+L + G C
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE--TACFREERNVL-VNGDCQWI 63
Query: 898 --------KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA---LGIAQGLSYL 946
+ + ++V +Y GG L +L + E RL D R++IA L I + L
Sbjct: 64 TTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYIAEMVLAI-HSIHQL 121
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
HY +HRDIK DN+LLD ++ DFG S L + + S VG+ YI+PE
Sbjct: 122 HY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 1007 AYST-----RLTEKSDVYSYGVILFELLFRKMP 1034
+ + + D +S GV ++E+L+ + P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRN--ILR 891
++IG+G G V N+ K +A+K LN R+ET E R + LV N I
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV-LVNGDNQWITT 65
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA-QGLSYLHYDC 950
+ + + + ++V +Y GG L +L + E RL D Y + IA + LHY
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
+HRDIK DNIL+D ++ DFG KL+ D S S VG+ YI+PE +
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SVAVGTPDYISPEILQA 177
Query: 1010 T-----RLTEKSDVYSYGVILFELLFRKMP 1034
+ + D +S GV ++E+L+ + P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 62/234 (26%), Positives = 105/234 (44%), Gaps = 40/234 (17%)
Query: 815 QDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETN 873
Q++ ++P RY+++ +G G +G V + + A+KKL+R ++
Sbjct: 4 QELNKTVWEVPD--RYQNL------SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA 55
Query: 874 FDV-----EIRTLSLVRHRNILRIVGSCTKDEHG------FIVTEYMPGGTLFNVLHQNE 922
E+R L + H N++ ++ T ++VT M G L N++
Sbjct: 56 IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ- 113
Query: 923 PRLVLDWNTRYHIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979
+L D HI + Q GL Y+H IIHRD+K NI ++ + E KI DFG+
Sbjct: 114 -KLSDD-----HIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL 164
Query: 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRK 1032
++ H+ + V + Y APE + + D++S G I+ ELL K
Sbjct: 165 AR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVG 894
+GKG G V + K +A KKL++ E E + L V R I+ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 895 SC-TKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ TKD+ ++T M GG L +++ + EP A I GL +LH
Sbjct: 61 AFETKDDLCLVMT-LMNGGDLKYHIYNVGEP--GFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
+I++RD+K +N+LLD +I D G++ + R G+ GY+APE
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVY 171
Query: 1013 TEKSDVYSYGVILFELLFRKMP 1034
D ++ G L+E++ + P
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILR--- 891
IG+G +G VYR S + A+KK ++ + EI L +RH NI+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 892 -IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH------IALGIAQGLS 944
+VG + F+V EY Q+ L+ + T + + L + +GL
Sbjct: 74 VVVGK--HLDSIFLVMEY---------CEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
YLH + IIHRD+K N+LL + KI DFG+++ T V +L Y AP
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK--VVTLWYRAP 177
Query: 1005 ENAY-STRLTEKSDVYSYGVILFELLFRK 1032
E T T D+++ G IL ELL K
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 49/299 (16%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-----NFDVEIRTL 881
D++Y++ I+G G GTVY+ +R+ AVK + T E+ L
Sbjct: 2 DIQYQE--------ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL 53
Query: 882 SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941
I+ G+ + I TE+M GG+L +++ P VL IA+ + +
Sbjct: 54 YKCDSPYIIGFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLG-----RIAVAVVK 106
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
GL+YL +I+HRD+K N+L+++ + K+ DFG+S + +S + + VG+ Y
Sbjct: 107 GLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAY 159
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061
+APE + SDV+S G+ EL + P ++Q+N +
Sbjct: 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYP---------------QIQKNQGSLM 204
Query: 1062 FLDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVG--FLIKLNDKN 1113
L D D + + + +C R+ RP+ ++ F+++ ND N
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGN 263
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSL--VRHRNILR 891
++IGKG G V K +AVK L + E + R + L V+H ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ S + + V +Y+ GG LF H R L+ R++ A IA L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLH---S 114
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
I++RD+K +NILLDS+ + DFG+ K + + T S G+ Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 1012 LTEKSDVYSYGVILFELLF 1030
D + G +L+E+L+
Sbjct: 173 YDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 62/268 (23%), Positives = 115/268 (42%), Gaps = 48/268 (17%)
Query: 852 RTLSN-NSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910
+TL + N+ + W F E ++ + H NI+ ++G T+++ ++ EY+
Sbjct: 40 KTLKDINNPQQW---------GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 911 GGTLFNVLHQNEP--------------RLVLDWNTRYHIALGIAQGLSYL--HYDCVPQI 954
G L L P + LD HIA+ IA G+ YL H+
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----F 145
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
+H+D+ + NIL+ +L KI D G+S+ I + + + + ++ PE + +
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205
Query: 1015 KSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074
SD++S+GV+L+E+ + P +G N E I + + S+D
Sbjct: 206 DSDIWSFGVVLWEIF--SFGLQPYYG-------------FSNQEVIEMVRKRQLLPCSED 250
Query: 1075 QLKALRLLELALECTRQVADMRPSMREV 1102
R+ L EC ++ RP +++
Sbjct: 251 C--PPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 49/201 (24%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-------RSETNFDVEIRTLSLVRHRNILRIVG 894
IG+G+ VYR RK A+KK+ ++ + EI L + H N+++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 895 SCTKDEHGFIVTEYMPGGTLFN-VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
S +D IV E G L + + + + ++ T + + + + ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
++HRDIK N+ + + K+GD G+ + S +++ ++VG+ Y++PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYN 184
Query: 1014 EKSDVYSYGVILFELLFRKMP 1034
KSD++S G +L+E+ + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNILRI 892
+++GKG G V + + +A+K L + D E R L+L L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 893 VGSC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYL 946
+ C TKD F V EY+ GG L + + +EPR +R++ A + L +L
Sbjct: 61 LHCCFQTKDRL-FFVMEYVNGGDLMFQIQRSRKFDEPR------SRFYAA-EVTLALMFL 112
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H V I+RD+K DNILLD+E K+ DFGM K + T + G+ YIAPE
Sbjct: 113 HRHGV---IYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEI 167
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
D ++ GV+++E+ M P F D +
Sbjct: 168 LQELEYGPSVDWWALGVLMYEM----MAGQPPFEADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVG 894
IG+G +G VY+ ++ + A+KK L+ + F + EI+ L + HRNI+ +
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 895 SCT---------KDEHGF-IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ--- 941
T KD+ F +V EYM L +L E LV ++ HI + Q
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLL---ESGLV-HFSED-HIKSFMKQLLE 127
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLG 1000
GL+Y H +HRDIK NILL+++ + K+ DFG+++L S+ T I +L
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TLW 182
Query: 1001 YIAPENAY-STRLTEKSDVYSYGVILFELLFRK 1032
Y PE R DV+S G IL EL +K
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-14
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 874 FDVEIRTLSLVRHRNILRIVGS-CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTR 932
F E + + H NI+ ++ S F V EY+PG TL VL + L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-AADG--ALPAGET 81
Query: 933 YHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEP--KIGDFGMSKLISDSHSS 989
+ L + L+ H I+HRD+K NI++ + + P K+ DFG+ L+ +
Sbjct: 82 GRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 990 S----TRSA-IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
TR+ ++G+ Y APE +T SD+Y++G+I E L
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECL 183
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 72/239 (30%), Positives = 101/239 (42%), Gaps = 50/239 (20%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETN----FDVEIRTLSLVRHR--NILRI 892
IG G G VY+ + AVK++ R+ E N D+++ S H I++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKC 79
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVL----HQNEPRLVLDWNTRYHIALGIAQGLSYL-- 946
G D FI E M T + L P +L + + I + L YL
Sbjct: 80 YGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE 132
Query: 947 -HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
H +IHRD+K NILLD+ K+ DFG+S + DS + TRSA G Y+APE
Sbjct: 133 KH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS-KAKTRSA--GCAAYMAPE 184
Query: 1006 --------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN 1056
Y R +DV+S G+ L EL + P T+ T+ LQE
Sbjct: 185 RIDPPDPNPKYDIR----ADVWSLGISLVELATGQFPYK---NCKTEFEVLTK-ILQEE 235
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-14
Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSL--VRHRNILR 891
++IGKG G V + +AVK L + E N + R + L ++H ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ S E + V +Y+ GG LF H R L+ R++ A +A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLH---S 114
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K +NILLDS+ + DFG+ K T S G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMP 1034
D + G +L+E+L+ P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-14
Identities = 35/87 (40%), Positives = 54/87 (62%)
Query: 512 LSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS 571
L N L+G +P + + + +++ GN ++G+IPP G ++L +LD S N +GSIP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 572 ELGNLENLQILRLSANKLDGRIPYELG 598
LG L +L+IL L+ N L GR+P LG
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 43/230 (18%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL----NRSETNFDVEIRTLSLV 884
RY D+ R +G G +G V+ + ++ K AVKK+ +S + EI+ + +
Sbjct: 6 RYMDL------RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL 59
Query: 885 RHRNILRI--------------VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN 930
H NI+++ VGS T+ +IV EYM L NVL Q L +
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG--PLSEE-- 114
Query: 931 TRYHIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDS 986
H L + Q GL Y+H ++HRD+K N+ +++E L KIGDFG+++ I D
Sbjct: 115 ---HARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDP 167
Query: 987 HSSST--RSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFRKM 1033
H S S + + Y +P S T+ D+++ G I E+L K
Sbjct: 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 38/90 (42%), Positives = 55/90 (61%), Gaps = 1/90 (1%)
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665
L L + L G IP+++ L +QS++L N++ G IP + S+ SL L L N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 666 PCSLSKLHHFSSILNVSNNKLSGKIPECLG 695
P SL +L ILN++ N LSG++P LG
Sbjct: 483 PESLGQLTSL-RILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 6e-14
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDV--EIRTLSLVRHRNI 889
T+ R IG G G VY + + A+KK++ S E D+ E++ L ++H N
Sbjct: 28 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNS 87
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
+ G ++ ++V EY G + +P ++ H AL QGL+YLH
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSH 144
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
+IHRDIK+ NILL + K+ DFG + + S ++S VG+ ++APE +
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILA 195
Query: 1010 T---RLTEKSDVYSYGVILFELLFRKMPV 1035
+ K DV+S G+ EL RK P+
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-14
Identities = 42/102 (41%), Positives = 59/102 (57%), Gaps = 3/102 (2%)
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
Q L +H+ +IHRDIKS NILL S K+GDFG SK+ + + S G+
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042
Y+APE ++K+D++S GV+L+ELL K P D GE+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GEN 249
|
Length = 496 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-14
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH-------RNILRI 892
R+IG+G + V + + +A+K + + + D +I + +H L
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 893 VGSCTKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ SC + F+V EY+ GG L + H R + + + R++ A I L++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAA-EICIALNFLHER-- 115
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K DN+LLD++ K+ D+GM K T S G+ YIAPE
Sbjct: 116 -GIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVD 1036
D ++ GV++FE++ + P D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRI 892
R++GKG G V + K +A KKL + E+ E + L V R ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 893 VGSC-TKDEHGFIVTEYMPGGTL-FNVLHQ-----NEPRLVLDWNTRYHIALGIAQGLSY 945
+ TKD ++T M GG L F++ H E R V A I GL
Sbjct: 66 AYAYETKDALCLVLT-LMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEICCGLED 117
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH + +I++RD+K +NILLD +I D G++ + + + R VG++GY+APE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPE 171
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+ R T D ++ G +L+E++ + P
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-14
Identities = 70/244 (28%), Positives = 109/244 (44%), Gaps = 71/244 (29%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR-HRNILR------I 892
++IG+G G V ++ +A+KKL +SE +E ++ VR R+IL +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM---LEKEQVAHVRAERDILAEADNPWV 63
Query: 893 VG---SCTKDEHGFIVTEYMPGG---TLF---NVLHQNEPRLVLDWNTRYHIALGIAQGL 943
V S + + +++ EY+PGG TL + + E TR++IA I
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIAETI---- 111
Query: 944 SYLHYDCVPQI--IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS------------- 988
L D + ++ IHRDIK DN+LLD++ K+ DFG+ + SH
Sbjct: 112 --LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 989 ----------SSTRSA-------------IVGSLGYIAPENAYSTRLTEKSDVYSYGVIL 1025
SS R A VG+ YIAPE T ++ D +S GVI+
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 1026 FELL 1029
+E+L
Sbjct: 230 YEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-----VEIRTL-SLVRHRNIL 890
+ +G G G+VY + + + A+KK+ + +++ E+++L L H NI+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH--- 947
++ +++ + V EYM G L+ ++ + + + I I QGL+++H
Sbjct: 62 KLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHKHG 119
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
+ HRD+K +N+L+ KI DFG+++ I S + V + Y APE
Sbjct: 120 F------FHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRAPEIL 170
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFEL 1028
+YS+ + D+++ G I+ EL
Sbjct: 171 LRSTSYSSPV----DIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 35/213 (16%)
Query: 840 RIIGKGKHGTVY---RTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSC 896
+++G+G G V+ + ++ + +A+K L ++ +RT R+IL V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVN-- 56
Query: 897 TKDEHGFIV-------TE--------YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941
H FIV TE ++ GG LF L ++ + + + ++++A +A
Sbjct: 57 ----HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYLA-ELAL 109
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
L +LH II+RD+K +NILLD E K+ DFG+SK D H S G++ Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYS-FCGTVEY 164
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+APE T+ +D +S+GV++FE+L +P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 21/196 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSC 896
IG+G G V +S K AVKK++ R E F+ E+ + +H N++ + S
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFN-EVVIMRDYQHENVVEMYNSY 86
Query: 897 TKDEHGFIVTEYMPGGTLFNVL---HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ ++V E++ GG L +++ NE ++ + L + + LS LH V
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-------VCLAVLKALSVLHAQGV-- 137
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRDIKSD+ILL + K+ DFG +S R ++VG+ ++APE
Sbjct: 138 -IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYG 194
Query: 1014 EKSDVYSYGVILFELL 1029
+ D++S G+++ E++
Sbjct: 195 PEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 841 IIGKGKHGTVYRTL--SNNSRKHWAVKKLNRSET-----NFDVEIRTL-SLVRHRNILRI 892
+IG+G G V + + R A+K++ + +F E+ L L H NI+ +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY------- 945
+G+C + ++ EY P G L + L ++ VL+ + + IA A LS
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSR---VLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 946 ------LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL 999
+ Y Q IHRD+ + NIL+ KI DFG+S+ + + T + +
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-QEVYVKKTMGRL--PV 175
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
++A E+ + T SDV+SYGV+L+E++
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 18/197 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFD---VEIRTLSLVRHRNILRIVGSCT 897
+G G G VY+ + + A K + +SE + VEI L+ H I++++G+
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN-TRYHIALGIAQGLSYLHYDCVPQIIH 956
D +I+ E+ PGG + ++ L LD T I + Q L L Y +IIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE-- 1014
RD+K+ N+LL + + K+ DFG+S + + R + +G+ ++APE + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTP 191
Query: 1015 ---KSDVYSYGVILFEL 1028
K+D++S G+ L E+
Sbjct: 192 YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-13
Identities = 54/162 (33%), Positives = 78/162 (48%), Gaps = 10/162 (6%)
Query: 877 EIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN-EPRLVLDWNTRYHI 935
E+ L+ H I++ D+ ++ EY GG L + Q + L Y +
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYEV 171
Query: 936 AL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992
L I L +H ++HRD+KS NI L K+GDFG SK SDS S
Sbjct: 172 GLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
S+ G+ Y+APE R ++K+D++S GVIL+ELL P
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 68/261 (26%), Positives = 118/261 (45%), Gaps = 41/261 (15%)
Query: 863 AVKKLNRSETN------FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916
AVK L R + N F EI+ +S ++ NI+R++ C + ++TEYM G L
Sbjct: 50 AVKML-REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 917 VLHQNEPR--------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968
L ++EP+ + + ++T +A IA G+ YL +HRD+ + N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
KI DFGMS+ + + V + +++ E+ + T SDV+++GV L+E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 1029 LFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALR-------L 1081
L + ++ + ++ EN F D Q+ + L
Sbjct: 226 L--------TLCKEQPYSQLSDEQVIENTGEF--------FRDQGRQVYLPKPALCPDSL 269
Query: 1082 LELALECTRQVADMRPSMREV 1102
+L L C R+ A RPS +E+
Sbjct: 270 YKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 40/114 (35%), Positives = 54/114 (47%), Gaps = 6/114 (5%)
Query: 244 FSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGT 303
+S + F W GL LD+ L G IP + L +LQ + LS N + G
Sbjct: 404 WSGADCQFDSTKGKWFIDGL------GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGN 457
Query: 304 ISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELG 357
I + L+V+ LS N+ G IP S+G L+SL L L N L G +P LG
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 65/206 (31%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 840 RIIGKGKHGTVY--RTLSN-NSRKHWAVKKLNRSETNFDVEIRTLSLVR-HRNILRIVGS 895
R++G G +G V+ R + ++ K +A+K L + + +T R R +L V
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKK--ATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 896 C----------TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
C D ++ +Y+ GG LF L+Q E R +IA I L +
Sbjct: 64 CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTES-EVRVYIA-EIVLALDH 120
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH II+RDIK +NILLDSE + DFG+SK S G++ Y+APE
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPE 176
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELL 1029
S + D +S GV+ FELL
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRNILRIV 893
++G+G G V + +A+K + +S F+ E LS+ I ++
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA-QGLSYLHYDCVP 952
+ ++ ++V EY PGG L ++L++ E + D Y L +A + + Y
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---- 123
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
+HRDIK +N+L+D K+ DFG + +L ++ +S VG+ YIAPE +
Sbjct: 124 --VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP--VGTPDYIAPEVLTTMN 179
Query: 1012 LTEKS------DVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR 1050
K D +S GVI +E+++ + P F E T T+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAKTYNN 220
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVG 894
++G+G +G V + + + A+KK SE + V EIR L +RH N++ ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ + ++V E++ T+ + L + L D + I +G+ + H I
Sbjct: 68 VFRRKKRLYLVFEFV-DHTVLDDLEKYPNGL--DESRVRKYLFQILRGIEFCHSH---NI 121
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRLT 1013
IHRDIK +NIL+ K+ DFG ++ ++ T V + Y APE T+
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRWYRAPELLVGDTKYG 179
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
D+++ G ++ E+L +P F D+DI
Sbjct: 180 RAVDIWAVGCLVTEMLTG----EPLFPGDSDI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL------NRSETNFDVEIRTLSL--VRHRNILR 891
++IGKG G V K +AVK L NR E + R + L V+H ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ S E + V +++ GG LF H R + R++ A IA L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENAYST 1010
I++RD+K +NILLDS+ + DFG+ K I+ S +++T G+ Y+APE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT---FCGTPEYLAPEVIRKQ 171
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
D + G +L+E+L+ +P P + D
Sbjct: 172 PYDNTVDWWCLGAVLYEMLY-GLP--PFYCRDV 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILR-- 891
R IG G G V+ K A+KK+ N E++ L +H N+L
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 892 -IVGSCTKD--EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL---GIAQGLSY 945
I+ D E ++VTE M L ++ +P L D H+ + I +GL Y
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQP-LSSD-----HVKVFLYQILRGLKY 118
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH I+HRDIK N+L++S KI DFG++++ + S + V + Y APE
Sbjct: 119 LH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPE 174
Query: 1006 NAY-STRLTEKSDVYSYGVILFELLFRKM 1033
S T D++S G I ELL R++
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 835 RATEGRIIGKGKHGTVYRTLSNNSRK-----HWAVKKLN-----RSETNFDVEIRTLSLV 884
+ T R +G+G G VY ++ K A+K +N R F E +
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 66
Query: 885 RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH------QNEPRLVL-DWNTRYHIAL 937
+++R++G ++ + ++ E M G L + L +N P +A
Sbjct: 67 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
IA G++YL+ + + +HRD+ + N ++ + KIGDFGM++ I ++ +
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057
+ +++PE+ T SDV+S+GV+L+E+ + E ++ N
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI--------ATLAEQP-------YQGMSNE 228
Query: 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103
+ + F+ E D D + L EL C + MRPS E++
Sbjct: 229 QVLRFV-MEGGLLDKPDNCPDM-LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----TNFD---VEIRTLSLVRHRNILRIVG 894
+GKG G V + K +A KKLN+ ++ VE R L+ V R I+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 895 SC-TKDEHGFIVTEYMPGGTL----FNVLHQN----EPRLVLDWNTRYHIALGIAQGLSY 945
+ TK + ++T M GG L +NV +N EPR ++ A I GL +
Sbjct: 61 AFQTKTDLCLVMT-IMNGGDLRYHIYNVDEENPGFPEPRAC------FYTA-QIISGLEH 112
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH +II+RD+K +N+LLD++ +I D G++ + D S + A G+ G++APE
Sbjct: 113 LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA--GTPGFMAPE 167
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
D ++ GV L+E++ + P
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 44/219 (20%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL-NRSETNFDV-----EIRTLSLVRHRNILRIVGS 895
IG+G +G V ++ + + A+KK+ N + D EI+ L + H N++ I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAI--- 69
Query: 896 CTKD----------EHGFIVTEYMPGGTLFNVLHQ--NEPRLVLDWNTRYHIALGIAQGL 943
KD +IV E M LHQ + + D + +Y + + +GL
Sbjct: 70 --KDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFL-YQLLRGL 121
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
Y+H ++HRD+K N+LL++ + KI DFG+++ S+ T V + Y A
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE--YVVTRWYRA 176
Query: 1004 PE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
PE + Y+T + DV+S G I ELL RK P+ P
Sbjct: 177 PELLLNCSEYTTAI----DVWSVGCIFAELLGRK-PLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 44/222 (19%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK-LNRSETN-FDV----EIRTLSLVRHRNILRIV-- 893
+G+G G VY+ + + A+KK L +E + F + EI+ L ++H N++ ++
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 894 ----GSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ---GLS 944
+K + G ++VT YM L +L +L T I + Q G++
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPSVKL-----TESQIKCYMLQLLEGIN 129
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR---------SAI 995
YLH + I+HRDIK+ NIL+D++ KI DFG+++ + + +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 996 VGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRK 1032
V + Y PE Y+T + D++ G + E+ R+
Sbjct: 187 VVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVR--HRNILR 891
++IG+G G V N+ + +A+K LN R+ET E R + LV R I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV-LVNGDRRWITN 65
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA---LGIAQGLSYLHY 948
+ + + + ++V +Y GG L +L + E RL D R+++A L I + L Y
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM-ARFYLAEMVLAI-DSVHQLGY 123
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMS-KLISDSHSSSTRSAIVGSLGYIAPENA 1007
+HRDIK DN+LLD ++ DFG +L++D S + VG+ YI+PE
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS--NVAVGTPDYISPEIL 175
Query: 1008 YST-----RLTEKSDVYSYGVILFELLFRKMP 1034
+ R + D +S GV ++E+L+ + P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 7e-13
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 33/208 (15%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL--NRSETNFDV----EIRTLSLVRHRNILRI--- 892
I +G +G VYR + + A+KKL + + F + EI L ++H NI+ +
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72
Query: 893 -VGSCTKDEHGFIVTEYMPGG--TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
VGS + ++V EY+ +L + Q P L + + L + G+++LH +
Sbjct: 73 VVGS--NLDKIYMVMEYVEHDLKSLMETMKQ--PFLQSEVKC---LMLQLLSGVAHLHDN 125
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE---- 1005
I+HRD+K+ N+LL++ KI DFG+++ T+ +V +L Y APE
Sbjct: 126 ---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQ--LVVTLWYRAPELLLG 180
Query: 1006 -NAYSTRLTEKSDVYSYGVILFELLFRK 1032
YST D++S G I ELL +K
Sbjct: 181 AKEYST----AIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 69/272 (25%), Positives = 111/272 (40%), Gaps = 80/272 (29%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH----RNIL----- 890
+ IG G G V ++ +A+K L ++ DV +R + H R+IL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKA----DVLMR--NQAAHVKAERDILAEADN 60
Query: 891 ----RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---EPRLVLDWNTRYHIALGIAQGL 943
++ S ++ + V +Y+PGG + ++L + E L R++IA + +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIA-ELTCAI 114
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM---------SKLIS-------DS- 986
+H IHRDIK DNIL+D + K+ DFG+ SK DS
Sbjct: 115 ESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 987 ------------------------HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYG 1022
H ++VG+ YIAPE T T+ D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 1023 VILFELLFRKMP-VDPSFGEDTDIVTWTRWKL 1053
VIL+E+L + P + + E T+ K+
Sbjct: 232 VILYEMLVGQPPFLADTPAE-------TQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLS-LVRHRNILRIVGS 895
++G G +G VY+ + + A+K ++ +E +EI L HRNI G+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 896 CTK------DEHGFIVTEYMPGGTLFNVLHQNEPR-LVLDWNTRYHIALGIAQGLSYLHY 948
K D+ ++V E+ G++ +++ + L DW +I I +GL++LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLH- 138
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP---- 1004
++IHRDIK N+LL E K+ DFG+S + + R+ +G+ ++AP
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIA 194
Query: 1005 --ENAYSTRLTEKSDVYSYGVILFEL 1028
EN +T +SD++S G+ E+
Sbjct: 195 CDENPDAT-YDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFD---VEIRTLSLVRHRNILRIVGSCT 897
+G G G VY+ + + A K ++ +SE + VEI L+ H NI++++ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957
+ + +I+ E+ GG + V+ + E L T I + Q L L+Y +IIHR
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPL-----TEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE--- 1014
D+K+ NIL + + K+ DFG+S ++ + R + +G+ ++APE +
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 1015 --KSDVYSYGVILFEL 1028
K+DV+S G+ L E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDV-EIRTLSLVRHRNILRI 892
+++GKG G V + K++A+K L + E + E R L RH + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 893 VGSC-TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
S T D F V EY GG LF H + R+ + R++ A I L YLH C
Sbjct: 61 KYSFQTHDRLCF-VMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH-SC- 114
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+++RD+K +N++LD + KI DFG+ K ISD + T G+ Y+APE
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVLEDN 170
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
D + GV+++E++ ++P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 32/222 (14%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRT-----LSLVRHRNILRIVGSC 896
IGKG +G VY+ + AVK L+ ++ D EI SL H N+++ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 897 TKDEHG-----FIVTEYMPGGT---LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
K + ++V E GG+ L L RL D +I G GL +LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL--DEAMISYILYGALLGLQHLHN 146
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP---- 1004
+ +IIHRD+K +NILL +E K+ DFG+S ++ + R+ VG+ ++AP
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIA 201
Query: 1005 -ENAYSTRLTEKSDVYSYGVILFEL------LFRKMPVDPSF 1039
E Y + DV+S G+ EL LF PV F
Sbjct: 202 CEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 21/197 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDV---EIRTLSLVRHRNILRIVGSC 896
+G G +G VY+ + ++ + AVK KL + +F + EI + +H NI+ GS
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
E +I EY GG+L ++ H P L + + R + QGL+YLH
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH---SKGK 127
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR--- 1011
+HRDIK NILL + K+ DFG++ I + + + R + +G+ ++APE A +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 1012 LTEKSDVYSYGVILFEL 1028
+ D+++ G+ EL
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 19/203 (9%)
Query: 842 IGKGKHGTVYRTLSNN--SRKHWAVKKLNRSET-----NFDVEIRTLSLVRHRNILRIVG 894
IG G G V ++ S+ VK+L S T F E++ + H N+L+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY--HIALGIAQGLSYLHYDCVP 952
C + +V E+ P G L N L N + +A +A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE------- 1005
IH D+ N L ++L KIGD+G++ T+ L ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 1006 NAYSTRLTEKSDVYSYGVILFEL 1028
+ T+KS+++S GV ++EL
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 65/224 (29%), Positives = 104/224 (46%), Gaps = 33/224 (14%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHRNILR 891
++I G +G VY +R+ +A+KK+N+ + F VE L+ + ++
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVS 65
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH-YDC 950
+ S H +V EY+ GG +L +N L +D Y +A L YLH Y
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVLA--LEYLHNYG- 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKL--------ISDSH-SSSTRS----AIVG 997
I+HRD+K DN+L+ S K+ DFG+SK+ + + H TR + G
Sbjct: 122 ---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
+ YIAPE + D ++ G+IL+E L + P FG+
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFL---VGCVPFFGD 219
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDV-EIRTLSLVRHRNILRI 892
+++GKG G V + +++A+K L + E V E R L RH + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ + V EY GG LF H + R+ + R++ A I L YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLHSR--- 114
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
+++RDIK +N++LD + KI DFG+ K ISD +T G+ Y+APE
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---GATMKTFCGTPEYLAPEVLEDND 171
Query: 1012 LTEKSDVYSYGVILFELLFRKMP 1034
D + GV+++E++ ++P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SE---TNFDVEIRTLS 882
RY D+ + +G G +GTV L + A+KKL R SE E+R L
Sbjct: 16 RYRDLKQ------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69
Query: 883 LVRHRNILRIVGSCTKDE-----HGF-IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
++H N++ ++ T D H F +V +M GT L ++E L + +
Sbjct: 70 HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK---LSEDRIQFLV 124
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
+ +GL Y+H IIHRD+K N+ ++ + E KI DFG+++ + S + V
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYV 176
Query: 997 GSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRK 1032
+ Y APE + T+ D++S G I+ E+L K
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-------RSETNFDVEIRTLSLVRHRNILRIVG 894
IG+G+ VYR A+KK+ ++ + EI L + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
S +D IV E G L ++ H + + ++ T + + + L ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
++HRDIK N+ + + K+GD G+ + S +++ ++VG+ Y++PE +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYN 184
Query: 1014 EKSDVYSYGVILFELLFRKMP 1034
KSD++S G +L+E+ + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 839 GRIIGKGKHGTVYR-TLS--NNSRKHWAVKKL-----NRSET-NFDVEIRTLSLVRHRNI 889
G+I+G+G+ G+V LS + S+ AVK + SE F E + H N+
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 890 LRIVGSC--TKDEHGF----IVTEYMPGGTLFNVLHQNEPRLV-----LDWNTRYHIALG 938
++++G C ++ +M G L + L + RL L T +
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS--RLGGLPEKLPLQTLLKFMVD 121
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI-SDSHSSSTRSAIVG 997
IA G+ YL IHRD+ + N +L ++ + DFG+SK I S + R A +
Sbjct: 122 IALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 177
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKM 1033
+ +IA E+ T KSDV+++GV ++E+ R
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRK-----HWAVKKLN-----RSETNFDVEIRTLSLVRHRNI 889
R +G+G G VY + + K AVK +N R F E + ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLH------QNEP-RLVLDWNTRYHIALGIAQG 942
+R++G +K + +V E M G L + L +N P R +A IA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
++YL+ + +HRD+ + N ++ + KIGDFGM++ I ++ + + ++
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 1003 APENAYSTRLTEKSDVYSYGVILFEL 1028
APE+ T SD++S+GV+L+E+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSL---VRHRNILRIVGSC 896
+G+G + TVY+ + + + A+K L+ E IR +SL ++H NI+R+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956
+ +V EYM L + + R LD NT + +G+++ H + +++H
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKS 1016
RD+K N+L++ E K+ DFG+++ +T S V +L Y AP+ +R S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGI--PVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181
Query: 1017 -DVYSYGVILFEL-----LFR 1031
D++S G I+ E+ LF
Sbjct: 182 IDIWSVGCIMAEMITGRPLFP 202
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 50/231 (21%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------------------EIRT 880
G +G+G +G V + + K A+KK+ E + DV E++
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH------ 934
++ ++H NI+ +V + + +V + M + + V+D R
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMAS----------DLKKVVDRKIRLTESQVKC 123
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS----------KLIS 984
I L I GL+ LH +HRD+ NI ++S+ KI DFG++ L
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 985 DSHSSSTR--SAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRK 1032
D ++ V +L Y APE + + D++S G I ELL K
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEI-------RTLSLVRHRNILRI 892
+++GKG G V + +++A+K L + E+ R L RH + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
S + V EY GG LF H + R+ + R++ A I L YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHSE--K 115
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
+++RD+K +N++LD + KI DFG+ K I D +T G+ Y+APE
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD---GATMKTFCGTPEYLAPEVLEDND 172
Query: 1012 LTEKSDVYSYGVILFELLFRKMP 1034
D + GV+++E++ ++P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRI 892
R++GKG G V + K +A KKL + E E + L V R ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 893 VGSC-TKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ TKD ++T M GG L F++ + P + Y A I GL LH +
Sbjct: 66 AYAYETKDALCLVLT-LMNGGDLKFHIYNMGNPGFDEERAVFY--AAEITCGLEDLHRE- 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+I++RD+K +NILLD +I D G++ I + + R VG++GY+APE +
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNE 176
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
R T D + G +++E++ K P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-12
Identities = 75/307 (24%), Positives = 120/307 (39%), Gaps = 95/307 (30%)
Query: 824 LPRDLRYE-DVIRATEGRIIGKGKHG-----TVYRTLSNNSRKHWAVKKLNRSETNFD-- 875
LP D ++E R + G+ +G G G T Y +++ AVK L S +
Sbjct: 24 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTERE 83
Query: 876 ---VEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLF---------------- 915
E++ LS L H NI+ ++G+CT ++TEY G L
Sbjct: 84 ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHE 143
Query: 916 ---------NVLHQNEP------------------------------------------- 923
N+LHQ E
Sbjct: 144 DHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEI 203
Query: 924 ----RLVLDWNTRYHIALGIAQGLSYL-HYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978
L LD + +A+G+S+L +C IHRD+ + NILL KI DFG
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFG 259
Query: 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL------FRK 1032
+++ I + + + + ++APE+ ++ T +SDV+SYG++L+E+ +
Sbjct: 260 LARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 1033 MPVDPSF 1039
MPVD F
Sbjct: 320 MPVDSKF 326
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-12
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 31/222 (13%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD----VEIRTLSLV 884
+YE V IG G +GTVY+ +S A+K + R +TN D +R ++L+
Sbjct: 1 QYEPVAE------IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALL 53
Query: 885 R------HRNILRIVGSCT-----KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY 933
+ H NI+R++ C ++ +V E++ + P L + T
Sbjct: 54 KRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE--TIK 111
Query: 934 HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS 993
+ +GL +LH +C I+HRD+K +NIL+ S + K+ DFG++++ S +
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALT 165
Query: 994 AIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPV 1035
+V +L Y APE + D++S G I E +FR+ P+
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE-MFRRKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 7e-12
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 35/208 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------------EIRTLS-LVRHRN 888
+GKG +G V++ + +++ A+KK+ FD EI L L H N
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI------FDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 889 ILRI--VGSCTKDEHGFIVTEYMPGGT-LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
I+++ V D+ ++V EYM T L V+ N ++ D + RY I + + L Y
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYME--TDLHAVIRAN---ILEDVHKRY-IMYQLLKALKY 122
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI---VGSLGYI 1002
+H +IHRD+K NILL+S+ K+ DFG+++ +S+ + + V + Y
Sbjct: 123 IH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 1003 APENAY-STRLTEKSDVYSYGVILFELL 1029
APE STR T+ D++S G IL E+L
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEML 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 32/88 (36%), Positives = 53/88 (60%), Gaps = 2/88 (2%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
LD +G L+G IP +L ++ S N + G+IP LG++ +L++L LS N +G I
Sbjct: 425 LDNQG--LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 594 PYELGKCTKMIKLDLSDNYLAGSIPSEV 621
P LG+ T + L+L+ N L+G +P+ +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHW--AVKKL-NRSETNFDVEIRTLSLVRHR----NILRIVG 894
+G G G V + + +K A+K L N +E + E+ + + H+ I+R++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ---GLSYLHYDCV 951
C + E +V E GG L L + + T ++ + Q G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEI-----TVSNVVELMHQVSMGMKYLEGK-- 114
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+HRD+ + N+LL ++ KI DFG+SK L +D RSA L + APE
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 1011 RLTEKSDVYSYGVILFELL------FRKM 1033
+ + +SDV+SYG+ ++E ++KM
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 35/208 (16%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSC 896
+EG + KHG + RK VK + +T EI L + HR I+ ++
Sbjct: 104 SEGEVFVCTKHG-------DEQRKKVIVKAVTGGKT-PGREIDILKTISHRAIINLI--- 152
Query: 897 TKDEHGF----IVTEYMPGGT--LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
H + V MP LF + ++ P L I + + L+YLH
Sbjct: 153 ----HAYRWKSTVCMVMPKYKCDLFTYVDRSGP---LPLEQAITIQRRLLEALAYLHGR- 204
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----N 1006
IIHRD+K++NI LD +GDFG + + + G+L +PE +
Sbjct: 205 --GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD 262
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMP 1034
Y K+D++S G++LFE+ + +
Sbjct: 263 PYCA----KTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD---------VEIRTLSLVRHRNI- 889
IG+G +G V + A+KK+ + F+ EI+ L +H NI
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI----SPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 890 --LRIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY-HIALGIAQ--- 941
L I+ + + +IV E M L+ +L+ + HI + Q
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMETD-----LY----KLIKTQHLSNDHIQYFLYQILR 117
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-SSSTRSAIVGSLG 1000
GL Y+H ++HRD+K N+LL++ + KI DFG++++ H + + V +
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174
Query: 1001 YIAPENAYSTRLTEKS-DVYSYGVILFELLFRK 1032
Y APE +++ K+ D++S G IL E+L +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 70/226 (30%), Positives = 107/226 (47%), Gaps = 44/226 (19%)
Query: 842 IGKGKHGTV--YRTLSNNSRKHWAVKKLNRSETN-FDVEI------RTLSLVR----HRN 888
+G+G +G V R + + A+KK+ TN F +I R L L+R H+N
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI----TNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 889 I-----LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ-- 941
I + IV +E ++ E M L ++ +P T H I Q
Sbjct: 64 ITCLYDMDIVFPGNFNEL-YLYEELMEA-DLHQIIRSGQPL------TDAHFQSFIYQIL 115
Query: 942 -GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR--SAIVGS 998
GL Y+H V +HRD+K N+L++++ E KI DFG+++ S++ + + V +
Sbjct: 116 CGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 999 LGYIAPENAYSTRLTEKS-DVYSYGVILFELLFRKMPVDPSF-GED 1042
Y APE S + K+ DV+S G IL ELL RK P F G+D
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVFKGKD 214
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRI 892
R++GKG G V + K +A K+L + E+ E + L V + ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 893 VGSC-TKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ TKD ++T M GG L F++ + P + Y A I GL LH +
Sbjct: 66 AYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGFEEERALFY--AAEILCGLEDLHRE- 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
++RD+K +NILLD +I D G++ I + S R VG++GY+APE +
Sbjct: 122 --NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVLNNQ 176
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
R T D + G +++E++ + P
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 839 GRIIGKGKHGTVYRTLSN--NSRKHWAVKKL-----NRSET-NFDVEIRTLSLVRHRNIL 890
G+ +G+G+ G+V N +S AVK + RSE +F E + H N++
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 891 RIVGSC--TKDEHGF----IVTEYMPGGTLFNVL---HQNEPRLVLDWNTRYHIALGIAQ 941
R++G C T + G+ ++ +M G L + L + L IA
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
G+ YL IHRD+ + N +L+ + + DFG+SK I + + +
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW--KLQENHEC 1059
IA E+ T KSDV+S+GV ++E+ R P E+++I + R +L++ +C
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-ENSEIYDYLRQGNRLKQPPDC 239
Query: 1060 I 1060
+
Sbjct: 240 L 240
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 70/237 (29%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD----VEIRTLSL---VRHRNILRIVG 894
IG+G +G VY+ + + A+KK+ R ET + IR +SL + H NI+R
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPNIVR--- 62
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDW-----------NTRYHIALG----- 938
L +V+H E +L L + ++ L
Sbjct: 63 -------------------LLDVVHS-ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK 102
Query: 939 -----IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS 993
+ QG++Y H +++HRD+K N+L+D E K+ DFG+++ + T
Sbjct: 103 SYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159
Query: 994 AIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ +L Y APE YST + D++S G I E++ R+ P F D++I
Sbjct: 160 VV--TLWYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR----PLFPGDSEI 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-------NFDVEIRTLSLVRHRNILR 891
G +G G G V + +++A+K L + E + E L + H I+
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
++ S + + + E++ GG LF L + R D YH L +A YLH
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAELVLA--FEYLH-SK- 137
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS-AIVGSLGYIAPENAYST 1010
II+RD+K +N+LLD++ K+ DFG +K + D R+ + G+ Y+APE S
Sbjct: 138 -DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPEVIQSK 190
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR 1050
+ D ++ GV+L+E + P F +DT + +
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGY----PPFFDDTPFRIYEK 226
|
Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-11
Identities = 35/87 (40%), Positives = 48/87 (55%)
Query: 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617
L L G IP+++ L +LQ + LS N + G IP LG T + LDLS N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 618 PSEVISLEKMQSLSLQENNLSGAIPDA 644
P + L ++ L+L N+LSG +P A
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 42/113 (37%), Positives = 57/113 (50%), Gaps = 25/113 (22%)
Query: 413 LALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGP 472
L L N L G IP DI++LR+LQ ++L+GNS G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ-------------------------SINLSGNSIRGN 457
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATL 525
IP ++ T+L VL L N FNGS P +G+ +SLR + L+ N L G +PA L
Sbjct: 458 IPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 65/261 (24%), Positives = 117/261 (44%), Gaps = 63/261 (24%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR-HRNIL-------- 890
++IG+G G V ++ +A+K L +++ +E ++ +R R+IL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---LEKEQVAHIRAERDILVEADGAWV 63
Query: 891 -RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
++ S + +++ E++PGG + +L + + + + T+++IA + L D
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETV------LAID 115
Query: 950 CVPQI--IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS------------------ 989
+ Q+ IHRDIK DN+LLD++ K+ DFG+ + +H +
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 990 --STRSA-------------IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
S R A VG+ YIAPE T + D +S GVI++E+L
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY-- 233
Query: 1035 VDPSFGEDTDIVTWTR---WK 1052
P F +T T+ + WK
Sbjct: 234 --PPFCSETPQETYRKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLS-LVRHRNILRIVGSC 896
++G G +G VY+ + + A+K ++ + E EI L HRNI G+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 897 TK------DEHGFIVTEYMPGGTLFNVLHQNEPR-LVLDWNTRYHIALGIAQGLSYLHYD 949
K D+ ++V E+ G++ +++ + L +W +I I +GLS+LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH 130
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP----- 1004
++IHRDIK N+LL E K+ DFG+S + + R+ +G+ ++AP
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 1005 -ENAYSTRLTEKSDVYSYGVILFEL 1028
EN +T KSD++S G+ E+
Sbjct: 186 DENPDAT-YDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 842 IGKGKHGTVYRTL--SNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIV 893
+G G GTV + + S K AVK L + + E + + + I+R++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G C + E +V E G L L +N + V + N + ++ G+ YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKN--KHVTEKNIT-ELVHQVSMGMKYLEET---N 115
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
+HRD+ + N+LL ++ KI DFG+SK L +D + ++ + + APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 1013 TEKSDVYSYGVILFE 1027
+ KSDV+S+GV+++E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 845 GKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGF 903
GK G V ++K + K + N E L++ + N +++ S T +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85
Query: 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDN 963
++ +Y+ G LF++L + L I + + L+ LH IIH DIK +N
Sbjct: 86 LIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLEN 139
Query: 964 ILLD-SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE------NAYSTRLTEKS 1016
+L D ++ + D+G+ K+I + S G+L Y +PE S
Sbjct: 140 VLYDRAKDRIYLCDYGLCKII---GTPSCYD---GTLDYFSPEKIKGHNYDVSF------ 187
Query: 1017 DVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
D ++ GV+ +ELL K P E+ D+
Sbjct: 188 DWWAVGVLTYELLTGKHPFKEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRI 892
R++GKG G V + K +A KKL + E E R L V R ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 893 VGSC-TKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ TKD ++T M GG L F++ + P D A + GL L +
Sbjct: 66 AYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGF--DEQRAIFYAAELCCGLEDLQRE- 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+I++RD+K +NILLD +I D G++ I + + R VG++GY+APE +
Sbjct: 122 --RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR---VGTVGYMAPEVINNE 176
Query: 1011 RLTEKSDVYSYGVILFELL-----FRKMP-------VDPSFGEDTDIVTWTRWKLQENHE 1058
+ T D + G +++E++ FRK VD ED + ++ K E+ +
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSE-KFSEDAK 233
Query: 1059 CIC 1061
IC
Sbjct: 234 SIC 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 34/101 (33%), Positives = 50/101 (49%)
Query: 374 GTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRN 433
G IP +I L L+ + L N I G IP +G ++ L L L N G IP + +L +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIP 474
L+ L+L N L+G V LG + + + T N+ IP
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 840 RIIGKGKHGTVYR-TLSNNSRKHW--AVKKL-----NRSETNFDVEIRTLSLVRHRNILR 891
RI+G G+ G + R L S++ A+ L ++ F E TL H NI+R
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ G T+ IVTEYM G L + L ++E +LV + G+A G+ YL
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLPGLASGMKYL---SE 125
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGM---SKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
+H+ + + +L++S+L KI F K + + S +S ++ + APE
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL----WAAPEAIQ 181
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
+ SDV+S+G++++E++ S+GE
Sbjct: 182 YHHFSSASDVWSFGIVMWEVM--------SYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 840 RIIGKGKHGTVY---RTLSNNSRKHWAVKKL-------NRSET-NFDVEIRTLSLVRHRN 888
+++GKG +G V+ + ++ K +A+K L N+ +T + E L V+H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
I+ ++ + +++ EY+ GG LF +H + ++ ++++ I+ L +LH
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELF--MHLEREGIFMEDTACFYLS-EISLALEHLHQ 118
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
II+RD+K +NILLD++ K+ DFG+ K H + G++ Y+APE
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 1009 STRLTEKSDVYSYGVILFELL 1029
+ + D +S G +++++L
Sbjct: 174 RSGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN----------FDVEIRTLSLVRHRNILR 891
+G+G +G V + + AVK++ R+ N D+ +R++ +
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCP---YTVT 64
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQN--EPRLVLDWNTRYHIALGIAQGLSYLHYD 949
G+ ++ +I E M T + ++ + L + + IA+ I + L YLH
Sbjct: 65 FYGALFREGDVWICMEVM--DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE---- 1005
+IHRD+K N+L++ + K+ DFG+S + DS + T A G Y+APE
Sbjct: 123 L--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS-VAKTIDA--GCKPYMAPERINP 177
Query: 1006 ----NAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
Y + SDV+S G+ + EL + P D
Sbjct: 178 ELNQKGYDVK----SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNIL---R 891
+IGKG +G V + ++ + A+KK+N T EI+ L L+RH +I+
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 892 IVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
I+ ++ E ++V E M L V+ N D T H + Q L L Y
Sbjct: 67 IMLPPSRREFKDIYVVFELM-ESDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYI 119
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI-----VGSLGYIAP 1004
+ HRD+K NIL +++ + KI DFG++++ + T +AI V + Y AP
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARV----AFNDTPTAIFWTDYVATRWYRAP 175
Query: 1005 E--NAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
E ++ ++ T D++S G I E+L K P+ P
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 66/261 (25%), Positives = 116/261 (44%), Gaps = 63/261 (24%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR-HRNIL-------- 890
++IG+G G V ++ +A+K L +++ +E + +R R+IL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM---LEKEQVGHIRAERDILVEADSLWV 63
Query: 891 -RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
++ S + +++ E++PGG + +L + + + + T+++IA + L D
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETV------LAID 115
Query: 950 CVPQI--IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS------------------ 989
+ Q+ IHRDIK DN+LLDS+ K+ DFG+ + +H +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 990 --STRSA-------------IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
S R A VG+ YIAPE T + D +S GVI++E+L
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY-- 233
Query: 1035 VDPSFGEDTDIVTWTR---WK 1052
P F +T T+ + WK
Sbjct: 234 --PPFCSETPQETYKKVMNWK 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 37/176 (21%)
Query: 884 VRHRNILRIVGSCTKD-EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTR-------YHI 935
+ H+NIL I+ C +D E F++ YM G L L Q RL N + H+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQ--CRLGEANNPQALSTQQLVHM 122
Query: 936 ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHSSSTRS 993
A+ IA G+SYLH +IH+DI + N ++D EL+ KI D +S+ + D H
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH------ 173
Query: 994 AIVGSLG--------YIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMP---VDP 1037
LG ++A E+ + + SDV+S+GV+L+EL+ + P +DP
Sbjct: 174 ----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 56/210 (26%), Positives = 103/210 (49%), Gaps = 38/210 (18%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLVR---HRNILRIVGS 895
IG+G +G VY+ + + + A+KK+ +E IR +SL++ H NI++++
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA--------QGLSYLH 947
+ ++V E+ LHQ+ + +D + I L + QGL++ H
Sbjct: 68 IHTENKLYLVFEF---------LHQDLKKF-MDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
+++HRD+K N+L+++E K+ DFG+++ + T V +L Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEIL 172
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELLFRK 1032
YST + D++S G I E++ R+
Sbjct: 173 LGCKYYSTAV----DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL------NRSETNFDVEIRT-LSLVRHRNILRIVG 894
IGKG G V + ++++ +A+K + +RSE + RT L+ V I+ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
S E ++V ++ GG LF+ L Q E R L R++ A + L LH +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-QREGRFDL-SRARFYTA-ELLCALENLHK---FNV 114
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
I+RD+K +NILLD + + DFG+ KL + D ++T G+ Y+APE T
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAPELLLGHGYT 171
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ D ++ GV+L+E+L +P P + E+ +
Sbjct: 172 KAVDWWTLGVLLYEML-TGLP--PFYDENVN 199
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 49/237 (20%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---EIRTLSLV- 884
+YE V + IG+G +G VY+ + + A+KK+ + + V IR +SL+
Sbjct: 3 QYEKVEK------IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLK 56
Query: 885 --RHRNILRIVGSCTKDEHGFIVTEY--------MPGGTLFNVLHQNEPRLVLDWNTRYH 934
+H NI+R+ ++ ++V EY M F PRL+ + Y
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFA----KNPRLIKTY--LYQ 110
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP-KIGDFGMSKLISDSHSSSTRS 993
I GIA Y H +++HRD+K N+L+D K+ DFG+++ + T
Sbjct: 111 ILRGIA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 994 AIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ +L Y APE YST + D++S G I E++ +K P F D++I
Sbjct: 164 VV--TLWYRAPEILLGSRHYSTPV----DIWSVGCIFAEMVNQK----PLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 31/221 (14%)
Query: 842 IGKGKHGTVY--RTLSNNSRKHWAVKKLNRSETNFD----VEIRTLSLVR------HRNI 889
IG+G +G V+ R L N R A+K++ R +T + IR ++++R H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGR-FVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 890 LRIVGSCT-----KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
+R+ CT ++ +V E++ + EP + + T + + +GL
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLD 124
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
+LH +++HRD+K NIL+ S + K+ DFG++++ S +++V +L Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAP 178
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
E + D++S G I E+ RK P F +D+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 318 ALSRNN--LVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGT 375
L +N L G IP + L L S+ L N ++G +PP LG+ SL L L +N G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIG 405
IP + L L +L L N + G +P +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-10
Identities = 58/249 (23%), Positives = 96/249 (38%), Gaps = 50/249 (20%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-------EIRTL 881
RY+ + R+IGKG G VY + A+KK+ + + E +
Sbjct: 3 RYDII------RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIA 56
Query: 882 SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN--------TRY 933
+ + H I+ + C+ + + Y+ G TL ++L + L
Sbjct: 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 934 HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI---------- 983
I I + Y+H ++HRD+K DNILL E I D+G +
Sbjct: 117 SIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 984 ------SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL-------- 1029
S + IVG+ Y+APE +E +D+Y+ GVIL+++L
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
Query: 1030 --FRKMPVD 1036
RK+
Sbjct: 234 KKGRKISYR 242
|
Length = 932 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 31/213 (14%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLS 882
+YE + + IG+G +G V++ + + + A+KK SE + + EIR L
Sbjct: 2 KYEKLSK------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLK 55
Query: 883 LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQG 942
++H N++ ++ + +V EY T+ N L +N PR V + + I Q
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYC-DHTVLNELEKN-PRGVPEHLIK-KIIWQTLQA 112
Query: 943 LSYLH-YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
+++ H ++C IHRD+K +NIL+ + + K+ DFG +++++ T V + Y
Sbjct: 113 VNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWY 166
Query: 1002 IAPE-----NAYSTRLTEKSDVYSYGVILFELL 1029
APE Y + DV++ G + ELL
Sbjct: 167 RAPELLVGDTQYGPPV----DVWAIGCVFAELL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 57/224 (25%)
Query: 842 IGKGKHGTVY--RTLSNNSRKHWAVKKLNRSETNFD----VEIRTLSLVR---HRNILRI 892
IG+G +G VY + + K +A+KK + + R ++L+R H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 893 VGSCTKDEHG--FIVTEY-------------------MPGGTLFNVLHQNEPRLVLDWNT 931
V + +++ +Y +P + ++L Q
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----------- 116
Query: 932 RYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLI-SDS 986
I G+ YLH + ++HRD+K NIL+ E KIGD G+++L +
Sbjct: 117 -------ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 987 HSSSTRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELL 1029
+ +V ++ Y APE R T+ D+++ G I ELL
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSL---VRHRN 888
R + + IG G G V + AVKKL+R ++T+ R L L V H+N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 889 ILRIVGSCTKD------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQG 942
I+ ++ T + ++V E M L V+H LD ++ + G
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME-----LDHERMSYLLYQMLCG 135
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
+ +LH IIHRD+K NI++ S+ KI DFG+++ ++ + V + Y
Sbjct: 136 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYR 189
Query: 1003 APENAYSTRLTEKSDVYSYGVILFELL 1029
APE E D++S G I+ EL+
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 44/220 (20%)
Query: 829 RYEDVIRATEGRIIGKGKHGTV---YRTLSNNSRKHWAVKKLNRSETNFD------VEIR 879
RY+++ + IG G G V Y T++ + A+KKL+R N E+
Sbjct: 17 RYQNL------KPIGSGAQGIVCAAYDTVTGQ---NVAIKKLSRPFQNVTHAKRAYRELV 67
Query: 880 TLSLVRHRNILRIVGSCTKD------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY 933
+ LV H+NI+ ++ T + ++V E M L V+ + LD
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ-----MDLDHERMS 121
Query: 934 HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS--- 990
++ + G+ +LH IIHRD+K NI++ S+ KI DFG+++ S +
Sbjct: 122 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 178
Query: 991 -TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
TR Y APE E D++S G I+ E++
Sbjct: 179 VTRY-------YRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 828 LRYEDVIRATEGRIIGKGKHGTV-YRTLSNNSRKHWAVKKLNRSET-------NFDVEIR 879
++YED R +G G G V T N A+K+ +S+ + E +
Sbjct: 27 MKYEDF---NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERK 83
Query: 880 TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
L+ + H + + GS + + ++V E++ GG F L +N+ R D Y
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFY-----A 137
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS-AIVGS 998
AQ + Y I++RD+K +N+LLD + K+ DFG +K++ TR+ + G+
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV------DTRTYTLCGT 191
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
YIAPE + + +D ++ G+ ++E+L
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 27/203 (13%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIV--GSC-- 896
IIG+G G VY ++ K +A+K L++ + TL+L R +L +V G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLAL-NERIMLSLVSTGDCPF 58
Query: 897 ---------TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
T D+ FI+ + M GG L H ++ + + R++ A I GL ++H
Sbjct: 59 IVCMTYAFHTPDKLCFIL-DLMNGGDLH--YHLSQHGVFSEKEMRFY-ATEIILGLEHMH 114
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN- 1006
V ++RD+K NILLD +I D G++ S A VG+ GY+APE
Sbjct: 115 NRFV---VYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVL 167
Query: 1007 AYSTRLTEKSDVYSYGVILFELL 1029
T +D +S G +LF+LL
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 29/215 (13%)
Query: 833 VIRATEGRIIGKGKHG---TVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNI 889
+I+ + I KG + RT + H K L N EI+ L + NI
Sbjct: 27 LIKENDQNSIYKGIFNNKEVIIRTFKKFHKGH---KVLIDITEN---EIKNLRRIDSNNI 80
Query: 890 LRIVG----SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
L+I G ++ EY G L VL + + L + T+ +A+ +GL
Sbjct: 81 LKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYN 137
Query: 946 LH-YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
L+ Y P ++++ S + L+ + KI G+ K++S + V + Y +
Sbjct: 138 LYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-----VNFMVYFSY 189
Query: 1005 E---NAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
+ + +S T K D+YS GV+L+E+ K+P +
Sbjct: 190 KMLNDIFS-EYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 36/210 (17%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRT-----LSLVRHRNILRIVGSC 896
IGKG +G V++ L+ + AVK L+ + D EI +L H N+++ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 897 TKDE-----HGFIVTEYMPGGTLFNVL--------HQNEPRLVLDWNTRYHIALGIAQGL 943
K + ++V E GG++ +++ EP + H AL GL
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY----ILHEAL---MGL 137
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
+LH V + IHRD+K +NILL +E K+ DFG+S ++ + R+ VG+ ++A
Sbjct: 138 QHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMA 192
Query: 1004 P-----ENAYSTRLTEKSDVYSYGVILFEL 1028
P E + + DV+S G+ EL
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 842 IGKGKHGTVY--RTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVG 894
IG G G V S + VK+L S + F E + ++H N+L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLH--QNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
CT+ +V E+ P G L L + + D T +A IA GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMS--KLISDSHSSSTRSAIVGSLGYIAPE----- 1005
IH D+ N LL ++L KIGD+G+S K D + + + + L +IAPE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEV 177
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELL 1029
N T++S+V+S GV ++EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVG 894
+GKG G V N+ K +A KKL++ E +E L V I+ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 895 SCTKDEHGFIVTEYMPGGTL-FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ H +V M GG L +++ + E L+ H + I G+ +LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
I++RD+K +N+LLD + ++ D G++ + D + + R+ G+ GY+APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA---GTNGYMAPEILKEEPYS 172
Query: 1014 EKSDVYSYGVILFELLFRKMP 1034
D ++ G ++E++ + P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 837 TEGRIIGKGKHGTVYRT---LSNNSRKHWAVKKLNRS-ETNFDVE--IRTLSLVR---HR 887
T GR++GKG+ G+V + S + AVK L ++ D+E +R + ++ H
Sbjct: 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHP 61
Query: 888 NILRIVG-SCTKDEHG-----FIVTEYMPGGTLFNVLHQN---EPRLVLDWNTRYHIALG 938
N+++++G S G ++ +M G L L + E L T +
Sbjct: 62 NVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998
IA G+ YL IHRD+ + N +L+ + + DFG+SK I A
Sbjct: 122 IASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELLFR 1031
+ ++A E+ T SDV+++GV ++E++ R
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 35/116 (30%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973
L+ L + L +D I I +GL YLH +IIHRD+K++NI ++ +
Sbjct: 143 LYTYLTKRSRPLPID--QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVC 197
Query: 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
IGD G ++ + + G++ APE + K+D++S G++LFE+L
Sbjct: 198 IGDLGAAQF---PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 42/230 (18%)
Query: 830 YEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLS 882
+E R + + +G G G V + ++ A+KK+ + ++ + E++ L
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLK 64
Query: 883 LVRHRNILRIVGSCTKD------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
+RH NI+ D E + VTE + GT + L + P L+ +
Sbjct: 65 HLRHENII-----SLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP---LEKQFIQYFL 114
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS---STRS 993
I +GL Y+H V +HRD+K NIL++ + KI DFG+++ I D + STR
Sbjct: 115 YQILRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTGYVSTRY 170
Query: 994 AIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042
Y APE + + + D++S G I E+L K P+ P G+D
Sbjct: 171 -------YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFP--GKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 47/211 (22%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 842 IGKGKHGTVYR-----TLSNNSRKHWAVKKL-NRSETNFDVEIRTLSLVR----HRNILR 891
+G+ + G VY+ T + A+K L +++E E + +++R H NI+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALG 938
++G TK++ ++ Y L L P + L+ HI
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998
IA G+ +L ++H+D+ + N+L+ +L KI D G+ + + + +
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ +++PE + + SD++SYGV+L+E+
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-09
Identities = 32/88 (36%), Positives = 49/88 (55%)
Query: 338 LNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIE 397
++ L L N L+G +P ++ L + L N I G IPP + ++ LEVL L N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 398 GAIPHQIGRMSKLVELALYNNRLTGRIP 425
G+IP +G+++ L L L N L+GR+P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-09
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 21/152 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSET---NFDVEIRT----LSLVRHRNILRIVG 894
I +G G VY N+ K +AVK + +++ N +++ L+L + I+ +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
S + ++V EY+ GG + ++LH +E +I+ +A L YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM------AVKYIS-EVALALDYLHRH- 123
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982
IIHRD+K DN+L+ +E K+ DFG+SK+
Sbjct: 124 --GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 48/234 (20%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVK-----------KLNRSETNFDVEIRTLSLVRHRN 888
+++GKG G V+ + K +A+K K+ R T E L+ + H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT----EQEILATLDHPF 62
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNT-RYHIALGIAQGLSYLH 947
+ + S + + +V +Y PGG LF +L Q +P L R++ A + L YLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFYAAEVLL-ALEYLH 120
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD---------------------- 985
+ I++RD+K +NILL + DF +SK
Sbjct: 121 ---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 986 ----SHSSSTRS-AIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
S S RS + VG+ YIAPE D ++ G++L+E+L+ P
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-09
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIV--GSC-- 896
IIG+G G VY ++ K +A+K L++ + TL+L R +L +V G C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLAL-NERIMLSLVSTGDCPF 58
Query: 897 ---------TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
T D+ FI+ + M GG L L Q+ + + R++ A I GL ++H
Sbjct: 59 IVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG--VFSEAEMRFY-AAEIILGLEHMH 114
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN- 1006
V ++RD+K NILLD +I D G++ S A VG+ GY+APE
Sbjct: 115 NRFV---VYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEVL 167
Query: 1007 AYSTRLTEKSDVYSYGVILFELL 1029
+D +S G +LF+LL
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVG 894
++G+G +G V + +++ A+KK SE N +V E++ L ++ NI+ +
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ + ++V EY+ L L + P V R +I Q + +H+ I
Sbjct: 68 AFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDI 121
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
+HRDIK +N+L+ K+ DFG ++ +S+ S++ + V + Y +PE +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 1015 KSDVYSYGVILFEL 1028
D++S G IL EL
Sbjct: 181 AVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDVEIRTLSLV---RHRNILRIVGS 895
IG+G +G VY+ + + + A+KK+ + E IR +SL+ +H NI+ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
++ +++ E++ L L +D I QG+ + H +++
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVL 123
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRLTE 1014
HRD+K N+L+D++ K+ DFG+++ T + +L Y APE S R +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSPRYST 181
Query: 1015 KSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
D++S G I E+ +K P F D++I
Sbjct: 182 PVDIWSIGTIFAEMATKK----PLFHGDSEI 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 33/110 (30%), Positives = 59/110 (53%), Gaps = 5/110 (4%)
Query: 920 QNEPRLVLDWNTRYHIALGIAQGLSYL-HYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978
E LD + + +AQG+ +L +C IHRD+ + N+LL KI DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFG 257
Query: 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
+++ I + + + + ++APE+ + T +SDV+SYG++L+E+
Sbjct: 258 LARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 28/202 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVG 894
+G G +G+V + AVKKL+R ++ + E+R L ++H N++ ++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 895 ------SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
S + ++VT M G L N++ + + D + ++ I I +GL Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLI-YQILRGLKYIH- 137
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
IIHRD+K N+ ++ + E KI DFG+++ H+ + V + Y APE
Sbjct: 138 --SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIML 190
Query: 1009 S-TRLTEKSDVYSYGVILFELL 1029
+ + D++S G I+ ELL
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVR---HRNILRIVGSC 896
+G+G + TVY+ +S + + A+K + E IR SL++ H NI+ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 897 TKDEHGFIVTEYM-----------PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
E V EYM PGG LH RL + + +GL+Y
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFM---------FQLLRGLAY 118
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
+H I+HRD+K N+L+ E K+ DFG+++ + S S T S+ V +L Y P+
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPD 173
Query: 1006 -----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
YS+ L D++ G I E + + P P
Sbjct: 174 VLLGATDYSSAL----DIWGAGCIFIE-MLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 32/204 (15%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNF------DVEIRTLSLVRHRNILRIVGS 895
+G G +G+V R+ AVKKL+R + E+R L ++H N++ ++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 896 CTKDEHG------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ---GLSYL 946
T ++VT M G L N++ +L + H+ I Q GL Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNNIVKCQ--KLSDE-----HVQFLIYQLLRGLKYI 134
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H IIHRD+K N+ ++ + E +I DFG+++ D + V + Y APE
Sbjct: 135 H---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEI 186
Query: 1007 AYS-TRLTEKSDVYSYGVILFELL 1029
+ + D++S G I+ ELL
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 840 RIIGKGKHGTVY--RTLSNNSRKH-WAVKKLNR--------SETNFDVEIRTLSLVRHRN 888
+++G G +G V+ R ++ + +A+K L + + + E L VR
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 889 ILRIVGSCTKDEHGF-IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
L + + E ++ +Y+ GG +F L+Q + + R++ I L +LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSG-EIILALEHLH 122
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
I++RDIK +NILLDSE + DFG+SK T S G++ Y+APE
Sbjct: 123 K---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEII 178
Query: 1008 YSTRLTEKS-DVYSYGVILFELL 1029
K+ D +S G+++FELL
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-09
Identities = 68/213 (31%), Positives = 108/213 (50%), Gaps = 13/213 (6%)
Query: 505 SSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENR 564
L + L+ N L+ ++ LE ++ LD+ N + P + SNL LD S+N+
Sbjct: 93 LPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNK 151
Query: 565 LSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISL 624
+ S+PS L NL NL+ L LS N L +P L + + LDLS N +P E+ L
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLPPEIELL 208
Query: 625 EKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN--IFDGSIPCSLSKLHHFSSILNVS 682
++ L L N++ + + S++++L L+L +N +LS L L++S
Sbjct: 209 SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLE----TLDLS 263
Query: 683 NNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715
NN++S LG+L L+ LDLS NS S +P
Sbjct: 264 NNQIS--SISSLGSLTNLRELDLSGNSLSNALP 294
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-09
Identities = 31/89 (34%), Positives = 48/89 (53%)
Query: 486 LVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSI 545
L L N G P +I K L+ + LS N ++G++P +L + LD+ N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 546 PPVFGFWSNLTMLDFSENRLSGSIPSELG 574
P G ++L +L+ + N LSG +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDV----EIRTLSLVRHRNILRIV 893
IG+G G V++ +++ A+KK+ N E F + EI+ L L++H N++ ++
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLI 77
Query: 894 GSCTKD---EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY---HIALGIAQ---GLS 944
C + + + Y+ +F + L+ + N ++ I + GL
Sbjct: 78 EICRTKATPYNRYKGSFYL----VFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS-----DSHSSSTRSAIVGSL 999
Y+H + +I+HRD+K+ NIL+ + K+ DFG+++ S + + R V +L
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR---VVTL 187
Query: 1000 GYIAPENAYSTR-LTEKSDVYSYGVILFELLFR 1031
Y PE R D++ G I+ E+ R
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 49/192 (25%), Positives = 86/192 (44%), Gaps = 39/192 (20%)
Query: 884 VRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGL 943
V H++I+ + G C +D +V E++ G L +H+ L W ++ +A +A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118
Query: 944 SYLHYDCVPQIIHRDIKSDNILL-----DSELEP--KIGDFGMSKLISDSHSSSTRSAIV 996
SYL ++H ++ + NILL D E P K+ D G+ + +R V
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECV 169
Query: 997 GSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLF--------------------RKMPV 1035
+ +IAPE ++ L+ +D +S+G L+E+ + + M V
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLV 229
Query: 1036 DPSFGEDTDIVT 1047
PS E D++T
Sbjct: 230 TPSCKELADLMT 241
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-08
Identities = 30/103 (29%), Positives = 52/103 (50%)
Query: 582 LRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641
L L L G IP ++ K + ++LS N + G+IP + S+ ++ L L N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 642 PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNN 684
P++ + SL L L N G +P +L + N ++N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVGS 895
IG+G +GTV++ + + + A+K++ + + V EI L ++H+NI+R+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 896 CTKDEHGFIVTEYMPGG--TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
D+ +V EY F+ + D + +GL++ H
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSC-NGDI----DPEIVKSFMFQLLKGLAFCHSH---N 119
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR--SAIVGSLGYIAPENAYSTR 1011
++HRD+K N+L++ E K+ DFG+++ + R SA V +L Y P+ + +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 1012 LTEKS-DVYSYGVILFELLFRKMPVDPSFGEDTD 1044
L S D++S G I EL P+ P G D D
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFP--GNDVD 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 840 RIIGKGKHGTVY--RTLS-NNSRKHWAVKKLNR--------SETNFDVEIRTLSLVRHRN 888
+++G G +G V+ R +S ++S K +A+K L + + + E + L +R
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 889 ILRIVGSCTKDEHGF-IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALG-IAQGLSYL 946
L + + + ++ +Y+ GG LF L Q E R I G I L +L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFK---EQEVQIYSGEIVLALEHL 121
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA--IVGSLGYIAP 1004
H II+RDIK +NILLDS + DFG+SK + H A G++ Y+AP
Sbjct: 122 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFHEDEVERAYSFCGTIEYMAP 175
Query: 1005 E--NAYSTRLTEKSDVYSYGVILFELL 1029
+ + D +S GV+++ELL
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLV---RHRNILRIVGSC 896
+G+G + TVY+ S + + A+K +L E IR SL+ +H NI+ +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 897 TKDEHGFIVTEYM-----------PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
+ +V EY+ GG L + RL L + +GL+Y
Sbjct: 73 HTKKTLTLVFEYLDTDLKQYMDDCGGG-----LSMHNVRLFL---------FQLLRGLAY 118
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
H +++HRD+K N+L+ E K+ DFG+++ + S S T S V +L Y P+
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTLWYRPPD 173
Query: 1006 -----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
YST L D++ G I +E + P+ P
Sbjct: 174 VLLGSTEYSTSL----DMWGVGCIFYE-MATGRPLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-08
Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 1/87 (1%)
Query: 389 LYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEV 448
L L N + G IP+ I ++ L + L N + G IPP + + +L+ L L++N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 449 ALELGKHFPYLSRLDLTGNSFYGPIPA 475
LG+ L L+L GNS G +PA
Sbjct: 483 PESLGQ-LTSLRILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSL---VRHRNILRIVGS 895
IG G G V ++ A+KKL+R ++T+ R L L V H+NI+ ++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 896 CTKD------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
T + +IV E M L V+ ++ LD ++ + G+ +LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
IIHRD+K NI++ S+ KI DFG+++ + +S + V + Y APE
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 1010 TRLTEKSDVYSYGVILFELL 1029
E D++S G I+ E++
Sbjct: 200 MGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 67/269 (24%), Positives = 108/269 (40%), Gaps = 72/269 (26%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR-HRNIL-------- 890
++IGKG G V ++ K +A+K L +SE + L+ V+ R++L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM---FKKDQLAHVKAERDVLAESDSPWV 63
Query: 891 -RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA---LGIAQGLSYL 946
+ S ++ +++ E++PGG L +L + + + TR+++A L I + L
Sbjct: 64 VSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIE-AVHKL 120
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS----------------- 989
+ IHRDIK DNIL+D K+ DFG+S H S
Sbjct: 121 GF------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 990 --------------STRSAI--------------VGSLGYIAPENAYSTRLTEKSDVYSY 1021
S++ I VG+ YIAPE ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 1022 GVILFELLFRKMPVDPSFGEDT--DIVTW 1048
G I+FE L P +T I+ W
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINW 263
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 42/176 (23%), Positives = 77/176 (43%), Gaps = 22/176 (12%)
Query: 865 KKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPR 924
S F+ +S + H++++++ G C +DE+ +V EY+ G L LH+ +
Sbjct: 40 SDHRDSLAFFET-ASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNN 97
Query: 925 LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEP----KIGDF 977
+ L W + +A +A L YL +++H ++ NIL+ K+ D
Sbjct: 98 VSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152
Query: 978 GMSKLISDSHSSSTRSAIVGSLGYIAPE--NAYSTRLTEKSDVYSYGVILFELLFR 1031
G+ + +R V + +IAPE LT +D +S+G L E+
Sbjct: 153 GIPI------TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 14/255 (5%)
Query: 111 SIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSL-CYS 169
+ L N L +L LN NR + +I + +L L+ LDL N+++ IPP + L +
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 170 LESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVG 229
L+ + +N + LP+ + +LP LK+L L+ N+L+ L N + +L + N
Sbjct: 142 LKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI-S 199
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
LP + L E S+N+ L L L L +N LE +PE++ L N
Sbjct: 200 DLPPEIELLSALEELDLSNNS--IIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSN 256
Query: 290 LQKLVLSANKL------NGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLL 343
L+ L LS N++ + + + + + + + L L
Sbjct: 257 LETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKAL 316
Query: 344 FNNRLQGTLPPELGN 358
L + +
Sbjct: 317 ELKLNSILLNNNILS 331
|
Length = 394 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 41/231 (17%)
Query: 815 QDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNF 874
++V +LP R T + +G G +G+V + + + A+KKL+R F
Sbjct: 4 EEVNKTVWELPE--------RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP---F 52
Query: 875 DVEI------RTLSLVRHRNILRIVG--------SCTKDEHGF-IVTEYMPGGTLFNVLH 919
EI R L+L++H ++G + F +V YM L
Sbjct: 53 QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQ 107
Query: 920 QNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979
+ + + +Y + + GL Y+H IIHRD+K N+ ++ + E KI DFG+
Sbjct: 108 KIMGHPLSEDKVQY-LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL 163
Query: 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELL 1029
++ H+ + + V + Y APE + + D++S G I+ E+L
Sbjct: 164 AR-----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSC---- 896
IG+G +G VY+ N+ K A+KK R E D E + +R ++L+++
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKK-TRLEM--DEEGIPPTALREISLLQMLSESIYIV 64
Query: 897 -------TKDEHG----FIVTEYMPGG-TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
++++G ++V EY+ F + P L T + +G++
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEP-KIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
+ H V +HRD+K N+L+D + KI D G+ + S S T + +L Y A
Sbjct: 125 HCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRA 179
Query: 1004 PE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
PE YST + D++S G I E+ RK P+ P
Sbjct: 180 PEVLLGSTHYSTPV----DIWSVGCIFAEMS-RKQPLFP 213
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 28/145 (19%), Positives = 57/145 (39%), Gaps = 16/145 (11%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV--EIRTLSLVRHRNIL--RIV 893
+++ G VY + + +K E D E+ L L+ + + +++
Sbjct: 2 SIKLLKGGLTNRVYLL--GTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVL 59
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
S D +++ E++ G TL V + + + +A+ L+ LH +
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLV 109
Query: 954 IIHRDIKSDNILLDSELEPKIGDFG 978
+ H D+ NIL+D I D+
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 36/205 (17%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVR---HRNILRIVGSC 896
+G+G + TVY+ S + K A+K +L E IR SL++ H NI+ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 897 TKDEHGFIVTEYM-----------PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
E +V EY+ PGG LH +L L + +GLSY
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENVKLFL---------FQLLRGLSY 118
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
+H I+HRD+K N+L+ E K+ DFG+++ + S S T S V +L Y P+
Sbjct: 119 IHQR---YILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173
Query: 1006 NAY-STRLTEKSDVYSYGVILFELL 1029
ST + D++ G I E++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-08
Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 62/249 (24%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL------NRSE-TNFDVEIRTLSLVRHRNILRI 892
+ +G G G V ++ +A+K L NR++ + E L+ + ++++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNE--PRLVLDWNTRYHIALGIAQGLSYLHYDC 950
S ++ + V +Y+PGG + ++L + E P ++ R++IA + + +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYIA-ELTLAIESVHK-- 119
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGM----------------SKLISDS-------- 986
IHRDIK DNIL+D + K+ DFG+ S + DS
Sbjct: 120 -MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 987 ---------------------HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVIL 1025
H ++VG+ YIAPE T+ D +S GVIL
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 1026 FELLFRKMP 1034
FE+L + P
Sbjct: 239 FEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-08
Identities = 26/72 (36%), Positives = 40/72 (55%)
Query: 670 SKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNI 729
+K F L + N L G IP + L LQ ++LS NS G IP + ++ SL +++
Sbjct: 414 TKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL 473
Query: 730 SFNHFSGKLPAS 741
S+N F+G +P S
Sbjct: 474 SYNSFNGSIPES 485
|
Length = 623 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSL---VRHRNILRIVGS 895
IG G G V ++ A+KKL+R ++T+ R L L V H+NI+ ++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 896 CTKD------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
T + ++V E M L V+ ++ LD ++ + G+ +LH
Sbjct: 85 FTPQKSLEEFQDVYLVMELM-DANLCQVI-----QMELDHERMSYLLYQMLCGIKHLH-- 136
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009
IIHRD+K NI++ S+ KI DFG+++ + +S + V + Y APE
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 1010 TRLTEKSDVYSYGVILFELLFRKM 1033
E D++S G I+ E++ K+
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 9e-08
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 39/213 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN---RSETNFDV---EIRTLSLVRHRNILRI 892
G+ + + N AVKK+N S+ + + EI T ++H NIL
Sbjct: 7 GKCFEDLMIVHLAKHKPTN--TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVL--HQNE--PRLVLDWNTRYHIAL---GIAQGLSY 945
V S D ++V+ M G+ ++L H E P L IA + L Y
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--------IAFILKDVLNALDY 116
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS-DSHS-------SSTRSAIVG 997
+H IHR +K+ +ILL + + + G+ +S H +S++
Sbjct: 117 IHSK---GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVK- 170
Query: 998 SLGYIAPENAYSTRL--TEKSDVYSYGVILFEL 1028
+L +++PE EKSD+YS G+ EL
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 9e-08
Identities = 30/87 (34%), Positives = 47/87 (54%)
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
Q LS + Y IIHRDIK++N+L++ + +GDFG + S S+ I G++
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFE 1027
APE T D++S G+++FE
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 33/108 (30%), Positives = 60/108 (55%), Gaps = 11/108 (10%)
Query: 939 IAQGLSYL-HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
+A+G+ +L +CV HRD+ + N+LL KI DFG+++ I + ++ +
Sbjct: 246 VARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFEL------LFRKMPVDPSF 1039
+ ++APE+ + T SDV+SYG++L+E+ + M VD +F
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 3/91 (3%)
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998
+A+G+ +L + IHRD+ + NILL KI DFG+++ I + +
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
L ++APE+ + T +SDV+S+GV+L+E+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 34/203 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVR---HRNILRIVGSC 896
+G+G + TV++ S + A+K +L E IR +SL++ H NI+ +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 897 TKDEHGFIVTEYMPGG------TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
D+ +V EY+ N++ + ++ L I +GL+Y H
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAYCHRR- 123
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
+++HRD+K N+L++ E K+ DFG+++ + S + T S V +L Y P+
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 1006 NAYSTRLTEKSDVYSYGVILFEL 1028
+ YST++ D++ G I FE+
Sbjct: 180 SEYSTQI----DMWGVGCIFFEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 36/122 (29%), Positives = 65/122 (53%), Gaps = 9/122 (7%)
Query: 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL-HYDCVPQIIHRDIKSDNILLDS 968
P T + L P L + + +A G+ +L +CV HRD+ + N+L+
Sbjct: 221 PERTRRDTLINESP--ALSYMDLVGFSYQVANGMEFLASKNCV----HRDLAARNVLICE 274
Query: 969 ELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFE 1027
KI DFG+++ ++ DS+ S S + L ++APE+ ++ T SDV+S+G++L+E
Sbjct: 275 GKLVKICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 1028 LL 1029
+
Sbjct: 334 IF 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 936 ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995
+ +A+G+ +L + IHRD+ + NILL KI DFG+++ I +
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
L ++APE+ + T +SDV+S+GV+L+E+
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-07
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 58/247 (23%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRI 892
+ +G G G V +++ +A+K L + + + E L+ + ++R+
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
S ++ + V +Y+PGG + ++L + + + R++IA S
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG--- 121
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS----------------------- 989
IHRDIK DNIL+D + K+ DFG+ +H S
Sbjct: 122 -FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 990 ------------STRSA----------IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFE 1027
R+A +VG+ YIAPE T T+ D +S GVIL+E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 1028 LLFRKMP 1034
+L + P
Sbjct: 241 MLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 3/91 (3%)
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998
+A+G+ +L + IHRD+ + NILL KI DFG+++ I +
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
L ++APE + T +SDV+S+GV+L+E+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 9e-07
Identities = 53/231 (22%), Positives = 100/231 (43%), Gaps = 47/231 (20%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIVGS 895
IG G+ G V+ +++ + K ++ R ++ +E+ + ++H+NI+R +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 896 CTK--DEHGFIVTEYMPGGTL-------FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
++ +I+ E+ G L + + + E ++D I + L+Y
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD------ITRQLLHALAYC 134
Query: 947 HY----DCVPQIIHRDIKSDNILLDSELE-----------------PKIGDFGMSKLISD 985
H +++HRD+K NI L + + KIGDFG+SK I
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG- 193
Query: 986 SHSSSTRSAIVGSLGYIAPENAY--STRLTEKSDVYSYGVILFELLFRKMP 1034
S + VG+ Y +PE + +KSD+++ G I++EL K P
Sbjct: 194 --IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVR---HRNILRIVGSC 896
+G+G + TVY+ S + A+K +L E IR +SL++ H NI+ +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 897 TKDEHGFIVTEYMPGG------TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
++ +V EY+ N ++ + +L L + +GL+Y H
Sbjct: 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL---------FQLLRGLNYCHRR- 123
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-S 1009
+++HRD+K N+L++ E K+ DFG+++ + S + T S V +L Y P+ S
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGS 179
Query: 1010 TRLTEKSDVYSYGVILFEL 1028
T + + D++ G I +E+
Sbjct: 180 TDYSTQIDMWGVGCIFYEM 198
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 46/248 (18%)
Query: 868 NRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL 927
N SE+ F+ +S + H++++ G C + +V EY+ G+L L +N+ + +
Sbjct: 41 NYSESFFEAA-SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI 99
Query: 928 DWNTRYHIALGIAQGLSY-LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986
W L +A+ L++ LH+ + H ++ + N+LL E + K G+ KL SD
Sbjct: 100 SWK------LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDP 152
Query: 987 HSSST---RSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFR-KMPV---DPS 1038
S T + ++ + ++ PE + + L+ +D +S+G L+E+ P+ D
Sbjct: 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212
Query: 1039 FGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELAL---ECTRQVADM 1095
+++ F++ QL A + ELA +C D
Sbjct: 213 --------------------------KKLQFYEDRHQLPAPKWTELANLINQCMDYEPDF 246
Query: 1096 RPSMREVV 1103
RPS R ++
Sbjct: 247 RPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 20/196 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVR---HRNILRIVGSC 896
+G+G + TV++ S + A+K +L E IR +SL++ H NI+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQ---NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ +V EY L + L Q N L+ N + + + +GLSY H +
Sbjct: 73 HTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFM-FQLLRGLSYCHKR---K 123
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRL 1012
I+HRD+K N+L++ + E K+ DFG+++ + S + T S V +L Y P+ ST
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 1013 TEKSDVYSYGVILFEL 1028
+ D++ G IL+E+
Sbjct: 182 STPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 864 VKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE--------YMPGGTLF 915
VK +R+ + EI L + H NIL+I + + +++T+ +M
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF- 258
Query: 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975
++ P L TR I + + Y+H ++IHRDIK +NI L+ + + +G
Sbjct: 259 --DWKDRPLL---KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309
Query: 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
DFG + + + + VG++ +PE E +D++S G+IL ++L
Sbjct: 310 DFG-TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 840 RIIGKGKHGT---VYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTL-SLVRHRNIL 890
+I+GK GT V + S + K++A+K + + + N EI+ L L H NIL
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 891 RIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
R++ + G +V E M L+ L + R L + + L ++H
Sbjct: 62 RLIEVLFDRKTGRLALVFELMDM-NLYE-LIKGRKRP-LPEKRVKSYMYQLLKSLDHMHR 118
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS----STRSAIVGSLGYIAP 1004
+ I HRDIK +NIL+ ++ K+ DFG + I STR Y AP
Sbjct: 119 N---GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-------WYRAP 167
Query: 1005 ENAYST-RLTEKSDVYSYGVILFELL 1029
E + K D+++ G + FE+L
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-06
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRI-----V 893
G IIG G G VY + ++ + A+KK+ + + E+ + + H NI+ +
Sbjct: 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYT 130
Query: 894 GSCTKDEHGF---IVTEYMPGGTLFNVLH--QNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
K+E +V E++P + H +N L L Y L + L+Y+H
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYIHS 188
Query: 949 DCVPQIIHRDIKSDNILLDSELEP-KIGDFGMSK-LISDSHSSSTRSAIVGSLGYIAPEN 1006
I HRD+K N+L+D K+ DFG +K L++ S S + S Y APE
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS----YICSRFYRAPEL 241
Query: 1007 AY-STRLTEKSDVYSYGVILFELLF 1030
+T T D++S G I+ E++
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMIL 266
|
Length = 440 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 23/161 (14%)
Query: 883 LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTR-------YHI 935
+++H NIL+ +G C + +V EY G L + L Q W+ R +
Sbjct: 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRM 104
Query: 936 ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995
A IA G++++H +H D+ N L S+L K+GD+G+ T
Sbjct: 105 ACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161
Query: 996 VGSLGYIAPE-------NAYSTRLTEKSDVYSYGVILFELL 1029
L ++APE + T+ S+V++ GV L+EL
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-06
Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 845 GKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHG-F 903
G G + + N + +H +K R T E L + H +I+++ G+ T ++
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQRGGTA--TEAHILRAINHPSIIQLKGTFTYNKFTCL 160
Query: 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDN 963
I+ Y L+ L + D I + + + YLH + +IIHRDIK++N
Sbjct: 161 ILPRYKT--DLYCYLAAKRNIAICDI---LAIERSVLRAIQYLHEN---RIIHRDIKAEN 212
Query: 964 ILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGV 1023
I ++ + +GDFG + D +++ G++ APE D++S G+
Sbjct: 213 IFINHPGDVCLGDFGAACFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGI 271
Query: 1024 ILFEL------LFRKMPVDPSFGEDTDI 1045
+LFE+ LF K +D D I
Sbjct: 272 VLFEMATCHDSLFEKDGLDGDCDSDRQI 299
|
Length = 391 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSR--KHWAVKKLNRSETNFDV--EIRTLSLVRHRNI--LR 891
EG +G+G +G VY+ + + K +A+K++ + + EI L ++H N+ L+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVL--HQ----NEPRLVLDWNTRYHIALGIAQGLSY 945
V D +++ +Y L++++ H+ N+ + L + + I G+ Y
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLI-SDSHSSSTRSAIVGSLG 1000
LH + V +HRD+K NIL+ E KI D G ++L S + +V +
Sbjct: 124 LHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 1001 YIAPENAYSTR-LTEKSDVYSYGVILFELL 1029
Y APE R T+ D+++ G I ELL
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-06
Identities = 27/88 (30%), Positives = 41/88 (46%), Gaps = 1/88 (1%)
Query: 149 LDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLL 208
L L L G IP +S L+SI N + G +P + S+ L+ L L+ N+ G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 209 PEFPNSCAILH-LLIHENDFVGSLPTSL 235
PE L L ++ N G +P +L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 24/118 (20%)
Query: 170 LESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVG 229
++ +G N L G +PNDI L L+S+ L+ N++ G
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR-----------------------G 456
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGL 287
++P SL + +L S N+F G+I P L L +L L+ N+L G++P L G
Sbjct: 457 NIPPSLGSITSLEVLDLSYNSFNGSI-PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 28/93 (30%), Positives = 44/93 (47%)
Query: 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLL 517
++ L L G IP +I +L + L N G+ P +G +SL + LS N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 518 QGSLPATLERNPGVSFLDVRGNLLQGSIPPVFG 550
GS+P +L + + L++ GN L G +P G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 25/53 (47%), Positives = 28/53 (52%)
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKL 300
SNN I FKGL L+VL L NNL PE GL +L+ L LS N L
Sbjct: 8 SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-05
Identities = 21/60 (35%), Positives = 26/60 (43%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
L+ L L +N L GL NL+ L LS N L S L+ + LS NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSR--KHWAVKKLNRSETNFDV--EIRTLSLVRHRNILRI- 892
EG +G+G +G VY+ + + + +A+K++ + + EI L ++H N++ +
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 64
Query: 893 -VGSCTKDEHGFIVTEYMPGGTLFNVL--HQ----NEPRLVLDWNTRYHIALGIAQGLSY 945
V D +++ +Y L++++ H+ N+ + L + I G+ Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLI-SDSHSSSTRSAIVGSLG 1000
LH + V +HRD+K NIL+ E KI D G ++L S + +V +
Sbjct: 124 LHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 1001 YIAPENAYSTR-LTEKSDVYSYGVILFELL 1029
Y APE R T+ D+++ G I ELL
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 24/60 (40%), Positives = 29/60 (48%)
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRL 348
NL+ L LS N+L G L+V+ LS NNL P + L SL SL L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-05
Identities = 83/289 (28%), Positives = 129/289 (44%), Gaps = 15/289 (5%)
Query: 303 TISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGN-CGS 361
S + + L + L+ N L I + L++L SL L NN + +PP +G +
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNI-TDIPPLIGLLKSN 141
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
L +L L N I ++P + NL L+ L L N + +P + +S L L L N+++
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS 199
Query: 422 GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT 481
+PP+I L L+ L L++N + L + LS L+L+ N +P +I +
Sbjct: 200 -DLPPEIELLSALEELDLSNNSI--IELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLS 255
Query: 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLL 541
NL L L NN+ S +G ++LR + LS N L +LP + L++ NLL
Sbjct: 256 NLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIAL---LLLLLELLLNLL 310
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590
S L + N S P L LE+L L N LD
Sbjct: 311 LTLKALELKLNSILLNNNILSN-GETSSPEALSILESLNNLWTLDNALD 358
|
Length = 394 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 64/260 (24%), Positives = 86/260 (33%), Gaps = 52/260 (20%)
Query: 71 LKALNLSGFGLSGVLNNSISYICK----NQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLL 126
L+ L L G L + + L L LS N TG IP+ L + Q T
Sbjct: 25 LQVLRLEGNTLGEE---AAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLT-- 78
Query: 127 LNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLC---YSLESIGFHNNFLNGE 183
K L LDL N+L + SL+ + +NN L
Sbjct: 79 ---------------KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDR 123
Query: 184 -LPNDICSL----PKLKSLYLNTNNLTG-----LLPEFPNSCAILHLLIHENDFVGSLPT 233
L L P L+ L L N L G L + + L + N +
Sbjct: 124 GLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIR 183
Query: 234 SL-----SNCRNLVEFSASSNNF---GGAISPWIFKGLLQLEVLYLDDNNLEGQIPETL- 284
+L +NC NL ++N G + L LEVL L DNNL L
Sbjct: 184 ALAEGLKANC-NLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242
Query: 285 ----WGLENLQKLVLSANKL 300
+L L LS N +
Sbjct: 243 SALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 39/130 (30%), Positives = 57/130 (43%), Gaps = 17/130 (13%)
Query: 903 FIVTEYMPGGTLFNVLHQ--NEPR-LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDI 959
F+V ++ GG L++ + + N P V W +AL LH + I+ RD+
Sbjct: 61 FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL------DALHRE---GIVCRDL 111
Query: 960 KSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVY 1019
+NILLD ++ F + DS + Y APE + TE D +
Sbjct: 112 NPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWW 166
Query: 1020 SYGVILFELL 1029
S G ILFELL
Sbjct: 167 SLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA 940
+S V H ++ + G C + +V E++ G L L + + R+ + W + +A +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SD---SHSSSTRSAI 995
LSYL ++H ++ + NILL + + G S I SD S ++ +R
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILLARL---GLAE-GTSPFIKLSDPGVSFTALSREER 180
Query: 996 VGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLF 1030
V + +IAPE L+ +D +S+G L E+ F
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICF 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-04
Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 824 LPRDLRYE-DVIRATEGRIIGKGK-----HGTVYRTLSNNSRKHWAVKKLNRSETNFD-- 875
LP D R+E GRI+G G GT Y + AVK L + + +
Sbjct: 26 LPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQ 85
Query: 876 ---VEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN 921
E++ ++ L H NI+ ++G+CTK +I+TEY G L N LH+N
Sbjct: 86 ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKN 135
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-04
Identities = 53/213 (24%), Positives = 80/213 (37%), Gaps = 55/213 (25%)
Query: 553 SNLTMLDFSENRLSGS----IPSELGNLENLQILRLSANKLDGRIPYE-------LGKCT 601
L +L N L + S L +L+ L LS N+ GRIP L K
Sbjct: 23 LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNET-GRIPRGLQSLLQGLTKGC 81
Query: 602 KMIKLDLSDNYLAGSIPSEVISL--------------------------------EKMQS 629
+ +LDLSDN L + SL ++
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141
Query: 630 LSLQENNLSG----AIPDAFSSVQSLFELQLGSN-IFDGSIPCSLSKLHHFSS--ILNVS 682
L L N L G A+ A + + L EL L +N I D I L + +L+++
Sbjct: 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLN 201
Query: 683 NNKL----SGKIPECLGNLDKLQILDLSSNSFS 711
NN L + + E L +L L++L+L N+ +
Sbjct: 202 NNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 6e-04
Identities = 22/61 (36%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 530 GVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANK 588
+ LD+ N L IP F NL +LD S N L+ P L +L+ L LS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 589 L 589
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-04
Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 18/111 (16%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLN----RSETN 873
++PRD GR +G G G V + + S AVK L SE
Sbjct: 33 EMPRD-------NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQ 85
Query: 874 -FDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE 922
E++ +S L H NI+ ++G+CTK +I+TEY G L + LH+N+
Sbjct: 86 ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNK 136
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.001
Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 385 KLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFLSLAHNH 443
L+ L L NNR+ + L L L N LT I P+ + L +L+ L L+ N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 444 L 444
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 17/58 (29%), Positives = 31/58 (53%)
Query: 677 SILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHF 734
L++SNN+L+ L L++LDLS N+ + P + + SL +++S N+
Sbjct: 3 KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 23/56 (41%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 605 KLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
LDLS+N L IP L ++ L L NNL+ P+AFS + SL L L N
Sbjct: 4 SLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 25/61 (40%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNS 155
+L SLDLS N T LK L L+ N SI PE F L L LDL N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 156 L 156
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 38/136 (27%), Positives = 62/136 (45%), Gaps = 32/136 (23%)
Query: 926 VLDWNTRY------HIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILL---DSELEP- 972
+LDW ++ H+A I Q L Y H + ++H D+K +NIL+ D+ ++P
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275
Query: 973 ------------KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYS 1020
+I D G + HS R+AIV + Y +PE +D++S
Sbjct: 276 TNRALPPDPCRVRICDLG--GCCDERHS---RTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330
Query: 1021 YGVILFELLFRKMPVD 1036
G I++EL K+ D
Sbjct: 331 MGCIIYELYTGKLLYD 346
|
Length = 467 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.003
Identities = 15/37 (40%), Positives = 20/37 (54%), Gaps = 3/37 (8%)
Query: 29 SLVQFLDSLPKQSQSHLP-WNQSVSTSAPCKWSGVSC 64
+L+ F SL L WN S +S PC W+GV+C
Sbjct: 7 ALLAFKSSLNGDPSGALSSWNPS--SSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1119 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.98 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.45 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.17 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.13 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.1 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.03 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.02 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.96 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.73 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.7 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.68 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.64 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.61 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.61 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.53 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.5 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.43 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.39 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-114 Score=1127.82 Aligned_cols=924 Identities=33% Similarity=0.574 Sum_probs=576.0
Q ss_pred hccccCCCcHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCc
Q 001226 18 ALSVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQH 97 (1119)
Q Consensus 18 ~~~~~~~~~~~~ll~~~~~~~~~~~~~~~w~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~ 97 (1119)
..+.+.++|+.||++||+++.++.+.+.+|+. ..+||.|.||+|++ .++|+.|+|++++++|.+++. +..+++
T Consensus 22 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~---~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~---~~~l~~ 94 (968)
T PLN00113 22 NFSMLHAEELELLLSFKSSINDPLKYLSNWNS---SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSA---IFRLPY 94 (968)
T ss_pred HccCCCHHHHHHHHHHHHhCCCCcccCCCCCC---CCCCCcCcceecCC-CCcEEEEEecCCCccccCChH---HhCCCC
Confidence 44555788999999999999766556779964 36799999999985 468888888887777665532 345566
Q ss_pred ccEEEcCCCcccCCCCcccc-cCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeec
Q 001226 98 LLSLDLSGNEFTGSIPKQLG-NCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFH 176 (1119)
Q Consensus 98 l~~L~Ls~n~~~~~~~~~l~-~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 176 (1119)
|++|+|++|.++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+++
T Consensus 95 L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~ 172 (968)
T PLN00113 95 IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172 (968)
T ss_pred CCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECc
Confidence 66666666666665655543 566666666666666555553 335555555555555554444444444444444444
Q ss_pred ccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccC
Q 001226 177 NNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAIS 256 (1119)
Q Consensus 177 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~ 256 (1119)
+|.+.+..|..++++++|++|++++
T Consensus 173 ~n~l~~~~p~~~~~l~~L~~L~L~~------------------------------------------------------- 197 (968)
T PLN00113 173 GNVLVGKIPNSLTNLTSLEFLTLAS------------------------------------------------------- 197 (968)
T ss_pred cCcccccCChhhhhCcCCCeeeccC-------------------------------------------------------
Confidence 4433333333333333333333333
Q ss_pred hhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCC
Q 001226 257 PWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLS 336 (1119)
Q Consensus 257 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 336 (1119)
|++++.+|..+.++++|++|+|++|++++.+|..+..+++|++|++++|.+++.+|..+++++
T Consensus 198 -----------------n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 260 (968)
T PLN00113 198 -----------------NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLK 260 (968)
T ss_pred -----------------CCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCC
Confidence 333333344444444444444444444333333333334444444444444434444444444
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEee
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 416 (1119)
+|++|++++|++++..|..+.++++|++|++++|.+.+.+|..+.++++|+.|++++|.+++..|..+..+++|+.|+++
T Consensus 261 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~ 340 (968)
T PLN00113 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLW 340 (968)
T ss_pred CCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECc
Confidence 44444444444444444444444444444444444444444444444444444444444444444334444444444444
Q ss_pred cccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCC
Q 001226 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGS 496 (1119)
Q Consensus 417 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~ 496 (1119)
+|.+++.+|..+..+++|+.| ++++|++++.+|..++.+.+|+.|++++|++.+.
T Consensus 341 ~n~l~~~~p~~l~~~~~L~~L-------------------------~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~ 395 (968)
T PLN00113 341 SNKFSGEIPKNLGKHNNLTVL-------------------------DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395 (968)
T ss_pred CCCCcCcCChHHhCCCCCcEE-------------------------ECCCCeeEeeCChhHhCcCCCCEEECcCCEeccc
Confidence 444433333333333333333 3333333333444444444444444444444444
Q ss_pred CCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCc
Q 001226 497 FPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNL 576 (1119)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 576 (1119)
+|..++.+++|+.|++++|++++ .+|..|..+++|+.|+|++|++++.+|..+..+
T Consensus 396 ~p~~~~~~~~L~~L~L~~n~l~~------------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 451 (968)
T PLN00113 396 IPKSLGACRSLRRVRLQDNSFSG------------------------ELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451 (968)
T ss_pred CCHHHhCCCCCCEEECcCCEeee------------------------ECChhHhcCCCCCEEECcCCcccCccChhhccC
Confidence 44445555555555555554444 444444445555555555555555555555555
Q ss_pred ccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeec
Q 001226 577 ENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQL 656 (1119)
Q Consensus 577 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 656 (1119)
++|+.|+|++|++.+.+|..+ ..++|+.|||++|++++.+|..+..+++|+.|+|++|++++.+|..|.++++|+.
T Consensus 452 ~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~--- 527 (968)
T PLN00113 452 PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS--- 527 (968)
T ss_pred CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCE---
Confidence 566666666666655555544 2466677777777777666766767777777777777777777777766666665
Q ss_pred CCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccccccceEEecccccccc
Q 001226 657 GSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736 (1119)
Q Consensus 657 ~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g 736 (1119)
|++++|+++|.+|..++.+++|+.|||++|+++|.+|..+..+.+|+.+|+++|+++|
T Consensus 528 ----------------------L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 528 ----------------------LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred ----------------------EECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 5556666667788888889999999999999999999999999999999999999999
Q ss_pred cCCCccccccccCCccccCCcccccCC------CCCCCCCCcccceeeehhhHHHHHHHHHHHhheeeEEEEeccc---c
Q 001226 737 KLPASWTTLMVSYPGSFLGNSELCRQG------NCGKNGRGHTRGRLAGIIIGVLLSVALLCALIYIMVVRVLRSK---C 807 (1119)
Q Consensus 737 ~~p~~~~~~~~~~~~~~~~n~~~c~~~------~c~~~~~~~~~~~~~~ii~~~~~~v~~~~~~~~~~~~r~~r~~---~ 807 (1119)
.+|+. +.+.++.+.+|.||+.+|+.. .|...++......+++++++++++++++++ +++++|+++.. +
T Consensus 586 ~~p~~-~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 662 (968)
T PLN00113 586 SLPST-GAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAF--GFVFIRGRNNLELKR 662 (968)
T ss_pred eCCCc-chhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHH--HHHHHHhhhcccccc
Confidence 99975 666677889999999999852 453221111111122222222222222222 12222222111 1
Q ss_pred cCCCccccccccccCCCCCCCCHHHH-HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCC
Q 001226 808 FSDPSLLQDVQSRSEDLPRDLRYEDV-IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH 886 (1119)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h 886 (1119)
........+.........+.++++++ ..+...++||+|+||.||+|.+..+++.||||+++........|++.+++++|
T Consensus 663 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~H 742 (968)
T PLN00113 663 VENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQH 742 (968)
T ss_pred cccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCC
Confidence 11110001111111112233455554 34556689999999999999998889999999997665555678999999999
Q ss_pred CCEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 001226 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL 966 (1119)
Q Consensus 887 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 966 (1119)
||||+++++|.+++..|+||||+++|+|.++++. ++|.++.+++.|+++|++|||+.+.++|+|||+||+||++
T Consensus 743 pnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~ 816 (968)
T PLN00113 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816 (968)
T ss_pred CCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE
Confidence 9999999999999999999999999999999963 7899999999999999999997767799999999999999
Q ss_pred CCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee
Q 001226 967 DSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 967 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 1046 (1119)
+.++.+++. ||.+..... .....+|+.|+|||++.+..++.++|||||||++|||++|+.||+...+......
T Consensus 817 ~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~ 889 (968)
T PLN00113 817 DGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889 (968)
T ss_pred CCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHH
Confidence 999888875 665543221 1223678999999999999999999999999999999999999976555555555
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.|.+..... .....++++.+......+.....++.+++.+||+.+|++||+|+|++++|+++.+...
T Consensus 890 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 890 EWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred HHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 555443222 2234455555543333345566688999999999999999999999999999876443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-61 Score=626.34 Aligned_cols=496 Identities=36% Similarity=0.551 Sum_probs=331.9
Q ss_pred CceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCE
Q 001226 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSW 148 (1119)
Q Consensus 69 ~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~ 148 (1119)
.+++.|+|+++.+.|.+|.. .+..+++|++|+|++|.++|.+|. +.+++|++|+|++|.+++.+|..++.+++|++
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~--~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 168 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDD--IFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168 (968)
T ss_pred CCCCEEECCCCccCCcCChH--HhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCE
Confidence 46899999999999888754 244789999999999999998886 57899999999999999999999999999999
Q ss_pred EEccCccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccc
Q 001226 149 LDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFV 228 (1119)
Q Consensus 149 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~ 228 (1119)
|||++|.+.+.+|..++++++|++|++++|.+++.+|..++++++|++|++++|++++.+|
T Consensus 169 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p------------------- 229 (968)
T PLN00113 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIP------------------- 229 (968)
T ss_pred EECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCC-------------------
Confidence 9999999999999999999999999999999999999999999999999998887764322
Q ss_pred cCccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccc
Q 001226 229 GSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308 (1119)
Q Consensus 229 ~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 308 (1119)
..+.++++|++|++++|++++.+|..+.++++|++|++++|++.+..|..+
T Consensus 230 -----------------------------~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 280 (968)
T PLN00113 230 -----------------------------YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280 (968)
T ss_pred -----------------------------hhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhH
Confidence 234456778888888888888888888888888888888888877777777
Q ss_pred cCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccce
Q 001226 309 SHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV 388 (1119)
Q Consensus 309 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~ 388 (1119)
..+++|++|+|++|.+.+.+|..+.++++|+.|++++|.+++..|..+..+++|+.|++++|.+++.+|..+..+++|+.
T Consensus 281 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~ 360 (968)
T PLN00113 281 FSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360 (968)
T ss_pred hhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcE
Confidence 77777777777777777667776777777777777777766666666666666666666666666666666666666666
Q ss_pred eeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccce
Q 001226 389 LYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS 468 (1119)
Q Consensus 389 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~ 468 (1119)
|++++|++++..|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|+++
T Consensus 361 L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~----------------------- 417 (968)
T PLN00113 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS----------------------- 417 (968)
T ss_pred EECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee-----------------------
Confidence 666666666555555555555555555555555555555555555555544444444
Q ss_pred eeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCcc
Q 001226 469 FYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPV 548 (1119)
Q Consensus 469 l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 548 (1119)
+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.||+++|++++.+|..
T Consensus 418 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~ 494 (968)
T PLN00113 418 --GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRK 494 (968)
T ss_pred --eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChh
Confidence 4444444444555555555555555555555555555555555555555444433 2234444444444444444444
Q ss_pred ccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCC
Q 001226 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQ 628 (1119)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 628 (1119)
+..+++|++|+|++|++++.+|..++++++|++|+|++|+++|.+|..+..+++|+.|||++|+++|.+|..+..++.|+
T Consensus 495 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 574 (968)
T PLN00113 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574 (968)
T ss_pred hhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred eeEccCccCccCCC
Q 001226 629 SLSLQENNLSGAIP 642 (1119)
Q Consensus 629 ~L~L~~N~l~~~~p 642 (1119)
.|++++|+++|.+|
T Consensus 575 ~l~ls~N~l~~~~p 588 (968)
T PLN00113 575 QVNISHNHLHGSLP 588 (968)
T ss_pred EEeccCCcceeeCC
Confidence 44444444444444
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=405.25 Aligned_cols=284 Identities=40% Similarity=0.678 Sum_probs=239.4
Q ss_pred CCCCCCHHHHHHhhCC----ceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeee
Q 001226 824 LPRDLRYEDVIRATEG----RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGS 895 (1119)
Q Consensus 824 ~~~~~~~~~~~~~~~~----~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~ 895 (1119)
..+.|++.++.++|.. +.||+|+||.||+|...+ +..||||++... ..+|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4567899999988854 799999999999999887 489999988542 3569999999999999999999999
Q ss_pred eecCC-ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEE
Q 001226 896 CTKDE-HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI 974 (1119)
Q Consensus 896 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 974 (1119)
|.+++ +.++|||||++|+|.++++..... .++|..+.+||.++|+||+|||+.+.+.||||||||+|||+|+++++||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99998 499999999999999999987644 6899999999999999999999999889999999999999999999999
Q ss_pred EeccccccccCCCCCCccccc-ccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-CCCCceeehhhhh
Q 001226 975 GDFGMSKLISDSHSSSTRSAI-VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDTDIVTWTRWK 1052 (1119)
Q Consensus 975 ~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~-~~~~~~~~~~~~~ 1052 (1119)
+|||+|+..... ....... .||.+|+|||+...+..+.++|||||||++.|+++|+.|.+... .....++.|....
T Consensus 219 sDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999655431 1111112 79999999999999999999999999999999999999988654 2333467776444
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
... ....+++|+.+............++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 297 ~~~-~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEE-GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHC-cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 433 37888999998632222225667799999999999999999999999999776544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.99 Aligned_cols=255 Identities=28% Similarity=0.417 Sum_probs=211.0
Q ss_pred CCCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCc
Q 001226 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 827 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 901 (1119)
.+...|+++ .+.||+|..|+||+++++.+++.+|+|++.. ...++.+|+++++..+||+||+++|+|...+.
T Consensus 75 ~i~~~dle~---~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 75 GISLSDLER---LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred ccCHHHhhh---hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 355566644 4679999999999999999999999999932 23567899999999999999999999999984
Q ss_pred -eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 902 -GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 902 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
.+++||||++|+|.+++...+ .+++....+++.++++||.|||+.+ +||||||||+|||+++.|+|||+|||.+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEecccccc
Confidence 999999999999999998765 4899999999999999999999632 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
+.+.+. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.||.+......+.... +.
T Consensus 227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L----------l~ 292 (364)
T KOG0581|consen 227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL----------LC 292 (364)
T ss_pred HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH----------HH
Confidence 887653 4456799999999999999999999999999999999999999997651111121111 11
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+++...+.... ...+.++..++..|+++||.+||+++|+++|
T Consensus 293 ~Iv~~ppP~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 293 AIVDEPPPRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHhcCCCCCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222211111111 1345678999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=387.05 Aligned_cols=254 Identities=36% Similarity=0.517 Sum_probs=207.8
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC-ceEEEEecc
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE-HGFIVTEYM 909 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~ 909 (1119)
...+.+|+|+||+||+|.++.+ ..||||++... ..+|.+|+.++.+++|||||+++|+|.+.. ..++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 3445699999999999999862 33999999643 247999999999999999999999999887 799999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeEeCCCC-ceEEEeccccccccCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ-IIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~~ 987 (1119)
++|+|.++++.. ....+++..+.+++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999885 234699999999999999999999999 7 99999999999999998 99999999998765422
Q ss_pred CCCcccccccCCCcccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY--STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
...+...||+.|||||++. ...|+.++||||||+++|||+||+.||..... .......... ...+
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~~---------~~Rp 265 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVVG---------GLRP 265 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhc---------CCCC
Confidence 2334478999999999999 66999999999999999999999999976532 1111100000 0001
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.+ +......+..++.+||+.||++||++.+++..|+.+.....
T Consensus 266 ~~------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 266 PI------PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CC------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11 11145678899999999999999999999999998876544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=371.15 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=208.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.|...+.+|+|+||.|-+|..+.+|+.||||++++. ...+.+|+++|++++|||||+++++|+.++..|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 456679999999999999999999999999998432 223579999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEecccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGDFGMS 980 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~DfGla 980 (1119)
+||||++||+|.+.+-.++. +.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|
T Consensus 253 mVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999988763 77788899999999999999999 99999999999999766 67899999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCC--C-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTR--L-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
+..+. .......+||+.|.|||++.++. + ..++|+||+|||+|-+++|..||....++.....
T Consensus 327 K~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----------- 392 (475)
T KOG0615|consen 327 KVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----------- 392 (475)
T ss_pred hcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH-----------
Confidence 98764 34456789999999999987654 3 3488999999999999999999986544332111
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+...++.+......+.+.+..+++.+||..||++|||++|+++|
T Consensus 393 ---QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 ---QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ---HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 122233333334445667788999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=385.16 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=209.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|..++.||+|||+.||++++.++|+.||+|++.+ ..+.+.+||++-+.++|||||+++++|++...+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 578899999999999999999999999999999853 2355788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|+|+.++|.+++++++ .+++.+++.+++||+.|+.|||+. +|+|||||..|++++++.+|||+|||+|..+...
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999999654 599999999999999999999999 9999999999999999999999999999988643
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.......+|||-|.|||++....++..+||||+|||+|-|+.|++||+...-. ..+.+.+ ...+
T Consensus 172 --~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----ety~~Ik-~~~Y--------- 235 (592)
T KOG0575|consen 172 --GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----ETYNKIK-LNEY--------- 235 (592)
T ss_pred --ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----HHHHHHH-hcCc---------
Confidence 23455679999999999999999999999999999999999999999742100 0111111 0111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+....++|.++|+.+|.+|||+++|+.+
T Consensus 236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122344567899999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=382.34 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=215.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc---ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
..+..+.||+|.||.||.|.+.. ...||+|.++. ..++|.+|+.+|++++|++||+++++|..++.+|||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 33445789999999999999986 45789998864 346799999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+|++... +..+...+.+.++.|||+||+||+++ ++|||||+++||||+++..|||+|||+|+...+ +.+..
T Consensus 286 GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTA 360 (468)
T ss_pred CcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC-Cceee
Confidence 99999999833 33588889999999999999999999 999999999999999999999999999996555 33444
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....-++.|.|||.+..+.++.+||||||||++|||+| |+.||..+... .+.+.+++..+..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp 424 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLP 424 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCC
Confidence 445566889999999999999999999999999999997 89998754211 1222222222221
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
.+..++..+.++|..||+.+|++|||++.+...++++....++
T Consensus 425 --~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 425 --RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred --CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 2334567889999999999999999999999999999887654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=364.11 Aligned_cols=197 Identities=32% Similarity=0.501 Sum_probs=178.4
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+.+|...+.||+|+||+||+|+++.++..||||.+... .+....|+.+++.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 34566677899999999999999999999999988544 234678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC------CceEEEecccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE------LEPKIGDFGMS 980 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~------~~vkl~DfGla 980 (1119)
|||.||+|.+|++.++ .+++..++.++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999876 499999999999999999999999 99999999999999875 45799999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
+.+.. .......+|++-|||||++...+|+.|+|+||+|+++|++++|+.||+..
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 98864 33445678999999999999999999999999999999999999999743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=393.22 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=217.6
Q ss_pred CceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 839 GRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+.||+|+||+||+|+... ....||||.++... .+|++|++.+..++|||||+++|+|.+++..++|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 3789999999999998543 34679999997543 4699999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEec
Q 001226 909 MPGGTLFNVLHQNEPR-----------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 977 (1119)
|..|||.++|+.+.+. ..++..+.+.||.|||.||.||.++ .+|||||+.+|+||.++..|||+||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEeccc
Confidence 9999999999865431 2378889999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccc
Q 001226 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 978 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
|+++.+...+++.......-+++|||||.+..++|+.+|||||||||+||+++ |+-||++...+ ++....+
T Consensus 648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--EVIe~i~------ 719 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--EVIECIR------ 719 (774)
T ss_pred ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--HHHHHHH------
Confidence 99999888788777767788999999999999999999999999999999996 99999865322 1111111
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
++.+ -+-+...+.++++||.+||+.+|.+||+++||-..|++.-+..++
T Consensus 720 -------~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 720 -------AGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred -------cCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 1111 123345677899999999999999999999999999998776654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=342.20 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=200.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccccc------HHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..-++|+|+||+||+++++++|+.||||++...+++ ..+|++++++++|+|+|.++++|...+..++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 455557899999999999999999999999999655442 46899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
|+.. +.+-+.+.+. .++.+.++++++|++.|+.|+|++ ++|||||||+||+++.+|.+|++|||+|+.+.. +
T Consensus 83 ~dhT-vL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--p 154 (396)
T KOG0593|consen 83 CDHT-VLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--P 154 (396)
T ss_pred cchH-HHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC--C
Confidence 9764 4444555443 488999999999999999999999 999999999999999999999999999998864 2
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehh----------hhhhcccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT----------RWKLQENH 1057 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~ 1057 (1119)
....+..+.|.+|+|||.+.+ .+|+.++||||+||++.||++|..-|.+. .+.+.+.... ........
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-SDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-chHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 334455688999999998887 78999999999999999999999666443 2222111110 00001111
Q ss_pred cccccccccccCCCch---HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECICFLDREISFWDSD---DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
-+..+.-+.......- -.....-+.+++.+|++.||++|++-+|++.|
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111111011 11223468899999999999999999998864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=382.67 Aligned_cols=488 Identities=28% Similarity=0.385 Sum_probs=332.1
Q ss_pred CCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceee
Q 001226 95 NQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIG 174 (1119)
Q Consensus 95 l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 174 (1119)
-..++.|++++|.++ .+-..+.++..|.+|++++|++. ..|++++.+..++.|+.++|+++ ++|..++.+.+|.+|+
T Consensus 44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 357788888888887 66677888889999999999887 67888999999999999999888 7788877777777777
Q ss_pred ecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCc
Q 001226 175 FHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGA 254 (1119)
Q Consensus 175 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~ 254 (1119)
+++|.+. +.|.+++.+..|..|+..+|+++ ++|..+.++.+|..+++.+
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~------------------------slp~~~~~~~~l~~l~~~~------ 169 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS------------------------SLPEDMVNLSKLSKLDLEG------ 169 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc------------------------cCchHHHHHHHHHHhhccc------
Confidence 7777776 56666777777777777777776 3344444444444444444
Q ss_pred cChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCC
Q 001226 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN 334 (1119)
Q Consensus 255 ~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 334 (1119)
|+++...|+.+. ++.|++||..+|-++ .+|..++.+.+|..|+|.+|++. ..| .|.+
T Consensus 170 -------------------n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~g 226 (565)
T KOG0472|consen 170 -------------------NKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPG 226 (565)
T ss_pred -------------------cchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCc
Confidence 444433333333 444555555444444 23334444444444444445544 445 5777
Q ss_pred CCCCCeEEccCCcccCCCCCCC-CCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEE
Q 001226 335 LSSLNSLLLFNNRLQGTLPPEL-GNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVEL 413 (1119)
Q Consensus 335 l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 413 (1119)
++.|++|+++.|+|+ .+|... .+++++..|||.+|+++ ..|+.++-+++|++||+++|.|+ ..|..++++ +|+.|
T Consensus 227 cs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L 302 (565)
T KOG0472|consen 227 CSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFL 302 (565)
T ss_pred cHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeeh
Confidence 777777777777777 444443 47777777777777777 77777888888888888888887 455567777 77888
Q ss_pred EeecccccccCCccccCCC---CcCEEE--ccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeec
Q 001226 414 ALYNNRLTGRIPPDITRLR---NLQFLS--LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVL 488 (1119)
Q Consensus 414 ~L~~N~l~~~~~~~~~~l~---~L~~L~--L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L 488 (1119)
.+.+|.+.. +-.++-+.. -|++|. +..-.++.. ..-.. ..-++ .. ..-.......+.+.|++
T Consensus 303 ~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~s--e~~~e-----~~~t~----~~-~~~~~~~~~i~tkiL~~ 369 (565)
T KOG0472|consen 303 ALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQS--EGGTE-----TAMTL----PS-ESFPDIYAIITTKILDV 369 (565)
T ss_pred hhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCC--ccccc-----ccCCC----CC-Ccccchhhhhhhhhhcc
Confidence 888887752 222221111 011111 000011100 00000 00000 00 01112234456777888
Q ss_pred cCccccCCCCcccccccc---ccEEEeccCccccCCCccccCCCCccee-eccCcccCCCCCccccccccceEEeccCCc
Q 001226 489 GNNRFNGSFPIEIGKCSS---LRRVILSNNLLQGSLPATLERNPGVSFL-DVRGNLLQGSIPPVFGFWSNLTMLDFSENR 564 (1119)
Q Consensus 489 ~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (1119)
+.-+++ .+|.++..... .+..+++.|++. .+|..+..+..+.+. ++++|.+ +-+|..+..+++|..|+|++|-
T Consensus 370 s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~ 446 (565)
T KOG0472|consen 370 SDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNL 446 (565)
T ss_pred cccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccch
Confidence 888887 56665544433 777888888887 677777777766554 4444444 4788888889999999999999
Q ss_pred ccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcc
Q 001226 565 LSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDA 644 (1119)
Q Consensus 565 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 644 (1119)
+. .+|.+++.+..|++|++|.|+|. .+|..+-.+..++.+-.++|++....|..+.+|.+|..|||.+|.+. ++|..
T Consensus 447 Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~ 523 (565)
T KOG0472|consen 447 LN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPI 523 (565)
T ss_pred hh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChh
Confidence 87 88999999999999999999998 78988888888888888889997555555999999999999999998 78999
Q ss_pred ccccccccEeecCCcccC
Q 001226 645 FSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 645 ~~~l~~L~~L~L~~N~l~ 662 (1119)
+++|++|++|++.+|+|.
T Consensus 524 LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 524 LGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hccccceeEEEecCCccC
Confidence 999999999999999997
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=375.49 Aligned_cols=483 Identities=28% Similarity=0.392 Sum_probs=398.4
Q ss_pred ccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCC
Q 001226 235 LSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQL 314 (1119)
Q Consensus 235 l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 314 (1119)
...-..|+.+.+++|.+.. ......++..|.+|++.+|++. ..|.+++.+.+++.|+.++|++. ..|..+..+.+|
T Consensus 41 wW~qv~l~~lils~N~l~~--l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l 116 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLEV--LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISL 116 (565)
T ss_pred hhhhcchhhhhhccCchhh--ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhh
Confidence 3444567788888888752 2345678889999999999999 68889999999999999999998 677788999999
Q ss_pred cEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCc
Q 001226 315 QVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394 (1119)
Q Consensus 315 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N 394 (1119)
+.++.++|.+. ..|+.++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|++... |+..-+++.|+.||...|
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N 193 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSN 193 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchh
Confidence 99999999998 78889999999999999999999 7888999999999999999999955 444445999999999999
Q ss_pred cccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccC
Q 001226 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIP 474 (1119)
Q Consensus 395 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 474 (1119)
-++ .+|..++.+.+|..|+|.+|++. ..| +|.+++.|+.|+++.|+|. .+|.+..++++++..|||..|+++ ..|
T Consensus 194 ~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~P 268 (565)
T KOG0472|consen 194 LLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVP 268 (565)
T ss_pred hhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCc
Confidence 998 67778999999999999999998 667 8999999999999999998 889999999999999999999998 789
Q ss_pred CccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCC--Ccceee-------ccCcc----c
Q 001226 475 ANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP--GVSFLD-------VRGNL----L 541 (1119)
Q Consensus 475 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~-------l~~N~----l 541 (1119)
+.+|.+.+|..||+|+|.|+ .+|..++++ .|+.|-+.+|++...-.+.+.+-+ -|++|. ++.-+ -
T Consensus 269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~ 346 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTET 346 (565)
T ss_pred hHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccc
Confidence 99999999999999999999 789999999 999999999998632111111100 011111 01000 0
Q ss_pred CCC-CC---ccccccccceEEeccCCcccCCCCCccCCccc---ccEEEcccCcccCcCCcccccCCCCc-EEeccCccc
Q 001226 542 QGS-IP---PVFGFWSNLTMLDFSENRLSGSIPSELGNLEN---LQILRLSANKLDGRIPYELGKCTKMI-KLDLSDNYL 613 (1119)
Q Consensus 542 ~~~-~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l 613 (1119)
.+. .+ .......+.++|+++.-+++ .+|++...-.. .+..+++.|++. ++|..+..+..+. .+++++|.+
T Consensus 347 ~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 347 AMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 001 11 12234567889999999998 77776544444 788999999998 7888777776654 456666666
Q ss_pred cccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccc
Q 001226 614 AGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693 (1119)
Q Consensus 614 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~ 693 (1119)
+ .+|..+..+++|..|+|++|.+. .+|..++.+..|+.||++.|.|. .+|..+..+..+. .+-.++|++....|..
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tllas~nqi~~vd~~~ 500 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLLASNNQIGSVDPSG 500 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHHhccccccccChHH
Confidence 5 89999999999999999999887 89999999999999999999997 7887776666554 3557889998666666
Q ss_pred cccccccceeeccCceecccCCccccccccceEEecccccccccCCC
Q 001226 694 LGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPA 740 (1119)
Q Consensus 694 ~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~ 740 (1119)
+.++.+|..|||.+|-+. .||+.+++|++|+.|++++|+|. .|.
T Consensus 501 l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 501 LKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred hhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 999999999999999998 89999999999999999999998 554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=339.36 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=206.7
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecc------cccccHHHHHHHHhhcCCCCEEEEee-eeecCCc-eE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIVG-SCTKDEH-GF 903 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~ 903 (1119)
.+..|.+.++||+|.||+||++....+|..||.|.++ +..++...|+.+++.++|||||++++ .+.++.. .+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3456777789999999999999999999999999884 33456778999999999999999999 4555544 89
Q ss_pred EEEeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVP-QIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
+|||++.+|+|...++..+ .+..+++..++++..|+++|+.++|+.... .|+||||||.||+++.+|.||++|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987643 345699999999999999999999984221 38999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
...... ......+|||.||+||.+.+..|++++||||+||++|||+.-+.||.+. ......+...
T Consensus 177 ~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~-------- 241 (375)
T KOG0591|consen 177 FLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIE-------- 241 (375)
T ss_pred Hhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHH--------
Confidence 886432 2334578999999999999999999999999999999999999999753 1111111111
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
..+.+ +-.+.-++.++..++..|+.+||+.||+.-.+++.+..
T Consensus 242 --qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 --QGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --cCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111 11235567889999999999999999995555544443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.92 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=202.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
..++...++||+|+||+||+++.+++++.+|+|++++. .+...+|..++.+++||.||++...|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 34556779999999999999999999999999999643 35578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
+||+.||.|...+.+.+ .+++..++-++..|+.||.|||+. +|||||+||+|||+|++|+++++|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 489999999999999999999999 999999999999999999999999999985433
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. .......+||+.|||||++.+..|+.++|.||+|+++|||++|..||... +...+.......
T Consensus 178 ~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~---------- 240 (357)
T KOG0598|consen 178 D--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKG---------- 240 (357)
T ss_pred C--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcC----------
Confidence 2 22334579999999999999999999999999999999999999999753 111111111111
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRP----SMREVVG 1104 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~ell~ 1104 (1119)
+.. ..+.-.+.+..+++.+.++.||++|. ++++|.+
T Consensus 241 k~~---~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 241 KLP---LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred cCC---CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 111 01111244678999999999999996 4555443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.73 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=207.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccc-----cHHHHHHHHhhcC-CCCEEEEeeeeecCC-ceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-----NFDVEIRTLSLVR-HRNILRIVGSCTKDE-HGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 905 (1119)
..+|+..++||.|.||.||+|....++..||||++++.-. .-.+|++.++++. |||||++.+++.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4688888999999999999999999999999999975432 2357999999998 999999999999887 89999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||| ..+|++.+++++ ..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+.+..
T Consensus 89 fE~M-d~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhh-hhhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 9999 569999999873 4699999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCCCcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-----------ceeehhhhhh
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-----------DIVTWTRWKL 1053 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-----------~~~~~~~~~~ 1053 (1119)
. ...+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-+.-|.+..+-+. +...|..
T Consensus 163 k---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e--- 236 (538)
T KOG0661|consen 163 K---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE--- 236 (538)
T ss_pred C---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh---
Confidence 3 3344568899999999765 67899999999999999999998877765322111 0111111
Q ss_pred cccccccccccccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 QENHECICFLDREISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+..+.-+++.....+ ...+.++.+++.+|+++||++||||+|.+++
T Consensus 237 --g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 --GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred --HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1122222222222221111 1245678999999999999999999999886
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=359.01 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=206.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|..++.||+|+|++||+|+.+.+++.||||++.+ ...-+.+|-.+|.++ .||.|++++..|.++..+|+|+
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 44557789999999999999999999999999843 234467888899999 7999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++++.+ .+++..++.++.+|+.|++|||++ |||||||||+|||+|+++++||+|||.|+.+.+.
T Consensus 154 e~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999886 499999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCC---------C--cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 987 HSS---------S--TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 987 ~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
... . ....++||..|.+||.+.....++.+|+|+|||++|+|+.|..||... .+...+.
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~----NeyliFq------ 297 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA----NEYLIFQ------ 297 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc----cHHHHHH------
Confidence 221 1 125589999999999999999999999999999999999999999753 1121111
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+++-.+.+. ...+..+.+|+.+.+..||.+|++.++|.+|
T Consensus 298 -----kI~~l~y~fp----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 298 -----KIQALDYEFP----EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HHHHhcccCC----CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1122112111 1123567899999999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=323.18 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=202.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|...+++|+|.||.||+|++..+|+.||||+++..+ ....+|++.++.++|+||+.++++|.+.+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 5666688999999999999999999999999986432 2367899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
|+ .+|+..++.... .++..+++.++.++.+|++|+|++ .|+|||+||.|++++++|.+|++|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 95 689999987653 688999999999999999999999 999999999999999999999999999998875443
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce------------eehhhhhhcc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI------------VTWTRWKLQE 1055 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~------------~~~~~~~~~~ 1055 (1119)
.. ...+.|.+|+|||.+.+ +.|+..+||||.||++.||+.|..-|.+. .+-+++ ..|..+....
T Consensus 157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-SDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-chHHHHHHHHHHcCCCCcccCccccccc
Confidence 33 33488999999998876 56999999999999999999887554332 111111 1121111111
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......+..... ..--.....+..+++.+|+..||.+|++++|.+++
T Consensus 234 dY~~~~~~P~~~~--~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPL--NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCcc--ccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000000000000 00112345567999999999999999999999876
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=375.76 Aligned_cols=251 Identities=29% Similarity=0.440 Sum_probs=212.9
Q ss_pred CceeeecCCccEEEEEeCCCc---eEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSR---KHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.++||.|.||.||+|+.+..+ ..||||.++. ...+|..|+.+|.++.||||+++.|+.......+||.|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 489999999999999987655 5699999964 45679999999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC-CC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-SS 989 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~-~~ 989 (1119)
+|+|..+|+.++. .+++.+...+.++||.||+||.+. ++|||||.++|||++.+..+||+|||+++.+.++. ..
T Consensus 714 NGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 714 NGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred CCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999999999875 488999999999999999999999 99999999999999999999999999999886543 23
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.+.....-+.+|.|||.+..++++.++||||||+|+||.+ .|++||..+...+ +...++..++
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIkaIe~gyR 852 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKAIEQGYR 852 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHHHHhccC
Confidence 3333345578999999999999999999999999999988 5999997653221 1122222222
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
. ..+.+++..+.+||..||++|-.+||.+.+|+.+|.++..+
T Consensus 853 L--PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 853 L--PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred C--CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2 22344566889999999999999999999999999998754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=365.67 Aligned_cols=366 Identities=25% Similarity=0.245 Sum_probs=250.1
Q ss_pred ceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccC
Q 001226 291 QKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHN 370 (1119)
Q Consensus 291 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 370 (1119)
+.|++++|+++.+.+..|.++++|++++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.++.++.|+.||||.|
T Consensus 81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence 44666666666666666666666666666666666 55654444455666666666666555566666666666666666
Q ss_pred cCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchh
Q 001226 371 FIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVAL 450 (1119)
Q Consensus 371 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 450 (1119)
.|+.+.-..|..-.++++|+|++|+|+....+.|..+.+|..|.|++|+++...+..|.++++|+.|+|..|+|. .+..
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-ive~ 238 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-IVEG 238 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee-eehh
Confidence 666444445555566666666666666666666666666666777777766555555666677777777777665 2323
Q ss_pred hhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCC
Q 001226 451 ELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPG 530 (1119)
Q Consensus 451 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 530 (1119)
--|.++++|+.|.|..|.++..-...|..+.++++|+|+.|+++..-..++.++++|+.|+||+|.|+..-+...+-.++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 33556666777777777666555566667777777777777777666666777777777777777777777777777777
Q ss_pred cceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCc---ccccCCCCcEEe
Q 001226 531 VSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPY---ELGKCTKMIKLD 607 (1119)
Q Consensus 531 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~ 607 (1119)
|+.|||+.|+++..-+..|..++.|++|.|++|++...-...|.++++|++|||++|.+++.+.+ .|..+++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 77777777777766667777777777777777777765566777777777777777777766543 366677777788
Q ss_pred ccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCc
Q 001226 608 LSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659 (1119)
Q Consensus 608 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 659 (1119)
|.+|+|....-.+|..++.|+.|||.+|-|..+-|++|..+ .|++|-+..-
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 88887774444567777778888888887777777777777 7777666443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=359.87 Aligned_cols=367 Identities=25% Similarity=0.228 Sum_probs=276.2
Q ss_pred CcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeee
Q 001226 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGF 175 (1119)
Q Consensus 96 ~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 175 (1119)
+..+.||+++|.+....+..|.++++|+++++.+|.++ .||.......+|+.|+|.+|.|+..-..+++-++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 46678999999998888888899999999999999988 78887777888999999999988777778888888888888
Q ss_pred cccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCcc
Q 001226 176 HNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI 255 (1119)
Q Consensus 176 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~ 255 (1119)
+.|.|+.+....|..-.++++|+|++|+|+.... ..|.++.+|..|.|+.|+++ .+
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~-----------------------~~F~~lnsL~tlkLsrNrit-tL 212 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLET-----------------------GHFDSLNSLLTLKLSRNRIT-TL 212 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeecccccccccc-----------------------ccccccchheeeecccCccc-cc
Confidence 8888886666677777788888888888874422 35666777888888888886 67
Q ss_pred ChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCC
Q 001226 256 SPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNL 335 (1119)
Q Consensus 256 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 335 (1119)
+...|+.|++|+.|+|..|+|.-.-.-+|.++++|+.|.|.+|.|.....+.|..+.++++|+|+.|++...-..++.++
T Consensus 213 p~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgL 292 (873)
T KOG4194|consen 213 PQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGL 292 (873)
T ss_pred CHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhccccccc
Confidence 77788888888888888888875546677788888888888888887777788888888888888888776666677777
Q ss_pred CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEe
Q 001226 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELAL 415 (1119)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 415 (1119)
++|+.|+||+|.|....++...-+++|++|+|++|+|+...+.+|..+..|++|+|++|+|.......|..+++|+.|||
T Consensus 293 t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdL 372 (873)
T KOG4194|consen 293 TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDL 372 (873)
T ss_pred chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcC
Confidence 88888888888777777777777777777788777777666777777777777777777777666666777777777777
Q ss_pred ecccccccCCc---cccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeecc
Q 001226 416 YNNRLTGRIPP---DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLG 489 (1119)
Q Consensus 416 ~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~ 489 (1119)
++|.++..+.+ .|.++++|+.|+|.+|+|. .++...+..++.|++|||.+|.|..+-|.+|..+ .|+.|.+.
T Consensus 373 r~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 373 RSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred cCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 77777654443 3556666666666666666 5666666666666666666666665555555554 55555443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=357.82 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=208.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.|+..++||+|+.|.||.|....+++.||||++... ++-+.+|+.+|+..+|+|||.+++.|..++..|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 456668899999999999999999999999999532 3447789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
||+|.|.+.... +++.+++.|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+.... .
T Consensus 354 ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~ 424 (550)
T KOG0578|consen 354 GGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--S 424 (550)
T ss_pred CCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc--C
Confidence 999999998764 89999999999999999999999 99999999999999999999999999998776533 3
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.+...+||+.|||||+.....|++++||||+|++.+||+-|+.||-.. ..-.+. +..+.--.+.+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE---~PlrAl---------yLIa~ng~P~l--- 489 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE---NPLRAL---------YLIATNGTPKL--- 489 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC---ChHHHH---------HHHhhcCCCCc---
Confidence 566789999999999999999999999999999999999999998632 111010 11111111122
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.||++||+++|+++|
T Consensus 490 -k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 -KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred -CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2334556788999999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=349.47 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=205.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCC--ceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDE--HGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 907 (1119)
.++..++.||+|+||.||++.+.++|...|||.+... .+.+.+|++++++++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 3456678999999999999999999999999998765 445799999999999999999999855444 6899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEEeccccccccC-
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGMSKLISD- 985 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~DfGla~~~~~- 985 (1119)
|+++|+|.+++...+. .+++..++.+.+||++|++|||++ |||||||||+|||++. ++.+||+|||.++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999998874 499999999999999999999999 9999999999999999 79999999999987653
Q ss_pred CCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........||+.|||||++..+ ...+++||||+||++.||+||+.||...... ..+.-...... ..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~----~~~~~~ig~~~------~~ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE----AEALLLIGRED------SL 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch----HHHHHHHhccC------CC
Confidence 1222334457899999999999854 3446999999999999999999998642000 00000000000 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
+. .+...+.+..+++.+|++.+|++||||+++++|--.-.+
T Consensus 242 P~------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 242 PE------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred CC------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 11 122245577899999999999999999999998655443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.41 Aligned_cols=260 Identities=25% Similarity=0.288 Sum_probs=201.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc--c----cHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--T----NFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~----~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 906 (1119)
.|+..++||+|.||.||+|++..+|+.||+|+++-+. . -..+||.+++++.||||+++.+...+. +..|+|+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3444478999999999999999999999999986433 2 256899999999999999999998876 6899999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|||+. +|..++.... ..+++.+++.++.|++.|++|+|++ ||+|||||.+|||+|.+|.+||+|||+|+++...
T Consensus 198 eYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99965 7877777654 3589999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-----------ceeehhhhhhc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-----------DIVTWTRWKLQ 1054 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-----------~~~~~~~~~~~ 1054 (1119)
. ....+..+.|.+|+|||.+.+ ..|+.++|+||.|||+.||++|+..|.+..+-+. ....|...+++
T Consensus 272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 3 333567789999999998876 5799999999999999999999988765422111 11113221211
Q ss_pred ccccccccccccccCCC---chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ENHECICFLDREISFWD---SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ...+.+...... ......+....+++..+|..||++|.|+.++++.
T Consensus 351 ~----~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 H----ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred c----ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1 011111111000 0011123467899999999999999999998864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=354.53 Aligned_cols=255 Identities=33% Similarity=0.502 Sum_probs=205.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+...++.||+|.||+||+|++.+ .||||+++.+ .+.|++|+.++++-||.||+=+.|||..++. .||+.|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred Hhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 34567889999999999999874 6899998643 3569999999999999999999999998877 999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
|+|.+|+.++|..+. .++..+..+||.||++|+.|||.+ +|||||+|..||++.+++.|||+|||++.....-..
T Consensus 469 CeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred ccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999998764 588999999999999999999999 999999999999999999999999999976544322
Q ss_pred CCcccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
........|...|||||++.. -+|++.+||||||+|+|||++|..||.. ...+-..|....- ++.+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG--------~l~p 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRG--------YLMP 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEeccc--------ccCc
Confidence 222233457789999998864 3689999999999999999999999972 2222222211110 0011
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
+.. ......++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 613 d~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 613 DLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111 12234566889999999999999999999999988877663
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.84 Aligned_cols=259 Identities=26% Similarity=0.375 Sum_probs=208.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
..|+...+||.|..++||+|+..-+++.||||+++- ..+.+.+|+..|+.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 456667899999999999999999999999999852 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
|.+|++.++++..-+. .+++..+..|.+++++||.|||.+ |.||||||+.|||++++|.||++|||.+..+.+...
T Consensus 106 Ma~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999886644 489999999999999999999999 999999999999999999999999999876654331
Q ss_pred -CCcc-cccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 989 -SSTR-SAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 989 -~~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.... ...+||++|||||++.+ ..|+.|+||||||++..|+.+|..||....+-.. ....+........
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLqn~pp~~~--- 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQNDPPTLL--- 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhcCCCCCcc---
Confidence 1222 56689999999999654 3589999999999999999999999975421110 0011111111000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...............+.+++..|++.||.+|||+++++++
T Consensus 254 -t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 -TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011122334455688999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.33 Aligned_cols=234 Identities=26% Similarity=0.368 Sum_probs=199.6
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.++...+.+|.|+||.|.+++.+.+|..+|+|++++. .+...+|.++++.+.||.++++.+.+.+.+..|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 44556668899999999999999999999999999643 34567899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||++||-|..++++.++ +++..++-+|.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||.|+....
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999998764 89999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.....+|||.|+|||.+....|..++|.|||||++|||+.|..||..... ... ...++..
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~i-----------Y~KI~~~ 256 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQI-----------YEKILEG 256 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHH-----------HHHHHhC
Confidence 35567899999999999999999999999999999999999999975321 111 1112222
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCC
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMR 1096 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 1096 (1119)
... .+.....++.+++...++.|-.+|
T Consensus 257 ~v~----fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KVK----FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccc----CCcccCHHHHHHHHHHHhhhhHhh
Confidence 222 222234567899999999999988
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=380.80 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=215.3
Q ss_pred hCCceeeecCCccEEEEEeCCCce-----EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRK-----HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+..+.||+|+||.||.|...+... .||||.+++. ..+|.+|+.+|+.+.|||||+++|+|.+.+..++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 445889999999999999765433 4999988643 456899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 907 EYMPGGTLFNVLHQNEP----RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|||++|+|..++++.++ ...++..+...++.|||+|+.||+++ ++|||||+.+|+|+++...|||+|||+|+.
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArD 851 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARD 851 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHh
Confidence 99999999999998733 23588999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
+.+.+++.......-+.+|||||.+..+.++.++|||||||++||+++ |..||......+. ...+..
T Consensus 852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v----~~~~~~-------- 919 (1025)
T KOG1095|consen 852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV----LLDVLE-------- 919 (1025)
T ss_pred hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH----HHHHHh--------
Confidence 877666666555566789999999999999999999999999999997 8888864321111 100000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
..++ ..+..++..++++|..||+.+|++||++..|++.+.++.+...+.
T Consensus 920 --ggRL----~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 920 --GGRL----DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred --CCcc----CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 0111 223345667889999999999999999999999999998877654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=354.99 Aligned_cols=243 Identities=30% Similarity=0.395 Sum_probs=207.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|..++.||.|+-|.|-.|++..+|+.+|||++.+. ...+++|+-+|+.+.||||+++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 34568899999999999999999999999999654 45689999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|-|++++-+.++ +++.++.+++.||+.|+.|+|+. +|+|||+||+|+++|..+.+||+|||+|.....
T Consensus 94 v~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--- 164 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--- 164 (786)
T ss_pred cCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC---
Confidence 999999999988764 89999999999999999999999 999999999999999999999999999986543
Q ss_pred CCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.......+|.+.|.|||++.+..| +.++||||+|||+|.|++|+.||+. +.+....... .
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV--------------~ 225 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKV--------------Q 225 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHH--------------H
Confidence 234455689999999999999888 5799999999999999999999973 1221111111 1
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
++.+..+...+.++.+++.+|+..||++|.|++||.+|-
T Consensus 226 ~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 226 RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 111122233455778999999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=350.03 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=206.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-c-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-E-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|...+.||+|.||.||||+.+.+.+.||+|.+.+. + ..+.+|+++++.++|||||.++++|+...+.++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 344456799999999999999999999999988432 2 2378899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+.| +|+.++...+ .++++.+..++.+++.|+.|||+. +|.|||+||+||+++..|.+|++|||+|+.+.. .
T Consensus 83 a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 83 AVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 976 9999999876 499999999999999999999999 999999999999999999999999999997764 2
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
........|||-|||||...++.|+..+|+||+||++||+++|+.||... .+....+....+
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d------------- 215 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD------------- 215 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC-------------
Confidence 34455678999999999999999999999999999999999999999642 111122211111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+...+..+..+++..+.+||..|.+..+++.|
T Consensus 216 -~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 -PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111223556678899999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=354.12 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=205.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 903 (1119)
.+|..++.||+|.||.|+.|.+..+++.||+|++++. ...+.+|+.++++++ ||||+++++++......|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3677789999999999999999999999999977543 234668999999999 999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEecccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKL 982 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~ 982 (1119)
+||||+.||+|.+++...+ .+.+..+.+++.|++.|++|+|+. ||+||||||+||+++.+ +.+||+|||++..
T Consensus 97 ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999844 388899999999999999999999 99999999999999999 9999999999987
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTR-LT-EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
.. .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.. ...............+
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~~~~~- 242 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKGEFKI- 242 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcCCccC-
Confidence 73 1223455678999999999999877 75 7899999999999999999999752 1111111111111111
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
+.+.. +.++..++.+|+..+|.+|+++.+|+ .-.-++
T Consensus 243 -------p~~~~-----S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 243 -------PSYLL-----SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred -------CCCcC-----CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 11110 45778999999999999999999999 444443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.80 Aligned_cols=244 Identities=30% Similarity=0.495 Sum_probs=204.6
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHH
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 916 (1119)
++.+-+|+|+-|.||+|+.+ ++.||||+++.-+ +.+|+-+++++||||+.+.|+|.....+|||||||+.|-|..
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~elk---ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK---ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhhh---hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 44467999999999999988 4899999986543 457889999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccc
Q 001226 917 VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996 (1119)
Q Consensus 917 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~ 996 (1119)
+++... .++....+.|..+||.|+.|||.+ .|||||+|.-||||+.+..|||+|||-++...+. .+...++
T Consensus 202 VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa 272 (904)
T KOG4721|consen 202 VLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA 272 (904)
T ss_pred HHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence 999866 488889999999999999999999 9999999999999999999999999999877553 4556689
Q ss_pred cCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHH
Q 001226 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQL 1076 (1119)
Q Consensus 997 gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1119)
||..|||||++...+.++|+||||||||+|||+||+.||... +.....|.... ..... .-+..
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV---dssAIIwGVGs-----NsL~L---------pvPst 335 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV---DSSAIIWGVGS-----NSLHL---------PVPST 335 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc---chheeEEeccC-----Ccccc---------cCccc
Confidence 999999999999999999999999999999999999998642 22222222110 00000 11233
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1077 KALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1077 ~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
++..+.-+++.||+-.|..||++++|+.||+-+..
T Consensus 336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 45567788999999999999999999999986543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=344.66 Aligned_cols=256 Identities=29% Similarity=0.413 Sum_probs=213.5
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
.+++||+|.||.|.+++... +..||||.++... .+|..|+++|.+++|||||+++|+|..++.+++|+|||++|
T Consensus 542 ~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 542 FKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred hhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 45899999999999998776 7999999996432 46899999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|..++..+.... ...+...+|+.||+.|++||.+. ++||||+.++|+|++.++++||+|||+++-+...+++...
T Consensus 621 DLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 621 DLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred cHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999999886432 45566788999999999999999 9999999999999999999999999999988777777777
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHH--hCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL--FRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
...+-+++|||||.+.-++++.++|||+||+++||++ +.+.||..... ++.++....... ++.....
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~---------~~~~~~~ 765 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFR---------DQGRQVV 765 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcC---------CCCccee
Confidence 7888999999999999999999999999999999988 48889875422 222221111111 1111112
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
...+...+..+.+++.+||..|.++||+++++..+|.+.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 233445577889999999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.47 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=205.5
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecc-cccccHHHHHHHHh--hcCCCCEEEEeeeeecCC----ceEEEEeccCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDVEIRTLS--LVRHRNILRIVGSCTKDE----HGFIVTEYMPG 911 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~lV~e~~~~ 911 (1119)
.+.||+|.||.||+|.++ |+.||||++. .++..+.+|.++++ .++|+||..+++.-..+. ..++|++|.+.
T Consensus 216 ~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~ 293 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEH 293 (513)
T ss_pred EEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccC
Confidence 378999999999999988 6899999995 45566777666665 569999999999876543 46999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD-----CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|||+||+.+. .++.+...+++..+|.||+|||.. .+|.|.|||||+.||||.+++.+.|+|+|+|......
T Consensus 294 GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~ 369 (513)
T KOG2052|consen 294 GSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSD 369 (513)
T ss_pred CcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEeccc
Confidence 9999999975 489999999999999999999954 4689999999999999999999999999999877554
Q ss_pred CC--CCcccccccCCCcccccccCCCC------CCCcchHHHHHHHHHHHHhC----------CCCCCCCCCCCCceeeh
Q 001226 987 HS--SSTRSAIVGSLGYIAPENAYSTR------LTEKSDVYSYGVILFELLFR----------KMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 987 ~~--~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg----------~~p~~~~~~~~~~~~~~ 1048 (1119)
.. .......+||.+|||||++...- ....+||||||.|+||+..+ +.||+...+.+..+.++
T Consensus 370 t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeM 449 (513)
T KOG2052|consen 370 TDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEM 449 (513)
T ss_pred CCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHH
Confidence 22 23456789999999999876432 23568999999999999854 47777665555444333
Q ss_pred hhhhhcccccccccccccccC-CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1049 TRWKLQENHECICFLDREISF-WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.+. -+.+-+.+.++. |. .......+.++|+.||..+|..|.|+-.|.+.+.++.+..|
T Consensus 450 rkV------VCv~~~RP~ipnrW~--s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 450 RKV------VCVQKLRPNIPNRWK--SDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred hcc------eeecccCCCCCcccc--cCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 221 122223333322 32 23455678999999999999999999999999999886443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.29 Aligned_cols=262 Identities=23% Similarity=0.254 Sum_probs=203.7
Q ss_pred HHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccc------cHHHHHHHHhhcCCCCEEEEeeeeecC--Cce
Q 001226 831 EDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET------NFDVEIRTLSLVRHRNILRIVGSCTKD--EHG 902 (1119)
Q Consensus 831 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 902 (1119)
..+.+|+....|++|.||.||+|+++.+++.||+|+++-+++ ...+||.++..++|||||.+-.+.... +..
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 345667777899999999999999999999999999964432 257899999999999999999887643 568
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+|||||+. +|..++...+. .+...+++.++.|+.+|++|||.. .|+|||+||+|+|++..|.+||+|||+|+.
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ 226 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLARE 226 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhh
Confidence 999999965 89999988763 588899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce-----------eehhh
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI-----------VTWTR 1050 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~-----------~~~~~ 1050 (1119)
++.. ....+..+.|.+|+|||.+.+ ..|+.++|+||+|||+.||++++.-|.+...-+.-. ..|..
T Consensus 227 ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 227 YGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 8653 344566789999999998876 469999999999999999999998876543222110 11111
Q ss_pred hhhcccc---cc----cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1051 WKLQENH---EC----ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1051 ~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....... .+ ...+.+.+.. ......-++++...+..||.+|.|++|.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~-----~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGA-----LSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccc-----cccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1100000 00 0000111110 0023567899999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=353.16 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=202.1
Q ss_pred HHhhCCceeeecCCccEEEEEeC-----CCceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecC-Cc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKD-EH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 901 (1119)
.+|+..++||+|+||.||+|.+. .+++.||+|+++.. ...+.+|+.+++.+ +||||+++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 36777899999999999999752 34568999998642 23477899999999 899999999988764 45
Q ss_pred eEEEEeccCCCCHHHhhccCCC----------------------------------------------------------
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEP---------------------------------------------------------- 923 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 923 (1119)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999875321
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcc
Q 001226 924 -RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002 (1119)
Q Consensus 924 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~ 1002 (1119)
...+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...............+++.|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 12477888999999999999999999 99999999999999999999999999998664332222233345678899
Q ss_pred cccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHH
Q 001226 1003 APENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRL 1081 (1119)
Q Consensus 1003 aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1081 (1119)
|||++.+..++.++|||||||++|||++ |..||....... . .... ..... ... .+...+..+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~---~~~~-~~~~~--------~~~----~~~~~~~~l 306 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-E---FCQR-LKDGT--------RMR----APENATPEI 306 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-H---HHHH-HhcCC--------CCC----CCCCCCHHH
Confidence 9999998899999999999999999997 999986432110 0 0000 00000 000 011223467
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1082 LELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1082 ~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=351.88 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=207.0
Q ss_pred hCCceeeecCCccEEEEEeCCCce---E-EEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRK---H-WAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~---~-vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.+++||+|+||.||+|..+..+. . ||||..+.+ ..++.+|+++|+.++|||||+++|++..+.++++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 344899999999999999765422 3 899988642 24578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
||+|+||+|.++++..+. .++..+...++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||+++....
T Consensus 240 mEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred EEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 999999999999998875 589999999999999999999999 999999999999999999999999999875431
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
+.........+.+|+|||.+..+.|++++|||||||++||+++ |..||.+.... +. ..+.....
T Consensus 315 --~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v---~~kI~~~~-------- 379 (474)
T KOG0194|consen 315 --YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EV---KAKIVKNG-------- 379 (474)
T ss_pred --eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HH---HHHHHhcC--------
Confidence 1122223357889999999999999999999999999999998 88898764221 11 11110110
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
.+. ..+...+..+..++.+||..+|+.||+|.++.+.++.+....+.
T Consensus 380 --~r~--~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 --YRM--PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred --ccC--CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 000 11123456778899999999999999999999999998877654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.11 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=200.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|...++||+|+||.||+|+-+++|..+|+|++++. ...+..|-.+|....+|.||+++..|.+.+.+|+|||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 455568999999999999999999999999999653 3457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC-
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS- 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~- 986 (1119)
|+|||++..+|...+ .+++..++.++.+++-|+..+|.. |+|||||||+|+|||..|++|++|||++.-+...
T Consensus 222 ylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred ecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999876 599999999999999999999999 9999999999999999999999999998533110
Q ss_pred ---------------------CCCC----cc-------------------cccccCCCcccccccCCCCCCCcchHHHHH
Q 001226 987 ---------------------HSSS----TR-------------------SAIVGSLGYIAPENAYSTRLTEKSDVYSYG 1022 (1119)
Q Consensus 987 ---------------------~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 1022 (1119)
+... .. ...+|||.|+|||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0000 00 124899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC---H
Q 001226 1023 VILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS---M 1099 (1119)
Q Consensus 1023 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~ 1099 (1119)
||+|||+.|.+||......+. ......|+.. +.+ ......+.+..++|.+|+. ||++|.- +
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr~~------------l~f--P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQET-YRKIVNWRET------------LKF--PEEVDLSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHH-HHHHHHHhhh------------ccC--CCcCcccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999975422211 1111122210 111 1112223677899999999 9999985 6
Q ss_pred HHHHHH
Q 001226 1100 REVVGF 1105 (1119)
Q Consensus 1100 ~ell~~ 1105 (1119)
+||.+|
T Consensus 440 ~EIK~H 445 (550)
T KOG0605|consen 440 EEIKKH 445 (550)
T ss_pred HHHhcC
Confidence 666654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=336.19 Aligned_cols=244 Identities=27% Similarity=0.414 Sum_probs=205.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|+..+.||+|.||.||+|.+..+++.||+|++.-+ .++++.|+.++..++++||.++++.+..+...+++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 44457899999999999999999999999999533 3457789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
||++.+.++.... +++..+.-+++++..|+.|+|++ +.+|||||+.||++..+|.||++|||.+........
T Consensus 95 gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~-- 166 (467)
T KOG0201|consen 95 GGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK-- 166 (467)
T ss_pred CcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence 9999999987653 47778888999999999999999 999999999999999999999999999987765332
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.+...+||+.|||||++.+..|+.++||||+|++.+||.+|..|+....+ ...+....+.. .+.+..
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk~~-----------PP~L~~- 233 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPKSA-----------PPRLDG- 233 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccCCC-----------CCcccc-
Confidence 33678999999999999998999999999999999999999999976543 11111111111 111111
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+..+.+++..|++.+|+.||+|+++++|
T Consensus 234 -----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 234467899999999999999999999876
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=307.16 Aligned_cols=261 Identities=24% Similarity=0.335 Sum_probs=210.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecc----cccccHHHHHHHHhhcCCCCEEEEeeeeecCC-----ceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDE-----HGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 904 (1119)
.||+..+.+|+|||+-||.++.-.+++.||+|++. ++.+...+|++..++++||||++++++...+. ..|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 47888899999999999999999999999999883 34456788999999999999999999875443 4899
Q ss_pred EEeccCCCCHHHhhccCCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRL-VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+++|...|+|.+.+.....+. .+++.++.+|+.++++|+++||+. .++++||||||.||++++++.+++.|||.++..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 999999999999998765433 799999999999999999999988 235999999999999999999999999998765
Q ss_pred cCCCCCC-------cccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 984 SDSHSSS-------TRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 984 ~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
.-.-... .......|..|+|||.+. +...++++||||+||++|+|+.|.-||+..++....+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla------- 252 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA------- 252 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-------
Confidence 3211111 112345889999999664 44578999999999999999999999987544322221
Q ss_pred cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1054 QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
.++..+.+..+...+ .+..+.+++.+|++.||.+||++.+++..++.+.
T Consensus 253 ------LAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ------LAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ------EeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 122233344333332 6778899999999999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.06 Aligned_cols=267 Identities=27% Similarity=0.389 Sum_probs=201.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccc-ccccHHHHHHHHh--hcCCCCEEEEeeeeecCC----ceEEEEeccCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-SETNFDVEIRTLS--LVRHRNILRIVGSCTKDE----HGFIVTEYMPG 911 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~lV~e~~~~ 911 (1119)
.+++|+|+||.||||...+ +.||||++.. .++.|.+|-++++ .++|+||++++++-.... .+++|+||.+.
T Consensus 215 ~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN--RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HHHhhcCccceeehhhccC--ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 4679999999999998875 8999999964 4566777777665 568999999999876544 78999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD------CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|+|.+|++.+- ++|....+++..|++||+|||+. ++|+|+|||||.+||||.+|+++.|+|||+|..+..
T Consensus 293 GsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 293 GSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred CcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 99999999874 99999999999999999999976 457899999999999999999999999999998876
Q ss_pred CCCCCcccccccCCCcccccccCCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTR------LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
.......-..+||.+|||||++.+.- .-.+.||||+|.|+|||+++..-+++. +..++..-..........+
T Consensus 369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~--~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG--PVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC--CCCcccCchhHHhcCCCCH
Confidence 65555555689999999999887542 224689999999999999887655421 1111000000000000010
Q ss_pred c---c-cc----cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1060 I---C-FL----DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1060 ~---~-~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
. + ++ .+.++...... ....-+.+.+..||..||+.|.|+.=+.+.+.++..-++
T Consensus 447 e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 447 EEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0 0 11 11221111111 345568899999999999999999988888887766554
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=321.64 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=205.5
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCC-EEEEeeeeecCC-----
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRN-ILRIVGSCTKDE----- 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 900 (1119)
+..|...++||+|+||+||+|+.+.+|+.||+|+++-.. ....+|+.+++.++|+| ||.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 344455567999999999999999999999999985332 23578999999999999 999999998776
Q ss_pred -ceEEEEeccCCCCHHHhhccCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 901 -HGFIVTEYMPGGTLFNVLHQNEPR-LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 901 -~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
..++|+||+ .-+|..++...... ..++...++.+++||++|++|+|++ +|+||||||+||+++++|.+|++|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 789999999 56999999887642 3577789999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce-----------e
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI-----------V 1046 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~-----------~ 1046 (1119)
+|+...- +.......++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+....+.-. .
T Consensus 166 lAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9996643 23345677899999999998876 78999999999999999999998876543311111 1
Q ss_pred ehhhhhhcccccccccccccccCCCch---H---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcc
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSD---D---QLKALRLLELALECTRQVADMRPSMREVVGF--LIKL 1109 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~ 1109 (1119)
.|......... +..+..+... . .....+..+++.+|++.+|.+|.|++.+++| +..+
T Consensus 244 ~Wp~v~~~~~~------k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDY------KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccc------cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111110010 0111111100 0 1111367899999999999999999999998 5554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.09 Aligned_cols=263 Identities=25% Similarity=0.328 Sum_probs=199.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCC-----ceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDE-----HGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~ 909 (1119)
.|+..+++|+|+||.||+|....+++.||||+.-.+..--.+|+.+|++++|||||+++-+|.... ...+|||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 445568999999999999999999999999999777766678999999999999999999886432 335899999
Q ss_pred CCCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccccccccCCC
Q 001226 910 PGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~~~~ 987 (1119)
|. +|.++++.. .....++...++-++.||++|++|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.....+
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 64 898888753 1123578888899999999999999998 99999999999999987 899999999999886644
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc--
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD-- 1064 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1064 (1119)
+ ......|..|+|||.+.+ ..|+.+.||||.|||+.||+.|+.-|.+..+.+. ++...+.--....+-...+.
T Consensus 181 p---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-L~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 P---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-LVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred C---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-HHHHHHHhCCCCHHHHhhcCcc
Confidence 3 344578999999998876 4699999999999999999999988865332221 11111110000000001111
Q ss_pred ------ccccC--CCc-hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 ------REISF--WDS-DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ------~~~~~--~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+.+.. |.. .....+.+..+++.++++.+|.+|.++.|+++|
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111 101 123345678999999999999999999999865
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=327.73 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=203.8
Q ss_pred HHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------------------ccHHHHHHHHhhcCCCCEEEE
Q 001226 831 EDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------------------TNFDVEIRTLSLVRHRNILRI 892 (1119)
Q Consensus 831 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------------~~~~~E~~~l~~l~h~niv~l 892 (1119)
..+-+|+..+.||+|.||.|-+|++..+++.||||++.+.+ +.+.+||.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34567888899999999999999999999999999984321 357889999999999999999
Q ss_pred eeeeecC--CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 001226 893 VGSCTKD--EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL 970 (1119)
Q Consensus 893 ~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 970 (1119)
+++..+. +..|+|+|||..|.+... ......+++.+++++.++++.||+|||.+ |||||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 9999774 578999999988866422 12122389999999999999999999999 999999999999999999
Q ss_pred ceEEEeccccccccCCCC---CCcccccccCCCcccccccCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001226 971 EPKIGDFGMSKLISDSHS---SSTRSAIVGSLGYIAPENAYSTR----LTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 1043 (1119)
+|||+|||.+.....+.. .......+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||...+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---- 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---- 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence 999999999886633211 11223468999999999877632 3578999999999999999999996431
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
.+.. ..+++...+.+. ...+...++.+++.++|.+||++|.+..+|..|....++
T Consensus 324 ~~~l-----------~~KIvn~pL~fP--~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 ELEL-----------FDKIVNDPLEFP--ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHH-----------HHHHhcCcccCC--CcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1111 122233333322 122345578899999999999999999999998776555
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=302.80 Aligned_cols=252 Identities=28% Similarity=0.354 Sum_probs=211.4
Q ss_pred CCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCC
Q 001226 828 LRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDE 900 (1119)
Q Consensus 828 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 900 (1119)
.+...+.++..++.||+|.||.||.|+.+.++-.||+|++.+ .+.++.+|+++-..++||||++++++|.++.
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 334456677889999999999999999999999999999853 3457889999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..|+++||.+.|.++..+...+. ..+++..+..++.|+|.|+.|+|.. +|+||||||+|+|++..+..|++|||.+
T Consensus 96 riyLilEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999986543 2488889999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
.... ...+...+||..|.|||...+..++..+|+|++|+..||++.|..||.....+ .......+.
T Consensus 172 V~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k~--------- 237 (281)
T KOG0580|consen 172 VHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRKV--------- 237 (281)
T ss_pred eecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHHc---------
Confidence 7543 34556678999999999999999999999999999999999999999754311 111111110
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
+. ..+...+..+.+++.+|+..+|.+|.+..|++++-
T Consensus 238 ~~---------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 DL---------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred cc---------cCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 01 11123345678999999999999999999999874
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.91 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=216.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.+...+||.|.||.||.|.++...-.||||.++.+ .++|..|+.+|+.++|||+|+++|+|..+...|||+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 345568999999999999999998899999999765 36789999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+|++++.. ..++.-..++++.||+.|++||..+ ++||||+..+|+||.++..|||+|||+++.+..+. +..
T Consensus 348 GNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTA 422 (1157)
T KOG4278|consen 348 GNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTA 422 (1157)
T ss_pred ccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc-eec
Confidence 999999999874 4577778899999999999999999 99999999999999999999999999999887643 333
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....-++.|.|||.+.-..++.++|||+|||++||+.| |-.||.+. +.. .+...+.+.++..
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlS-----------qVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLS-----------QVYGLLEKGYRMD 486 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHH-----------HHHHHHhcccccc
Confidence 344455789999999998899999999999999999997 88887543 111 1112223333322
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.+..++..++++|+.||++.|..||+++|+-+.++.+.....
T Consensus 487 --~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 487 --GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred --CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 233456688999999999999999999999999999877654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=370.31 Aligned_cols=448 Identities=27% Similarity=0.310 Sum_probs=332.9
Q ss_pred hccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccc
Q 001226 92 ICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLE 171 (1119)
Q Consensus 92 ~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~ 171 (1119)
+....+++.|+++.|.+-...-+.+.+.-+|+.||+++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..++++|+
T Consensus 17 i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~ 94 (1081)
T KOG0618|consen 17 ILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQ 94 (1081)
T ss_pred hccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcch
Confidence 345567899999999776433334455666999999999987 78999999999999999999998 6789999999999
Q ss_pred eeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCcc
Q 001226 172 SIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNF 251 (1119)
Q Consensus 172 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i 251 (1119)
+|.|.+|.+. ..|..+..+++|++|++++|++. .+|..+..++.++.+..++|..
T Consensus 95 ~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~------------------------~~Pl~i~~lt~~~~~~~s~N~~ 149 (1081)
T KOG0618|consen 95 YLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG------------------------PIPLVIEVLTAEEELAASNNEK 149 (1081)
T ss_pred hheeccchhh-cCchhHHhhhcccccccchhccC------------------------CCchhHHhhhHHHHHhhhcchh
Confidence 9999999987 78999999999999999999987 4566777888888888888822
Q ss_pred CCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcc
Q 001226 252 GGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRS 331 (1119)
Q Consensus 252 ~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 331 (1119)
.. .++.. .++.+++..|.+.+.++..+..+++ .|+|++|.+. ...+..+.+|+.|....|+++..
T Consensus 150 ~~-----~lg~~-~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l---- 214 (1081)
T KOG0618|consen 150 IQ-----RLGQT-SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL---- 214 (1081)
T ss_pred hh-----hhccc-cchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----
Confidence 11 12222 2888999999999999988888877 8999999987 33577889999999999998732
Q ss_pred cCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcce
Q 001226 332 VGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLV 411 (1119)
Q Consensus 332 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 411 (1119)
--..++|+.|+.++|.++...+. .--.+|+++++++|+++ .+|++++.+.+|+.++..+|+++ .+|..+..+++|+
T Consensus 215 ~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~ 290 (1081)
T KOG0618|consen 215 EISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLV 290 (1081)
T ss_pred EecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHH
Confidence 23457899999999999833332 22358999999999998 56799999999999999999996 7888899999999
Q ss_pred EEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCc-cceeccccceeeCccCCccccccccceeeccC
Q 001226 412 ELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPY-LSRLDLTGNSFYGPIPANICVGTNLFVLVLGN 490 (1119)
Q Consensus 412 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~ 490 (1119)
.|.+..|.+. -+|+...+++.|++|+|..|+|. ..|..++..... |..|+.+.|++....-..-.....|+.|.+.+
T Consensus 291 ~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lylan 368 (1081)
T KOG0618|consen 291 SLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLAN 368 (1081)
T ss_pred HHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhc
Confidence 9999999999 78888999999999999999998 556566555554 77788888877633322222344566666666
Q ss_pred ccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCC
Q 001226 491 NRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIP 570 (1119)
Q Consensus 491 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 570 (1119)
|++++..-..+.+...|+.|+|++|++.......+.+++.|+.|+||+|+|+ .+|.....+..|++|....|+|. ..|
T Consensus 369 N~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 369 NHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred CcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 6666655555666666666666666665433344455555555555555554 34444444555555555555554 344
Q ss_pred CccCCcccccEEEcccCccc
Q 001226 571 SELGNLENLQILRLSANKLD 590 (1119)
Q Consensus 571 ~~~~~l~~L~~L~Ls~N~l~ 590 (1119)
++..+++|+.+|+|.|+|+
T Consensus 447 -e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred -hhhhcCcceEEecccchhh
Confidence 4444555555555555554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.18 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=211.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCC----ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS----RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
..+.+++||+|.||.||+|.+... .-.||||..+.+ .+.|..|+.+|+.++|||||+++|+|.+ ...|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 345568999999999999987543 345899988753 3458899999999999999999999986 477999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
||.++-|.|.+|+..++. .++......++.||+.|++|||+. .+|||||..+||++.+...||++|||+++.+.+
T Consensus 469 mEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999998865 488889999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL-FRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
..++.. +...-++.|||||.+.-++++.++|||-|||.+||++ .|..||.+....+.-.......
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe------------- 609 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE------------- 609 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC-------------
Confidence 655443 3566788999999999999999999999999999998 4999998754333221111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
++ ..+..++..+..++.+||+.+|.+||.+.++.+.|..+.+++
T Consensus 610 -Rl----P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 610 -RL----PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred -CC----CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 11 123345667889999999999999999999999999888743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.06 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=197.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 904 (1119)
+.+++..++||+|.||+|++|..+.+++.+|||+++++. +....|.+++... +||.++.++..|...++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 345566689999999999999999999999999997542 4466788888777 59999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+.||++..+.+.. .+++..++-++..|+.||.|||++ +|||||||.+|||+|.+|.+||+|||+++.--
T Consensus 447 vmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999955444432 499999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
......+..+||+.|||||++.+..|+.++|.|||||++|||+.|..||.+..++ ++ +|
T Consensus 520 --~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--e~-----------------Fd 578 (694)
T KOG0694|consen 520 --GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--EV-----------------FD 578 (694)
T ss_pred --CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--HH-----------------HH
Confidence 2334567789999999999999999999999999999999999999999753211 11 11
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSM 1099 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 1099 (1119)
.-+......+.-.+.+...|+++++..+|++|.-+
T Consensus 579 sI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111122333455678899999999999999965
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.90 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=207.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|.||.|-+|.....|+.||||.+++++ -.+.+|+++|..+.||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 36666788999999999999998999999999886543 23678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||..+|.|+||+.+++ .+++.+++.+++||++|+.|+|.+ ++||||+|.+||++|.++.+||+|||++-.+.+.
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999877 499999999999999999999999 9999999999999999999999999999887653
Q ss_pred CCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.....++|++-|.+||.+.+.+| ++.+|-||+||++|-++.|..||++.. .....+..-. .
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQIs~----------G 268 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQISR----------G 268 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHhhc----------c
Confidence 33456789999999999999887 578999999999999999999998631 1111111110 0
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
. ..+...+.+..-+|++|+..+|++|.|+.+|..|..
T Consensus 269 a-----YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 269 A-----YREPETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred c-----ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 0 111223345678999999999999999999998864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=333.20 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=198.6
Q ss_pred HhhCCceeeecCCccEEEEEeCC----------------CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN----------------SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIV 893 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~ 893 (1119)
+|+..++||+|+||.||+|.+.. ++..||+|+++.. ..++.+|+.++++++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 56677899999999999997543 3457999988643 23578899999999999999999
Q ss_pred eeeecCCceEEEEeccCCCCHHHhhccCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001226 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEP----------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957 (1119)
Q Consensus 894 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 957 (1119)
+++.+.+..++||||+++|+|.+++..... ...+++..+.+++.|++.|++|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 999999999999999999999999865321 12467888999999999999999999 99999
Q ss_pred CCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCC
Q 001226 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF--RKMPV 1035 (1119)
Q Consensus 958 Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~ 1035 (1119)
||||+||+++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ +..||
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999986644332223334456889999999888889999999999999999986 55666
Q ss_pred CCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1036 DPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
..... ................ . .....+...+..+.+++.+||+.+|++|||+++|.+.|+.
T Consensus 243 ~~~~~--~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTD--EQVIENAGEFFRDQGR-------Q--VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCH--HHHHHHHHHHhhhccc-------c--ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 53211 1111000000000000 0 0000111224578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.52 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=206.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+...+.||.|.-|+||+++.++++..+|+|++.+.. ...+.|.++++.+.||.++.+++.++.+...|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3444578999999999999999999999999996432 346779999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
||+||+|....++... ..+++..++-++..++-||+|||.. |||+|||||+||||.++|++.++||.++.......
T Consensus 158 yCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999998887664 4699999999999999999999999 99999999999999999999999999976432100
Q ss_pred -------------------------------C-C----------------------CcccccccCCCcccccccCCCCCC
Q 001226 988 -------------------------------S-S----------------------STRSAIVGSLGYIAPENAYSTRLT 1013 (1119)
Q Consensus 988 -------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~~~~~~ 1013 (1119)
. . .....++||-+|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 011235899999999999999999
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCC
Q 001226 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVA 1093 (1119)
Q Consensus 1014 ~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 1093 (1119)
.++|.|+|||++|||+.|+.||.+.... ..+..++.+.+.+.. ....+..+.++|++.|.+||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~--~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPE--EPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCC--CCcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999764222 122333333333321 12455678999999999999
Q ss_pred CCCCC----HHHHHHH
Q 001226 1094 DMRPS----MREVVGF 1105 (1119)
Q Consensus 1094 ~~RPs----~~ell~~ 1105 (1119)
.+|.. ++||.+|
T Consensus 377 ~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhccccchHHhhcC
Confidence 99998 8888765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=344.29 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=200.9
Q ss_pred HHhhCCceeeecCCccEEEEEe-----CCCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+.++.||+|+||.||+|.+ ..++..||||+++... ..+.+|+.+++.+ +||||+++++++.+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3577789999999999999974 3456789999986432 3467899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCC-----------------------------------------------------------
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP----------------------------------------------------------- 923 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 923 (1119)
++||||+++|+|.++++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999865321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 924 -------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 924 -------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
...+++..+.+++.||++|++|||+. +|+||||||+||+++.++.+|++|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 12478889999999999999999998 99999999999999999999999999998664432222
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||.+.+..++.++|||||||++|||++ |..||....... .. .... ......
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~---~~~~-----------~~~~~~ 336 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KF---YKMI-----------KEGYRM 336 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HH---HHHH-----------HhCccC
Confidence 2223345678999999999999999999999999999997 888886432111 10 0100 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
. .+...+.++.+++.+||+.||++||+++||++.|++.
T Consensus 337 ~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 L--SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0011234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.49 Aligned_cols=259 Identities=22% Similarity=0.264 Sum_probs=197.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeec-----CCceEEEEe
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTK-----DEHGFIVTE 907 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~lV~e 907 (1119)
.+.||+|+||.|+.|.++.+|+.||||++.. ......+|++.++.++|+||+.+.+++.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 4779999999999999999999999999852 23446789999999999999999998865 356799999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
+| +.+|...++..+ .++.+.+..+++|+.+|++|+|+. +|+|||+||.|++++.+..+||+|||+|+......
T Consensus 107 lM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 679999998765 389999999999999999999999 99999999999999999999999999999886432
Q ss_pred CCCcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce-e-------ehhhhhhccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI-V-------TWTRWKLQENHE 1058 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~-~-------~~~~~~~~~~~~ 1058 (1119)
.....+..+.|.+|+|||.+. ...|+.+.||||.||++.||++|+.-|.+...-+.-. . .......-....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 233446678999999999765 5679999999999999999999998886542111100 0 000000000000
Q ss_pred ccccccccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...++. .++... ..-+.......+++++|+..||.+|+|++|.++|
T Consensus 260 ar~yi~-slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIK-SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHH-hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000110 000000 0011234467899999999999999999999886
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=332.16 Aligned_cols=248 Identities=23% Similarity=0.270 Sum_probs=198.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|...+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++|++|+++.+++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 34458899999999999999999999999987532 12467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999988865432 2488999999999999999999999 99999999999999999999999999998654321
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......||..|+|||++.+..++.++||||+||++|||++|+.||......... ....... .....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~----------~~~~~- 222 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRV----------KEDQE- 222 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHh----------hcccc-
Confidence 223456899999999999999999999999999999999999999753211100 0000000 00000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
......+..+.+++.+||+.||++||+ +++++++
T Consensus 223 ---~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 ---EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ---cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011123456789999999999999997 8898875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=334.39 Aligned_cols=266 Identities=21% Similarity=0.251 Sum_probs=199.8
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
++.+|+..++||+|+||.||+|+++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 345678889999999999999999999999999988532 235678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++ +|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99974 89998876543 478889999999999999999999 9999999999999999999999999998765322
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeeh--------hhhhh-ccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTW--------TRWKL-QEN 1056 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~--------~~~~~-~~~ 1056 (1119)
. .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+...... ..|.. ...
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 T--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred C--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 1 12234567899999998765 568999999999999999999999996532111000000 00000 000
Q ss_pred ccccccccccccCC--CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREISFW--DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+..... .........++.+++.+|++.||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000000 00001123467899999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=365.30 Aligned_cols=461 Identities=26% Similarity=0.313 Sum_probs=247.0
Q ss_pred EEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeeccccc
Q 001226 101 LDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFL 180 (1119)
Q Consensus 101 L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l 180 (1119)
+|.+..+++ .||..+-.-..++.|+++.|-+-...-+.+.+.-+|+.|||++|+++ ..|..+..+++|+.|+++.|.+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 566666666 66666655555777777777554322233344444777777777766 4555666666666666665555
Q ss_pred ccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChhhh
Q 001226 181 NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIF 260 (1119)
Q Consensus 181 ~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~ 260 (1119)
. ..|....++.+|++|.|..|++. .+|.+ +
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~------------------------~lP~~-------------------------~ 110 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ------------------------SLPAS-------------------------I 110 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh------------------------cCchh-------------------------H
Confidence 5 34455555555555555555544 23334 4
Q ss_pred hcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCe
Q 001226 261 KGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNS 340 (1119)
Q Consensus 261 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 340 (1119)
..+++|++|+++.|++. .+|..+..++.++.+..++|..... ++... .+.++|..|.+.+.++..+.+++. .
T Consensus 111 ~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ 182 (1081)
T KOG0618|consen 111 SELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--Q 182 (1081)
T ss_pred HhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--e
Confidence 44455555555555555 5666666666666666666621111 11111 556666666666666655555555 5
Q ss_pred EEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccc
Q 001226 341 LLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRL 420 (1119)
Q Consensus 341 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 420 (1119)
|+|.+|.+. . ..+..+++|+.|....|++.... -..++|+.|+.++|.++...+ -..-.+|+++++++|++
T Consensus 183 ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l 253 (1081)
T KOG0618|consen 183 LDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNL 253 (1081)
T ss_pred eecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecc--ccccccceeeecchhhh
Confidence 666666665 1 23555666666666666665221 123556666666666663222 12234666777777776
Q ss_pred cccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcc
Q 001226 421 TGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIE 500 (1119)
Q Consensus 421 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~ 500 (1119)
+ .+|+++..+.+|+.++..+|+|+ .+|...+. ..+|+.|....|.+ . .+|..
T Consensus 254 ~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~-~~~L~~l~~~~nel------------------------~-yip~~ 305 (1081)
T KOG0618|consen 254 S-NLPEWIGACANLEALNANHNRLV-ALPLRISR-ITSLVSLSAAYNEL------------------------E-YIPPF 305 (1081)
T ss_pred h-cchHHHHhcccceEecccchhHH-hhHHHHhh-hhhHHHHHhhhhhh------------------------h-hCCCc
Confidence 6 45566667777777777777664 34444332 33444444444444 3 33444
Q ss_pred ccccccccEEEeccCccccCCCccccCCCC-cceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccc
Q 001226 501 IGKCSSLRRVILSNNLLQGSLPATLERNPG-VSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENL 579 (1119)
Q Consensus 501 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 579 (1119)
...+++|+.|+|..|+|....+..+..... |..|+.+.|.+.....-.-..++.|+.|+|.+|.++...-..+.+.++|
T Consensus 306 le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hL 385 (1081)
T KOG0618|consen 306 LEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHL 385 (1081)
T ss_pred ccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccce
Confidence 444445555555555544322222222222 4444444444442221111233445555555555555544555555556
Q ss_pred cEEEcccCcccCcCCc-ccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCC
Q 001226 580 QILRLSANKLDGRIPY-ELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658 (1119)
Q Consensus 580 ~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 658 (1119)
+.|+|++|+|. .+|. .+.++..|++|+||+|+|+ .+|..+..+..|++|...+|+|. ..| .+..++.|+.+|++.
T Consensus 386 KVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~ 461 (1081)
T KOG0618|consen 386 KVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSC 461 (1081)
T ss_pred eeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEeccc
Confidence 66666666554 3443 3455555566666666655 45555555555666666555555 444 555555555555555
Q ss_pred cccC
Q 001226 659 NIFD 662 (1119)
Q Consensus 659 N~l~ 662 (1119)
|+++
T Consensus 462 N~L~ 465 (1081)
T KOG0618|consen 462 NNLS 465 (1081)
T ss_pred chhh
Confidence 5443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=340.59 Aligned_cols=239 Identities=25% Similarity=0.345 Sum_probs=195.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||+|.++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999988642 134667999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 9999998654 488999999999999999999999 9999999999999999999999999998753221 1223
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ........ ....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~~----------~~~~---- 213 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM----------EEIR---- 213 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHHHc----------CCCC----
Confidence 3457999999999999999999999999999999999999999642110 00000000 0000
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.+...+.++.+++.+||+.||++|| +++++++|
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0112345678999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=336.62 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=198.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 356678999999999999999999999999998532 2347789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 999999999998654 488899999999999999999999 9999999999999999999999999998865431
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.....|++.|+|||.+.+..++.++||||+||++|||++|+.||...... . .... ......
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~---~~~~----------i~~~~~ 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--G---IYEK----------ILAGKL 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H---HHHH----------HHhCCc
Confidence 22346899999999998888999999999999999999999998643110 0 0000 000111
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.. +......+.+++.+|++.||.+||+ ++|+++|
T Consensus 216 ~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EF----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CC----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 10 1112346789999999999999995 9998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.77 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=200.2
Q ss_pred CCCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeec-
Q 001226 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTK- 898 (1119)
Q Consensus 827 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~- 898 (1119)
.+..+++.. .....||+|++|.||+|.+. ++.||||+++.. .+.+.+|+.++++++||||+++++++.+
T Consensus 14 ~i~~~~i~~-~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 14 CIESDDIDK-YTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred ecCHHHcCC-CCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 344455522 22368999999999999884 789999998643 1346699999999999999999999876
Q ss_pred ---CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 899 ---DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 899 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
....++||||+++|+|.++++..+ .+++..+.+++.+++.|+.|+|+.. +++||||||+||++++++.+|++
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEc
Confidence 346789999999999999998754 4889999999999999999999742 78899999999999999999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+. .....
T Consensus 166 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~---~~~i~ 235 (283)
T PHA02988 166 CHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEI---YDLII 235 (283)
T ss_pred ccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHH---HHHHH
Confidence 99998865432 123467899999998875 6889999999999999999999999974311 111 01000
Q ss_pred cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1054 QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
... .... .+...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 236 ~~~--------~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 236 NKN--------NSLK----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred hcC--------CCCC----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000 0000 111234568899999999999999999999999998754
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=343.54 Aligned_cols=257 Identities=24% Similarity=0.416 Sum_probs=201.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.+|..++.||+|+||.||+|.+.. ++..||+|+++... ..+.+|+.+++.+ +||||+++++++..++..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 467778999999999999998643 33579999986432 3467899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCC-----------------------------------------------------------
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP----------------------------------------------------------- 923 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 923 (1119)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864311
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCccccc
Q 001226 924 --------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995 (1119)
Q Consensus 924 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 995 (1119)
...+++..+.+++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12477888999999999999999999 9999999999999999999999999999765433222222233
Q ss_pred ccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 996 ~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
.++..|+|||++.+..++.++||||+||++|||++ |+.||....... . .... .... ......
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~---~~~~-~~~~------~~~~~~------ 337 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-K---FYKM-VKRG------YQMSRP------ 337 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-H---HHHH-HHcc------cCccCC------
Confidence 45678999999988899999999999999999997 999986432111 0 0000 0000 000000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1075 QLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
...+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112357789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=341.78 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=211.1
Q ss_pred hCCceeeecCCccEEEEEeCCCc----eEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSR----KHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
...++||+|+||+||+|.+--.| .+||||++.. ...++..|+..|..++|||+++++++|..+. ..+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34589999999999999875444 4689998843 3456889999999999999999999998765 789999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|||.|+|.+|++.++. .+-.+..+.|..|||+||.|||++ ++|||||..+||||.+...+||.|||+++......
T Consensus 778 ~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999998764 578889999999999999999999 99999999999999999999999999999887766
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
..........++.|||-|.+....|+.++|||||||++||++| |..||+....++. .+.+...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhcc
Confidence 6666566677889999999999999999999999999999996 9999976422211 1111111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
-+ -..++..+.+++.++.+||..|++.||+++++...+.++-..
T Consensus 917 eR--LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ER--LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cc--CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11 123445677899999999999999999999999999987654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=341.10 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=200.4
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.+|+..+.||+|+||.||+|+++.+++.||+|+++.. ...+.+|+.++++++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 45677789999999999999999999999999988532 23577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999998754 478889999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. .....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...+ ... ...
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~~~-~~i----------~~~ 230 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FRIY-EKI----------LAG 230 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HHHH-HHH----------hcC
Confidence 2 1234689999999999998899999999999999999999999864211 0000 000 001
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.... +...+..+.+++.+||+.||++||+ ++++++|
T Consensus 231 ~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 RLKF----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CcCC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1110 0012345789999999999999997 7888876
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=346.15 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=206.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcC-CCCEEEEeeee-ec---C---Cce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVR-HRNILRIVGSC-TK---D---EHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~-~~---~---~~~ 902 (1119)
++++.++|.+|||+.||.|.+...|..||+|++-.. -..+.+||.+|+.++ |+|||.+++.. .. . -.+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 345568899999999999999998899999988432 234788999999998 99999999932 21 1 246
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++.||||+||.|-|++..+.... +++.++++|+.|+++|+++||.. +++|||||||-+|||++.++..||||||.|.-
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 89999999999999999766443 99999999999999999999976 67899999999999999999999999999875
Q ss_pred ccCCCCCC-------cccccccCCCccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh
Q 001226 983 ISDSHSSS-------TRSAIVGSLGYIAPENA---YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 983 ~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
........ ..-....|+.|+|||.+ .+..+++|+||||+||++|-|+....||+... .
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----~-------- 263 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----K-------- 263 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----c--------
Confidence 43322111 01123689999999965 46678999999999999999999999997431 1
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..+++..+.+ .....+...+.+||..||+++|++||++.+|+..+.++..+.
T Consensus 264 -------laIlng~Y~~--P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 264 -------LAILNGNYSF--PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred -------eeEEeccccC--CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1222322222 122467788999999999999999999999999999987764
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=300.46 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=205.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------c------ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------E------TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|...+.+|+|..++|-++.++.+++.+|+|++... + +....|+.+++++ .||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3566778899999999999999999999999988421 1 2345689999987 5999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..++|+|.|+.|.|+||+...- .+++++..+|++|+.+|++|||.. .|||||+||+||+++++.++||+|||+|
T Consensus 97 F~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecccee
Confidence 9999999999999999998754 599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAY------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
+.+..+ ......+|||+|+|||.+. ...|+..+|+||+||++|-++.|..||+.. .+..
T Consensus 171 ~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR------------kQml 235 (411)
T KOG0599|consen 171 CQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR------------KQML 235 (411)
T ss_pred eccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH------------HHHH
Confidence 987553 3445578999999999764 345788999999999999999999999631 1110
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. +..++.....+...+....+....+++.+|++.||.+|.|++|.++|
T Consensus 236 M---LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 236 M---LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred H---HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 0 11223333433333445566778999999999999999999999976
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.46 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=201.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||.||++.+..++..||+|+++.. ...+.+|+++++.++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 566678899999999999999999999999988543 245788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++.... .+++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 86 DGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 9999999998654 3889999999999999999999863 6999999999999999999999999998765432
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh-cccc-----------
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-QENH----------- 1057 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~----------- 1057 (1119)
......|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ......... ....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccc
Confidence 2233468999999999998899999999999999999999999996432110 000000000 0000
Q ss_pred ----c-------------cccccccccc--CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1058 ----E-------------CICFLDREIS--FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1058 ----~-------------~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
. .....+.... ...........++.+++.+||+.||++|||++|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000000000 00000112345789999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=302.16 Aligned_cols=246 Identities=24% Similarity=0.360 Sum_probs=198.0
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecc------cccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|...++||+|+|+.||++.++.+|+.+|+|.++ .+.+++++|+++-+.++|||||++.+.+.+++..|+|+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 344467999999999999999999999999774 24466889999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccccCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~~~~ 986 (1119)
.|++|..-+-.+ ...++..+-..++||.+++.|.|.+ +|||||+||+|+++-+ ..-+|++|||+|....+
T Consensus 93 ~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 93 TGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred cchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 999986444332 3477888889999999999999999 9999999999999954 34589999999998863
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
...-..++|||+|||||++...+|+.++|||+.||++|-++.|+.||++. +.. ....... ...+|-.
T Consensus 166 --g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~--rlye~I~------~g~yd~~ 232 (355)
T KOG0033|consen 166 --GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQH--RLYEQIK------AGAYDYP 232 (355)
T ss_pred --ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHH--HHHHHHh------ccccCCC
Confidence 33445678999999999999999999999999999999999999999752 111 1111111 1112222
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
-+.|. ..+....+++++|+..||.+|.|+.|.+.|
T Consensus 233 ~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcccC----cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 22232 234456899999999999999999998765
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=326.46 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=205.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc-----eEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR-----KHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+++..+.||+|+||.||+|.....+ ..||+|.++... ..+.+|+..++.++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 45566788999999999999876544 679999886432 34788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 001226 904 IVTEYMPGGTLFNVLHQNEPR-------------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL 970 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 970 (1119)
++|||+++++|.+++...... ..+++..+..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 999999999999999764321 3478889999999999999999999 999999999999999999
Q ss_pred ceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehh
Q 001226 971 EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWT 1049 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1049 (1119)
.++|+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |..||...... +....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~- 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEM- 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH-
Confidence 999999999986544333333344567889999999988899999999999999999998 99998653211 11000
Q ss_pred hhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
. ..+... ..+...+.++.+++.+||+.+|++||+++||+++|+++
T Consensus 239 ---i---------~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 ---I---------RSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---H---------HcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 0 000000 11223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.23 Aligned_cols=263 Identities=19% Similarity=0.223 Sum_probs=198.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||+|+++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 456678999999999999999999999999988532 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++++.+..+.... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 154 (287)
T cd07848 82 VEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS- 154 (287)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence 9987776554332 2488999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh---------hhhc-cccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR---------WKLQ-ENHE 1058 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~-~~~~ 1058 (1119)
........+++.|+|||++.+..++.++||||+||++|||++|+.||......+. ...... +... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccch
Confidence 1222345689999999999888899999999999999999999999965321110 000000 0000 0000
Q ss_pred ccccccccccCCCc----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWDS----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+....... .....+..+.+++.+|++.||++|||++|+++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 001234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=323.35 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=200.3
Q ss_pred HHhhCCceeeecCCccEEEEEeC---CCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.++ ..+..||+|.++... ..+.+|+..++.++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45677789999999999999865 346789999986432 3577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999986542 488999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.. ........++..|+|||.+.+..++.++||||+||++||+++ |+.||...... . ..... ....
T Consensus 160 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~---~~~~~-~~~~------- 225 (266)
T cd05064 160 EA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--D---VIKAV-EDGF------- 225 (266)
T ss_pred cc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--H---HHHHH-HCCC-------
Confidence 11 111122345678999999988999999999999999999775 99998643211 0 00000 0000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.. ..+...+..+.+++.+||+.+|++||++++|.+.|+++
T Consensus 226 -~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -RL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 01122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=339.08 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=199.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+... ..+.+|+.++++++||||+++++++..+...++|+|++. ++|
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 46677899999999999999999999999997643 457889999999999999999999999999999999995 788
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ......
T Consensus 170 ~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~ 242 (391)
T PHA03212 170 YCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYG 242 (391)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccccc
Confidence 88887654 488999999999999999999999 99999999999999999999999999997543221 122234
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce------eehhhhh--------hccccccc
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI------VTWTRWK--------LQENHECI 1060 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~------~~~~~~~--------~~~~~~~~ 1060 (1119)
..||+.|+|||++.+..++.++||||+||++|||++|+.||....+.+... ....... ........
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 579999999999988899999999999999999999998875432211110 0000000 00000000
Q ss_pred ccc----c---cc--ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFL----D---RE--ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~----~---~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+ . .. .+.........+.++.+++.+||+.||++|||++|++++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0 00 000001112345578899999999999999999999964
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.69 Aligned_cols=244 Identities=23% Similarity=0.332 Sum_probs=199.3
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCc-eEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSR-KHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
++.+|+..+.||+|+||.||+|.++.++ ..||+|++... ...+.+|+.+++.++||||+++++++.+++..|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4567888899999999999999876654 68999988432 234678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999998765 488999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+.. . .
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~-i----------~ 241 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQK-I----------L 241 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHH-H----------h
Confidence 331 2345689999999999888899999999999999999999999964311 000000 0 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
...... +...+..+.+++.+|++.+|++|+ +++++++|
T Consensus 242 ~~~~~~----p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 EGIIYF----PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred cCCCCC----CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 000000 111234568999999999999995 89999876
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=335.10 Aligned_cols=239 Identities=26% Similarity=0.358 Sum_probs=195.4
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||++.+..+++.||+|++++. ...+.+|+++++.++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998532 234677999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 9999987654 488999999999999999999999 9999999999999999999999999998753221 1122
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ......... +..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~--------~~~~----- 214 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME--------DIKF----- 214 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC--------CccC-----
Confidence 3456899999999999889999999999999999999999999643110 000000000 0001
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
+...+.++.+++.+|++.||++|| +++|++++
T Consensus 215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 -PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112234678999999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=334.72 Aligned_cols=239 Identities=25% Similarity=0.357 Sum_probs=194.7
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||++.+..+++.||+|+++.. ...+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998542 234567999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 152 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCcc
Confidence 9999887654 488999999999999999999999 9999999999999999999999999998753221 1122
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .. . ... ......
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~--~-~~~----------~~~~~~---- 213 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL--F-ELI----------LMEEIR---- 213 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HH--H-HHH----------hcCCCC----
Confidence 3456899999999999889999999999999999999999998643111 00 0 000 000000
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.+...+..+.+++.+||+.||++|| ++++++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0112245678999999999999998 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=333.03 Aligned_cols=237 Identities=24% Similarity=0.333 Sum_probs=192.6
Q ss_pred eeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999988532 23466799999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 99997654 488999999999999999999999 99999999999999999999999999987543221 12234
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........ ...... +
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~----------~~~~~~----~ 213 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKIL----------QEPLRF----P 213 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHH----------cCCCCC----C
Confidence 5789999999999998999999999999999999999999964211 11111111 011111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPS---MREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs---~~ell~~ 1105 (1119)
...+..+.+++.+||+.||++||+ ++|++.|
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 123346789999999999999975 6677654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=336.93 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=201.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|++..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 356678999999999999999999999999998532 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999997654 488899999999999999999999 999999999999999999999999999976533
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ......+.. .+...
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~--------~~~~~- 220 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKE--------TLQRP- 220 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhccc--------cccCC-
Confidence 22345689999999999988999999999999999999999999964321110 000000000 00000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.........+.++.+++.+|++.+|++||++++++++
T Consensus 221 -~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 -VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000011234577899999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=329.03 Aligned_cols=248 Identities=26% Similarity=0.359 Sum_probs=209.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCc-eEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEH-GFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 906 (1119)
..|...+++|+|+||.++.++++..+..|++|.+.- .......|+.++.+++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 456667899999999999999999999999998842 22356789999999999999999999999988 89999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
+|++||++.+.+.+.+ ...++++.+.+|+.|++.|+.|||+. .|+|||||+.||+++.++.||++|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998876 34689999999999999999999988 9999999999999999999999999999988654
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. ......+||+.|++||.+.+.+|..++||||+||++|||++-+.+|..... .. ...... ...+
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--~~---Li~ki~------~~~~--- 223 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--SE---LILKIN------RGLY--- 223 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--HH---HHHHHh------hccC---
Confidence 3 244567999999999999999999999999999999999999999975311 11 110000 0011
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+..+..++..++..|++.+|+.||++.+++.+
T Consensus 224 ----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 ----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12234456788999999999999999999999976
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=329.26 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=209.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 905 (1119)
..|+.++.||+|.||.||+++.+.+|+.+|+|++.+.. ..+.+|+.+|+.+. |||||.+.++|++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 46777899999999999999999999999999985432 47889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC----CceEEEeccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE----LEPKIGDFGMSK 981 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~vkl~DfGla~ 981 (1119)
||++.||.|.+.+... .+++..+..++.|++.+++|+|+. ||+|||+||+|+++... +.+|++|||++.
T Consensus 115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999876 289999999999999999999998 99999999999999644 479999999999
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.... .......+||+.|+|||++....|+.++||||+||++|.|++|..||.......... .
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------------~ 249 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------------A 249 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---------------H
Confidence 8755 345566799999999999999999999999999999999999999997542211111 1
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+....+.+........+..+.+++..|+..||.+|+|+.++++|
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12222222222233446678899999999999999999999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=338.34 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=202.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC-----ceEEEEEecccc-----cccHHHHHHHHhhcC-CCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRS-----ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 902 (1119)
.+|+.+++||+|+||.||+|.+... +..||||+++.. .+.+.+|+.+++.+. ||||+++++++.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 3667789999999999999986432 346999998532 235778999999996 99999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCC-----------------------------------------------------------
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP----------------------------------------------------------- 923 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 923 (1119)
|+||||+++|+|.++++....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 999999999999999865321
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 001226 924 ----------------------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969 (1119)
Q Consensus 924 ----------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 969 (1119)
...+++..+..++.|+++|++|||+. +|+||||||+||+++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence 12377888899999999999999998 99999999999999999
Q ss_pred CceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeeh
Q 001226 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 970 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 1048 (1119)
+.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......... +
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---~ 350 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---Y 350 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---H
Confidence 9999999999986644322222333457788999999988889999999999999999996 99998643211110 0
Q ss_pred hhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
. ..... ... ..+...+.++.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 351 ~--~~~~~----------~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 N--KIKSG----------YRM--AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H--HHhcC----------CCC--CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 00000 000 0111234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.96 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=196.7
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
+.||+|+||.||+|.+..+++.||+|.+... ...+.+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999999988999999987532 24578899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+|++|||++..............
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999976442 478999999999999999999999 999999999999999999999999999876543221111122
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCch
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1119)
...+..|+|||.+.++.++.++||||+||++|||++ |..||....... ..... ....... .
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~----------~~~~~~~--~ 217 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAI----------EQGVRLP--C 217 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHH----------HcCCCCC--C
Confidence 234567999999988889999999999999999997 888886431110 00000 0000000 0
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1074 DQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1074 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
+...+..+.+++.+|++.+|++|||++++.+.|++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 11224578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=331.55 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=201.5
Q ss_pred HhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeec-CCce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTK-DEHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~~ 902 (1119)
+|...++||+|+||.||+|.... +++.||+|+++... ..+..|+.+++++ +|+||+++++++.. +...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 67778999999999999997543 35789999986422 2456799999999 79999999998865 4567
Q ss_pred EEEEeccCCCCHHHhhccCCC----------------------------------------------------------C
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP----------------------------------------------------------R 924 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------~ 924 (1119)
++||||+++++|.+++..... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 899999999999999864321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccc
Q 001226 925 LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004 (1119)
Q Consensus 925 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 1004 (1119)
..+++..+.+++.||+.|++|||+. +|+||||||+||+++.++.++|+|||+++...............++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2578999999999999999999999 9999999999999999999999999999876443322233344567789999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHH
Q 001226 1005 ENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLE 1083 (1119)
Q Consensus 1005 E~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1083 (1119)
|++.+..++.++||||+||++|||++ |+.||......+. +... .... ... ..+...+.++.+
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~~-~~~~----------~~~--~~~~~~~~~~~~ 307 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCRR-LKEG----------TRM--RAPEYATPEIYS 307 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHHH-Hhcc----------CCC--CCCccCCHHHHH
Confidence 99999999999999999999999997 9999864321110 0000 0000 000 001122356789
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1084 LALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1084 l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
++.+||+.+|++||+++|++++|+++.+.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.92 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=203.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+++..+.||+|+||.||+|.++.+++.||+|+++... .++.+|++++++++||||+++++++..++..++||||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 4566788999999999999999889999999986543 3577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++..... ..+++..+..++.|+++|++|||+. +++||||||+||++++++.+|++|||.+........ ..
T Consensus 87 ~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~ 161 (263)
T cd05052 87 GNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA 161 (263)
T ss_pred CcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence 999999976542 3588999999999999999999998 999999999999999999999999999986644221 11
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....++..|+|||...+..++.++|||||||++|||++ |..||.....+ .. +.. .... ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~--~~~--~~~~------~~~----- 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QV--YEL--LEKG------YRM----- 224 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH--HHH--HHCC------CCC-----
Confidence 122334678999999988899999999999999999998 89888642111 00 000 0000 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=328.22 Aligned_cols=196 Identities=28% Similarity=0.422 Sum_probs=172.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..++||+|+||.||+|.+..++..||+|.+... ...+.+|+++++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 3577778999999999999999999999999987543 23578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++...+ .+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.+|++|||++......
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 85 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 99999999998654 3788899999999999999999752 7999999999999999999999999998765332
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
......++..|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346889999999998888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=334.79 Aligned_cols=264 Identities=24% Similarity=0.286 Sum_probs=194.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 903 (1119)
+|+..++||+|+||.||+|.+..+++.||||+++.. ...+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 366778999999999999999999999999987532 23477899999999999999999987543 2479
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++ ++|.+++.... .+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68999887654 388999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCC-CCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc-----------eeehh
Q 001226 984 SDSHS-SSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD-----------IVTWT 1049 (1119)
Q Consensus 984 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~-----------~~~~~ 1049 (1119)
..... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ...+.
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 112234578999999998765 67899999999999999999999998643210000 00000
Q ss_pred hhhhcccccccccccccccCCC-chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1050 RWKLQENHECICFLDREISFWD-SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+.+...... .........+.+++.+||+.+|++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000000000000 0001123467899999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.31 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=202.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCce----EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRK----HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+|+..+.||+|+||.||+|.+..++. .||+|+++.. ..++.+|+.+++.++||||+++++++..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 356777899999999999998765544 4899998532 23577899999999999999999998765 5679
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|+||+++|+|.+++..... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999987643 478899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... . +.... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~---~~~~~-~~~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E---ISSIL-EKG------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H---HHHHH-hCC-------
Confidence 4322222222335678999999999999999999999999999997 99998643111 0 10000 000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.... .+...+.++.+++.+||+.+|++||++.++++.+.++..+..
T Consensus 228 -~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 228 -ERLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -CCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 0000 011123467899999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=345.98 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=200.4
Q ss_pred hhCCceeeecCCccEEEEEeCCC-ceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNS-RKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~-~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|...+.||+|+||.||+|....+ ++.||+|++... ...+.+|+.+++.++||||+++++++..++..|+||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 66678999999999999998777 788999976432 2346779999999999999999999999999999999999
Q ss_pred CCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 911 GGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 911 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+|+|.++++.. .....+++..+..++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988653 2233588999999999999999999999 9999999999999999999999999999876543322
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... . ...... ......
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~---~~~~~~----------~~~~~~- 289 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--R---EIMQQV----------LYGKYD- 289 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHH----------HhCCCC-
Confidence 333456799999999999988999999999999999999999999864211 0 000000 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.+|++||++++++++
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0011234568899999999999999999998754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=316.79 Aligned_cols=248 Identities=25% Similarity=0.440 Sum_probs=198.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+++..+.||+|+||.||+|..+. +..+|+|.++.. ..++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 456677899999999999998865 567999987543 3568889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.++++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++....... .
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 9999999976542 488999999999999999999999 999999999999999999999999999886543221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||+|+++|||++ |+.||...... .. ....... .. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~---~~~i~~~-~~---~------- 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EV---VEMISRG-FR---L------- 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HH---HHHHHCC-CC---C-------
Confidence 1222345678999999988889999999999999999999 89998643111 00 0100000 00 0
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
..+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 221 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 --YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00111234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.23 Aligned_cols=263 Identities=22% Similarity=0.240 Sum_probs=196.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..+.||+|+||.||+|.++.+++.||+|+++... ..+.+|+.+++.++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 35667789999999999999999889999999985322 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++ +++.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 156 (303)
T cd07869 85 VH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-- 156 (303)
T ss_pred CC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence 95 688888776532 478889999999999999999999 9999999999999999999999999998754321
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc--------ccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN--------HEC 1059 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~ 1059 (1119)
........+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||............. ....... ...
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI-FLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH-HHHhCCCChhhccchhhc
Confidence 122234568899999998765 457889999999999999999999997532111100000 0000000 000
Q ss_pred cccccccccCCCchH-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDD-------QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............... ......+.+++.+|++.||++|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000000000000 0112457799999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=336.78 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=199.3
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
..+|+..+.||+|+||.||+|.+..+++.||+|++++. ...+.+|+.+++.++||||+++++++.++...|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45677889999999999999999999999999998532 23366899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998754 377888899999999999999999 999999999999999999999999999986543
Q ss_pred CCCCCcccccccCCCcccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYST----RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.. ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+..
T Consensus 195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~----------- 258 (370)
T cd05596 195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSK----------- 258 (370)
T ss_pred CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHHH-----------
Confidence 21 1122345799999999987643 4789999999999999999999999743110 00100
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~ 1105 (1119)
.++.............+..+.+++.+|++.+|++ ||+++|+++|
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0010000000111123457789999999999998 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.01 Aligned_cols=364 Identities=27% Similarity=0.395 Sum_probs=221.1
Q ss_pred CCcEEEccccccc-cccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeec
Q 001226 313 QLQVIALSRNNLV-GQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL 391 (1119)
Q Consensus 313 ~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L 391 (1119)
-.+-+|+++|.++ +..|.....+++++.|.|...++. .+|+.++.|.+|++|.++||++. .+-..+..++.|+.+.+
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 3444566666665 345666666666666666666665 56666666666666666666665 33445556666666666
Q ss_pred cCccccC-CCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceee
Q 001226 392 FNNRIEG-AIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470 (1119)
Q Consensus 392 ~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1119)
.+|++.. -+|..+-.+..|+.||||+|+++ +.|..+..-+++-+|+||+|+|. .+|..++-+
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfin--------------- 148 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFIN--------------- 148 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHh---------------
Confidence 6666642 23444555666666666666666 56666666666666666666665 455544444
Q ss_pred CccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccC-CCCCccc
Q 001226 471 GPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQ-GSIPPVF 549 (1119)
Q Consensus 471 ~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~ 549 (1119)
++.|-.||||+|++. .+|..+..+..|+.|.|++|++.-.--..+..+++|+.|.+++.+-+ .-+|.++
T Consensus 149 ---------LtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl 218 (1255)
T KOG0444|consen 149 ---------LTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL 218 (1255)
T ss_pred ---------hHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch
Confidence 444555555555554 55556666666666666666654332233444555555555554422 2466667
Q ss_pred cccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCe
Q 001226 550 GFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQS 629 (1119)
Q Consensus 550 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 629 (1119)
..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+ .+....+...+|++|+||+|+++ .+|+.+..|++|+.
T Consensus 219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k 295 (1255)
T KOG0444|consen 219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK 295 (1255)
T ss_pred hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence 77777777777777776 67777777777777777777776 55555666667777777777776 57777777777777
Q ss_pred eEccCccCc-cCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCc
Q 001226 630 LSLQENNLS-GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSN 708 (1119)
Q Consensus 630 L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 708 (1119)
|++.+|+|+ .-||+.++++.+|+.+..++|.+. -+|+.++.+..|+.|.|++|
T Consensus 296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE--------------------------lVPEglcRC~kL~kL~L~~N 349 (1255)
T KOG0444|consen 296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE--------------------------LVPEGLCRCVKLQKLKLDHN 349 (1255)
T ss_pred HHhccCcccccCCccchhhhhhhHHHHhhccccc--------------------------cCchhhhhhHHHHHhccccc
Confidence 777777766 235666777766666555555554 44555555555555555555
Q ss_pred eecccCCccccccccceEEeccccccc
Q 001226 709 SFSGEIPTEVNNMVSLYFVNISFNHFS 735 (1119)
Q Consensus 709 ~l~g~ip~~~~~~~~l~~l~ls~N~~~ 735 (1119)
++- ++|+.|.-++.|..||+..|+--
T Consensus 350 rLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 350 RLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred cee-echhhhhhcCCcceeeccCCcCc
Confidence 554 44555555555555555555433
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=321.78 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=195.1
Q ss_pred eeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||+|+||+||++.++.+++.||+|++.... ..+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999999999999999985321 3456799999999999999999999999999999999999999
Q ss_pred HHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCccc
Q 001226 915 FNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS 993 (1119)
Q Consensus 915 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~ 993 (1119)
.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98875432 223589999999999999999999999 999999999999999999999999999976543221 223
Q ss_pred ccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCch
Q 001226 994 AIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073 (1119)
Q Consensus 994 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1119)
...||+.|+|||.+.+..++.++||||+||++|||++|+.||......... ..... ....... ..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~----------~~~~~~~----~~ 220 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQ----------RILNDSV----TY 220 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHH----------hhcccCC----CC
Confidence 356899999999999999999999999999999999999999643211110 00000 0001111 11
Q ss_pred HHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1074 DQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1074 ~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
+...+..+.+++.+|++.||++|| +++++++|
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 122345678999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=332.80 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=191.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..++||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4455668899999999999999988999999998533 23577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+.. ..++..+..++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986432 245677889999999999999999 99999999999999999999999999998664321
Q ss_pred CCcccccccCCCcccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.......||..|+|||.+.. ...+.++|||||||++|||++|+.||..... .+ |........ .
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~---~~~~~~~~~------~ 290 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GD---WASLMCAIC------M 290 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--cc---HHHHHHHHh------c
Confidence 12234578999999997643 2345689999999999999999999973211 11 111000000 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .........++.+++.+||+.||++||+++|++++
T Consensus 291 ~~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQP----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111234568899999999999999999999987
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.83 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=199.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.++. ++..||+|+++... .++.+|+.+++.++||||+++++++.++...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 467778999999999999998653 35679999885422 34778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP-------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
+||||+++++|.+++..... ....++..+..++.|++.|++|||+. +++||||||+||++++++.++++|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 99999999999999875332 12467888999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||...... ........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~~~~~~~~- 236 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----QVLRFVME- 236 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHc-
Confidence 999876544332222223455788999999988889999999999999999998 68887543111 11111000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
.... ..+...+..+.+++.+|++.+|++|||+.|+++++++
T Consensus 237 ---------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 ---------GGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0000 0011123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=328.98 Aligned_cols=238 Identities=27% Similarity=0.396 Sum_probs=189.1
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhh-cCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSL-VRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|.+..+++.||+|+++... .....|..++.. .+||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999886421 233456666654 4799999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99999987654 388999999999999999999998 99999999999999999999999999997543222 22
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .. ........ .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--~~---~~~~i~~~--------~~~~---- 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--DE---LFDSILND--------RPHF---- 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHcC--------CCCC----
Confidence 3345789999999999988899999999999999999999999964311 00 00000000 0001
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMR-EVVG 1104 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ell~ 1104 (1119)
+...+.++.+++.+||+.+|++||++. ++++
T Consensus 216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 --PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111234668999999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=336.45 Aligned_cols=367 Identities=30% Similarity=0.378 Sum_probs=225.6
Q ss_pred CCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEE
Q 001226 238 CRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVI 317 (1119)
Q Consensus 238 l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 317 (1119)
++-.+-.++++|.++|.-.|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++.. +-+.++.++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHH
Confidence 3445667888888888777888888888888888888888 788888888888888888888873 34456666666666
Q ss_pred Ecccccccc-ccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccc
Q 001226 318 ALSRNNLVG-QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRI 396 (1119)
Q Consensus 318 ~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l 396 (1119)
++.+|++.. -+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|.
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie----------------------- 139 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE----------------------- 139 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-----------------------
Confidence 666666652 24445555555555555555555 44545555555555555555554
Q ss_pred cCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceee-CccCC
Q 001226 397 EGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY-GPIPA 475 (1119)
Q Consensus 397 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~ 475 (1119)
.++...|.+++.|-.||||+|++. ..|+.+.++..|++|.|++|.+... ...-...+.+|+.|.+++.+=+ .-+|.
T Consensus 140 -tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hf-QLrQLPsmtsL~vLhms~TqRTl~N~Pt 216 (1255)
T KOG0444|consen 140 -TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHF-QLRQLPSMTSLSVLHMSNTQRTLDNIPT 216 (1255)
T ss_pred -cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHH-HHhcCccchhhhhhhcccccchhhcCCC
Confidence 333333444444444444444444 3444455555555555555544310 0000011223333333332211 13455
Q ss_pred ccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccc
Q 001226 476 NICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNL 555 (1119)
Q Consensus 476 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 555 (1119)
++..+.||..+|+|.|.+. .+|..+-++.+|++|+||+|+|+ ++....+.|.+|
T Consensus 217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-------------------------eL~~~~~~W~~l 270 (1255)
T KOG0444|consen 217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-------------------------ELNMTEGEWENL 270 (1255)
T ss_pred chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-------------------------eeeccHHHHhhh
Confidence 5555555555555555555 45555555555555555555554 344455666777
Q ss_pred eEEeccCCcccCCCCCccCCcccccEEEcccCccc-CcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccC
Q 001226 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLD-GRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634 (1119)
Q Consensus 556 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 634 (1119)
++|+||+|+++ .+|+.++.|+.|+.|.+.+|+++ .-+|..++++.+|+.+..++|.+. .+|+.++.+..|+.|.|++
T Consensus 271 EtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~ 348 (1255)
T KOG0444|consen 271 ETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDH 348 (1255)
T ss_pred hhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccc
Confidence 77777777776 67777777777777777777764 236777777777777777777776 6777777777777777777
Q ss_pred ccCccCCCccccccccccEeecCCcccC
Q 001226 635 NNLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 635 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
|+|. ++|+++.-++-|+.|||..|.-.
T Consensus 349 NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 349 NRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred ccee-echhhhhhcCCcceeeccCCcCc
Confidence 7776 67777777777777777777654
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=320.89 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=200.6
Q ss_pred HHhhCCceeeecCCccEEEEEeC----CCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN----NSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+++..+.||+|+||.||+|... ..+..||+|.++... ..+.+|+.++++++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 44566788999999999999853 346789999986422 357789999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 001226 905 VTEYMPGGTLFNVLHQNEP--------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL 970 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 970 (1119)
||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999864321 23478889999999999999999999 999999999999999999
Q ss_pred ceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehh
Q 001226 971 EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWT 1049 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1049 (1119)
.+|++|||+++...............++..|+|||+..+..++.++||||+||++|||++ |..||..... .......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence 999999999986644332223334456778999999988889999999999999999998 8888864211 0100000
Q ss_pred hhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
. ... ... .+...+..+.+++.+|++.+|++||++.+|.++|++.
T Consensus 240 ~----~~~--------~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 240 R----KRQ--------LLP----CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred H----cCC--------cCC----CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 0 000 000 0111234678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=328.08 Aligned_cols=245 Identities=23% Similarity=0.350 Sum_probs=194.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||.||+|.+..+++.||+|++++. ...+.+|..+++.+ +||||+++++++.++...|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999998642 12366788888888 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++...+ .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDT 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCc
Confidence 99999887654 489999999999999999999999 999999999999999999999999999874321 1122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC---ceeehhhhhhccccccccccccccc
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT---DIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+. ....+... ........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------VILEKQIR 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------HHHcCCCC
Confidence 3345789999999999999999999999999999999999999974321111 00011000 00111111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPS------MREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ell~~ 1105 (1119)
. +...+..+.+++.+|++.||.+||+ ++++++|
T Consensus 224 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 224 I----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0 1112346789999999999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=337.29 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=194.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||+|+||+||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 45568899999999999999999999999998532 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++.......
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999998754 488889999999999999999998 999999999999999999999999999754311000
Q ss_pred ---------------------------------------------CCcccccccCCCcccccccCCCCCCCcchHHHHHH
Q 001226 989 ---------------------------------------------SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGV 1023 (1119)
Q Consensus 989 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~ 1023 (1119)
........||+.|+|||.+.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012347999999999998888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHH--ccccCCCCCCCHHH
Q 001226 1024 ILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALE--CTRQVADMRPSMRE 1101 (1119)
Q Consensus 1024 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs~~e 1101 (1119)
++|||++|+.||.......... ....+ ...... ......+.++.+++.+ |+..+|..||+++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~~-~i~~~------------~~~~~~--~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL-KVINW------------ENTLHI--PPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH-HHHcc------------ccccCC--CCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 9999999999997532111100 00000 000000 0001123456788877 55666667999999
Q ss_pred HHHH
Q 001226 1102 VVGF 1105 (1119)
Q Consensus 1102 ll~~ 1105 (1119)
+++|
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=329.60 Aligned_cols=239 Identities=27% Similarity=0.366 Sum_probs=192.0
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|+++.+++.||+|++++. ...+..|..+++.. +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998532 12355677788766 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 99999987654 488999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ....... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~----------~~~~~--- 214 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAIL----------NDEVV--- 214 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHh----------cCCCC---
Confidence 33457899999999999889999999999999999999999999643110 0011110 00000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSM------REVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ell~~ 1105 (1119)
.+...+.++.+++.+|++.||++||++ +++++|
T Consensus 215 -~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 -YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 011123467899999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=302.86 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=207.9
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
.+..++|+|.||.||+|.++.+|+.||||++.. +-+++..|+.+|++++.|+||+++|.+......++|||||..|+.
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 344789999999999999999999999999854 446788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+.++.+.. ++++.++..+.+.-++|++|||.. .-+|||||+.||+++.+|.+|++|||.|..+.+.. ..+..
T Consensus 116 SDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNT 188 (502)
T KOG0574|consen 116 SDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNT 188 (502)
T ss_pred HHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCc
Confidence 999987653 699999999999999999999998 88999999999999999999999999998776522 23456
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..||+.|||||++..-.|..++||||+|++..||..|+.||....+- +.+.- +.-..+.-+..+
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-RAIFM---------------IPT~PPPTF~KP 252 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-RAIFM---------------IPTKPPPTFKKP 252 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-ceeEe---------------ccCCCCCCCCCh
Confidence 78999999999999989999999999999999999999998753221 11111 000111111234
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..-+.++.++++.|+-..|++|.|+.++.+|
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4456788999999999999999999999887
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.83 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=193.4
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|.+..+++.||+|++++.. ..+.+|+.++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999986421 2356788888766 799999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~ 152 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT 152 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence 99999887654 489999999999999999999999 9999999999999999999999999998753221 112
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...............+.. ..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~------~~i~~~~~~~-- 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF------QVILEKQIRI-- 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH------HHHhcCCCCC--
Confidence 23457899999999999999999999999999999999999999643211111100000000 0000111111
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPS------MREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ell~~ 1105 (1119)
+...+..+.+++.+||+.||++||+ ++++++|
T Consensus 225 --p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 --PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1122346789999999999999998 5677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=325.76 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=203.2
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
-++|+|.||+||-|++.++...+|||.+.. ..+...+|+..-+.++|.|||+++|.+.+++..-+.||-+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 479999999999999999999999998853 3345788999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCceEEEeccccccccCCCCCCcccc
Q 001226 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 916 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
+.++..=....-.+.++..+.+||.+|+.|||+. .|||||||-+||+++ -.|.+||+|||-++..... ......
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 9998754333347788889999999999999999 999999999999996 4689999999999877543 334456
Q ss_pred cccCCCcccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 995 IVGSLGYIAPENAYST--RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
+.||..|||||++..+ .|+.++|||||||++.||.||++||............... +..-+.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGm----------------yKvHP~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGM----------------YKVHPP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcc----------------eecCCC
Confidence 7899999999998765 4889999999999999999999999765333222221111 112223
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
.+...+.++..++.+|+.+||..||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 45566778899999999999999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=334.45 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=197.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++.+ ....+.+|+.+++.++||||+++++++.++...|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 467778999999999999999999999999998853 1234678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 123 EYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 999999999999754 378889999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCCcccccccCCCcccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYST----RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. ........||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+. ..
T Consensus 196 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~----~~~~-----------~i 259 (370)
T cd05621 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV----GTYS-----------KI 259 (370)
T ss_pred C-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH----HHHH-----------HH
Confidence 2 1122345799999999987653 3788999999999999999999999643110 0010 01
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~ 1105 (1119)
++.............+..+.+++.+|++.+|.+ ||+++|+++|
T Consensus 260 ~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 110000000111223456778899999865554 8999999998
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=334.24 Aligned_cols=197 Identities=26% Similarity=0.416 Sum_probs=172.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||+||+|.+..+++.||+|++++. ...+.+|+.+++.++||+|+++++.+.++...|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 356678999999999999999999999999998542 1346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 82 FLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999999998754 489999999999999999999999 99999999999999999999999999987543211
Q ss_pred CC---------------------------------CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 001226 988 SS---------------------------------STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034 (1119)
Q Consensus 988 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 1034 (1119)
.. ......+||+.|+|||.+.+..++.++||||+||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001235799999999999988999999999999999999999999
Q ss_pred CCC
Q 001226 1035 VDP 1037 (1119)
Q Consensus 1035 ~~~ 1037 (1119)
|..
T Consensus 236 f~~ 238 (363)
T cd05628 236 FCS 238 (363)
T ss_pred CCC
Confidence 964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.55 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=202.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC---ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|....+ ...||||..+.. ..++.+|+..++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 3567789999999999999988643 457999988543 23567899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++..... .+++..+.+++.|++.|++|||+. +|+||||||+||++++++.++++|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999987543 588999999999999999999998 999999999999999999999999999987752
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........++..|+|||...+..++.++||||+|+++|||++ |..||...... .. ..... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~---~~~~~-~~~------- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DV---IKAVE-DGY------- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HH---HHHHH-cCC-------
Confidence 222222223345678999999988889999999999999999997 99998543111 00 00000 000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.. ..+...+..+.+++.+|++.+|++||+++||+++|+++
T Consensus 226 ---~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 00112345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=332.45 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=194.0
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||++.+..+++.||+|+++.. ...+.+|+++++.++||||+++.+++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999999999999999998542 234567889999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
+|.+++.... .+++..+..++.|++.|++|||+ . +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9999887654 48999999999999999999997 6 99999999999999999999999999987532211 12
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.....+ ........ .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~----------~~~~~-- 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILM----------EEIRF-- 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhc----------CCCCC--
Confidence 23356899999999999889999999999999999999999999643111 00000000 00000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
+...+.++.+++.+|++.||++|+ ++++++++
T Consensus 216 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 --PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111234678999999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.88 Aligned_cols=239 Identities=23% Similarity=0.374 Sum_probs=192.5
Q ss_pred ceeeecCCccEEEEEeC---CCceEEEEEecccc--------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 840 RIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+.||+|+||.||+++.. .+++.||+|+++.. ...+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999863 46789999988532 13456899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999997654 378888999999999999999999 99999999999999999999999999987543211
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .... ........
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~----------~~~~~~~~ 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTID----------KILKGKLN 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHH----------HHHcCCCC
Confidence 1223356899999999998888999999999999999999999999643110 0000 00011111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
. +...+..+.+++.+|++.+|++|| ++++++++
T Consensus 219 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 L----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred C----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 0 111234678999999999999999 88988775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.31 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=202.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.... +++.||+|+++.. ...+.+|+++++.++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 346666889999999999998753 3578999998542 346788999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCce
Q 001226 904 IVTEYMPGGTLFNVLHQNEP-----------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 972 (1119)
+||||+++++|.++++..+. ...+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999976432 23578889999999999999999999 99999999999999999999
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhh
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRW 1051 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 1051 (1119)
|++|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |+.||...... ... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~---~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVI---EC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH---HH
Confidence 9999999976543322222334456789999999999999999999999999999998 99998643211 111 00
Q ss_pred hhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1052 KLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
.. ..... ..+...+..+.+++.+||+.+|++||+++|+++.|++
T Consensus 237 ~~----------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 IT----------QGRLL---QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH----------cCCcC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00 00000 0011234567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.41 Aligned_cols=248 Identities=24% Similarity=0.298 Sum_probs=199.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..++||+|+||+||++.+..+++.||+|++... ...+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 45568899999999999999988999999988532 13456799999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 82 MNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999998886543 23589999999999999999999999 99999999999999999999999999987653321
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......|+..|+|||.+.+..++.++||||+||++|||++|+.||........ ...... .+....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~~~~-----------~~~~~~- 221 (285)
T cd05605 157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REEVER-----------RVKEDQ- 221 (285)
T ss_pred --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHHHHH-----------Hhhhcc-
Confidence 12234689999999999888899999999999999999999999974321100 000000 000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
...+...+..+.+++.+||+.||++|| ++++++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011122345678999999999999999 89999776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=342.33 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=193.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecC--------CceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKD--------EHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~~~lV~ 906 (1119)
+|+.+++||+|+||.||+|.+..+++.||||++........+|+.+++.++||||+++++++... ...++||
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 57778999999999999999999999999999876666677899999999999999999876432 2357899
Q ss_pred eccCCCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEecccccccc
Q 001226 907 EYMPGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLIS 984 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~ 984 (1119)
||+++ ++.+++... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .+||+|||+|+...
T Consensus 147 E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 99974 777776542 1233588999999999999999999999 999999999999999765 69999999998664
Q ss_pred CCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ ...................+
T Consensus 223 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 223 AGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred CCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHh
Confidence 322 2223568999999998765 468999999999999999999999996532111 00000000000000000000
Q ss_pred cc-----cccCCCch------HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DR-----EISFWDSD------DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~-----~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+ .+...... +...+.++.+++.+||+.||.+|||+.|+++|
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 00000000 01124578899999999999999999999966
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=336.97 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=201.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||+||+|++..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 456678999999999999999999999999998532 2357789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 82 YMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999998763 488999999999999999999998 99999999999999999999999999998664422
Q ss_pred ---------------------------CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 001226 988 ---------------------------SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFG 1040 (1119)
Q Consensus 988 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 1040 (1119)
.........||+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 01122345789999999999999999999999999999999999999975321
Q ss_pred CCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 001226 1041 EDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS-MREVVGF 1105 (1119)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ell~~ 1105 (1119)
. ..+.. ... . ....... .....+..+.+++.+|++ +|++||+ +++++++
T Consensus 236 ~----~~~~~--i~~------~-~~~~~~p--~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q----ETYNK--IIN------W-KESLRFP--PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HHHHH--Hhc------c-CCcccCC--CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 00000 000 0 0000000 001134567899999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.47 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=201.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..++||+|+||.||+|.... +..||+|.+... .+.+.+|+.+++.++|+||+++++++.+++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 456777999999999999998765 577999988543 3467889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.++++... ...+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+........ .
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence 999999997653 23578889999999999999999998 999999999999999999999999999987654221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||+.....++.++||||+||++|||++ |+.||...... ... .. ..... ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~---~~-~~~~~--------~~~- 224 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVM---SA-LQRGY--------RMP- 224 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHH---HH-HHcCC--------CCC-
Confidence 1223345778999999988889999999999999999998 99998642111 100 00 00000 000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.....+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 225 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 ---RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.61 Aligned_cols=262 Identities=22% Similarity=0.260 Sum_probs=192.2
Q ss_pred HhhCCceeeecCCccEEEEEeCC-CceEEEEEecccc------cccHHHHHHHHhhc---CCCCEEEEeeeee-----cC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-SRKHWAVKKLNRS------ETNFDVEIRTLSLV---RHRNILRIVGSCT-----KD 899 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~------~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~~ 899 (1119)
+|+..+.||+|+||.||+|++.. +++.||+|+++.. ...+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 46677899999999999999854 4688999987532 12456677777765 6999999999885 24
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
...++||||++ ++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 56799999996 689999876542 2488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENHE 1058 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 1058 (1119)
++..... .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ........ ......
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhh
Confidence 9765432 223345689999999999888899999999999999999999999975321110 00000000 000000
Q ss_pred ccc---cccccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CIC---FLDREISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~---~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .....+..... .....+..+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00000000000 001234467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.97 Aligned_cols=239 Identities=24% Similarity=0.341 Sum_probs=192.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||.||+|++..+++.||+|+++.. ...+..|.++++.+ +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998642 12355688888765 799999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99999987654 488899999999999999999999 99999999999999999999999999987543211 22
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... . ......... ...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~---~~~~i~~~~--------~~~p--- 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--D---LFESILHDD--------VLYP--- 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--H---HHHHHHcCC--------CCCC---
Confidence 23456899999999999889999999999999999999999999743111 0 000000000 0001
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRP-------SMREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~ell~~ 1105 (1119)
...+.++.+++.+|++.||++|| ++++++++
T Consensus 217 ---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 ---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11234678999999999999999 88888866
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.27 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=205.8
Q ss_pred HHHHHHhhCCceeeecCCccEEEEEeCCC---ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCc
Q 001226 830 YEDVIRATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 830 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 901 (1119)
.+++..| ++||+|.||+|++|.+... ...||||.++.+ .++|.+|+.+|.+++|||+++++|++.+ ..
T Consensus 109 ee~i~l~---e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLY---ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHH---HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 3444444 6799999999999998753 246899998643 4679999999999999999999999987 77
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
..+|||.++.|+|.+.+++ ..+..+.......++.|||.||.||.++ ++||||+..+|+++-....|||+|||+.+
T Consensus 185 ~mMV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hhHHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence 8899999999999999998 3355688889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCC-cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 982 LISDSHSSS-TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 982 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
-++..+..+ .......++.|+|||.+....++.++|||+|||++|||++ |+.||-+..+. .+
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qI 324 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QI 324 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HH
Confidence 887664444 3345667889999999999999999999999999999996 88888654221 11
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.+.+|..-+. ..+..++.++++++..||..+|++|||+.+|.+.+
T Consensus 325 L~~iD~~erL--pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 325 LKNIDAGERL--PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHhccccccC--CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1122211111 22344577899999999999999999999998544
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.14 Aligned_cols=241 Identities=25% Similarity=0.372 Sum_probs=191.5
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHH---hhcCCCCEEEEeeeeecCCceEEEE
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTL---SLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+..+.||+|+||.||+|.+..+++.||||+++.. ...+..|++++ +.++||||+++++++..++..|+||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 3457899999999999999999999999998532 12355566554 4567999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|..+++.. .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 999999999888643 489999999999999999999999 9999999999999999999999999998743221
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
........|++.|+|||.+.+..++.++||||+||++|||++|+.||...... . ..... ....
T Consensus 155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~---~~~~i----------~~~~ 217 (324)
T cd05589 155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--E---VFDSI----------VNDE 217 (324)
T ss_pred --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--H---HHHHH----------HhCC
Confidence 12233457899999999999889999999999999999999999998643111 0 00000 0000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.. .+...+..+.+++.+||+.||++|| ++++++++
T Consensus 218 ~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 VR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 00 0111245678999999999999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=326.25 Aligned_cols=238 Identities=26% Similarity=0.393 Sum_probs=190.3
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhh-cCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSL-VRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|++..+++.||+|+++.. ......|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999988643 2234567777765 4899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99999997654 378899999999999999999999 99999999999999999999999999987532211 12
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .... ..... ......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~---~~i~~--------~~~~~~--- 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELF---QSIRM--------DNPCYP--- 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHH---HHHHh--------CCCCCC---
Confidence 2345689999999999988999999999999999999999999964311 0000 00000 001111
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMR-EVVG 1104 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ell~ 1104 (1119)
.....++.+++.+|++.+|++||++. ++.+
T Consensus 217 ---~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 ---RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11234678999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=319.25 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=204.6
Q ss_pred HhhCCceeeecCCccEEEEEeC-----CCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.|...+.||+|+||.||++... .++..||+|.+... ...+.+|+.++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 4567788999999999999852 34567999988643 23578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 906 TEYMPGGTLFNVLHQNEP----------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
|||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++++
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 999999999999975431 22489999999999999999999998 99999999999999999999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhc
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
|||.++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... .. .....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~---~~~i~- 236 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV---IECIT- 236 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHHH-
Confidence 9999986643322222333445778999999988889999999999999999998 89888643211 00 00000
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
. ..... .....+..+.+++.+||+.+|.+|||++++.+.|+++.++.
T Consensus 237 ~---------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 Q---------GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred c---------CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 00000 00112346899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=317.04 Aligned_cols=255 Identities=22% Similarity=0.386 Sum_probs=199.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce----EEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK----HWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
++...+.||+|+||+||+|.+..+++ +|++|.+.... .++..|+..++.+.||||+++++++.. ...++|
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 45566889999999999999876655 47888774321 345667778889999999999998764 457889
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
+||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||.++....
T Consensus 87 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999986543 489999999999999999999998 999999999999999999999999999986644
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........++..|+|||...+..++.++|||||||++||+++ |+.||....... .... .....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~----~~~~~------- 228 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDL----LEKGE------- 228 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH----HHCCC-------
Confidence 332223334457789999999988899999999999999999998 999986432110 0000 00000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
.... +...+.++.+++.+||..+|++|||+.|+++.|+++.++.
T Consensus 229 -~~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 -RLAQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -cCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0000 0012345678999999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=315.62 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=204.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|++..+++.||||.++.. ...+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 466778999999999999999989999999976421 2347789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|+++++|.+++..... ...+++..+..++.|+++|++|||+. +++|+||||+||+++.++.++++|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999998864322 23478889999999999999999998 9999999999999999999999999998865432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .......+++.|+|||...+..++.++|+||+|+++|||++|+.||..... +...+..... . ..
T Consensus 160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~-~---------~~ 224 (267)
T cd08228 160 T--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQKIE-Q---------CD 224 (267)
T ss_pred h--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHHHHh-c---------CC
Confidence 1 111234678899999999888899999999999999999999999854211 1111111100 0 00
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
. ........+..+.+++.+||+.+|++||+++++++.+++++
T Consensus 225 ~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 Y--PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C--CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 00111233457889999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=347.74 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=203.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..++||+|+||.||+|.+..+++.||+|+++.. ...+.+|+++++.++||||+++++++.+++..++|||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 567779999999999999999999999999998542 2357789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 908 YMPGGTLFNVLHQNEP--------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
|++||+|.+++..... ....++..+..++.||++|++|||+. +|+||||||+||+++.++.++++|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999999864211 12356778899999999999999999 999999999999999999999999999
Q ss_pred cccccCCCC----------------CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001226 980 SKLISDSHS----------------SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043 (1119)
Q Consensus 980 a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 1043 (1119)
++....... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||........
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 986621110 0111235699999999999999999999999999999999999999965211110
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHccccc
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRP-SMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ell~~L~~~~~~ 1112 (1119)
. ... ...... .. ......+..+.+++.+|++.||++|| +++++.+.++.+.+.
T Consensus 240 --~-~~~-~i~~P~--------~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 240 --S-YRD-VILSPI--------EV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --h-hhh-hccChh--------hc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000 000000 00 00112345678999999999999995 678888888877554
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=326.63 Aligned_cols=193 Identities=30% Similarity=0.371 Sum_probs=170.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcC-C-----CCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVR-H-----RNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lV 905 (1119)
+|++.+.||+|.||.|.+|.+..+++.||||+++... .+-..|++++..++ | -|+|+++++|...++.|+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 6778899999999999999999999999999997654 35567999999886 3 3899999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC--ceEEEeccccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL--EPKIGDFGMSKLI 983 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~DfGla~~~ 983 (1119)
+|.. ..+|+++++.+..+ .++...++.++.||+.||..||+. +|||+||||+|||+...+ .|||+|||.|+..
T Consensus 267 fELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999 67999999988754 599999999999999999999999 999999999999997654 6999999999977
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~ 1037 (1119)
..... ..+.+..|+|||++.+.+|+.+.||||||||++||++|..-|.+
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 55322 45668899999999999999999999999999999999766543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.34 Aligned_cols=240 Identities=23% Similarity=0.349 Sum_probs=204.2
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
.+.||+|.|++|-+|++.-+|++||||++.+.+ ..+..|++.|+.++|||||+++++.......|+|+|.-++|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 467999999999999999999999999996543 34678999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCceEEEeccccccccCCCCCCc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
+|+||+.++.. .+.+.-+.+++.||+.|+.|+|.. .+||||+||+||.+- .-|-||+.|||++-.+.. ...
T Consensus 103 Dl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G~k 174 (864)
T KOG4717|consen 103 DLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---GKK 174 (864)
T ss_pred hHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC---cch
Confidence 99999998865 488999999999999999999998 899999999998764 568999999999977644 344
Q ss_pred ccccccCCCcccccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLT-EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
....+|...|-|||.+.+..|+ +++||||+||++|.+++|+.||...... +.+..++|=..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDCKY--- 236 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDCKY--- 236 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhcccc---
Confidence 5567899999999999999886 6899999999999999999999743211 12222333222
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.-+...+.++.++|..|+..||.+|.+.+||+.+
T Consensus 237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2344567789999999999999999999999865
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=319.26 Aligned_cols=246 Identities=35% Similarity=0.533 Sum_probs=190.4
Q ss_pred CceeeecCCccEEEEEeC----CCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 839 GRIIGKGKHGTVYRTLSN----NSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+.||+|+||.||+|.+. ..+..|+||.++.. ...+.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999988 44678999999532 356888999999999999999999999888899999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++|+|.++++... ...+++..+..++.|+++|+.|||+. +++|+||+++||++++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999872 22489999999999999999999999 9999999999999999999999999999876332222
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
...........|+|||.+....++.++||||||+++||+++ |+.||.... ..+ ..... ..... ..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~---~~~~~-~~~~~--------~~ 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEE---IIEKL-KQGQR--------LP 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHH---HHHHH-HTTEE--------TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc---ccccc-ccccc--------ce
Confidence 33344557789999999988889999999999999999999 678875431 111 11000 00000 00
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111245678999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=342.75 Aligned_cols=251 Identities=24% Similarity=0.299 Sum_probs=200.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC-------
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------- 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 900 (1119)
.+|+..+.||+|+||+||+|.+..+++.||||+++.. ...+.+|+..+..++|+|++++.+.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3777889999999999999999999999999998532 234678999999999999999988765432
Q ss_pred -ceEEEEeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 901 -HGFIVTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 901 -~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
..++||||+++|+|.++++... ....+++..+..++.|++.|+.|+|+. +|+||||||+||+++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3589999999999999987543 223588999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
+++...............||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~~----- 258 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKTL----- 258 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHh-----
Confidence 99876543323333456799999999999999999999999999999999999999964211 00100000
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..... ..+...+.++.+++.+||+.+|++||++.+++++
T Consensus 259 -----~~~~~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 -----AGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -----cCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00000 0111234568899999999999999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=335.51 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=196.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||+||+|++..+++.||||+++.. ...+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 355678999999999999999999999999998642 1346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||++.......
T Consensus 82 ~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 82 YLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999999998654 489999999999999999999999 99999999999999999999999999987543211
Q ss_pred CCC------------------------------------cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhC
Q 001226 988 SSS------------------------------------TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFR 1031 (1119)
Q Consensus 988 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg 1031 (1119)
... .....+||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 01124689999999999888999999999999999999999
Q ss_pred CCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 001226 1032 KMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS---MREVVGF 1105 (1119)
Q Consensus 1032 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ell~~ 1105 (1119)
+.||....... ......... ..+.. ......+..+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~~~-----~~~~i~~~~--------~~~~~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQE-----TYRKIINWK--------ETLQF--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHH-----HHHHHHcCC--------CccCC--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99996432110 000000000 00000 0001123466789999996 9999998 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=333.02 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=198.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|...+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 355668999999999999999999999999998642 2347789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++..... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 82 YQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999987632 488999999999999999999999 99999999999999999999999999998664322
Q ss_pred CCCcccccccCCCcccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.. ......||+.|+|||.+. ...++.++||||+||++|||++|+.||...... ..+.. ....
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~--i~~~----- 224 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNN--IMNF----- 224 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHH--HHcC-----
Confidence 21 223346899999999876 456789999999999999999999999643111 00000 0000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.... ......+..+.+++.+|++ +|++||++++++++
T Consensus 225 --~~~~~~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 --QRFLKF--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred --CCccCC--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000000 0111234567899999998 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=318.76 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=205.5
Q ss_pred HhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|...+.||+|+||.||+|.... ++..|++|.++... ..+.+|+..+++++||||+++++++..+...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 45666889999999999998543 35678999986432 4588899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCce
Q 001226 906 TEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 972 (1119)
|||+++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 999999999999976432 23478999999999999999999999 99999999999999999999
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhh
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRW 1051 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 1051 (1119)
+++|||++................++..|+|||.+.+..++.++||||+||++|||++ |+.||....... . + ..
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~--~-~~ 237 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V--I-EC 237 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H--H-HH
Confidence 9999999976544322223334556789999999988899999999999999999998 999986432110 0 0 00
Q ss_pred hhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1052 KLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
.. ..... ......+..+.+++.+||+.+|++||++++|++.|+++....
T Consensus 238 ~~----------~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 238 IT----------QGRVL---ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred Hh----------CCCCC---CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 00 00000 001122456789999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.64 Aligned_cols=238 Identities=26% Similarity=0.380 Sum_probs=189.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhh-cCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSL-VRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||.||+|+++.+++.||+|+++.. ......|..++.. .+||+|+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999998642 2235567777765 4899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++|+|||+++..... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 99999987654 488899999999999999999999 9999999999999999999999999998743221 112
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ... +.... .. .+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~~~--~~~~~-~~--------~~~~~~-- 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--DEL--FESIR-VD--------TPHYPR-- 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHH--HHHHH-hC--------CCCCCC--
Confidence 2345689999999999999999999999999999999999999964311 100 00000 00 011111
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMR-EVVG 1104 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ell~ 1104 (1119)
....++.+++.+|++.||++||++. ++.+
T Consensus 218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 218 ----WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred ----CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1234678999999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=316.77 Aligned_cols=243 Identities=24% Similarity=0.310 Sum_probs=192.6
Q ss_pred eeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||+|+||.||+++.+.+++.||+|++... ......|+.+++.++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999988532 22345699999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 988865442 3488999999999999999999999 99999999999999999999999999987654321 2223
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..++..|+|||++.+..++.++||||+||++|||++|+.||........ ........ ....... ..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~----------~~~~~~~---~~ 219 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRT----------LEDEVKF---EH 219 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHh----------hcccccc---cc
Confidence 4689999999999888899999999999999999999999864321111 00000000 0001100 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+.++.+++.+||+.||++||+++|+++.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 1234467899999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=329.54 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=194.6
Q ss_pred hhCCceeeecCCccEEEEEeC---CCceEEEEEecccc--------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 903 (1119)
|+..+.||+|+||.||+++.. .+++.||+|++++. ...+..|+.+++.++ ||+|+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 556789999999999998764 46889999988532 134667999999994 999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 9999999999999997654 488999999999999999999999 9999999999999999999999999999765
Q ss_pred cCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... .........
T Consensus 156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~-------- 225 (332)
T cd05614 156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK-------- 225 (332)
T ss_pred cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhc--------
Confidence 33221 122345789999999988765 4788999999999999999999999643211110 011110000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.+..+ +...+..+.+++.+|++.||++|| ++++++++
T Consensus 226 ~~~~~------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CDPPF------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCC------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01111 112244678999999999999999 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=319.53 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=202.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC-----ceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+..+.||+|+||.||++..... ...||+|.+.... ..+.+|+.+++++ +||||+++++++..++..
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 3566778999999999999987643 3789999886432 2467899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 001226 903 FIVTEYMPGGTLFNVLHQNE-------------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 969 (1119)
++||||+++|+|.++++... ....+++..+.+++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED 168 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence 99999999999999997532 234588999999999999999999998 99999999999999999
Q ss_pred CceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeeh
Q 001226 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 970 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 1048 (1119)
+.+|++|||.++...............++..|+|||...+..++.++|||||||++||+++ |..||...... ...
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~-- 244 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--ELF-- 244 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--HHH--
Confidence 9999999999987654332222223345678999999888889999999999999999997 88888543111 000
Q ss_pred hhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
... ...... ..+...+..+.+++.+|++.+|++|||++|+++.|+++.
T Consensus 245 -~~~-----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 -KLL-----------KEGYRM--EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHH-----------HcCCcC--CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 000 000000 011122446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=325.97 Aligned_cols=239 Identities=28% Similarity=0.369 Sum_probs=193.4
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||+||+|.++.+++.||+|++++. ...+..|+.+++.+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998642 23356788888877 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99999987654 489999999999999999999999 99999999999999999999999999986432211 12
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....|++.|+|||.+.+..++.++||||+||++|||++|+.||..... . ....... .....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~---~~~~~i~----------~~~~~--- 214 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--D---ELFQSIL----------EDEVR--- 214 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--H---HHHHHHH----------cCCCC---
Confidence 2334689999999999999999999999999999999999999964311 0 0000000 00000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSM-----REVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ell~~ 1105 (1119)
.+...+..+.+++.+||+.||++||++ .+++++
T Consensus 215 -~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 -YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 011224567899999999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=336.02 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=194.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..++||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++||||+++++++.++...|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 356678999999999999999999999999988532 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++......
T Consensus 82 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 82 FLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999999997654 488889999999999999999999 99999999999999999999999999986432110
Q ss_pred CC------------C---------------------------------cccccccCCCcccccccCCCCCCCcchHHHHH
Q 001226 988 SS------------S---------------------------------TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYG 1022 (1119)
Q Consensus 988 ~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG 1022 (1119)
.. . .....+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 0 00124699999999999888999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCC---CCCH
Q 001226 1023 VILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADM---RPSM 1099 (1119)
Q Consensus 1023 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~---RPs~ 1099 (1119)
|++|||++|+.||......+. ......+. ..+.. ......+..+.+++.+|++ +|.+ |+++
T Consensus 236 vil~elltG~~Pf~~~~~~~~-~~~i~~~~------------~~~~~--p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHET-YRKIINWR------------ETLYF--PDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHH-HHHHHccC------------CccCC--CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999964321100 00000000 00000 0011123467799999997 6666 4699
Q ss_pred HHHHHH
Q 001226 1100 REVVGF 1105 (1119)
Q Consensus 1100 ~ell~~ 1105 (1119)
+|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 999886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=313.86 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=204.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..++||+|+||.||+|.+.. ++.||+|++... ..++.+|+.+++.++||||+++++++.+....++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 356777899999999999999988 889999998643 346788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 99999999987542 3589999999999999999999998 9999999999999999999999999999866442211
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.....++..|+|||......++.++||||+|+++|+|++ |+.||...... .... ... ....
T Consensus 161 --~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~--~~~------------~~~~ 222 (261)
T cd05148 161 --SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYD--QIT------------AGYR 222 (261)
T ss_pred --ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHH--HHH------------hCCc
Confidence 223446778999999988889999999999999999998 89998643210 0000 000 0000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
. ..+...+..+.+++.+||+.+|++|||++++.+.|+.+
T Consensus 223 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 M--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred C--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0 01122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=336.10 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=193.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..++||+|+||+||+|++..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 55668999999999999999999999999998542 23577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++.+.+ .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 99999999997654 478889999999999999999999 999999999999999999999999999753210000
Q ss_pred ---------------------------------------------CCcccccccCCCcccccccCCCCCCCcchHHHHHH
Q 001226 989 ---------------------------------------------SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGV 1023 (1119)
Q Consensus 989 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~ 1023 (1119)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC---HH
Q 001226 1024 ILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS---MR 1100 (1119)
Q Consensus 1024 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ 1100 (1119)
++|||++|+.||........ ......+ ...... ......+.++.+++.+|+ .+|++|++ ++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~------------~~~~~~--p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET-QMKVINW------------QTSLHI--PPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH-HHHHHcc------------CCCcCC--CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999964321100 0000000 000000 001112345567777765 59999997 88
Q ss_pred HHHHH
Q 001226 1101 EVVGF 1105 (1119)
Q Consensus 1101 ell~~ 1105 (1119)
++++|
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 88765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=311.65 Aligned_cols=248 Identities=24% Similarity=0.431 Sum_probs=198.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+++..+.||+|+||.||+|.++. +..+|+|++... ..++.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 456777889999999999998864 668999988643 3467889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++...+... .
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 9999999986543 489999999999999999999999 999999999999999999999999999876543211 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||+|+++||+++ |+.||...... .. ... .... .. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~--~~~--~~~~------~~--~-- 220 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EV--VES--VSAG------YR--L-- 220 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HH--HHH--HHcC------Cc--C--
Confidence 1112234568999999988899999999999999999998 89988643111 10 000 0000 00 0
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
..+...+..+.+++.+||+.+|++|||++|+++.|
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 --YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01112345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=314.54 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=195.0
Q ss_pred hCCceeeecCCccEEEEEeCCCce--EEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------Cce
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRK--HWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------EHG 902 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 902 (1119)
..+++||+|+||.||+|.+...+. .||+|.++.. ...+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 346889999999999999877664 6899987532 24577899999999999999999987432 246
Q ss_pred EEEEeccCCCCHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
++||||+++|+|.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 123488999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
++...............+++.|+|||...+..++.++||||+|+++|||++ |+.||..... ... +.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~--~~~--~~~~~- 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEI--YDY--LRQGN- 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHH--HHH--HHcCC-
Confidence 987654332222233456778999999998899999999999999999998 7888854211 110 000 00000
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.... ....+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 232 -------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 -------RLKQ----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 011234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=327.76 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=200.8
Q ss_pred HHhhCCceeeecCCccEEEEEeC-----CCceEEEEEeccccc-----ccHHHHHHHHhhcC-CCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRSE-----TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 902 (1119)
.++..++.||+|+||.||+|.++ ..++.||+|+++... ..+..|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35667789999999999999864 345689999996432 24678999999997 99999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCC-----------------------------------------------------------
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP----------------------------------------------------------- 923 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 923 (1119)
++||||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 924 ------------------------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 924 ------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
...+++..+.+++.|++.|++|||+. +++||||||+||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 12367778899999999999999998 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
+++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+. .
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~- 351 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-F- 351 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-H-
Confidence 999999999999986543222122223456889999999988889999999999999999998 8889854311100 0
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
.... .+..+. ..+...+.++.+++.+||+.+|++||+++||++.|+++.
T Consensus 352 ---~~~~----------~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 ---YNAI----------KRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHH----------HcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000 000000 001112457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=316.06 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=200.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
..|+..+.||+|+||.||+|.+.. ++..||+|.+... ...+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 346667899999999999999877 6788999988532 235788999999999999999999999888999
Q ss_pred EEEeccCCCCHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP----RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 976 (1119)
+||||+++++|.++++.... ...+++..+.+++.||+.|++|||+. +++||||||+||+++.++ .+|++|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999976542 12588999999999999999999999 999999999999998764 589999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++................+..|+|||++.+..++.++||||+||++|||++ |+.||...... ... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~---~~~--- 234 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVM---EFV--- 234 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH---HHH---
Confidence 999987643222222222334568999999998899999999999999999996 99998643111 100 000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
...... ..+...+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus 235 --------~~~~~~--~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 --------TGGGRL--DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred --------HcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 000000 0011224567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=314.30 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=197.5
Q ss_pred hCCceeeecCCccEEEEEeCCC---ceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCc------
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH------ 901 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 901 (1119)
..++.||+|+||.||+|..... +..||+|+++.. ...+.+|+..++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 4568899999999999987643 478999988633 2357789999999999999999998866544
Q ss_pred eEEEEeccCCCCHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
.++||||+++|+|.+++.... ....+++..+..++.|++.|++|+|+. +++||||||+||++++++.+|++|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence 699999999999999985432 223589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
+++................+..|+|||......++.++||||+||++|||++ |..||...... .. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~---~~~~~~~-- 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EI---YDYLRHG-- 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHHHcC--
Confidence 9987654332222223345678999999988889999999999999999998 88887542111 11 0100000
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
... ..+...+..+.+++.+||+.||++||++.|++++|+++
T Consensus 232 -------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -------NRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------CCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 01112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.27 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=201.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+++..+.||+|+||.||+|.+.. ++.||+|.++.. ..++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 46667899999999999998765 578999998643 34678899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++++|||+++....... ..
T Consensus 86 ~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05068 86 GSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EA 160 (261)
T ss_pred CcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cc
Confidence 99999997654 23589999999999999999999999 999999999999999999999999999987653221 11
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......+..|+|||+..+..++.++||||+|+++|||++ |+.||...... ...... .+....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~------------~~~~~~- 223 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQV------------DQGYRM- 223 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH------------HcCCCC-
Confidence 112223468999999988889999999999999999999 99998643110 000000 000000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
......+..+.+++.+|++.+|++||+++++++.|+.+
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=318.06 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=199.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC-----ceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|...+.||+|+||.||+|.+..+ ++.||+|+++... ..+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3455567899999999999987543 5789999986432 34778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 001226 904 IVTEYMPGGTLFNVLHQNE-------------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL 970 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 970 (1119)
+++||+++++|.+++.... ....+++..+..++.|++.|++|+|+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 123478888999999999999999999 999999999999999999
Q ss_pred ceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehh
Q 001226 971 EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWT 1049 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1049 (1119)
.+|++|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||..... .+ ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~---~~ 236 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QD---VI 236 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--HH---HH
Confidence 999999999886644332222233456789999999988889999999999999999998 8888754211 11 11
Q ss_pred hhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.... +..... .+...+..+.+++.+||+.+|++||++++|++.|+.+
T Consensus 237 ~~i~----------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 237 EMIR----------NRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHH----------cCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 1100 000000 0112345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.54 Aligned_cols=248 Identities=24% Similarity=0.364 Sum_probs=194.5
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||+|+||.||+|++..+++.||+|++... ...+.+|+.+++.++||||+++++.+.+++..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 56678999999999999999999999999998532 23477899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC-
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH- 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~- 987 (1119)
+++|+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999997754 478889999999999999999999 99999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHH
Q 001226 988 ----------------------------------------SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFE 1027 (1119)
Q Consensus 988 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~e 1027 (1119)
.........||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0000123479999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCC---CHHHHHH
Q 001226 1028 LLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRP---SMREVVG 1104 (1119)
Q Consensus 1028 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~ell~ 1104 (1119)
|++|+.||......+.. .....+.. . ..... ....+..+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~~~~-~~i~~~~~----~------~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPAETQ-LKVINWET----T------LHIPS----QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHHHHH-HHHhccCc----c------ccCCC----CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999753211100 00000000 0 00000 0112345667788876 5999999 8999987
Q ss_pred H
Q 001226 1105 F 1105 (1119)
Q Consensus 1105 ~ 1105 (1119)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=327.36 Aligned_cols=234 Identities=26% Similarity=0.363 Sum_probs=186.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHH-HHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIR-TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||+||+|.+..+++.||+|++.... ..+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999985321 22334443 45778999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 99999987654 488899999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...... ........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~----------i~~~~~~~-- 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDN----------ILNKPLRL-- 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHH----------HHcCCCCC--
Confidence 3345689999999999998999999999999999999999999964311 000000 00111111
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMR 1100 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 1100 (1119)
....+..+.+++.+|++.||++||+++
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 --KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111245678999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=317.42 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=201.1
Q ss_pred hhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
|+..+.||+|+||.||+|.... ....||+|.+.... .++.+|+.+++.++||||+++++.+..++..++|
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 4556889999999999998653 23568999875432 3577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 001226 906 TEYMPGGTLFNVLHQNE---------------------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNI 964 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 964 (1119)
+||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ni 158 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNV 158 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheE
Confidence 99999999999986432 113478899999999999999999998 999999999999
Q ss_pred EeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 001226 965 LLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDT 1043 (1119)
Q Consensus 965 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 1043 (1119)
++++++.+|++|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-- 236 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-- 236 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999999986543322222233345778999999888889999999999999999998 99998643111
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.... .+.+.... ..+...+.++.+++.+|++.+|++||+++++++.|+++..+
T Consensus 237 ~~~~--------------~~~~~~~~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RLFN--------------LLKTGYRM--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHH--------------HHhCCCCC--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 0000 00000000 01112345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.08 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=198.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||.|.||.||-|++..+.+.||||++.. ...++..|++.++.++|||+|.+-|+|..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445789999999999999999999999999942 234678899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
| -|+-.|++.-++. ++.+.++..|..+.++|++|||+. +.||||||+.||++++.|.||++|||.|....+
T Consensus 108 C-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred H-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence 9 5677777766543 578889999999999999999999 999999999999999999999999999986643
Q ss_pred CCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
...++|||.|||||++. .+.|+-++||||+|++..|+..+++|+..+..-. .+ + .++.--.+
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-AL--Y---------HIAQNesP 243 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-AL--Y---------HIAQNESP 243 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HH--H---------HHHhcCCC
Confidence 34578999999999875 5889999999999999999999999976431100 00 0 00000011
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
.+. ...-+..+..++..|++.-|.+|||.+++++|-=
T Consensus 244 tLq-----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 244 TLQ-----SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred CCC-----CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 111 1122556789999999999999999999998743
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=311.36 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=199.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||+||+|.... +..||+|.++.. .+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 466777899999999999998765 456999988643 3467889999999999999999999998889999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.+|++|||.++....... .
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999976543 489999999999999999999999 999999999999999999999999999876544221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++|||||||++|||++ |+.||...... .... ..... ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~---~~~~~-----------~~~ 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVE---KVSQG-----------LRL 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHH---HHhcC-----------CCC
Confidence 1122345678999999988889999999999999999998 99998643211 0000 00000 000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
......+..+.+++.+||+.+|++||++.++++.++
T Consensus 221 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 --YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112457789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=325.43 Aligned_cols=243 Identities=26% Similarity=0.344 Sum_probs=193.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCC-CCEEEEeeeeecCCceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRH-RNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 907 (1119)
|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+..|+++++.++| ++|+++++++.+.+..|+|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 45568899999999999999999999999988532 2345678888888876 568889999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 82 YVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 999999999987654 378899999999999999999999 9999999999999999999999999998643211
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ..... .....
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~---~~~~i----------~~~~~ 218 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--E---LFQSI----------MEHNV 218 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--H---HHHHH----------HcCCC
Confidence 11223456899999999999989999999999999999999999999643111 0 00000 00000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSM-----REVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ell~~ 1105 (1119)
.. +...+..+.+++.+|++.+|.+|++. +++.++
T Consensus 219 ~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 219 SY----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 11123467899999999999999976 676654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=324.57 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=198.1
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+.+|+..+.||+|+||.||+|+++.+++.||+|+++.. ...+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 34577789999999999999999998999999988532 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++ ++.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 85 YLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 9974 88888876543 478889999999999999999999 99999999999999999999999999987543321
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc------ccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH------ECI 1060 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~ 1060 (1119)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+............... ...
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12233467899999998765 568899999999999999999999996532111100000000000000 000
Q ss_pred ccccccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+....... ......+.++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000000000 0011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=320.25 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=204.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-------CceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|..++.||+|+||.||+|.+.. +...||+|.++... .++..|+.+++.+ +||||+++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 478888999999999999998643 23569999986432 2466799999999 7999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..|+||||+++|+|.+++....+ ...+++.++.+++.|++.|++|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999976532 12488999999999999999999998 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+|++|||.++...............+++.|+|||...+..++.++||||+||++|||++ |..||..... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-----~ 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----E 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----H
Confidence 999999999999876543221111222234568999999988889999999999999999998 8888753211 0
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
..... ... .... ..+...+.++.+++.+|++.+|++||++.++++.|+++.+....
T Consensus 250 ~~~~~-~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 250 ELFKL-LKE----------GHRM--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHHHH-HHc----------CCCC--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 00000 000 0000 01112345778999999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=314.69 Aligned_cols=254 Identities=26% Similarity=0.433 Sum_probs=202.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC-----ceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.++.. +..||+|.+.... ..+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 4667779999999999999987653 3789999985432 35778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP-------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
+||||+++++|.+++..... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|++|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 99999999999999975432 22478889999999999999999998 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...............++..|+|||...++.++.++|||||||++||+++ |+.||...... ... .... .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~---~~~~-~ 236 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVL---KFVI-D 236 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHH---HHHh-c
Confidence 999986654332223334456789999999988889999999999999999998 89888542111 110 0000 0
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
. . .... +...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ~-~-----~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 G-G-----HLDL------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred C-C-----CCCC------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0 0 0000 11124578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.85 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=199.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+.... ...+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4677889999999999999999988999999988532 234678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++... .+++..+..++.|++.|+.|||+. +|+|||++|+||+++.++.++++|||++.......
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999987654 478999999999999999999998 99999999999999999999999999998654321
Q ss_pred CcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.......++..|+|||.+. ...++.++||||+||++|||++|+.||......... ..+..... ..+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~~~---------~~~~ 230 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKSNF---------QPPK 230 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecCCC---------CCCC
Confidence 1223346888999999874 345788999999999999999999998643221111 11000000 0000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.. .....+..+.+++.+||+.+|++||+++++++++
T Consensus 231 ~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LK----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred Cc----cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00 0112235678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.77 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=199.1
Q ss_pred hCCceeeecCCccEEEEE----eCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEE
Q 001226 837 TEGRIIGKGKHGTVYRTL----SNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIV 905 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 905 (1119)
...+.||+|+||+||++. ...+++.||+|.++.. ...+.+|+.+++.++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 566889999999998765 3346788999988643 23567899999999999999999987653 457899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++++|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999764 389999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.... .......++..|+|||...+..++.++||||+|+++|||++|+.||........+........ ..........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQ-MTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccc-cchhhhhhhhh
Confidence 2221 112223456679999999888899999999999999999999999864322111111100000 00000111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
..... ..+...+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 239 ~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11110 011223457899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=318.05 Aligned_cols=261 Identities=23% Similarity=0.405 Sum_probs=205.1
Q ss_pred HHHhhCCceeeecCCccEEEEEeC-------CCceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecC
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSN-------NSRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKD 899 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 899 (1119)
..+|+.++.||+|+||.||+|++. ..+..||+|.++.. ..++.+|+.+++.+ +||||+++++++..+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356778899999999999999753 23457999988642 23577899999999 899999999999999
Q ss_pred CceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL 966 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 966 (1119)
+..++||||+++|+|.+++..... ...+++.++..++.|+++|+.|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999976432 23578889999999999999999999 99999999999999
Q ss_pred CCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCce
Q 001226 967 DSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDI 1045 (1119)
Q Consensus 967 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~ 1045 (1119)
+.++.+|++|||.++...............+++.|+|||...+..++.++||||+|+++||+++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 9999999999999987654332222233446778999999988889999999999999999998 7888753211
Q ss_pred eehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1046 VTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
...... ...... . ..+...+..+.+++.+||+.+|++||++.|+++.|+++.+-..
T Consensus 246 ~~~~~~-~~~~~~--------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 EELFKL-LKEGHR--------M----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHH-HHcCCc--------C----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 011100 000000 0 0011234567899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=318.44 Aligned_cols=263 Identities=26% Similarity=0.430 Sum_probs=204.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-------CceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|..+++||+|+||.||+|.+.. ....||+|.++... ..+..|+.+++.+ +||||+++++++.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 467788999999999999997532 34579999886432 3467899999999 6999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..++||||+++|+|.+++..... ...+++.++..++.|++.|+.|||+. |++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999976431 13488999999999999999999998 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+|++|||.++...............++..|+|||.+.+..++.++||||+||++|||++ |+.||...... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--ELF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HHH
Confidence 999999999999986644322222222234567999999988889999999999999999998 88888542110 000
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
.... ... ... .....+.++.+++.+|++.+|++||++.|+++.|+++....+.+|
T Consensus 247 ---~~~~-~~~--------~~~----~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 301 (314)
T cd05099 247 ---KLLR-EGH--------RMD----KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301 (314)
T ss_pred ---HHHH-cCC--------CCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCc
Confidence 0000 000 000 011223467899999999999999999999999999886555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=322.92 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=193.4
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999998642 12366788888887 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 99999887654 489999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-ceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-DIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......... ........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~---------~~~~~~~~- 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---------ILEKPIRI- 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH---------HHhCCCCC-
Confidence 2345789999999999999999999999999999999999999964322111 110000000 00111110
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPS------MREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~ell~~ 1105 (1119)
+...+..+.+++.+|++.||++||+ ++++++|
T Consensus 223 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 ---PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1112345689999999999999998 4577655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=313.86 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=203.0
Q ss_pred HHHhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCce
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 902 (1119)
..+|+..++||+|+||.||+|..++ .+..||+|.++... ..+.+|+..++.++||||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3577888999999999999997653 35689999875332 2467799999999999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP-------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
++||||+++|+|.++++.... ....++..+..++.|++.|++|||+. +|+||||||+||++++++.++++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975321 23456778899999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhc
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
|||+++...............++..|+|||...++.++.++||||+||++|||++ |+.||.....+ .......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~- 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----QVLKFVM- 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH-
Confidence 9999886544332222333345778999999988889999999999999999998 78887542111 1111100
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+..... .+...+..+.+++.+|++.+|++|||+.++++.+++....+
T Consensus 236 ---------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 236 ---------DGGYLD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred ---------cCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 000000 01112357899999999999999999999999998865443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.86 Aligned_cols=243 Identities=25% Similarity=0.343 Sum_probs=193.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
|+..+.||+|+||.||+|++..+++.||+|++++.. ..+..|..++... +|++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 455688999999999999999999999999886421 2345577777766 58999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 82 YVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 999999999987654 388999999999999999999999 9999999999999999999999999998754321
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. .... .....
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~---~~~i----------~~~~~ 218 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL---FQSI----------MEHNV 218 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HH---HHHH----------HhCCC
Confidence 11223456899999999999999999999999999999999999999643111 00 0000 01111
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSM-----REVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ell~~ 1105 (1119)
. .+...+.++.+++.+|++.+|++|++. +++.++
T Consensus 219 ~----~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 219 A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred C----CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 1 011234567899999999999999984 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=328.80 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=198.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
.|...+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|+|||++++++..++..++|||++ .++|
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L 246 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDL 246 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCH
Confidence 4666789999999999999999999999999643 335678999999999999999999999999999999999 4789
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... .+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.............
T Consensus 247 ~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 321 (461)
T PHA03211 247 YTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321 (461)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccc
Confidence 888876432 589999999999999999999999 999999999999999999999999999986643222222334
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC------ceeehhhhhhccccccccc------
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT------DIVTWTRWKLQENHECICF------ 1062 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~------ 1062 (1119)
..||+.|+|||++.+..++.++|||||||++|||++|..|+........ .+.................
T Consensus 322 ~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~ 401 (461)
T PHA03211 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLV 401 (461)
T ss_pred cCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHH
Confidence 5799999999999999999999999999999999998876543221110 0000000000000000000
Q ss_pred ---cc---c----cc--cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 ---LD---R----EI--SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ---~~---~----~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. . .. ..| .........+.+++.+||+.||.+|||++|++++
T Consensus 402 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 402 SQYRHRAARNRRPAYTRPAW-TRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHhhhhcccCCccCCcch-hhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0 00 001 0001223467899999999999999999999986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.98 Aligned_cols=196 Identities=23% Similarity=0.411 Sum_probs=161.8
Q ss_pred CceeeecCCccEEEEEeCC--CceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEEEEeccCCC
Q 001226 839 GRIIGKGKHGTVYRTLSNN--SRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFIVTEYMPGG 912 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~g 912 (1119)
+++||+|+||+||+|.++. +++.||+|+++.. .....+|+.++++++||||+++++++.. +...++||||++ +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 5789999999999999653 5688999998643 3457789999999999999999998854 456789999995 5
Q ss_pred CHHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCceEEEecccccc
Q 001226 913 TLFNVLHQNE------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL----DSELEPKIGDFGMSKL 982 (1119)
Q Consensus 913 sL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~DfGla~~ 982 (1119)
++.+++.... ....+++..+..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 8888875432 122588999999999999999999999 99999999999999 4567899999999987
Q ss_pred ccCCCC-CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 983 ISDSHS-SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 983 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
...... ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 643221 122334678999999998876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=313.28 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=204.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|....+++.||||.+.. ...++.+|+.+++.++||||+++++++.+++..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 45666889999999999999988899999997743 12457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|+++++|.+++..... ...+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999875322 33589999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.. ......++..|+|||...+..++.++|+||+|+++|||++|..||.....+ ......... ....+.
T Consensus 160 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-------~~~~~~ 227 (267)
T cd08229 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE-------QCDYPP 227 (267)
T ss_pred Cc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh-------cCCCCC
Confidence 21 122346888999999998888999999999999999999999998643111 111110000 000000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
. .....+..+.+++.+||+.+|++|||+++|+++++++-
T Consensus 228 ~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 L-----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C-----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 11123457889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.38 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=198.5
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
|..++.||+|++|.||+|.+..++++||+|++... ...+.+|+.++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 55678999999999999999988999999987432 134778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||.++.....
T Consensus 84 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 9999999999988654 378889999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCCc-ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSST-RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
..... .....++..|+|||...+..++.++||||+|+++|||++|+.||...... ..... ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~-~~~~~------~~~ 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFK-IATQP------TNP 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHH-HhccC------CCC
Confidence 11111 12345788999999999888999999999999999999999998642110 00000 00000 000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+......+.+++.+||+.+|++|||++|++++
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 ------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1112234567899999999999999999999876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=315.83 Aligned_cols=261 Identities=28% Similarity=0.393 Sum_probs=201.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc----------------eEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR----------------KHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRI 892 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~----------------~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l 892 (1119)
.+|+..+.||+|+||.||+|.+...+ ..||+|++... ...+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 35677789999999999998876533 56899998643 3457789999999999999999
Q ss_pred eeeeecCCceEEEEeccCCCCHHHhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 001226 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP--------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNI 964 (1119)
Q Consensus 893 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 964 (1119)
++++..++..++||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence 9999999999999999999999999976541 12488999999999999999999998 999999999999
Q ss_pred EeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCC
Q 001226 965 LLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF--RKMPVDPSFGED 1042 (1119)
Q Consensus 965 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~~~~~~~~ 1042 (1119)
+++.++.++++|||.++...............+++.|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-- 239 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence 999999999999999876544332223334456789999999888889999999999999999998 6777753211
Q ss_pred CceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
... +..... ......... ........+.++.+++.+|++.+|++|||++||++.|++
T Consensus 240 ~~~--~~~~~~-----~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQV--IENAGH-----FFRDDGRQI--YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHH--HHHHHh-----ccccccccc--cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 110 000000 000000000 000111233578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=310.44 Aligned_cols=251 Identities=29% Similarity=0.368 Sum_probs=189.7
Q ss_pred ceeeecCCccEEEEEeCC--CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNN--SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||+|.... ++..+|+|.++... ..+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998643 45679999886432 35778999999999999999999999989999999999999
Q ss_pred CHHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 913 TLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 913 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|.++++.... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 22466778889999999999999999 99999999999999999999999999987654332222
Q ss_pred cccccccCCCcccccccCCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAYST-------RLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
......++..|+|||++... .++.++||||||+++|||++ |+.||......+ .... ... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~---~~~--~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTY---TVR--EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHH---Hhh--cccCCC
Confidence 23344578899999987532 35789999999999999996 999986432111 1000 000 000001
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
.++... ......+.+++..|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 112335678999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=316.88 Aligned_cols=255 Identities=23% Similarity=0.403 Sum_probs=201.7
Q ss_pred HHhhCCceeeecCCccEEEEEe-----CCCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.++...+.||+|+||.||+|.+ ..++..||+|.++... ..+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3677789999999999999975 3345689999886432 3477899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++++|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999976442 2389999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
..............++..|+|||.+.+..++.++||||+||++|||++ |..||....... ......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~--------- 257 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLI--------- 257 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHH---------
Confidence 543222112223346788999999998889999999999999999998 999986432110 000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
...... ..+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 258 --~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 --KEGYRM--AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HcCCcC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000000 00111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.28 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=201.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCce----EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRK----HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+++..++||+|+||+||+|.+..+++ +||+|+++.. ...+.+|+..++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 355667899999999999998766555 5899988532 23567899999999999999999998754 5679
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
++||+++|+|.++++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999986542 488999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
............+++.|+|||...+..++.++|||||||++|||++ |..||..... .....+.. ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~----~~~------ 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLE----KGE------ 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHH----CCC------
Confidence 3222212222345678999999988889999999999999999998 8888864311 11110000 000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.. ..+...+.++.+++.+||+.||++||++.++++.++++..+.+
T Consensus 229 --~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 229 --RL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred --cC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 00 0011234567899999999999999999999999999877664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=328.68 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=196.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|+++.+++.||+|++.+. ...+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 5778889999999999999999999999999998531 234668999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 123 Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 123 EYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999998754 378888999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCCcccccccCCCcccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYST----RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. ........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+.... ...
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~-~~~------ 263 (371)
T cd05622 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIM-NHK------ 263 (371)
T ss_pred C-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHH-cCC------
Confidence 2 1122345799999999987643 378999999999999999999999964311 00111100 000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGFL 1106 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~L 1106 (1119)
..+.. ......+..+.+++.+|++..+.+ ||+++|++++.
T Consensus 264 --~~~~~--~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 --NSLTF--PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred --CcccC--CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00000 111123456788999999844443 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.23 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=195.3
Q ss_pred ceeeecCCccEEEEEeCCCc---eEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSR---KHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||.||+|.+..++ ..||+|.+.... .++.+|+.+++.+.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876544 789999986433 35778999999999999999999876 4567999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC-
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS- 990 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~- 990 (1119)
++|.+++.... .+++..+..++.|++.|++|||.. +++||||||+||+++.++.+|++|||.++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998765 488999999999999999999998 99999999999999999999999999998664432211
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||||+++|||++ |+.||....+ .... ...... .. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~---~~~~~~-~~--------~-- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVI---AMLESG-ER--------L-- 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHH---HHHHcC-Cc--------C--
Confidence 1112234568999999988889999999999999999997 9999864321 1111 111000 00 0
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
..+...+..+.+++.+|++.+|++||++.++++.|+++.
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 001122356789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=324.54 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=199.3
Q ss_pred HHhhCCceeeecCCccEEEEEeC-----CCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecC-Cc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKD-EH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 901 (1119)
.+|...+.||+|+||.||+|.+. .+++.||||+++... ..+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 36777899999999999999843 457889999986422 3466899999999 689999999988654 56
Q ss_pred eEEEEeccCCCCHHHhhccCCC----------------------------------------------------------
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEP---------------------------------------------------------- 923 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 923 (1119)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999865321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCccccccc
Q 001226 924 ------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997 (1119)
Q Consensus 924 ------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~g 997 (1119)
...+++..+.+++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999 999999999999999999999999999986543222222223345
Q ss_pred CCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHH
Q 001226 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQL 1076 (1119)
Q Consensus 998 t~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1076 (1119)
++.|+|||...+..++.++||||+|+++|||++ |..||....... . ... ...... ...... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~---~~~-~~~~~~------~~~~~~------~ 306 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E---FCR-RLKEGT------RMRAPD------Y 306 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H---HHH-HHhccC------CCCCCC------C
Confidence 678999999988889999999999999999996 898886431110 0 000 000000 000000 1
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1077 KALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1077 ~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+.++.+++.+||+.+|++|||+.||+++|+++.++
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 224678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=319.24 Aligned_cols=258 Identities=24% Similarity=0.390 Sum_probs=201.0
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCce--EEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRK--HWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 904 (1119)
+.+|+..+.||+|+||.||+|.++.++. .+|+|.++.. ...+.+|+.++.++ +||||+++++++.+++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3456777899999999999999877664 4688876532 23577899999999 89999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc
Q 001226 905 VTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE 971 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 971 (1119)
||||+++++|.++++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975431 12578999999999999999999998 9999999999999999999
Q ss_pred eEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhh
Q 001226 972 PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTR 1050 (1119)
Q Consensus 972 vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 1050 (1119)
+|++|||++..... ........++..|+|||...+..++.++|||||||++|||++ |..||...... +. ..
T Consensus 163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~---~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL---YE 234 (303)
T ss_pred EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HH---HH
Confidence 99999999864321 111112234678999999888889999999999999999998 99998643211 10 00
Q ss_pred hhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1051 WKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
. ..... ... .....+..+.+++.+||+.+|++||++++++++++++.....
T Consensus 235 ~-~~~~~--------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 K-LPQGY--------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred H-HhcCC--------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0 00000 000 011123467899999999999999999999999998776654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.73 Aligned_cols=269 Identities=27% Similarity=0.374 Sum_probs=197.5
Q ss_pred HhhCCceeeecCCccEEEEEe----CCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLS----NNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 904 (1119)
+++..+.||+|+||.||++.. ..+++.||+|++.... ..+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 345568899999999999974 4467899999986432 357889999999999999999998743 346799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999976532 488999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCC-cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSS-TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
...... ......++..|+|||...+..++.++||||+||++|||++|..|+.........................+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 432211 1112234556999999988889999999999999999999887654321100000000000000000000111
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
...... ......+..+.+++.+||+.+|++|||++||++.|++++
T Consensus 240 ~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 240 KNNGRL--PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 111110 011123456889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=309.75 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=199.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..++||+|+||.||+|.+..+ ..||+|+++.. ...+.+|+.++++++||||+++++++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 4678889999999999999988765 46999998643 2457889999999999999999998754 56799999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.+++..... ..+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.++....... .
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 158 (262)
T ss_pred CCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence 9999999986432 2478999999999999999999999 999999999999999999999999999976644221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||+..+..++.++||||+|+++|||++ |+.||...... . ... .... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~--~~~--~~~~----------~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--E--VLD--QVER----------GYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--H--HHH--HHhc----------CCCC
Confidence 2223346778999999888889999999999999999999 88887543111 0 000 0000 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
......+..+.+++.+|++.+|++||+++++.+.|+.+.
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 --PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011233457789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=296.16 Aligned_cols=277 Identities=22% Similarity=0.328 Sum_probs=205.7
Q ss_pred CCCCHHHHHHhhCCceeeecCCccEEEEEeCCCc----eEEEEEecccccc------cHHHHHHHHhhcCCCCEEEEeee
Q 001226 826 RDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSR----KHWAVKKLNRSET------NFDVEIRTLSLVRHRNILRIVGS 895 (1119)
Q Consensus 826 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~l~~~ 895 (1119)
++.+.+++..|.....||+|.||.||+|..+++. +.+|||+++..++ ...+|+..++.++||||+.++.+
T Consensus 16 er~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~V 95 (438)
T KOG0666|consen 16 ERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKV 95 (438)
T ss_pred hhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHH
Confidence 3456688899999999999999999999765543 3789999976532 35789999999999999999999
Q ss_pred eec-CCceEEEEeccCCCCHHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---
Q 001226 896 CTK-DEHGFIVTEYMPGGTLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE--- 969 (1119)
Q Consensus 896 ~~~-~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--- 969 (1119)
+.. +...++++||.+. +|.++++.+.. ...++...++.++.||+.|+.|||++ =|+|||+||.|||+..+
T Consensus 96 fl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 96 FLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred HhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCc
Confidence 977 8889999999965 78888875432 34688889999999999999999999 69999999999999887
Q ss_pred -CceEEEeccccccccCC-CCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc--
Q 001226 970 -LEPKIGDFGMSKLISDS-HSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD-- 1044 (1119)
Q Consensus 970 -~~vkl~DfGla~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~-- 1044 (1119)
|.|||+|+|+++.+... .+.......+.|.+|+|||.+.+. .|+.+.||||+||++.||+|-+.-|.........
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~ 251 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN 251 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence 89999999999988654 233355678899999999988764 6899999999999999999987666432111110
Q ss_pred ------------------eeehhhhhhcccc-ccccccccc------ccCCCchHHHHHHHHHHHHHHccccCCCCCCCH
Q 001226 1045 ------------------IVTWTRWKLQENH-ECICFLDRE------ISFWDSDDQLKALRLLELALECTRQVADMRPSM 1099 (1119)
Q Consensus 1045 ------------------~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 1099 (1119)
...|...+..... .....+... +..|.......+....+++.++++.||.+|.|+
T Consensus 252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta 331 (438)
T KOG0666|consen 252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA 331 (438)
T ss_pred CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence 0112111111111 000000000 000000011112237899999999999999999
Q ss_pred HHHHHHH
Q 001226 1100 REVVGFL 1106 (1119)
Q Consensus 1100 ~ell~~L 1106 (1119)
++.+++-
T Consensus 332 ~qAleh~ 338 (438)
T KOG0666|consen 332 EQALEHP 338 (438)
T ss_pred HHHhccc
Confidence 9998763
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=325.77 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=195.4
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC-----
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE----- 900 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 900 (1119)
-+.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 356888889999999999999999999999999998532 234678999999999999999999886543
Q ss_pred -ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 901 -HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 901 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
..|+||||+++ ++.+.++. .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999965 56666542 377888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc--
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH-- 1057 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 1057 (1119)
++..... .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .+.........
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID----QWNKVIEQLGTPS 242 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCc
Confidence 9754321 22234578999999999999999999999999999999999999997532110 00000000000
Q ss_pred ---------ccccccc-----------ccccCC-----CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ---------ECICFLD-----------REISFW-----DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ---------~~~~~~~-----------~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+.. .....+ ..........+.+++.+|++.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 000000 00111224567899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.70 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=192.9
Q ss_pred eeeecCCccEEEEEe--CCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 841 IIGKGKHGTVYRTLS--NNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
.||+|+||.||+|.+ ..++..||+|+++.. .+++.+|+.+++.++||||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 455788999988533 235778999999999999999999885 45678999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC-c
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS-T 991 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~-~ 991 (1119)
+|.+++.... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||.+.......... .
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997654 488999999999999999999998 99999999999999999999999999998764432211 1
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....++..|+|||......++.++|+|||||++|||++ |+.||...... .... . ...... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~---~-i~~~~~------~~~--- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQ---M-IESGER------MEC--- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---H-HHCCCC------CCC---
Confidence 122334678999999888888999999999999999998 99998643111 1110 0 000000 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
+...+.++.+++.+||+.||++||++++|++.|+.+
T Consensus 220 ---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.28 Aligned_cols=260 Identities=24% Similarity=0.259 Sum_probs=192.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhc---CCCCEEEEeeeeec-----CCc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLV---RHRNILRIVGSCTK-----DEH 901 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~~ 901 (1119)
|+..+.||+|+||+||+|.++.+++.||+|.++.. ...+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 56678999999999999999999999999988532 12456777777665 69999999998764 245
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.++||||++ ++|.+++..... ..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+|++|||+++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 799999997 589888876542 3489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehh---------hhh
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT---------RWK 1052 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~---------~~~ 1052 (1119)
...... ......+|..|+|||++.+..++.++||||+||++|||++|+.||......+. ..... .|.
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCc
Confidence 664321 22334678999999999888899999999999999999999999864321110 00000 000
Q ss_pred hccccccccccccc-ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1053 LQENHECICFLDRE-ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... ...+.+. ...........+..+.+++.+|++.||++|||+.|++++
T Consensus 233 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 233 RDVTLP-RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccc-ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000000 000000001234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.90 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=198.9
Q ss_pred HhhCCceeeecCCccEEEEEeC-----CCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
++...++||+|+||.||++... .++..||+|..+.. ...+.+|++.++.++|+||+++++++.+.+..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4455688999999999999743 34668999988643 34688899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceE
Q 001226 906 TEYMPGGTLFNVLHQNEPR------------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 973 (1119)
|||+++++|.++++...+. ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEE
Confidence 9999999999999865421 2478899999999999999999998 999999999999999999999
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhh
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
++|||++................+++.|+|||...+..++.++|||||||++|||++ |+.||......+ .. ...
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~---~~~ 237 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AI---ECI 237 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HH---HHH
Confidence 999999876543222222233345788999999988899999999999999999998 898885431110 00 000
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
.... .. ..+...+..+.+++.+||+.||++||+++||.+.|++
T Consensus 238 ----------~~~~-~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 ----------TQGR-EL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----------HcCc-cC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000 00 0011223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=326.20 Aligned_cols=235 Identities=24% Similarity=0.370 Sum_probs=189.3
Q ss_pred ceeeecCCccEEEEEe---CCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 840 RIIGKGKHGTVYRTLS---NNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~---~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+.||+|+||.||++++ ..+++.||+|+++.. ...+..|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 356899999998642 2345679999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999999997654 489999999999999999999999 99999999999999999999999999987654321 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......|++.|+|||.+.+..++.++||||+||++|||++|+.||...... ....... .....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~----------~~~~~-- 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMIL----------KAKLG-- 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHH----------cCCCC--
Confidence 223456899999999998888999999999999999999999998643110 0000000 00000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMRE 1101 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 1101 (1119)
.+...+..+.+++.+||+.||++||++.+
T Consensus 217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01122346789999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=324.94 Aligned_cols=237 Identities=25% Similarity=0.343 Sum_probs=187.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHH-HHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEI-RTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||+||+|++..+++.||+|++.... ..+..|. .+++.++||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999985321 1233333 346778999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.||++|+.|||+. ||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 99999997654 377888889999999999999999 9999999999999999999999999998754321 122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... .......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i----------~~~~~~~-- 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNI----------LNKPLQL-- 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHH----------HhCCcCC--
Confidence 33457899999999999999999999999999999999999999642110 000000 0011110
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVV 1103 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell 1103 (1119)
....+..+.+++.+|++.+|.+||++++.+
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 --KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 112244678999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.50 Aligned_cols=258 Identities=25% Similarity=0.325 Sum_probs=204.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCC----CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeec-CCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN----SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTK-DEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+.. ++..||+|+++.. ...+.+|+.++++++||||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 456777899999999999999876 3578999988643 2346789999999999999999998766 46789
Q ss_pred EEEeccCCCCHHHhhccCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPR-----LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
+++||+++++|.+++...... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999999765322 4589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
+++.+.............++..|+|||++.+..++.++||||+||++||+++ |+.||..... . .+...... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~---~~~~~~~~-~~ 236 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--F---EMAAYLKD-GY 236 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--H---HHHHHHHc-CC
Confidence 9986644322222223346778999999988889999999999999999998 9999864311 1 11111100 00
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
... .....+..+.+++.+||+.+|++|||+.++++.|+.+.++
T Consensus 237 --------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 --------RLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred --------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 000 0111234678999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=325.84 Aligned_cols=235 Identities=26% Similarity=0.352 Sum_probs=187.0
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHH-HHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIR-TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||+||+|.+..+++.||+|++... ...+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999999999999999998532 123344444 46778999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99999887654 488999999999999999999999 9999999999999999999999999998753221 122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..... .........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~----------~~~~~~~~~- 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDN----------ILHKPLVLR- 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHH----------HHcCCccCC-
Confidence 23457899999999999999999999999999999999999998643110 00000 001111110
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMRE 1101 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 1101 (1119)
...+..+.+++.+|++.+|++||++++
T Consensus 217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 ---PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ---CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 112346779999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=309.55 Aligned_cols=252 Identities=28% Similarity=0.447 Sum_probs=199.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce---EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK---HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..+.||+|+||.||+|....++. .||+|..+.. ...+..|+++++.++|||++++.+++.+.+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 45667899999999999999876544 7999988643 235778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++..... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.+|++|||++......
T Consensus 86 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 86 EYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999976532 488999999999999999999999 9999999999999999999999999998766432
Q ss_pred CCCC-cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 987 HSSS-TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 987 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.... .......+..|+|||++....++.++||||+||++||+++ |+.||...... . ...... .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~---~~~~i~-~--------- 225 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--E---VMKAIN-D--------- 225 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--H---HHHHHh-c---------
Confidence 2111 1112233567999999988889999999999999999997 99998643111 0 111000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.... ......+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 -~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 -GFRL--PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 00112345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=324.19 Aligned_cols=234 Identities=25% Similarity=0.362 Sum_probs=185.8
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHH-HHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIR-TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||.||+|++..+++.||+|++.+.. ..+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999985321 22334443 57788999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|..++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 99998887643 478889999999999999999998 9999999999999999999999999998753221 122
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ........ .......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i----------~~~~~~~-- 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNI----------LHKPLQL-- 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHH----------hcCCCCC--
Confidence 334578999999999988889999999999999999999999996431 10110100 0111110
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMR 1100 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 1100 (1119)
+......+.+++.+|++.+|.+||++.
T Consensus 216 --~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 --PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111234678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=313.92 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=198.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCC--------------ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeee
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS--------------RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGS 895 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~--------------~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~ 895 (1119)
+|...+.||+|+||.||++.+... ...||+|+++.. ...+.+|++++++++|||+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 566778899999999999887542 235899988643 2357789999999999999999999
Q ss_pred eecCCceEEEEeccCCCCHHHhhccCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe
Q 001226 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEP---------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL 966 (1119)
Q Consensus 896 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill 966 (1119)
+..+...++||||+++++|.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill 162 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV 162 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEE
Confidence 9999999999999999999999865421 12368889999999999999999999 99999999999999
Q ss_pred CCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCCc
Q 001226 967 DSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF--RKMPVDPSFGEDTD 1044 (1119)
Q Consensus 967 ~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~~~~~~~~~~ 1044 (1119)
+.++.+|++|||++................++..|+|||....+.++.++|||||||++|||++ |..||...... .
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--~ 240 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--Q 240 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--H
Confidence 9999999999999976543322222333455779999999988889999999999999999998 56676542111 1
Q ss_pred eeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1045 IVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
............ .... ........+..+.+++.+|++.+|++||++++|++.|++
T Consensus 241 ~~~~~~~~~~~~-------~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEFFRNQ-------GRQI--YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHhhhhc-------cccc--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 000000000000 0000 000011124578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=328.63 Aligned_cols=263 Identities=20% Similarity=0.253 Sum_probs=199.2
Q ss_pred HhhCCceeeecCCccEEEEEeCC--CceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN--SRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+|...+.||+|+||.||++...+ .++.||+|.+... ....+|+++++.++||||+++++++..+...++|||++. +
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 57777999999999999997643 4678999988654 356789999999999999999999999999999999995 6
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||+++...........
T Consensus 171 ~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 171 DLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 8888885433 489999999999999999999999 9999999999999999999999999999866543333333
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc--eeehhhhhhccccccc--------cc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD--IVTWTRWKLQENHECI--------CF 1062 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~--------~~ 1062 (1119)
....||+.|+|||++.+..++.++||||+||++|||++|+.||......... +....+.......... ..
T Consensus 245 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 324 (392)
T PHA03207 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKH 324 (392)
T ss_pred cccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHH
Confidence 4567999999999999889999999999999999999999999754322110 0000000000000000 00
Q ss_pred ---ccccccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 ---LDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ---~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+....+..... ......++.+++.+|++.||++|||+.|++.+
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 325 FKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 01123467789999999999999999999987
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=315.16 Aligned_cols=250 Identities=34% Similarity=0.498 Sum_probs=198.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccccc------cHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET------NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+.++.||+|+||+||++.+..+++.||+|++..... ...+|+..++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4556899999999999999999999999999965432 1234899999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++.... .+++..+..++.|+++|+++||+. +++|+||||+||++++++.++++|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred ccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence 9999999998433 489999999999999999999999 99999999999999999999999999987642 122
Q ss_pred CcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......++..|+|||... +..++.++||||+|+++|+|++|..||...... ...... .....+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~-----------~~~~~~~~~ 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEII-----------EKILKRPLP 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHH-----------HHHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhh-----------hhccccccc
Confidence 3344567899999999988 788999999999999999999999998753000 000000 000000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+.+++.+|++.||++||++++++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001112678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=315.82 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=199.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 3667778999999999999999888999999988532 245778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++.. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-- 170 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc--
Confidence 999999998653 378889999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......+++.|+|||...+..++.++|||||||++|||++|+.||........ +..... .. .+..
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~----~~~~~~-~~-------~~~~-- 236 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA----LYLIAT-NG-------TPEL-- 236 (296)
T ss_pred cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh----HHHHhc-CC-------CCCC--
Confidence 112234688999999999888889999999999999999999999964321110 000000 00 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+......+.+++.+||+.+|++||+++|++++
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112234567899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=319.61 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=203.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-------CceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|+.++.||+|+||.||+|.+.. .+..||+|..+.. ..++.+|+.+++++ +||||+++++++.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 367888999999999999998643 2346899988642 23577899999999 7999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNE-------------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..++||||+++|+|.+++.... +...+++.++..++.|++.|++|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999997642 123578899999999999999999998 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+||+|||+++...............++..|+|||...+..++.++||||+|+++|||++ |..||..... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 243 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E 243 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-----H
Confidence 999999999999986644322222222334568999999998899999999999999999998 8888754211 1
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.+..... .. ... ..+...+..+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 244 ~~~~~~~-~~----------~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 244 ELFKLLK-EG----------HRM--DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHHHH-cC----------CCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111000 00 000 0011223467899999999999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=315.23 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=200.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce--EEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK--HWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..+.||+|+||.||+|..+.++. .+++|.++.. ...+.+|+.+++++ +||||+++++++.+.+..++||
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 45667889999999999999877654 4788887632 23577899999999 7999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceE
Q 001226 907 EYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 973 (1119)
||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEE
Confidence 99999999999976431 12488899999999999999999998 999999999999999999999
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhh
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
++|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||....... . +...
T Consensus 160 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~--~~~~- 231 (297)
T cd05089 160 IADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--L--YEKL- 231 (297)
T ss_pred ECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H--HHHH-
Confidence 9999998643211 11111233567999999988889999999999999999997 999986432110 0 0000
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
.+.... ..+...+..+.+++.+||+.+|.+||+++++++.|+++.++...
T Consensus 232 -----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 232 -----------PQGYRM--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred -----------hcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 000000 00112234678999999999999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=309.71 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=195.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|...++||+|+||.||+|.+..+++.||+|++... ...+.+|+.++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 34557899999999999999999999999988533 2347789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++++..+. .+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++++|||++......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 99996542 367888899999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......++..|+|||++.+..++.++||||+||++|||++|+.||................. ...++.....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 220 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ--------CIVDEDPPVL 220 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH--------HHhccCCCCC
Confidence 22335689999999999988899999999999999999999999975432222111100000 0000000000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+.++.+++.+|++.+|++||+++|++++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011123467899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=313.07 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=198.5
Q ss_pred HhhCCceeeecCCccEEEEEeCC----------------CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN----------------SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIV 893 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~----------------~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~ 893 (1119)
+|+..++||+|+||.||++.+.. ++..||+|+++... .++.+|+.+++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 56778899999999999986432 34568999986432 3578899999999999999999
Q ss_pred eeeecCCceEEEEeccCCCCHHHhhccCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeE
Q 001226 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEP--------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNIL 965 (1119)
Q Consensus 894 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nil 965 (1119)
+++..++..++||||+++++|.+++..... ...+++.++..++.|++.|++|||+. +++||||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence 999999999999999999999999976432 12477889999999999999999999 9999999999999
Q ss_pred eCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 001226 966 LDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF--RKMPVDPSFGEDT 1043 (1119)
Q Consensus 966 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt--g~~p~~~~~~~~~ 1043 (1119)
++.++.++++|||+++...............++..|+|||....+.++.++||||+||++|||++ |..||......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-- 240 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-- 240 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH--
Confidence 99999999999999986543322222223345678999998888889999999999999999998 67787543111
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
............ ...... . ..+...+..+.+++.+||+.||++||++++|.+.|++
T Consensus 241 ~~~~~~~~~~~~-~~~~~~----~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGEFFRD-QGRQVY----L----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHHHhh-cccccc----C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 110000000000 000000 0 0011223577899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.03 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=205.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|....+++.||+|.++. ....+.+|++++++++|++++++++++.+++..++|||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 45667889999999999999998899999998742 13457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|+++++|.+++..... ...+++.++..++.++++|++|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999875322 33588999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .......++..|+|||...+..++.++||||+||++|||++|+.||.... ........... ...
T Consensus 160 ~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~----------~~~ 224 (267)
T cd08224 160 T--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKKIE----------KCD 224 (267)
T ss_pred C--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhhhh----------cCC
Confidence 1 11223457889999999988889999999999999999999999986431 11111100000 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
.. .......+..+.+++.+||+.+|++||++.+|++.++.+.
T Consensus 225 ~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YP--PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CC--CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00 0111133457889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.63 Aligned_cols=246 Identities=28% Similarity=0.392 Sum_probs=200.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|....+++.|++|.+.. ....+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 4456789999999999999999999999998742 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++... ...+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||++........
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 82 ENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999998753 23588999999999999999999998 999999999999999999999999999886654221
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+++.|+|||+..+..++.++|+||+||++|||++|+.||..... .. ..... ......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~----------~~~~~~- 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GA---LILKI----------IRGVFP- 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHH----------HcCCCC-
Confidence 12234678899999999988899999999999999999999999864321 00 00000 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+..+.+++.+||+.+|++||++.+++++
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 --PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0111334578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=308.09 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=200.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc---eEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR---KHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|...+.||+|+||.||+|.+..++ ..||+|.++.. ...+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45677899999999999999876433 47999988643 23578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999986543 478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCC-cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 986 SHSSS-TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 986 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
..... ......++..|+|||++.+..++.++|+||+|+++||+++ |+.||...... +.. .... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~---~~~~-~~~------ 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVI---KAIE-EGY------ 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHH---HHHh-CCC------
Confidence 22111 1122234568999999988889999999999999999886 99998643211 110 0000 000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
... .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 227 --~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 0112244678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=309.17 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=199.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCce---EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRK---HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
..|...+.||+|+||.||+|..+.+++ .||||.++.. ..++..|+..++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 345667899999999999999876554 6999998643 23577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999986543 488999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCcccc-c--ccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 986 SHSSSTRSA-I--VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 986 ~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
......... . ..+..|+|||.+.+..++.++||||+||++||+++ |..||...... .. ..... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~---~~~i~-~~~---- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DV---INAIE-QDY---- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HH---HHHHH-cCC----
Confidence 222111111 1 12457999999988899999999999999999886 99998643111 11 11100 000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
... .....+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 229 ----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 ----RLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0112244678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=329.97 Aligned_cols=260 Identities=23% Similarity=0.274 Sum_probs=194.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC-----ceEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE-----HGFI 904 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 904 (1119)
++..++||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++.... ..|+
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 45568899999999999999988999999988532 234678999999999999999999998766 7899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++ ++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 82 VTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred Eeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 999996 67888776543 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc-------
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN------- 1056 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 1056 (1119)
... ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||........ ...........
T Consensus 155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHH
Confidence 322 1222344678999999988764 578999999999999999999999965321100 00000000000
Q ss_pred --ccccccc-cccccCC-----CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 --HECICFL-DREISFW-----DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 --~~~~~~~-~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+ ....... ..........+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000 0000000 00001124567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=308.26 Aligned_cols=246 Identities=30% Similarity=0.436 Sum_probs=198.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------------ccHHHHHHHHhhcCCCCEEEEeeeeecCCce
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 902 (1119)
|+.++.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999998889999999874321 3467899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999997754 378889999999999999999998 999999999999999999999999999887
Q ss_pred ccCCCCC----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 983 ISDSHSS----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 983 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
....... .......++..|+|||...+..++.++|+||+||++|||++|+.||....... ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~--~~----- 224 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----AIF--KI----- 224 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----HHH--HH-----
Confidence 6532111 11123457889999999988889999999999999999999999996431100 000 00
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+.. +...+..+.+++.+||+.+|++||++.|++++
T Consensus 225 -~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 -GENASPEI------PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred -hccCCCcC------CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00001111 11234567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=311.46 Aligned_cols=248 Identities=24% Similarity=0.299 Sum_probs=197.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||+|+||.||++.+..+++.||+|.+... ...+.+|+.+++.++|++++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 34557899999999999999999999999987532 12356799999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999999865442 3488999999999999999999998 99999999999999999999999999987553321
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......|+..|+|||.+.+..++.++||||+||++|||++|+.||........ +..... .........
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~----~~~~~~-----~~~~~~~~~- 224 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVER-----LVKEVQEEY- 224 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch----HHHHHh-----hhhhhhhhc-
Confidence 12234689999999999988999999999999999999999999975321100 000000 000000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.......+.+++.+||+.||++||| ++|+++|
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 -----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0112345789999999999999999 8899874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=304.92 Aligned_cols=245 Identities=23% Similarity=0.375 Sum_probs=192.1
Q ss_pred eeeecCCccEEEEEeC--CCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 841 IIGKGKHGTVYRTLSN--NSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
.||+|+||.||+|.++ ..+..||+|+..... ..+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999765 445679999885432 34778999999999999999999885 457799999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC-cc
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS-TR 992 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~-~~ 992 (1119)
|.+++..... .+++..+.+++.|++.|++|||++ +++||||||+||+++.++.+|++|||++.......... ..
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999875432 489999999999999999999998 99999999999999999999999999997654322211 12
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
....++..|+|||......++.++|||||||++||+++ |+.||...... .. .... .... +.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~---~~~~-~~~~----------~~-- 217 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EV---MSFI-EQGK----------RL-- 217 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HH---HHHH-HCCC----------CC--
Confidence 22234678999999888889999999999999999996 99998643211 00 0000 0000 00
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..+...+.++.+++.+||+.+|++||++.+|.+.|+++
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00112245778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=312.63 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=199.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+.. ++..||+|++... ..++.+|+.++++++||||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 356667889999999999998743 5788999988643 245778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP-------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNI 964 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Ni 964 (1119)
+||||+++++|.+++..... ...+++..+..++.|++.|++|+|+. +++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence 99999999999999975321 12477888999999999999999998 999999999999
Q ss_pred EeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 001226 965 LLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDT 1043 (1119)
Q Consensus 965 ll~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~ 1043 (1119)
+++.++.++++|||.+.................+..|+|||...+..++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-- 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-- 239 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999876543222222223345678999999888899999999999999999997 88887543111
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
...... .+..... .+...+..+.+++.+|++.+|++|||++|+++.|++
T Consensus 240 ---~~~~~~----------~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ---EVIYYV----------RDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HHHHHH----------hcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 011100 0000000 011224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=312.97 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=200.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5778889999999999999999888999999988532 234678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++++|||.+........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 999999998653 378889999999999999999998 999999999999999999999999999876543221
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+++.|+|||...+..++.++|+||+||++|++++|+.||............. ... .+..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~~~-----------~~~~-- 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNG-----------TPEL-- 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-cCC-----------CCCC--
Confidence 1233468889999999988889999999999999999999999996432111111000 000 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.+|++||++++++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112234457899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.86 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=191.9
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEec
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+..+.||+|+||+||+|.++.+++.||+|++++. ...+..|+.+++.+. |++|+++.+++.+++..|+||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 4457899999999999999999999999988542 123566888888775 67788899999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 83 VNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 99999999987654 488999999999999999999999 99999999999999999999999999987543211
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .. ... .......
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~---~~~----------i~~~~~~ 219 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--EL---FQS----------IMEHNVS 219 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HH---HHH----------HHhCCCC
Confidence 1223456899999999998888999999999999999999999999643110 00 000 0011110
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSM-----REVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ell~~ 1105 (1119)
.+...+.++.+++.+|++.+|.+|++. +++.++
T Consensus 220 ----~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 220 ----YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 011123467899999999999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=322.58 Aligned_cols=190 Identities=24% Similarity=0.357 Sum_probs=165.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
.|+..+.||+|+||.||+|.+..+++.||+|+.... ....|+.++++++||||+++++++.++...++|||++. ++|
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 477779999999999999999998999999986433 34679999999999999999999999999999999994 688
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... .+++..+..++.||+.|+.|||+. +|+||||||+||+++.++.+||+|||.++..... .....
T Consensus 144 ~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~ 215 (357)
T PHA03209 144 YTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLG 215 (357)
T ss_pred HHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC---ccccc
Confidence 888876432 489999999999999999999999 9999999999999999999999999998754321 12233
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPV 1035 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~ 1035 (1119)
..||+.|+|||++.+..++.++||||+||++|||+++..|+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 56899999999999999999999999999999999865554
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.34 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=198.6
Q ss_pred hhCCceeeecCCccEEEEEe----CCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLS----NNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFI 904 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~----~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 904 (1119)
|+..+.||+|+||.||++.. ..+++.||+|.++.. ...+.+|+.+++.++|||++++++++.+. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 45568899999999999974 456788999998532 24578899999999999999999998775 56799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++..... .+++..+..++.|++.|++|+|+. +++||||||+||+++.++.++++|||+++...
T Consensus 86 v~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999976532 489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
..... .......++..|+|||+..+..++.++||||+||++|||++++.|.................... .......+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMT-VTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccccc-HHHHHHHH
Confidence 32211 11223456778999999888889999999999999999999887653321100000000000000 00000000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..... .......+..+.+++.+|++.+|++||+++++++.++++
T Consensus 240 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCcc--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 001112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=313.70 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=197.0
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 55668899999999999999988999999988532 235778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+ ++|.+++........+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-- 155 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--
Confidence 7 68988887655444689999999999999999999999 99999999999999999999999999987554321
Q ss_pred CcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc------cccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ------ENHECICF 1062 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 1062 (1119)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+........+... .......
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD- 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH-
Confidence 122234568899999987654 57889999999999999999999986432111000000000000 0000000
Q ss_pred ccccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......+.. .....+.++.+++.+||+.||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000000 001124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=314.26 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=199.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|+..+.||+|+||.||++.+..++..||+|.++.. ..++.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 55668899999999999999999999999988543 2347789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.++++..+ .+++..+..++.|+++|+.|||+.+ +++||||||+||+++.++.+|++|||++......
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (308)
T cd06615 83 GGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 153 (308)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc----
Confidence 999999998754 4889999999999999999999732 8999999999999999999999999998755332
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc-------------
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH------------- 1057 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 1057 (1119)
......++..|+|||...+..++.++|+||+|+++|||++|+.||...... ....+.........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCCC
Confidence 123346889999999988888999999999999999999999998643211 10000000000000
Q ss_pred ------cccccccccccCC--CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ------ECICFLDREISFW--DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ------~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+...... .......+.++.+++.+|++.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000 00001134568899999999999999999999998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=313.34 Aligned_cols=197 Identities=24% Similarity=0.422 Sum_probs=161.3
Q ss_pred CCceeeecCCccEEEEEeCC--CceEEEEEeccccc--ccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEEEEeccCC
Q 001226 838 EGRIIGKGKHGTVYRTLSNN--SRKHWAVKKLNRSE--TNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFIVTEYMPG 911 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 911 (1119)
++++||+|+||.||+|..+. ++..||+|.++... ..+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 34789999999999999654 56789999886532 357789999999999999999998853 456799999986
Q ss_pred CCHHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCceEEEeccccc
Q 001226 912 GTLFNVLHQNE------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL----DSELEPKIGDFGMSK 981 (1119)
Q Consensus 912 gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~DfGla~ 981 (1119)
+++.+++.... ....+++..+..++.|++.|+.|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57877775321 123588899999999999999999999 99999999999999 566789999999998
Q ss_pred cccCCCCC-CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 982 LISDSHSS-STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 982 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
........ .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543211 12234578999999998876 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.21 Aligned_cols=248 Identities=22% Similarity=0.266 Sum_probs=197.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||+|+||+||+|.+..+++.||+|++... ...+.+|+.+++.++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 34557899999999999999999999999988532 12367799999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++..... ..+++..+..++.|++.|+.|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988876442 2589999999999999999999998 99999999999999999999999999987653321
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......|+..|+|||.+.+..++.++|+||+||++|||++|+.||........ ....... .. .....
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~-~~---------~~~~~ 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRR-VL---------ETEEV 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHh-hh---------ccccc
Confidence 12334689999999999888899999999999999999999999964311100 0000000 00 00000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.....+..+.+++.+|++.+|++||+ +++++++
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 ----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01112345689999999999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=305.04 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=197.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..++||+|+||.||+|.... +..||+|.++.. .+.+.+|+.++++++|++++++++++. +...++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 356777899999999999998765 567999988642 356889999999999999999999875 456789999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.++++.... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+........ .
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05070 84 KGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence 9999999976542 2478999999999999999999999 999999999999999999999999999976543221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||||+++|||++ |+.||...... + ..... ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~---~~~~~-----------~~~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--E---VLEQV-----------ERGYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--H---HHHHH-----------HcCCCC
Confidence 1122345678999999888889999999999999999999 88888642111 0 00000 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
..+...+..+.+++.+|++.+|++|||++++.+.|+.
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 --PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=334.17 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=190.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCC------CCEEEEeeeeecC-CceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRH------RNILRIVGSCTKD-EHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~~~~ 903 (1119)
.+|...++||+|+||+||+|.+..+++.||||+++.. ..+...|+.+++.++| .+++++++++..+ +..+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 3577778999999999999999998999999998542 2345668888777754 4589999988764 5688
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-------------
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL------------- 970 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~------------- 970 (1119)
+|||++ +++|.+++...+ .+++..+..++.||+.||+|||+++ +||||||||+||+++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred EEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccccccCC
Confidence 999988 788999887654 4899999999999999999999732 999999999999998765
Q ss_pred ---ceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee
Q 001226 971 ---EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 971 ---~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 1047 (1119)
.+||+|||.+..... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||+..... .....
T Consensus 283 ~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-EHLHL 356 (467)
T ss_pred CCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence 499999998764322 233467899999999999999999999999999999999999999753211 00000
Q ss_pred hhh--------hhhcc-ccccccccccc--ccC-------------CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001226 1048 WTR--------WKLQE-NHECICFLDRE--ISF-------------WDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103 (1119)
Q Consensus 1048 ~~~--------~~~~~-~~~~~~~~~~~--~~~-------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell 1103 (1119)
... |.... ......+++.. +.. ...........+.+++.+||+.||++|||++|++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 000 00000 00000000000 000 0000111234577999999999999999999999
Q ss_pred HH
Q 001226 1104 GF 1105 (1119)
Q Consensus 1104 ~~ 1105 (1119)
+|
T Consensus 437 ~H 438 (467)
T PTZ00284 437 TH 438 (467)
T ss_pred cC
Confidence 84
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=304.89 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=202.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+|+..+.||+|+||.||+|....+++.||+|.++.. .+++.+|+++++.++||||+++++++.++...|+++||++++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 83 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG 83 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence 456668899999999999999988899999998643 457889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++..... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++....... ...
T Consensus 84 ~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (256)
T cd06612 84 SVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AKR 156 (256)
T ss_pred cHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc--ccc
Confidence 99999976442 589999999999999999999999 99999999999999999999999999988664422 122
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....++..|+|||.+.+..++.++||||+|+++|||++|+.||.......... .. .........
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~---------------~~~~~~~~~ 220 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MI---------------PNKPPPTLS 220 (256)
T ss_pred ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hh---------------ccCCCCCCC
Confidence 33457889999999988889999999999999999999999986432111000 00 000000001
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+......+.+++.+|++.+|++|||++|++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122334578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=327.25 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=193.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||+|+||.||+|.++.+++.||+|+++.. ...+.+|+.++..++||+|+++++++.+++..|+||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 45568899999999999999999999999998532 23467799999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999997654 488999999999999999999999 999999999999999999999999999875432110
Q ss_pred C---------------------------------CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 001226 989 S---------------------------------STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPV 1035 (1119)
Q Consensus 989 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~ 1035 (1119)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011347999999999999999999999999999999999999999
Q ss_pred CCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 001226 1036 DPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS---MREVVGF 1105 (1119)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ell~~ 1105 (1119)
....... .+... ... ...+.. ......+.++.+++.+|+ .+|++|++ ++|+++|
T Consensus 237 ~~~~~~~----~~~~i--~~~-------~~~~~~--p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE----TYRKV--MNW-------KETLVF--PPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH----HHHHH--HcC-------CCceec--CCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 6432110 00000 000 000000 000112345677888876 49999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=308.58 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=202.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCce----EEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRK----HWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+|...+.||+|+||.||+|..+.+++ .||+|..+... ..+.+|+..+++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 456777899999999999999766554 68999886432 357789999999999999999999887 78899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999987543 489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
............++..|+|||......++.++|+||+|+++||+++ |+.||...... + +..... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~---~~~~~~-~~~------ 228 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--E---IPDLLE-KGE------ 228 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--H---HHHHHh-CCC------
Confidence 3322222222334678999999888889999999999999999998 99998643111 1 111000 000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
.. ..+...+..+.+++.+||..+|++||++.++++.|+++..+.
T Consensus 229 --~~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 229 --RL----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred --CC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00 001112346789999999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=306.39 Aligned_cols=247 Identities=29% Similarity=0.511 Sum_probs=201.4
Q ss_pred ceeeecCCccEEEEEeCCC---ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|..... +..||+|.++.. ...+.+|++.++.++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 889999998643 34677899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 912 GTLFNVLHQNEP------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 912 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
++|.+++..... ...+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987621 13589999999999999999999998 999999999999999999999999999987765
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........++..|+|||......++.++||||+|+++|||++ |+.||..... ... ..... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~---~~~~~-~~-------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEV---LEYLR-KG-------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHH---HHHHH-cC--------
Confidence 432233344567889999999888889999999999999999998 6999865311 110 00000 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
... ..+...+.++.+++.+|++.+|++|||++|++++|+
T Consensus 224 ~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRL----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 111222567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=303.61 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=197.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|...+.||+|+||.||+|.+..+ ..||+|...... ..+.+|++++++++|||++++++++. ++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3566778999999999999988764 468999875432 45788999999999999999999875 456789999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||.+........ .
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05069 84 KGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence 9999999976542 3478999999999999999999998 999999999999999999999999999976643221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||+|+++|||++ |+.||...... . .+ .... . ....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~--~~-~~~~-~----------~~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--E--VL-EQVE-R----------GYRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H--HH-HHHH-c----------CCCC
Confidence 1222345678999999988889999999999999999999 89898643111 0 00 0000 0 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..+...+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 223 --PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred --CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 00112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=302.84 Aligned_cols=244 Identities=28% Similarity=0.428 Sum_probs=194.2
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
++||+|+||.||+|... ++..||+|.++... ..+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999865 47889999885432 3477899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... .+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||++........ .....
T Consensus 80 ~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 80 LSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 999876542 478999999999999999999998 999999999999999999999999999875543211 11122
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCch
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1119)
..++..|+|||+..+..++.++||||+|+++||+++ |..||....... . ......... .. .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~----~~~~~~~~~--------~~----~ 215 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--A----REQVEKGYR--------MS----C 215 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--H----HHHHHcCCC--------CC----C
Confidence 344678999999988889999999999999999998 999986431110 0 000000000 00 0
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1074 DQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1074 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 250 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence 11124578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=304.94 Aligned_cols=250 Identities=27% Similarity=0.448 Sum_probs=198.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
.|...++||+|+||.||+|..+. ++.||+|.+.... .++.+|+.++++++|||++++++++. ++..++||||+++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 45667899999999999998765 6789999886433 46888999999999999999999874 4568999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+........ ..
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05067 85 GSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence 999999876542 3588999999999999999999998 999999999999999999999999999876643221 11
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....++..|+|||+.....++.++||||+|+++||+++ |+.||..... ...... . ......
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~--~------------~~~~~~- 222 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQN--L------------ERGYRM- 222 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHH--H------------HcCCCC-
Confidence 223345778999999988889999999999999999998 9999864321 111000 0 000000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
......+.++.+++.+|++.+|++||+++++.+.|+.+
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 -PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 00011234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=315.47 Aligned_cols=265 Identities=20% Similarity=0.226 Sum_probs=198.5
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+.+|+..+.||+|+||.||+|.++.+++.||+|.++.. ...+.+|+..++.++||||+++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 345678889999999999999999998999999988532 234678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++ ++|.+++..... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||++......
T Consensus 84 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 589988876543 478899999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hccccccccc--
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENHECICF-- 1062 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-- 1062 (1119)
. .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ........ ..........
T Consensus 158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhc
Confidence 1 12223457889999998765 4578899999999999999999999965321100 00000000 0000000000
Q ss_pred ----ccccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 ----LDREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ----~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......... ......+..+.+++.+|++.||.+|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000 0001224467899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.19 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=198.5
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|+..+.||+|+||.||++.+..+++.||+|.++. ..+.+.+|+.+++.++||||+++++.+.+++..|+||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 4566899999999999999999999999998743 22457789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++++.+++..... ..+++..+..++.|++.|+.|||+. +++|+||||+||++++++.++++|||.+....... .
T Consensus 82 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 82 GGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 9999998875432 2478899999999999999999998 99999999999999999999999999987654322 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......+++.|+|||+..+..++.++|+||+|+++|+|++|+.||..... ..... .... ....
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~-~~~~---------~~~~-- 218 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLIL-KVCQ---------GSYK-- 218 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHH-HHhc---------CCCC--
Confidence 22335688899999999888899999999999999999999999864211 00000 0000 0000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.+|++||++++++..
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=324.17 Aligned_cols=262 Identities=24% Similarity=0.283 Sum_probs=195.5
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------ 899 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 899 (1119)
-+.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346788889999999999999999989999999988642 13456799999999999999999988643
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
...|+||||+++ ++.+++.. .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcc
Confidence 346999999965 66666643 378889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce----------eeh-
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI----------VTW- 1048 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~----------~~~- 1048 (1119)
++..... .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+... ..+
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 22234578999999999988899999999999999999999999996432110000 000
Q ss_pred h------hhhhccccccc-----ccc-cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1049 T------RWKLQENHECI-----CFL-DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1049 ~------~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ........... ... +.............+..+.+++.+|++.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00000000000 000 000000001111234567899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=308.54 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=194.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhc-CCCCEEEEeeeeecC------CceEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLV-RHRNILRIVGSCTKD------EHGFIV 905 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~~~~lV 905 (1119)
|+..+.||+|+||.||+|....+++.||+|++... ...+..|+.+++++ +||||+++++++... ...|+|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 45557899999999999999999999999998543 34578899999988 699999999998653 357899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++..... ..+++..+..++.|++.|++|||+. +|+|||+||+||++++++.++++|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 999999999999986442 3588999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
.. .......|+..|+|||++. +..++.++||||+||++|||++|+.||....... ... .... .
T Consensus 164 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~--~~~~-~--- 231 (272)
T cd06637 164 TV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALF--LIPR-N--- 231 (272)
T ss_pred cc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHH--HHhc-C---
Confidence 21 2233456889999999875 3457889999999999999999999986431110 000 0000 0
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+... ....+..+.+++.+||+.+|++|||+++++++
T Consensus 232 --~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 --PAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --CCCCCC-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000 01123467899999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=306.45 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=193.3
Q ss_pred ceeeecCCccEEEEEeCCCce--EEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRK--HWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|....++. .+|+|.++.. ...+.+|+.+++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999887665 4688887632 23577899999999 799999999999999999999999999
Q ss_pred CCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 912 GTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 912 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
|+|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999976431 12478999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
++..... .........+..|+|||+.....++.++|||||||++|||++ |..||...... .. + .. .....
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~--~-~~-~~~~~ 228 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--EL--Y-EK-LPQGY 228 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HH--H-HH-HhCCC
Confidence 9863221 111112234567999999988889999999999999999997 99998643111 00 0 00 00000
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
... .....+..+.+++.+|++.+|.+|||++++++.|+++.
T Consensus 229 --------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 --------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCC----CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000 00112346789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=303.01 Aligned_cols=247 Identities=25% Similarity=0.433 Sum_probs=200.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|... ++.||+|+++... .++.+|+.+++.++|+||+++++++.++...++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35566789999999999999875 6889999997554 367889999999999999999999998899999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++++|||.++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999986542 2589999999999999999999999 999999999999999999999999999986633211
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
....+..|+|||+...+.++.++||||+|+++||+++ |+.||...... +... .. ......
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~---~~-----------~~~~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVP---HV-----------EKGYRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHH---HH-----------hcCCCC
Confidence 2234668999999988889999999999999999997 99998643111 1000 00 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..+...+..+.+++.+|++.+|++||+++|++++|+++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 --EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00112245788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=304.22 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=197.2
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc--ccHHHHHHHHhhcCCCCEEEEeeeee-cCCceEEEEecc
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEIRTLSLVRHRNILRIVGSCT-KDEHGFIVTEYM 909 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~ 909 (1119)
..+|+..+.||+|+||.||++... +..||+|..+... ..+.+|+.++++++|+|++++++++. +++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 456777899999999999999765 6789999886433 35788999999999999999999764 456789999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999986543 3488999999999999999999998 99999999999999999999999999987543321
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
....++..|+|||+..+..++.++||||+||++|||++ |+.||.... ......... ... ...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~-~~~------~~~-- 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVE-KGY------KMD-- 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHh-cCC------CCC--
Confidence 12234668999999988889999999999999999997 999985321 111111000 000 000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.....+..+.+++.+|++.+|++|||++++++.|+++
T Consensus 220 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 ----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0112245678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=317.59 Aligned_cols=266 Identities=23% Similarity=0.297 Sum_probs=209.5
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCC------ceEEEEe
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDE------HGFIVTE 907 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e 907 (1119)
.+.||+||||.||+|+++.+|+.||||.++. ..+...+|++++++++|||||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3679999999999999999999999999854 4456788999999999999999999866543 4589999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCCc--eEEEeccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD--SELE--PKIGDFGMSKLI 983 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~--vkl~DfGla~~~ 983 (1119)
||.||||..++.+......+++.+...+..+++.|+.|||++ +||||||||.||++- ++|+ -|++|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999999988888899999999999999999999998 999999999999983 4454 599999999988
Q ss_pred cCCCCCCcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.+.. .....+||..|.+||... ++.|+..+|.|||||++||.+||..||.+..+...............+......
T Consensus 175 ~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 175 DDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred CCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 6643 556789999999999887 588999999999999999999999999886655433322222222222222222
Q ss_pred ccccc----------cCCCchHHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHccc
Q 001226 1063 LDREI----------SFWDSDDQLKALRLLELALECTRQVADMRP--SMREVVGFLIKLN 1110 (1119)
Q Consensus 1063 ~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--s~~ell~~L~~~~ 1110 (1119)
.++.. +............+-+.+..++..+|++|. ...+..+.+..+.
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 22221 111122344555678888899999999999 6666555555443
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=307.69 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=196.1
Q ss_pred ceeeecCCccEEEEEeCCCc------eEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 840 RIIGKGKHGTVYRTLSNNSR------KHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~------~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+.||+|+||.||+|...... +.||+|.+... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46899999999999876533 67999987532 34577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-----ceEEEeccc
Q 001226 909 MPGGTLFNVLHQNE----PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-----EPKIGDFGM 979 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~DfGl 979 (1119)
+++++|.+++.... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 123478899999999999999999998 999999999999999887 899999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~---~------- 225 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQ---H------- 225 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHH---H-------
Confidence 976644332222333456788999999998999999999999999999998 9999863211 01000 0
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
+...... ......+..+.+++.+||+.+|++||+++++.+.|++
T Consensus 226 ----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 ----VTAGGRL--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----HhcCCcc--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0000000 0112234578899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=312.83 Aligned_cols=256 Identities=24% Similarity=0.418 Sum_probs=200.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce----EEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK----HWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+++..+.||+|+||.||+|.+..+++ .||+|.+.... ..+.+|+.+++.++||||+++++++... ..++|
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 44556889999999999999876665 57888875432 2567899999999999999999998654 46799
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
+||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 87 ~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999876542 478899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .....+.. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~----~~-------- 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLE----KG-------- 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH----CC--------
Confidence 322222223445778999999988889999999999999999997 8999864311 11111100 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
..... +...+.++.+++.+||..+|++||+++++++.++++..+.+
T Consensus 228 ~~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 228 ERLPQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 00000 01123467899999999999999999999999999866554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=304.26 Aligned_cols=246 Identities=26% Similarity=0.394 Sum_probs=196.2
Q ss_pred ceeeecCCccEEEEEeCC-Cc--eEEEEEecccccc-----cHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNN-SR--KHWAVKKLNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~-~~--~~vavK~~~~~~~-----~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|++|.||+|.+.. .+ ..||+|.++.... .+.+|+..+++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998755 23 3699999865433 57789999999999999999999988 888999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC-C
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-S 990 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~-~ 990 (1119)
++|.+++..... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++......... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999987653 3589999999999999999999999 9999999999999999999999999999876542211 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||+||++|||++ |+.||......+ ......... ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~--------~~~-- 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDKEG--------ERL-- 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhcC--------CcC--
Confidence 2223457789999999988889999999999999999998 999986431110 000000000 000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
..+...+..+.+++.+|++.+|++||+++++++.|.
T Consensus 221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 001123457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=307.28 Aligned_cols=251 Identities=27% Similarity=0.358 Sum_probs=186.6
Q ss_pred ceeeecCCccEEEEEeCC--CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNN--SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||+|.... ....||+|.+... ...+.+|+..++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999996543 3457899977532 234678999999999999999999999999999999999999
Q ss_pred CHHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 913 TLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 913 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|.+++..... ....++..+..++.||+.|++|||+. +|+||||||+||+++.++.+|++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999987543 12356778899999999999999999 99999999999999999999999999987543322222
Q ss_pred cccccccCCCcccccccC-------CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAY-------STRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
......++..|+|||+.. ...++.++||||+||++|||++ |..||......+ .......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~~~---~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQVVREQD---IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhhccC---ccC
Confidence 223345677899999754 3456889999999999999998 778875431110 0000000000 000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
..+. .+...+..+.+++..|+ .||++|||+++|++.+.
T Consensus 231 ~~~~------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0010 11123345677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=304.43 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=201.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..++||+|+||.||+|...+ ++.||||.+... ..++.+|+..+++++|||++++++++..+...++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 467778999999999999999765 578999988643 3468899999999999999999999998889999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... ..+++.++..++.|++.|++|||+. +++|+||||+||++++++.++++|||.+....... ..
T Consensus 85 ~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 159 (261)
T cd05034 85 KGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT 159 (261)
T ss_pred CCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence 9999999987542 3589999999999999999999999 99999999999999999999999999987664321 11
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||...+..++.++||||+|+++||+++ |+.||...... . ...... .....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~--~~~~~~------------~~~~~ 223 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--E--VLEQVE------------RGYRM 223 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H--HHHHHH------------cCCCC
Confidence 1122334678999999988889999999999999999998 99998543110 0 000000 00000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..+...+..+.+++.+|++.+|++||+++++.+.|+.+
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 00111245688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=314.90 Aligned_cols=266 Identities=18% Similarity=0.215 Sum_probs=195.2
Q ss_pred ceeeec--CCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKG--KHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+| +|++||++.++.+++.||+|+++... ..+.+|+.+++.++||||+++++++..++..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 579999 67899999999999999999986432 3467799999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC--
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-- 989 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~-- 989 (1119)
|+|.+++..+.. ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 84 GSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999976532 2488999999999999999999998 9999999999999999999999999865443221110
Q ss_pred ---CcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc----------
Q 001226 990 ---STRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ---------- 1054 (1119)
Q Consensus 990 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 1054 (1119)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||.......... ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-HHhcCCccccccccchhh
Confidence 01122356778999998875 458899999999999999999999997432111000 00000000
Q ss_pred -----------ccccccc--ccccccc-----CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHccc
Q 001226 1055 -----------ENHECIC--FLDREIS-----FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLN 1110 (1119)
Q Consensus 1055 -----------~~~~~~~--~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~ 1110 (1119)
....... ...+... ............+.+++.+||+.||++|||++|++++ +++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0000000 0000000 0000112234578899999999999999999999985 44443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=318.98 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=193.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||+||++.+..+++.||+|++++ ....+.+|+.+++.++|+||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 45667899999999999999999999999999853 12346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++..... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 82 YYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred cCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999976432 488999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCCcccccccCCCcccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ..+.. ....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~----~~~~~-i~~~------- 223 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGK-IMNH------- 223 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH----HHHHH-HHcC-------
Confidence 1 12223468999999998763 45788999999999999999999998642110 00000 0000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVAD--MRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~RPs~~ell~~ 1105 (1119)
....... ......+..+.+++.+|+..+++ .||++++++++
T Consensus 224 -~~~~~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 -KEHFQFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCcccCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000000 00111344667888887765444 38899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=321.34 Aligned_cols=257 Identities=25% Similarity=0.295 Sum_probs=195.1
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------C
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------E 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 900 (1119)
+.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46788889999999999999999999999999998542 23466899999999999999999987543 3
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..|+||||+++ ++.+++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 56999999965 67777643 377889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc------
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ------ 1054 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 1054 (1119)
+..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+......
T Consensus 174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~ 246 (364)
T cd07875 174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQLGTPCP 246 (364)
T ss_pred cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCH
Confidence 865432 1223456899999999999999999999999999999999999999643211 000000000
Q ss_pred ---------------ccc-----ccccccccc-ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ---------------ENH-----ECICFLDRE-ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ---------------~~~-----~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ......... ..............+.+++.+|++.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000000000 000000011123467899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=340.50 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=194.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 905 (1119)
.+|+..+.||+|+||+||+|.+..++..||+|++... ...+..|+.+++.++|||||+++++|.+ ....|+|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 4677789999999999999999999999999988532 2457789999999999999999998854 3568999
Q ss_pred EeccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeEeCC------------
Q 001226 906 TEYMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCV----PQIIHRDIKSDNILLDS------------ 968 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~Dlkp~Nill~~------------ 968 (1119)
|||+++|+|.+++..... ...+++..++.|+.||+.||.|||+... .+||||||||+|||++.
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999999976422 2358999999999999999999998521 25999999999999964
Q ss_pred -----CCceEEEeccccccccCCCCCCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCC
Q 001226 969 -----ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041 (1119)
Q Consensus 969 -----~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~ 1041 (1119)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-- 247 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-- 247 (1021)
T ss_pred cccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC--
Confidence 2458999999998664321 2234578999999998754 458899999999999999999999996421
Q ss_pred CCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1042 DTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
........ .... +.+. ....+..+.+++..||+.+|++||++.|+++
T Consensus 248 --~~~qli~~-lk~~--------p~lp-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 --NFSQLISE-LKRG--------PDLP-----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --cHHHHHHH-HhcC--------CCCC-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11111000 0000 0010 0112456789999999999999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=310.62 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=199.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.||.|+||.||+|.+..+++.||+|.+... ...+.+|+..++.++|||++++++++..++..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 566778999999999999999999999999988532 2456789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++........
T Consensus 100 ~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 100 GGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 99999988653 378999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......++..|+|||.+.+..++.++||||+||++|+|++|+.||........ ..... .... +..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~~~~-~~~~-------~~~--- 235 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIA-TNGT-------PEL--- 235 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHH-hcCC-------ccc---
Confidence 12334688899999999888899999999999999999999999865321100 00000 0000 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+..+.+++.+||+.+|++||++++++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 -QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0111223467899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.91 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=200.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCC---ceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+++..+.||+|+||.||+|.+... ...||||...... +.+.+|+.+++.++||||+++++++.+ ...++||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~ 85 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVM 85 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEE
Confidence 466678999999999999987543 4568999875432 357889999999999999999998875 4578999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999976543 489999999999999999999998 9999999999999999999999999998766443
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
... ......++..|+|||......++.++||||+|+++||+++ |+.||......+ ... ... ...
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~--~~~--~~~-------- 225 (270)
T cd05056 161 SYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIG--RIE--NGE-------- 225 (270)
T ss_pred cce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHH--HHH--cCC--------
Confidence 211 1222334568999999888889999999999999999986 999986542111 000 000 000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
... .+...+..+.+++.+|+..+|++|||+.++++.|+++..+.
T Consensus 226 ~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 226 RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000 01122457889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=308.38 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=202.4
Q ss_pred hhCCceeeecCCccEEEEEeCC----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNN----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFI 904 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 904 (1119)
++..+.||+|+||.||+|.... ++..||||+++... ..+.+|+..++.++||||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 4445889999999999998653 47889999986433 368899999999999999999999877 557899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 86 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999987653 489999999999999999999998 99999999999999999999999999998775
Q ss_pred CCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
..... .......++..|+|||...+..++.++||||+|+++|||++|+.|+............... ...........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ-GQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc-ccccHHHHHHHH
Confidence 32221 1112234566799999998888999999999999999999999998653221111000000 000000000111
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
...... ..+...+.++.+++.+||+.+|++||+++||+++|+++.
T Consensus 240 ~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGERL--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCCcC--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111110 011123357889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.72 Aligned_cols=249 Identities=30% Similarity=0.466 Sum_probs=190.4
Q ss_pred ceeeecCCccEEEEEeCC---CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeee-cCCceEEEEeccC
Q 001226 840 RIIGKGKHGTVYRTLSNN---SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCT-KDEHGFIVTEYMP 910 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~ 910 (1119)
+.||+|+||.||+|.+.. ....||+|.+... ...+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 3467999988532 235678999999999999999999775 4556799999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC-
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS- 989 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~- 989 (1119)
+++|.+++..... ..++..+..++.|+++|++|||+. +++||||||+||++++++.+|++|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976543 367788899999999999999998 9999999999999999999999999998765432111
Q ss_pred -CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 990 -STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK-MPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 990 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.......++..|+|||...+..++.++|||||||++|||++|. .||.... ... ........ ...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~---~~~~~~~~---------~~~ 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFD---ITVYLLQG---------RRL 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHH---HHHHHhcC---------CCC
Confidence 1112334577899999988888999999999999999999965 4443211 001 11100000 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
. .+...+..+.+++.+||+.+|++||++.|+++.++++..
T Consensus 222 ~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0 011123467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.23 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=203.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||.|+||+||+|....++..||+|++... ...+.+|+..++.++|+|++++++.+..++..++|||++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 466778999999999999999888999999988532 245788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++...+...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 9999999998754434589999999999999999999998 9999999999999999999999999998776543222
Q ss_pred C--cccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 990 S--TRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 990 ~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. ......++..|+|||.+... .++.++|+||+||++|||++|+.||....... ......... ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~--------~~~ 226 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQND--------PPS 226 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcCC--------CCC
Confidence 1 23345688999999988776 78999999999999999999999986432110 011100000 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.... ......+..+.+++.+|++.+|++||++++++++
T Consensus 227 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1000 0011234567899999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.04 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=195.8
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
++||+|+||.||+|.+.. ++.||+|.++.. ...+.+|+.+++.++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999888 899999988643 23578899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... .+++..+..++.+++.|++|||+. +++||||+|+||+++.++.++++|||.+..............
T Consensus 80 ~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 80 LTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999976532 478889999999999999999999 999999999999999999999999999976543221111122
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCch
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1119)
...+..|+|||.+.++.++.++|+||+||++|||++ |..||...... ... .. ..... .. ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~---~~-~~~~~--------~~----~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTR---ER-IESGY--------RM----PA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHH---HH-HhcCC--------CC----CC
Confidence 334667999999888889999999999999999998 88887543211 000 00 00000 00 01
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1074 DQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1074 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
+...+..+.+++.+|++.+|++||+++|+++.|++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.39 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=201.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||.|+||.||.++...+++.|++|.+... ..++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 356678999999999999999999999999987432 23577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999998754 23588999999999999999999998 999999999999999999999999999886644221
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......+++.|+|||...+..++.++||||+|+++|||++|+.||...... ..... .......
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~----------~~~~~~~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVK----------IVQGNYT 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHH----------HHcCCCC
Confidence 223456899999999998888899999999999999999999998642110 00000 0001111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
......+.++.+++.+||+.+|++||++++++++.
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 01122345688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.62 Aligned_cols=248 Identities=23% Similarity=0.419 Sum_probs=198.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+++..+.||+|+||.||+|.+.. ++.+|+|.++.. ..++.+|++++++++||+++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 45666889999999999998864 678999988643 35688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++..... .++++.+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+........ ..
T Consensus 84 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 84 GCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999999976542 478899999999999999999999 999999999999999999999999999876543211 11
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....++.+|+|||...++.++.++||||+|+++|||++ |+.||..... .. .... .... .....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--~~---~~~~-~~~~---~~~~~------ 222 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--SE---VVET-INAG---FRLYK------ 222 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--HH---HHHH-HhCC---CCCCC------
Confidence 222345678999999988889999999999999999998 9999864211 00 0000 0000 00000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
+...+..+.+++.+||+.+|++||+++|+++.|+
T Consensus 223 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 ---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 0112357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=320.87 Aligned_cols=257 Identities=25% Similarity=0.321 Sum_probs=193.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecC------Cc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKD------EH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 901 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46777899999999999999999999999999986432 3466799999999999999999987543 34
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.|+++|++ +++|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999988 78998887643 388999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc--
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE-- 1058 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1058 (1119)
..... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ ....+..........
T Consensus 167 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 167 QADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEVL 240 (343)
T ss_pred ecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 65432 223468999999998876 568899999999999999999999986431110 000000000000000
Q ss_pred -------ccccccccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 -------CICFLDREISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 -------~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+ ..+....... ......+.+++.+|++.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000000 0112346799999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.85 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=195.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
|+..+.||+|+||.||+|.+..++..+|+|.+... ...+.+|+.+++.++|||++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 44557899999999999999999999999988532 23577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++.... ..+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+|++|||++....... ..
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 99998886533 2489999999999999999999999 99999999999999999999999999987653321 12
Q ss_pred ccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 992 RSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.....++..|+|||.+. +..++.++||||+||++|||++|+.||...... ........ . . ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~-~--~-----~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIAK-S--E-----PPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHhh-c--C-----CCC
Confidence 23456889999999873 345788999999999999999999998642110 00000000 0 0 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ..+...+..+.+++.+||+.+|++||++++++++
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 L----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111224567899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.64 Aligned_cols=252 Identities=29% Similarity=0.413 Sum_probs=197.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--------------cccHHHHHHHHhhcCCCCEEEEeeeeecCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE 900 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 900 (1119)
+|...+.||+|+||.||+|....+++.||+|.++.. .+.+..|+.+++.++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 456678999999999999999888999999987421 124677999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..++||||+++++|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999998764 488899999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTR--LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
+...............++..|+|||...... ++.++|+||+|+++||+++|..||..... ...... .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~--~~~~-~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFK--LGNK-R 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHH--hhcc-c
Confidence 7654322222223345788999999877654 78999999999999999999999853211 000000 0000 0
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+.. ......+..+.+++.+|++.+|++||++++++++
T Consensus 229 ~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPP------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCc------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000000 1111234578899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.95 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=199.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.|+..+.||.|+||.||+|.+..++..||+|+++... ..+.+|+.+++.+.||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3455678999999999999999889999999886432 35778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++... .+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06640 85 GGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc--
Confidence 999999998753 378889999999999999999998 99999999999999999999999999997664322
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......++..|+|||.+.+..++.++|+|||||++|||++|..||......... . ......
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~-----------~~~~~~-- 217 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----F-----------LIPKNN-- 217 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----h-----------hhhcCC--
Confidence 1222346788999999998888999999999999999999999998643211000 0 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+..+.+++.+||+.+|++||++++++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 001122345678899999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.76 Aligned_cols=236 Identities=24% Similarity=0.394 Sum_probs=184.3
Q ss_pred ceeeecCCccEEEEEeCC------------CceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 840 RIIGKGKHGTVYRTLSNN------------SRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~------------~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
+.||+|+||.||+|.... ....||+|++.... ..+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 23468999875432 34677889999999999999999999988999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc-------eEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE-------PKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------vkl~D 976 (1119)
+||||+++++|..+++.... .+++..+.+++.||++|++|||+. +|+||||||+||+++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988875432 488999999999999999999999 9999999999999987664 89999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCCceeehhhhhhc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELL-FRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+ ....
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~--- 221 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----KERF--- 221 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----HHHH---
Confidence 998865432 22345788999999876 466899999999999999998 5888875321110 0000
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
........ ......+.+++.+||+.||++||++++|++++
T Consensus 222 --------~~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 --------YEGQCMLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------HhcCccCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00000000 01124678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=305.56 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=197.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+++... ..+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 5566688999999999999999999999999885432 346789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++...+ .+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||.+...... ..
T Consensus 90 ~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 90 GGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 999999987654 488999999999999999999999 9999999999999999999999999998765432 12
Q ss_pred cccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
......|+..|+|||.+. ...++.++|+||+||++|||++|+.||....... ........ ....+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~~---------~~~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTKS---------NFQPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhcc---------CCCCCcc
Confidence 223456899999999874 4567889999999999999999999985432111 00000000 0000000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. .....+..+.+++.+|++.+|++||++++++++
T Consensus 232 ~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 K----DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred c----ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 001123457899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=308.30 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=195.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|.+..+|+.||+|+++.. ...+.+|+.+++.++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 55668899999999999999999999999988532 235678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+ +++.+++..... .+++..+..++.||++|+.|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 82 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 82 D-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred C-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 6 588888765432 489999999999999999999999 99999999999999999999999999987654321
Q ss_pred CcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee------------ehhhhhhccc
Q 001226 990 STRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV------------TWTRWKLQEN 1056 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~------------~~~~~~~~~~ 1056 (1119)
.......++..|+|||.+.+. .++.++||||+||++|||++|+.|+........... .|........
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 122234578899999987664 478999999999999999999999754322111000 0000000000
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......... ...+.........++.+++.+||+.||++|||+++++++
T Consensus 234 ~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPA-TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCC-cchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000 000000111234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=316.71 Aligned_cols=240 Identities=25% Similarity=0.399 Sum_probs=193.2
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEec------cccc--ccHHHHHHHHhhcCCCCEEEEeeeeecCCc--eEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL------NRSE--TNFDVEIRTLSLVRHRNILRIVGSCTKDEH--GFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~------~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~~ 909 (1119)
.+||+|+|-+||+|.+..+|..||--.+ +... +.+..|+.+++.++|||||++++++.+... .-+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 4599999999999999999998875433 2222 568899999999999999999999987654 67899999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccccccccCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~~~~~ 988 (1119)
..|+|..|.++++. ++.+..+.|++||.+||.|||++ .|+|+|||||-+||+|+.+ |.|||+|.|+|......
T Consensus 126 TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 126 TSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred cCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 99999999999874 88899999999999999999997 6799999999999999865 89999999999987543
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.....+|||.|||||... ..|++.+||||||+.+.||+|+.+||........-+....... .+..+..+
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi--KP~sl~kV------ 268 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI--KPAALSKV------ 268 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC--CHHHhhcc------
Confidence 223478999999999665 8899999999999999999999999975432211110000000 01111111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...++.++|.+|+.. ..+|||+.|++++
T Consensus 269 --------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 --------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 123678999999999 8899999999874
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.85 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=192.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeec--CCceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 903 (1119)
.|+.++.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+ +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 356678999999999999999999999999987422 1346789999999999999999998865 35678
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+++||+++++|.+++.... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++++|||+++..
T Consensus 83 l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 9999999999999997654 378889999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCC-CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHS-SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... ........++..|+|||.+.+..++.++||||+||++||+++|+.||..... ...... .. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~--~~-----~~~ 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFK--IA-----TQP 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHH--Hh-----cCC
Confidence 32111 1112234578899999999888899999999999999999999999864211 000000 00 000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+. .+......+.+++ +||..+|++||+++||++|
T Consensus 226 ~~~~------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 TNPQ------LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCC------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0011 1122233455666 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=316.17 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=194.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..++||+|+||.||+++++.+++.||+|++.+. ...+.+|+.++..++|++|+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 355678999999999999999999999999998531 2236788999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++++... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999986432 488889999999999999999999 99999999999999999999999999987553321
Q ss_pred CCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
........||+.|+|||++. ...++.++||||+||++|||++|+.||...... ..... ....
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~----~~~~~-i~~~------- 223 (332)
T cd05623 157 -TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGK-IMNH------- 223 (332)
T ss_pred -cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH----HHHHH-HhCC-------
Confidence 12223457899999999875 346789999999999999999999999643110 00000 0000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~ 1105 (1119)
...... .......+..+.+++.+|+..+|++ |++++|+++|
T Consensus 224 -~~~~~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 -KERFQF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -CccccC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000000 0111123456788899988665544 7899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.75 Aligned_cols=245 Identities=27% Similarity=0.382 Sum_probs=192.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
..||+|+||.||+|.+..++..||+|.+... ...+.+|+.+++.++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 5799999999999999988999999987543 345788999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEEeccccccccCCCCCCcccc
Q 001226 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 916 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
+++.........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++++|||.+....... .....
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 168 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTET 168 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCC--Ccccc
Confidence 9998653222237888899999999999999998 9999999999999986 6789999999987654321 11223
Q ss_pred cccCCCcccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 995 IVGSLGYIAPENAYST--RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
..+++.|+|||+.... .++.++||||+|+++|||++|+.||........ ..+...... ..+.
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~--------~~~~------ 232 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFK--------IHPE------ 232 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhc--------cCCC------
Confidence 4578999999987654 378899999999999999999999864311110 000000000 0000
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.....++.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 111234567899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.00 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=195.9
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
|+.++.||+|+||.||+|... +++.||+|.++... ..+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 567789999999999999864 57899999875321 3477899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997654 378899999999999999999998 999999999999999999999999999876532
Q ss_pred CC----CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 986 SH----SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 986 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.. .........++..|+|||+..+..++.++||||+||++|||++|+.||....... .... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~-~~~~~~---- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMFY-IGAHRG---- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHHH-hhhccC----
Confidence 11 1111223468899999999988889999999999999999999999986431100 0000 000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+.. +...+..+.+++++||+.+|++||++.+++++
T Consensus 226 -~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 -LMPRL------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -CCCCC------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00011 11234567899999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.36 Aligned_cols=245 Identities=29% Similarity=0.401 Sum_probs=199.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||.|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4556688999999999999999999999999885432 35778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++++|||.++......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 999999999865 488999999999999999999998 99999999999999999999999999998775432
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......+++.|+|||...+..++.++||||+|+++|||++|+.||....... .. ..... ...+....
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~-~~~~~------~~~~~~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VL-FLIPK------NNPPSLEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HH-HHhhh------cCCCCCcc
Confidence 12233467889999999988889999999999999999999999986432100 00 00000 00000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+..+.+++.+|++.+|++||++++++++
T Consensus 221 -----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 -----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0134467899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=316.76 Aligned_cols=251 Identities=21% Similarity=0.293 Sum_probs=194.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||++++..+++.||+|++.+. ...+.+|+.+++.++|++|+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 356678999999999999999999999999988532 2336778999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++..... .+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 y~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 82 YYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999986432 488899999999999999999999 99999999999999999999999999997664322
Q ss_pred CCCcccccccCCCcccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. .......||+.|+|||++.+ +.++.++||||+||++|||++|+.||...... ..+.. ....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~-i~~~------- 223 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----ETYGK-IMNH------- 223 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----HHHHH-HHcC-------
Confidence 1 12233568999999998765 46788999999999999999999999643110 00000 0000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~ 1105 (1119)
...... .......+.++.+++.+|+...+.+ |+++++++++
T Consensus 224 -~~~~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 224 -EERFQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -CCcccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000000 0000112456788999999876654 5689988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=306.07 Aligned_cols=243 Identities=28% Similarity=0.425 Sum_probs=197.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|+..+.||+|+||.||+|.+..+++.||+|.++... ..+.+|+.+++.++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445577999999999999998889999999886332 357889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++... .+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++....... .
T Consensus 86 ~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06642 86 GGSALDLLKPG----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc--h
Confidence 99999998643 378899999999999999999998 99999999999999999999999999987654321 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......++..|+|||...+..++.++|||||||++|||++|+.||........ ... .... ..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~-~~~~------~~~----- 219 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFL-IPKN------SPP----- 219 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----Hhh-hhcC------CCC-----
Confidence 22234578899999999888899999999999999999999999864321110 000 0000 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+..+.+++.+||+.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0111234567899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=301.23 Aligned_cols=236 Identities=22% Similarity=0.355 Sum_probs=188.5
Q ss_pred ceeeecCCccEEEEEeCCCc----------eEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 840 RIIGKGKHGTVYRTLSNNSR----------KHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~----------~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+.||+|+||.||+|.+..++ ..|++|.+... ...+.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999998766 45888877543 3467889999999999999999999988 7789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-------ceEEEeccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-------EPKIGDFGM 979 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~vkl~DfGl 979 (1119)
||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+|++|||+
T Consensus 80 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 80 EYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999987653 488999999999999999999998 999999999999999887 799999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCC--CCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYST--RLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
+..... .....++..|+|||++.+. .++.++||||+||++||+++ |..||...... .+..... ..
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~~~~~-~~ 222 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKERFYQ-DQ 222 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHHHHHh-cC
Confidence 886533 2234567789999988776 78999999999999999999 57776543111 0101000 00
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
...... ....+.+++.+||+.+|++||++.++++.|+
T Consensus 223 --------~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 --------HRLPMP------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CCCCCC------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 0157789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.55 Aligned_cols=251 Identities=24% Similarity=0.423 Sum_probs=198.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|...++||+|+||.||+|.+.. +..||+|.+... .+.+.+|+.++++++|+|++++.+++.+ ...++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 356677899999999999998654 567999988643 3467889999999999999999999887 77899999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... ...++.++..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||.+........ .
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 84 KGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 9999999976542 3578889999999999999999998 999999999999999999999999999876543221 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||++....++.++|+||+||++||+++ |+.||..... .+.. .... ... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~---~~~~-~~~--------~~-- 222 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVI---RALE-RGY--------RM-- 222 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHH---HHHh-CCC--------CC--
Confidence 2222345678999999988889999999999999999998 8999864311 1110 0000 000 00
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
......+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00112345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=303.80 Aligned_cols=236 Identities=22% Similarity=0.326 Sum_probs=183.4
Q ss_pred eeeecCCccEEEEEeCC------------------------CceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEE
Q 001226 841 IIGKGKHGTVYRTLSNN------------------------SRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRI 892 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~~------------------------~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l 892 (1119)
.||+|+||.||+|.... ....||+|+++... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999987432 12458999886432 356778899999999999999
Q ss_pred eeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC--
Q 001226 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-- 970 (1119)
Q Consensus 893 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 970 (1119)
++++.++...++||||+++|+|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999876432 478999999999999999999998 999999999999997643
Q ss_pred -----ceEEEeccccccccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 001226 971 -----EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELL-FRKMPVDPSFGEDT 1043 (1119)
Q Consensus 971 -----~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~ell-tg~~p~~~~~~~~~ 1043 (1119)
.+|++|||.+..... .....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 479999998764322 122356788999998865 56899999999999999995 78988864321110
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
..+ ........ .....++.+++.+||+.+|++||++++|++.|+
T Consensus 231 --~~~--------------~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ERF--------------YEKKHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHH--------------HHhccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 000 00000000 011235789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=305.41 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=194.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhc-CCCCEEEEeeeee-----cCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLV-RHRNILRIVGSCT-----KDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~~lV 905 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+.+.. ..++.+|+.+++.+ +||||+++++++. .++..++|
T Consensus 19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 556668899999999999999999999999987542 24577899999999 6999999999874 34568999
Q ss_pred EeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|||+++++|.++++... ....+++..+..++.|+++|+.|||+. +++||||||+||+++.++.++++|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 99999999999876432 223578889999999999999999998 99999999999999999999999999987664
Q ss_pred CCCCCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
... .......+++.|+|||++. +..++.++||||+||++|||++|+.||...... ........ ...
T Consensus 176 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~------~~~ 246 (286)
T cd06638 176 STR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RALFKIPR------NPP 246 (286)
T ss_pred cCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HHHhhccc------cCC
Confidence 321 1223346899999999875 345788999999999999999999998643111 00000000 000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
....+ +...+..+.+++.+||+.+|++|||++|++++.
T Consensus 247 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 247 PTLHQ---------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CcccC---------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 011234678999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=305.04 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=195.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.|+..++||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 4556688999999999999999999999999986432 346779999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++++..++.+... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+...... ..
T Consensus 93 ~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 93 GGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred CCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 9999888765432 488999999999999999999998 9999999999999999999999999988754321 11
Q ss_pred cccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
......+++.|+|||++. ...++.++||||+||++|||++|+.||...... . ...... .. . .+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~---~~~~~~--~~-~-----~~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-R---VLLKIA--KS-E-----PP 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-H---HHHHHh--cC-C-----Cc
Confidence 223346788999999874 345788999999999999999999998642110 0 000000 00 0 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. ..+...+.++.+++.+||+.+|++||++++++++
T Consensus 234 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 234 TL----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cC----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0111233467899999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=319.31 Aligned_cols=238 Identities=25% Similarity=0.318 Sum_probs=185.6
Q ss_pred eeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc---CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV---RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
||+|+||+||+|++..+++.||+|++.... .....|..++... +||+|+++++++.++...|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999999999999999985321 1233455666554 699999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... .+++..+..++.||++|++|||+. +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99999987654 488999999999999999999999 99999999999999999999999999987543211 12
Q ss_pred ccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... .......... ...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~--------~~~~~-- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFG--------KVRFP-- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcC--------CCCCC--
Confidence 2345689999999988754 478999999999999999999999864311 0000000000 00011
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCC----CHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRP----SMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~ell~~ 1105 (1119)
....+..+.+++.+||+.||++|| ++++++++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 011234667999999999999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.41 Aligned_cols=250 Identities=25% Similarity=0.422 Sum_probs=199.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
|+.++.||+|+||.||+|.+..+++.||+|++... ...+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 56678899999999999999999999999988532 24577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~ 984 (1119)
|||+++++|.+++.+.+ .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++ .++++|||.+....
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999997654 478899999999999999999999 999999999999998876 58999999987665
Q ss_pred CCCCC--CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 985 DSHSS--STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 985 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... .......++..|+|||...+..++.++||||+|+++|||++|+.||........ ..... .... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~-~~~~-----~- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIF-KIAS-----A- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHH-HHhc-----c-
Confidence 42111 112234678899999998888899999999999999999999999863211100 00000 0000 0
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+.....++.+++.+|++.+|++||++.+++++
T Consensus 227 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 -----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 00011122345678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.23 Aligned_cols=246 Identities=23% Similarity=0.365 Sum_probs=193.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.|+..++||+||.+.||++...+. +.||+|++.. ..+.|..|+..+.+++ |.+||++++|-..++..|+|||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 466668999999999999988774 4556665531 2345889999999996 9999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|- ..+|..+++..... ...| .++.+..||+.|+.++|.+ ||||.||||.|+++- .|.+|++|||.|..+....
T Consensus 441 ~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 86 67999999887642 2334 7788999999999999999 999999999999884 5689999999999888766
Q ss_pred CCCcccccccCCCcccccccCCC-----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYST-----------RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
........+||+-||+||.+... ..++++||||+||++|+|+.|+.||..... .|.
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~a------- 580 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIA------- 580 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHH-------
Confidence 66677788999999999976532 256899999999999999999999863210 111
Q ss_pred ccccccccccc--cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREI--SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+..+.++.- .+.... ...++.++|+.||++||.+||+..+++++
T Consensus 581 -Kl~aI~~P~~~Iefp~~~---~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIP---ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHhhcCCCccccccCCC---CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1223334322 221111 11237899999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.22 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=199.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|...+.||+|+||.||+|+.+. ..+.||+|.+.... ..+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 345667889999999999999653 34679999885433 35888999999999999999999999989999
Q ss_pred EEEeccCCCCHHHhhccCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEec
Q 001226 904 IVTEYMPGGTLFNVLHQNEPR------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 977 (1119)
+||||+++|+|.+++...... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999865522 1489999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccc
Q 001226 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 978 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
|++....... ........++..|+|||...+..++.++||||+|+++||+++ |..||..... ..... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~---~~~--- 232 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLN---RLQ--- 232 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHH---HHH---
Confidence 9987543221 222233456778999999888888999999999999999998 7888853211 11111 000
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
...... ......+..+.+++.+|++.+|++||++.|++++|.+
T Consensus 233 -------~~~~~~--~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 -------AGKLEL--PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -------cCCcCC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000000 0011223478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=300.09 Aligned_cols=246 Identities=25% Similarity=0.375 Sum_probs=197.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec-CCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK-DEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~ 908 (1119)
|+..+.||+|++|.||++.++.+++.||+|++... ...+.+|+.++++++|+|++++++.+.. +...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 56678999999999999999988999999988432 2357789999999999999999998764 4467899999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++..... ..+++.++..++.+++.|++++|+. +++||||||+||+++.++.++++|||++.......
T Consensus 82 ~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 82 CEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred cCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999986432 3489999999999999999999999 99999999999999999999999999987664321
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......+++.|+|||...+..++.++||||+|+++|||++|+.||..... ..... ... .....
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~-~~~---------~~~~~ 220 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVY-RII---------EGKLP 220 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHH-HHH---------hcCCC
Confidence 122344678999999999988999999999999999999999999864211 00000 000 00000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+|++.+|++||++.+++++
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ---PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0112234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.15 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=197.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|.++.. ...+.+|+.++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 455668899999999999999988999999987542 235778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++........+++..+..++.|+++|+.|||+.+ +++||||||+||+++.++.++++|||.+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence 99999999876533335899999999999999999999642 8999999999999999999999999998765332
Q ss_pred CcccccccCCCcccccccCCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYST------RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
......+++.|+|||.+.+. .++.++|+||+||++|||++|+.||..... ... +... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~--~~~~--------~~~~ 223 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANI--FAQL--------SAIV 223 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhH--HHHH--------HHHh
Confidence 12234578899999987543 357899999999999999999999864211 000 0000 0000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+.... ..+.....++.+++.+|++.+|++||++++++++
T Consensus 224 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGDPP---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcCCC---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 10000 0111245577899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=305.82 Aligned_cols=248 Identities=24% Similarity=0.323 Sum_probs=198.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.||+|+||.||+|.+..++..||+|+++.. ...+.+|+.+++.++||||+++++++..+...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 466678899999999999999888999999998543 2357789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++...+. .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+....... .
T Consensus 86 ~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 86 GGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred CCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999876543 489999999999999999999999 99999999999999999999999999887553321 1
Q ss_pred cccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
......+++.|+|||.+. ...++.++|+||+|+++|||++|+.||...... .......... .+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--------~~ 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSE--------PP 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCC--------CC
Confidence 223456889999999764 345678999999999999999999998643111 0000000000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+ ..+...+..+.+++.+||+.+|++||++++++++
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TL----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred Cc----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00 0111223467899999999999999999999887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=306.07 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=197.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||+|.++.+++.||+|++.... ..+.+|+.+++.++|||++++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 4566688999999999999999889999999874321 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++++.+..+..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 99988888766543 489999999999999999999998 999999999999999999999999999987654221
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc---c---cccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ---E---NHECIC 1061 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~---~~~~~~ 1061 (1119)
......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+. .......... . ......
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhccccc
Confidence 1223457889999998765 5678999999999999999999999964322111 0000000000 0 000000
Q ss_pred cc----cccccCCCch---HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FL----DREISFWDSD---DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~----~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
++ .+........ ....+..+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 0000000000 01224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=300.18 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=197.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
|+..+.||+|+||.||+|....+++.|++|.+... ...+.+|+.+++.++||||+++++++.++...++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 56678899999999999999888999999987432 235778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999997654 378899999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCCcccccccCCCcccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ......++..|+|||...... ++.++|+||+|+++|+|++|+.||..... .... .........
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~--~~~~~~~~~------ 220 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAV--FKIGRSKEL------ 220 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHH--HHHHhcccC------
Confidence 2 223456888999999887666 89999999999999999999999864321 0000 000000000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ..+......+.+++.+||+.+|++||++++++++
T Consensus 221 --~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 --P---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --C---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0 0011123567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=303.99 Aligned_cols=237 Identities=21% Similarity=0.374 Sum_probs=185.7
Q ss_pred ceeeecCCccEEEEEeCCCce-------EEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 840 RIIGKGKHGTVYRTLSNNSRK-------HWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~-------~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+.||+|+||.||+|..+..+. +||+|.+... .+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998765443 4888887543 24577899999999999999999999998899999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc--------eEEEecccc
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE--------PKIGDFGMS 980 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------vkl~DfGla 980 (1119)
+++|+|.++++..+. .+++..+..++.||+.|++|||+. +|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999987653 478999999999999999999999 9999999999999987765 699999988
Q ss_pred ccccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCceeehhhhhhccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRK-MPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
..... .....++..|+|||++.+ ..++.++||||+||++|||++|. .||...... . ...
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~----~~~-------- 216 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-K----KLQ-------- 216 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-H----HHH--------
Confidence 65432 223457889999998876 45789999999999999999985 454321100 0 000
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
........ +.....++.+++.+||+.+|++|||++++++.|+
T Consensus 217 ---~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 ---FYEDRHQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---HHHccccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000000 0111246789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=305.46 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=200.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||+||++.+..+++.||+|++... ...+.+|+.+++.++||||+++++++......++||||+
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 455668899999999999999988999999987432 245778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++...+ .+++..+..++.+++.|+.|||+.+ +++||||+|+||+++.++.++++|||++......
T Consensus 86 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 86 DCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred CCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 9999999987654 4889999999999999999999742 8999999999999999999999999998654321
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||++.+..++.++|+||+||++||+++|+.||................. .............
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQIVQEPPPR 232 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH----HHHHHHhhccCCC
Confidence 11234689999999998888899999999999999999999999975432211000000000 0000000000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
. .....+..+.+++.+|++.||++||+++|++++.
T Consensus 233 ~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 233 L--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred C--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0 0112345688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=299.59 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=200.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.+|+|+||.||+|.+..+++.+|+|++... ...+.+|+.+++.++||||+++++++.+++..+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 456678899999999999999888899999988543 3457889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+....... .
T Consensus 84 ~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 84 GGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred CCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 999999987652 2488999999999999999999998 99999999999999999999999999987654321 1
Q ss_pred cccccccCCCcccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAYST---RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
......++..|+|||...+. .++.++||||+||++|||++|+.||........ ... ... . .+.+.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~---~~~---~----~~~~~- 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFL---ISK---S----NFPPP- 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH---HHh---c----cCCCc-
Confidence 22334678899999988766 788999999999999999999999864321100 000 000 0 00000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+..+.+++.+||+.+|++|||+++|+.+
T Consensus 225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 --KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 001123345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=300.12 Aligned_cols=247 Identities=22% Similarity=0.369 Sum_probs=199.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||++....+++.||+|.+.. ...++.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 35667899999999999999998899999998742 223578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++..... ..+++..+.+++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999876432 2478899999999999999999998 99999999999999999999999999987654321
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......+++.|+|||+..+..++.++|+||+||++|||++|+.||..... . ...... ......
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~---~~~~~~----------~~~~~~ 219 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--K---NLVLKI----------IRGSYP 219 (256)
T ss_pred -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--H---HHHHHH----------hcCCCC
Confidence 112234578899999999888899999999999999999999999863210 0 000000 000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+.++.+++.+||+.+|++||++++|+++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 ---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0112234568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=304.70 Aligned_cols=260 Identities=22% Similarity=0.255 Sum_probs=198.0
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.++++++|||++++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 56678899999999999999988999999988533 245788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+++|.+++.... ..+++..+..++.|+++|++|||+. +++|+||||+||+++.++.++++|||.+........
T Consensus 82 -~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 82 -PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred -CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 999999987654 2589999999999999999999999 999999999999999999999999999987654321
Q ss_pred CcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehh---------hhhhcccccc
Q 001226 990 STRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT---------RWKLQENHEC 1059 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~ 1059 (1119)
.......++..|+|||.+.+. .++.++||||+|+++|||++|..||...... ....... .|.. ....
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPG--LTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhh--ccCc
Confidence 222345688999999987654 4689999999999999999997777532110 0000000 0000 0000
Q ss_pred cccccccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............ .........+.+++.+|++.+|++||+++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0001224678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=305.82 Aligned_cols=265 Identities=21% Similarity=0.245 Sum_probs=196.4
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+.+|+..+.||+|+||.||+|.++.+++.||+|.+... ...+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 35677778999999999999999988999999988532 2346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++ +|.+++..... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+|++|||.++......
T Consensus 84 ~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9974 99999876543 588999999999999999999999 99999999999999999999999999987543211
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee-hhhhhhccc------ccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT-WTRWKLQEN------HEC 1059 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~------~~~ 1059 (1119)
.......++..|+|||...+ ..++.++||||+|+++|||++|+.||............ +........ ...
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11222346889999998765 45789999999999999999999998643211000000 000000000 000
Q ss_pred cccccccccCCCch-------HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSD-------DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~-------~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............. .......+.+++.+|++.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00000000000000 00112567899999999999999999998864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=280.48 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=201.6
Q ss_pred HHhhCC-ceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhc-CCCCEEEEeeeeec----CCceEEEEe
Q 001226 834 IRATEG-RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLV-RHRNILRIVGSCTK----DEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~lV~e 907 (1119)
++|+.. ++||-|-.|.|..+.++.+++++|+|++.... ...+|++.--+. .|||||.++++|.. .....+|||
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 344433 78999999999999999999999999986433 335677664444 59999999999864 356689999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEecccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGDFGMSKLIS 984 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~DfGla~~~~ 984 (1119)
.|+||.|+..+.+++. ..+++.++..|+.||..|+.|||+. .|.||||||+|+|.+.. ..+|++|||+|+...
T Consensus 140 ~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred cccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC
Confidence 9999999999998774 4699999999999999999999999 99999999999999754 468999999998654
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
. .......+-|+.|.|||++...+|+...|+||+||++|-|++|..||+...+. .+..-.+.+ +..
T Consensus 216 ~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispgMk~r---------I~~ 281 (400)
T KOG0604|consen 216 E---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKRR---------IRT 281 (400)
T ss_pred C---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChhHHhH---------hhc
Confidence 3 23334456799999999999999999999999999999999999999876442 111111111 111
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+.+...+....+.+..++++.++..+|++|.|+.+++.+
T Consensus 282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 22233334446677888999999999999999999999875
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=300.46 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=184.8
Q ss_pred ceeeecCCccEEEEEeCCC--ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNS--RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~--~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||+|..... ...+++|.++.. ...+.+|+..++.++||||+++++.+.+....|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999975432 345677766432 245788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 913 TLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 913 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
+|.++++.... ....++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986532 22466777889999999999999998 999999999999999999999999999864322221122
Q ss_pred ccccccCCCcccccccCC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 992 RSAIVGSLGYIAPENAYS-------TRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.....++..|+|||+... ..++.++|||||||++|||++ |..||..... .. .+..... .......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~--~~~~~~~---~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--RE--VLNHVIK---DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HH--HHHHHHh---hcccccC
Confidence 234567889999998643 345789999999999999997 5667653211 00 0000000 0001111
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
++.+. ......+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 112346678999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=300.80 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=194.7
Q ss_pred hCCceeeecCCccEEEEEeCC---CceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC------c
Q 001226 837 TEGRIIGKGKHGTVYRTLSNN---SRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------H 901 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 901 (1119)
+..+.||+|+||.||+|..+. +++.||||++... .+++.+|+.++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 446789999999999998643 5789999988643 234778999999999999999999886532 2
Q ss_pred eEEEEeccCCCCHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
.++++||+++|+|.+++.... ....+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|++|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECccc
Confidence 378999999999998875321 123478899999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
.++...............+++.|++||......++.++||||+||++|||++ |+.||..... ... ....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~---~~~~~~~-~ 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEI---YNYLIKG-N 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHH---HHHHHcC-C
Confidence 9986644332222333456678999999988889999999999999999998 8888753211 110 0100000 0
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
... .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 233 --------~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 233 --------RLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 0011234788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.02 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=195.6
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
...||+|+||.||++.+..++..||||++... ...+.+|+..++.++||||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46799999999999999888999999987532 23577899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||++....... .....
T Consensus 107 ~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 177 (292)
T cd06658 107 TDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKS 177 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCce
Confidence 9988543 378899999999999999999999 99999999999999999999999999987554322 12233
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..++..|+|||...+..++.++||||+|+++|||++|+.||...... ...... ...+..... ..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~--------~~~~~~~~~----~~ 241 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRI--------RDNLPPRVK----DS 241 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH--------HhcCCCccc----cc
Confidence 56889999999998888999999999999999999999998642110 000000 000111111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+..+.+++.+|++.+|.+|||++|++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=298.23 Aligned_cols=246 Identities=25% Similarity=0.399 Sum_probs=196.3
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+.+|+..+.||+|+||.||++.. +++.||+|.++.. ...+.+|+.+++.++|||++++++++..+ ..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 46788889999999999999864 4678999988643 34678899999999999999999998765 4689999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||.+......
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999986542 3478999999999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+..|+|||.+.+..++.++|+||+||++|||++ |+.||...... ...... ......
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~-----------~~~~~~ 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKECV-----------EKGYRM 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHH-----------hCCCCC
Confidence 112234568999999988889999999999999999997 99998643111 111100 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
. .....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 E--PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred C--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 011234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=296.74 Aligned_cols=247 Identities=31% Similarity=0.526 Sum_probs=197.9
Q ss_pred hCCceeeecCCccEEEEEeCCCc----eEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSR----KHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+..+.||+|+||.||++.+...+ ..||+|+++... ..+..|+..++.++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 34578999999999999998766 889999986433 367889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++...... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 82 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999865432 289999999999999999999999 99999999999999999999999999998765532
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
..... ...+++.|+|||...+..++.++||||+|+++|||++ |+.||..... .... .... . ..
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~---~~~~-~---------~~ 221 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVL---EYLK-K---------GY 221 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHH---HHHh-c---------CC
Confidence 22211 2337789999999888889999999999999999998 7888754211 0000 0000 0 00
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.. ......+.++.+++.+|++.+|++|||++|+++.|
T Consensus 222 -~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RL--PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CC--CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 00111355788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=298.93 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=193.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 903 (1119)
.|+.++.||+|+||.||+|.+..+++.||+|++... ...+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 356678999999999999999999999999987421 12467799999999999999999988764 4578
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++.... .+++..+.+++.|++.|++|||+. +++|+||||+||+++.++.++++|||.++..
T Consensus 83 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 9999999999999987654 378888999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
...... .......++..|+|||...+..++.++|||||||++|||++|+.||..... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~---------- 222 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIA---------- 222 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHHh----------
Confidence 321111 112234588899999998888899999999999999999999999863210 00000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+. ....+......+.+++.+|+. +|++||+++|++++
T Consensus 223 ~~~~---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 TQPT---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred cCCC---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000 001122344567889999994 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=285.79 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=197.8
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
.+++|+|.||.|-+++.+.+++.||+|++++.. .....|-++++..+||.+..+...|...++.|+||||+.|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 478999999999999999999999999986542 2345688999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|.|+-.+.+.+ .+++..++.+...|+.|+.|||+. +||.||+|.+|.|+|.+|++||+|||+++.- ......
T Consensus 253 GeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t 324 (516)
T KOG0690|consen 253 GELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDT 324 (516)
T ss_pred ceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc--ccccce
Confidence 99988877654 588889999999999999999999 9999999999999999999999999998742 234456
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
....+|||.|+|||++....|+.++|.|.+|||+|||++|+.||+....+ .+. .-++-..+++
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLF-------------eLIl~ed~kF-- 387 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLF-------------ELILMEDLKF-- 387 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh--HHH-------------HHHHhhhccC--
Confidence 67889999999999999999999999999999999999999999753111 110 0111122221
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
+...+.+...++...+..||.+|. .++||.++
T Consensus 388 --Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 388 --PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred --CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 222344667889999999999997 56666654
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=298.94 Aligned_cols=245 Identities=28% Similarity=0.396 Sum_probs=197.9
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|....+++.||+|.+... ...+.+|+.++++++|||++++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 55668899999999999999999999999987532 235778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~~~ 988 (1119)
++++|.+++..... ..+++..+.+++.++++|++|||++ +++|+||+|+||+++.++ .+|++|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 82 PGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999986542 3478999999999999999999999 999999999999998654 57999999998764422
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ......... ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~----------~~~~ 219 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMS----------GTFA 219 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHh----------cCCC
Confidence 22234678899999999888899999999999999999999999864311 111111100 0000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+..+.+++.+||+.+|++|||++|++++
T Consensus 220 ---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 ---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0011134567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=303.23 Aligned_cols=247 Identities=26% Similarity=0.371 Sum_probs=200.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|...+.||+|+||.||++....+++.||+|.+... .+.+.+|+.+++.++||||+++++++..++..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4667778999999999999999888999999988532 245778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++.+. .+++..+..++.|++.|+.|||+. +++|||++|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999998754 378889999999999999999999 999999999999999999999999998875543221
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+++.|+|||......++.++|||||||++||+++|+.||....... ........ +. ..
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~-------------~~-~~ 234 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATN-------------GT-PE 234 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeehhcC-------------CC-CC
Confidence 2233468889999999888889999999999999999999999996432111 11110000 00 00
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ......+..+.+++.+||+.+|++||++++++.+
T Consensus 235 ~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 L-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111234467899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=306.97 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=196.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
-.||.|+||.||+|..+.++...|-|++... -+++..||.++..+.||+||++++.|..++..+++.|||+||-..
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 4689999999999999998888889988532 356888999999999999999999999999999999999999998
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCccccc
Q 001226 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995 (1119)
Q Consensus 916 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 995 (1119)
.++-.-+. .+++.++..+++|++.|+.|||++ .|||||+|+.|||++-+|.++++|||.+..... ....+..+
T Consensus 118 aimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsF 190 (1187)
T KOG0579|consen 118 AIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSF 190 (1187)
T ss_pred HHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--HHhhhccc
Confidence 88876553 599999999999999999999999 999999999999999999999999999865432 22345678
Q ss_pred ccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 996 VGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 996 ~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.|||+|||||+.. ..+|++++||||||+++.||..+.+|...... .....+.. . ......+.+
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----MRVllKia--K-SePPTLlqP----- 258 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIA--K-SEPPTLLQP----- 258 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----HHHHHHHh--h-cCCCcccCc-----
Confidence 9999999999654 56899999999999999999999988653211 00011100 0 001111111
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..-+..+.+++.+|+..+|+.||+++++++|
T Consensus 259 ----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 ----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ----chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1224467899999999999999999999876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=277.84 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=189.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccc--c---cHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--T---NFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~---~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
...+|+|..|+||+++.+.++..+|||.+.+.. + .+...+.++..-+ .|+||+.+|+|..+...++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 356999999999999999999999999996532 2 2333444444333 799999999999999999999998 44
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
.....+++-.. ++++.-+-++...++.||.||.++| +|+|||+||+|||+|+.|.+|++|||.+..+.++ ...
T Consensus 176 C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAh 248 (391)
T KOG0983|consen 176 CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAH 248 (391)
T ss_pred HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---ccc
Confidence 55666665443 4888888899999999999999887 9999999999999999999999999999877653 344
Q ss_pred cccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 993 SAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
+...|.+.|||||.+.. ..|+-++||||||+.++|+.||+.||.... .+.....+.-... .+.++.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~---tdFe~ltkvln~e--------PP~L~~ 317 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK---TDFEVLTKVLNEE--------PPLLPG 317 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC---ccHHHHHHHHhcC--------CCCCCc
Confidence 55678999999997754 468899999999999999999999997642 2222211111111 111211
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ...+..+.+++..|++.|+.+||...++++|
T Consensus 318 ~----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 H----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c----cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 1135577899999999999999999999875
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=306.63 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=194.7
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
...||+|+||.||+|.+..+++.||+|+++. ....+.+|+..++.++|||++++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 4579999999999999988899999999843 223577899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++....... .....
T Consensus 106 ~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~ 176 (297)
T cd06659 106 TDIVSQT----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS 176 (297)
T ss_pred HHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence 9887543 378999999999999999999999 99999999999999999999999999987554321 12233
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..++..|+|||++.+..++.++||||+||++|||++|+.||...... . ...... .. . .... ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~--~~~~~~--~~-~-----~~~~----~~~ 240 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q--AMKRLR--DS-P-----PPKL----KNA 240 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H--HHHHHh--cc-C-----CCCc----ccc
Confidence 56889999999998888999999999999999999999998642110 0 000000 00 0 0000 001
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+..+.+++.+|++.+|++||++++++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1123467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=299.66 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=197.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~ 908 (1119)
|...+.||.|++|.||++.+..+++.||+|.+... ..++.+|+++++.++||||+++++++.+. +..++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 34457899999999999999988999999988643 24578899999999999999999988653 467999999
Q ss_pred cCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
+++++|.+++.... ....+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998876422 223578889999999999999999999 99999999999999999999999999987553321
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.....++..|+|||...+..++.++||||+||++|||++|+.||...............+..... . ..+
T Consensus 160 ----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~-----~~~ 228 (287)
T cd06621 160 ----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--N-----PEL 228 (287)
T ss_pred ----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--c-----hhh
Confidence 12345788999999998889999999999999999999999999754221111111111111100 0 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..........+..+.+++.+||+.+|++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00001111234568899999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=303.92 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=198.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||++.+..+++.||+|++... ...+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 356678999999999999999988999999988532 2457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+|++|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999998764 488999999999999999999998 9999999999999999999999999998866442
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.....+++.|+|||...+..++.++||||+|+++|+|++|+.||..... .... ... .....
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~----------~~~~~ 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----IQIY-EKI----------LEGKV 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----HHHH-HHH----------hcCCc
Confidence 2334688999999998888889999999999999999999999864321 0000 000 00000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
. .+...+..+.+++.+||+.+|++|| +++|++++
T Consensus 216 ~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 R----FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred c----CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 0111245678999999999999999 88888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=303.92 Aligned_cols=261 Identities=22% Similarity=0.265 Sum_probs=195.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
|+..+.||+|+||.||+|.+..+++.||+|+++... ..+..|+.++++++|+||+++++++.++...++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 455678999999999999999889999999985432 23567999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+ +++|.+++.... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 899999997654 2489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh-------hhccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW-------KLQENHE 1058 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 1058 (1119)
.. ......+++.|+|||.+.+ ..++.++||||+||++|||++|..||......+ ........ .......
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccc
Confidence 21 1223356788999998754 457899999999999999999977765322110 00000000 0000000
Q ss_pred ccccccccccCC---CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFW---DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............ .......+..+.+++.+||+.+|++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 00011224578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=297.31 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=198.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|...+.||+|+||.||+|....+++.||+|+++.. ...+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 356678999999999999999888999999998533 23577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++.... .+++..+..++.++++|+.|||+. +++|+||+|+||++++++.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999998654 378889999999999999999999 999999999999999999999999999887654322
Q ss_pred CCc--ccccccCCCcccccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 989 SST--RSAIVGSLGYIAPENAYSTR---LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 989 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... .....+++.|+|||.+.+.. ++.++||||||+++||+++|+.||........ ... ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~-~~~------~~~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMF-HVG------AGH 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHH-HHh------cCC
Confidence 111 12346788999999887765 88999999999999999999999964321100 000 000 000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.++. ....+..+.+++.+|++.+|++||+++|++.+
T Consensus 224 ~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 224 KPPIPD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCCc----ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 011111 11124466799999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=301.69 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=198.7
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+..+.||+|+||.||+|.++.+++.||+|.+... ..++.+|+..+++++||||+++++++..+...++|+||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 3446799999999999999988999999988543 23577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++|.+++.... ..+++..+..++.|++.|++|+|+ . +++|+||||+||+++.++.++++|||.+........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 84 GSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred CcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 99999998763 258889999999999999999999 7 999999999999999999999999999876533211
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
....++..|+|||...+..++.++||||+|+++|+|++|+.||................. ........
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~~~~~~ 224 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI----------VNEPPPRL 224 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH----------hcCCCCCC
Confidence 115678899999999888999999999999999999999999865422111111111100 00000000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+||..+|++|||+.+++++
T Consensus 225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 --PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred --ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011145568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=305.14 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=195.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|...+.||+|+||.||++.+..+++.||+|.+... ...+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 44568899999999999999999999999988532 23466899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++...+ .+++..+..++.|+++|++|+|+. +++||||||+||+++.++.++++|||.++.......
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 99999999997654 488999999999999999999998 999999999999999999999999999864211000
Q ss_pred -------------CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 989 -------------SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 989 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
........++..|+|||.+.+..++.++|+|||||++||+++|+.||...... .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-----~~~~~~~-- 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-----ELFGQVI-- 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH--
Confidence 00111245788999999998888999999999999999999999998642110 0000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHc
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIK 1108 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~ 1108 (1119)
...... .......+..+.+++.+||+.+|++||++.++.+.++.
T Consensus 230 --------~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 --------SDDIEW-PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------hcccCC-CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000 00111234567899999999999999996555554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-33 Score=335.35 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=200.2
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
.+..||.|.||.||-|...++|+..|+|.++- .-..+.+|..++..++|||+|+++|+-.+++..+|.||||++
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 45789999999999999999999999997742 234578899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC--C
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS--S 989 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~--~ 989 (1119)
|+|.+.+...+ ..++.-...+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+..... .
T Consensus 1319 GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1319 GSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred CcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 99999998764 366666777889999999999999 999999999999999999999999999998765421 1
Q ss_pred CcccccccCCCcccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYST---RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.......||+.|||||++.+. ....++||||+|||+.||+||+.||.....+ |.++.. +..
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------~aIMy~--V~~----- 1456 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------WAIMYH--VAA----- 1456 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------hHHHhH--Hhc-----
Confidence 223456899999999998764 3567999999999999999999998754221 111110 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...++.+...+.+-.+++..|++.||.+|+++.|++++
T Consensus 1457 -gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 -GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 01112233466677899999999999999999998876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=294.91 Aligned_cols=239 Identities=25% Similarity=0.284 Sum_probs=198.0
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecc-------cccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-------RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+..++||+|+||.||-++.+.+|+.||.|++. +.+....+|-.++.++..+.||.+-.+|...+..++|+..|
T Consensus 188 ~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 188 RVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred eeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 34489999999999999999999999999873 23445678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
.||+|.-.+...+. ..+++..+..++.+|+.||++||.. +||.||+||+|||+|+.|+|+|+|.|+|..+.+..
T Consensus 268 NGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-- 341 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-- 341 (591)
T ss_pred cCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC--
Confidence 99999988887774 4699999999999999999999999 99999999999999999999999999999886643
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc-
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS- 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1068 (1119)
....++||.+|||||++..+.|+...|.||+||++|||+.|+.||..... .+.+. .+|++..
T Consensus 342 -~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke----Kvk~e------------Evdrr~~~ 404 (591)
T KOG0986|consen 342 -PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE----KVKRE------------EVDRRTLE 404 (591)
T ss_pred -ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh----hhhHH------------HHHHHHhc
Confidence 33445899999999999999999999999999999999999999964311 11110 1111111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCC
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPS 1098 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 1098 (1119)
.....+..-+.++.++.+..++.||++|.-
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 111112233557788999999999999873
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=301.81 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=197.9
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|+..++||+|++|.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 55668999999999999999999999999988533 2356689999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+ +|.+++........+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++....... .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 5 8988887665445689999999999999999999998 99999999999999999999999999987554321 1
Q ss_pred cccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc-----cccc
Q 001226 991 TRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI-----CFLD 1064 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 1064 (1119)
......++..|+|||.+.+. .++.++||||+||++|||++|+.||......+.................. ....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22334578899999987654 56889999999999999999999986532211000000000000000000 0000
Q ss_pred ccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........ .....+..+.+++.+|++.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=297.83 Aligned_cols=243 Identities=29% Similarity=0.438 Sum_probs=197.0
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|+..+.||+|+||.||+|.+..+++.||+|...... ..+.+|+..+++++||||+++++++.++...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 445688999999999999998889999999875322 357789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus 86 ~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06641 86 GGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch--h
Confidence 99999998753 378999999999999999999998 99999999999999999999999999987654321 1
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......++..|+|||...+..++.++|+||+||++|||++|..||...... ..... .... . .+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~-~-----~~~---- 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKN-N-----PPT---- 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcC-C-----CCC----
Confidence 122346788999999988888899999999999999999999998642110 00000 0000 0 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+|++.+|++||++++++++
T Consensus 221 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 --LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111234567899999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=303.56 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=196.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..++||+|+||.||+|.+..+++.||+|++... ...+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 355668999999999999999988999999987432 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++++++.++..... .+++..+..++.|+++|++|||+. +++|||++|+||++++++.++++|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 82 VDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred CCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 99999988776543 389999999999999999999999 99999999999999999999999999987654322
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh----------hhcccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW----------KLQENH 1057 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~~ 1057 (1119)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+ ........ ......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence 12223457889999998765 457889999999999999999998885321100 00000000 000000
Q ss_pred cccccccccccCCC---chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECICFLDREISFWD---SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......+...... ......+..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000000000000 0001234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=300.67 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=193.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhc-CCCCEEEEeeeeec------CCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLV-RHRNILRIVGSCTK------DEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~l 904 (1119)
.|+..+.+|.|+||.||+|.+..+++.||+|+.... ..++..|+.+++++ +||||+++++++.. ....|+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 456668899999999999999999999999988543 24577889999888 69999999999853 456799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++|||++|+||+++.++.++++|||++....
T Consensus 97 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 9999999999999876442 3478888999999999999999999 99999999999999999999999999987553
Q ss_pred CCCCCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
... .......++..|+|||.+. ...++.++||||+||++|||++|+.||......... .. ...
T Consensus 173 ~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~-----~~~---- 240 (282)
T cd06636 173 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FL-----IPR---- 240 (282)
T ss_pred ccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hh-----Hhh----
Confidence 211 1223456889999999875 345788999999999999999999998643211000 00 000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... .....+..+.+++.+||+.||.+||++.|++++
T Consensus 241 --~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 241 --NPPPKL-----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --CCCCCC-----cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000000 011234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=300.27 Aligned_cols=264 Identities=21% Similarity=0.222 Sum_probs=193.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++|+||+++.+++..++..|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 35667789999999999999999889999999885321 2467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++ +++.+++..... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++++|||+++......
T Consensus 85 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 85 MH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred cc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 95 677777655432 477888899999999999999999 99999999999999999999999999987543321
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee-hhhhhhcccc------ccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT-WTRWKLQENH------ECI 1060 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~------~~~ 1060 (1119)
.......++..|+|||...+ ..++.++||||+||++|||++|+.||............ +......... ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233457889999998865 35788999999999999999999999753211000000 0000000000 000
Q ss_pred ccccccccCCC-------chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWD-------SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........... ......+..+.+++.+|++.||++|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000 0000113467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=305.87 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=199.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|.+.... ..+..|+.+++.++||||+++++.+.++...|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 3566688999999999999999999999999885432 346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++.... ...+++..+..++.|+++|++|||+. +++||||||+||+++.++.++++|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999987543 23589999999999999999999999 99999999999999999999999999987553221
Q ss_pred CC---------------------------CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 001226 988 SS---------------------------STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFG 1040 (1119)
Q Consensus 988 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 1040 (1119)
.. .......|+..|+|||...+..++.++||||+|+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011234678899999999888899999999999999999999999864321
Q ss_pred CCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 001226 1041 EDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS----MREVVGF 1105 (1119)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~ell~~ 1105 (1119)
.. .+. ...+...... .....+..+.+++.+|++.+|++||+ ++|++++
T Consensus 238 ~~----~~~-----------~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DE----TFS-----------NILKKEVTFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HH----HHH-----------HHhcCCccCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 10 000 0111111110 11114567899999999999999999 7777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=297.36 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=195.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcC---CCCEEEEeeeeecCCceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVR---HRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e 907 (1119)
|+..+.||+|+||.||+|.+..+++.||+|.++.. ..++.+|+.+++.++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 44557899999999999999888999999987532 235778999999987 9999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.++++.. .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 83 ~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999998653 488999999999999999999999 99999999999999999999999999988765432
Q ss_pred CCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.......++..|+|||...++ .++.++|+||+||++|+|++|+.||....... ...... ....+.
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~-------~~~~~~ 221 (277)
T cd06917 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIP-------KSKPPR 221 (277)
T ss_pred --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccc-------cCCCCC
Confidence 222334688899999987654 46889999999999999999999986431110 000000 000001
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+.. ...+.++.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LED-----NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCc-----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 110 0134567899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=300.06 Aligned_cols=239 Identities=28% Similarity=0.331 Sum_probs=187.3
Q ss_pred eeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhh---cCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSL---VRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.||+|+||.||++.+..+++.||+|.+.... ..+.+|..+++. .+||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999989999999885321 123344444443 369999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++...+ .+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999987654 489999999999999999999999 99999999999999999999999999987554321
Q ss_pred cccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.....++..|+|||.... ..++.++||||+||++|||++|+.||......... ........ ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~--------~~~~--- 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT--------VNVE--- 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--HHHHHhhc--------CCcC---
Confidence 123468999999998764 56789999999999999999999999753221111 11110000 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.+...+.++.+++.+|++.||++|| +++|+++|
T Consensus 218 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 ---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1122345778999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=299.90 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=196.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+...+.||+|++|.||++.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 33447899999999999999888999999988532 23467899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....... ..
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~ 171 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PR 171 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cc
Confidence 9999998762 378899999999999999999999 99999999999999999999999999887554321 12
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....+++.|+|||...+..++.++||||+||++|||++|+.||..... ........ .. ..+...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~~~-~~-------~~~~~~--- 236 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKRIR-DN-------LPPKLK--- 236 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHHHH-hc-------CCCCCc---
Confidence 2334688999999999888899999999999999999999999864211 00000000 00 000000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+||+.+|++||++++++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111134578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=301.00 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=190.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHH-HhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRT-LSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|.+..+++.||+|+++... .++..|+.. ++..+||||+++++++..++..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 455688999999999999999999999999886432 234445554 56678999999999999999999999999
Q ss_pred CCCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 910 PGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 910 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+ |+|.+++... .....+++..+..++.|++.|++|||+++ +++||||||+||+++.++.+||+|||.+.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 6 6888877653 22345899999999999999999999853 89999999999999999999999999988654321
Q ss_pred CCcccccccCCCcccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||........ ..... . ....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~-~-------~~~~ 225 (283)
T cd06617 159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ---QLKQV-V-------EEPS 225 (283)
T ss_pred --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH---HHHHH-H-------hcCC
Confidence 1223467889999998754 4568899999999999999999999863211100 00000 0 0000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+. ....+.++.+++.+||+.+|++||++++++++
T Consensus 226 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 PQLP-----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0110 11234568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=300.86 Aligned_cols=265 Identities=22% Similarity=0.243 Sum_probs=196.9
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFI 904 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 904 (1119)
+.+|+..+.||+|+||.||+|.+..+++.||+|.++... ..+.+|+.++++++||||+++++++..+ ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 456777789999999999999999889999999885321 2356799999999999999999998877 88999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++ ++|.+++..... .+++..+..++.|++.|++|||+. +++|+||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999997 599998876543 589999999999999999999999 99999999999999999999999999988665
Q ss_pred CCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce-----------eehhhhh
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI-----------VTWTRWK 1052 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~-----------~~~~~~~ 1052 (1119)
... .......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||......+... ..|..+.
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 432 122234578899999987654 46899999999999999999999986432110000 0000000
Q ss_pred hcccccccccccccccCCCc-hHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1053 LQENHECICFLDREISFWDS-DDQL-KALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.................... .+.. ....+.+++.+|++.+|++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000000000 0000 24567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=296.66 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=195.4
Q ss_pred hhCCceeeecCCccEEEEEeCC-CceEEEEEecccc--------------cccHHHHHHHHhh-cCCCCEEEEeeeeecC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNN-SRKHWAVKKLNRS--------------ETNFDVEIRTLSL-VRHRNILRIVGSCTKD 899 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~--------------~~~~~~E~~~l~~-l~h~niv~l~~~~~~~ 899 (1119)
|+..+.||+|+||.||+|.+.. +++.+|+|.+... ..++..|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4556789999999999999887 6788999987421 1224567777764 7899999999999999
Q ss_pred CceEEEEeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
+..++||||+++++|.+++.... ....+++..+++++.|++.|+.|||+.. +++|+||+|+||+++.++.++++|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999999885421 2235889999999999999999999631 89999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
.+....... ......++..|+|||...+..++.++||||+|+++|||++|+.||..... ........
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~----- 226 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIV----- 226 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHh-----
Confidence 998654422 23345688899999999988899999999999999999999999864211 10000000
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
+..... ......+..+.+++.+||+.||++||++.|+.++++
T Consensus 227 -----~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 -----EAVYEP--LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----hccCCc--CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000 001122356789999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=279.51 Aligned_cols=268 Identities=27% Similarity=0.383 Sum_probs=208.2
Q ss_pred CCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----ccHHHHHHHHhhcC-CCCEEEEeeeeecCCce
Q 001226 828 LRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 828 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 902 (1119)
-+++|+.+.|. +.||+|+|+.|--+....++..||||++.+.. ..+-+|++++...+ |+||++++++|+++...
T Consensus 73 g~F~d~YkLt~-e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 73 GKFEDMYKLTS-ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred chHHHHHHhHH-HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 35677776664 78999999999999999999999999997643 45778999999886 99999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc---eEEEeccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGM 979 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~DfGl 979 (1119)
|+|||-|.||+|...+.++. .+++.++.++..+|+.|+.+||.+ ||.|||+||+||+-.+... |||+||.+
T Consensus 152 YLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 99999999999999998866 489999999999999999999999 9999999999999977654 69999988
Q ss_pred cccccCCC-----CCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehh
Q 001226 980 SKLISDSH-----SSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT 1049 (1119)
Q Consensus 980 a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~ 1049 (1119)
+.-+.... ........+|+..|||||+.. ...|+.+.|.||+|||+|-|+.|..||.+.-+++- -|.
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWd 302 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWD 302 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---Ccc
Confidence 75432211 112223457888999999543 23588999999999999999999999987544322 122
Q ss_pred hhhhc---ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1050 RWKLQ---ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1050 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+...- +..-+..+-+..+.+........+.+..+++...+..|+..|.++.+++.+
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 11110 001112222333333333344556778899999999999999999999873
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=299.79 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=194.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhc-CCCCEEEEeeeeecC-----CceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLV-RHRNILRIVGSCTKD-----EHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~lV 905 (1119)
+|+..+.||+|+||.||+|....+++.||+|++... ...+.+|+.+++++ +|||++++++++... +..++|
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 456668899999999999999999999999998543 34567899999998 799999999998643 357999
Q ss_pred EeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|||+++++|.++++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 99999999999886422 123588999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCcccccccCCCcccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYST-----RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
.... ......++..|+|||.+... .++.++||||+||++|||++|+.||...... ... ........
T Consensus 180 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~---~~~~~~~~--- 250 (291)
T cd06639 180 STRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTL---FKIPRNPP--- 250 (291)
T ss_pred cccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHH---HHHhcCCC---
Confidence 3221 12234678899999987543 3688999999999999999999998643111 000 00000000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+ .........+.+++.+||+.+|++||++.|++++
T Consensus 251 -----~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 251 -----PTL----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----CCC----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0011223468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=303.11 Aligned_cols=266 Identities=25% Similarity=0.246 Sum_probs=195.9
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecC--CceE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGF 903 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 903 (1119)
.+.+|+..+.||+|+||.||+|.+..+++.||+|+++... ..+.+|+.++++++|+|++++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3456777889999999999999999999999999885321 2356799999999999999999998755 4679
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++ ++|.+++.... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||.+...
T Consensus 85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999996 58888887643 2589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce-----------eehhhh
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI-----------VTWTRW 1051 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~-----------~~~~~~ 1051 (1119)
.... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+... ..|...
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 5422 12223345788999998765 457899999999999999999999986432111000 000000
Q ss_pred hhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1052 KLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...........-..............+..+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000000000000001124567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=297.79 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=196.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhc-CCCCEEEEeeeeecCC------ceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLV-RHRNILRIVGSCTKDE------HGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------~~~ 903 (1119)
.+|+..+.||+|+||.||+|.++.+++.|++|++... ..++.+|+.+++++ .|+||+++++++.+.. ..+
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 4677789999999999999999988999999998643 34678899999998 6999999999997644 479
Q ss_pred EEEeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
+||||+++++|.+++.... ....+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++++|||.+..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 9999999999999987533 123588999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
..... .......++..|+|||.+.. ..++.++||||+||++|||++|+.||...... ... ....
T Consensus 163 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~---~~~~----- 231 (275)
T cd06608 163 LDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RAL---FKIP----- 231 (275)
T ss_pred cccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHH---HHhh-----
Confidence 54321 22234568899999997643 34678999999999999999999998642111 000 0000
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....... ......+..+.+++.+|++.||++|||++|++++
T Consensus 232 ------~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 ------RNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ------ccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000000 1112245578899999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=293.24 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=201.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
|...+.||+|++|.||+|.+..+++.||+|++... ...+.+|+..+++++|+|++++++++..++..++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 44568899999999999999999999999988644 3568889999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+++|.+++.... .+++..+..++.|+++|++|+|+ . +++||||+|+||+++.++.++++|||.+.........
T Consensus 83 ~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 83 GGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999998753 48999999999999999999999 8 9999999999999999999999999998866432221
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.....++..|+|||...+..++.++|+||||+++|||++|+.||..... ........... ......
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~----------~~~~~~ 222 (264)
T cd06623 157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAIC----------DGPPPS 222 (264)
T ss_pred --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHh----------cCCCCC
Confidence 1234678899999999888899999999999999999999999865421 01111111100 001000
Q ss_pred CCchHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQL-KALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ... .+..+.+++.+|++.+|++||++.+++++
T Consensus 223 ~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 L---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 111 34578899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=300.98 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=197.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+++++.++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 456678899999999999999988999999988532 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++++.+..+..... .+++..+..++.|++.|+.|||+. +++|||++|+||++++++.+|++|||.+........
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99877766554433 388999999999999999999999 999999999999999999999999999887654322
Q ss_pred CCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh--hhccc----ccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW--KLQEN----HECIC 1061 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--~~~~~----~~~~~ 1061 (1119)
.......++..|+|||++.+. .++.++||||+|+++|||++|+.||......+. ....... ..... .....
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCc
Confidence 122335678899999998887 789999999999999999999999864311100 0000000 00000 00000
Q ss_pred cccc-cccCCC-------chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDR-EISFWD-------SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~-~~~~~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.. ...... ..+...+.++.+++++||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000 000000 0011125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=297.69 Aligned_cols=242 Identities=23% Similarity=0.281 Sum_probs=193.1
Q ss_pred eeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||+|+||+||+|.+..+++.||+|.+... ...+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999988432 22456799999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++..... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+...... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 999976553 3588999999999999999999999 9999999999999999999999999998765431 12233
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..++..|+|||+..+..++.++||||+||++|+|++|+.||......... ....... ..... ..+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~----------~~~~~----~~~ 218 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-EELKRRT----------LEMAV----EYP 218 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-HHHHhcc----------ccccc----cCC
Confidence 46788999999988888999999999999999999999998653221100 0000000 00000 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
...+..+.+++.+||+.+|++|| ++.+++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 12245678999999999999999 77778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=305.34 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=195.6
Q ss_pred hhCCceeeecCCccEEEEEeCC--CceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNN--SRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFI 904 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 904 (1119)
|...++||+|+||.||+|.+.. +++.||+|.+.... ..+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4556789999999999999988 78999999986532 3567899999999999999999999887 78999
Q ss_pred EEeccCCCCHHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC----CCceEEEecc
Q 001226 905 VTEYMPGGTLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS----ELEPKIGDFG 978 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~----~~~vkl~DfG 978 (1119)
||||+++ ++.+++..... ...+++..+..++.|++.|++|||+. +++||||||+||+++. ++.+|++|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999964 67777654322 22588899999999999999999999 9999999999999999 8999999999
Q ss_pred ccccccCCCC-CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh---
Q 001226 979 MSKLISDSHS-SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL--- 1053 (1119)
Q Consensus 979 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--- 1053 (1119)
++........ ........++..|+|||...+ ..++.++||||+||++|||++|+.||............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986643222 222334567889999998765 45789999999999999999999999754332210000000000
Q ss_pred ---------------ccccccccccccc-ccCCC--chHH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 ---------------QENHECICFLDRE-ISFWD--SDDQ------LKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 ---------------~~~~~~~~~~~~~-~~~~~--~~~~------~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..........+.. ..... .... ..+.++.+++.+|++.||++|||++|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000000 00000 0000 233568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=296.39 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=197.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e 907 (1119)
|+..+.||.|+||.||+|.+..+++.||+|+++.. ...+..|+.+++.++||||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 45568899999999999999999999999988532 2346779999999999999999997754 456799999
Q ss_pred ccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 908 YMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLH-----YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
|+++++|.+++.... ....+++..++.++.|++.|++||| +. +++|+||+|+||+++.++.+|++|||++.
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999997642 1335899999999999999999999 66 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.... .. .......
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~---~~~~~~~-------- 223 (265)
T cd08217 159 ILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QL---QLASKIK-------- 223 (265)
T ss_pred cccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HH---HHHHHHh--------
Confidence 7654321 1223468899999999988889999999999999999999999987532 11 1111100
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+ ..+...+..+.+++.+|++.+|++||++++|+++
T Consensus 224 --~~~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 --EGKFR---RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --cCCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 1112334578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=300.69 Aligned_cols=262 Identities=20% Similarity=0.273 Sum_probs=194.8
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|.+..+++.||||+++... ..+.+|++++++++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 455688999999999999999889999999885321 35778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+ ++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++.......
T Consensus 82 ~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-- 154 (284)
T cd07860 82 H-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-- 154 (284)
T ss_pred c-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence 5 68988887654 23589999999999999999999998 99999999999999999999999999987654321
Q ss_pred CcccccccCCCcccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc----ccc--
Q 001226 990 STRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC----ICF-- 1062 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-- 1062 (1119)
.......++..|+|||...+.. ++.++||||+||++|||++|+.||......+ ................ ...
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1122335688999999876544 6889999999999999999999986432111 0000000000000000 000
Q ss_pred ccccccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......+... .......+.+++.+|++.||++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 01123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=292.64 Aligned_cols=242 Identities=22% Similarity=0.328 Sum_probs=189.6
Q ss_pred hhCCce--eeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 836 ATEGRI--IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 836 ~~~~~~--lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
++..+. +|+|+||.||++..+.+++.+|+|.+...... ..|+.....+ +|||++++++++..++..++||||++++
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 94 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDG 94 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCC
Confidence 334444 59999999999999999999999998653211 1133333323 6999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCCCCCCc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~~~~~~ 991 (1119)
+|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++ .++++|||.+......
T Consensus 95 ~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----- 163 (267)
T PHA03390 95 DLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----- 163 (267)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----
Confidence 9999998764 489999999999999999999999 999999999999999998 9999999998765431
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
....++..|+|||++.+..++.++||||+|+++|||++|+.||.....+......+.... .+...
T Consensus 164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~--- 228 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-----------QKKLP--- 228 (267)
T ss_pred -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-----------cccCC---
Confidence 223578999999999888899999999999999999999999974322221111111110 01111
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPS-MREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ell~~ 1105 (1119)
.....+..+.+++.+|++.+|++||+ ++|++++
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 229 -FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 11134457789999999999999996 6998864
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=299.68 Aligned_cols=244 Identities=29% Similarity=0.380 Sum_probs=193.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|...+.||+|+||.||+|....+++.||+|++... ..++.+|+.+++.++||||+++.+++.+++..++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 466668899999999999999988999999987422 1346789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|++ |++.+++..... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 96 YCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred hhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 996 677777765432 489999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
....+++.|+|||++. .+.++.++||||||+++|||++|+.||...... ......... . .
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~--~-----~ 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQN--D-----S 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcC--C-----C
Confidence 2345788999999874 456889999999999999999999998643110 000000000 0 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
+. ......+..+.+++.+||+.+|++||++++++++-.
T Consensus 232 ~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 PT-----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred CC-----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 001123457899999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=295.95 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=198.5
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||+|..+.++..||+|.+.. ....+.+|+.+++.++|+||+++++.+.++...++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 5566889999999999999999999999998843 2346778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc-eEEEeccccccccCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE-PKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-vkl~DfGla~~~~~~~~ 988 (1119)
++++|.+++..... ..+++..+..++.|+++|+.|||+. +++|+||||+||++++++. +|++|||.+........
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999976542 2478999999999999999999998 9999999999999998864 69999999876643221
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......+++.|+|||+..+..++.++|+||+|+++|||++|+.||.... .......... ....+
T Consensus 158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~------~~~~~--- 221 (257)
T cd08225 158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ------GYFAP--- 221 (257)
T ss_pred --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc------ccCCC---
Confidence 1223458889999999888889999999999999999999999986421 1111111100 00000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+|++.+|++|||++|++++
T Consensus 222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011223468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=293.54 Aligned_cols=240 Identities=22% Similarity=0.325 Sum_probs=194.8
Q ss_pred eeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||.|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999988532 24578899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++.... .+++..+..++.|+++|++|+|+. +++|+||+|+||+++.++.++++|||.+....... ....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 99998754 388899999999999999999998 99999999999999999999999999998765432 2223
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..++..|+|||.+.+..++.++|+||+|+++|||++|..||.....+. ...... ..+.... ...+
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----------~~~~~~~--~~~~ 216 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND----------ILKGNGK--LEFP 216 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH----------HhccCCC--CCCC
Confidence 467889999999888889999999999999999999999997542111 000000 0000000 0011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
...+..+.+++.+||+.+|++||+ ++|++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 112457899999999999999999 8888773
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=301.21 Aligned_cols=248 Identities=22% Similarity=0.300 Sum_probs=206.0
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|...+.||+|.|+.|..|++..++..||||.+++.. ..+.+|+++|..+.|||||+++.+...+...|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 444588999999999999999999999999986532 23678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
.+|.+++|+..++. ..+..+..+..|+.+|++|+|++ .|||||||++|++++.+..+||+|||++..+.. .
T Consensus 138 ~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~---~ 208 (596)
T KOG0586|consen 138 SGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY---G 208 (596)
T ss_pred cCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc---c
Confidence 99999999998874 45578889999999999999999 999999999999999999999999999988753 3
Q ss_pred CcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......+|++.|.|||.+.+..| ++++|+||+|+++|-|+.|..||++..- ..... +.+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----k~Lr~--------------rvl~ 269 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----KELRP--------------RVLR 269 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----ccccc--------------hhee
Confidence 44556789999999999998776 5889999999999999999999985421 11000 1111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
.....+.....++.+++++++-.+|.+|++.+++.++-.....
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 1111122234567899999999999999999999987655443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=290.21 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=200.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
|+..+.||+|++|.||++.+..+++.|++|++.... ..+.+|+..++.++||+++++++++..+...++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 456688999999999999999889999999986543 5688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++.... ..+++..+..++.|++.|+++||.. +++||||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999988763 2489999999999999999999998 999999999999999999999999999887654321
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...... . ....... ... +..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~--~~~~~~~---~~~-----~~~---- 217 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--K--ALFKIAT---NGP-----PGL---- 217 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--H--HHHHHHh---cCC-----CCc----
Confidence 33456888999999988888999999999999999999999998643110 0 0000000 000 000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+..+.+++.+|++.+|++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111124568899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=297.58 Aligned_cols=244 Identities=26% Similarity=0.299 Sum_probs=198.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||.|+||.||+|.+..++..||+|++... ...+.+|+.++++++||||+++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 55668999999999999999988999999988532 34577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++.... .+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 82 ~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 82 LLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999997653 488999999999999999999998 99999999999999999999999999988664322
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||......... ...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~----------~~--- 216 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQ----------ET--- 216 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHHHHh----------cc---
Confidence 223345788999999988888999999999999999999999998754221010 000000 00
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSM--REVVG 1104 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~ell~ 1104 (1119)
.....+...+..+.+++.+||+.+|.+||++ +|+++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 0001112234678899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=295.70 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=204.7
Q ss_pred CCCCCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecc------cccccHHHHHHHHhhcCCCCEEEEeeeeec
Q 001226 825 PRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIVGSCTK 898 (1119)
Q Consensus 825 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 898 (1119)
.....+..+.+.-..+++|+|.||+||-|.++.+|+.||||++. +.+++..+|+.+++.++||.||.+...|+.
T Consensus 555 qe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET 634 (888)
T KOG4236|consen 555 QENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET 634 (888)
T ss_pred hhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC
Confidence 34445555655556689999999999999999999999999984 345778999999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEE
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIG 975 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~ 975 (1119)
.+..++|||-+.|.=|.-++.... ..+++...+.++.||+.|++|||.+ +|||+|+||+||++.+. .++|++
T Consensus 635 ~ervFVVMEKl~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 635 PERVFVVMEKLHGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred CceEEEEehhhcchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeec
Confidence 999999999996544555555443 3588888899999999999999999 99999999999999654 579999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
|||+|+.+++. ..+...+||+.|+|||++..+.|...-|+||.||++|--+.|..||... .++.+-..
T Consensus 710 DFGfARiIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQ----- 777 (888)
T KOG4236|consen 710 DFGFARIIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQ----- 777 (888)
T ss_pred cccceeecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhh-----
Confidence 99999998763 3345679999999999999999999999999999999999999998642 22221110
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ++++-+ .....+.+....++|...++..=.+|-|.+.-+.|
T Consensus 778 --N-AaFMyP-----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 778 --N-AAFMYP-----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred --c-cccccC-----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 0 111111 12224445567889999999999999988776543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=308.78 Aligned_cols=269 Identities=23% Similarity=0.296 Sum_probs=196.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 904 (1119)
+|+..++||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.++++++||||+++++++... ...|+
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 566778999999999999999999999999988532 23466799999999999999999987544 35799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|+||++ +++.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++....
T Consensus 86 v~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 5888777543 488999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCC-CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hcccccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENHECIC 1061 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1061 (1119)
..... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....+.... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDLNC 236 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHH
Confidence 32211 12233568899999998654 568899999999999999999999986421100 000000000 000000000
Q ss_pred cccc-------cccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHccccc
Q 001226 1062 FLDR-------EISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDK 1112 (1119)
Q Consensus 1062 ~~~~-------~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~ 1112 (1119)
..+. ....... .....+.++.+++.+||+.+|++|||++|++++ ++...+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 0000 0000000 001224568899999999999999999999998 7666654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=300.00 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=192.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcC-CCCEEEEeeeeecCCc-----e
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVR-HRNILRIVGSCTKDEH-----G 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----~ 902 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+.+... ..+.+|+.+++.++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 3566788999999999999999999999999875322 35778999999995 6999999999877655 7
Q ss_pred EEEEeccCCCCHHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEEeccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGM 979 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~DfGl 979 (1119)
|+||||+++ ++.+++..... ...+++..+..++.||++|+.|||+. +++||||+|+||+++. ++.+|++|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999985 89888865432 23589999999999999999999999 9999999999999998 88999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hcccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENH 1057 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~ 1057 (1119)
+....... .......+++.|+|||.+.+ ..++.++||||+|+++|||++|..||........ ........ .....
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~ 234 (295)
T cd07837 158 GRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTEQ 234 (295)
T ss_pred ceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCChh
Confidence 87653321 11223356889999998765 4578999999999999999999999864311100 00000000 00000
Q ss_pred ccccccc--c--cccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECICFLD--R--EISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~~~~~--~--~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....... . ....+... ....+..+.+++.+|++.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 0 00000000 01234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=301.29 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=190.6
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
++..+.||+|+||.||++.+..+++.||+|.+... ...+.+|+.++.++. ||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 34457799999999999999999999999988532 235678999999986 999999999999989999999998
Q ss_pred CCCCHHHhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 910 PGGTLFNVL---HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 910 ~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
+ +++.++. .... ...+++..+..++.+++.|++|||+.. +++||||||+||+++.++.++++|||+++.....
T Consensus 86 ~-~~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 86 D-ISLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred c-CCHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 5 4554433 2221 235899999999999999999999743 8999999999999999999999999998765432
Q ss_pred CCCCcccccccCCCcccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYST---RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
. ......++..|+|||.+.+. .++.++||||+||++|||++|+.||..... ........ ... .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~-~~~-------~ 227 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQV-VKG-------D 227 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhh-cCC-------C
Confidence 1 12233578899999988765 688999999999999999999999864310 00000000 000 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.+. .......+..+.+++.+||+.+|++|||+++|+++
T Consensus 228 ~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILS--NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCC--CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 01112245578899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=291.58 Aligned_cols=248 Identities=29% Similarity=0.422 Sum_probs=202.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 907 (1119)
|+..+.||+|++|.||+|.+..+++.|++|++... .+.+.+|+..+++++||||+++++.+.+. ...++|+|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 45568899999999999999988999999988543 34578899999999999999999999888 88999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+|++|+||+++.++.++++|||.+.......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 82 YVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred ecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 999999999998765 589999999999999999999998 99999999999999999999999999998775543
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.........++..|+|||...+..++.++||||+|+++|+|++|+.||..... .. ...+..... ...
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~--~~~~~~~~~--------~~~ 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PM--AALYKIGSS--------GEP 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hH--HHHHhcccc--------CCC
Confidence 21123345688899999999888899999999999999999999999875420 00 000000000 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+...+..+.+++.+|++.+|++||++.|++++
T Consensus 223 ---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 ---PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 01111225678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=283.21 Aligned_cols=254 Identities=20% Similarity=0.287 Sum_probs=207.5
Q ss_pred CCceeeecCCccEEEEEeCCC-----ceEEEEEeccccccc-----HHHHHHHHhhcCCCCEEEEeeeeecC-CceEEEE
Q 001226 838 EGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRSETN-----FDVEIRTLSLVRHRNILRIVGSCTKD-EHGFIVT 906 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~ 906 (1119)
...++.+|.||.||.|.+++. .+.|.+|.++....+ +..|...+..+.|||+.++.+++.++ ...+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 345789999999999987653 345677777654443 45688888888999999999988664 5678999
Q ss_pred eccCCCCHHHhhcc-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 907 EYMPGGTLFNVLHQ-----NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 907 e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.++.-|+|+.++.. ....+.++..+.+.++.|++.|++|||.+ +|||.||..+|+++|+..+||++|-.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 99999999999983 33345688889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
...+.++.........+..||+||.+....|+.++|||||||++|||+| |+.||....+ .+..
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----------------fEm~ 508 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----------------FEME 508 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----------------HHHH
Confidence 9988888887788888999999999999999999999999999999997 9999864311 1111
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.++....+. ..+..++.+++.+|.-||+..|++||+++|++.-|.++-.+
T Consensus 509 ~ylkdGyRl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 HYLKDGYRL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHhcccee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 111111111 12345677899999999999999999999999998887543
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=296.24 Aligned_cols=255 Identities=16% Similarity=0.200 Sum_probs=183.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCC---ceEEEEEecccccccHHH---------------HHHHHhhcCCCCEEEEeeee
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRSETNFDV---------------EIRTLSLVRHRNILRIVGSC 896 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~~~~~~---------------E~~~l~~l~h~niv~l~~~~ 896 (1119)
+|...++||+|+||.||+|.+..+ +..+|+|+.......+.. +...++.+.|++++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 577788999999999999998876 667777765433222222 22334556899999999876
Q ss_pred ecCC----ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCce
Q 001226 897 TKDE----HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972 (1119)
Q Consensus 897 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 972 (1119)
.... ..++++|+.. .++.+.+.... ..++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 5443 3477888773 46666665432 256788899999999999999999 99999999999999999999
Q ss_pred EEEeccccccccCCCCC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee
Q 001226 973 KIGDFGMSKLISDSHSS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 1047 (1119)
+++|||+|+........ .......||+.|+|||...+..++.++||||+||++|||++|+.||......... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~-~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL-IH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH-HH
Confidence 99999999866432111 1122346999999999999999999999999999999999999999754221111 10
Q ss_pred hhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
...... ........... ...+..+.+++..|++.+|++||+++++++.++
T Consensus 245 ~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 245 AAKCDF-----IKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhHHHH-----HHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000000 00000011110 112456889999999999999999999998763
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=301.42 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=194.1
Q ss_pred HHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCC----
Q 001226 831 EDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDE---- 900 (1119)
Q Consensus 831 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 900 (1119)
.++.+|+..+.||+|+||.||+|....+++.||||++.... ..+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 34567888899999999999999999999999999874321 23467999999999999999999886543
Q ss_pred ----ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 901 ----HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 901 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
..++||||++ +++.+++.... ..+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.+|++|
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 3499999996 58888876543 2489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCC--CcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh---
Q 001226 977 FGMSKLISDSHSS--STRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR--- 1050 (1119)
Q Consensus 977 fGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--- 1050 (1119)
||.+......... .......++..|+|||.+.+. .++.++||||+|+++|||++|+.||....... .......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~~~~~~~ 241 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLISQLCG 241 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 9999866432211 122234578899999987654 47889999999999999999999986432110 0000000
Q ss_pred ----hhhcccccccccccccccCCC--ch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1051 ----WKLQENHECICFLDREISFWD--SD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1051 ----~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............-........ .. .......+.+++.+|++.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000000000000000 00 00112456799999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=298.61 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=193.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
.+||+|+||.||++....+++.||+|++... ...+.+|+.+++.++|+|++++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999999999999999987532 235778999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCccccc
Q 001226 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995 (1119)
Q Consensus 916 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~ 995 (1119)
+++... .+++..+..++.|++.|++|+|+. +++||||+|+||++++++.++++|||.+....... ......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 987543 378899999999999999999999 99999999999999999999999999887554321 122334
Q ss_pred ccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHH
Q 001226 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQ 1075 (1119)
Q Consensus 996 ~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1075 (1119)
.+++.|+|||...+..++.++|+||+|+++|||++|..||...... ....... ....+.+. ...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~----------~~~~~~~~----~~~ 240 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIR----------DNLPPKLK----NLH 240 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH----------hhCCcccC----Ccc
Confidence 6789999999988888899999999999999999999998642110 0000000 00011110 011
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1076 LKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1076 ~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+..+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 223467789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=294.13 Aligned_cols=239 Identities=27% Similarity=0.312 Sum_probs=187.0
Q ss_pred eeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHH---HhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRT---LSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.||+|+||.||+|.+..+++.||+|.+.... ..+..|..+ ++...||+|+++++++.+++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999889999999885321 113334333 344579999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++.++++|||++.......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999887644 489999999999999999999998 99999999999999999999999999987554321
Q ss_pred cccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.....|+..|+|||...++ .++.++||||+||++|||++|+.||.......... ...... .....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~--------~~~~~~-- 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMTL--------TMAVEL-- 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--HHHHhh--------ccCCCC--
Confidence 2234689999999988754 68899999999999999999999997542211110 000000 000111
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
+...+..+.+++.+|++.+|.+|| ++++++++
T Consensus 219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111245788999999999999999 99999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=294.79 Aligned_cols=257 Identities=21% Similarity=0.221 Sum_probs=190.6
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcC-CCCEEEEeeeeecC--CceEEEEec
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVR-HRNILRIVGSCTKD--EHGFIVTEY 908 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e~ 908 (1119)
+..+.||+|+||.||+|.+..++..||+|+++... ....+|+.+++++. |||++++++++.++ +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 44578999999999999999889999999886432 12346888888885 99999999999887 889999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++ +++.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++. +.+|++|||.+........
T Consensus 82 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 96 58888877543 2589999999999999999999999 9999999999999999 9999999999986643221
Q ss_pred CCcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc-cccc------c
Q 001226 989 SSTRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE-NHEC------I 1060 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~------~ 1060 (1119)
.....++..|+|||... +..++.++||||+||++|||++|+.||......+ ........... .... .
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhccc
Confidence 12345788999999764 4567889999999999999999999996532111 00000000000 0000 0
Q ss_pred ccccccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+....... ......+..+.+++.+||+.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 0011335688999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=294.88 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=199.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
|+..+.+|+|+||.||+|.+..+++.||+|+++.. ...+.+|+..++.++|+|++++++++..+...++|+||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 44457799999999999999988999999998644 346788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++.... ..+++..+..++.|++.|++|||+. +++|+|++|+||+++.++.++|+|||.+....... ...
T Consensus 101 ~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~ 173 (286)
T cd06614 101 SLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK--SKR 173 (286)
T ss_pred cHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch--hhh
Confidence 9999998765 2589999999999999999999998 99999999999999999999999999887554321 122
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....++..|+|||...+..++.++|+||+||++|+|++|+.||...... ....... ...... ..
T Consensus 174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~~~-----------~~~~~~-~~ 237 (286)
T cd06614 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFLIT-----------TKGIPP-LK 237 (286)
T ss_pred ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-----------hcCCCC-Cc
Confidence 2345788999999988888999999999999999999999998632111 0000000 000000 01
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+|++.+|.+||++.+++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111234578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=296.36 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=196.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|...+.||+|+||.||+|.+..++..||+|++... ..++.+|+.+++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44557899999999999999988999999988532 12467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++ |++.+.+..... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 107 ~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 107 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 96 578777765432 489999999999999999999999 999999999999999999999999998865432
Q ss_pred CCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.....+++.|+|||.+. .+.++.++||||+||++|||++|+.||..... ......... .
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~-----------~ 239 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ-----------N 239 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHHh-----------c
Confidence 12345788999999863 45688999999999999999999999864210 000000000 0
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
.... ......+..+.+++.+|++.+|.+||++.+++++...+....
T Consensus 240 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 240 ESPT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred cCCC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 0000 011123346789999999999999999999999876555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=289.20 Aligned_cols=244 Identities=25% Similarity=0.432 Sum_probs=199.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|++|.||+|.+..+++.||+|.+.... ..+.+|++++++++|||++++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 566789999999999999999889999999985433 35788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+.........
T Consensus 82 ~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998663 489999999999999999999999 9999999999999999999999999999877543221
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||.... ..... +.... .. ...
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~--~~~~~-~~-----~~~--- 218 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAAL--FRIVQ-DD-----HPP--- 218 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHH--HHHhc-cC-----CCC---
Confidence 233467889999998887778999999999999999999999986421 10000 00000 00 000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+...+..+.+++.+|++.+|++||++.+++.+
T Consensus 219 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 219 ---LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 111224567899999999999999999999853
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=297.35 Aligned_cols=260 Identities=22% Similarity=0.258 Sum_probs=194.6
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+..+.||+|++|.||+|.+..++..||+|++... ...+.+|+.+++.++|||++++++++.+++..|+||||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4457899999999999999988999999988532 2347789999999999999999999999999999999995
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++|.+++..... ..+++..+..++.|+++|++|||+. +++||||+|+||+++.++.++++|||.+....... .
T Consensus 82 -~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~ 154 (283)
T cd07835 82 -LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--R 154 (283)
T ss_pred -cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--c
Confidence 689999876542 3589999999999999999999998 99999999999999999999999999987653321 1
Q ss_pred cccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc-------ccccccc
Q 001226 991 TRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE-------NHECICF 1062 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 1062 (1119)
......++..|+|||++.+. .++.++||||+|+++|||++|+.||....... ............ ......+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 12233568899999987654 57889999999999999999999986431110 000000000000 0000000
Q ss_pred ccccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. ....+. ......+..+.+++.+|++.+|++||+++|++++
T Consensus 234 ~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 KP-TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hh-hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000 0011123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=253.52 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=195.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|...++||+|.||+||+|+.+++++.||+|.++-+. ....+|+-+++.++|.|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 333478999999999999999999999999986433 34678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
..+|..|...... .++.+.++.++.|+.+|+.+.|++ ++.|||+||+|.+++.+|+.|++|||+++..+- +.
T Consensus 84 -dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi--pv 155 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PV 155 (292)
T ss_pred -hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC--ce
Confidence 5688888876543 488899999999999999999999 999999999999999999999999999997754 23
Q ss_pred CcccccccCCCcccccccCCCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhc----cccc-cccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQ----ENHE-CICF 1062 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~ 1062 (1119)
...+..+.|.+|++|.++.+.. |+...|+||.||++.|+.. |+.-|.+. ..++.+.. .-+... +.+. +...
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkr-if~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKR-IFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHH-HHHHhCCCccccCCccccC
Confidence 3445668899999999988754 8899999999999999995 55444332 21111111 000000 0000 0011
Q ss_pred ccc-------cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDR-------EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
-|- ....|...-+.....-.+++++.+.-+|..|.++++.+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 110 0001111112222345678888899999999999998875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=293.73 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=196.9
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+..+.||+|++|.||+|.+..+++.+|+|+++... ..+.+|+.++++++|+||+++++++.++...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 44578999999999999999889999999885432 347789999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+ ++.+++.... ..+++..+..++.|+++|+.|||+. +++|+||+|+||+++.++.++++|||.+....... .
T Consensus 82 ~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 82 T-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred C-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 5 8888887643 2589999999999999999999999 99999999999999999999999999987665432 1
Q ss_pred cccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce-----------eehhhhhhccccc
Q 001226 991 TRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI-----------VTWTRWKLQENHE 1058 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~ 1058 (1119)
......++..|+|||...+. .++.++|+||+|+++|+|++|+.||......+.-. ..|..........
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22234578899999988766 78999999999999999999999986432110000 0000000000000
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+.............+.++.+++.+||+.||.+||++++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000001112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=291.04 Aligned_cols=238 Identities=24% Similarity=0.341 Sum_probs=185.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHH-hhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTL-SLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+.||+|+||.||+|.+..+++.||+|+++... ..+..|...+ ...+|||++++++++..++..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999999889999999985432 1233344433 345899999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++.... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999997654 488999999999999999999998 999999999999999999999999999875432
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....++..|+|||...+..++.++||||+|+++|||++|..||...... . .+.... ........
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~--~~~~~~-----------~~~~~~~~ 214 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--A--VFDNIL-----------SRRINWPE 214 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--H--HHHHHH-----------hcccCCCC
Confidence 22345788999999988888899999999999999999999998643111 0 010000 00000000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
......+..+.+++.+||+.+|++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 111123457889999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=300.04 Aligned_cols=259 Identities=19% Similarity=0.254 Sum_probs=190.4
Q ss_pred eeeec--CCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 841 IIGKG--KHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 841 ~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
.||+| +||+||+|.+..+++.||+|++.... +.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 35555 99999999999999999999985322 34678999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC---
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--- 989 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~--- 989 (1119)
++.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++||+.+.........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999887543 2488899999999999999999998 9999999999999999999999999865433211110
Q ss_pred --CcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh-----hh---hc---
Q 001226 990 --STRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR-----WK---LQ--- 1054 (1119)
Q Consensus 990 --~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-----~~---~~--- 1054 (1119)
.......++..|+|||++.+ ..++.++||||+||++|||++|+.||............... +. ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 01112235667999998876 34789999999999999999999999654211100000000 00 00
Q ss_pred -----ccccc----c----------ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 -----ENHEC----I----------CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 -----~~~~~----~----------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..... . ...+... ...........+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000 0 0000000 011223456678999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=301.18 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=198.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhc-CCCCEEEEeeeeecC--CceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLV-RHRNILRIVGSCTKD--EHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~l 904 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++.. ....+.+|+.+++++ +||||+++++++... ...|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 467777899999999999999998899999998743 123466799999999 999999999988653 35799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++ ++|..++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||.+....
T Consensus 87 v~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 87 VFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred Eecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 999997 5898888754 478889999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCC---CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee------------h
Q 001226 985 DSHSS---STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT------------W 1048 (1119)
Q Consensus 985 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~------------~ 1048 (1119)
..... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+. ... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDI 237 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 43221 12233568899999998754 4578899999999999999999999864321110 000 0
Q ss_pred hhhhhcccccccccc-cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHccccc
Q 001226 1049 TRWKLQENHECICFL-DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDK 1112 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~ 1112 (1119)
..............+ ..............+..+.+++.+||+.+|++|||+++++++ +.++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 000000000000000 000000000001134578999999999999999999999987 5565444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=303.17 Aligned_cols=257 Identities=25% Similarity=0.331 Sum_probs=195.2
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------C
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------E 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 900 (1119)
..+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 45778889999999999999999999999999998532 13456799999999999999999988643 3
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..|+||||++ ++|.+++... ++...+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 5699999995 5888877542 78889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh--------
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-------- 1052 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------- 1052 (1119)
+...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||......+ .+....
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~ 238 (353)
T cd07850 166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID----QWNKIIEQLGTPSD 238 (353)
T ss_pred eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhcCCCCH
Confidence 8664321 1223467889999999998899999999999999999999999986432100 000000
Q ss_pred -------------hcc-----cccccccccccccC--CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1053 -------------LQE-----NHECICFLDREISF--WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1053 -------------~~~-----~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .............. ........+..+.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000000000000 000011235567899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=295.09 Aligned_cols=261 Identities=25% Similarity=0.294 Sum_probs=194.9
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEEEec
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIVTEY 908 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~ 908 (1119)
+..+.||+|+||.||+|....+++.||+|++.... ..+.+|+.+++.++|||++++++++.+. +..++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 44578999999999999999989999999986442 3467899999999999999999999887 789999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++ +|.+++.... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+........
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 974 8888887653 2589999999999999999999998 999999999999999999999999999987654321
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh-hhhccccccccc----
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR-WKLQENHECICF---- 1062 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---- 1062 (1119)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...... ............
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccch
Confidence 12233456788999997664 4578999999999999999999999864321100 000000 000000000000
Q ss_pred ----ccccccCCC---chHHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 ----LDREISFWD---SDDQL-KALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ----~~~~~~~~~---~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......... ..... .+..+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 00001 25678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=304.34 Aligned_cols=272 Identities=22% Similarity=0.282 Sum_probs=200.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 903 (1119)
+|...+.||+|+||+||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++... ...|
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 566678999999999999999999999999987532 23466799999999999999999988644 3479
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+. ++|.+++...+ .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 86 IVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 9999995 78988887654 489999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc--eeeh------hhhhhc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD--IVTW------TRWKLQ 1054 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~--~~~~------~~~~~~ 1054 (1119)
.... .......++..|+|||.+.. ..++.++||||+||++|+|++|+.||......... .... ..+...
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 4321 12233467889999998764 46889999999999999999999998643110000 0000 000000
Q ss_pred ccccccccccc---cccC-CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccccCCC
Q 001226 1055 ENHECICFLDR---EISF-WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDKNEG 1115 (1119)
Q Consensus 1055 ~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~~~~ 1115 (1119)
........+.. .... ........+..+.+++.+|++.+|++|||++|++++ ++.+.+..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~ 303 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccC
Confidence 00000000000 0000 000011234568899999999999999999999999 7777665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=296.46 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=193.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|++|.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.++...|+||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 466678999999999999999988999999988532 23577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~DfGla~~~~~~~ 987 (1119)
++ +++.+++..... ...++..+..++.||+.|++|||+. +++||||+|+||+++. ++.+|++|||++.......
T Consensus 83 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 83 LD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred cc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 96 578888765442 2367888889999999999999999 9999999999999985 5679999999997653321
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc------cccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN------HECI 1060 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~ 1060 (1119)
.......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||......+.....+........ ....
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 11223456889999998765 45789999999999999999999998643211100000000000000 0000
Q ss_pred ccccccccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .....+... ....+..+.+++.+|++.+|++||++++++++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYK-SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhh-hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000000 01124467899999999999999999999874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=294.39 Aligned_cols=265 Identities=24% Similarity=0.269 Sum_probs=194.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCC------
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDE------ 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 900 (1119)
+.+|+..+.||+|+||.||+|.++.+++.||+|+++... ..+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 456778899999999999999999889999999885321 34668999999999999999999887654
Q ss_pred ----ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 901 ----HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 901 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.|++|||+. +|+||||||+||++++++.+|++|
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence 78999999976 7777766542 2589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh-c
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-Q 1054 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~ 1054 (1119)
||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ............ .
T Consensus 160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~~~~~~~~~~~ 237 (302)
T cd07864 160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQLELISRLCGSP 237 (302)
T ss_pred ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCC
Confidence 999986654321 12222356788999997764 4578999999999999999999999864311 000000000000 0
Q ss_pred cccccccc--------ccccc---cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ENHECICF--------LDREI---SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ~~~~~~~~--------~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......+ .+... +.........+..+.+++.+||+.+|++||++++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 00000 00000001124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.27 Aligned_cols=243 Identities=27% Similarity=0.387 Sum_probs=193.7
Q ss_pred eeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||+|+||.||++.+..+++.||+|++.... ..+.+|+..+++++|||++++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999999889999999985432 3577899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC------
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS------ 988 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~------ 988 (1119)
.+++...+ .+++..+..++.|+++|++|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99998754 489999999999999999999999 999999999999999999999999999875433211
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
........++..|+|||......++.++||||+|+++||+++|+.||...... . ..... ......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~---~~~~~----------~~~~~~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--E---IFQNI----------LNGKIE 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--H---HHHHH----------hcCCcC
Confidence 11223456788999999988888999999999999999999999998643210 0 00000 000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
. ......+..+.+++.+|++.+|++|||+.++.+.++
T Consensus 220 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 W--PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred C--CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 001112457789999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=289.94 Aligned_cols=260 Identities=25% Similarity=0.270 Sum_probs=192.9
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhc---CCCCEEEEeeeeecCCc-----e
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLV---RHRNILRIVGSCTKDEH-----G 902 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----~ 902 (1119)
+..+.||+|+||.||+|+++.+++.||+|+++... ..+.+|+.+++++ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999999889999999986321 2355677777666 59999999999987766 8
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
+++|||++ ++|.+++..... ..+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||.+..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999996 489998876543 2589999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hcccccc--
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENHEC-- 1059 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-- 1059 (1119)
..... ......++..|+|||.+.+..++.++|+||+||++|||++|+.||......+ ......... .......
T Consensus 157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCC
Confidence 64321 1123357889999999998889999999999999999999998886432110 000000000 0000000
Q ss_pred -----ccccccccc-CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 -----ICFLDREIS-FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 -----~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......... ............+.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 0001112334677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=317.56 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=181.4
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeec-------------
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTK------------- 898 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~------------- 898 (1119)
++.+.||+||||.||+++.+-+|+.||||++.-. ...+.+|++.+.+++|||||+++..+.+
T Consensus 482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 3347799999999999999999999999998533 2347789999999999999999754310
Q ss_pred ------------------------------------------C-------------------------------------
Q 001226 899 ------------------------------------------D------------------------------------- 899 (1119)
Q Consensus 899 ------------------------------------------~------------------------------------- 899 (1119)
.
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred ---------------------------CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 001226 900 ---------------------------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952 (1119)
Q Consensus 900 ---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 952 (1119)
...||-||||+..++.++++++... -.....++++++|++|++|+|++
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~--- 716 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQ--- 716 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhC---
Confidence 1136778888887777777765421 14668899999999999999999
Q ss_pred CeEecCCCCCCeEeCCCCceEEEecccccccc----------------CCCCCCcccccccCCCcccccccCCC---CCC
Q 001226 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLIS----------------DSHSSSTRSAIVGSLGYIAPENAYST---RLT 1013 (1119)
Q Consensus 953 ~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~ 1013 (1119)
|+|||||||.||++++++.|||+|||+|+... .+......+..+||.-|+|||.+.+. .|+
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999999999999999998721 00111234567899999999987654 599
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCC
Q 001226 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVA 1093 (1119)
Q Consensus 1014 ~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 1093 (1119)
.|+|+||+|||++||+ .||....+....+. ..-+..++............-.++++++++.||
T Consensus 797 ~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~--------------~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEML---YPFGTSMERASILT--------------NLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred chhhhHHHHHHHHHHh---ccCCchHHHHHHHH--------------hcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 9999999999999998 45543211100000 011111111101111122233689999999999
Q ss_pred CCCCCHHHHHH
Q 001226 1094 DMRPSMREVVG 1104 (1119)
Q Consensus 1094 ~~RPs~~ell~ 1104 (1119)
++||||.|++.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=289.10 Aligned_cols=245 Identities=25% Similarity=0.369 Sum_probs=199.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||.||++.+..+++.+|+|.+... ...+.+|+.+++.++|+||+++.+++.++...++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 45567899999999999999988999999988532 234667999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 910 PGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++++|.+++..... ...+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999876321 23588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......+++.|+|||...+..++.++|+||+|+++|||++|+.||...... ...... ......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~----------~~~~~~ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKV----------QRGKYP 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHH----------hcCCCC
Confidence 122345788999999998888999999999999999999999998643110 000000 000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........++.+++.+|++.+|++||++.+++++
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=294.50 Aligned_cols=256 Identities=21% Similarity=0.203 Sum_probs=187.7
Q ss_pred CCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHHhhc
Q 001226 846 KHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH 919 (1119)
Q Consensus 846 ~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~ 919 (1119)
++|.||.++...+++.||+|+++.. ...+..|+..++.++||||+++++++.+++..+++|||++++++.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4456666666778999999998543 2357889999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC-----CCcccc
Q 001226 920 QNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS-----SSTRSA 994 (1119)
Q Consensus 920 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~-----~~~~~~ 994 (1119)
.... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||.+........ ......
T Consensus 92 ~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 92 THFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred Hhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 6542 2478889999999999999999999 999999999999999999999999998875532211 112233
Q ss_pred cccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh--------hhcc-ccccc---
Q 001226 995 IVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW--------KLQE-NHECI--- 1060 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~-~~~~~--- 1060 (1119)
..++..|+|||.+.+ ..++.++||||+||++|||++|+.||................ .... .....
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 457788999998865 357899999999999999999999997432111000000000 0000 00000
Q ss_pred -ccccccc--cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 -CFLDREI--SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 -~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...++.. ............++.+++.+||+.+|++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 00111122344578899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=316.04 Aligned_cols=268 Identities=18% Similarity=0.234 Sum_probs=185.8
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCce-EEEEE------------------eccc---ccccHHHHHHHHhhcCCCCEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRK-HWAVK------------------KLNR---SETNFDVEIRTLSLVRHRNIL 890 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~vavK------------------~~~~---~~~~~~~E~~~l~~l~h~niv 890 (1119)
+.+|...++||+|+||+||++..+.... .+++| .++. ....+.+|+.+++.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3578888999999999999987654221 11211 1111 123477899999999999999
Q ss_pred EEeeeeecCCceEEEEeccCCCCHHHhhccCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC
Q 001226 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP--RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968 (1119)
Q Consensus 891 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 968 (1119)
++++++.+++..|+|+|++ ++++.+++..... ........+..++.|++.||+|||+. +||||||||+||+++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 9999999999999999998 4677777654321 11234567788999999999999999 9999999999999999
Q ss_pred CCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC--cee
Q 001226 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT--DIV 1046 (1119)
Q Consensus 969 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~--~~~ 1046 (1119)
++.+||+|||+++....... .......||..|+|||++.+..++.++||||+||++|||++|..++........ ...
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999987654221 222345789999999999999999999999999999999998865432211111 000
Q ss_pred ehhhhhhcccc-------ccccccccc-ccCC-Cch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1047 TWTRWKLQENH-------ECICFLDRE-ISFW-DSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1047 ~~~~~~~~~~~-------~~~~~~~~~-~~~~-~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........... ....+++.. +... ... ......++.+++.+|++.||++|||++|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000 000000000 0000 000 00112356778999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=318.46 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=200.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|.+.++||+|+||.|..++++.+++.||+|++++ ...-|..|-.+|..-..+-|+.+..+|.++.+.|+|||
T Consensus 76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd 155 (1317)
T KOG0612|consen 76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD 155 (1317)
T ss_pred hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence 45566889999999999999999999999998853 23457888889988889999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
||+||+|...+.... .++++-++.+...|+-|+.-+|+. |+|||||||+|||+|..|++|++|||.+-.+...
T Consensus 156 Y~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d- 228 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD- 228 (1317)
T ss_pred cccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC-
Confidence 999999999999877 488999999999999999999999 9999999999999999999999999998777643
Q ss_pred CCCcccccccCCCcccccccC----C-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY----S-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
........+|||.|.+||++. + +.|++.+|.||+||++|||+.|..||+.. .-..++ ..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveTY-----------~KI 293 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVETY-----------GKI 293 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHHH-----------HHH
Confidence 233455679999999999764 3 67999999999999999999999999742 111111 112
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPS---MREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~ell~~ 1105 (1119)
++..-...++.....+....++|.+.+. +|+.|.. ++++..|
T Consensus 294 m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 294 MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 2221111111223356677888888774 5667776 8888776
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=287.66 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=193.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 903 (1119)
.|..++.||+|+||.||+|.+..++..||+|.+... ...+.+|+.++++++||||+++++++.+. +..+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 456678999999999999999999999999986321 13577899999999999999999998664 4578
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+|+||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||.++..
T Consensus 83 ~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 9999999999999987654 378889999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCC-CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHS-SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... ........++..|+|||...+..++.++|+||+||++||+++|+.||..... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~---------- 222 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKIA---------- 222 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHHH----------
Confidence 32111 1112234688999999999888889999999999999999999999864211 00000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..... ...+......+.+++.+|++ +|.+||++.+++.|
T Consensus 223 -~~~~~--~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 -TQPTK--PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -cCCCC--CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00000 01112234568899999999 57999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=292.11 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=195.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|+..+.||+|+||+||+|....+++.||||++.... ....+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 345678999999999999999889999999885432 23456889999999 999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+|++.+++.... ...+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 889999887654 23589999999999999999999998 99999999999999999999999999997664322
Q ss_pred CcccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee--h----hhhhhccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT--W----TRWKLQENHECICF 1062 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~ 1062 (1119)
......++..|+|||.+. ...++.++|+||||+++|||++|+.||......+..... . ..............
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122346788999999774 455789999999999999999999998643211100000 0 00000000000001
Q ss_pred ccccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
++.......... ...+.++.+++.+||+.+|++||+++|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 111111000000 0113578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=300.78 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=194.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec----CCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK----DEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 3566678899999999999999999999999988543 2346679999999999999999998753 34679
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++ ++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68998887654 389999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCC--CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc------
Q 001226 984 SDSHSS--STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ------ 1054 (1119)
Q Consensus 984 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 1054 (1119)
...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~-~-~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ-L-KLILSVLGSPSEEV 235 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH-H-HHHHHHhCCChhHh
Confidence 432211 11223468899999998765 4688999999999999999999999964321100 0 00000000
Q ss_pred ----cccccccccc---cccc-CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ----ENHECICFLD---REIS-FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ----~~~~~~~~~~---~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.........+ .... .+.......+.++.+++.+|++.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 0000 0000011235678999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=318.40 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=202.7
Q ss_pred hCCceeeecCCccEEEEEeCC-------CceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceE
Q 001226 837 TEGRIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 903 (1119)
..++.+|+|+||.|++|.... ....||||..+.. ...+..|+++|+.+ +|+||+.++|+|..++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 345699999999999987431 1467999998643 34678899999988 5999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCC---------C--C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 001226 904 IVTEYMPGGTLFNVLHQNE---------P--R--LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL 970 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 970 (1119)
+|+||++.|+|.++++..+ . . ..++......++.|||.|++||++. ++||||++++||+++++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCC
Confidence 9999999999999998876 0 0 1388899999999999999999999 999999999999999999
Q ss_pred ceEEEeccccccccCCCCCCcc-cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeeh
Q 001226 971 EPKIGDFGMSKLISDSHSSSTR-SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 1048 (1119)
.+||+|||+|+...+...+... +...-+..|||||.+....|+.++|||||||++||+++ |..||.... ...++..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-~~~~l~~- 533 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-PTEELLE- 533 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-cHHHHHH-
Confidence 9999999999977665444322 22125678999999999999999999999999999997 888886421 0111111
Q ss_pred hhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
..+... +. ..+.....+++++|+.||+.+|++||++.++++.+++..+
T Consensus 534 ---~l~~G~----------r~--~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 534 ---FLKEGN----------RM--EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ---HHhcCC----------CC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 111110 10 1122335678899999999999999999999999998543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=270.07 Aligned_cols=267 Identities=21% Similarity=0.315 Sum_probs=195.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecc--cc----cccHHHHHHHHhhcCCCCEEEEeeeeec--------C
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN--RS----ETNFDVEIRTLSLVRHRNILRIVGSCTK--------D 899 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 899 (1119)
-.|....+||+|.||.||+|+.+.+++.||+|+.- .. .....+|+++++.++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34455578999999999999999999999998651 11 2345789999999999999999998853 2
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
...|+|+.+|+. +|...+..... .++..++.+++.++..|+.|+|+. .|+|||+||.|++++.+|.+|++|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 457999999964 78888876643 488889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCC--CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-c-------eeeh
Q 001226 980 SKLISDSH--SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-D-------IVTW 1048 (1119)
Q Consensus 980 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~-------~~~~ 1048 (1119)
++.+.... .......++.|.+|++||.+.+ ++|+++.|||+.|||+.||++|.+-+.+...... . ...-
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97664332 2233456788999999998776 5699999999999999999999876654321100 0 0000
Q ss_pred hhhhhccccccccccccc-ccC-CCchHHH------HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1049 TRWKLQENHECICFLDRE-ISF-WDSDDQL------KALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
..|.......+...+.-. +.. ....-.. ...+..+++.+++..||.+|+++++++.|-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111111111111000 100 0000001 123678999999999999999999998763
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=295.25 Aligned_cols=260 Identities=22% Similarity=0.206 Sum_probs=191.6
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccc------------------ccHHHHHHHHhhcCCCCEEEEeeeeecCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------------------TNFDVEIRTLSLVRHRNILRIVGSCTKDE 900 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------------~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 900 (1119)
.+.||+|+||+||+|.+..+++.||||+++... ..+.+|+.+++.++||||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999999889999999885321 13668999999999999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..++||||++ ++|.+++.... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccce
Confidence 9999999996 68999887543 488999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCC------------CCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee
Q 001226 981 KLISDSHS------------SSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 981 ~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 1047 (1119)
........ ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 76541110 1111223467889999988764 4689999999999999999999998643211100000
Q ss_pred hhhhhhccccccccc--------ccccccC-CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1048 WTRWKLQENHECICF--------LDREISF-WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1048 ~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............... ....... ........+.++.+++.+|++.+|++||+++|++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000000000000000 0000000 000001124567899999999999999999999974
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=285.64 Aligned_cols=247 Identities=27% Similarity=0.363 Sum_probs=200.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
|...+.||+|+||.||++.+..++..||+|++... ...+.+|+++++.++|||++++.+.+..++..++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 45568899999999999999988999999998533 235778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 910 PGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 910 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++++|.+++.... ....+++..+..++.++++|+.|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999998753 123589999999999999999999999 99999999999999999999999999998665432
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... . ...... ......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~---~~~~~~----------~~~~~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--L---ELALKI----------LKGQYP 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--H---HHHHHH----------hcCCCC
Confidence 122334678899999998888899999999999999999999999864311 0 000000 000000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. .+...+..+.+++.+||+.+|++||++.+++++
T Consensus 222 ~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 222 P---IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 011224567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=293.33 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=200.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|...+.||+|+||.||+|....+++.||+|++... ...+.+|+.++++++ ||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 356678899999999999999989999999988542 245778999999998 999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++...+ .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 9999999999998764 489999999999999999999998 9999999999999999999999999998866443
Q ss_pred CCC------------------CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeeh
Q 001226 987 HSS------------------STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 987 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 1048 (1119)
... .......++..|+|||......++.++|+||+|+++|++++|+.||.... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~ 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----EYLTF 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc----HHHHH
Confidence 211 22234567889999999888889999999999999999999999987432 10000
Q ss_pred hhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 001226 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSM----REVVGF 1105 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~ell~~ 1105 (1119)
.. ...... ..+...+..+.+++.+||+.+|++||++ ++++++
T Consensus 232 ~~-----------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 232 QK-----------ILKLEY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HH-----------HHhcCC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 00 000000 0111224567899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=299.96 Aligned_cols=271 Identities=26% Similarity=0.301 Sum_probs=203.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC-----ceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE-----HGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 903 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 356678999999999999999988999999988542 235778999999999999999999988765 789
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++ ++|.++++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58988887654 589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-CCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee--------ehhhhhh
Q 001226 984 SDSHS-SSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV--------TWTRWKL 1053 (1119)
Q Consensus 984 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~--------~~~~~~~ 1053 (1119)
..... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||........... ....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 0122334678899999998877 789999999999999999999999865421100000 0000000
Q ss_pred cccccccccccc---cc-cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHccccc
Q 001226 1054 QENHECICFLDR---EI-SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDK 1112 (1119)
Q Consensus 1054 ~~~~~~~~~~~~---~~-~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~ 1112 (1119)
.........+.. .. ..+.......+..+.+++.+||+.+|++||++++++++ ++++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 000000000000 00 00000011134578899999999999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=296.80 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=192.6
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC------
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------ 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 900 (1119)
+.+|+..++||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 45778889999999999999999999999999987422 234678999999999999999999875433
Q ss_pred --ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 901 --HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 901 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
..++||||+++ ++...+.... ..+++..+..++.|+++|++|||+. +++||||||+||++++++.++++|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 45999999964 6777766543 2589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCC---------cccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeeh
Q 001226 979 MSKLISDSHSSS---------TRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 979 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~ 1048 (1119)
+++......... ......+++.|+|||...+ ..++.++||||+||++|||++|+.||............+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 997654322111 1123456888999998765 457899999999999999999999986432110000000
Q ss_pred hhhhhc------ccccccccc----cccccCC-CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1049 TRWKLQ------ENHECICFL----DREISFW-DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1049 ~~~~~~------~~~~~~~~~----~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... ......... ....... ..........+.+++.+|++.+|++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000 000000000 0000000 00001112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.76 Aligned_cols=248 Identities=24% Similarity=0.294 Sum_probs=192.7
Q ss_pred hhCCceeeecCCccEEEEEeC---CCceEEEEEecccc--------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 903 (1119)
|+..+.||+|+||.||+|... .+|+.||+|+++.. .+.+.+|+++++++ +|++|+++++++..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 455688999999999999874 36889999988532 24467899999999 5999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++.... .+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.+|++|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 9999999999999997654 378889999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCcccccccCCCcccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYST--RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.... ........++..|+|||...+. .++.++||||+|+++|+|++|+.||..... ............
T Consensus 156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~-------- 225 (290)
T cd05613 156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRIL-------- 225 (290)
T ss_pred cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhh--------
Confidence 4322 1222234688999999987653 467899999999999999999999863211 111111111000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.... ..+......+.+++.+|++.+|++|| ++++++++
T Consensus 226 --~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 226 --KSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --ccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 01112345678999999999999997 78888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=281.24 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=199.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc---ccccHHHHHHHHhhcC--CC----CEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVR--HR----NILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~~~~~l 904 (1119)
.+|++.+.+|+|.||.|-++.+..++..||||+++. -.++...|+++++++. .| -+|.+.+||+..++.++
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi 168 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI 168 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence 367777889999999999999999999999999863 3455677999999993 22 47899999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC----------------
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---------------- 968 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---------------- 968 (1119)
|+|.+ |-|+++++..+.. .+++...+..++.|+++++++||+. +++|.|+||+||++.+
T Consensus 169 vfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 169 VFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred EEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcccee
Confidence 99998 7799999998764 4689999999999999999999999 9999999999999842
Q ss_pred ----CCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 001226 969 ----ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044 (1119)
Q Consensus 969 ----~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 1044 (1119)
+..|+++|||.|+.... ..+..+.|..|+|||++.+-.++.++||||+|||++|+.+|..-|..-. +..+
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n~EH 317 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-NLEH 317 (415)
T ss_pred ccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-cHHH
Confidence 24589999999986543 2356788999999999999999999999999999999999998886532 1111
Q ss_pred eeehhhhhhcc-ccc------cccccc------------c--------c--ccCCCchHHHHHHHHHHHHHHccccCCCC
Q 001226 1045 IVTWTRWKLQE-NHE------CICFLD------------R--------E--ISFWDSDDQLKALRLLELALECTRQVADM 1095 (1119)
Q Consensus 1045 ~~~~~~~~~~~-~~~------~~~~~~------------~--------~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1095 (1119)
++-+. ..... +.. ..+++. + . +.........+...+++++++|+..||.+
T Consensus 318 LaMMe-rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMME-RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHH-HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 11100 00000 000 000000 0 0 00000112234567999999999999999
Q ss_pred CCCHHHHHHH
Q 001226 1096 RPSMREVVGF 1105 (1119)
Q Consensus 1096 RPs~~ell~~ 1105 (1119)
|+|++|++.|
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=301.02 Aligned_cols=264 Identities=22% Similarity=0.293 Sum_probs=193.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC------ce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------HG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 902 (1119)
+|...+.||+|+||.||+|.+..+++.||+|++.+. ...+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 95 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceE
Confidence 455668999999999999999988999999988542 134678999999999999999999886543 45
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++|+||++ .++.++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.
T Consensus 96 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 96 YLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 89999996 46766542 1378899999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc--
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC-- 1059 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 1059 (1119)
... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ................
T Consensus 167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 432 1223457889999998766 468899999999999999999999997532100 0000000000000000
Q ss_pred -------cccccccccCCCch----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccccC
Q 001226 1060 -------ICFLDREISFWDSD----DQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDKN 1113 (1119)
Q Consensus 1060 -------~~~~~~~~~~~~~~----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~~ 1113 (1119)
.............. ....+..+.+++.+||+.||++||++++++++ ++.+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~ 307 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence 00000000000000 01123467899999999999999999999977 77776653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=294.41 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=196.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
.|+....+|.|+|+.|-.+.+..+++..++|++.+...+..+|+.++... .|||++++.+.+.++.+.|+|||.+.|+-
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred hhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 34445669999999999999999999999999988877778888777666 69999999999999999999999999998
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe-CCCCceEEEeccccccccCCCCCCcc
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL-DSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+.+.+...+. .. ..+..|+.+|+.|+.|||++ ||||||+||+|||+ ++.++++++|||.++..... .
T Consensus 403 ll~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~ 470 (612)
T KOG0603|consen 403 LLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----C 470 (612)
T ss_pred HHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----h
Confidence 8777765542 22 67788999999999999998 99999999999999 68899999999999876543 2
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
...+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+ .....+.. . + .
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~--~---------~------~ 530 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ--M---------P------K 530 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc--C---------C------c
Confidence 2335688999999999999999999999999999999999999753222 11111100 0 0 0
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.....+....+++.+||+.||++||+|.++.++=
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 1133455778999999999999999999998763
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=290.69 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=192.9
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|+..+.||+|+||.||+|.+..++..||+|.+... ..++.+|+.+++.++|+|++++++++..+...++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55557899999999999999988999999987521 12466799999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 97 ~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 97 CL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred cC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 96 688887765432 478899999999999999999998 999999999999999999999999999876532
Q ss_pred CCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.....++..|+|||.+. ...++.++||||+||++|||++|+.||........ .. ... ..
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~---~~~-----------~~ 229 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LY---HIA-----------QN 229 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HH---HHh-----------hc
Confidence 12345788999999864 35678899999999999999999999854211000 00 000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.... ......+..+.+++.+||+.+|++||++++++++-.-.
T Consensus 230 ~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 230 ESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred CCCC--cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0000 00112345678999999999999999999999875433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=290.76 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=191.1
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+..|+..+.||+|+||.||+|.+..+++.||||.++... ..+..|+..+.+.. ||||+++++++.++...|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 345677789999999999999999889999999986422 23455666666664 999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++ +++.+++..... .+++..+..++.|++.|++|||+.+ +|+||||+|+||++++++.+||+|||.+......
T Consensus 94 e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 577777655332 5889999999999999999999732 8999999999999999999999999998765432
Q ss_pred CCCCcccccccCCCcccccccCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTR----LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||.....+ . ..........
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~-~~~~~~~~~~------ 235 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---F-EVLTKILQEE------ 235 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---H-HHHHHHhcCC------
Confidence 21 12235788999999876543 788999999999999999999998642111 0 0000000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.+... .....+.++.+++.+||+.+|++||++++++++-
T Consensus 236 -~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 -PPSLP----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -CCCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00000 0012244678999999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=319.16 Aligned_cols=143 Identities=31% Similarity=0.464 Sum_probs=130.3
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.+|+..++||+|+||.||+|.+..+++.||||+++... ..+..|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 346777899999999999999999999999999986432 4578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
|||+++++|.+++.... .+++..++.++.||+.||+|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997654 378889999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=288.48 Aligned_cols=241 Identities=27% Similarity=0.365 Sum_probs=190.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
|...+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++|||++++++++.++...|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44557899999999999999988999999988532 13467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++ +++.+++..... .+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.+|++|||.+.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 578777765432 488999999999999999999999 999999999999999999999999998864321
Q ss_pred CCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.....++..|+|||.+. ...++.++||||+||++|||++|..||...... . ........ ...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~---~~~~~~~~--~~~----- 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S---ALYHIAQN--DSP----- 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--H---HHHHHHhc--CCC-----
Confidence 22346788999999874 456888999999999999999999998643110 0 00000000 000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ....+..+.+++.+|++.+|++||++.+++++
T Consensus 239 ~~~-----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQ-----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01123357899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=285.48 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=193.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc---------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|...+.||+|+||.||++.+...+..+++|+.+. ...++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 45667899999999999999887766666666542 112356789999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|||+++++|.+++.... ....+++..+..++.|+++|+.|||+. +++|+|++|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887532 234589999999999999999999998 9999999999999975 569999999987664
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... .......+++.|+|||...+..++.++|+||+|+++|+|++|..||.... ........ ..
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~----------~~ 219 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRI----------VE 219 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH----------Hc
Confidence 322 12223457889999999888888999999999999999999999985321 11100000 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.... ..+...+.++.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 GPTP---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCC---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0000 1112344578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=297.43 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=189.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecC-----------
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKD----------- 899 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~----------- 899 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 566778999999999999999999999999988542 23477899999999999999999876543
Q ss_pred ---CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEE
Q 001226 900 ---EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIG 975 (1119)
Q Consensus 900 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~ 975 (1119)
...++||||++ ++|.+++... .+++..+..++.|++.|+.|||+. +++||||||+||+++. ++.+|++
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 34689999997 5898888643 378999999999999999999998 9999999999999985 5578999
Q ss_pred eccccccccCCCCC-CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 976 DFGMSKLISDSHSS-STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 976 DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
|||.++........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..................
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99998765332111 11123357889999997654 56788999999999999999999999643211100000000000
Q ss_pred ccc-------ccccccccccccCC-Cch---HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 QEN-------HECICFLDREISFW-DSD---DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 ~~~-------~~~~~~~~~~~~~~-~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ......+....... ... ....+.++.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 00000000000000 000 01133567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=289.27 Aligned_cols=252 Identities=24% Similarity=0.274 Sum_probs=194.1
Q ss_pred hhCCceeeecCCccEEEEEeC---CCceEEEEEecccc--------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 903 (1119)
|+..+.||+|+||.||++... .++..||||+++.. ...+.+|+.+++++ +||+|+++.+.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 455688999999999998854 35688999988532 23467899999999 5999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++.... .+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.++++|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 9999999999999987643 488899999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCcccccccCCCcccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTR--LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
..... .......++..|+|||...+.. .+.++||||+|+++|||++|..||...... ..........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~--------- 224 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRI--------- 224 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHH---------
Confidence 43221 1122345788999999876654 688999999999999999999998532111 0000000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..... ..+...+..+.+++.+||+.+|++|||++++.+.++..
T Consensus 225 -~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 225 -LKSKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -HccCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00000 01112334678999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=296.99 Aligned_cols=257 Identities=24% Similarity=0.305 Sum_probs=189.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------Cce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------EHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 902 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.++++++||||+++++++... ...
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccE
Confidence 566678999999999999999888999999998643 23466799999999999999999987543 346
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||++++++.+|++|||+++.
T Consensus 98 ~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 98 YLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred EEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 7888887 78998887643 388999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc-
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI- 1060 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 1060 (1119)
... ......++..|+|||...+ ..++.++||||+||++|||++|+.||....... .................
T Consensus 170 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 170 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLK 243 (345)
T ss_pred ccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHh
Confidence 432 1223467889999998765 567889999999999999999999985432110 00000000000000000
Q ss_pred --------cc---ccccccCCC-chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 --------CF---LDREISFWD-SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 --------~~---~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+ +........ .........+.+++.+|++.+|++||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000000 0000123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=281.55 Aligned_cols=236 Identities=28% Similarity=0.373 Sum_probs=192.3
Q ss_pred eeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
||+|+||.||++.+..+++.||+|+++.. ...+..|+.+++.++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999988543 23578899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~ 994 (1119)
.+++.... .+++..+..++.|+++|+.|+|+. +++|+||+|+||+++.++.++++|||.+....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 99998654 488999999999999999999998 99999999999999999999999999987664321 12234
Q ss_pred cccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 995 ~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
..++..|+|||...+...+.++|+||+|+++||+++|+.||..... ......... .... .+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~----------~~~~----~~ 213 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK----------DPLR----FP 213 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc----------CCCC----CC
Confidence 5678899999998888889999999999999999999999864311 111111000 0111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH---HHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPSM---REVVG 1104 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~---~ell~ 1104 (1119)
...+..+.+++.+|+..||++||++ +++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 1124567899999999999999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=286.94 Aligned_cols=258 Identities=23% Similarity=0.287 Sum_probs=196.1
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+..+.||+|+||.||+|....+++.||+|++.... ..+..|+.+++.++|+|++++++++.+.+..++||||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34577999999999999999999999999886431 346679999999999999999999999999999999997
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.+........
T Consensus 82 -~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 82 -MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred -cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 58999998763 2489999999999999999999999 999999999999999999999999999876643221
Q ss_pred cccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc--ee------ehhhhhhcccccccc
Q 001226 991 TRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD--IV------TWTRWKLQENHECIC 1061 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~--~~------~~~~~~~~~~~~~~~ 1061 (1119)
......++..|+|||.+.+. .++.++||||+||++||+++|+.||......... .. ....|... ....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~- 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV--TKLP- 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh--cccc-
Confidence 22234567789999988766 7899999999999999999999998643210000 00 00000000 0000
Q ss_pred cccccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+.....+.... ......+.+++.+|++.+|++||++++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0111111111110 1124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=277.82 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=195.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----------ccHHHHHHHHhhcCCCCEEEEeeeeec-CCce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----------TNFDVEIRTLSLVRHRNILRIVGSCTK-DEHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 902 (1119)
+|-...+||+|+|+.||+|.+....++||||+-...+ ....+|.++-+.+.||.||++++++.- .+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 3444478999999999999999889999999763211 124568888899999999999999964 5677
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGM 979 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGl 979 (1119)
|-|+|||+|.+|.-|++.++ .+++++++.|+.||+.|+.||.+. .++|||-|+||.||++-. -|.+||.|||+
T Consensus 544 CTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 99999999999999999876 489999999999999999999987 678999999999999954 47899999999
Q ss_pred cccccCCCCCC-----cccccccCCCcccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh
Q 001226 980 SKLISDSHSSS-----TRSAIVGSLGYIAPENAYS----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR 1050 (1119)
Q Consensus 980 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~ 1050 (1119)
++.+.+..+.. ..+...||++|++||.+.- ...+.++||||+||++|..+.|+.||..... ..++....
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdILqeN- 697 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDILQEN- 697 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHHHhhh-
Confidence 99887643331 3356789999999997753 3468899999999999999999999974311 11111111
Q ss_pred hhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1051 WKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
.+...- .. .+...+..+.+..++|++|+++--+.|....++..
T Consensus 698 -------TIlkAt--EV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 698 -------TILKAT--EV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------chhcce--ec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 000000 00 01112233456789999999999999988887754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=289.57 Aligned_cols=263 Identities=22% Similarity=0.272 Sum_probs=195.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeec-CCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTK-DEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++.. ....+..|+.+++.++||||+++.+++.. ....++|+|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 56677899999999999999999999999998743 22457789999999999999999998865 557899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+ +++|.++++.. .+++..+..++.|+++|++|||+. +++||||+|+||++++++.++++|||.+......
T Consensus 91 ~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 91 LL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred hh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 98 56898888643 377888889999999999999999 9999999999999999999999999998754321
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh--------hhc-ccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW--------KLQ-ENH 1057 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~-~~~ 1057 (1119)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ....... ... ...
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhccch
Confidence 123456889999998765 5689999999999999999999999864321000 0000000 000 000
Q ss_pred cccccccccccC--CCch---HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHccccc
Q 001226 1058 ECICFLDREISF--WDSD---DQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDK 1112 (1119)
Q Consensus 1058 ~~~~~~~~~~~~--~~~~---~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~ 1112 (1119)
....++. .... .... ....+..+.+++.+|++.+|++||++++++.+ +++..+.
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 237 NTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0000000 0000 0000 01124578899999999999999999999987 5544444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=277.85 Aligned_cols=220 Identities=22% Similarity=0.218 Sum_probs=178.4
Q ss_pred cCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCC
Q 001226 845 GKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPR 924 (1119)
Q Consensus 845 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 924 (1119)
|.||.||++++..+++.||+|+++... .+..|...+....|||++++++++.+....++||||+++|+|.+++....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 80 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-- 80 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--
Confidence 899999999999999999999986543 34456666666679999999999999999999999999999999987654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccc
Q 001226 925 LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004 (1119)
Q Consensus 925 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP 1004 (1119)
.+++..+..++.|+++|+.|+|+. +++||||||+||+++.++.++++|||.+...... .....++..|+||
T Consensus 81 -~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aP 151 (237)
T cd05576 81 -NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAP 151 (237)
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCC
Confidence 388999999999999999999998 9999999999999999999999999987655431 1223456789999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHH
Q 001226 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLEL 1084 (1119)
Q Consensus 1005 E~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1084 (1119)
|......++.++||||+|+++|||++|+.|+......... .....++ ...+..+.++
T Consensus 152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-----------------~~~~~~~------~~~~~~~~~l 208 (237)
T cd05576 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----------------HTTLNIP------EWVSEEARSL 208 (237)
T ss_pred cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----------------ccccCCc------ccCCHHHHHH
Confidence 9988888899999999999999999999887532100000 0000011 1123467899
Q ss_pred HHHccccCCCCCCCH
Q 001226 1085 ALECTRQVADMRPSM 1099 (1119)
Q Consensus 1085 ~~~cl~~dP~~RPs~ 1099 (1119)
+.+|++.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=272.54 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=192.9
Q ss_pred CCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-----ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCc
Q 001226 828 LRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 828 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 901 (1119)
|+-+++++. ..||.|+||+|+|-.++.+|+..|||+++. +..++..|.....+- ..||||+++|++..++.
T Consensus 61 F~~~~Lqdl---g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 61 FTSDNLQDL---GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cccchHHHH---HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 444444433 459999999999999999999999999853 334566666655443 69999999999999999
Q ss_pred eEEEEeccCCCCHHHhh---ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 902 GFIVTEYMPGGTLFNVL---HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
.|+.||.| ..++..+- +..+ +..+++.-.-.|....+.||.||.+.. .|+|||+||+|||++..|.||++|||
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeeccc
Confidence 99999999 45654333 2222 235888888888888899999999876 89999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
.+..+.+ ....+.-+|...|||||.+.. ..|+-++||||+|+++||+.||..||........++...+.
T Consensus 214 IcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~------ 284 (361)
T KOG1006|consen 214 ICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI------ 284 (361)
T ss_pred chHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc------
Confidence 9876643 234455678899999998764 34889999999999999999999999764221111111110
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
-|+..-............+..++..|+.+|-..||...++.++
T Consensus 285 ------gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 ------GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111111222234456678999999999999999999998764
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=292.78 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=192.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC------ce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------HG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 902 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.++++++||||+++++++..+. ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 566778999999999999999989999999988532 134678999999999999999999887553 35
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++||||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 8999999 77998887643 388999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc--
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC-- 1059 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 1059 (1119)
.... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||........ ..............+
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 168 TDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 5331 123456889999998765 4578999999999999999999999864321100 000000000000000
Q ss_pred -------cccccccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHcc
Q 001226 1060 -------ICFLDREISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVG--FLIKL 1109 (1119)
Q Consensus 1060 -------~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~--~L~~~ 1109 (1119)
..... .+..... ........+.+++.+|++.||++|||+.++++ .++.+
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 242 KLQSEDAKNYVK-KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred hhcchhHHHHHH-hccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00000 0000000 00122345789999999999999999999994 34444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=291.38 Aligned_cols=263 Identities=24% Similarity=0.249 Sum_probs=189.6
Q ss_pred hhCCceeeecCCccEEEEEeCCC--ceEEEEEecccc------cccHHHHHHHHhhc-CCCCEEEEeeeeec----CCce
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNS--RKHWAVKKLNRS------ETNFDVEIRTLSLV-RHRNILRIVGSCTK----DEHG 902 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~--~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 902 (1119)
|+..+.||+|+||.||++.+..+ +..||+|++... ...+.+|+.+++++ .||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 45568899999999999999887 889999987532 23467799999998 59999999987543 2456
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++++||++ ++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 88999985 68999887544 488999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCC--CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-----------ceeeh
Q 001226 983 ISDSHSS--STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-----------DIVTW 1048 (1119)
Q Consensus 983 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-----------~~~~~ 1048 (1119)
....... .......++..|+|||...+ ..++.++|+||+||++|++++|+.||........ ....+
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 6432211 11233568999999998765 4688999999999999999999999864321000 00000
Q ss_pred hhhhhccccccccccccccc-CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1049 TRWKLQENHECICFLDREIS-FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.................... ............+.+++.+|++.+|++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000000000 0000001123568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=297.10 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=192.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCc------e
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH------G 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 902 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++|||++++++++..++. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 456678999999999999999999999999988532 1345679999999999999999998876554 8
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.++++|||.+..
T Consensus 96 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999999 67999988753 489999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh-c------
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-Q------ 1054 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~------ 1054 (1119)
.... .....++..|+|||...+ ..++.++||||+||++||+++|+.||........ ......... .
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 168 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHHh
Confidence 5432 223457889999998765 4678999999999999999999999864321100 000000000 0
Q ss_pred --ccccccccccccccCCC----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 --ENHECICFLDREISFWD----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 --~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......++........ ......+..+.+++.+|++.+|++|||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000000 0001125678899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=307.18 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=169.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC----ceEEEEEecccccccHHHHHHHHhhc---CCCCEEEEeee------eecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS----RKHWAVKKLNRSETNFDVEIRTLSLV---RHRNILRIVGS------CTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~vavK~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~------~~~~~ 900 (1119)
.+|...++||+|+||.||+|.+..+ +..||+|++..... .|+.+..++ .+.++..++.. ...+.
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccccCC
Confidence 4577789999999999999999988 89999998754321 122222222 22222222221 24556
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRL-----------------VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDN 963 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 963 (1119)
..++||||+++++|.+++....... ......+..++.|++.||.|||+. +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 7899999999999999987543110 112334567999999999999999 99999999999
Q ss_pred eEeCC-CCceEEEeccccccccCCCCCCcccccccCCCcccccccCCC----------------------CCCCcchHHH
Q 001226 964 ILLDS-ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST----------------------RLTEKSDVYS 1020 (1119)
Q Consensus 964 ill~~-~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDvws 1020 (1119)
||++. ++.+||+|||+|+...... ........+++.|+|||.+... .++.++||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred EEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 99986 5789999999998654322 2223446789999999954321 2345679999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCC-----CceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCC
Q 001226 1021 YGVILFELLFRKMPVDPSFGED-----TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADM 1095 (1119)
Q Consensus 1021 lG~vl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1095 (1119)
+||++|||+++..|++...... ........|....... ..+................++++.+|++.||++
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc----cchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999876643210000 0000011111000000 000000000000011224568999999999999
Q ss_pred CCCHHHHHHH
Q 001226 1096 RPSMREVVGF 1105 (1119)
Q Consensus 1096 RPs~~ell~~ 1105 (1119)
|||++|+++|
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=268.36 Aligned_cols=235 Identities=26% Similarity=0.359 Sum_probs=189.9
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+....+||+|+||.|.+|+.+.+.+.+|||+++++. +-...|-+++..- +-|.++++...|..-++.|+|||
T Consensus 351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME 430 (683)
T KOG0696|consen 351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME 430 (683)
T ss_pred cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence 334578999999999999999999999999997643 1133566666655 57889999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+.||+|--.+.+.+. +.+..++.+|..||-||-+||++ ||+.||+|.+|||+|.+|++||+|||+++.-- .
T Consensus 431 yvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~ 502 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--F 502 (683)
T ss_pred EecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc--c
Confidence 9999999877777653 66778889999999999999999 99999999999999999999999999987432 2
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
...+....+|||.|+|||.+.-.+|+.++|.|||||++|||+.|+.||++..+ ..+ +..+++...
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~el-------------F~aI~ehnv 567 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DEL-------------FQAIMEHNV 567 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHH-------------HHHHHHccC
Confidence 23345568999999999999999999999999999999999999999986421 111 112222222
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCC
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRP 1097 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1097 (1119)
..+...+.+..++....+...|.+|.
T Consensus 568 ----syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 ----SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcccccHHHHHHHHHHhhcCCcccc
Confidence 22334456677888899999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=284.77 Aligned_cols=245 Identities=24% Similarity=0.359 Sum_probs=199.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhc-CCCCEEEEeeeeec-----CCceEEEEecc
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLV-RHRNILRIVGSCTK-----DEHGFIVTEYM 909 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~~~~~lV~e~~ 909 (1119)
.+.||.|.+|.||+++.+.+++.+|+|++... .++++.|.++++.. .|||++.++|++.. ++.+|+|||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 36799999999999999999999999988543 34577888888877 59999999998853 56889999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
.+|+..|.++... ...+.|+.+..|++.++.|+.|||.. .++|||||-.||+++.++.||+.|||.+...+.. .
T Consensus 104 ~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~ 177 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--V 177 (953)
T ss_pred CCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc--c
Confidence 9999999998876 45699999999999999999999999 8999999999999999999999999999877542 2
Q ss_pred CcccccccCCCcccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
..+...+|||.|||||++.. ..|+.++|+||+|++..||.-|..|+..+.+... +....+
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-LF~IpR-------------- 242 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPR-------------- 242 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-hccCCC--------------
Confidence 34556789999999998753 3477899999999999999999999876533211 111111
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+..-..+..-..++.++|..|+..|-++||++.++++|
T Consensus 243 -NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 -NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111123345678899999999999999999998865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=264.52 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=194.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcC--------CCCEEEEeeeeec----C
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVR--------HRNILRIVGSCTK----D 899 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~--------h~niv~l~~~~~~----~ 899 (1119)
||...++||-|.|++||+|.+....+.||+|+.+... +....||++++.++ ..+||++++.|.. +
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG 158 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG 158 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence 5777799999999999999999999999999997654 34566999999884 2479999999975 4
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC----------
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---------- 969 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---------- 969 (1119)
.++++|+|+. |.+|..++.....+ .++...+++|++||+.||.|||++| ||||.||||+|||+..+
T Consensus 159 ~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 159 QHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred cEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhh
Confidence 5789999999 88999999887644 5899999999999999999999999 99999999999999411
Q ss_pred -C------------------------------------------------------------------------------
Q 001226 970 -L------------------------------------------------------------------------------ 970 (1119)
Q Consensus 970 -~------------------------------------------------------------------------------ 970 (1119)
+
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence 0
Q ss_pred -----------------------------------------------------------------------------ceE
Q 001226 971 -----------------------------------------------------------------------------EPK 973 (1119)
Q Consensus 971 -----------------------------------------------------------------------------~vk 973 (1119)
+||
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 022
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-----ceeeh
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-----DIVTW 1048 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-----~~~~~ 1048 (1119)
|+|||-|+.... ..+.-..|..|+|||++.+..|++.+||||++|+.|||+||..-|++-.++.- +++..
T Consensus 395 IaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 333333322211 00112457789999999999999999999999999999999999987654321 11111
Q ss_pred h-------hhhhccccccccccc--------ccccCCC---------chHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1049 T-------RWKLQENHECICFLD--------REISFWD---------SDDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1049 ~-------~~~~~~~~~~~~~~~--------~~~~~~~---------~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
. +.......-..++++ +++++|. .-+.+.+.++.+++.-||+.+|++||||.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1 111111111112222 1223332 224566788999999999999999999999997
Q ss_pred H
Q 001226 1105 F 1105 (1119)
Q Consensus 1105 ~ 1105 (1119)
|
T Consensus 550 h 550 (590)
T KOG1290|consen 550 H 550 (590)
T ss_pred C
Confidence 6
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=256.06 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=195.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
++...++||+|.|+.|.+++++.+.+.||+|++++. .+.++.|-.+..+. .||.+|.+..+|..+...++|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 445568999999999999999999999999998642 24467788887766 6999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++||+|--.+.+.+ .++++.++.+...|+-|+.|||+. ||+.||+|..||++|.+|++|+.|+|+.+.--
T Consensus 331 eyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred EEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 9999999976665543 499999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.+....+..+|||.|.|||.+.+.+|...+|.|++||+++||+.|+.||+....+..+.-. +.+.+.-++.+.
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-------edylfqvilekq 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-------EDYLFQVILEKQ 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-------hHHHHHHHhhhc
Confidence 3445667789999999999999999999999999999999999999999864322221110 111122233333
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCC
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRP 1097 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1097 (1119)
++.. ...+-+...+++.-+++||.+|.
T Consensus 476 irip----rslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIP----RSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccc----ceeehhhHHHHHHhhcCCcHHhc
Confidence 3322 22233456788889999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=245.70 Aligned_cols=264 Identities=19% Similarity=0.311 Sum_probs=201.4
Q ss_pred HHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-ccccHHHHHHHHhhcC-CCCEEEEeeeeecC--CceEEE
Q 001226 830 YEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-SETNFDVEIRTLSLVR-HRNILRIVGSCTKD--EHGFIV 905 (1119)
Q Consensus 830 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 905 (1119)
+....+|+..+++|+|.|+.||.|....+.++++||+++. .+..+.+|+++++.++ ||||++++++..+. ....+|
T Consensus 34 wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 34 WGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3445567777999999999999999888899999999974 4567899999999998 99999999998775 456899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~ 984 (1119)
+||+.+.+...... .++...+...+.++..|+.|+|++ ||+|||+||.|+|+|.. ...+++|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999887765543 366678899999999999999999 99999999999999976 468999999999886
Q ss_pred CCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh-------------
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR------------- 1050 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~------------- 1050 (1119)
... ....++.+..|--||.+... .|+..-|+|||||++..|+..+.||.......++++...+
T Consensus 185 p~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 643 33445677888999988764 5788999999999999999999999765444333332211
Q ss_pred hhhcccccccccccccccC-C----CchH-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1051 WKLQENHECICFLDREISF-W----DSDD-QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~-~----~~~~-~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....-......++.+..+. | .... .....++.+++.+.+..|-.+|||++|.++|
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111122222211110 1 0111 1123578899999999999999999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=276.40 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=198.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
..||-|+||.|-++........+|+|.+++. .+.+..|-++|...+.|.||+++-.|.++...|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 5699999999999988775556888887532 345677999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
.+...+++++ .++..+++.++..+.+|++|||++ +||.||+||+|.+++.+|-+|+.|||+|+.+.. ....
T Consensus 506 ElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~KT 576 (732)
T KOG0614|consen 506 ELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GRKT 576 (732)
T ss_pred hhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc---CCce
Confidence 9999999876 388888999999999999999999 999999999999999999999999999998865 3466
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
+.++||+.|.|||.+..+.++.++|.||+|+++||+++|..||....+-.. +.. .+ .-+| .+ .
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----Yn~-IL-------kGid----~i-~ 639 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----YNL-IL-------KGID----KI-E 639 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----HHH-HH-------hhhh----hh-h
Confidence 778999999999999999999999999999999999999999976422111 100 00 0000 00 1
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPS-----MREVVGFL 1106 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~L 1106 (1119)
.+...+....+++++.+..+|.+|.- +.||.+|-
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 12334456678999999999999985 66766653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-29 Score=289.02 Aligned_cols=242 Identities=29% Similarity=0.391 Sum_probs=189.1
Q ss_pred ceeeecCCcc-EEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCCCCHHH
Q 001226 840 RIIGKGKHGT-VYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 840 ~~lG~G~fg~-Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 916 (1119)
+++|.|+.|+ ||+|... ++.||||++-.. .+-..+|+..++.- +|||||++++.-.+++..|+..|.| ..+|.+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~d 591 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQD 591 (903)
T ss_pred HHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHH
Confidence 5689999986 6999887 589999988543 44568899999988 5999999999999999999999999 569999
Q ss_pred hhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---C--CceEEEeccccccccCCCCC-
Q 001226 917 VLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---E--LEPKIGDFGMSKLISDSHSS- 989 (1119)
Q Consensus 917 ~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~vkl~DfGla~~~~~~~~~- 989 (1119)
++.... ..........+.+..|+++|++|||+. +|||||+||+||||+. + .+++|+|||+++....+...
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~ 668 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF 668 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence 998741 111111134578899999999999998 9999999999999976 3 46899999999988755332
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFR-KMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||.+|+|||.+....-+.++||||+|||+|+.++| .+||......+..+..- .......-.
T Consensus 669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~~L~~---- 737 (903)
T KOG1027|consen 669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLVHLEP---- 737 (903)
T ss_pred hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------ccceeeecc----
Confidence 234667899999999999988888999999999999999985 99998654443333221 111111100
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+. ...++|.+|++++|..||++.+|+.|
T Consensus 738 ---~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 ---LPDC----EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ---CchH----HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0011 56799999999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=262.96 Aligned_cols=235 Identities=27% Similarity=0.403 Sum_probs=191.0
Q ss_pred CCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHHhhcc
Q 001226 846 KHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ 920 (1119)
Q Consensus 846 ~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 920 (1119)
+||.||+|....+++.||+|++... ...+.+|++.+++++|+|++++++++..+...++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999988999999998543 35788999999999999999999999998999999999999999999876
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCC
Q 001226 921 NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000 (1119)
Q Consensus 921 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~ 1000 (1119)
... +++..+..++.++++++.|||.. +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 543 78899999999999999999999 99999999999999999999999999998765432 2334567889
Q ss_pred cccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHH
Q 001226 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALR 1080 (1119)
Q Consensus 1001 y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1080 (1119)
|+|||......++.++||||+|+++|++++|..||...... ....... ..............+.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----~~~~~~~-----------~~~~~~~~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----LELFKKI-----------GKPKPPFPPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHH-----------hccCCCCccccccCCHH
Confidence 99999988888899999999999999999999998642111 0000000 00000000000003457
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 001226 1081 LLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1081 l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=265.89 Aligned_cols=198 Identities=28% Similarity=0.442 Sum_probs=171.6
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||-|+||.|.+++..++...||+|.+++. ...++.|-.++.....+-||+++..|.+.+.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 7899999999999999999889999988542 345788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc---cCCCCC
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI---SDSHSS 989 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~---~~~~~~ 989 (1119)
++-.+|.+.+ .+++.-++.++..+..|+++.|.. |+|||||||+|||||.+|++|+.|||++.-+ .+..++
T Consensus 715 DmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 715 DMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred cHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 9999998876 588889999999999999999999 9999999999999999999999999997532 111110
Q ss_pred C-------------------------------------cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 001226 990 S-------------------------------------TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK 1032 (1119)
Q Consensus 990 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~ 1032 (1119)
. ..-..+||+.|+|||++....|+..+|.||.|||+|||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 0 001247999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 001226 1033 MPVDPSFGEDT 1043 (1119)
Q Consensus 1033 ~p~~~~~~~~~ 1043 (1119)
.||-.....+.
T Consensus 869 ~pf~~~tp~~t 879 (1034)
T KOG0608|consen 869 PPFLADTPGET 879 (1034)
T ss_pred CCccCCCCCcc
Confidence 99976554444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-30 Score=254.88 Aligned_cols=260 Identities=27% Similarity=0.320 Sum_probs=191.2
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceEEEEe
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGFIVTE 907 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e 907 (1119)
.+.||-|+||+||.+.+..+|+.||+|++.. ....+-+|++++.-++|.||...++...-. ...|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 4789999999999999999999999998842 234577899999999999999998876543 34588899
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
.| ..+|..++-... .++.+.++-+.+||.+|++|||+. +|.||||||.|.+++++...||+|||+++.... +
T Consensus 138 Lm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-d 209 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-R 209 (449)
T ss_pred HH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch-h
Confidence 88 457777766544 488889999999999999999999 999999999999999999999999999987654 3
Q ss_pred CCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-ce-e------ehhhhhhccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-DI-V------TWTRWKLQENHE 1058 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~~-~------~~~~~~~~~~~~ 1058 (1119)
.....+..+.|..|+|||.+++. .|+.++||||.||++.|++.++.-|....+-.. +. . .....+..-...
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 34455667889999999998874 689999999999999999999988864321111 00 0 000000000000
Q ss_pred cccccccccc-----CCC--chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1059 CICFLDREIS-----FWD--SDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1059 ~~~~~~~~~~-----~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
...++.+..+ ... ..+.....+...+...++..||++|.+.++.+++.
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0011111110 000 11112223456778899999999999999988765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=234.22 Aligned_cols=195 Identities=25% Similarity=0.373 Sum_probs=160.1
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhh-cCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSL-VRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
...||+|+||.|-+.++..+|...|+|.++.. ..+..+|+.+..+ ...|.+|+++|...+++..++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 35699999999999999999999999988532 2334556665544 36999999999999999999999999 45
Q ss_pred CHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 913 TLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 913 sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
+|..+-++. .....+++.-.-+|+..+++|+.|||++. .++|||+||+|||++.+|+||++|||.+..+.++ ..
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS---iA 204 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS---IA 204 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh---hH
Confidence 666554431 22346889999999999999999999986 8999999999999999999999999999877553 22
Q ss_pred ccccccCCCcccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 001226 992 RSAIVGSLGYIAPENAY----STRLTEKSDVYSYGVILFELLFRKMPVDPSF 1039 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~----~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 1039 (1119)
.+...|...|||||.+. +..|+.++||||+|+.+.||.+++.||+...
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 33346788999999664 3478999999999999999999999997653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=274.84 Aligned_cols=258 Identities=20% Similarity=0.237 Sum_probs=177.3
Q ss_pred HHhhCCceeeecCCccEEEEEeC----------------CCceEEEEEeccccc------------------ccHHHHHH
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN----------------NSRKHWAVKKLNRSE------------------TNFDVEIR 879 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~----------------~~~~~vavK~~~~~~------------------~~~~~E~~ 879 (1119)
.+|...++||+|+||+||+|... ..++.||||+++... +....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 35677799999999999999752 235679999975321 22334777
Q ss_pred HHhhcCCCCE-----EEEeeeeec--------CCceEEEEeccCCCCHHHhhccCCC---------------------CC
Q 001226 880 TLSLVRHRNI-----LRIVGSCTK--------DEHGFIVTEYMPGGTLFNVLHQNEP---------------------RL 925 (1119)
Q Consensus 880 ~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~ 925 (1119)
++.+++|.++ ++++++|.. .+..++||||+++++|.++++.... ..
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777776654 677777653 3567999999999999999875321 11
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCccccc
Q 001226 926 VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005 (1119)
Q Consensus 926 ~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE 1005 (1119)
..++..+..++.|+++|+.|+|+. +|+||||||+||+++.++.+|++|||++........ .......+++.|+|||
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 346778899999999999999999 999999999999999999999999999976543211 1112234578999999
Q ss_pred ccCCCC--------------------C--CCcchHHHHHHHHHHHHhCCC-CCCCCCCCCCce----eehhhhhhccccc
Q 001226 1006 NAYSTR--------------------L--TEKSDVYSYGVILFELLFRKM-PVDPSFGEDTDI----VTWTRWKLQENHE 1058 (1119)
Q Consensus 1006 ~~~~~~--------------------~--~~~sDvwslG~vl~elltg~~-p~~~~~~~~~~~----~~~~~~~~~~~~~ 1058 (1119)
.+.... + ..+.||||+||++|||++|.. ||.....-.... .....|.......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 765322 1 134799999999999999875 664321100000 0001111100000
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVA---DMRPSMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~ell~~ 1105 (1119)
..+. .........++++.+++..+| .+|+|++|+++|
T Consensus 461 ------~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 ------YDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ------CCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0011 111224567899999999766 689999999976
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=266.16 Aligned_cols=198 Identities=24% Similarity=0.416 Sum_probs=174.0
Q ss_pred CHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------------ccHHHHHHHHhhcC---CCCEEEEe
Q 001226 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------------TNFDVEIRTLSLVR---HRNILRIV 893 (1119)
Q Consensus 829 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~---h~niv~l~ 893 (1119)
.+.....|+..+.+|+|+||.|+.|.++.....|+||.+.+.+ -.+..|+.+|..++ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 3445556888899999999999999999998999999885432 12557999999997 99999999
Q ss_pred eeeecCCceEEEEecc-CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCce
Q 001226 894 GSCTKDEHGFIVTEYM-PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972 (1119)
Q Consensus 894 ~~~~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 972 (1119)
++|++++.+|++||-. ++.+|++++...+. +++.++..|.+|++.|+++||+. +|||||||-+||.++.+|-+
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeE
Confidence 9999999999999986 45699999988763 89999999999999999999999 99999999999999999999
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVD 1036 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~ 1036 (1119)
|++|||.|..... .....++||..|.|||++.+..| +.+-|||++|+++|-++..+-||+
T Consensus 710 klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 710 KLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999876644 23456789999999999998877 567899999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=244.65 Aligned_cols=255 Identities=25% Similarity=0.312 Sum_probs=195.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------Cc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------EH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 901 (1119)
.||...+.+|.|+- .|.-|.+.-.+++||+|++... .....+|..++..+.|+|+++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35555678898888 7778888888999999988432 23467899999999999999999999654 35
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.|+|||+| ..+|...+.. .++-++...+..|++.|++|+|+. ||+|||+||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 69999999 5688887773 266778899999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.... ....+..+.|..|+|||++.+-.+.+.+||||.||++.||++|+.-|.+. ..+..|.+....-+.....
T Consensus 167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHH
Confidence 6543 24566778999999999999888999999999999999999999887632 2222232222111111111
Q ss_pred cc---------------------------cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FL---------------------------DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~---------------------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
++ |..+......+......+.+++.+|+..+|++|-+++++++|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11 111111111122334467899999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-25 Score=237.09 Aligned_cols=208 Identities=38% Similarity=0.626 Sum_probs=183.7
Q ss_pred eeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHH
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 916 (1119)
||+|.+|.||++....+++.+++|++.... ..+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999998889999999997654 458999999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEEeccccccccCCCCCCccccc
Q 001226 917 VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGMSKLISDSHSSSTRSAI 995 (1119)
Q Consensus 917 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~DfGla~~~~~~~~~~~~~~~ 995 (1119)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++++|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 998753 2488999999999999999999999 9999999999999999 89999999999986654321 12334
Q ss_pred ccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchH
Q 001226 996 VGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074 (1119)
Q Consensus 996 ~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1074 (1119)
.+...|++||..... .++.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999988776 788999999999999999
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1075 QLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1075 ~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
..+.+++.+|++.+|++||+++++++++
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2567999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-27 Score=256.51 Aligned_cols=263 Identities=21% Similarity=0.203 Sum_probs=201.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccccc---HHHHHHHHhhcC------CCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVR------HRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~lV 905 (1119)
+|.+.-..|+|-|++|.+|.+...|..||||++...+.. =..|+.+++++. --|+++++-.|....++|+|
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV 512 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV 512 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence 566667789999999999999999999999999765543 356999999985 34789999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~ 984 (1119)
+|-. ..+|.++++..+....+....+..++.|++-||..|-.. +|+|+||||.||||.+.- .+||||||.|....
T Consensus 513 FE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 513 FEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred ehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccc
Confidence 9988 679999999988777788899999999999999999988 999999999999999875 56999999998776
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc-ee-----ehhhhhhccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD-IV-----TWTRWKLQENHE 1058 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~-~~-----~~~~~~~~~~~~ 1058 (1119)
+.. .+....+..|.|||.+.+-.|+.+.|+||.||++||+.||+..|.+......- +. .+....+....-
T Consensus 589 ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 589 ENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred ccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 532 22344567899999999999999999999999999999999988654221110 00 000000000000
Q ss_pred cccccccccc--------------------------------C---CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001226 1059 CICFLDREIS--------------------------------F---WDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103 (1119)
Q Consensus 1059 ~~~~~~~~~~--------------------------------~---~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell 1103 (1119)
...-+|..+. . ...........+.+++.+|+..||++|.|..+.+
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 0000111111 0 1122334456789999999999999999999988
Q ss_pred HH
Q 001226 1104 GF 1105 (1119)
Q Consensus 1104 ~~ 1105 (1119)
+|
T Consensus 745 ~H 746 (752)
T KOG0670|consen 745 KH 746 (752)
T ss_pred cC
Confidence 75
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=231.72 Aligned_cols=249 Identities=18% Similarity=0.305 Sum_probs=192.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhc-CCCCEEEEeee-eecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLV-RHRNILRIVGS-CTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~e~~ 909 (1119)
.|++.+.+|+|.||.+-+++++.+...+++|.+.+.. .+|.+|..---.+ .|.||+.-+++ |...+.+++++||+
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 5777889999999999999999999999999986543 4677776554444 49999988874 56667888999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-C-CCceEEEeccccccccCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-S-ELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~-~~~vkl~DfGla~~~~~~~ 987 (1119)
|.|+|.+.+...+ +-+...++++.|+++|+.|||++ .+||||||.+||||- . ..+||++|||..+..+..
T Consensus 105 P~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t- 176 (378)
T KOG1345|consen 105 PRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT- 176 (378)
T ss_pred ccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce-
Confidence 9999998887654 77888899999999999999999 999999999999994 3 347999999998865432
Q ss_pred CCCcccccccCCCcccccccCC---C--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS---T--RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
-.....+..|.|||.... + ...+.+|+|.||+++|..+||+.||....-.+.....|..|..+.......
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~- 251 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK- 251 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch-
Confidence 122334667999995432 2 346789999999999999999999986666666677777776554432222
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
.++ ..+..+.++.++-+.++|++|--..++.++-
T Consensus 252 ---~F~-------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 252 ---KFN-------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ---hhc-------ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 122 1234567788899999999996555555443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-27 Score=260.85 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=196.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|.....+|+|.||.||||+++.+++..|+|+++-.. ...+.|+-+++..+|||||.+++.+...+..+++||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 3444578999999999999999999999999986433 346779999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.+.-+..+ .+++.++..+++...+|++|+|++ |=+|||||-.||++++.|.+|++|||.+..++. ...
T Consensus 96 ggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti~ 167 (829)
T KOG0576|consen 96 GGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TIA 167 (829)
T ss_pred CCcccceeeecc---cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh--hhh
Confidence 999999888766 488999999999999999999999 899999999999999999999999999877653 223
Q ss_pred cccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 991 TRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.+....||+.|||||+.. .+.|...+|||+.|+...|+-.-+.|.. +........++....+ -.+.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf-------dlhpmr~l~LmTkS~~---qpp~l 237 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF-------DLHPMRALFLMTKSGF---QPPTL 237 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc-------ccchHHHHHHhhccCC---CCCcc
Confidence 445678999999999653 5668899999999999999876665532 2222222222111110 01111
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
+ ....-...+.++++.|+..+|.+||+++.+++
T Consensus 238 k----Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 K----DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred c----CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 01112446789999999999999999988765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-26 Score=242.14 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=194.1
Q ss_pred HhhCCceeeecCCccEEEEEeCC---CceEEEEEeccc--ccccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN---SRKHWAVKKLNR--SETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.|...++||+|.|++||++.+.. ..++||+|.+.. ....+.+|++++.++. +.||+++.+++...+...+|+||
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~ 116 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPY 116 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecc
Confidence 35556899999999999999877 788999998853 4567899999999985 99999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~~~~ 987 (1119)
++.....++... ++...+..+++.+..||+++|.. |||||||||+|++.+.. +.-.|.|||+|.......
T Consensus 117 ~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 117 FEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred cCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 999998888764 55778899999999999999999 99999999999999864 667999999997221000
Q ss_pred ------------------------------------------CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHH
Q 001226 988 ------------------------------------------SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVI 1024 (1119)
Q Consensus 988 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~v 1024 (1119)
.......+.||++|+|||++.. ...+.++||||.||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0001123579999999998765 567899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCceeehhh---hh-------hccc------cc---cccc------cc-ccccCCCc------
Q 001226 1025 LFELLFRKMPVDPSFGEDTDIVTWTR---WK-------LQEN------HE---CICF------LD-REISFWDS------ 1072 (1119)
Q Consensus 1025 l~elltg~~p~~~~~~~~~~~~~~~~---~~-------~~~~------~~---~~~~------~~-~~~~~~~~------ 1072 (1119)
+.-+++++.||.....+...+..... +. .... .. ..+. ++ +.+.....
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999999765444332211100 00 0000 00 0000 00 00000000
Q ss_pred h-HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1073 D-DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1073 ~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ....+..+.+++.+|+..||.+|.|+++.++|
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00112357899999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-27 Score=247.46 Aligned_cols=305 Identities=20% Similarity=0.184 Sum_probs=186.9
Q ss_pred EEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEcc
Q 001226 73 ALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLG 152 (1119)
Q Consensus 73 ~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls 152 (1119)
.++.++.||+.++-+. -+..+.|+|..|+|+...|.+|+.+++|+.||||+|+|+.+-|.+|..+++|..|-+.
T Consensus 50 ~VdCr~~GL~eVP~~L------P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvly 123 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANL------PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLY 123 (498)
T ss_pred eEEccCCCcccCcccC------CCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhh
Confidence 3566777888775532 2467888888888886666678888888888888888888888888888887666554
Q ss_pred C-ccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCc
Q 001226 153 Y-NSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSL 231 (1119)
Q Consensus 153 ~-n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~l 231 (1119)
+ |+|+..--..|+++..|+.|.+.-|++..+..+.|..|++|..|.+..|.+.. +
T Consensus 124 g~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~------------------------i 179 (498)
T KOG4237|consen 124 GNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQS------------------------I 179 (498)
T ss_pred cCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhh------------------------h
Confidence 4 88885555677888888888888888887777788888888888887777652 2
Q ss_pred cc-cccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccC
Q 001226 232 PT-SLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISH 310 (1119)
Q Consensus 232 p~-~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 310 (1119)
+. .+..+.+++.+.+..|.+.. ..+|+++- .+....|..+++..-.....+.++++..+.+..|..
T Consensus 180 ~~~tf~~l~~i~tlhlA~np~ic---------dCnL~wla----~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c 246 (498)
T KOG4237|consen 180 CKGTFQGLAAIKTLHLAQNPFIC---------DCNLPWLA----DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLC 246 (498)
T ss_pred ccccccchhccchHhhhcCcccc---------ccccchhh----hHHhhchhhcccceecchHHHHHHHhcccchhhhhh
Confidence 22 45555666666666555321 11122110 011123344555555556666677776665555543
Q ss_pred C-CCCcEEEccccccccccC-cccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccce
Q 001226 311 C-NQLQVIALSRNNLVGQIP-RSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV 388 (1119)
Q Consensus 311 l-~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~ 388 (1119)
. ..+..=-.+.+...+..| ..|..+++|+.|+|++|+|+++-+.+|.++.++++|.|..|+|.......|.++..|+.
T Consensus 247 ~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~t 326 (498)
T KOG4237|consen 247 SLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKT 326 (498)
T ss_pred hHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhcccccee
Confidence 3 111111111222222222 34566666666666666666666666666666666666666665444445556666666
Q ss_pred eeccCccccCCCCccccccCcceEEEeecccc
Q 001226 389 LYLFNNRIEGAIPHQIGRMSKLVELALYNNRL 420 (1119)
Q Consensus 389 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 420 (1119)
|+|.+|+|+...|.+|..+..|.+|+|-.|.+
T Consensus 327 L~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~ 358 (498)
T KOG4237|consen 327 LSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF 358 (498)
T ss_pred eeecCCeeEEEecccccccceeeeeehccCcc
Confidence 66666666655555555555555555555554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=275.48 Aligned_cols=339 Identities=19% Similarity=0.241 Sum_probs=209.5
Q ss_pred cccccCCCCCcEEEccccc------cccccCcccCCCC-CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCc
Q 001226 305 SGQISHCNQLQVIALSRNN------LVGQIPRSVGNLS-SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIP 377 (1119)
Q Consensus 305 ~~~~~~l~~L~~L~Ls~N~------l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~ 377 (1119)
+.+|.++++|+.|.+..+. +...+|..+..++ +|+.|.+.++.++ .+|..| ...+|++|++++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3455666666666664432 2223455555543 5777777777665 555555 3566777777777766 455
Q ss_pred hhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCC
Q 001226 378 PEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFP 457 (1119)
Q Consensus 378 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~ 457 (1119)
..+..+++|+.|+|++|.....+|. +..+++|+.|+|++|.....+|..+..+++|+.|++++|.-.+.+|... .++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~ 704 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI--NLK 704 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC--CCC
Confidence 5666677777777776643334453 6666777777777765444667677777777777777654333444433 456
Q ss_pred ccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccc-------cCCCccccCCCC
Q 001226 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQ-------GSLPATLERNPG 530 (1119)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------~~~p~~~~~l~~ 530 (1119)
+|+.|++++|...+.+|.. .++|+.|++++|.+. .+|..+ .+++|+.|++.++... ...+..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 6777777776554445532 356777777777765 555544 4667777777664321 111222233456
Q ss_pred cceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccC
Q 001226 531 VSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD 610 (1119)
Q Consensus 531 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 610 (1119)
|+.|++++|...+.+|..++.+++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~ 855 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSR 855 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCC
Confidence 7777777776666677777777777777777765444666655 5677777777776554455543 35677777777
Q ss_pred ccccccCChhhhhcccCCeeEccC-ccCccCCCccccccccccEeecCCcc
Q 001226 611 NYLAGSIPSEVISLEKMQSLSLQE-NNLSGAIPDAFSSVQSLFELQLGSNI 660 (1119)
Q Consensus 611 N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~ 660 (1119)
|.++ .+|.++..+++|+.|+|++ |+|. .+|..+..+++|+.+++++|.
T Consensus 856 n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 856 TGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 7776 5677777777777777776 4444 466666777777777776664
|
syringae 6; Provisional |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=227.93 Aligned_cols=195 Identities=33% Similarity=0.519 Sum_probs=170.2
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
...+.||+|++|.||++....+++.+|+|.+... ...+.+|+..+++++|+|++++++++..+...++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 3457899999999999999988899999998643 45678899999999999999999999998999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++..... .+++.....++.+++.++.++|.. +++|+|++|.||+++.++.++++|||.+........ ..
T Consensus 82 ~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (225)
T smart00221 82 GDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL 155 (225)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence 999999987542 178889999999999999999999 999999999999999999999999999987754321 12
Q ss_pred ccccccCCCccccccc-CCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 001226 992 RSAIVGSLGYIAPENA-YSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~p~~~ 1037 (1119)
.....++..|++||.. ....++.++|+|++|+++|||++|+.||+.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2345678899999988 667788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-26 Score=242.76 Aligned_cols=413 Identities=22% Similarity=0.237 Sum_probs=239.5
Q ss_pred EcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccC-Ccc
Q 001226 270 YLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN-NRL 348 (1119)
Q Consensus 270 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l 348 (1119)
+-++-+++ .+|..+. +.-+.|+|..|+|+.+++++|+.+++|+.||||+|+|+.+.|.+|.++.+|..|-+.+ |+|
T Consensus 52 dCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 52 DCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred EccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 33444444 4454443 3556777777777777777777777777777777777777777777777776666555 777
Q ss_pred cCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccc------
Q 001226 349 QGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG------ 422 (1119)
Q Consensus 349 ~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------ 422 (1119)
+......|++|..|+.|.+.-|++.-+..+.|..+++|..|.+.+|.+..+.-..|..+..++.+.+..|.+..
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~w 208 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPW 208 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccch
Confidence 76555667777777777777777765556667777777777777777764444467777777777777776321
Q ss_pred ------cCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCC
Q 001226 423 ------RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGS 496 (1119)
Q Consensus 423 ------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~ 496 (1119)
..|-.++...-..-..+.++++..+-+..+... ...+..=-.+.+...+.
T Consensus 209 la~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~------------------------~esl~s~~~~~d~~d~~ 264 (498)
T KOG4237|consen 209 LADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS------------------------LESLPSRLSSEDFPDSI 264 (498)
T ss_pred hhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh------------------------HHhHHHhhccccCcCCc
Confidence 112222222323333333333332111111111 11111111112222222
Q ss_pred CC-ccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCC
Q 001226 497 FP-IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGN 575 (1119)
Q Consensus 497 ~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 575 (1119)
-| ..|..+++|+.|+|++|+++++.+.+|.+...++.|.|..|++...-...|..++.|++|+|.+|+|+..-|.+|..
T Consensus 265 cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~ 344 (498)
T KOG4237|consen 265 CPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQT 344 (498)
T ss_pred ChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccc
Confidence 22 35777888888888888888888888888888888888888887666677888888888888888888888888888
Q ss_pred cccccEEEcccCcccC-----------------cCCcccccCCCCcEEeccCccccc---cCChhhhhcccCCeeEccCc
Q 001226 576 LENLQILRLSANKLDG-----------------RIPYELGKCTKMIKLDLSDNYLAG---SIPSEVISLEKMQSLSLQEN 635 (1119)
Q Consensus 576 l~~L~~L~Ls~N~l~~-----------------~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~L~~N 635 (1119)
+..|.+|+|-.|.+.= ..|.. .+-..++.++++++.+.. ..|++.+-++
T Consensus 345 ~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~---------- 413 (498)
T KOG4237|consen 345 LFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLT---------- 413 (498)
T ss_pred cceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCC-CCCchhccccchhccccccccCCccccCCCC----------
Confidence 8888888888877631 01111 112345666666665531 1222221110
Q ss_pred cCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCC
Q 001226 636 NLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715 (1119)
Q Consensus 636 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip 715 (1119)
.+..-..++-+.+.-=-.|+....+|..+..-. ..|.+.+|.++ .+|.. .++.| .+|||+|+++-.--
T Consensus 414 -----s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~d~---telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn 481 (498)
T KOG4237|consen 414 -----SSPCPPPCTCLDTVVRCSNKLLKLLPRGIPVDV---TELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSN 481 (498)
T ss_pred -----CCCCCCCcchhhhhHhhcccchhhcCCCCCchh---HHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhc
Confidence 011111122222211112222223443332221 12556666666 55655 55666 66777777764444
Q ss_pred ccccccccceEEecccc
Q 001226 716 TEVNNMVSLYFVNISFN 732 (1119)
Q Consensus 716 ~~~~~~~~l~~l~ls~N 732 (1119)
-.+.+++.|..|-||+|
T Consensus 482 ~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 482 YTFSNMTQLSTLILSYN 498 (498)
T ss_pred ccccchhhhheeEEecC
Confidence 45666666777766665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=273.93 Aligned_cols=339 Identities=22% Similarity=0.284 Sum_probs=254.8
Q ss_pred chhhhcccccceeeccCcc------ccCCCCccccccC-cceEEEeecccccccCCccccCCCCcCEEEccCccCcccch
Q 001226 377 PPEICNLAKLEVLYLFNNR------IEGAIPHQIGRMS-KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVA 449 (1119)
Q Consensus 377 ~~~l~~l~~L~~L~L~~N~------l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 449 (1119)
+.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|+.|+|++|++. .++
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence 3456677777777775543 2234555555553 5777888777776 566665 4677888888887776 344
Q ss_pred hhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCC
Q 001226 450 LELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP 529 (1119)
Q Consensus 450 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 529 (1119)
... ..++.|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ .++
T Consensus 628 ~~~-~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~ 704 (1153)
T PLN03210 628 DGV-HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK 704 (1153)
T ss_pred ccc-ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence 333 3577788888877665556663 6777888888888887666888888888888888888876555677655 688
Q ss_pred CcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCccc-------CcCCcccccCCC
Q 001226 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD-------GRIPYELGKCTK 602 (1119)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------~~~p~~~~~l~~ 602 (1119)
+|+.|++++|...+.+|.. .++|++|+|++|.+. .+|..+ .+++|+.|+++++... ...|..+...++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 8888888888766666643 467889999999987 677765 5788888888774432 122223344578
Q ss_pred CcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeec
Q 001226 603 MIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVS 682 (1119)
Q Consensus 603 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls 682 (1119)
|+.|+|++|...+.+|.+++++++|+.|+|++|..-+.+|..+ ++++|+.|++++|.....+|..... ++.|+|+
T Consensus 780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~~~n----L~~L~Ls 854 (1153)
T PLN03210 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTN----ISDLNLS 854 (1153)
T ss_pred chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccccccc----cCEeECC
Confidence 9999999998777899999999999999999986556788877 7899999999998777777765433 3458999
Q ss_pred cccccCCcccccccccccceeeccC-ceecccCCccccccccceEEeccccc
Q 001226 683 NNKLSGKIPECLGNLDKLQILDLSS-NSFSGEIPTEVNNMVSLYFVNISFNH 733 (1119)
Q Consensus 683 ~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~~~~l~~l~ls~N~ 733 (1119)
+|.++ .+|.+++.+++|+.|+|++ |+++ .+|..+..+++|+.++++++.
T Consensus 855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 99998 7899999999999999998 5666 688889999999999998874
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=252.62 Aligned_cols=265 Identities=27% Similarity=0.353 Sum_probs=129.4
Q ss_pred cccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceec
Q 001226 384 AKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLD 463 (1119)
Q Consensus 384 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 463 (1119)
.+-..|++++|.++ .+|..+. ++|+.|++++|+++ .+|. ..++|++|+|++|+|+. +|. ..+.|+.|+
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~----lp~sL~~L~ 268 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV----LPPGLLELS 268 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccC----cccccceee
Confidence 34556777777777 4555444 36677777777776 3443 23566666666666652 221 123344444
Q ss_pred cccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCC
Q 001226 464 LTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQG 543 (1119)
Q Consensus 464 L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 543 (1119)
+++|.+ + .+|.. .++|+.|++++|+++. +|.. .++|+.|++++|++++
T Consensus 269 Ls~N~L------------------------~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~ 316 (788)
T PRK15387 269 IFSNPL------------------------T-HLPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS 316 (788)
T ss_pred ccCCch------------------------h-hhhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc
Confidence 444444 3 22221 1234444555554442 2221 2334444444444442
Q ss_pred CCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhh
Q 001226 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS 623 (1119)
Q Consensus 544 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 623 (1119)
+|.. ..+|+.|++++|+|+ .+|... .+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|++ +|...
T Consensus 317 -Lp~l---p~~L~~L~Ls~N~L~-~LP~lp---~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l~-- 381 (788)
T PRK15387 317 -LPAL---PSELCKLWAYNNQLT-SLPTLP---SGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPALP-- 381 (788)
T ss_pred -CCCC---cccccccccccCccc-cccccc---cccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Ccccc--
Confidence 2221 123445555555554 233211 24555555555555 23332 1344445555555542 44321
Q ss_pred cccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCccccccccccccee
Q 001226 624 LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQIL 703 (1119)
Q Consensus 624 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L 703 (1119)
.+|+.|+|++|+|++ +|... ++|+. |++++|+|+ .+|... .+|+.|
T Consensus 382 -~~L~~LdLs~N~Lt~-LP~l~---s~L~~-------------------------LdLS~N~Ls-sIP~l~---~~L~~L 427 (788)
T PRK15387 382 -SGLKELIVSGNRLTS-LPVLP---SELKE-------------------------LMVSGNRLT-SLPMLP---SGLLSL 427 (788)
T ss_pred -cccceEEecCCcccC-CCCcc---cCCCE-------------------------EEccCCcCC-CCCcch---hhhhhh
Confidence 344555555555542 33221 23333 455555555 244322 345566
Q ss_pred eccCceecccCCccccccccceEEecccccccccCCCcc
Q 001226 704 DLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASW 742 (1119)
Q Consensus 704 ~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~~~ 742 (1119)
+|++|+|+ .+|..+.++.+|+.+++++|+|+|.+|..+
T Consensus 428 ~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 428 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 66666666 566666666666667777777776666543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=246.34 Aligned_cols=127 Identities=28% Similarity=0.359 Sum_probs=76.9
Q ss_pred CcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEecc
Q 001226 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLS 609 (1119)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 609 (1119)
+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|... .+|+.|+|++|+|. .+|.. .++|+.|+++
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS 410 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVL---PSELKELMVS 410 (788)
T ss_pred ccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCc---ccCCCEEEcc
Confidence 34444444444442 3322 234556666666666 345432 35667777777776 35543 2467777777
Q ss_pred CccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhc
Q 001226 610 DNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLH 673 (1119)
Q Consensus 610 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 673 (1119)
+|+|++ +|... .+|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|+|.+|..+.++.
T Consensus 411 ~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 411 GNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred CCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 777763 55432 35667777777777 5777777777777777777777777776665443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=265.66 Aligned_cols=197 Identities=19% Similarity=0.192 Sum_probs=138.4
Q ss_pred hcCC-CCEEEEeeee-------ecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001226 883 LVRH-RNILRIVGSC-------TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954 (1119)
Q Consensus 883 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 954 (1119)
.++| +||.+++++| .+.+..+.++||+ +++|.+++.... ..+++.++..++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4445 5788888877 2234567888987 669999997543 3589999999999999999999999 99
Q ss_pred EecCCCCCCeEeCCCC-------------------ceEEEeccccccccCCCC--------------CCcccccccCCCc
Q 001226 955 IHRDIKSDNILLDSEL-------------------EPKIGDFGMSKLISDSHS--------------SSTRSAIVGSLGY 1001 (1119)
Q Consensus 955 vH~Dlkp~Nill~~~~-------------------~vkl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y 1001 (1119)
+||||||+|||++..+ .+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 455556665543211000 0001124588999
Q ss_pred ccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHH
Q 001226 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRL 1081 (1119)
Q Consensus 1002 ~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1081 (1119)
+|||++.+..++.++|||||||++|||++|..|+.... ........ ..+.+. ........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~----------~~~~~~-------~~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRH----------RVLPPQ-------ILLNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHH----------hhcChh-------hhhcCHHH
Confidence 99999999999999999999999999999887764210 00000000 000000 01112344
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 001226 1082 LELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1082 ~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..++.+||+++|.+||+++|++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999875
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=207.40 Aligned_cols=170 Identities=19% Similarity=0.189 Sum_probs=127.6
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.++++..+. .+++.+++.++.|+++|++|||+. + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999986542 489999999999999999999998 5 999999999999999 99987654321
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
..||+.|+|||++.+..++.++||||+||++|||++|+.||................. .+......
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-----------PADDPRDR 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHh-----------ccCCcccc
Confidence 2578999999999999999999999999999999999999864321111111110000 00000000
Q ss_pred chHHHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1072 SDDQLKA--LRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1072 ~~~~~~~--~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
....... ..+.+++.+||+.+|++||++.|+++++.....+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1111222 2689999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-23 Score=206.38 Aligned_cols=241 Identities=25% Similarity=0.400 Sum_probs=184.6
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecc------cccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN------RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
.+|.+...|..|+|++.. ..+++|+++ +...+|..|...++.+.||||.++++.|.......++..|||.|+
T Consensus 196 tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 568899999999999885 445666663 234678999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE--eccccccccCCCCCCc
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG--DFGMSKLISDSHSSST 991 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~--DfGla~~~~~~~~~~~ 991 (1119)
|+.++++... ..++..++++++.+|++|++|||+.. +-|.---+.+..|++|++.+++|. |--++. .
T Consensus 274 lynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---------q 342 (448)
T KOG0195|consen 274 LYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---------Q 342 (448)
T ss_pred HHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---------e
Confidence 9999998653 45778899999999999999999874 223344588999999999887664 333222 1
Q ss_pred ccccccCCCcccccccCCCCC---CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 992 RSAIVGSLGYIAPENAYSTRL---TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.....-.+.||+||.+...+- -+++|+|||++++||+.|++.||....+-+-.... . .+-+.
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----a-------leglr---- 407 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----A-------LEGLR---- 407 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----h-------hcccc----
Confidence 122344678999998876543 36899999999999999999999754322111100 0 00011
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
...++..+..+.+++.-|++.||.+||.++.|+-.|+++.
T Consensus 408 --v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 408 --VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred --ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1123344567889999999999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5e-21 Score=197.55 Aligned_cols=261 Identities=18% Similarity=0.210 Sum_probs=199.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEec--ccccccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL--NRSETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
.|.++++||+|.||+.+.|..--++++||||.- +.+..+...|.+..+.+. .++|..++.+..++.+..+|+|.. |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 567889999999999999999888999999975 344567888999999885 789999998888898999999999 8
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-----ceEEEeccccccccCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-----EPKIGDFGMSKLISDS 986 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~vkl~DfGla~~~~~~ 986 (1119)
-+|+|++.-++. .++.++++.+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|+.+.+.
T Consensus 108 PSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 108 PSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred cCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 899999988875 489999999999999999999999 899999999999997543 4799999999988654
Q ss_pred CC-----CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 987 HS-----SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 987 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.. +.......||.+||+-....+++.+++.|+-|+|-|+.+++.|..||.+...+.. ...+.+.-......-.+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKYEKIGETKRSTPIE 261 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHHHHhccccccCCHH
Confidence 32 3344556799999999999999999999999999999999999999987633221 11111111111111011
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+. ...+.++..-+.-.-..+=++-|+.+-+...+..+.+.
T Consensus 262 ~Lc----------~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 262 VLC----------EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHH----------hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 111 11233444444444455666778888777666655544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=213.29 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=196.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCc-eEEEEEecccc----cccHHHHHHHHhhcCC----CCEEEEeeee-ecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSR-KHWAVKKLNRS----ETNFDVEIRTLSLVRH----RNILRIVGSC-TKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~-~~vavK~~~~~----~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 904 (1119)
+|...++||+|+||.||.+.+..++ ..+|+|.-... ...+..|+.++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 6788899999999999999987764 57888876432 2268889999998873 6899999988 47778899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-----CceEEEeccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-----LEPKIGDFGM 979 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~vkl~DfGl 979 (1119)
||+.+ |.+|.++..... ...++..++.+++.|++.+|+++|+. |++||||||.|+++... ..+.+.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999887666 44699999999999999999999999 99999999999999865 3589999999
Q ss_pred cc--cccCCCC-----CCc-ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh
Q 001226 980 SK--LISDSHS-----SST-RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW 1051 (1119)
Q Consensus 980 a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 1051 (1119)
++ ....... ... .....||.+|++++...+.+.+++.|+||++.++.|+..|..||........ .......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~ 252 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD 252 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence 98 4322211 111 2345699999999999999999999999999999999999999854321111 1111000
Q ss_pred hhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1052 KLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
... ..... . ....+..+.++...+-..+...+|....+...++....+.+
T Consensus 253 ~~~------~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 253 PRK------LLTDR---F----GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred hhh------hcccc---c----cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 000 00000 0 01112344556666666899999999999999887766653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=216.16 Aligned_cols=160 Identities=19% Similarity=0.183 Sum_probs=124.8
Q ss_pred HhhCCceeeecCCccEEEEEeCC-CceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-SRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..+.||+|+||+||+|.++. +++.||||+.... ...+.+|+++++.++|+|+++.+.. .+..|+
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEE
Confidence 57778999999999999998876 6777899986422 2347899999999999999853332 245799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEeCCCCceEEEeccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDI-KSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
||||++|++|... ... . ...++.++++|+.|+|+. ||+|||| ||+||+++.++.+||+|||+|+..
T Consensus 96 VmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 96 VRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 9999999999632 111 1 146788999999999999 9999999 999999999999999999999876
Q ss_pred cCCCCCCc------ccccccCCCcccccccCCC
Q 001226 984 SDSHSSST------RSAIVGSLGYIAPENAYST 1010 (1119)
Q Consensus 984 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 1010 (1119)
........ -....+++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 54321111 1345688899999977643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.6e-21 Score=232.11 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=131.5
Q ss_pred CCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEcc
Q 001226 361 SLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLA 440 (1119)
Q Consensus 361 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 440 (1119)
+...|+++++.++ .+|..+. +.|+.|+|++|+|+. +|..+. ++|++|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 4566777777776 4454442 356667777776663 333332 35666666666665 3444332 245555555
Q ss_pred CccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccC
Q 001226 441 HNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS 520 (1119)
Q Consensus 441 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 520 (1119)
+|+++ .+|..+. .+|+.|++++|+++ .+|..+. ++|+.|++++|+|++
T Consensus 250 ~N~L~-~LP~~l~---------------------------s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~- 297 (754)
T PRK15370 250 INRIT-ELPERLP---------------------------SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT- 297 (754)
T ss_pred CCccC-cCChhHh---------------------------CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-
Confidence 55554 3333221 23444455555444 3343332 345555555555553
Q ss_pred CCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccC
Q 001226 521 LPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC 600 (1119)
Q Consensus 521 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 600 (1119)
+|..+. ++|+.|++++|+++. +|..+ .++|+.|++++|.++ .+|..+. ++|+.|+|++|+|. .+|..+.
T Consensus 298 LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp-- 366 (754)
T PRK15370 298 LPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP-- 366 (754)
T ss_pred Ccccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--
Confidence 232221 245556666666653 34322 245666667776666 3555543 46677777777666 4555442
Q ss_pred CCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcccc----ccccccEeecCCcccC
Q 001226 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFS----SVQSLFELQLGSNIFD 662 (1119)
Q Consensus 601 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~L~~N~l~ 662 (1119)
++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+. .++++..|+|.+|.++
T Consensus 367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 46667777777766 3555543 24666666666666 3444332 2345555555555554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=185.63 Aligned_cols=199 Identities=21% Similarity=0.290 Sum_probs=170.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecc--cccccHHHHHHHHhhcCC-CCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN--RSETNFDVEIRTLSLVRH-RNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|...++||+|+||.+|.|....+|..||||+-. ....+...|.++.+.+++ ..|..+..+..+.....+||+.. |
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G 94 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G 94 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence 4556689999999999999999999999999864 344678889999999974 56777777888888899999998 8
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEeccccccccCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~DfGla~~~~~~~~ 988 (1119)
-+|.+.+.-+.. .++.+++.-.+.|++.-++|+|.+ +++||||||+|++..-+ ..+.++|||+|+.+.+...
T Consensus 95 PsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 95 PSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred ccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 899999987764 488999999999999999999999 99999999999999754 4578999999998765432
Q ss_pred -----CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 001226 989 -----SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF 1039 (1119)
Q Consensus 989 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~ 1039 (1119)
+.......||.+|.+-....+.+.+.+.|+-|+|.|+.++-.|..||.+..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 233455689999999888888888999999999999999999999998753
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-21 Score=231.69 Aligned_cols=187 Identities=26% Similarity=0.419 Sum_probs=100.3
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
+|+.|+|++|++. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+|++ +|..+. ++|+.|+++
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQ 312 (754)
T ss_pred cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhc
Confidence 5666666666666 5555543 46777777777776 3454443 356666666666663 443332 356666666
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCC
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 641 (1119)
+|+++ .+|..+. ++|+.|++++|.++ .+|..+. ++|+.|+|++|+|+ .+|..+. +.|+.|+|++|+|+ .+
T Consensus 313 ~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~L 382 (754)
T PRK15370 313 SNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NL 382 (754)
T ss_pred CCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CC
Confidence 66665 3444332 45666666666665 3454432 45666666666655 3454432 35555555555555 33
Q ss_pred CccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceec
Q 001226 642 PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711 (1119)
Q Consensus 642 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 711 (1119)
|..+. .+|+.|++++|+++ .+|..+ |..++.++.+..|+|.+|+|+
T Consensus 383 P~~l~--~sL~~LdLs~N~L~-~LP~sl---------------------~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 383 PENLP--AALQIMQASRNNLV-RLPESL---------------------PHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CHhHH--HHHHHHhhccCCcc-cCchhH---------------------HHHhhcCCCccEEEeeCCCcc
Confidence 43332 23444444444443 233222 222333456667777777776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=230.80 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=187.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecc----ccccc------HHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN----RSETN------FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~----~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
++++|.|++|.|+.+.........+.|.++ ....+ +..|.-+-..++|||++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 478999999988887766655555555443 11111 33455556778999999998888777666666999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++ +|+..+.... .+...++..++.|+..|++|+|+. |+.|||+||+|++++.+|.+||+|||.+....-...
T Consensus 403 ~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred ccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 999 9999998763 377888999999999999999999 999999999999999999999999999887654333
Q ss_pred C--CcccccccCCCcccccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 S--STRSAIVGSLGYIAPENAYSTRLTE-KSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ......+|...|+|||++.+.+|++ ..||||.|+++..|.+|+.||......+........ ... ...
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~-----~~~-~~~--- 546 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY-----SDQ-RNI--- 546 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----ccc-ccc---
Confidence 3 4456678999999999999999875 589999999999999999999765443332100000 000 000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~ 1104 (1119)
...........+.+...++.+|++++|.+|.|+++|++
T Consensus 547 -~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 -FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00011112344567789999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-18 Score=197.28 Aligned_cols=258 Identities=29% Similarity=0.367 Sum_probs=193.0
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCC-CEEEEeeeeecCCceEEEEe
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHR-NILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e 907 (1119)
|+..+.+|.|+||.||++.+. ..+++|.+... ...+.+|+..++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 345678999999999999887 67889988432 34578899999999988 79999999977777899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~ 986 (1119)
++.++++.+++........++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999997776653212488889999999999999999999 999999999999999998 7999999999865443
Q ss_pred CCCC----cccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 987 HSSS----TRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 987 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
.... ......++..|+|||...+ ..+....|+||+|++++++++|..||............+..... ....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE-LPTP- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh-cCCc-
Confidence 2221 3456789999999998887 57889999999999999999999996543221000000000000 0000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......... ........+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPS--NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCcc--ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 001223467899999999999999999988765
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.7e-21 Score=178.72 Aligned_cols=182 Identities=29% Similarity=0.509 Sum_probs=147.6
Q ss_pred ccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCee
Q 001226 551 FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSL 630 (1119)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 630 (1119)
.+++++.|.||+|+++ .+|..+..+.+|+.|++++|++. .+|..+..+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 5677788888888887 77778888888888888888887 78888888888888888888886 688888888888888
Q ss_pred EccCccCcc-CCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCce
Q 001226 631 SLQENNLSG-AIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709 (1119)
Q Consensus 631 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 709 (1119)
||..|++.. .+|..|..++.|+.|+|++|.|. .+|..++++.++. +|.++.|.+- .+|..++.|++|+.|.+.+|+
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lq-il~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQ-ILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhccee-EEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 888888873 57888888888888888888886 7888888888764 6888888888 799999999999999999999
Q ss_pred ecccCCccccccc---cceEEecccccccccCC
Q 001226 710 FSGEIPTEVNNMV---SLYFVNISFNHFSGKLP 739 (1119)
Q Consensus 710 l~g~ip~~~~~~~---~l~~l~ls~N~~~g~~p 739 (1119)
++ .+|++++++. +=+.+.+.+|++..+|-
T Consensus 185 l~-vlppel~~l~l~~~k~v~r~E~NPwv~pIa 216 (264)
T KOG0617|consen 185 LT-VLPPELANLDLVGNKQVMRMEENPWVNPIA 216 (264)
T ss_pred ee-ecChhhhhhhhhhhHHHHhhhhCCCCChHH
Confidence 98 8999988763 22445666776654433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.9e-19 Score=181.42 Aligned_cols=134 Identities=19% Similarity=0.180 Sum_probs=104.7
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc-------------ccH-----------------HHHHHHHhhcCCCCE
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------------TNF-----------------DVEIRTLSLVRHRNI 889 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------~~~-----------------~~E~~~l~~l~h~ni 889 (1119)
..||+|+||.||+|.+. +|++||||+++... ..| ..|++.++++.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 57999999999999987 79999999985431 112 238899999987766
Q ss_pred EEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeEeCC
Q 001226 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL-HYDCVPQIIHRDIKSDNILLDS 968 (1119)
Q Consensus 890 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dlkp~Nill~~ 968 (1119)
.....+. ....++||||++++++........ .++...+..++.|++.++.|+ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 3222221 123389999999887765432222 478889999999999999999 677 999999999999998
Q ss_pred CCceEEEeccccccc
Q 001226 969 ELEPKIGDFGMSKLI 983 (1119)
Q Consensus 969 ~~~vkl~DfGla~~~ 983 (1119)
++.++++|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=186.10 Aligned_cols=227 Identities=20% Similarity=0.272 Sum_probs=143.5
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcC----------CCCEEEEeeee----
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVR----------HRNILRIVGSC---- 896 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~----------h~niv~l~~~~---- 896 (1119)
.++.||.|+++.||.+.+..+++++|+|++.. ..+++++|.-....+. |-.++.-++..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 45789999999999999999999999998832 1233455554443322 11222212211
Q ss_pred -----ecC---C-----ceEEEEeccCCCCHHHhhcc---CCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 001226 897 -----TKD---E-----HGFIVTEYMPGGTLFNVLHQ---NEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDI 959 (1119)
Q Consensus 897 -----~~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl 959 (1119)
... . ..+++|+-+ .++|.+++.. ... ...+....+..+..|+++.+++||+. |+||+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 111 1 236788877 5688777543 221 12234445567778999999999999 9999999
Q ss_pred CCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCC--------CCCCCcchHHHHHHHHHHHHhC
Q 001226 960 KSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS--------TRLTEKSDVYSYGVILFELLFR 1031 (1119)
Q Consensus 960 kp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~vl~elltg 1031 (1119)
+|+|++++.+|.+.++||+.....+.... ....+..|.+||.... -.++.+.|.|++|+++|.|++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999998776543211 1234577999995533 2468899999999999999999
Q ss_pred CCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCC
Q 001226 1032 KMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMR 1096 (1119)
Q Consensus 1032 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 1096 (1119)
+.||+....+..... .+.. . ...+..+..++..+++++|++|
T Consensus 247 ~lPf~~~~~~~~~~~-------------------~f~~--C--~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW-------------------DFSR--C--RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG-------------------GGTT--S--S---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc-------------------cchh--c--CCcCHHHHHHHHHHccCCcccC
Confidence 999986422211111 1111 1 1456788999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=171.00 Aligned_cols=182 Identities=12% Similarity=0.145 Sum_probs=136.5
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEecccccc--------cHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEec
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET--------NFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
++..|++|+||+||.+.. .+.+++.+.+..... .+.+|+++++++. |+++++++++ ...+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 357899999999997755 468888777754433 3678999999995 5889999886 346899999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeEeCCCCceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDI-KSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-kp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
++|.+|...... ....++.|+++++.++|+. ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999988654321 1134678999999999999 9999999 7999999999999999999998554322
Q ss_pred CC----Cc-------ccccccCCCcccccccCC-CCCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 988 SS----ST-------RSAIVGSLGYIAPENAYS-TRLT-EKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 988 ~~----~~-------~~~~~gt~~y~aPE~~~~-~~~~-~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
.. .. ......++.|++|+...- ...+ .+.+.++-|+-+|.++||+.|+...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 00 011235777888873321 1223 5678999999999999999987643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-20 Score=174.14 Aligned_cols=160 Identities=34% Similarity=0.525 Sum_probs=96.3
Q ss_pred cceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccC
Q 001226 459 LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRG 538 (1119)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 538 (1119)
...|.||+|+++ .+|..+..+.+|+.|++++|++. .+|..++.+++|+.|++.-|++. ..|..|+.+|.|+.|||.+
T Consensus 35 ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 35 ITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence 344445555554 45556666666666666666666 56666666666666666666665 5566666666666666666
Q ss_pred cccCC-CCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccC
Q 001226 539 NLLQG-SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617 (1119)
Q Consensus 539 N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 617 (1119)
|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.++.|++|.+.+|+++ .+
T Consensus 112 nnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vl 188 (264)
T KOG0617|consen 112 NNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VL 188 (264)
T ss_pred cccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ec
Confidence 66543 45555556666666666666665 55566666666666666666655 45666666666666666666665 45
Q ss_pred Chhhhhc
Q 001226 618 PSEVISL 624 (1119)
Q Consensus 618 p~~~~~l 624 (1119)
|.+++++
T Consensus 189 ppel~~l 195 (264)
T KOG0617|consen 189 PPELANL 195 (264)
T ss_pred Chhhhhh
Confidence 5555443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.1e-20 Score=207.08 Aligned_cols=277 Identities=25% Similarity=0.256 Sum_probs=144.6
Q ss_pred EEccCCccCCccChhhhhcCCCccEEEcCCCccCCC----cchhhcCCCCCceeeeccccccc------cCcccccCCCC
Q 001226 244 FSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKLVLSANKLNG------TISGQISHCNQ 313 (1119)
Q Consensus 244 L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~~ 313 (1119)
|+|..+.+++.-....|..+.+|++|+++++.+++. ++..+...++|++|+++++.+.+ ..+..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 455555555444455666666677777777766432 34445556667777777766652 12334555666
Q ss_pred CcEEEccccccccccCcccCCCCC---CCeEEccCCcccC----CCCCCCCCC-CCCcEEEcccCcCccc----Cchhhh
Q 001226 314 LQVIALSRNNLVGQIPRSVGNLSS---LNSLLLFNNRLQG----TLPPELGNC-GSLVDLRLQHNFIGGT----IPPEIC 381 (1119)
Q Consensus 314 L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~l~~l-~~L~~L~L~~N~i~~~----~~~~l~ 381 (1119)
|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 666666666665444444444433 6666666666652 112233444 5666666666666532 223344
Q ss_pred cccccceeeccCccccCC----CCccccccCcceEEEeeccccccc----CCccccCCCCcCEEEccCccCcccchhhhh
Q 001226 382 NLAKLEVLYLFNNRIEGA----IPHQIGRMSKLVELALYNNRLTGR----IPPDITRLRNLQFLSLAHNHLTGEVALELG 453 (1119)
Q Consensus 382 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 453 (1119)
.+++|++|++++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++.....+.
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~ 242 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHH
Confidence 555666666666666532 122233445666666666665532 223344556666666666666543333332
Q ss_pred ccC----CccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccC----CCccc
Q 001226 454 KHF----PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS----LPATL 525 (1119)
Q Consensus 454 ~~l----~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 525 (1119)
..+ +.|++|++++|.++.... ..+...+..+++|+++++++|.+... ....+
T Consensus 243 ~~~~~~~~~L~~L~l~~n~i~~~~~--------------------~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 243 SALLSPNISLLTLSLSCNDITDDGA--------------------KDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred HHHhccCCCceEEEccCCCCCcHHH--------------------HHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 222 345555555554431100 11222333445566666666665532 22333
Q ss_pred cCC-CCcceeeccCcc
Q 001226 526 ERN-PGVSFLDVRGNL 540 (1119)
Q Consensus 526 ~~l-~~L~~L~l~~N~ 540 (1119)
... +.|+.+++.+|.
T Consensus 303 ~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 303 LEPGNELESLWVKDDS 318 (319)
T ss_pred hhcCCchhhcccCCCC
Confidence 333 556666665554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=175.27 Aligned_cols=136 Identities=19% Similarity=0.197 Sum_probs=107.6
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccccc------------------------------cHHHHHHHHhhcCCCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET------------------------------NFDVEIRTLSLVRHRN 888 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------------------------~~~~E~~~l~~l~h~n 888 (1119)
.+.||+|+||.||+|.+. +|+.||||+++.... ...+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 367999999999999987 799999999864311 1246888899999888
Q ss_pred EEEEeeeeecCCceEEEEeccCCCCHHHh-hccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEe
Q 001226 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNV-LHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILL 966 (1119)
Q Consensus 889 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill 966 (1119)
+.....+... ..++||||++|+++... +... .++......++.|++.++.++|+ . ||+||||||+||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 7433333222 24899999998855433 3322 36778899999999999999999 7 99999999999999
Q ss_pred CCCCceEEEeccccccccC
Q 001226 967 DSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 967 ~~~~~vkl~DfGla~~~~~ 985 (1119)
+ ++.++++|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-18 Score=181.09 Aligned_cols=164 Identities=12% Similarity=0.145 Sum_probs=126.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cc---------cHHHHHHHHhhcCCCCEEEEeeeeecC--
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ET---------NFDVEIRTLSLVRHRNILRIVGSCTKD-- 899 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~---------~~~~E~~~l~~l~h~niv~l~~~~~~~-- 899 (1119)
+|...+++|.|+||.||++.. . +..+|+|+++.. +. .+++|+..+.++.||+|....+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~-~-~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDT-D-YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred ceEEEEEecCCCceEEEEEec-C-CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 455668999999999999765 3 668999998532 11 157899999999999999998875532
Q ss_pred ------CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceE
Q 001226 900 ------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973 (1119)
Q Consensus 900 ------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 973 (1119)
+..++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|+||+++++| ++
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988732 222 2456899999999999 999999999999999988 99
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHH
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ell 1029 (1119)
++|||........... ..+.....+..++|+|++|+.+..+.
T Consensus 175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999987644221100 11344556778999999999887654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-19 Score=206.19 Aligned_cols=264 Identities=25% Similarity=0.238 Sum_probs=136.9
Q ss_pred ccCCcccEEEcCCCcccC----CCCcccccCCCccEEEcccccccc------cCCccccccCccCEEEccCccccCCCCc
Q 001226 93 CKNQHLLSLDLSGNEFTG----SIPKQLGNCGQLKTLLLNDNRFQG------SIPPEIFKLKRLSWLDLGYNSLSGKIPP 162 (1119)
Q Consensus 93 ~~l~~l~~L~Ls~n~~~~----~~~~~l~~l~~L~~L~L~~n~i~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~ 162 (1119)
..+.+|++|+++++.+++ .++..+...+.|++|+++++.+.+ .++..+..+++|++|+|++|.+.+..+.
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99 (319)
T ss_pred HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence 344556666666666543 244445555666666666665541 1233444455666666666655544444
Q ss_pred ccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCC-CCC
Q 001226 163 QVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNC-RNL 241 (1119)
Q Consensus 163 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l-~~L 241 (1119)
.+..+.+ . ++|++|++++|++++... ..+...+..+ ++|
T Consensus 100 ~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~-------------------~~l~~~l~~~~~~L 139 (319)
T cd00116 100 VLESLLR--------------------S-SSLQELKLNNNGLGDRGL-------------------RLLAKGLKDLPPAL 139 (319)
T ss_pred HHHHHhc--------------------c-CcccEEEeeCCccchHHH-------------------HHHHHHHHhCCCCc
Confidence 4433333 0 125555555444432100 0111223333 445
Q ss_pred cEEEccCCccCCccC---hhhhhcCCCccEEEcCCCccCCC----cchhhcCCCCCceeeeccccccccC----cccccC
Q 001226 242 VEFSASSNNFGGAIS---PWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKLVLSANKLNGTI----SGQISH 310 (1119)
Q Consensus 242 ~~L~l~~n~i~~~~~---~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~ 310 (1119)
++|++++|++++... ...+..+++|++|++++|.+++. ++..+..+++|++|++++|.+++.. ...+..
T Consensus 140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~ 219 (319)
T cd00116 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS 219 (319)
T ss_pred eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcc
Confidence 555555555442211 22344445566666666655532 2233344456666666666665332 233455
Q ss_pred CCCCcEEEccccccccccCcccC-----CCCCCCeEEccCCcccC----CCCCCCCCCCCCcEEEcccCcCccc----Cc
Q 001226 311 CNQLQVIALSRNNLVGQIPRSVG-----NLSSLNSLLLFNNRLQG----TLPPELGNCGSLVDLRLQHNFIGGT----IP 377 (1119)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~i~~~----~~ 377 (1119)
+++|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.++.. ..
T Consensus 220 ~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~ 299 (319)
T cd00116 220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLA 299 (319)
T ss_pred cCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHH
Confidence 66677777777766642222221 23677888888887752 2233455567888888888888744 23
Q ss_pred hhhhcc-cccceeeccCccc
Q 001226 378 PEICNL-AKLEVLYLFNNRI 396 (1119)
Q Consensus 378 ~~l~~l-~~L~~L~L~~N~l 396 (1119)
..+... +.|+.+++.+|.+
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 300 ESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHhhcCCchhhcccCCCCC
Confidence 333344 6788888877753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.8e-19 Score=207.24 Aligned_cols=243 Identities=21% Similarity=0.268 Sum_probs=172.3
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHH--HhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRT--LSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
...+.+|++.|=.|.+|+++. |. |+||++-+.. +.+.++++. ...++|||++++.-+-..+...|+|-+|+
T Consensus 26 ~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 344679999999999998876 44 8999884322 334444333 45568999999999888888889999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc--CCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS--DSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~--~~~ 987 (1119)
. -+|+|.+..++ .+...+.+.|+.|+..|+..+|.. ||+|||||.+|||+++=.=+.++||..-+... .+.
T Consensus 104 k-hnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 K-HNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred h-hhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 4 58999888765 477778889999999999999999 99999999999999988778999997644321 111
Q ss_pred C---CCcccccccCCCcccccccCCC----------C-CCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhh
Q 001226 988 S---SSTRSAIVGSLGYIAPENAYST----------R-LTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 988 ~---~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
+ .........-.+|.|||.+... . .+++.||||+|||++|+++ |+.||... .+..+ +
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aY---r 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAY---R 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhH---h
Confidence 1 1111111223479999965431 1 5678999999999999997 67777532 11111 1
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
..........+. . -....+..++..|++.||++|.++++.++.-
T Consensus 249 ~~~~~~~e~~Le-~---------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 249 SGNADDPEQLLE-K---------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCccCHHHHHH-h---------CcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 110000000000 0 0112567999999999999999999999873
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1e-17 Score=202.82 Aligned_cols=247 Identities=20% Similarity=0.198 Sum_probs=183.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-ccccHHHHHHHHhhcC---CCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-SETNFDVEIRTLSLVR---HRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.|.+.+.+|+|+||+||+|...+ |+.||+|+-+. ...+|..=..++.+++ -+.|+++..++.-.+..++|+||.+
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~ 777 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP 777 (974)
T ss_pred eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence 45566899999999999999988 99999998754 3345554455556665 3345555555566677789999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-------CCceEEEeccccccc
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-------ELEPKIGDFGMSKLI 983 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~vkl~DfGla~~~ 983 (1119)
.|+|.+++...+ .++|.-...++.|+++.+++||.. +|||+||||+|+|+.. ...++|+|||.+..+
T Consensus 778 ~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 778 YGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred cccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999998544 589999999999999999999999 9999999999999953 245899999999877
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.--.........++|-.+-.+|...++.+++.+|.|.++.+++-|+.|++.- .+.... ..+
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~--------~~~ 912 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSS--------WMV 912 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcc--------eec
Confidence 5444444556678899999999999999999999999999999999998542 000000 000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
+..++.. .. ..-+-++...+|+.|-..=|...++...++...++
T Consensus 913 ~~~~~Ry--~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 913 KTNFPRY--WK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred cccchhh--hh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 1111100 01 12345666677776666677888888877776554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.9e-17 Score=187.99 Aligned_cols=220 Identities=27% Similarity=0.459 Sum_probs=165.0
Q ss_pred HhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCC
Q 001226 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI-IHRDI 959 (1119)
Q Consensus 881 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~Dl 959 (1119)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+.... ..+++.....++++++.|++|+|.. .| .|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 356789999999999999999999999999999999998743 3589999999999999999999987 44 89999
Q ss_pred CCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCC-------CCCCcchHHHHHHHHHHHHhCC
Q 001226 960 KSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-------RLTEKSDVYSYGVILFELLFRK 1032 (1119)
Q Consensus 960 kp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslG~vl~elltg~ 1032 (1119)
+++|+++|..+.+|++|||+.....+..............-|.|||.+... ..+.+.||||||++++|+++++
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766431111122222345579999977653 1467799999999999999999
Q ss_pred CCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1033 MPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1033 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.||+......... .... +... .....+.+.+.. ..+...++..++.+||..+|++||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~-eii~-~~~~--~~~~~~rP~i~~----~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPD-EIIL-RVKK--GGSNPFRPSIEL----LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChH-HHHH-HHHh--cCCCCcCcchhh----hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9998643333221 1111 1111 001111111111 112333688999999999999999999999999988776
Q ss_pred C
Q 001226 1113 N 1113 (1119)
Q Consensus 1113 ~ 1113 (1119)
.
T Consensus 228 ~ 228 (484)
T KOG1023|consen 228 G 228 (484)
T ss_pred c
Confidence 4
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.3e-18 Score=193.16 Aligned_cols=221 Identities=24% Similarity=0.308 Sum_probs=174.9
Q ss_pred eeecCCccEEEEE---eCCCceEEEEEecccc------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEeccCC
Q 001226 842 IGKGKHGTVYRTL---SNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 842 lG~G~fg~Vy~~~---~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|.|.||.|++++ ..+.+.-+|+|+.++. ......|..++...+ ||.+|++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7899999998654 3445677888877432 224556778888887 99999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|.+...+.... .+++.....+...++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-+....
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99988877655 367777778888899999999999 9999999999999999999999999999866442211
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
+||..|||||+.. .+..++|.||||++++||++|..||.. + ..+.. +....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~---~~~~I--------------l~~~~ 204 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------D---TMKRI--------------LKAEL 204 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------H---HHHHH--------------hhhcc
Confidence 7899999999887 567899999999999999999999864 0 00100 11112
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSM 1099 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 1099 (1119)
..+......+.+++..+...+|..|.-.
T Consensus 205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 205 EMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 2344555567788888888889888755
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.9e-17 Score=169.80 Aligned_cols=197 Identities=23% Similarity=0.270 Sum_probs=134.3
Q ss_pred CCCCEEEEeeeeec---------------------------CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHH
Q 001226 885 RHRNILRIVGSCTK---------------------------DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937 (1119)
Q Consensus 885 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 937 (1119)
+|||||++..+|.+ ....|+||...+ .+|..|+..+. .+.....-+..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999988753 234588888774 58888888654 45567778899
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCC--ceEEEeccccccccCC----CCCCcccccccCCCcccccccCC
Q 001226 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLD--SEL--EPKIGDFGMSKLISDS----HSSSTRSAIVGSLGYIAPENAYS 1009 (1119)
Q Consensus 938 ~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~vkl~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 1009 (1119)
|+.+|+.|||.+ ||.|||+|++||++. +|+ ...|+|||++---..- .+....-...|.-.-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 999999999999993 333 4689999986422110 01111112346667899997654
Q ss_pred CC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHH
Q 001226 1010 TR------LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLE 1083 (1119)
Q Consensus 1010 ~~------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1083 (1119)
.+ -..++|.|+.|.+.||+++..-||+......-+...+... .++ .-+...+..+.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~--------------qLP---alp~~vpp~~rq 488 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES--------------QLP---ALPSRVPPVARQ 488 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh--------------hCC---CCcccCChHHHH
Confidence 22 2358999999999999999999998621111111111110 011 111223446789
Q ss_pred HHHHccccCCCCCCCHHHHHHHH
Q 001226 1084 LALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1084 l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
++...++.||.+||+..-....+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999876554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=163.93 Aligned_cols=132 Identities=20% Similarity=0.316 Sum_probs=103.9
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhc-----CCCCEEEEeeeeecCC---ceE-
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLV-----RHRNILRIVGSCTKDE---HGF- 903 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 903 (1119)
+..+.||+|+||.||. +..++.. +||++... ...+.+|++.++.+ .||||++++|++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 4557899999999995 6665555 69987542 45688999999999 5799999999998763 333
Q ss_pred EEEec--cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeEeCC----CCceEEEe
Q 001226 904 IVTEY--MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGL-SYLHYDCVPQIIHRDIKSDNILLDS----ELEPKIGD 976 (1119)
Q Consensus 904 lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~vkl~D 976 (1119)
+|+|| +++++|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 55799999997632 4444 35677777777 999999 9999999999999974 34799999
Q ss_pred cccc
Q 001226 977 FGMS 980 (1119)
Q Consensus 977 fGla 980 (1119)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.7e-16 Score=164.33 Aligned_cols=138 Identities=21% Similarity=0.252 Sum_probs=108.2
Q ss_pred hhCCceeeecCCccEEEEE-eCCCceEEEEEeccccc----------------------------ccHHHHHHHHhhcCC
Q 001226 836 ATEGRIIGKGKHGTVYRTL-SNNSRKHWAVKKLNRSE----------------------------TNFDVEIRTLSLVRH 886 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~-~~~~~~~vavK~~~~~~----------------------------~~~~~E~~~l~~l~h 886 (1119)
|...+.||+|+||.||+|. +..+|+.||+|+++... ..+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4456899999999999998 66679999999885321 114579999998875
Q ss_pred C--CEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCC
Q 001226 887 R--NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ-IIHRDIKSDN 963 (1119)
Q Consensus 887 ~--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlkp~N 963 (1119)
. .+.+++++ ...++||||++++++..+..... .....++..++.|++.++.++|+. + ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 3 34455543 23589999999988876543322 245556789999999999999999 9 9999999999
Q ss_pred eEeCCCCceEEEecccccccc
Q 001226 964 ILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 964 ill~~~~~vkl~DfGla~~~~ 984 (1119)
|+++ ++.++++|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=189.21 Aligned_cols=205 Identities=26% Similarity=0.355 Sum_probs=140.1
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHHhh
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVL 918 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 918 (1119)
.|.|-.|+||.||.++++.+.+++|+|. +++..-.++ ++.....|.+| |+=.+.+
T Consensus 88 IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn---ilt~a~npfvv---------------------gDc~tll 142 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN---ILTFAGNPFVV---------------------GDCATLL 142 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcc-cccchhhhc---cccccCCccee---------------------chhhhhc
Confidence 3789999999999999999999999954 333221111 22222334333 2223333
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC----------
Q 001226 919 HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS---------- 988 (1119)
Q Consensus 919 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~---------- 988 (1119)
+..+. ++. +++.+++|+|+. ||||||+||+|.+|+.-|++|+.|||+++..-....
T Consensus 143 k~~g~---lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k 208 (1205)
T KOG0606|consen 143 KNIGP---LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEK 208 (1205)
T ss_pred ccCCC---Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHH
Confidence 33221 221 237899999999 999999999999999999999999999875321110
Q ss_pred ---CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 ---SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.......+||+.|+|||++..+.|+.++|.|++|+++||++-|++||++...++-- ..++.
T Consensus 209 ~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf---------------g~vis- 272 (1205)
T KOG0606|consen 209 DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF---------------GQVIS- 272 (1205)
T ss_pred HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH---------------hhhhh-
Confidence 11223468999999999999999999999999999999999999999764222110 00000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCC
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPS 1098 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 1098 (1119)
+...|...+.....++.+++.+.++.+|.+|--
T Consensus 273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 011111222333456778899999999999863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1e-16 Score=177.69 Aligned_cols=176 Identities=26% Similarity=0.331 Sum_probs=133.3
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
...|+.|+++.-.+|.+|+.+.+.....++.....++.|++.|+.| + +.+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 3568999999999999999877666678888999999999999999 6 899999999999999999999999999
Q ss_pred cccccCCC----CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhc
Q 001226 980 SKLISDSH----SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 980 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
........ .....+..+||.+||+||.+.+..|+.++||||+|++++|++. -..+++.. ..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----~t---------- 468 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----AT---------- 468 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----Hh----------
Confidence 88765533 2334566789999999999999999999999999999999996 22222211 00
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~el 1102 (1119)
...+-+..++ .........-..++++++...|.+||++.+.
T Consensus 469 ----~~d~r~g~ip---~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 469 ----LTDIRDGIIP---PEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----hhhhhcCCCC---hHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0111111111 0000011122578999999999999955444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.4e-15 Score=157.51 Aligned_cols=130 Identities=22% Similarity=0.276 Sum_probs=109.7
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc------------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+.||+|++|.||+|.. .+..|++|+..... ..+.+|+..+..++|+++.....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5699999999999987 46788999754211 246679999999999988776666667778899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|++|++|.+++.... + .+..++.+++.++.++|.. +++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986532 1 7788999999999999999 999999999999999 78899999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.4e-15 Score=153.34 Aligned_cols=132 Identities=22% Similarity=0.225 Sum_probs=104.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc--------------------------ccHHHHHHHHhhcCCC--
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--------------------------TNFDVEIRTLSLVRHR-- 887 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~-- 887 (1119)
|...+.||+|+||.||++... +++.||||+++... .....|...+..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 445688999999999999876 58999999864221 1245688888888777
Q ss_pred CEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 888 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
.+++.++. ...++||||++|++|.+.... .....++.+++.++.++|+. +++||||||+||+++
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD 159 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence 44444442 345899999999998765321 23457889999999999998 999999999999999
Q ss_pred CCCceEEEecccccccc
Q 001226 968 SELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~ 984 (1119)
+++.++++|||.+....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.2e-15 Score=178.01 Aligned_cols=131 Identities=23% Similarity=0.290 Sum_probs=107.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEec--c---cc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL--N---RS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~--~---~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
+...+.||+|+||+||+|.+... .+++|+. + .. ...+.+|+++++.++|++++....++.++...+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34568999999999999987653 3344332 1 10 134678999999999999988877777777789
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++. ....++.++++++.|+|+. +++|||+||+||++ .++.++++|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998875 3457899999999999999 99999999999999 6789999999998743
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.8e-15 Score=154.03 Aligned_cols=126 Identities=24% Similarity=0.301 Sum_probs=102.4
Q ss_pred eeeecCCccEEEEEeCCCceEEEEEecccc------------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.||+|+||.||+|.. .+..|++|+.... ...+.+|++.++.++|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 3678999985321 13356799999999888755444444556677899999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++|++|.+++..... .++.++++++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988764321 7899999999999999 999999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-14 Score=176.48 Aligned_cols=147 Identities=36% Similarity=0.570 Sum_probs=97.1
Q ss_pred CCCcHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCc-----eeeeeeeecC--C--CceEEEecCCCcccccCccchhhhc
Q 001226 23 SPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPC-----KWSGVSCYNN--S--SSLKALNLSGFGLSGVLNNSISYIC 93 (1119)
Q Consensus 23 ~~~~~~~ll~~~~~~~~~~~~~~~w~~~~~~~~~c-----~w~gv~C~~~--~--~~v~~l~l~~~~l~~~~~~~~~~~~ 93 (1119)
.++|..||++||+++..+. ..+|+. ++| .|.||+|... . .+|+.|+|+++++.|.+|.. ++
T Consensus 370 ~~~~~~aL~~~k~~~~~~~--~~~W~g-----~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~---i~ 439 (623)
T PLN03150 370 LLEEVSALQTLKSSLGLPL--RFGWNG-----DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND---IS 439 (623)
T ss_pred CchHHHHHHHHHHhcCCcc--cCCCCC-----CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHH---Hh
Confidence 5668899999999986542 248963 244 7999999632 1 24667777777777666643 44
Q ss_pred cCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccc-cccce
Q 001226 94 KNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLC-YSLES 172 (1119)
Q Consensus 94 ~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l-~~L~~ 172 (1119)
.+++|+.|+|++|.+.|.+|..++.+++|+.|+|++|+++|.+|+.++++++|++|+|++|.++|.+|..++.. .++..
T Consensus 440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~ 519 (623)
T PLN03150 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519 (623)
T ss_pred CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence 56666777777776666666666667777777777776666666666666667777776666666666665542 24445
Q ss_pred eeecccc
Q 001226 173 IGFHNNF 179 (1119)
Q Consensus 173 L~L~~n~ 179 (1119)
+++.+|.
T Consensus 520 l~~~~N~ 526 (623)
T PLN03150 520 FNFTDNA 526 (623)
T ss_pred EEecCCc
Confidence 5555543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.1e-15 Score=178.56 Aligned_cols=90 Identities=34% Similarity=0.574 Sum_probs=45.3
Q ss_pred eeeccccccCCcccccccccccceeeccCceecccCCcccccc-ccceEEecccccccccCCCccccccccCCccccCCc
Q 001226 679 LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNM-VSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNS 757 (1119)
Q Consensus 679 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~-~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~~~~n~ 757 (1119)
|+|++|+++|.+|+.++++++|+.|||++|+|+|.+|..+... ..+.. ..+.+|+
T Consensus 471 LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~------------------------l~~~~N~ 526 (623)
T PLN03150 471 LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS------------------------FNFTDNA 526 (623)
T ss_pred EECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce------------------------EEecCCc
Confidence 3444444444555555555555555555555555555554432 12223 3455666
Q ss_pred ccccC---CCCCCCCCCcccceeeehhhHHHHHHHHHHHhh
Q 001226 758 ELCRQ---GNCGKNGRGHTRGRLAGIIIGVLLSVALLCALI 795 (1119)
Q Consensus 758 ~~c~~---~~c~~~~~~~~~~~~~~ii~~~~~~v~~~~~~~ 795 (1119)
.+|+. ..|.. ....+.+++++++++++++++++++
T Consensus 527 ~lc~~p~l~~C~~---~~~~~~~i~~~~~~~~~~l~~~~~~ 564 (623)
T PLN03150 527 GLCGIPGLRACGP---HLSVGAKIGIAFGVSVAFLFLVICA 564 (623)
T ss_pred cccCCCCCCCCcc---cCCCceEEEEEhHHHHHHHHHHHHH
Confidence 66653 34532 1234556777777665544444333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5e-15 Score=177.36 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=188.8
Q ss_pred hCCceeeecCCccEEEEEeC-CCceEEEEEeccccc------ccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEec
Q 001226 837 TEGRIIGKGKHGTVYRTLSN-NSRKHWAVKKLNRSE------TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~------~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
...+.||+|+|+.|-.+... .....+|+|.+.... .....|..+-+.+. |+|++++++...+.+..+++.||
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 33466999999999887663 334567777664321 12334666666666 99999999999999999999999
Q ss_pred cCCCCHHHhh-ccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccC
Q 001226 909 MPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQGLSYLH-YDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~ 985 (1119)
..++++.+-+ +... ...+...+..+..|+..++.|+| .. +++|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 103 s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999888 4332 13555667788999999999999 77 999999999999999999 999999999998876
Q ss_pred -CCCCCccccccc-CCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 986 -SHSSSTRSAIVG-SLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 986 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+.....|.......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 250 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF------- 250 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc-------
Confidence 444555556678 9999999988874 456889999999999999999999987655554444433322100
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....| ........++..+++..+|+.|.+.+++...
T Consensus 251 ---~~~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 ---TQLPW----NSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---ccCcc----ccCChhhhhcccccccCCchhcccccccccc
Confidence 01111 1122345688889999999999999987654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=135.70 Aligned_cols=132 Identities=22% Similarity=0.291 Sum_probs=113.0
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccc--ccHHHHHHHHhhcCC--CCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEIRTLSLVRH--RNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
.+.+|+|.++.||++.... ..+++|...... ..+.+|+..++.++| .++++++++...++..+++|||++++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999998764 678999986654 478999999999976 5899999988888889999999988777
Q ss_pred HHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 915 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 544 4456677899999999999986545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3e-15 Score=165.58 Aligned_cols=195 Identities=30% Similarity=0.456 Sum_probs=141.8
Q ss_pred cccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEec
Q 001226 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDF 560 (1119)
Q Consensus 481 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 560 (1119)
+.-...||+.|++. .+|.++..+..|+.+.|..|.+. .+|..++.+..|+++|++.|+++ .+|..++.++ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 33445666666666 66777777777777777777776 66777777777777777777776 5666666664 888888
Q ss_pred cCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccC
Q 001226 561 SENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 561 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
++|+++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|++..|++. .+|+++..| .|..||+|.|+++ .
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 888887 78888888888888888888887 67778888888888888888887 577777754 5778888888888 7
Q ss_pred CCccccccccccEeecCCcccCCCccccchh--hccccceeeecccc
Q 001226 641 IPDAFSSVQSLFELQLGSNIFDGSIPCSLSK--LHHFSSILNVSNNK 685 (1119)
Q Consensus 641 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--l~~~~~~L~ls~N~ 685 (1119)
+|-.|.+|+.|++|.|.+|.+. +.|..+.. ..+.-++|+..-++
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 8888888888888888888886 55555432 22333445554443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.6e-15 Score=164.91 Aligned_cols=195 Identities=31% Similarity=0.434 Sum_probs=151.7
Q ss_pred CCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceee
Q 001226 456 FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535 (1119)
Q Consensus 456 l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (1119)
+..-...||+.|++. .+|..++.+..|..+.|..|.+. .+|..+.++..|+.|+|+.|+++ .+|..++.++ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 334456788888887 67888888888888888888888 78888888888888888888887 5676676665 78888
Q ss_pred ccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccc
Q 001226 536 VRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615 (1119)
Q Consensus 536 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 615 (1119)
+++|+++ .+|..++....|..||.+.|++. .+|..++++.+|+.|.+..|++. .+|.++.. -.|..||+|.|+++
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccCcee-
Confidence 8888887 67777887888888888888887 77888888888888888888887 67777774 45788888888887
Q ss_pred cCChhhhhcccCCeeEccCccCccCCCccccc---cccccEeecCCcc
Q 001226 616 SIPSEVISLEKMQSLSLQENNLSGAIPDAFSS---VQSLFELQLGSNI 660 (1119)
Q Consensus 616 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~~L~~L~L~~N~ 660 (1119)
.+|-+|..|+.|++|-|.+|.|+ ..|..+.. ..=.++|+..-++
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 68888888888888888888888 56665543 3334555555553
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.6e-13 Score=140.92 Aligned_cols=133 Identities=23% Similarity=0.284 Sum_probs=95.0
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccccc------H----------------------HHHHHHHhhcCCC--C
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------F----------------------DVEIRTLSLVRHR--N 888 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~------~----------------------~~E~~~l~~l~h~--n 888 (1119)
.+.||+|+||.||+|.+. ++++||||+++..... . ..|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999887 6899999987542211 1 2344444444332 2
Q ss_pred EEEEeeeeecCCceEEEEeccCCCCHHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEe
Q 001226 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFN-VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILL 966 (1119)
Q Consensus 889 iv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill 966 (1119)
+.+.++. ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. . +|+|||+||+||++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 3344432 24589999999854321 111111 11 5678899999999999998 7 99999999999999
Q ss_pred CCCCceEEEeccccccccC
Q 001226 967 DSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 967 ~~~~~vkl~DfGla~~~~~ 985 (1119)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.8e-13 Score=142.60 Aligned_cols=134 Identities=22% Similarity=0.313 Sum_probs=104.5
Q ss_pred hCCceee-ecCCccEEEEEeCCCceEEEEEecccc-----------------cccHHHHHHHHhhcCCCCE--EEEeeee
Q 001226 837 TEGRIIG-KGKHGTVYRTLSNNSRKHWAVKKLNRS-----------------ETNFDVEIRTLSLVRHRNI--LRIVGSC 896 (1119)
Q Consensus 837 ~~~~~lG-~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~~l~~l~h~ni--v~l~~~~ 896 (1119)
..+..+| .|+.|+||.+... +..++||.+... ...+.+|+..+..++|+++ ++.+++.
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred hcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 3457898 9999999999775 678899877421 1246779999999998774 6777764
Q ss_pred ecC-Cc---eEEEEeccCC-CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc
Q 001226 897 TKD-EH---GFIVTEYMPG-GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE 971 (1119)
Q Consensus 897 ~~~-~~---~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 971 (1119)
..+ +. .++|||+++| .+|.+++... .++.. .+.+++.++.++|+. ||+||||||+||+++.++.
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK 180 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence 432 22 2599999997 6898887653 24433 357899999999999 9999999999999999999
Q ss_pred eEEEeccccccc
Q 001226 972 PKIGDFGMSKLI 983 (1119)
Q Consensus 972 vkl~DfGla~~~ 983 (1119)
++++|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988743
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.9e-13 Score=158.25 Aligned_cols=242 Identities=30% Similarity=0.369 Sum_probs=155.3
Q ss_pred cccceeeccCccccCCCCccccccc-cccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEe
Q 001226 481 TNLFVLVLGNNRFNGSFPIEIGKCS-SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLD 559 (1119)
Q Consensus 481 ~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 559 (1119)
+.++.|++.+|+++ .+|.....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+..++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 45566666666666 4555555553 6777777777776 44456677777777777777776 4555555677888888
Q ss_pred ccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCcc
Q 001226 560 FSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 560 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
+++|+++ .+|..+..+..|++|.+++|.+. ..+..+.++.++..+.+++|++. .+|..+..++.+++|++++|.++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~ 269 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence 8888887 67777666667888888888654 56777788888888888888886 457777888888888888888883
Q ss_pred CCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCcccc
Q 001226 640 AIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVN 719 (1119)
Q Consensus 640 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 719 (1119)
++. ++.+.+++.|++++|.+...+|.............+ +.++ ..+........+...++..|... ..|..+.
T Consensus 270 -i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 342 (394)
T COG4886 270 -ISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN---LLLT-LKALELKLNSILLNNNILSNGET-SSPEALS 342 (394)
T ss_pred -ccc-ccccCccCEEeccCccccccchhhhccchhHHhhhh---hhhh-ccccccccccccccccccccccc-ccchhhc
Confidence 444 888888888888888887666554333222211111 2222 22223333344445555555554 4455555
Q ss_pred ccccceEEeccccccc
Q 001226 720 NMVSLYFVNISFNHFS 735 (1119)
Q Consensus 720 ~~~~l~~l~ls~N~~~ 735 (1119)
....+..++...+...
T Consensus 343 ~~~~~~~~~~~~~~~~ 358 (394)
T COG4886 343 ILESLNNLWTLDNALD 358 (394)
T ss_pred ccccccCceecccccc
Confidence 5555555555444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=9.4e-13 Score=153.95 Aligned_cols=202 Identities=31% Similarity=0.356 Sum_probs=98.0
Q ss_pred CccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCcccccccc
Q 001226 475 ANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554 (1119)
Q Consensus 475 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 554 (1119)
..+..+++|+.|++++|+++ .+|...+.++.|+.|++++|+++ .+|........
T Consensus 157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-------------------------~l~~~~~~~~~ 210 (394)
T COG4886 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-------------------------DLPPEIELLSA 210 (394)
T ss_pred hhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-------------------------cCchhhhhhhh
Confidence 34455556666666666665 44444445555555555555555 33333334444
Q ss_pred ceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccC
Q 001226 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634 (1119)
Q Consensus 555 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 634 (1119)
|++|++++|.+. ..+..+.++.++..|.+++|++. .++..++.+++++.|++++|+++. ++. ++.+..++.|++++
T Consensus 211 L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~-i~~-~~~~~~l~~L~~s~ 286 (394)
T COG4886 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS-ISS-LGSLTNLRELDLSG 286 (394)
T ss_pred hhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc-ccc-ccccCccCEEeccC
Confidence 555555555433 34555555555555555555554 335555555556666666666652 333 55555666666666
Q ss_pred ccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceec
Q 001226 635 NNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711 (1119)
Q Consensus 635 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 711 (1119)
|.+...+|...........+.- +.+. ......+........++..+... ..|..+.....+..++...+...
T Consensus 287 n~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 358 (394)
T COG4886 287 NSLSNALPLIALLLLLLELLLN--LLLT--LKALELKLNSILLNNNILSNGET-SSPEALSILESLNNLWTLDNALD 358 (394)
T ss_pred ccccccchhhhccchhHHhhhh--hhhh--ccccccccccccccccccccccc-ccchhhcccccccCceecccccc
Confidence 6665544443332222211111 1111 00011111111112333344444 45556666666666666666554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.1e-14 Score=146.48 Aligned_cols=191 Identities=28% Similarity=0.312 Sum_probs=116.2
Q ss_pred hccCCcccEEEcCCCcccC----CCCcccccCCCccEEEcccc---cccccCCccc-------cccCccCEEEccCcccc
Q 001226 92 ICKNQHLLSLDLSGNEFTG----SIPKQLGNCGQLKTLLLNDN---RFQGSIPPEI-------FKLKRLSWLDLGYNSLS 157 (1119)
Q Consensus 92 ~~~l~~l~~L~Ls~n~~~~----~~~~~l~~l~~L~~L~L~~n---~i~~~~p~~l-------~~l~~L~~L~Ls~n~l~ 157 (1119)
+..+..++.|+||+|.|.- .+.+.+.+.++|+..++|+- +....+|+.+ ...++|++||||+|-+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 4456788888999998853 46667788889999998875 4444566543 34568999999999887
Q ss_pred CCCCccc----ccccccceeeecccccccccCcc-------------CCCcccccEEEeccccccccCCCCCccccceee
Q 001226 158 GKIPPQV----SLCYSLESIGFHNNFLNGELPND-------------ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHL 220 (1119)
Q Consensus 158 ~~~p~~l----~~l~~L~~L~L~~n~l~~~~~~~-------------l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l 220 (1119)
...+..| .++..|++|.|.||.+....-.. .+.-++|+++...+|++.....
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga----------- 174 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGA----------- 174 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccH-----------
Confidence 6666554 45678888888888766433222 2234556666666666542221
Q ss_pred eeeccccccCccccccCCCCCcEEEccCCccCCc---cChhhhhcCCCccEEEcCCCccCCC----cchhhcCCCCCcee
Q 001226 221 LIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGA---ISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKL 293 (1119)
Q Consensus 221 ~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~---~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L 293 (1119)
..+...+...+.|+++.++.|.|... .....|..+++|++|||.+|-++.. +.+++..+++|+.|
T Consensus 175 --------~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El 246 (382)
T KOG1909|consen 175 --------TALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL 246 (382)
T ss_pred --------HHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence 12334455556666666666665421 2234455566666666666655432 22334445555555
Q ss_pred eecccccc
Q 001226 294 VLSANKLN 301 (1119)
Q Consensus 294 ~Ls~N~l~ 301 (1119)
++++|.+.
T Consensus 247 ~l~dcll~ 254 (382)
T KOG1909|consen 247 NLGDCLLE 254 (382)
T ss_pred cccccccc
Confidence 55555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.1e-12 Score=145.10 Aligned_cols=145 Identities=19% Similarity=0.199 Sum_probs=102.0
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc----------------------------------------
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------------------------------------- 871 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------------------------------- 871 (1119)
++..+-..+.||+|++|.||+|+.++ |+.||||+.+...
T Consensus 115 ~~F~~fd~~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 193 (437)
T TIGR01982 115 ELFAEFEEKPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKT 193 (437)
T ss_pred HHHhhCCCcceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHH
Confidence 33333344789999999999999875 8999999874321
Q ss_pred ----ccHHHHHHHHhhcC----CCCEEEEeeeee-cCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHH-
Q 001226 872 ----TNFDVEIRTLSLVR----HRNILRIVGSCT-KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ- 941 (1119)
Q Consensus 872 ----~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~- 941 (1119)
-++.+|++.+.+++ |..-+.+-.++. .....++||||++|+++.++...... .. ...+++..++.
T Consensus 194 l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 194 LRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARS 268 (437)
T ss_pred HHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHH
Confidence 12444555555552 333334333332 24457999999999999887654221 12 23456666665
Q ss_pred HHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 942 ~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
.+..+|.. |++|+|++|.||+++.+++++++|||++.....
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 46788888 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-12 Score=134.25 Aligned_cols=205 Identities=22% Similarity=0.286 Sum_probs=142.0
Q ss_pred HhhcCCCCEEEEeeeeecC-----CceEEEEeccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001226 881 LSLVRHRNILRIVGSCTKD-----EHGFIVTEYMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954 (1119)
Q Consensus 881 l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 954 (1119)
+-.+.|.|+|++..|+.+. ....++.|||..|++..++++... ...+..+...+|+.||..|+.|||+. .|.|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 3445699999999998754 346889999999999999987543 23577778889999999999999976 7899
Q ss_pred EecCCCCCCeEeCCCCceEEEeccccccc--cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 001226 955 IHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK 1032 (1119)
Q Consensus 955 vH~Dlkp~Nill~~~~~vkl~DfGla~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~ 1032 (1119)
+|+++.-+-|++..+|-+|+.--.-.... .............+-++|.|||+-.....+.++|||+||+...||..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999998887532211111 0111112223345678999999888888889999999999999999887
Q ss_pred CCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1033 MPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1033 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
.--.. .+....+... ....+- ... .+ .=...+.+|++..|..||+|++++.|.-
T Consensus 280 iq~tn--seS~~~~ee~---------ia~~i~---~le--n~-----lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 280 IQSTN--SESKVEVEEN---------IANVII---GLE--NG-----LQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eccCC--Ccceeehhhh---------hhhhee---ecc--Cc-----cccCcCcccccCCCCCCcchhhhhcCce
Confidence 54211 1111111000 000000 000 00 0035677999999999999999887643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6e-12 Score=128.81 Aligned_cols=140 Identities=30% Similarity=0.420 Sum_probs=95.3
Q ss_pred CCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhh
Q 001226 543 GSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI 622 (1119)
Q Consensus 543 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 622 (1119)
|..-.....|+.|++||||+|.|+ .+.+++.-++.++.|++|+|.+. .+. .+..+++|+.||||+|.++ .+-.+-.
T Consensus 274 G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~ 349 (490)
T KOG1259|consen 274 GSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHL 349 (490)
T ss_pred CceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHh
Confidence 334445566778888888888887 67777777888888888888887 333 3777888888888888887 4666666
Q ss_pred hcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccce
Q 001226 623 SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQI 702 (1119)
Q Consensus 623 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~ 702 (1119)
.|-+++.|.|++|.|.. -+.++++-+|..||+++|++.. + .--..+|+|+.|++
T Consensus 350 KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~--------l----------------deV~~IG~LPCLE~ 403 (490)
T KOG1259|consen 350 KLGNIKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEE--------L----------------DEVNHIGNLPCLET 403 (490)
T ss_pred hhcCEeeeehhhhhHhh--hhhhHhhhhheeccccccchhh--------H----------------HHhcccccccHHHH
Confidence 77778888888887762 2445555555555555554430 0 01224566677777
Q ss_pred eeccCceecc
Q 001226 703 LDLSSNSFSG 712 (1119)
Q Consensus 703 L~Ls~N~l~g 712 (1119)
+.|-+|++.+
T Consensus 404 l~L~~NPl~~ 413 (490)
T KOG1259|consen 404 LRLTGNPLAG 413 (490)
T ss_pred HhhcCCCccc
Confidence 7777777663
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.2e-11 Score=119.64 Aligned_cols=127 Identities=21% Similarity=0.230 Sum_probs=95.8
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEE-EEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNIL-RIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
+.++.|.++.||++... ++.|++|+..... ..+.+|+..++.+.+.+++ +++++. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999998865 6789999985543 4578899999998655544 444443 23458999999998775
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC--VPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 916 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
+. . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~----~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 0 11245678999999999882 12369999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.9e-11 Score=137.93 Aligned_cols=136 Identities=16% Similarity=0.136 Sum_probs=92.8
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccccc--------------------------------------------ccHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--------------------------------------------TNFD 875 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------------------------------------~~~~ 875 (1119)
+.+|+|++|.||+|+.+++|+.||||+.+... -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 78999999999999999889999999885321 1234
Q ss_pred HHHHHHhhcC----CCCEEEEeeeeec-CCceEEEEeccCCCCHHHhh--ccCCC-CCCCCHHHHHHHHHHHHHHHHHHH
Q 001226 876 VEIRTLSLVR----HRNILRIVGSCTK-DEHGFIVTEYMPGGTLFNVL--HQNEP-RLVLDWNTRYHIALGIAQGLSYLH 947 (1119)
Q Consensus 876 ~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH 947 (1119)
+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++- ...+. ...+....+..++ ..+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~-------~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF-------TQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-------HHHH
Confidence 4555444442 4444444444433 45678999999999998752 22221 0012222222223 3334
Q ss_pred hCCCCCeEecCCCCCCeEeCCCC----ceEEEeccccccccC
Q 001226 948 YDCVPQIIHRDIKSDNILLDSEL----EPKIGDFGMSKLISD 985 (1119)
Q Consensus 948 ~~~~~~ivH~Dlkp~Nill~~~~----~vkl~DfGla~~~~~ 985 (1119)
.. |++|+|++|.||+++.++ +++++|||++...+.
T Consensus 278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999988 999999999987654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.6e-11 Score=135.53 Aligned_cols=245 Identities=23% Similarity=0.247 Sum_probs=177.2
Q ss_pred hhCCceeee--cCCccEEEEEe--CCCceEEEEEecccc------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEE
Q 001226 836 ATEGRIIGK--GKHGTVYRTLS--NNSRKHWAVKKLNRS------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 836 ~~~~~~lG~--G~fg~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 904 (1119)
+...+.+|+ |.+|.||.+.. ..++..+|+|+-+.. ...-.+|+...+.++ |++.++....+..++..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 334477899 99999999988 778899999975321 122345666666664 9999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ----GLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGM 979 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGl 979 (1119)
-+|++ +.++.++.+.... .++....+....+..+ |+.++|+. +++|-|+||.||+..++ ...+.+|||+
T Consensus 196 qtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 99998 5788888776543 3666777778888888 99999999 99999999999999999 7889999999
Q ss_pred cccccCCCCCCcc---cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc
Q 001226 980 SKLISDSHSSSTR---SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 980 a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
...+.+....... ....+...|++||. ..+.++.++|+|++|.+..+..++..+..... ...|......
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~~W~~~r~~-- 341 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGK-----NSSWSQLRQG-- 341 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCC-----CCCccccccc--
Confidence 9988765432221 12256778999994 45677899999999999999998876653221 1111111100
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..-.++.+ ....++...+..|++.+|-.|++.+.+..+
T Consensus 342 ~ip~e~~~-----------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 342 YIPLEFCE-----------GGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cCchhhhc-----------CcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00000110 112234457889999999999999887653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.4e-12 Score=135.55 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=135.0
Q ss_pred cccccCCCccEEEccccccccc----CCccccccCccCEEEccCc---cccCCCCccc-------ccccccceeeecccc
Q 001226 114 KQLGNCGQLKTLLLNDNRFQGS----IPPEIFKLKRLSWLDLGYN---SLSGKIPPQV-------SLCYSLESIGFHNNF 179 (1119)
Q Consensus 114 ~~l~~l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~Ls~n---~l~~~~p~~l-------~~l~~L~~L~L~~n~ 179 (1119)
+.+..+..+++|+||+|.|... +.+.+.+.++|+..++|+- ++...+|..+ ..+++|++|+||.|.
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 3466788899999999988653 4455667788999998863 3334555544 334466666666666
Q ss_pred cccccCccCC----CcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCcc
Q 001226 180 LNGELPNDIC----SLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI 255 (1119)
Q Consensus 180 l~~~~~~~l~----~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~ 255 (1119)
+....+..|. ++..|++|+|.+|.+.-.... .+..++ .+|. .
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~-------------------~l~~al------~~l~--~------- 149 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGG-------------------RLGRAL------FELA--V------- 149 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHH-------------------HHHHHH------HHHH--H-------
Confidence 6544444332 345566666665544311000 000000 0000 0
Q ss_pred ChhhhhcCCCccEEEcCCCccCCCc----chhhcCCCCCceeeecccccccc----CcccccCCCCCcEEEccccccccc
Q 001226 256 SPWIFKGLLQLEVLYLDDNNLEGQI----PETLWGLENLQKLVLSANKLNGT----ISGQISHCNQLQVIALSRNNLVGQ 327 (1119)
Q Consensus 256 ~~~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (1119)
......-++|+++....|++..-. ...|...+.|+.+.+++|.|... ....|.++++|++|||.+|-++..
T Consensus 150 -~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~e 228 (382)
T KOG1909|consen 150 -NKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLE 228 (382)
T ss_pred -HhccCCCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhH
Confidence 000112345666666666665332 23344556777777777766521 234566777777777777776632
Q ss_pred ----cCcccCCCCCCCeEEccCCcccCCCCCCC-----CCCCCCcEEEcccCcCccc----CchhhhcccccceeeccCc
Q 001226 328 ----IPRSVGNLSSLNSLLLFNNRLQGTLPPEL-----GNCGSLVDLRLQHNFIGGT----IPPEICNLAKLEVLYLFNN 394 (1119)
Q Consensus 328 ----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~i~~~----~~~~l~~l~~L~~L~L~~N 394 (1119)
+...+..+++|+.|++++|.++.....+| ...++|+.|.+.+|.|+.. +...+...+.|+.|+|++|
T Consensus 229 gs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN 308 (382)
T KOG1909|consen 229 GSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGN 308 (382)
T ss_pred HHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcc
Confidence 23345556667777777776664332222 1245666666666666521 1122334455556666666
Q ss_pred cc
Q 001226 395 RI 396 (1119)
Q Consensus 395 ~l 396 (1119)
++
T Consensus 309 ~l 310 (382)
T KOG1909|consen 309 RL 310 (382)
T ss_pred cc
Confidence 55
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=125.97 Aligned_cols=167 Identities=20% Similarity=0.260 Sum_probs=127.9
Q ss_pred EEEeCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCC
Q 001226 852 RTLSNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL 927 (1119)
Q Consensus 852 ~~~~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l 927 (1119)
.|..+.++.+|.|++++... +...+-++.++.+|||+|+++++.++.++..|+|+|.+. .|..++++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence 45667778889998886433 335677888999999999999999999999999999984 5677776543
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCccccccc
Q 001226 928 DWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007 (1119)
Q Consensus 928 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 1007 (1119)
.......+.||+.||.+||..| +++|++|.-..|+|++.|+.|+++|.++........ ......--..|..|+.+
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI 177 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence 4566778899999999999776 899999999999999999999999998865533221 11111222346666644
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhCC
Q 001226 1008 YSTRLTEKSDVYSYGVILFELLFRK 1032 (1119)
Q Consensus 1008 ~~~~~~~~sDvwslG~vl~elltg~ 1032 (1119)
.... -..|.|.||+++||++.|.
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCcc
Confidence 3322 4569999999999999983
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-11 Score=132.43 Aligned_cols=211 Identities=23% Similarity=0.169 Sum_probs=111.9
Q ss_pred cccccceeeecccccccccC-ccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEE
Q 001226 166 LCYSLESIGFHNNFLNGELP-NDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEF 244 (1119)
Q Consensus 166 ~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L 244 (1119)
++.+|+...|.++.+..... .....+++++.|||++|-+...- .+..-...+++|+.|
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~---------------------~v~~i~eqLp~Le~L 177 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWF---------------------PVLKIAEQLPSLENL 177 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHH---------------------HHHHHHHhcccchhc
Confidence 34445555555544442221 24445666666666666544211 112223445566666
Q ss_pred EccCCccCCccChhhhhcCCCccEEEcCCCccCCCcc-hhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccc
Q 001226 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIP-ETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNN 323 (1119)
Q Consensus 245 ~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 323 (1119)
+++.|++.-......-..+.+|+.|.|+.|+++.... .....+|+|+.|+|..|..-.+......-+..|++|||++|+
T Consensus 178 Nls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~ 257 (505)
T KOG3207|consen 178 NLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNN 257 (505)
T ss_pred ccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCc
Confidence 6666665543333333345667777777777763322 223466777777777775333334444556677777777777
Q ss_pred ccccc-CcccCCCCCCCeEEccCCcccCCC-CCC-----CCCCCCCcEEEcccCcCccc-CchhhhcccccceeeccCcc
Q 001226 324 LVGQI-PRSVGNLSSLNSLLLFNNRLQGTL-PPE-----LGNCGSLVDLRLQHNFIGGT-IPPEICNLAKLEVLYLFNNR 395 (1119)
Q Consensus 324 l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~-----l~~l~~L~~L~L~~N~i~~~-~~~~l~~l~~L~~L~L~~N~ 395 (1119)
+.... -...+.++.|+.|+++.+.++..- |+. ...+++|++|++.+|+|..- .-..+..+++|+.|.+..|.
T Consensus 258 li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ 337 (505)
T KOG3207|consen 258 LIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNY 337 (505)
T ss_pred ccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccc
Confidence 65321 134566777777777777766332 222 23456666666666666411 11223334455555555555
Q ss_pred cc
Q 001226 396 IE 397 (1119)
Q Consensus 396 l~ 397 (1119)
+.
T Consensus 338 ln 339 (505)
T KOG3207|consen 338 LN 339 (505)
T ss_pred cc
Confidence 54
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.4e-11 Score=131.39 Aligned_cols=163 Identities=25% Similarity=0.204 Sum_probs=96.3
Q ss_pred cCCCCCCCeEEccCCcccCCCC-CCCCCCCCCcEEEcccCcCcccCc--hhhhcccccceeeccCccccCCCCccccccC
Q 001226 332 VGNLSSLNSLLLFNNRLQGTLP-PELGNCGSLVDLRLQHNFIGGTIP--PEICNLAKLEVLYLFNNRIEGAIPHQIGRMS 408 (1119)
Q Consensus 332 ~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~--~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 408 (1119)
-.++.+|+...|.++.+..... .....|++++.|||++|-+....+ .-...+++|+.|+|+.|++......
T Consensus 117 Qsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s------ 190 (505)
T KOG3207|consen 117 QSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS------ 190 (505)
T ss_pred hhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc------
Confidence 3566778888888777762211 245567777777777776653211 2233456666666666665421111
Q ss_pred cceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeec
Q 001226 409 KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVL 488 (1119)
Q Consensus 409 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L 488 (1119)
.. -..++.|+.|.|+.|.|+...-......+|.|+.|+|.+|..-..-......+..|+.|||
T Consensus 191 ----------~~-------~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 191 ----------NT-------TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred ----------cc-------hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 01 1145677888888888875555556667888888888888532222333344556677777
Q ss_pred cCccccCCCC--ccccccccccEEEeccCccc
Q 001226 489 GNNRFNGSFP--IEIGKCSSLRRVILSNNLLQ 518 (1119)
Q Consensus 489 ~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~ 518 (1119)
++|++- .++ ...+.++.|+.|+++.|.+.
T Consensus 254 s~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 254 SNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred cCCccc-ccccccccccccchhhhhccccCcc
Confidence 777765 233 23556666666666666554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.8e-11 Score=123.99 Aligned_cols=130 Identities=22% Similarity=0.260 Sum_probs=73.9
Q ss_pred CCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEE
Q 001226 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414 (1119)
Q Consensus 335 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 414 (1119)
...|+.+||++|.|+ .+.++..-+|+++.|++++|.|... ..+..+++|+.|||++|.++ ....+-..+.+++.|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 345666666666666 4455555566666666666666522 33666666666666666665 3333444556666666
Q ss_pred eecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceee
Q 001226 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470 (1119)
Q Consensus 415 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1119)
|+.|.|.. -..+.++-+|..||+++|+|.......-...+|.|+.+.|.+|++.
T Consensus 359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 66666642 2345556666666666666653222222334555555555555554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=6.8e-10 Score=113.19 Aligned_cols=133 Identities=14% Similarity=0.139 Sum_probs=96.7
Q ss_pred ceeeecCCccEEEEEeCC------CceEEEEEecccc-------------c-------------cc----HHHHHHHHhh
Q 001226 840 RIIGKGKHGTVYRTLSNN------SRKHWAVKKLNRS-------------E-------------TN----FDVEIRTLSL 883 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~-------------~-------------~~----~~~E~~~l~~ 883 (1119)
-.||.|.-+.||.|...+ .+..+|||+++.. . .. .++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998654 3578999987311 0 01 2378888888
Q ss_pred cCC--CCEEEEeeeeecCCceEEEEeccCCCCHHH-hhccCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCC
Q 001226 884 VRH--RNILRIVGSCTKDEHGFIVTEYMPGGTLFN-VLHQNEPRLVLDWNTRYHIALGIAQGLSYL-HYDCVPQIIHRDI 959 (1119)
Q Consensus 884 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dl 959 (1119)
+.. -++.+.+++ ...++||||+.+..+.. .+++. .++.++...+..+++.++..+ |.. ++||+|+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 456666654 45689999997653321 22221 244456677889999999999 777 9999999
Q ss_pred CCCCeEeCCCCceEEEecccccccc
Q 001226 960 KSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 960 kp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
++.||+++ ++.+.++|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.3e-10 Score=114.18 Aligned_cols=126 Identities=29% Similarity=0.310 Sum_probs=34.1
Q ss_pred CCCCCCeEEccCCcccCCCCCCCC-CCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceE
Q 001226 334 NLSSLNSLLLFNNRLQGTLPPELG-NCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVE 412 (1119)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 412 (1119)
+..++++|+|.+|.|+. + +.++ .+.+|+.|++++|.|+.. +.+..++.|+.|++++|+|+...+.....+++|++
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 33445555555555552 2 2333 345555555555555532 23455555555555555555332211124555666
Q ss_pred EEeecccccccC-CccccCCCCcCEEEccCccCcccch--hhhhccCCccceec
Q 001226 413 LALYNNRLTGRI-PPDITRLRNLQFLSLAHNHLTGEVA--LELGKHFPYLSRLD 463 (1119)
Q Consensus 413 L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~~l~~L~~L~ 463 (1119)
|++++|+|.... -..+..+++|+.|+|.+|+++.... ..+...+|+|+.||
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 666666554311 1344556666666666666653221 12334566666665
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.7e-11 Score=139.69 Aligned_cols=245 Identities=27% Similarity=0.268 Sum_probs=120.9
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEee
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 416 (1119)
.++.+.+..|.+.. .-..+..+++|+.|++.+|+|..+ ...+..+++|++|++++|+|+.+.+ +..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhheec
Confidence 33334444444441 222344445555555555555422 1114455555555555555554322 4444556666666
Q ss_pred cccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCC
Q 001226 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGS 496 (1119)
Q Consensus 417 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~ 496 (1119)
+|.|+. ...+..+.+|+.+++++|+++...+.. ...+.+++.+++.+|.+.. ...+..+..+..+++..|.++..
T Consensus 149 ~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 149 GNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred cCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceec
Confidence 666552 223444666666666666665322211 2345556666666665542 22233334444445555555422
Q ss_pred CCccccccc--cccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccC
Q 001226 497 FPIEIGKCS--SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELG 574 (1119)
Q Consensus 497 ~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 574 (1119)
-+ +..+. .|+.+++++|++.. .+..+..+.++..|++++|++... ..+.
T Consensus 224 ~~--l~~~~~~~L~~l~l~~n~i~~-------------------------~~~~~~~~~~l~~l~~~~n~~~~~--~~~~ 274 (414)
T KOG0531|consen 224 EG--LNELVMLHLRELYLSGNRISR-------------------------SPEGLENLKNLPVLDLSSNRISNL--EGLE 274 (414)
T ss_pred cC--cccchhHHHHHHhcccCcccc-------------------------ccccccccccccccchhhcccccc--cccc
Confidence 11 11111 25555555555542 223344555666666666666532 2234
Q ss_pred CcccccEEEcccCcccCc---CCc-ccccCCCCcEEeccCccccccCCh
Q 001226 575 NLENLQILRLSANKLDGR---IPY-ELGKCTKMIKLDLSDNYLAGSIPS 619 (1119)
Q Consensus 575 ~l~~L~~L~Ls~N~l~~~---~p~-~~~~l~~L~~L~Ls~N~l~~~~p~ 619 (1119)
....+..+.+..|++... ... .......++.+.+..|.+....+.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred ccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 445666666666666521 111 145567777777777777654443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.8e-11 Score=139.62 Aligned_cols=218 Identities=29% Similarity=0.344 Sum_probs=110.1
Q ss_pred cccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccce
Q 001226 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR 461 (1119)
Q Consensus 382 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 461 (1119)
.+..++.+++..|.|.. +-..+..+.+|..|++.+|+|. .+...+..+++|++|++++|+|+...+.. .++.|+.
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~l~---~l~~L~~ 144 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEGLS---TLTLLKE 144 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccchh---hccchhh
Confidence 34445555555555553 2233455556666666666665 23323555666666666666665433222 2344666
Q ss_pred eccccceeeCccCCccccccccceeeccCccccCCCC-ccccccccccEEEeccCccccCCCccccCCCCcceeeccCcc
Q 001226 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP-IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540 (1119)
Q Consensus 462 L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 540 (1119)
|++++|.|+.. ..+..+++|+.+++++|++...-+ . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 66666665422 233335666677777777663322 1 3556677777777777652 2233333444444555555
Q ss_pred cCCCCCccccccc--cceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccc
Q 001226 541 LQGSIPPVFGFWS--NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 541 l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
++..-+ +..+. .|+.+++++|++. .++..+..+.++..|++.+|++... ..+.....+..+.++.|.+.
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 542211 11111 2555666666655 3334455555555555555555421 12233444555555555543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=3e-10 Score=113.41 Aligned_cols=80 Identities=26% Similarity=0.409 Sum_probs=13.5
Q ss_pred CccEEEcccccccccCCcccc-ccCccCEEEccCccccCCCCcccccccccceeeecccccccccCccC-CCcccccEEE
Q 001226 121 QLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI-CSLPKLKSLY 198 (1119)
Q Consensus 121 ~L~~L~L~~n~i~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~ 198 (1119)
++++|+|++|+|+. + +.++ .+.+|+.|||++|.|+.. +.+..++.|++|++++|.|+...+ .+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~-~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISE-GLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CH-HHHHH-TT--EEE
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcccc-chHHhCCcCCEEE
Confidence 44444444444442 1 2233 244444444444444422 123333333444444443332211 11 1244444444
Q ss_pred ecccccc
Q 001226 199 LNTNNLT 205 (1119)
Q Consensus 199 L~~n~l~ 205 (1119)
+++|+|.
T Consensus 95 L~~N~I~ 101 (175)
T PF14580_consen 95 LSNNKIS 101 (175)
T ss_dssp -TTS---
T ss_pred CcCCcCC
Confidence 4444443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.6e-10 Score=138.81 Aligned_cols=107 Identities=21% Similarity=0.229 Sum_probs=80.5
Q ss_pred CcccEEEcCCCc--ccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCccccccccccee
Q 001226 96 QHLLSLDLSGNE--FTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESI 173 (1119)
Q Consensus 96 ~~l~~L~Ls~n~--~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L 173 (1119)
+.|++|-+.+|. +.-..+..|..++.|++|||++|.=-+.+|+.+++|-+|++|+|+++.++ .+|..+++++.|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 467777777775 44233334677888888888887655678888888888888888888887 788888888888888
Q ss_pred eecccccccccCccCCCcccccEEEecccc
Q 001226 174 GFHNNFLNGELPNDICSLPKLKSLYLNTNN 203 (1119)
Q Consensus 174 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 203 (1119)
++..+.-...+|..+..|++|++|.+..-.
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccc
Confidence 888776555557777778888888876654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.1e-08 Score=107.17 Aligned_cols=267 Identities=14% Similarity=0.124 Sum_probs=161.4
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccccc-HHHHHHHHhhc-CCCCEEEEeeee-------ecCCceEEEEe
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-FDVEIRTLSLV-RHRNILRIVGSC-------TKDEHGFIVTE 907 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~E~~~l~~l-~h~niv~l~~~~-------~~~~~~~lV~e 907 (1119)
+.++.+|+|+.+.+|-.-.- +..+-|++....-. -...+.+|... .||-+-.-+.|= ..+....++|+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 34688999999999954322 22345766443221 11222233332 455443322221 12233567888
Q ss_pred ccCCCC-HHHhhcc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 908 YMPGGT-LFNVLHQ---NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 908 ~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
.+++.- ..++... ++......|....++++.++.+.+.||.. |.+-+|+.++|+|+++++.|.+.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 887652 2222221 22223578999999999999999999999 9999999999999999999999986644333
Q ss_pred cCCCCCCcccccccCCCcccccc-----cCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCCCCCceeehhhhhhcccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPEN-----AYSTRLTEKSDVYSYGVILFELLFR-KMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~sDvwslG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
.. .......+|..+|.+||. +.+...+...|.|.+|+++++++.| ++||.+.......--....... ..
T Consensus 168 ~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--~g 242 (637)
T COG4248 168 AN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--HG 242 (637)
T ss_pred cC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh--cc
Confidence 22 222334578899999994 3345567889999999999999976 9999765321110000000000 00
Q ss_pred cccccccccc--cCCC--chHHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHcccccCC
Q 001226 1058 ECICFLDREI--SFWD--SDDQLKALRLLELALECTRQV--ADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1058 ~~~~~~~~~~--~~~~--~~~~~~~~~l~~l~~~cl~~d--P~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.+...-++.. ..-. ..-...+.++..+..+|+... +.-|||++..+..|..+.++-.
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 0000011000 0000 011233456777888888654 5679999999999988877643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.5e-10 Score=126.45 Aligned_cols=244 Identities=19% Similarity=0.186 Sum_probs=170.3
Q ss_pred HhhCCceeeecCCccEEEEEeC-CCceEEEEEecccccccHH------HHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSN-NSRKHWAVKKLNRSETNFD------VEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~~~~~~------~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
++.....||.|.|+.||+...+ .++..|++|........+. .|+.+...+ .|.++++....+..-+..|+--
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 3445578999999999987755 5677889997754433332 344444444 4889999888888778888999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccccccccC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISD 985 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~~ 985 (1119)
||+++++......- ...+++...+++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+....-
T Consensus 346 e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred hhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccce
Confidence 99999988766522 23477778889999999999999988 99999999999999987 6779999998864321
Q ss_pred CCCCCcccccccCCCcc--cccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYI--APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
. ........+++ +|+......+..+.|++|+|.-+.|..++..--.. ..... .+.
T Consensus 420 ~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----~~~~~--------------~i~ 476 (524)
T KOG0601|consen 420 S-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----GVQSL--------------TIR 476 (524)
T ss_pred e-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc----cccce--------------eee
Confidence 1 11122333444 55555667788999999999999999988743211 11100 001
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
....... .........+...+...++..||.+.++..+.+..++
T Consensus 477 ~~~~p~~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 477 SGDTPNL----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cccccCC----CchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 1111111 1111455677888999999999999999887765544
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-08 Score=108.89 Aligned_cols=138 Identities=20% Similarity=0.293 Sum_probs=105.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCC--CEEEEeeeeecC---CceEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHR--NILRIVGSCTKD---EHGFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~ 909 (1119)
+.++.|.++.||++...+ |+.+++|+.... ...+..|+.+++.+++. .+.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 678999988643 35688999999999753 456677776653 3668999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC--------------------------------------- 950 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 950 (1119)
+|.++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99888765532 12566677777888888888887421
Q ss_pred --------------CCCeEecCCCCCCeEeCC--CCceEEEecccccc
Q 001226 951 --------------VPQIIHRDIKSDNILLDS--ELEPKIGDFGMSKL 982 (1119)
Q Consensus 951 --------------~~~ivH~Dlkp~Nill~~--~~~vkl~DfGla~~ 982 (1119)
...++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=8e-10 Score=132.00 Aligned_cols=242 Identities=21% Similarity=0.251 Sum_probs=170.1
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
...+.+-+|.++.++.+.-..++...++|+..... .....+-.+.-..++|-+++....+......++|++|.
T Consensus 807 ~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 807 EITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYL 886 (1205)
T ss_pred eecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHh
Confidence 33457889999999998877777666666553221 11112222222234677777766666778889999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC---
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS--- 986 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~--- 986 (1119)
.++++...++..+. .+.+.+......+.++.+|||+. .+.|||++|.|.+...++..+++|||.....+..
T Consensus 887 ~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred ccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999987663 44445556677788999999988 7999999999999999999999999844322110
Q ss_pred ------------------CC--------CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCC
Q 001226 987 ------------------HS--------SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFG 1040 (1119)
Q Consensus 987 ------------------~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~ 1040 (1119)
.. ........+|+.|.|||...+.....++|.|+.|++++|.++|..||.....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 00 0112235799999999999999999999999999999999999999975432
Q ss_pred CCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHH
Q 001226 1041 EDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMR 1100 (1119)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 1100 (1119)
.... ..+..+.+ .|...+...+....+++...+..+|.+|-.|.
T Consensus 1041 q~~f---------------~ni~~~~~-~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1041 QQIF---------------ENILNRDI-PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh---------------hccccCCC-CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2110 11111111 22333344455667888888889999988776
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.2e-08 Score=99.83 Aligned_cols=128 Identities=23% Similarity=0.300 Sum_probs=95.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEec-ccc-----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL-NRS-----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~-~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
..+++|+-+.+|.+.+. |.++++|.= ++. .....+|++++.+++--.|..-.-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999998764 445667643 111 1235679999998875555444444456667789999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
|++|-.|.+++.... ..++..+-.-+.-||.. ||||+|+.++||++..++ +.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEAR----------PDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999998988652 23555666667789999 999999999999998776 999999998743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.3e-08 Score=93.96 Aligned_cols=137 Identities=25% Similarity=0.285 Sum_probs=99.1
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEec-cc-----------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKL-NR-----------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~-~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
..+-+|+-+.|+++.+. |+.++||.- .+ ......+|++.+.+++--.|.--.-++.+.....++||
T Consensus 13 ~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 56889999999998776 577777742 11 12345679999988875444433334555566679999
Q ss_pred ccCC-CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceEEEecccccc
Q 001226 908 YMPG-GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPKIGDFGMSKL 982 (1119)
Q Consensus 908 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~DfGla~~ 982 (1119)
|++| .++.+++...-.....+ +.....+..|-+.+.-||.. +++|+|+..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 47888877654322222 22367888888999999999 999999999999997665 358999999863
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.1e-08 Score=124.92 Aligned_cols=296 Identities=23% Similarity=0.217 Sum_probs=167.0
Q ss_pred CCCCceeeeccccccccCcccccCCCCCcEEEccccc--cccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcE
Q 001226 287 LENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNN--LVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVD 364 (1119)
Q Consensus 287 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 364 (1119)
....+...+-+|.+..+. .. ..+++|++|-+..|. +....+..|..++.|+.|||++|.=-+.+|..++++-+|++
T Consensus 522 ~~~~rr~s~~~~~~~~~~-~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry 599 (889)
T KOG4658|consen 522 WNSVRRMSLMNNKIEHIA-GS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY 599 (889)
T ss_pred hhheeEEEEeccchhhcc-CC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence 356677777777765322 21 223468888887775 44344445777888888888877655578888888888888
Q ss_pred EEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccc--cccCCccccCCCCcCEEEccCc
Q 001226 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRL--TGRIPPDITRLRNLQFLSLAHN 442 (1119)
Q Consensus 365 L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l--~~~~~~~~~~l~~L~~L~L~~N 442 (1119)
|++++..|. .+|..+.++++|.+|++..+.-...+|.....+++|++|.+..-.. +...-..+..+.+|+.+.....
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~ 678 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITIS 678 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecc
Confidence 888888887 7788888888888888887765545566667788888887765542 2222233445555555554332
Q ss_pred cCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCC
Q 001226 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLP 522 (1119)
Q Consensus 443 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 522 (1119)
.. .+...+ ..++.|.. ..+.+.+..+... ..+..++.+.+|+.|.+.++.+.....
T Consensus 679 s~--~~~e~l-~~~~~L~~--------------------~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~ 734 (889)
T KOG4658|consen 679 SV--LLLEDL-LGMTRLRS--------------------LLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVI 734 (889)
T ss_pred hh--HhHhhh-hhhHHHHH--------------------HhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhc
Confidence 21 000111 11111111 1111111122222 334456667777777777777654333
Q ss_pred ccccCCC------CcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCc-CCc
Q 001226 523 ATLERNP------GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR-IPY 595 (1119)
Q Consensus 523 ~~~~~l~------~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~ 595 (1119)
.+..... ++..+...++... ..+.+....++|+.|++..++....+......+..++.+.+..+.+.+. .-.
T Consensus 735 ~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~ 813 (889)
T KOG4658|consen 735 EWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLC 813 (889)
T ss_pred ccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeee
Confidence 3322221 2222222222111 1222334557788888887777666666666666677777777777654 233
Q ss_pred ccccCCCCcEEeccC
Q 001226 596 ELGKCTKMIKLDLSD 610 (1119)
Q Consensus 596 ~~~~l~~L~~L~Ls~ 610 (1119)
..+.++++..+.++.
T Consensus 814 ~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 814 SLGGLPQLYWLPLSF 828 (889)
T ss_pred cCCCCceeEecccCc
Confidence 444555555444443
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.68 E-value=8.8e-09 Score=77.21 Aligned_cols=41 Identities=39% Similarity=0.726 Sum_probs=28.7
Q ss_pred CCcHHHHHHHHhcCCCC-CCCCCCCCCCCCCCCCceeeeeeee
Q 001226 24 PPSAISLVQFLDSLPKQ-SQSHLPWNQSVSTSAPCKWSGVSCY 65 (1119)
Q Consensus 24 ~~~~~~ll~~~~~~~~~-~~~~~~w~~~~~~~~~c~w~gv~C~ 65 (1119)
++|++||++||+++..+ .+.+.+|+.+. .++||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~-~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSS-DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT---S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcC-CCCCeeeccEEeC
Confidence 46899999999999964 46678998642 3689999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.6e-08 Score=83.03 Aligned_cols=59 Identities=39% Similarity=0.524 Sum_probs=27.3
Q ss_pred cceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcc
Q 001226 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612 (1119)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 612 (1119)
+|++|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444443334444444444444444444
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.7e-10 Score=127.92 Aligned_cols=197 Identities=28% Similarity=0.279 Sum_probs=131.8
Q ss_pred CCCccEEEcCCCccCCCc-chhhcCCCCCceeeeccccccccCcccccCC-CCCcEEEccccccc----------cccCc
Q 001226 263 LLQLEVLYLDDNNLEGQI-PETLWGLENLQKLVLSANKLNGTISGQISHC-NQLQVIALSRNNLV----------GQIPR 330 (1119)
Q Consensus 263 l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~----------~~~~~ 330 (1119)
+++++.|.+-.-.-.+.. |-.+..+.+|+.|.|.++.|... . .+..+ .+|++|.-. |.+. |.+..
T Consensus 83 lqkt~~lkl~~~pa~~pt~pi~ifpF~sLr~LElrg~~L~~~-~-GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~n 159 (1096)
T KOG1859|consen 83 LQKTKVLKLLPSPARDPTEPISIFPFRSLRVLELRGCDLSTA-K-GLQELRHQLEKLICH-NSLDALRHVFASCGGDISN 159 (1096)
T ss_pred HhhheeeeecccCCCCCCCCceeccccceeeEEecCcchhhh-h-hhHHHHHhhhhhhhh-ccHHHHHHHHHHhcccccc
Confidence 444455554433222222 56677778888888888877631 1 11111 234433322 2211 11111
Q ss_pred ccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCc-cccccCc
Q 001226 331 SVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPH-QIGRMSK 409 (1119)
Q Consensus 331 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~ 409 (1119)
++. .-.|...+.+.|.+. ....++.-++.|+.|+|++|+++.. +.+..+++|++|||++|++.. +|. ....+ +
T Consensus 160 s~~-Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~ 233 (1096)
T KOG1859|consen 160 SPV-WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-K 233 (1096)
T ss_pred chh-hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc-ccccchhhh-h
Confidence 111 135778888999988 5666778888999999999999854 488889999999999999984 443 22233 4
Q ss_pred ceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceee
Q 001226 410 LVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470 (1119)
Q Consensus 410 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 470 (1119)
|+.|.+++|.++. -..+.++++|+.||+++|-|.+.-.......+..|..|+|.||++-
T Consensus 234 L~~L~lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 234 LQLLNLRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred heeeeecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999999999873 3467889999999999999887655555566788999999999874
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-08 Score=82.47 Aligned_cols=59 Identities=37% Similarity=0.528 Sum_probs=30.5
Q ss_pred CCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcc
Q 001226 602 KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNI 660 (1119)
Q Consensus 602 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 660 (1119)
+|++|++++|+++...+..|..+++|++|++++|+++...|++|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 44555555555554333444555555555555555554445555555555555555554
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.3e-07 Score=98.07 Aligned_cols=129 Identities=22% Similarity=0.253 Sum_probs=94.9
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEeccccc--------------------------ccHHHHHHHHhhcCCC--CE
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--------------------------TNFDVEIRTLSLVRHR--NI 889 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------------------~~~~~E~~~l~~l~h~--ni 889 (1119)
.+.+||.|.-+.||.|.+.. |.++|||.-+... ...++|.+.|+++.-. .|
T Consensus 95 iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 35889999999999999885 8999999753111 1245788888888643 55
Q ss_pred EEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 001226 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969 (1119)
Q Consensus 890 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 969 (1119)
.+.+++ +...+|||+++|--|...- ++.+....++..|.+-+..+-.. ||||+|+.+-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 555553 4557999999886654321 12334445666666666666667 99999999999999999
Q ss_pred CceEEEecccccc
Q 001226 970 LEPKIGDFGMSKL 982 (1119)
Q Consensus 970 ~~vkl~DfGla~~ 982 (1119)
|.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.1e-07 Score=96.86 Aligned_cols=121 Identities=24% Similarity=0.263 Sum_probs=78.5
Q ss_pred cEEEEEeCCCceEEEEEecccc------------------------------cccHHHHHHHHhhcCCC--CEEEEeeee
Q 001226 849 TVYRTLSNNSRKHWAVKKLNRS------------------------------ETNFDVEIRTLSLVRHR--NILRIVGSC 896 (1119)
Q Consensus 849 ~Vy~~~~~~~~~~vavK~~~~~------------------------------~~~~~~E~~~l~~l~h~--niv~l~~~~ 896 (1119)
.||.|...+ +.++|+|+.+.. ....++|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 389998765 789999987311 01256799999999755 456666542
Q ss_pred ecCCceEEEEeccC--CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeEeCCCCceE
Q 001226 897 TKDEHGFIVTEYMP--GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY-LHYDCVPQIIHRDIKSDNILLDSELEPK 973 (1119)
Q Consensus 897 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlkp~Nill~~~~~vk 973 (1119)
..++||||++ |..+..+.... ++......++.++...+.. +|.. |+||+|+.+.||+++++ .+.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 55454333221 1122445677777775555 4677 99999999999999988 999
Q ss_pred EEeccccccc
Q 001226 974 IGDFGMSKLI 983 (1119)
Q Consensus 974 l~DfGla~~~ 983 (1119)
++|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.1e-07 Score=98.47 Aligned_cols=139 Identities=17% Similarity=0.145 Sum_probs=99.6
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEeccccc---------------ccHHHHHHHHhhcCCC--CEEEEeeeeec--
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------------TNFDVEIRTLSLVRHR--NILRIVGSCTK-- 898 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~--niv~l~~~~~~-- 898 (1119)
.++.+-+.....|++.... |+.|.||...... ..+.+|.+.+.++... .+++.+++...
T Consensus 26 ~~e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~ 103 (268)
T PRK15123 26 QGEVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS 103 (268)
T ss_pred CCcEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC
Confidence 3456665555667776553 6789999763211 1367899988888432 23344444432
Q ss_pred ---CCceEEEEeccCCC-CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC------
Q 001226 899 ---DEHGFIVTEYMPGG-TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS------ 968 (1119)
Q Consensus 899 ---~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~------ 968 (1119)
....++|||++++. +|.+++..... ...+......++.+++..+..||.. ||+|+|+++.||+++.
T Consensus 104 ~~~~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 104 NPATRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred CCccceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence 23568999999886 89988854221 1245567778999999999999999 9999999999999975
Q ss_pred -CCceEEEecccccc
Q 001226 969 -ELEPKIGDFGMSKL 982 (1119)
Q Consensus 969 -~~~vkl~DfGla~~ 982 (1119)
++.+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46789999998753
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.7e-08 Score=104.03 Aligned_cols=216 Identities=21% Similarity=0.274 Sum_probs=103.6
Q ss_pred CCCCCcEEEccCCccCCccChhhhh-cCCCccEEEcCCCccCC--CcchhhcCCCCCceeeeccccccccCcccccCCCC
Q 001226 237 NCRNLVEFSASSNNFGGAISPWIFK-GLLQLEVLYLDDNNLEG--QIPETLWGLENLQKLVLSANKLNGTISGQISHCNQ 313 (1119)
Q Consensus 237 ~l~~L~~L~l~~n~i~~~~~~~~~~-~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 313 (1119)
..+.++-|.+-++.|........|. ..+.+++|||.+|.|++ .+...+.++|.|+.|+|+.|.+...+...-..+.+
T Consensus 43 s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~n 122 (418)
T KOG2982|consen 43 SLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKN 122 (418)
T ss_pred cccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccc
Confidence 3334444444455544333223332 23455555555555542 22223345555555555555554332222123344
Q ss_pred CcEEEccccccccc-cCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCch--hhhcccccceee
Q 001226 314 LQVIALSRNNLVGQ-IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPP--EICNLAKLEVLY 390 (1119)
Q Consensus 314 L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~--~l~~l~~L~~L~ 390 (1119)
|++|-|.+..+.-. ....+..++.++.|.++.|.+. .+++..|-++...|. .+...+.+..+.
T Consensus 123 l~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w 188 (418)
T KOG2982|consen 123 LRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR--------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLW 188 (418)
T ss_pred eEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh--------------hhccccccccccchhhhhhhcCCcHHHHH
Confidence 44444444433311 1122233344444444443222 112222222211111 112233334444
Q ss_pred ccCccccCCCCccccccCcceEEEeeccccccc-CCccccCCCCcCEEEccCccCcccchhhhhccCCccceecccccee
Q 001226 391 LFNNRIEGAIPHQIGRMSKLVELALYNNRLTGR-IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469 (1119)
Q Consensus 391 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 469 (1119)
++-|++... ++++..+.+..|.+... ....+..++.+..|+|+.|+|...........+|+|..|.+++|++
T Consensus 189 ~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl 261 (418)
T KOG2982|consen 189 LNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPL 261 (418)
T ss_pred HHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcc
Confidence 444444432 34667777888877643 2345566777778888888887655555566788888888888877
Q ss_pred eCcc
Q 001226 470 YGPI 473 (1119)
Q Consensus 470 ~~~~ 473 (1119)
.+.+
T Consensus 262 ~d~l 265 (418)
T KOG2982|consen 262 SDPL 265 (418)
T ss_pred cccc
Confidence 6443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1e-06 Score=98.49 Aligned_cols=167 Identities=17% Similarity=0.277 Sum_probs=128.6
Q ss_pred CCccEEEEEeCCCceEEEEEeccccccc----HHHHHHHHhhcCCCCEEEEeeeee----cCCceEEEEeccCC-CCHHH
Q 001226 846 KHGTVYRTLSNNSRKHWAVKKLNRSETN----FDVEIRTLSLVRHRNILRIVGSCT----KDEHGFIVTEYMPG-GTLFN 916 (1119)
Q Consensus 846 ~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e~~~~-gsL~~ 916 (1119)
.-.+.|++....+|..|++|++...+.+ ...-+++++++.|+|||++.+++. .+...++||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3457899999999999999999544433 234577899999999999999886 34567999999987 46766
Q ss_pred hhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 917 VLHQNEP------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 917 ~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
+.-...+ ....++...|.++.|+..||.++|+. |+.-+-+.|.+|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6433221 12467889999999999999999999 99999999999999999999999888765553
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 1034 (1119)
.+. . |.+.+ -.+-|.=.+|.++..+.+|..-
T Consensus 445 ~d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 0 11111 2356999999999999999743
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.6e-09 Score=104.54 Aligned_cols=218 Identities=22% Similarity=0.215 Sum_probs=129.7
Q ss_pred hhhhccCCcccEEEcCCCcccC----CCCcccccCCCccEEEcccc---cccccCCc-------cccccCccCEEEccCc
Q 001226 89 ISYICKNQHLLSLDLSGNEFTG----SIPKQLGNCGQLKTLLLNDN---RFQGSIPP-------EIFKLKRLSWLDLGYN 154 (1119)
Q Consensus 89 ~~~~~~l~~l~~L~Ls~n~~~~----~~~~~l~~l~~L~~L~L~~n---~i~~~~p~-------~l~~l~~L~~L~Ls~n 154 (1119)
+.-+..+..++.+|||+|-|.. .+...|.+-.+|+..++++- +..+.+|+ ++.++++|+..+||.|
T Consensus 23 ~eel~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDN 102 (388)
T COG5238 23 VEELEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDN 102 (388)
T ss_pred HHHHHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeecccc
Confidence 3345567888999999998864 35666777788999888775 23333433 4566889999999999
Q ss_pred cccCCCCccc----ccccccceeeecccccccccCccCC-------------CcccccEEEeccccccccCCCCCccccc
Q 001226 155 SLSGKIPPQV----SLCYSLESIGFHNNFLNGELPNDIC-------------SLPKLKSLYLNTNNLTGLLPEFPNSCAI 217 (1119)
Q Consensus 155 ~l~~~~p~~l----~~l~~L~~L~L~~n~l~~~~~~~l~-------------~l~~L~~L~L~~n~l~~~~~~~~~~~~l 217 (1119)
.+....|..+ ++-+.|++|.+++|.+....-..++ .-|.|++.....|++..-..
T Consensus 103 Afg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~-------- 174 (388)
T COG5238 103 AFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSK-------- 174 (388)
T ss_pred ccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcH--------
Confidence 9887776654 4557888888888877644433333 24667777777776651110
Q ss_pred eeeeeeccccccCccccccCCCCCcEEEccCCccCCcc----ChhhhhcCCCccEEEcCCCccCCC----cchhhcCCCC
Q 001226 218 LHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI----SPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLEN 289 (1119)
Q Consensus 218 ~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~ 289 (1119)
.-....+..-.+|+++.+..|.|.... .-..+..+.+|++|||++|-++-. ..+++..++.
T Consensus 175 -----------~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~ 243 (388)
T COG5238 175 -----------ELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNL 243 (388)
T ss_pred -----------HHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccch
Confidence 011112222346677777777665221 111123356677777777766532 2234445566
Q ss_pred CceeeeccccccccCcccc----c--CCCCCcEEEccccccc
Q 001226 290 LQKLVLSANKLNGTISGQI----S--HCNQLQVIALSRNNLV 325 (1119)
Q Consensus 290 L~~L~Ls~N~l~~~~~~~~----~--~l~~L~~L~Ls~N~l~ 325 (1119)
|++|.+..|-++....+.+ . ..++|..|-..+|.+.
T Consensus 244 lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~ 285 (388)
T COG5238 244 LRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERR 285 (388)
T ss_pred hhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhc
Confidence 6777777766654333221 1 1344555555555444
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.4e-09 Score=109.21 Aligned_cols=180 Identities=25% Similarity=0.258 Sum_probs=98.3
Q ss_pred CccCEEEccCccccC-CCCcccccccccceeeecccccccccCccCCCcccccEEEecccc-ccccCCCCCccccceeee
Q 001226 144 KRLSWLDLGYNSLSG-KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNN-LTGLLPEFPNSCAILHLL 221 (1119)
Q Consensus 144 ~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~~~~~~~~~l~~l~ 221 (1119)
++|++||||+..|+- ..-.-+..|++|+.|.|.++.+.+.+...+++-.+|+.|+|+.+. ++.
T Consensus 185 sRlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~--------------- 249 (419)
T KOG2120|consen 185 SRLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTE--------------- 249 (419)
T ss_pred hhhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccch---------------
Confidence 348888888877753 222345677888888888888888888888888888888888763 220
Q ss_pred eeccccccCccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeecccccc
Q 001226 222 IHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301 (1119)
Q Consensus 222 l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 301 (1119)
| .+.--+.+|+.|.+|+++.|.+...+....... + -++|+.|+|+++.=.
T Consensus 250 ---n----~~~ll~~scs~L~~LNlsWc~l~~~~Vtv~V~h---------------------i--se~l~~LNlsG~rrn 299 (419)
T KOG2120|consen 250 ---N----ALQLLLSSCSRLDELNLSWCFLFTEKVTVAVAH---------------------I--SETLTQLNLSGYRRN 299 (419)
T ss_pred ---h----HHHHHHHhhhhHhhcCchHhhccchhhhHHHhh---------------------h--chhhhhhhhhhhHhh
Confidence 0 111223445555555555544433221111111 1 134555555544211
Q ss_pred ---ccCcccccCCCCCcEEEccccc-cccccCcccCCCCCCCeEEccCCcccCCCCC---CCCCCCCCcEEEcccC
Q 001226 302 ---GTISGQISHCNQLQVIALSRNN-LVGQIPRSVGNLSSLNSLLLFNNRLQGTLPP---ELGNCGSLVDLRLQHN 370 (1119)
Q Consensus 302 ---~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~l~~l~~L~~L~L~~N 370 (1119)
..+......+++|.+||||+|. ++...-..|..++.|++|.++.|.. .+|. .+...|+|.+|++-++
T Consensus 300 l~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~lSlsRCY~--i~p~~~~~l~s~psl~yLdv~g~ 373 (419)
T KOG2120|consen 300 LQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHLSLSRCYD--IIPETLLELNSKPSLVYLDVFGC 373 (419)
T ss_pred hhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheeeehhhhcC--CChHHeeeeccCcceEEEEeccc
Confidence 1112223456666666666543 3333333455666677777766653 2333 3455677777776653
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.1e-08 Score=99.64 Aligned_cols=87 Identities=24% Similarity=0.286 Sum_probs=51.3
Q ss_pred ccccceeeccCccccC--CCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccc
Q 001226 383 LAKLEVLYLFNNRIEG--AIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460 (1119)
Q Consensus 383 l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~ 460 (1119)
.+.++.+||.+|.|+. .+...+.++|.|+.|+|+.|++...+...-..+.+|++|-|.+-.+.-.....+.+.+|.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 4556666666666652 22233456666666666666665433222245567777777776666545555566677777
Q ss_pred eecccccee
Q 001226 461 RLDLTGNSF 469 (1119)
Q Consensus 461 ~L~L~~N~l 469 (1119)
+|++|.|.+
T Consensus 150 elHmS~N~~ 158 (418)
T KOG2982|consen 150 ELHMSDNSL 158 (418)
T ss_pred hhhhccchh
Confidence 777777743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=101.67 Aligned_cols=139 Identities=18% Similarity=0.184 Sum_probs=95.0
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEeccccc--------------------------------------------cc
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--------------------------------------------TN 873 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------------------------------------~~ 873 (1119)
..+.++.++-|.||+|+.+. |+.||||+.+... -+
T Consensus 129 ~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 129 EPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred CCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 34789999999999999987 9999999874211 12
Q ss_pred HHHHHHHHhhcC----CCCEEEEeeeee-cCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 001226 874 FDVEIRTLSLVR----HRNILRIVGSCT-KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQG-LSYLH 947 (1119)
Q Consensus 874 ~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH 947 (1119)
+.+|+.-+.+++ ..--+++-.++. -.+...++|||++|..+.+...-... ..+.+ .++..++++ +..+-
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k---~ia~~~~~~f~~q~~ 282 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRK---ELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHH---HHHHHHHHHHHHHHH
Confidence 445666655552 222333333333 35667899999999988887432221 24433 333333333 33343
Q ss_pred hCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 948 ~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
.. |++|+|..|.||+++.+|++.+.|||+...+.+
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 45 999999999999999999999999999887654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=7.9e-09 Score=118.16 Aligned_cols=179 Identities=23% Similarity=0.255 Sum_probs=112.0
Q ss_pred hccCCcccEEEcCCCcccCCCCcccccC-CCccEEEcccc--cccccCCccccc------cCccCEEEccCccccCCCCc
Q 001226 92 ICKNQHLLSLDLSGNEFTGSIPKQLGNC-GQLKTLLLNDN--RFQGSIPPEIFK------LKRLSWLDLGYNSLSGKIPP 162 (1119)
Q Consensus 92 ~~~l~~l~~L~Ls~n~~~~~~~~~l~~l-~~L~~L~L~~n--~i~~~~p~~l~~------l~~L~~L~Ls~n~l~~~~p~ 162 (1119)
+..+..|++|.|.++.+.- ...+..+ .+|++|-=++. .+...+....+. -..|..-+.++|++. ..-.
T Consensus 105 ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD~ 181 (1096)
T KOG1859|consen 105 IFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMDE 181 (1096)
T ss_pred eccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHHH
Confidence 4567777888888777652 1122111 12333322111 111111111111 134777788888876 3445
Q ss_pred ccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCc
Q 001226 163 QVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLV 242 (1119)
Q Consensus 163 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~ 242 (1119)
++.-++.|+.|+|++|+++... .+..+++|++|||++|.++-++--....+++..|.+.+|.++.- ..+.++++|+
T Consensus 182 SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN~l~tL--~gie~LksL~ 257 (1096)
T KOG1859|consen 182 SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNNALTTL--RGIENLKSLY 257 (1096)
T ss_pred HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeecccHHHhh--hhHHhhhhhh
Confidence 6777788888888888887543 67888899999999998886554445556666666666665422 3566777888
Q ss_pred EEEccCCccCCccChhhhhcCCCccEEEcCCCccC
Q 001226 243 EFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLE 277 (1119)
Q Consensus 243 ~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~ 277 (1119)
.||+++|-+.+.-....+..|..|++|+|.+|.+-
T Consensus 258 ~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 258 GLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88888887776666666666777777777777764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1119 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-54 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-48 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-54 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-48 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-48 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-21 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-21 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-21 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-21 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-20 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-20 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-20 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-20 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-20 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-20 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-20 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-20 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-20 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-20 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-20 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-20 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-20 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-16 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-07 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-05 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 2e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 2e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 2e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 607 bits (1567), Expect = 0.0
Identities = 209/778 (26%), Positives = 329/778 (42%), Gaps = 41/778 (5%)
Query: 18 ALSVSSPPSAISLVQFLDSLPKQSQSHLP-WNQSVSTSAPCKWSGVSCYNNSSSLKALNL 76
+ S S L+ F D LP ++ LP W+ + PC + GV+C + +++L
Sbjct: 5 SPSQSLYREIHQLISFKDVLP--DKNLLPDWSSN---KNPCTFDGVTC--RDDKVTSIDL 57
Query: 77 SGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSI 136
S L+ + S + L SL LS + GS+ L +L L+ N G +
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPV 116
Query: 137 PP--EIFKLKRLSWLDLGYNSLSGKIP-PQVSLCYSLESIGFHNNFLNGELPNDIC---S 190
+ L +L++ N+L SLE + N ++G
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176
Query: 191 LPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNN 250
+LK L ++ N ++G + + L + N+F +P L +C L S N
Sbjct: 177 CGELKHLAISGNKISGDVD-VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234
Query: 251 FGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISH 310
G S I +L++L + N G IP L++LQ L L+ NK G I +S
Sbjct: 235 LSGDFSRAIST-CTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 311 -CNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQ 368
C+ L + LS N+ G +P G+ S L SL L +N G LP + L L L L
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 369 HNFIGGTIPPEICNL-AKLEVLYLFNNRIEGAIPHQIGR--MSKLVELALYNNRLTGRIP 425
N G +P + NL A L L L +N G I + + + L EL L NN TG+IP
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
Query: 426 PDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFV 485
P ++ L L L+ N+L+G + LG L L L N G IP + L
Sbjct: 412 PTLSNCSELVSLHLSFNYLSGTIPSSLGS-LSKLRDLKLWLNMLEGEIPQELMYVKTLET 470
Query: 486 LVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSI 545
L+L N G P + C++L + LSNN L G +P + R ++ L + N G+I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 546 PPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIK 605
P G +L LD + N +G+IP+ + ++AN + G+ + +
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKE 586
Query: 606 LDLSDNY--LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663
+ N G ++ L ++ G F + S+ L + N+ G
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646
Query: 664 SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVS 723
IP + + + LN+ +N +SG IP+ +G+L L ILDLSSN G IP ++ +
Sbjct: 647 YIPKEIGSMPYLFI-LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705
Query: 724 LYFVNISFNHFSGKLPASW--TTLMVSYPGSFLGNSELC---RQGNCGKNGRGHTRGR 776
L +++S N+ SG +P T + FL N LC N G+ +
Sbjct: 706 LTEIDLSNNNLSGPIPEMGQFETFPPA---KFLNNPGLCGYPLPRCDPSNADGYAHHQ 760
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 330 bits (847), Expect = e-100
Identities = 130/688 (18%), Positives = 218/688 (31%), Gaps = 86/688 (12%)
Query: 68 SSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLL 127
+ S + + S L+ V ++ + ++ L+L+ N+ QL +L +
Sbjct: 3 TVSHEVADCSHLKLTQVPDDLPT------NITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 128 NDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPND 187
N P KL L L+L +N LS + C +L + +N + N
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 188 ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS 247
L +L L+ N L+ + NL E S
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLG-----------------------TQVQLENLQELLLS 153
Query: 248 SNNFGGAISPWI-FKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISG 306
+N S + L+ L L N ++ P + L L L+ +L +++
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 307 QIS---HCNQLQVIALSRNNLVGQIPRSVGNL--SSLNSLLLFNNRLQGTLPPELGNCGS 361
++ ++ ++LS + L + L ++L L L N L
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN---------RIEGAIPHQIGRMSKLVE 412
L L++N I + L + L L + + + L
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333
Query: 413 LALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGP 472
L + +N + G T L NL++LSL+++ S LT +F
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSF---------------TSLRTLTNETFVS- 377
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERN-PGV 531
+ L +L L N+ + L + L N + L R +
Sbjct: 378 -----LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432
Query: 532 SFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG--SIPSELGNLENLQILRLSANKL 589
+ + N F +L L L S PS L NL IL LS N +
Sbjct: 433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492
Query: 590 DGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQ 649
L K+ LDL N LA L ++ G +
Sbjct: 493 ANINDDMLEGLEKLEILDLQHNNLA----------------RLWKHANPGGPIYFLKGLS 536
Query: 650 SLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709
L L L SN FD L I+++ N L+ N L+ L+L N
Sbjct: 537 HLHILNLESNGFDEIPVEVFKDLFEL-KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 710 FSGEIPTEV-NNMVSLYFVNISFNHFSG 736
+ +L +++ FN F
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = 3e-98
Identities = 121/670 (18%), Positives = 211/670 (31%), Gaps = 45/670 (6%)
Query: 57 CKWSG--VSCYNNS---------SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSG 105
C S C + +++ LNL+ L + + + L SLD+
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRY---SQLTSLDVGF 58
Query: 106 NEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVS 165
N + P+ LK L L N L+ L L NS+
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 166 LCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPE---FPNSCAILHLLI 222
+L ++ +N L+ L L+ L L+ N + L E + ++ L +
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178
Query: 223 HENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG--LLQLEVLYLDDNNLEGQI 280
N P L ++ G +++ + + L L ++ L
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238
Query: 281 PETLWGLE--NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSL 338
T GL+ NL L LS N LN + + QL+ L NN+ S+ L ++
Sbjct: 239 NTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298
Query: 339 NSLLLFNN---------RLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVL 389
L L + L L L ++ N I G L L+ L
Sbjct: 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358
Query: 390 YLFNNRIEGAIPHQIG----RMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
L N+ S L L L N+++ + L +L+ L L N +
Sbjct: 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 446 GEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG--SFPIEIGK 503
E+ + + + + L+ N + + + +L L+L S P
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 504 CSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQ--------GSIPPVFGFWSNL 555
+L + LSNN + LE + LD++ N L G S+L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615
+L+ N +L L+I+ L N L+ + L+L N +
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598
Query: 616 SIPSEV-ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHH 674
+ + L ++ N V + E C+ +H
Sbjct: 599 VEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
Query: 675 FSSILNVSNN 684
+ +
Sbjct: 659 GFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 2e-86
Identities = 112/546 (20%), Positives = 201/546 (36%), Gaps = 34/546 (6%)
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
+P L N+ + + N + F QL L + N + PE L
Sbjct: 18 QVPDDLP--TNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L+ L L N+L+ + C L + L N++ +L +L L +N L
Sbjct: 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134
Query: 350 GTLPPELGNCGSLVDLRLQHNFIGGTIPPEI--CNLAKLEVLYLFNNRIEGAIPHQIGRM 407
T +L +L L +N I E+ + L+ L L +N+I+ P +
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI 194
Query: 408 SKLVELALYNNRLTGRIPPDIT---RLRNLQFLSLAHNHLTGEVALELGK-HFPYLSRLD 463
+L L L N +L + + +++ LSL+++ L+ + L+ LD
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 464 LTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSL-- 521
L+ N+ + L L N F + ++R + L + + S+
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 522 -------PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSE-- 572
+ + + L++ N + G +F NL L S + S +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 573 LGNLEN--LQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQS 629
+L + L IL L+ NK+ + LDL N + + + LE +
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 630 LSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSS--ILNVSNNKLS 687
+ L N ++F+ V SL L L + S S + IL++SNN ++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN-VDSSPSPFQPLRNLTILDLSNNNIA 493
Query: 688 GKIPECLGNLDKLQILDLSSNSFS--------GEIPTEVNNMVSLYFVNISFNHFSGKLP 739
+ L L+KL+ILDL N+ + G + + L+ +N+ N F
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPV 553
Query: 740 ASWTTL 745
+ L
Sbjct: 554 EVFKDL 559
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = 1e-96
Identities = 97/667 (14%), Positives = 185/667 (27%), Gaps = 101/667 (15%)
Query: 54 SAPCKWSGVSCYN--NSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGS 111
G N + K L++ G LN+ N + L L G +G
Sbjct: 44 GKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNS-------NGRVTGLSLEGFGASGR 96
Query: 112 IPKQLGNCGQLKTLLLNDNRFQG----SIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLC 167
+P +G +L+ L L + + P I
Sbjct: 97 VPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRE 156
Query: 168 Y--SLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHEN 225
L +++ + K + +NN+T + + + +
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNS 216
Query: 226 DFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLW 285
FV N + L L + + + ++P L
Sbjct: 217 PFVAENICEAWENENS-----EYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270
Query: 286 GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN 345
L +Q + ++ N+ + Q + + +
Sbjct: 271 ALPEMQLINVACNRGIS----------------GEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 346 NRLQ-GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI 404
N L+ + L L L +N + G P + KL L L N+I +
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFC 373
Query: 405 GRMSKLVELALYNNRLTGRIPP--DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRL 462
G ++ L+ +N+L IP D + + + ++N +
Sbjct: 374 GFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS---------------- 416
Query: 463 DLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLP 522
+ G +F P+ G N+ + L NN+ + S L + L N+L +P
Sbjct: 417 -VDGKNF-DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IP 473
Query: 523 ATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS-ELGNLENLQI 581
F LT +D N+L+ L L
Sbjct: 474 KNSL----------------KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVG 517
Query: 582 LRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641
+ LS N P + + + + + Q N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREW 558
Query: 642 PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQ 701
P+ + SL +LQ+GSN + S+L++ +N + +
Sbjct: 559 PEGITLCPSLTQLQIGSNDIRKVNEKITPNI----SVLDIKDNPNISIDLSYVCPYIEAG 614
Query: 702 ILDLSSN 708
+ L +
Sbjct: 615 MYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = 1e-95
Identities = 98/697 (14%), Positives = 195/697 (27%), Gaps = 144/697 (20%)
Query: 47 WNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGN 106
WN + GVS N++ + L+L GFG SG + ++I + L L L +
Sbjct: 60 WNFNKELDMWGAQPGVSL-NSNGRVTGLSLEGFGASGRVPDAIGQL---TELEVLALGSH 115
Query: 107 EFTG----SIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLK--RLSWLDLGYNSLSGKI 160
PK + + +Q + + L + + I
Sbjct: 116 GEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
Query: 161 PPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHL 220
+ IG +N + + + L KL+ Y+ + A +
Sbjct: 176 KKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENI----CEAWENE 230
Query: 221 LIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQI 280
+ N ++L + + + + ++
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTD-------------------------VEVYNCPNLTKL 265
Query: 281 PETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNS 340
P L L +Q + ++ N+ + Q +
Sbjct: 266 PTFLKALPEMQLINVACNRGIS----------------GEQLKDDWQALADAPVGEKIQI 309
Query: 341 LLLFNNRLQ-GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGA 399
+ + N L+ + L L L +N + G P + KL L L N+I
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEI 368
Query: 400 IPHQIGRMSKLVELALYNNRLTGRIPP--DITRLRNLQFLSLAHNHLTGEVALELGKHFP 457
+ G ++ L+ +N+L IP D + + + ++N +
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS----------- 416
Query: 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLL 517
+ G +F P+ G N+ + L NN+ + S L + L N+L
Sbjct: 417 ------VDGKNF-DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 518 QGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS-ELGNL 576
+P F LT +D N+L+ L
Sbjct: 470 TE-IPKNSL----------------KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTL 512
Query: 577 ENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENN 636
L + LS N P + + + + + Q N
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNR 553
Query: 637 LSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGN 696
P+ + SL + L + +N + + E +
Sbjct: 554 TLREWPEGITLCPSL-------------------------TQLQIGSNDIRK-VNEKI-- 585
Query: 697 LDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNH 733
+ +LD+ N + V + + ++
Sbjct: 586 TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 7e-67
Identities = 71/466 (15%), Positives = 142/466 (30%), Gaps = 62/466 (13%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLL 126
+ L+ + N+ + + + + + + N L +
Sbjct: 204 RLTKLRQFYMG--------NSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 127 LNDNRFQGSIPPEIFKLKRLSWLDLGYNSL--------SGKIPPQVSLCYSLESIGF-HN 177
+ + +P + L + +++ N + + ++ I +N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 178 NFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSN 237
N + + + KL L N L G LP F + + L + N
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 238 CRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG-------QIPETLWGLENL 290
+ S + N + + K + + + N + + T + N+
Sbjct: 376 TEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
Query: 291 QKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG-------QIPRSVGNLSSLNSLLL 343
+ LS N+++ S + L I L N L + N L S+ L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 344 FNNRLQGTLPPEL--GNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401
N+L L + LV + L +N P + N + L+ + N R
Sbjct: 496 RFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD----- 548
Query: 402 HQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR 461
NR P IT +L L + N + V ++ P +S
Sbjct: 549 -------------AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI---TPNISV 591
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSL 507
LD+ N + +C + +L ++ +I C +L
Sbjct: 592 LDIKDNPNISIDLSYVCPYIEAGMYMLFYDK-----TQDIRGCDAL 632
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 5e-60
Identities = 57/446 (12%), Positives = 139/446 (31%), Gaps = 72/446 (16%)
Query: 307 QISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQG----TLPPELGNCGSL 362
++ ++ ++L G++P ++G L+ L L L ++ + P + S
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 363 VDLRLQHNFIGGTIPPEICNLA--KLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRL 420
+ T L + ++ + +I K ++ +N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 421 TGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG 480
T + + RL L+ + ++ E E ++ + Y
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYKTEDLKWDNL 248
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
+L + + N P + ++ + ++ N
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ----------------LK 292
Query: 541 LQGSIPPVFGFWSNLTMLDFSENRL-SGSIPSELGNLENLQILRLSANKLDGRIPYELGK 599
+ ++ N L + + + L ++ L +L N+L+G++P G
Sbjct: 293 DDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGS 351
Query: 600 CTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
K+ L+L+ N + + E++++LS N L IP+ F +
Sbjct: 352 EIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDA------------ 398
Query: 660 IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVN 719
S+S + ++ S N++ + +
Sbjct: 399 -------KSVSVMS----AIDFSYNEIGSVDGKNFDP-----------------LDPTPF 430
Query: 720 NMVSLYFVNISFNHFSGKLPASWTTL 745
+++ +N+S N S ++T
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTG 456
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-18
Identities = 20/166 (12%), Positives = 48/166 (28%), Gaps = 6/166 (3%)
Query: 596 ELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG----AIPDAFSSVQSL 651
L ++ L L +G +P + L +++ L+L + P S+ S
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 652 FELQLGSNIFDGSIPCSLSKLHHFS-SILNVSNNKLSGKIPECLGNLDKLQILDLSSNSF 710
+ Q + + + ++++ I + K + SN+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 711 SGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGN 756
+ + V + L + + F + S
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 8e-10
Identities = 22/140 (15%), Positives = 36/140 (25%), Gaps = 21/140 (15%)
Query: 64 CYNNSSSLKALNLSGFGLSGVLNNSISYI----CKNQHLLSL------DLSGNEFTGSIP 113
L ++LS NS S + L D GN P
Sbjct: 508 RATTLPYLVGIDLS--------YNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWP 559
Query: 114 KQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESI 173
+ + C L L + N + + +I +S LD+ N V
Sbjct: 560 EGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 174 GFHNNFLNGELPNDICSLPK 193
+ D + +
Sbjct: 617 MLFYDKTQDIRGCDALDIKR 636
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 8e-88
Identities = 98/297 (32%), Positives = 160/297 (53%), Gaps = 22/297 (7%)
Query: 825 PRDLRYEDVIRATEG----RIIGKGKHGTVYR-TLSNNSRKHWAVKKLNR-----SETNF 874
+ ++ A++ I+G+G G VY+ L++ + AVK+L E F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLV--AVKRLKEERTQGGELQF 74
Query: 875 DVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH-QNEPRLVLDWNTRY 933
E+ +S+ HRN+LR+ G C +V YM G++ + L + E + LDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 934 HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-STR 992
IALG A+GL+YLH C P+IIHRD+K+ NILLD E E +GDFG++KL+ + +T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVD---PSFGEDTDIVTWT 1049
+ G++G+IAPE + + +EK+DV+ YGV+L EL+ + D + +D ++ W
Sbjct: 195 --VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
L + + +D ++ + + +L+++AL CT+ RP M EVV L
Sbjct: 253 -KGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-86
Identities = 114/574 (19%), Positives = 197/574 (34%), Gaps = 33/574 (5%)
Query: 188 ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS 247
+ +P + + N + P S +L + N S + L S
Sbjct: 4 VEVVPNITYQCME-LNFYKIPDNLPFS--TKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQ 307
I ++ L L L L N ++ GL +LQKLV L +
Sbjct: 61 RCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 308 ISHCNQLQVIALSRNNLVG-QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSL---- 362
I H L+ + ++ N + ++P NL++L L L +N++Q +L +
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179
Query: 363 VDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQ-IGRMSKLVELALYNNRLT 421
+ L L N + I P +L L L NN + I ++ L L
Sbjct: 180 LSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 422 GRI---PPDITRLRNLQFLSLAHNHLT-----GEVALELGKHFPYLSRLDLTGNSFYGPI 473
D + L L L++ L + ++L +S L +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSF 533
+ L L N +F +++ L +G + P + F
Sbjct: 299 DFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEF 351
Query: 534 LDVRGNLLQ--GSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG 591
LD+ N L G ++L LD S N + + S LE L+ L + L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 592 RIPYE-LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI-PDAFSSVQ 649
+ +I LD+S + + L ++ L + N+ PD F+ ++
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 650 SLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709
+L L L + P + + L LN+S+N L+ LQ+LD S N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQV-LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 710 FSGEIPTEVNNMV-SLYFVNISFNHFSGKLPASW 742
E+ + SL F+N++ N F+
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS 563
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 283 bits (727), Expect = 1e-83
Identities = 108/537 (20%), Positives = 185/537 (34%), Gaps = 31/537 (5%)
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
+P +L + S N + + F +L+VL L ++ L +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L L+L+ N + G S + LQ + NL +G+L +L L + +N +Q
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 350 GT-LPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV----LYLFNNRIEGAIPHQI 404
LP N +L L L N I ++ L ++ + L L N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 405 GRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFLSLAHNHLTGEVALEL-------GKHF 456
+ +L +L L NN + + I L L+ L E LE G
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 457 PYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515
+ L +Y ++ TN+ L + + + L N
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNC 314
Query: 516 LLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS--GSIPSEL 573
L+ ++F +G +L LD S N LS G
Sbjct: 315 KFGQFPTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 574 GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSL 632
+L+ L LS N + + ++ LD + L V SL + L +
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 633 QENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI-PCSLSKLHHFSSILNVSNNKLSGKIP 691
+ A F+ + SL L++ N F + P ++L + + L++S +L P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSP 487
Query: 692 ECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVS 748
+L LQ+L++S N+F + SL ++ S NH S
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 5e-83
Identities = 123/645 (19%), Positives = 190/645 (29%), Gaps = 84/645 (13%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSL 156
+LDLS N + +L+ L L+ Q L LS L L N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 157 SGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLP--EFPNS 214
S SL+ + L I L LK L + N + F N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 215 CAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS---SNNFGGAISPWIFKGLLQLEVLYL 271
+ HL + N T L + + S S N I P FK ++L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTL 207
Query: 272 DDNNLEGQIPET-LWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPR 330
+N + +T + GL L+ L + NL
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE------------------GNLEKFDKS 249
Query: 331 SVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLY 390
++ L +L L ++ I L +
Sbjct: 250 ALEGLCNLTIEEFRLAYL---------------------DYYLDDIIDLFNCLTNVSSFS 288
Query: 391 LFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVAL 450
L + IE L L N + + L+ L F S + EV L
Sbjct: 289 LVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346
Query: 451 ELGKHFPYLSRLDLTGN--SFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLR 508
P L LDL+ N SF G + T+L L L N L
Sbjct: 347 ------PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLE 399
Query: 509 RVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGS 568
+ ++ L+ VF NL LD S +
Sbjct: 400 HLDFQHSNLKQMSE-----------------------FSVFLSLRNLIYLDISHTHTRVA 436
Query: 569 IPSELGNLENLQILRLSANKLDGRI-PYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKM 627
L +L++L+++ N P + + LDLS L P+ SL +
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 628 QSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLS 687
Q L++ NN + + SL L N S L + LN++ N +
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556
Query: 688 GKIPEC--LGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNIS 730
L + + L + P++ M + +NI+
Sbjct: 557 CTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 3e-82
Identities = 118/612 (19%), Positives = 196/612 (32%), Gaps = 58/612 (9%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTL 125
N S K L+LS L + + S L LDLS E + L TL
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFF---SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL 81
Query: 126 LLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGF-HNNFLNGEL 184
+L N Q L L L +L+ + +L+ + HN + +L
Sbjct: 82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 185 PNDICSLPKLKSLYLNTNNLTGLLPE----FPN-SCAILHLLIHENDFVGSLPTSLSNCR 239
P +L L+ L L++N + + L L + N P +
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI- 200
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYL------DDNNLEGQIPETLWGLENLQKL 293
L + + +N + +GL LEV L ++ NLE L GL NL
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 294 VLSANKLN---GTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQG 350
L+ I + + +L + S L L N +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ 318
Query: 351 TLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRI--EGAIPHQIGRMS 408
+L + RL G +L LE L L N + +G +
Sbjct: 319 FPTLKLKSL-----KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 409 KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS 468
L L L N + + + L L+ L H++L + L LD
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD----- 427
Query: 469 FYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSL-PATLER 527
+ + +F SSL + ++ N Q + P
Sbjct: 428 -------------------ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
Query: 528 NPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSAN 587
++FLD+ L+ P F S+L +L+ S N L +LQ+L S N
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528
Query: 588 KLDGRIPYELGKCTKMIK-LDLSDNYLAGSIPSE--VISLEKMQSLSLQENNLSGAIPDA 644
+ EL + L+L+ N A + + + ++ + L ++ + A P
Sbjct: 529 HIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
Query: 645 FSSVQSLFELQL 656
+ L +
Sbjct: 589 KQG-MPVLSLNI 599
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 6e-82
Identities = 107/693 (15%), Positives = 199/693 (28%), Gaps = 130/693 (18%)
Query: 32 QFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISY 91
++ + L WN + GV +N+ + L+L+GFG G + ++I
Sbjct: 287 RYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL-DNNGRVTGLSLAGFGAKGRVPDAIGQ 345
Query: 92 ICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLD 150
+ L L + T S +R + +RL+ D
Sbjct: 346 L---TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402
Query: 151 LGYNSLS-----GKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLT 205
L ++++ I + IG N + + I L KL+ +Y + T
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFT 461
Query: 206 GLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQ 265
+ + S SN ++
Sbjct: 462 YD----NIAVDWEDANSDYAKQYENEELSWSNLKD------------------------- 492
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
L + L + Q+P+ L+ L LQ L ++ N+ +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW--------------- 537
Query: 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPE--LGNCGSLVDLRLQHNFIGGTIPPEICNL 383
++ + + N L+ P L L L HN +
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTN 594
Query: 384 AKLEVLYLFNNRIEGAIPHQIGR-MSKLVELALYNNRLTGRIPPD--ITRLRNLQFLSLA 440
KL L L N+IE IP ++ L +N+L IP + + + +
Sbjct: 595 VKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFS 652
Query: 441 HNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIE 500
+N + E + G N + L N
Sbjct: 653 YNKIGSE--------------------GRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 501 IGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDF 560
S + +ILSNNL+ S+P + LT +D
Sbjct: 693 FATGSPISTIILSNNLMT-SIPEN----------------SLKPKDGNYKNTYLLTTIDL 735
Query: 561 SENRLSGSIPSEL--GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618
N+L+ S+ + L L + +S N P + +++ +
Sbjct: 736 RFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ------- 786
Query: 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSI 678
+ N + P ++ SL +LQ+GSN +L+
Sbjct: 787 -----------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQLYI---- 831
Query: 679 LNVSNNKL-SGKIPECLGNLDKLQI-LDLSSNS 709
L++++N S + ++ L
Sbjct: 832 LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 3e-72
Identities = 93/675 (13%), Positives = 183/675 (27%), Gaps = 143/675 (21%)
Query: 72 KALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNR 131
+AL+ + N+ + LD+ G+ L N G++ L L
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGD----QPGVDLDNNGRVTGLSLAGFG 334
Query: 132 FQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSL 191
+G +P I +L L L G +S + + + +
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKH------------- 381
Query: 192 PKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNF 251
+ ++ + + N +L I+ N + + + +N
Sbjct: 382 ----RIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437
Query: 252 GGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHC 311
+ L +L+++Y ++ + + K S+
Sbjct: 438 TF--ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNL 490
Query: 312 NQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNF 371
L + L + Q+P + +L L SL + NR +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTR---------- 539
Query: 372 IGGTIPPEICNLAKLEVLYLFNNRIEG-AIPHQIGRMSKLVELALYNNRLTGRIPPDITR 430
+ + K+++ Y+ N +E + +M KL L +N++
Sbjct: 540 ----LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGT 593
Query: 431 LRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT-NLFVLVLG 489
L L L +N + IP + C T + L
Sbjct: 594 NVKLTDLKLDYNQIEE--------------------------IPEDFCAFTDQVEGLGFS 627
Query: 490 NNRFNGSFP--IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
+N+ P + V S N + S + +
Sbjct: 628 HNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKG------------- 672
Query: 548 VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLD 607
N + + S N + + + LS N + IP
Sbjct: 673 -----INASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSL--------- 717
Query: 608 LSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPC 667
+ + ++ L+ N L+ + D F +
Sbjct: 718 -------KPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRA-------------------T 750
Query: 668 SLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDL------SSNSFSGEIPTEVNNM 721
+L L S ++VS N S P N +L+ + N + PT +
Sbjct: 751 TLPYL----SNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805
Query: 722 VSLYFVNISFNHFSG 736
SL + I N
Sbjct: 806 PSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-62
Identities = 80/521 (15%), Positives = 159/521 (30%), Gaps = 69/521 (13%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYICKNQHL----LSLDLSGNEFTGSIPKQLGNCGQ 121
+ L +L ++ N + I K+ + + N T I K + +
Sbjct: 393 DYDQRLNLSDLLQDAINR--NPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTK 449
Query: 122 LKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
L+ + ++ F + Y S L + +N
Sbjct: 450 LQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
+LP+ + LP+L+SL + N + L +
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADW--------------TRLADDEDTGPKI 550
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
F NN + + +++L +L N + E L L L N++
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE 608
Query: 302 GTISGQISHCNQLQVIALSRNNLVGQIPR--SVGNLSSLNSLLLFNNRLQGTLPPELGNC 359
+ +Q++ + S N L IP + ++ + S+ N++ +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNIS-- 664
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNR 419
+ + L N I+ S + + L NN
Sbjct: 665 ----------------CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 420 LT-------GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGP 472
+T + L + L N LT PYLS +D++ N F
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS- 767
Query: 473 IPANICVGTNLFVLVL------GNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLE 526
P + L + NR +P I C SL ++ + +N ++ + L
Sbjct: 768 FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL- 825
Query: 527 RNPGVSFLDVRGN-LLQGSIPPVFGFW-SNLTMLDFSENRL 565
P + LD+ N + + V + + + +L + + +
Sbjct: 826 -TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 3e-51
Identities = 65/433 (15%), Positives = 135/433 (31%), Gaps = 33/433 (7%)
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394
+ +L N R + + + + + G ++ N ++ L L
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK 454
+G +P IG++++L L+ + T + +
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 455 HFPYLSRLDLTGNSF-----YGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
+ L+ DL ++ PI + + + NR I + + L+
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI-TFISKAIQRLTKLQI 452
Query: 510 VILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSI 569
+ +N+ A + + + + +LT ++ +
Sbjct: 453 IYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507
Query: 570 PSELGNLENLQILRLSANKLDG---------RIPYELGKCTKMIKLDLSDNYLAGSIPSE 620
P L +L LQ L ++ N+ R+ + K+ + N L S
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567
Query: 621 VIS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSIL 679
+ + K+ L N + +AF + L +L+L N + IP L
Sbjct: 568 SLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGL 624
Query: 680 NVSNNKLSGKIPEC--LGNLDKLQILDLSSNSFSGEIPT-----EVNNMVSLYFVNISFN 732
S+NKL IP ++ + +D S N E + ++ V +S+N
Sbjct: 625 GFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683
Query: 733 HFSGKLPASWTTL 745
+ T
Sbjct: 684 EIQKFPTELFATG 696
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-25
Identities = 46/364 (12%), Positives = 103/364 (28%), Gaps = 43/364 (11%)
Query: 409 KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGE--VALELGKHFPYL------- 459
++V Y+ R + +R F ++ N LT + V ++L + Y+
Sbjct: 217 QVVAYTTYSQSGIKRSELETQSVRGESF-TVIDNKLTKDANVPIQLKETAEYIKDYKALK 275
Query: 460 ---SRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNL 516
LD +Y N N + + +++ + + L+
Sbjct: 276 AIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFG 334
Query: 517 LQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSE-LGN 575
+G +P + + + L + S M + ++R+ L
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 576 LENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635
+ L + L + + + N I + K + N
Sbjct: 395 DQRLNLSDLLQDAI-------------------NRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 636 NLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG 695
++ I A + L + ++ F + N K
Sbjct: 436 RITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED------ANSDYAKQYENEELSWS 488
Query: 696 NLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLG 755
NL L ++L + ++P + ++ L +NI+ N A
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS--AAQLKADWTRLADDEDT 546
Query: 756 NSEL 759
++
Sbjct: 547 GPKI 550
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-80
Identities = 83/299 (27%), Positives = 140/299 (46%), Gaps = 36/299 (12%)
Query: 830 YEDVIRATEG----------RIIGKGKHGTVYR-TLSNNSRKHWAVKKLNRSETN----- 873
+ ++ T +G+G G VY+ ++N AVKKL
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN---TTVAVKKLAAMVDITTEEL 73
Query: 874 ---FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN 930
FD EI+ ++ +H N++ ++G + + +V YMP G+L + L + L W+
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 931 TRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS- 989
R IA G A G+++LH + IHRDIKS NILLD KI DFG+++ +
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 990 -STRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047
++R IVG+ Y+APE +T KSD+YS+GV+L E++ VD ++
Sbjct: 191 MTSR--IVGTTAYMAPE--ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLLD 245
Query: 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
E ++D++++ DS + +A +C + + RP +++V L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-79
Identities = 97/290 (33%), Positives = 148/290 (51%), Gaps = 23/290 (7%)
Query: 830 YEDVIRAT----EGRIIGKGKHGTVYR-TLSNNSRKHWAVKKLNRS----ETNFDVEIRT 880
D+ AT +IG G G VY+ L + A+K+ F+ EI T
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG--AKVALKRRTPESSQGIEEFETEIET 88
Query: 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH-QNEPRLVLDWNTRYHIALGI 939
LS RH +++ ++G C + ++ +YM G L L+ + P + + W R I +G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--STRSAIVG 997
A+GL YLH IIHRD+KS NILLD PKI DFG+SK ++ + ST + G
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV--VKG 203
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDTDIVTWTRWKLQEN 1056
+LGYI PE RLTEKSDVYS+GV+LFE+L + + S E ++ W + N
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV-ESHNN 262
Query: 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
+ +D ++ + L+ + + A++C ++ RPSM +V+ L
Sbjct: 263 GQLEQIVDPNLADKIRPESLR--KFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 3e-78
Identities = 114/577 (19%), Positives = 197/577 (34%), Gaps = 45/577 (7%)
Query: 149 LDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLL 208
+ L+ +IP + S E + F N L L L L L + +
Sbjct: 17 YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 209 PE-FPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLE 267
+ F + + L++ N + T+LS + L I LE
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLE 132
Query: 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALS-RNNLVG 326
LYL N++ + E L+ L N ++ +S Q ++L+ N +
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 327 QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG--SLVDLRLQHNFIGGTIPPEICNLA 384
I + + SL + + L N SL + P L
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 385 K--LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
+ +E + L + + S L EL L L+ +P + L L+ L L+ N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGS--FPI 499
+ +FP L+ L + GN+ + NL L L ++ S +
Sbjct: 312 KFENLCQISAS-NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 500 EIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLD 559
++ S L+ + LS N F L +LD
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSL------------------------KTEAFKECPQLELLD 406
Query: 560 FSENRLSGSIP-SELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618
+ RL S NL L++L LS + LD + L+L N+
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
Query: 619 SEV---ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHF 675
+ +L +++ L L +LS AF+S++ + + L N S +LS L
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-- 524
Query: 676 SSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712
LN+++N +S +P L L + + ++L N
Sbjct: 525 GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 2e-76
Identities = 109/527 (20%), Positives = 192/527 (36%), Gaps = 17/527 (3%)
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
+P +L N + S N I F L+ L L L + +T
Sbjct: 26 EIPGTLPN--STECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L LVL+AN L +S L+ + + + + N +L SL L +N +
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 350 GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL--FNNRIEGAIPHQIGRM 407
P+ L L Q+N I ++ +L + L L N I G I
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDS 201
Query: 408 SKLVELALYNNRLTGRIPPDI--TRLRNLQFLSLAHNHLTG-EVALELGKHFPYLSRLDL 464
+ L + I + + +++L + A+ G + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 465 TGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPAT 524
+ F+ + L L L + P + S+L++++LS N + +
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 525 LERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRL--SGSIPSELGNLENLQI 581
P ++ L ++GN + + NL LD S + + S +L NL +LQ
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQS 380
Query: 582 LRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGA 640
L LS N+ +C ++ LDL+ L L ++ L+L + L +
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 641 IPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSS--ILNVSNNKLSGKIPECLGNLD 698
F + +L L L N F + L IL +S LS +L
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 699 KLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTL 745
+ +DLS N + ++++ +Y +N++ NH S LP+ L
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPIL 546
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 5e-76
Identities = 111/626 (17%), Positives = 189/626 (30%), Gaps = 66/626 (10%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNS 155
L+ S N L L L + I + F+ RL L L N
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTANP 92
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
L +S +L+ + F ++ + + L+SLYL +N+++ +
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP----- 147
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN 275
L +N +S L Q L L+ N
Sbjct: 148 ------------------KGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNG 188
Query: 276 LE-GQIPETLWGLENLQKLVLSANKLNGTISGQISHCN--QLQVIALSRNNLVGQIPRSV 332
+ I + Q L + I + + L + + P
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF 248
Query: 333 GNLSSLN--SLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLY 390
L ++ S+ L + L +L L + +P + L+ L+ L
Sbjct: 249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLV 307
Query: 391 LFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFLSLAHNHLTGEVA 449
L N+ E L L++ N + + L NL+ L L+H+ +
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET--- 364
Query: 450 LELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
D ++L L L N +C L
Sbjct: 365 ------------SDCCNLQLRNL--------SHLQSLNLSYNEPLSLKTEAFKECPQLEL 404
Query: 510 VILSNNLLQGSLP-ATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGS 568
+ L+ L+ + + + L++ +LL S +F L L+ N
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464
Query: 569 I---PSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLE 625
+ L L L+IL LS L + M +DLS N L S E +S
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHL 523
Query: 626 KMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNK 685
K L+L N++S +P + + L N D + CS + + K
Sbjct: 524 KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT--CSNIYFLEW---YKENMQK 578
Query: 686 LSGKIPECLGNLDKLQILDLSSNSFS 711
L N L+ + LS + S
Sbjct: 579 LEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-72
Identities = 123/563 (21%), Positives = 202/563 (35%), Gaps = 34/563 (6%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
+L L+L+ I +I L +L L+ N L LK
Sbjct: 57 INLTFLDLT--------RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 124 TLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGE 183
L + K L L LG N +S P+ L+ + F NN ++
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL 168
Query: 184 LPNDICSLPKLK--SLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNC--R 239
D+ SL + SL LN N++ G+ P +S L + + L N +
Sbjct: 169 SKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 240 NLVEFSASSNNFGGAISPWIFKGL--LQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSA 297
+L + + ISP +F+GL + +E + L + T LQ+L L+A
Sbjct: 229 SLWLGTFEDMDDED-ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 298 NKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE-L 356
L+ + + + L+ + LS N S N SL L + N + L L
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 357 GNCGSLVDLRLQHNFIG--GTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414
N +L +L L H+ I ++ NL+ L+ L L N +L L
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 415 LYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPI 473
L RL + L L+ L+L+H+ L P L L+L GN F
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD-GLPALQHLNLQGNHFPKGN 465
Query: 474 ---PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPG 530
++ L +LVL + + V LS+N L S L G
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 531 VSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590
+ +L++ N + +P + S ++ +N L + N+ L+ + + KL+
Sbjct: 526 I-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIYFLEWYKENMQKLE 580
Query: 591 GRIPYELGKCTKMIKLDLSDNYL 613
+ + LSD L
Sbjct: 581 DTEDTLCENPPLLRGVRLSDVTL 603
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 3e-67
Identities = 99/484 (20%), Positives = 157/484 (32%), Gaps = 22/484 (4%)
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
+ ++ L +IP TL + + L S N L + S L + L+R +
Sbjct: 15 KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 327 QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKL 386
+ + L++L+L N L L +L L I + N L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 387 EVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTG 446
E LYL +N I + KL L NN + D++ L+ LSL N
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 447 EVALELGKHFPYLSRLDLTGNSFYGPIPANI--CVGTNLFVLVLGNNRFNG--SFPIEIG 502
L+ G I + +L++ + E
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562
S+ + L + T G+ LD+ L +P S L L S
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEV 621
N+ N +L L + N + L + +LDLS + + S +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 622 I--SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----IFDGSIPCSLSKLHHF 675
+L +QSL+L N +AF L L L S +L L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV- 429
Query: 676 SSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVN---NMVSLYFVNISFN 732
LN+S++ L + L LQ L+L N F + N + L + +SF
Sbjct: 430 ---LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
Query: 733 HFSG 736
S
Sbjct: 487 DLSS 490
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-74
Identities = 79/317 (24%), Positives = 132/317 (41%), Gaps = 33/317 (10%)
Query: 818 QSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---F 874
S DL + Y + + +G+ G V++ N + AVK +
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQN 65
Query: 875 DVEIRTLSLVRHRNILRIVGSCTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWN 930
+ E+ +L ++H NIL+ +G+ + +++T + G+L + L N V+ WN
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWN 121
Query: 931 TRYHIALGIAQGLSYLHYDCV-------PQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983
HIA +A+GL+YLH D P I HRDIKS N+LL + L I DFG++
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 984 SDSHSSSTRSAIVGSLGYIAPENA-----YSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038
S+ VG+ Y+APE + + D+Y+ G++L+EL R D
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 1039 FGEDT---DIVTWTRWKLQENHECICF--LDREI-SFWDSDDQLKALRLLELALECTRQV 1092
E + L++ E + + +W + L E EC
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC--ETIEECWDHD 299
Query: 1093 ADMRPSMREVVGFLIKL 1109
A+ R S V + ++
Sbjct: 300 AEARLSAGCVGERITQM 316
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-72
Identities = 113/572 (19%), Positives = 194/572 (33%), Gaps = 33/572 (5%)
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
G L I +P + + L+ + + P+S ++ + N S SN L
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLSKVPDDIPSS--TKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
S I + GL L L L N ++ P + GL +L+ LV KL
Sbjct: 59 QWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 302 GTISGQISHCNQLQVIALSRNNLVG-QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGN-- 358
S I L+ + ++ N + ++P NL++L + L N +Q +L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 359 --CGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGR-MSKLVELAL 415
+ L + N I I + KL L L N I + ++ L L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 416 YNNRLTG-----RIPPDI-TRLRNLQF--LSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
P I L ++ L + + + ++ +S + L G
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF-HCLANVSAMSLAGV 295
Query: 468 SFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLER 527
S ++ L + + L+ + L+ N +GS+
Sbjct: 296 SI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMN--KGSISFKKVA 348
Query: 528 NPGVSFLDVRGNLLQGSIPPVFGFW--SNLTMLDFSENRLSGSIPSELGNLENLQILRLS 585
P +S+LD+ N L S + ++L LD S N + + LE LQ L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 586 ANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIP-D 643
+ L + K++ LD+S + L + +L + N+ +
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467
Query: 644 AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQIL 703
F++ +L L L + LH LN+S+N L L L L
Sbjct: 468 VFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL-LNMSHNNLLFLDSSHYNQLYSLSTL 526
Query: 704 DLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735
D S N + SL F N++ N +
Sbjct: 527 DCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-66
Identities = 114/622 (18%), Positives = 185/622 (29%), Gaps = 103/622 (16%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSL 156
++DLS N N +L+ L L+ + L LS L L N +
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 157 SGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCA 216
P S SLE++ L I L LK L + N +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC--------- 143
Query: 217 ILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL----LQLEVLYLD 272
LP SN NLV S N I+ + L L +
Sbjct: 144 -------------KLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMS 189
Query: 273 DNNLEGQIPETLWGLENLQKLVLSANKLNGTI-SGQISHCNQLQVIALSRNNLVGQIPRS 331
N ++ + G+ L +L L N + I + + L V L +
Sbjct: 190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 332 VGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL 391
+ S + L ++ + RL + + LA + + L
Sbjct: 249 IFEPSIMEGLCDV----------------TIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 392 FNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALE 451
I+ + + K L++ +L P L L+ L+L N +
Sbjct: 293 AGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGSISFKKV 347
Query: 452 LGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVI 511
P LS LDL+ N+ S+ +SLR +
Sbjct: 348 ---ALPSLSYLDLSRNALSFSGC--------------------CSY--SDLGTNSLRHLD 382
Query: 512 LSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIP 570
LS N + A + LD + + L+ F L LD S
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 571 SELGNLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQS 629
L +L L+++ N T + LDLS L +L ++Q
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 630 LSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGK 689
L++ NNL ++ + SL S L+ S N++
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSL-------------------------STLDCSFNRIETS 536
Query: 690 IPECLGNLDKLQILDLSSNSFS 711
L +L++NS +
Sbjct: 537 KGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-57
Identities = 87/512 (16%), Positives = 166/512 (32%), Gaps = 49/512 (9%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
S L+ L+LS + + + + HL +L L+GN P L+ L+
Sbjct: 56 SELQWLDLSRCEIETIEDKAWH---GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSG-KIPPQVSLCYSLESIGFHNNFLNGELPND 187
+ + I +L L L++ +N + K+P S +L + N++ ND
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
Query: 188 ICSLPKLK----SLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLP-TSLSNCRNLV 242
+ L + SL ++ N + + + + L + N ++ T L N L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH 232
Query: 243 EFSASSNNFGG-----AISPWIFKGL--LQLEVLYLDDNNLEGQIPETLWGLENLQKLVL 295
F P I +GL + ++ L N L N+ + L
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 296 SANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE 355
+ + + Q +++ R L Q P +L L SL L N+ ++ +
Sbjct: 293 AGVSIKYLEDV--PKHFKWQSLSIIRCQL-KQFP--TLDLPFLKSLTLTMNKG--SISFK 345
Query: 356 LGNCGSLVDLRLQHNFIGG-------------------------TIPPEICNLAKLEVLY 390
SL L L N + + L +L+ L
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLD 405
Query: 391 LFNNRIEGAIPHQ-IGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVA 449
++ ++ + KL+ L + L +L L +A N
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 450 LELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
+ + L+ LDL+ L +L + +N + SL
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST 525
Query: 510 VILSNNLLQGSLPATLERNPGVSFLDVRGNLL 541
+ S N ++ S ++F ++ N +
Sbjct: 526 LDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-52
Identities = 92/485 (18%), Positives = 172/485 (35%), Gaps = 43/485 (8%)
Query: 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQ 327
D L ++P+ + + + + LS N L S S+ ++LQ + LSR +
Sbjct: 15 TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLE 387
++ L L++L+L N +Q P SL +L + I L L+
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 388 VLYLFNNRIEGA-IPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQF----LSLAHN 442
L + +N I +P ++ LV + L N + D+ LR L ++ N
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEI 501
+ + + + L L L GN I L V L F +EI
Sbjct: 192 PID-FIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561
++++G + + + F +N++ + +
Sbjct: 250 ----------FEPSIMEGL------CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293
Query: 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEV 621
+ ++ Q L + +L +L + L L+ N SI +
Sbjct: 294 GVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKG--SISFKK 346
Query: 622 ISLEKMQSLSLQENNLSGAIPDAFSSVQ--SLFELQLGSN--IFDGSIPCSLSKLHHFSS 677
++L + L L N LS + ++S + SL L L N I + L +L H
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQH--- 403
Query: 678 ILNVSNNKLSGKIP-ECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736
L+ ++ L +L+KL LD+S + + + SL + ++ N F
Sbjct: 404 -LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462
Query: 737 KLPAS 741
++
Sbjct: 463 NTLSN 467
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-35
Identities = 63/290 (21%), Positives = 99/290 (34%), Gaps = 21/290 (7%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYI---CKNQHLLSLDLSGNEFTGSIPKQLGNCGQL 122
+ +++ A++L+ SI Y+ K+ SL + + L L
Sbjct: 282 HCLANVSAMSLA--------GVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF---L 330
Query: 123 KTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSL--CYSLESIGFHNNFL 180
K+L L N+ GSI + L LS+LDL N+LS S SL + N
Sbjct: 331 KSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 181 NGELPNDICSLPKLKSLYLNTNNLTGLLPE--FPNSCAILHLLIHENDFVGSLPTSLSNC 238
+ + L +L+ L + L + F + +L+L I +
Sbjct: 389 I-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSAN 298
+L + N+F +F L L L LE L LQ L +S N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507
Query: 299 KLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRL 348
L S + L + S N + SL L NN +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-33
Identities = 72/387 (18%), Positives = 125/387 (32%), Gaps = 30/387 (7%)
Query: 374 GTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRN 433
G++ P I + + + ++ +P I S + L N L +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRF 493
LQ+L L+ + +LS L LTGN P + T+L LV +
Sbjct: 58 LQWLDLSRCEIETIEDKAWH-GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 494 NGSFPIEIGKCSSLRRVILSNNLLQG-SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFW 552
IG+ +L+++ +++N + LPA + +D+ N +Q F
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 553 SNLTM----LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIP-YELGKCTKMIKLD 607
LD S N + I + L L L N I L +
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 608 LSDNYLAGSIPSEVISLE--------KMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
L E+ + L N F + ++ + L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 660 -IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718
I K L++ +L P +L L+ L L+ N S I +
Sbjct: 296 SIKYLEDVPKHFKWQS----LSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS--ISFKK 346
Query: 719 NNMVSLYFVNISFNHFSGKLPASWTTL 745
+ SL ++++S N S S++ L
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDL 373
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 6e-71
Identities = 64/302 (21%), Positives = 119/302 (39%), Gaps = 30/302 (9%)
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPI--EIGKCSSLRRVILSNNLLQG 519
D ++ G + + L L +PI + L + +
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI---- 86
Query: 520 SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENL 579
N L G IPP + L L + +SG+IP L ++ L
Sbjct: 87 -------------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 580 QILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKM-QSLSLQENNLS 638
L S N L G +P + ++ + N ++G+IP S K+ S+++ N L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 639 GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLD 698
G IP F+++ +L + L N+ +G + ++++ N L+ + + +G
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQK-IHLAKNSLAFDLGK-VGLSK 244
Query: 699 KLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSE 758
L LDL +N G +P + + L+ +N+SFN+ G++P ++ N
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS-AYANNKC 303
Query: 759 LC 760
LC
Sbjct: 304 LC 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 6e-70
Identities = 74/296 (25%), Positives = 117/296 (39%), Gaps = 30/296 (10%)
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGT--LPPELGNCGSLVDLRLQH-NFIGGT 375
+G + + +N+L L L +P L N L L + N + G
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQ 435
IPP I L +L LY+ + + GAIP + ++ LV L N L+G +PP I+ L NL
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV 152
Query: 436 FLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG 495
++ N ++G + G + + ++ N G IP NL + L N G
Sbjct: 153 GITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEG 211
Query: 496 SFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNL 555
+ G + +++ L+ N L L G NL
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGK-------------------------VGLSKNL 246
Query: 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611
LD NR+ G++P L L+ L L +S N L G IP + G + ++N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-66
Identities = 88/336 (26%), Positives = 138/336 (41%), Gaps = 38/336 (11%)
Query: 29 SLVQFLDSLPKQSQSHLP-WNQSVSTSAPCKWSGVSCYN--NSSSLKALNLSGFGLSGVL 85
+L+Q L + + L W + W GV C + + L+LSG L
Sbjct: 10 ALLQIKKDL--GNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY 66
Query: 86 NNSISYICKNQHLLSLDLSG-NEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLK 144
S + +L L + G N G IP + QL L + G+IP + ++K
Sbjct: 67 PIP-SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 145 RLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKL-KSLYLNTNN 203
L LD YN+LSG +PP +S +L I F N ++G +P+ S KL S+ ++ N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 204 LTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL 263
LT G +P + +N NL S N G S
Sbjct: 186 LT-----------------------GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS-D 220
Query: 264 LQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNN 323
+ ++L N+L + + + +NL L L N++ GT+ ++ L + +S NN
Sbjct: 221 KNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 324 LVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC 359
L G+IP+ GNL + NN+ P L C
Sbjct: 280 LCGEIPQG-GNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-66
Identities = 87/395 (22%), Positives = 134/395 (33%), Gaps = 105/395 (26%)
Query: 327 QIPRSVGNLSSLNS----LLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGT--IPPEI 380
QI + +GN ++L+S N G L + +L L + IP +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 381 CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLA 440
NL L LY+ N L G IPP I +L L +L +
Sbjct: 73 ANLPYLNFLYIGGI-----------------------NNLVGPIPPAIAKLTQLHYLYIT 109
Query: 441 HNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIE 500
H +++G IP + L L N +G+ P
Sbjct: 110 HTNVSG-------------------------AIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
Query: 501 IGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDF 560
I +L + N + G++P + G+ T +
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSY------------GSFS-----------KLFTSMTI 181
Query: 561 SENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSE 620
S NRL+G IP NL NL + LS N L+G G K+ L+ N LA +
Sbjct: 182 SRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK- 239
Query: 621 VISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILN 680
V + + L L+ N + G +P + ++ L LN
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL-------------------------HSLN 274
Query: 681 VSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715
VS N L G+IP+ GNL + + ++N P
Sbjct: 275 VSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 6e-65
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 11/285 (3%)
Query: 225 NDFVGSLPTSLSNCRNLVEFSASSNNFGG--AISPWIFKGLLQLEVLYL-DDNNLEGQIP 281
++G L + + + S N I + L L LY+ NNL G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIP 94
Query: 282 ETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSL 341
+ L L L ++ ++G I +S L + S N L G +P S+ +L +L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 342 LLFNNRLQGTLPPELGNCGSLV-DLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAI 400
NR+ G +P G+ L + + N + G IPP NL L + L N +EG
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 401 PHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460
G ++ L N L + + +NL L L +N + G + L + +L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQ-LKFLH 271
Query: 461 RLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCS 505
L+++ N+ G IP V NN+ P + C+
Sbjct: 272 SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 29/115 (25%), Positives = 49/115 (42%), Gaps = 2/115 (1%)
Query: 629 SLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS--IPCSLSKLHHFSSILNVSNNKL 686
+ G + D + + L L IP SL+ L + + + N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 687 SGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPAS 741
G IP + L +L L ++ + SG IP ++ + +L ++ S+N SG LP S
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 20/88 (22%), Positives = 33/88 (37%), Gaps = 6/88 (6%)
Query: 664 SIPCSLSKLHHFSS---ILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE--IPTEV 718
I L SS + N G + + ++ LDLS + IP+ +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 719 NNMVSLYFVNIS-FNHFSGKLPASWTTL 745
N+ L F+ I N+ G +P + L
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKL 100
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-66
Identities = 73/204 (35%), Positives = 115/204 (56%), Gaps = 11/204 (5%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLSLVRHRNIL 890
IG G GTV+R + AVK L + + F E+ + +RH NI+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+G+ T+ + IVTEY+ G+L+ +LH++ R LD R +A +A+G++YLH +
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NR 156
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
P I+HR++KS N+L+D + K+ DFG+S+L + + SS + G+ ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMAPEVLRDE 214
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
EKSDVYS+GVIL+EL + P
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 9e-64
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 30/285 (10%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET--NFDVEIRTLSLVRHRNILRIVG 894
++G+G G V + K A+K++ F VE+R LS V H NI+++ G
Sbjct: 11 EVEEVVGRGAFGVVCKAKWRA--KDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+C +V EY GG+L+NVLH EP L +QG++YLH +
Sbjct: 69 ACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 955 IHRDIKSDNILLDSELE-PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRD+K N+LL + KI DFG + I +++ GS ++APE + +
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----GSAAWMAPEVFEGSNYS 181
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR-EISFWDS 1072
EK DV+S+G+IL+E++ R+ P F E W + R +
Sbjct: 182 EKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGT-------RPPL----I 226
Query: 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117
+ K + L C + RPSM E+V + L G
Sbjct: 227 KNLPKPIE--SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-60
Identities = 70/299 (23%), Positives = 120/299 (40%), Gaps = 52/299 (17%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHW----AVKKLNRSETN------FDVEIRTLSLVRH 886
G +IGKG+ G VY W A++ ++ N F E+ RH
Sbjct: 36 EIGELIGKGRFGQVYHG-------RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
N++ +G+C H I+T G TL++V+ + LD N IA I +G+ YL
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYL 146
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD---SHSSSTRSAIVGSLGYIA 1003
H I+H+D+KS N+ D + I DFG+ + G L ++A
Sbjct: 147 HA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202
Query: 1004 PE---------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054
PE ++ SDV++ G I +EL R+ P + + + W++
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK---TQPAEAI---IWQMG 256
Query: 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113
+ +S ++ ++ L C + RP+ +++ L KL +N
Sbjct: 257 TG------MKPNLSQIGMGKEIS-----DILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-60
Identities = 78/311 (25%), Positives = 132/311 (42%), Gaps = 61/311 (19%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
+GKG++G V+R ++ AVK + + + E+ ++RH NIL + S
Sbjct: 13 LECVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 896 CTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
H +++T Y G+L++ L LD + I L IA GL++LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 952 -----PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--STRSAIVGSLGYIAP 1004
P I HRD+KS NIL+ + I D G++ + S S + + VG+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 1005 E------NAYSTRLTEKSDVYSYGVILFELLFRKM----------------PVDPSFGED 1042
E ++ D++++G++L+E+ R + P DPSF +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 1043 TDIVTWTRWKLQENHECICFLDR--EI-SFWDSDDQLKALRLLELALECTRQVADMRPSM 1099
+V C + I + W SD L +L +L EC Q R +
Sbjct: 247 RKVV--------------CVDQQRPNIPNRWFSDPTLTSLA--KLMKECWYQNPSARLTA 290
Query: 1100 REVVGFLIKLN 1110
+ L K++
Sbjct: 291 LRIKKTLTKID 301
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN--------FDVEIRTLSLVRHRN 888
T IIG G G VYR AVK E + ++++H N
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
I+ + G C K+ + +V E+ GG L VL + + + A+ IA+G++YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHD 123
Query: 949 DCVPQIIHRDIKSDNILLDSELEP--------KIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
+ + IIHRD+KS NIL+ ++E KI DFG+++ +T+ + G+
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAGAYA 179
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
++APE ++ ++ SDV+SYGV+L+ELL ++P
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-60
Identities = 83/287 (28%), Positives = 128/287 (44%), Gaps = 47/287 (16%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLSLVRHRNIL 890
T G+ IG G GTVY+ + AVK LN + F E+ L RH NIL
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+G T IVT++ G +L++ LH +E + + IA A+G+ YLH
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKF--EMKKLIDIARQTARGMDYLH--- 137
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE---NA 1007
IIHRD+KS+NI L + KIGDFG++ S S + GS+ ++APE
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF----- 1062
S + +SDVY++G++L+EL+ ++P + N + I
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP----------------YSNINNRDQIIEMVGRG 241
Query: 1063 ---LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
D + ++K L EC ++ D RPS ++ +
Sbjct: 242 SLSPDLSKVRSNCPKRMK-----RLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-60
Identities = 71/301 (23%), Positives = 122/301 (40%), Gaps = 33/301 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
+ IGKG++G V+ + AVK +E + EI L+RH NIL + +
Sbjct: 42 VKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 896 CTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD-- 949
K +++T+Y G+L++ L LD + +A GL +LH +
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 950 ---CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI--VGSLGYIAP 1004
P I HRD+KS NIL+ I D G++ + VG+ Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 1005 E------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT--DIVTWTRWKLQEN 1056
E N + +D+YS+G+IL+E+ R + + + ++
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 1057 HECICFLDR--EI-SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113
E +C + W SD+ L+ + +L EC R + V L K+++
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMG--KLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
Query: 1114 E 1114
+
Sbjct: 334 D 334
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 8e-60
Identities = 74/311 (23%), Positives = 127/311 (40%), Gaps = 48/311 (15%)
Query: 818 QSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---- 873
+ L ++ + IGKG G V++ + A+K L ++
Sbjct: 6 SEFPKSRLPTLADNEI---EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 874 -------FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV 926
F E+ +S + H NI+++ G +V E++P G L++ L +
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPI- 119
Query: 927 LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE-----PKIGDFGMSK 981
W+ + + L IA G+ Y+ + P I+HRD++S NI L S E K+ DFG+S+
Sbjct: 120 -KWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 982 LISDSHSSSTRSAIVGSLGYIAPE--NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF 1039
+ S ++G+ ++APE A TEK+D YS+ +IL+ +L + P D
Sbjct: 178 QSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD--- 229
Query: 1040 GEDTDIVTWTRWKLQENHECICFLDR-EISFWDSDDQLKALRLLELALECTRQVADMRPS 1098
+ + +E R I +D LR + C RP
Sbjct: 230 EYSYGKIKFINMIREEGL-------RPTI----PEDCPPRLR--NVIELCWSGDPKKRPH 276
Query: 1099 MREVVGFLIKL 1109
+V L +L
Sbjct: 277 FSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-59
Identities = 48/212 (22%), Positives = 96/212 (45%), Gaps = 32/212 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLNRSETN------FDVEIRTLSLVRHR 887
+ + G +++ W VK L + + F+ E L + H
Sbjct: 15 LTKLNENHSGELWKG-------RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 888 NILRIVGSCTK--DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
N+L ++G+C H ++T +MP G+L+NVLH+ V+D + AL +A+G+++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAF 126
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH P I + S ++++D ++ +I + S + + ++APE
Sbjct: 127 LH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE 178
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+D++S+ V+L+EL+ R++P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-59
Identities = 80/315 (25%), Positives = 133/315 (42%), Gaps = 43/315 (13%)
Query: 819 SRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET----NF 874
S R R D+I G ++GKG G + + + +K+L R + F
Sbjct: 1 SMPH---RIFRPSDLIH---GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF 54
Query: 875 DVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH 934
E++ + + H N+L+ +G KD+ +TEY+ GGTL ++ + + W+ R
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVS 112
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST--- 991
A IA G++YLH IIHRD+ S N L+ + DFG+++L+ D +
Sbjct: 113 FAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 992 ---------RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042
R +VG+ ++APE EK DV+S+G++L E++ R DP +
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPR 228
Query: 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
T L FLDR + + + C + RPS ++
Sbjct: 229 TMDFG-----LNVRG----FLDRYCPP-NCPPS-----FFPITVRCCDLDPEKRPSFVKL 273
Query: 1103 VGFLIKLNDKNEGGM 1117
+L L G +
Sbjct: 274 EHWLETLRMHLAGHL 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 205 bits (522), Expect = 8e-59
Identities = 75/331 (22%), Positives = 135/331 (40%), Gaps = 34/331 (10%)
Query: 813 LLQDVQSRSEDLPRDLRYEDVIRA-TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE 871
+ S S L + R IGKG+ G V+R + AVK + E
Sbjct: 20 IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSRE 77
Query: 872 TN---FDVEIRTLSLVRHRNILRIVGSCTKDEHG----FIVTEYMPGGTLFNVLHQNEPR 924
+ EI ++RH NIL + + KD ++V++Y G+LF+ L++
Sbjct: 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--- 134
Query: 925 LVLDWNTRYHIALGIAQGLSYLHYDCV-----PQIIHRDIKSDNILLDSELEPKIGDFGM 979
+ +AL A GL++LH + V P I HRD+KS NIL+ I D G+
Sbjct: 135 -TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193
Query: 980 SKLISDSHSSSTRSAI--VGSLGYIAPE------NAYSTRLTEKSDVYSYGVILFELLFR 1031
+ + + + VG+ Y+APE N +++D+Y+ G++ +E+ R
Sbjct: 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
Query: 1032 KMPVD--PSFGEDTDIVTWTRWKLQENHECICFLDR--EI-SFWDSDDQLKALRLLELAL 1086
+ + + ++E + +C I + W S + L+ + ++
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA--KIMR 311
Query: 1087 ECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117
EC R + + L +L+ + M
Sbjct: 312 ECWYANGAARLTALRIKKTLSQLSQQEGIKM 342
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-58
Identities = 67/310 (21%), Positives = 123/310 (39%), Gaps = 40/310 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFD--VEIRTLSLVRHRNILRIVGS 895
+IG+G++G VY+ + + AVK + + NF I + L+ H NI R +
Sbjct: 18 LELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 896 CTKDEHG-----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD- 949
+ +V EY P G+L L + DW + +A + +GL+YLH +
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 950 -----CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS------AIVGS 998
P I HRD+ S N+L+ ++ I DFG+S ++ + + VG+
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 999 LGYIAPENAYST-------RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-----DIV 1046
+ Y+APE ++ D+Y+ G+I +E+ R + P
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251
Query: 1047 TWTRWKLQENHECICFLDR--EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVG 1104
++ + + + ++ L L E +C Q A+ R + +
Sbjct: 252 VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
Query: 1105 FLIKLNDKNE 1114
+ +L E
Sbjct: 312 RMAELMMIWE 321
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-53
Identities = 105/528 (19%), Positives = 181/528 (34%), Gaps = 39/528 (7%)
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
+P +L + S N + + F +L+VL L ++ L +
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L L+L+ N + G S + LQ + NL +G+L +L L + +N +Q
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 350 -GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV----LYLFNNRIEGAIPHQI 404
LP N +L L L N I ++ L ++ + L L N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 405 GRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFLSLAHNHLTGEVALEL--GKHFPYLSR 461
+ +L +L L NN + + I L L+ L E LE L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 462 LDLTGNS------FYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515
L + + I TN+ L + + + L N
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNC 314
Query: 516 LLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS--GSIPSEL 573
P ++ + L N + +L LD S N LS G
Sbjct: 315 KFG-QFPTLKLKS--LKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 574 GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEV-ISLEKMQSLSL 632
+L+ L LS N + + ++ LD + L V +SL + L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 633 QENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP----CSLSKLHHFSSILNVSNNKLSG 688
+ A F+ + SL L++ N F + L L L++S +L
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF----LDLSQCQLEQ 484
Query: 689 KIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFNHFS 735
P +L LQ+L+++SN +P + + + SL + + N +
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-51
Identities = 113/602 (18%), Positives = 191/602 (31%), Gaps = 87/602 (14%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNS 155
+LDLS N + +L+ L L+ Q +I + L LS L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 156 LSGKIPPQV-SLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLT--GLLPEFP 212
+ + S SL+ + L I L LK L + N + L F
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 213 NSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS---SNNFGGAISPWIFKGLLQLEVL 269
N + HL + N T L + + S S N I P FK ++L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKL 205
Query: 270 YLDDNNLEGQIPET-LWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQI 328
L +N + +T + GL L+ L + L+ S + +
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--------EGNLEKFDKSALEGLCNL 257
Query: 329 PRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV 388
L+ L+ + + + ++ L I + +
Sbjct: 258 TIEEFRLAYLD---YYLDDIIDLFN----CLTNVSSFSLVSVTI--ERVKDFSYNFGWQH 308
Query: 389 LYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEV 448
L L N + ++ L L +N+ L +L+FL L+ N L+
Sbjct: 309 LELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLS--- 360
Query: 449 ALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLR 508
S +G T+L L L N + L
Sbjct: 361 ------------FKGCCSQSDFGT--------TSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 509 RVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGS 568
+ ++ L+ + VF NL LD S +
Sbjct: 400 HLDFQHSNLK-QMSE----------------------FSVFLSLRNLIYLDISHTHTRVA 436
Query: 569 IPSELGNLENLQILRLSANKLDGRI-PYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEK 626
L +L++L+++ N P + + LDLS L + + L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSS 495
Query: 627 MQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKL 686
+Q L++ N L F + SL ++ L +N +D CS ++ + S LN ++ K
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD----CSCPRIDYLSRWLNKNSQKE 551
Query: 687 SG 688
G
Sbjct: 552 QG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-45
Identities = 96/497 (19%), Positives = 167/497 (33%), Gaps = 32/497 (6%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
L+ L+LS + + + + HL +L L+GN L+ L+
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQ---SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 129 DNRFQGSIPPEIF-KLKRLSWLDLGYNSL-SGKIPPQVSLCYSLESIGFHNNFLNGELPN 186
+ S+ LK L L++ +N + S K+P S +LE + +N +
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 187 DICSLPKLK----SLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSL------S 236
D+ L ++ SL L+ N + + P + L + N ++ +
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 237 NCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG---QIPETLWGLENLQKL 293
LV + +GL L + L+ I + L N+
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 294 VLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLP 353
L + + S+ Q + L GQ P L SL L +N+
Sbjct: 288 SLVSVTIERVKDF--SYNFGWQHLELVNCKF-GQFPT--LKLKSLKRLTFTSNKGGN--A 340
Query: 354 PELGNCGSLVDLRLQHNFIG--GTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLV 411
+ SL L L N + G L+ L L N + + + +L
Sbjct: 341 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE 399
Query: 412 ELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470
L ++ L + LRNL +L ++H H + L L + GNSF
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 471 GPIPANICVG-TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP 529
+I NL L L + P SSL+ + +++N L+ +R
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLT 518
Query: 530 GVSFLDVRGNLLQGSIP 546
+ + + N S P
Sbjct: 519 SLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-40
Identities = 94/487 (19%), Positives = 161/487 (33%), Gaps = 46/487 (9%)
Query: 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQ 327
+ N +IP+ L + + L LS N L S +LQV+ LSR +
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLE 387
+ +LS L++L+L N +Q SL L + I +L L+
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127
Query: 388 VLYLFNNRI-EGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQF----LSLAHN 442
L + +N I +P ++ L L L +N++ D+ L + L L+ N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEI 501
+ + K L +L L N + G L V L F
Sbjct: 188 PMN-FIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF-------- 237
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS---IPPVFGFWSNLTML 558
+ L+ + LE ++ + R L I +F +N++
Sbjct: 238 ----------RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 559 DFSENRLSGSIP-SELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617
+ S ++L+++ + L +L + N G+
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL------KRLTFTSNKG-GNA 340
Query: 618 PSEVISLEKMQSLSLQENNLS--GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHF 675
SEV L ++ L L N LS G + SL L L N ++ + L
Sbjct: 341 FSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ- 397
Query: 676 SSILNVSNNKLSGKIPEC-LGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHF 734
L+ ++ L +L L LD+S N + SL + ++ N F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 735 SGKLPAS 741
Sbjct: 458 QENFLPD 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 2e-52
Identities = 95/554 (17%), Positives = 171/554 (30%), Gaps = 54/554 (9%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
S + + T + + + L + N L C NL S
Sbjct: 2 LSCDASGVCDGRSRSFTSIPSGLTAA--MKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNG-TISGQ 307
+ I F L LE L L DN+L L +L+ L L N ++
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLR 366
+ LQ + + +I R L+SLN L + L+ L + + L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 367 LQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPP 426
L + + L+ + L L + + + + R
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR------- 231
Query: 427 DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVL 486
+ N L +L ++ LS ++ + G +
Sbjct: 232 ------GSVLTDESFNELL-----KLLRYILELSEVEFDDCTLNG-------------LG 267
Query: 487 VLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIP 546
+ + + + ++RR+ + L L V + V + +
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 547 PVFGFWSNLTMLDFSENRLSGSI---PSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
+L LD SEN + + G +LQ L LS N L + +
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTL 386
Query: 604 IKL---DLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNI 660
L D+S N +P EKM+ L+L + +++ L + +N
Sbjct: 387 KNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLD---VSNNN 442
Query: 661 FDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNN 720
D S L +L L +S NKL +P+ L ++ +S N +
Sbjct: 443 LD-SFSLFLPRLQE----LYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDR 495
Query: 721 MVSLYFVNISFNHF 734
+ SL + + N +
Sbjct: 496 LTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-50
Identities = 106/595 (17%), Positives = 194/595 (32%), Gaps = 92/595 (15%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNS 155
+ SLDLS N+ T L C L+ L+L +R +I + F L L LDL N
Sbjct: 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNH 85
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
LS SL S F L LK L L N L
Sbjct: 86 LS-----------SLSSSWFGP-------------LSSLKYLNLMGNPYQTL-------- 113
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN 275
+ + N NL + I F GL L L + +
Sbjct: 114 --------------GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 276 LEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNL 335
L ++L + ++ L L ++ + + ++ + L NL +
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
Query: 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNR 395
+ + R L+ L+ + + E + + +
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSE 273
Query: 396 IEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKH 455
+ + L + L + + L ++ +++ ++ + V +H
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQH 332
Query: 456 FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515
L LDL+ N N G SL+ ++LS N
Sbjct: 333 LKSLEFLDLSENLMVEEYLKN---------------------SACKGAWPSLQTLVLSQN 371
Query: 516 LLQ--GSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL 573
L+ L ++ LD+ N +P + + L+ S + + + +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI 429
Query: 574 GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQ 633
+ L++L +S N LD L ++ +L +S N L ++P + + + +
Sbjct: 430 --PQTLEVLDVSNNNLD-SFSLFL---PRLQELYISRNKLK-TLPDASL-FPVLLVMKIS 481
Query: 634 ENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSG 688
N L F + SL ++ L +N +D CS ++ + S LN ++ K G
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTNPWD----CSCPRIDYLSRWLNKNSQKEQG 532
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-38
Identities = 80/431 (18%), Positives = 150/431 (34%), Gaps = 17/431 (3%)
Query: 311 CNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHN 370
C+ V + IP + +++ SL L N++ +L C +L L L+ +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 371 FIGGTIPPEIC-NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG-RIPPDI 428
I TI + +L LE L L +N + G +S L L L N +
Sbjct: 61 RIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 429 TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVL 488
L NLQ L + + E+ L+ L++ S ++ ++ L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 489 GNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPV 548
+ I SS+R + L + L + L + S +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDL 608
F L + + + + + ++ D + + +L +
Sbjct: 240 FNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHI 293
Query: 609 SDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCS 668
YL + + LEK++ ++++ + + ++SL L L N+ +
Sbjct: 294 PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 669 LSKLHHFSSI--LNVSNNKLS--GKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL 724
+ + S+ L +S N L K E L L L LD+S N+F +P +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 725 YFVNISFNHFS 735
F+N+S
Sbjct: 413 RFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-18
Identities = 57/317 (17%), Positives = 106/317 (33%), Gaps = 21/317 (6%)
Query: 41 SQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLS 100
+ + ++ ++ + + ++ N L +L S
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 101 LDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKI 160
D + +E ++ L + + L+++ + + + + +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325
Query: 161 PPQV-SLCYSLESIGFHNNFLNGEL---PNDICSLPKLKSLYLNTNNLTGLLPE---FPN 213
P SLE + N + E + P L++L L+ N+L +
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 214 SCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQ-LEVLYLD 272
+ L I N F +P S + + SS + + Q LEVL +
Sbjct: 386 LKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGI-----RVVKTCIPQTLEVLDVS 439
Query: 273 DNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV 332
+NNL+ L LQ+L +S NKL T+ S L V+ +SRN L
Sbjct: 440 NNNLD-SFSL---FLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIF 493
Query: 333 GNLSSLNSLLLFNNRLQ 349
L+SL + L N
Sbjct: 494 DRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-17
Identities = 42/214 (19%), Positives = 86/214 (40%), Gaps = 14/214 (6%)
Query: 529 PGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANK 588
D R SIP G + + LD S N+++ +L NLQ+L L +++
Sbjct: 5 DASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 589 LDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSG-AIPDAFS 646
++ + LDLSDN+L+ S+ S L ++ L+L N + F
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 647 SVQSLFELQLGSNIFDGSIP----CSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQI 702
++ +L L++G+ I L+ L+ L + L + L ++ +
Sbjct: 121 NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE----LEIKALSLRNYQSQSLKSIRDIHH 176
Query: 703 LDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736
L L + + + + + S+ ++ + + +
Sbjct: 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 7e-05
Identities = 20/114 (17%), Positives = 47/114 (41%), Gaps = 4/114 (3%)
Query: 622 ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNV 681
+S + + + + +IP ++ ++ L L N L + +L +
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQ-VLIL 57
Query: 682 SNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735
+++++ + +L L+ LDLS N S + + SL ++N+ N +
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-51
Identities = 103/528 (19%), Positives = 183/528 (34%), Gaps = 90/528 (17%)
Query: 190 SLPKLKSLYLNTNNLTGLLP--EFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS 247
+L + L N+T + + + L + NL + + S
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQTDLDQ---VTTLQADRLGI--KSIDGVEYLNNLTQINFS 76
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQ 307
+N I+P K L +L + +++N + P L L NL L L N++
Sbjct: 77 NNQLTD-ITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRL 367
+ + L + LS N + ++ L+SL L N L N +L L +
Sbjct: 130 LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDI 184
Query: 368 QHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD 427
N + + + L LE L NN+I P +G ++ L EL+L N+L
Sbjct: 185 SSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGT 238
Query: 428 ITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLV 487
+ L NL L LA+N ++ LS L T L L
Sbjct: 239 LASLTNLTDLDLANNQISN---------LAPLSGL------------------TKLTELK 271
Query: 488 LGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
LG N+ + + ++L + L+ N L+
Sbjct: 272 LGANQISNI--SPLAGLTALTNLELNENQLED--------------------------IS 303
Query: 548 VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLD 607
NLT L N +S P + +L LQ L NK+ L T + L
Sbjct: 304 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLS 359
Query: 608 LSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPC 667
N ++ P + +L ++ L L + + A + ++V ++ + P
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPA 415
Query: 668 SLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715
++S ++ +++ N S E + + + +FSG +
Sbjct: 416 TISDGGSYTE-PDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-50
Identities = 97/488 (19%), Positives = 178/488 (36%), Gaps = 40/488 (8%)
Query: 86 NNSISYICKN---QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK 142
+ I+ I + + L T ++ + Q+ TL + +
Sbjct: 11 DTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSIDGVEY 66
Query: 143 LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN 202
L L+ ++ N L+ P + L I +NN + + +L L L L N
Sbjct: 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNN 122
Query: 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG 262
+T + N + L + N S ++LS +L + S + + P
Sbjct: 123 QITD-IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFGNQVTD--LKP--LAN 175
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
L LE L + N + L L NL+ L+ + N+++ + L ++L+ N
Sbjct: 176 LTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231
Query: 323 NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICN 382
L ++ +L++L L L NN++ L L +L+L N I P +
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISP--LAG 285
Query: 383 LAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
L L L L N++E P I + L L LY N ++ P ++ L LQ L +N
Sbjct: 286 LTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502
++ +L + ++ L N P + T + L L + + + P+
Sbjct: 342 KVSDVSSLA---NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYK 395
Query: 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562
S+ + + PAT+ + D+ NL V +S +
Sbjct: 396 ANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGT 453
Query: 563 NRLSGSIP 570
SG++
Sbjct: 454 TTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-48
Identities = 106/467 (22%), Positives = 182/467 (38%), Gaps = 60/467 (12%)
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
L + + QI T L K VL + T+S + +Q+ + R +
Sbjct: 3 LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI- 58
Query: 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK 385
+ V L++L + NN+L L N LVD+ + +N I + NL
Sbjct: 59 -KSIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQI--ADITPLANLTN 113
Query: 386 LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
L L LFNN+I P + ++ L L L +N ++ ++ L +LQ LS N +T
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVT 168
Query: 446 GEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCS 505
L + L RLD++ N + + TNL L+ NN+ + P+ G +
Sbjct: 169 DLKPLA---NLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPL--GILT 221
Query: 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRL 565
+L + L+ N L+ TL ++ LD+ N + P + LT L N++
Sbjct: 222 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277
Query: 566 SGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLE 625
S P L L L L L+ N+L+ P + + L L N ++ P SL
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVS--SLT 331
Query: 626 KMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNK 685
K+Q L N +S + +++ ++ L + +N+
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWL-------------------------SAGHNQ 364
Query: 686 LSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFN 732
+S P L NL ++ L L+ +++ N+ V
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTG 409
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 8e-48
Identities = 100/450 (22%), Positives = 166/450 (36%), Gaps = 61/450 (13%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
+ L G+ SI + +L ++ S N+ T P L N +L +L+N
Sbjct: 46 DQVTTLQADRLGIK-----SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 98
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
+N+ P + L L+ L L N ++ P + +L + +N ++ + +
Sbjct: 99 NNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISAL 152
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
L L+ L N +T L P L+N L SS
Sbjct: 153 SGLTSLQQLSFG-NQVTDLKP-------------------------LANLTTLERLDISS 186
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N IS L LE L +N + P L L NL +L L+ N+L I +
Sbjct: 187 NKVSD-ISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGT-L 239
Query: 309 SHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ 368
+ L + L+ N + P + L+ L L L N++ L +L +L L
Sbjct: 240 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELN 295
Query: 369 HNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI 428
N + I NL L L L+ N I P + ++KL L YNN+++ +
Sbjct: 296 ENQL--EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSL 349
Query: 429 TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVL 488
L N+ +LS HN ++ L + +++L L ++ P N ++ V
Sbjct: 350 ANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQAWTN-APVNYKANVSIPNTVK 405
Query: 489 GNNRFNGSFPIEIGKCSSLRRVILSNNLLQ 518
P I S ++ NL
Sbjct: 406 NVTG-ALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 8e-42
Identities = 83/437 (18%), Positives = 154/437 (35%), Gaps = 58/437 (13%)
Query: 60 SGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNC 119
+ ++ N + L + ++ ++ I+ + +L L L N+ T P L N
Sbjct: 81 TDITPLKNLTKLVDILMNNNQIA-----DITPLANLTNLTGLTLFNNQITDIDP--LKNL 133
Query: 120 GQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNF 179
L L L+ N S + L L L G N ++ P ++ +LE + +N
Sbjct: 134 TNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNK 188
Query: 180 LNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCR 239
++ + + L L+SL N ++ + P L
Sbjct: 189 VSD--ISVLAKLTNLESLIATNNQISDITP-------------------------LGILT 221
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK 299
NL E S + N L L L L +N + P L GL L +L L AN+
Sbjct: 222 NLDELSLNGNQL---KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 276
Query: 300 LNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC 359
++ ++ L + L+ N L P + NL +L L L+ N + + +
Sbjct: 277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI--SPVSSL 330
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNR 419
L L +N + + + NL + L +N+I P + ++++ +L L +
Sbjct: 331 TKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 386
Query: 420 LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICV 479
T + N+ + N +A + D+T N
Sbjct: 387 WTN---APVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP-SYTNEVSYT 442
Query: 480 GTNLFVLVLGNNRFNGS 496
+ + G F+G+
Sbjct: 443 FSQPVTIGKGTTTFSGT 459
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-19
Identities = 53/342 (15%), Positives = 101/342 (29%), Gaps = 92/342 (26%)
Query: 60 SGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNC 119
S ++ ++L L+L+G L I + +L LDL+ N+ + P L
Sbjct: 212 SDITPLGILTNLDELSLNGNQLK-----DIGTLASLTNLTDLDLANNQISNLAP--LSGL 264
Query: 120 GQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNF 179
+L L L N+ P + L L+ L+L N L P
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP------------------ 304
Query: 180 LNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCR 239
I +L L L L NN++ + P
Sbjct: 305 --------ISNLKNLTYLTLYFNNISDISP------------------------------ 326
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK 299
L +L+ L+ +N + +L L N+ L N+
Sbjct: 327 --------------------VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQ 364
Query: 300 LNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC 359
++ +++ ++ + L+ N+S N++ L P + +
Sbjct: 365 ISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDG 420
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401
GS + + N ++ + G +
Sbjct: 421 GSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-51
Identities = 145/752 (19%), Positives = 240/752 (31%), Gaps = 123/752 (16%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNS 155
L LS N QL+ L L +I E F+ L L LDLG +
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
+ + P L L L L L+ + +
Sbjct: 85 IY-FLHPDA-----------------------FQGLFHLFELRLYFCGLSDAVLK----- 115
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN 275
N + L S N F L L+ + N
Sbjct: 116 ----------------DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ 159
Query: 276 LEGQIPETLWGLE--NLQKLVLSANKLNGTISGQISHC-NQLQVIALSRNNLVGQIPRSV 332
+ L L+ L L+AN L +S C N + + L ++
Sbjct: 160 IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV-------S 212
Query: 333 GNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK--LEVLY 390
GN +++ F+N + + L ++ + I LA+ + L
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272
Query: 391 LFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVA 449
L + + + L L L N++ +I + L NLQ L+L++N L
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLG---- 327
Query: 450 LELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
+L ++FYG + + L N L+
Sbjct: 328 -------------ELYSSNFYG--------LPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 510 VILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG-S 568
+ L +N L T+ P + + + GN L ++P ++ SENRL
Sbjct: 367 LDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLD 417
Query: 569 IPSELGNLENLQILRLSANKLDGRIPYE--LGKCTKMIKLDLSDNYLAGSIPSEV----- 621
I L + +LQIL L+ N+ + + + +L L +N L + +E+
Sbjct: 418 ILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 622 ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSS--IL 679
L +Q L L N L+ P FS + +L L L SN LS ++ IL
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-----TVLSHNDLPANLEIL 531
Query: 680 NVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLP 739
++S N+L P+ L +LD++ N F E F+N NH + +
Sbjct: 532 DISRNQLLAPNPD---VFVSLSVLDITHNKFICECELS-------TFIN-WLNHTNVTIA 580
Query: 740 ASWTTLMVSYPGSFLGNSEL-CRQGNCGKNGRGHTRGRLAGIIIGVLLSVALLCALIYIM 798
+ YP SF G S C + + I+ + L ++ +
Sbjct: 581 GPPADIYCVYPDSFSGVSLFSLSTEGC-DEEEVLKSLKFSLFIVCTVTLTLFLMTILTVT 639
Query: 799 VVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRY 830
R C+ L P +Y
Sbjct: 640 KFRGFCFICYKTAQRLVFKDHPQGTEPDMYKY 671
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 6e-47
Identities = 114/570 (20%), Positives = 205/570 (35%), Gaps = 46/570 (8%)
Query: 195 KSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGA 254
+ + NLT + LL+ N +S L S
Sbjct: 7 RIAFYRFCNLTQVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTI--SGQISHCN 312
I F+ L L +L L + + P+ GL +L +L L L+ + G +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
Query: 313 QLQVIALSRNNLVG-QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG--SLVDLRLQH 369
L + LS+N + + S G L+SL S+ +N++ EL +L L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 370 NFIGGTIPPEICNLAK------LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGR 423
N + + + LE+L + N I ++N ++
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG------------NFSNAISKS 231
Query: 424 IPPDITRLRNLQFLSLAHNHLTG-EVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-T 481
+ ++ +++ + G + LDL+ + + + +
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLK 290
Query: 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLL 541
+L VL L N+ N +L+ + LS NLL + P V+++D++ N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCT 601
F F L LD +N L + + + ++ + LS NKL L
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINLTANL 405
Query: 602 KMIKLDLSDNYLAG-SIPSEVISLEKMQSLSLQENNLSGAIPDA-FSSVQSLFELQLGSN 659
+ LS+N L I ++ + +Q L L +N S D S SL +L LG N
Sbjct: 406 ----IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 660 IFDGSIPCSLSK--LHHFSS--ILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715
+ + L S +L +++N L+ P +L L+ L L+SN + +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 716 TEVNNMVSLYFVNISFNHFSGKLPASWTTL 745
+L ++IS N P + +L
Sbjct: 521 HND-LPANLEILDISRNQLLAPNPDVFVSL 549
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-37
Identities = 108/539 (20%), Positives = 185/539 (34%), Gaps = 67/539 (12%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSI--PKQLGNC 119
N +L+ L+L ++ I ++ HL L L + ++ N
Sbjct: 71 NLPNLRILDLG--------SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 120 GQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQV--SLCY-SLESIGF 175
L L L+ N+ + F KL L +D N + + L +L
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSL 181
Query: 176 HNNFLNGELPNDICSLPK------LKSLYLNTNNLTGLLP-------------EFPNSCA 216
N L + D L+ L ++ N T + +
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241
Query: 217 ILHLLIHENDFVGSLPTSLSN--CRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
I+ ++ + + ++ S +++ +F+ L L+VL L N
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYN 300
Query: 275 NLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN 334
+ E +GL+NLQ L LS N L S ++ I L +N++ ++
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394
L L +L L +N L + S+ D+ L N + T+P +++L N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL-VTLPKINLT---ANLIHLSEN 411
Query: 395 RIEG-AIPHQIGRMSKLVELALYNNRLTGRIPPD--ITRLRNLQFLSLAHNHLTGEVALE 451
R+E I + + R+ L L L NR + D + +L+ L L N L E
Sbjct: 412 RLENLDILYFLLRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETE 470
Query: 452 LG----KHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEIGKCSS 506
L + +L L L N +P + T L L L +NR ++
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLNS-LPPGVFSHLTALRGLSLNSNRLT-VLSHNDLP-AN 527
Query: 507 LRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPV-FGFWSNLTMLDFSENR 564
L + +S N L P +S LD+ N F W N T + +
Sbjct: 528 LEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPP 583
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-49
Identities = 97/576 (16%), Positives = 176/576 (30%), Gaps = 125/576 (21%)
Query: 136 IPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLK 195
I P L ++L+ E+P + ++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-------------------------EMPVEAENVKSKT 37
Query: 196 SLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI 255
Y + P E + R E ++ ++
Sbjct: 38 EYYNAWSEWERNAPP----------GNGEQREMAVSRLRDCLDRQAHELELNNLGL-SSL 86
Query: 256 SPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQ 315
LE L N+L ++PE L++L + L+ L+
Sbjct: 87 PELPP----HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLE 134
Query: 316 VIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGT 375
+ +S N L ++P + N S L + + NN L+ LP + L + +N +
Sbjct: 135 YLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQL--E 186
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQ 435
PE+ NL L +Y NN ++ +P L + NN L P++ L L
Sbjct: 187 ELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNILE--ELPELQNLPFLT 240
Query: 436 FLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG 495
+ +N L +P +L L + +N
Sbjct: 241 TIYADNNLLKT--------------------------LPDLPP---SLEALNVRDNYLT- 270
Query: 496 SFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNL 555
P + L + L LP L L+ N ++ S+ +L
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLS-ELPPNLYY------LNASSNEIR-SLC---DLPPSL 319
Query: 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615
L+ S N+L +P+ L+ L S N L +P +L + N L
Sbjct: 320 EELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQNLK---QLHVEYNPLR- 370
Query: 616 SIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHF 675
P S+E L+ N+ +P+ Q+L +L + +N P +
Sbjct: 371 EFPDIPESVE-----DLRMNSHLAEVPE---LPQNLKQLHVETNPLR-EFPDIPESVED- 420
Query: 676 SSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711
L +++ ++ DKL+ +
Sbjct: 421 ---LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 2e-47
Identities = 102/547 (18%), Positives = 183/547 (33%), Gaps = 100/547 (18%)
Query: 92 ICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDL 151
N L + T +P + N + ++ + PP + + ++ L
Sbjct: 7 NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65
Query: 152 GYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEF 211
L + +N L+ LP P L+SL + N+LT
Sbjct: 66 RDC-----------LDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT------ 104
Query: 212 PNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYL 271
LP + ++L+ + + LE L +
Sbjct: 105 ------------------ELPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGV 138
Query: 272 DDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRS 331
+N LE ++PE L L+ + + N L + L+ IA N L ++P
Sbjct: 139 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-E 190
Query: 332 VGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL 391
+ NL L ++ NN L+ LP + L + +N + PE+ NL L +Y
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNIL--EELPELQNLPFLTTIYA 244
Query: 392 FNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALE 451
NN ++ +P L L + +N LT +P L L + L+
Sbjct: 245 DNNLLK-TLPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS------ 293
Query: 452 LGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVI 511
+ P L L+ + N + +L L + NN+ P + L R+I
Sbjct: 294 --ELPPNLYYLNASSNEI-RSLCDLP---PSLEELNVSNNKLI-ELPALPPR---LERLI 343
Query: 512 LSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS 571
S N L +P + L V N L+ P + +L M + L+ +P
Sbjct: 344 ASFNHLA-EVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRMN----SHLA-EVPE 393
Query: 572 ELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLS 631
NL+ L + N L P L ++ + + +K++
Sbjct: 394 LPQ---NLKQLHVETNPLR-EFPDIPESVE---DLRMNSERVVDPYEFAHETTDKLEDDV 446
Query: 632 LQENNLS 638
+ ++
Sbjct: 447 FEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-47
Identities = 98/575 (17%), Positives = 177/575 (30%), Gaps = 126/575 (21%)
Query: 161 PPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHL 220
P VS + E + +N E+P + ++ Y + P
Sbjct: 5 PRNVSNTFLQEPLRHSSNL--TEMPVEAENVKSKTEYYNAWSEWERNAPP---------- 52
Query: 221 LIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQI 280
E + R E ++ ++ LE L N+L ++
Sbjct: 53 GNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPP----HLESLVASCNSLT-EL 106
Query: 281 PETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNS 340
PE L++L + L+ L+ + +S N L ++P + N S L
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKI 157
Query: 341 LLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAI 400
+ + NN L+ LP + L + +N + PE+ NL L +Y NN ++ +
Sbjct: 158 IDVDNNSLK-KLPDLPPS---LEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KL 210
Query: 401 PHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460
P L + NN L P++ L L + +N L
Sbjct: 211 PDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-------------- 251
Query: 461 RLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS 520
+P +L L + +N P + L + L
Sbjct: 252 ------------LPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-E 294
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQ 580
LP L L+ N ++ S+ +L L+ S N+L +P+ L +
Sbjct: 295 LPPNLYY------LNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPPRL---E 340
Query: 581 ILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGA 640
L S N L +P + L + N L P S+E L+ N+
Sbjct: 341 RLIASFNHL-AEVPELPQNLKQ---LHVEYNPLR-EFPDIPESVE-----DLRMNSHLAE 390
Query: 641 IPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKL 700
+P+ +++ L +V N L + P+ + +
Sbjct: 391 VPELPQNLKQL----------------------------HVETNPLR-EFPDIPES---V 418
Query: 701 QILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735
+ L ++S L +H
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-33
Identities = 75/377 (19%), Positives = 138/377 (36%), Gaps = 54/377 (14%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
L+ L +S L + + + L +D+ N +P + L+ +
Sbjct: 131 PLLEYLGVSNNQLE-----KLPELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAG 181
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
+N+ PE+ L L+ + NSL K+P L SLESI NN L E ++
Sbjct: 182 NNQL--EELPELQNLPFLTAIYADNNSLK-KLPD---LPLSLESIVAGNNIL--EELPEL 233
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
+LP L ++Y + N L L P+ L L ++++ LP + L
Sbjct: 234 QNLPFLTTIYADNNLLKTLPDLPPS----LEALNVRDNYLTDLPELPQSLTFLDVSENIF 289
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
+ + + L L N + + + +L++L +S NKL +
Sbjct: 290 SG--------LSELPPNLYYLNASSNEIR-SLCDL---PPSLEELNVSNNKLI-ELPALP 336
Query: 309 SHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ 368
+L+ + S N+L ++P NL L+ + N L+ P + L+
Sbjct: 337 P---RLERLIASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVED-----LR 383
Query: 369 HNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI 428
N +P N L+ L++ N + P + +L + + R+
Sbjct: 384 MNSHLAEVPELPQN---LKQLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAH 436
Query: 429 TRLRNLQFLSLAHNHLT 445
L+ H+H
Sbjct: 437 ETTDKLEDDVFEHHHHH 453
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 171 bits (437), Expect = 3e-47
Identities = 73/373 (19%), Positives = 132/373 (35%), Gaps = 28/373 (7%)
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
L + P L + VL + ++ + + ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK 385
I + L++L L L N++ L N L +L + N I T + NL
Sbjct: 57 ASIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 386 LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
L LYL + I P + ++K+ L L N ++ + L +L++ + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168
Query: 446 GEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCS 505
+ + L L L N P + T+L N+ + +
Sbjct: 169 DVTPIA---NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDI--TPVANMT 221
Query: 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRL 565
L + + NN + P L +++L++ N + + L ML+ N++
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
Query: 566 SGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLE 625
S S L NL L L L+ N+L +G T + L LS N++ P + SL
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333
Query: 626 KMQSLSLQENNLS 638
KM S +
Sbjct: 334 KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-43
Identities = 69/353 (19%), Positives = 134/353 (37%), Gaps = 28/353 (7%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
+ L ++ + + + + L ++G + SI + L+ L LN
Sbjct: 22 AEGIRAVLQKASVTD-----VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLN 74
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
N+ P + L +L+ L +G N ++ + +L + + + ++ + +
Sbjct: 75 GNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPL 128
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
+L K+ SL L N+ L N + +L + E+ P ++N +L S +
Sbjct: 129 ANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N ISP L L N + P + + L L + NK+ +
Sbjct: 187 NQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L 239
Query: 309 SHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ 368
++ +QL + + N + +V +L+ L L + +N++ L N L L L
Sbjct: 240 ANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLN 295
Query: 369 HNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
+N +G I L L L+L N I P + +SK+ N +
Sbjct: 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 71/375 (18%), Positives = 141/375 (37%), Gaps = 31/375 (8%)
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
L I P +LA+ L + + + + +L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 422 GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT 481
I L NL++L+L N +T L + L+ L + N + + T
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLL 541
NL L L + + + + + + L N S + L G+++L V + +
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCT 601
+ P ++L L + N++ P L +L +L N++ P + T
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 602 KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIF 661
++ L + +N + P +L ++ L + N +S +A + L L +GSN
Sbjct: 222 RLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
Query: 662 DGSIPCS-LSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNN 720
+ LS+L + L ++NN+L + E +G L L L LS N + P + +
Sbjct: 278 SDISVLNNLSQL----NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LAS 331
Query: 721 MVSLYFVNISFNHFS 735
+ + + +
Sbjct: 332 LSKMDSADFANQVIK 346
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 1e-44
Identities = 71/458 (15%), Positives = 147/458 (32%), Gaps = 47/458 (10%)
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318
I + + ++ + D++L+ + N+++L LS N L+ + ++ +L+++
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
LS N L + +LS+L +L L NN +Q EL S+ L +N I +
Sbjct: 65 LSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSC 116
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFL 437
+ +YL NN+I G S++ L L N + + L+ L
Sbjct: 117 SR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF 497
+L +N + + + L L L +N+
Sbjct: 175 NLQYNFIYD--------------------------VKGQVVF-AKLKTLDLSSNKLA-FM 206
Query: 498 PIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTM 557
E + + + L NN L + L + + D+RGN F F N +
Sbjct: 207 GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRV 264
Query: 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS- 616
++ + + A + + + + + + GS
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324
Query: 617 ---IPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLH 673
+ E + + + + + I Q+ L+ D +
Sbjct: 325 TERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHA 384
Query: 674 HFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711
L + ++ + LQ+L +
Sbjct: 385 ELDGTLQQAVGQIE--LQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-39
Identities = 54/409 (13%), Positives = 119/409 (29%), Gaps = 44/409 (10%)
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLE 387
I N + + ++ L+ L + ++ +L L N + ++ KLE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 388 VLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGE 447
+L L +N + + + +S L L L NN + ++ +++ L A+N+++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-- 112
Query: 448 VALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG-SFPIEIGKCSS 506
+ + L N + + + L L N + +F +
Sbjct: 113 -RVSCS-RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 507 LRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS 566
L + L N + + + ++ L LD S N+L+
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-------------------------VFAKLKTLDLSSNKLA 204
Query: 567 GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEK 626
+ E + + + L NKL I L + DL N +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKN 261
Query: 627 MQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN---IFDGSIPCSLSKLHHFSSILNVSN 683
+ ++ + + G+ L L L
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321
Query: 684 NKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFN 732
+ ++ N + + +D + I + +
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-37
Identities = 62/456 (13%), Positives = 134/456 (29%), Gaps = 41/456 (8%)
Query: 138 PEIFK-LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKS 196
EI + R + +SL + ++++ + N L+ D+ KL+
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 197 LYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAIS 256
L L++N L + + + L ++ N L ++ A++NN +S
Sbjct: 63 LNLSSNVLYET-LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115
Query: 257 PWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQ-ISHCNQLQ 315
+G + +YL +N + +Q L L N+++ + + + L+
Sbjct: 116 CSRGQGK---KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 316 VIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGT 375
+ L N + + V + L +L L +N+L + PE + + + L++N +
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-L 228
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQ 435
I + LE L N + + + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 436 FLSLAHNHLTGEVALELGKHFPY-LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN 494
+L F L L ++ L +
Sbjct: 288 LGHYGAYCCE-----DLPAPFADRLIALKRKEHAL----------------LSGQGSETE 326
Query: 495 GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554
E + R + + + R L+ + L + +
Sbjct: 327 -RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590
L + LQ+LR + +
Sbjct: 386 LDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-35
Identities = 63/491 (12%), Positives = 144/491 (29%), Gaps = 46/491 (9%)
Query: 95 NQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYN 154
++ + ++ + +K L L+ N ++ +L L+L N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNS 214
L SL +L ++ +NN++ ++ P +++L+ NN++ +
Sbjct: 69 VLYE-TLDLESL-STLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQG 121
Query: 215 CAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
++L +NN + +++ L L N
Sbjct: 122 KKNIYL---------------------------ANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 275 NLEG-QIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVG 333
++ E + L+ L L N + + GQ+ +L+ + LS N L +
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 334 NLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN 393
+ + + + L NN+L + L +L L+ N + V +
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAK 269
Query: 394 NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG 453
++ + P RL L+ A G L
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
Query: 454 K---HFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
+ +D + + + + L + + L
Sbjct: 330 CERENQARQREIDALKEQYRT-VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
Query: 510 VILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSI 569
+ AT E++P + + + + + D +++ + +
Sbjct: 389 TLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QL 447
Query: 570 PSELGNLENLQ 580
E L+ L
Sbjct: 448 AEENARLKKLN 458
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 60/358 (16%), Positives = 121/358 (33%), Gaps = 20/358 (5%)
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
N + ++ + ++ ++ A+ + EL L N L+ D+ L+ L+L+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEI 501
N L + LE L LDL N + VG ++ L NN + +
Sbjct: 68 NVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VSC 116
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQG-SIPPVFGFWSNLTMLDF 560
+ + + L+NN + V +LD++ N + + + L L+
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 561 SENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSE 620
N + + ++ L+ L LS+NKL + E + + L +N L I
Sbjct: 177 QYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 621 VISLEKMQSLSLQENNLS-GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSIL 679
+ + ++ L+ N G + D FS Q + + + +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 680 NVSNNKLSGKIPECLGNLD--KLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735
L + L L + +L + + E N ++ +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 52/386 (13%), Positives = 124/386 (32%), Gaps = 25/386 (6%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLL 126
+ S+L+ L+L+ NN + + + +L + N + + G K +
Sbjct: 78 SLSTLRTLDLN--------NNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIY 126
Query: 127 LNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQ--VSLCYSLESIGFHNNFLNGEL 184
L +N+ + R+ +LDL N + + + +LE + NF+ ++
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DV 184
Query: 185 PNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEF 244
+ KLK+L L++N L + PEF ++ + + + N V + +L +NL F
Sbjct: 185 KGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTI 304
N F F ++ + ++ + A
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 305 SGQISHCNQLQVIALS----RNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG 360
+ L+ + + + ++ N + + + + +
Sbjct: 301 APFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 361 SLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRL 420
+ + L + + + A+L+ + + H S L L R
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRY 419
Query: 421 T-GRIPPDITRLRNLQFLSLAHNHLT 445
+ + ++ + + T
Sbjct: 420 EEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 37/193 (19%), Positives = 73/193 (37%), Gaps = 12/193 (6%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
+I + + + +++ L ++ S + N++ L LS N L +L TK+
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 604 IKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663
L+LS N L ++ SL +++L L N + S+ L +N
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 664 SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG-EIPTEVNNMV 722
+ + ++NNK++ G ++Q LDL N +
Sbjct: 114 VSCSRGQGKKN----IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 723 SLYFVNISFNHFS 735
+L +N+ +N
Sbjct: 170 TLEHLNLQYNFIY 182
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 50/317 (15%), Positives = 103/317 (32%), Gaps = 21/317 (6%)
Query: 98 LLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLS 157
+L G+ L + N +L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK 69
Query: 158 GKIPPQVSLCYS--LESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
+ ++ + L + P+ L L+ + ++ L L
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFA 127
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNN--------FGGAISPWIFKGLLQLE 267
+ L + N +LP S+++ L E S + + +GL+ L+
Sbjct: 128 GLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ 186
Query: 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQ 327
L L+ + +P ++ L+NL+ L + + L+ + I H +L+ + L +
Sbjct: 187 SLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244
Query: 328 IPRSVGNLSSLNSLLLFN-NRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKL 386
P G + L L+L + + L TLP ++ L L L+ +P I L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 387 EVLYLFNNRIEGAIPHQ 403
++ + + H+
Sbjct: 304 CIILVPPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 56/329 (17%), Positives = 107/329 (32%), Gaps = 28/329 (8%)
Query: 287 LENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346
+ L + +S + +R + + N ++
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGR 66
Query: 347 RLQGTLPPELGNC--GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI 404
L+ L + V L L+ + P + L+ L+ + + + +P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 405 GRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDL 464
+ + L L L N L +P I L L+ LS+ E+ L L
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 465 TGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPAT 524
NL L L S P I +L+ + + N+ L +L
Sbjct: 183 V----------------NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA 224
Query: 525 LERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRL 584
+ P + LD+RG + PP+FG + L L + ++P ++ L L+ L L
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 585 SANKLDGRIPYELGKCTKMIKLDLSDNYL 613
R+P + + + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 59/348 (16%), Positives = 114/348 (32%), Gaps = 47/348 (13%)
Query: 110 GSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYS 169
GS + + L + + + +R D + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSN----N 57
Query: 170 LESIGFHNNFLNGELPNDI--CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDF 227
+ L + + + P +L L + L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP---------------------- 94
Query: 228 VGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGL 287
P +L + + + + + LE L L N L +P ++ L
Sbjct: 95 --QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQ-FAGLETLTLARNPLR-ALPASIASL 149
Query: 288 ENLQKLVLSA-NKL--------NGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSL 338
L++L + A +L + SG+ LQ + L + +P S+ NL +L
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208
Query: 339 NSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN-NRIE 397
SL + N+ L L P + + L +L L+ PP A L+ L L + + +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267
Query: 398 GAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
+P I R+++L +L L R+P I +L + + +
Sbjct: 268 -TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 52/386 (13%), Positives = 103/386 (26%), Gaps = 77/386 (19%)
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA 384
+G + S +L + L + N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSN 56
Query: 385 KLEVLYLFNNRIEGAIPHQIGR--MSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
++ ++ A + V L L + L + P RL +LQ +++
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502
L +P + L L L N + P I
Sbjct: 115 GLME--------------------------LPDTMQQFAGLETLTLARNPLR-ALPASIA 147
Query: 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562
+ LR + + LP L NL L
Sbjct: 148 SLNRLRELSIRACPELTELPE---------------PLASTDASGEHQGLVNLQSLRLEW 192
Query: 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI 622
+ S+P+ + NL+NL+ L++ + L + + K+ +LDL + P
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFG 250
Query: 623 SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVS 682
++ L L++ + +P + L L++
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQL-------------------------EKLDLR 285
Query: 683 NNKLSGKIPECLGNLDKLQILDLSSN 708
++P + L I+ + +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 35/263 (13%), Positives = 85/263 (32%), Gaps = 28/263 (10%)
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
+ L + + + + + + G
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRA 67
Query: 541 LQGSIPPVFGFWS--NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELG 598
L+ + + + L+ L P + L +LQ + + A L +P +
Sbjct: 68 LK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124
Query: 599 KCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658
+ + L L+ N L ++P+ + SL +++ LS++ +P+ +S + E
Sbjct: 125 QFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH---- 179
Query: 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718
L L L + + +P + NL L+ L + ++ S + +
Sbjct: 180 --------QGLVNLQS----LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 719 NNMVSLYFVNISFNHFSGKLPAS 741
+++ L +++ P
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-15
Identities = 28/162 (17%), Positives = 51/162 (31%), Gaps = 13/162 (8%)
Query: 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISY----ICKNQHLLSLDLSGNEFTGSI 112
+ +L++L L I I Q+L SL + + + ++
Sbjct: 171 ASTDASGEHQGLVNLQSLRLE--------WTGIRSLPASIANLQNLKSLKIRNSPLS-AL 221
Query: 113 PKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLES 172
+ + +L+ L L + PP L L L S +P + LE
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 173 IGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNS 214
+ LP+ I LP + + + L P +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA 323
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 29/205 (14%), Positives = 54/205 (26%), Gaps = 33/205 (16%)
Query: 553 SNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612
S L F + L + + + +
Sbjct: 12 SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRA 67
Query: 613 LAGSIPS-EVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSK 671
L + E + +L L+ L PD LS
Sbjct: 68 LKATADLLEDATQPGRVALELRSVPLP-QFPDQA---------------------FRLSH 105
Query: 672 LHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISF 731
L H + + L ++P+ + L+ L L+ N +P + ++ L ++I
Sbjct: 106 LQH----MTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159
Query: 732 NHFSGKLPASWTTLMVSYPGSFLGN 756
+LP + S L N
Sbjct: 160 CPELTELPEPLASTDASGEHQGLVN 184
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 65/237 (27%), Positives = 107/237 (45%), Gaps = 26/237 (10%)
Query: 815 QDVQSRSEDLPRDLRYEDVIRATEGR------IIGKGKHGTVYRTLSNNSRKHWAVKKLN 868
Q+ +++ +D +L + V + +GR IG+G TVY+ L + A +L
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 869 RSETN------FDVEIRTLSLVRHRNILRIVGS----CTKDEHGFIVTEYMPGGTLFNVL 918
+ F E L ++H NI+R S + +VTE M GTL L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 919 HQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDF 977
+ + + I +GL +LH P IIHRD+K DNI + KIGD
Sbjct: 121 KRFKV---MKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
G++ L S + + ++G+ ++APE Y + E DVY++G+ + E+ + P
Sbjct: 177 GLATLKRASFAKA----VIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-39
Identities = 76/408 (18%), Positives = 138/408 (33%), Gaps = 30/408 (7%)
Query: 200 NTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWI 259
+ C + I N + ++ + +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64
Query: 260 FKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIAL 319
Q+E+L L+D +E +QKL + N + + L V+ L
Sbjct: 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124
Query: 320 SRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHNFIGGTIP 377
RN+L +PR + N L +L + NN L+ + + SL +L+L N + +
Sbjct: 125 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD 181
Query: 378 PEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFL 437
+ L + N + + + EL +N + + + L L
Sbjct: 182 LS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 231
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGS 496
L HN+LT L ++P L +DL+ N I + V L L + NNR +
Sbjct: 232 KLQHNNLTDTAWLL---NYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-A 286
Query: 497 FPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLT 556
+ +L+ + LS+N L + + + L + N + ++ L
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 342
Query: 557 MLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL--GKCTK 602
L S N + L N+ + +I Y+L G C K
Sbjct: 343 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCK 388
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-38
Identities = 81/376 (21%), Positives = 135/376 (35%), Gaps = 71/376 (18%)
Query: 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYN 154
+ + + L + Q++ L LND + + I F + L +G+N
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 103
Query: 155 SLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNS 214
++ +PP V F N +P L L L N+L+ L
Sbjct: 104 AIR-YLPPHV----------FQN-------------VPLLTVLVLERNDLSSLPRG---- 135
Query: 215 CAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
N L S S+NN I F+ L+ L L N
Sbjct: 136 -------------------IFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSN 175
Query: 275 NLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN 334
L + +L + +L +S N L+ ++ ++ + S N++ + V
Sbjct: 176 RLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV-- 224
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI-CNLAKLEVLYLFN 393
L L L +N L T L N LV++ L +N + I + +LE LY+ N
Sbjct: 225 NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISN 281
Query: 394 NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG 453
NR+ A+ + L L L +N L + + + L+ L L HN + L+L
Sbjct: 282 NRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLS 336
Query: 454 KHFPYLSRLDLTGNSF 469
L L L+ N +
Sbjct: 337 -THHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-32
Identities = 68/388 (17%), Positives = 135/388 (34%), Gaps = 50/388 (12%)
Query: 351 TLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKL 410
+ L D+ + E L +++ N+ + + ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 411 VELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
L L + ++ I +Q L + N + + + ++ P L+ L L N
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 470 YGPIPANICVG-TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERN 528
+P I L L + NN +SL+ + LS+N L + +
Sbjct: 130 SS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI--- 185
Query: 529 PGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANK 588
P + +V NLL ++ + LD S N ++ + + L IL+L N
Sbjct: 186 PSLFHANVSYNLLS-TLAIP----IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN 237
Query: 589 LDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSS 647
L L ++++DLS N L I +++++ L + N L A+
Sbjct: 238 LT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293
Query: 648 VQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSS 707
+ +L +L++S+N L + D+L+ L L
Sbjct: 294 IPTL-------------------------KVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327
Query: 708 NSFSGEIPTEVNNMVSLYFVNISFNHFS 735
NS + ++ +L + +S N +
Sbjct: 328 NSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 60/289 (20%), Positives = 100/289 (34%), Gaps = 57/289 (19%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQ-LGNCG 120
N L L L N +S + L +L +S N I
Sbjct: 115 NVPLLTVLVLE--------RNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 165
Query: 121 QLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFL 180
L+ L L+ NR + + L ++ YN LS +++ ++E + +N +
Sbjct: 166 SLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
Query: 181 NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRN 240
N + + +L L L NNLT L N
Sbjct: 218 N-VVRGPV--NVELTILKLQHNNLTDT-------------------------AWLLNYPG 249
Query: 241 LVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKL 300
LVE S N I F + +LE LY+ +N L + + L+ L LS N L
Sbjct: 250 LVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307
Query: 301 NGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
+ ++L+ + L N++V + + +L +L L +N
Sbjct: 308 L-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 31/293 (10%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVS 532
I +N+ + + + + F E ++ + V N+ ++ A L+ V
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 533 FLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLD 590
L++ ++ I F + + L N + +P N+ L +L L N L
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 591 GRIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSSV 648
+P + K+ L +S+N L I + +Q+L L N L+ + S +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185
Query: 649 QSLFELQLGSN-IFDGSIPCSLSKLH----HFSSI----------LNVSNNKLSGKIPEC 693
SLF + N + +IP ++ +L + + L + +N L+
Sbjct: 186 PSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DTAW- 243
Query: 694 LGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFNHFSGKLPASWTTL 745
L N L +DLS N +I M L + IS N L +
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 15/160 (9%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
L L L L+ +++ L+ +DLS NE + +L+ L ++
Sbjct: 226 VELTILKLQHNNLT-----DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
+NR ++ + L LDL +N L + LE++ +N + L
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS- 336
Query: 189 CSLPKLKSLYLNTNNLTG--LLPEFPNSCAILHLLIHEND 226
+ LK+L L+ N+ L F N + + + D
Sbjct: 337 -THHTLKNLTLSHNDWDCNSLRALFRN---VARPAVDDAD 372
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILR----- 891
E +IG G G V++ K + +K++ + + E++ L+ + H NI+
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 892 -----------IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA 940
S +K + FI E+ GTL + + LD + I
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
+G+ Y+H ++I+RD+K NI L + KIGDFG+ + + R+ G+L
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSKGTLR 186
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELL 1029
Y++PE S ++ D+Y+ G+IL ELL
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL 215
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-39
Identities = 50/224 (22%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILR 891
+ +G+G G V+ + ++A+K++ E++ L+ + H I+R
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 892 IVGSCTKDEHG------------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
+ + +I + L + ++ + + HI L I
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST-------- 991
A+ + +LH ++HRD+K NI + K+GDFG+ + T
Sbjct: 128 AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 992 --RSAIVGSLGYIAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
+ VG+ Y++PE N+YS K D++S G+ILFELL
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYS----HKVDIFSLGLILFELL 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 42/226 (18%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---EIRTLSLVRHRNILRIV 893
E ++G+G G V + + +++A+KK+ +E E+ L+ + H+ ++R
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 894 GSCTKDEHG-------------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA 940
+ + + FI EY GTL++++H L + + + I
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQIL 126
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS------------HS 988
+ LSY+H IIHRD+K NI +D KIGDFG++K + S S
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 989 SSTRSAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELL 1029
S ++ +G+ Y+A E Y EK D+YS G+I FE++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHY----NEKIDMYSLGIIFFEMI 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 71/289 (24%), Positives = 112/289 (38%), Gaps = 47/289 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-----FDVEIRTLSLVRHRNILRIV 893
G IG+G G V+ AVK + F E R L H NI+R++
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G CT+ + +IV E + GG L RL + T + A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESK---C 233
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI-----APENAY 1008
IHRD+ + N L+ + KI DFGMS+ +D +++ G L + APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-----GGLRQVPVKWTAPEALN 288
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068
R + +SDV+S+G++L+E S G + N + F+++
Sbjct: 289 YGRYSSESDVWSFGILLWETF--------SLGA----SPYPNLS---NQQTREFVEK--- 330
Query: 1069 FWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112
+L + L +C RPS + L + +
Sbjct: 331 ----GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN----RSETNFDVEIRTLSLVRHRNILRI 892
+ +G+G V + +A+K++ + E L H NILR+
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 893 VGSCTKDEHG----FIVTEYMPGGTLFNVL---HQNEPRL----VLDWNTRYHIALGIAQ 941
V C ++ +++ + GTL+N + L +L + LGI +
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL------WLLLGICR 145
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV----- 996
GL +H HRD+K NILL E +P + D G S ++ +
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 997 --GSLGYIAPE--NAYS-TRLTEKSDVYSYGVILFELLFRKMP 1034
++ Y APE + S + E++DV+S G +L+ ++F + P
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 48/241 (19%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------------------E 877
R + +GK + L K +A+KK +S E
Sbjct: 36 IRTLNQGKFNKII--LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 878 IRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY---- 933
++ ++ +++ L G T + +I+ EYM ++ + L ++
Sbjct: 94 LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQV 152
Query: 934 --HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991
I + SY+H + I HRD+K NIL+D K+ DFG S+ + D +
Sbjct: 153 IKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS 210
Query: 992 RSAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046
G+ ++ PE ++Y+ K D++S G+ L+ + + +P F +V
Sbjct: 211 ----RGTYEFMPPEFFSNESSYN---GAKVDIWSLGICLYVMFYNVVP----FSLKISLV 259
Query: 1047 T 1047
Sbjct: 260 E 260
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILR 891
G ++GKG VYR S ++ A+K +++ E++ ++H +IL
Sbjct: 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ + ++V E G + L + R+ + I G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF-SENEARHFMH-QIITGMLYLHSH-- 131
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NA 1007
I+HRD+ N+LL + KI DFG++ + + G+ YI+PE +A
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMP 1034
+ +SDV+S G + + LL + P
Sbjct: 189 HG----LESDVWSLGCMFYTLLIGRPP 211
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 1e-37
Identities = 77/403 (19%), Positives = 133/403 (33%), Gaps = 72/403 (17%)
Query: 307 QISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLR 366
+ N V+ + + L +P + + +L++ +N L +LP L L
Sbjct: 35 RACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLE 87
Query: 367 LQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPP 426
+ N + ++P L +L + + S L +L ++ N+LT +P
Sbjct: 88 VSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPV 138
Query: 427 DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVL 486
LQ LS++ N L L L +L N +P + L L
Sbjct: 139 LPP---GLQELSVSDNQLA-----SLPALPSELCKLWAYNNQLTS-LPMLP---SGLQEL 186
Query: 487 VLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIP 546
+ +N+ S P L ++ NN L SLPA
Sbjct: 187 SVSDNQLA-SLPTLPS---ELYKLWAYNNRLT-SLPALP--------------------- 220
Query: 547 PVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKL 606
S L L S NRL+ S+P L+ L +S N+L +P L
Sbjct: 221 ------SGLKELIVSGNRLT-SLPVLPSELKE---LMVSGNRLT-SLPMLPSGLL---SL 266
Query: 607 DLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP 666
+ N L +P +I L +++L+ N LS + G I
Sbjct: 267 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 667 CSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709
S + ++ + + L D+ + N+
Sbjct: 325 ASAPRETR--ALHLAAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-36
Identities = 73/351 (20%), Positives = 122/351 (34%), Gaps = 47/351 (13%)
Query: 92 ICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDL 151
C N L++ + T ++P L + TL++ DN S+P +L+ L++
Sbjct: 36 ACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELR---TLEV 88
Query: 152 GYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEF 211
N L+ +P L L L L++ N LT L
Sbjct: 89 SGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLTSLPVLP 140
Query: 212 PNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYL 271
P L L ++ + SLP S L A +N + L+ L +
Sbjct: 141 PG----LQELSVSDNQLASLPALPSELCKL---WAYNNQLTS-----LPMLPSGLQELSV 188
Query: 272 DDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRS 331
DN L +P L KL N+L ++ S L+ + +S N L +P
Sbjct: 189 SDNQLA-SLPT---LPSELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRL-TSLPVL 239
Query: 332 VGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL 391
L L + NRL +LP L+ L + N + +P + +L+ + L
Sbjct: 240 PSELKELM---VSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNL 291
Query: 392 FNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
N + Q R ++ Y+ + + R + L LA
Sbjct: 292 EGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-35
Identities = 81/419 (19%), Positives = 137/419 (32%), Gaps = 99/419 (23%)
Query: 345 NNRLQGTLPPELGNCG--SLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPH 402
+R + + ++ C L + + + T+P + A + L + +N + ++P
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA 78
Query: 403 QIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRL 462
+L L + N+LT +P L L S HL L +L
Sbjct: 79 LPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL--------PSGLCKL 126
Query: 463 DLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLP 522
+ GN +P L L + +N+ S P + L NN L SLP
Sbjct: 127 WIFGNQLTS-LPVLP---PGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLP 177
Query: 523 ATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQIL 582
S L L S+N+L+ S+P+ L L
Sbjct: 178 MLP---------------------------SGLQELSVSDNQLA-SLPTLPSELYKLWAY 209
Query: 583 RLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIP 642
N+L +P + L +S N L S+P L + L + N L+
Sbjct: 210 N---NRLT-SLPALPSGLKE---LIVSGNRL-TSLPVLPSEL---KELMVSGNRLT---- 254
Query: 643 DAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQI 702
S+P S L L+V N+L+ ++PE L +L
Sbjct: 255 ---------------------SLPMLPSGLLS----LSVYRNQLT-RLPESLIHLSSETT 288
Query: 703 LDLSSNSFSGEIPTEVNNMVSLYFVN---ISFNHFSGKLPASWTTLMVSYPGSFLGNSE 758
++L N S + + S + I F+ P L ++ + E
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPARE 347
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 7e-15
Identities = 36/194 (18%), Positives = 67/194 (34%), Gaps = 25/194 (12%)
Query: 552 WSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611
W + S R + +L + + L +P L L + DN
Sbjct: 15 WRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCLPAHIT--TLVIPDN 71
Query: 612 YLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSK 671
L S+P+ ++++L + N L+ ++P + L +P S
Sbjct: 72 NLT-SLPAL---PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSG 122
Query: 672 LHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISF 731
L L + N+L+ +P LQ L +S N + +P + + L+
Sbjct: 123 LCK----LWIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSELCKLW---AYN 170
Query: 732 NHFSGKLPASWTTL 745
N + LP + L
Sbjct: 171 NQLT-SLPMLPSGL 183
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-37
Identities = 92/530 (17%), Positives = 178/530 (33%), Gaps = 52/530 (9%)
Query: 186 NDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHL-LIHENDFVGSLPTSLSNCRNLVEF 244
N P+ K + N +H+ + ++ + G +L+N + +
Sbjct: 8 NVKPRQPEYKCIDSNLQYDC--------VFYDVHIDMQTQDVYFGFEDITLNNQKIVT-- 57
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTI 304
N+ + + Q+E+L L+D +E +QKL + N +
Sbjct: 58 --FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLP 115
Query: 305 SGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSL 362
+ L V+ L RN+L +PR + N L +L + NN L+ + + SL
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 173
Query: 363 VDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG 422
+L+L N + + + L + N + + + EL +N +
Sbjct: 174 QNLQLSSNRL-THVDLS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN- 224
Query: 423 RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-T 481
+ + L L L HN+LT L ++P L +DL+ N I + V
Sbjct: 225 VVRGPV--NVELTILKLQHNNLTDTAWLL---NYPGLVEVDLSYNEL-EKIMYHPFVKMQ 278
Query: 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLL 541
L L + NNR + + +L+ + LS+N L + + + L + N +
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL--GK 599
++ L L S N + L N+ + +I Y+L G
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGL 391
Query: 600 CTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
C K D L + V+ + + ++ + + L N
Sbjct: 392 CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
Query: 660 IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709
+L + L +L+ + + L L ++
Sbjct: 452 ----------EQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLR 491
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 97/594 (16%), Positives = 187/594 (31%), Gaps = 52/594 (8%)
Query: 135 SIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKL 194
I + + + + + + + + F N+ + + S ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 195 KSLYLNTNNLTGLLPE-FPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGG 253
+ L LN + + F + I L + N P N L N+
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-S 136
Query: 254 AISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQ 313
++ IF +L L + +NNLE +T +LQ L LS+N+L +S
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPS 193
Query: 314 LQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIG 373
L +S N L ++ ++ L +N + + + L L+LQHN +
Sbjct: 194 LFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL- 244
Query: 374 GTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRN 433
T + N L + L N +E + H +M +L L + NNRL + +
Sbjct: 245 -TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRF 493
L+ L L+HNHL + N L L L +N
Sbjct: 303 LKVLDLSHNHLLH--------------------------VERNQPQFDRLENLYLDHNSI 336
Query: 494 NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWS 553
+++ +L+ + LS+N + L RN V+ V I
Sbjct: 337 V---TLKLSTHHTLKNLTLSHNDWDCNSLRALFRN--VARPAVDDADQHCKIDYQLEHGL 391
Query: 554 NLTMLD--FSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611
D + + L + + R SA + T+ + L N
Sbjct: 392 CCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
Query: 612 Y-LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLS 670
L + ++++ + +Q+ L + + + L S
Sbjct: 452 EQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDG--LARSSDNLNK 509
Query: 671 KLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL 724
H + + E + + L+ + + ++ + L
Sbjct: 510 VFTHLKERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAEL 563
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 60/386 (15%), Positives = 117/386 (30%), Gaps = 67/386 (17%)
Query: 351 TLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKL 410
+ L D+ + E L +++ N+ + + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 411 VELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
L L + ++ I +Q L + N + + + ++ P L+ L L N
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 470 YGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP 529
+P I F+ L + +SNN L+ T +
Sbjct: 136 SS-LPRGI---------------FHN--------TPKLTTLSMSNNNLERIEDDTFQATT 171
Query: 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKL 589
+ L + N L + +L + S N LS L ++ L S N +
Sbjct: 172 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 223
Query: 590 DGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQ 649
+ + + ++ L L N L +++ + + L N L + F +Q
Sbjct: 224 N-VVRGPV--NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
Query: 650 SLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709
L L + SNN+L + + L++LDLS N
Sbjct: 279 RLERLYI-------------------------SNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 710 FSGEIPTEVNNMVSLYFVNISFNHFS 735
+ L + + N
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-24
Identities = 59/288 (20%), Positives = 99/288 (34%), Gaps = 55/288 (19%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQLGNCGQ 121
N L L L N +S + L +L +S N
Sbjct: 121 NVPLLTVLVLE--------RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172
Query: 122 LKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
L+ L L+ NR + + L ++ YN LS +++ ++E + +N +N
Sbjct: 173 LQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
+ + +L L L NNLT L N L
Sbjct: 225 -VVRGPVN--VELTILKLQHNNLTDT-------------------------AWLLNYPGL 256
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
VE S N I F + +LE LY+ +N L + + L+ L LS N L
Sbjct: 257 VEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
Query: 302 GTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
+ ++L+ + L N++V + + +L +L L +N
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 70/409 (17%), Positives = 127/409 (31%), Gaps = 36/409 (8%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
SL N+S N +S + + LD S N + +L L L
Sbjct: 192 PSLFHANVS--------YNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQ 240
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQV-SLCYSLESIGFHNNFLNGELPND 187
N + + L +DL YN L KI LE + NN L L
Sbjct: 241 HNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLY 296
Query: 188 ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS 247
+P LK L L+ N+L + P + +L + N V +L LS L + S
Sbjct: 297 GQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLS 353
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDN-----NLEGQI--PETLWGLENLQKLVLSANKL 300
N++ +F+ + + V D + LE + E+ + ++ +
Sbjct: 354 HNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSV 413
Query: 301 NGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG 360
+ C+ I ++ + L L N L+ +
Sbjct: 414 VEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ------- 466
Query: 361 SLVDLRLQHNFIGGTIPPEIC-NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNR 419
L + ++Q + + EI NL + + R + + + L +
Sbjct: 467 QLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQ 526
Query: 420 LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS 468
R + + + L + L ++ + K L
Sbjct: 527 A--RRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQK 573
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 74/332 (22%), Positives = 132/332 (39%), Gaps = 62/332 (18%)
Query: 801 RVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNN 857
++ + +++P ++ R++ + +IIG G G V +
Sbjct: 19 KLPEPQFYAEPHTYEEPGRAGRSFTREIEASRI---HIEKIIGSGDSGEVCYGRLRVPGQ 75
Query: 858 SRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912
A+K L R +F E + H NI+R+ G T+ IVTEYM G
Sbjct: 76 RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENG 135
Query: 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSE 969
+L L ++ + + + G+ G+ YL Y +HRD+ + N+L+DS
Sbjct: 136 SLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYLSDLGY------VHRDLAARNVLVDSN 187
Query: 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY--IAPENAYSTRLTEKSDVYSYGVILFE 1027
L K+ DFG+S+++ D + + G + APE + SDV+S+GV+++E
Sbjct: 188 LVCKVSDFGLSRVLEDD-PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 1028 LLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLL----- 1082
+L ++GE + N + I ++ RL
Sbjct: 247 VL--------AYGE----RPYWNMT---NRDVISSVEEG------------YRLPAPMGC 279
Query: 1083 -----ELALECTRQVADMRPSMREVVGFLIKL 1109
+L L+C + RP ++V L L
Sbjct: 280 PHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 75/219 (34%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILR 891
GR +GKGK G VY S+ A+K L ++ E E+ S +RH NILR
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 73
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ G +++ EY P GT++ L Q + + T +I +A LSY H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFD-EQRTATYITE-LANALSYCHSK-- 128
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
++IHRDIK +N+LL S E KI DFG S S R+ + G+L Y+ PE
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRM 183
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR 1050
EK D++S GV+ +E L K P F +T T+ R
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR 218
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 62/315 (19%), Positives = 116/315 (36%), Gaps = 23/315 (7%)
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318
I + + ++ + D++L+ + N+++L LS N L+ + ++ +L+++
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
LS N L + + +LS+L +L L NN +Q EL S+ L +N I +
Sbjct: 65 LSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSC 116
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG-RIPPDITRLRNLQFL 437
+ +YL NN+I G S++ L L N + L+ L
Sbjct: 117 SR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF 497
+L +N + ++ F L LDL+ N + + + L NN+
Sbjct: 175 NLQYNFIY---DVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LI 229
Query: 498 PIEIGKCSSLRRVILSNNLLQ-GSLPATLERNPGVSFLD------VRGNLLQGSIPPVFG 550
+ +L L N G+L +N V + + G + P G
Sbjct: 230 EKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 551 FWSNLTMLDFSENRL 565
+ D
Sbjct: 290 HYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 54/362 (14%), Positives = 121/362 (33%), Gaps = 49/362 (13%)
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLE 387
I N + + ++ L+ L + ++ +L L N + ++ KLE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 388 VLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGE 447
+L L +N + + + +S L L L NN + ++ +++ L A+N+++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-- 112
Query: 448 VALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG-SFPIEIGKCSS 506
+ + + L N + + + L L N + +F +
Sbjct: 113 -RVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 507 LRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS 566
L + L N + + + ++ L LD S N+L+
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-------------------------VFAKLKTLDLSSNKLA 204
Query: 567 GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA-GSIPSEVISLE 625
+ E + + + L NKL I L + DL N G++ +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 626 KMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNK 685
++Q+++ Q + +V +L G+ C ++ + ++
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHY--------GAYCCEDLPAPFADRLIALGHHH 314
Query: 686 LS 687
Sbjct: 315 HH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 58/302 (19%), Positives = 105/302 (34%), Gaps = 15/302 (4%)
Query: 280 IPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLN 339
I E + ++ + L ++ ++ + LS N L + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 340 SLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGA 399
L L +N L +L + +L L L +N++ E+ +E L+ NN I
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 400 IPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYL 459
+ G+ + L NN++T D +Q+L L N + EL L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 460 SRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQG 519
L+L N Y + + L L L +N+ E + + + L NN L
Sbjct: 172 EHLNLQYNFIYD-VKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 520 SLPATLERNPGVSFLDVRGNLLQ-GSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLEN 578
+ L + + D+RGN G++ F + + + E +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 579 LQ 580
L
Sbjct: 288 LG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 53/322 (16%), Positives = 104/322 (32%), Gaps = 19/322 (5%)
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
++ N + ++ + + ++ L L N L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L+ L LS+N L + + + L+ + L+ N + + + S+ +L NN +
Sbjct: 60 LELLNLSSNVL--YETLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
Query: 350 GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEG-AIPHQIGRMS 408
+ G ++ L +N I + ++++ L L N I+
Sbjct: 113 -RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 409 KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS 468
L L L N + + + L+ L L+ N L + E ++ + L N
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQ-SAAGVTWISLRNNK 225
Query: 469 FYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERN 528
I + NL L N F+ + + R ++ ++ L E
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEE 282
Query: 529 PGVSFLDVRGNLLQGSIPPVFG 550
V L G +P F
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 59/341 (17%), Positives = 119/341 (34%), Gaps = 31/341 (9%)
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQ 435
I N + ++ + ++ ++ A+ + EL L N L+ D+ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 436 FLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG 495
L+L+ N L + LE L LDL N + VG ++ L NN +
Sbjct: 62 LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113
Query: 496 SFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQG-SIPPVFGFWSN 554
+ + + + L+NN + V +LD++ N + + +
Sbjct: 114 ---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614
L L+ N + + ++ L+ L LS+NKL + E + + L +N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 615 GSIPSEVISLEKMQSLSLQENNLS-GAIPDAFSSVQSLFELQLGSNIF---DGSIPCSLS 670
I + + ++ L+ N G + D FS Q + + + C++
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 671 KLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711
L H+ + +++ L +
Sbjct: 287 TLGHYGAYCCEDLPAPFA-----------DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 52/348 (14%), Positives = 112/348 (32%), Gaps = 42/348 (12%)
Query: 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNS 155
++ + ++ + +K L L+ N ++ +L L+L N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
L + +L ++ +NN++ ++ P +++L+ NN++ +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV-------- 114
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN 275
S S + ++N + +++ L L N
Sbjct: 115 ------------------SCSRGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNE 155
Query: 276 LEG-QIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN 334
++ E + L+ L L N + + GQ+ +L+ + LS N L + +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQS 212
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394
+ + + L NN+L + L +L L+ N V +
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQ 270
Query: 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIP-PDITRLRNLQFLSLAH 441
++ + Q + L Y +P P RL L H
Sbjct: 271 TVKK-LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 46/257 (17%), Positives = 94/257 (36%), Gaps = 18/257 (7%)
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
+ + ++ + +++ + LS N L A L + L++ N+
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 541 LQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC 600
L S L LD + N + EL +++ L + N + R+ G
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG-- 119
Query: 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG-AIPDAFSSVQSLFELQLGSN 659
+ L++N + + ++Q L L+ N + + +S +L L L N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 660 -IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718
I+D +KL L++S+NKL+ + + + + L +N I +
Sbjct: 180 FIYDVKGQVVFAKLKT----LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 719 NNMVSLYFVNISFNHFS 735
+L ++ N F
Sbjct: 234 RFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 44/245 (17%), Positives = 94/245 (38%), Gaps = 22/245 (8%)
Query: 505 SSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENR 564
+ + ++++ L+ +L + + V LD+ GN L ++ L +L+ S N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 565 LSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISL 624
L +L +L L+ L L+ N + EL + L ++N ++ +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RG 119
Query: 625 EKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----IFDGSIPCSLSKLHHFSSILN 680
+ +++ L N ++ + L L N + + S L H LN
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH----LN 175
Query: 681 VSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPA 740
+ N + + + KL+ LDLSSN + + E + + ++++ N +
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 741 SWTTL 745
+
Sbjct: 232 ALRFS 236
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 42/227 (18%), Positives = 85/227 (37%), Gaps = 17/227 (7%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
S+L+ L+L+ NN + + + +L + N + + G K + L
Sbjct: 80 STLRTLDLN--------NNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLA 128
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQ--VSLCYSLESIGFHNNFLNGELPN 186
+N+ + R+ +LDL N + + + +LE + NF+ ++
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
Query: 187 DICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSA 246
+ KLK+L L++N L + PEF ++ + + + N V + +L +NL F
Sbjct: 187 QVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244
Query: 247 SSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKL 293
N F F +++ + E + L
Sbjct: 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 37/199 (18%), Positives = 74/199 (37%), Gaps = 13/199 (6%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
+I + + + +++ L ++ S + N++ L LS N L +L TK+
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 604 IKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663
L+LS N L ++ SL +++L L N + S+ L +N
Sbjct: 61 ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 664 SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG-EIPTEVNNMV 722
+ + ++NNK++ G ++Q LDL N +
Sbjct: 114 VSCSRGQGKKN----IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 723 SLYFVNISFNHFSGKLPAS 741
+L +N+ +N +
Sbjct: 170 TLEHLNLQYNFIY-DVKGQ 187
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 60/232 (25%), Positives = 105/232 (45%), Gaps = 32/232 (13%)
Query: 821 SEDLPRDLRYEDVIRATE-GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ET 872
++++P L R GR +GKG + ++++ +A K + +S
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 873 NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN----EPRLVLD 928
+EI + H++++ G ++ F+V E +L + + EP
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---- 116
Query: 929 WNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988
RY++ I G YLH + V IHRD+K N+ L+ +LE KIGDFG++ + +
Sbjct: 117 --ARYYLR-QIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYD 168
Query: 989 SSTRSAIVGSLGYIAPE----NAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
+ + G+ YIAPE +S + DV+S G I++ LL K P +
Sbjct: 169 GERKKVLCGTPNYIAPEVLSKKGHS----FEVDVWSIGCIMYTLLVGKPPFE 216
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 63/285 (22%), Positives = 123/285 (43%), Gaps = 48/285 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRN--IL 890
+ IG G V++ L N ++ +A+K +N E + EI L+ ++ + I+
Sbjct: 33 LKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
R+ D++ ++V E L + L + + +D R + + + +H
Sbjct: 92 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH- 146
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
I+H D+K N L+ + K+ DFG++ + +S + + VG++ Y+ PE
Sbjct: 147 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 1006 ------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
++++ KSDV+S G IL+ + + K P F + + ++ KL
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQIS----KLHA---- 251
Query: 1060 ICFLDREISFWD--SDDQLKALRLLELALECTRQVADMRPSMREV 1102
I + EI F D D L ++ C ++ R S+ E+
Sbjct: 252 IIDPNHEIEFPDIPEKD------LQDVLKCCLKRDPKQRISIPEL 290
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-37
Identities = 80/331 (24%), Positives = 140/331 (42%), Gaps = 65/331 (19%)
Query: 804 RSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR-TLSNNSRKHW 862
+ ++ D ++ V T ++IG G+ G VY+ L +S K
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 863 ---AVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914
A+K L + +F E + H NI+R+ G +K + I+TEYM G L
Sbjct: 74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 915 FNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELE 971
L + + + + GIA G+ YL +Y +HRD+ + NIL++S L
Sbjct: 134 DKFLREKDGEFSV--LQLVGMLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLV 185
Query: 972 PKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAYSTRLTEKSDVYSYGVILFEL 1028
K+ DFG+S+++ D ++ ++ G I APE + T SDV+S+G++++E+
Sbjct: 186 CKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243
Query: 1029 LFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLL------ 1082
+ ++GE + NHE + ++ RL
Sbjct: 244 M--------TYGE----RPYWELS---NHEVMKAINDGF------------RLPTPMDCP 276
Query: 1083 ----ELALECTRQVADMRPSMREVVGFLIKL 1109
+L ++C +Q RP ++V L KL
Sbjct: 277 SAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 29/234 (12%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVKK 866
D +LL +V + +P + + R+IGKG G VY +R A+K
Sbjct: 4 DSALLAEV--KDVLIPHER-----VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS 56
Query: 867 LN-----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDE-HGFIVTEYMPGGTLFNVLHQ 920
L+ + F E + + H N+L ++G E ++ YM G L +
Sbjct: 57 LSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
+ + L +A+G+ YL + +HRD+ + N +LD K+ DF
Sbjct: 117 PQRNPTV--KDLISFGLQVARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADF 168
Query: 978 GMSKLISDSHSSSTRSAIVGSL--GYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
G+++ I D S + L + A E+ + R T KSDV+S+GV+L+ELL
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILR 891
GR +GKG + ++++ +A K + +S +EI + H++++
Sbjct: 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVG 105
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQN----EPRLVLDWNTRYHIALGIAQGLSYLH 947
G ++ F+V E +L + + EP RY++ I G YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE------ARYYLR-QIVLGCQYLH 158
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
+ V IHRD+K N+ L+ +LE KIGDFG++ + + + + G+ YIAPE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEVL 213
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+S + DV+S G I++ LL K P
Sbjct: 214 SKKGHS----FEVDVWSIGCIMYTLLVGKPP 240
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 13/206 (6%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD------VEIRTLSLVRHRNILRIV 893
IG G +G + + K K+L+ E+ L ++H NI+R
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 894 GSCTKDEHG--FIVTEYMPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQGLSYLHY-- 948
+ +IV EY GG L +V+ + R LD + + L H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
D ++HRD+K N+ LD + K+GDFG+++++ +H +S VG+ Y++PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMN 189
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMP 1034
EKSD++S G +L+EL P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 63/285 (22%), Positives = 122/285 (42%), Gaps = 48/285 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRH--RNIL 890
+ IG G V++ L N ++ +A+K +N E + EI L+ ++ I+
Sbjct: 14 LKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
R+ D++ ++V E L + L + + +D R + + + +H
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH- 127
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
I+H D+K N L+ + K+ DFG++ + +S + + VG++ Y+ PE
Sbjct: 128 --GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 1006 ------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
++++ KSDV+S G IL+ + + K P F + + ++ KL
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQIS----KLHA---- 232
Query: 1060 ICFLDREISFWD--SDDQLKALRLLELALECTRQVADMRPSMREV 1102
I + EI F D D L ++ C ++ R S+ E+
Sbjct: 233 IIDPNHEIEFPDIPEKD------LQDVLKCCLKRDPKQRISIPEL 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD------VEIRTLSLVRHRNILRI 892
+ IG+G G S + + +K++N S + E+ L+ ++H NI++
Sbjct: 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL-----VLDWNTRYHIALGIAQGLSYLH 947
S ++ +IV +Y GG LF ++ + L +LDW + I L ++H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVH 142
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
+I+HRDIKS NI L + ++GDFG+++++ + + A +G+ Y++PE
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEIC 197
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
Y+ KSD+++ G +L+EL K
Sbjct: 198 ENKPYNN----KSDIWALGCVLYELCTLKHA 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 46/225 (20%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDVEIRTLSLVRHRNILRI- 892
I+G+G V+R + +A+K R E L + H+NI+++
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 893 -VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ T H ++ E+ P G+L+ VL + L + + + G+++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 952 PQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
I+HR+IK NI+ + K+ DFG ++ + D + + G+ Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMY 187
Query: 1006 ------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ + D++S GV + +P P G +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 83/334 (24%), Positives = 147/334 (44%), Gaps = 64/334 (19%)
Query: 800 VRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR-TLSNNS 858
+++ + F DP +D + ++L ++ + +++G G+ G V L S
Sbjct: 14 LKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPS 70
Query: 859 RKHW--AVKKLN-----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911
+K A+K L + +F E + H NI+R+ G TK + IVTEYM
Sbjct: 71 KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMEN 130
Query: 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDS 968
G+L + L +++ + + + GIA G+ YL Y +HRD+ + NIL++S
Sbjct: 131 GSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYLSDMGY------VHRDLAARNILINS 182
Query: 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAYSTRLTEKSDVYSYGVIL 1025
L K+ DFG+ +++ D ++ + G I +PE + T SDV+SYG++L
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTT--RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVL 240
Query: 1026 FELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLL--- 1082
+E++ S+GE + N + I +D RL
Sbjct: 241 WEVM--------SYGE----RPYWEMS---NQDVIKAVDEGY------------RLPPPM 273
Query: 1083 -------ELALECTRQVADMRPSMREVVGFLIKL 1109
+L L+C ++ + RP ++V L KL
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGS 895
+ IG G+ G V+ N K A+K + SE +F E + + H ++++ G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
C + +VTE+M G L + L + T + L + +G++YL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEACV---- 125
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAYS 1009
IHRD+ + N L+ K+ DFGM++ + D ++ G+ + +PE
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASPEVFSF 179
Query: 1010 TRLTEKSDVYSYGVILFELL-FRKMP 1034
+R + KSDV+S+GV+++E+ K+P
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 29/234 (12%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVKK 866
+P L+Q VQ +IG+G G VY ++ + H AVK
Sbjct: 8 NPELVQAVQHVVIGPSSL-------IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60
Query: 867 LNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDEH-GFIVTEYMPGGTLFNVLHQ 920
LNR F E + H N+L ++G C + E +V YM G L N +
Sbjct: 61 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
+ L +A+G+ YL + +HRD+ + N +LD + K+ DF
Sbjct: 121 ETHNPTV--KDLIGFGLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADF 172
Query: 978 GMSKLISDSHSSSTRSAIVGSL--GYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
G+++ + D S + L ++A E+ + + T KSDV+S+GV+L+EL+
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTL 881
RY+ I +G G TVY A+K + F+ E+
Sbjct: 12 RYK--I----VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 882 SLVRHRNILRI--VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
S + H+NI+ + V +D+ ++V EY+ G TL + + P L +T + I
Sbjct: 66 SQLSHQNIVSMIDVD--EEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQI 120
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL 999
G+ + H +I+HRDIK NIL+DS KI DFG++K +S++ + T + ++G++
Sbjct: 121 LDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTV 176
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
Y +PE A E +D+YS G++L+E+L
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEML 206
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-36
Identities = 106/511 (20%), Positives = 188/511 (36%), Gaps = 39/511 (7%)
Query: 202 NNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFK 261
N L + + IL++ +N + + + L S N + +FK
Sbjct: 10 NGLIHVPKDLSQKTTILNI--SQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFK 66
Query: 262 GLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNG-TISGQISHCNQLQVIALS 320
+LE L L N L I NL+ L LS N + I + + +QL+ + LS
Sbjct: 67 FNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 321 RNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI 380
+L + +L+ LL+ + L F I
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 381 CNLAKLEVLYLFNNRIEG-----------AIPHQIGRMSKLVELALYNNRLTGRIPPDIT 429
+++ V L + I+ +I ++ KL L L N T I
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 430 RL---RNLQFLSLAHNHLTGEVALEL----GKHFPYLSRLDLTGNSFYGPIPANICVGTN 482
+L + + S+++ L G++ G LS + + F P + +N
Sbjct: 242 QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 483 LFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQ 542
+ + + + K S + SNNLL ++ + L ++ N L+
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
Query: 543 GSIPP---VFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDGRIPYELG 598
+ + +L LD S+N +S ++L L +S+N L I L
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420
Query: 599 KCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658
++ LDL N + SIP +V+ LE +Q L++ N L F + SL ++ L +
Sbjct: 421 --PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
Query: 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGK 689
N +D CS ++ + S LN ++ K G
Sbjct: 478 NPWD----CSCPRIDYLSRWLNKNSQKEQGS 504
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-31
Identities = 94/473 (19%), Positives = 178/473 (37%), Gaps = 41/473 (8%)
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNR 347
L +S N ++ + I ++L+++ +S N + + SV L L L +N+
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQELEYLDLSHNK 80
Query: 348 LQGTLPPELGNCGSLVDLRLQHNFIGG-TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGR 406
L + +L L L N I E N+++L+ L L +E + I
Sbjct: 81 LV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 407 MSKLVELALYNNRLTGRIPPD-----------ITRLRNLQFLSLAHNHLTGEVALELGKH 455
++ L + + P+ I N +F + + LEL
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 456 FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKC---SSLRRVIL 512
L S++ I A + L L L N + I I + +++ +
Sbjct: 198 KCVLED---NKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 513 SNNLLQGSLPATLERNPGVS-----FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG 567
SN LQG L G S V ++ ++ +SN+ + +F+ +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 568 SIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEV---ISL 624
+ L S N L + G T++ L L N L + +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373
Query: 625 EKMQSLSLQENNLSGAIPD-AFSSVQSLFELQLGSNIFDGSIP-CSLSKLHHFSSILNVS 682
+ +Q L + +N++S S +SL L + SNI +I C ++ +L++
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK----VLDLH 429
Query: 683 NNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFNHF 734
+NK+ IP+ + L+ LQ L+++SN +P + + + SL + + N +
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 83/452 (18%), Positives = 147/452 (32%), Gaps = 67/452 (14%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
S L+ L +S +N I Y+ NQ L LDLS N+ N LK
Sbjct: 45 SKLRILIIS--------HNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVN---LK 93
Query: 124 TLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSL-SGKIPPQVSLCYSLESIGFHNNFLN 181
L L+ N F + F + +L +L L L + P L S + +
Sbjct: 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE 153
Query: 182 GELPNDICSLP--KLKSLYLNTNNLTGLLPEFPNSCAILHLL----IHENDFVGSLPTSL 235
E P + L ++ +L + A L L + E++ + L
Sbjct: 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSIL 213
Query: 236 SNCR------------------------------NLVEFSASSNNFGGAI----SPWIFK 261
+ + + FS S+ G + +
Sbjct: 214 AKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 262 GLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSR 321
L L + + + N+ + + S + + S
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 322 NNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELG---NCGSLVDLRLQHNFIGGTIPP 378
N L + + G+L+ L +L+L N+L+ L SL L + N +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
Query: 379 EIC-NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFL 437
C L L + +N + I + ++ L L++N++ IP + +L LQ L
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
++A N L V + L ++ L N +
Sbjct: 450 NVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 65/400 (16%), Positives = 130/400 (32%), Gaps = 32/400 (8%)
Query: 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEIC-NLAKLEVLYLFNN 394
L + N + ++ + L L + HN I + + +LE L L +N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHN 79
Query: 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD--ITRLRNLQFLSLAHNHLTGEVALEL 452
++ I L L L N +P + L+FL L+ HL + ++
Sbjct: 80 KLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE-KSSVLP 134
Query: 453 GKHFPYLSRLDLTGNSFYGPIPAN---ICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
H L + G ++ +L ++ N F+ + + ++L
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 510 VILSNNLLQG------SLPATLERNPGVSFLDVRGNLLQGSI---PPVFGFWSNLTMLDF 560
+ L S+ A L+ NP +S L + + + + +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 561 SENRLSGSIPSELG-----NLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615
S +L G + +L+ L I ++ ++ Y + M + + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-R 313
Query: 616 SIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHH 674
+ S + L N L+ + + + L L L N +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372
Query: 675 FSS--ILNVSNNKLSGKIPECL-GNLDKLQILDLSSNSFS 711
S L++S N +S + L L++SSN +
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 57/363 (15%), Positives = 117/363 (32%), Gaps = 19/363 (5%)
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNL 434
+P ++ K +L + N I I +SKL L + +NR+ + + + L
Sbjct: 15 VPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQEL 71
Query: 435 QFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYG-PIPANICVGTNLFVLVLGNNRF 493
++L L+HN L + L LDL+ N+F PI + L L L
Sbjct: 72 EYLDLSHNKLV---KISCH-PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL 127
Query: 494 -NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFW 552
S S ++L + P L + +
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGL---QDFNTESLHIVFPTNKEFHFILDV 184
Query: 553 SNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612
S T+ + + + + + + +L N + + T + +
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244
Query: 613 LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKL 672
++ IS ++ LQ + +S+++L Q+ S++F
Sbjct: 245 WHTTVWYFSIS-----NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 673 HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFN 732
+ + I N + + C + LD S+N + + ++ L + + N
Sbjct: 300 SNMN-IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358
Query: 733 HFS 735
Sbjct: 359 QLK 361
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-36
Identities = 74/300 (24%), Positives = 128/300 (42%), Gaps = 42/300 (14%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKL----NRSETNFDVEIRTLSLVRHRNIL 890
+ +GKG G+V L +N+ + AVKKL +F+ EI L ++H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 891 RIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL-- 946
+ G C ++ EY+P G+L + L +++ R+ I +G+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH--IKLLQYTSQICKGMEYLGT 132
Query: 947 -HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-----SSSTRSAIVGSLG 1000
Y IHRD+ + NIL+++E KIGDFG++K++ S I
Sbjct: 133 KRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----F 182
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060
+ APE+ ++ + SDV+S+GV+L+EL E ++ + I
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242
Query: 1061 CFLDREISFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115
L + +L + + EC + RPS R++ + ++ D G
Sbjct: 243 ELLKN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGS 895
+ +G G+ G V A+K + SE F E + + + H ++++ G
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
CTK FI+TEYM G L N L + R + + + + YL +
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESKQF---- 141
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAYS 1009
+HRD+ + N L++ + K+ DFG+S+ + D ++ VGS + PE
Sbjct: 142 --LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPEVLMY 195
Query: 1010 TRLTEKSDVYSYGVILFELL-FRKMP 1034
++ + KSD++++GV+++E+ KMP
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 31/207 (14%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTL-------SLVRHRNI 889
+G G +G V++ S + +AVK+ R L + +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL----VLDWNTRYHIALGIAQGLSY 945
+R+ + + ++ TE G +L L V + L++
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY------LRDTLLALAH 172
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH ++H D+K NI L K+GDFG+ + ++ G Y+APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPE 226
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELL 1029
+Y T +DV+S G+ + E+
Sbjct: 227 LLQGSYGT----AADVFSLGLTILEVA 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILR 891
GR +GKGK G VY ++ A+K L +S E EI S +RH NILR
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ + +++ E+ P G L+ L Q R + + + +A L Y H
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFD-EQRSATFMEE-LADALHYCHER-- 133
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
++IHRDIK +N+L+ + E KI DFG S R + G+L Y+ PE
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKT 188
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR 1050
EK D++ GV+ +E L P F + T R
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP----FDSPSHTETHRR 223
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 52/305 (17%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKL----NRSETNFDVEIRTLSLVRHRNIL 890
+ +GKG G+V L +N+ + AVKKL +F+ EI L ++H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 891 RIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL-- 946
+ G C ++ EY+P G+L + L +++ R+ I +G+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH--IKLLQYTSQICKGMEYLGT 163
Query: 947 -HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-----SSSTRSAIVGSLG 1000
Y IHRD+ + NIL+++E KIGDFG++K++ S I
Sbjct: 164 KRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----F 213
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060
+ APE+ ++ + SDV+S+GV+L+EL E ++ + I
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273
Query: 1061 CFLDREISFWDSDDQLKALRLL----------ELALECTRQVADMRPSMREVVGFLIKLN 1110
L RL + EC + RPS R++ + ++
Sbjct: 274 ELLKN------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
Query: 1111 DKNEG 1115
D+ G
Sbjct: 322 DQMAG 326
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-------EIRTLSLVRHRNI 889
+ IG+G+ VYR A+KK+ + EI L + H N+
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
++ S +D IV E G L ++ H + + ++ T + + + L ++H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE--- 1005
+++HRDIK N+ + + K+GD G+ + S ++ ++VG+ Y++PE
Sbjct: 155 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIH 209
Query: 1006 -NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
N Y+ KSD++S G +L+E+ + P
Sbjct: 210 ENGYNF----KSDIWSLGCLLYEMAALQSP 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 29/249 (11%)
Query: 809 SDPSLLQDVQSRSEDLPR--DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKK 866
S PSL QD + + + ++G G GT+ ++R AVK+
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFC------PKDVLGHGAEGTIVYRGMFDNRD-VAVKR 55
Query: 867 LNRS-ETNFDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPR 924
+ + D E++ L H N++R + + +I E TL + Q +
Sbjct: 56 ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114
Query: 925 LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL-----DSELEPKIGDFGM 979
+ + GL++LH I+HRD+K NIL+ +++ I DFG+
Sbjct: 115 HLGL--EPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 980 SK-LISDSHSSSTRSAIVGSLGYIAPE---NAYSTRLTEKSDVYSYGVILFELLFRKMPV 1035
K L HS S RS + G+ G+IAPE T D++S G + + ++
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH- 228
Query: 1036 DPSFGEDTD 1044
P FG+
Sbjct: 229 -P-FGKSLQ 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 29/234 (12%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVKK 866
+P L+Q VQ +IG+G G VY ++ + H AVK
Sbjct: 72 NPELVQAVQHVVIGPSSL-------IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124
Query: 867 LNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDEH-GFIVTEYMPGGTLFNVLHQ 920
LNR F E + H N+L ++G C + E +V YM G L N +
Sbjct: 125 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
+ L +A+G+ +L + +HRD+ + N +LD + K+ DF
Sbjct: 185 ETHNPTV--KDLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADF 236
Query: 978 GMSKLISDSHSSSTRSAIVGSL--GYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
G+++ + D S + L ++A E+ + + T KSDV+S+GV+L+EL+
Sbjct: 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 63/285 (22%), Positives = 121/285 (42%), Gaps = 48/285 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRH--RNIL 890
+ IG G V++ L N ++ +A+K +N E + EI L+ ++ I+
Sbjct: 61 LKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
R+ D++ ++V E L + L + + +D R + + + +H
Sbjct: 120 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH- 174
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
I+H D+K N L+ K+ DFG++ + +S + + VG++ Y+ PE
Sbjct: 175 --GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 1006 ------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
++++ KSDV+S G IL+ + + K P F + + ++ KL
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQIINQIS----KLHA---- 279
Query: 1060 ICFLDREISFWD--SDDQLKALRLLELALECTRQVADMRPSMREV 1102
I + EI F D D L ++ C ++ R S+ E+
Sbjct: 280 IIDPNHEIEFPDIPEKD------LQDVLKCCLKRDPKQRISIPEL 318
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 63/290 (21%), Positives = 130/290 (44%), Gaps = 49/290 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGS 895
+ +G G+ G V AVK + SE F E +T+ + H +++ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
C+K+ +IVTEY+ G L N L + L + + +G+++L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMAFLESHQF---- 125
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAYS 1009
IHRD+ + N L+D +L K+ DFGM++ + D S+ G+ + APE +
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHY 179
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069
+ + KSDV+++G++++E+ S G+ + + + N E + + +
Sbjct: 180 FKYSSKSDVWAFGILMWEVF--------SLGK----MPYDLYT---NSEVVLKVSQ---- 220
Query: 1070 WDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
+L + ++ C ++ + RP+ ++++ + L +K++
Sbjct: 221 ---GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-35
Identities = 61/289 (21%), Positives = 121/289 (41%), Gaps = 45/289 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGS 895
+G G++G VY + AVK L F E + ++H N+++++G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
CT++ +I+TE+M G L + L + + + ++A I+ + YL I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HR++ + N L+ K+ DFG+S+L++ ++ A + + APE+ + + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQ 1075
SDV+++GV+L+E+ ++G + + + + L+
Sbjct: 400 SDVWAFGVLLWEIA--------TYGM-------SPYPGIDLSQVYELLE----------- 433
Query: 1076 LKALRLL----------ELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
K R+ EL C + RPS E+ + ++
Sbjct: 434 -KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 64/295 (21%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW---AVKKLN-----RSETNFDVEIRTLSLVRHRNIL 890
RI+G+G G VY + N + AVK ++ F E + + H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---H 947
+++G + E +I+ E P G L + L +N+ L + T +L I + ++YL +
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESIN 133
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---AP 1004
+HRDI NIL+ S K+GDFG+S+ I D + I +P
Sbjct: 134 C------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS----VTRLPIKWMSP 183
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E+ R T SDV+ + V ++E+L SFG+ + + N + I L+
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEIL--------SFGK----QPFFWLE---NKDVIGVLE 228
Query: 1065 REISFWDSDDQLKALRLL----------ELALECTRQVADMRPSMREVVGFLIKL 1109
+ RL L C RP E+V L +
Sbjct: 229 K------------GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--------TNFDVEIRT 880
RYE + G I+G G V+ + AVK L R++ F E +
Sbjct: 13 RYE--L----GEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQN 65
Query: 881 LSLVRHRNILRI--VGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
+ + H I+ + G +IV EY+ G TL +++H P + +
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVI 122
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR-SAI 995
Q L++ H + IIHRD+K NI++ + K+ DFG+++ I+DS +S T+ +A+
Sbjct: 123 ADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+G+ Y++PE A + +SDVYS G +L+E+L
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKL-----NRSETNFDVEIRTLSLVRHRNI 889
R +G+G G V +N+ + AVK L + EI L + H NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 890 LRIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL- 946
++ G CT+D ++ E++P G+L L +N+ ++ L + A+ I +G+ YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG 143
Query: 947 --HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-----SSSTRSAIVGSL 999
Y +HRD+ + N+L++SE + KIGDFG++K I S +
Sbjct: 144 SRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV---- 193
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ APE ++ SDV+S+GV L ELL
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELL 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 63/290 (21%), Positives = 124/290 (42%), Gaps = 52/290 (17%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNI 889
+++G G GTVY+ + A+K+L ++ E ++ V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL--- 946
R++G C ++T+ MP G L + + +++ + + + IA+G++YL
Sbjct: 80 CRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDR 136
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL--GYIAP 1004
+HRD+ + N+L+ + KI DFG++KL+ A G + ++A
Sbjct: 137 RL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMAL 188
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E+ T +SDV+SYGV ++EL+ +FG + E L+
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM--------TFGS-------KPYDGIPASEISSILE 233
Query: 1065 REISFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKL 1109
+ ++L + + + +C AD RP RE++ K+
Sbjct: 234 K-------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 47/249 (18%), Positives = 97/249 (38%), Gaps = 25/249 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDVEIRTLSLVRHRNILRI- 892
I+G+G V+R + +A+K R E L + H+NI+++
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 893 -VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ T H ++ E+ P G+L+ VL + L + + + G+++L +
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 952 PQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
I+HR+IK NI+ + K+ DFG ++ + D + + G+ Y+ P+
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMY 187
Query: 1006 ------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
+ + D++S GV + +P P G + + +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 1060 ICFLDREIS 1068
I + + +
Sbjct: 248 ISGVQKAEN 256
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 69/316 (21%), Positives = 113/316 (35%), Gaps = 11/316 (3%)
Query: 183 ELPNDICSLPKLKSLYLNTNNLTGLLPE-FPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
+P I + + L L N + L + F + + L ++EN P + +N NL
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
SN I +F GL L L + +N + + L NL+ L + N L
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
Query: 302 GTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPELGNCG 360
S N L+ + L + NL IP +L L L L + +
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 361 SLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRL 420
L L + H T+ P L L + + + + + L L L N +
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260
Query: 421 TGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICV 479
+ I + L LQ + L L V + YL L+++GN + ++
Sbjct: 261 S-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL-TTLEESVFH 317
Query: 480 G-TNLFVLVLGNNRFN 494
NL L+L +N
Sbjct: 318 SVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 84/408 (20%), Positives = 137/408 (33%), Gaps = 104/408 (25%)
Query: 57 CKWSG--VSCYNNS---------SSLKALNLSGFGLSGVLNNSISYICKNQ-----HLLS 100
C V C+ + + L+L N I + +++ HL
Sbjct: 9 CSAQDRAVLCHRKRFVAVPEGIPTETRLLDLG--------KNRIKTLNQDEFASFPHLEE 60
Query: 101 LDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGK 159
L+L+ N + P N L+TL L NR + IP +F L L+ LD+ N +
Sbjct: 61 LELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-I 118
Query: 160 IPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILH 219
+ + F + L LKSL + N+L
Sbjct: 119 LLDYM----------FQD-------------LYNLKSLEVGDNDLV-------------- 141
Query: 220 LLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ 279
IS F GL LE L L+ NL
Sbjct: 142 ----------------------------------YISHRAFSGLNSLEQLTLEKCNLTSI 167
Query: 280 IPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLN 339
E L L L L L +N +L+V+ +S + + + +L
Sbjct: 168 PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 340 SLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHNFIGGTIPPEI-CNLAKLEVLYLFNNRIE 397
SL + + L +P + + L L L +N I TI + L +L+ + L ++
Sbjct: 228 SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLA 285
Query: 398 GAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHL 444
P+ ++ L L + N+LT + + + NL+ L L N L
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 69/329 (20%), Positives = 127/329 (38%), Gaps = 21/329 (6%)
Query: 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIP 474
+ R +P I + L L N + + + FP+L L+L N +
Sbjct: 18 CHRKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVE 72
Query: 475 ANICVG-TNLFVLVLGNNRF----NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP 529
NL L L +NR G F S+L ++ +S N + L +
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFT----GLSNLTKLDISENKIVILLDYMFQDLY 128
Query: 530 GVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSAN 587
+ L+V N L I F ++L L + L+ SIP+E L +L L +LRL
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL 186
Query: 588 KLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSS 647
++ Y + ++ L++S ++ + + SLS+ NL+ A
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246
Query: 648 VQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSS 707
+ L L L N L +L + + +L+ P L+ L++L++S
Sbjct: 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQE-IQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305
Query: 708 NSFSGEIPTEV-NNMVSLYFVNISFNHFS 735
N + + V +++ +L + + N +
Sbjct: 306 NQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 39/262 (14%), Positives = 71/262 (27%), Gaps = 85/262 (32%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
+SL+ L L +++ I L+ L L +LK
Sbjct: 152 NSLEQLTLE--------KCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 124 TLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGE 183
L ++ + ++ P L+ L + + +L+ +P +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA----------VRH------ 246
Query: 184 LPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVE 243
L L+ L L+ N ++
Sbjct: 247 -------LVYLRFLNLSYNPIS-------------------------------------- 261
Query: 244 FSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGT 303
I + LL+L+ + L L P GL L+ L +S N+L
Sbjct: 262 ----------TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL 311
Query: 304 ISGQISHCNQLQVIALSRNNLV 325
L+ + L N L
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDV--EIRTLSLVRHRNILRIV 893
+ ++GKG +G VY +++ A+K S + + EI ++H+NI++ +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
GS +++ I E +PGG+L +L L + T I +GL YLH + Q
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---Q 142
Query: 954 IIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE--NAYST 1010
I+HRDIK DN+L+++ KI DFG SK ++ + G+L Y+APE +
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPR 200
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
+ +D++S G + E+ K P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 52/204 (25%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGS 895
+G G++G VY + AVK L F E + ++H N+++++G
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
CT++ +I+TE+M G L + L + + + ++A I+ + YL ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNF---- 132
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLIS-DSHSSSTRSAIVGSLGYIAPENAYSTR 1011
IHRD+ + N L+ K+ DFG+S+L++ D++++ + + + APE+ +
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNK 188
Query: 1012 LTEKSDVYSYGVILFELL-FRKMP 1034
+ KSDV+++GV+L+E+ + P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 12/220 (5%)
Query: 815 QDVQSRSEDLPRDLRYEDVIR-ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN 873
+ V + P D Y + + T +G+G G V+R + AVKK+
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97
Query: 874 FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY 933
+ E+ + + I+ + G+ + I E + GG+L ++ Q L +
Sbjct: 98 VE-ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRAL 153
Query: 934 HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHSSST- 991
+ +GL YLH +I+H D+K+DN+LL S+ + DFG + + +
Sbjct: 154 YYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 992 --RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
I G+ ++APE K D++S ++ +L
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-34
Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 24/242 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIV 893
+G G G V R + ++ + A+K+ + + + EI+ + + H N++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 894 ------GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
++ + EY GG L L+Q E L + I+ L YLH
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 948 YDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
+ +IIHRD+K +NI+L + KI D G +K + + VG+L Y+AP
Sbjct: 139 EN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYLAP 192
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E + T D +S+G + FE + P P + V W ++++E I D
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP----NWQPVQWHGKVREKSNEHIVVYD 248
Query: 1065 RE 1066
Sbjct: 249 DL 250
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 69/290 (23%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 839 GRIIGKGKHGTVYR---TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNIL 890
GR IG+G+ G V++ N A+K F E T+ H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---H 947
+++G T+ +I+ E G L + L + L L + A ++ L+YL
Sbjct: 80 KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKR 136
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS---HSSSTRSAIVGSLGYIAP 1004
+ +HRDI + N+L+ S K+GDFG+S+ + DS +S + I ++AP
Sbjct: 137 F------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI----KWMAP 186
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E+ R T SDV+ +GV ++E+L G + K N++ I ++
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEIL--------MHGV----KPFQGVK---NNDVIGRIE 231
Query: 1065 REISFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKL 1109
++L L L +C RP E+ L +
Sbjct: 232 N-------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-34
Identities = 64/256 (25%), Positives = 104/256 (40%), Gaps = 41/256 (16%)
Query: 819 SRSEDLPRDLRYEDVIRA--TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFD 875
SR ++P +E ++ +I+G G GTV S R AVK++
Sbjct: 1 SRIANIPN---FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIAL 56
Query: 876 VEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN----EPRLVLDWN 930
+EI+ L+ H N++R S T D +I E L +++ E +
Sbjct: 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEY 115
Query: 931 TRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP-------------KIGDF 977
+ IA G+++LH +IIHRD+K NIL+ + I DF
Sbjct: 116 NPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 978 GMSKLISDSHSS--STRSAIVGSLGYIAPE-------NAYSTRLTEKSDVYSYGVILFEL 1028
G+ K + SS + + G+ G+ APE RLT D++S G + + +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 1029 LFRKMPVDPSFGEDTD 1044
L + P FG+
Sbjct: 233 LSKGKH--P-FGDKYS 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-34
Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHW--AVKKLNRSETN-------FDVEIR 879
Y + R++G+G G VY ++ + A+K ++ + ++ E R
Sbjct: 35 PYR--L----RRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREAR 86
Query: 880 TLSLVRHRNILRI--VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937
T ++ +++ I G D ++ + G L +L + P L I
Sbjct: 87 TAGRLQEPHVVPIHDFG--EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVR 141
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
I L H HRD+K +NIL+ ++ + DFG++ +D + VG
Sbjct: 142 QIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVG 197
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+L Y+APE + T ++D+Y+ +L+E L
Sbjct: 198 TLYYMAPERFSESHATYRADIYALTCVLYECL 229
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 56/297 (18%), Positives = 110/297 (37%), Gaps = 62/297 (20%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-------AVKKLNRSETN----FDVEIRTLSLVRHR 887
+G+G +++ + + +K L+++ N F +S + H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL- 946
+++ G C + +V E++ G+L L +N+ + + W + +A +A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE 130
Query: 947 --HYDCVPQIIHRDIKSDNILLDSELEP--------KIGDFGMSKLISDSHSSSTRSAIV 996
IH ++ + NILL E + K+ D G+S + + I
Sbjct: 131 ENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP--KDILQERI- 181
Query: 997 GSLGYIAPEN-AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055
++ PE L +D +S+G L+E+ S G+ +
Sbjct: 182 ---PWVPPECIENPKNLNLATDKWSFGTTLWEIC--------SGGD----KPLSALD--- 223
Query: 1056 NHECICFLDREISFWDSDDQLKALR---LLELALECTRQVADMRPSMREVVGFLIKL 1109
+ + F + QL A + L L C D RPS R ++ L L
Sbjct: 224 SQRKLQFYED-------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
+G G+ G V+ N K AVK L + + F E + ++H+ ++R+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
T+ E +I+TEYM G+L + L L N +A IA+G++++ +Y
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERNY---- 130
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS---HSSSTRSAIVGSLGYIAPENAYS 1009
IHRD+++ NIL+ L KI DFG+++LI D+ + I + APE
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAINY 184
Query: 1010 TRLTEKSDVYSYGVILFELL-FRKMP 1034
T KSDV+S+G++L E++ ++P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKLNRSETN----FDVEIRTLSLVRHRNIL 890
+GKG G+V L +N+ AVK+L S + F EI+ L + I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 891 RIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL-- 946
+ G +V EY+P G L + L ++ RL + + I +G+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA--SRLLLYSSQICKGMEYLGS 145
Query: 947 -HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-----SSSTRSAIVGSLG 1000
+HRD+ + NIL++SE KI DFG++KL+ +S I
Sbjct: 146 RRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI----F 195
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ APE+ + +SDV+S+GV+L+EL
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 46/301 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW----AVKKLN-----RSETNFDVEIRTLSLVRHRNI 889
R +G+G G V + + AVK L + + + EI L + H +I
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 890 LRIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL- 946
++ G C +V EY+P G+L + L ++ + A I +G++YL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH 151
Query: 947 --HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH-----SSSTRSAIVGSL 999
HY IHRD+ + N+LLD++ KIGDFG++K + + H S +
Sbjct: 152 AQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---- 201
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
+ APE + SDV+S+GV L+ELL + +++ + ++
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLRL 260
Query: 1060 ICFLDREISFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
L+R ++L + L C A RP+ ++ L +++K +
Sbjct: 261 TELLER-------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
Query: 1115 G 1115
G
Sbjct: 314 G 314
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 33/209 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLVRHRNILRIVGSC 896
+ IGKG+ G V ++ AVK + + F E ++ +RH N+++++G
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 897 TKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
+++ G +IVTEYM G+L + L VL + +L + + + YL ++
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNF---- 138
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS------TRSAIVGSLGYIAPEN 1006
+HRD+ + N+L+ + K+ DFG++K S + + T APE
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-----------APEA 185
Query: 1007 AYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
+ + KSDV+S+G++L+E+ F ++P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-33
Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 39/280 (13%)
Query: 839 GRIIGKGKHGTVYR-TLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVG 894
+G+G G V+ T + +R A+K L + F E + + +RH ++++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRV--AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
++ E +IVTEYM G+L + L + L +A IA G++Y+
Sbjct: 247 VVSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
+HRD+++ NIL+ L K+ DFG+++LI D+ ++ + A + + APE A R T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTI 360
Query: 1015 KSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDD 1074
KSDV+S+G++L EL + G V + +E + + +
Sbjct: 361 KSDVWSFGILLTELT--------TKGR----VPYPGMVNREVLDQV----------ERGY 398
Query: 1075 QLKA-----LRLLELALECTRQVADMRPSMREVVGFLIKL 1109
++ L +L +C R+ + RP+ + FL
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 58/226 (25%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDV---EIRTL-SLVRHRNI 889
R R++ +G VY S + +A+K+L E E+ + L H NI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 890 LRIVGSCTKDEHG--------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941
++ + + + ++TE G L L + E R L +T I +
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS-------- 993
+ ++H P IIHRD+K +N+LL ++ K+ DFG + IS S +
Sbjct: 148 AVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 994 --AIVGSLGYIAPE--NAYSTR-LTEKSDVYSYGVILFELLFRKMP 1034
+ Y PE + YS + EK D+++ G IL+ L FR+ P
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 76/301 (25%), Positives = 117/301 (38%), Gaps = 63/301 (20%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLN-----RSETNFDVEIRTLSLVRHRN 888
R +G G G VY + AVK L + E +F +E +S H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL----VLDWNTRYHIALGIAQGLS 944
I+R +G + FI+ E M GG L + L + PR L H+A IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 945 YL---HYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGS 998
YL H+ IHRDI + N LL KIGDFGM++ I +S R G
Sbjct: 155 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR--ASYYR---KGG 203
Query: 999 LGYI-----APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053
+ PE T K+D +S+GV+L+E+ S G +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------SLGY-------MPYPS 248
Query: 1054 QENHECICFLDREISFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIK 1108
+ N E + F+ S ++ + + +C + + RP+ ++ +
Sbjct: 249 KSNQEVLEFV-------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301
Query: 1109 L 1109
Sbjct: 302 C 302
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-33
Identities = 83/380 (21%), Positives = 129/380 (33%), Gaps = 45/380 (11%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
+DLS N L+ L + I F L L L L YN
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 159 KIPPQV-SLCYSLESIGFHNNFLNG-ELPNDI-CSLPKLKSLYLNTNNLTGLLPE--FPN 213
++ + +LE + L+G L + L L+ L L NN+ + P F N
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 214 SCAILHLLIHEN-----------DFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG 262
L + N +F G T L + + G
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI--TLQDMNEYWLGWEKCGNPFK 210
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKL-----VLSANKLNGTISGQISHC------ 311
+ L L N + + + + K+ S N +
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 312 ----NQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDL 365
+ ++ LS++ + + +SV + + L L L N + + L+ L
Sbjct: 271 GLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 366 RLQHNFIGGTIPPEIC-NLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGR 423
L NF+ G+I + NL KLEVL L N I A+ Q + L ELAL N+L
Sbjct: 329 NLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 424 IPPDI-TRLRNLQFLSLAHN 442
+P I RL +LQ + L N
Sbjct: 386 VPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-32
Identities = 82/435 (18%), Positives = 147/435 (33%), Gaps = 71/435 (16%)
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNR 347
++ + LS N + S LQ + + + I + LSSL L L N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 348 LQGTLPPE-LGNCGSLVDLRLQHNFIGGTIPPEIC--NLAKLEVLYLFNNRIEGAIPHQI 404
L +L L L + G + L LE+L L +N I+ P
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 405 -GRMSKLVELALYNNRLTGRIPPDI---TRLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460
M + L L N++ I + + ++ L L+ L
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITL---------------- 192
Query: 461 RLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS 520
D+ N T++ L L N F + +
Sbjct: 193 -QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF-----------KESMAKRFFDAIAGTK 240
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPPVFG--FWSNLTMLDFSENRLSGSIPSEL-GNLE 577
+ + + N + F S + D S++++ ++ + +
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFT 299
Query: 578 NLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENN 636
+L+ L L+ N+++ T ++KL+LS N+L GSI S + +L+K++ L L N+
Sbjct: 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNH 358
Query: 637 LSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPE-CLG 695
+ LG F G L L L + N+L +P+
Sbjct: 359 IR----------------ALGDQSFLG-----LPNLKE----LALDTNQLK-SVPDGIFD 392
Query: 696 NLDKLQILDLSSNSF 710
L LQ + L +N +
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 94/514 (18%), Positives = 171/514 (33%), Gaps = 108/514 (21%)
Query: 188 ICSLPK-LKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSA 246
+ LP + + L+ N++ L TS S ++L
Sbjct: 25 VPELPAHVNYVDLSLNSIAEL-----------------------NETSFSRLQDLQFLKV 61
Query: 247 SSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTI-- 304
G I F+GL L +L LD N GL NL+ L L+ L+G +
Sbjct: 62 EQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLS 121
Query: 305 SGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPELGNCGSLV 363
L+++ L NN+ P S N+ + L L N+++ ++ L+
Sbjct: 122 GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICE-----EDLL 175
Query: 364 DLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGR 423
+ + +H +L L + + + L
Sbjct: 176 NFQGKH----------------FTLLRLSSITL----------------QDMNEYWLGWE 203
Query: 424 IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNL 483
+ + ++ L L+ N + F ++ + G
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFK---ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQG 543
F N F G + S ++ LS + + +L +
Sbjct: 261 FK-DPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKS------------------- 293
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLDGRIPYELGKCTK 602
VF +++L L ++N ++ I L +L L LS N L K
Sbjct: 294 ----VFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDK 348
Query: 603 MIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIF 661
+ LDLS N++ ++ + L ++ L+L N L F + SL ++ L +N +
Sbjct: 349 LEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
Query: 662 DGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG 695
D CS ++ + S LN ++ K G +C G
Sbjct: 408 D----CSCPRIDYLSRWLNKNSQKEQGS-AKCSG 436
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-21
Identities = 70/339 (20%), Positives = 114/339 (33%), Gaps = 49/339 (14%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSI--PKQLGNCGQ 121
SSL L L N + +L L L+ G++
Sbjct: 79 SSLIILKLD--------YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTS 130
Query: 122 LKTLLLNDNRFQGSIPPEIF--KLKRLSWLDLGYNSLSGKIPPQV---SLCYSLESIGFH 176
L+ L+L DN + I P F ++R LDL +N + I + +
Sbjct: 131 LEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLS 188
Query: 177 NNFLNGELPNDICSLP--------KLKSLYLNTNNLTGLLPE-FPNSCAI-----LHLLI 222
+ L + + +L L+ N + + F ++ A L L
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 223 HENDFVGSLPTSLSNCRNLVEFSAS---------SNNFGGAISPWIFKGLLQLEVLYLDD 273
N T+ + N S + A+ +F LE L L
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQ 308
Query: 274 NNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV- 332
N + WGL +L KL LS N L S + ++L+V+ LS N++ +
Sbjct: 309 NEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI-RALGDQSF 367
Query: 333 GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHN 370
L +L L L N+L+ ++P SL + L N
Sbjct: 368 LGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-19
Identities = 73/363 (20%), Positives = 127/363 (34%), Gaps = 53/363 (14%)
Query: 410 LVELALYNNRLTGRIPP-DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS 468
+ + L N + + +RL++LQFL + + + L L L N
Sbjct: 32 VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 469 FYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEIG---KCSSLRRVILSNNLLQGSLPAT 524
F + G NL VL L + + +SL ++L +N ++ PA+
Sbjct: 91 FLQ-LETGAFNGLANLEVLTLTQCNLD-GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 525 L-ERNPGVSFLDVRGNLLQGSIPPVFGF----------WSNLTMLDFSENRLSGSIPSEL 573
LD+ N ++ S++T+ D +E L
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208
Query: 574 GNLENLQILRLSANKLDGRIP---YELGKCTKMIKLDLSDNYLAGSIPSE---------- 620
++ L LS N + ++ TK+ L LS++Y GS
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 621 --VISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN--------IFDGSIPCSLS 670
+ +++ L ++ + + FS L +L L N F G L+
Sbjct: 269 FKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG-----LT 323
Query: 671 KLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNI 729
L LN+S N L NLDKL++LDLS N + + + +L + +
Sbjct: 324 HLLK----LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELAL 378
Query: 730 SFN 732
N
Sbjct: 379 DTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 11/141 (7%)
Query: 68 SSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQ-LGNCGQLKTLL 126
+S +K +LS + +L + S+ L L L+ NE I L L
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHF---TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLN 329
Query: 127 LNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQV-SLCYSLESIGFHNNFLNGEL 184
L+ N SI +F L +L LDL YN + + Q +L+ + N L +
Sbjct: 330 LSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SV 386
Query: 185 PNDI-CSLPKLKSLYLNTNNL 204
P+ I L L+ ++L+TN
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPW 407
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 42/227 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLN----RSETNFDVEIRTLSLVRHRNI 889
R +G+G G V+ N AVK L + +F E L+ ++H +I
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY-------------HIA 936
++ G C + +V EYM G L L + P ++ + + HIA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 937 LGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHSSST 991
IA G+ YL H+ +HRD+ + N L+ + L KIGDFGMS+ + +D +
Sbjct: 140 SQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 193
Query: 992 RSAIVGSLGYI---APENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
+ + I PE+ + T +SDV+S+GVIL+E+ + K P
Sbjct: 194 HTMLP-----IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 63/298 (21%)
Query: 839 GRIIGKGKHGTVYR---TLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRN 888
+G G G V R + AVK L + F E+ + + HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL-- 946
++R+ G +VTE P G+L + L +++ +L T A+ +A+G+ YL
Sbjct: 83 LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139
Query: 947 -HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI--- 1002
+ IHRD+ + N+LL + KIGDFG+ + + +
Sbjct: 140 KRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWC 191
Query: 1003 APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062
APE+ + + SD + +GV L+E+ ++G+ W + +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMF--------TYGQ----EPWIGLN---GSQILHK 236
Query: 1063 LDREISFWDSDDQLKALRLL----------ELALECTRQVADMRPSMREVVGFLIKLN 1110
+D+E RL + ++C + RP+ + FL++
Sbjct: 237 IDKE-----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 36/210 (17%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIV 893
R +G G G V+ +S +K +N+ + + EI L + H NI++I
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH--------IALGIAQGLSY 945
+ +IV E GG L R+V + + L+Y
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLE-------RIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
H ++H+D+K +NIL KI DFG+++L S+ G+ Y+
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYM 193
Query: 1003 APE---NAYSTRLTEKSDVYSYGVILFELL 1029
APE + K D++S GV+++ LL
Sbjct: 194 APEVFKRDVT----FKCDIWSAGVVMYFLL 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 38/210 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDV-----EIRTLSLVRHRNILRI 892
+GKG V R + + +A K +N + + D E R ++H NI+R+
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYL 946
S ++ ++V + + GG LF + E Y H I + ++Y
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYC 121
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
H + I+HR++K +N+LL S+ + K+ DFG++ ++DS + G+ GY++
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 1004 PE----NAYSTRLTEKSDVYSYGVILFELL 1029
PE + YS + D+++ GVIL+ LL
Sbjct: 176 PEVLKKDPYS----KPVDIWACGVILYILL 201
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 40/195 (20%), Positives = 76/195 (38%), Gaps = 13/195 (6%)
Query: 846 KHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905
K + V+IR + +N + + + + +I
Sbjct: 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQ 139
Query: 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNIL 965
+ L + +++ + HI + IA+ + +LH ++HRD+K NI
Sbjct: 140 MQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIF 196
Query: 966 LDSELEPKIGDFGMSKLISDSHSSST----------RSAIVGSLGYIAPENAYSTRLTEK 1015
+ K+GDFG+ + T + VG+ Y++PE + + K
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 1016 SDVYSYGVILFELLF 1030
D++S G+ILFELL+
Sbjct: 257 VDIFSLGLILFELLY 271
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 96/520 (18%), Positives = 184/520 (35%), Gaps = 35/520 (6%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
S + + NLT + + P L L +N +S L S
Sbjct: 28 FSNELESMVDYSNRNLTHVPKDLPPRTKALSL--SQNSISELRMPDISFLSELRVLRLSH 85
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNG-TISGQ 307
N ++ +F LE L + N L+ I + +L+ L LS N + + +
Sbjct: 86 NRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKE 141
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRL 367
+ +L + LS V +L LL + E + L L
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 368 QHNFIGGTIPPEICNLAKLEVLYLFNNRIEGA-------IPHQIGRMSKLVELALYNNRL 420
+ ++ L L L N ++ ++ R L+ + L +
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIET 261
Query: 421 TGRIPPDITRL---RNLQFLSLAHNHLTGEVALELGKHF----PYLSRLDLTGNSFYGPI 473
T + + + R +++L++ + +T + E + L + F
Sbjct: 262 TWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSK 321
Query: 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSF 533
A V + + +L + + SS + + N+ S+ +
Sbjct: 322 EALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT 381
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRL----SGSIPSELGNLENLQILRLSANKL 589
L ++ N L+ + V N++ L+ + L S + E++ +L LS+N L
Sbjct: 382 LILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 590 DGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPD-AFSSV 648
G + L K LDL +N + SIP +V L+ +Q L++ N L ++PD F +
Sbjct: 441 TGSVFRCLPPKVK--VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRL 496
Query: 649 QSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSG 688
SL + L N +D C+ + + S +N + +
Sbjct: 497 TSLQYIWLHDNPWD----CTCPGIRYLSEWINKHSGVVRN 532
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-27
Identities = 91/472 (19%), Positives = 160/472 (33%), Gaps = 45/472 (9%)
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQL 314
+ L +L VL L N + ++L+ L +S N+L ++ L
Sbjct: 67 LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMAS---L 123
Query: 315 QVIALSRNNLVGQIPRSV--GNLSSLNSLLLFNNRLQ-GTLPPELGNCGSLVDLRLQHNF 371
+ + LS N+ +P GNL+ L L L + + L P S + L L
Sbjct: 124 RHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYH 182
Query: 372 IGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGR-------I 424
I G + VL+L + ++ L L L N +L
Sbjct: 183 IKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF 241
Query: 425 PPDITRLRNLQFLSLAHNHLTGEVALELGKHF--PYLSRLDLTGNSFYGPIPANICVGTN 482
++TR L ++L H T + +++L + F + L++ + I +
Sbjct: 242 LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSE 301
Query: 483 LFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQ 542
+ L + N + S A ++ + +
Sbjct: 302 TALKSLMIEH-------------------VKNQVFLFSKEALYSVFAEMNIKMLSISDTP 342
Query: 543 GSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTK 602
S+ T L+F++N + S+ L+ LQ L L N L
Sbjct: 343 FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKN 401
Query: 603 MIKLDLSDNYL----AGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658
M L+ D L + + E + L+L N L+G++ + L L +
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHN 459
Query: 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSF 710
N SIP ++ L LNV++N+L L LQ + L N +
Sbjct: 460 NRIM-SIPKDVTHLQALQE-LNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 74/401 (18%), Positives = 139/401 (34%), Gaps = 41/401 (10%)
Query: 69 SSLKALNLSG-----FGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
+SL+ L+LS + N L L LS +F + L
Sbjct: 121 ASLRHLDLSFNDFDVLPVCKEFGN-------LTKLTFLGLSAAKFR-QLDLLPVAHLHLS 172
Query: 124 TLLLNDNRFQGS-IPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNG 182
+LL+ + E ++ + L L ++ S +L + N LN
Sbjct: 173 CILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLND 232
Query: 183 -------ELPNDICSLPKLKSLYLNTNNLTG----LLPEFPNSCAILHLLIHENDFVGSL 231
+++ P L ++ L T L +F + +L I+ +
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292
Query: 232 ----PTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGL 287
T + N ++ ++ + L ++
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSP 352
Query: 288 ENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNR 347
+ L + N ++ S +LQ + L RN L + +++SL +
Sbjct: 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVS 411
Query: 348 LQGTLPPELGNC-----GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPH 402
L +L + S++ L L N + G++ C K++VL L NNRI +IP
Sbjct: 412 LN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--CLPPKVKVLDLHNNRIM-SIPK 467
Query: 403 QIGRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHN 442
+ + L EL + +N+L +P + RL +LQ++ L N
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 6e-18
Identities = 65/436 (14%), Positives = 126/436 (28%), Gaps = 60/436 (13%)
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNR 347
+ L LS N ++ IS ++L+V+ LS N + + V L L + +NR
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR 111
Query: 348 LQGTLPPELGNCGSLVDLRLQHN-FIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGR 406
LQ + SL L L N F + E NL KL L L + +
Sbjct: 112 LQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVA 167
Query: 407 MSKLVELALYNNRLTG-RIPPDITRLRNLQFLSLAHNHLTGEVALELGK----HFPYLSR 461
L + L + ++ N L L + + LS
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP-----IEIGKCSSLRRVILSNNL 516
+ L + + + +L + ++ + + + + N
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287
Query: 517 LQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNL 576
+ + + +L + S +
Sbjct: 288 ITERIDREEFTYSETAL-------------------KSLMIEHVKNQVFLFSKEALYSVF 328
Query: 577 ENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENN 636
+ I LS + + L+ + N S+ +L+++Q+L LQ N
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNG 388
Query: 637 LSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECL-G 695
L +++ L+ S N L+ +
Sbjct: 389 LK-NFFKVALMTKNMSSLETLDV----------------------SLNSLNSHAYDRTCA 425
Query: 696 NLDKLQILDLSSNSFS 711
+ + +L+LSSN +
Sbjct: 426 WAESILVLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 7e-17
Identities = 52/324 (16%), Positives = 116/324 (35%), Gaps = 17/324 (5%)
Query: 11 FSLNQFLALSVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSS 70
+ L + P+++ VQ S+ L + + + +S +
Sbjct: 191 LQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPT 250
Query: 71 LKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLG--NCGQLKTLLLN 128
L + L + + + + + L++ T I ++ + LK+L++
Sbjct: 251 LLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIE 310
Query: 129 DNRFQG--SIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELP 185
+ Q ++ ++ L + S + F N +
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370
Query: 186 NDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNC-----RN 240
+L +L++L L N L + + L + + SL + + +
Sbjct: 371 QGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 241 LVEFSASSNNFGGAISPWIFKGL-LQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK 299
++ + SSN ++ +F+ L +++VL L +N + IP+ + L+ LQ+L +++N+
Sbjct: 430 ILVLNLSSNM----LTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484
Query: 300 LNGTISGQISHCNQLQVIALSRNN 323
L G LQ I L N
Sbjct: 485 LKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 4e-15
Identities = 59/363 (16%), Positives = 120/363 (33%), Gaps = 21/363 (5%)
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNL 434
+P ++ + + L L N I I +S+L L L +NR+ + + ++L
Sbjct: 46 VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102
Query: 435 QFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF-YGPIPANICVGTNLFVLVLGNNRF 493
++L ++HN L + L LDL+ N F P+ T L L L +F
Sbjct: 103 EYLDVSHNRLQ---NISCCP-MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 494 NGSFPIEIGKCSSLRRVILSNNLLQGS-LPATLERNPGVSFLDVRGNLLQGSIPPVFGFW 552
+ L ++L + P + L + + V
Sbjct: 159 R-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
Query: 553 SNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612
+ L L S +L+ L + + + + KC+ +
Sbjct: 218 NALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKL-------- 269
Query: 613 LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKL 672
P V L + +L++ E + ++++SL + + +F S S
Sbjct: 270 FQFFWPRPVEYLN-IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328
Query: 673 HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFN 732
+ I +S + C + L+ + N F+ + + + L + + N
Sbjct: 329 AEMN-IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 733 HFS 735
Sbjct: 388 GLK 390
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 77/316 (24%), Positives = 122/316 (38%), Gaps = 79/316 (25%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLN----RSETNFDVEIRTLSLVRHRNI 889
+G+G G V+ +N AVK L + +F E L++++H++I
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------------HIAL 937
+R G CT+ +V EYM G L L + P L +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 938 GIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
+A G+ YL H+ +HRD+ + N L+ L KIGDFGMS+ I + R
Sbjct: 166 QVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--TDYYR-- 215
Query: 995 IVGSLGYI-----APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT 1049
VG + PE+ + T +SDV+S+GV+L+E+ ++G+
Sbjct: 216 -VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF--------TYGK-------Q 259
Query: 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLE-----------LALECTRQVADMRPS 1098
W N E I D + R LE + C ++ R S
Sbjct: 260 PWYQLSNTEAI-------------DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS 306
Query: 1099 MREVVGFLIKLNDKNE 1114
+++V L L
Sbjct: 307 IKDVHARLQALAQAPP 322
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 37/279 (13%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGS 895
+G+G G V+ N + + A+K L S F E + + +RH ++++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
++ E +IVTEYM G+L + L + L +A IA G++Y+ +
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERM---NYV 385
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRD+++ NIL+ L K+ DFG+++LI D+ ++ + A + + APE A R T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQ 1075
SDV+S+G++L EL + G V + +E + + + +
Sbjct: 445 SDVWSFGILLTELT--------TKGR----VPYPGMVNREVLDQV----------ERGYR 482
Query: 1076 LKA-----LRLLELALECTRQVADMRPSMREVVGFLIKL 1109
+ L +L +C R+ + RP+ + FL
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 49/213 (23%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW---AVKKLNRSETN------FDVEIRTLSLVRHRNI 889
G+I+G+G+ G+V AVK + ++ F E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 890 LRIVGSCTKDE-----HGFIVTEYMPGGTLFNVLHQNEPRL---VLDWNTRYHIALGIAQ 941
+R++G C + ++ +M G L L + + T + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 942 GLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHSSSTRSAIV 996
G+ YL ++ +HRD+ + N +L ++ + DFG+SK I D + + +
Sbjct: 159 GMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM- 211
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ +IA E+ T KSDV+++GV ++E+
Sbjct: 212 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 52/217 (23%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNI 889
+++G G GTVY+ + A+K+L ++ E ++ V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL--- 946
R++G C ++T+ MP G L + + +++ + + + IA+G++YL
Sbjct: 80 CRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDR 136
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL--GYIAP 1004
+HRD+ + N+L+ + KI DFG++KL+ A G + ++A
Sbjct: 137 RL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMAL 188
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
E+ T +SDV+SYGV ++EL+ +FG
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM--------TFGS 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRH 886
+ +G G G V + K A++ +++ N + EI L + H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIA 940
I++I +++ +IV E M GG LF+ ++V N R +
Sbjct: 200 PCIIKIKNFFDAEDY-YIVLELMEGGELFD-------KVVG--NKRLKEATCKLYFYQML 249
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVG 997
+ YLH + IIHRD+K +N+LL S+ E KI DFG SK++ ++ T + G
Sbjct: 250 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 303
Query: 998 SLGYIAPE---NAYSTRLTEKSDVYSYGVILFELL 1029
+ Y+APE + + D +S GVILF L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 76/413 (18%), Positives = 129/413 (31%), Gaps = 42/413 (10%)
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC-GSLVDLRLQHNFIGGTIP-PEICNLAK 385
I + N SL S F N + + + L + + C + +
Sbjct: 3 IMLPINNNFSL-SQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 386 LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
L L + ++P + ++ L + N L +P +L++L N L+
Sbjct: 61 FSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS 113
Query: 446 GEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCS 505
L + L LD+ N +P L + NN+ P
Sbjct: 114 -----TLPELPASLKHLDVDNNQL-TMLPELPA---LLEYINADNNQLT-MLPELPT--- 160
Query: 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLT----MLDFS 561
SL + + NN L LP E + LDV NLL+ S+P V +
Sbjct: 161 SLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCR 215
Query: 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEV 621
ENR++ IP + +L+ + L N L RI L + T Y S+
Sbjct: 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQ 272
Query: 622 ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNV 681
+ S + FE + +N F + LS +
Sbjct: 273 QNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGF 331
Query: 682 SNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHF 734
+ L L L S + + + + V+L + N+
Sbjct: 332 REQ-----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 66/316 (20%), Positives = 121/316 (38%), Gaps = 34/316 (10%)
Query: 457 PYLSRLDLTGNSFYG---PIPANI--CVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVI 511
P + L+ NSFY A+ + G NR ++ + +
Sbjct: 6 PINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ 65
Query: 512 LSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS 571
L+ L SLP L ++ L++ N L S+P + +L LD +NRLS ++P
Sbjct: 66 LNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPE 117
Query: 572 ELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLS 631
+L++L + N+L +P ++ +N L +P SLE LS
Sbjct: 118 LPASLKHL---DVDNNQLT-MLPELPALLEY---INADNNQL-TMLPELPTSLEV---LS 166
Query: 632 LQENNLSGAIPDAFSSVQSLFELQLGSNIFDG--SIPCSLSKLHHFSSILNVSNNKLSGK 689
++ N L+ +P+ +SL L + +N+ + ++P N+++
Sbjct: 167 VRNNQLT-FLPE---LPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRIT-H 221
Query: 690 IPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL---YFVNISFNHFSGKLPASWTTLM 746
IPE + +LD + L N S I ++ + + I F+ G+ L
Sbjct: 222 IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLA 281
Query: 747 VSYPGSFLGNSELCRQ 762
+ F N +
Sbjct: 282 DAVTAWFPENKQSDVS 297
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 58/382 (15%), Positives = 117/382 (30%), Gaps = 82/382 (21%)
Query: 88 SISYICKNQHLLSLDLSGNEFTGSIPKQLGNC-GQLKTL-LLNDNRFQGSIPPEIFKLKR 145
SI N LS + N + + + + L +NR + + + +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ 60
Query: 146 LSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLT 205
S L L +LS LP+++ P++ L + N L
Sbjct: 61 FSELQLNRLNLS-------------------------SLPDNLP--PQITVLEITQNALI 93
Query: 206 GLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQ 265
L + + +L +N +LP ++ ++L +N + +
Sbjct: 94 SLPELPAS---LEYLDACDNRLS-TLPELPASLKHL---DVDNNQL-----TMLPELPAL 141
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
LE + D+N L +PE +L+ L + N+L
Sbjct: 142 LEYINADNNQLT-MLPELP---TSLEVLSVRNNQLT------------------------ 173
Query: 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSL----VDLRLQHNFIGGTIPPEIC 381
+P +L +L+ + N L+ +LP + R + N I IP I
Sbjct: 174 -FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
+L + L +N + I + + + + + T R L
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAV--T 285
Query: 442 NHLTGEVALELGKHFPYLSRLD 463
++ + + +
Sbjct: 286 AWFPENKQSDVSQIWHAFEHEE 307
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 50/215 (23%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRNI 889
+++G G GTV++ + + +K + +S + + + H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL--- 946
+R++G C +VT+Y+P G+L + + Q+ L + + IA+G+ YL
Sbjct: 78 VRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEH 134
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
+HR++ + N+LL S + ++ DFG++ L+ S + ++A E+
Sbjct: 135 GM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
+ + T +SDV+SYGV ++EL+ +FG
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELM--------TFGA 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 55/227 (24%), Positives = 111/227 (48%), Gaps = 22/227 (9%)
Query: 814 LQDVQSRSEDLPRDLRYEDVIRATEGR-------IIGKGKHGTVYRTLSNNSRKHWAVKK 866
L+ VQ R+ + + ++ + +G+G +G+VY+ + + + A+K+
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 867 LNRSETNFDV--EIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPR 924
+ ++ EI + ++++ GS K+ +IV EY G++ +++
Sbjct: 62 VPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121
Query: 925 LVLDWNTRYHIAL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981
L T IA +GL YLH+ + IHRDIK+ NILL++E K+ DFG++
Sbjct: 122 L-----TEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
++D+ + R+ ++G+ ++APE +D++S G+ E+
Sbjct: 174 QLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-32
Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
+ +G G+ G V+ N K AVK + + F E + ++H ++++
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
TK E +I+TE+M G+L + L +E + IA+G++++ +Y
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNY---- 305
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAYS 1009
IHRD+++ NIL+ + L KI DFG++++I D + +A G+ I APE
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAINF 359
Query: 1010 TRLTEKSDVYSYGVILFELL-FRKMP 1034
T KSDV+S+G++L E++ + ++P
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 51/283 (18%)
Query: 842 IGKGKHGTVYRTLSNNSRKHW--AVKKL-----NRSETNFDVEIRTLSLVRHRNILRIVG 894
+G G G+V + + +K A+K L E + + + + I+R++G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCV 951
C + +V E GG L L + + + ++ G+ YL ++
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNF--- 131
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---APENAY 1008
+HRD+ + N+LL + KI DFG+SK + S +A + APE
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECIN 186
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068
+ + +SDV+SYGV ++E L S+G+ + + K E + F+++
Sbjct: 187 FRKFSSRSDVWSYGVTMWEAL--------SYGQ----KPYKKMK---GPEVMAFIEQ--- 228
Query: 1069 FWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFL 1106
+++ L L +C + RP V +
Sbjct: 229 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN--RSETNFDV---EIRTLSLVRHRNILRIVGSC 896
IG G V ++ A+K++N + +T+ D EI+ +S H NI+ S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN--TRYHIAL---GIAQGLSYLHYDCV 951
+ ++V + + GG++ +++ + IA + +GL YLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-- 140
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS---HSSSTRSAIVGSLGYIAPE--- 1005
IHRD+K+ NILL + +I DFG+S ++ + R VG+ ++APE
Sbjct: 141 -GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 1006 --NAYSTRLTEKSDVYSYGVILFEL 1028
Y K+D++S+G+ EL
Sbjct: 200 QVRGYD----FKADIWSFGITAIEL 220
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-32
Identities = 55/203 (27%), Positives = 105/203 (51%), Gaps = 21/203 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVRHRNILRIVGSC 896
+ IGKG+ G V ++ AVK K + + F E ++ +RH N+++++G
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 897 TKDEHGF-IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL---HYDCVP 952
+++ G IVTEYM G+L + L VL + +L + + + YL ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNF---- 310
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
+HRD+ + N+L+ + K+ DFG++K S + + + + + APE +
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPV----KWTAPEALREKKF 363
Query: 1013 TEKSDVYSYGVILFELL-FRKMP 1034
+ KSDV+S+G++L+E+ F ++P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 55/238 (23%), Positives = 93/238 (39%), Gaps = 42/238 (17%)
Query: 819 SRSEDLPRDLRYEDVIRA-TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------- 870
+R LP I+G+G V R + + K +AVK ++ +
Sbjct: 1 TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 871 ------ETNFDVEIRTL-SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP 923
E+ L + H NI+++ + + F+V + M G LF+
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD------- 113
Query: 924 RLVLDWNTRY------HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
L I + + + LH I+HRD+K +NILLD ++ K+ DF
Sbjct: 114 YLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168
Query: 978 GMSKLISDSHSSSTRSAIVGSLGYIAPE------NAYSTRLTEKSDVYSYGVILFELL 1029
G S + + G+ Y+APE N ++ D++S GVI++ LL
Sbjct: 169 GFSCQLDPGEKLRE---VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 58/258 (22%), Positives = 93/258 (36%), Gaps = 59/258 (22%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNI 889
IG+G +G V + N +R A+K +N++ E+R + + H NI
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLF-------------------------------NVL 918
R+ +++ +V E GG L +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 919 HQNEPRLVLDWNTRY------HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS--EL 970
+ + + +I I L YLH I HRDIK +N L +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 971 EPKIGDFGMSKLISDSHSSSTR--SAIVGSLGYIAPE--NAYSTRLTEKSDVYSYGVILF 1026
E K+ DFG+SK ++ + G+ ++APE N + K D +S GV+L
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 1027 ELLFRKMPVDPSFGEDTD 1044
LL +P F D
Sbjct: 268 LLLMGAVP----FPGVND 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 34/218 (15%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSRKHW--AVKKL------NRSETNFDVEIRTLSLVRHRNI 889
E + +G G GTV + + AVK L + E + + + I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL--- 946
+R++G C + +V E G L L QN + + ++ G+ YL
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 136
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI---A 1003
++ +HRD+ + N+LL ++ KI DFG+SK + + A + A
Sbjct: 137 NF------VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYA 188
Query: 1004 PENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
PE + + KSDV+S+GV+++E S+G+
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAF--------SYGQ 218
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-32
Identities = 70/316 (22%), Positives = 124/316 (39%), Gaps = 55/316 (17%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVKK 866
+ +R ++ R E + GR IG+G+ G V++ N A+K
Sbjct: 373 EEDTYTMPSTRDYEIQR----ERIEL---GRCIGEGQFGDVHQGIYMSPENPAMAVAIKT 425
Query: 867 LN-----RSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN 921
F E T+ H +I++++G T+ +I+ E G L + L
Sbjct: 426 CKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR 484
Query: 922 EPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978
+ L L + A ++ L+YL + +HRDI + N+L+ S K+GDFG
Sbjct: 485 KFSLDL--ASLILYAYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFG 536
Query: 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038
+S+ + DS + + ++APE+ R T SDV+ +GV ++E+L
Sbjct: 537 LSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEIL--------M 587
Query: 1039 FGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKA-----LRLLELALECTRQVA 1093
G + K N++ I ++ ++L L L +C
Sbjct: 588 HGV----KPFQGVK---NNDVIGRIEN-------GERLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 1094 DMRPSMREVVGFLIKL 1109
RP E+ L +
Sbjct: 634 SRRPRFTELKAQLSTI 649
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-32
Identities = 75/301 (24%), Positives = 116/301 (38%), Gaps = 63/301 (20%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLN-----RSETNFDVEIRTLSLVRHRN 888
R +G G G VY + AVK L + E +F +E +S H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL----VLDWNTRYHIALGIAQGLS 944
I+R +G + FI+ E M GG L + L + PR L H+A IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 945 YL---HYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGS 998
YL H+ IHRDI + N LL KIGDFGM++ I + R G
Sbjct: 196 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR--AGYYRK---GG 244
Query: 999 LGYI-----APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053
+ PE T K+D +S+GV+L+E+ S G +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF--------SLGY-------MPYPS 289
Query: 1054 QENHECICFLDREISFWDSDDQLKA-----LRLLELALECTRQVADMRPSMREVVGFLIK 1108
+ N E + F+ S ++ + + +C + + RP+ ++ +
Sbjct: 290 KSNQEVLEFV-------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
Query: 1109 L 1109
Sbjct: 343 C 343
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 37/222 (16%)
Query: 839 GRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRSET-----NFDVEIRTLSLVRHRN 888
R +G+G G VY + + A+K +N + + F E + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTR-------YHIALGIAQ 941
++R++G ++ + ++ E M G L + L P + + +A IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 942 GLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998
G++YL + +HRD+ + N ++ + KIGDFGM++ I + + R G
Sbjct: 150 GMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYR---KGG 198
Query: 999 LGYI-----APENAYSTRLTEKSDVYSYGVILFELL-FRKMP 1034
G + +PE+ T SDV+S+GV+L+E+ + P
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 34/226 (15%)
Query: 814 LQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN 873
L +Q+ D P +L + + IGKG G V++ + N ++K A+K ++ E
Sbjct: 10 LPGMQNLKAD-PEEL-FTKL------EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61
Query: 874 FDV-----EIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ---NEPRL 925
++ EI LS + + GS KD +I+ EY+ GG+ ++L +E
Sbjct: 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET-- 119
Query: 926 VLDWNTRYHIAL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982
IA I +GL YLH + + IHRDIK+ N+LL E K+ DFG++
Sbjct: 120 --------QIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
++D+ R+ VG+ ++APE + K+D++S G+ EL
Sbjct: 169 LTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRH 886
+ +G G G V + K A+K +++ N + EI L + H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIA 940
I++I +++ +IV E M GG LF+ ++V N R +
Sbjct: 75 PCIIKIKNFFDAEDY-YIVLELMEGGELFD-------KVVG--NKRLKEATCKLYFYQML 124
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVG 997
+ YLH + IIHRD+K +N+LL S+ E KI DFG SK++ ++ T + G
Sbjct: 125 LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 178
Query: 998 SLGYIAPE---NAYSTRLTEKSDVYSYGVILFELL 1029
+ Y+APE + + D +S GVILF L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW---AVKKLNRSET------NFDVEIRTLSLVRHRNI 889
GR++GKG+ G+V + AVK L F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 890 LRIVGSCTKDE------HGFIVTEYMPGGTLFNVLHQNEPR---LVLDWNTRYHIALGIA 940
++VG + ++ +M G L L + L T + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 941 QGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI--SDSHSSSTRSAI 995
G+ YL ++ IHRD+ + N +L ++ + DFG+S+ I D + S +
Sbjct: 148 CGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ ++A E+ T SDV+++GV ++E++
Sbjct: 202 --PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRI 892
+ +G G +G V + A+K + ++ + E+ L L+ H NI+++
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYL 946
+ ++V E GG LF+ + ++ I + G++YL
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYL 152
Query: 947 HYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
H I+HRD+K +N+LL+S+ + KI DFG+S + + +G+ YIA
Sbjct: 153 HKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIA 206
Query: 1004 PENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
PE + EK DV+S GVILF LL P FG TD
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGYPP----FGGQTD 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 38/220 (17%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLN-----RSETNFDVEIRTLSLVRHRN 888
+G+ + G VY+ A+K L F E + ++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY-------------HI 935
++ ++G TKD+ ++ Y G L L P + H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 936 ALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992
IA G+ YL H +H+D+ + N+L+ +L KI D G+ + + +++
Sbjct: 134 VAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYY 184
Query: 993 SAIVGSLGYI---APENAYSTRLTEKSDVYSYGVILFELL 1029
+ SL I APE + + SD++SYGV+L+E+
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 38/210 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDV-----EIRTLSLVRHRNILRI 892
+GKG V R + + +A K +N + + D E R ++H NI+R+
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYL 946
S ++ ++V + + GG LF + E Y H I + ++Y
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYC 144
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
H + I+HR++K +N+LL S+ + K+ DFG++ ++DS + G+ GY++
Sbjct: 145 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 198
Query: 1004 PE----NAYSTRLTEKSDVYSYGVILFELL 1029
PE + YS + D+++ GVIL+ LL
Sbjct: 199 PEVLKKDPYS----KPVDIWACGVILYILL 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 36/222 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDV--EIRTLSLVRHRNILR 891
R++GKG G V + + AVK ++ + + E++ L + H NI++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSY 945
+ + ++V E GG LF+ + + R+ I + G++Y
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITY 141
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
+H + +I+HRD+K +N+LL+S+ + +I DFG+S S +G+ YI
Sbjct: 142 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYI 195
Query: 1003 APENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
APE EK DV+S GVIL+ LL P F +
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPP----FNGANE 232
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDV-----EIRTLSLVRHRNILRI 892
++GKG G V + +++ +AVK +N++ N D E+ L + H NI+++
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYL 946
+IV E GG LF+ ++ R+ I + G++Y+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFD-------EIIK--RKRFSEHDAARIIKQVFSGITYM 137
Query: 947 HYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
H I+HRD+K +NILL+S+ + KI DFG+S + +G+ YIA
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIA 191
Query: 1004 PE---NAYSTRLTEKSDVYSYGVILFELL 1029
PE Y EK DV+S GVIL+ LL
Sbjct: 192 PEVLRGTYD----EKCDVWSAGVILYILL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-31
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 35/218 (16%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNN-SRKHWAVKKLNRSE-----TNFDVEIRTLS 882
+YE + I G G +Y L N + + +K L S E + L+
Sbjct: 81 QYE--V----KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLA 134
Query: 883 LVRHRNILRI-----VGSCTKDEHGFIVTEYMPGGTLFNVLHQN-EPRLVLDWNTRYHIA 936
V H +I++I D G+IV EY+ G +L Q +
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YL 188
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
L I LSYLH +++ D+K +NI+L E + K+ D G I+ +
Sbjct: 189 LEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLY 238
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
G+ G+ APE T T +D+Y+ G L L
Sbjct: 239 GTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 60/420 (14%), Positives = 124/420 (29%), Gaps = 43/420 (10%)
Query: 220 LLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ 279
+ + + S L +++ ++ + L L L NN+
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG--IEKLTGLTKLICTSNNIT-T 78
Query: 280 IPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLN 339
+ L NL L +NKL + ++ +L + N L V L
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKL---TKLDVSQNPLLT 130
Query: 340 SLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGA 399
L N L + + + L +L N ++ +L L N+I
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-E 184
Query: 400 IPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYL 459
+ + + L L N +T D+ + L FL + N LT +++ L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT---EIDVTP-LTQL 235
Query: 460 SRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQG 519
+ D + N + + + L L I++ + L
Sbjct: 236 TYFDCSVNPL-TELDVSTL--SKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIK 289
Query: 520 SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENL 579
L + N + LD + + + L L + L+ + + + L
Sbjct: 290 ELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKL 341
Query: 580 QILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG 639
+ L + +GK + ++ + + ++S + G
Sbjct: 342 KSLSCVNAHIQD-FS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 77/421 (18%), Positives = 140/421 (33%), Gaps = 44/421 (10%)
Query: 170 LESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVG 229
S + L L SL + +++T + + L+ N+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNIT- 77
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
+L LS NL + SN ++ L +L L D N L ++ +
Sbjct: 78 TLD--LSQNTNLTYLACDSNK----LTNLDVTPLTKLTYLNCDTNKLT-KLDVS--QNPL 128
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L L + N L +SH QL + N + ++ V + L +L N++
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 350 GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSK 409
L + L L N I ++ +L L +N++ I + +++
Sbjct: 184 -ELD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 410 LVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
L N LT D++ L L L L ++L H L G
Sbjct: 235 LTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL---EIDLT-HNTQLIYFQAEGCRK 287
Query: 470 YGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP 529
+ ++ T L++L +++ + L + L+N L L + N
Sbjct: 288 IKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNT 339
Query: 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKL 589
+ L +Q G L +E + ++P E +L I +S + L
Sbjct: 340 KLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIA-VSPDLL 395
Query: 590 D 590
D
Sbjct: 396 D 396
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 81/471 (17%), Positives = 154/471 (32%), Gaps = 50/471 (10%)
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
++ + L L L + + ++G I L + + NN+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK 385
+ + ++L L +N+L L + L L N + + +
Sbjct: 78 -TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 386 LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
L L N + + ++L EL + N+ D+T L L + N +T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT 183
Query: 446 GEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCS 505
L++ + L+RL+ N+ + N L L +N+ I++ +
Sbjct: 184 ---ELDVSQ-NKLLNRLNCDTNNITK-LDLNQN--IQLTFLDCSSNKLTE---IDVTPLT 233
Query: 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRL 565
L S N L L + ++ L L I + L R
Sbjct: 234 QLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK 287
Query: 566 SGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLE 625
+ ++ + L +L A + +L + K++ L L++ L + V
Sbjct: 288 IKEL--DVTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELT-ELD--VSHNT 339
Query: 626 KMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNK 685
K++SLS ++ FSSV + L +I L + S + VS +
Sbjct: 340 KLKSLSCVNAHIQ-----DFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394
Query: 686 LSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736
L + GN ++ D + T N V +F +G
Sbjct: 395 L-----DQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENG 440
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 80/455 (17%), Positives = 142/455 (31%), Gaps = 49/455 (10%)
Query: 122 LKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
+ + Q + +L L+ LD +S++ + L + +N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
L D+ L L ++N LT L + + +L N L +S L
Sbjct: 78 -TL--DLSQNTNLTYLACDSNKLTNL--DVTPLTKLTYLNCDTNKL-TKLD--VSQNPLL 129
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
+ + N ++ QL L N ++ + L L S NK+
Sbjct: 130 TYLNCARNT----LTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 302 GTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGS 361
+ +S L + NN+ ++ + L L +N+L + +
Sbjct: 184 -ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
L N + + + L+KL L+ + I + ++L+ R
Sbjct: 235 LTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288
Query: 422 GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT 481
D+T L L +T L+L + P L L L + + T
Sbjct: 289 --KELDVTHNTQLYLLDCQAAGIT---ELDLSQ-NPKLVYLYLNNTELTE-LDVSHN--T 339
Query: 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP-----GVSFLDV 536
L L N F +GK +L + TL N LD
Sbjct: 340 KLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 537 RGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS 571
GN + +I P G + + LS P+
Sbjct: 398 FGNPM--NIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 79/446 (17%), Positives = 145/446 (32%), Gaps = 70/446 (15%)
Query: 282 ETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSL 341
+ +N V +A ++ T + L + + +++ +
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNS-----------SITDM--- 57
Query: 342 LLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401
+ L L N I T+ + L L +N++ +
Sbjct: 58 ------------TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD 101
Query: 402 HQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR 461
+ ++KL L N+LT D+++ L +L+ A N LT +++ H L+
Sbjct: 102 --VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVS-HNTQLTE 152
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSL 521
LD N + + T L L N+ +++ + L R+ N + L
Sbjct: 153 LDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KL 206
Query: 522 PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQI 581
L +N ++FLD N L I + LT D S N L+ + + L L
Sbjct: 207 D--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTT 258
Query: 582 LRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641
L L I L T++I + +V ++ L Q ++ +
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-EL 312
Query: 642 PDAFSSVQSLFELQLGSNIFDGSIPCS-LSKLHHFSSILNVSNNKLSGKIPECLGNLDKL 700
S L L L + + S +KL L+ N + +G + L
Sbjct: 313 D--LSQNPKLVYLYLNNTELT-ELDVSHNTKLKS----LSCVNAHIQ-DFSS-VGKIPAL 363
Query: 701 QILDLSSNSFSGEIPTEVNNMVSLYF 726
+ +P E SL
Sbjct: 364 NNNFEAEGQTI-TMPKETLTNNSLTI 388
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 43/288 (14%), Positives = 81/288 (28%), Gaps = 59/288 (20%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYI--CKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
+ + L LN N+I+ + +N L LD S N+ T I + QL
Sbjct: 188 SQNKLLNRLNCD--------TNNITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 124 TLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGE 183
+ N + L +L+ L L +I ++ L E
Sbjct: 237 YFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKE 290
Query: 184 LPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVE 243
L D+ +L L +T L LS LV
Sbjct: 291 L--DVTHNTQLYLLDCQAAGITEL--------------------------DLSQNPKLVY 322
Query: 244 FSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGT 303
++ + +L+ L + +++ + + L + + T
Sbjct: 323 LYLNNTEL-TELD---VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-T 375
Query: 304 ISGQISHCNQLQVIALSRN-----NLVGQIPRSVGNLSSLNSLLLFNN 346
+ + N L + N + P G + + + N
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWEN 423
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-31
Identities = 64/316 (20%), Positives = 121/316 (38%), Gaps = 52/316 (16%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRI-IGKGKHGTVYR-TLSNNSRKHW-AVKK 866
D S+ + S E+L + I +G G G+V + ++ A+K
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV 370
Query: 867 L-----NRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN 921
L E + + + + I+R++G C + +V E GG L L
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK 429
Query: 922 EPRLVLDWNTRYHIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978
+ + + ++ G+ YL ++ +HR++ + N+LL + KI DFG
Sbjct: 430 REEI--PVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFG 481
Query: 979 MSKLISDSHSSSTRSAIVGSLGYI---APENAYSTRLTEKSDVYSYGVILFELLFRKMPV 1035
+SK + S +A + APE + + +SDV+SYGV ++E L
Sbjct: 482 LSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL------ 533
Query: 1036 DPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKA-----LRLLELALECTR 1090
S+G+ + + K E + F+++ +++ L L +C
Sbjct: 534 --SYGQ----KPYKKMK---GPEVMAFIEQ-------GKRMECPPECPPELYALMSDCWI 577
Query: 1091 QVADMRPSMREVVGFL 1106
+ RP V +
Sbjct: 578 YKWEDRPDFLTVEQRM 593
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVG 894
++G G V+ + K +A+K + +S +++ + EI L ++H NI+ +
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHY 948
H ++V + + GG LF+ R++ Y + + + YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFD-------RILE--RGVYTEKDASLVIQQVLSAVKYLHE 124
Query: 949 DCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
+ I+HRD+K +N+L + E I DFG+SK+ + S G+ GY+APE
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPE 177
Query: 1006 NAYSTRLTEKSDVYSYGVILFELL 1029
++ D +S GVI + LL
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILL 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-31
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDV-----EIRTLSLVRHRNILRI 892
++GKG G V + +++ +AVK +N++ N D E+ L + H NI+++
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYL 946
+IV E GG LF+ + + + R+ I + G++Y+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYM 137
Query: 947 HYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
H I+HRD+K +NILL+S+ + KI DFG+S + +G+ YIA
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAYYIA 191
Query: 1004 PE---NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
PE Y EK DV+S GVIL+ LL P F +
Sbjct: 192 PEVLRGTYD----EKCDVWSAGVILYILLSGTPP----FYGKNE 227
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-31
Identities = 59/283 (20%), Positives = 96/283 (33%), Gaps = 34/283 (12%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
CS + + L+ + P++ L+L EN+ + + +L
Sbjct: 52 CS-NQFSKVVCTRRGLSEVPQGIPSNTRYLNL--MENNIQMIQADTFRHLHHLEVLQLGR 108
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N+ I F GL L L L DN L L L++L L N + S
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167
Query: 309 SHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRL 367
+ L + L + I L +L L L +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI------------------- 208
Query: 368 QHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD 427
P + L LE L + N P +S L +L + N++++ I +
Sbjct: 209 -------KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERN 260
Query: 428 -ITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
L +L L+LAHN+L+ + +L YL L L N +
Sbjct: 261 AFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 51/256 (19%), Positives = 79/256 (30%), Gaps = 31/256 (12%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNS 155
+ L+L N + L+ L L N + I F L L+ L+L N
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNW 134
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
L+ IP F L KL+ L+L N + + N
Sbjct: 135 LT-VIPSGA----------FEY-------------LSKLRELWLRNNPIESIPSYAFNRV 170
Query: 216 AILHLLI--HENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDD 273
L L + NL + N L+ LE L +
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI---KDMPNLTPLVGLEELEMSG 227
Query: 274 NNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVG 333
N+ P + GL +L+KL + ++++ L + L+ NNL
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 334 NLSSLNSLLLFNNRLQ 349
L L L L +N
Sbjct: 288 PLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 64/284 (22%), Positives = 108/284 (38%), Gaps = 41/284 (14%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
Q + L ++P+ + N + L L N + + H + L+V+ L RN++
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 325 VGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHNFIGGTIPPEI-C 381
QI L+SLN+L LF+N L +P L +L L++N I +IP
Sbjct: 112 -RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168
Query: 382 NLAKLEVLYLFN-NRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSL 439
+ L L L ++E I + L L L + P++T L L+ L +
Sbjct: 169 RVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEM 225
Query: 440 AHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPI 499
+ NH E+ L +L + + V ++ N F+G
Sbjct: 226 SGNHFP-EIRPGSFHGLSSLKKLWVMNSQ----------------VSLIERNAFDG---- 264
Query: 500 EIGKCSSLRRVILSNNLLQGSLPA-TLERNPGVSFLDVRGNLLQ 542
+SL + L++N L SLP + L + N
Sbjct: 265 ----LASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 60/292 (20%), Positives = 93/292 (31%), Gaps = 66/292 (22%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRN 433
+P I + L L N I+ + L L L N + +I L +
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRF 493
L L L N LT + +F + L L L NN
Sbjct: 125 LNTLELFDNWLT-----------------VIPSGAFEYL--------SKLRELWLRNNPI 159
Query: 494 ----NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-V 548
+ +F + SL R+ L L+ I
Sbjct: 160 ESIPSYAF----NRVPSLMRLDLGEL-----------------------KKLE-YISEGA 191
Query: 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDL 608
F NL L+ + +P+ L L L+ L +S N P + + KL +
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249
Query: 609 SDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
++ ++ I L + L+L NNLS D F+ ++ L EL L N
Sbjct: 250 MNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 56/237 (23%), Positives = 98/237 (41%), Gaps = 20/237 (8%)
Query: 505 SSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSEN 563
S+ R + L N +Q T + L + N ++ I F ++L L+ +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133
Query: 564 RLSGSIPSE-LGNLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEV 621
L+ IPS L L+ L L N + IP + +++LDL + I
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGA 191
Query: 622 -ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----IFDGSIPCSLSKLHHFS 676
L ++ L+L N+ +P+ + + L EL++ N I GS LS L
Sbjct: 192 FEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFH-GLSSLKK-- 246
Query: 677 SILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFN 732
L V N+++S L L L+L+ N+ S +P ++ + L +++ N
Sbjct: 247 --LWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 4e-18
Identities = 67/307 (21%), Positives = 110/307 (35%), Gaps = 62/307 (20%)
Query: 408 SKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
++ ++ L+ +P I N ++L+L N++ + + +H +L L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 468 SFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLER 527
S I VG FNG +SL + L +N L E
Sbjct: 110 SI-----RQIEVGA-----------FNG--------LASLNTLELFDNWLTVIPSGAFEY 145
Query: 528 NPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSE-NRLSGSIPSE-LGNLENLQILRL 584
+ L +R N ++ SIP F +L LD E +L I L NL+ L L
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNL 203
Query: 585 SANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPD 643
+ +P L + +L++S N+ I L ++ L + + +S +
Sbjct: 204 GMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERN 260
Query: 644 AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQIL 703
AF + SL EL L ++N LS + L L L
Sbjct: 261 AFDGLASLVELNL-------------------------AHNNLSSLPHDLFTPLRYLVEL 295
Query: 704 DLSSNSF 710
L N +
Sbjct: 296 HLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 28/204 (13%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYE-LGKCTK 602
+P G SN L+ EN + +L +L++L+L N + +I
Sbjct: 68 EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLAS 124
Query: 603 MIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN-- 659
+ L+L DN+L IPS L K++ L L+ N + AF+ V SL L LG
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183
Query: 660 -------IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712
F+G L L + LN+ + +P L L L+ L++S N F
Sbjct: 184 LEYISEGAFEG-----LFNLKY----LNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP- 231
Query: 713 EIPTEV-NNMVSLYFVNISFNHFS 735
EI + + SL + + + S
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/202 (27%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV--EIRTLSLVRHRNILRIVGSC 896
+G+G VYR ++K +A+K L ++ V EI L + H NI+++
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHYDC 950
+V E + GG LF+ R+V Y I + ++YLH +
Sbjct: 118 ETPTEISLVLELVTGGELFD-------RIVE--KGYYSERDAADAVKQILEAVAYLHEN- 167
Query: 951 VPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
I+HRD+K +N+L + KI DFG+SK++ T + G+ GY APE
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAPEIL 222
Query: 1008 YSTRLTEKSDVYSYGVILFELL 1029
+ D++S G+I + LL
Sbjct: 223 RGCAYGPEVDMWSVGIITYILL 244
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN----RSETNFDV-----EIRTLSLVRHRNI 889
+IGKG V R ++ + + +AVK ++ S E +++H +I
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGL 943
+ ++ + + D ++V E+M G L + + D Y H I + L
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRA-----DAGFVYSEAVASHYMRQILEAL 143
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
Y H + IIHRD+K +LL S+ K+G FG++ + +S + VG+
Sbjct: 144 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG--GRVGTPH 198
Query: 1001 YIAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
++APE Y + DV+ GVILF LL
Sbjct: 199 FMAPEVVKREPYG----KPVDVWGCGVILFILL 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 35/207 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVG 894
IG+G G V + +R A KK+ + F EI + + H NI+R+
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHY 948
+ + ++V E GG LF + + I + ++Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHK 124
Query: 949 DCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
+ HRD+K +N L ++ K+ DFG++ T VG+ Y++P+
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KVGTPYYVSPQ 178
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELL 1029
Y + D +S GV+++ LL
Sbjct: 179 VLEGLYG----PECDEWSAGVMMYVLL 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 36/307 (11%), Positives = 74/307 (24%), Gaps = 61/307 (19%)
Query: 817 VQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN--- 873
V S R L+ + G V+ + +A+K N
Sbjct: 53 VDSLLSQGERKLKL--------VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRS 104
Query: 874 ----FDVEIRTLSLVRHRNILRIVGSC--------------------------TKDEHGF 903
+ + + +
Sbjct: 105 ELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164
Query: 904 IVTEYMPG--GTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIK 960
++ LF+ L R + + + + + L ++H
Sbjct: 165 LLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFT 221
Query: 961 SDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE--NAYSTRLTEKSDV 1018
DN+ + + +GD + A + Y E NA + T +
Sbjct: 222 PDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYAPREFLNASTATFTHALNA 276
Query: 1019 YSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKA 1078
+ G+ ++ + +P FG T + + + L D +K
Sbjct: 277 WQLGLSIYRVWCLFLP----FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDF-VKT 331
Query: 1079 L--RLLE 1083
L R L
Sbjct: 332 LIGRFLN 338
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 34/225 (15%)
Query: 814 LQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSET 872
L+ + S + P+ Y + IG+G GTVY + + + A++++N + +
Sbjct: 9 LRSIVSVGD--PKKK-YTRFEK------IGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 873 NFDV---EIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---EPRLV 926
++ EI + ++ NI+ + S + ++V EY+ GG+L +V+ + E
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--- 116
Query: 927 LDWNTRYHIAL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983
IA Q L +LH + Q+IHRDIKSDNILL + K+ DFG I
Sbjct: 117 -------QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
+ S RS +VG+ ++APE K D++S G++ E+
Sbjct: 167 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-30
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 41/220 (18%)
Query: 839 GRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRSETNFDV-----EIRTLS-LVRHR 887
G+ +G G G V ++ AVK L + + E++ +S L +H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY-----------HIA 936
NI+ ++G+CT ++TEY G L N L + L D H +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 937 LGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS 993
+AQG+++L + IHRD+ + N+LL + KIGDFG+++ I + +
Sbjct: 171 SQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----N 219
Query: 994 AIVGSLGYI-----APENAYSTRLTEKSDVYSYGVILFEL 1028
IV + APE+ + T +SDV+SYG++L+E+
Sbjct: 220 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 821 SEDLPRDLRYEDVIRA--TEGRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLNRSET- 872
LP D ++E R + G+ +G G G V + K AVK L S
Sbjct: 9 PTQLPYDHKWE-FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 873 ----NFDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL 927
E++ LS L H NI+ ++G+CT ++TEY G L N L + +
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 928 DWNTR---------------YHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972
+ + +A+G+++L IHRD+ + NILL
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRIT 184
Query: 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYI-----APENAYSTRLTEKSDVYSYGVILFE 1027
KI DFG+++ I + + +V + APE+ ++ T +SDV+SYG+ L+E
Sbjct: 185 KICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 1028 L 1028
L
Sbjct: 240 L 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 40/216 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTL-SLVR 885
+IG+G V R + + +AVK + + E L +
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGI 939
H +I+ ++ S F+V + M G LF+ L I +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFD-------YLTE--KVALSEKETRSIMRSL 209
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL 999
+ +S+LH + I+HRD+K +NILLD ++ ++ DFG S + + G+
Sbjct: 210 LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTP 263
Query: 1000 GYIAPE------NAYSTRLTEKSDVYSYGVILFELL 1029
GY+APE + ++ D+++ GVILF LL
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-30
Identities = 51/210 (24%), Positives = 97/210 (46%), Gaps = 37/210 (17%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDV-----EIRTLSLVRHRNILRI 892
+GKG V R + + + +A +N + + D E R L++H NI+R+
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYL 946
S +++ H +++ + + GG LF +V Y H I + + +
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFE-------DIVA--REYYSEADASHCIQQILEAVLHC 126
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
H ++HR++K +N+LL S+L+ K+ DFG++ + + G+ GY++
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLS 181
Query: 1004 PE----NAYSTRLTEKSDVYSYGVILFELL 1029
PE + Y + D+++ GVIL+ LL
Sbjct: 182 PEVLRKDPYG----KPVDLWACGVILYILL 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 5e-30
Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 43/215 (20%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDV-----EIRTLSLVRHRN 888
G +G G+ V + + K +A K +L+ S E+ L +RH N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQG 942
I+ + ++ E + GG LF+ L I G
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFD-------FLAEK--ESLTEDEATQFLKQILDG 120
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGS 998
+ YLH +I H D+K +NI+L + P K+ DFG++ I + I G+
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGT 174
Query: 999 LGYIAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
++APE ++D++S GVI + LL
Sbjct: 175 PEFVAPEIVNYEPLGL----EADMWSIGVITYILL 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 74/333 (22%), Positives = 116/333 (34%), Gaps = 65/333 (19%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNS 155
LDL N+ T I FK LK L L L N
Sbjct: 53 DTALLDLQNNKIT-------------------------EIKDGDFKNLKNLHTLILINNK 87
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
+S KI P F L KL+ LYL+ N L L + P +
Sbjct: 88 IS-KISPGA----------FAP-------------LVKLERLYLSKNQLKELPEKMPKTL 123
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFG-GAISPWIFKGLLQLEVLYLDDN 274
L + HEN+ + + ++ +N I F+G+ +L + + D
Sbjct: 124 QELRV--HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 275 NLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN 334
N+ IP+ L +L +L L NK+ + + N L + LS N++ S+ N
Sbjct: 182 NIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFI----GGTIPPE--ICNLAKLEV 388
L L L NN+L +P L + + + L +N I P A
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 297
Query: 389 LYLFNNRIE-GAIPHQI-GRMSKLVELALYNNR 419
+ LF+N ++ I + + L N +
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 68/330 (20%), Positives = 121/330 (36%), Gaps = 37/330 (11%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
L V+ D LE ++P+ L + L L NK+ G + L + L N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI-CNL 383
P + L L L L N+L+ LP ++ +L +LR+ N I + + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNGL 144
Query: 384 AKLEVLYLFNNRI-EGAIPHQI-GRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
++ V+ L N + I + M KL + + + +T IP + +L L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIE 500
N +T +V K L++L L+ NS + +L L L NN+ P
Sbjct: 202 NKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGG 258
Query: 501 IGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDF 560
+ ++ V L NN + ++ + PG ++ + +
Sbjct: 259 LADHKYIQVVYLHNNNIS-AIGSNDFCPPGY-----------------NTKKASYSGVSL 300
Query: 561 SENRLS-GSIPSEL-GNLENLQILRLSANK 588
N + I + ++L K
Sbjct: 301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 71/359 (19%), Positives = 125/359 (34%), Gaps = 68/359 (18%)
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQH 369
C+ L+V+ S L ++P+ + L L NN++ + N +L L L +
Sbjct: 30 QCH-LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85
Query: 370 NFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI 428
N I I P L KLE LYL N+++ +P L EL ++ N +T ++ +
Sbjct: 86 NKIS-KISPGAFAPLVKLERLYLSKNQLK-ELP--EKMPKTLQELRVHENEIT-KVRKSV 140
Query: 429 -TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLV 487
L + + L N L + +F G L +
Sbjct: 141 FNGLNQMIVVELGTNPLK---------------SSGIENGAFQGM--------KKLSYIR 177
Query: 488 LGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
+ + I G SL + L N + A+L+ ++ L + N + ++
Sbjct: 178 IADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDN 233
Query: 548 -VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKL------DGRIPYELGKC 600
+L L + N+L +P L + + +Q++ L N + D P K
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
+ L N + Q +Q P F V +QLG+
Sbjct: 293 ASYSGVSLFSNPV--------------QYWEIQ--------PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 63/304 (20%), Positives = 105/304 (34%), Gaps = 46/304 (15%)
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQ 307
NN I FK L L L L +N + P L L++L LS N+L
Sbjct: 60 QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK------ 113
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLR 366
++P + +L L + N + + ++ +
Sbjct: 114 -------------------ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVE 151
Query: 367 LQHNFIG-GTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRI 424
L N + I + KL + + + I IP + L EL L N++T ++
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KV 207
Query: 425 PPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNL 483
L NL L L+ N ++ V + P+L L L N +P + +
Sbjct: 208 DAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYI 265
Query: 484 FVLVLGNNRF----NGSF--PIEIGKCSSLRRVILSNNLLQGSL--PATLERNPGVSFLD 535
V+ L NN + F P K +S V L +N +Q P+T + +
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 325
Query: 536 VRGN 539
+
Sbjct: 326 LGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/342 (18%), Positives = 118/342 (34%), Gaps = 65/342 (19%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRN 433
+P ++ +L L NN+I + L L L NN+++ +I P L
Sbjct: 45 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNR 492
L+ L L+ N L E+ ++ L L + N + ++ G + V+ LG N
Sbjct: 102 LERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNP 156
Query: 493 FNGSFPIEIG---KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVF 549
S IE G L + +++ + +IP
Sbjct: 157 LK-SSGIENGAFQGMKKLSYIRIADTNIT-------------------------TIPQ-- 188
Query: 550 GFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDL 608
G +LT L N+++ + + L L NL L LS N + L + +L L
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247
Query: 609 SDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCS 668
++N L +P + + +Q + L NN+S + F
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYN---------------TK 291
Query: 669 LSKLHHFSSILNVSNNKLS-GKIPECL-GNLDKLQILDLSSN 708
+ +++ +N + +I + + L +
Sbjct: 292 KASYSG----VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 57/290 (19%), Positives = 108/290 (37%), Gaps = 36/290 (12%)
Query: 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLL 517
S L L +P ++ + +L L NN+ + +L +IL NN +
Sbjct: 37 QCSDLGLEK------VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 518 QGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSE-LGNL 576
P + L + N L+ +P L L EN ++ + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 577 ENLQILRLSANKL-DGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634
+ ++ L N L I K+ + ++D + +IP + + L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 201
Query: 635 NNLSGAIPDAFSSVQSLFELQLGSN----IFDGSIPCSLSKLHHFSSILNVSNNKLSGKI 690
N ++ + + +L +L L N + +GS+ + L L+++NNKL K+
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA-NTPHLRE----LHLNNNKLV-KV 255
Query: 691 PECLGNLDKLQILDLSSNSFSGEIPTEV-------NNMVSLYFVNISFNH 733
P L + +Q++ L +N+ S I + S V++ N
Sbjct: 256 PGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNP 304
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 58/254 (22%), Positives = 104/254 (40%), Gaps = 33/254 (12%)
Query: 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENR 564
LR V S+ L+ +P L P + LD++ N + I F NL L N+
Sbjct: 32 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87
Query: 565 LSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS- 623
+S P L L+ L LS N+L +P ++ K + +L + +N + + V +
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNG 143
Query: 624 LEKMQSLSLQENNLSGAI--PDAFSSVQSLFELQLGSN---IFDGSIPCSLSKLH----H 674
L +M + L N L + AF ++ L +++ +P SL++LH
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNK 203
Query: 675 FSSI-------------LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNM 721
+ + L +S N +S L N L+ L L++N ++P + +
Sbjct: 204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
Query: 722 VSLYFVNISFNHFS 735
+ V + N+ S
Sbjct: 263 KYIQVVYLHNNNIS 276
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 45/224 (20%), Positives = 84/224 (37%), Gaps = 45/224 (20%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD------VEIRTLS-LVRHRNI 889
E IG G+ G+V++ + +A+K+ + E+ + L +H ++
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRL-VLDWNTRYHIALGIAQGLSYLHY 948
+R + +D+H I EY GG+L + + +N + + L + +GL Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 949 DCVPQIIHRDIKSDNILLDSELEP-------------------KIGDFGMSKLISDSHSS 989
++H DIK NI + P KIGD G IS
Sbjct: 134 M---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV- 189
Query: 990 STRSAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFEL 1028
G ++A E + K+D+++ + +
Sbjct: 190 -----EEGDSRFLANEVLQENYTHLP----KADIFALALTVVCA 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 53/214 (24%), Positives = 96/214 (44%), Gaps = 33/214 (15%)
Query: 839 GRIIGKGKHGTVYR-TLSNNSRKHW-AVKKLN-----RSETNFDVEIRTLS-LVRHRNIL 890
+IG+G G V + + + + A+K++ +F E+ L L H NI+
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH-------------IAL 937
++G+C + ++ EY P G L + L ++ + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 938 GIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
+A+G+ YL + IHRD+ + NIL+ KI DFG+S+ + + T
Sbjct: 150 DVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGR 202
Query: 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
+ + ++A E+ + T SDV+SYGV+L+E+
Sbjct: 203 L--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 814 LQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSET 872
L+ V + + PR L + ++ IG+G G V +S + AVK ++ R +
Sbjct: 34 LRMVVDQGD--PRLL-LDSYVK------IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ 84
Query: 873 NFDV---EIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDW 929
++ E+ + +H N++ + S E +++ E++ GG L +++ Q RL
Sbjct: 85 RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RL---- 138
Query: 930 NTRYHIAL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986
IA + Q L+YLH +IHRDIKSD+ILL + K+ DFG IS
Sbjct: 139 -NEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 194
Query: 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
R ++VG+ ++APE + + D++S G+++ E+
Sbjct: 195 VPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 49/266 (18%)
Query: 799 VVRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRA--TEGRIIGKGKHGTVYR---- 852
+VR+ + + + S E LP D ++E R T G+ +G+G G V
Sbjct: 46 LVRITTRLSSTADTPMLAGVSEYE-LPEDPKWE-FPRDKLTLGKPLGEGCFGQVVMAEAV 103
Query: 853 TLSNNSRKHW---AVKKLN-----RSETNFDVEIRTLS-LVRHRNILRIVGSCTKDEHGF 903
+ + K AVK L + ++ E+ + + +H+NI+ ++G+CT+D +
Sbjct: 104 GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 163
Query: 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRY-------------HIALGIAQGLSYL---H 947
++ EY G L L P + +A+G+ YL
Sbjct: 164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 223
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI----- 1002
IHRD+ + N+L+ KI DFG+++ I++ + G +
Sbjct: 224 C------IHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWM 272
Query: 1003 APENAYSTRLTEKSDVYSYGVILFEL 1028
APE + T +SDV+S+GV+++E+
Sbjct: 273 APEALFDRVYTHQSDVWSFGVLMWEI 298
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 46/232 (19%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----------------EIRTL 881
R +G G +G V N A+K + +S+ + EI L
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 882 SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HI 935
+ H NI+++ ++ ++VTE+ GG LF + ++ +I
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANI 151
Query: 936 ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISDSHSSSTR 992
I G+ YLH I+HRDIK +NILL++ L KI DFG+S S +
Sbjct: 152 MKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD- 207
Query: 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+G+ YIAPE + EK DV+S GVI++ LL P FG D
Sbjct: 208 --RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP----FGGQND 252
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 33/206 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDV--EIRTLSLVRHRNILRIVGS 895
+G+G+ G V+R + +S+K + K + + V EI L++ RHRNIL + S
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHYD 949
E ++ E++ G +F R+ + + L +LH
Sbjct: 70 FESMEELVMIFEFISGLDIFE-------RINTS-AFELNEREIVSYVHQVCEALQFLHSH 121
Query: 950 CVPQIIHRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-- 1005
I H DI+ +NI+ + KI +FG ++ + + + + Y APE
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELL 1029
+ ST +D++S G +++ LL
Sbjct: 176 QHDVVST----ATDMWSLGTLVYVLL 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 50/213 (23%), Positives = 84/213 (39%), Gaps = 39/213 (18%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDV-----EIRTLSLVRHRN 888
G +G G+ V + ++ +A K + S E+ L V H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALG----IAQGLS 944
++ + ++ E + GG LF+ L + A I G++
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFD-------FLAQKESLSEEEATSFIKQILDGVN 129
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
YLH +I H D+K +NI+L + P K+ DFG++ I D I G+
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPE 183
Query: 1001 YIAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
++APE ++D++S GVI + LL
Sbjct: 184 FVAPEIVNYEPLG----LEADMWSIGVITYILL 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 50/236 (21%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------------------- 876
IGKG +G V + N ++A+K L++ +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 877 --------EIRTLSLVRHRNILRI--VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV 926
EI L + H N++++ V ++H ++V E + G + V L
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLS 135
Query: 927 LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986
D Y + +G+ YLHY +IIHRDIK N+L+ + KI DFG+S S
Sbjct: 136 EDQARFYF--QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 987 HSSSTRSAIVGSLGYIAPE------NAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
+ + + G+ ++APE +S + DV++ GV L+ +F + P
Sbjct: 191 DALLSNTV--GTPAFMAPESLSETRKIFSGK---ALDVWAMGVTLYCFVFGQCPFM 241
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 33/275 (12%), Positives = 81/275 (29%), Gaps = 60/275 (21%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTL------- 881
R ++R G ++G+ + + + V +E I+ +
Sbjct: 76 RPRTLVR---GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 882 ----------------------SLVRHRNILRIVGSCTKDEHGFIVTEY--MP------- 910
LV+ +++ + ++++ + P
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 911 --GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968
G L + ++ L + R + L + + L+ LH+ ++H ++ +I+LD
Sbjct: 193 TFGEVLLSHSSTHKS---LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQ 246
Query: 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGV 1023
+ F S S A T +T D ++ G+
Sbjct: 247 RGGVFLTGFEHLVRDGASAVSPIGRG-FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 1024 ILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058
++ + +P +D + W +
Sbjct: 306 AIYWIWCADLP----NTDDAALGGS-EWIFRSCKN 335
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRT 880
+L+ +D + +E +G G G V++ S A K + E + E++
Sbjct: 29 ELKDDDFEKISE---LGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQV 84
Query: 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIA 936
L I+ G+ D I E+M GG+L VL + E L ++
Sbjct: 85 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-------KVS 137
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
+ + +GL+YL +I+HRD+K NIL++S E K+ DFG+S + DS ++S V
Sbjct: 138 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FV 191
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP-VDPSFGEDTDIVTWTRWKLQE 1055
G+ Y++PE T + +SD++S G+ L E+ + P P E +
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 1056 NHECICFLDREISFWDSDDQLKALRLLEL 1084
D + + EL
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 50/211 (23%), Positives = 82/211 (38%), Gaps = 35/211 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDV-----EIRTLSLVRHRN 888
G +G G+ V + ++ +A K + S E+ L ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQG 942
++ + ++ E + GG LF+ L I G
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFD-------FLAEK--ESLTEEEATEFLKQILNG 126
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGS 998
+ YLH QI H D+K +NI+L P KI DFG++ I + I G+
Sbjct: 127 VYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 180
Query: 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
++APE L ++D++S GVI + LL
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILL 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 58/256 (22%), Positives = 100/256 (39%), Gaps = 67/256 (26%)
Query: 821 SEDLPRDLRYEDVIRA--TEGRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLNRSETN 873
+ DL++E R G+++G G G V + K AVK L +
Sbjct: 31 FREYEYDLKWE-FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS 89
Query: 874 FDV-----EIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL 927
+ E++ ++ L H NI+ ++G+CT +++ EY G L N L +
Sbjct: 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 149
Query: 928 DWNTRY--------------------HIALGIAQGLSYL---HYDCVPQIIHRDIKSDNI 964
D A +A+G+ +L +HRD+ + N+
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC------VHRDLAARNV 203
Query: 965 LLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI------------APENAYSTRL 1012
L+ KI DFG+++ I + Y+ APE+ +
Sbjct: 204 LVTHGKVVKICDFGLARDIMSDSN------------YVVRGNARLPVKWMAPESLFEGIY 251
Query: 1013 TEKSDVYSYGVILFEL 1028
T KSDV+SYG++L+E+
Sbjct: 252 TIKSDVWSYGILLWEI 267
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 44/223 (19%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLNRSET-----NFDVEIRTLS-LVRHR 887
G+ +G+G G V + K AVK L T E++ L + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 888 NILRIVGSCTK-DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH------------ 934
N++ ++G+CTK ++ E+ G L L V
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 935 -IALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990
+ +A+G+ +L IHRD+ + NILL + KI DFG+++ I
Sbjct: 152 CYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKDP--- 202
Query: 991 TRSAIVGSLGYI-----APENAYSTRLTEKSDVYSYGVILFEL 1028
+ + APE + T +SDV+S+GV+L+E+
Sbjct: 203 --DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 44/227 (19%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHW-----AVKKLN-----RSETNFDVEIRTLSLVRHRN 888
R IG+G G V++ + + AVK L + +F E ++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY--------------- 933
I++++G C + ++ EYM G L L P V +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 934 ------HIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI- 983
IA +A G++YL + +HRD+ + N L+ + KI DFG+S+ I
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 984 -SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+D + + AI + ++ PE+ + R T +SDV++YGV+L+E+
Sbjct: 226 SADYYKADGNDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 839 GRIIGKGKHGTVYR----TLSNNSRKHW---AVKKLNRSET-----NFDVEIRTLS-LVR 885
G+ +G+G G V + + K AVK L T + E+ + + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 886 HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------------ 933
H+NI+ ++G+CT+D +++ EY G L L P +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 934 -HIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989
+A+G+ YL IHRD+ + N+L+ KI DFG+++ I++
Sbjct: 160 VSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNID-- 211
Query: 990 STRSAIVGSLGYI-----APENAYSTRLTEKSDVYSYGVILFEL 1028
+ G + APE + T +SDV+S+GV+++E+
Sbjct: 212 ---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-29
Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 35/207 (16%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTL-SLVRHRNILRIVGSCT 897
IG G + R + + +AVK +++S+ + EI L +H NI+ +
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYD 86
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHYDCV 951
++ ++VTE M GG L + + + + + + I + + YLH
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLHAQ-- 135
Query: 952 PQIIHRDIKSDNILLDSELEP----KIGDFGMSKLI-SDSHSSSTRSAIVGSLGYIAPE- 1005
++HRD+K NIL E +I DFG +K + +++ T + ++APE
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT---PCYTANFVAPEV 191
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELL 1029
Y D++S GV+L+ +L
Sbjct: 192 LERQGY----DAACDIWSLGVLLYTML 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 52/199 (26%), Positives = 100/199 (50%), Gaps = 22/199 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFD---VEIRTLSLVRHRNILRIVGSCT 897
+G G G VY+ + + A K + +SE + VEI L+ H I++++G+
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL---GIAQGLSYLHYDCVPQI 954
D +I+ E+ PGG + ++ + + L T I + + + L++LH +I
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGL-----TEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE 1014
IHRD+K+ N+L+ E + ++ DFG+S + R + +G+ ++APE + +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMKD 196
Query: 1015 -----KSDVYSYGVILFEL 1028
K+D++S G+ L E+
Sbjct: 197 TPYDYKADIWSLGITLIEM 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-29
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV--EIRTL-SLVRHRNILRIV 893
+++G G +G V + + +++ +A+K L E+ + +I+RIV
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARREVELHWRASQCPHIVRIV 121
Query: 894 G----SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGL 943
+ IV E + GG LF+ R+ + + I I + +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFS-------RIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
YLH I HRD+K +N+L S+ K+ DFG +K + +S +T +
Sbjct: 175 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPY 228
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELL 1029
Y+APE + + D++S GVI++ LL
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILL 257
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-29
Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 38/285 (13%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
CS + + NL + + +L+L
Sbjct: 41 CS-NQFSKVICVRKNLREVPDGISTNTRLLNL---------------------------H 72
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N I FK L LE+L L N++ GL NL L L N+L +G
Sbjct: 73 ENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAF 132
Query: 309 SHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSL-LLFNNRLQGTLPPE-LGNCGSLVDL 365
+ ++L+ + L N + IP + SL L L RL + +L L
Sbjct: 133 VYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYL 190
Query: 366 RLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIP 425
L + P + L KL+ L L N + P + L +L + +++ I
Sbjct: 191 NLAMCNL--REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE 247
Query: 426 PD-ITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
+ L++L ++LAHN+LT + +L +L R+ L N +
Sbjct: 248 RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 76/328 (23%), Positives = 110/328 (33%), Gaps = 63/328 (19%)
Query: 45 LPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLS 104
+ ++ C S SC N S + L V + IS + L+L
Sbjct: 23 MGCVAETGSAQTCP-SVCSCSNQFSKV---ICVRKNLREVPDG-IS-----TNTRLLNLH 72
Query: 105 GNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGKIPPQ 163
N+ + L+ L L+ N + +I F L L+ L+L N L+ IP
Sbjct: 73 ENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNG 130
Query: 164 VSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIH 223
F L KLK L+L N + + N L L
Sbjct: 131 A----------FVY-------------LSKLKELWLRNNPIESIPSYAFNRIPSLRRL-- 165
Query: 224 ENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPET 283
L + L IS F+GL L L L NL +IP
Sbjct: 166 ----------DLGELKRLSY-----------ISEGAFEGLSNLRYLNLAMCNLR-EIP-N 202
Query: 284 LWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLL 343
L L L +L LS N L+ G LQ + + ++ + + NL SL + L
Sbjct: 203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINL 262
Query: 344 FNNRLQGTLPPE-LGNCGSLVDLRLQHN 370
+N L LP + L + L HN
Sbjct: 263 AHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 73/354 (20%), Positives = 114/354 (32%), Gaps = 113/354 (31%)
Query: 312 NQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNF 371
NQ + R NL ++P + ++ L L N++Q + L L+L N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 372 IGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDI- 428
I TI LA L L LF+NR+ IP+ +SKL EL L NN + IP
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 429 TRLRNLQFLSLAH-NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLV 487
R+ +L+ L L L+ ++ +F G
Sbjct: 157 NRIPSLRRLDLGELKRLS-----------------YISEGAFEG---------------- 183
Query: 488 LGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
S+LR + L+ L+ +P
Sbjct: 184 ----------------LSNLRYLNLAMCNLR-EIPN------------------------ 202
Query: 548 VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLDGRIPYELGKCTKMIKL 606
L LD S N LS +I L +LQ L + +++
Sbjct: 203 -LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ---------------- 244
Query: 607 DLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
I L+ + ++L NNL+ D F+ + L + L N
Sbjct: 245 ---------VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 31/167 (18%), Positives = 59/167 (35%), Gaps = 21/167 (12%)
Query: 578 NLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNL 637
+ L +P + T++ L+L +N + + L ++ L L N++
Sbjct: 44 QFSKVICVRKNLR-EVPDGISTNTRL--LNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 638 SGAIPDAFSSVQSLFELQLGSN--------IFDGSIPCSLSKLHHFSSILNVSNNKLSGK 689
AF+ + +L L+L N F LSKL L + NN +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY-----LSKLKE----LWLRNNPIESI 151
Query: 690 IPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFNHFS 735
+ L+ LDL I + +L ++N++ +
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 839 GRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLN-----RSETNFDVEIRTLSLVRHRN 888
G+ +G+G+ G V + AVK L + E L V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY--------------- 933
++++ G+C++D ++ EY G+L L ++ +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 934 ------HIALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984
A I+QG+ YL +HRD+ + NIL+ + KI DFG+S+ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 985 DSHSSSTRSAIVGSLGYI-----APENAYSTRLTEKSDVYSYGVILFEL 1028
+ S + S G I A E+ + T +SDV+S+GV+L+E+
Sbjct: 202 EED-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 33/208 (15%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVR-HRNILRIVG 894
+ + +G+G + + S + +AVK +++ E N EI L L H NI+++
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHY 948
H F+V E + GG LF + + + + +I + +S++H
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMHD 124
Query: 949 DCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
++HRD+K +N+L E + KI DFG ++L + +L Y APE
Sbjct: 125 V---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPE 179
Query: 1006 ----NAYSTRLTEKSDVYSYGVILFELL 1029
N Y E D++S GVIL+ +L
Sbjct: 180 LLNQNGYD----ESCDLWSLGVILYTML 203
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-29
Identities = 43/209 (20%), Positives = 80/209 (38%), Gaps = 33/209 (15%)
Query: 842 IGKGKH--GTVYRTLSNNSRKHWAVKKLN---RSETNFDV---EIRTLSLVRHRNILRIV 893
IGKG TV + ++ V+++N S E+ L H NI+
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL---GIAQGLSYLHYDC 950
+ D ++VT +M G+ +++ + + IA G+ + L Y+H+
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGM----NELAIAYILQGVLKALDYIHHM- 147
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS-----SSTRSAIVGSLGYIAPE 1005
+HR +K+ +IL+ + + + + + V L +++PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 1006 ------NAYSTRLTEKSDVYSYGVILFEL 1028
Y KSD+YS G+ EL
Sbjct: 206 VLQQNLQGY----DAKSDIYSVGITACEL 230
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 37/212 (17%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHR-NIL 890
+ +G+GK V + +S ++ + +A K L + EI L L + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLS 944
+ ++ EY GG +F+ + + + I +G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFS-------LCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
YLH + I+H D+K NILL S KI DFGMS+ I + I+G+ Y
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEY 199
Query: 1002 IAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
+APE + + +D+++ G+I + LL
Sbjct: 200 LAPEILNYDPIT----TATDMWNIGIIAYMLL 227
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 43/215 (20%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK-----KLNRSETNFDV-----EIRTLSLVRHRN 888
G +G G+ V + ++ +A K + S E+ L V H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQG 942
I+ + ++ E + GG LF+ L I G
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFD-------FLAQK--ESLSEEEATSFIKQILDG 127
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGS 998
++YLH +I H D+K +NI+L + P K+ DFG++ I D I G+
Sbjct: 128 VNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGT 181
Query: 999 LGYIAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
++APE ++D++S GVI + LL
Sbjct: 182 PEFVAPEIVNYEPLG----LEADMWSIGVITYILL 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 36/218 (16%), Positives = 73/218 (33%), Gaps = 25/218 (11%)
Query: 839 GRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLN-RSETNFDV---EIRTLSLVRHRNI 889
++G+G VY +++ + +K + F + + L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ--NEPRLVLDWNTRYHIALGIAQGLSYLH 947
++ + +V E GTL N ++ N P V+ A+ + + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 948 YDCVPQIIHRDIKSDNILLDSELEP-----------KIGDFGMSKLISDSHSSSTRSAIV 996
+IIH DIK DN +L + + D G S + + +A
Sbjct: 190 DC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+ G+ E + + D + ++ +LF
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRI 892
+ IGKG V + + A+K +++++ N E+R + ++ H NI+++
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
++ +++ EY GG +F+ L + + I + Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR-- 134
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAY 1008
I+HRD+K++N+LLD+++ KI DFG S + G+ Y APE Y
Sbjct: 135 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPELFQGKKY 190
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVD 1036
+ DV+S GVIL+ L+ +P D
Sbjct: 191 DGP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIV 893
+ +G+G +G V ++ + + AVK ++ EI ++ H N+++
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G + ++ EY GG LF+ + + + R+ L +A G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQL-MA-GVVYLHGI---G 125
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAYS 1009
I HRDIK +N+LLD KI DFG++ + ++ + + G+L Y+APE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVD 1036
E DV+S G++L +L ++P D
Sbjct: 186 ---AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 48/242 (19%)
Query: 823 DLPRDLRYEDVIRA--TEGRIIGKGKHGTVYR-TLSNNSRKHW------AVKKLN----- 868
+LP D R+E + R G+ +G+G G V + AVK L
Sbjct: 57 ELPEDPRWE-LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 115
Query: 869 RSETNFDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL 927
+ ++ E+ + + +H+NI+ ++G+CT+D +++ EY G L L P +
Sbjct: 116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 175
Query: 928 DWNTRYH-------------IALGIAQGLSYL---HYDCVPQIIHRDIKSDNILLDSELE 971
H A +A+G+ YL IHRD+ + N+L+ +
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNV 229
Query: 972 PKIGDFGMSKLISDSHSSSTRSAIVGSLGYI-----APENAYSTRLTEKSDVYSYGVILF 1026
KI DFG+++ I + G + APE + T +SDV+S+GV+L+
Sbjct: 230 MKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284
Query: 1027 EL 1028
E+
Sbjct: 285 EI 286
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-28
Identities = 35/284 (12%), Positives = 83/284 (29%), Gaps = 73/284 (25%)
Query: 815 QDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNF 874
Q + SE R G ++G+ + + + V +E
Sbjct: 60 QPFRVESELGERPRTL------VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113
Query: 875 DVEIRTL-----------------------------SLVRHRNILRIVGSCTKDEHGFIV 905
I+ + LV+ +++ + +++
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173
Query: 906 TEYM-----------PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ + G L + ++ L + R + L + + L+ LH+ +
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKS---LVHHARLQLTLQVIRLLASLHHYG---L 227
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE--------- 1005
+H ++ +I+LD + F S S G+ PE
Sbjct: 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVS------SVSRGFEPPELEARRATIS 281
Query: 1006 --NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047
T +T D ++ G++++ + +P +D +
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLP----ITKDAALGG 321
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 63/207 (30%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGS 895
+ IG G G +++ AVK + R + N EI +RH NI+R
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
H I+ EY GG L+ + R D + + G+SY H QI
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQ--LLSGVSYCHSM---QIC 138
Query: 956 HRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAYS 1009
HRD+K +N LLD P KI DFG SK + VG+ YIAPE Y
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRQEYD 195
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVD 1036
+ +DV+S GV L+ +L P +
Sbjct: 196 GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDV--EIRTLSLVR-HRNILRIVGS 895
++G+G H V ++ + + +AVK + + V E+ L + HRN+L ++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHYD 949
+++ ++V E M GG++ + +H+ + + +A L +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHN- 129
Query: 950 CVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSA-----IVGSLGY 1001
I HRD+K +NIL + + KI DF + I + S S GS Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 1002 IAPE-----NAYSTRLTEKSDVYSYGVILFELL 1029
+APE + ++ ++ D++S GVIL+ LL
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 38/203 (18%), Positives = 84/203 (41%), Gaps = 26/203 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK----KLNRSETNFDVEIRTLSLVRHRNILRIVG 894
+G G G V+R + + + + K + EI ++ + H ++ +
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHY 948
+ ++ E++ GG LF+ R+ + + + + +GL ++H
Sbjct: 116 AFEDKYEMVLILEFLSGGELFD-------RIAAE-DYKMSEAEVINYMRQACEGLKHMHE 167
Query: 949 DCVPQIIHRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
I+H DIK +NI+ +++ KI DFG++ ++ + + APE
Sbjct: 168 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEI 221
Query: 1007 AYSTRLTEKSDVYSYGVILFELL 1029
+ +D+++ GV+ + LL
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLL 244
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 33/205 (16%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV--EIRTL-SLVRHRNILRIVGSCT 897
++G G +G V + + A+K L S E+ +I+ I+
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILDVYE 92
Query: 898 KDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLH 947
HG I+ E M GG LF+ R+ + + I I + +LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFS-------RIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 948 YDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
I HRD+K +N+L S+ + K+ DFG +K + + + Y+AP
Sbjct: 146 SH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAP 198
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELL 1029
E + + D++S GVI++ LL
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILL 223
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 58/238 (24%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 809 SDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN 868
S L ++ + P + +E V ++G G +G VY+ + + A+K ++
Sbjct: 6 SPARSLDEIDLSALRDPAGI-FELV------ELVGNGTYGQVYKGRHVKTGQLAAIKVMD 58
Query: 869 RSETNFD---VEIRTLS-LVRHRNILRIVGS------CTKDEHGFIVTEYMPGGTLFNVL 918
+ + EI L HRNI G+ D+ ++V E+ G++ +++
Sbjct: 59 VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 919 HQNEPRLVLDWNTRYHIAL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975
+ + IA I +GLS+LH ++IHRDIK N+LL E K+
Sbjct: 119 KNTKGNTL----KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171
Query: 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE-----KSDVYSYGVILFEL 1028
DFG+S + + R+ +G+ ++APE + KSD++S G+ E+
Sbjct: 172 DFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSLVRHRNILRIV 893
+ +G+G +G V ++ + + AVK ++ EI ++ H N+++
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G + ++ EY GG LF+ + + + R+ L +A G+ YLH
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQL-MA-GVVYLHGI---G 125
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAYS 1009
I HRDIK +N+LLD KI DFG++ + ++ + + G+L Y+APE +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVD 1036
E DV+S G++L +L ++P D
Sbjct: 186 ---AEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 71/303 (23%), Positives = 108/303 (35%), Gaps = 37/303 (12%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRN 433
+P EI +L L NN I + L L L NN+++ +I + LR
Sbjct: 47 AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNR 492
LQ L ++ NHL E+ L L L + N +P + G N+ + +G N
Sbjct: 104 LQKLYISKNHLV-EIPPNL---PSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNP 158
Query: 493 FNGSFPIEIG--KCSSLRRVILSNNLL---QGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
+ E G L + +S L LP TL L + N +Q +I
Sbjct: 159 LE-NSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNE------LHLDHNKIQ-AIEL 210
Query: 548 -VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLDGRIPYELGKCTKMIK 605
+S L L N++ I + L L L+ L L NKL R+P L +
Sbjct: 211 EDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV 268
Query: 606 LDLSDNYLAGSIPSEVIS-------LEKMQSLSLQENNLSGAI--PDAFSSVQSLFELQL 656
+ L N + + +SL N + P F V +Q
Sbjct: 269 VYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327
Query: 657 GSN 659
G+
Sbjct: 328 GNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 64/329 (19%), Positives = 108/329 (32%), Gaps = 36/329 (10%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
L V+ D L+ +P+ + + L L N ++ L + L N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEIC-NL 383
++ L L L + N L +PP L + SLV+LR+ N I +P + L
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGL 146
Query: 384 AKLEVLYLFNNRI-EGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
+ + + N + KL L + +LT IP D+ L L L HN
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEI 501
+ + LE + L RL L N I L L L NN+ + P +
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGL 260
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561
L+ V L N + + F V + + +
Sbjct: 261 PDLKLLQVVYLHTNNIT-KVGVN-------DFCPVGFGVK----------RAYYNGISLF 302
Query: 562 ENRLS-GSIPSEL-GNLENLQILRLSANK 588
N + + + + ++ K
Sbjct: 303 NNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 67/321 (20%), Positives = 106/321 (33%), Gaps = 52/321 (16%)
Query: 57 CKWSGVSCYNN---------SSSLKALNLSGFGLSGVLNNSISYICKNQ-----HLLSLD 102
C V C + S L+L NN IS + K+ HL +L
Sbjct: 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQ--------NNDISELRKDDFKGLQHLYALV 84
Query: 103 LSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPP 162
L N+ + K +L+ L ++ N IPP + L L + N + K+P
Sbjct: 85 LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-KVPK 140
Query: 163 QV-SLCYSLESIGFHNNFL-NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHL 220
V S ++ I N L N KL L ++ LTG+ + P + LHL
Sbjct: 141 GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHL 200
Query: 221 ------LIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
I D L N I L L L+LD+N
Sbjct: 201 DHNKIQAIELEDL--------LRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNN 251
Query: 275 NLEGQIPETLWGLENLQKLVLSANKL----NGTISGQISHCN--QLQVIALSRNNL-VGQ 327
L ++P L L+ LQ + L N + I+L N + +
Sbjct: 252 KLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWE 310
Query: 328 IPRSV-GNLSSLNSLLLFNNR 347
+ + ++ ++ N +
Sbjct: 311 VQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 62/280 (22%), Positives = 98/280 (35%), Gaps = 43/280 (15%)
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQ 307
NN + FKGL L L L +N + + L LQKL +S N L
Sbjct: 62 QNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV------ 115
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLR 366
+IP ++ SSL L + +NR++ +P ++ +
Sbjct: 116 -------------------EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIE 153
Query: 367 LQHNFIGGT-IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIP 425
+ N + + P + KL L + ++ IP + L EL L +N++ I
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIE 209
Query: 426 PDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLF 484
+ R L L L HN + + P L L L N +PA + L
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQ 267
Query: 485 VLVLGNNRF----NGSFP--IEIGKCSSLRRVILSNNLLQ 518
V+ L N F K + + L NN +
Sbjct: 268 VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 41/184 (22%), Positives = 73/184 (39%), Gaps = 12/184 (6%)
Query: 553 SNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612
+ T+LD N +S + L++L L L NK+ K+ KL +S N+
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 613 LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN-IFDGSIPC-SLS 670
L IP + + L + +N + FS ++++ +++G N + + +
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 671 KLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNI 729
L + L +S KL+ IP+ + L L L N I E LY + +
Sbjct: 171 GLK--LNYLRISEAKLT-GIPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 730 SFNH 733
N
Sbjct: 225 GHNQ 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 52/204 (25%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------TNFDVEIRTLSLVRHRNI 889
G+I+G+G TV + + +A+K L + E +S + H
Sbjct: 35 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT--RERDVMSRLDHPFF 92
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSY 945
+++ + DE + Y G L + + +E TR++ A I L Y
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTA-EIVSALEY 145
Query: 946 LHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
LH IIHRD+K +NILL+ ++ +I DFG +K++S + ++ VG+ Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 1006 NAYSTRLTEKSDVYSYGVILFELL 1029
+ SD+++ G I+++L+
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLV 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 55/217 (25%), Positives = 86/217 (39%), Gaps = 33/217 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------------EIRTLSLVRH 886
+G G G V+ + K VK + + + D EI LS V H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 887 RNILRIVGSCTKDEHGFIVTE-YMPGGTLFN--VLHQNEPRLVLDWNTRYHIALGIAQGL 943
NI++++ +V E + G LF H LD +I + +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-----LDEPLASYIFRQLVSAV 143
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIA 1003
YL IIHRDIK +NI++ + K+ DFG + + T G++ Y A
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTIEYCA 197
Query: 1004 PE----NAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
PE N Y + +++S GV L+ L+F + P
Sbjct: 198 PEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 38/238 (15%)
Query: 804 RSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWA 863
R+ DP + + +D P L + D+ IG G G VY + + A
Sbjct: 34 RAGSLKDPDVAELF---FKDDPEKL-FSDLRE------IGHGSFGAVYFARDVRNSEVVA 83
Query: 864 VKKLNRSETNFD-------VEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916
+KK++ S + E+R L +RH N ++ G ++ ++V EY G +
Sbjct: 84 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS-D 142
Query: 917 VLHQNEPRLVLDWNTRYHIAL---GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973
+L ++ L IA G QGL+YLH +IHRD+K+ NILL K
Sbjct: 143 LLEVHKKPL-----QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 194
Query: 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTE---KSDVYSYGVILFEL 1028
+GDFG + +++ ++ VG+ ++APE + + K DV+S G+ EL
Sbjct: 195 LGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-27
Identities = 53/251 (21%), Positives = 102/251 (40%), Gaps = 33/251 (13%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRI 892
++IG+G V + + +A+K +N+ + + F E L R I ++
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ + + ++V EY GG L +L + R+ + R+++A I + +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVHRL--- 181
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL 1012
+HRDIK DNILLD ++ DFG + + + A VG+ Y++PE +
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-VGTPDYLSPEILQAVGG 240
Query: 1013 TEKSDVY-------SYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065
+ Y + GV +E+ + + P + + T + I
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPF---YADSTA-------ETYGK---IVHYKE 287
Query: 1066 EISFWDSDDQL 1076
+S D+ +
Sbjct: 288 HLSLPLVDEGV 298
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 48/228 (21%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 815 QDVQSRSEDLPRDLRYEDVIRA-TEGRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSE 871
D+ + P +++++ V+ +G G G V+R + ++A K
Sbjct: 137 FDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES 196
Query: 872 TNFDV--EIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDW 929
V EI+T+S++RH ++ + + D ++ E+M GG LF ++ +
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-------KVADE- 248
Query: 930 NTRY------HIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP--KIGDFGMSK 981
+ + + +GL ++H + +H D+K +NI+ ++ K+ DFG++
Sbjct: 249 HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
+ S G+ + APE A + +D++S GV+ + LL
Sbjct: 306 HLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHRNIL 890
G ++G+G +G V L + + AVK L + E N EI+ L +RH+N++
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 891 RI--VGSCTKDEHGFIVTEYMPGGT--LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
++ V + + ++V EY G + + + + R + Y + GL YL
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFCQ--LIDGLEYL 125
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H I+H+DIK N+LL + KI G+++ + + T GS + PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 1007 AYSTRLTE--KSDVYSYGVILFELLFRKMPVD 1036
A K D++S GV L+ + P +
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDV------EIRTLSLVRHRNILR 891
G +G G G V + AVK LNR + + DV EI+ L L RH +I++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ + F+V EY+ GG LF+ + ++ R+ R I + Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQ--ILSAVDYCHRHM- 131
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NA 1007
++HRD+K +N+LLD+ + KI DFG+S ++SD T GS Y APE
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRL 186
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
Y+ + D++S GVIL+ LL +P D
Sbjct: 187 YAGP---EVDIWSCGVILYALLCGTLPFD 212
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 26/201 (12%)
Query: 841 IIGKGKHGTVYRTLSNNSRKHWAVK----KLNRSETNFDVEIRTLSLVRHRNILRIVGSC 896
I+G G+ G V++ + A K + + + EI ++ + H N++++ +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGLSYLHYDC 950
+V EY+ GG LF+ R++ D + I +G+ ++H
Sbjct: 156 ESKNDIVLVMEYVDGGELFD-------RII-DESYNLTELDTILFMKQICEGIRHMHQM- 206
Query: 951 VPQIIHRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008
I+H D+K +NIL + KI DFG+++ G+ ++APE
Sbjct: 207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVN 261
Query: 1009 STRLTEKSDVYSYGVILFELL 1029
++ +D++S GVI + LL
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLL 282
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 61/224 (27%), Positives = 97/224 (43%), Gaps = 37/224 (16%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRI 892
R IGKG G V N+++K +A+K +N+ + N E++ + + H ++ +
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQN----EPRLVLDWNTRYHIALGIAQGLSYLHY 948
S +E F+V + + GG L L QN E + I + L YL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET------VKLFIC-ELVMALDYLQN 133
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE--- 1005
+IIHRD+K DNILLD I DF ++ ++ +T + G+ Y+APE
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFS 187
Query: 1006 ----NAYSTRLTEKS-DVYSYGVILFELLFRKMPVDPSFGEDTD 1044
YS + D +S GV +ELL + P +
Sbjct: 188 SRKGAGYS-----FAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 49/203 (24%), Positives = 79/203 (38%), Gaps = 29/203 (14%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTL-SLVRHRNILRIVG 894
+G G G V++ + AVK++ R N + ++ + I++ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ + FI E M E L + + I + L YL
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-------KMTVAIVKALYYLKEK- 143
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
+IHRD+K NILLD + K+ DFG+S + D + G Y+APE
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDR---SAGCAAYMAPERIDPP 199
Query: 1006 NAYSTRLTEKSDVYSYGVILFEL 1028
+ ++DV+S G+ L EL
Sbjct: 200 DPTKPDYDIRADVWSLGISLVEL 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRI 892
++IG+G G V N+ K +A+K LN+ E F E L + I +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ D + ++V +Y GG L +L + E RL + R+++A + + +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVHQL--- 194
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NA 1007
+HRDIK DNIL+D ++ DFG + + + + A VG+ YI+PE
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEG 253
Query: 1008 YSTRLTEKSDVYSYGVILFELLF 1030
R + D +S GV ++E+L+
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLY 276
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 53/295 (17%), Positives = 99/295 (33%), Gaps = 21/295 (7%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
S + ++ +L + + L L N + L C NL +S
Sbjct: 28 LSCDRNGICKGSSGSLNSIPSGLTEAVKSLDL--SNNRITYISNSDLQRCVNLQALVLTS 85
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTIS--G 306
N I F L LE L L N L L +L L L N T+
Sbjct: 86 NGI-NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETS 143
Query: 307 QISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVD 364
SH +LQ++ + + +I R L+ L L + + LQ + P+ L + ++
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSH 202
Query: 365 LRLQHNFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI--------GRMSKLVELAL 415
L L + + +E L L + ++ ++ + + +
Sbjct: 203 LILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 416 YNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470
+ L ++ + ++ L L + N L V + L ++ L N +
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 62/352 (17%), Positives = 103/352 (29%), Gaps = 95/352 (26%)
Query: 98 LLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSL 156
+ SLDLS N T L C L+ L+L N +I + F L L LDL YN L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112
Query: 157 SGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCA 216
S + F L L L L N L
Sbjct: 113 S-NLSSSW----------FKP-------------LSSLTFLNLLGNPYKTLGE------- 141
Query: 217 ILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNL 276
+F L +L++L + + +
Sbjct: 142 ----------------------------------------TSLFSHLTKLQILRVGNMDT 161
Query: 277 EGQIPE-TLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GN 334
+I GL L++L + A+ L + + + L + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDV 220
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394
SS+ L L + L + + + + + +
Sbjct: 221 TSSVECLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDE 264
Query: 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLT 445
+ + + ++S L+EL N+L +P I RL +LQ + L N
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 59/294 (20%), Positives = 107/294 (36%), Gaps = 30/294 (10%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRN 433
+IP + ++ L L NNRI + R L L L +N + I D + L +
Sbjct: 45 SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 434 LQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGN 490
L+ L L++N+L+ L K L+ L+L GN + ++ T L +L +GN
Sbjct: 102 LEHLDLSYNYLS---NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 491 NRFNGSFPIEI-GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-V 548
+ + L + + + LQ P +L+ VS L + +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIF 217
Query: 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDL 608
S++ L+ + L LS + + L K + +
Sbjct: 218 VDVTSSVECLELRDTDLD-----------TFHFSELSTGETNS-----LIKKFTFRNVKI 261
Query: 609 SDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD 662
+D L + + + + L N L F + SL ++ L +N +D
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 53/276 (19%), Positives = 110/276 (39%), Gaps = 22/276 (7%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPA-TLERNPGV 531
IP+ + + L L NNR ++ +C +L+ ++L++N + ++ + +
Sbjct: 46 IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 532 SFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIP--SELGNLENLQILRLSANK 588
LD+ N L ++ F S+LT L+ N ++ S +L LQILR+
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 589 LDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPDAFS 646
+I + T + +L++ + L S + + S++ + L L +
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVD 219
Query: 647 SVQSLFELQLGSNIFDGSIPCSLSKLHHFS-------SILNVSNNKLSGKIPECLGNLDK 699
S+ L+L D LS S + +++ L ++ + L +
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 700 LQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFNHF 734
L L+ S N +P + + + SL + + N +
Sbjct: 279 LLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 44/201 (21%), Positives = 76/201 (37%), Gaps = 17/201 (8%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
SIP G + LD S NR++ S+L NLQ L L++N ++ +
Sbjct: 45 SIPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 604 IKLDLSDNYLAGSIPSEV-ISLEKMQSLSLQENNLSGAIPD--AFSSVQSLFELQLGSNI 660
LDLS NYL+ ++ S L + L+L N + + FS + L L++G+
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 661 FDGSIP----CSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPT 716
I L+ L L + + L P+ L ++ + L L +
Sbjct: 161 TFTKIQRKDFAGLTFLEE----LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215
Query: 717 EV-NNMVSLYFVNISFNHFSG 736
+ S+ + +
Sbjct: 216 IFVDVTSSVECLELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 8/97 (8%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQLGNCG 120
+ +SS++ L L L + +S K ++ ++ + K L
Sbjct: 219 DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQIS 277
Query: 121 QLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSL 156
L L + N+ + S+P IF L L + L N
Sbjct: 278 GLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 20/200 (10%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRT-LSLVRHRNILRIVG 894
IG+G +G+V + + S + AVK++ RS + ++ + I++ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY--HIALGIAQGLSYLHYDCVP 952
+ ++ +I E M + L I L + L++L +
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL-- 145
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAY 1008
+IIHRDIK NILLD K+ DFG+S + D S ++ G Y+APE +A
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSAS 202
Query: 1009 STRLTEKSDVYSYGVILFEL 1028
+SDV+S G+ L+EL
Sbjct: 203 RQGYDVRSDVWSLGITLYEL 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 26/203 (12%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRI 892
R++GKG G V + K +A KKL + E E + L V R ++ +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQ------NEPRLVLDWNTRYHIALGIAQGLSYL 946
+ + +V M GG L ++ E R ++ A I GL L
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR------AVFYAA-EICCGLEDL 302
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
H + +I++RD+K +NILLD +I D G++ + + + R VG++GY+APE
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEV 356
Query: 1007 AYSTRLTEKSDVYSYGVILFELL 1029
+ R T D ++ G +L+E++
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMI 379
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 46/198 (23%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIR-TLSLVRHRNILRIVG 894
+G+G +G V + S + AVK++ R+ N ++ ++ V + G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+ ++ +I E M + + + IA+ I + L +LH +
Sbjct: 74 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAYST 1010
IHRD+K N+L+++ + K+ DFG+S + D + G Y+APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERINPELNQK 188
Query: 1011 RLTEKSDVYSYGVILFEL 1028
+ KSD++S G+ + EL
Sbjct: 189 GYSVKSDIWSLGITMIEL 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRI 892
++IG+G G V ++RK +A+K L++ E F E ++ ++++
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ D + ++V EYMPGG L N + + W R++ A + L +H
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKW-ARFYTA-EVVLALDAIHSM--- 187
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NAY 1008
IHRD+K DN+LLD K+ DFG ++ +A VG+ YI+PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGG 246
Query: 1009 STRLTEKSDVYSYGVILFELLF 1030
+ D +S GV L+E+L
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLV 268
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 58/303 (19%), Positives = 93/303 (30%), Gaps = 59/303 (19%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
+ + T S+P + + L L N+ Q S+P +F KL +L+ L L N LS
Sbjct: 11 EIRCNSKGLT-SVPTGIPS--SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAIL 218
K S LK L L+ N +
Sbjct: 67 K---------GCCSQSDFG-------------TTSLKYLDLSFNGVI------------- 91
Query: 219 HLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG 278
++ ++ L +N +F L L L + +
Sbjct: 92 -----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 140
Query: 279 QIPETLWGLENLQKLVLSANKLNGTI-SGQISHCNQLQVIALSRNNLVGQIPRSV-GNLS 336
GL +L+ L ++ N + L + LS+ L Q+ + +LS
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199
Query: 337 SLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHNFIGGTIPPEI-CNLAK-LEVLYLFN 393
SL L + +N +L SL L N I T + + L L L
Sbjct: 200 SLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-MTSKKQELQHFPSSLAFLNLTQ 257
Query: 394 NRI 396
N
Sbjct: 258 NDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 56/282 (19%), Positives = 98/282 (34%), Gaps = 37/282 (13%)
Query: 412 ELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGNSF 469
E+ + LT +P I + L L N L +L G L++L L+ N
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ---SLPHGVFDKLTQLTKLSLSSN-- 62
Query: 470 YGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP 529
L + G+ +SL+ + LS N + ++ +
Sbjct: 63 ------------GLSFKGCCSQSDFGT--------TSLKYLDLSFNGVI-TMSSNFLGLE 101
Query: 530 GVSFLDVRGNLLQGSIPPVFGFWS--NLTMLDFSENRLSGSIPSELGNLENLQILRLSAN 587
+ LD + + L+ + F S NL LD S + L +L++L+++ N
Sbjct: 102 QLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160
Query: 588 KLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEV-ISLEKMQSLSLQENNLSGAIPDAF 645
+ + + LDLS L + SL +Q L++ NN +
Sbjct: 161 SFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 646 SSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLS 687
+ SL L N S L + LN++ N +
Sbjct: 220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 58/310 (18%), Positives = 99/310 (31%), Gaps = 65/310 (20%)
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQH 369
C+ ++ + L +P + SS L L +N+LQ L L L
Sbjct: 6 SCSGTEIR-CNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSS 61
Query: 370 NFI--GGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD 427
N + G L+ L L N + + + +L L ++ L
Sbjct: 62 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFS 120
Query: 428 I-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFV 485
+ LRNL +L ++H H I G ++L V
Sbjct: 121 VFLSLRNLIYLDISHTHTRV--------------------------AFNGIFNGLSSLEV 154
Query: 486 LVLGNNRFNGSFPIEI-GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS 544
L + N F +F +I + +L + LS L+
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-------------------------Q 189
Query: 545 IPP-VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL--GKCT 601
+ P F S+L +L+ S N L +LQ+L S N + + +
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPS 248
Query: 602 KMIKLDLSDN 611
+ L+L+ N
Sbjct: 249 SLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 53/205 (25%), Positives = 82/205 (40%), Gaps = 26/205 (12%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR--IPYELGKCT 601
S+P G S+ T L+ N+L L L L LS+N L + T
Sbjct: 21 SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 602 KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIP-DAFSSVQSLFELQLGSN- 659
+ LDLS N + ++ S + LE+++ L Q +NL F S+++L L +
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 660 -------IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPE-CLGNLDKLQILDLSSNSFS 711
IF+G LS L L ++ N L L LDLS
Sbjct: 138 TRVAFNGIFNG-----LSSLEV----LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 712 GEIPTEV-NNMVSLYFVNISFNHFS 735
++ N++ SL +N+S N+F
Sbjct: 189 -QLSPTAFNSLSSLQVLNMSHNNFF 212
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 63/235 (26%), Positives = 84/235 (35%), Gaps = 12/235 (5%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
C + L + P + + L H N S CRNL S
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRIFL--HGNRISHVPAASFRACRNLTILWLHS 65
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIP-ETLWGLENLQKLVLSANKLNGTISGQ 307
N I F GL LE L L DN + T GL L L L L G
Sbjct: 66 NVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDL 365
LQ + L N L +P +L +L L L NR+ ++P SL L
Sbjct: 125 FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRL 182
Query: 366 RLQHNFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNN 418
L N + + P +L +L LYLF N + A+P + + L L L +N
Sbjct: 183 LLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 50/249 (20%), Positives = 74/249 (29%), Gaps = 51/249 (20%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSG 158
+ L GN + C L L L+ N I F L L LDL N+
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAIL 218
+ P FH L +L +L+L+ L
Sbjct: 95 SVDPAT----------FHG-------------LGRLHTLHLDRCGLQ------------- 118
Query: 219 HLLIHENDFVGSLPT-SLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLE 277
L L N A+ F+ L L L+L N +
Sbjct: 119 -----------ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 278 GQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSS 337
GL +L +L+L N++ +L + L NNL ++ L +
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 338 LNSLLLFNN 346
L L L +N
Sbjct: 227 LQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 53/231 (22%), Positives = 88/231 (38%), Gaps = 19/231 (8%)
Query: 510 VILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSI 569
LQ ++P + + + GN + F NLT+L N L+ I
Sbjct: 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RI 71
Query: 570 PSE-LGNLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEVIS-LEK 626
+ L L+ L LS N + ++ L L L + + L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA 130
Query: 627 MQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP----CSLSKLHHFSSILNVS 682
+Q L LQ+N L D F + +L L L N S+P L L L +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR----LLLH 185
Query: 683 NNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFN 732
N+++ P +L +L L L +N+ S +PTE + +L ++ ++ N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 46/213 (21%), Positives = 76/213 (35%), Gaps = 16/213 (7%)
Query: 314 LQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHNFI 372
Q I L N + S +L L L +N L + L L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 373 GGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDI-T 429
++ P L +L L+L ++ + + ++ L L L +N L +P D
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 430 RLRNLQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVL 486
L NL L L N ++ ++ + L RL L N + + L L
Sbjct: 151 DLGNLTHLFLHGNRIS---SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTL 206
Query: 487 VLGNNRFNGSFPIEI-GKCSSLRRVILSNNLLQ 518
L N + + P E +L+ + L++N
Sbjct: 207 YLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 52/252 (20%), Positives = 81/252 (32%), Gaps = 43/252 (17%)
Query: 320 SRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPE 379
+ L +P + ++ + L NR+ C +L L L N + I
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAA 74
Query: 380 I-CNLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDI-TRLRNLQF 436
LA LE L L +N ++ + +L L L L + P + L LQ+
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 437 LSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRF--- 493
L L N L L ++F NL L L NR
Sbjct: 134 LYLQDNALQ-----------------ALPDDTFRDL--------GNLTHLFLHGNRISSV 168
Query: 494 -NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGF 551
+F SL R++L N + P + L + N L ++P
Sbjct: 169 PERAF----RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAP 223
Query: 552 WSNLTMLDFSEN 563
L L ++N
Sbjct: 224 LRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 52/221 (23%), Positives = 76/221 (34%), Gaps = 18/221 (8%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRN 433
+P I A + ++L NRI L L L++N L RI T L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNR 492
L+ L L+ N V L L L + + G L L L +N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNA 140
Query: 493 F----NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP- 547
+ +F +L + L N + + L + N + + P
Sbjct: 141 LQALPDDTF----RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPH 195
Query: 548 VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSAN 587
F L L N LS ++P+E L L LQ LRL+ N
Sbjct: 196 AFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 51/259 (19%), Positives = 88/259 (33%), Gaps = 60/259 (23%)
Query: 410 LVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTG 466
+ L+ NR++ +P RNL L L N L ++ L +LDL+
Sbjct: 34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA---RIDAAAFTGLALLEQLDLSD 89
Query: 467 NSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLE 526
N+ + F+G L + L LQ
Sbjct: 90 NAQLRSVDPAT---------------FHG--------LGRLHTLHLDRCGLQ-------- 118
Query: 527 RNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRL 584
+ P +F + L L +N L ++P + +L NL L L
Sbjct: 119 -----------------ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFL 160
Query: 585 SANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNLSGAIPD 643
N++ + +L L N +A + L ++ +L L NNLS +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 644 AFSSVQSLFELQLGSNIFD 662
A + +++L L+L N +
Sbjct: 220 ALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 53/234 (22%), Positives = 87/234 (37%), Gaps = 31/234 (13%)
Query: 62 VSCYNN---------SSSLKALNLSGFGLSGVLNNSISYICKNQ-----HLLSLDLSGNE 107
SC ++ + + L N IS++ +L L L N
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLH--------GNRISHVPAASFRACRNLTILWLHSNV 67
Query: 108 FTGSIPKQ-LGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGKIPPQV- 164
I L+ L L+DN S+ P F L RL L L L ++ P +
Sbjct: 68 LA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF 125
Query: 165 SLCYSLESIGFHNNFLNGELPNDICS-LPKLKSLYLNTNNLTGLLPE-FPNSCAILHLLI 222
+L+ + +N L LP+D L L L+L+ N ++ + F ++ LL+
Sbjct: 126 RGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 223 HENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNL 276
H+N P + + L+ +NN A+ L L+ L L+DN
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 28/137 (20%), Positives = 53/137 (38%), Gaps = 12/137 (8%)
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664
++ L N ++ + + + L L N L+ AF+ + L +L L N S
Sbjct: 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95
Query: 665 IP----CSLSKLHHFSSILNVSNNKLSGKIPE-CLGNLDKLQILDLSSNSFSGEIPTEV- 718
+ L +LH L++ L ++ L LQ L L N+ +P +
Sbjct: 96 VDPATFHGLGRLHT----LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 719 NNMVSLYFVNISFNHFS 735
++ +L + + N S
Sbjct: 150 RDLGNLTHLFLHGNRIS 166
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 71/209 (33%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDV------EIRTLSLVRHRNILR 891
G +G G G V + AVK LNR + + DV EI+ L L RH +I++
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ + F+V EY+ GG LF+ + +N RL + R I G+ Y H V
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQ--ILSGVDYCHRHMV 137
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NA 1007
+HRD+K +N+LLD+ + KI DFG+S ++SD T GS Y APE
Sbjct: 138 ---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRL 191
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
Y+ + D++S GVIL+ LL +P D
Sbjct: 192 YAGP---EVDIWSSGVILYALLCGTLPFD 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-------EIRTLSLVRHRNILR 891
+G+G G V +++ A+K ++R EI L L+RH +I++
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ T +V EY GG LF+ + + + R+ D R+ I + Y H
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQ--IICAIEYCHRHK- 128
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----NA 1007
I+HRD+K +N+LLD L KI DFG+S +++D + T GS Y APE
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVINGKL 183
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
Y+ + DV+S G++L+ +L ++P D
Sbjct: 184 YAGP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV----------EIRTLSLVR--- 885
G ++GKG GTV+ R A+K + R+ E+ L V
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 886 -HRNILRIVGSCTKDEHGFIVTEY-MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGL 943
H ++R++ E +V E +P LF+ + + P L + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAI 152
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
+ H V +HRDIK +NIL+D K+ DFG L+ D + G+ Y
Sbjct: 153 QHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF----DGTRVYS 205
Query: 1003 APE----NAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
PE + Y + V+S G++L++++ +P +
Sbjct: 206 PPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFE 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 49/226 (21%), Positives = 94/226 (41%), Gaps = 35/226 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV----------EIRTLSLVRHR- 887
G ++G G G+VY + + A+K + + + E+ L V
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 888 -NILRIVGSCTKDEHGFIVTEY-MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSY 945
++R++ + + ++ E P LF+ + + L + + + +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRH 164
Query: 946 LHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
H V +HRDIK +NIL+D E K+ DFG L+ D+ + G+ Y P
Sbjct: 165 CHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPP 217
Query: 1005 E----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046
E + Y R + V+S G++L++++ +P F D +I+
Sbjct: 218 EWIRYHRYHGR---SAAVWSLGILLYDMVCGDIP----FEHDEEII 256
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 8e-24
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRI 892
R++G+G G V+ + K +A KKLN+ VE + L+ V R I+ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQ--------NEPRLVLDWNTRYHIALGIAQGLS 944
+ +V M GG + ++ EPR ++ A I GL
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR------AIFYTA-QIVSGLE 303
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK-LISDSHSSSTRSAIVGSLGYIA 1003
+LH II+RD+K +N+LLD + +I D G++ L + + G+ G++A
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMA 357
Query: 1004 PENAYSTRLTEKSDVYSYGVILFELL 1029
PE D ++ GV L+E++
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMI 383
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLVRHRNILRI 892
+++GKG G V + +++A+K L + E R L RH + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLHY 948
S + V EY GG LF L + +E R R++ A I L YLH
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR------ARFYGA-EIVSALDYLHS 266
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPENA 1007
+ +++RD+K +N++LD + KI DFG+ K I D + T G+ Y+APE
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FCGTPEYLAPEVL 321
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
D + GV+++E++ ++P + +D +
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHE 355
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 35/208 (16%)
Query: 840 RIIGKGKHGTVY---RTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILR----- 891
+++G+G G V+ + +++R+ +A+K L ++ +RT R+IL
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVEVNHP 86
Query: 892 -IVG--SC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQG 942
IV T+ +++ +++ GG LF L + E ++++A +A
Sbjct: 87 FIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEED------VKFYLA-ELALA 138
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGY 1001
L +LH II+RD+K +NILLD E K+ DFG+SK I + + G++ Y
Sbjct: 139 LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS---FCGTVEY 192
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELL 1029
+APE T+ +D +S+GV++FE+L
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-22
Identities = 58/214 (27%), Positives = 90/214 (42%), Gaps = 47/214 (21%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH----RNILRIVGS 895
RIIG+G G VY ++ K +A+K L++ I+ R +L +V +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLSLVST 248
Query: 896 CTKDEHGFIVT---------------EYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIA 936
+ FIV + M GG L L Q +E R++ A
Sbjct: 249 ---GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD------MRFYAA 299
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
I GL ++H +++RD+K NILLD +I D G++ S + V
Sbjct: 300 -EIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 351
Query: 997 GSLGYIAPEN-AYSTRLTEKSDVYSYGVILFELL 1029
G+ GY+APE +D +S G +LF+LL
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-21
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 39/223 (17%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEIRTLSLVRHRNILRIVGSC- 896
+++GKG G V+ + + +A+K L + + DVE + + +L +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE----CTMVEKRVLSLAWEHP 78
Query: 897 ----------TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQG 942
TK+ + F V EY+ GG L + + R ++ A I G
Sbjct: 79 FLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQSCHKFDLSR------ATFYAA-EIILG 130
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGY 1001
L +LH I++RD+K DNILLD + KI DFGM K + ++T G+ Y
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT---FCGTPDY 184
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
IAPE + D +S+GV+L+E+L + P G+D +
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEE 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-21
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 48/234 (20%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSC--- 896
R+IG+G + V + + +A+K + + N D +I + +++ +
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID--WVQTEKHVFEQASNHPFL 72
Query: 897 --------TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLS 944
T+ F V EY+ GG L + + E R++ A I+ L+
Sbjct: 73 VGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEH------ARFYSA-EISLALN 124
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIA 1003
YLH II+RD+K DN+LLDSE K+ D+GM K + ++ST G+ YIA
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYIA 178
Query: 1004 PE----NAYSTRLTEKS-DVYSYGVILFELLFRKMP------VDPSFGEDTDIV 1046
PE Y S D ++ GV++FE++ + P D D +
Sbjct: 179 PEILRGEDYG-----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 62/238 (26%), Positives = 94/238 (39%), Gaps = 55/238 (23%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------EIR 879
RY+++ + IG G G V ++ A+KKL+R F E+
Sbjct: 26 RYQNL------KPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELV 76
Query: 880 TLSLVRHRNILRI--VGSCTKDEHGF----IVTEYMPGGTLFNVLHQNEPRLVLDWNTRY 933
+ V H+NI+ + V + K F IV E M L V+ L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME-----L---DHE 127
Query: 934 HIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS- 989
++ + Q G+ +LH IIHRD+K NI++ S+ KI DFG+++ S
Sbjct: 128 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
Query: 990 ---STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDT 1043
TR Y APE E D++S G I+ E++ F G D
Sbjct: 185 PYVVTRY-------YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDH 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 1e-21
Identities = 70/226 (30%), Positives = 104/226 (46%), Gaps = 45/226 (19%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSC--- 896
++GKG G V + + + +AVK L + D ++ + + +L + G
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE--CTMVEKRVLALPGKPPFL 404
Query: 897 --------TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLS 944
T D + V EY+ GG L + Q EP ++ A IA GL
Sbjct: 405 TQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPH------AVFYAA-EIAIGLF 456
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIA 1003
+L II+RD+K DN++LDSE KI DFGM K I D ++ T G+ YIA
Sbjct: 457 FLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGTPDYIA 510
Query: 1004 PE----NAYSTRLTEKS-DVYSYGVILFELLFRKMPVDPSFGEDTD 1044
PE Y KS D +++GV+L+E+L + P + GED D
Sbjct: 511 PEIIAYQPYG-----KSVDWWAFGVLLYEMLAGQAPFE---GEDED 548
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-21
Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 39/223 (17%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEIRTLSLVRHRNILRIVGSC- 896
++GKG G V + + + +AVK L + + DVE + + +L + G
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE----CTMVEKRVLALPGKPP 81
Query: 897 ----------TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQG 942
T D + V EY+ GG L + Q EP ++ A IA G
Sbjct: 82 FLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPH------AVFYAA-EIAIG 133
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGY 1001
L +L II+RD+K DN++LDSE KI DFGM K I D ++ T G+ Y
Sbjct: 134 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT---FCGTPDY 187
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
IAPE + D +++GV+L+E+L + P + GED D
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDED 227
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 38/222 (17%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDV-----EIRTLSLVRHRNILRI 892
+++GKG G V + +++A+K L + +V E R L RH + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYLHY 948
+ + V EY GG LF L + E R R++ A I L YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGA-EIVSALEYLHS 123
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIAPE-- 1005
+++RDIK +N++LD + KI DFG+ K ISD + T G+ Y+APE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FCGTPEYLAPEVL 177
Query: 1006 --NAYSTRLTEKS-DVYSYGVILFELLFRKMPVDPSFGEDTD 1044
N Y ++ D + GV+++E++ ++P +D +
Sbjct: 178 EDNDYG-----RAVDWWGLGVVMYEMMCGRLPFY---NQDHE 211
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-21
Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 49/228 (21%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEIRTLSLVRHRNILRIVGSC- 896
R++GKG G V + +AVK L + + DVE T++ + IL + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE-CTMT---EKRILSLARNHP 84
Query: 897 ----------TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQG 942
T D F V E++ GG L + + +E R R++ A I
Sbjct: 85 FLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEAR------ARFYAA-EIISA 136
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGY 1001
L +LH II+RD+K DN+LLD E K+ DFGM K I + +++T G+ Y
Sbjct: 137 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT---FCGTPDY 190
Query: 1002 IAPE----NAYSTRLTEKS-DVYSYGVILFELLFRKMPVDPSFGEDTD 1044
IAPE Y + D ++ GV+L+E+L P + E+ D
Sbjct: 191 IAPEILQEMLYG-----PAVDWWAMGVLLYEMLCGHAPFE---AENED 230
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 840 RIIGKGKHGTVY---RTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH----RNILRI 892
+++G G +G V+ + +++ K +A+K L + ++ H R +L
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKK-----ATIVQKAKTTEHTRTERQVLEH 114
Query: 893 VGSC-----------TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941
+ T+ ++ +Y+ GG LF L R + ++ I
Sbjct: 115 IRQSPFLVTLHYAFQTET-KLHLILDYINGGELFTHL-SQRERFTEHE-VQIYVG-EIVL 170
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
L +LH II+RDIK +NILLDS + DFG+SK + G++ Y
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 1002 IAPE--NAYSTRLTEKSDVYSYGVILFELL 1029
+AP+ + + D +S GV+++ELL
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 41/212 (19%)
Query: 840 RIIGKGKHGTVY---RTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH----RNILR- 891
R++GKG +G V+ + N+ K +A+K L + + +R H RNIL
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK-----AMIVRNAKDTAHTKAERNILEE 77
Query: 892 -----IVG--SC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALG 938
IV T +++ EY+ GG LF L + E +++A
Sbjct: 78 VKHPFIVDLIYAFQTGG-KLYLILEYLSGGELFMQLEREGIFMEDT------ACFYLA-E 129
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVG 997
I+ L +LH II+RD+K +NI+L+ + K+ DFG+ K I D + T G
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCG 183
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELL 1029
++ Y+APE + D +S G +++++L
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-21
Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 48/232 (20%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSC--- 896
R+IG+G + V + + +A++ + + N D +I + +++ +
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID--WVQTEKHVFEQASNHPFL 115
Query: 897 --------TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLS 944
T+ F V EY+ GG L + + E R++ A I+ L+
Sbjct: 116 VGLHSCFQTES-RLFFVIEYVNGGDLMFHMQRQRKLPEEH------ARFYSA-EISLALN 167
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGYIA 1003
YLH II+RD+K DN+LLDSE K+ D+GM K + ++ST G+ YIA
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST---FCGTPNYIA 221
Query: 1004 PE----NAYSTRLTEKS-DVYSYGVILFELLFRKMP------VDPSFGEDTD 1044
PE Y S D ++ GV++FE++ + P D D
Sbjct: 222 PEILRGEDYG-----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED 268
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 59/212 (27%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV--EIRTL-SLVRHRNILRIV 893
+++G G +G V + + +++ +A+K L E+ + +I+RIV
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARREVELHWRASQCPHIVRIV 77
Query: 894 G----SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY------HIALGIAQGL 943
+ IV E + GG LF+ R+ + + I I + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFS-------RIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
YLH I HRD+K +N+L S+ K+ DFG
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165
Query: 1001 YIAPE---NAYSTRLTEKSDVYSYGVILFELL 1029
A E Y + D++S GVI++ LL
Sbjct: 166 -FAKETTGEKYD----KSCDMWSLGVIMYILL 192
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 73/263 (27%), Positives = 120/263 (45%), Gaps = 47/263 (17%)
Query: 800 VRVLRSKCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSR 859
++V R K S + + + D P+++ Y D ++IG G G VY+ +S
Sbjct: 26 MKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT------KVIGNGSFGVVYQAKLCDSG 79
Query: 860 KHWAVKKL-------NRSETNFDVEIRTLSLVRHRNILRI------VGSCTKDEHGFIVT 906
+ A+KK+ NR E++ + + H NI+R+ G + + +V
Sbjct: 80 ELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 907 EYMPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQ---GLSYLHYDCVPQIIHRDIKSD 962
+Y+P T++ V H + + L ++ L + Q L+Y+H I HRDIK
Sbjct: 133 DYVPE-TVYRVARHYSRAKQTL---PVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQ 185
Query: 963 NILLDSELEP-KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRLTEKSDVYS 1020
N+LLD + K+ DFG +K + + S I S Y APE + +T T DV+S
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYIC-SRYYRAPELIFGATDYTSSIDVWS 242
Query: 1021 YGVILFELLFRKMPVDPSF-GED 1042
G +L ELL + P F G+
Sbjct: 243 AGCVLAELLLGQ----PIFPGDS 261
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-21
Identities = 56/244 (22%), Positives = 108/244 (44%), Gaps = 35/244 (14%)
Query: 817 VQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNF 874
+ R++ R+ G+G GTV ++ A+KK + N
Sbjct: 12 AAADERSRKEMDRFQVE------RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 875 DV-EIRTLSLVRHRNILRI------VGSCTKDE-HGFIVTEYMPGGTLFNVL-HQNEPRL 925
++ ++ L+++ H NI+++ +G + + + +V EY+P TL + ++
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 926 VLDWNTRYHIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIGDFGMSK 981
I + + Q + LH V + HRDIK N+L++ ++ K+ DFG +K
Sbjct: 125 AP---PPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 982 LISDSHSSSTRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSF- 1039
+S S + + I S Y APE + + T D++S G I E++ + P F
Sbjct: 181 KLSPSEPNV--AYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE----PIFR 233
Query: 1040 GEDT 1043
G+++
Sbjct: 234 GDNS 237
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-21
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 22/199 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------TNFDVEIRTLSLVRHRNIL 890
+ +G G G V S H+A+K L++ + T E R L V ++
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL--NEKRILQAVNFPFLV 104
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
++ S + + ++V EY+ GG +F+ L + R R++ A I YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPH-ARFYAA-QIVLTFEYLHSL- 160
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+I+RD+K +N+L+D + ++ DFG +K + T + + G+ +APE S
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWT-LCGTPEALAPEIILSK 213
Query: 1011 RLTEKSDVYSYGVILFELL 1029
+ D ++ GV+++E+
Sbjct: 214 GYNKAVDWWALGVLIYEMA 232
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 21/296 (7%)
Query: 261 KGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALS 320
L + +N+ T L+ + L + TI G + + N L + L
Sbjct: 16 PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 321 RNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI 380
N + P + NL+ + L L N L + S+ L L I T +
Sbjct: 72 DNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQI--TDVTPL 125
Query: 381 CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLA 440
L+ L+VLYL N+I P + ++ L L++ N +++ + P + L L L
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKAD 181
Query: 441 HNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIE 500
N ++ L P L + L N P + +NLF++ L N
Sbjct: 182 DNKISDISPLA---SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFY 236
Query: 501 IGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLT 556
++ PAT+ N + ++ NL + F ++T
Sbjct: 237 NNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVT 290
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 53/293 (18%), Positives = 106/293 (36%), Gaps = 26/293 (8%)
Query: 356 LGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELAL 415
+ + + + + T+ +L + L F + + ++ L+ L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLEL 70
Query: 416 YNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPA 475
+N++T + P + L + L L+ N L A+ + LDLT P
Sbjct: 71 KDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDLTSTQITDVTPL 125
Query: 476 NICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535
+NL VL L N+ P+ ++L+ + + N + L L ++ L
Sbjct: 126 AGL--SNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179
Query: 536 VRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPY 595
N + I P+ NL + N++S S L N NL I+ L+ + + +
Sbjct: 180 ADDNKIS-DISPLASL-PNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVF 235
Query: 596 ELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSV 648
++ ++ I IS + + NL+ + ++V
Sbjct: 236 YN---NNLVVPNVVKGPSGAPIAPATIS----DNGTYASPNLTWNLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 48/249 (19%), Positives = 101/249 (40%), Gaps = 21/249 (8%)
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
N + G + + + + + ++ ++ + L+++ N
Sbjct: 19 ANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 541 LQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC 600
+ + P+ + +T L+ S N L S + L++++ L L++ ++ P L
Sbjct: 75 IT-DLAPLKNL-TKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN- 659
+ + L L N + + S + L +Q LS+ +S P +++ L L+ N
Sbjct: 129 SNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK 184
Query: 660 IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVN 719
I D S SL L +++ NN++S P L N L I+ L++ + + + N
Sbjct: 185 ISDISPLASLPNL----IEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 720 NMVSLYFVN 728
N+V V
Sbjct: 239 NLVVPNVVK 247
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 49/278 (17%), Positives = 99/278 (35%), Gaps = 52/278 (18%)
Query: 23 SPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLS 82
+ P+AI+++ +L + + + + + L+ G G++
Sbjct: 4 TQPTAINVIFPDPALANAIKIAAGKSNV---------TDTVTQADLDGITTLSAFGTGVT 54
Query: 83 GVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK 142
+I + +L+ L+L N+ T P L N ++ L L+ N + ++ I
Sbjct: 55 -----TIEGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAG 105
Query: 143 LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN 202
L+ + LDL ++ P ++ +L+ + N + + + L L+ L +
Sbjct: 106 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNA 161
Query: 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG 262
++ L T L+N L A N ISP
Sbjct: 162 QVSDL-------------------------TPLANLSKLTTLKADDNKISD-ISP--LAS 193
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKL 300
L L ++L +N + P L NL + L+ +
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 28/164 (17%), Positives = 62/164 (37%), Gaps = 15/164 (9%)
Query: 571 SELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSL 630
L N + + + + + L + +I V L + L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGL 68
Query: 631 SLQENNLSGAIPDAFSSVQSLFELQLGSN-IFDGSIPCSLSKLHHFSSILNVSNNKLSGK 689
L++N ++ P ++ + EL+L N + + S L + L++++ +++
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPLKNVSAIAGLQSIKT----LDLTSTQITDV 122
Query: 690 IPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNH 733
P L L LQ+L L N + I + + +L +++I
Sbjct: 123 TP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQ 162
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 40/208 (19%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------TNFDVEIRTLSLVRHRNIL 890
R +G G G V+ S ++ +++A+K L + TN E LS+V H I+
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN--DERLMLSIVTHPFII 69
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQGLSYL 946
R+ G+ + F++ +Y+ GG LF++L + P +++ A + L YL
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV------AKFYAA-EVCLALEYL 122
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE- 1005
H II+RD+K +NILLD KI DFG +K + D T + + G+ YIAPE
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT-LCGTPDYIAPEV 174
Query: 1006 ---NAYSTRLTEKS-DVYSYGVILFELL 1029
Y+ KS D +S+G++++E+L
Sbjct: 175 VSTKPYN-----KSIDWWSFGILIYEML 197
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-20
Identities = 65/223 (29%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE--TNFDVEIRTLSLVRHRNILR------ 891
++IGKG G V +AVK L + + + +S RN+L
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK-HIMS---ERNVLLKNVKHP 99
Query: 892 -IVG--SC--TKDEHGFIVTEYMPGGTLFNVLHQ----NEPRLVLDWNTRYHIALGIAQG 942
+VG T D + V +Y+ GG LF L + EPR R++ A IA
Sbjct: 100 FLVGLHFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAA-EIASA 151
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL-ISDSHSSSTRSAIVGSLGY 1001
L YLH I++RD+K +NILLDS+ + DFG+ K I + ++ST G+ Y
Sbjct: 152 LGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST---FCGTPEY 205
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+APE + D + G +L+E+L+ P +T
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY---SRNTA 245
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 64/242 (26%), Positives = 103/242 (42%), Gaps = 59/242 (24%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSL 883
RY ++ IG+G +G V N ++ A+KK++ E EI+ L
Sbjct: 28 RYTNL------SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 884 VRHRNILRIV-----GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALG 938
RH NI+ I + + + +IV + M L+ +L L + HI
Sbjct: 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ--HL-----SNDHICYF 133
Query: 939 IAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS----- 990
+ Q GL Y+H ++HRD+K N+LL++ + KI DFG++++ H +
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 991 ---TRSAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF-GE 1041
TR Y APE Y T+ D++S G IL E+L + P F G+
Sbjct: 191 YVATR-------WYRAPEIMLNSKGY----TKSIDIWSVGCILAEMLSNR----PIFPGK 235
Query: 1042 DT 1043
Sbjct: 236 HY 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 16/205 (7%)
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPE-TLWGLENLQKLVLSANKLNGTISG 306
S N + + F +L+VL L ++ I + L +L L+L+ N + G
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALG 94
Query: 307 QISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE--LGNCGSLV 363
S + LQ + NL + G+L +L L + +N +Q + N +L
Sbjct: 95 AFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLE 152
Query: 364 DLRLQHNFIGGTIPPEI-CNLAKLEV----LYLFNNRIEGAIPHQIGRMSKLVELALYNN 418
L L N I +I L ++ + L L N + I + +L ELAL N
Sbjct: 153 HLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 419 RLTGRIPPDI-TRLRNLQFLSLAHN 442
+L +P I RL +LQ + L N
Sbjct: 211 QLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 51/210 (24%), Positives = 82/210 (39%), Gaps = 13/210 (6%)
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
+ L L N L + + LQ L LS ++ G + L + L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI- 88
Query: 326 GQIPRSV-GNLSSLNSLLLFNNRLQGTLPPEL-GNCGSLVDLRLQHNFIGGTIPPEIC-N 382
+ LSSL L+ L +L G+ +L +L + HN I PE N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 383 LAKLEVLYLFNNRIEGAIPHQI-GRMSKL----VELALYNNRLTGRIPPDITRLRNLQFL 437
L LE L L +N+I+ +I + ++ + L L N + I P + L+ L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
+L N L V + L ++ L N
Sbjct: 206 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 58/260 (22%), Positives = 90/260 (34%), Gaps = 63/260 (24%)
Query: 412 ELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGNS 468
L L N L + LQ L L+ + +E G + +LS L LTGN
Sbjct: 32 NLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ---TIEDGAYQSLSHLSTLILTGNP 87
Query: 469 FYGPIPANICVG-TNLFVLVLGNNRF----NGSFPIEIGKCSSLRRVILSNNLLQGSLPA 523
+ G ++L LV N G +L+ + +++NL+Q S
Sbjct: 88 IQS-LALGAFSGLSSLQKLVAVETNLASLENFPI----GHLKTLKELNVAHNLIQ-SFK- 140
Query: 524 TLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQIL 582
+P F +NL LD S N++ SI L L + +L
Sbjct: 141 ---------------------LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLL 178
Query: 583 RLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIP 642
L LDLS N + I +++ L+L N L
Sbjct: 179 NL--------------------SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPD 217
Query: 643 DAFSSVQSLFELQLGSNIFD 662
F + SL ++ L +N +D
Sbjct: 218 GIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/277 (19%), Positives = 81/277 (29%), Gaps = 65/277 (23%)
Query: 86 NNSISYICKNQHLLS-----------LDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQG 134
+I+Y C + LDLS N + +L+ L L+ Q
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65
Query: 135 SIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPK 193
+I + L LS L L N + + F L
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQ-SLALGA----------FSG-------------LSS 101
Query: 194 LKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGG 253
L+ L NL L + + + L E + + N
Sbjct: 102 LQKLVAVETNLASL-----------------------ENFPIGHLKTLKELNVAHNLIQS 138
Query: 254 AISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQ----KLVLSANKLNGTISGQIS 309
P F L LE L L N ++ L L + L LS N +N I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346
+L+ +AL N L L+SL + L N
Sbjct: 198 KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/232 (21%), Positives = 84/232 (36%), Gaps = 31/232 (13%)
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNR 347
+ + L LS N L S +LQV+ LSR + I +LS L++L+L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 348 LQGTLPPEL-GNCGSLVDLRLQHNFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI- 404
+Q +L SL L + ++ +L L+ L + +N I+ +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 405 GRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLD 463
++ L L L +N++ I L + L+L LD
Sbjct: 146 SNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL---------------------SLD 183
Query: 464 LTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515
L+ N I L L L N+ + +SL+++ L N
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 41/219 (18%)
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSEL-GNLEN 578
LP + + LD+ N L+ + F + L +LD S + +I +L +
Sbjct: 26 LPFSTKN------LDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 579 LQILRLSANKLDGRIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENN 636
L L L+ N + + + + KL + LA S+ + I L+ ++ L++ N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 637 L-SGAIPDAFSSVQSLFELQLGSN--------IFDG--SIPCSLSKLH----HFSSI--- 678
+ S +P+ FS++ +L L L SN +P L + I
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 679 ---------LNVSNNKLSGKIPECLGNLDKLQILDLSSN 708
L + N+L L LQ + L +N
Sbjct: 196 AFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 37/220 (16%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKL--------DG---- 591
IP + LD S N L + LQ+L LS ++
Sbjct: 21 KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 592 -----------RIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVIS-LEKMQSLSLQENNL- 637
+ + + KL + LA S+ + I L+ ++ L++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 638 SGAIPDAFSSVQSLFELQLGSNIFDGSIPC----SLSKLHHFSSILNVSNNKLSGKIPEC 693
S +P+ FS++ +L L L SN SI C L ++ + L++S N ++ I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG 195
Query: 694 LGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFN 732
+L+ L L +N +P + + + SL + + N
Sbjct: 196 AFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-20
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 55/238 (23%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------EIR 879
RY+++ + IG G G V ++ A+KKL+R F E+
Sbjct: 63 RYQNL------KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELV 113
Query: 880 TLSLVRHRNILRIV------GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY 933
+ V H+NI+ ++ + + + ++V E M L V+
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMEL--------DHE 164
Query: 934 HIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS- 989
++ + Q G+ +LH + IHRD+K NI++ S+ KI DFG+++ S
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 990 ---STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDT 1043
TR Y APE E D++S G I+ E++ K F G D
Sbjct: 222 PYVVTRY-------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDY 268
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 59/302 (19%), Positives = 92/302 (30%), Gaps = 22/302 (7%)
Query: 236 SNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLD-DNNLEGQIPETLWGLENLQKLV 294
N + +S+ N GA ++ G LE L D + + +L++L
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLT 74
Query: 295 LSANKLNGTISGQISH---CNQLQVIALSRNNLVGQIPRSVGNLS--SLNSLLLFNNRLQ 349
+ A ++ I + LQ + L + G P + + LN L L N
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 350 G--TLPPELGNC--GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI- 404
EL L L + ++ L L L +N G
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 405 ---GRMSKLVELALYNNRLT---GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPY 458
+ L LAL N + G LQ L L+HN L
Sbjct: 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
Query: 459 LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQ 518
L+ L+L+ + L VL L NR + P + + + L N
Sbjct: 255 LNSLNLSFTGLKQVPK---GLPAKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFL 309
Query: 519 GS 520
S
Sbjct: 310 DS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 59/275 (21%), Positives = 95/275 (34%), Gaps = 21/275 (7%)
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRN---LQFLS 438
+ +L + + I + L L + R+ RI R+ LQ L+
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 439 LAHNHLTGEVALELGK-HFPYLSRLDLTGNSFYGPIPA----NICVGTNLFVLVLGNNRF 493
L + +TG L + P L+ L+L S+ + L VL +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 494 NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGV----SFLDVRGNLLQ---GSIP 546
++ +L + LS+N G P L +R ++ G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 547 PVFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDGRIPYELGKCTKMIK 605
+ L LD S N L + + L L LS L ++P L K+
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSV 278
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGA 640
LDLS N L PS L ++ +LSL+ N +
Sbjct: 279 LDLSYNRLD-RNPSP-DELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 52/274 (18%), Positives = 98/274 (35%), Gaps = 22/274 (8%)
Query: 480 GTNLFVLVLGNNRFNGSFPI-EIGKCSSLRRVILSNNLLQGSLPATLERN---PGVSFLD 535
G +L L+ + +I K SL+R+ + + + R G+ L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 536 VRGNLLQGSIPP--VFGFWSNLTMLDFSENRLSG--SIPSELGNL--ENLQILRLSANKL 589
+ + G+ PP + +L +L+ + + +EL L++L ++
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 590 DGRIPYELGKCTKMIKLDLSDNYLAGSIPSE----VISLEKMQSLSLQENN---LSGAIP 642
++ + LDLSDN G + +Q L+L+ SG
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 643 DAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQI 702
++ L L L N + + LN+S L ++P+ L KL +
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSV 278
Query: 703 LDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736
LDLS N P + + + +++ N F
Sbjct: 279 LDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 46/246 (18%), Positives = 73/246 (29%), Gaps = 42/246 (17%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTG--SIPKQLGNCGQ--L 122
S L+ L L ++G + L L+L + + +L + L
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLL-EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
Query: 123 KTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCY----SLESIGFHNN 178
K L + ++ LS LDL N G+ +LC +L+ + N
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 179 FLN---GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSL 235
+ G + +L+ L L+ N+L S
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG----------------------APSC 249
Query: 236 SNCRNLVEFSASSNNFGGAISPWIFKGLLQ-LEVLYLDDNNLEGQIPETLWGLENLQKLV 294
L + S + KGL L VL L N L+ P L + L
Sbjct: 250 DWPSQLNSLNLSFTGLKQ-----VPKGLPAKLSVLDLSYNRLDR-NPS-PDELPQVGNLS 302
Query: 295 LSANKL 300
L N
Sbjct: 303 LKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 32/144 (22%), Positives = 51/144 (35%), Gaps = 12/144 (8%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQ--HLLSLDLSGNEFT---GSIPKQLGNCGQLK 123
+L L+LS G IS +C + L L L G QL+
Sbjct: 173 PALSTLDLSDNPELG-ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 124 TLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNG 182
L L+ N + + +L+ L+L + L ++P L L + N L+
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLSVLDLSYNRLD- 287
Query: 183 ELPNDICSLPKLKSLYLNTNNLTG 206
P LP++ +L L N
Sbjct: 288 RNP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 26/174 (14%), Positives = 53/174 (30%), Gaps = 12/174 (6%)
Query: 574 GNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPS---EVISLEKMQSL 630
G +L+ + D ++ K + +L + + I V+ + +Q L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 631 SLQENNLSGAIP-----DAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNK 685
+L+ ++G P + L + D + L +L+++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 686 LSGKIPECLGNLDKLQILDLSSNSFSGEIP----TEVNNMVSLYFVNISFNHFS 735
E + L LDLS N GE +L + +
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 26/153 (16%), Positives = 53/153 (34%), Gaps = 8/153 (5%)
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQS---LFELQLGSNIFD 662
L D +++I ++ L+++ + I V L EL L +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 663 GSIPCSLSKLHHFS----SILNVSNNKLSGKIPECLGNLDK-LQILDLSSNSFSGEIPTE 717
G+ P L + ++ NVS + E L L++L ++ +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 718 VNNMVSLYFVNISFNHFSGKLPASWTTLMVSYP 750
V +L +++S N G+ + +P
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-20
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 54/243 (22%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-----EIRTLSL 883
++ ++G+G +G V + + A+KK+ + EI+ L
Sbjct: 12 DFQLK------SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 884 VRHRNILRIV-----GSCTKDEHGFIVTEYMPGGT-LFNVLHQNEPRLVLDWNTRYHIAL 937
+H NI+ I S +I+ E M T L V+ L + HI
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQ--ML-----SDDHIQY 116
Query: 938 GIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
I Q + LH +IHRD+K N+L++S + K+ DFG++++I +S + ++
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 995 IVGSL--GYI------APE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF-G 1040
S ++ APE Y + DV+S G IL EL R+ P F G
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKY----SRAMDVWSCGCILAELFLRR----PIFPG 225
Query: 1041 EDT 1043
D
Sbjct: 226 RDY 228
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-20
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDV-----EIRTLS 882
Y +G G +G+V + S + A+KKL+R ++ E+ L
Sbjct: 25 TYVSP------THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 883 LVRHRNILRIV------GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
++H N++ ++ S ++V +M L ++ + I
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKF--------SEEKIQ 129
Query: 937 LGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--ST 991
+ Q GL Y+H ++HRD+K N+ ++ + E KI DFG+++ + T
Sbjct: 130 YLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 186
Query: 992 RSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDT 1043
R Y APE S + D++S G I+ E+L K F G+D
Sbjct: 187 RW-------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDY 229
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-20
Identities = 57/237 (24%), Positives = 93/237 (39%), Gaps = 53/237 (22%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDV-----EIRTLS 882
Y +IG+G +G VY N+ K+ A+KK+NR E D EI L+
Sbjct: 27 NYIIK------HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 883 LVRHRNILRIV-----GSCTKDEHGFIVTEYMPGGT-LFNVLHQNEPRLVLDWNTRYHIA 936
++ I+R+ K + +IV E + L + L T HI
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIF---L---TEEHIK 132
Query: 937 LGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS 993
+ G +++H IIHRD+K N LL+ + K+ DFG+++ I+ ++ +
Sbjct: 133 TILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189
Query: 994 AIVGSLGYIAPENAYSTRLTE--------------------KS-DVYSYGVILFELL 1029
+ + +LT KS D++S G I ELL
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-20
Identities = 53/246 (21%), Positives = 87/246 (35%), Gaps = 60/246 (24%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------------ 876
Y R I G +G V + ++ A+K++ + ++
Sbjct: 23 PYTVQ------RFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 877 ---EIRTLSLVRHRNILRIV-----GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLD 928
EIR L+ H NIL + ++VTE M L V+H +
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVI--- 131
Query: 929 WNTRYHIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985
+ HI + GL LH ++HRD+ NILL + I DF +++ +
Sbjct: 132 --SPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 986 SHSS----STRSAIVGSLGYIAPE---NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038
+ + R Y APE T+ D++S G ++ E+ RK
Sbjct: 187 DANKTHYVTHRW-------YRAPELVMQ--FKGFTKLVDMWSAGCVMAEMFNRK----AL 233
Query: 1039 F-GEDT 1043
F G
Sbjct: 234 FRGSTF 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 47/234 (20%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDV-----EIRTLS 882
Y D+ + +G G +G V + + A+KKL R ++ E+R L
Sbjct: 26 VYRDL------QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79
Query: 883 LVRHRNILRI--VGSCTKDEHGF----IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
+RH N++ + V + + F +V +M G L ++ +L I
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KL-----GEDRIQ 131
Query: 937 LGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--ST 991
+ Q GL Y+H IIHRD+K N+ ++ + E KI DFG+++ + T
Sbjct: 132 FLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188
Query: 992 RSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDT 1043
R Y APE + R T+ D++S G I+ E++ K F G D
Sbjct: 189 RW-------YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDH 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 21/199 (10%), Positives = 48/199 (24%), Gaps = 46/199 (23%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRNILR 891
G ++ L + A+ ++ LS + + R
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
++ G +V E++ GG+L V + P + +A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA- 148
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
+ + + + + + +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA----- 179
Query: 1011 RLTEKSDVYSYGVILFELL 1029
+ D+ G L+ LL
Sbjct: 180 --NPQDDIRGIGASLYALL 196
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-19
Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 53/237 (22%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------EIR 879
RY+++ +G G +G+V + AVKKL+R F E+R
Sbjct: 30 RYQNL------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSIIHAKRTYRELR 80
Query: 880 TLSLVRHRNILRIV------GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRY 933
L ++H N++ ++ S + ++VT M G L N++ + L T
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----L---TDD 132
Query: 934 HIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS- 989
H+ I Q GL Y+H IIHRD+K N+ ++ + E KI DFG+++ +D +
Sbjct: 133 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 990 -STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSF-GEDT 1043
+TR Y APE + + D++S G I+ ELL + F G D
Sbjct: 190 VATRW-------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR----TLFPGTDH 235
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-19
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 44/222 (19%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN---RSETNFDVEIRTL-SLV 884
Y+ V R +G+GK+ V+ ++ + + VK L + + EI+ L +L
Sbjct: 37 DYQLV------RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK--REIKILENLR 88
Query: 885 RHRNILR---IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941
NI+ IV + T F L+Q L T Y I + +
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVN--NTDFKQLYQ---TL-----TDYDIRFYMYE 138
Query: 942 ---GLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSSSTRSAIVG 997
L Y H I+HRD+K N+++D E + ++ D+G+++ + R V
Sbjct: 139 ILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VA 192
Query: 998 SLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
S + PE Y L D++S G +L ++FRK P
Sbjct: 193 SRYFKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 53/286 (18%), Positives = 101/286 (35%), Gaps = 42/286 (14%)
Query: 87 NSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRL 146
I + +L T ++ + ++ N++ + S+ I L +
Sbjct: 12 KQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNV 67
Query: 147 SWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTG 206
+ L L N L+ I P ++ +L + N + +L + + L KLKSL L N ++
Sbjct: 68 TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD 123
Query: 207 LLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQL 266
+ L + L +N I+ L +L
Sbjct: 124 I-------------------------NGLVHLPQLESLYLGNNKITD-ITV--LSRLTKL 155
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
+ L L+DN + I L GL LQ L LS N ++ + ++ L V+ L +
Sbjct: 156 DTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLN 211
Query: 327 QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFI 372
+ NL N++ + L P + + G ++ +
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLP 255
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.2 bits (210), Expect = 5e-17
Identities = 51/327 (15%), Positives = 105/327 (32%), Gaps = 34/327 (10%)
Query: 338 LNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIE 397
+ + + ++ P + L+ + + L ++ + N+ I+
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 398 GAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFP 457
I + + +L L N+LT I P +T L+NL +L L N + +L+
Sbjct: 57 SVQG--IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLK---DLK 109
Query: 458 YLSRLDLTGNSFYGPIP--ANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515
L L L N I + L L LGNN+ + + + L + L +N
Sbjct: 110 KLKSLSLEHN----GISDINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDN 163
Query: 516 LLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGN 575
+ + L + L + N + + + G NL +L+ + N
Sbjct: 164 QIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRALAGL-KNLDVLELFSQECLNKPINHQSN 219
Query: 576 LENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635
L ++ + L P + K ++ + S +
Sbjct: 220 LVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL---------PEFTNEVSFIFYQP 268
Query: 636 NLSGAIPDAFSSVQSLFELQLGSNIFD 662
G F + ++ + +D
Sbjct: 269 VTIGKAKARFHGRVTQPLKEVYTVSYD 295
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.7 bits (201), Expect = 5e-16
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 21/240 (8%)
Query: 486 LVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSI 545
+ + FP + + + L + T + + + ++ S+
Sbjct: 4 TITVSTPIKQIFPDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV 58
Query: 546 PPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIK 605
+ N+T L + N+L+ I L NL+NL L L NK+ + L K+
Sbjct: 59 QGIQYL-PNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKS 113
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN-IFDGS 664
L L N + S + ++ L +++SL L N ++ S + L L L N I D
Sbjct: 114 LSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIV 169
Query: 665 IPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL 724
L+KL + L +S N +S L L L +L+L S + +N+V
Sbjct: 170 PLAGLTKLQN----LYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 825 PRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV-EIRTLSL 883
R++ Y + ++IG G G V++ S + A+KK+ + F E++ + +
Sbjct: 37 QREIAYTNC------KVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKNRELQIMRI 88
Query: 884 VRHRNILRI------VGSCTKDEHGFIVTEYMPGGTLFNVL-HQNEPRLVLDWNTRYHIA 936
V+H N++ + G + +V EY+P T++ H + + + I
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTM---PMLLIK 144
Query: 937 LGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEP-KIGDFGMSKLISDSHSSSTR 992
L + Q L+Y+H I HRDIK N+LLD K+ DFG +K++ +
Sbjct: 145 LYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV-- 199
Query: 993 SAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRK 1032
S I S Y APE Y+T + D++S G ++ EL+ +
Sbjct: 200 SYIC-SRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-18
Identities = 52/180 (28%), Positives = 71/180 (39%), Gaps = 10/180 (5%)
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
+L+L +N L TL L +L L +L T L + LS N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPEL-GNCGSLVDLRLQHNFIGGTIPPEIC-NL 383
+P L +L L + NRL +LP G L +L L+ N + T+PP +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL-KTLPPGLLTPT 147
Query: 384 AKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
KLE L L NN + +P + + L L L N L IP L F L N
Sbjct: 148 PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 12/193 (6%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVS 532
+P ++ + +L L N + + L ++ L L L P +
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLG 80
Query: 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDG 591
LD+ N LQ S+P + LT+LD S NRL+ S+P L LQ L L N+L
Sbjct: 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK- 137
Query: 592 RIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPDAFSSVQ 649
+P L K+ KL L++N L +P+ ++ LE + +L LQEN+L F S
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS-H 195
Query: 650 SLFELQLGSNIFD 662
L L N +
Sbjct: 196 LLPFAFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 47/229 (20%), Positives = 72/229 (31%), Gaps = 31/229 (13%)
Query: 118 NCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHN 177
+ + ++PP++ K + L L N L
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLY-TFSLAT----------LM- 52
Query: 178 NFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSN 237
+L L L+ LT L + L + N SLP
Sbjct: 53 ------------PYTRLTQLNLDRAELTKL-QVDGTLPVLGTLDLSHNQLQ-SLPLLGQT 98
Query: 238 CRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSA 297
L S N ++ +GL +L+ LYL N L+ P L L+KL L+
Sbjct: 99 LPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157
Query: 298 NKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346
N L +G ++ L + L N+L IP+ L L N
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 51/207 (24%), Positives = 75/207 (36%), Gaps = 24/207 (11%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
++ L ++PP + T+L SEN L + L L L L +L ++
Sbjct: 15 VNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKL 70
Query: 594 PYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFE 653
G + LDLS N L S+P +L + L + N L+ A + L E
Sbjct: 71 Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 654 LQLGSN--------IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDL 705
L L N + KL L+++NN L+ L L+ L L L
Sbjct: 129 LYLKGNELKTLPPGLLTP-----TPKLEK----LSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 706 SSNSFSGEIPTEVNNMVSLYFVNISFN 732
NS IP L F + N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 48/184 (26%), Positives = 64/184 (34%), Gaps = 13/184 (7%)
Query: 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNR 395
L L N L L L L L + T L L L L +N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQ 88
Query: 396 IEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELG- 453
++ ++P + L L + NRLT +P L LQ L L N L L G
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK---TLPPGL 143
Query: 454 -KHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVI 511
P L +L L N+ +PA + G NL L+L N + P L
Sbjct: 144 LTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 512 LSNN 515
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 46/182 (25%), Positives = 63/182 (34%), Gaps = 17/182 (9%)
Query: 412 ELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYG 471
L L N L + L L+L LT L++ P L LDL+ N
Sbjct: 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT---KLQVDGTLPVLGTLDLSHNQLQS 91
Query: 472 PIPANICVGTNLFVLVLGNNRF----NGSFPIEIGKCSSLRRVILSNNLLQGSLPA-TLE 526
+P L VL + NR G+ L+ + L N L+ +LP L
Sbjct: 92 -LPLLGQTLPALTVLDVSFNRLTSLPLGAL----RGLGELQELYLKGNELK-TLPPGLLT 145
Query: 527 RNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLS 585
P + L + N L +P + NL L EN L +IP L L
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 586 AN 587
N
Sbjct: 204 GN 205
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-18
Identities = 83/460 (18%), Positives = 155/460 (33%), Gaps = 80/460 (17%)
Query: 68 SSSLKALNLSGFGLSGVLNNSISYICK-NQHLLSLDLSGNEFT----GSIPKQLGNCGQL 122
S +++L++ LS + + + Q + L T I L L
Sbjct: 2 SLDIQSLDIQCEELS---DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 58
Query: 123 KTLLLNDNRFQGSIPPEIFK-LK----RLSWLDLGYNSLSGK----IPPQVSLCYSLESI 173
L L N + + L+ ++ L L L+G + + +L+ +
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 174 GFHNNFLNGELPNDICSL-----PKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFV 228
+N L +C +L+ L L +L+ SC
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS------AASCE------------ 160
Query: 229 GSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL----LQLEVLYLDDNNLEGQ----I 280
L + L + E + S+N+ A + +GL QLE L L+ + +
Sbjct: 161 -PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219
Query: 281 PETLWGLENLQKLVLSANKLNGT----ISGQISHCN-QLQVIALSRNNL----VGQIPRS 331
+ +L++L L +NKL + + H + +L+ + + + G + R
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279
Query: 332 VGNLSSLNSLLLFNNRLQGT----LPPELGNCG-SLVDLRLQHNFIGGTIPPEICNLAK- 385
+ SL L L N L L L G L L ++ ++
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 386 ---LEVLYLFNNRIEGAIPHQIGRM-----SKLVELALYNNRLTGRIPPDI----TRLRN 433
L L + NNR+E A ++ + S L L L + ++ + +
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 434 LQFLSLAHNHLTGEVALELGKHFPY----LSRLDLTGNSF 469
L+ L L++N L L+L + L +L L +
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 82/469 (17%), Positives = 148/469 (31%), Gaps = 76/469 (16%)
Query: 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKLV 294
++ A + L Q +V+ LDD L I L L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 295 LSANKLNG----TISGQISHCN-QLQVIALSRNNL----VGQIPRSVGNLSSLNSLLLFN 345
L +N+L + + + ++Q ++L L G + ++ L +L L L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 346 NRLQGTLPPELG-----NCGSLVDLRLQHNFIGGT----IPPEICNLAKLEVLYLFNNRI 396
N L L L L+L++ + + + + L + NN I
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 397 EGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELG--- 453
A +++ L ++ L+ L L +T + +L
Sbjct: 183 NEA-------GVRVLCQGLKDSPCQ------------LEALKLESCGVTSDNCRDLCGIV 223
Query: 454 KHFPYLSRLDLTGNSFYGP-----IPANICVGTNLFVLVLGNNRFNGSFPIEIGK----C 504
L L L N P + + L L + ++ +
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283
Query: 505 SSLRRVILSNNLLQGS-----LPATLERNPGVSFLDVRGNLLQG----SIPPVFGFWSNL 555
SL+ + L+ N L LE + L V+ V L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 556 TMLDFSENRLSGSIPSELG-----NLENLQILRLSANKLD----GRIPYELGKCTKMIKL 606
L S NRL + EL L++L L+ + + L + +L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 607 DLSDNYL--AGSIP-SEVISL--EKMQSLSLQENNLSGAIPDAFSSVQS 650
DLS+N L AG + E + ++ L L + S + D +++
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 452
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 76/461 (16%), Positives = 140/461 (30%), Gaps = 84/461 (18%)
Query: 314 LQVIALSRNNLVGQ-IPRSVGNLSSLNSLLLFNNRLQGT----LPPELGNCGSLVDLRLQ 368
+Q + + L + L + L + L + L +L +L L+
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 369 HNFIGGTIPPEICNL-----AKLEVLYLFNNRI--EGA--IPHQIGRMSKLVELALYNNR 419
N +G + K++ L L N + G + + + L EL L +N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 420 LTGRIPPDITRLR-----NLQFLSLAHNHLTGEVALELG---KHFPYLSRLDLTGNSFYG 471
L + L+ L L + L+ L + P L ++ N
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 472 PIPANICVG-----TNLFVLVLGNNRFNGSFPIEIG----KCSSLRRVILSNNLLQGS-- 520
+C G L L L + ++ +SLR + L +N L
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 521 ---LPATLERNPGVSFLDVRGNLLQ----GSIPPVFGFWSNLTMLDFSENRLSGSIPSEL 573
P L + + L + + G + V +L L + N L L
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 574 GNL-----ENLQILRLSANKLDGR----IPYELGKCTKMIKLDLSDN--------YLAGS 616
L+ L + + L + +++L +S+N L
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 617 IPSEVISLEKMQSLSLQENNLS----GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKL 672
+ ++ L L + ++S ++ + SL EL L +N + L +
Sbjct: 365 LGQ---PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE- 420
Query: 673 HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713
S + P C L+ L L +S E
Sbjct: 421 --------------SVRQPGC-----LLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 8e-14
Identities = 64/379 (16%), Positives = 119/379 (31%), Gaps = 69/379 (18%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSI-SYICKNQHLLSLDLSGNEFTGSIPKQLG-----NC 119
S ++ L+L L+G + S + L L LS N + + L
Sbjct: 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ 141
Query: 120 GQLKTLLLNDNRFQGSIPPEIFKL----KRLSWLDLGYNSLSGKIPPQVSLC-----YSL 170
+L+ L L + + + L + N ++ + L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201
Query: 171 ESIGFHNNFLNGE----LPNDICSLPKLKSLYLNTNNLT-------GLLPEFPNSCAILH 219
E++ + + + L + S L+ L L +N L P+ +
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPS-SRLRT 260
Query: 220 LLIHENDF----VGSLPTSLSNCRNLVEFSASSNNFGG----AISPWIFKGLLQLEVLYL 271
L I E G L L +L E S + N G + + + QLE L++
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 272 DDNNLEGQ----IPETLWGLENLQKLVLSANKLNGT----ISGQISHCN-QLQVIALSRN 322
+ L L +L +S N+L + + L+V+ L+
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380
Query: 323 NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEIC- 381
++ S +L++ L SL +L L +N +G ++
Sbjct: 381 DVSDS---SCSSLAAT-----------------LLANHSLRELDLSNNCLGDAGILQLVE 420
Query: 382 ----NLAKLEVLYLFNNRI 396
LE L L++
Sbjct: 421 SVRQPGCLLEQLVLYDIYW 439
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-13
Identities = 73/401 (18%), Positives = 130/401 (32%), Gaps = 67/401 (16%)
Query: 361 SLVDLRLQHNFIGGTIPPEIC-NLAKLEVLYLFNNRI--EGA--IPHQIGRMSKLVELAL 415
+ L +Q + E+ L + +V+ L + + I + L EL L
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63
Query: 416 YNNRLTGRIPPDITRL-----RNLQFLSLAHNHLTGEVALELG---KHFPYLSRLDLTGN 467
+N L + + +Q LSL + LTG L + P L L L+ N
Sbjct: 64 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123
Query: 468 SFYGPIPANICVG-----TNLFVLVLGNNRFNGSFPIEIGK----CSSLRRVILSNNLLQ 518
+C G L L L + + + + + +SNN +
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
Query: 519 GSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS----GSIPSELG 574
GV L L+ S L L ++ + +
Sbjct: 184 ---------EAGVRVL---CQGLKDS-------PCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 575 NLENLQILRLSANKLDGR-----IPYELGKCTKMIKLDLSDNYL----AGSIPSEVISLE 625
+ +L+ L L +NKL P L +++ L + + + G + + + E
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 626 KMQSLSLQENNLSG----AIPDAFSSVQ-SLFELQLGSN-IFDGSIP--CSLSKLHHFSS 677
++ LSL N L + + L L + S S+ + F
Sbjct: 285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLL 344
Query: 678 ILNVSNNKLSGK----IPECLGNLD-KLQILDLSSNSFSGE 713
L +SNN+L + + LG L++L L+ S
Sbjct: 345 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-11
Identities = 54/357 (15%), Positives = 102/357 (28%), Gaps = 78/357 (21%)
Query: 432 RNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF----YGPIPANICVGTNLFVLV 487
++Q L + L+ EL + L I + + V L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 488 LGNNRFNGSFPIEIGKC-----SSLRRVILSNNLLQ----GSLPATLERNPGVSFLDVRG 538
L +N + + ++++ L N L G L +TL P + L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 539 NLLQGS---------------------------------IPPVFGFWSNLTMLDFSENRL 565
NLL + + V + L S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 566 SGSIPSELG-----NLENLQILRLSANKLDGR----IPYELGKCTKMIKLDLSDN----- 611
+ + L + L+ L+L + + + + + +L L N
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242
Query: 612 ---YLAGSIPSEVISLEKMQSLSLQENNLS----GAIPDAFSSVQSLFELQLGSNIFDGS 664
L + L ++L + E ++ G + + +SL EL L N
Sbjct: 243 GMAELCPGLLHPSSRL---RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299
Query: 665 ----IPCSLSKLHHFSSILNVSNNKLSGK----IPECLGNLDKLQILDLSSNSFSGE 713
+ +L + L V + + L L L +S+N
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-17
Identities = 49/258 (18%), Positives = 89/258 (34%), Gaps = 22/258 (8%)
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
V ++ + +IP L N +L KL G S L+ I +S+N+++
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 327 QIPRSV-GNLSSLNSLLLFN-NRLQGTLPPE-LGNCGSLVDLRLQHNFIGGTIPPEI-CN 382
I V NL L+ + + N L + PE N +L L + + I +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIH 126
Query: 383 LAKLEVLYLF-NNRIEGAIPHQI--GRMSKLVELALYNNRLTGRIPPDITR-LRNLQFLS 438
+ +L + N I I G + V L L N + I + +
Sbjct: 127 SLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184
Query: 439 LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNNRFNGSF 497
+N+L E+ ++ LD++ +P+ L N + +
Sbjct: 185 SDNNNLE-ELPNDVFHGASGPVILDISRTRI-HSLPSYGLENLKKLRARSTYNLKKLPTL 242
Query: 498 PIEIGKCSSLRRVILSNN 515
K +L L+
Sbjct: 243 ----EKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 34/209 (16%), Positives = 68/209 (32%), Gaps = 8/209 (3%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDL-GYN 154
+ + L + G L+ + ++ N I ++F L +L + + N
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 155 SLSGKIPPQV-SLCYSLESIGFHNNFLNGELPNDI-CSLPKLKSLYLNTNNLTGLLPE-- 210
+L I P+ +L+ + N + LP+ + L + N +
Sbjct: 91 NLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 211 FPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLY 270
F +L + + + S N L E + S NN + +F G +L
Sbjct: 149 FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208
Query: 271 LDDNNLEGQIPETLWGLENLQKLVLSANK 299
+ + L L+ L+ K
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARSTYNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 46/248 (18%), Positives = 86/248 (34%), Gaps = 23/248 (9%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRN 433
IP ++ L ++ L ++ + N + I D+ + L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 434 LQFLSLAH-NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG-TNLFVLVLGNN 491
L + + N+L + E ++ P L L ++ +P + +L + +N
Sbjct: 81 LHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI-KHLPDVHKIHSLQKVLLDIQDN 138
Query: 492 RF-----NGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIP 546
SF G + L+ N +Q + N L+ +P
Sbjct: 139 INIHTIERNSFV---GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELP 194
Query: 547 P-VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLDGRIPYELGKCTKMI 604
VF S +LD S R+ S+PS L NL+ L+ K ++P L K ++
Sbjct: 195 NDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALM 249
Query: 605 KLDLSDNY 612
+ L+
Sbjct: 250 EASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 34/207 (16%), Positives = 67/207 (32%), Gaps = 10/207 (4%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
+ + + IP N L F +L +L+ + +S N + I
Sbjct: 14 FLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 594 PYE-LGKCTKMIKLDLSDNYLAGSIPSEV-ISLEKMQSLSLQENNLSGAIPD-AFSSVQS 650
+ K+ ++ + I E +L +Q L + + +PD
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQ 129
Query: 651 LFELQLGSNIFDGSIP-CSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709
L + NI +I S L S IL ++ N + ++ +N+
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189
Query: 710 FSGEIPTEV-NNMVSLYFVNISFNHFS 735
E+P +V + ++IS
Sbjct: 190 LE-ELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 27/155 (17%), Positives = 50/155 (32%), Gaps = 21/155 (13%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYI-----CKNQHLLSLDLSGNEFTGSIPKQL--GNCGQ 121
+L+ L +S N I ++ + + LD+ N +I + G +
Sbjct: 104 PNLQYLLIS--------NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155
Query: 122 LKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGKIPPQV-SLCYSLESIGFHNNF 179
L LN N Q I F + N+L ++P V +
Sbjct: 156 SVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTR 213
Query: 180 LNGELPNDIC-SLPKLKSLYLNTNNLTGLLPEFPN 213
++ LP+ +L KL++ L +
Sbjct: 214 IH-SLPSYGLENLKKLRARSTYNLKKLPTLEKLVA 247
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 66/250 (26%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV---------EIR 879
RY D+ + +G G +G V+ + N+ K A+KK+ EI+
Sbjct: 12 RYMDL------KPLGCGGNGLVFSAVDNDCDKRVAIKKIV-----LTDPQSVKHALREIK 60
Query: 880 TLSLVRHRNILRIV----------GSCTKDEHGF----IVTEYMPGGT-LFNVLHQNEPR 924
+ + H NI+++ IV EYM T L NVL Q
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGP-- 116
Query: 925 LVLDWNTRYHIALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMS 980
L H L + Q GL Y+H ++HRD+K N+ +++E L KIGDFG++
Sbjct: 117 --L---LEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 981 KLISDSHSSSTR-SAIVGSLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+++ +S S + + Y +P N Y T+ D+++ G I E+L K
Sbjct: 169 RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY----TKAIDMWAAGCIFAEMLTGK-- 222
Query: 1035 VDPSF-GEDT 1043
F G
Sbjct: 223 --TLFAGAHE 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 62/271 (22%), Positives = 99/271 (36%), Gaps = 79/271 (29%)
Query: 825 PRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL-------NRSETNFDVE 877
+Y + +G G G V S K +A+KK+ NR E
Sbjct: 4 TSSKKYSLG------KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------E 50
Query: 878 IRTLSLVRHRNILR---IVGSCTKDEHGF------------------------------- 903
+ + ++ H NI++ + +E
Sbjct: 51 LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 904 ----IVTEYMPGGTLFNVL-HQNEPRLVLDWNTRYHIALGIAQ---GLSYLHYDCVPQII 955
++ EY+P TL VL + I++ I Q + ++H I
Sbjct: 111 KYLNVIMEYVPD-TLHKVLKSFIRSGRSI---PMNLISIYIYQLFRAVGFIHS---LGIC 163
Query: 956 HRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY-STRLT 1013
HRDIK N+L++S+ K+ DFG +K + S S + I S Y APE +T T
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--AYIC-SRFYRAPELMLGATEYT 220
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSF-GEDT 1043
D++S G + EL+ K P F GE +
Sbjct: 221 PSIDLWSIGCVFGELILGK----PLFSGETS 247
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDV----EIRTLSLVRHRNILRIVGSC 896
+G G + TVY+ L+ + + A+K++ SE EI + ++H NI+R+
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ---GLSYLHYDCVPQ 953
+ +V E+M L + + Q GL++ H + +
Sbjct: 73 HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---K 128
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAY 1008
I+HRD+K N+L++ + K+GDFG+++ +T S+ V +L Y AP+ Y
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI--PVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
ST + D++S G IL E++ K P F D
Sbjct: 187 STSI----DIWSCGCILAEMITGK----PLFPGTNDE 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVGS 895
IG+G +GTV++ + + + A+K+ L+ + EI L ++H+NI+R+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
D+ +V E+ L LD + +GL + H ++
Sbjct: 70 LHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVL 123
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAYST 1010
HRD+K N+L++ E K+ +FG+++ + A V +L Y P+ YST
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS--AEVVTLWYRPPDVLFGAKLYST 181
Query: 1011 RLTEKSDVYSYGVILFELLFRKMP 1034
+ D++S G I EL P
Sbjct: 182 SI----DMWSAGCIFAELANAGRP 201
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 44/266 (16%), Positives = 82/266 (30%), Gaps = 39/266 (14%)
Query: 185 PNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEF 244
+ C + + + ++ + P P S L L E + SN N+
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRI-PSLPPSTQTLKL--IETHLRTIPSHAFSNLPNISRI 60
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIP-ETLWGLENLQKLVLSANKLNGT 303
S + + F L ++ + + + I + L L L+ L + L
Sbjct: 61 YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-- 118
Query: 304 ISGQISHCNQLQVIALSRNNLVGQIP--RSVGNLSSLNSLLLFNNRLQGTLPPEL--GNC 359
P V + L + +N ++P G C
Sbjct: 119 -----------------------MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI--GRMSKLVELALYN 417
+ L+L +N ++ N KL+ +YL N+ I G S L +
Sbjct: 156 NETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214
Query: 418 NRLTGRIPPDITRLRNLQFLSLAHNH 443
+T +P L +L+ L +
Sbjct: 215 TSVT-ALPSKG--LEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 53/230 (23%), Positives = 84/230 (36%), Gaps = 35/230 (15%)
Query: 361 SLVDLRLQHNFIGGTIPPEI-CNLAKLEVLYL-FNNRIEGAIPHQIGRMSKLVELALYNN 418
S L+L + TIP NL + +Y+ + ++ H +SK+ + + N
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 419 RLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANI 477
R I PD L L+FL + + L L L++T N + IP N
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 478 CVG--TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535
G L L NN F S + L V L+ N
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN-------------------- 189
Query: 536 VRGNLLQGSIPP-VF-GFWSNLTMLDFSENRLSGSIPSE-LGNLENLQIL 582
L I F G +S ++LD S+ ++ ++PS+ L +L+ L
Sbjct: 190 ---KYLT-VIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 46/240 (19%), Positives = 92/240 (38%), Gaps = 29/240 (12%)
Query: 504 CSSLRRVILSNNLLQG--SLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDF 560
C ++ +Q SLP + + L + L+ +IP F N++ +
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQT------LKLIETHLR-TIPSHAFSNLPNISRIYV 62
Query: 561 SENRLSGSIPSEL-GNLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIP 618
S + + S NL + + + + I + L + + L + + L P
Sbjct: 63 SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
Query: 619 SE--VISLEKMQSLSLQENNLSGAIP-DAFSSVQS-LFELQLGSNIFDGSIPC---SLSK 671
V S + L + +N +IP +AF + + L+L +N F S+ + +K
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTK 180
Query: 672 LHHFSSILNVSNNKLSGKIPECL--GNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVN 728
L + ++ NK I + G +LD+S S + +P++ ++ L N
Sbjct: 181 LDA----VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 38/258 (14%), Positives = 75/258 (29%), Gaps = 58/258 (22%)
Query: 59 WSGVSCYNNS--------SSLKALNLSGFGLSGVLNNSISYICKN-----QHLLSLDLSG 105
S + L L + I + ++ + +S
Sbjct: 13 EEDFRVTCKDIQRIPSLPPSTQTLKLI--------ETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 106 NEFTGSIPKQL-GNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGKIPPQ 163
+ + N ++ + + + R I P+ K L L +L + L P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD- 122
Query: 164 VSLCYSLESIGF----HNNFLNGELPNDICSLPK-LKSLYLNTNNLTGLLPEFPNSCAIL 218
++ YS + N ++ N L +L L N T
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS------------ 170
Query: 219 HLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQ-LEVLYLDDNNLE 277
+ F G+ L + N + I F G+ +L + ++
Sbjct: 171 ---VQGYAFNGT---------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
Query: 278 GQIPETLWGLENLQKLVL 295
+P GLE+L++L+
Sbjct: 219 -ALPSK--GLEHLKELIA 233
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 39/208 (18%), Positives = 76/208 (36%), Gaps = 9/208 (4%)
Query: 505 SSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSEN 563
S + + L L+ P +S + V ++ + F S +T ++
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 564 RLSGSIPSE-LGNLENLQILRLSANKLDGRIP--YELGKCTKMIKLDLSDNYLAGSIPSE 620
R I + L L L+ L + L P ++ L+++DN SIP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 621 VIS--LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP-CSLSKLHHFSS 677
+ +L L N + AF+ + L + L N + I + ++ S
Sbjct: 150 AFQGLCNETLTLKLYNNGFTSVQGYAFNGTK-LDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 678 ILNVSNNKLSGKIPECLGNLDKLQILDL 705
+L+VS ++ + L +L +L +
Sbjct: 209 LLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 9/134 (6%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQL--GNCGQLKTLL 126
LK L + GL ++ + L+++ N + SIP G C + TL
Sbjct: 105 PLLKFLGIFNTGLKMF--PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 127 LNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQV--SLCYSLESIGFHNNFLNGEL 184
L +N F S+ F +L + L N I + + + L
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220
Query: 185 PNDIC-SLPKLKSL 197
P+ L +L +
Sbjct: 221 PSKGLEHLKELIAR 234
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 28/148 (18%), Positives = 59/148 (39%), Gaps = 16/148 (10%)
Query: 600 CTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
C + ++ + IPS Q+L L E +L AFS++ ++ + + +
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 660 IFDGSIP----CSLSKLHHFSSILNVSNNKLSGKIP-ECLGNLDKLQILDLSSNSFSGEI 714
+ + +LSK+ H + + N + I + L L L+ L + +
Sbjct: 66 VTLQQLESHSFYNLSKVTH----IEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 715 P--TEVNNMVSLYFVNISFNHFSGKLPA 740
P T+V + + + I+ N + +P
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 5e-17
Identities = 53/246 (21%), Positives = 92/246 (37%), Gaps = 66/246 (26%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDV-----EIRTLS 882
RYE +IG G +G V ++ A+KK+ R E D EI L+
Sbjct: 54 RYEIR------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 883 LVRHRNILRIV-----GSCTKDEHGFIVTEYMPGGT-LFNVLHQNEPRLVLDWNTRYHIA 936
+ H ++++++ K + ++V E + + L T HI
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVY---L---TELHIK 159
Query: 937 LGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS 993
+ G+ Y+H I+HRD+K N L++ + K+ DFG+++ + + +++
Sbjct: 160 TLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216
Query: 994 AIVGSLG-------------------------YIAPE-----NAYSTRLTEKSDVYSYGV 1023
I Y APE Y+ + DV+S G
Sbjct: 217 PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIGC 272
Query: 1024 ILFELL 1029
I ELL
Sbjct: 273 IFAELL 278
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 49/228 (21%), Positives = 98/228 (42%), Gaps = 41/228 (17%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVGS 895
IG+G G V++ + + A+KK + + F + EI+ L L++H N++ ++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 896 CTKDEHG--------FIVTEYMP---GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
C ++V ++ G L + + + + + GL
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLL------SNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR--SAIVGSLGYI 1002
Y+H + +I+HRD+K+ N+L+ + K+ DFG+++ S + +S + V +L Y
Sbjct: 139 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 195
Query: 1003 APE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
PE Y + D++ G I+ E+ R P +T+
Sbjct: 196 PPELLLGERDYGPPI----DLWGAGCIMAEMWTRS----PIMQGNTEQ 235
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLN-RSETNFDV----EIRTLSLVRHRNILRIVGSC 896
+G+G + TVY+ S + A+K++ E E+ L ++H NI+ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ---GLSYLHYDCVPQ 953
++ +V EY+ L L + +++ L + Q GL+Y H +
Sbjct: 70 HTEKSLTLVFEYLD-KDLKQYLDDCGNII-----NMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAY 1008
++HRD+K N+L++ E K+ DFG+++ S + T V +L Y P+ Y
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
ST++ D++ G I +E+ + P F T
Sbjct: 179 STQI----DMWGVGCIFYEMATGR----PLFPGSTVE 207
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 9e-17
Identities = 57/324 (17%), Positives = 103/324 (31%), Gaps = 33/324 (10%)
Query: 171 ESIGFHNNFL--NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFV 228
+S F++ +L E + +C + + + + L +L ++ V
Sbjct: 226 QSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSV 285
Query: 229 GSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWG-- 286
N + V P ++ + L PE
Sbjct: 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS 345
Query: 287 --LENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQI---PRSVGNLSSLNSL 341
E L + LS K + ++ C +LQ + + I R++ L
Sbjct: 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET 404
Query: 342 LLFNNRLQGTLPPELG------------------NCGSLVDLRLQHNFIGGTIPPEICNL 383
L + + L+ P + L L H + T+ + L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQL 462
Query: 384 AKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNH 443
+ L L +NR+ A+P + + L L +N L + + L LQ L L +N
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 519
Query: 444 LTGEVALELGKHFPYLSRLDLTGN 467
L A++ P L L+L GN
Sbjct: 520 LQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 68.6 bits (167), Expect = 6e-12
Identities = 45/276 (16%), Positives = 82/276 (29%), Gaps = 13/276 (4%)
Query: 378 PEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFL 437
P L L L + + E L +R D L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSATDEQLFRC 354
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF 497
L+ T V + L L+ I + L L+
Sbjct: 355 ELSVEKST--VLQSELESCKELQELEPENKWCL---LTIILLMRALDPLLYEKETLQYFS 409
Query: 498 PIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTM 557
++ + + V L + L ++ +T
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTH 467
Query: 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG-S 616
LD S NRL ++P L L L++L+ S N L+ + + ++ +L L +N L +
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSA 524
Query: 617 IPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLF 652
++S ++ L+LQ N+L + +
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 44/217 (20%), Positives = 79/217 (36%), Gaps = 18/217 (8%)
Query: 89 ISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSW 148
++ L +LS + T + +L +C +L+ L + +I + L L +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 149 LDLG---YNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLT 205
+++L P + + L S N + ++ L+L +LT
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL------KMEYADVRVLHLAHKDLT 454
Query: 206 GLLPEFPNSCAIL-HLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLL 264
L ++ HL + N +LP +L+ R L AS N + L
Sbjct: 455 VL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLP 508
Query: 265 QLEVLYLDDNNLEG-QIPETLWGLENLQKLVLSANKL 300
+L+ L L +N L+ + L L L L N L
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 3e-09
Identities = 38/226 (16%), Positives = 75/226 (33%), Gaps = 25/226 (11%)
Query: 491 NRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFG 550
+ + L R LS L + LE + L+ +I +
Sbjct: 335 KDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM- 392
Query: 551 FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD-----GRIPYELGKCTKMIK 605
L L + + L L+ + +R + + +
Sbjct: 393 --RALDPLLYEKETLQ-----YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV 445
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665
L L+ L ++ + L + L L N L A+P A ++++ L LQ N +
Sbjct: 446 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--- 499
Query: 666 PCSLSKLHHFSS--ILNVSNNKLSG-KIPECLGNLDKLQILDLSSN 708
++ + + L + NN+L + L + +L +L+L N
Sbjct: 500 --NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 36/197 (18%), Positives = 69/197 (35%), Gaps = 16/197 (8%)
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCT 601
L + S + + + SEL + + LQ L I +
Sbjct: 338 PECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALD 396
Query: 602 KMIKLDLS---DNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658
++ + + L P L+ ++S L EN++ + L L
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL------KMEYADVRVLHLAH 450
Query: 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718
++ C L +L + L++S+N+L +P L L L++L S N+ + V
Sbjct: 451 KDL--TVLCHLEQLLLVTH-LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504
Query: 719 NNMVSLYFVNISFNHFS 735
N+ L + + N
Sbjct: 505 ANLPRLQELLLCNNRLQ 521
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 70/256 (27%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEI---RTL---- 881
+YE V + +GKG +G V++++ + + AVKK+ + F RT
Sbjct: 10 KYELV------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---FQNSTDAQRTFREIM 60
Query: 882 ---SLVRHRNILRI--VGSCTKDEHGFIVTEYMPGGT-LFNVLHQNEPRLVLDWNTRYHI 935
L H NI+ + V D ++V +YM T L V+ N +L H
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRAN----IL---EPVHK 111
Query: 936 ALGIAQ---GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992
+ Q + YLH ++HRD+K NILL++E K+ DFG+S+ + +
Sbjct: 112 QYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 993 SAIVGSLG-------------------YIAPE-----NAYSTRLTEKSDVYSYGVILFEL 1028
+ + Y APE Y T+ D++S G IL E+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY----TKGIDMWSLGCILGEI 224
Query: 1029 LFRKMPVDPSF-GEDT 1043
L K P F G T
Sbjct: 225 LCGK----PIFPGSST 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVGS 895
+G+G +G V + + ++ + A+KK S+ + V EI+ L +RH N++ ++
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
C K + ++V E++ T+ + L L +Y I G+ + H II
Sbjct: 93 CKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKY--LFQIINGIGFCHSH---NII 146
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAYST 1010
HRDIK +NIL+ K+ DFG ++ ++ V + Y APE Y
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD--DEVATRWYRAPELLVGDVKYGK 204
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ DV++ G ++ E+ + P F D+DI
Sbjct: 205 AV----DVWAIGCLVTEMFMGE----PLFPGDSDI 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVGS 895
+G+G +G VY+ + + + A+K+ L E E+ L ++HRNI+ +
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ ++ EY L + +N + + G+++ H + +
Sbjct: 102 IHHNHRLHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCH---SRRCL 154
Query: 956 HRDIKSDNILLDSELEP-----KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE----- 1005
HRD+K N+LL KIGDFG+++ T + +L Y PE
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH--EIITLWYRPPEILLGS 212
Query: 1006 NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
YST + D++S I E+L + P F D++I
Sbjct: 213 RHYSTSV----DIWSIACIWAEMLMKT----PLFPGDSEI 244
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDV------EIRTLSLVRHRNILRI 892
+G+G+ TVY+ N+ + A+KK+ +RSE + EI+ L + H NI+ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+ + + +V ++M L ++ LVL + L QGL YLH
Sbjct: 78 LDAFGHKSNISLVFDFMETD-LEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH--- 131
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NA 1007
I+HRD+K +N+LLD K+ DFG++K + + T V + Y APE
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARM 189
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
Y + D+++ G IL ELL R P D+D+
Sbjct: 190 YGVGV----DMWAVGCILAELLLRV----PFLPGDSDL 219
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 31/188 (16%), Positives = 68/188 (36%), Gaps = 12/188 (6%)
Query: 261 KGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALS 320
L ++ T + +L + L+ + ++G I + + ++ + ++
Sbjct: 20 STFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTIN 74
Query: 321 RNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI 380
+ P + LS+L L + + P L SL L + H+ +I +I
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 381 CNLAKLEVLYL-FNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSL 439
L K+ + L +N I +P + + +L L + + + I L L
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHD-YRG-IEDFPKLNQLYA 188
Query: 440 AHNHLTGE 447
+ G+
Sbjct: 189 FSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 31/180 (17%), Positives = 66/180 (36%), Gaps = 8/180 (4%)
Query: 288 ENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNR 347
+ + + T + + N L I L+ N+ + ++ L + N
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIH 77
Query: 348 LQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRM 407
P + +L LR+ + P + L L +L + ++ + +I +I +
Sbjct: 78 ATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 408 SKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
K+ + L N I P + L L+ L++ + + +E FP L++L
Sbjct: 136 PKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE---DFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 22/161 (13%), Positives = 58/161 (36%), Gaps = 8/161 (4%)
Query: 553 SNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612
++LT + + ++ + + + N++ L ++ P + + + +L +
Sbjct: 44 NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 613 LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKL 672
+ + L + L + + +I +++ + + L N I L L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158
Query: 673 HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713
S LN+ + + + + KL L S + G+
Sbjct: 159 PELKS-LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 35/184 (19%), Positives = 65/184 (35%), Gaps = 31/184 (16%)
Query: 191 LPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNN 250
+ L + L N+T L T + N+ + + ++ +
Sbjct: 43 MNSLTYITLANINVTDL-------------------------TGIEYAHNIKDLTINNIH 77
Query: 251 FGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISH 310
+P GL LE L + ++ L GL +L L +S + + +I +I+
Sbjct: 78 ATN-YNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 311 CNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHN 370
++ I LS N + I + L L SL + + + + + L L
Sbjct: 135 LPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 371 FIGG 374
IGG
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 7/179 (3%)
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNL 540
+ + G + + I + +SL + L+N + L +E + L +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIH 77
Query: 541 LQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC 600
+ P+ G SNL L ++ L L +L +L +S + D I ++
Sbjct: 78 AT-NYNPISGL-SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135
Query: 601 TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
K+ +DLS N I + +L +++SL++Q + + L +L S
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-11
Identities = 28/183 (15%), Positives = 64/183 (34%), Gaps = 9/183 (4%)
Query: 121 QLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFL 180
K L + ++ L+++ L +++ + + ++++ + +N
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA 78
Query: 181 NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLL-IHENDFVGSLPTSLSNCR 239
P I L L+ L + ++T + L LL I + S+ T ++
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK 299
+ S N I P K L +L+ L + + + + L +L +
Sbjct: 137 KVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192
Query: 300 LNG 302
+ G
Sbjct: 193 IGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 30/139 (21%), Positives = 56/139 (40%), Gaps = 8/139 (5%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
++K L ++ + + + I +L L + G + T L L L ++
Sbjct: 66 HNIKDLTINNIHAT-----NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
+ SI +I L +++ +DL YN I P +L L+S+ + ++ I
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLP-ELKSLNIQFDGVHDYRG--I 177
Query: 189 CSLPKLKSLYLNTNNLTGL 207
PKL LY + + G
Sbjct: 178 EDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 31/208 (14%), Positives = 62/208 (29%), Gaps = 35/208 (16%)
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
L + Q M+ L + L N +T + I N++ L++ +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEI 501
H T + L RL + G N+ T+L +L + ++ + S +I
Sbjct: 76 IHATNYNPI---SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561
+ + LS N + L+ P L L+
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMP-LKTLP------------------------ELKSLNIQ 167
Query: 562 ENRLSGSIPSELGNLENLQILRLSANKL 589
+ + + + L L + +
Sbjct: 168 FDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 24/161 (14%), Positives = 59/161 (36%), Gaps = 9/161 (5%)
Query: 575 NLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634
+ L + + + + L++ + + + + ++ L++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 635 NNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECL 694
+ + P S + +L L++ +LS L + L++S++ I +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKI 132
Query: 695 GNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735
L K+ +DLS N +I + + L +NI F+
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 49/232 (21%)
Query: 827 DLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNF----DVEIRTLS 882
D RY ++R +G G TV+ + H A+K + R + + + EI+ L
Sbjct: 18 DARYI-LVR-----KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQ 70
Query: 883 LVR-----------HRNILRIVGS----CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVL 927
V +IL+++ H +V E + G L ++ + E R +
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GI 128
Query: 928 DWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP------KIGDFGMSK 981
I+ + GL Y+H C IIH DIK +N+L++ P KI D G +
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 982 LISDSHSSSTRSAIVGSLGYIAPE----NAYSTRLTEKSDVYSYGVILFELL 1029
+ +++ + + Y +PE + +D++S ++FEL+
Sbjct: 187 WYDEHYTN-----SIQTREYRSPEVLLGAPWGC----GADIWSTACLIFELI 229
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNR 347
+ +KL L +NKL+ S +L+++ L+ N L +P + L +L +L + +N+
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 348 LQGTLPPEL-GNCGSLVDLRLQHNFIGGTIPPEIC-NLAKLEVLYLFNNRIEGAIPHQI- 404
LQ LP + +L +LRL N + ++PP + +L KL L L N ++ ++P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 405 GRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLD 463
+++ L EL LYNN+L R+P +L L+ L L +N L V L L
Sbjct: 154 DKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQ 211
Query: 464 LTGN 467
L N
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-16
Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 16/185 (8%)
Query: 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
+ L L N L + L L+ L L+ NKL +G L+ + ++ N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 326 GQIPRSV-GNLSSLNSLLLFNNRLQGTLPP----ELGNCGSLVDLRLQHNFIGGTIPPEI 380
+P V L +L L L N+L+ +LPP L L L L +N + ++P +
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK---LTYLSLGYNEL-QSLPKGV 152
Query: 381 C-NLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFL 437
L L+ L L+NN+++ +P ++++L L L NN+L R+P L L+ L
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 438 SLAHN 442
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 473 IPANICVGTNLFVLVLGNNRF----NGSFPIEIGKCSSLRRVILSNNLLQGSLPATL-ER 527
IP+NI T L L +N+ + +F + + LR + L++N LQ +LPA + +
Sbjct: 31 IPSNIPADTK--KLDLQSNKLSSLPSKAFH----RLTKLRLLYLNDNKLQ-TLPAGIFKE 83
Query: 528 NPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLS 585
+ L V N LQ ++P VF NL L N+L S+P + +L L L L
Sbjct: 84 LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141
Query: 586 ANKLDGRIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPD 643
N+L +P + K T + +L L +N L +P L ++++L L N L
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEG 199
Query: 644 AFSSVQSLFELQLGSNIFD 662
AF S++ L LQL N +D
Sbjct: 200 AFDSLEKLKMLQLQENPWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 43/228 (18%)
Query: 502 GKCS---SLRRVILSNNLLQ---GSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSN 554
G CS + V S+ L ++PA ++ LD++ N L S+P F +
Sbjct: 10 GVCSCNNNKNSVDCSSKKLTAIPSNIPADTKK------LDLQSNKLS-SLPSKAFHRLTK 62
Query: 555 LTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKL---DGRIPYELGKCTKMIKLDLSD 610
L +L ++N+L ++P+ + L+NL+ L ++ NKL + +L + +L L
Sbjct: 63 LRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQL---VNLAELRLDR 118
Query: 611 NYLAGSIPSEV-ISLEKMQSLSLQENNLSGAIPD-AFSSVQSLFELQLGSN--------I 660
N L S+P V SL K+ LSL N L ++P F + SL EL+L +N
Sbjct: 119 NQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGA 176
Query: 661 FDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSN 708
FD L++L L + NN+L +L+KL++L L N
Sbjct: 177 FDK-----LTELKT----LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/204 (27%), Positives = 79/204 (38%), Gaps = 34/204 (16%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
LDL N+ + K +L+ L LNDN+ Q ++P IF +LK L L + N L
Sbjct: 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98
Query: 159 KIPPQV--SLCYSLESIGFHNNFLNGELPNDIC-SLPKLKSLYLNTNNLTGLLPEFPNSC 215
+P V L +L + N L LP + SL KL L L N L
Sbjct: 99 ALPIGVFDQL-VNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ---------- 146
Query: 216 AILHLLIHENDFVGSLPTSL-SNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
SLP + +L E +N + F L +L+ L LD+N
Sbjct: 147 --------------SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNN 191
Query: 275 NLEGQIPETLWGLENLQKLVLSAN 298
L+ LE L+ L L N
Sbjct: 192 QLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 30/204 (14%)
Query: 194 LKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGG 253
K L L +N L+ L + L + N
Sbjct: 39 TKKLDLQSNKLSSL-----------------------PSKAFHRLTKLRLLYLNDNKL-Q 74
Query: 254 AISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQ 313
+ IFK L LE L++ DN L+ L NL +L L N+L +
Sbjct: 75 TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK 134
Query: 314 LQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPEL-GNCGSLVDLRLQHNF 371
L ++L N L +P+ V L+SL L L+NN+L+ +P L L+L +N
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQ 192
Query: 372 IGGTIPPEI-CNLAKLEVLYLFNN 394
+ +P +L KL++L L N
Sbjct: 193 L-KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 39/136 (28%), Positives = 49/136 (36%), Gaps = 31/136 (22%)
Query: 588 KLDGRIPYELGKCT---KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDA 644
K DG G C+ +D S L +IPS I + + L LQ N LS A
Sbjct: 6 KKDG------GVCSCNNNKNSVDCSSKKLT-AIPSN-IPADT-KKLDLQSNKLSSLPSKA 56
Query: 645 FSSVQSLFELQLGSN--------IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECL-G 695
F + L L L N IF L L L V++NKL +P +
Sbjct: 57 FHRLTKLRLLYLNDNKLQTLPAGIFKE-----LKNLET----LWVTDNKLQ-ALPIGVFD 106
Query: 696 NLDKLQILDLSSNSFS 711
L L L L N
Sbjct: 107 QLVNLAELRLDRNQLK 122
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKL---NRSETNFDV------EI---RTLSLVRHRNI 889
IG G +GTVY+ +S A+K + N + E+ R L H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 890 LR----IVGSCTKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
+R S T E +V E++ L L P L T + +GL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLPAETIKDLMRQFLRGLD 134
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
+LH + I+HRD+K +NIL+ S K+ DFG++++ S + + V +L Y AP
Sbjct: 135 FLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV---VVTLWYRAP 188
Query: 1005 E----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
E + Y+T + D++S G I E+ RK P F +++
Sbjct: 189 EVLLQSTYATPV----DMWSVGCIFAEMFRRK----PLFCGNSEA 225
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDV------EIRTLSLVRHRNILRIVGS 895
IG+G +G V++ + ++ + A+KK SE + + EIR L ++H N++ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ +V EY T+ + L R V + + Q +++ H I
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSIT-WQTLQAVNFCHKH---NCI 124
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAYST 1010
HRD+K +NIL+ K+ DFG ++L++ V + Y +PE Y
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVGDTQYGP 182
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ DV++ G + ELL P + +D+
Sbjct: 183 PV----DVWAIGCVFAELLSGV----PLWPGKSDV 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVGS 895
+G+G +G VY+ + R A+K+ L+ + EI L + H NI+ ++
Sbjct: 29 VGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ +V E+M L VL +N + L + + +G+++ H +I+
Sbjct: 88 IHSERCLTLVFEFMEKD-LKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAYST 1010
HRD+K N+L++S+ K+ DFG+++ S T V +L Y AP+ YST
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT--HEVVTLWYRAPDVLMGSKKYST 199
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ D++S G I E++ K P F TD
Sbjct: 200 SV----DIWSIGCIFAEMITGK----PLFPGVTDD 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 842 IGKGKHGTVYRTLSNNSRKHWAVKK--LNRSETNFDV----EIRTLSLVRHRNILRIVGS 895
IG+G +G VY+ NN + +A+KK L + + EI L ++H NI+++
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ +V E++ L +L L+ T L + G++Y H +++
Sbjct: 69 IHTKKRLVLVFEHLDQD-LKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE-----NAYST 1010
HRD+K N+L++ E E KI DFG+++ + + +L Y AP+ YST
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
+ D++S G I E++ P F ++
Sbjct: 181 TI----DIWSVGCIFAEMVNGT----PLFPGVSEA 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 38/242 (15%)
Query: 838 EGRIIGKGKHGTVY--RTLSNNSRKHWAVKKLNRSETNFDV----EIRTLSLVRHRNILR 891
EG +G+G +G VY + K +A+K++ T + EI L ++H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVIS 82
Query: 892 IVGSCTKDEHG--FIVTEYMPGGTLFNVLH------QNEPRLVLDWNTRYHIALGIAQGL 943
+ +++ +Y L++++ N+ + L + I G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 944 SYLHYDCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISD-SHSSSTRSAIVGS 998
YLH + ++HRD+K NIL+ E KI D G ++L + + +V +
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 999 LGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053
Y APE Y+ + D+++ G I ELL + P F + + +
Sbjct: 199 FWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE----PIFHCRQEDIKTSNPYH 250
Query: 1054 QE 1055
+
Sbjct: 251 HD 252
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 47/165 (28%), Positives = 71/165 (43%), Gaps = 12/165 (7%)
Query: 266 LEVLYLDDNNLEGQIPET-LWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
+L L NNL E L NL L+LS N LN S L+ + LS N+L
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL 100
Query: 325 VGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHNFIGGTIPPEI-- 380
+ + +L +L LLL+NN + + + L L L N I P E+
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 381 --CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVE--LALYNNRLT 421
L KL +L L +N+++ + ++ V+ L L+NN L
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 42/185 (22%), Positives = 65/185 (35%), Gaps = 30/185 (16%)
Query: 192 PKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNF 251
L L+ NNL+ L E+ + + NL S N+
Sbjct: 39 SYTALLDLSHNNLSRLRAEW----------------------TPTRLTNLHSLLLSHNHL 76
Query: 252 GGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHC 311
IS F + L L L N+L L+ L+ L+L N +
Sbjct: 77 N-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135
Query: 312 NQLQVIALSRNNLVGQIP----RSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLV--DL 365
QLQ + LS+N + + P + L L L L +N+L+ +L + V L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 366 RLQHN 370
L +N
Sbjct: 195 YLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 46/196 (23%), Positives = 75/196 (38%), Gaps = 35/196 (17%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSE--LGNLENLQILRLSANKLDGRIPYE-LGKC 600
++P S +LD S N LS + +E L NL L LS N L+ I E
Sbjct: 32 NVPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 601 TKMIKLDLSDNYLAGSIPSEV-ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
+ LDLS N+L ++ + L+ ++ L L N++ +AF + L +L L N
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN 146
Query: 660 IFDGSIPCSLSKLHH--FSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTE 717
+S+ L KL +LDLSSN T+
Sbjct: 147 --------QISRFPVELIKD----------------GNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 718 VNNMVSLYFVNISFNH 733
+ + + + ++
Sbjct: 183 LQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 43/230 (18%), Positives = 65/230 (28%), Gaps = 82/230 (35%)
Query: 101 LDLSGNEFTGSIPKQ--LGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLS 157
LDLS N + + + L +LLL+ N I E F + L +LDL N L
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 158 GKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAI 217
+ + F + L L+ L L N++
Sbjct: 102 -TLDEFL----------FSD-------------LQALEVLLLYNNHIV------------ 125
Query: 218 LHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLE 277
+ F+ + QL+ LYL N +
Sbjct: 126 ------------------------------------VVDRNAFEDMAQLQKLYLSQNQIS 149
Query: 278 GQIPE----TLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNN 323
+ P L L L LS+NKL + L +N
Sbjct: 150 -RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 47/207 (22%), Positives = 74/207 (35%), Gaps = 46/207 (22%)
Query: 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPAN 476
+L +P + L L+HN+L+ L L
Sbjct: 27 KQQLP-NVPQSL--PSYTALLDLSHNNLS---RLRAEWTPTRL----------------- 63
Query: 477 ICVGTNLFVLVLGNNRF----NGSFPIEIGKCSSLRRVILSNNLLQGSLPA-TLERNPGV 531
TNL L+L +N + +F +LR + LS+N L +L +
Sbjct: 64 ----TNLHSLLLSHNHLNFISSEAF----VPVPNLRYLDLSSNHLH-TLDEFLFSDLQAL 114
Query: 532 SFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSE----LGNLENLQILRLSA 586
L + N + + F + L L S+N++S P E L L +L LS+
Sbjct: 115 EVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSS 172
Query: 587 NKLDGRIPYELGKCTKMIK--LDLSDN 611
NKL +L K +K L L +N
Sbjct: 173 NKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 24/150 (16%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKN-----QHLLSLDLSGNEFTGSIPKQ-LGNCGQL 122
++L +L LS +N +++I +L LDLS N ++ + + L
Sbjct: 64 TNLHSLLLS--------HNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQAL 114
Query: 123 KTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQV----SLCYSLESIGFHN 177
+ LLL +N + F + +L L L N +S + P ++ + L + +
Sbjct: 115 EVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSS 172
Query: 178 NFLNGELPNDICSLPKLK--SLYLNTNNLT 205
N L D+ LP LYL+ N L
Sbjct: 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 605 KLDLSDNYLAGSIPSEVI--SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN--- 659
LDLS N L+ + +E L + SL L N+L+ +AF V +L L L SN
Sbjct: 43 LLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH 101
Query: 660 -----IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEI 714
+F L L L + NN + ++ +LQ L LS N S
Sbjct: 102 TLDEFLFSD-----LQALEV----LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RF 151
Query: 715 PTEV----NNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFL 754
P E+ N + L +++S N KLP + + ++ + L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGL 194
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 48/258 (18%), Positives = 93/258 (36%), Gaps = 40/258 (15%)
Query: 188 ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSAS 247
+ + L ++T + + ++ + A+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT-------------------------QNELNSIDQIIAN 54
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQ 307
+++ ++ + L + L+L+ N L I + L L+NL L L NK+ +S
Sbjct: 55 NSDIK-SVQG--IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS- 107
Query: 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRL 367
+ +L+ ++L N + I + +L L SL L NN++ + L L L L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSL 163
Query: 368 QHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPD 427
+ N I + + L KL+ LYL N I + + L L L++ +
Sbjct: 164 EDNQI--SDIVPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINH 219
Query: 428 ITRLRNLQFLSLAHNHLT 445
+ L + L
Sbjct: 220 QSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 45/293 (15%)
Query: 86 NNSISYICKN---QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK 142
I I + + +L T ++ + ++ N++ + S+ I
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQY 66
Query: 143 LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN 202
L ++ L L N L+ I P ++ +L + N + +L + + L KLKSL L N
Sbjct: 67 LPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHN 122
Query: 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG 262
++ + L + L +N I+
Sbjct: 123 GISDI-------------------------NGLVHLPQLESLYLGNNKITD-ITV--LSR 154
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
L +L+ L L+DN + I L GL LQ L LS N ++ + ++ L V+ L
Sbjct: 155 LTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQ 210
Query: 323 NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGT 375
+ + NL N++ + L P + + G ++ + T
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 44/234 (18%), Positives = 79/234 (33%), Gaps = 17/234 (7%)
Query: 380 ICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSL 439
A+ L + A+ ++ + ++ N+ + + I L N+ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 440 AHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPI 499
N LT ++ + L L L N L L L +N + +
Sbjct: 76 NGNKLT---DIKPLANLKNLGWLFLDENKVKDLSSLKDL--KKLKSLSLEHNGISDINGL 130
Query: 500 EIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLD 559
L + L NN + L R + L + N + I P+ G + L L
Sbjct: 131 V--HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVPLAGL-TKLQNLY 184
Query: 560 FSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613
S+N +S + L L+NL +L L + + + + +D L
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 52/240 (21%), Positives = 91/240 (37%), Gaps = 21/240 (8%)
Query: 486 LVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSI 545
+ F + + + L + T + + + ++ S+
Sbjct: 7 TITVPTPIKQIFSDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV 61
Query: 546 PPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIK 605
+ N+T L + N+L+ I L NL+NL L L NK+ + L K+
Sbjct: 62 QGIQYL-PNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKS 116
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN-IFDGS 664
L L N + S + ++ L +++SL L N ++ S + L L L N I D
Sbjct: 117 LSLEHNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIV 172
Query: 665 IPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSL 724
L+KL L +S N +S + L L L +L+L S + +N+V
Sbjct: 173 PLAGLTKL----QNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 226
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 45/234 (19%), Positives = 88/234 (37%), Gaps = 41/234 (17%)
Query: 70 SLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLND 129
++ L L+G L+ I + ++L L L N+ + L + +LK+L L
Sbjct: 69 NVTKLFLNGNKLT-----DIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEH 121
Query: 130 NRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDIC 189
N I + L +L L LG N ++ I +S L+++ +N ++ ++ +
Sbjct: 122 NGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LA 175
Query: 190 SLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSN 249
L KL++LYL+ N+++ L +L+ +NL S
Sbjct: 176 GLTKLQNLYLSKNHISDL-------------------------RALAGLKNLDVLELFSQ 210
Query: 250 NFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGT 303
L+ + D +L PE + + +K + + T
Sbjct: 211 ECLN-KPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 842 IGKGKHGTVYRTLSNNSRKHW-AVKK--LNRSETNFDV----EI---RTLSLVRHRNILR 891
IG+G +G V++ + + A+K+ + E + E+ R L H N++R
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 892 ----IVGSCTKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
S T E +V E++ L L P + T + + +GL +L
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFL 136
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE- 1005
H ++HRD+K NIL+ S + K+ DFG++++ S + ++ V +L Y APE
Sbjct: 137 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV---VVTLWYRAPEV 190
Query: 1006 ---NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045
++Y+T + D++S G I E+ RK P F +D+
Sbjct: 191 LLQSSYATPV----DLWSVGCIFAEMFRRK----PLFRGSSDV 225
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 25/211 (11%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD---VEIRTLSLVR 885
RYE +IGKG G V + ++ A+K + + + +E+R L L+
Sbjct: 55 RYEID------SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN 108
Query: 886 HR------NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
I+ + H +V E + L+++L R V TR A +
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTR-KFAQQM 166
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIVG 997
L +L + IIH D+K +NILL + KI DFG S + +
Sbjct: 167 CTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-----YIQ 220
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
S Y +PE D++S G IL E+
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 29/212 (13%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNF----DVEIRTLSLV 884
RYE V++ +IGKG G V + + +H A+K + R+E F EIR L +
Sbjct: 98 RYE-VLK-----VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHL 150
Query: 885 RHR------NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALG 938
R + N++ ++ + T H + E + L+ ++ +N+ + R A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVR-KFAHS 208
Query: 939 IAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIV 996
I Q L LH +IIH D+K +NILL + K+ DFG S + +
Sbjct: 209 ILQCLDALH-KN--RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT-----YI 260
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFEL 1028
S Y APE R D++S G IL EL
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 40/183 (21%), Positives = 73/183 (39%), Gaps = 4/183 (2%)
Query: 846 KHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905
K G + L + + K + + + R + I S + GF+
Sbjct: 110 KFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169
Query: 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNIL 965
+ + L + +A+G+ +L + IHRD+ + NIL
Sbjct: 170 EKSLSDVEEEEAPEDLYKD-FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNIL 225
Query: 966 LDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVIL 1025
L + KI DFG+++ I + L ++APE + T +SDV+S+GV+L
Sbjct: 226 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
Query: 1026 FEL 1028
+E+
Sbjct: 286 WEI 288
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 40/190 (21%), Positives = 65/190 (34%), Gaps = 28/190 (14%)
Query: 817 VQSRSEDLPRDL-RYEDVI---RATEGRIIGKGKHGTVYR-----TLSNNSRKHWAVKKL 867
+ E LP D ++E R G+ +G+G G V + + AVK L
Sbjct: 3 LDEHCERLPYDASKWE--FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 60
Query: 868 NRSETNFDV-----EIRTLS-LVRHRNILRIVGSCTK-DEHGFIVTEYMPGGTLFNVLHQ 920
T+ + E++ L + H N++ ++G+CTK ++ E+ G L L
Sbjct: 61 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980
V QG Y+ I D+K + S F
Sbjct: 121 KRNEFVPYKTKGAR----FRQGKDYVG------AIPVDLKRRLDSITSSQSSASSGFVEE 170
Query: 981 KLISDSHSSS 990
K +SD
Sbjct: 171 KSLSDVEEEE 180
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 30/118 (25%), Positives = 51/118 (43%), Gaps = 4/118 (3%)
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQL 314
I P F +L + L +N + P+ GL +L LVL NK+ L
Sbjct: 47 IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSL 106
Query: 315 QVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQHN 370
Q++ L+ N + + +L +LN L L++N+LQ T+ ++ + L N
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 45/203 (22%), Positives = 77/203 (37%), Gaps = 23/203 (11%)
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSEL-GNLEN 578
LP T+ + + N ++ IPP F + L +D S N++S + + L +
Sbjct: 30 LPETITE------IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 579 LQILRLSANKLDGRIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENN 636
L L L NK+ +P L + L L+ N + + + L + LSL +N
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 637 LSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG- 695
L FS ++++ + L N F C L + L+ + + SG C
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQNPFI----CDCH-LKWLADYLHTNPIETSG--ARCTSP 192
Query: 696 -NLDKLQILDLSSNSFSGEIPTE 717
L +I + S F
Sbjct: 193 RRLANKRIGQIKSKKFRCSAAAH 215
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 44/201 (21%), Positives = 63/201 (31%), Gaps = 74/201 (36%)
Query: 123 KTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
+ L N + IPP F K+L +DL N +S ++ P F
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA----------FQ----- 77
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
L L SL L N +T LP S
Sbjct: 78 --------GLRSLNSLVLYGNKIT------------------------ELPKS------- 98
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
+F+GL L++L L+ N + + L NL L L NKL
Sbjct: 99 -----------------LFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
Query: 302 GTISGQISHCNQLQVIALSRN 322
G S +Q + L++N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 42/158 (26%), Positives = 66/158 (41%), Gaps = 30/158 (18%)
Query: 288 ENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNN 346
E + ++ L N + G S +L+ I LS N + ++ L SLNSL+L+ N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 347 RLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI-G 405
++ LP L F G L L++L L N+I +
Sbjct: 91 KIT-ELPKSL--------------FEG---------LFSLQLLLLNANKIN-CLRVDAFQ 125
Query: 406 RMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHN 442
+ L L+LY+N+L I + LR +Q + LA N
Sbjct: 126 DLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 7/130 (5%)
Query: 365 LRLQHNFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTG 422
+RL+ N I IPP KL + L NN+I + + L L LY N++T
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 423 RIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT 481
+P + L +LQ L L N + + ++ + L+ L L N
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 482 NLFVLVLGNN 491
+ + L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 31/184 (16%), Positives = 59/184 (32%), Gaps = 59/184 (32%)
Query: 412 ELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470
E+ L N + IPP + + L+ + L++N ++
Sbjct: 36 EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISE------------------------ 70
Query: 471 GPIPANICVG-TNLFVLVLGNNRFNGSFPIEI-GKCSSLRRVILSNNLLQGSLPATLERN 528
+ + G +L LVL N+ P + SL+ ++L+ N +
Sbjct: 71 --LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN---------- 117
Query: 529 PGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSA 586
+ F NL +L +N+L +I L +Q + L+
Sbjct: 118 ---------------CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQ 161
Query: 587 NKLD 590
N
Sbjct: 162 NPFI 165
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 58/291 (19%), Positives = 93/291 (31%), Gaps = 57/291 (19%)
Query: 234 SLSNCRNLVEFSASSNNFGGAISPWIFKGLL---QLEVLYLDDNNLEGQIPETLWGLE-- 288
L ++ E S N G + W+ + + LE+ D E L
Sbjct: 27 VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86
Query: 289 --------NLQKLVLSANKLNGT----ISGQISHCNQLQVIALSRNNL------------ 324
L + LS N T + +S L+ + L N L
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146
Query: 325 -VGQIPRSVGNLSSLNSLLLFNNRLQG----TLPPELGNCGSLVDLRLQHNFIGGT-IPP 378
+ + N L S++ NRL+ + L +++ N I I
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEH 206
Query: 379 EICNLAK----LEVLYLFNNRI--EGAIPHQIGRM----SKLVELALYNNRLTGR----I 424
+ L+VL L +N G+ + L EL L + L+ R +
Sbjct: 207 LLLEGLAYCQELKVLDLQDNTFTHLGSS--ALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 425 PPDITRLRN--LQFLSLAHNHLTGEVALELGK----HFPYLSRLDLTGNSF 469
++L N LQ L L +N + + L P L L+L GN F
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 54/344 (15%), Positives = 104/344 (30%), Gaps = 75/344 (21%)
Query: 410 LVELALYNNRLTGR----IPPDITRLRNLQFLSLAHNHLTGEVALELG---KHFPYLSRL 462
+ +L + +T + + +++ + L+ N + E A L L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 463 DLTGNSFYGPIPANICVG-----------TNLFVLVLGNNRF--NGSFPIE--IGKCSSL 507
+ + F G + I L + L +N F P+ + K + L
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 508 RRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG 567
+ L NN L + + L + ++ L + NRL
Sbjct: 125 EHLYLHNNGLG---------PQAGAKI--ARALQELAVNKKAKNAPPLRSIICGRNRLEN 173
Query: 568 ----SIPSELGNLENLQILRLSANKLDGR-----IPYELGKCTKMIKLDLSDNYL----A 614
+ L +++ N + + L C ++ LDL DN +
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233
Query: 615 GSIPSEVISLEKMQSLSLQENNLS--GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKL 672
++ + S ++ L L + LS GA A N L
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAA--AVVDA-----FSKLEN----------IGL 276
Query: 673 HHFSSILNVSNNKLSGK----IPECLG-NLDKLQILDLSSNSFS 711
L + N++ + + + L L+L+ N FS
Sbjct: 277 QT----LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 60/332 (18%), Positives = 105/332 (31%), Gaps = 74/332 (22%)
Query: 70 SLKALNLS--GFGLSGVLNNSISYICKNQHLLSLDLSGNEFTG----SIPKQLGNCGQLK 123
S++ +L + + + ++ + + LSGN + + + + L+
Sbjct: 5 SIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 124 TLLLNDNRFQGSIPPEIF-----------KLKRLSWLDLGYNSLSGK----IPPQVSLCY 168
+D F G + EI K +L + L N+ + +S
Sbjct: 64 IAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 122
Query: 169 SLESIGFHNNFL-------------NGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
LE + HNN L + + P L+S+ N L
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL----------- 171
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGA-ISPWIFKGLL---QLEVLYL 271
EN + + + R L N I + +GL +L+VL L
Sbjct: 172 --------ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223
Query: 272 DDNNL--EG--QIPETLWGLENLQKLVLSANKLNGT----ISGQISHCN--QLQVIALSR 321
DN G + L NL++L L+ L+ + S LQ + L
Sbjct: 224 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 283
Query: 322 NNL----VGQIPRSVG-NLSSLNSLLLFNNRL 348
N + V + + + L L L NR
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 44/279 (15%), Positives = 81/279 (29%), Gaps = 66/279 (23%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSI-------SYICKNQHLLSLDLSGNEFTG----SIPKQ 115
+ L+ S V + + K L ++ LS N F +
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 116 LGNCGQLKTLLLNDNRF-------------QGSIPPEIFKLKRLSWLDLGYNSLSGK--- 159
L L+ L L++N + ++ + L + G N L
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 160 -IPPQVSLCYSLESIGFHNNFLNGE-----LPNDICSLPKLKSLYLNTNNLTGLLPEFPN 213
L ++ N + E L + +LK L L N T +
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT-------H 230
Query: 214 SCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFG--GAISPWIFKGL-----LQL 266
+ +L +L + NL E + GA + + + L
Sbjct: 231 LGSS------------ALAIALKSWPNLRELGLNDCLLSARGAAA--VVDAFSKLENIGL 276
Query: 267 EVLYLDDNNLEGQ----IPETLWG-LENLQKLVLSANKL 300
+ L L N +E + + + +L L L+ N+
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 40/255 (15%), Positives = 82/255 (32%), Gaps = 47/255 (18%)
Query: 506 SLRRVILSNNLLQG----SLPATLERNPGVSFLDVRGNLL--QG--SIPPVFGFWSNLTM 557
S+ L + + S+ A L + V + + GN + + + +L +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 558 LDFSENRLS----------GSIPSELGNLENLQILRLSANKLDGR----IPYELGKCTKM 603
+FS+ + L L +RLS N + L K T +
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 604 IKLDLSDN--------YLAGSIPSEVISLEKMQSLSLQENNLSG---------AIPDAFS 646
L L +N +A ++ ++ + + L+ F
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184
Query: 647 SVQSLFELQLGSN-IFDGSIPCSLSK-LHHFSSI--LNVSNNKLSGK----IPECLGNLD 698
S + L +++ N I I L + L + + L++ +N + + L +
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244
Query: 699 KLQILDLSSNSFSGE 713
L+ L L+ S
Sbjct: 245 NLRELGLNDCLLSAR 259
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 38/205 (18%), Positives = 81/205 (39%), Gaps = 20/205 (9%)
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPP--VFGFWSNLTMLDFSENRLSGSIPSELGNLEN 578
+P L + N + +F L ++FS N+++
Sbjct: 30 IPQYTAE------LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 579 LQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEV-ISLEKMQSLSLQENNL 637
+ + L++N+L+ + L L N + + ++ I L ++ LSL +N +
Sbjct: 83 VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI 141
Query: 638 SGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG-- 695
+ P AF ++ SL L L +N F+ + C L+ L + + ++ P C
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLANPFNCN--CYLAWLGEW-----LRKKRIVTGNPRCQKPY 194
Query: 696 NLDKLQILDLSSNSFSGEIPTEVNN 720
L ++ I D++ F+ + ++
Sbjct: 195 FLKEIPIQDVAIQDFTCDDAHHHHH 219
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 4/126 (3%)
Query: 247 SSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISG 306
++N F + IFK L QL + +N + G + +++L++N+L
Sbjct: 40 NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHK 99
Query: 307 QISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVD 364
L+ + L N + + LSS+ L L++N++ T+ P SL
Sbjct: 100 MFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLST 157
Query: 365 LRLQHN 370
L L N
Sbjct: 158 LNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 27/136 (19%), Positives = 54/136 (39%), Gaps = 15/136 (11%)
Query: 315 QVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPP----ELGNCGSLVDLRLQH 369
+ L+ N + L L + NN++ + + ++ L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG---VNEILLTS 90
Query: 370 NFIGGTIPPEIC-NLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPD 427
N + + ++ L L+ L L +NRI + + +S + L+LY+N++T + P
Sbjct: 91 NRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 428 I-TRLRNLQFLSLAHN 442
L +L L+L N
Sbjct: 148 AFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 32/135 (23%), Positives = 56/135 (41%), Gaps = 9/135 (6%)
Query: 289 NLQKLVLSANKLNG-TISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNN 346
+L L+ N+ +G QL+ I S N + I S +N +LL +N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSN 91
Query: 347 RLQGTLPPEL-GNCGSLVDLRLQHNFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQI 404
RL+ + ++ SL L L+ N I + + L+ + +L L++N+I +
Sbjct: 92 RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 405 -GRMSKLVELALYNN 418
+ L L L N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 36/200 (18%), Positives = 56/200 (28%), Gaps = 75/200 (37%)
Query: 101 LDLSGNEFTGSIPK-QLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
L L+ NEFT QL+ + ++N+ I F ++ + L N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN 95
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAIL 218
+ ++ F L LK+L L +N +T
Sbjct: 96 -VQHKM----------FKG-------------LESLKTLMLRSNRIT------------- 118
Query: 219 HLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG 278
+ F GL + +L L DN +
Sbjct: 119 -----------CVGND------------------------SFIGLSSVRLLSLYDNQITT 143
Query: 279 QIPETLWGLENLQKLVLSAN 298
P L +L L L AN
Sbjct: 144 VAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 12/109 (11%)
Query: 365 LRLQHNFIGGTIPPEIC--NLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLT 421
LRL +N + L +L + NN+I I S + E+ L +NRL
Sbjct: 37 LRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE 94
Query: 422 GRIPPDI-TRLRNLQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGN 467
+ + L +L+ L L N +T + + L L N
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRIT---CVGNDSFIGLSSVRLLSLYDN 139
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 9/121 (7%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEI-GKCSSLRRVILSNNLLQGSLPA-TLERNPG 530
IP +I T L L NN F I K LR++ SNN + + E G
Sbjct: 26 IPEHIPQYTA--ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 531 VSFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANK 588
V+ + + N L+ ++ +F +L L NR++ + ++ L ++++L L N+
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 589 L 589
+
Sbjct: 141 I 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 32/170 (18%), Positives = 63/170 (37%), Gaps = 36/170 (21%)
Query: 424 IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNL 483
IP LR L +N T A + K P L +++ + N I
Sbjct: 30 IPQYTAELR------LNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGA------ 76
Query: 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPA-TLERNPGVSFLDVRGNLLQ 542
F G+ S + ++L++N L+ ++ + + L +R N +
Sbjct: 77 ---------FEGA--------SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT 118
Query: 543 GSIPP-VFGFWSNLTMLDFSENRLSGSIPSE-LGNLENLQILRLSANKLD 590
+ F S++ +L +N+++ ++ L +L L L AN +
Sbjct: 119 -CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.6 bits (159), Expect = 7e-11
Identities = 97/705 (13%), Positives = 210/705 (29%), Gaps = 235/705 (33%)
Query: 305 SGQISHCNQ--LQVI--ALSRN---NLVGQIPRSVGNLSS--LNSLLLFNNRLQGTL--- 352
+G+ + + L V A N V +P+S+ LS ++ +++ + + GTL
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLF 68
Query: 353 -----PPELGNCGSLVD------LRLQHNFIGGTIPPEICNLAKLEVLY------LFNNR 395
E +V LR+ + F+ I E + + +Y L+N+
Sbjct: 69 WTLLSKQE-----EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND- 122
Query: 396 IEGAIPHQIGRMSKLVEL--ALYNNRLTGRIPPDITRLRNLQFLSLAHNH-LTGEVALEL 452
+ + + R+ ++L AL LR + + + + G
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLE-------------LRPAKNVLI---DGVLG-----S 161
Query: 453 GKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP-----IEIGKCSSL 507
GK T + + V + + + + C+S
Sbjct: 162 GK--------------------------TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSP 195
Query: 508 RRVILS-NNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN---LTMLDFSEN 563
V+ LL P R+ S + +R + +Q + + L +L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL---- 251
Query: 564 RLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKC-TKMIKLDLSD-NYLAGSIPSEV 621
N++N + N + C + ++L+ + + +
Sbjct: 252 -----------NVQNAKAW----NAFNLS-------CKILLTTRFKQVTDFLSAATTTHI 289
Query: 622 ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP---CSLSKLH----- 673
+L+ E V+SL L D +P + +
Sbjct: 290 SLDHHSMTLTPDE-------------VKSLLLKYLDCRPQD--LPREVLTTNPRRLSIIA 334
Query: 674 --------HFSSILNVSNNKLSGKIPECLGNLD---------KLQILDLSSNSFSGEIPT 716
+ + +V+ +KL+ I L L+ +L + S++ IPT
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-----IPT 389
Query: 717 EVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQGNCGKNGRGHTRGR 776
+ L W ++ S + ++L + K + T
Sbjct: 390 IL-------------------LSLIWFDVIKSDVMVVV--NKLHKYSLVEKQPKESTI-S 427
Query: 777 LAGIIIGVLLSVALLCAL--IYIMVVRVLRSKCFSDPS---------------LLQDVQS 819
+ I + + + + AL + + ++ D L
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
Query: 820 RSEDLPRDLRYEDVIRATEGRIIGKG----KHGTVYRTLS--NNSRKHWAVKKLNRSETN 873
L R + + D R E +I G++ TL + + + ++
Sbjct: 488 ERMTLFRMV-FLD-FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY-----ICDNDPK 540
Query: 874 FDVEIRTL---------SLVR--HRNILRIVGSCTKDEHGFIVTE 907
++ + + +L+ + ++LRI E I E
Sbjct: 541 YERLVNAILDFLPKIEENLICSKYTDLLRIA---LMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 2e-07
Identities = 60/401 (14%), Positives = 121/401 (30%), Gaps = 130/401 (32%)
Query: 673 HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE-------IPTEVNNMVSLY 725
+ + IL+V + N D + D+ + S E V+ + L+
Sbjct: 16 YQYKDILSVF-------EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 726 -------------FVNISFN----------HFSGKLPASWTTLMVSYPGSFLGNSELCRQ 762
FV + P+ T + + ++++ +
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128
Query: 763 GN-------------------------CGKNGRGHTRGRLAGIIIGVLLSVALLCAL--- 794
N G G G T +A + V LS + C +
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW--VA---LDVCLSYKVQCKMDFK 183
Query: 795 IYIMVVRVLRSKCFSDPSLLQDVQ--------------SRSEDLPRDLRYEDVIRATEGR 840
I+ + ++ C S ++L+ +Q S ++ LR + R
Sbjct: 184 IFWLNLK----NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK--LRIHSIQAELR-R 236
Query: 841 IIGKGKHGTVYRTLSN-NSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKD 899
++ + L N + K W F++ + L R + + + + T
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNA---------FNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 900 EHGFIVTEYMPGG-------TLF-NVLH---QNEPRLVLDWNTRYHIALGIAQGLS---- 944
I ++ +L L Q+ PR VL N R +++ IA+ +
Sbjct: 288 H---ISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR-RLSI-IAESIRDGLA 342
Query: 945 ----YLHYDC--VPQIIHRDIKSDNILLDSELEPKIGDFGM 979
+ H +C + II + N+L +E +
Sbjct: 343 TWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 4e-04
Identities = 56/297 (18%), Positives = 90/297 (30%), Gaps = 103/297 (34%)
Query: 30 LVQFLD----SLPKQSQSHLPWNQSVSTSA------PCKWSGVSCYNN-------SSSLK 72
L+++LD LP++ + P + +S A W N SSL
Sbjct: 307 LLKYLDCRPQDLPREVLTTNP--RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 73 ALN----------LSGFGLS-----GVL----NNSISY----ICKNQHLLSL-DLSGNEF 108
L LS F S +L + I + H SL + E
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424
Query: 109 TGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKL-KRLSWLDLGYN-----SLSGKIPP 162
T SIP L+ + +N + L + + +D YN IPP
Sbjct: 425 TISIPSI-----YLELKVKLENEYA---------LHRSI--VD-HYNIPKTFDSDDLIPP 467
Query: 163 QVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN------NLTGLLPEFPNSCA 216
+ Y IG H N E P + ++L+ S
Sbjct: 468 YLDQ-YFYSHIGHH--LKNIEHPERMTLFRM---VFLDFRFLEQKIRHDSTAWNASGS-- 519
Query: 217 ILHLL---------IHEND------------FVGSLPTSL--SNCRNLVEFSASSNN 250
IL+ L I +ND F+ + +L S +L+ + + +
Sbjct: 520 ILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 6e-04
Identities = 64/450 (14%), Positives = 135/450 (30%), Gaps = 128/450 (28%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYI----C-------KNQHLLSLDLSGN-----EFTGSI 112
+ + + + ++ I ++ C + L + N + + +I
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 113 PKQLGNCGQLKTLLLNDNRFQGSI-------PPEIFKLKRLSWLDLG------------Y 153
++ + LL ++ + + + +L
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA-----FNLSCKILLTTRFKQVT 278
Query: 154 NSLSGKIPPQVSLCYSL------ESIGFHNNFLN---GELPNDICSL-PKLKSLYLNTNN 203
+ LS +SL + E +L+ +LP ++ + P+ S+
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------ 332
Query: 204 LTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL 263
+ + + + D NC L SS N + P ++ +
Sbjct: 333 IAESIRDGLAT----------WDN-----WKHVNCDKLTTIIESSLN---VLEPAEYRKM 374
Query: 264 LQLEVLYLDDNNLEGQIPETLWG----------LENLQK--LVLSANKLNGTISGQISHC 311
++ ++ + +W + L K LV K TIS I
Sbjct: 375 FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK-ESTIS--I-PS 430
Query: 312 NQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ--- 368
L+ L ++ N +L+ ++ + + T + L+ L
Sbjct: 431 IYLE--------LKVKLE----NEYALHRSIVDHYNIPKTFDSD-----DLIPPYLDQYF 473
Query: 369 HNFIG----GTIPPEICNLAKLEVLYLFNNR-IEGAIPH-------QIGRMSKLVELALY 416
++ IG PE L +++L + R +E I H ++ L +L Y
Sbjct: 474 YSHIGHHLKNIEHPERMTL--FRMVFL-DFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 417 NNRLTGRIPPDITRLRN--LQFLSLAHNHL 444
+ P RL N L FL +L
Sbjct: 531 KPYIC-DNDPKYERLVNAILDFLPKIEENL 559
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 62/329 (18%), Positives = 106/329 (32%), Gaps = 96/329 (29%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD---VEIRTLSLVR--------HRN 888
R +G G TV+ + +K A+K + +E + EIR L VR
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102
Query: 889 ILRIVGSCT----KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
+++++ H +V E + G L + ++ + + + I + QGL
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLD 160
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSE----------------------------------- 969
YLH C +IIH DIK +NILL
Sbjct: 161 YLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 970 --------------LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
L+ KI D G + + + + + Y + E +
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSGYNTP 273
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGE----DTDIVT-------------WTRWKLQENHE 1058
+D++S + FEL +P GE D D + K +
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE-- 331
Query: 1059 CICFLDREISFWDSDDQLKALRLLELALE 1087
F ++ +LK L E+ +E
Sbjct: 332 ---FFTKKGD-LKHITKLKPWGLFEVLVE 356
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 35/136 (25%), Positives = 59/136 (43%), Gaps = 11/136 (8%)
Query: 264 LQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNN 323
+ L+ +E + TL L+ + L LS N + IS +S L++++L RN
Sbjct: 25 AEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNL 81
Query: 324 LVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNL 383
+ +I +L L + N++ +L + +L L + +N I EI L
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKL 136
Query: 384 A---KLEVLYLFNNRI 396
A KLE L L N +
Sbjct: 137 AALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 30/131 (22%), Positives = 52/131 (39%), Gaps = 12/131 (9%)
Query: 340 SLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA---KLEVLYLFNNRI 396
L ++ + L + L L N I +I +L+ L +L L N I
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLI 82
Query: 397 EGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHF 456
+ I + L EL + N++ + I +L NL+ L +++N +T ++
Sbjct: 83 K-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAAL 139
Query: 457 PYLSRLDLTGN 467
L L L GN
Sbjct: 140 DKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 98 LLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLS 157
+ L + L K L L+ N + I + ++ L L LG N +
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK 83
Query: 158 GKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGL 207
KI ++ +LE + N + L I L L+ LY++ N +T
Sbjct: 84 -KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNW 130
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 35/154 (22%), Positives = 59/154 (38%), Gaps = 36/154 (23%)
Query: 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617
L + + + L L+ + L LS N + K+ L
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----------EKISSLS---------- 67
Query: 618 PSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSS 677
+E ++ LSL N + I + + +L EL + N SLS + +
Sbjct: 68 -----GMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-----SLSGIEKLVN 116
Query: 678 --ILNVSNNKLSG-KIPECLGNLDKLQILDLSSN 708
+L +SNNK++ + L LDKL+ L L+ N
Sbjct: 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 25/144 (17%), Positives = 51/144 (35%), Gaps = 6/144 (4%)
Query: 139 EIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLY 198
+ +++ L + K+ +S + + + N + ++ + + + L+ L
Sbjct: 21 VATEAEKVE-LHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILS 76
Query: 199 LNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258
L N + + + + L I N + SL + + NL S+N
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYN-QIASL-SGIEKLVNLRVLYMSNNKITNWGEID 134
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPE 282
L +LE L L N L E
Sbjct: 135 KLAALDKLEDLLLAGNPLYNDYKE 158
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 62/445 (13%), Positives = 144/445 (32%), Gaps = 46/445 (10%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSG-NEFTGSIPKQLG-NCGQLK 123
++ + L+ + L ++ I+ KN L LS F+ + C LK
Sbjct: 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKN--FKVLVLSSCEGFSTDGLAAIAATCRNLK 159
Query: 124 TLLLNDNRFQGSIPPEIFKL----KRLSWLDLGYNSLSGKIPPQ-----VSLCYSLESIG 174
L L ++ + L L++ + L+ ++ V+ C +L+S+
Sbjct: 160 ELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI--SCLASEVSFSALERLVTRCPNLKSLK 217
Query: 175 FHNNFLNGELPNDICSLPKLKSLYLN-------TNNLTGLLPEFPNSCAILHLLIHENDF 227
+ +L + P+L+ L + +GL + L +
Sbjct: 218 LNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAV 277
Query: 228 VGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGL 287
LP S C L + S + +L+ L++ D + +
Sbjct: 278 PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTC 337
Query: 288 ENLQKLVLS-ANKLNGTISGQIS---------HCNQLQVIALSRNNL----VGQIPRSVG 333
++L++L + + + ++ C +L+ + + + I R+
Sbjct: 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRP 397
Query: 334 NLSSLN--------SLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK 385
N++ L L + +C L L L K
Sbjct: 398 NMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKK 457
Query: 386 LEVLYLFNNRI-EGAIPHQIGRMSKLVELALYNNRLTGR-IPPDITRLRNLQFLSLAHNH 443
+E+L + + + H + L +L + + + + + ++L ++ L ++
Sbjct: 458 MEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517
Query: 444 LTGEVALELGKHFPYLSRLDLTGNS 468
++ LG+ P L+ +
Sbjct: 518 VSFGACKLLGQKMPKLNVEVIDERG 542
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 67/444 (15%), Positives = 138/444 (31%), Gaps = 67/444 (15%)
Query: 234 SLSNCRNLVEFSASSNNFGGAISPW---IFKGLLQLEVLYLDDNNLEGQIPETL-WGLEN 289
L + +F+ + +GG + PW + LE + L + E + +N
Sbjct: 72 ELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKN 131
Query: 290 LQKLVLSANKL--NGTISGQISHCNQLQVIALSRNNL-------VGQIPRSVGNLSSLNS 340
+ LVLS+ + ++ + C L+ + L +++ + P + +L SLN
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI 191
Query: 341 LLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL--FNNRIEG 398
L + L + C +L L+L + + +LE L + +
Sbjct: 192 SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRP 251
Query: 399 AIPHQI----GRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK 454
+ + +L L+ + + + +P + L L+L++ + ++L
Sbjct: 252 DVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLC 311
Query: 455 HFPYLSRLDLTGN---------------------SFYGPIPANICVG------------- 480
P L RL + P V
Sbjct: 312 QCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGC 371
Query: 481 TNLFVLVLGNNRFNGSFPIEIGK-CSSLRRVILS-----------NNLLQGSLPATLERN 528
L ++ + + I I + ++ R L L A +E
Sbjct: 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC 431
Query: 529 PGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG-SIPSELGNLENLQILRLSA- 586
+ L + G L + + + ML + S + L ++L+ L +
Sbjct: 432 KDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDC 491
Query: 587 NKLDGRIPYELGKCTKMIKLDLSD 610
D + K M L +S
Sbjct: 492 PFGDKALLANASKLETMRSLWMSS 515
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 50/193 (25%), Positives = 75/193 (38%), Gaps = 32/193 (16%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVS 532
+P+ I T L L + + L + L N LQ +L A
Sbjct: 29 VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAG-------- 77
Query: 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDG 591
VF + L L + N+L+ S+P + +L L L L N+L
Sbjct: 78 ---------------VFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK- 120
Query: 592 RIPYEL-GKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPDAFSSVQ 649
+P + + TK+ +L L+ N L SIP+ L +Q+LSL N L AF +
Sbjct: 121 SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG 179
Query: 650 SLFELQLGSNIFD 662
L + L N FD
Sbjct: 180 KLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 52/225 (23%), Positives = 69/225 (30%), Gaps = 76/225 (33%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
LDL +L L L+ N+ Q ++ +F L L L L N L+
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAIL 218
+P V F L +L LYL N L
Sbjct: 97 SLPLGV----------FD-------------HLTQLDKLYLGGNQLK------------- 120
Query: 219 HLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG 278
SLP +F L +L+ L L+ N L+
Sbjct: 121 -----------SLP------------------------SGVFDRLTKLKELRLNTNQLQ- 144
Query: 279 QIPETLW-GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
IP + L NLQ L LS N+L G +LQ I L N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-09
Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 35/180 (19%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLD-- 590
LD++ L F + LT L+ N+L ++ + + +L L L L+ N+L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASL 98
Query: 591 -GRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPDAFSSV 648
+ L T++ KL L N L S+PS V L K++ L L N L +IP
Sbjct: 99 PLGVFDHL---TQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA----- 148
Query: 649 QSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSN 708
FD L+ L L++S N+L L KLQ + L N
Sbjct: 149 ----------GAFD-----KLTNLQT----LSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 51/227 (22%), Positives = 76/227 (33%), Gaps = 78/227 (34%)
Query: 123 KTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
+ L L ++ F L +L+WL+L YN L + V F
Sbjct: 38 EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV----------FD----- 80
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
L +L +L L N L SLP
Sbjct: 81 --------DLTELGTLGLANNQLA------------------------SLP--------- 99
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLW-GLENLQKLVLSANKL 300
+F L QL+ LYL N L+ +P ++ L L++L L+ N+L
Sbjct: 100 ---------------LGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQL 143
Query: 301 NGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNN 346
+G LQ ++LS N L +P L L ++ LF N
Sbjct: 144 QSIPAGAFDKLTNLQTLSLSTNQL-QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 291 QKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQ 349
+KL L + L +L + L N L + V +L+ L +L L NN+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 350 GTLPP----ELGNCGSLVDLRLQHNFIGGTIPPEIC-NLAKLEVLYLFNNRIEGAIPHQI 404
+LP L L L L N + ++P + L KL+ L L N+++ +IP
Sbjct: 97 -SLPLGVFDHLTQ---LDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150
Query: 405 -GRMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHN 442
+++ L L+L N+L +P RL LQ ++L N
Sbjct: 151 FDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
E L L L T GL L L L N+L +G +L + L+ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 327 QIPRSV-GNLSSLNSLLLFNNRLQGTLPP----ELGNCGSLVDLRLQHNFIGGTIPPEIC 381
+P V +L+ L+ L L N+L+ +LP L L +LRL N + +IP
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK---LKELRLNTNQL-QSIPAGAF 151
Query: 382 N-LAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNN 418
+ L L+ L L N+++ ++PH R+ KL + L+ N
Sbjct: 152 DKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 49/190 (25%), Positives = 69/190 (36%), Gaps = 47/190 (24%)
Query: 412 ELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYG 471
+L L + L L L +L+L +N L
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT------------------------- 73
Query: 472 PIPANICVG-TNLFVLVLGNNRFNGSFPIEI-GKCSSLRRVILSNNLLQGSLPATLERNP 529
+ A + T L L L NN+ S P+ + + L ++ L N L+ SLP
Sbjct: 74 -LSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLP------S 124
Query: 530 GV-------SFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIP-SELGNLENLQ 580
GV L + N LQ SIP F +NL L S N+L S+P L LQ
Sbjct: 125 GVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQ 182
Query: 581 ILRLSANKLD 590
+ L N+ D
Sbjct: 183 TITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 32/115 (27%), Positives = 46/115 (40%), Gaps = 23/115 (20%)
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----- 659
KLDL LA + L K+ L+L N L F + L L L +N
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 660 ---IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG---NLDKLQILDLSSN 708
+FD L++L L + N+L +P G L KL+ L L++N
Sbjct: 99 PLGVFD-----HLTQL----DKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNTN 141
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 73/245 (29%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNF----DVEIRTLSLV 884
+ VIR +G G G V +++K++AVK + R+ + +E L +
Sbjct: 36 AFL-VIR-----KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKI 88
Query: 885 RHR-----NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE-----PRLVLDWNTRYH 934
++ NI++ G +H ++ E + G +L+ ++ +N +
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI------KL 141
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP---------------------- 972
+ I + L+YL + H D+K +NILLD
Sbjct: 142 YCIEILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198
Query: 973 ---KIGDFGMSKLISDSHSS--STRSAIVGSLGYIAPE----NAYSTRLTEKSDVYSYGV 1023
K+ DFG + SD H S +TR Y APE + SD++S+G
Sbjct: 199 TGIKLIDFGCATFKSDYHGSIINTRQ-------YRAPEVILNLGWDV----SSDMWSFGC 247
Query: 1024 ILFEL 1028
+L EL
Sbjct: 248 VLAEL 252
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 50/293 (17%), Positives = 93/293 (31%), Gaps = 68/293 (23%)
Query: 86 NNSISYICKNQ---HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK 142
I+ + + + + +L T + ++ +++ Q S+ +
Sbjct: 6 PTPINQVFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQF 61
Query: 143 LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN 202
L L L +N +S + P + L KL+ L +N N
Sbjct: 62 FTNLKELHLSHNQIS-DLSP-------------------------LKDLTKLEELSVNRN 95
Query: 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG 262
L L S + L + N L + +L
Sbjct: 96 RLKNL--NGIPSACLSRLFLDNN--------ELRDTDSL-------------------IH 126
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
L LE+L + +N L+ L L L+ L L N++ G ++ ++ I L+
Sbjct: 127 LKNLEILSIRNNKLK--SIVMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQ 182
Query: 323 NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGT 375
V + + L N++ + R P + N GS VD + T
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCVLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 45/229 (19%), Positives = 81/229 (35%), Gaps = 28/229 (12%)
Query: 292 KLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGT 351
+ + +N + L + ++ + LS + + N+ +Q +
Sbjct: 1 ESIQRPTPIN-QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-S 55
Query: 352 LPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLV 411
L + +L +L L HN I + P + +L KLE L + NR++ + L
Sbjct: 56 LAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIP---SACLS 109
Query: 412 ELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN--SF 469
L L NN L + L+NL+ LS+ +N L V L L LDL GN +
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVMLG---FLSKLEVLDLHGNEITN 164
Query: 470 YGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQ 518
G + + + L + ++N +
Sbjct: 165 TGGLTRL----KKVNWIDLTGQ------KCVNEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 43/227 (18%), Positives = 82/227 (36%), Gaps = 42/227 (18%)
Query: 412 ELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYG 471
E + ++ PD L N +L +T V+ + + + ++
Sbjct: 1 ESIQRPTPIN-QVFPD-PGLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQ- 54
Query: 472 PIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGV 531
A + TNL L L +N+ + P++ + L + ++ N L+
Sbjct: 55 -SLAGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLK------------- 98
Query: 532 SFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG 591
++ + + L+ L N L L +L+NL+IL + NKL
Sbjct: 99 ------------NLNGIPS--ACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK- 141
Query: 592 RIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLS 638
I LG +K+ LDL N + + + L+K+ + L
Sbjct: 142 SIV-MLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 32/238 (13%), Positives = 62/238 (26%), Gaps = 72/238 (30%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
S ++ N + S++ + +L L LS N+ + + L + +L+ L +N
Sbjct: 41 SGVQNFNGDNSNIQ-----SLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVN 93
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
NR + ++ LS L L N L +
Sbjct: 94 RNRLK-NLNG--IPSACLSRLFLDNNELR-DTDS-------------------------L 124
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
L L+ L + N L + L L
Sbjct: 125 IHLKNLEILSIRNNKLKSI-------------------------VMLGFLSKLEVLDLHG 159
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSAN--KLNGTI 304
N L ++ + L ++ +L ++ +G
Sbjct: 160 NEI-TNTGG--LTRLKKVNWIDLTGQKC------VNEPVKYQPELYITNTVKDPDGRW 208
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 27/135 (20%), Positives = 48/135 (35%), Gaps = 16/135 (11%)
Query: 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQ 327
++ L +E Q + ++L L K+ I + +Q I S N +
Sbjct: 1 MVKLTAELIE-QAAQ-YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--- 54
Query: 328 IPRSVGNLSS---LNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA 384
R + L +LL+ NNR+ L +L L +N + ++ LA
Sbjct: 55 --RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLA 110
Query: 385 ---KLEVLYLFNNRI 396
L L + N +
Sbjct: 111 SLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 24/117 (20%), Positives = 41/117 (35%), Gaps = 9/117 (7%)
Query: 354 PELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRI---EGAIPHQIGRMSKL 410
+ N +L L+ I I L + + + +N I +G + +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRL 66
Query: 411 VELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
L + NNR+ L +L L L +N L L+ L+ L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 24/126 (19%), Positives = 39/126 (30%), Gaps = 11/126 (8%)
Query: 86 NNSISYICKNQHLLS---LDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK 142
I + + + LDL G + I Q + +DN + +
Sbjct: 6 AELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPL 62
Query: 143 LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSL---PKLKSLYL 199
L+RL L + N + L + NN L D+ L L L +
Sbjct: 63 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCI 120
Query: 200 NTNNLT 205
N +T
Sbjct: 121 LRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 21/117 (17%), Positives = 41/117 (35%), Gaps = 9/117 (7%)
Query: 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQK 292
+N E I + L Q + + DN + ++ + L L+
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIE-NLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68
Query: 293 LVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLS---SLNSLLLFNN 346
L+++ N++ G L + L+ N+L + L+ SL L + N
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 24/152 (15%), Positives = 49/152 (32%), Gaps = 29/152 (19%)
Query: 557 MLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS 616
M+ + + + ++ N + L L K+ I + +D SDN +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56
Query: 617 IPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFS 676
+ L ++++L + N + ++ L EL L +N L
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-----------SLVELG 104
Query: 677 SILNVSNNKLSGKIPECLGNLDKLQILDLSSN 708
+ + L +L L L + N
Sbjct: 105 DL-------------DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 8/105 (7%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
LD+RG + I + +DFS+N + + L L+ L ++ N++
Sbjct: 24 LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIG 80
Query: 594 PYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKM---QSLSLQEN 635
+ +L L++N L ++ L + L + N
Sbjct: 81 EGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 23/114 (20%), Positives = 43/114 (37%), Gaps = 5/114 (4%)
Query: 138 PEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSL 197
+ R LDL + I + ++I F +N + +L L +LK+L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 198 YLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPT--SLSNCRNLVEFSASSN 249
+N N + + + L LI N+ + L L++ ++L N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 33/130 (25%), Positives = 53/130 (40%), Gaps = 3/130 (2%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDGR 592
L + N + P VF NL L N+L ++P + +L L +L L N+L
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLF 652
+ + +L + N L +P + L + L+L +N L AF + SL
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 653 ELQLGSNIFD 662
L N +D
Sbjct: 163 HAYLFGNPWD 172
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 1/116 (0%)
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQL 314
+ P +F L+ L+ LYL N L L L L L N+L S L
Sbjct: 55 LEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHL 114
Query: 315 QVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHN 370
+ + + N L ++PR + L+ L L L N+L+ SL L N
Sbjct: 115 KELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 37/128 (28%), Positives = 50/128 (39%), Gaps = 1/128 (0%)
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
++LYL DN + P L NL++L L +N+L G QL V+ L N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 327 QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKL 386
L L L + N+L LP + L L L N + L+ L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSL 161
Query: 387 EVLYLFNN 394
YLF N
Sbjct: 162 THAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 36/108 (33%), Positives = 49/108 (45%), Gaps = 7/108 (6%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
L L N+ T P + LK L L N+ ++P +F L +L+ LDLG N L+
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 159 KIPPQV--SLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNL 204
+P V L L+ + N L ELP I L L L L+ N L
Sbjct: 102 VLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 40/147 (27%), Positives = 58/147 (39%), Gaps = 18/147 (12%)
Query: 376 IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI-TRLRNL 434
+P I ++LYL +N+I P + L EL L +N+L +P + L L
Sbjct: 34 VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 435 QFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNR 492
L L N LT L +L L + N +P I T+L L L N+
Sbjct: 91 TVLDLGTNQLT---VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQ 146
Query: 493 F----NGSFPIEIGKCSSLRRVILSNN 515
+G+F + SSL L N
Sbjct: 147 LKSIPHGAF----DRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 44/201 (21%), Positives = 61/201 (30%), Gaps = 75/201 (37%)
Query: 123 KTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
+ L L+DN+ + P +F L L L LG N L +P V F
Sbjct: 43 QILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGV----------FD----- 85
Query: 182 GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
SL +L L L TN LT LP
Sbjct: 86 --------SLTQLTVLDLGTNQLT------------------------VLP--------- 104
Query: 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
+F L+ L+ L++ N L +P + L +L L L N+L
Sbjct: 105 ---------------SAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK 148
Query: 302 GTISGQISHCNQLQVIALSRN 322
G + L L N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 32/112 (28%), Positives = 43/112 (38%), Gaps = 18/112 (16%)
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----- 659
L L DN + P SL ++ L L N L F S+ L L LG+N
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 660 ---IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSN 708
+FD L L L + NKL+ ++P + L L L L N
Sbjct: 104 PSAVFD-----RLVHLKE----LFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 8e-10
Identities = 65/436 (14%), Positives = 134/436 (30%), Gaps = 57/436 (13%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYICKNQ--HLLSLDLSG-NEFTGSIPKQLG-NCGQ 121
NN LK+++ V + + + K + L +L L + FT + +C +
Sbjct: 109 NNLRQLKSVHFRR---MIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRK 165
Query: 122 LKTLLLNDNRFQGSIPPEIFKL----KRLSWLDLGYNSLSG----KIPPQVSLCYSLESI 173
+KTLL+ ++ F + +L L L+ + + C SL S+
Sbjct: 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225
Query: 174 GFHNNFLNGELPNDICSLPKLKSL-YLNTNNLTGLLPEFPNSCAILHLLIHENDFVG--S 230
+F EL + L+ + N G+ ++ N L ++G
Sbjct: 226 KV-GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE 284
Query: 231 LPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENL 290
+P + + + + LEVL + + + + L
Sbjct: 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQL 344
Query: 291 QKLVLSANKLNGTISGQIS------------HCNQLQVIALSRNNL----VGQIPRSVGN 334
++L + + + C +L+ +A+ +++ + I + N
Sbjct: 345 KRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKN 404
Query: 335 LSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394
L + L + DL L + + KL +
Sbjct: 405 LCDFRLV-------------LLDREERITDLPLDNGVRSL-----LIGCKKLRRFAFYLR 446
Query: 395 --RIEGAIPHQIGRMSK-LVELALYNNRLTGRIPPDITR-LRNLQFLSLAHNHLTGEVAL 450
+ IG+ S + + L + + +R NLQ L + +
Sbjct: 447 QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIA 506
Query: 451 ELGKHFPYLSRLDLTG 466
P L L + G
Sbjct: 507 AAVTKLPSLRYLWVQG 522
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 9e-08
Identities = 72/529 (13%), Positives = 141/529 (26%), Gaps = 94/529 (17%)
Query: 97 HLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSL 156
+L SL L G N G T + + L++L + +
Sbjct: 74 NLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTE---------ISNNLRQLKSVHFRRMIV 124
Query: 157 SGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNT-NNLTGLLPEFPNSC 215
S L+ + L++L L+ + T +
Sbjct: 125 S---------DLDLDRLAK-------------ARADDLETLKLDKCSGFT--------TD 154
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIF---KGLLQLEVLYLD 272
+L + +++CR + ++F W+ + LEVL
Sbjct: 155 GLLSI--------------VTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200
Query: 273 DNNLEGQIPETL----WGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQI 328
P+ L +L + + + + G L+ N +
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFE-ILELVGFFKAAANLEEFCGGSLNEDIGM 259
Query: 329 PRSVGNLSSLNSLLLFNNRLQG--TLPPELGNCGSLVDLRLQH-NFIGGTIPPEICNLAK 385
P NL L G +P + L L + I
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPN 319
Query: 386 LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRL------------RN 433
LEVL N + + +L L + + + + +
Sbjct: 320 LEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQE 379
Query: 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPI-----------PANICVGTN 482
L+++++ + +T E +G + L L I C
Sbjct: 380 LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLR 439
Query: 483 LFVLVLGNNRFNGSFPIEIGK-CSSLRRVILSN-NLLQGSLPATLERNPGVSFLDVRG-N 539
F L IG+ ++R ++L L P + L++RG
Sbjct: 440 RFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC 499
Query: 540 LLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELG---NLENLQILRLS 585
+ +I +L L R S + + N++++
Sbjct: 500 FSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 74/510 (14%), Positives = 165/510 (32%), Gaps = 77/510 (15%)
Query: 234 SLSNCRNLVEFSASSNNFGGAISPW---IFKGLLQLEVLYLDDNNL--EGQIPETLWGLE 288
L F+ N+GG ++PW I L QL+ ++ + +
Sbjct: 79 KLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARAD 138
Query: 289 NLQKLVLSANKL--NGTISGQISHCNQLQVIALSRNNLVGQIPRSVG----NLSSLNSLL 342
+L+ L L + ++HC +++ + + ++ + + + + +SL L
Sbjct: 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN 198
Query: 343 LFNNRLQG----TLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEG 398
+ L NC SLV +++ +F + A LE + +
Sbjct: 199 FYMTEFAKISPKDLETIARNCRSLVSVKV-GDFEILELVGFFKAAANLEEFCGGSLNEDI 257
Query: 399 AIPHQIGRMSKLVELALYNNRLTGR--IPPDITRLRNLQFLSLAHNHLTGEVALELGKHF 456
+P + + +L G +P ++ L L + L E L +
Sbjct: 258 GMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKC 317
Query: 457 PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNL 516
P L L+ + + + VL C L+R+ +
Sbjct: 318 PNLEVLETRN-----------VI-GDRGLEVLAQY------------CKQLKRLRIERGA 353
Query: 517 LQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS----GSIPSE 572
+ + D G + Q + + L + + ++ SI +
Sbjct: 354 DEQGME------------DEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTY 401
Query: 573 LGNLENLQILRLSANK------LDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEK 626
L NL + +++ L + LD + L C K+ + G + +S
Sbjct: 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ--GGLTDLGLSYIG 459
Query: 627 MQSLSLQENNLSG------AIPDAFSSVQSLFELQL-GSNIFDGSIPCSLSKLHHFSSIL 679
S +++ L + + +L +L++ G + +I +++KL L
Sbjct: 460 QYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRY-L 518
Query: 680 NVSNNKLSGKIPECLG---NLDKLQILDLS 706
V + S + + ++++
Sbjct: 519 WVQGYRASMTGQDLMQMARPYWNIELIPSR 548
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 51/236 (21%), Positives = 88/236 (37%), Gaps = 59/236 (25%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTL-SNNSRKHWAVKKLNRSETNF----DVEIRTLSL 883
RYE ++ +G+G G V L + A+K + R+ + +EI L
Sbjct: 20 RYE-IVG-----NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKK 72
Query: 884 VRHR------NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937
++ + + + H I E + G F L +N + + R H+A
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVR-HMAY 130
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP-------------------KIGDFG 978
+ L +LH + Q+ H D+K +NIL + ++ DFG
Sbjct: 131 QLCHALRFLH-EN--QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 979 MSKLISDSHSS--STRSAIVGSLGYIAPE----NAYSTRLTEKSDVYSYGVILFEL 1028
+ + H++ +TR Y PE ++ DV+S G ILFE
Sbjct: 188 SATFDHEHHTTIVATRH-------YRPPEVILELGWAQ----PCDVWSIGCILFEY 232
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 69/241 (28%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTL-SNNSRKHWAVKKLNRSETNF----DVEIRTLSL 883
RYE ++ +G+G G V + +H AVK + ++ + EI+ L
Sbjct: 15 RYE-IVD-----TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEH 67
Query: 884 VRHR------NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE-----PRLVLDWNTR 932
+ ++++ H IV E + G + ++ + +N +
Sbjct: 68 LNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHI------ 120
Query: 933 YHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL-DSELEP------------------K 973
+A I + +++LH ++ H D+K +NIL S+ K
Sbjct: 121 RKMAYQICKSVNFLH-SN--KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 974 IGDFGMSKLISDSHSS--STRSAIVGSLGYIAPE----NAYSTRLTEKSDVYSYGVILFE 1027
+ DFG + + HS+ STR Y APE +S DV+S G IL E
Sbjct: 178 VVDFGSATYDDEHHSTLVSTRH-------YRAPEVILALGWSQ----PCDVWSIGCILIE 226
Query: 1028 L 1028
Sbjct: 227 Y 227
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 34/121 (28%), Positives = 61/121 (50%), Gaps = 7/121 (5%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
+P G ++T L N+ + +P EL N ++L ++ LS N++ T++
Sbjct: 24 VLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 604 IKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPD-AFSSVQSLFELQLGSNIF 661
+ L LS N L IP L+ ++ LSL N++S +P+ AF+ + +L L +G+N
Sbjct: 81 LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
Query: 662 D 662
Sbjct: 139 Y 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 30/129 (23%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
L L GN+FT +PK+L N L + L++NR ++ + F + +L L L YN L
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPE--FPNSCA 216
IPP+ F L L+ L L+ N+++ +PE F + A
Sbjct: 93 -IPPRT----------FD-------------GLKSLRLLSLHGNDISV-VPEGAFNDLSA 127
Query: 217 ILHLLIHEN 225
+ HL I N
Sbjct: 128 LSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 28/81 (34%), Positives = 39/81 (48%), Gaps = 3/81 (3%)
Query: 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRI 424
L L N +P E+ N L ++ L NNRI M++L+ L L NRL I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 425 PPDIT-RLRNLQFLSLAHNHL 444
PP L++L+ LSL N +
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 32/127 (25%), Positives = 46/127 (36%), Gaps = 21/127 (16%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGV- 531
+P I L L N+F P E+ L + LSNN + +L
Sbjct: 25 LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLS------NQSF 74
Query: 532 ------SFLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILR 583
L + N L+ IPP F +L +L N +S +P +L L L
Sbjct: 75 SNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA 132
Query: 584 LSANKLD 590
+ AN L
Sbjct: 133 IGANPLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 24/115 (20%)
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----- 659
+L L N +P E+ + + + + L N +S +FS++ L L L N
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCI 93
Query: 660 ---IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLG---NLDKLQILDLSSN 708
FDG L L L++ N +S +PE G +L L L + +N
Sbjct: 94 PPRTFDG-----LKSLRL----LSLHGNDIS-VVPE--GAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 38/145 (26%), Positives = 55/145 (37%), Gaps = 32/145 (22%)
Query: 204 LTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL 263
L L P L+L N F +P LSN ++L S+N +S F +
Sbjct: 22 LKVLPKGIPRDVTELYL--DGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNM 77
Query: 264 LQLEVLYLDDNNLEGQIPETLW-GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
QL L L N L IP + GL++L+ L L H N + V
Sbjct: 78 TQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSL--------------HGNDISV------ 116
Query: 323 NLVGQIPRSV-GNLSSLNSLLLFNN 346
+P +LS+L+ L + N
Sbjct: 117 -----VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 13/110 (11%)
Query: 315 QVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPP----ELGNCGSLVDLRLQHN 370
+ L N +P+ + N L + L NNR+ TL + L+ L L +N
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ---LLTLILSYN 88
Query: 371 FIGGTIPPEICN-LAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNN 418
+ IPP + L L +L L N I +P +S L LA+ N
Sbjct: 89 RL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 60/309 (19%), Positives = 87/309 (28%), Gaps = 115/309 (37%)
Query: 49 QSVSTSAPCKWSGVSCYNNS-SSLKALN----LSGFGLSGVLNNSISYICKNQHLLSLDL 103
Q A + + S + N + + S+ I ++ L L
Sbjct: 11 QIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLAL 70
Query: 104 SGNEFTGSIPKQLG---NCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGK 159
GN+ + L L+L N+ Q S+P +F KL L L L N L
Sbjct: 71 GGNKLH-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-S 123
Query: 160 IPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILH 219
+P V F L L L L N L
Sbjct: 124 LPDGV----------FD-------------KLTNLTYLNLAHNQLQ-------------- 146
Query: 220 LLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ 279
SLP +F L L L L N L+
Sbjct: 147 ----------SLP------------------------KGVFDKLTNLTELDLSYNQLQ-S 171
Query: 280 IPETLWG-LENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV-GNLSS 337
+PE ++ L L+ L L + NQL+ +P V L+S
Sbjct: 172 LPEGVFDKLTQLKDLRL--------------YQNQLK-----------SVPDGVFDRLTS 206
Query: 338 LNSLLLFNN 346
L + L +N
Sbjct: 207 LQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 27/220 (12%)
Query: 423 RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTN 482
+ + NL+ S+ + ++ + N
Sbjct: 16 DAFAETIKA-NLKKKSVTD--------AVTQNELNSIDQIIANNSDIKSVQGIQYL--PN 64
Query: 483 LFVLVLGNNRFN--GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPG-VSFLDVRGN 539
+ L LG N+ + + + ++L +IL+ N LQ SLP + + L + N
Sbjct: 65 VRYLALGGNKLHDISAL----KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119
Query: 540 LLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDGRIPYEL 597
LQ S+P VF +NLT L+ + N+L S+P + L NL L LS N+L +P +
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEGV 176
Query: 598 -GKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQEN 635
K T++ L L N L S+P V L +Q + L +N
Sbjct: 177 FDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 44/190 (23%), Positives = 78/190 (41%), Gaps = 37/190 (19%)
Query: 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRI 593
+++ + +++ + + + + S+ + L N++ L L NKL
Sbjct: 24 ANLKKKSVT-DAVT-QNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH--- 76
Query: 594 PYELG---KCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPDAFSSVQ 649
++ + T + L L+ N L S+P+ V L ++ L L EN L F +
Sbjct: 77 --DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT 133
Query: 650 SLFELQLGSN--------IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKL- 700
+L L L N +FD L+ L + L++S N+L +PE G DKL
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFD-----KLTNL----TELDLSYNQLQ-SLPE--GVFDKLT 181
Query: 701 --QILDLSSN 708
+ L L N
Sbjct: 182 QLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 50/191 (26%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 260 FKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIAL 319
L ++ + +++++ + + + L N++ L L NKL + L + L
Sbjct: 37 QNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKL--HDISALKELTNLTYLIL 92
Query: 320 SRNNLVGQIPRSV-GNLSSLNSLLLFNNRLQGTLPP----ELGNCGSLVDLRLQHNFIGG 374
+ N L +P V L++L L+L N+LQ +LP +L N L L L HN +
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTN---LTYLNLAHNQLQ- 146
Query: 375 TIPPEIC-NLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGRIPPDI-TRL 431
++P + L L L L N+++ ++P + ++++L +L LY N+L +P + RL
Sbjct: 147 SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 204
Query: 432 RNLQFLSLAHN 442
+LQ++ L N
Sbjct: 205 TSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQK 292
T L N S + L + L L N L I L L NL
Sbjct: 32 TDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLH-DIS-ALKELTNLTY 89
Query: 293 LVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGN-LSSLNSLLLFNNRLQGT 351
L+L+ N+L +G L+ + L N L +P V + L++L L L +N+LQ +
Sbjct: 90 LILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 352 LPP----ELGNCGSLVDLRLQHNFIGGTIPPEICN-LAKLEVLYLFNNRIEGAIPHQI-G 405
LP +L N L +L L +N + ++P + + L +L+ L L+ N+++ ++P +
Sbjct: 148 LPKGVFDKLTN---LTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFD 202
Query: 406 RMSKLVELALYNN 418
R++ L + L++N
Sbjct: 203 RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 33/161 (20%), Positives = 72/161 (44%), Gaps = 18/161 (11%)
Query: 291 QKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQG 350
K L + ++ N + I + +++ + + + L ++ L L N+L
Sbjct: 22 IKANLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH- 76
Query: 351 TLPPELGNCGSLVD---LRLQHNFIGGTIPPEICN-LAKLEVLYLFNNRIEGAIPHQI-G 405
++ L + L L N + ++P + + L L+ L L N+++ ++P +
Sbjct: 77 ----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130
Query: 406 RMSKLVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLT 445
+++ L L L +N+L +P + +L NL L L++N L
Sbjct: 131 KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 34/158 (21%), Positives = 61/158 (38%), Gaps = 14/158 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVRH-RNILRIVGS 895
GR IG+G G ++ + + + A+K E RT L+ I +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ H +V + + G +L ++L + + T A + + +H ++
Sbjct: 75 GQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIHEKS---LV 128
Query: 956 HRDIKSDNILLDSELEPK-----IGDFGMSKLISDSHS 988
+RDIK DN L+ + DFGM K D +
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 32/117 (27%), Positives = 45/117 (38%), Gaps = 14/117 (11%)
Query: 287 LENLQKLVLSANKLN-GTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLS---SLNSLL 342
+++LVL K N G I G + L+ ++L L SV NL L L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLE 77
Query: 343 LFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA---KLEVLYLFNNRI 396
L NR+ G L +L L L N + + L L+ L LFN +
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 29/104 (27%), Positives = 40/104 (38%), Gaps = 3/104 (2%)
Query: 364 DLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGR 423
L + G I LE L L N + + ++ KL +L L NR+ G
Sbjct: 30 VLDNCKSNDG-KIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGG 86
Query: 424 IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
+ +L NL L+L+ N L LE K L LDL
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 31/136 (22%), Positives = 54/136 (39%), Gaps = 10/136 (7%)
Query: 334 NLSSLNSLLLFNNRLQGTLPPELG-NCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLF 392
+++ L+L N + L +L L L + + ++ + L KL+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 393 NNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLR---NLQFLSLAHNHLTGEVA 449
NRI G + ++ L L L N+L + L+ L+ L L + +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVTNLND 137
Query: 450 --LELGKHFPYLSRLD 463
+ K P L+ LD
Sbjct: 138 YRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSG 158
L LD + G I L+ L L + S+ + KL +L L+L N + G
Sbjct: 29 LVLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFG 85
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDIC---SLPKLKSLYLNTNNLT 205
+ +L + N L + + + L LKSL L +T
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKL--KDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 5/86 (5%)
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
+ LE L L + L + L L L+KL LS N++ G + L + LS N
Sbjct: 48 FVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105
Query: 323 NL--VGQIPRSVGNLSSLNSLLLFNN 346
L + + + L L SL LFN
Sbjct: 106 KLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 5/119 (4%)
Query: 377 PPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPP-DITRLRNLQ 435
P C + + ++ H + L EL + N + + D+ L L+
Sbjct: 2 PDACCPHGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR 59
Query: 436 FLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN 494
L++ + L VA + P LSRL+L+ N+ + G +L LVL N +
Sbjct: 60 NLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 23/96 (23%), Positives = 35/96 (36%), Gaps = 1/96 (1%)
Query: 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLEN 289
L NL E + + +GL +L L + + L P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
L +L LS N L ++S + LQ + LS N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 21/114 (18%), Positives = 42/114 (36%), Gaps = 5/114 (4%)
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPE-LGNCGSLVDLRLQ 368
+ + +R+ + + +L L + N + L L G L +L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 369 HNFIGGTIPPEI-CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
+ + + P+ +L L L N +E ++ + + L EL L N L
Sbjct: 65 KSGL-RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 21/99 (21%), Positives = 35/99 (35%), Gaps = 9/99 (9%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIP-HQIGRMSKLVELALYNNRLTGRIPPDI-TRLR 432
+ L LY+ N + + + + +L L + + L + PD
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 433 NLQFLSLAHNHLTGEVALELGKHFPYLS--RLDLTGNSF 469
L L+L+ N L +L LS L L+GN
Sbjct: 81 RLSRLNLSFNALE---SLSWK-TVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 4/99 (4%)
Query: 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSDNYLAGSIPSEV 621
+ L ENL L + + + L ++ L + + L + +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75
Query: 622 IS-LEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659
++ L+L N L + SL EL L N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 19/119 (15%), Positives = 34/119 (28%), Gaps = 25/119 (21%)
Query: 111 SIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGKIPPQVSLCYS 169
L L L + + + + + L L L + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA----- 75
Query: 170 LESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFV 228
FH P+L L L+ N L L + ++ L++ N
Sbjct: 76 -----FHF-------------TPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 9e-06
Identities = 28/114 (24%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPT-SLSNCRNLVEFSAS 247
C L + L P + + L I + L L L +
Sbjct: 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 248 SNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN 301
+ ++P F +L L L N LE +T+ GL +LQ+LVLS N L+
Sbjct: 65 KSGL-RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 14/94 (14%), Positives = 29/94 (30%), Gaps = 15/94 (15%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQ-----HLLSLDLSGNEFTGSIPKQ-LGNCGQL 122
+L L + + ++ L +L + + + +L
Sbjct: 31 ENLTELYIEN-------QQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 123 KTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSL 156
L L+ N + S+ + + L L L N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 26/111 (23%), Positives = 49/111 (44%), Gaps = 3/111 (2%)
Query: 358 NCGSLVDLRLQHNFIG-GTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416
+ +L L ++ G + +LE L N + +I + + +++KL +L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467
+NR++G + + NL L+L+ N + +E K L LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 34/136 (25%), Positives = 53/136 (38%), Gaps = 10/136 (7%)
Query: 334 NLSSLNSLLLFNNRLQ-GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLF 392
S + L+L N+R G L L L + + T + L KL+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELS 72
Query: 393 NNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLR---NLQFLSLAHNHLTGEVA 449
+NR+ G + + L L L N++ I L+ NL+ L L + +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 450 --LELGKHFPYLSRLD 463
+ K P L+ LD
Sbjct: 131 YRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 32/158 (20%), Positives = 55/158 (34%), Gaps = 35/158 (22%)
Query: 287 LENLQKLVLSANKLN-GTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN 345
++++LVL ++ N G + G +L+ ++ L S+ NL LN L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKL---- 66
Query: 346 NRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEG-AIPHQI 404
L L N + G + L L L N+I+ + +
Sbjct: 67 -----------------KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL 109
Query: 405 GRMSKLVELALYNNRLTGRIPPD-----ITRLRNLQFL 437
++ L L L+N +T D L L +L
Sbjct: 110 KKLENLKSLDLFNCEVTNL--NDYRENVFKLLPQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 26/85 (30%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
+LE L + L I L L L+KL LS N+++G + C L + LS N
Sbjct: 41 FEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN 98
Query: 323 NLVG-QIPRSVGNLSSLNSLLLFNN 346
+ + L +L SL LFN
Sbjct: 99 KIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 30/111 (27%), Positives = 45/111 (40%), Gaps = 4/111 (3%)
Query: 503 KCSSLRRVILSNNLLQ-GSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561
S ++ ++L N+ G L + + FL L SI + L L+ S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 562 ENRLSGSIPSELGNLENLQILRLSANKL-DGRIPYELGKCTKMIKLDLSDN 611
+NR+SG + NL L LS NK+ D L K + LDL +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 7/85 (8%)
Query: 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613
L L L+ SI + L L L+ L LS N++ G + KC + L+LS N +
Sbjct: 43 ELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 614 AGSIPSEVISLEKM---QSLSLQEN 635
S + L+K+ +SL L
Sbjct: 101 KD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 553 SNLTMLDFSENRLS-GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611
S++ L +R + G + E L+ L L I L K K+ KL+LSDN
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELSDN 74
Query: 612 YLAGSIPSEVISLEKMQSLSLQENNLS 638
++G + + L+L N +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 33/142 (23%), Positives = 46/142 (32%), Gaps = 33/142 (23%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYI---CKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
S +K L L +N + + L L T SI L +LK
Sbjct: 15 TPSDVKELVLDNSR-----SNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLK 67
Query: 124 TLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGE 183
L L+DNR G + K L+ L+L N + L +I
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----------DLSTI---------- 106
Query: 184 LPNDICSLPKLKSLYLNTNNLT 205
+ L LKSL L +T
Sbjct: 107 --EPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 24/110 (21%), Positives = 42/110 (38%), Gaps = 7/110 (6%)
Query: 433 NLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIP--ANICVGTNLFVLVLGN 490
+++ L L ++ L F L L + AN+ L L L +
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKLELSD 73
Query: 491 NRFNGSFPIEIGKCSSLRRVILSNNLLQG-SLPATLERNPGVSFLDVRGN 539
NR +G + KC +L + LS N ++ S L++ + LD+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 28/135 (20%), Positives = 53/135 (39%), Gaps = 27/135 (20%)
Query: 575 NLENLQILRLSANKLD-GRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQ 633
+++ L L ++ + G++ + ++ L + L SI + + L K++ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 634 ENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693
+N +SG + +L L L N K+ S+I E
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGN-----------KIKDLSTI-------------EP 108
Query: 694 LGNLDKLQILDLSSN 708
L L+ L+ LDL +
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 31/158 (19%), Positives = 63/158 (39%), Gaps = 14/158 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVRH-RNILRIVGS 895
G+ IG G G + + + ++ A+K + +E R + I ++
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
++ +V E + G +L ++ + L T IA+ + + Y+H +I
Sbjct: 74 GPCGKYNAMVLELL-GPSLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHSKN---LI 127
Query: 956 HRDIKSDNILLDSELEPK-----IGDFGMSKLISDSHS 988
+RD+K +N L+ I DF ++K D +
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 25/138 (18%), Positives = 44/138 (31%), Gaps = 22/138 (15%)
Query: 898 KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957
KD+ FIV E+ GG + + T I + L+ + HR
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEASL--RFEHR 186
Query: 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSD 1017
D+ N+LL K+ K + + S G Y+ S
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTL-----SR 230
Query: 1018 VYSYGVILFELLFRKMPV 1035
+ G+++F + +
Sbjct: 231 LERDGIVVFCDVSMDEDL 248
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 28/174 (16%), Positives = 60/174 (34%), Gaps = 30/174 (17%)
Query: 839 GRIIGKGKHGTVYRTL---------------------SNNSRKHWAVKKLNRSETNFDVE 877
+ G +Y + + R R+ V
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 878 I-RTLSLVRHRNILRIVGS-CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHI 935
+ L I +G +D++ F+V + G +L + L + P+ VL + +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQV 164
Query: 936 ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI--GDFGMSKLISDSH 987
A + L +LH + +H ++ ++NI +D E + ++ +G + S
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 33/156 (21%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVR-HRNILRIVGS 895
GR IG G G +Y + + + A+K + E + +++ I +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ ++ +V + + G +L ++ + +L L T +A + + ++H +
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---FL 125
Query: 956 HRDIKSDNILLDSELEPK---IGDFGMSKLISDSHS 988
HRDIK DN L+ I DFG++K D+ +
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 36/130 (27%), Positives = 62/130 (47%), Gaps = 11/130 (8%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSE--LGNLENLQILRLSANKLDGRIPYELGKCT 601
IP + T L ++N L I S+ G L +L L L N+L G P +
Sbjct: 22 EIPR--DIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 602 KMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPD-AFSSVQSLFELQLGSN 659
+ +L L +N + I +++ L ++++L+L +N +S + +F + SL L L SN
Sbjct: 79 HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
Query: 660 IFDGSIPCSL 669
F+ + C L
Sbjct: 137 PFNCN--CHL 144
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 23/84 (27%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 365 LRLQHNFIGGTIPPEIC--NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG 422
L L N +G I + L L L L N++ G P+ S + EL L N++
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91
Query: 423 RIPPDI-TRLRNLQFLSLAHNHLT 445
I + L L+ L+L N ++
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 29/131 (22%)
Query: 267 EVLYLDDNNLEGQIPETLW-GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325
L L+DN L + L+ L +L KL L N+L G + +Q + L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI- 90
Query: 326 GQIPRSV-GNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEIC-NL 383
+I + L L +L L++N++ + P +L
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQIS-------------------------CVMPGSFEHL 125
Query: 384 AKLEVLYLFNN 394
L L L +N
Sbjct: 126 NSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 7/87 (8%)
Query: 123 KTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQV--SLCYSLESIGFHNNF 179
LLLNDN +F +L L L+L N L+ I P ++ + N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS-HIQELQLGENK 89
Query: 180 LNGELPNDIC-SLPKLKSLYLNTNNLT 205
+ E+ N + L +LK+L L N ++
Sbjct: 90 IK-EISNKMFLGLHQLKTLNLYDNQIS 115
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 35/156 (22%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVK--KLNRSETNFDVEIRTLSLVRH-RNILRIVGS 895
GR IG G G +Y + + A+K + +E + +++ I I
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ ++ +V E + G +L ++ + + L T +A + + Y+H I
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHSKN---FI 127
Query: 956 HRDIKSDNILLDSELEPK---IGDFGMSKLISDSHS 988
HRD+K DN L+ + I DFG++K D+ +
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 63/372 (16%), Positives = 114/372 (30%), Gaps = 84/372 (22%)
Query: 95 NQHLLSLDLSGNEFTGSIPKQLG-----NCGQLKTLLLNDNRFQGSIPPEIFKL-----K 144
+ SLDLS N +L + +L L+ N E+ ++
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 145 RLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNL 204
++ L+L N LS K L +L +I F + L L N+
Sbjct: 81 NVTSLNLSGNFLSYK--SSDELVKTLAAIPFT-----------------ITVLDLGWNDF 121
Query: 205 TGLLPEFPNSC-AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL 263
+ S + ++ + N+ G S + + L
Sbjct: 122 S------SKSSSEFKQAFSNLP-------------ASITSLNLRGNDLGIKSSDELIQIL 162
Query: 264 ----LQLEVLYLDDNNL--EG--QIPETLWGL-ENLQKLVLSANKLNGT----ISGQISH 310
+ L L NNL + ++ + L + ++ L LSAN L ++ S
Sbjct: 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222
Query: 311 CN-QLQVIALSRNNL----VGQIPRSVGNLSSLNSLLLFNNRLQGT-------LPPELGN 358
+ + L N L + + +L L ++ L + ++ L N
Sbjct: 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPN 282
Query: 359 CGSLVDLRLQHNFIGGTIPPEICNLAK-----LEVLYLFNNRIEGAIPHQIGRM-----S 408
++ + I + I NL + +V L N + A HQ
Sbjct: 283 IQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPD 342
Query: 409 KLVELALYNNRL 420
+L E L
Sbjct: 343 ELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 59/358 (16%), Positives = 109/358 (30%), Gaps = 73/358 (20%)
Query: 67 NSSSLKALNLSGFGLSGVLNNSISYICK-----NQHLLSLDLSGNEFTGSIPKQLG---- 117
+ +L+LS L + S + + + SL+LSGN +L
Sbjct: 20 IPHGVTSLDLSLNNLY---SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 118 -NCGQLKTLLLNDNRFQGSIPPEIFKL-----KRLSWLDLGYNSLSGK-----IPPQVSL 166
+ +L L+ N E+ K ++ LDLG+N S K +L
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 167 CYSLESIGFHNNFLNGELPNDICSL-----PKLKSLYLNTNNLTGLLPEFPNSCAILHLL 221
S+ S+ N L + +++ + + SL L NNL
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA---------------- 180
Query: 222 IHENDFVGSLPTSL-SNCRNLVEFSASSNNFGGAISPWIFKGLLQ----LEVLYLDDNNL 276
+ L L S ++ S+N G + + L L N L
Sbjct: 181 ---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 277 EGQ----IPETLWGLENLQKLVLSANKLNGT-------ISGQISHCNQLQVIALSRNNL- 324
G + L++LQ + L + + + + ++ ++ + +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
Query: 325 ---VGQIPRSVGNLS-SLNSLLLFNNRL-----QGTLPPELGNCGSLVDLRLQHNFIG 373
I + LS + L N L T +L L + +
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 42/278 (15%), Positives = 92/278 (33%), Gaps = 43/278 (15%)
Query: 66 NNSSSLKALNLSG--FGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLG-----N 118
+++ +LNLSG + + LDL N+F+ +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 119 CGQLKTLLLNDNRFQGSIPPEIFKL-----KRLSWLDLGYNSLSGKIPPQV-----SLCY 168
+ +L L N E+ ++ ++ L+L N+L+ K ++ S+
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 169 SLESIGFHNNFLNGELPNDICSL-----PKLKSLYLNTNNLTG-----LLPEFPNSCAIL 218
S+ S+ N L + ++ + + SL L N L G L + +
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 219 HLLIHENDF-------VGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQ----LE 267
+ + + +L + N + ++ + + S I + + +
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKAD 316
Query: 268 VLYLDDNNL-----EGQIPETLWGLENLQKLVLSANKL 300
V L + L E L + L++ + + L
Sbjct: 317 VPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 58/319 (18%), Positives = 97/319 (30%), Gaps = 78/319 (24%)
Query: 432 RNLQFLSLAHNHLTGEVALELGKHFP----YLSRLDLTGNSFYGPIPANICVGTNLFVLV 487
+ L L+ N+L +EL + F ++ L+L+GNS ++ V +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF-------KNSDELVQI 74
Query: 488 LGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547
L +++ + LS N L L L
Sbjct: 75 LAAI------------PANVTSLNLSGNFLS---------YKSSDEL---VKTLAAIP-- 108
Query: 548 VFGFWSNLTMLDFSENRLSGSIPSELGNL-----ENLQILRLSANKLDGRIPYELGKC-- 600
+T+LD N S SE ++ L L N L + EL +
Sbjct: 109 -----FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA 163
Query: 601 ---TKMIKLDLSDN--------YLAGSIPSEVISLEKMQSLSLQENNLS----GAIPDAF 645
+ L+L N LA + S S+ SL L N L + F
Sbjct: 164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT---SLDLSANLLGLKSYAELAYIF 220
Query: 646 SSVQ-SLFELQLGSNIFDGSIPCSLSKLHHFSS---ILNVSNNKLSGKIPEC-------L 694
SS+ + L L N G +L L + + + + E
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAF 280
Query: 695 GNLDKLQILDLSSNSFSGE 713
N+ K+ ++D +
Sbjct: 281 PNIQKIILVDKNGKEIHPS 299
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 39/278 (14%), Positives = 85/278 (30%), Gaps = 46/278 (16%)
Query: 236 SNCRNLVEFSASSNNFGGAISPWIFKGLL----QLEVLYLDDNNLEGQ----IPETLWGL 287
+ ++ + S N+ G S + + L + L L N L + + +TL +
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107
Query: 288 -ENLQKLVLSANKLNGT----ISGQISHCNQ-LQVIALSRNNL----VGQIPRSVGNL-S 336
+ L L N + S+ + + L N+L ++ + + + +
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167
Query: 337 SLNSLLLFNNRLQGTLPPELG-----NCGSLVDLRLQHNFIGGTIPPEIC-----NLAKL 386
++NSL L N L EL S+ L L N +G E+ +
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHV 227
Query: 387 EVLYLFNNRIEGAIPHQIGRM----SKLVELALYNNRLTGRIPPD--------ITRLRNL 434
L L N + G + + L + L + + + + ++ +
Sbjct: 228 VSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAAFPNIQKI 286
Query: 435 QFLSLAHNHLTGEVALELGKHF----PYLSRLDLTGNS 468
+ + ++ + L
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQC 324
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 49.2 bits (116), Expect = 4e-06
Identities = 26/181 (14%), Positives = 65/181 (35%), Gaps = 21/181 (11%)
Query: 301 NGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG 360
+S + L + + N + + NL SL + + L ++ ++
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE---IISGGLPDSVVEDILGSD 217
Query: 361 --SLVDLRL---QHNFIGGTIPPEICNLA------KLEVLYLFNNRIEGAIPHQIGR--- 406
+L L L ++ L L+ L + + + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 407 MSKLVELALYNNRLTGR----IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRL 462
+ +L + + LT + + ++++L+F+++ +N+L+ E+ EL K P +
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337
Query: 463 D 463
Sbjct: 338 S 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 6e-04
Identities = 24/187 (12%), Positives = 60/187 (32%), Gaps = 40/187 (21%)
Query: 542 QGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELG--K 599
Q + PV L L + + ++ NL+ L + + L + ++
Sbjct: 161 QVDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 600 CTKMIKLDL---SDNYLAGSIPSEVISL------EKMQSLSLQENNLSGAIPDAFSSVQS 650
+ KL L ++Y + L ++ L + + + + F
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 651 LFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGK----IPECLGNLDKLQILDLS 706
L +L+ +++S L+ + + + + + L+ +++
Sbjct: 278 LPQLE----------------------TMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 707 SNSFSGE 713
N S E
Sbjct: 316 YNYLSDE 322
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 37/121 (30%), Positives = 58/121 (47%), Gaps = 6/121 (4%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
S+P G S+ T L+ N+L L L L LS N++ K TK+
Sbjct: 21 SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 604 IKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGAIPD-AFSSVQSLFELQLGSNIF 661
L L +N L S+P+ V L +++ L+L N L ++PD F + SL ++ L +N +
Sbjct: 79 TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 136
Query: 662 D 662
D
Sbjct: 137 D 137
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 4/94 (4%)
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEGQIPETLW-GLENLQKLVLSANKLNGTISGQISHCNQ 313
+ +F L QL L L N ++ +P+ ++ L L L L NKL +G Q
Sbjct: 43 LPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQ 101
Query: 314 LQVIALSRNNLVGQIPRSV-GNLSSLNSLLLFNN 346
L+ +AL N L +P + L+SL + L N
Sbjct: 102 LKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 30/130 (23%), Positives = 46/130 (35%), Gaps = 28/130 (21%)
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
L L+ N L+ L L KL LS N++ G +L ++ L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL-Q 89
Query: 327 QIPRSV-GNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEIC-NLA 384
+P V L+ L L L N+L+ ++P I L
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLK-------------------------SVPDGIFDRLT 124
Query: 385 KLEVLYLFNN 394
L+ ++L N
Sbjct: 125 SLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 30/106 (28%), Positives = 41/106 (38%), Gaps = 26/106 (24%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
L+L N+ QL L L+ N+ Q S+P +F KL +L+ L L N L
Sbjct: 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 159 KIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNL 204
+P V F L +LK L L+TN L
Sbjct: 90 SLPNGV----------FDK-------------LTQLKELALDTNQL 112
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 10/144 (6%)
Query: 496 SFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSN 554
S P I + + L N L+ + ++ L + GN LQ S+P VF ++
Sbjct: 21 SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77
Query: 555 LTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDGRIPYEL-GKCTKMIKLDLSDNY 612
LT L+ S N+L S+P+ + L L+ L L+ N+L +P + K T++ L L N
Sbjct: 78 LTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQ 135
Query: 613 LAGSIPSEVI-SLEKMQSLSLQEN 635
L S+P V L +Q + L +N
Sbjct: 136 LK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 34/109 (31%), Positives = 47/109 (43%), Gaps = 8/109 (7%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSG 158
LDL N L L L N+ Q S+P +F KL L++L+L N L
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 159 KIPPQV--SLCYSLESIGFHNNFLNGELPNDIC-SLPKLKSLYLNTNNL 204
+P V L L+ + + N L LP+ + L +LK L L N L
Sbjct: 90 SLPNGVFDKLT-QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 38/133 (28%), Positives = 58/133 (43%), Gaps = 10/133 (7%)
Query: 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
L L+ N+L+ L +L +L L NKL +G + L + LS N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 327 QIPRSVGNLSSLNSLLLFNNRLQGTLPP----ELGNCGSLVDLRLQHNFIGGTIPPEIC- 381
L+ L L L N+LQ +LP +L L DLRL N + ++P +
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ---LKDLRLYQNQL-KSVPDGVFD 145
Query: 382 NLAKLEVLYLFNN 394
L L+ ++L +N
Sbjct: 146 RLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 22/83 (26%), Positives = 40/83 (48%), Gaps = 4/83 (4%)
Query: 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI-GRMSKLVELALYNNRLTGR 423
L L+ N + L L LYL N+++ ++P+ + +++ L L L N+L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 424 IPPDI-TRLRNLQFLSLAHNHLT 445
+P + +L L+ L+L N L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQ 113
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 31/115 (26%), Positives = 44/115 (38%), Gaps = 23/115 (20%)
Query: 605 KLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN----- 659
LDL N L L + L L N L F+ + SL L L +N
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 660 ---IFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKL---QILDLSSN 708
+FD L++L L ++ N+L +P+ G DKL + L L N
Sbjct: 92 PNGVFD-----KLTQL----KELALNTNQLQ-SLPD--GVFDKLTQLKDLRLYQN 134
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 34/172 (19%), Positives = 60/172 (34%), Gaps = 31/172 (18%)
Query: 839 GRIIGKGKHGTVY---RTLSNNSRKHWAVKKLNRSETNFDVEIRTL-------------- 881
G+ IG G G +Y T VK + E++
Sbjct: 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 882 -SLVRHRNILRIVGS----CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
+ + I GS + F+V E + G L + QN +T +
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKK--STVLQLG 157
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI--GDFGMSKLISDS 986
+ + L Y+H + +H DIK+ N+LL + ++ D+G+S +
Sbjct: 158 IRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 33/169 (19%), Positives = 62/169 (36%), Gaps = 32/169 (18%)
Query: 839 GRIIGKGKHGTVY----RTLSNNSRKHWAVKKLNRS-------ETNF---------DVEI 878
G IG+G G +Y + + V K+ S E F +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 879 RTLSLVRHRNILRIVGS----CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH 934
+++ + + GS + F++ + G L + N R T
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR--KTVLQ 156
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI--GDFGMSK 981
++L I L Y+H +H DIK+ N+LL+ + ++ D+G++
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 39/246 (15%), Positives = 69/246 (28%), Gaps = 34/246 (13%)
Query: 231 LPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNL-EGQIPETLWGLEN 289
P + + +++ + L ++ + + L
Sbjct: 60 HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK 119
Query: 290 LQKLVLSANKLNGTISGQISHCNQLQVIALSR-----NNLVGQIPRSVGNLSSLNSLLLF 344
LQ L L +L+ I ++ + L + LS + + S L LN
Sbjct: 120 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN----- 174
Query: 345 NNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIE---GAIP 401
L C + +Q + + L L R +
Sbjct: 175 -----------LSWCFDFTEKHVQV------AVAHVSE--TITQLNLSGYRKNLQKSDLS 215
Query: 402 HQIGRMSKLVELAL-YNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460
+ R LV L L + L + +L LQ LSL+ + L P L
Sbjct: 216 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 275
Query: 461 RLDLTG 466
L + G
Sbjct: 276 TLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 39/190 (20%), Positives = 65/190 (34%), Gaps = 10/190 (5%)
Query: 431 LRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGN 490
+Q + L+++ + + L L L G PI + +NL L L
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 491 NRF--NGSFPIEIGKCSSLRRVILSNNLL---QGSLPATLERNPGVSFLDVRG---NLLQ 542
+ + CS L + LS + A + ++ L++ G NL +
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 211
Query: 543 GSIPPVFGFWSNLTMLDFSE-NRLSGSIPSELGNLENLQILRLSA-NKLDGRIPYELGKC 600
+ + NL LD S+ L E L LQ L LS + ELG+
Sbjct: 212 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 271
Query: 601 TKMIKLDLSD 610
+ L +
Sbjct: 272 PTLKTLQVFG 281
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 45/304 (14%), Positives = 79/304 (25%), Gaps = 56/304 (18%)
Query: 194 LKSLYLNTNNLTGLLPEFPNSC-AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFG 252
L+ L L +T P C + +L S L E + +S
Sbjct: 74 LRQLNLAGVRMT------PVKCTVVAAVL-------------GSGRHALDEVNLASCQLD 114
Query: 253 GAISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLE-NLQKLVLSANKLNGT---- 303
A + L+ L L N+L + + + L + + L LS N L
Sbjct: 115 PAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAV 174
Query: 304 ISGQISHCNQLQVIALSRNNL----VGQIPRSVGNLSSLNSLLLFNNRLQGT----LPPE 355
+ ++ + ++L L + + + L L + N T L
Sbjct: 175 LMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234
Query: 356 LGNCGSLVDLRLQHNFIGGTIPPEIC-------NLAKLEVLYLFNNRIEGAIPHQIGRMS 408
SL L L N + + A++ V +
Sbjct: 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS------EYWSV 288
Query: 409 KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHF---PYLSRLDLT 465
L E+ N + R L L + + + L
Sbjct: 289 ILSEVQRNLNSWD---RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQ 345
Query: 466 GNSF 469
S
Sbjct: 346 LGSS 349
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1119 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.98 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.98 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.6 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.58 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.57 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.14 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.06 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.85 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.77 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.65 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.43 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.37 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.33 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.28 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.09 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.09 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.02 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.67 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.58 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.37 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.24 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.96 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.85 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.65 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.24 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.23 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.48 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.26 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.81 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 91.46 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.34 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-93 Score=903.68 Aligned_cols=704 Identities=28% Similarity=0.432 Sum_probs=647.6
Q ss_pred cCCCcHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCceeeeeeeecCCCceEEEecCCCccccc---CccchhhhccCCcc
Q 001226 22 SSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGV---LNNSISYICKNQHL 98 (1119)
Q Consensus 22 ~~~~~~~~ll~~~~~~~~~~~~~~~w~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~~~~~~~~~l~~l 98 (1119)
+.++|++|||+||+++.+++ .+.+|+. .++||+|+||+|+ +++|++|+|++.++.|. ++ ..+..+++|
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~---~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~---~~l~~L~~L 79 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSS---NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVS---SSLLSLTGL 79 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCT---TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHH---HHTTTCTTC
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCC---CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccC---hhHhccCcc
Confidence 35678999999999998766 7789974 3689999999998 58999999999999997 55 346678999
Q ss_pred cEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCc--cccccCccCEEEccCccccCCCCccc-ccccccceeee
Q 001226 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPP--EIFKLKRLSWLDLGYNSLSGKIPPQV-SLCYSLESIGF 175 (1119)
Q Consensus 99 ~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~L~L 175 (1119)
+.++++.+.+. .+|..++++++|++|+|++|+++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++|++
T Consensus 80 ~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 80 ESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred cccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 99999998775 4678999999999999999999999998 99999999999999999999888876 89999999999
Q ss_pred cccccccccCcc---CCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccC
Q 001226 176 HNNFLNGELPND---ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFG 252 (1119)
Q Consensus 176 ~~n~l~~~~~~~---l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~ 252 (1119)
++|.+++..|.. +.++++|++|++++|++++..+ +.++++|++|++++|++.
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-------------------------~~~l~~L~~L~Ls~n~l~ 213 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-------------------------VSRCVNLEFLDVSSNNFS 213 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCB-------------------------CTTCTTCCEEECCSSCCC
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCC-------------------------cccCCcCCEEECcCCcCC
Confidence 999999988877 8899999999999999885432 367899999999999998
Q ss_pred CccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCccc
Q 001226 253 GAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV 332 (1119)
Q Consensus 253 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 332 (1119)
+.++. +.++++|++|+|++|++++.+|..+.++++|++|++++|++++.+|.. .+++|++|+|++|.+++.+|..+
T Consensus 214 ~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~ 289 (768)
T 3rgz_A 214 TGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFL 289 (768)
T ss_dssp SCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCS
T ss_pred CCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHH
Confidence 76654 889999999999999999999999999999999999999999877765 89999999999999999999988
Q ss_pred CCC-CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchh-hhcccccceeeccCccccCCCCccccccC-c
Q 001226 333 GNL-SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPE-ICNLAKLEVLYLFNNRIEGAIPHQIGRMS-K 409 (1119)
Q Consensus 333 ~~l-~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~ 409 (1119)
... ++|++|++++|++++..|..|+++++|++|++++|.+++.+|.. +.++++|++|++++|++++.+|..+..++ +
T Consensus 290 ~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~ 369 (768)
T 3rgz_A 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369 (768)
T ss_dssp CTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTT
T ss_pred HhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcC
Confidence 775 99999999999999999999999999999999999999888876 89999999999999999999999999987 9
Q ss_pred ceEEEeecccccccCCccccC--CCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceee
Q 001226 410 LVELALYNNRLTGRIPPDITR--LRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLV 487 (1119)
Q Consensus 410 L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ 487 (1119)
|++|++++|++++.+|..+.. +++|+.|++++|++++.+|..+ ..+++|+.|++++|++++.+|..+..+++|+.|+
T Consensus 370 L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 448 (768)
T 3rgz_A 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL-SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448 (768)
T ss_dssp CSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGG-GGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred CcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHH-hcCCCCCEEECcCCcccCcccHHHhcCCCCCEEE
Confidence 999999999999989988887 8899999999999998877765 4689999999999999999999999999999999
Q ss_pred ccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccC
Q 001226 488 LGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG 567 (1119)
Q Consensus 488 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (1119)
+++|++++.+|..++.+++|++|++++|++++.+|..+..+++|++|++++|++++.+|..++.+++|++|+|++|+++|
T Consensus 449 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 528 (768)
T 3rgz_A 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSG 528 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEE
T ss_pred CCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCc----------------------cccccCChhhhhcc
Q 001226 568 SIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN----------------------YLAGSIPSEVISLE 625 (1119)
Q Consensus 568 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N----------------------~l~~~~p~~~~~l~ 625 (1119)
.+|..++++++|+.|+|++|++.|.+|..+.....+..+++..+ .+.+..|..+..+.
T Consensus 529 ~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 608 (768)
T 3rgz_A 529 NIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLS 608 (768)
T ss_dssp ECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGG
T ss_pred cCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccc
Confidence 99999999999999999999999999999988887777666542 35667788888899
Q ss_pred cCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeec
Q 001226 626 KMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDL 705 (1119)
Q Consensus 626 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~L 705 (1119)
.++.++++.|.++|.+|..|+.+++|+.|||++|+++|.+|..++.+..+. .|+|++|+++|.+|+.++++++|+.|||
T Consensus 609 ~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~-~L~Ls~N~l~g~ip~~l~~L~~L~~LdL 687 (768)
T 3rgz_A 609 TRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF-ILNLGHNDISGSIPDEVGDLRGLNILDL 687 (768)
T ss_dssp GTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCC-EEECCSSCCCSCCCGGGGGCTTCCEEEC
T ss_pred cccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCC-EEeCcCCccCCCCChHHhCCCCCCEEEC
Confidence 999999999999999999999999999999999999999999999998875 6999999999999999999999999999
Q ss_pred cCceecccCCccccccccceEEecccccccccCCCccccccccCCccccCCcccccC--CCCCC
Q 001226 706 SSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSELCRQ--GNCGK 767 (1119)
Q Consensus 706 s~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~~~~n~~~c~~--~~c~~ 767 (1119)
|+|+|+|.||..+..+++|+.||+|+|+|+|.||.+ .+|.++.+.+|.||+++||. ..|..
T Consensus 688 s~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp CSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred CCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 999999999999999999999999999999999986 67888899999999999996 47853
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-76 Score=746.42 Aligned_cols=631 Identities=30% Similarity=0.463 Sum_probs=583.9
Q ss_pred CCcccEEEcCCCcccCC---CCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCc--ccccccc
Q 001226 95 NQHLLSLDLSGNEFTGS---IPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPP--QVSLCYS 169 (1119)
Q Consensus 95 l~~l~~L~Ls~n~~~~~---~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~ 169 (1119)
-.+++.|||+++.+.|. +|..++++++|+.++++.+.+. .+|..++.+++|++|||++|.++|.+|. .++++++
T Consensus 49 ~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~ 127 (768)
T 3rgz_A 49 DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSG 127 (768)
T ss_dssp TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTT
T ss_pred CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCC
Confidence 36899999999999998 9999999999999999999876 4778999999999999999999999998 9999999
Q ss_pred cceeeecccccccccCccC-CCcccccEEEeccccccccCCCCCccccceeeeeeccccccCcccc---ccCCCCCcEEE
Q 001226 170 LESIGFHNNFLNGELPNDI-CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTS---LSNCRNLVEFS 245 (1119)
Q Consensus 170 L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~---l~~l~~L~~L~ 245 (1119)
|++|+|++|.+++..|..+ .++++|++|++++|++++.. |.. +.++++|++|+
T Consensus 128 L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-----------------------~~~~~~~~~l~~L~~L~ 184 (768)
T 3rgz_A 128 LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN-----------------------VVGWVLSDGCGELKHLA 184 (768)
T ss_dssp CCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEET-----------------------HHHHHHTTCCTTCCEEE
T ss_pred CCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcC-----------------------ChhhhhhccCCCCCEEE
Confidence 9999999999999988876 89999999999999988543 333 78899999999
Q ss_pred ccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccc
Q 001226 246 ASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV 325 (1119)
Q Consensus 246 l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (1119)
+++|.+.+.++. ..+++|++|+|++|++++.+|. +.++++|++|++++|++++..+..+..+++|++|+|++|.++
T Consensus 185 Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~ 260 (768)
T 3rgz_A 185 ISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260 (768)
T ss_dssp CCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCE
T ss_pred CCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCccc
Confidence 999999876543 7889999999999999988887 999999999999999999999999999999999999999999
Q ss_pred cccCcccCCCCCCCeEEccCCcccCCCCCCCCCC-CCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCcc-
Q 001226 326 GQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC-GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQ- 403 (1119)
Q Consensus 326 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~- 403 (1119)
+.+|.. .+++|++|++++|++++.+|..+... ++|++|++++|.+++.+|..|.++++|++|++++|++++.+|..
T Consensus 261 ~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~ 338 (768)
T 3rgz_A 261 GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338 (768)
T ss_dssp ESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHH
T ss_pred CccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHH
Confidence 888765 89999999999999999999998875 99999999999999999999999999999999999999777765
Q ss_pred ccccCcceEEEeecccccccCCccccCCC-CcCEEEccCccCcccchhhhhcc-CCccceeccccceeeCccCCcccccc
Q 001226 404 IGRMSKLVELALYNNRLTGRIPPDITRLR-NLQFLSLAHNHLTGEVALELGKH-FPYLSRLDLTGNSFYGPIPANICVGT 481 (1119)
Q Consensus 404 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~~~ 481 (1119)
+..+++|++|++++|++++.+|..+..++ +|+.|++++|++++.++..+... ++.|++|++++|.+++.+|..++.++
T Consensus 339 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~ 418 (768)
T 3rgz_A 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418 (768)
T ss_dssp HTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT
T ss_pred HhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC
Confidence 99999999999999999999999999998 99999999999998888776543 78899999999999999999999999
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
+|+.|++++|++++.+|..++++++|+.|++++|++++.+|..+..+++|++|++++|++++.+|..++.+++|++|+|+
T Consensus 419 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 498 (768)
T 3rgz_A 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498 (768)
T ss_dssp TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCc------
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN------ 635 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N------ 635 (1119)
+|++++.+|.+|+++++|++|+|++|++.|.+|..++.+++|+.|||++|+++|.+|.++.....+..+++..+
T Consensus 499 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~ 578 (768)
T 3rgz_A 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI 578 (768)
T ss_dssp SSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEE
T ss_pred CCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999988777666555442
Q ss_pred ----------------cCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccc
Q 001226 636 ----------------NLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDK 699 (1119)
Q Consensus 636 ----------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~ 699 (1119)
.+.|..|..+..+..+..++++.|.+.|.+|..+..+..+. .||+++|+++|.+|..++++++
T Consensus 579 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~-~LdLs~N~l~g~ip~~l~~l~~ 657 (768)
T 3rgz_A 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM-FLDMSYNMLSGYIPKEIGSMPY 657 (768)
T ss_dssp ECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCC-EEECCSSCCBSCCCGGGGGCTT
T ss_pred ccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccccc-EEECcCCcccccCCHHHhcccc
Confidence 35677888888999999999999999999999999888764 6999999999999999999999
Q ss_pred cceeeccCceecccCCccccccccceEEecccccccccCCCccccccccCCccccCC
Q 001226 700 LQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGN 756 (1119)
Q Consensus 700 L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~~~~n 756 (1119)
|+.|||++|+|+|.||+.++++++|+.||+|+|+++|.||..+..+.....-..+.|
T Consensus 658 L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N 714 (768)
T 3rgz_A 658 LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714 (768)
T ss_dssp CCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred CCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence 999999999999999999999999999999999999999998777655544455555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-62 Score=615.52 Aligned_cols=588 Identities=21% Similarity=0.188 Sum_probs=412.8
Q ss_pred EecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccC
Q 001226 74 LNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGY 153 (1119)
Q Consensus 74 l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~ 153 (1119)
+++++.+++.++.. + .+++++|+|++|.+++..+..|+++++|++|+|++|++++..|..++++++|++|+|++
T Consensus 9 ~~cs~~~L~~ip~~-~-----~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 9 ADCSHLKLTQVPDD-L-----PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp EECCSSCCSSCCSC-S-----CTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eECCCCCccccccc-c-----CCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 45566677665432 2 16899999999999988888899999999999999999998899999999999999999
Q ss_pred ccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccc
Q 001226 154 NSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPT 233 (1119)
Q Consensus 154 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~ 233 (1119)
|.+++..+..|+++++|++|++++|.+++..|..|+++++|++|++++|++++.. |.
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-----------------------~~ 139 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK-----------------------LG 139 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCC-----------------------CC
T ss_pred CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccC-----------------------ch
Confidence 9999665668999999999999999999888899999999999999999987543 34
Q ss_pred cccCCCCCcEEEccCCccCCccChhhhh--cCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCccccc--
Q 001226 234 SLSNCRNLVEFSASSNNFGGAISPWIFK--GLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQIS-- 309 (1119)
Q Consensus 234 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-- 309 (1119)
.++++++|++|++++|++++. .+..+. .+++|++|++++|++++..|..+..+++|+.|++++|.+.......+.
T Consensus 140 ~~~~l~~L~~L~L~~n~l~~~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~ 218 (680)
T 1ziw_A 140 TQVQLENLQELLLSNNKIQAL-KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218 (680)
T ss_dssp SSSCCTTCCEEECCSSCCCCB-CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHH
T ss_pred hhcccccCCEEEccCCccccc-CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHH
Confidence 578899999999999999754 444443 568999999999999999999999999999999999988643322221
Q ss_pred -CCCCCcEEEccccccccccCcccCCCCC--CCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhccccc
Q 001226 310 -HCNQLQVIALSRNNLVGQIPRSVGNLSS--LNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKL 386 (1119)
Q Consensus 310 -~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L 386 (1119)
..++|++|++++|.+++..|..+.+++. |+.|++++|++++..+..|+.+++|++|++++|.+++..|..|.++++|
T Consensus 219 l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 298 (680)
T 1ziw_A 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNV 298 (680)
T ss_dssp HTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTC
T ss_pred hhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCc
Confidence 3578999999999999888999988865 9999999999998888899999999999999999998889999999999
Q ss_pred ceeeccCccccC-----CCCc----cccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCccc-chhhhhcc-
Q 001226 387 EVLYLFNNRIEG-----AIPH----QIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGE-VALELGKH- 455 (1119)
Q Consensus 387 ~~L~L~~N~l~~-----~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~- 455 (1119)
+.|++++|...+ .+|. .|..+++|++|++++|++++..+..|..+++|++|++++|.++.. ++...+..
T Consensus 299 ~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~ 378 (680)
T 1ziw_A 299 RYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378 (680)
T ss_dssp CEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGG
T ss_pred cEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhccc
Confidence 999999886553 2222 677888888999988888887777888888888888888876432 22221111
Q ss_pred -CCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCccee
Q 001226 456 -FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFL 534 (1119)
Q Consensus 456 -l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 534 (1119)
.+.|+.|++++|++++..|..+..+++|+.|++++|++++.+| +..+..+++|++|
T Consensus 379 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----------------------~~~~~~l~~L~~L 435 (680)
T 1ziw_A 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT-----------------------GQEWRGLENIFEI 435 (680)
T ss_dssp TTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC-----------------------SGGGTTCTTCCEE
T ss_pred ccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC-----------------------cccccCcccccEE
Confidence 1345555555555555545555555555555555555544333 1344444444444
Q ss_pred eccCcccCCCCCccccccccceEEeccCCccc--CCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcc
Q 001226 535 DVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS--GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612 (1119)
Q Consensus 535 ~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 612 (1119)
++++|++++..+..|..+++|+.|++++|.++ +.+|..|.++++|+.|+|++|++++..|..+..+++|++|+|++|+
T Consensus 436 ~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 515 (680)
T 1ziw_A 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515 (680)
T ss_dssp ECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCC
Confidence 44444444444444555555555555555544 3445555555555555555555554444445555555555555555
Q ss_pred ccccC--------ChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccc
Q 001226 613 LAGSI--------PSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNN 684 (1119)
Q Consensus 613 l~~~~--------p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N 684 (1119)
+++.. +..+..+++|+.|+|++|+++...+..|.++++|+.|+|++|+++
T Consensus 516 l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~---------------------- 573 (680)
T 1ziw_A 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN---------------------- 573 (680)
T ss_dssp CGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC----------------------
T ss_pred ccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCC----------------------
Confidence 54321 122555666666666666666443445666666666444444333
Q ss_pred cccCCcccccccccccceeeccCceecccCCcccc-ccccceEEecccccccccCC
Q 001226 685 KLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVN-NMVSLYFVNISFNHFSGKLP 739 (1119)
Q Consensus 685 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~-~~~~l~~l~ls~N~~~g~~p 739 (1119)
+..|..|.++++|+.|+|++|+|++..|..+. .+++|+.+++++|++.+.-+
T Consensus 574 ---~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 574 ---TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp ---CCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ---cCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 22233344455555555555555544443343 44555555555555555433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=614.94 Aligned_cols=591 Identities=21% Similarity=0.195 Sum_probs=346.1
Q ss_pred cEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeeccc
Q 001226 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN 178 (1119)
Q Consensus 99 ~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1119)
+.+|.++++++ .+|..+. +++++|+|++|++++..+..+.++++|++|||++|.+++..|..++++++|++|+|++|
T Consensus 7 ~~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 7 EVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp SEEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred CeeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 46888888887 6777665 78999999999999877778999999999999999999888888888999999999999
Q ss_pred ccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChh
Q 001226 179 FLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258 (1119)
Q Consensus 179 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~ 258 (1119)
.++...+..|+++++|++|++++|++++..| ..++++++|++|++++|.+++. .+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-----------------------~~~~~l~~L~~L~Ls~n~l~~~-~~~ 139 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKN-----------------------NPFVKQKNLITLDLSHNGLSST-KLG 139 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCS-----------------------CTTTTCTTCCEEECCSSCCSCC-CCC
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccCh-----------------------hHccccCCCCEEECCCCccccc-Cch
Confidence 8887766678888888888888888764322 3455566666666666655432 233
Q ss_pred hhhcCCCccEEEcCCCccCCCcchhhc--CCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCC
Q 001226 259 IFKGLLQLEVLYLDDNNLEGQIPETLW--GLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLS 336 (1119)
Q Consensus 259 ~~~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 336 (1119)
.|.++++|++|++++|++++..+..+. .+++|++|++++|++++..+..|..+++|+.|++++|.+.+.....+.
T Consensus 140 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~--- 216 (680)
T 1ziw_A 140 TQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC--- 216 (680)
T ss_dssp SSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHH---
T ss_pred hhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHH---
Confidence 445555555555555555554444433 234555555555555554454555555555555544444321111100
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccc--cceeeccCccccCCCCccccccCcceEEE
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK--LEVLYLFNNRIEGAIPHQIGRMSKLVELA 414 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 414 (1119)
..+ ..++|+.|++++|.+++..|..+..++. |+.|++++|++++..|..|+.+++|++|+
T Consensus 217 -----------------~~l-~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 278 (680)
T 1ziw_A 217 -----------------LEL-ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278 (680)
T ss_dssp -----------------HHH-TTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred -----------------HHh-hhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEee
Confidence 000 1245555555555555555555555543 66666666666655555566666666666
Q ss_pred eecccccccCCccccCCCCcCEEEccCccCcccch--------hhhhccCCccceeccccceeeCccCCcccccccccee
Q 001226 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVA--------LELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVL 486 (1119)
Q Consensus 415 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L 486 (1119)
+++|++++..|..|..+++|+.|++++|...+.++ ...+..+++|++|++++|.+++..|..+..+++|++|
T Consensus 279 L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 358 (680)
T 1ziw_A 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYL 358 (680)
T ss_dssp CCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEE
T ss_pred CCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEE
Confidence 66666665555666666666666666554432211 1112233444444444444444444444444444444
Q ss_pred eccCccccCC--CCcccccc--ccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccC
Q 001226 487 VLGNNRFNGS--FPIEIGKC--SSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562 (1119)
Q Consensus 487 ~L~~N~l~~~--~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (1119)
++++|.+... .+..+..+ ++|+.|++++|++++..|..+..+++|+.|++++|++++.+|
T Consensus 359 ~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---------------- 422 (680)
T 1ziw_A 359 SLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT---------------- 422 (680)
T ss_dssp ECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECC----------------
T ss_pred ECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccC----------------
Confidence 4444443211 11112111 344555555555554444444444444444444444444333
Q ss_pred CcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccc--ccCChhhhhcccCCeeEccCccCccC
Q 001226 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA--GSIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 563 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
+..|.++++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..+..+++|+.|+|++|++++.
T Consensus 423 -------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i 495 (680)
T 1ziw_A 423 -------GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI 495 (680)
T ss_dssp -------SGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCC
T ss_pred -------cccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcC
Confidence 134444444555555555444444444444445555555554443 23444444445555555555555544
Q ss_pred CCccccccccccEeecCCcccCCCcc--------ccchhhccccceeeeccccccCCcccccccccccceeeccCceecc
Q 001226 641 IPDAFSSVQSLFELQLGSNIFDGSIP--------CSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712 (1119)
Q Consensus 641 ~p~~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 712 (1119)
.|..|..+++|++|+|++|.+++..+ ..+..+..+ +.|++++|+++...+..|+++++|+.|||++|+|++
T Consensus 496 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L-~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 574 (680)
T 1ziw_A 496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL-HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574 (680)
T ss_dssp CTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred ChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCC-CEEECCCCCCCCCCHHHcccccCcceeECCCCCCCc
Confidence 44445555555555555554443211 113334433 347777777774444578999999999999999996
Q ss_pred cCCccccccccceEEecccccccccCCCccc-cccccCCccccCCccccc
Q 001226 713 EIPTEVNNMVSLYFVNISFNHFSGKLPASWT-TLMVSYPGSFLGNSELCR 761 (1119)
Q Consensus 713 ~ip~~~~~~~~l~~l~ls~N~~~g~~p~~~~-~~~~~~~~~~~~n~~~c~ 761 (1119)
..|..+..+++|+.|++++|++++.+|..+. .+.....-...+||-.|.
T Consensus 575 l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 575 LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 5555578999999999999999987776544 454555667789988775
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-58 Score=565.84 Aligned_cols=534 Identities=19% Similarity=0.165 Sum_probs=346.8
Q ss_pred EEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEcc
Q 001226 73 ALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLG 152 (1119)
Q Consensus 73 ~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls 152 (1119)
.+++++.+++.++... .+++++|||++|.+++..|..|+++++|++|+|++|++++..|.+|+++++|++|+|+
T Consensus 16 ~~~c~~~~l~~iP~~l------~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 89 (606)
T 3t6q_A 16 TYNCENLGLNEIPGTL------PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLT 89 (606)
T ss_dssp EEECTTSCCSSCCTTS------CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred eEECCCCCcccCcCCC------CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCC
Confidence 3556666776654322 2478999999999998888899999999999999999998889999999999999999
Q ss_pred CccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCcc
Q 001226 153 YNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLP 232 (1119)
Q Consensus 153 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp 232 (1119)
+|.+++..|..++++++|++|++++|.+++..+..++++++|++|++++|++++.. .|
T Consensus 90 ~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~----------------------~~ 147 (606)
T 3t6q_A 90 ANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIK----------------------LP 147 (606)
T ss_dssp TCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCC----------------------CC
T ss_pred CCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccC----------------------cc
Confidence 99999888999999999999999999999887888999999999999999887532 12
Q ss_pred ccccCCCCCcEEEccCCccCCccChhhhhcCCCcc--EEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccC
Q 001226 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLE--VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISH 310 (1119)
Q Consensus 233 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~--~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 310 (1119)
.+..+++|++|++++|+++ .+.+..|..+++|+ +|++++|++++..|..+.. .+|++|++++|. ..+..+..
T Consensus 148 -~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~ 221 (606)
T 3t6q_A 148 -KGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKG 221 (606)
T ss_dssp -TTCCCTTCCEEECCSSCCC-EECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHH
T ss_pred -cccCCcccCEEEcccCccc-ccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhh
Confidence 2233777888888887776 44566677777777 7777777777666665543 567777777775 22334444
Q ss_pred CCCCcEEEcccccccc-----ccCcccCCCC--CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcc
Q 001226 311 CNQLQVIALSRNNLVG-----QIPRSVGNLS--SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNL 383 (1119)
Q Consensus 311 l~~L~~L~Ls~N~l~~-----~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l 383 (1119)
+.+++...+..+.+.+ ..+..+..+. +|+.|++++|.+++..+..|+.+++|++|++++|+++ .+|..+..+
T Consensus 222 l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l 300 (606)
T 3t6q_A 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300 (606)
T ss_dssp TTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSC
T ss_pred ccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhccc
Confidence 4444444433222211 1111222221 3444445544444444444444444444444444444 334444444
Q ss_pred cccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceec
Q 001226 384 AKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLD 463 (1119)
Q Consensus 384 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 463 (1119)
++|++|++++|++++..|..+..+++|++|++++|.+. +.++...+..+++|++|+
T Consensus 301 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~------------------------~~~~~~~~~~l~~L~~L~ 356 (606)
T 3t6q_A 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR------------------------LELGTGCLENLENLRELD 356 (606)
T ss_dssp TTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSC------------------------CBCCSSTTTTCTTCCEEE
T ss_pred ccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcc------------------------cccchhhhhccCcCCEEE
Confidence 44444444444444444444444444444444444444 333333333344444444
Q ss_pred cccceeeCcc--CCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCc-cccCCCCcceeeccCcc
Q 001226 464 LTGNSFYGPI--PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPA-TLERNPGVSFLDVRGNL 540 (1119)
Q Consensus 464 L~~N~l~~~~--p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~ 540 (1119)
+++|.+++.. |..+..+++|+.|++++|++++..|..+..+++|++|++++|++.+..|. .+..+++|+.|++++|+
T Consensus 357 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~ 436 (606)
T 3t6q_A 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436 (606)
T ss_dssp CCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCC
T ss_pred CCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCc
Confidence 4444444333 44555556666666666666656666666666666666666666655443 36666666677777776
Q ss_pred cCCCCCccccccccceEEeccCCcccCC---CCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccC
Q 001226 541 LQGSIPPVFGFWSNLTMLDFSENRLSGS---IPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617 (1119)
Q Consensus 541 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 617 (1119)
+++..|..+..+++|++|+|++|++++. .+..+.++++|++|+|++|++++..|..|..+++|++|||++|++++..
T Consensus 437 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 516 (606)
T 3t6q_A 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516 (606)
T ss_dssp CBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGG
T ss_pred cCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCC
Confidence 6666666666677777777777776652 2345667777777777777777666777777777777777777777777
Q ss_pred ChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCcc
Q 001226 618 PSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP 666 (1119)
Q Consensus 618 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 666 (1119)
|..+..++.| .|+|++|++++.+|..|..+++|+.|++++|++.+..+
T Consensus 517 ~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 517 IEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp GGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred hhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 7777777777 77777777777777777777777777777777665433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-57 Score=559.00 Aligned_cols=540 Identities=20% Similarity=0.211 Sum_probs=357.4
Q ss_pred cEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeeccc
Q 001226 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN 178 (1119)
Q Consensus 99 ~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1119)
..++.++..++ .+|..+.. ++++|+|++|+|++..|..++++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 15 ~~~~c~~~~l~-~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n 91 (606)
T 3t6q_A 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91 (606)
T ss_dssp TEEECTTSCCS-SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred ceEECCCCCcc-cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCC
Confidence 36788888887 67877754 7999999999999888999999999999999999999888999999999999999999
Q ss_pred ccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChh
Q 001226 179 FLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258 (1119)
Q Consensus 179 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~ 258 (1119)
.+++..|..|+++++|++|++++|++++.. |..++++++|++|++++|++.+...+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~-----------------------~~~~~~l~~L~~L~L~~n~l~~~~~~~ 148 (606)
T 3t6q_A 92 PLIFMAETALSGPKALKHLFFIQTGISSID-----------------------FIPLHNQKTLESLYLGSNHISSIKLPK 148 (606)
T ss_dssp CCSEECTTTTSSCTTCCEEECTTSCCSCGG-----------------------GSCCTTCTTCCEEECCSSCCCCCCCCT
T ss_pred cccccChhhhcccccccEeeccccCcccCC-----------------------cchhccCCcccEEECCCCcccccCccc
Confidence 999888999999999999999999887532 234566777777777777765432222
Q ss_pred hhhcCCCccEEEcCCCccCCCcchhhcCCCCCc--eeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCC
Q 001226 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQ--KLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLS 336 (1119)
Q Consensus 259 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~--~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 336 (1119)
+.++++|++|++++|++++..|..|..+++|+ +|++++|.+++..+..|.. ..|++|++++|. .++..+..+.
T Consensus 149 -~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~ 223 (606)
T 3t6q_A 149 -GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLK 223 (606)
T ss_dssp -TCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTT
T ss_pred -ccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhcc
Confidence 22366666666666666665566666666666 5666666666555554443 356666665554 1223333333
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhccc--ccceeeccCccccCCCCccccccCcceEEE
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA--KLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 414 (1119)
+++...+.-+.+. .+... .+ .+..+..+. +|+.|++++|.+++..+..|..+++|++|+
T Consensus 224 ~~~l~~l~~~~~~-----------~~~~~-----~i---~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 284 (606)
T 3t6q_A 224 NSTIQSLWLGTFE-----------DMDDE-----DI---SPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284 (606)
T ss_dssp TCEEEEEECCCCT-----------TSCCC-----CC---CGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEE
T ss_pred ccchhheechhhc-----------ccccc-----cc---ChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEe
Confidence 3333322221111 11111 11 122333332 677777777777777777777777777777
Q ss_pred eecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCcccc
Q 001226 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN 494 (1119)
Q Consensus 415 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~ 494 (1119)
+++|+++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+.+|..
T Consensus 285 l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~~~~~~~~~------------------ 344 (606)
T 3t6q_A 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ-ISASNFPSLTHLSIKGNTKRLELGTG------------------ 344 (606)
T ss_dssp CTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGG-GCGGGCTTCSEEECCSCSSCCBCCSS------------------
T ss_pred ccCCccC-CCChhhcccccCCEEECccCCcCcCch-hhhhccCcCCEEECCCCCcccccchh------------------
Confidence 7777777 567777777777777777777764333 22234555555555555544333322
Q ss_pred CCCCccccccccccEEEeccCccccCC--CccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCc
Q 001226 495 GSFPIEIGKCSSLRRVILSNNLLQGSL--PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSE 572 (1119)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 572 (1119)
.+..+++|++|++++|.+++.. |..+..+++|+.|++++|++.+..|..|..+++|++|+|++|++++..|..
T Consensus 345 -----~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 419 (606)
T 3t6q_A 345 -----CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419 (606)
T ss_dssp -----TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCC
T ss_pred -----hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccch
Confidence 2555555666666666555443 555666666666666666666666666666677777777777776655443
Q ss_pred -cCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccccc---CChhhhhcccCCeeEccCccCccCCCcccccc
Q 001226 573 -LGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS---IPSEVISLEKMQSLSLQENNLSGAIPDAFSSV 648 (1119)
Q Consensus 573 -~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 648 (1119)
+.++++|++|++++|++.+..|..+..+++|++|+|++|++++. .+..+..+++|+.|+|++|++++..|.+|..+
T Consensus 420 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 499 (606)
T 3t6q_A 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499 (606)
T ss_dssp TTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred hhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccc
Confidence 66777777777777777766677777777777777777777652 23557777777777777777777777777777
Q ss_pred ccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCC
Q 001226 649 QSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715 (1119)
Q Consensus 649 ~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip 715 (1119)
++|++|+|++|++++.+|..+..+..+ .|++++|++++.+|..++.+++|+.|++++|++++..+
T Consensus 500 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 500 KMMNHVDLSHNRLTSSSIEALSHLKGI--YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp TTCCEEECCSSCCCGGGGGGGTTCCSC--EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCCCEEECCCCccCcCChhHhCccccc--EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 777776666666665555555555544 36666666666666666666667777777776665443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=563.59 Aligned_cols=488 Identities=22% Similarity=0.171 Sum_probs=254.7
Q ss_pred EEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccC-CccccccCccCEEEc
Q 001226 73 ALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSI-PPEIFKLKRLSWLDL 151 (1119)
Q Consensus 73 ~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~-p~~l~~l~~L~~L~L 151 (1119)
..+++++++++++. ..+++++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |.++.++++|++|+|
T Consensus 8 ~~dcs~~~L~~vP~-------lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~L 80 (844)
T 3j0a_A 8 IAFYRFCNLTQVPQ-------VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80 (844)
T ss_dssp EEEESCCCSSCCCS-------SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEEC
T ss_pred EEEccCCCCCCCCC-------CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEEC
Confidence 45667778887754 2368888999999888888888889999999999888665555 777888888888888
Q ss_pred cCccccCCCCcccccccccceeeecccccccccCcc--CCCcccccEEEeccccccccCCCCCccccceeeeeecccccc
Q 001226 152 GYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPND--ICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVG 229 (1119)
Q Consensus 152 s~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~ 229 (1119)
++|.+++..|..|+++++|++|+|++|.+++..|.. |+++++|++|+|++|++++..
T Consensus 81 s~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~--------------------- 139 (844)
T 3j0a_A 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY--------------------- 139 (844)
T ss_dssp TTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCC---------------------
T ss_pred CCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccc---------------------
Confidence 888888877888888888888888888888766554 778888888888888776432
Q ss_pred CccccccCCCCCcEEEccCCccCCccChhhhhcC--CCccEEEcCCCccCCCcchhhcCCCC------Cceeeecccccc
Q 001226 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL--LQLEVLYLDDNNLEGQIPETLWGLEN------LQKLVLSANKLN 301 (1119)
Q Consensus 230 ~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~------L~~L~Ls~N~l~ 301 (1119)
.+..++++++|++|++++|.+++.. +..|..+ ++|+.|++++|.+.+..|..+..+++ |++|++++|.++
T Consensus 140 -~~~~~~~L~~L~~L~Ls~N~i~~~~-~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~ 217 (844)
T 3j0a_A 140 -LHPSFGKLNSLKSIDFSSNQIFLVC-EHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217 (844)
T ss_dssp -CCGGGGTCSSCCEEEEESSCCCCCC-SGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSS
T ss_pred -cchhHhhCCCCCEEECCCCcCCeeC-HHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCc
Confidence 2234566666666666666665332 3333433 55566666666555555554444433 555555555554
Q ss_pred ccCcccccCC---CCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCC--CCCcEEEcccCcCcccC
Q 001226 302 GTISGQISHC---NQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC--GSLVDLRLQHNFIGGTI 376 (1119)
Q Consensus 302 ~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l--~~L~~L~L~~N~i~~~~ 376 (1119)
+..+..+... .+++.|.++.+.+... +..+.+.+.....|.++ ++|+.|++++|.+.+..
T Consensus 218 ~~~~~~~~~~l~~~~l~~L~l~~~~~~~~---------------~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~ 282 (844)
T 3j0a_A 218 VDITGNFSNAISKSQAFSLILAHHIMGAG---------------FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLN 282 (844)
T ss_dssp TTTTSGGGGTSCSCCBSEEECCSSCCBCS---------------SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEEC
T ss_pred hhHHHHHHhhcCcccccceeccccccccc---------------ccccccCCCChhhhhccccCCccEEECCCCcccccC
Confidence 4444333322 3344444432211100 01112222222222222 34444444444444444
Q ss_pred chhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccC
Q 001226 377 PPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHF 456 (1119)
Q Consensus 377 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l 456 (1119)
|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++
T Consensus 283 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i------------ 350 (844)
T 3j0a_A 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI------------ 350 (844)
T ss_dssp SCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCC------------
T ss_pred hhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCC------------
Confidence 44444444444444444444444444444444444444444444433344444444444444444443
Q ss_pred CccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeec
Q 001226 457 PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDV 536 (1119)
Q Consensus 457 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 536 (1119)
++..+..+..+++|+.|+|++|.+++ + ..+++|+.|++++|+++ .+|.. ..+++.|++
T Consensus 351 -------------~~~~~~~~~~l~~L~~L~Ls~N~l~~-i----~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~l 408 (844)
T 3j0a_A 351 -------------AIIQDQTFKFLEKLQTLDLRDNALTT-I----HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHL 408 (844)
T ss_dssp -------------CCCCSSCSCSCCCCCEEEEETCCSCC-C----SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEEC
T ss_pred -------------CccChhhhcCCCCCCEEECCCCCCCc-c----cCCCCcchhccCCCCcc-ccccc---ccccceeec
Confidence 33333344444455555555555442 1 12445555555555555 22221 223344444
Q ss_pred cCcccCCCC-CccccccccceEEeccCCcccCCCCC-ccCCcccccEEEcccCccc-----CcCCcccccCCCCcEEecc
Q 001226 537 RGNLLQGSI-PPVFGFWSNLTMLDFSENRLSGSIPS-ELGNLENLQILRLSANKLD-----GRIPYELGKCTKMIKLDLS 609 (1119)
Q Consensus 537 ~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls 609 (1119)
++|++++.. +..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|+++ +..|..|..+++|+.|||+
T Consensus 409 s~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls 488 (844)
T 3j0a_A 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488 (844)
T ss_dssp CSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCC
T ss_pred ccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECC
Confidence 444443211 11122344444444444444432222 2233444444444444443 1222334444444444444
Q ss_pred CccccccCChhhhhcccCCeeEccCccCcc
Q 001226 610 DNYLAGSIPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 610 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
+|+|++.+|..+..+++|+.|+|++|+|++
T Consensus 489 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 518 (844)
T 3j0a_A 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLTV 518 (844)
T ss_dssp HHHHTTCCTTSSSSCCSCSEEEEESCCCSS
T ss_pred CCcccccChhHccchhhhheeECCCCCCCc
Confidence 444444444444444444444444444443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=544.02 Aligned_cols=537 Identities=20% Similarity=0.144 Sum_probs=421.3
Q ss_pred EEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEcc
Q 001226 73 ALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLG 152 (1119)
Q Consensus 73 ~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls 152 (1119)
.+++++.+++.++... .+++++|+|++|.+++..+..|+++++|++|+|++|++++..|..+.++++|++|+|+
T Consensus 15 ~~~c~~~~l~~ip~~~------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls 88 (606)
T 3vq2_A 15 TYQCMDQKLSKVPDDI------PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILT 88 (606)
T ss_dssp EEECTTSCCSSCCTTS------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred ceEccCCCcccCCCCC------CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECC
Confidence 5677788888765532 2789999999999998888899999999999999999998889999999999999999
Q ss_pred CccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCcc
Q 001226 153 YNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLP 232 (1119)
Q Consensus 153 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp 232 (1119)
+|.+++..|..|+++++|++|++++|.+++..+..++++++|++|++++|++++. .+|
T Consensus 89 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----------------------~lp 146 (606)
T 3vq2_A 89 GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC----------------------KLP 146 (606)
T ss_dssp TCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCC----------------------CCC
T ss_pred CCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccce----------------------ech
Confidence 9999988899999999999999999999988888899999999999999988742 356
Q ss_pred ccccCCCCCcEEEccCCccCCccChhhhhcCCCcc----EEEcCCCccCCCcchhhcCCCCCceeeecccccc-ccCccc
Q 001226 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLE----VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN-GTISGQ 307 (1119)
Q Consensus 233 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~ 307 (1119)
..++++++|++|++++|++++ +.+..|..+++|+ +|++++|++++..+..+... +|++|++++|.++ +..+..
T Consensus 147 ~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~ 224 (606)
T 3vq2_A 147 AYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTC 224 (606)
T ss_dssp GGGGTCTTCCEEECCSSCCCE-ECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHH
T ss_pred HhHhhcCCCCEEEccCCccee-cChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHH
Confidence 778888999999999888874 4455566555554 78888888886666555544 7888888888876 456677
Q ss_pred ccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEc-ccCcCcccCchhhhccccc
Q 001226 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRL-QHNFIGGTIPPEICNLAKL 386 (1119)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L-~~N~i~~~~~~~l~~l~~L 386 (1119)
+..++.|+.+++..+.+.+.. .+.. +....+..+..+ +++.+++ ..|.+.+.+|. +..+++|
T Consensus 225 ~~~l~~L~~l~l~~~~~~~~~--------~l~~-------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L 287 (606)
T 3vq2_A 225 LQNLAGLHVHRLILGEFKDER--------NLEI-------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANV 287 (606)
T ss_dssp HHTTTTCEEEEEEEECCTTSC--------CCSC-------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTC
T ss_pred hccccccccccccccccccCC--------cccc-------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCC
Confidence 788888888877665544210 1110 001111222222 4555666 55566666555 6667777
Q ss_pred ceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceecccc
Q 001226 387 EVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTG 466 (1119)
Q Consensus 387 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 466 (1119)
+.|++++|.++. +| .+..+++|++|++++|++ +.+| .+ .+++|+.|++++|+..+.. .+..+++|++|++++
T Consensus 288 ~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~ 359 (606)
T 3vq2_A 288 SAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF---KKVALPSLSYLDLSR 359 (606)
T ss_dssp SEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC---CCCCCTTCCEEECCS
T ss_pred CEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch---hhccCCCCCEEECcC
Confidence 777777777753 34 566777777777777777 3566 34 7777777777777544333 223567777777777
Q ss_pred ceeeCc--cCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCC-ccccCCCCcceeeccCcccCC
Q 001226 467 NSFYGP--IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLP-ATLERNPGVSFLDVRGNLLQG 543 (1119)
Q Consensus 467 N~l~~~--~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 543 (1119)
|.+++. +|..+..+++|+.|++++|++++ +|..+..+++|+.|++++|++.+..| ..+..+++|++|++++|++++
T Consensus 360 n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 438 (606)
T 3vq2_A 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438 (606)
T ss_dssp SCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEE
T ss_pred CccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCc
Confidence 777765 36677778888888888888874 66778888899999999999888777 688889999999999999988
Q ss_pred CCCccccccccceEEeccCCcccC-CCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhh
Q 001226 544 SIPPVFGFWSNLTMLDFSENRLSG-SIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI 622 (1119)
Q Consensus 544 ~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 622 (1119)
..|..+..+++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++.+|..+.
T Consensus 439 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 439 DFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp CCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred cchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 888889999999999999999987 4788999999999999999999988888899999999999999999988899999
Q ss_pred hcccCCeeEccCccCccCCCccccccc-cccEeecCCcccCCCcc
Q 001226 623 SLEKMQSLSLQENNLSGAIPDAFSSVQ-SLFELQLGSNIFDGSIP 666 (1119)
Q Consensus 623 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p 666 (1119)
.+++|+.|+|++|+|+ .+|..+..++ +|+.|++++|++.+..+
T Consensus 519 ~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 519 QLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999999999998 6777788887 59999999999986544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=545.96 Aligned_cols=539 Identities=19% Similarity=0.186 Sum_probs=461.3
Q ss_pred cEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeeccc
Q 001226 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN 178 (1119)
Q Consensus 99 ~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1119)
.+++.++++++ .+|..+. ++|++|+|++|++++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n 90 (606)
T 3vq2_A 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90 (606)
T ss_dssp TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence 46899999998 6787665 78999999999999888889999999999999999999888999999999999999999
Q ss_pred ccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChh
Q 001226 179 FLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258 (1119)
Q Consensus 179 ~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~ 258 (1119)
.+++..|..|+++++|++|++++|++++..+ ..++++++|++|++++|.+.+...+.
T Consensus 91 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~-----------------------~~~~~l~~L~~L~L~~n~l~~~~lp~ 147 (606)
T 3vq2_A 91 PIQSFSPGSFSGLTSLENLVAVETKLASLES-----------------------FPIGQLITLKKLNVAHNFIHSCKLPA 147 (606)
T ss_dssp CCCCCCTTSSTTCTTCCEEECTTSCCCCSSS-----------------------SCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred cccccChhhcCCcccCCEEEccCCccccccc-----------------------cccCCCCCCCEEeCCCCcccceechH
Confidence 9999999999999999999999999885432 45788889999999999887544466
Q ss_pred hhhcCCCccEEEcCCCccCCCcchhhcCCCCCc----eeeeccccccccCcccccCCCCCcEEEccccccc-cccCcccC
Q 001226 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQ----KLVLSANKLNGTISGQISHCNQLQVIALSRNNLV-GQIPRSVG 333 (1119)
Q Consensus 259 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~ 333 (1119)
.|.++++|++|++++|++++..|..|..+++|+ +|++++|.++++.+..+... +|++|++++|.++ +..|..+.
T Consensus 148 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~ 226 (606)
T 3vq2_A 148 YFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQ 226 (606)
T ss_dssp GGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHH
T ss_pred hHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhc
Confidence 788888888888888888887787777766655 78888888887777666665 7888888888876 45666777
Q ss_pred CCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeec-cCccccCCCCccccccCcceE
Q 001226 334 NLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL-FNNRIEGAIPHQIGRMSKLVE 412 (1119)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L-~~N~l~~~~~~~~~~l~~L~~ 412 (1119)
++++|+.+++..+.+.+. ..+.. +....+..+..+ .++.+++ ..|.+.+.+|. +..+++|+.
T Consensus 227 ~l~~L~~l~l~~~~~~~~--------~~l~~-------~~~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~ 289 (606)
T 3vq2_A 227 NLAGLHVHRLILGEFKDE--------RNLEI-------FEPSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSA 289 (606)
T ss_dssp TTTTCEEEEEEEECCTTS--------CCCSC-------CCGGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSE
T ss_pred cccccccccccccccccC--------Ccccc-------cChHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCE
Confidence 888888877766554421 11110 111222333333 5777787 77888888887 999999999
Q ss_pred EEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCcc
Q 001226 413 LALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNR 492 (1119)
Q Consensus 413 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~ 492 (1119)
|++++|.++ .+| .+..+++|+.|++++|++ +.+| .+ .++.|++|++++|+..+.+ .+..+++|+.|++++|+
T Consensus 290 L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~--~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~ 361 (606)
T 3vq2_A 290 MSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL--DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNA 361 (606)
T ss_dssp EEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC--CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSC
T ss_pred EEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC--CCCccceeeccCCcCccch--hhccCCCCCEEECcCCc
Confidence 999999997 566 899999999999999999 5777 34 7999999999999665444 56789999999999999
Q ss_pred ccCC--CCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCC-ccccccccceEEeccCCcccCCC
Q 001226 493 FNGS--FPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIP-PVFGFWSNLTMLDFSENRLSGSI 569 (1119)
Q Consensus 493 l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 569 (1119)
+++. .|..+..+++|++|++++|.+.+ +|..+..+++|+.|++++|++.+..| ..+..+++|++|++++|++++..
T Consensus 362 l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 440 (606)
T 3vq2_A 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440 (606)
T ss_dssp EEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECC
T ss_pred cCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccc
Confidence 9876 48889999999999999999986 66899999999999999999999888 68999999999999999999999
Q ss_pred CCccCCcccccEEEcccCcccC-cCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcccccc
Q 001226 570 PSELGNLENLQILRLSANKLDG-RIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSV 648 (1119)
Q Consensus 570 p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 648 (1119)
|..|.++++|++|++++|++.+ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|..|..+
T Consensus 441 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 520 (606)
T 3vq2_A 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520 (606)
T ss_dssp TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTC
T ss_pred hhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCC
Confidence 9999999999999999999997 479999999999999999999999999999999999999999999999999999999
Q ss_pred ccccEeecCCcccCCCccccchhhccccceeeeccccccCCcc
Q 001226 649 QSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIP 691 (1119)
Q Consensus 649 ~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p 691 (1119)
++|+.|+|++|+++ .+|..+..++..++.|++++|++++..+
T Consensus 521 ~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 521 YSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999999999998 7888888887656779999999997655
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=546.57 Aligned_cols=517 Identities=21% Similarity=0.282 Sum_probs=307.7
Q ss_pred CcHHHHHHHHhcCCCCCCC--------CCCCCCCCCCCCCcee---eeeeeecCCCceEEEecCCCcccccCccchhhhc
Q 001226 25 PSAISLVQFLDSLPKQSQS--------HLPWNQSVSTSAPCKW---SGVSCYNNSSSLKALNLSGFGLSGVLNNSISYIC 93 (1119)
Q Consensus 25 ~~~~~ll~~~~~~~~~~~~--------~~~w~~~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~ 93 (1119)
.|+.||.+||+++.++... ..+|+. +++||.| .||+|+.. +||+.|+|++++++|.+|+. ++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~---~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~---l~ 102 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF---NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDA---IG 102 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCC---SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGG---GG
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC---CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChH---Hh
Confidence 4688999999998765322 236874 3689999 99999865 89999999999999998854 56
Q ss_pred cCCcccEEEcCCCcc------cC------CCCcccccCCCccEEEcccccccccCCccccc-cCccCEEEccCccccCCC
Q 001226 94 KNQHLLSLDLSGNEF------TG------SIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGKI 160 (1119)
Q Consensus 94 ~l~~l~~L~Ls~n~~------~~------~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~ 160 (1119)
++++|++|||++|.+ .| .+|... +..|+ +++++|.+.+.+|..++. +.++..+++....+...
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~- 178 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS- 178 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCC-
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccc-
Confidence 889999999999976 33 444444 56677 888888888877777764 44555555555443311
Q ss_pred Ccccccccccceeee--cccccccccCccCCCcccccEEEecccccccc-CCC-CCccccceeeeeeccccccCcccccc
Q 001226 161 PPQVSLCYSLESIGF--HNNFLNGELPNDICSLPKLKSLYLNTNNLTGL-LPE-FPNSCAILHLLIHENDFVGSLPTSLS 236 (1119)
Q Consensus 161 p~~l~~l~~L~~L~L--~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~~~-~~~~~~l~~l~l~~n~~~~~lp~~l~ 236 (1119)
....++.+.+ .+|++++ +|..|+++++|++|+|++|++++. ++. +... ..+...+.+|..++
T Consensus 179 -----~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~--------~~~~~~~~ip~~l~ 244 (636)
T 4eco_A 179 -----SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE--------NSEYAQQYKTEDLK 244 (636)
T ss_dssp -----CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT--------TSHHHHHHTTSCCC
T ss_pred -----cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc--------ccchhcccCchhhh
Confidence 1122333333 3678888 899999999999999999999873 111 0000 00111122455555
Q ss_pred --CCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCc-cCC-CcchhhcCCCCCceeeeccccccccCcccccCCC
Q 001226 237 --NCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN-LEG-QIPETLWGLENLQKLVLSANKLNGTISGQISHCN 312 (1119)
Q Consensus 237 --~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 312 (1119)
++++|++|++++|++.+.++ ..|.++++|++|+|++|+ +++ .+|..+..+. .+..++
T Consensus 245 ~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~------------------~~~~l~ 305 (636)
T 4eco_A 245 WDNLKDLTDVEVYNCPNLTKLP-TFLKALPEMQLINVACNRGISGEQLKDDWQALA------------------DAPVGE 305 (636)
T ss_dssp GGGCTTCCEEEEECCTTCSSCC-TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHH------------------HSGGGG
T ss_pred hcccCCCCEEEecCCcCCccCh-HHHhcCCCCCEEECcCCCCCccccchHHHHhhh------------------ccccCC
Confidence 55555555555555444332 334444444444444444 444 4444444330 000115
Q ss_pred CCcEEEccccccccccCc--ccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccc-ccee
Q 001226 313 QLQVIALSRNNLVGQIPR--SVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAK-LEVL 389 (1119)
Q Consensus 313 ~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~-L~~L 389 (1119)
+|++|+|++|+++ .+|. .++++++|++|++++|+++|.+| .++.+++|++|++++|+++ .+|..+..+++ |++|
T Consensus 306 ~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L 382 (636)
T 4eco_A 306 KIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENL 382 (636)
T ss_dssp TCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEE
T ss_pred CCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEE
Confidence 5555555555555 4554 55555555555555555555555 5555555555555555555 55555555655 6666
Q ss_pred eccCccccCCCCccccccC--cceEEEeecccccccCCcccc-------CCCCcCEEEccCccCcccchhhhhccCCccc
Q 001226 390 YLFNNRIEGAIPHQIGRMS--KLVELALYNNRLTGRIPPDIT-------RLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460 (1119)
Q Consensus 390 ~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~ 460 (1119)
++++|+++ .+|..+..++ +|++|++++|++++.+|..+. .+++|+.|+|++|+++ .+|..++..++.|+
T Consensus 383 ~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~ 460 (636)
T 4eco_A 383 SFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLS 460 (636)
T ss_dssp ECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCS
T ss_pred EccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCC
Confidence 66666665 4455554433 566666666666666666555 5666667777777666 45555555566666
Q ss_pred eeccccceeeCccCCcccc--------ccccceeeccCccccCCCCcccc--ccccccEEEeccCccccCCCccccCCCC
Q 001226 461 RLDLTGNSFYGPIPANICV--------GTNLFVLVLGNNRFNGSFPIEIG--KCSSLRRVILSNNLLQGSLPATLERNPG 530 (1119)
Q Consensus 461 ~L~L~~N~l~~~~p~~~~~--------~~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 530 (1119)
+|+|++|+++ .+|..... +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++
T Consensus 461 ~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~ 537 (636)
T 4eco_A 461 SINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537 (636)
T ss_dssp EEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSS
T ss_pred EEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCC
Confidence 6666666666 44433222 114555555555554 3444443 44555555555555543 4444444444
Q ss_pred cceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccC
Q 001226 531 VSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD 610 (1119)
Q Consensus 531 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 610 (1119)
|+.|++++|+ ++++|++.+.+|..|+++++|++|+|++|++ +.+|..+. ++|+.|||++
T Consensus 538 L~~L~Ls~N~------------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~ 596 (636)
T 4eco_A 538 LKGFGIRNQR------------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKD 596 (636)
T ss_dssp CCEEECCSCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCS
T ss_pred CCEEECCCCc------------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcC
Confidence 4444444433 3356667777777777777777777777777 46666654 6777777777
Q ss_pred cccc
Q 001226 611 NYLA 614 (1119)
Q Consensus 611 N~l~ 614 (1119)
|++.
T Consensus 597 N~l~ 600 (636)
T 4eco_A 597 NPNI 600 (636)
T ss_dssp CTTC
T ss_pred CCCc
Confidence 7665
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=546.26 Aligned_cols=531 Identities=21% Similarity=0.195 Sum_probs=376.0
Q ss_pred ceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCC-CcccccCCCccEEEccccccccc
Q 001226 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSI-PKQLGNCGQLKTLLLNDNRFQGS 135 (1119)
Q Consensus 57 c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~-~~~l~~l~~L~~L~L~~n~i~~~ 135 (1119)
|+|+.|.+ ...+++.|+|+++.+++..+.. +..+++|++|||++|.+.+.+ |..|+++++|++|+|++|++++.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~---~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~ 88 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASS---FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL 88 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSS---CSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhH---CcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc
Confidence 67888888 4578999999999999887654 568899999999999777666 78899999999999999999999
Q ss_pred CCccccccCccCEEEccCccccCCCCcc--cccccccceeeecccccccccC-ccCCCcccccEEEeccccccccCCCCC
Q 001226 136 IPPEIFKLKRLSWLDLGYNSLSGKIPPQ--VSLCYSLESIGFHNNFLNGELP-NDICSLPKLKSLYLNTNNLTGLLPEFP 212 (1119)
Q Consensus 136 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~--l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~ 212 (1119)
.|..++++++|++|+|++|.+++.+|.. ++++++|++|+|++|.+++..+ ..|+++++|++|++++|++++..
T Consensus 89 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~---- 164 (844)
T 3j0a_A 89 HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVC---- 164 (844)
T ss_dssp CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCC----
T ss_pred CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeC----
Confidence 9999999999999999999999877765 9999999999999999998765 57999999999999999988543
Q ss_pred ccccceeeeeeccccccCccccccCC--CCCcEEEccCCccCCccChhhhhcCC------CccEEEcCCCccCCCcchhh
Q 001226 213 NSCAILHLLIHENDFVGSLPTSLSNC--RNLVEFSASSNNFGGAISPWIFKGLL------QLEVLYLDDNNLEGQIPETL 284 (1119)
Q Consensus 213 ~~~~l~~l~l~~n~~~~~lp~~l~~l--~~L~~L~l~~n~i~~~~~~~~~~~l~------~L~~L~L~~n~l~~~~p~~l 284 (1119)
+..+..+ ++|+.|+++.|.+.+.++.. +..+. .|++|++++|++++..+..+
T Consensus 165 -------------------~~~l~~l~~~~L~~L~L~~n~l~~~~~~~-~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 224 (844)
T 3j0a_A 165 -------------------EHELEPLQGKTLSFFSLAANSLYSRVSVD-WGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224 (844)
T ss_dssp -------------------SGGGHHHHHCSSCCCEECCSBSCCCCCCC-CCSSSCTTTTCCBSEEBCSSCCSSTTTTSGG
T ss_pred -------------------HHHcccccCCccceEECCCCccccccccc-hhhcCCccccCceeEEecCCCcCchhHHHHH
Confidence 3455555 78999999999998755432 33333 49999999999998888887
Q ss_pred cCC---CCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCC--CCCCeEEccCCcccCCCCCCCCCC
Q 001226 285 WGL---ENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNL--SSLNSLLLFNNRLQGTLPPELGNC 359 (1119)
Q Consensus 285 ~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~l~~l 359 (1119)
... .+++.|.++.+.+.. ++..+.+.+..+..|..+ ++|+.|++++|.+++..+..|..+
T Consensus 225 ~~~l~~~~l~~L~l~~~~~~~---------------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l 289 (844)
T 3j0a_A 225 SNAISKSQAFSLILAHHIMGA---------------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289 (844)
T ss_dssp GGTSCSCCBSEEECCSSCCBC---------------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSC
T ss_pred HhhcCcccccceecccccccc---------------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcC
Confidence 653 678888887554431 122334443444445444 567777777777776667777777
Q ss_pred CCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEc
Q 001226 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSL 439 (1119)
Q Consensus 360 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 439 (1119)
++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|..+++|+.|+|
T Consensus 290 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 369 (844)
T 3j0a_A 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369 (844)
T ss_dssp CCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEE
T ss_pred CCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEEC
Confidence 77777777777777776777777777777777777777777777777777777777777777666666777777777777
Q ss_pred cCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCC-CccccccccccEEEeccCccc
Q 001226 440 AHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF-PIEIGKCSSLRRVILSNNLLQ 518 (1119)
Q Consensus 440 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 518 (1119)
++|.+++. + .++.|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+.++++|+.|+|++|+++
T Consensus 370 s~N~l~~i-~-----~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~ 439 (844)
T 3j0a_A 370 RDNALTTI-H-----FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439 (844)
T ss_dssp ETCCSCCC-S-----SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCC
T ss_pred CCCCCCcc-c-----CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCccc
Confidence 77777632 1 1566666777766665 33332 345666666666666421 122345566666666666665
Q ss_pred cCCCc-cccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCccc
Q 001226 519 GSLPA-TLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL 597 (1119)
Q Consensus 519 ~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 597 (1119)
+..+. .+..+++|+.|++++|.+++..+ .+..|..|.++++|+.|+|++|++++..|..|
T Consensus 440 ~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 500 (844)
T 3j0a_A 440 SCSGDQTPSENPSLEQLFLGENMLQLAWE-------------------TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500 (844)
T ss_dssp CCCSSSSSCSCTTCCBCEEESCCCSSSCC-------------------SCCCSSCSSCBCCEECCCCCHHHHTTCCTTSS
T ss_pred ccccccccccCCccccccCCCCccccccc-------------------cccchhhhcCcccccEEECCCCcccccChhHc
Confidence 43322 23334444444444444431111 02334556666666666666666666666666
Q ss_pred ccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCc
Q 001226 598 GKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665 (1119)
Q Consensus 598 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 665 (1119)
..+++|+.|||++|+|++..|..+. ++|+.|+|++|+|++.+|+.|. +|+.|++++|++...-
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICEC 563 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSS
T ss_pred cchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCccccc
Confidence 6666666666666666654444443 5677777777777766666654 5667777777776543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=537.98 Aligned_cols=526 Identities=19% Similarity=0.217 Sum_probs=301.1
Q ss_pred CCcHHHHHHHHhcCCCCCCCCCCCCCCC--CCCCC--cee------------eeeeeecCCCceEEEecCCCcccccCcc
Q 001226 24 PPSAISLVQFLDSLPKQSQSHLPWNQSV--STSAP--CKW------------SGVSCYNNSSSLKALNLSGFGLSGVLNN 87 (1119)
Q Consensus 24 ~~~~~~ll~~~~~~~~~~~~~~~w~~~~--~~~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~~~~~~ 87 (1119)
.+|+.||++||+++.++ +|+.+. ...+| |+| .||+|+. .+||+.|+|+++++.|.+|+
T Consensus 268 ~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred hHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 45789999999999664 887543 01345 999 9999986 58999999999999999985
Q ss_pred chhhhccCCcccEEEc-CCCcccCCCCcccccC----CCcc--EE---------Ec-cccccccc-----------CCcc
Q 001226 88 SISYICKNQHLLSLDL-SGNEFTGSIPKQLGNC----GQLK--TL---------LL-NDNRFQGS-----------IPPE 139 (1119)
Q Consensus 88 ~~~~~~~l~~l~~L~L-s~n~~~~~~~~~l~~l----~~L~--~L---------~L-~~n~i~~~-----------~p~~ 139 (1119)
. ++++++|++||| ++|.++|..|...... ...+ .+ +. ....+.+. .+..
T Consensus 342 ~---l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 342 A---IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp G---GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred H---HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 4 568899999999 9999988744331111 0000 00 00 00011100 0111
Q ss_pred ccccCccCEEEccC--ccccCCCCcccccccccceeeecccccccc-cCccCCCcccccEEEeccccccccCCCCCcccc
Q 001226 140 IFKLKRLSWLDLGY--NSLSGKIPPQVSLCYSLESIGFHNNFLNGE-LPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCA 216 (1119)
Q Consensus 140 l~~l~~L~~L~Ls~--n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 216 (1119)
......++.+.++. |++++ +|..++++++|++|+|++|.++++ ++..... .+.|.++
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~--------~s~n~~~----------- 478 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED--------ANSDYAK----------- 478 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC--------TTSHHHH-----------
T ss_pred cccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccc--------ccccccc-----------
Confidence 12233445555544 78887 788888888888888888888872 2211111 0112221
Q ss_pred ceeeeeeccccccCcccccc--CCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCc-cCC-CcchhhcCCCCCce
Q 001226 217 ILHLLIHENDFVGSLPTSLS--NCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN-LEG-QIPETLWGLENLQK 292 (1119)
Q Consensus 217 l~~l~l~~n~~~~~lp~~l~--~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~ 292 (1119)
+.+|..++ ++++|++|++++|++.+.++ ..|.++++|++|+|++|+ +++ .+|..+..++
T Consensus 479 ------------g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP-~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~---- 541 (876)
T 4ecn_A 479 ------------QYENEELSWSNLKDLTDVELYNCPNMTQLP-DFLYDLPELQSLNIACNRGISAAQLKADWTRLA---- 541 (876)
T ss_dssp ------------HHTTSCCCGGGCTTCCEEEEESCTTCCSCC-GGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHH----
T ss_pred ------------ccCChhhhhccCCCCCEEECcCCCCCccCh-HHHhCCCCCCEEECcCCCCcccccchHHHHhhh----
Confidence 23333433 44444444444444333322 334444555555555554 554 4555444332
Q ss_pred eeeccccccccCcccccCCCCCcEEEccccccccccCc--ccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccC
Q 001226 293 LVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPR--SVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHN 370 (1119)
Q Consensus 293 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 370 (1119)
..+..+++|++|+|++|+++ .+|. .++++++|+.|+|++|+++ .+| .|+.+++|+.|+|++|
T Consensus 542 -------------~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N 605 (876)
T 4ecn_A 542 -------------DDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYN 605 (876)
T ss_dssp -------------HCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSS
T ss_pred -------------hcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCC
Confidence 01222335555555555555 4454 5555555555555555555 444 5555555666666666
Q ss_pred cCcccCchhhhcccc-cceeeccCccccCCCCccccccCc--ceEEEeecccccccCCcc---cc--CCCCcCEEEccCc
Q 001226 371 FIGGTIPPEICNLAK-LEVLYLFNNRIEGAIPHQIGRMSK--LVELALYNNRLTGRIPPD---IT--RLRNLQFLSLAHN 442 (1119)
Q Consensus 371 ~i~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~---~~--~l~~L~~L~L~~N 442 (1119)
+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.|++++|++++.+|.. +. .+++|+.|+|++|
T Consensus 606 ~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N 683 (876)
T 4ecn_A 606 QIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYN 683 (876)
T ss_dssp CCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSS
T ss_pred ccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCC
Confidence 555 55555555555 666666666665 44555554433 666666666666544321 12 3346777777777
Q ss_pred cCcccchhhhhccCCccceeccccceeeCccCCccccc--------cccceeeccCccccCCCCcccc--ccccccEEEe
Q 001226 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG--------TNLFVLVLGNNRFNGSFPIEIG--KCSSLRRVIL 512 (1119)
Q Consensus 443 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~--------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L 512 (1119)
+++ .+|..++..++.|+.|+|++|+++ .+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|
T Consensus 684 ~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~L 760 (876)
T 4ecn_A 684 EIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDV 760 (876)
T ss_dssp CCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEEC
T ss_pred cCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEe
Confidence 776 566666666677777777777776 444433321 24555555555555 4444444 4555555555
Q ss_pred ccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCc
Q 001226 513 SNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR 592 (1119)
Q Consensus 513 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 592 (1119)
++|++++ +|..+..+++|+.|+|++|+ ++++|++.+.+|..|.++++|+.|+|++|++ +.
T Consensus 761 s~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~ 820 (876)
T 4ecn_A 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RK 820 (876)
T ss_dssp CSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CB
T ss_pred CCCCCCc-cchhhhcCCCCCEEECCCCC------------------CcccccccccChHHHhcCCCCCEEECCCCCC-Cc
Confidence 5555554 34444444444444444443 3445677777777777777777777777777 46
Q ss_pred CCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCc
Q 001226 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLS 638 (1119)
Q Consensus 593 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 638 (1119)
+|..+. ++|+.|||++|++....+..+.....+..+.|.+|++.
T Consensus 821 Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 821 VDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp CCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred cCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 776654 47777777777776555566655556666666666654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=498.37 Aligned_cols=513 Identities=21% Similarity=0.162 Sum_probs=369.8
Q ss_pred EecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccC
Q 001226 74 LNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGY 153 (1119)
Q Consensus 74 l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~ 153 (1119)
+++++.+++.++... .+++++|||++|.+++..+..|.++++|++|+|++|++++..|..++++++|++|+|++
T Consensus 12 ~~c~~~~l~~ip~~l------~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 85 (570)
T 2z63_A 12 YQCMELNFYKIPDNL------PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85 (570)
T ss_dssp EECCSSCCSSCCSSS------CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred EEeCCCCccccCCCc------cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence 455555666544311 14566677777766665566666666666666666666655555666666666666666
Q ss_pred ccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccc
Q 001226 154 NSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPT 233 (1119)
Q Consensus 154 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~ 233 (1119)
|.+++..|..|+++++|++|++++|.+++..+..++++++|++|+++
T Consensus 86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~--------------------------------- 132 (570)
T 2z63_A 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA--------------------------------- 132 (570)
T ss_dssp CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECC---------------------------------
T ss_pred CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecC---------------------------------
Confidence 66665444555555555555555555444433344444444444444
Q ss_pred cccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCC----ceeeeccccccccCccccc
Q 001226 234 SLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENL----QKLVLSANKLNGTISGQIS 309 (1119)
Q Consensus 234 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L----~~L~Ls~N~l~~~~~~~~~ 309 (1119)
+|.+.+.-.+..|.++++|++|++++|++++..|..+..+++| ++|++++|.++++.+..|.
T Consensus 133 --------------~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~ 198 (570)
T 2z63_A 133 --------------HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK 198 (570)
T ss_dssp --------------SSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTT
T ss_pred --------------CCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhc
Confidence 4444332224556778889999999999988888888888888 7888999988888887777
Q ss_pred CCCCCcEEEcccccccc-ccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhccc--cc
Q 001226 310 HCNQLQVIALSRNNLVG-QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA--KL 386 (1119)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~--~L 386 (1119)
.+ +|++|++++|.... .++..+..+++++.+.+....+.. ..+++ .+. ...+..++ .+
T Consensus 199 ~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~--------~~~l~--~~~--------~~~~~~l~~l~l 259 (570)
T 2z63_A 199 EI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN--------EGNLE--KFD--------KSALEGLCNLTI 259 (570)
T ss_dssp TC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC--------CSSCE--ECC--------TTTTGGGGGSEE
T ss_pred cC-cceeEecccccccccchhhhhcCccccceeeeccccccC--------chhhh--hcc--------hhhhccccccch
Confidence 66 78888888875432 345556677777766655433221 11111 111 11222222 35
Q ss_pred ceeeccCc-cccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccc
Q 001226 387 EVLYLFNN-RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLT 465 (1119)
Q Consensus 387 ~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 465 (1119)
+.+++++| .+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.++ .+|. ..++.|+.|+++
T Consensus 260 ~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~---~~l~~L~~L~l~ 333 (570)
T 2z63_A 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT---LKLKSLKRLTFT 333 (570)
T ss_dssp EEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB---CBCSSCCEEEEE
T ss_pred hhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc---ccccccCEEeCc
Confidence 66667666 666677777777778888888888777 567777777 7888888888776 4443 356778888888
Q ss_pred cceeeCccCCccccccccceeeccCccccCCC--CccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCC
Q 001226 466 GNSFYGPIPANICVGTNLFVLVLGNNRFNGSF--PIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQG 543 (1119)
Q Consensus 466 ~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 543 (1119)
+|.+.+..+. ..+++|+.|++++|++++.. |..+.++++|++|++++|.+.+..+. +..+++|+.|++++|++.+
T Consensus 334 ~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~ 410 (570)
T 2z63_A 334 SNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQ 410 (570)
T ss_dssp SCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEES
T ss_pred CCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCcccc
Confidence 8877766554 56788888888888887543 67788889999999999998865554 8889999999999999987
Q ss_pred CCC-ccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCccc-CcCCcccccCCCCcEEeccCccccccCChhh
Q 001226 544 SIP-PVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD-GRIPYELGKCTKMIKLDLSDNYLAGSIPSEV 621 (1119)
Q Consensus 544 ~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 621 (1119)
..| ..+..+++|++|++++|++++..|..|.++++|++|+|++|++. +.+|..+..+++|++|+|++|++++..|..+
T Consensus 411 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 411 MSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp CTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 766 57888999999999999999888999999999999999999997 5789999999999999999999998889999
Q ss_pred hhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccc
Q 001226 622 ISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPC 667 (1119)
Q Consensus 622 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 667 (1119)
..+++|++|+|++|++++.+|..|..+++|+.|++++|++++..|.
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999999999988888899999999999999999887764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=495.60 Aligned_cols=499 Identities=20% Similarity=0.203 Sum_probs=432.8
Q ss_pred CccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCccccc
Q 001226 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQIS 309 (1119)
Q Consensus 230 ~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 309 (1119)
.+|..+. +++++|++++|+++ .+.+..|.++++|++|+|++|++++..|.+|.++++|++|+|++|++++..+..|.
T Consensus 21 ~ip~~l~--~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (570)
T 2z63_A 21 KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97 (570)
T ss_dssp SCCSSSC--SSCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred ccCCCcc--ccccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhc
Confidence 3444432 47899999999987 45677889999999999999999988888999999999999999999998889999
Q ss_pred CCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccC-CCCCCCCCCCCCcEEEcccCcCcccCchhhhccccc--
Q 001226 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQG-TLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKL-- 386 (1119)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L-- 386 (1119)
.+++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..+..+++|
T Consensus 98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 177 (570)
T 2z63_A 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177 (570)
T ss_dssp TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTT
T ss_pred CccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccch
Confidence 99999999999999997666679999999999999999986 368899999999999999999998888889999888
Q ss_pred --ceeeccCccccCCCCccccccCcceEEEeecccccc-cCCccccCCCCcCEEEccCccCcc-----cchhhhhccCC-
Q 001226 387 --EVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG-RIPPDITRLRNLQFLSLAHNHLTG-----EVALELGKHFP- 457 (1119)
Q Consensus 387 --~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~-----~~~~~~~~~l~- 457 (1119)
+.|++++|.+++..|..+... +|+.|++++|.... .++..+..+++++.+.+..+.+.. .++...+..++
T Consensus 178 ~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~ 256 (570)
T 2z63_A 178 LNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256 (570)
T ss_dssp CCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGG
T ss_pred hhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccc
Confidence 899999999998888888766 89999999986442 345567778888777665443321 12222222333
Q ss_pred -ccceeccccc-eeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceee
Q 001226 458 -YLSRLDLTGN-SFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535 (1119)
Q Consensus 458 -~L~~L~L~~N-~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (1119)
.++.+++++| .+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|+
T Consensus 257 l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~ 331 (570)
T 2z63_A 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLT 331 (570)
T ss_dssp SEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEE
T ss_pred cchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEe
Confidence 3677888888 889999999999999999999999999 688889998 9999999999998 5555 5789999999
Q ss_pred ccCcccCCCCCccccccccceEEeccCCcccCCC--CCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccc
Q 001226 536 VRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSI--PSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613 (1119)
Q Consensus 536 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 613 (1119)
+++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|++.+. |..+..+++|++|++++|++
T Consensus 332 l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l 408 (570)
T 2z63_A 332 FTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNL 408 (570)
T ss_dssp EESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEE
T ss_pred CcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEEccCCcc
Confidence 999999877665 78899999999999998654 78899999999999999999954 44599999999999999999
Q ss_pred cccCC-hhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccC-CCccccchhhccccceeeeccccccCCcc
Q 001226 614 AGSIP-SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD-GSIPCSLSKLHHFSSILNVSNNKLSGKIP 691 (1119)
Q Consensus 614 ~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~~~~~L~ls~N~l~~~~p 691 (1119)
++..| ..+..+++|++|++++|++++.+|..|..+++|++|+|++|.++ +.+|..+..++.+. .|++++|++++..|
T Consensus 409 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~-~L~l~~n~l~~~~~ 487 (570)
T 2z63_A 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSP 487 (570)
T ss_dssp ESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC-EEECTTSCCCEECT
T ss_pred ccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC-EEECCCCccccCCh
Confidence 98766 57889999999999999999999999999999999999999998 68998888888764 69999999999889
Q ss_pred cccccccccceeeccCceecccCCccccccccceEEecccccccccCCCc
Q 001226 692 ECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPAS 741 (1119)
Q Consensus 692 ~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~~ 741 (1119)
..|+++++|++|+|++|++++.+|..+..+++|+.+++++|+++|.+|..
T Consensus 488 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 488 TAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 99999999999999999999888888999999999999999999999963
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=492.95 Aligned_cols=494 Identities=19% Similarity=0.235 Sum_probs=294.1
Q ss_pred CceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEccccccccc
Q 001226 56 PCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGS 135 (1119)
Q Consensus 56 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~ 135 (1119)
.|.|.|| |+- ++++++.+++.. .++|++|+|++|.+++..|..|+++++|++|+|++|++++.
T Consensus 3 ~C~~~~~-c~~----------~~~~l~~ip~~~------~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~ 65 (549)
T 2z81_A 3 SCDASGV-CDG----------RSRSFTSIPSGL------TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65 (549)
T ss_dssp EECTTSE-EEC----------TTSCCSSCCSCC------CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEE
T ss_pred cCCCCce-EEC----------CCCccccccccC------CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCcc
Confidence 5999999 963 345565544321 26788888888888877778888888888888888888877
Q ss_pred CCccccccCccCEEEccCccccCCCCcccccccccceeeecccccccc-cCccCCCcccccEEEeccccccccCCCCCcc
Q 001226 136 IPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGE-LPNDICSLPKLKSLYLNTNNLTGLLPEFPNS 214 (1119)
Q Consensus 136 ~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~ 214 (1119)
.|..++.+++|++|||++|.+++..|..++++++|++|++++|.+++. .|..++++++|++|++++|++.
T Consensus 66 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~--------- 136 (549)
T 2z81_A 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF--------- 136 (549)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSC---------
T ss_pred ChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccc---------
Confidence 777888888888888888888866666677777777777777776652 4556666666666666666532
Q ss_pred ccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceee
Q 001226 215 CAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLV 294 (1119)
Q Consensus 215 ~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 294 (1119)
+.+++..|.++++|++|++++|++++..|..+..+++|++|+
T Consensus 137 --------------------------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 178 (549)
T 2z81_A 137 --------------------------------------SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178 (549)
T ss_dssp --------------------------------------CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEE
T ss_pred --------------------------------------cccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEe
Confidence 222233444455555566666666655666666666666666
Q ss_pred eccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcc
Q 001226 295 LSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGG 374 (1119)
Q Consensus 295 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~ 374 (1119)
+++|.+.......+..+++|++|++++|++++.... .......+++|+.|++++|.+++
T Consensus 179 l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---------------------~~~~~~~~~~L~~L~l~~n~l~~ 237 (549)
T 2z81_A 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS---------------------PLPVDEVSSPMKKLAFRGSVLTD 237 (549)
T ss_dssp EECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCC---------------------CCSSCCCCCCCCEEEEESCEEEH
T ss_pred cccCcccccchhhHhhcccccEEEccCCcccccccc---------------------ccchhhhhhcccceeccccccch
Confidence 666655533333334455555555555555432100 00011123334444444444433
Q ss_pred cCch----hhhcccccceeeccCccccCCC------CccccccCcceEEEeeccccccc-----CCccccCCCCcCEEEc
Q 001226 375 TIPP----EICNLAKLEVLYLFNNRIEGAI------PHQIGRMSKLVELALYNNRLTGR-----IPPDITRLRNLQFLSL 439 (1119)
Q Consensus 375 ~~~~----~l~~l~~L~~L~L~~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L 439 (1119)
..+. .+..+++|+.+++++|.+.+.. ...+..+++|+.|++.++.+... .+..+....+|+.|++
T Consensus 238 ~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l 317 (549)
T 2z81_A 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV 317 (549)
T ss_dssp HHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEE
T ss_pred hHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEe
Confidence 2222 1223344444444444443321 11223344445555555443311 1111122234444444
Q ss_pred cCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCcccc
Q 001226 440 AHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQG 519 (1119)
Q Consensus 440 ~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 519 (1119)
++|+++ .+|..++..+++|++|++++|++++.+|.. +..++.+++|+.|++++|++++
T Consensus 318 ~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~---------------------~~~~~~l~~L~~L~Ls~N~l~~ 375 (549)
T 2z81_A 318 ENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN---------------------SACKGAWPSLQTLVLSQNHLRS 375 (549)
T ss_dssp ESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHH---------------------HTCTTSSTTCCEEECTTSCCCC
T ss_pred ccCccc-cCCHHHHhcCccccEEEccCCccccccccc---------------------hhhhhccccCcEEEccCCcccc
Confidence 444443 333333333444444444444443322210 1224455566666666666654
Q ss_pred CCC--ccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCccc
Q 001226 520 SLP--ATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL 597 (1119)
Q Consensus 520 ~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 597 (1119)
..+ ..+..+++|++|++++|+++ .+|..+..+++|++|+|++|+++ .+|..+. ++|++|+|++|++++.+
T Consensus 376 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~---- 447 (549)
T 2z81_A 376 MQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS---- 447 (549)
T ss_dssp HHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----
T ss_pred cccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----
Confidence 322 34566666666666666666 46666677777777777777776 4454443 57888888888887532
Q ss_pred ccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCcc
Q 001226 598 GKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP 666 (1119)
Q Consensus 598 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 666 (1119)
..+++|++|||++|+|+ .+|. ...+++|++|+|++|++++.+|..|..+++|+.|++++|++.+..|
T Consensus 448 ~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 448 LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 46788888888888887 5665 4677888888888888888888888888888888888888887766
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=480.87 Aligned_cols=471 Identities=20% Similarity=0.198 Sum_probs=301.0
Q ss_pred CCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEE
Q 001226 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318 (1119)
Q Consensus 239 ~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (1119)
++|++|++++|+++ .+.+..|.++++|++|+|++|++++..|++|.++++|++|+|++|++++.++..|+.+++|++|+
T Consensus 26 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 104 (549)
T 2z81_A 26 AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104 (549)
T ss_dssp TTCCEEECCSSCCC-EECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEE
T ss_pred CCccEEECcCCccC-ccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEE
Confidence 56777777777776 34455677777777777777777777777777777777777777777777777777777777777
Q ss_pred cccccccc-ccCcccCCCCCCCeEEccCCc-ccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccc
Q 001226 319 LSRNNLVG-QIPRSVGNLSSLNSLLLFNNR-LQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRI 396 (1119)
Q Consensus 319 Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l 396 (1119)
|++|.+++ ..|..++++++|++|++++|. ++...+..+.++++|++|++++|.+++..|..+..+++|+.|++++|.+
T Consensus 105 Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp CTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred CCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 77777775 245667777777777777777 3333335677777777777777777777777777777777777777777
Q ss_pred cCCCCccccccCcceEEEeecccccccC--C-ccccCCCCcCEEEccCccCcccchhhhh---ccCCccceeccccceee
Q 001226 397 EGAIPHQIGRMSKLVELALYNNRLTGRI--P-PDITRLRNLQFLSLAHNHLTGEVALELG---KHFPYLSRLDLTGNSFY 470 (1119)
Q Consensus 397 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~---~~l~~L~~L~L~~N~l~ 470 (1119)
.......+..+++|++|++++|++++.. | .....+++|+.|++++|.+++..+..+. ..++.|+.+++++|.+.
T Consensus 185 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~ 264 (549)
T 2z81_A 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264 (549)
T ss_dssp TTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEE
T ss_pred cccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccc
Confidence 6433333355777777777777777532 1 1234566777777777777665544432 34556677777777665
Q ss_pred CccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccC-----CCccccCCCCcceeeccCcccCCCC
Q 001226 471 GPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS-----LPATLERNPGVSFLDVRGNLLQGSI 545 (1119)
Q Consensus 471 ~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~~ 545 (1119)
+...-.. .....+..+.+|+.|++.++.+... ++..+...++|+.|++++|++. .+
T Consensus 265 ~~~~~~~------------------~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~i 325 (549)
T 2z81_A 265 GLGDFNP------------------SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325 (549)
T ss_dssp CCSCCCC------------------CTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CC
T ss_pred ccccccc------------------cchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cC
Confidence 4311000 0011223344455555555443321 1111223345566666666654 34
Q ss_pred Cccc-cccccceEEeccCCcccCCCC---CccCCcccccEEEcccCcccCcCC--cccccCCCCcEEeccCccccccCCh
Q 001226 546 PPVF-GFWSNLTMLDFSENRLSGSIP---SELGNLENLQILRLSANKLDGRIP--YELGKCTKMIKLDLSDNYLAGSIPS 619 (1119)
Q Consensus 546 p~~~-~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~ 619 (1119)
|..+ ..+++|++|+|++|++++.+| ..++.+++|++|+|++|++++..+ ..+..+++|++|||++|+++ .+|.
T Consensus 326 p~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~ 404 (549)
T 2z81_A 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPD 404 (549)
T ss_dssp CHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCS
T ss_pred CHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCCh
Confidence 4433 345666666666666665442 235556666666666666653221 33556666666666666665 4565
Q ss_pred hhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccc
Q 001226 620 EVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDK 699 (1119)
Q Consensus 620 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~ 699 (1119)
.+..+++|++|+|++|+++ .+|..+. ++|+.|+|++|++++.+ . .++.+ +.|++++|+|+ .+|. .+.+++
T Consensus 405 ~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~-~---~l~~L-~~L~Ls~N~l~-~ip~-~~~l~~ 474 (549)
T 2z81_A 405 SCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS-L---FLPRL-QELYISRNKLK-TLPD-ASLFPV 474 (549)
T ss_dssp CCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC-C---CCTTC-CEEECCSSCCS-SCCC-GGGCTT
T ss_pred hhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc-c---cCChh-cEEECCCCccC-cCCC-cccCcc
Confidence 6666666666666666665 2333332 45666666666666532 2 22222 34777777777 6776 467889
Q ss_pred cceeeccCceecccCCccccccccceEEecccccccccCCC
Q 001226 700 LQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPA 740 (1119)
Q Consensus 700 L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~ 740 (1119)
|+.|||++|+|++.+|..+..+++|+.+++++|+++|..|.
T Consensus 475 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 475 LLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred CCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 99999999999988888899999999999999999998884
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=498.74 Aligned_cols=450 Identities=19% Similarity=0.278 Sum_probs=249.1
Q ss_pred CccEEEcCCCccCCCcchhhcCCCCCceeeecccccc------c------cCcccccCCCCCcEEEccccccccccCccc
Q 001226 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN------G------TISGQISHCNQLQVIALSRNNLVGQIPRSV 332 (1119)
Q Consensus 265 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~------~------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 332 (1119)
+++.|+|++|+++|.+|.+++++++|++|+|++|.+. + .+|... +..|+ +++++|.+.+.+|..+
T Consensus 82 ~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~ 158 (636)
T 4eco_A 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDF 158 (636)
T ss_dssp CEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGS
T ss_pred CEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhH
Confidence 4566666666666666666666666666666666541 1 111111 23344 5555555555555444
Q ss_pred CCC-CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcc--cCcCcccCchhhhcccccceeeccCccccCC----------
Q 001226 333 GNL-SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ--HNFIGGTIPPEICNLAKLEVLYLFNNRIEGA---------- 399 (1119)
Q Consensus 333 ~~l-~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~--~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~---------- 399 (1119)
..+ ..+..+++....+.. .....++.+.+. +|++++ +|..++++++|++|+|++|++++.
T Consensus 159 ~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~ 231 (636)
T 4eco_A 159 SDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN 231 (636)
T ss_dssp CHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred HHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccc
Confidence 321 112222222111110 011112222222 344444 455555555555555555555543
Q ss_pred -------CCcccc--ccCcceEEEeecccccccCCccccCCCCcCEEEccCcc-Ccc-cchhhhhc-----cCCccceec
Q 001226 400 -------IPHQIG--RMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNH-LTG-EVALELGK-----HFPYLSRLD 463 (1119)
Q Consensus 400 -------~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~-----~l~~L~~L~ 463 (1119)
+|..++ ++++|++|++++|++.+.+|..+.++++|++|++++|+ ++| .+|..+.. .+++|++|+
T Consensus 232 ~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~ 311 (636)
T 4eco_A 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311 (636)
T ss_dssp SHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEE
T ss_pred cchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEE
Confidence 455555 55555555555555555555555555555555555555 554 44444432 125555555
Q ss_pred cccceeeCccCC--ccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCC-cceeeccCcc
Q 001226 464 LTGNSFYGPIPA--NICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPG-VSFLDVRGNL 540 (1119)
Q Consensus 464 L~~N~l~~~~p~--~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~l~~N~ 540 (1119)
+++|+++ .+|. .+..+++|+.|++++|+++|.+| .++.+++|++|++++|+++ .+|..+..+++ |+.|++++|+
T Consensus 312 L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 388 (636)
T 4eco_A 312 IGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNK 388 (636)
T ss_dssp CCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSC
T ss_pred CCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCc
Confidence 5555555 4555 55555555555555555555555 5555555555555555555 45555555555 5555555555
Q ss_pred cCCCCCccccccc--cceEEeccCCcccCCCCCccC-------CcccccEEEcccCcccCcCCcc-cccCCCCcEEeccC
Q 001226 541 LQGSIPPVFGFWS--NLTMLDFSENRLSGSIPSELG-------NLENLQILRLSANKLDGRIPYE-LGKCTKMIKLDLSD 610 (1119)
Q Consensus 541 l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~ 610 (1119)
++ .+|..++.++ +|++|+|++|++++.+|..|. .+++|+.|+|++|++. .+|.. +..+++|++|+|++
T Consensus 389 l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 389 LK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCS
T ss_pred Cc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCC
Confidence 55 4555544433 555555555555555555555 4555555555555555 33332 33355555555555
Q ss_pred ccccccCChhhhhc--------ccCCeeEccCccCccCCCcccc--ccccccEeecCCcccCCCccccchhhccccceee
Q 001226 611 NYLAGSIPSEVISL--------EKMQSLSLQENNLSGAIPDAFS--SVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILN 680 (1119)
Q Consensus 611 N~l~~~~p~~~~~l--------~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ 680 (1119)
|+++ .+|..+... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..++.++.+. .|+
T Consensus 467 N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~-~L~ 542 (636)
T 4eco_A 467 NMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK-GFG 542 (636)
T ss_dssp SCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCC-EEE
T ss_pred CCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCC-EEE
Confidence 5555 344332221 15555555555555 4555554 55555555555555554 555555554442 355
Q ss_pred e------ccccccCCcccccccccccceeeccCceecccCCccccccccceEEecccccccc
Q 001226 681 V------SNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736 (1119)
Q Consensus 681 l------s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g 736 (1119)
+ ++|++.+.+|..++++++|+.|||++|+| +.||..+. ++|+.||+++|++..
T Consensus 543 Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred CCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 5 67899999999999999999999999999 69999876 799999999998764
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=474.89 Aligned_cols=553 Identities=20% Similarity=0.128 Sum_probs=374.8
Q ss_pred CCCCCCCCCCCCCCceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCc
Q 001226 43 SHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQL 122 (1119)
Q Consensus 43 ~~~~w~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L 122 (1119)
.+.+|+.+ -|..|....|.... +..++++.+++.+++.. -+++++|||++|.|++..+..|.++++|
T Consensus 12 ~~~~~~~~----~p~~~~~c~~~~~~---~~~~c~~~~l~~vP~~l------p~~~~~LdLs~N~i~~l~~~~f~~l~~L 78 (635)
T 4g8a_A 12 KLAAANSS----IPESWEPCVEVVPN---ITYQCMELNFYKIPDNL------PFSTKNLDLSFNPLRHLGSYSFFSFPEL 78 (635)
T ss_dssp -----------------CCSEEEETT---TEEECTTSCCSSCCSSS------CTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhhcccCC----CCCCCCCccccCCC---CEEECCCCCcCccCCCC------CcCCCEEEeeCCCCCCCCHHHHhCCCCC
Confidence 45566643 24556554554321 23577888888776532 1489999999999997777889999999
Q ss_pred cEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccc
Q 001226 123 KTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN 202 (1119)
Q Consensus 123 ~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n 202 (1119)
++|+|++|+|++..|.+|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|++++|
T Consensus 79 ~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N 158 (635)
T 4g8a_A 79 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 158 (635)
T ss_dssp CEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccC
Confidence 99999999999877888999999999999999999777778999999999999999999888888999999999999999
Q ss_pred cccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChhhhhcCCCc----cEEEcCCCccCC
Q 001226 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQL----EVLYLDDNNLEG 278 (1119)
Q Consensus 203 ~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L----~~L~L~~n~l~~ 278 (1119)
++++. .+|..++++++|++|++++|++++ +.+..|..+.++ ..++++.|.++.
T Consensus 159 ~l~~~----------------------~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~L~~l~~~~~~~~ls~n~l~~ 215 (635)
T 4g8a_A 159 LIQSF----------------------KLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMNF 215 (635)
T ss_dssp CCCCC----------------------CCCGGGGGCTTCCEEECCSSCCCE-ECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred ccccC----------------------CCchhhccchhhhhhcccCccccc-cccccccchhhhhhhhhhhhcccCcccc
Confidence 88743 345677788888888888888864 445555554443 367788888875
Q ss_pred CcchhhcCCCCCceeeecccccc-ccCcccccCCCCCcEEEccccccc------cccCcccCCCCCCCeEEccCCccc--
Q 001226 279 QIPETLWGLENLQKLVLSANKLN-GTISGQISHCNQLQVIALSRNNLV------GQIPRSVGNLSSLNSLLLFNNRLQ-- 349 (1119)
Q Consensus 279 ~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~------~~~~~~~~~l~~L~~L~L~~N~l~-- 349 (1119)
..+..+. ...++.+++++|... ...+..+..+..++...+..+... ......+..+..+....+..+...
T Consensus 216 i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~ 294 (635)
T 4g8a_A 216 IQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 294 (635)
T ss_dssp ECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSC
T ss_pred cCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhccc
Confidence 5444443 345677777777554 233455666777776666443322 122223333344444443333221
Q ss_pred -CCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccc
Q 001226 350 -GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI 428 (1119)
Q Consensus 350 -~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 428 (1119)
...+..+..+.+++.+++.+|.+... ..+.....|+.|++.+|.+....+. .+..|+.+++..|.+.. +...
T Consensus 295 ~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~--~~~~ 367 (635)
T 4g8a_A 295 LDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGN--AFSE 367 (635)
T ss_dssp EEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCC--BCCC
T ss_pred ccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCC--Cccc
Confidence 11222334444555555555544322 1233344455555555554433221 23344444455444432 1122
Q ss_pred cCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcccccccccc
Q 001226 429 TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLR 508 (1119)
Q Consensus 429 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 508 (1119)
..+++|+.|++++|.+.. .+..+..+....+|+.|+++.|.+. ..+..+..+++|+
T Consensus 368 ~~l~~L~~L~ls~n~l~~-----------------------~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~ 423 (635)
T 4g8a_A 368 VDLPSLEFLDLSRNGLSF-----------------------KGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLE 423 (635)
T ss_dssp CBCTTCCEEECCSSCCBE-----------------------EEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCC
T ss_pred ccccccccchhhcccccc-----------------------ccccccchhhhhhhhhhhccccccc-ccccccccccccc
Confidence 334444444444444431 1223344445566777777777665 3445567778888
Q ss_pred EEEeccCccccCCC-ccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCccc-CCCCCccCCcccccEEEccc
Q 001226 509 RVILSNNLLQGSLP-ATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS-GSIPSELGNLENLQILRLSA 586 (1119)
Q Consensus 509 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~ 586 (1119)
.+++++|......+ ..+..+++++.++++.|++.+..|..+..+++|++|+|++|++. +.+|..|..+++|++|+|++
T Consensus 424 ~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~ 503 (635)
T 4g8a_A 424 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 503 (635)
T ss_dssp EEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred chhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCC
Confidence 88888777665443 46777888888888888888888888888888999999988754 45788888999999999999
Q ss_pred CcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcccccc-ccccEeecCCcccCC
Q 001226 587 NKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSV-QSLFELQLGSNIFDG 663 (1119)
Q Consensus 587 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~ 663 (1119)
|++++..|..|.++++|++|+|++|+|++..|..+..+++|++|+|++|+|++..|+.|..+ ++|+.|+|++|+|..
T Consensus 504 N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 504 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred CccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 99988888889999999999999999988888888889999999999999999889999888 689999999998874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=475.66 Aligned_cols=454 Identities=20% Similarity=0.209 Sum_probs=302.6
Q ss_pred EEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCc
Q 001226 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNR 347 (1119)
Q Consensus 268 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 347 (1119)
+|++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 3445555554 2333333 455555555555554444455555555555555555554445555555555555555555
Q ss_pred ccCCCCCCCCCCCCCcEEEcccCcCcc-cCchhhhcccccceeeccCccccCCCCccccccCcc--eEEEeecccc--cc
Q 001226 348 LQGTLPPELGNCGSLVDLRLQHNFIGG-TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKL--VELALYNNRL--TG 422 (1119)
Q Consensus 348 l~~~~~~~l~~l~~L~~L~L~~N~i~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~ 422 (1119)
++ .+|.. .+++|++|++++|++++ .+|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ .+
T Consensus 81 l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 55 23333 45555555555555554 244555555555555555555543 234444444 5555555555 44
Q ss_pred cCCccccCCC-CcCEEEccCccCcccchhhhhccCCccceeccccce-------eeCccCCccccccccceeeccCcccc
Q 001226 423 RIPPDITRLR-NLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS-------FYGPIPANICVGTNLFVLVLGNNRFN 494 (1119)
Q Consensus 423 ~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~~~~L~~L~L~~N~l~ 494 (1119)
..|..+..+. +...+++++|++.+.++...+..++.|+.|++++|. +.+.+| .+..+++|+.|++++|.++
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~ 233 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETT 233 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEE
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccC
Confidence 5555554444 233445555555555555555555666666666655 554444 5556666666666666665
Q ss_pred CCCCcccc---ccccccEEEeccCccccCCCccc-----cCCCCcceeeccCcccCCCCC-cccccc---ccceEEeccC
Q 001226 495 GSFPIEIG---KCSSLRRVILSNNLLQGSLPATL-----ERNPGVSFLDVRGNLLQGSIP-PVFGFW---SNLTMLDFSE 562 (1119)
Q Consensus 495 ~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~p-~~~~~l---~~L~~L~Ls~ 562 (1119)
+..+..+. .+++|++|++++|+++|.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~ 311 (520)
T 2z7x_B 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSG 311 (520)
T ss_dssp HHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCC
Confidence 43222211 13577888888888877777777 7788888888888887 455 444444 5688888888
Q ss_pred CcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccc--cCChhhhhcccCCeeEccCccCccC
Q 001226 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG--SIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 563 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
|.+.+.. .+..+++|++|++++|++++.+|..++.+++|++|+|++|++++ .+|..+..+++|++|+|++|++++.
T Consensus 312 n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~ 389 (520)
T 2z7x_B 312 TRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYD 389 (520)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCC
T ss_pred Ccccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcc
Confidence 8886322 12678889999999999988888888889999999999999886 5667788889999999999999885
Q ss_pred CCc-cccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCcc-c
Q 001226 641 IPD-AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTE-V 718 (1119)
Q Consensus 641 ~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-~ 718 (1119)
+|. .|..+++|++|++++|.+++.+|..+. .-++.|++++|+++ .+|..+..+++|++|+|++|+|+ .+|+. +
T Consensus 390 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~---~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~ 464 (520)
T 2z7x_B 390 EKKGDCSWTKSLLSLNMSSNILTDTIFRCLP---PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIF 464 (520)
T ss_dssp GGGCSCCCCTTCCEEECCSSCCCGGGGGSCC---TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTT
T ss_pred cccchhccCccCCEEECcCCCCCcchhhhhc---ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHh
Confidence 665 488889999999999999888887664 23456999999999 88998889999999999999999 67776 8
Q ss_pred cccccceEEecccccccccCCC
Q 001226 719 NNMVSLYFVNISFNHFSGKLPA 740 (1119)
Q Consensus 719 ~~~~~l~~l~ls~N~~~g~~p~ 740 (1119)
..+++|+.+++++|++++..|.
T Consensus 465 ~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 465 DRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TTCTTCCEEECCSSCBCCCHHH
T ss_pred ccCCcccEEECcCCCCcccCCc
Confidence 8999999999999999997763
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=437.81 Aligned_cols=259 Identities=27% Similarity=0.422 Sum_probs=203.2
Q ss_pred HhhCCceeeecCCccEEEEEeCC-----CceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+++..++||+|+||+||+|+++. +++.||||+++.. .++|.+|++++++++|||||+++|+|.+++..|+|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34566889999999999998653 5789999999643 34588999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceE
Q 001226 906 TEYMPGGTLFNVLHQNEP------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 973 (1119)
||||++|+|.++++.... ...++|.++..++.||++||+|||+. +||||||||+|||+++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEE
Confidence 999999999999986532 23589999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhh
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
|+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.....
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i--- 273 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCI--- 273 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHH---
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHH---
Confidence 999999987755444444456789999999999999999999999999999999998 8999975321 1111100
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
... .+.. .+...+.++.+++.+||+.||++||||+||+++|+++.+...
T Consensus 274 -~~g--------~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 274 -TQG--------RELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp -HHT--------CCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred -HcC--------CCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 000 0010 111234578899999999999999999999999999877643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=464.85 Aligned_cols=439 Identities=20% Similarity=0.191 Sum_probs=263.4
Q ss_pred CCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEE
Q 001226 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318 (1119)
Q Consensus 239 ~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (1119)
++|++|++++|+++ .+.+..|.++++|++|+|++|++++..|++|.++++|++|+|++|+++.+++. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEE
T ss_pred ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEe
Confidence 66777777777775 34456677777777777777777766677777777777777777777744333 667777777
Q ss_pred cccccccc-ccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCC--cEEEcccCcC--cccCchhhhccc-ccceeecc
Q 001226 319 LSRNNLVG-QIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSL--VDLRLQHNFI--GGTIPPEICNLA-KLEVLYLF 392 (1119)
Q Consensus 319 Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~N~i--~~~~~~~l~~l~-~L~~L~L~ 392 (1119)
|++|.+++ .+|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ .+..|..+..+. +...++++
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 77777765 356677777777777777777664 245555666 7777777776 556666665554 33345666
Q ss_pred CccccCCCC-ccccccCcceEEEeeccc-------ccccCCccccCCCCcCEEEccCccCcccchhhhhc--cCCcccee
Q 001226 393 NNRIEGAIP-HQIGRMSKLVELALYNNR-------LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK--HFPYLSRL 462 (1119)
Q Consensus 393 ~N~l~~~~~-~~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--~l~~L~~L 462 (1119)
+|.+.+.++ ..+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+++..+..+.. ..+.|++|
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L 252 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence 666654433 345566677777777665 554444 5666666777777666666433332221 12456666
Q ss_pred ccccceeeCccCCcc-----ccccccceeeccCccccCCCC-ccccccccccEEEeccCccccCCCccccCCCCcceeec
Q 001226 463 DLTGNSFYGPIPANI-----CVGTNLFVLVLGNNRFNGSFP-IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDV 536 (1119)
Q Consensus 463 ~L~~N~l~~~~p~~~-----~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 536 (1119)
++++|.++|.+|..+ ..+++|+.+++++|.+ .+| ..+..+ ....+|+.|++
T Consensus 253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~---------------------~~~~~L~~L~l 309 (520)
T 2z7x_B 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEI---------------------FSNMNIKNFTV 309 (520)
T ss_dssp EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHH---------------------HHTCCCSEEEE
T ss_pred EeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcc---------------------cccCceeEEEc
Confidence 666666665555555 4455555555555554 233 233322 00033444444
Q ss_pred cCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccC--cCCcccccCCCCcEEeccCcccc
Q 001226 537 RGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG--RIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 537 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
++|.+.... .+..+++|++|+|++|++++.+|..++++++|++|+|++|++.+ .+|..+..+++|++|||++|+++
T Consensus 310 ~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~ 387 (520)
T 2z7x_B 310 SGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVS 387 (520)
T ss_dssp ESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCB
T ss_pred CCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCC
Confidence 444443211 11344555556666665555555555555666666666666554 33445555666666666666665
Q ss_pred ccCChh-hhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccc
Q 001226 615 GSIPSE-VISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693 (1119)
Q Consensus 615 ~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~ 693 (1119)
+.+|.. +..+++|++|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..++.++.+. .|++++|+|+ .+|..
T Consensus 388 ~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~-~L~L~~N~l~-~l~~~ 462 (520)
T 2z7x_B 388 YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQ-ELNVASNQLK-SVPDG 462 (520)
T ss_dssp CCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCC-EEECCSSCCC-CCCTT
T ss_pred cccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCC-EEECCCCcCC-ccCHH
Confidence 534432 45555666666666666555555543 45666666666665 5565555555543 4777777777 45654
Q ss_pred -cccccccceeeccCceecccCC
Q 001226 694 -LGNLDKLQILDLSSNSFSGEIP 715 (1119)
Q Consensus 694 -~~~l~~L~~L~Ls~N~l~g~ip 715 (1119)
+..+++|+.|+|++|++++..|
T Consensus 463 ~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 463 IFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TTTTCTTCCEEECCSSCBCCCHH
T ss_pred HhccCCcccEEECcCCCCcccCC
Confidence 8889999999999999998655
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=435.11 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=210.4
Q ss_pred HhhCCceeeecCCccEEEEEeC-----CCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+++..+.||+|+||+||+|++. .++..||||+++.. ..+|.+|++++++++|||||+++|+|.+++..|+|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 4567789999999999999875 35788999999643 34588999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 906 TEYMPGGTLFNVLHQNE----------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
||||++|+|.++++..+ ....++|.++..++.||++|++|||++ +||||||||+|||+++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 99999999999998643 234699999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhc
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .++... . .
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~---i-~ 244 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIEC---I-T 244 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH---H-H
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH---H-H
Confidence 9999987655444444445679999999999999999999999999999999998 8999975321 111110 0 0
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.. .... .+...+.++.+++.+||+.||++|||++||++.|+++.+...
T Consensus 245 ~~--------~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 QG--------RVLQ----RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp HT--------CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred cC--------CCCC----CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 00 0000 111234578899999999999999999999999998876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=433.94 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=207.6
Q ss_pred hCCceeeecCCccEEEEEeC-----CCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 837 TEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
...++||+|+||+||+|.+. .+++.||||+++.. .++|.+|+.++++++|||||+++|+|.+++..++||
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~ 108 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIF 108 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEE
Confidence 44578999999999999864 35688999998542 246899999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceE
Q 001226 907 EYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPK 973 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vk 973 (1119)
|||++|+|.++++...+ ...++|..+.+++.||++||+|||++ +||||||||+|||+++++.+|
T Consensus 109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~K 185 (308)
T 4gt4_A 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVK 185 (308)
T ss_dssp ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEE
Confidence 99999999999975432 23589999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhh
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
|+|||+|+...............||++|||||++.++.|+.++|||||||++|||+| |+.||..... .++.....
T Consensus 186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--~~~~~~i~-- 261 (308)
T 4gt4_A 186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--QDVVEMIR-- 261 (308)
T ss_dssp ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--HHHHHHHH--
T ss_pred ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH--
Confidence 999999987765444444556789999999999999999999999999999999998 8999975321 11111100
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
... ..+ .+...+..+.+++.+||+.||++||||+||+++|+++.
T Consensus 262 --~~~--------~~~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 262 --NRQ--------VLP----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp --TTC--------CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --cCC--------CCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 000 000 11123456889999999999999999999999999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=429.14 Aligned_cols=257 Identities=32% Similarity=0.463 Sum_probs=198.8
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
++.+++||+|+||+||+|+++. .||||+++.. ...|.+|+.++++++|||||++++++.+ +..|+|||||
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~ 113 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC 113 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred eEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence 4556889999999999998754 5899998532 2458899999999999999999998865 5689999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++|+|.++++.... .+++.++..++.||++||+|||++ +||||||||+|||+++++.+||+|||+|+........
T Consensus 114 ~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 114 EGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp SSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999986543 499999999999999999999999 9999999999999999999999999999876544333
Q ss_pred CcccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.......||+.|||||++.+ +.|+.++|||||||++|||+||+.||....... .. ....... ...+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~--~~---~~~~~~~-----~~~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD--QI---IFMVGRG-----YASPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HH---HHHHHTT-----CCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH--HH---HHHHhcC-----CCCCC
Confidence 34455689999999998853 468999999999999999999999997432110 00 0000000 00111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.. ......+..+.+++.+||+.||++||||+||+++|+.++....
T Consensus 259 ~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 LS---KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ST---TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cc---cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11 0111234578899999999999999999999999998876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=430.88 Aligned_cols=256 Identities=23% Similarity=0.228 Sum_probs=207.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
..|+..++||+|+||+||+|+++.+|+.||||+++... ...+|+.+++.++|||||++++++.+++..|+|||||+||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 34666788999999999999999999999999997543 33579999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCCCCC---
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSS--- 989 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~~~~--- 989 (1119)
|.++++..+ .+++..+..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||+|+........
T Consensus 137 L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 137 LGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp HHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 999998765 499999999999999999999999 999999999999999998 6999999999877543221
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||....... ... . ......... .+
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~--~-i~~~~~~~~-----~~-- 278 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCL--K-IASEPPPIR-----EI-- 278 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHH--H-HHHSCCGGG-----GS--
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHH--H-HHcCCCCch-----hc--
Confidence 12334679999999999999999999999999999999999999997532211 110 0 000000000 01
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
+...+..+.+++.+||+.||++|||++|+++++.+..++
T Consensus 279 ----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 279 ----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 112245678999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=430.40 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=205.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.|+..++||+|+||+||+|+++.+|+.||||+++. ..+.+.+|+.+++.++|||||++++++.+++..|+|||||+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 36667899999999999999999999999999843 33568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
||+|.+++... .+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+...... .
T Consensus 155 gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 225 (346)
T 4fih_A 155 GGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 225 (346)
T ss_dssp TEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence 99999999764 389999999999999999999999 99999999999999999999999999998775432 2
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ....+.... ....+.+.
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~--------~~~~~~~~-- 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIR--------DNLPPRLK-- 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHH--------HSSCCCCS--
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHH--------cCCCCCCC--
Confidence 3345789999999999999999999999999999999999999996421 111111100 00011111
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+.++.+++.+||+.||++|||++|+++|
T Consensus 292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112234577899999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=475.62 Aligned_cols=438 Identities=19% Similarity=0.238 Sum_probs=239.7
Q ss_pred CCccEEEcCCCccCCCcchhhcCCCCCceeee-ccccccccCcccc----------------------------------
Q 001226 264 LQLEVLYLDDNNLEGQIPETLWGLENLQKLVL-SANKLNGTISGQI---------------------------------- 308 (1119)
Q Consensus 264 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L-s~N~l~~~~~~~~---------------------------------- 308 (1119)
.+++.|+|++|++.|.+|.+|+++++|++|+| ++|.+++..+...
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 46888899999888888888888999999999 8887765522110
Q ss_pred -----------------cCCCCCcEEEccc--cccccccCcccCCCCCCCeEEccCCcccC-----------------CC
Q 001226 309 -----------------SHCNQLQVIALSR--NNLVGQIPRSVGNLSSLNSLLLFNNRLQG-----------------TL 352 (1119)
Q Consensus 309 -----------------~~l~~L~~L~Ls~--N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------~~ 352 (1119)
.....++.+.++. |++++ +|..++++++|++|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 0111222233322 55665 56666666666666666666665 25
Q ss_pred CCCCC--CCCCCcEEEcccCcCcccCchhhhcccccceeeccCcc-ccC-CCCccccccC-------cceEEEeeccccc
Q 001226 353 PPELG--NCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNR-IEG-AIPHQIGRMS-------KLVELALYNNRLT 421 (1119)
Q Consensus 353 ~~~l~--~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~ 421 (1119)
|..++ ++++|++|+|++|.+.+.+|..|.++++|+.|+|++|+ +++ .+|..++.++ +|+.|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 55555 66666666666666666666666666666666666665 555 4555444443 6666666666665
Q ss_pred ccCCc--cccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccc-cceeeccCccccCCCC
Q 001226 422 GRIPP--DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTN-LFVLVLGNNRFNGSFP 498 (1119)
Q Consensus 422 ~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~-L~~L~L~~N~l~~~~p 498 (1119)
.+|. .+.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp 635 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCC
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCc
Confidence 5555 5666666666666666655 444 3344555555555555555 45555555555 555555555555 455
Q ss_pred cccccccc--ccEEEeccCccccCCCccc---c--CCCCcceeeccCcccCCCCCcc-ccccccceEEeccCCcccCCCC
Q 001226 499 IEIGKCSS--LRRVILSNNLLQGSLPATL---E--RNPGVSFLDVRGNLLQGSIPPV-FGFWSNLTMLDFSENRLSGSIP 570 (1119)
Q Consensus 499 ~~~~~l~~--L~~L~Ls~N~l~~~~p~~~---~--~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p 570 (1119)
..+..++. |+.|+|++|++.+.+|... . .+++|+.|++++|+++ .+|.. +..+++|+.|+|++|+|+ .+|
T Consensus 636 ~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip 713 (876)
T 4ecn_A 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIP 713 (876)
T ss_dssp SCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCC
T ss_pred hhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccC
Confidence 54444433 5555555555555443222 1 2224555555555555 23332 224445555555555554 333
Q ss_pred CccCC--------cccccEEEcccCcccCcCCcccc--cCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccC
Q 001226 571 SELGN--------LENLQILRLSANKLDGRIPYELG--KCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 571 ~~~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
..+.. +++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~---- 787 (876)
T 4ecn_A 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR---- 787 (876)
T ss_dssp TTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB----
T ss_pred hHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC----
Confidence 33221 114555555555554 4444444 45555555555555543 44444555555555554311
Q ss_pred CCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccc
Q 001226 641 IPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNN 720 (1119)
Q Consensus 641 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 720 (1119)
++++|++.+.+|..+..++.+. .|+|++|+| +.+|..+. ++|+.|||++|++...-+..+..
T Consensus 788 --------------~ls~N~l~~~ip~~l~~L~~L~-~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~ 849 (876)
T 4ecn_A 788 --------------DAEGNRILRQWPTGITTCPSLI-QLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCP 849 (876)
T ss_dssp --------------CTTCCBCCCCCCTTGGGCSSCC-EEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHH
T ss_pred --------------CcccccccccChHHHhcCCCCC-EEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccc
Confidence 0122555555555555555443 366666666 45666554 46667777777666444444444
Q ss_pred cccceEEecccccc
Q 001226 721 MVSLYFVNISFNHF 734 (1119)
Q Consensus 721 ~~~l~~l~ls~N~~ 734 (1119)
...+..+.+++|.+
T Consensus 850 ~~~~~~~~L~~n~~ 863 (876)
T 4ecn_A 850 YIEAGMYVLLYDKT 863 (876)
T ss_dssp HHHTTCCEEECCTT
T ss_pred cccchheeecCCCc
Confidence 44555555666544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=426.68 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=206.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||+||+|+++.+++.||||++++. ...+.+|+++++.++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3588889999999999999999999999999998532 245789999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++||+|.+++.+.+ .+++..++.++.||+.|++|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998765 499999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ... ...... ...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~---~~~~i~----------~~~ 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGL---IFAKII----------KLE 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHH---HHHHHH----------HTC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHH---HHHHHH----------cCC
Confidence 44444556789999999999999999999999999999999999999996421 111 111111 111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell 1103 (1119)
.... ...+.++.+++.+||+.||++|||++|+.
T Consensus 251 ~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCC----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111 11234678999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=427.28 Aligned_cols=276 Identities=24% Similarity=0.308 Sum_probs=201.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-cc--HHHHHHHHhhcCCCCEEEEeeeeecCC----ceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TN--FDVEIRTLSLVRHRNILRIVGSCTKDE----HGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~--~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 907 (1119)
++..+++||+|+||+||+|+++ |+.||||+++... .. +++|+..+..++|||||++++++.+++ ..|+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4556789999999999999874 7899999996543 22 345666667889999999999998654 4699999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD-----CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
||++|+|.++++... ++|+.+.+++.|+++|++|||++ +.++||||||||+|||++.++.+||+|||+|+.
T Consensus 82 y~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999998653 89999999999999999999976 245899999999999999999999999999987
Q ss_pred ccCCCCC--CcccccccCCCcccccccCCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh-
Q 001226 983 ISDSHSS--STRSAIVGSLGYIAPENAYST------RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL- 1053 (1119)
Q Consensus 983 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~- 1053 (1119)
....... ......+||+.|||||++.+. .++.++|||||||++|||+||+.||............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 7543321 223346899999999988654 3677999999999999999998887543211111100000000
Q ss_pred ---cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1054 ---QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1054 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
.........+++.++.. .........+.+++.+||+.||++||||+||++.|+++.++.+.+|
T Consensus 238 ~~~~~~~~~~~~~rp~~p~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ik~ 303 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 303 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHHHHHHhcccCCCCCCcc-ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 00000001111222111 1123455678899999999999999999999999999998876654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=434.56 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=201.3
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+.+|+..+.||+|+||+||+|+++.+++.||||+++.. ...+.+|+++++.++|||||++++++.+++..|+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 345788889999999999999999999999999998532 24578999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
||||+||+|.+++...+. ..+++..++.++.||+.||+|||++ +||||||||+|||++++|.+||+|||+|+....
T Consensus 102 mEy~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EeCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999999976542 3478999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ........ ..
T Consensus 178 ~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~----------~~ 240 (350)
T 4b9d_A 178 TV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLKII----------SG 240 (350)
T ss_dssp HH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH----------HT
T ss_pred Cc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHH----------cC
Confidence 11 122346799999999999999999999999999999999999999964311 11000000 11
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.... .+...+.++.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 241 SFPP---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1100 011224567899999999999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=455.06 Aligned_cols=443 Identities=23% Similarity=0.170 Sum_probs=248.7
Q ss_pred hhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeecccccccc-CcccccCCCCCcEEEccccccccccCcccCCCCCC
Q 001226 260 FKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGT-ISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSL 338 (1119)
Q Consensus 260 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 338 (1119)
|.++++|++|+|++|++++..+.+|+++++|++|+|++|+++.. .+..+..+++|++|+|++|++++..+..+..+.++
T Consensus 120 f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l 199 (635)
T 4g8a_A 120 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 199 (635)
T ss_dssp GTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTC
T ss_pred hcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhh
Confidence 33344444444444444433334444444444444444444432 23344444444555555554444444444433322
Q ss_pred ----CeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcc-cCchhhhcccccceeeccCcc------ccCCCCcccccc
Q 001226 339 ----NSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGG-TIPPEICNLAKLEVLYLFNNR------IEGAIPHQIGRM 407 (1119)
Q Consensus 339 ----~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~-~~~~~l~~l~~L~~L~L~~N~------l~~~~~~~~~~l 407 (1119)
..++++.|.++...+..+ ....++.+++.+|.... ..+..+..+..++...+..+. +.......+..+
T Consensus 200 ~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~ 278 (635)
T 4g8a_A 200 PLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 278 (635)
T ss_dssp TTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGG
T ss_pred hhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccc
Confidence 245566666653333333 23345566666665442 223345555655555543322 222333445555
Q ss_pred CcceEEEeecccccc---cCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccc
Q 001226 408 SKLVELALYNNRLTG---RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLF 484 (1119)
Q Consensus 408 ~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~ 484 (1119)
..+....+..+.... ..+..+..+.+++.+++.+|.+....+ +.....++.|++++|.+.+..+. .+..|+
T Consensus 279 ~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~---~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~ 352 (635)
T 4g8a_A 279 CNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQHLELVNCKFGQFPTL---KLKSLK 352 (635)
T ss_dssp GGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGG---GGSCCCCSEEEEESCEESSCCCC---BCTTCC
T ss_pred cchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccc---cccchhhhhhhcccccccCcCcc---cchhhh
Confidence 566666665544321 233445556677777777776653222 12345667777777766544332 334566
Q ss_pred eeeccCccccCCCCccccccccccEEEeccCcccc--CCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccC
Q 001226 485 VLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQG--SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562 (1119)
Q Consensus 485 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (1119)
.+++..|.+... .....+++|+.|++++|.+.. ..+..+..+.+|++++++.|.... ++..+..+++|+.++++.
T Consensus 353 ~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~ 429 (635)
T 4g8a_A 353 RLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 429 (635)
T ss_dssp EEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTT
T ss_pred hcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhh
Confidence 666666665532 223456677777777776642 344455556666666666666553 344455566666666666
Q ss_pred CcccCCCC-CccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccc-cccCChhhhhcccCCeeEccCccCccC
Q 001226 563 NRLSGSIP-SELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL-AGSIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 563 N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
|+..+..+ ..|.++.+|+.+++++|++.+..|..+..+++|+.|+|++|++ .+.+|..+..+++|+.|+|++|+|++.
T Consensus 430 ~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l 509 (635)
T 4g8a_A 430 SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 509 (635)
T ss_dssp SEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCc
Confidence 65554433 3455666666666666666666666666666666666666653 334555666666666666666666666
Q ss_pred CCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccc
Q 001226 641 IPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNN 720 (1119)
Q Consensus 641 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 720 (1119)
+|.+|.++++|++ |+|++|+|++..|..|+.+++|+.|||++|+|++.+|..+..
T Consensus 510 ~~~~f~~l~~L~~-------------------------L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 564 (635)
T 4g8a_A 510 SPTAFNSLSSLQV-------------------------LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 564 (635)
T ss_dssp CTTTTTTCTTCCE-------------------------EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTC
T ss_pred ChHHHcCCCCCCE-------------------------EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHh
Confidence 6666666666665 455555555566677778888888888888888877877777
Q ss_pred c-ccceEEeccccccccc
Q 001226 721 M-VSLYFVNISFNHFSGK 737 (1119)
Q Consensus 721 ~-~~l~~l~ls~N~~~g~ 737 (1119)
+ ++|+.|++++|+|+..
T Consensus 565 l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 565 FPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp CCTTCCEEECTTCCBCCS
T ss_pred hhCcCCEEEeeCCCCccc
Confidence 6 5788888888888763
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=416.74 Aligned_cols=240 Identities=28% Similarity=0.424 Sum_probs=193.5
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec----CCceEEEEec
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK----DEHGFIVTEY 908 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 908 (1119)
.++||+|+||+||+|.++.+++.||+|++... ...+.+|+++++.++|||||++++++.+ ++..|+||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 46799999999999999999999999998532 2458899999999999999999999865 3457999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeCC-CCceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLDS-ELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~-~~~vkl~DfGla~~~~~ 985 (1119)
|+||+|.+++++.+ .+++..+..++.||+.||+|||++ + ||||||||+|||++. ++.+||+|||+|+....
T Consensus 111 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999998765 489999999999999999999998 6 999999999999984 79999999999985432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
......+||+.|||||++.+ .|+.++||||+||++|||+||+.||..... ........ ..... ..
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i-~~~~~-----~~ 249 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRV-TSGVK-----PA 249 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHH-TTTCC-----CG
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHH-HcCCC-----CC
Confidence 22345689999999998764 699999999999999999999999964211 11110100 00000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. +...+.++.+++.+||+.||++|||++|+++|
T Consensus 250 ~~------~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SF------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 11122357899999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=432.00 Aligned_cols=246 Identities=23% Similarity=0.304 Sum_probs=205.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.|+..++||+|+||+||+|+++.+|+.||||+++. ..+.+.+|+.+|+.++|||||+++++|.+++..|+|||||+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 46677899999999999999999999999999843 33568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
||+|.++++.. .+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+...... .
T Consensus 232 gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 302 (423)
T 4fie_A 232 GGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 302 (423)
T ss_dssp TEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred CCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence 99999999754 389999999999999999999999 99999999999999999999999999998775432 2
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ....+.... ......+..+
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~~~i~--------~~~~~~~~~~ 370 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAMKMIR--------DNLPPRLKNL 370 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHH--------HSCCCCCSCT
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHHHHHH--------cCCCCCCccc
Confidence 3345789999999999999999999999999999999999999996421 111111000 0011111111
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+.++.+++.+||+.||++|||++|+++|
T Consensus 371 ----~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 371 ----HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ----TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1224567899999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=410.99 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=190.6
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+-+|+..+.||+|+||+||+|+++.+++.||||++++. ...+.+|+++++.++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 45788889999999999999999999999999998532 23578999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+ +|+|.+++...+ .+++..++.++.||+.|++|||++ +|+||||||+|||+++++.+||+|||+|+...+
T Consensus 92 mEy~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred EeCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 9999 689999998765 499999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
. ......+||+.|||||++.+..| +.++||||+||++|||++|+.||.... ..........
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~---------- 226 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISN---------- 226 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH----------
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHc----------
Confidence 2 22345689999999999988776 579999999999999999999996421 1111111110
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... ...+.++.+++.+||+.||++|||++|+++|
T Consensus 227 ~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 227 GVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp TCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111110 1123467899999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=428.48 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=210.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCC-----ceEEEEEecccc-----cccHHHHHHHHhhcCC-CCEEEEeeeeecC-Cce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRS-----ETNFDVEIRTLSLVRH-RNILRIVGSCTKD-EHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~~~ 902 (1119)
+|+.+++||+|+||+||+|.+... ++.||||+++.. ...+.+|+++++.++| ||||+++|+|.++ +..
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 567789999999999999987653 468999998643 2457889999999965 9999999998764 568
Q ss_pred EEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 969 (1119)
|+|||||++|+|.++++.... +..+++.++..++.||++||+|||++ +||||||||+|||++++
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 221 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCC
Confidence 999999999999999976432 23589999999999999999999999 99999999999999999
Q ss_pred CceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeeh
Q 001226 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 970 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~ 1048 (1119)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||....... .+.
T Consensus 222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~~-- 298 (353)
T 4ase_A 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC-- 298 (353)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHH--
T ss_pred CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HHH--
Confidence 9999999999997765444444556789999999999999999999999999999999998 999997532111 111
Q ss_pred hhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
. ...... .... +...+.++.+++.+||+.||++|||++||+++|+++.+...
T Consensus 299 -~-~i~~g~------~~~~------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 299 -R-RLKEGT------RMRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp -H-HHHHTC------CCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -H-HHHcCC------CCCC------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 0 000000 0011 11124567899999999999999999999999999887654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=449.48 Aligned_cols=453 Identities=19% Similarity=0.187 Sum_probs=267.9
Q ss_pred cEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCC
Q 001226 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346 (1119)
Q Consensus 267 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 346 (1119)
+++++++|++++ +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 444444444442 333222 34444444444444444444444444444444444444444444444444444444444
Q ss_pred cccCCCCCCCCCCCCCcEEEcccCcCccc-CchhhhcccccceeeccCccccCCCCccccccCcc--eEEEeecccc--c
Q 001226 347 RLQGTLPPELGNCGSLVDLRLQHNFIGGT-IPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKL--VELALYNNRL--T 421 (1119)
Q Consensus 347 ~l~~~~~~~l~~l~~L~~L~L~~N~i~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~ 421 (1119)
+++ .+|.. .+++|++|++++|++++. +|..|+++++|++|++++|++++. .+..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 444 23322 444444444444444431 234444444444444444444432 12222222 4444444444 4
Q ss_pred ccCCccccCCC--CcCEEEccCccCcccchhhhhccCCccceeccccce-----eeCccCCccccccccceeeccCcccc
Q 001226 422 GRIPPDITRLR--NLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNS-----FYGPIPANICVGTNLFVLVLGNNRFN 494 (1119)
Q Consensus 422 ~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~-----l~~~~p~~~~~~~~L~~L~L~~N~l~ 494 (1119)
+..|..+..+. .+ .+++++|.+.+.++...+..++.|+.|++++|. +.+. +..+..+++|+.|+++++.+.
T Consensus 185 ~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 185 GGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp SSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEEEEC
T ss_pred ccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCCcCc
Confidence 44444444332 12 234444444444443333444444555554442 1111 112333444455555444443
Q ss_pred CC----CCccccccccccEEEeccCccccCCCccc-----cCCCCcceeeccCcccCCCCC-cccccc---ccceEEecc
Q 001226 495 GS----FPIEIGKCSSLRRVILSNNLLQGSLPATL-----ERNPGVSFLDVRGNLLQGSIP-PVFGFW---SNLTMLDFS 561 (1119)
Q Consensus 495 ~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~p-~~~~~l---~~L~~L~Ls 561 (1119)
+. ++..+ ..++|++|++++|.++|.+|..+ ..++.|+.++++.|.+ .+| ..+..+ .+|++|+++
T Consensus 263 ~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~ 339 (562)
T 3a79_B 263 WKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSIS 339 (562)
T ss_dssp HHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEE
T ss_pred HHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEcc
Confidence 21 11111 22367777777777776666665 5666666666666666 344 222222 468888888
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccccc--CChhhhhcccCCeeEccCccCcc
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS--IPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
+|.+.... ....+++|++|++++|++++.+|..+..+++|++|+|++|++++. +|..+..+++|++|+|++|++++
T Consensus 340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 417 (562)
T 3a79_B 340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417 (562)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred CCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence 88875321 126778888888888888877888888888888888888888752 34567888888888888888887
Q ss_pred CCCc-cccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCcc-
Q 001226 640 AIPD-AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTE- 717 (1119)
Q Consensus 640 ~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~- 717 (1119)
.+|. .|..+++|++|+|++|.+++.+|..+. .-++.|++++|+|+ .+|..+..+++|+.|||++|+|+ .+|+.
T Consensus 418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~---~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~ 492 (562)
T 3a79_B 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP---PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGV 492 (562)
T ss_dssp CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC---TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTS
T ss_pred ccChhhhcCcccCCEEECCCCCCCcchhhhhc---CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHH
Confidence 4554 588888888888888888887777664 22346899999998 78888889999999999999999 67777
Q ss_pred ccccccceEEecccccccccCCC
Q 001226 718 VNNMVSLYFVNISFNHFSGKLPA 740 (1119)
Q Consensus 718 ~~~~~~l~~l~ls~N~~~g~~p~ 740 (1119)
+..+++|+.+++++|+++|..|.
T Consensus 493 ~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 493 FDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TTTCTTCCCEECCSCCBCCCHHH
T ss_pred HhcCCCCCEEEecCCCcCCCcch
Confidence 88999999999999999998874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=413.65 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=195.3
Q ss_pred HHhhCCceeeecCCccEEEEEeC---CCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+|+..+.||+|+||+||+|++. .+++.||||++++. ...+.+|+++++.++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 36788899999999999999874 46789999998532 2457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++||+|.+++.+.+ .+++.++..++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998765 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
+.. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .. ...... .
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~---~~~~i~----------~ 240 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KE---TMTMIL----------K 240 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHH----------H
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HH---HHHHHH----------c
Confidence 322 223456899999999999999999999999999999999999999964311 01 011111 1
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
..... +...+.++.+++.+||+.||++||| ++|+++|
T Consensus 241 ~~~~~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 241 AKLGM----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp CCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred CCCCC----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11111 1112456789999999999999998 4777764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=439.30 Aligned_cols=439 Identities=21% Similarity=0.201 Sum_probs=245.4
Q ss_pred CCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEE
Q 001226 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318 (1119)
Q Consensus 239 ~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (1119)
++|++|++++|+++ .+.+..|.++++|++|+|++|++++..|++|.++++|++|+|++|+++.+++. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEE
T ss_pred CCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEE
Confidence 56666777777665 34455666666677777777776666666666667777777777766644333 566666666
Q ss_pred ccccccccc-cCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCC--cEEEcccCcC--cccCchhhhccc--ccceeec
Q 001226 319 LSRNNLVGQ-IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSL--VDLRLQHNFI--GGTIPPEICNLA--KLEVLYL 391 (1119)
Q Consensus 319 Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L--~~L~L~~N~i--~~~~~~~l~~l~--~L~~L~L 391 (1119)
|++|++++. +|..|+++++|++|++++|++++ ..+..+++| ++|++++|.+ ++..|..+..+. .+ .+++
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l 203 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVF 203 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEE
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEe
Confidence 666666642 34566666666666666666654 234444444 6666666666 555565555543 22 4456
Q ss_pred cCccccCCCCc-cccccCcceEEEeeccc-----ccccCCccccCCCCcCEEEccCccCcccchhhhhc--cCCccceec
Q 001226 392 FNNRIEGAIPH-QIGRMSKLVELALYNNR-----LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK--HFPYLSRLD 463 (1119)
Q Consensus 392 ~~N~l~~~~~~-~~~~l~~L~~L~L~~N~-----l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--~l~~L~~L~ 463 (1119)
++|.+.+.++. .+..+++|+.|++++|+ +.+ ....+..+++|+.|+++++.+++.....+.. ..++|++|+
T Consensus 204 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~ 282 (562)
T 3a79_B 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLN 282 (562)
T ss_dssp CSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEE
T ss_pred cCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEE
Confidence 66666554333 34456666666666664 221 1234555666666666666554322111110 123555555
Q ss_pred cccceeeCccCCcc-----ccccccceeeccCccccCCCC-ccccccccccEEEeccCccccCCCccccCCCCcceeecc
Q 001226 464 LTGNSFYGPIPANI-----CVGTNLFVLVLGNNRFNGSFP-IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVR 537 (1119)
Q Consensus 464 L~~N~l~~~~p~~~-----~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 537 (1119)
+++|.++|.+|..+ ..++.|+.++++.|.+ .+| ..+..+ ....+|+.|+++
T Consensus 283 l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~---------------------~~~~~L~~L~l~ 339 (562)
T 3a79_B 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV---------------------FAEMNIKMLSIS 339 (562)
T ss_dssp EEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH---------------------HHTCCCSEEEEE
T ss_pred EeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh---------------------hccCcceEEEcc
Confidence 55555555555544 3334444444444443 222 111111 011344555555
Q ss_pred CcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccC--cCCcccccCCCCcEEeccCccccc
Q 001226 538 GNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG--RIPYELGKCTKMIKLDLSDNYLAG 615 (1119)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~ 615 (1119)
+|.+.... ....+++|++|+|++|++++.+|..++++++|++|+|++|++++ .+|..+..+++|++|+|++|++++
T Consensus 340 ~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 417 (562)
T 3a79_B 340 DTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417 (562)
T ss_dssp SSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred CCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence 55443211 11344555555555555555555555555555555555555553 123445555556666666666555
Q ss_pred cCCh-hhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccc-
Q 001226 616 SIPS-EVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC- 693 (1119)
Q Consensus 616 ~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~- 693 (1119)
.+|. .+..+++|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..++.++.+ +.|++++|+|+ .+|..
T Consensus 418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L-~~L~L~~N~l~-~l~~~~ 492 (562)
T 3a79_B 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQAL-QELNVASNQLK-SVPDGV 492 (562)
T ss_dssp CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCC-SEEECCSSCCC-CCCTTS
T ss_pred ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCC-CEEECCCCCCC-CCCHHH
Confidence 3333 345555566666666666555554443 45566666666655 455555555444 34777777777 45655
Q ss_pred cccccccceeeccCceecccCCc
Q 001226 694 LGNLDKLQILDLSSNSFSGEIPT 716 (1119)
Q Consensus 694 ~~~l~~L~~L~Ls~N~l~g~ip~ 716 (1119)
++.+++|+.|+|++|++++..|.
T Consensus 493 ~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 493 FDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TTTCTTCCCEECCSCCBCCCHHH
T ss_pred HhcCCCCCEEEecCCCcCCCcch
Confidence 88999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=404.63 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=190.4
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCC-------
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------- 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 900 (1119)
+.+|+..+.||+|+||+||+|+++.+++.||||+++.. .+.+.+|+++++.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 34677889999999999999999999999999998532 235778999999999999999999986543
Q ss_pred -----ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 901 -----HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 901 -----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
..|+||||+++|+|.+++.........++..++.++.||++|++|||++ +||||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998766544567778899999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCCC----------CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce
Q 001226 976 DFGMSKLISDSHSS----------STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045 (1119)
Q Consensus 976 DfGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 1045 (1119)
|||+|+........ ......+||+.|||||++.+..|+.++||||+||++|||++ ||... ....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~~ 234 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MERV 234 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHHH
Confidence 99999877543221 12234579999999999999999999999999999999996 76421 0000
Q ss_pred eehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1046 VTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.... ...... .............+++.+||+.||++|||++|++++
T Consensus 235 ~~~~-----------~~~~~~---~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 235 RTLT-----------DVRNLK---FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH-----------HHHTTC---CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-----------HHhcCC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 000001 111222334456789999999999999999999985
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=408.01 Aligned_cols=199 Identities=22% Similarity=0.248 Sum_probs=85.5
Q ss_pred CCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeecccccccccCccCCCcccccEEE
Q 001226 119 CGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLY 198 (1119)
Q Consensus 119 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 198 (1119)
.++|++|++++|++ +.+|++++++++|++|++++|.++|.+|.+++++++|+.+++..|.. .++++|+
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 35566666666665 45666666666666666666666666666666666666555555432 3566677
Q ss_pred eccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCC
Q 001226 199 LNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG 278 (1119)
Q Consensus 199 L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~ 278 (1119)
+++|++++.+ .. .++|++|++++|++++ ++. .+++|++|++++|++++
T Consensus 78 l~~~~l~~lp------------------------~~---~~~L~~L~l~~n~l~~-lp~----~~~~L~~L~l~~n~l~~ 125 (454)
T 1jl5_A 78 LNNLGLSSLP------------------------EL---PPHLESLVASCNSLTE-LPE----LPQSLKSLLVDNNNLKA 125 (454)
T ss_dssp CTTSCCSCCC------------------------SC---CTTCSEEECCSSCCSS-CCC----CCTTCCEEECCSSCCSC
T ss_pred ecCCccccCC------------------------CC---cCCCCEEEccCCcCCc-ccc----ccCCCcEEECCCCccCc
Confidence 7766665321 10 1344444444444443 211 12445555555555553
Q ss_pred CcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCC
Q 001226 279 QIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGN 358 (1119)
Q Consensus 279 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~ 358 (1119)
. |.. .++|++|++++|++++ +| .|..+++|++|++++|++++ +|..+ ++|++|++++|++++ +| .+++
T Consensus 126 l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~ 193 (454)
T 1jl5_A 126 L-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQN 193 (454)
T ss_dssp C-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTT
T ss_pred c-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccC
Confidence 1 111 1355555555555554 22 35555555555555555543 33222 244555555554443 22 3444
Q ss_pred CCCCcEEEcccCcCc
Q 001226 359 CGSLVDLRLQHNFIG 373 (1119)
Q Consensus 359 l~~L~~L~L~~N~i~ 373 (1119)
+++|++|++++|+++
T Consensus 194 l~~L~~L~l~~N~l~ 208 (454)
T 1jl5_A 194 LPFLTAIYADNNSLK 208 (454)
T ss_dssp CTTCCEEECCSSCCS
T ss_pred CCCCCEEECCCCcCC
Confidence 444444444444444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=405.09 Aligned_cols=425 Identities=25% Similarity=0.317 Sum_probs=253.1
Q ss_pred CCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEE
Q 001226 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318 (1119)
Q Consensus 239 ~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (1119)
++|++|++++|++ +.+ |..+.++++|++|++++|++++.+|..++++++|+.+++++|.. .++++|+
T Consensus 11 ~~L~~L~l~~n~l-~~i-P~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~ 77 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEM-PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE 77 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred ccchhhhcccCch-hhC-ChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence 4455555555555 333 22344555555555555555555555555544443333333321 2358888
Q ss_pred ccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccC
Q 001226 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEG 398 (1119)
Q Consensus 319 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 398 (1119)
+++|.+++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++
T Consensus 78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~ 145 (454)
T 1jl5_A 78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK 145 (454)
T ss_dssp CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS
T ss_pred ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC
Confidence 88888874 3432 3678888888888885 5543 3678888888888874 2221 1678888888888886
Q ss_pred CCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccc
Q 001226 399 AIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANIC 478 (1119)
Q Consensus 399 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 478 (1119)
+| .++.+++|++|++++|++++ +|..+ .+|++|++++|++++ +| . +..+++|+.|++++|.+++ +|...
T Consensus 146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~-~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-E-LQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-C-CTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-c-ccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 55 48888888888888888884 55433 478888888888875 44 2 4567888888888888876 44332
Q ss_pred cccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEE
Q 001226 479 VGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTML 558 (1119)
Q Consensus 479 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 558 (1119)
.+|+.|++++|+++ .+| .++.+++|++|++++|++++ +|.. .++|+.|++++|++++ +|.. +++|++|
T Consensus 215 --~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 58889999999888 677 48889999999999999886 4443 4788999999999886 5543 3789999
Q ss_pred eccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCc
Q 001226 559 DFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLS 638 (1119)
Q Consensus 559 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 638 (1119)
++++|++++ +|.. .++|+.|++++|++.+ ++.. .++|++|++++|++++ +|.. +++|+.|++++|+++
T Consensus 283 ~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 283 DVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA 350 (454)
T ss_dssp ECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred ECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc
Confidence 999999985 3321 1578999999999985 3321 2589999999999986 6665 478999999999998
Q ss_pred cCCCccccccccccEeecCCcccCC--CccccchhhccccceeeeccccccCCcccccccccccceeeccCceecc--cC
Q 001226 639 GAIPDAFSSVQSLFELQLGSNIFDG--SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG--EI 714 (1119)
Q Consensus 639 ~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~i 714 (1119)
.+|. .+++|+.|++++|++++ .+|.++.. ++.|++.|.+|.. +++|+.||+++|+++| .|
T Consensus 351 -~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~---------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~i 414 (454)
T 1jl5_A 351 -EVPE---LPQNLKQLHVEYNPLREFPDIPESVED---------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDI 414 (454)
T ss_dssp -CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE---------EECCC-------------------------------
T ss_pred -cccc---hhhhccEEECCCCCCCcCCCChHHHHh---------hhhcccccccccc---cCcCCEEECCCCcCCccccc
Confidence 4666 47889999999999998 77776543 4567888888874 5789999999999998 78
Q ss_pred CccccccccceEEecccccccccCCCccccc
Q 001226 715 PTEVNNMVSLYFVNISFNHFSGKLPASWTTL 745 (1119)
Q Consensus 715 p~~~~~~~~l~~l~ls~N~~~g~~p~~~~~~ 745 (1119)
|+++ +.+.+++|.+.+++|.+...+
T Consensus 415 P~sl------~~L~~~~~~~~~~~~~~~~~~ 439 (454)
T 1jl5_A 415 PESV------EDLRMNSERVVDPYEFAHETT 439 (454)
T ss_dssp -------------------------------
T ss_pred hhhH------hheeCcCcccCCccccCHHHh
Confidence 8654 456788999999888654443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=397.71 Aligned_cols=262 Identities=23% Similarity=0.258 Sum_probs=198.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeec------CCce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTK------DEHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 902 (1119)
+|+..+.||+|+||+||+|+++.+|+.||||+++... ..+.+|+++|+.++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 5777899999999999999999999999999986432 346789999999999999999998753 3678
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+|||||+ |+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.++.+|++|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999995 67999998754 499999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCC--CCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc-
Q 001226 983 ISDSH--SSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE- 1058 (1119)
Q Consensus 983 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1058 (1119)
..... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ..............
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHH
Confidence 64432 12234457899999999988775 569999999999999999999999975311100 00000000000000
Q ss_pred --------ccccccccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 --------CICFLDREISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 --------~~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+ ..+......+ ...+.++.+++.+||+.||++|||++|+++|
T Consensus 287 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000000 1123467899999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=401.31 Aligned_cols=367 Identities=21% Similarity=0.213 Sum_probs=213.4
Q ss_pred CCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccc-cCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEE
Q 001226 264 LQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNG-TISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLL 342 (1119)
Q Consensus 264 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 342 (1119)
++|++|+|++|++++..|..|.++++|++|+|++|.+.+ +.+..|..+++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 456666666666665556666666666666666665542 3344556666666666666666555555566666666666
Q ss_pred ccCCcccCCCCC--CCCCCCCCcEEEcccCcCcccCchh-hhcccccceeeccCccccCCCCcccccc--CcceEEEeec
Q 001226 343 LFNNRLQGTLPP--ELGNCGSLVDLRLQHNFIGGTIPPE-ICNLAKLEVLYLFNNRIEGAIPHQIGRM--SKLVELALYN 417 (1119)
Q Consensus 343 L~~N~l~~~~~~--~l~~l~~L~~L~L~~N~i~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~ 417 (1119)
+++|++++..+. .+..+++|++|++++|++++..|.. +.++++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 666665543322 2555566666666666655554443 5555666666666666555555555544 4555555555
Q ss_pred ccccccCCcc--------ccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeecc
Q 001226 418 NRLTGRIPPD--------ITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLG 489 (1119)
Q Consensus 418 N~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~ 489 (1119)
|.+.+..+.. +..+++|+.|++++|++++..+..+...+ ..++|+.|+++
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~----------------------~~~~L~~L~l~ 247 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAI----------------------AGTKIQSLILS 247 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHT----------------------TTCCEEEEECT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccc----------------------cccceeeEeec
Confidence 5555332222 12334445555555544444433332211 01334444444
Q ss_pred CccccCCCCccccccccccEEEeccCccccCCCccccC--CCCcceeeccCcccCCCCCccccccccceEEeccCCcccC
Q 001226 490 NNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLER--NPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSG 567 (1119)
Q Consensus 490 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~--l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 567 (1119)
+|.+.+... ..+.+.+..+..+.. .++|+.|++++|++++.+|..++.+++|++|+|++|++++
T Consensus 248 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~ 313 (455)
T 3v47_A 248 NSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK 313 (455)
T ss_dssp TCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE
T ss_pred ccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc
Confidence 443332110 011111111112221 2456666666666666666667777777777777777776
Q ss_pred CCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccc
Q 001226 568 SIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSS 647 (1119)
Q Consensus 568 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 647 (1119)
..|..|.++++|++|+|++|++.+..|..+..+++|++|||++|++++..|..+..+++|++|+|++|++++..+..|..
T Consensus 314 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 393 (455)
T 3v47_A 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDR 393 (455)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred cChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhcc
Confidence 66777777777777777777777666677777777777777777777766777777777777777777777666666777
Q ss_pred cccccEeecCCcccCCCcc
Q 001226 648 VQSLFELQLGSNIFDGSIP 666 (1119)
Q Consensus 648 l~~L~~L~L~~N~l~~~~p 666 (1119)
+++|+.|++++|++++..|
T Consensus 394 l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 394 LTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CTTCCEEECCSSCBCCCTT
T ss_pred CCcccEEEccCCCcccCCC
Confidence 7777777777777776665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=401.38 Aligned_cols=381 Identities=18% Similarity=0.180 Sum_probs=203.0
Q ss_pred eeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCC-CCCCCCCCCCcEEEcccC
Q 001226 292 KLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTL-PPELGNCGSLVDLRLQHN 370 (1119)
Q Consensus 292 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N 370 (1119)
.++.+++.++.++. + .++|++|+|++|.+++..|..|+++++|++|++++|.+.+.+ +..|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l~~lp~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGLHQVPE--L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCCSSCCC--C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCcccCCC--C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 45555555553322 1 145566666666665555555566666666666666554332 344555555555555555
Q ss_pred cCcccCchhhhcccccceeeccCccccCCCCcc--ccccCcceEEEeecccccccCCcc-ccCCCCcCEEEccCccCccc
Q 001226 371 FIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQ--IGRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFLSLAHNHLTGE 447 (1119)
Q Consensus 371 ~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~ 447 (1119)
++++..|..|.++++|++|+|++|++++..+.. +..+++|++|++++|++++..|.. +.++++|++|++++|++++
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~- 168 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS- 168 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC-
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc-
Confidence 555555555555555555555555555433222 455555555555555555444433 4445555555555555443
Q ss_pred chhhhhccCCccceeccccceeeCccCCccccc--cccceeeccCccccCCCCcc--------ccccccccEEEeccCcc
Q 001226 448 VALELGKHFPYLSRLDLTGNSFYGPIPANICVG--TNLFVLVLGNNRFNGSFPIE--------IGKCSSLRRVILSNNLL 517 (1119)
Q Consensus 448 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~--~~L~~L~L~~N~l~~~~p~~--------~~~l~~L~~L~Ls~N~l 517 (1119)
..|..+..+ .+|+.|++++|.+.+..+.. +..+++|++|++++|++
T Consensus 169 ------------------------~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 224 (455)
T 3v47_A 169 ------------------------ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224 (455)
T ss_dssp ------------------------CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCC
T ss_pred ------------------------cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcc
Confidence 333333322 34444444444444322222 12344555555555555
Q ss_pred ccCCCccccCC---CCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCc--ccccEEEcccCcccCc
Q 001226 518 QGSLPATLERN---PGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNL--ENLQILRLSANKLDGR 592 (1119)
Q Consensus 518 ~~~~p~~~~~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~ 592 (1119)
.+..|..+... ++|+.|++++|.+.+.. +..+.+.+..+..+.++ ++|+.|++++|++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 290 (455)
T 3v47_A 225 KESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFAL 290 (455)
T ss_dssp CHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEE
T ss_pred cccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCcccccc
Confidence 54444433322 44444444444433211 11122222222233322 4566666666666655
Q ss_pred CCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhh
Q 001226 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKL 672 (1119)
Q Consensus 593 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 672 (1119)
+|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|..+++|++|+
T Consensus 291 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~----------------- 353 (455)
T 3v47_A 291 LKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD----------------- 353 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE-----------------
T ss_pred chhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE-----------------
Confidence 566666666666666666666655555666666666666666666655566666666665544
Q ss_pred ccccceeeeccccccCCcccccccccccceeeccCceecccCCccccccccceEEecccccccccCCC
Q 001226 673 HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPA 740 (1119)
Q Consensus 673 ~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~ 740 (1119)
+++|++++..|..|+.+++|++|+|++|+|++..|..+..+++|+.|++++|+++|.+|.
T Consensus 354 --------Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 413 (455)
T 3v47_A 354 --------LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 413 (455)
T ss_dssp --------CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred --------CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence 444444445566677777777777777777755445556777777777777777777774
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=390.04 Aligned_cols=195 Identities=23% Similarity=0.381 Sum_probs=167.3
Q ss_pred HhhCCceeeecCCccEEEEEeC---CCceEEEEEecccc--cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..++||+|+||+||+|+++ .+++.||||++... ...+.+|+++++.+ +|||||++++++.+++..|+||||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~ 101 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY 101 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence 4777899999999999999875 45789999988543 34577899999988 699999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~~~~ 987 (1119)
+++|+|.+++. .+++.+++.++.|++.|++|||++ ||+||||||+|||++.+ +.+||+|||+|+...+..
T Consensus 102 ~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 102 LEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred CCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999984 288999999999999999999999 99999999999999877 799999999998654321
Q ss_pred CC--------------------------CcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 988 SS--------------------------STRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 988 ~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
.. ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 10 112345799999999998775 5899999999999999999999999654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=407.91 Aligned_cols=245 Identities=27% Similarity=0.309 Sum_probs=198.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHH---HHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVE---IRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..++||+|+||+||+|+++.+|+.||||++++. .....+| +.+++.++|||||+++++|.+++..|+
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 467779999999999999999999999999998532 1223334 556667789999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++||+|.+++...+ .+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+...
T Consensus 270 VmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 999999999999998765 499999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.. .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+. ........
T Consensus 344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~---------- 407 (689)
T 3v5w_A 344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL---------- 407 (689)
T ss_dssp SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHH----------
T ss_pred CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhc----------
Confidence 42 2234689999999999864 5799999999999999999999999964321111 11111111
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
......+ ...+.++.+++.+||+.||++|++ ++||++|
T Consensus 408 ~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 408 TMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1111111 112456789999999999999998 7888765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=408.00 Aligned_cols=249 Identities=20% Similarity=0.289 Sum_probs=205.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||+||+|.++.+|+.||+|++... ...+.+|+.+|+.++|||||++++++.+++..|+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 4688889999999999999999999999999988543 345788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC--CceEEEeccccccccCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE--LEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~DfGla~~~~~~~ 987 (1119)
+||+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 237 ~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 237 SGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred CCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999999975432 489999999999999999999999 99999999999999864 89999999999977542
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ..... ... ...
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----~~~~~-i~~----------~~~ 373 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ETLRN-VKS----------CDW 373 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHH-HHT----------TCC
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHH-HHh----------CCC
Confidence 2334568999999999999999999999999999999999999999743111 00000 000 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..........+.++.+++.+||+.||++|||++|+++|
T Consensus 374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00001111224567899999999999999999999986
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=370.60 Aligned_cols=178 Identities=30% Similarity=0.535 Sum_probs=124.7
Q ss_pred ccCCCcHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCce--eeeeeeecCC--CceEEEecCCCcccc--cCccchhhhcc
Q 001226 21 VSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCK--WSGVSCYNNS--SSLKALNLSGFGLSG--VLNNSISYICK 94 (1119)
Q Consensus 21 ~~~~~~~~~ll~~~~~~~~~~~~~~~w~~~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~~~~~~~ 94 (1119)
.|.++|++||++||+++.++. .+.+|+. +++||. |.||+|+..+ ++|+.|+|++++++| .++.. +..
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~---~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~---l~~ 74 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSS---LAN 74 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT---TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGG---GGG
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC---CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChh---HhC
Confidence 367889999999999997654 6779965 357898 9999998654 678888887777776 55532 445
Q ss_pred CCcccEEEcCC-CcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCccccccccccee
Q 001226 95 NQHLLSLDLSG-NEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESI 173 (1119)
Q Consensus 95 l~~l~~L~Ls~-n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L 173 (1119)
+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..+.++++|++|+|++|.+++.+|..+..+++|++|
T Consensus 75 l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (313)
T 1ogq_A 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence 66777777774 66666677777777777777777777766667667777777777777777766666666666666666
Q ss_pred eecccccccccCccCCCcc-cccEEEecccccc
Q 001226 174 GFHNNFLNGELPNDICSLP-KLKSLYLNTNNLT 205 (1119)
Q Consensus 174 ~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~ 205 (1119)
++++|.+++.+|..++.++ +|++|++++|+++
T Consensus 155 ~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~ 187 (313)
T 1ogq_A 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred ECcCCcccCcCCHHHhhhhhcCcEEECcCCeee
Confidence 6666666655665555555 5555555555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=381.30 Aligned_cols=215 Identities=20% Similarity=0.191 Sum_probs=122.2
Q ss_pred CccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCccccc
Q 001226 230 SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQIS 309 (1119)
Q Consensus 230 ~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 309 (1119)
..+..++++++|++|++++|.+++. + .+..+++|++|+|++|++++. | +..+++|++|++++|++++. + ++
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~~~--~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~ 103 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSITDM--T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VT 103 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCCCC--T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CT
T ss_pred ccccChhHcCCCCEEEccCCCcccC--h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cC
Confidence 3444566666666666666666643 2 456666666666666666653 2 56666666666666666654 1 55
Q ss_pred CCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhccccccee
Q 001226 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVL 389 (1119)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L 389 (1119)
.+++|++|++++|++++ +| ++.+++|++|++++|++++. .++.+++|++|++++|...+.+ .+..+++|+.|
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L 175 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL 175 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence 66666666666666664 22 56666666666666666642 2555666666666666433233 35555666666
Q ss_pred eccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceecccccee
Q 001226 390 YLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469 (1119)
Q Consensus 390 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 469 (1119)
++++|++++. | +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| ...++.|+.|++++|++
T Consensus 176 ~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip---~~~l~~L~~L~l~~N~l 245 (457)
T 3bz5_A 176 DCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID---VTPLTQLTYFDCSVNPL 245 (457)
T ss_dssp ECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC---CTTCTTCSEEECCSSCC
T ss_pred ECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC---ccccCCCCEEEeeCCcC
Confidence 6666666542 2 55555666666666665542 25555555555555555554 22 22344455555555554
Q ss_pred eC
Q 001226 470 YG 471 (1119)
Q Consensus 470 ~~ 471 (1119)
++
T Consensus 246 ~~ 247 (457)
T 3bz5_A 246 TE 247 (457)
T ss_dssp SC
T ss_pred CC
Confidence 44
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=380.01 Aligned_cols=359 Identities=18% Similarity=0.180 Sum_probs=209.2
Q ss_pred hhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCC
Q 001226 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSL 338 (1119)
Q Consensus 259 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 338 (1119)
.+..+++|++|++++|++++. | .+..+++|++|++++|+++++ + ++.+++|++|++++|++++. + ++++++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcC
Confidence 445556666666666666643 3 456666666666666666653 1 55566666666666666542 2 5555666
Q ss_pred CeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecc
Q 001226 339 NSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNN 418 (1119)
Q Consensus 339 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 418 (1119)
++|++++|++++. + ++.+++|++|++++|++++. .+..+++|++|++++|+..+.+ .+..+++|++|++++|
T Consensus 109 ~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 109 TYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp CEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence 6666666665542 2 55555566666666655542 2455555555555555333232 2444555555555555
Q ss_pred cccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCC
Q 001226 419 RLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP 498 (1119)
Q Consensus 419 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p 498 (1119)
++++ +| +..+++|+.|++++|+++ +. .+..+++|+.|++++|++++ +|
T Consensus 181 ~l~~-l~--l~~l~~L~~L~l~~N~l~-------------------------~~---~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 181 KITE-LD--VSQNKLLNRLNCDTNNIT-------------------------KL---DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp CCCC-CC--CTTCTTCCEEECCSSCCS-------------------------CC---CCTTCTTCSEEECCSSCCSC-CC
T ss_pred ccce-ec--cccCCCCCEEECcCCcCC-------------------------ee---ccccCCCCCEEECcCCcccc-cC
Confidence 5553 22 444455555555555444 32 24445556666666666664 34
Q ss_pred ccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCccc
Q 001226 499 IEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLEN 578 (1119)
Q Consensus 499 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 578 (1119)
++.+++|+.|++++|++++.. +..+++|+.|++++| +|+.|++++|.+.+.+| ++++++
T Consensus 229 --~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~ 287 (457)
T 3bz5_A 229 --VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRK 287 (457)
T ss_dssp --CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTT
T ss_pred --ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--cccccc
Confidence 556666666666666666543 344556666666554 34556677777666665 456677
Q ss_pred ccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCC
Q 001226 579 LQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGS 658 (1119)
Q Consensus 579 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 658 (1119)
|+.|+|++|.+.+.+|. ..++|+.|++++| ++|++|+|++|+|++. | ++++++|+.|++++
T Consensus 288 L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~ 348 (457)
T 3bz5_A 288 IKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVN 348 (457)
T ss_dssp CCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCS
T ss_pred CCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCC
Confidence 77777777776666664 3455666666655 4677777777777763 3 77777777777777
Q ss_pred cccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCcccc
Q 001226 659 NIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVN 719 (1119)
Q Consensus 659 N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 719 (1119)
|++++ +| .+ ..|++++|+++|. +++..|+.++|++|+|+|.||+.+.
T Consensus 349 N~l~~-l~----~L----~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~ 395 (457)
T 3bz5_A 349 AHIQD-FS----SV----GKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLL 395 (457)
T ss_dssp SCCCB-CT----TG----GGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCB
T ss_pred CCCCC-cc----cc----ccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHh
Confidence 77764 21 12 1255667777764 3556677777777777777776653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=365.14 Aligned_cols=273 Identities=33% Similarity=0.538 Sum_probs=219.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.||+|+||.||+|.++ +++.||||++... ...+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred ccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 5667789999999999999975 4889999988543 2457899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 911 GGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 911 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+|+|.+++..... ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 9999999976542 23589999999999999999999999 9999999999999999999999999999876543333
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC-ceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT-DIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ....|.... .........+++...
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-HTTTCCCSSSSSSCT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-cccccHHHhcChhhc
Confidence 334455689999999999888899999999999999999999999976433221 111111111 111222333333332
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
. ......+..+.+++.+||+.||++|||++|++++|+.+.+..+
T Consensus 275 ~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 275 D--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp T--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred c--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 2 2234567789999999999999999999999999998876554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=363.84 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=210.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+.+++||+|+||+||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 3567789999999999999999999999999987532 345789999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.++++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999987543 489999999999999999999999 9999999999999999999999999999876443221
Q ss_pred C------------cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 990 S------------TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 990 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
. ......||+.|+|||.+.+..++.++||||+|+++|||++|..|+.................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----- 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----- 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH-----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc-----
Confidence 1 11245799999999999999999999999999999999999999875433222211111100
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+.... ...+..+.+++.+||+.||++|||++++++.|++++..
T Consensus 240 -----~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 -----LDRYCP------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp -----HHHTCC------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----ccccCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000 11123578999999999999999999999999998765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=360.37 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=204.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||+||+|.+..+++.||||++.. ....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 467888999999999999999999999999998843 2345788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++|+|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 170 (297)
T 3fxz_A 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170 (297)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence 999999999865 388999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .......... .+..
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~--------~~~~-- 236 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIATNG--------TPEL-- 236 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHHC--------SCCC--
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCC--------CCCC--
Confidence 2334567999999999999999999999999999999999999999643110 0000000000 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.||++|||++|++++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112234567899999999999999999999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=373.07 Aligned_cols=345 Identities=26% Similarity=0.360 Sum_probs=209.7
Q ss_pred CCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEE
Q 001226 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLL 342 (1119)
Q Consensus 263 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 342 (1119)
+.+|+.|+++++.++. +| .+..+++|++|++++|.+++..+ +..+++|++|++++|.+++..+ +.++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 3456666666666653 33 25556666666666666665443 5556666666666666554332 55555555555
Q ss_pred ccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccc
Q 001226 343 LFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG 422 (1119)
Q Consensus 343 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 422 (1119)
+++|.+++..+ +..+++|++|++++|.+++. + .+..+++|+.|+++ |.+.+..+ +..+++|++|++++|.+++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~ 191 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD 191 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCC
Confidence 55555553322 55555555555555555432 2 34455555555553 33332211 4444555555555554442
Q ss_pred cCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcccc
Q 001226 423 RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502 (1119)
Q Consensus 423 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 502 (1119)
. ..+..++ +|++|++++|.+++..| +..+++|+.|++++|++++. ..+.
T Consensus 192 ~--~~l~~l~-------------------------~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 240 (466)
T 1o6v_A 192 I--SVLAKLT-------------------------NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240 (466)
T ss_dssp C--GGGGGCT-------------------------TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred C--hhhccCC-------------------------CCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh
Confidence 1 2244444 44444444444444333 34455566666666665532 2456
Q ss_pred ccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEE
Q 001226 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQIL 582 (1119)
Q Consensus 503 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 582 (1119)
.+++|+.|++++|.+++..| +..+++|+.|++++|++++..+ +..+++|++|+|++|++++..| +..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 66777777777777765544 6667777777777777775433 6677778888888887775443 6777788888
Q ss_pred EcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccC
Q 001226 583 RLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 583 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
+|++|++.+..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|.++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 888888876554 66778888888888888753 467777888888888888887766 777888888888888777
Q ss_pred C
Q 001226 663 G 663 (1119)
Q Consensus 663 ~ 663 (1119)
+
T Consensus 389 ~ 389 (466)
T 1o6v_A 389 N 389 (466)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=368.74 Aligned_cols=258 Identities=24% Similarity=0.433 Sum_probs=210.1
Q ss_pred HHhhCCceeeecCCccEEEEEeC-------CCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-------NSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|+.++.||+|+||.||+|++. .++..||||+++... ..+.+|+.+++.+ +||||+++++++.+++
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 46777899999999999999864 346789999996432 3578899999999 8999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..|+||||+++|+|.+++..... ...+++..+..++.||++|++|||+. +|+||||||+||+++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 99999999999999999987542 23478999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--~~~ 315 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--ELF 315 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 999999999999987765443334445567889999999999999999999999999999999 99998653111 110
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.. ..... ... .+...+..+.+++.+||+.||++||+++|++++|+++.+.
T Consensus 316 ---~~-~~~~~------~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 ---KL-LKEGH------RMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ---HH-HHTTC------CCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HH-HhcCC------CCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00 00000 000 1112345688999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=366.58 Aligned_cols=271 Identities=26% Similarity=0.357 Sum_probs=207.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCc----eEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEH----GFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lV~ 906 (1119)
.+|+..++||+|+||+||+|++. ++.||||+++... ....+|+.+++.++||||+++++++.++.. .++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46777899999999999999876 6899999986433 345668888999999999999999987543 69999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD-------CVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
||+++|+|.++++... +++..+..++.|+++|++|||+. +.++|+||||||+||+++.++.+||+|||+
T Consensus 102 e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 102 AFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp ECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999997643 89999999999999999999976 234899999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYST-----RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
++...............||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ..+......
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~ 255 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM--LPFEEEIGQ 255 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC--CTTHHHHCS
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc--cchhhhhcc
Confidence 9877654444344456799999999988763 456688999999999999999999976432211 111110000
Q ss_pred --ccccccc-----cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1055 --ENHECIC-----FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1055 --~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
....... ...+.+... ......+..+.+++.+||+.||++|||++|+++.|+++.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDY-WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGG-GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCchhhhhhhhhcccCCCCcccc-ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000000 001111100 012234566899999999999999999999999999987653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=363.34 Aligned_cols=280 Identities=34% Similarity=0.603 Sum_probs=221.5
Q ss_pred CCCCHHHHH----HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeee
Q 001226 826 RDLRYEDVI----RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSC 896 (1119)
Q Consensus 826 ~~~~~~~~~----~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~ 896 (1119)
+.+++.++. +|+..+.||+|+||.||+|.+. +++.||||++... ...+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 345556654 5777799999999999999865 4889999998543 23688999999999999999999999
Q ss_pred ecCCceEEEEeccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 897 TKDEHGFIVTEYMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 897 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
.+++..++||||+++|+|.++++.... ...+++..+..++.|++.|++|||+.+.++|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999987543 3358999999999999999999999877799999999999999999999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---CCCCceeehhhhh
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF---GEDTDIVTWTRWK 1052 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~---~~~~~~~~~~~~~ 1052 (1119)
|||+++...... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ........|....
T Consensus 177 Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999998765422 223344569999999999988889999999999999999999999996321 1111112222111
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
. .........+..... ......+..+.+++.+||+.||++|||++|++++|++..
T Consensus 256 ~-~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 L-KEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp T-SSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred h-hchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 1 112222333333322 223556778999999999999999999999999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=364.66 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=202.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++.... ..+.+|+++++.++||||+++++++..++..|+||||
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 5777799999999999999999999999999985432 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++...+ .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 96 ASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp CTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 99999999998765 389999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCcccccccCCCcccccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLT-EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.......||+.|+|||.+.+..++ .++||||+||++|||++|+.||.... .......... ...
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~----------~~~ 231 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRERVLR----------GKY 231 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHH----------CCC
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh----------CCC
Confidence 233456799999999998887765 78999999999999999999996431 1111111100 001
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. .+...+.++.+++.+||+.||++|||++|++++
T Consensus 232 ~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 R----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp C----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 011123467899999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=353.24 Aligned_cols=276 Identities=30% Similarity=0.519 Sum_probs=219.0
Q ss_pred CCCCHHHHHHhhC----------CceeeecCCccEEEEEeCCCceEEEEEecccc--------cccHHHHHHHHhhcCCC
Q 001226 826 RDLRYEDVIRATE----------GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHR 887 (1119)
Q Consensus 826 ~~~~~~~~~~~~~----------~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~ 887 (1119)
..+++.++.+++. ++.||+|+||.||+|.+ +++.||||++... ...+.+|+.+++.++||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4566667665543 38899999999999987 3789999988532 24578899999999999
Q ss_pred CEEEEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 888 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
||+++++++.+++..++||||+++++|.+++........+++..+..++.|+++|+.|||+. +|+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999999999998655445689999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 1047 (1119)
.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||+|+++|||++|+.||...... .....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHH
Confidence 999999999999987654333333345678999999997764 5889999999999999999999999754222 11112
Q ss_pred hhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
+..............+++.+.. .....+..+.+++.+||+.||++|||+++++++|+++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2221112222233344443332 234566788999999999999999999999999998864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=358.28 Aligned_cols=269 Identities=18% Similarity=0.258 Sum_probs=211.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCC--ceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDE--HGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 907 (1119)
+|+..++||+|+||+||+|.+..+++.||||+++.. ...+.+|+++++.++||||+++++++.... ..++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 466778999999999999999999999999998642 245678999999999999999999987655 7799999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCceEEEeccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL----DSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~DfGla~~~ 983 (1119)
|+++++|.+++........+++..+..++.|+++|++|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999998766555599999999999999999999999 99999999999999 78888999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAY--------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
.... ......||+.|+|||.+. +..++.++||||+||++|||++|+.||....................
T Consensus 167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (319)
T 4euu_A 167 EDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (319)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred CCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence 5432 223457899999999765 57789999999999999999999999975433222211111111111
Q ss_pred ccccc----cc------ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1056 NHECI----CF------LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1056 ~~~~~----~~------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
..... .. ..+.++.........+..+.+++.+||+.||++|||++|++++...-
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00000 00 01111222233456677889999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=364.48 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=202.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..+.||+|+||.||+|.++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++.++...|+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 467789999999999999999999999999988532 2457899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----ceEEEecccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL----EPKIGDFGMS 980 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~DfGla 980 (1119)
||||+++|+|.+++.... .+++..+..++.||+.|+.|||+. +|+||||||+||+++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999997654 489999999999999999999999 999999999999998877 7999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. .. ...
T Consensus 167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~--~~-~~i-------- 230 (361)
T 2yab_A 167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QE--TL-ANI-------- 230 (361)
T ss_dssp EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HH--HH-HHH--------
T ss_pred eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HH--HH-HHH--------
Confidence 8765422 23345799999999999988999999999999999999999999964311 00 00 000
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...............+..+.+++.+||+.||++|||++|+++|
T Consensus 231 --~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 231 --TAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp --HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000000011224567899999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=374.30 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=208.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+++++.++||||+++++++.+++..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 3567789999999999999999988999999998643 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.++++..+. .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999986542 488999999999999999999999 999999999999999999999999999986544322
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
........+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ..... ..... ..
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~----~~~~~--------~~ 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREF----VEKGG--------RL 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHH----HHTTC--------CC
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCC--------CC
Confidence 222223346778999999988889999999999999999998 99998653211 00000 00000 00
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
. .+...+..+.+++.+||+.||++|||++++++.|+++.++
T Consensus 335 ~----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 335 P----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 0 0111245678999999999999999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=365.05 Aligned_cols=347 Identities=24% Similarity=0.333 Sum_probs=247.5
Q ss_pred cCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCc
Q 001226 236 SNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQ 315 (1119)
Q Consensus 236 ~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 315 (1119)
..+++|++|++++|.+.. ++ .+..+++|++|+|++|++++..| +.++++|++|++++|++++..+ +..+++|+
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~--~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 115 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-ID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLT 115 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCC
T ss_pred hHhccccEEecCCCCCcc-Cc--chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCC
Confidence 346789999999999874 33 37889999999999999997655 9999999999999999997766 99999999
Q ss_pred EEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCcc
Q 001226 316 VIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNR 395 (1119)
Q Consensus 316 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~ 395 (1119)
+|++++|.+++..+ +.++++|++|++++|.+++. + .+..+++|++|+++ |.+.+. ..+.++++|+.|++++|.
T Consensus 116 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~--~~~~~l~~L~~L~l~~n~ 188 (466)
T 1o6v_A 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL--KPLANLTTLERLDISSNK 188 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC--GGGTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc--hhhccCCCCCEEECcCCc
Confidence 99999999996543 99999999999999999853 3 58999999999997 555533 248999999999999999
Q ss_pred ccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCC
Q 001226 396 IEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPA 475 (1119)
Q Consensus 396 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 475 (1119)
+++. ..+..+++|++|++++|.+++..| +..+++|+.|++++|++++. + .+..+++|+.|++++|.+++..|
T Consensus 189 l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~--~l~~l~~L~~L~l~~n~l~~~~~- 260 (466)
T 1o6v_A 189 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-G--TLASLTNLTDLDLANNQISNLAP- 260 (466)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G--GGGGCTTCSEEECCSSCCCCCGG-
T ss_pred CCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-h--hhhcCCCCCEEECCCCccccchh-
Confidence 9864 348899999999999999996544 78899999999999998753 1 23456666666666666654433
Q ss_pred ccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccc
Q 001226 476 NICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNL 555 (1119)
Q Consensus 476 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 555 (1119)
+..+++|+.|++++|++++..+ +..+++|+.|++++|+++ +..| +..+++|
T Consensus 261 -~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~------------------------~~~~--~~~l~~L 311 (466)
T 1o6v_A 261 -LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE------------------------DISP--ISNLKNL 311 (466)
T ss_dssp -GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS------------------------CCGG--GGGCTTC
T ss_pred -hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc------------------------Cchh--hcCCCCC
Confidence 4445555555555555553222 444455555555555444 3322 4455555
Q ss_pred eEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCc
Q 001226 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635 (1119)
Q Consensus 556 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 635 (1119)
++|+|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|++++|
T Consensus 312 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n 385 (466)
T 1o6v_A 312 TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 385 (466)
T ss_dssp SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCE
T ss_pred CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCC
Confidence 555555555554433 44555555555555555532 245555555666666665555444 555555666666666
Q ss_pred cCcc
Q 001226 636 NLSG 639 (1119)
Q Consensus 636 ~l~~ 639 (1119)
++++
T Consensus 386 ~~~~ 389 (466)
T 1o6v_A 386 AWTN 389 (466)
T ss_dssp EEEC
T ss_pred cccC
Confidence 5554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.09 Aligned_cols=256 Identities=30% Similarity=0.446 Sum_probs=198.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||+||+|++. ++.||||++.... ..+.+|+.++++++||||+++++++.+++..++||||
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred HceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 5677799999999999999874 7889999985432 3577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
+++|+|.+++........+++..+..++.|+++|++|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999998765444589999999999999999999999 8 999999999999999999999999999755432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ......... ...
T Consensus 193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~-----------~~~ 257 (309)
T 3p86_A 193 --FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFK-----------CKR 257 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHS-----------CCC
T ss_pred --ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc-----------CCC
Confidence 12233457899999999999999999999999999999999999999643111 000000000 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.. .+...+..+.+++.+||+.||++|||++++++.|+++.+...
T Consensus 258 ~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 258 LE----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 00 011223467899999999999999999999999999877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=362.31 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=204.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 3577789999999999999999999999999998432 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999997654 489999999999999999999999 999999999999999999999999999987654333
Q ss_pred CCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
........||+.|+|||.+.+..+ +.++||||+||++|||++|+.||............ +..... ..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~~-----~~---- 228 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKT-----YL---- 228 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH---HHTTCT-----TS----
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hhcccc-----cC----
Confidence 333445689999999999877665 77899999999999999999999754322221111 111000 00
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+..+.+++.+||+.||++|||++|++++
T Consensus 229 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011224467899999999999999999999886
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=350.18 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=205.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|++..+++.||+|++... ...+.+|+..++.++||||+++++++.+++..|+|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 567779999999999999999999999999987321 1357789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 92 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 92 YIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 999999999998765 489999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
........||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ ............. ...
T Consensus 166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~----~~~ 236 (294)
T 4eqm_A 166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIKHIQDSVPNVT----TDV 236 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHHHHSSCCCCHH----HHS
T ss_pred -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHhhccCCCcc----hhc
Confidence 2223345799999999999999999999999999999999999999964311100 0000000000000 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHcccccCC
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRP-SMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ell~~L~~~~~~~~ 1114 (1119)
....+..+.+++.+|++.||++|| +++++.+.|+++..+..
T Consensus 237 ------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 237 ------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp ------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred ------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 011245688999999999999999 99999999999876654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=360.08 Aligned_cols=248 Identities=20% Similarity=0.303 Sum_probs=204.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 567789999999999999999999999999998643 24577899999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--CCceEEEeccccccccCCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS--ELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~DfGla~~~~~~~~~ 989 (1119)
|+|.+++..... .+++..+..++.|+++|+.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 86 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--- 157 (321)
T 1tki_A 86 LDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--- 157 (321)
T ss_dssp CBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC---
Confidence 999999976532 489999999999999999999999 9999999999999987 789999999999876442
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .. .... +.......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~---~~~~----------i~~~~~~~ 222 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQ---IIEN----------IMNAEYTF 222 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HH---HHHH----------HHHTCCCC
T ss_pred CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HH---HHHH----------HHcCCCCC
Confidence 223446789999999999888899999999999999999999999964311 00 0000 00111110
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+.++.+++.+|++.||++|||++|++++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000111234578899999999999999999999985
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=360.02 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=206.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc---eEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR---KHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+..++ ..||||+++.. ...+.+|+.+++.++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 35667799999999999999987544 45999998643 24578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.++++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999976543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 986 SHS-SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 986 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... ........+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... .... . .. .. .
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~--~-~~-~~------~ 271 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVIS--S-VE-EG------Y 271 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHH--H-HH-TT------C
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHH--H-HH-cC------C
Confidence 322 112233456788999999988889999999999999999998 99998643111 1000 0 00 00 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
.. ..+...+..+.+++.+||+.||++|||++++++.|+++.+..+.
T Consensus 272 --~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 272 --RL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --CC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 00 01112345788999999999999999999999999999876653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=357.41 Aligned_cols=248 Identities=22% Similarity=0.298 Sum_probs=203.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.++...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4678889999999999999999999999999988532 245889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----ceEEEeccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL----EPKIGDFGM 979 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~DfGl 979 (1119)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999997654 489999999999999999999999 999999999999999887 799999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
++...... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .......
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~------- 230 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVS------- 230 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHH-------
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHH-------
Confidence 98765322 223457999999999999889999999999999999999999999643110 0000000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..............+..+.+++.+||+.||++|||++|++++
T Consensus 231 ----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 ----AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000000011224567899999999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=356.85 Aligned_cols=245 Identities=24% Similarity=0.327 Sum_probs=203.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|+++.+++.||+|++++. ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 3567779999999999999999999999999998532 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++...+ .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999998654 489999999999999999999999 9999999999999999999999999999854321
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ........ ...
T Consensus 159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~----------~~~ 221 (337)
T 1o6l_A 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELIL----------MEE 221 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH----------HCC
T ss_pred --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHHH----------cCC
Confidence 1233456799999999999999999999999999999999999999964211 00101000 011
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
... +...+..+.+++.+||+.||++|| +++|+++|
T Consensus 222 ~~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 110 111234678999999999999999 89999876
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=357.34 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=200.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|...+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3577779999999999999999999999999998532 245889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+ +|+|.+++...+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 789999987654 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ......||+.|+|||.+.+..+ ++++||||+||++|||++|+.||........ ... ....
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--~~~-------------i~~~ 223 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--FKK-------------VNSC 223 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--BCC-------------CCSS
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--HHH-------------HHcC
Confidence 2 2334579999999999988776 6899999999999999999999975321111 000 0000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. ..+...+..+.+++.+||+.||++|||++|++++
T Consensus 224 ~~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VY----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CC----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CC----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00 0011123467899999999999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=352.54 Aligned_cols=244 Identities=23% Similarity=0.334 Sum_probs=200.4
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
...+.||+|+||.||+|.+..+|+.||||+++.. ...+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 127 (321)
T 2c30_A 48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127 (321)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCC
Confidence 3346899999999999999988999999998532 245789999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 128 ~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 198 (321)
T 2c30_A 128 ALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR 198 (321)
T ss_dssp BHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCB
T ss_pred CHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--ccc
Confidence 999998753 389999999999999999999999 99999999999999999999999999998765422 223
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ......... ...+.. .
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~~~~~~--------~~~~~~----~ 262 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLRD--------SPPPKL----K 262 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH--------SSCCCC----T
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhc--------CCCCCc----C
Confidence 456799999999999999999999999999999999999999964311 000000000 000000 0
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+||+.||++|||++|++++
T Consensus 263 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 263 NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111224467899999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.85 Aligned_cols=265 Identities=17% Similarity=0.232 Sum_probs=212.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++.. ....+.+|+.+++.+ +|++++++++++.++...++||||+ +
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 89 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 89 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-C
Confidence 46677899999999999999999999999998853 445789999999999 7999999999999999999999999 9
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc-----eEEEeccccccccCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE-----PKIGDFGMSKLISDS 986 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~DfGla~~~~~~ 986 (1119)
++|.+++...+. .+++..+..++.|+++|++|||+. +|+||||||+||+++.++. +||+|||+++.....
T Consensus 90 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 90 PSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999987643 489999999999999999999999 9999999999999988776 999999999877543
Q ss_pred CCC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 987 HSS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 987 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......... ..........
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~----- 238 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQ----- 238 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHH-----
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhcc-----
Confidence 221 12345679999999999999999999999999999999999999997542211110 0000000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
..... ......+..+.+++.+||+.||++||++++|++.|+++.++.+..
T Consensus 239 --~~~~~---~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 239 --STPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp --HSCHH---HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --CccHH---HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 00000 000112457889999999999999999999999999998775543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=361.70 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=203.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc---------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+|+..+.||+|+||+||+|.++.+++.||||+++. ....+.+|+.+++.++||||+++++++.+++..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 368888999999999999999999999999998842 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc---eEEEecccc
Q 001226 905 VTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMS 980 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~DfGla 980 (1119)
||||+++++|.+++.... ....+++..+..++.||++|++|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988876532 223589999999999999999999999 9999999999999987654 999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
+...... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.... .. .+..
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~--~~~~---------- 243 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ER--LFEG---------- 243 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HH--HHHH----------
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HH--HHHH----------
Confidence 8765422 22334579999999999999899999999999999999999999996421 10 0000
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
................+..+.+++.+||+.||++|||++|+++|
T Consensus 244 -i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 244 -IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000000000011224578899999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.54 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=206.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.++. +..||+|+++.. ..++.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 356777899999999999998875 678999998643 3568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+....... ..
T Consensus 87 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YV 160 (268)
T ss_dssp TCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EE
T ss_pred CCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh-hh
Confidence 9999999987542 489999999999999999999999 99999999999999999999999999998765432 12
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||........ ..... ... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~--~~~------~~~--- 225 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV----VLKVS--QGH------RLY--- 225 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHH--TTC------CCC---
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH----HHHHH--cCC------CCC---
Confidence 2233456778999999988889999999999999999998 9999864311100 00000 000 000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.+...+..+.+++.+||+.||++|||++|++++|++++++..
T Consensus 226 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 226 ---RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp ---CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred ---CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 001123467899999999999999999999999999988754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=367.41 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=202.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||+||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 4788889999999999999999999999999998543 2457899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCceEEEecccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD---SELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~DfGla~~~~ 984 (1119)
|+++|+|.+++.... .+++..+..++.||+.|+.|||+. +|+||||||+||+++ .++.+||+|||+++...
T Consensus 91 ~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 91 LVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp CCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999998765 489999999999999999999999 999999999999998 46789999999998665
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. .+.... .
T Consensus 165 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~--~~~~i~-----------~ 227 (444)
T 3soa_A 165 GEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HR--LYQQIK-----------A 227 (444)
T ss_dssp TTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH--HHHHHH-----------H
T ss_pred CCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HH--HHHHHH-----------h
Confidence 422 223346799999999999998999999999999999999999999964211 00 000000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+..+.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000011224567899999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=360.17 Aligned_cols=248 Identities=22% Similarity=0.337 Sum_probs=202.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||.||+|.++.+++.||+|+++... ..+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47888899999999999999999999999999985432 357789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceEEEecccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPKIGDFGMSKLIS 984 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~DfGla~~~~ 984 (1119)
|+++|+|.+++.... .+++..+..++.||++|++|||+. +|+||||||+||+++.++ .+||+|||++....
T Consensus 109 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 109 LVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999987654 489999999999999999999999 999999999999998654 59999999998765
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. .+.. ...
T Consensus 183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~--~~~~-i~~---------- 244 (362)
T 2bdw_A 183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HR--LYAQ-IKA---------- 244 (362)
T ss_dssp TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--HHHH-HHH----------
T ss_pred CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HH--HHHH-HHh----------
Confidence 422 22345799999999999998999999999999999999999999964311 00 0000 000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+..+.+++.+||+.||++||+++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000001111234567899999999999999999999876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.59 Aligned_cols=261 Identities=16% Similarity=0.193 Sum_probs=210.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++.. ....+.+|+.+++.+ +||||+++++++.+++..++||||+ +
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 46667899999999999999999999999998853 345789999999999 8999999999999999999999999 9
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc-----eEEEeccccccccCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE-----PKIGDFGMSKLISDS 986 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----vkl~DfGla~~~~~~ 986 (1119)
++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||+++.....
T Consensus 89 ~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 89 PSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999999987532 589999999999999999999999 9999999999999999887 999999999876543
Q ss_pred CCCC-----cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 987 HSSS-----TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 987 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......... .......
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-~~~~~i~--------- 233 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-ERYQKIG--------- 233 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-HHHHHHH---------
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-HHHHHHH---------
Confidence 2211 234568999999999999999999999999999999999999999754221110 0000000
Q ss_pred cccccccCCCch-HHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1062 FLDREISFWDSD-DQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1062 ~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.......... ....+ .+.+++.+||+.||++||++++|++.|+++.++.+
T Consensus 234 --~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 234 --DTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp --HHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --hhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 0000000000 00113 78899999999999999999999999998876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.01 Aligned_cols=254 Identities=22% Similarity=0.387 Sum_probs=207.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+.. ++.||+|++... ..++.+|+.++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 356777899999999999999875 778999998643 3568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 89 ~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 9999999976543 589999999999999999999999 99999999999999999999999999998664321 11
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... . ...... .. ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~---~~~~~~-~~------~~~~--- 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--E---VVEDIS-TG------FRLY--- 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H---HHHHHH-TT------CCCC---
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--H---HHHHHh-cC------ccCC---
Confidence 2233456788999999988889999999999999999999 99998643111 0 000000 00 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+...+..+.+++.+||+.||++|||++|++++|+++.++
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 228 ---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0111245678999999999999999999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=361.52 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=207.9
Q ss_pred HhhCCceeeecCCccEEEEEeC-----CCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..+.||+|+||.||+|.+. .+++.||||+++.. ...+.+|+.+++.++||||+++++++.+++..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 5667789999999999999987 34589999998643 2457889999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001226 905 VTEYMPGGTLFNVLHQNEP---------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDN 963 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 963 (1119)
||||+++|+|.+++..... ...+++.+++.++.||++|+.|||+. +|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence 9999999999999987532 13589999999999999999999999 99999999999
Q ss_pred eEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001226 964 ILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGED 1042 (1119)
Q Consensus 964 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 1042 (1119)
|+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 283 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-
Confidence 9999999999999999987654333333445578899999999888889999999999999999999 99998643110
Q ss_pred CceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
. ...... +..... .+...+..+.+++.+||+.||++|||+++++++|+++.++.+...
T Consensus 284 -~---~~~~~~----------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~~ 341 (343)
T 1luf_A 284 -E---VIYYVR----------DGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTV 341 (343)
T ss_dssp -H---HHHHHH----------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC------
T ss_pred -H---HHHHHh----------CCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhhc
Confidence 0 000000 000000 011223468899999999999999999999999999999887653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=364.61 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=207.6
Q ss_pred HHhhCCceeeecCCccEEEEE-----eCCCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC-c
Q 001226 834 IRATEGRIIGKGKHGTVYRTL-----SNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE-H 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 901 (1119)
.+|...+.||+|+||.||+|+ ...+++.||||+++... ..+.+|+++++.+ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 367778999999999999998 55667999999986532 3478899999999 7999999999988754 4
Q ss_pred eEEEEeccCCCCHHHhhccCCC----------------------------------------------------------
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEP---------------------------------------------------------- 923 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 923 (1119)
.++||||+++|+|.++++....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999999999999986542
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccC
Q 001226 924 -----RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGS 998 (1119)
Q Consensus 924 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt 998 (1119)
...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...............+|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 11288999999999999999999999 9999999999999999999999999999876554433444556789
Q ss_pred CCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHH
Q 001226 999 LGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLK 1077 (1119)
Q Consensus 999 ~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1119)
+.|+|||.+.+..++.++||||+||++|||++ |+.||........ . ........ .... +...
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~--~~~~~~~~--------~~~~------~~~~ 321 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F--CRRLKEGT--------RMRA------PDYT 321 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-H--HHHHHHTC--------CCCC------CTTC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-H--HHHHHcCC--------CCCC------CCCC
Confidence 99999999988899999999999999999998 9999865321111 0 00000000 0000 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1078 ALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1078 ~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
+..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 322 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 322 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 34678999999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=358.62 Aligned_cols=273 Identities=25% Similarity=0.380 Sum_probs=203.3
Q ss_pred HHhhCCceeeecCCccEEEEE----eCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeec--CCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTL----SNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 903 (1119)
.+|+..+.||+|+||+||+|+ +..+++.||||++.... ..+.+|+.+++.++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 356777999999999999998 56678999999986433 457889999999999999999999855 35689
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999987643 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
...... .......++..|+|||.+.+..++.++||||+|+++|||++|..|+.....+.....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 543221 2233445778899999998889999999999999999999999998642110000000000000000000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+...... ..+...+..+.+++.+||+.||++|||++|+++.|+++.++-
T Consensus 245 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 245 LKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHTTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HhccCcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 0000000 011223457889999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=361.95 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=195.6
Q ss_pred HHhhCCceeeecCCccEEEEEeC---CCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|++. .++..||||+++.. ...+.+|+.++++++||||+++++++.+++..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46788899999999999999876 45778999998643 24578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.++++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999986543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 986 SHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 986 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ... .. +
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--~~~---~~-----------i 263 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVI---KA-----------V 263 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--HHH---HH-----------H
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HH-----------H
Confidence 3211 12222345778999999988899999999999999999997 99998643111 100 00 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
....... .+...+..+.+++.+||+.||++||++++|++.|+++.+.
T Consensus 264 ~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 DEGYRLP--PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HTTEECC--CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HcCCCCC--CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0000000 0112245688999999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=349.85 Aligned_cols=260 Identities=27% Similarity=0.356 Sum_probs=199.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhh--cCCCCEEEEeeeeec----CCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSL--VRHRNILRIVGSCTK----DEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~lV~e 907 (1119)
+|+..+.||+|+||+||+|.+ +++.||||++... ...+..|.+++.. ++||||+++++++.+ ....++|||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 567778999999999999987 4789999998654 3445566666665 789999999998654 345799999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH--------YDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
|+++|+|.++++.. .+++..+..++.|++.|++||| +. +|+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 87 YHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp CCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred hccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 99999999999643 4899999999999999999999 66 999999999999999999999999999
Q ss_pred cccccCCCCCC--cccccccCCCcccccccCCC------CCCCcchHHHHHHHHHHHHhC----------CCCCCCCCCC
Q 001226 980 SKLISDSHSSS--TRSAIVGSLGYIAPENAYST------RLTEKSDVYSYGVILFELLFR----------KMPVDPSFGE 1041 (1119)
Q Consensus 980 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslG~vl~elltg----------~~p~~~~~~~ 1041 (1119)
++......... ......||+.|+|||.+.+. .++.++||||+||++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 98665432211 12345799999999988776 445789999999999999999 7777654333
Q ss_pred CCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1042 DTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
.............. ...+.... .......+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 240 DPSFEDMRKVVCVD------QQRPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp SCCHHHHHHHHTTS------CCCCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcchhhhhHHHhcc------CCCCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 22221111111000 00011110 0112345678899999999999999999999999999863
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.83 Aligned_cols=255 Identities=23% Similarity=0.319 Sum_probs=202.3
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 904 (1119)
+.+|+..++||+|+||.||+|+++.+++.||+|++++. ...+.+|..+++++ +||||+++++++.+++..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 34677889999999999999999999999999998542 23477899999877 89999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++|+|.+++...+ .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998754 489999999999999999999999 99999999999999999999999999998532
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||......+.......... ......
T Consensus 205 ~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~------~~~i~~ 276 (396)
T 4dc2_A 205 R--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL------FQVILE 276 (396)
T ss_dssp C--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH------HHHHHH
T ss_pred c--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH------HHHHhc
Confidence 2 12234456899999999999999999999999999999999999999975322111100000000 000011
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSM------REVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ell~~ 1105 (1119)
..... +...+.++.+++.+||+.||++||++ +|+++|
T Consensus 277 ~~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 KQIRI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCC----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cccCC----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11111 11224467899999999999999985 677654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=353.75 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=209.7
Q ss_pred HHhhCCceeeecCCccEEEEEeC-----CCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|...+.||+|+||.||+|.+. .+++.||||+++... ..+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 46777899999999999999873 456899999986432 45778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001226 904 IVTEYMPGGTLFNVLHQNEP---------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSD 962 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 962 (1119)
+||||+++++|.+++..... ...+++..+..++.|+++|++|||+. +|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchh
Confidence 99999999999999987542 12488999999999999999999999 9999999999
Q ss_pred CeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 001226 963 NILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGE 1041 (1119)
Q Consensus 963 Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 1041 (1119)
||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655433333444567889999999988889999999999999999999 99998653211
Q ss_pred CCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1042 DTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.... ... ... ... .+...+..+.+++.+||+.||++||+++|++++|+++.++
T Consensus 260 --~~~~--~~~--~~~------~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 260 --RLFN--LLK--TGH------RME------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp --GHHH--HHH--TTC------CCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HHHH--Hhh--cCC------cCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1100 000 000 000 0112245688999999999999999999999999998765
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=355.39 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=200.4
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCC-------
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDE------- 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 900 (1119)
+.+|+..+.||+|+||.||+|+++.+++.||||+++. ..+.+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4578888999999999999999999999999999853 2245789999999999999999999886543
Q ss_pred --------------------------------------------------ceEEEEeccCCCCHHHhhccCCCCCCCCHH
Q 001226 901 --------------------------------------------------HGFIVTEYMPGGTLFNVLHQNEPRLVLDWN 930 (1119)
Q Consensus 901 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~ 930 (1119)
..++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 279999999999999999987665567788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC----------CcccccccCCC
Q 001226 931 TRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS----------STRSAIVGSLG 1000 (1119)
Q Consensus 931 ~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~----------~~~~~~~gt~~ 1000 (1119)
.+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 9999999999999999999999999999877543211 22344579999
Q ss_pred cccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHH
Q 001226 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALR 1080 (1119)
Q Consensus 1001 y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1080 (1119)
|+|||.+.+..++.++||||+||++|||++|..|+... ..... ..... ............
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~----------~~~~~---~~~~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIIT----------DVRNL---KFPLLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHH----------HHHTT---CCCHHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHH----------Hhhcc---CCCcccccCChh
Confidence 99999999999999999999999999999987664210 00000 00000 111222344556
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1081 LLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1081 l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+.+++.+||+.||++|||++|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=365.65 Aligned_cols=259 Identities=27% Similarity=0.385 Sum_probs=207.2
Q ss_pred HHhhCCceeeecCCccEEEEEe-----CCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.. ..+++.||||+++.. ...+.+|+.+++.++||||+++++++.++...+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 3567779999999999999994 446788999998542 235778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP----RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~D 976 (1119)
+||||+++|+|.+++..... ...+++..++.++.|+++|++|||+. +|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999986542 23589999999999999999999999 999999999999999655 599999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||..... .... ......
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~---~~i~~~ 302 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVL---EFVTSG 302 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH---HHHHTT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH---HHHHcC
Confidence 999986654333344455678999999999988899999999999999999998 9999864311 1100 000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
. .. ..+...+..+.+++.+||+.||++|||+++|+++++.+.+..
T Consensus 303 -~--------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 303 -G--------RM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -C--------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -C--------CC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0 00 001122346789999999999999999999999999887643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=351.82 Aligned_cols=242 Identities=27% Similarity=0.422 Sum_probs=202.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|+++.+++.||+|++++. ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 4577789999999999999999999999999998532 345678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 9999999999998754 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...+. . ++...
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~-~----------i~~~~ 219 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYE-K----------ILNAE 219 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHH-H----------HHHCC
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHH-H----------HHhCC
Confidence 22345799999999999999999999999999999999999999964311 00000 0 01111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
... +...+.++.+++.+|++.||++|| +++|+++|
T Consensus 220 ~~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 LRF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111 011234678999999999999999 89999865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=364.83 Aligned_cols=272 Identities=18% Similarity=0.258 Sum_probs=213.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCC--ceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDE--HGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 907 (1119)
+|+..++||+|+||.||+|.+..+++.||||+++.. ...+.+|+++++.++||||+++++++.+.. ..++|||
T Consensus 10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 466778999999999999999999999999998642 245678999999999999999999988655 6799999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCceEEEeccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL----DSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~DfGla~~~ 983 (1119)
|+++|+|.+++........+++..++.++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999998765544599999999999999999999999 99999999999999 77888999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCC--------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYS--------TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....................
T Consensus 167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 243 (396)
T 4eut_A 167 EDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243 (396)
T ss_dssp CCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred cCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence 5422 2234578999999997754 4677899999999999999999999976543332222111111111
Q ss_pred cccccc----c------ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1056 NHECIC----F------LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1056 ~~~~~~----~------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
...... . ....+.............+.+++.+||+.||++||+++|+++.++++.++
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 100000 0 01112222223356677889999999999999999999999999887654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=359.11 Aligned_cols=246 Identities=26% Similarity=0.328 Sum_probs=201.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4677789999999999999999999999999998532 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++.... .+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999998754 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCCcccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||......... .........
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~-------- 235 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFETT-------- 235 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHHC--------
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhhc--------
Confidence 23345679999999998864 45899999999999999999999999753222111 110000000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPS-MREVVG 1104 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~ell~ 1104 (1119)
... .+...+..+.+++.+||+.||++||+ ++++.+
T Consensus 236 --~~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 --VVT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --ccC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000 01112356789999999999999998 777765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=356.42 Aligned_cols=255 Identities=24% Similarity=0.403 Sum_probs=200.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceE----EEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKH----WAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~----vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+|+..++||+|+||+||+|.+..+++. ||+|.++. ....+.+|+.+++.++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 3567779999999999999998776654 58887743 2346888999999999999999999998754 789
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|+||+++|+|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999987643 489999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... ......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~-------------- 232 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSIL-------------- 232 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH--------------
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHH--------------
Confidence 5444334444567889999999999999999999999999999999 99999753211 111000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
...... ..+...+..+.+++.+||+.+|++||+++|++++|+++...
T Consensus 233 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 233 EKGERL--PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HTTCCC--CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HcCCCC--CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 000000 00112234678999999999999999999999999987653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=365.43 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=201.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..++||+|+||+||+|+++.+++.||+|++++ ....+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 56667899999999999999999999999999853 23458899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|++||+|.++++.. .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999764 388999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCCcccccccCCCcccccccCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTR----LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.......+||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... ...+.. ++
T Consensus 223 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~-----------i~ 286 (410)
T 3v8s_A 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSK-----------IM 286 (410)
T ss_dssp -EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHH-----------HH
T ss_pred -cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----hhHHHH-----------HH
Confidence 11233567999999999887654 78999999999999999999999974311 000000 00
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~ 1105 (1119)
..............+..+.+++.+|++.+|.+ ||+++||++|
T Consensus 287 ~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 287 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp THHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred hccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00000000001112356789999999999998 9999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=352.90 Aligned_cols=253 Identities=22% Similarity=0.369 Sum_probs=201.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceE----EEEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKH----WAVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~----vavK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|+..+.||+|+||.||+|.+..+++. ||+|++.. ....+.+|+.+++.++||||+++++++. ++..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 566678999999999999998877765 77777632 2245778999999999999999999986 5678999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999986532 488889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... ......... .....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~--~~~~~----- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKG--ERLAQ----- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTT--CBCCC-----
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcC--CCCCC-----
Confidence 444444455678889999999988899999999999999999999 99999753211 111110000 00000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
+...+..+.+++.+||+.||++|||++|++++|+++..
T Consensus 239 ---------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 ---------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00112346789999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=360.06 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=211.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-------CceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|..+++||+|+||.||+|.+.. .+..||||+++... ..+.+|+++++.+ +||||+++++++.+++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 367778999999999999999643 34679999986432 4577899999999 8999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..++||||+++|+|.+++..... ...+++..++.++.|++.|++|||+. +|+||||||+||+++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 99999999999999999987542 23589999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... .
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~-- 301 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E-- 301 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H--
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H--
Confidence 999999999999987765443344445567889999999999999999999999999999999 99998643111 1
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
........ . .... +...+.++.+++.+||+.||++|||++|++++|+++.....
T Consensus 302 -~~~~~~~~-~------~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 -LFKLLKEG-H------RMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp -HHHHHHTT-C------CCCC------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -HHHHHHcC-C------CCCC------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11100000 0 0000 11123468899999999999999999999999999876554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=357.33 Aligned_cols=263 Identities=23% Similarity=0.386 Sum_probs=208.6
Q ss_pred HHhhCCceeeecCCccEEEEEe-----CCCceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+..+.||+|+||.||+|.+ ..++..||||+++.. ...+.+|+.+++++ +||||+++++++..++..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 4667789999999999999997 345678999998532 34578999999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPR--------------------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSD 962 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~ 962 (1119)
++||||+++|+|.+++...... ..+++..+..++.|+++|++|||+. +|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence 9999999999999999875431 2378999999999999999999999 9999999999
Q ss_pred CeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCC
Q 001226 963 NILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGE 1041 (1119)
Q Consensus 963 Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~ 1041 (1119)
||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||+||++|||++ |+.||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999987755443334445667889999999988889999999999999999998 99998654211
Q ss_pred CCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1042 DTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
. ....... .. ..... +...+..+.+++.+||+.||++|||++|++++|+.+....+.+
T Consensus 282 ~-~~~~~~~----~~------~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 282 A-NFYKLIQ----NG------FKMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp H-HHHHHHH----TT------CCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred H-HHHHHHh----cC------CCCCC------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 1 1000000 00 00000 1112456789999999999999999999999999998876654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=360.26 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=197.5
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 904 (1119)
+.+|+..++||+|+||.||+|+++.+++.||||++++. ...+.+|.++++.+ +||||+++++++.+++..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 34677789999999999999999999999999998642 23467899999988 69999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++|+|.+++...+ .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999998764 489999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||..... .. ..... ..
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~---~~~~i----------~~ 238 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DD---LFEAI----------LN 238 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHH----------HH
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HH---HHHHH----------Hc
Confidence 21 2233456799999999999888899999999999999999999999964311 00 00000 01
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSM------REVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ell~~ 1105 (1119)
..... +...+..+.+++.+|++.||++||++ +|+++|
T Consensus 239 ~~~~~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 239 DEVVY----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCC----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11110 11123467899999999999999998 777764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=348.70 Aligned_cols=246 Identities=27% Similarity=0.386 Sum_probs=195.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------------------------------cccHHHHHHHHhh
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------------------------ETNFDVEIRTLSL 883 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------------------------~~~~~~E~~~l~~ 883 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... .+.+.+|+.+++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 3677789999999999999999999999999998532 2457889999999
Q ss_pred cCCCCEEEEeeeeec--CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 001226 884 VRHRNILRIVGSCTK--DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKS 961 (1119)
Q Consensus 884 l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp 961 (1119)
++||||+++++++.+ ++..++||||+++++|.+++... .+++..+..++.|+++|++|||+. +|+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 999999999999986 56789999999999998875432 489999999999999999999999 999999999
Q ss_pred CCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 962 DNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR---LTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 962 ~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
+||+++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999998765422 2233457999999999887655 377899999999999999999999642
Q ss_pred CCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1039 FGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ........... .... ......+..+.+++.+||+.||++|||++|+++|
T Consensus 244 ~-----~~~~~~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 R-----IMCLHSKIKSQ----------ALEF--PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp S-----HHHHHHHHHHC----------CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred c-----HHHHHHHHhcc----------cCCC--CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1 10110000000 0000 0001123467899999999999999999999865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=353.95 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=183.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEeccCCCCHHH
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 916 (1119)
++.||+|+||.||+|.++.+++.||||++... ...+.+|+.+++.++ ||||+++++++.++...|+||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 47899999999999999999999999998654 456788999999997 9999999999999999999999999999999
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceEEEeccccccccCCCCCCccc
Q 001226 917 VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPKIGDFGMSKLISDSHSSSTRS 993 (1119)
Q Consensus 917 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~DfGla~~~~~~~~~~~~~ 993 (1119)
++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||+++...... ....
T Consensus 96 ~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~ 167 (325)
T 3kn6_A 96 RIKKKK---HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLK 167 (325)
T ss_dssp HHHHCS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cccc
Confidence 998764 489999999999999999999999 999999999999997765 89999999998654322 2233
Q ss_pred ccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCch
Q 001226 994 AIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073 (1119)
Q Consensus 994 ~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1073 (1119)
...+|+.|+|||.+.+..++.++||||+||++|||++|+.||............... ...+...........
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~--------~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI--------MKKIKKGDFSFEGEA 239 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHH--------HHHHTTTCCCCCSHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHH--------HHHHHcCCCCCCccc
Confidence 456899999999999999999999999999999999999999754221110000000 000111111111111
Q ss_pred HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1074 DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1074 ~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+.++.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 22345678999999999999999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=357.11 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=204.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
.+|+..+.||+|+||.||+|.++.+++.||||+++.......+|+.++.++ +||||+++++++.+++..|+||||+++|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 478888999999999999999999999999999987777788899999888 7999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC----CceEEEeccccccccCCCC
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE----LEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~----~~vkl~DfGla~~~~~~~~ 988 (1119)
+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||++..+ +.+||+|||+++......
T Consensus 102 ~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~- 174 (342)
T 2qr7_A 102 ELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN- 174 (342)
T ss_dssp BHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-
Confidence 9999998654 489999999999999999999999 99999999999998543 359999999998765422
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ......... .....
T Consensus 175 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i~----------~~~~~ 241 (342)
T 2qr7_A 175 -GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARIG----------SGKFS 241 (342)
T ss_dssp -CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHHH----------HCCCC
T ss_pred -CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHHc----------cCCcc
Confidence 22334578999999999887778999999999999999999999997532111 111111000 00011
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.........+..+.+++.+||+.||++||+++|+++|
T Consensus 242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111234567899999999999999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=374.18 Aligned_cols=256 Identities=23% Similarity=0.377 Sum_probs=210.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|.++.++..||||+++.. ..++.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~ 300 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 300 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence 566778999999999999999988999999999643 35688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.++++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 301 g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 375 (495)
T 1opk_A 301 GNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTA 375 (495)
T ss_dssp CBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EEC
T ss_pred CCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc-eee
Confidence 999999987542 3589999999999999999999999 99999999999999999999999999998765422 222
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+|+.|+|||.+....++.++|||||||++|||++ |+.||...... ..... +....+.
T Consensus 376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~--------------~~~~~~~- 438 (495)
T 1opk_A 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYEL--------------LEKDYRM- 438 (495)
T ss_dssp CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHH--------------HHTTCCC-
T ss_pred cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------------HHcCCCC-
Confidence 233456789999999988889999999999999999999 99998653211 11000 0111100
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..+...+..+.+++.+||+.||++|||+++|++.|+++.++.
T Consensus 439 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 439 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred -CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 011123456789999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.04 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=198.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||+||+|.++.+++.||+|+++... ..+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 5677789999999999999999999999999985322 4567899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++ ++.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 154 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154 (292)
T ss_dssp CSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence 975 66666655432 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccCCCcccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc-cccc---ccc--
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ-ENHE---CIC-- 1061 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~---~~~-- 1061 (1119)
........+|+.|+|||.+.+.. ++.++||||+||++|||++|..||................... .... ...
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 22334457899999999887765 7999999999999999999998875432211111100000000 0000 000
Q ss_pred -cc----cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 -FL----DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 -~~----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. .+............+..+.+++.+|++.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000000001111234567899999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=354.56 Aligned_cols=243 Identities=21% Similarity=0.310 Sum_probs=203.1
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.+|+..+.||+|+||.||+|+++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35677889999999999999999999999999998532 24577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998754 389999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. .....||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ...+.. . ...
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~-i----------~~~ 253 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQIYEK-I----------VSG 253 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHH-H----------HHC
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH----HHHHHH-H----------HcC
Confidence 2 2345799999999999999999999999999999999999999964311 000000 0 001
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.... +...+..+.+++.+||+.||++||+ ++|+++|
T Consensus 254 ~~~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 254 KVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1110 0112356789999999999999998 8988875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=351.88 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=212.5
Q ss_pred HHhhCCceeeecCCccEEEEEe-----CCCceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+..+.||+|+||.||+|.+ ..+++.||||+++.. ...+.+|+.+++++ +||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 3677789999999999999985 456789999998643 24578899999999 899999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPR---------------LVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
++||||+++|+|.+++...... ..+++..+..++.|+++|++|||+. +|+||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEc
Confidence 9999999999999999875421 2489999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||........ ..
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~ 258 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 258 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-HH
Confidence 999999999999987765443333445567889999999988899999999999999999998 9999865321110 00
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
.... .. .... .+...+..+.+++.+||+.||++|||++|++++|+++.++...
T Consensus 259 ~~~~----~~------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 259 KMIK----EG------FRML------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp HHHH----HT------CCCC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred HHhc----cC------CCCC------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 0000 00 0000 0112245678999999999999999999999999998876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=371.45 Aligned_cols=259 Identities=24% Similarity=0.425 Sum_probs=209.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|.+.. +..||||+++.. .+.+.+|+.+++.++||||+++++++. ++..++||||+++
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 56677899999999999999875 678999998643 356889999999999999999999987 5678999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.++++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 267 g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~ 341 (454)
T 1qcf_A 267 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA 341 (454)
T ss_dssp CBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHT
T ss_pred CcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eec
Confidence 99999998643 12478899999999999999999999 99999999999999999999999999998764321 112
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+|+.|+|||.+....++.++|||||||++|||++ |+.||...... ..... . ....+.
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~----i----------~~~~~~- 404 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRA----L----------ERGYRM- 404 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHH----H----------HHTCCC-
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHH----H----------HcCCCC-
Confidence 233456789999999988889999999999999999999 99998643111 10000 0 000000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGMR 1118 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~ 1118 (1119)
..+...+..+.+++.+||+.||++|||+++|++.|+++....+.+|.
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~~ 451 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSSB
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccccc
Confidence 00112345788999999999999999999999999999998887764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=355.63 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=188.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 133 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG 133 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCC
Confidence 466778999999999999999999999999998643 356788999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccccCCCCC
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+|.+++...+ .+++..+..++.|++.|+.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 134 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--- 204 (349)
T 2w4o_A 134 ELFDRIVEKG---YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--- 204 (349)
T ss_dssp BHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---
Confidence 9999998654 489999999999999999999999 9999999999999975 889999999999866432
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||........ .+.... ......
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~i~-----------~~~~~~ 270 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRIL-----------NCEYYF 270 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHHHH-----------TTCCCC
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH---HHHHHH-----------hCCCcc
Confidence 122345789999999999998999999999999999999999999964321110 010000 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+..+.+++.+||+.||++|||++|++++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011234567899999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=355.75 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=200.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|+++.+++.||||++++. ...+..|..+++.+ +||||+++++++.+++..|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 4677789999999999999999999999999998542 23467788888876 899999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++.... .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999998754 489999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.. .......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .. .+.. .... ..
T Consensus 171 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~--~~~~-i~~~--------~~ 235 (345)
T 1xjd_A 171 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EE--LFHS-IRMD--------NP 235 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--HHHH-HHHC--------CC
T ss_pred CC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HH--HHHH-HHhC--------CC
Confidence 11 223456799999999999999999999999999999999999999964311 00 0100 0000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMR-EVVG 1104 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ell~ 1104 (1119)
.+. ...+..+.+++.+||+.||++||++. |+++
T Consensus 236 ~~p------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 FYP------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCC------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCC------cccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111 11234678999999999999999997 6654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=341.22 Aligned_cols=249 Identities=28% Similarity=0.443 Sum_probs=199.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----------ccHHHHHHHHhhcCCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 35667789999999999999999999999999984321 45788999999999999999999987654
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeCCCCc-----eEEE
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLDSELE-----PKIG 975 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----vkl~ 975 (1119)
++||||+++|+|.+++..... .+++..+..++.|++.|++|||+. + |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998876543 589999999999999999999999 8 999999999999988876 9999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY--STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
|||+++.... ......||+.|+|||.+. ...++.++||||+||++|||++|+.||............ ...
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~ 243 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN---MIR 243 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH---HHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH---HHh
Confidence 9999975432 234467899999999883 456789999999999999999999999753221111000 000
Q ss_pred cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1054 QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
... ..... +...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ~~~------~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEG------LRPTI------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSC------CCCCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccC------CCCCC------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000 00011 112245688999999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.92 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=205.9
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
-+.+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 346788889999999999999999999999999998532 245788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++.... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||.+......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999997654 489999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
..........||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||.......... ..+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~--------- 226 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKT--------- 226 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH---HHHHTTCT---------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHhhhccc---------
Confidence 32233345678999999999887665 778999999999999999999997543222111 11111000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. ......+..+.+++.+||+.||++|||++|++++
T Consensus 227 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 YL----NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TS----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cc----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00 0011224467899999999999999999999885
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=346.74 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=204.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+.. +..||+|+++.. ..++.+|+++++.++||||+++++++.+++..++||||++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 467778999999999999998874 778999998643 4568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 103 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 176 (283)
T 3gen_A 103 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT 176 (283)
T ss_dssp TCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence 9999999986432 489999999999999999999999 99999999999999999999999999998664321 11
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .. ... ... ......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~--~~~--~~~------~~~~~~-- 242 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ET--AEH--IAQ------GLRLYR-- 242 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HH--HHH--HHT------TCCCCC--
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HH--HHH--Hhc------ccCCCC--
Confidence 2233456788999999988889999999999999999998 99998653211 00 000 000 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+...+..+.+++.+||+.+|++|||++|++++|+++.++.
T Consensus 243 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 ----PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1112346789999999999999999999999999988764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=349.53 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=201.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|+++.+++.||+|++++.. ..+.+|+.+++.+ +||||+++++++.+++..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46777899999999999999999999999999986432 2367899999887 899999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++...+ .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999998754 489999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ........||+.|+|||.+.+..++.++||||+||++|||++|+.||......+.......... .......
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------~~~i~~~ 234 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL------FQVILEK 234 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH------HHHHHHC
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH------HHHHHcC
Confidence 1 1233456799999999999999999999999999999999999999975322111100000000 0000111
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSM------REVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~ell~~ 1105 (1119)
.... +...+..+.+++.+||+.||++||++ +|+++|
T Consensus 235 ~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 235 QIRI----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCC----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 11224467899999999999999995 677654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=347.75 Aligned_cols=262 Identities=20% Similarity=0.258 Sum_probs=198.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||+||+|.+.. ++.||+|+++... ..+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 357777999999999999999865 8999999985322 347789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|++ +++.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 997 488888876543 489999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hccccc------c
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENHE------C 1059 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~------~ 1059 (1119)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ........ ...... .
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTS
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhcc
Confidence 22334578999999998876 5689999999999999999999999975432221 11000000 000000 0
Q ss_pred cccccccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+.+........ .......++.+++.+||+.||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000000 001123467899999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=349.05 Aligned_cols=256 Identities=31% Similarity=0.475 Sum_probs=199.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
.+|+..+.||+|+||.||+|.+. ++.||||++... ...+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 46677799999999999999876 688999999643 3468899999999999999999998874 47899999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc-eEEEeccccccccCCCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE-PKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~-vkl~DfGla~~~~~~~~~~ 990 (1119)
|+|.+++........+++..+..++.|+++|++|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---- 159 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---- 159 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence 999999987665445789999999999999999999943239999999999999998886 799999999765431
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......... .+...... ....
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~------~~~~--- 225 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGT------RPPL--- 225 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HHHHHTTC------CCCC---
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HHHHhcCC------CCCc---
Confidence 223468999999999999999999999999999999999999997532211100 00000000 0000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
....+..+.+++.+||+.||++|||+++++++|+++.+...
T Consensus 226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 01123467899999999999999999999999999876654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=358.10 Aligned_cols=249 Identities=18% Similarity=0.264 Sum_probs=203.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||.||+|.++.+++.||+|++... ...+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 3577789999999999999999999999999998643 345788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--CCceEEEeccccccccCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS--ELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~DfGla~~~~~~~ 987 (1119)
++|+|.+++..... .+++..+..++.||+.|++|||+. +|+||||||+||+++. ++.+||+|||+++......
T Consensus 131 ~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999976532 489999999999999999999999 9999999999999974 4779999999998765422
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ..... .+.
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~~i~-~~~~~----~~~-- 271 (387)
T 1kob_A 206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVK-RCDWE----FDE-- 271 (387)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHHHHHH-HCCCC----CCS--
T ss_pred ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHHHHHH-hCCCC----CCc--
Confidence 22345789999999999999999999999999999999999999974311 10000000 00000 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+.++.+++.+||+.||++|||++|++++
T Consensus 272 ----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 ----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0011224567899999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=356.40 Aligned_cols=250 Identities=28% Similarity=0.316 Sum_probs=193.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||+||+|+++.+++.||||++... ...+.+|+..++.++||||+++++++.+++..++||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4677889999999999999999999999999998543 3567899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc--eEEEeccccccccCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE--PKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~DfGla~~~~~~~~ 988 (1119)
+|+|.+++...+ .+++..+..++.|+++|++|||+. +|+||||||+||+++.++. +||+|||+++....
T Consensus 100 ~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--- 170 (361)
T 3uc3_A 100 GGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 170 (361)
T ss_dssp SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc---
Confidence 999999997654 389999999999999999999999 9999999999999987765 99999999974432
Q ss_pred CCcccccccCCCcccccccCCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEK-SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
........||+.|+|||.+.+..++.+ +||||+||++|||++|+.||......... ........ ....
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~~----------~~~~ 239 (361)
T 3uc3_A 171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRIL----------SVKY 239 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHHH----------TTCC
T ss_pred cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHh----------cCCC
Confidence 122334579999999999888777655 89999999999999999999753221111 11000000 0000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. ......+..+.+++.+||+.||++|||++|+++|
T Consensus 240 ~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SI--PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC--CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC--CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00 0011123467899999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=351.81 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=201.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------------cccHHHHHHHHhhcCCCCEEEEeeeeecCCc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 901 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5788889999999999999999999999999988542 2357789999999999999999999999999
Q ss_pred eEEEEeccCCC-CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 902 GFIVTEYMPGG-TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 902 ~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
.++||||+.+| +|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 99999999777 9999998765 389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
+...... ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||.......
T Consensus 178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------- 237 (335)
T 3dls_A 178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----------------- 237 (335)
T ss_dssp EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------
T ss_pred eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------
Confidence 8765432 2234578999999999888776 789999999999999999999986421000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... +...+..+.+++.+||+.||++|||++|++++
T Consensus 238 ----~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----EAAIHP----PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hhccCC----CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00123467899999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=356.68 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=195.4
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
...+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999999999999999998642 356889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe--CCCCceEEEeccccccccCCCCCC
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL--DSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill--~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|.+++.... ..+++..+..++.|+++|++|||+. +|+||||||+||++ +.++.+||+|||+++......
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 9999987643 2489999999999999999999999 99999999999999 677899999999998765432
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ...... . .......
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i-~----------~~~~~~~ 308 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----ETLNNI-L----------ACRWDLE 308 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH-H----------HTCCCSC
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-H----------hccCCCC
Confidence 223456999999999998889999999999999999999999999643111 000000 0 0000000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.......+..+.+++.+||+.||++|||++|++++
T Consensus 309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 01111234577899999999999999999999984
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=363.57 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=202.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..++||+|+||+||+|+++.+++.||+|++++ ....+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 56677999999999999999999999999999853 23448899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 155 y~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 229 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229 (437)
T ss_dssp CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred cCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence 9999999999987432 489999999999999999999999 99999999999999999999999999998664422
Q ss_pred CCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.......+||+.|+|||++. ...++.++||||+||++|||++|+.||...... + .+... .....
T Consensus 230 -~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~--~~~~i-~~~~~----- 298 (437)
T 4aw2_A 230 -TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--E--TYGKI-MNHKE----- 298 (437)
T ss_dssp -CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H--HHHHH-HTHHH-----
T ss_pred -CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--H--HHHhh-hhccc-----
Confidence 22233467999999999886 567899999999999999999999999743111 0 00000 00000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADM--RPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~ell~~ 1105 (1119)
...++. .....+.++.+++.+|++.+|++ ||+++|+++|
T Consensus 299 -~~~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 -RFQFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -HCCCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -cccCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 000000 00112346789999999998888 9999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=354.11 Aligned_cols=259 Identities=25% Similarity=0.318 Sum_probs=201.1
Q ss_pred CHHHH-HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeec
Q 001226 829 RYEDV-IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTK 898 (1119)
Q Consensus 829 ~~~~~-~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~ 898 (1119)
...++ .+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+++++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34444 5788899999999999999999999999999988432 2457889999999999999999999999
Q ss_pred CCceEEEEeccCCCCHHHhhccCCC-------------------------------------CCCCCHHHHHHHHHHHHH
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEP-------------------------------------RLVLDWNTRYHIALGIAQ 941 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~ 941 (1119)
++..++||||+++|+|.+++..... ...+++..++.++.|+++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999863110 112457778899999999
Q ss_pred HHHHHHhCCCCCeEecCCCCCCeEeCCCC--ceEEEeccccccccCCCC--CCcccccccCCCcccccccCC--CCCCCc
Q 001226 942 GLSYLHYDCVPQIIHRDIKSDNILLDSEL--EPKIGDFGMSKLISDSHS--SSTRSAIVGSLGYIAPENAYS--TRLTEK 1015 (1119)
Q Consensus 942 ~l~~LH~~~~~~ivH~Dlkp~Nill~~~~--~vkl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 1015 (1119)
|++|||+. +|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 899999999986643221 122345679999999998865 678999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCC
Q 001226 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADM 1095 (1119)
Q Consensus 1016 sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1095 (1119)
+||||+||++|||++|+.||......+ .. . .................+..+.+++.+||+.||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~----~~-~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD----TI-S----------QVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH----HH-H----------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH----HH-H----------HHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999996432110 00 0 00111111111111123457889999999999999
Q ss_pred CCCHHHHHHH
Q 001226 1096 RPSMREVVGF 1105 (1119)
Q Consensus 1096 RPs~~ell~~ 1105 (1119)
||+++|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=345.53 Aligned_cols=270 Identities=25% Similarity=0.334 Sum_probs=204.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-ccHHHHHHHHhhc--CCCCEEEEeeeeecC----CceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDVEIRTLSLV--RHRNILRIVGSCTKD----EHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+. ++.||||++.... ..+.+|.+++... +||||+++++++.+. ...++||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 114 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEE
Confidence 57888899999999999999886 7899999985433 3445566665554 899999999998876 6789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC-----VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
||+++|+|.++++.. .+++..+..++.|++.|++|||+.+ .++|+||||||+||+++.++.+||+|||+++
T Consensus 115 e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~ 190 (337)
T 3mdy_A 115 DYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190 (337)
T ss_dssp CCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred eccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence 999999999999764 3899999999999999999999762 3489999999999999999999999999997
Q ss_pred cccCCCCC--CcccccccCCCcccccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCCCCCCCCC
Q 001226 982 LISDSHSS--STRSAIVGSLGYIAPENAYSTRLTEK------SDVYSYGVILFELLFR----------KMPVDPSFGEDT 1043 (1119)
Q Consensus 982 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslG~vl~elltg----------~~p~~~~~~~~~ 1043 (1119)
........ .......||+.|+|||.+.+..++.+ +||||+||++|||++| +.||........
T Consensus 191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 66443221 11234579999999999887766665 9999999999999999 555543322222
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
.......... .....+..... ......+..+.+++.+||+.||++|||++|++++|+++.+..+.+
T Consensus 271 ~~~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 271 SYEDMREIVC------IKKLRPSFPNR-WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336 (337)
T ss_dssp CHHHHHHHHT------TSCCCCCCCGG-GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred chhhhHHHHh------hhccCcccccc-chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence 1111111000 00011111100 112356678999999999999999999999999999999887754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=347.70 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=203.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4688889999999999999999999999999988532 235889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----ceEEEeccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL----EPKIGDFGM 979 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~DfGl 979 (1119)
+||||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999998654 488999999999999999999999 999999999999999888 799999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
+....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... . .... ..
T Consensus 166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~--~~~~-i~------ 231 (321)
T 2a2a_A 166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--E--TLAN-IT------ 231 (321)
T ss_dssp CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--H--HHHH-HH------
T ss_pred ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--H--HHHH-HH------
Confidence 98765422 223456899999999999899999999999999999999999999643110 0 0000 00
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..............+..+.+++.+||+.||++|||++|++++
T Consensus 232 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 232 ----SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----TTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----hcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000011224567899999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=352.42 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=191.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCce---EEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCce--
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRK---HWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHG-- 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-- 902 (1119)
.+|+..+.||+|+||.||+|.+..++. .||||+++.. ...+.+|+.+++.++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 367778999999999999999887664 8999998542 24578999999999999999999999876655
Q ss_pred ----EEEEeccCCCCHHHhhccCCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 903 ----FIVTEYMPGGTLFNVLHQNEP---RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 903 ----~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
++||||+++|+|.+++..... ...+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence 999999999999999965421 22589999999999999999999999 99999999999999999999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhc
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... ... .. ...
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~--~~-~~~ 254 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIY--NY-LIG 254 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHH--HH-HHT
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHH--HH-Hhc
Confidence 9999987755443344445567889999999988899999999999999999999 89998753211 110 00 000
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
. . .. ..+...+..+.+++.+||+.||++|||++++++.++++.+..
T Consensus 255 ~-~--------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 255 G-N--------RL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp T-C--------CC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred C-C--------CC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 0 00 001122356889999999999999999999999999886543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=367.57 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=205.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|.+.. +..||||+++.. .+++.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 56677899999999999999886 567999999643 3568899999999999999999999876 678999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.++++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 263 gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 337 (452)
T 1fmk_A 263 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 337 (452)
T ss_dssp CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCc-eec
Confidence 99999998542 12488999999999999999999999 99999999999999999999999999998765422 222
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .... ...... ...
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~--------~~~-- 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGY--------RMP-- 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH----HHHTTC--------CCC--
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCC--------CCC--
Confidence 233457889999999988899999999999999999999 99998643111 1000 000000 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGMR 1118 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~ 1118 (1119)
.+...+..+.+++.+||+.||++|||++++++.|+++....++.|+
T Consensus 402 --~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~ 447 (452)
T 1fmk_A 402 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 447 (452)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence 0112345678999999999999999999999999999988887765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=363.40 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=203.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecCC-ceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKDE-HGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+. ++.||||+++.. ...+.+|+.+++.++||||+++++++.+.. ..|+||||++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 35666789999999999999886 679999999653 456889999999999999999999987655 7899999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.++++..+. ..+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 271 ~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 342 (450)
T 1k9a_A 271 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 342 (450)
T ss_dssp TCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence 9999999987642 2478999999999999999999999 9999999999999999999999999999854321
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..... .... +.
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i----~~~~--------~~-- 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRV----EKGY--------KM-- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHH----HTTC--------CC--
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH----HcCC--------CC--
Confidence 122357889999999999999999999999999999998 999997542211 11100 0000 00
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..+...+..+.+++.+||+.||++|||++++++.|+++.+..
T Consensus 406 --~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 011123457889999999999999999999999999987653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=356.71 Aligned_cols=274 Identities=18% Similarity=0.191 Sum_probs=205.4
Q ss_pred HHhhCCceeeec--CCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKG--KHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G--~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..++||+| +||.||+|+++.+++.||||+++... ..+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 467888999999 99999999999999999999985432 3467799999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++..... ..+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||.+.....
T Consensus 105 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999987642 2489999999999999999999999 999999999999999999999999999865432
Q ss_pred CC-----CCCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc----
Q 001226 986 SH-----SSSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ---- 1054 (1119)
Q Consensus 986 ~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---- 1054 (1119)
.. .........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...................
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 21 1112233578999999999887 678999999999999999999999997542221111000000000
Q ss_pred ---ccccc---------ccccccccc-----------CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcc
Q 001226 1055 ---ENHEC---------ICFLDREIS-----------FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKL 1109 (1119)
Q Consensus 1055 ---~~~~~---------~~~~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~ 1109 (1119)
..... ......... .........+..+.+++.+||+.||++|||++|++++ ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 00000 000000000 0000112234568999999999999999999999987 5554
Q ss_pred cc
Q 001226 1110 ND 1111 (1119)
Q Consensus 1110 ~~ 1111 (1119)
..
T Consensus 341 ~~ 342 (389)
T 3gni_B 341 KR 342 (389)
T ss_dssp --
T ss_pred hh
Confidence 43
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=355.95 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=192.7
Q ss_pred HhhCC-ceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHh-hcCCCCEEEEeeeeec----CCceEEEEec
Q 001226 835 RATEG-RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLS-LVRHRNILRIVGSCTK----DEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~lV~e~ 908 (1119)
+|... ++||+|+||+||+|.++.+++.||||+++. ...+.+|+.++. ..+||||+++++++.. +...|+||||
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 34443 689999999999999999999999999864 345778888874 5589999999998865 5678999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~~~ 985 (1119)
+++|+|.+++..... ..+++..+..++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 141 ~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 141 LDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999999987542 3589999999999999999999999 9999999999999998 78999999999986543
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||............... ....
T Consensus 217 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-i~~~---------- 282 (400)
T 1nxk_A 217 H---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-IRMG---------- 282 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH-HHHT----------
T ss_pred C---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH-HHcC----------
Confidence 2 2233457899999999999999999999999999999999999999754322211000000 0000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+.++.+++.+||+.||++|||++|+++|
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000011234567899999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=352.22 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=201.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|+++.+++.||||++++. ...+.+|..++..+ +||+|+++++++.+.+..|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 4677779999999999999999999999999998542 23467899999887 799999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||++||+|.+++...+ .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 99999999999998754 389999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ........||+.|+|||.+.+..++.++||||+||++|||++|+.||..... . ...... ...
T Consensus 174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~---~~~~~i----------~~~ 236 (353)
T 2i0e_A 174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--D---ELFQSI----------MEH 236 (353)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHH----------HHC
T ss_pred C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--H---HHHHHH----------HhC
Confidence 1 1233456799999999999999999999999999999999999999964311 0 000000 111
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.... +...+.++.+++.+||+.||++||+ ++|+++|
T Consensus 237 ~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 NVAY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCC----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111 1122456789999999999999995 6888765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.68 Aligned_cols=265 Identities=18% Similarity=0.246 Sum_probs=208.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecc--cccccHHHHHHHHhhcCCCCEEEEeeee-ecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN--RSETNFDVEIRTLSLVRHRNILRIVGSC-TKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||+.. .....+.+|+.+++.++|++++..+.++ .+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 46778899999999999999999999999999763 3446789999999999988777666655 5667789999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCceEEEeccccccccCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~DfGla~~~~~~~ 987 (1119)
+++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||+++......
T Consensus 88 ~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 88 GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999999986543 489999999999999999999999 99999999999999 788999999999998765432
Q ss_pred CC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 SS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.. .......||+.|+|||.+.+..++.++||||+||++|||++|+.||........... .....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~---------- 231 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERIS---------- 231 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH-HHHHH----------
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh-hhhhh----------
Confidence 21 223456799999999999999999999999999999999999999976432221111 00000
Q ss_pred ccccccCCC-chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1063 LDREISFWD-SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1063 ~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
........ ......+..+.+++.+||+.||++|||++++++.|+++.++.+..
T Consensus 232 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 232 -EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred -cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 00000000 000112457889999999999999999999999999998876544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.49 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=211.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++... ..+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 92 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 92 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence 35677789999999999999999999999999986543 457899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+....... ..
T Consensus 93 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 167 (288)
T 3kfa_A 93 YGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT 167 (288)
T ss_dssp TEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SE
T ss_pred CCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cc
Confidence 9999999987543 3589999999999999999999999 99999999999999999999999999998765422 22
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||...... .... .. ......
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~---~~-----------~~~~~~ 231 (288)
T 3kfa_A 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYE---LL-----------EKDYRM 231 (288)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHH---HH-----------HTTCCC
T ss_pred cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH---HH-----------hccCCC
Confidence 3344567889999999988889999999999999999999 99998643211 1100 00 000000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
..+...+..+.+++.+|++.||++|||++|+++.|+++.++
T Consensus 232 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 232 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 00112235688999999999999999999999999988764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=341.28 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=182.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4677789999999999999999988999999998532 245788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++..... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 91 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999986532 589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||......... .. .....
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~-----------~~~~~ 228 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NK-----------VVLAD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred C--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----HH-----------Hhhcc
Confidence 1 1223456899999999998888999999999999999999999999753211110 00 00000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. .+...+..+.+++.+||+.||++|||+++++++
T Consensus 229 ~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00 011123467899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=363.67 Aligned_cols=244 Identities=29% Similarity=0.421 Sum_probs=202.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|..++.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3577789999999999999999999999999998532 235789999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999998654 489999999999999999999999 9999999999999999999999999999876542
Q ss_pred CCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||..... ........ +.
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~----------~~ 231 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKKIC----------DG 231 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHHHH----------TT
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHh----------cC
Confidence 2 2334579999999999888765 6899999999999999999999974311 11111000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .+...+..+.+++.+||+.||++|||++|+++|
T Consensus 232 ~~~----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 IFY----TPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CcC----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 000 001123467899999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=348.47 Aligned_cols=264 Identities=23% Similarity=0.239 Sum_probs=199.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcC---CCCEEEEeeeeecCC-
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVR---HRNILRIVGSCTKDE- 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~- 900 (1119)
.+|+..+.||+|+||+||+|++..+++.||||+++.. ...+.+|+.+++.++ ||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 3677789999999999999999999999999998532 235678888887775 999999999997654
Q ss_pred ----ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 901 ----HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 901 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
..++||||++ ++|.+++..... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECS
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEee
Confidence 4799999996 699999987653 2489999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
||+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+..............
T Consensus 164 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 164 FGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp CSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred CccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999866432 2334567899999999998999999999999999999999999999653211100000000000000
Q ss_pred cccccc---ccccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICF---LDREISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~---~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... ....+..... .....+..+.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000000 0000000000 001224567899999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=340.83 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=201.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 5667789999999999999999999999999985432 4577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc---eEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~DfGla~~~~~ 985 (1119)
+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||.+.....
T Consensus 87 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 87 VTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999887754 489999999999999999999999 9999999999999987655 99999999986654
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .. ..... . .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~--~~~~~-~----------~ 222 (284)
T 3kk8_A 161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RL--YAQIK-A----------G 222 (284)
T ss_dssp SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH--HHHHH-H----------T
T ss_pred Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HH--HHHHH-h----------c
Confidence 22 223457899999999999999999999999999999999999999643110 00 00000 0 0
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+..+.+++.+|++.||++|||++|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 223 AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000011223567899999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=339.33 Aligned_cols=254 Identities=25% Similarity=0.367 Sum_probs=208.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeec---------------
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTK--------------- 898 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------------- 898 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.....+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 57888899999999999999999889999999998877889999999999999999999998754
Q ss_pred -CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEec
Q 001226 899 -DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977 (1119)
Q Consensus 899 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 977 (1119)
....++||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCC
T ss_pred CcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcc
Confidence 345799999999999999997653 23589999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc
Q 001226 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057 (1119)
Q Consensus 978 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1119)
|++....... ......+|+.|+|||.+.+..++.++||||+|+++|||++|..|+... . ....
T Consensus 167 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~---~~~~------- 229 (284)
T 2a19_B 167 GLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----S---KFFT------- 229 (284)
T ss_dssp TTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----H---HHHH-------
T ss_pred hhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----H---HHHH-------
Confidence 9998765432 223456899999999998889999999999999999999999886421 0 0000
Q ss_pred cccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
......+.. ..+..+.+++.+||+.||++|||++|++++++.+.+..+..-
T Consensus 230 ---~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 230 ---DLRDGIISD------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp ---HHHTTCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred ---Hhhcccccc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 000011110 123457899999999999999999999999999998877653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=341.51 Aligned_cols=243 Identities=32% Similarity=0.462 Sum_probs=199.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 4677889999999999999999999999999998432 345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 9999999999998754 389999999999999999999998 9999999999999999999999999998654332
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ..+.. .... ...
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~--------~~~ 225 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKR-ISRV--------EFT 225 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHH-HHHT--------CCC
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----HHHHH-HHhC--------CCC
Confidence 223457899999999999999999999999999999999999998642110 00000 0000 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. +...+..+.+++.+||+.||++|||++|++++
T Consensus 226 ~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 F------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp C------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred C------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 11123467899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.02 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=193.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC---ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+..+ +..||+|+.+.. ...+.+|+..++.++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 3677789999999999999998653 467999998643 245778999999999999999999985 4678999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999986542 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... +... ... ...
T Consensus 169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~---~i~-~~~------- 234 (281)
T 1mp8_A 169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG---RIE-NGE------- 234 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHH---HHH-TTC-------
T ss_pred ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHH---HHH-cCC-------
Confidence 321 22234457789999999988889999999999999999996 99998753211 1110 000 000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
... .+...+..+.+++.+||+.||++|||++|++++|+++.++
T Consensus 235 -~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 -RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000 0112245678999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=338.48 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=201.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||.||+|.+..++..||+|++.. ....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 468888999999999999999999999999998853 3356889999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCceEEEeccccccccCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~DfGla~~~~~~ 986 (1119)
++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999988754 389999999999999999999999 99999999999999 78899999999999876542
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. ......+|+.|+|||.+.+ .++.++||||+|+++|||++|+.||...... . ..... ....
T Consensus 163 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~--~~~~~-----------~~~~ 223 (277)
T 3f3z_A 163 K---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--E--VMLKI-----------REGT 223 (277)
T ss_dssp S---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--H--HHHHH-----------HHCC
T ss_pred c---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--H--HHHHH-----------HhCC
Confidence 2 2334578999999998765 4899999999999999999999999643110 0 00000 0000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...........+..+.+++.+|++.||++|||+.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 224 FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000001234578899999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=357.03 Aligned_cols=268 Identities=16% Similarity=0.222 Sum_probs=205.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCC-----ceEEEEEecccccccHHHHHH---------------HHhhcCCCCEEEEee
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS-----RKHWAVKKLNRSETNFDVEIR---------------TLSLVRHRNILRIVG 894 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~E~~---------------~l~~l~h~niv~l~~ 894 (1119)
+|+..+.||+|+||.||+|.+..+ ++.||||++......+.+|++ .++.++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 577789999999999999998764 578999998665544444444 445567999999999
Q ss_pred eeecC----CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--C
Q 001226 895 SCTKD----EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD--S 968 (1119)
Q Consensus 895 ~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~ 968 (1119)
++... ...|+||||+ +++|.+++..... .+++..+..++.||+.||+|||+. +|+||||||+||+++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSC
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCC
Confidence 98764 4579999999 9999999987532 589999999999999999999999 999999999999999 8
Q ss_pred CCceEEEeccccccccCCCCC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001226 969 ELEPKIGDFGMSKLISDSHSS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043 (1119)
Q Consensus 969 ~~~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 1043 (1119)
++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-~ 268 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-P 268 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-H
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-H
Confidence 899999999999876543211 1123456999999999999999999999999999999999999999743211 1
Q ss_pred ceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
........ .........+++.+.. ...+..+.+++..||+.+|++||++++|++.|+++.++.+..
T Consensus 269 ~~~~~~~~--~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 KYVRDSKI--RYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHH--HHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHH--HhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 11111110 0111122222222211 112457889999999999999999999999999988765543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=349.81 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=207.6
Q ss_pred HHhhCCceeeecCCccEEEEEeC-------CCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-------NSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|+..+.||+|+||.||+|.+. .+++.||||+++... ..+.+|+.+++++ +||||+++++++.+++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 46778899999999999999975 356789999996432 3477899999999 8999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..++||||+++|+|.+++..... ...+++..+..++.|+++|++|||+. +|+||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence 99999999999999999987542 12488999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~-- 267 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E-- 267 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H--
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH--H--
Confidence 999999999999987655333333344567889999999888889999999999999999999 99998643110 0
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
...... ... ... .+...+..+.+++.+||+.||++|||++|++++|+++.+..
T Consensus 268 -~~~~~~-~~~------~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 268 -LFKLLK-EGH------RMD------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp -HHHHHH-HTC------CCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHHh-cCC------CCC------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000000 000 000 01122346789999999999999999999999999987643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.04 Aligned_cols=268 Identities=24% Similarity=0.330 Sum_probs=208.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhh--cCCCCEEEEeeeeecCC----ceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSL--VRHRNILRIVGSCTKDE----HGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+. ++.||||+++.. ...+.+|+++++. ++||||+++++++..+. ..++||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~ 119 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 119 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEE
Confidence 47888899999999999999884 799999998643 3456788888887 78999999999998775 789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH--------YDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
||+++|+|.+++... .+++..++.++.|++.|++||| +. +|+||||||+||+++.++.+||+|||
T Consensus 120 e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 120 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999999764 3899999999999999999999 66 99999999999999999999999999
Q ss_pred ccccccCCCCCC--cccccccCCCcccccccCCCC------CCCcchHHHHHHHHHHHHhC----------CCCCCCCCC
Q 001226 979 MSKLISDSHSSS--TRSAIVGSLGYIAPENAYSTR------LTEKSDVYSYGVILFELLFR----------KMPVDPSFG 1040 (1119)
Q Consensus 979 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg----------~~p~~~~~~ 1040 (1119)
+++......... ......||+.|+|||.+.+.. ++.++||||+||++|||++| +.||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 998765432211 234457999999999887652 33689999999999999999 677765433
Q ss_pred CCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1041 EDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
.......+...... ....+.+... .........+.+++.+||+.||++|||++|++++|+++.++...+|
T Consensus 273 ~~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~~~ 342 (342)
T 1b6c_B 273 SDPSVEEMRKVVCE------QKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 342 (342)
T ss_dssp SSCCHHHHHHHHTT------SCCCCCCCGG-GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC---
T ss_pred CcccHHHHHHHHHH------HHhCCCCccc-ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcCCC
Confidence 22222221111110 0111111100 0123456688999999999999999999999999999998876554
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=345.05 Aligned_cols=260 Identities=18% Similarity=0.212 Sum_probs=198.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.+|...+.||+|+||.||+|.+..+++.||+|+++... ..+.+|+.+++.++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 456788899999999999999999999999999986431 4577899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999998754 489999999999999999999999 999999999999999999999999999986654
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.. ........+++.|+|||.+.+..++.++||||+|+++|||++|+.||..... . .... ...........
T Consensus 187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~--~~~~-~~~~~~~~~~~--- 256 (309)
T 2h34_A 187 EK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S--VMGA-HINQAIPRPST--- 256 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H--HHHH-HHHSCCCCGGG---
T ss_pred cc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H--HHHH-HhccCCCCccc---
Confidence 22 1223345789999999999999999999999999999999999999864311 0 0000 00000000000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHcccccCCC
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRP-SMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ell~~L~~~~~~~~~ 1115 (1119)
.....+..+.+++.+||+.||++|| +++++++.|+++......
T Consensus 257 -------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 257 -------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp -------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred -------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0111234678999999999999999 999999999988776543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=349.26 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=195.3
Q ss_pred HhhC-CceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATE-GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~-~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+. ++.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++++ +||||+++++++.+++..|+||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 3444 37899999999999999999999999998543 34578899999885 799999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc---eEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~DfGla~~~~~ 985 (1119)
+++++|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++. +||+|||++.....
T Consensus 93 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 93 MRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred CCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999998754 489999999999999999999999 9999999999999998876 99999999876542
Q ss_pred CCC-----CCcccccccCCCcccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 986 SHS-----SSTRSAIVGSLGYIAPENAYS-----TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 986 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.............
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 112223468999999998764 4578999999999999999999999976533221110000000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
......+...............+..+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000001111111000011234578899999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=347.19 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=193.5
Q ss_pred HHhhCCceeeecCCccEEEEEeC---CCceEEEEEecccc--------cccHHHHHHHHhhcCCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+..+.||+|+||.||+|++. .+++.||+|++++. ...+.+|+.+++.++||||+++++++.+++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 46777899999999999999985 57899999998642 23467899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+||||+++++|.+++...+ .+++..+..++.||+.|+.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999998754 488999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... . .....
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~---~~~~i---------- 233 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--K---TIDKI---------- 233 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H---HHHHH----------
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--H---HHHHH----------
Confidence 43221 1233457899999999999889999999999999999999999999643110 0 00000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
....... +...+..+.+++.+||+.||++|| +++|+++|
T Consensus 234 ~~~~~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 234 LKCKLNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHTCCCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HhCCCCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0001110 111235678999999999999999 78888875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.19 Aligned_cols=264 Identities=18% Similarity=0.243 Sum_probs=208.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhcCCCCEEEEeeee-ecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLVRHRNILRIVGSC-TKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||.||+|++..+++.||||++.. ....+.+|+.+++.++|+++++.+.++ .+++..++||||+ +
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-C
Confidence 56777999999999999999999999999998743 345789999999999988866666655 5567789999999 9
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCceEEEeccccccccCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD---SELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++ .++.+||+|||+++.......
T Consensus 89 ~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 89 PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999999985443 489999999999999999999999 999999999999995 788999999999987655332
Q ss_pred C-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 989 S-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 989 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
. .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......... .+.....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~---------- 232 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISE---------- 232 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHH----------
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-hhhhhcc----------
Confidence 1 12345679999999999999999999999999999999999999997643221111 0100000
Q ss_pred cccccCCC-chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1064 DREISFWD-SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1064 ~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
....... ......+..+.+++.+||+.||++|||++++++.|+++..+.+..
T Consensus 233 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 233 -KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -HHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -cccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 0000000 000112356889999999999999999999999999998876553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=358.04 Aligned_cols=320 Identities=18% Similarity=0.146 Sum_probs=196.5
Q ss_pred cEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCC
Q 001226 267 EVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346 (1119)
Q Consensus 267 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 346 (1119)
+.++.++++++ .+|..+. ++++.|+|++|+++++.+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 46777888877 4565543 57788888888888777777777888888888888777776777777777777777777
Q ss_pred cccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCc
Q 001226 347 RLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPP 426 (1119)
Q Consensus 347 ~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 426 (1119)
+++...+..|.++++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|++++|++++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77765555677777777777777777766666777777777777777777666666666666666666666666654444
Q ss_pred cccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcccccccc
Q 001226 427 DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSS 506 (1119)
Q Consensus 427 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 506 (1119)
.+..+++|+.|+|++|.+++ ..+..+..+++|+.|++++|.+.+.+|..+....+
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~-------------------------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~ 225 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINA-------------------------IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCE-------------------------ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCC
T ss_pred HhcccCCCcEEeCCCCcCcE-------------------------eChhhcccCcccceeeCCCCccccccCcccccCcc
Confidence 55566666666666655542 23333344444455555554444444444444445
Q ss_pred ccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEccc
Q 001226 507 LRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSA 586 (1119)
Q Consensus 507 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 586 (1119)
|+.|++++|.+++..+..+..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|+.|+|++
T Consensus 226 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 305 (477)
T 2id5_A 226 LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305 (477)
T ss_dssp CSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCS
T ss_pred ccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCC
Confidence 55555555555543333444445555555555554444444445555555555555555554555555555555555555
Q ss_pred CcccCcCCcccccCCCCcEEeccCcccc
Q 001226 587 NKLDGRIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 587 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
|++++..+..|..+++|+.|+|++|+++
T Consensus 306 N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp SCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 5555433344455555555555555554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=348.85 Aligned_cols=277 Identities=24% Similarity=0.338 Sum_probs=201.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-ccHHHHHHH--HhhcCCCCEEEEeeeee-----cCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNFDVEIRT--LSLVRHRNILRIVGSCT-----KDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+ +++.||||+++... ..+..|..+ +..++||||+++++++. .....++|
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 4677789999999999999976 47999999986433 334444444 44589999999998543 23456899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC------VPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
|||+++|+|.+++.... .++..+..++.|+++|++|||+.+ .++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp ECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 99999999999997654 588999999999999999999873 33899999999999999999999999999
Q ss_pred cccccCCCC------CCcccccccCCCcccccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee
Q 001226 980 SKLISDSHS------SSTRSAIVGSLGYIAPENAYS-------TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 980 a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 1046 (1119)
++....... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~ 246 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM 246 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence 987654221 122234579999999998876 3566789999999999999999888765432221111
Q ss_pred ehhhhhhccc--ccc-----cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1047 TWTRWKLQEN--HEC-----ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1047 ~~~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
.+........ ... .....+.+..........+..+.+++.+||+.||++|||++|+++.|+++...++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 1110000000 000 000111111111223345667999999999999999999999999999998887754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=338.11 Aligned_cols=242 Identities=19% Similarity=0.245 Sum_probs=191.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..++||+|+||+||+|.+..+++.||||++.... .....|+..+..+ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888899999999999999999999999999875422 2233455555444 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+ +++|.+++...+. .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 7799998877643 589999999999999999999999 9999999999999999999999999999876442
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. ......||+.|+|||++.+ .++.++||||+||++|||++|..|+... . .+..... . ...+.
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~---~~~~~~~---~----~~~~~ 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----E---GWQQLRQ---G----YLPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----H---HHHHHTT---T----CCCHH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----c---HHHHHhc---c----CCCcc
Confidence 2 2334568999999998775 7899999999999999999997765421 0 0111000 0 00000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+..+.+++.+||+.||++|||++|++++
T Consensus 273 ------~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ------FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111234578899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=349.36 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=208.8
Q ss_pred HHhhCCceeeecCCccEEEEEeC-----CCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+. .+++.||+|++.... ..+.+|+.+++.++||||+++++++.+++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 46788899999999999999876 357889999986432 34778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP-------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
+||||+++|+|.+++..... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 99999999999999976321 13478999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~~-- 254 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRFVM-- 254 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----HHHHHHH--
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----HHHHHHH--
Confidence 999987654333333344567889999999988889999999999999999999 88888643110 0000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..... ..+...+..+.+++.+||+.||++|||++|++++|++....+
T Consensus 255 --------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~ 301 (322)
T 1p4o_A 255 --------EGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 301 (322)
T ss_dssp --------TTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred --------cCCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence 00000 001122456789999999999999999999999999876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=343.94 Aligned_cols=256 Identities=32% Similarity=0.481 Sum_probs=190.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||+||+|.+.. .||+|+++... ..+.+|+.+++.++||||+++++++ .....++||||
T Consensus 25 ~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 25 QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp SCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred ceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 56777999999999999998754 49999885322 4578899999999999999999965 45668999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 101 CEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred cCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999976543 489999999999999999999999 999999999999999999999999999986654333
Q ss_pred CCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
........||+.|+|||.+. +..++.++||||+|+++|||++|+.||......+. ........ . ...
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~--~----~~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIEMVGRG--S----LSP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH----HHHHHHHT--S----CCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH----HHHHhccc--c----cCc
Confidence 33344567899999999876 56788899999999999999999999965321111 00000000 0 001
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.... .....+..+.+++.+||+.+|++|||++++++.|+++.++
T Consensus 246 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 246 DLSK---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp CTTS---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred chhh---ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 1100 0112245788999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=349.38 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=196.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEE----EEEeccc-----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHW----AVKKLNR-----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~v----avK~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|+..++||+|+||.||+|.+..+++.| |+|.+.. ....+.+|+.+++.++||||+++++++..+. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 5677799999999999999988777654 6666632 2346788999999999999999999998754 7899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
+||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp ECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999987643 489999999999999999999999 999999999999999999999999999987755
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........+|+.|+|||.+.+..++.++||||+||++|||++ |+.||....... ..... .
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~--------------~ 233 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSIL--------------E 233 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH--------------H
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHH--------------H
Confidence 443334444567889999999999999999999999999999999 999997532111 11000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
..... ..+...+..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 234 ~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 234 KGERL--PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00000 00111234678999999999999999999999999988754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=346.35 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=189.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..+.||+|+||.||+|.++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 84 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence 4667778999999999999999999999999988532 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
++ |+|.+++.... ....+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 97 69999987542 123588999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc----cc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE----CI 1060 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 1060 (1119)
.. .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .............. ..
T Consensus 161 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 161 PV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ-LKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCTTTCGGGG
T ss_pred Cc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhHhhhhh
Confidence 21 22334578999999998876 4689999999999999999999999975321100 00000000000000 00
Q ss_pred --ccccccccCCCc----------hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 --CFLDREISFWDS----------DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 --~~~~~~~~~~~~----------~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+.+..... .....+.++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000000 000123468899999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.80 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=194.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||+||+|.+ .+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 567778999999999999998 56899999988532 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++ +|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 89999876543 488999999999999999999999 99999999999999999999999999998664321
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh-hhcccccc-----cc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW-KLQENHEC-----IC 1061 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~ 1061 (1119)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ....... ........ ..
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhccc
Confidence 22234578999999998875 4589999999999999999999999975321100 0000000 00000000 00
Q ss_pred cccccccCC-----CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFW-----DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..++..... .......+..+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111000 00011234567899999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=356.90 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=200.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..++||+|+||.||+|+++.+++.||||++++ ....+.+|..++..++||||+++++++.+++..|+|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 56667899999999999999999999999999853 23458899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++...+. .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 142 ~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 9999999999987542 489999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCCcccccccCCCcccccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAY-------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
.......+||+.|+|||++. ...++.++||||+||++|||++|+.||...... ..+... ....
T Consensus 217 -~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~i-~~~~---- 286 (412)
T 2vd5_A 217 -TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA----ETYGKI-VHYK---- 286 (412)
T ss_dssp -CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH-HTHH----
T ss_pred -ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH----HHHHHH-Hhcc----
Confidence 11223457999999999876 457899999999999999999999999643110 000000 0000
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMR---PSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~ell~~ 1105 (1119)
.... ........+.++.+++.+||+ +|++| |+++|+++|
T Consensus 287 ----~~~~-~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 287 ----EHLS-LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ----HHCC-CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ----cCcC-CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000 000011234577899999999 99998 699999876
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=358.54 Aligned_cols=322 Identities=20% Similarity=0.166 Sum_probs=275.6
Q ss_pred cEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccc
Q 001226 242 VEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSR 321 (1119)
Q Consensus 242 ~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 321 (1119)
+.++.++++++ .++... .+++++|+|++|++++..|..|.++++|++|+|++|.++++.+..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~ip~~~---~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCC---CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCC---CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 56788888876 344322 25799999999999998899999999999999999999999999999999999999999
Q ss_pred cccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCC
Q 001226 322 NNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401 (1119)
Q Consensus 322 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 401 (1119)
|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|.++++|+.|+|++|++++..+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred CcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 99997777789999999999999999998889999999999999999999998889999999999999999999998888
Q ss_pred ccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCcccccc
Q 001226 402 HQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGT 481 (1119)
Q Consensus 402 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~ 481 (1119)
..+..+++|+.|++++|.+++..+..|..+++|+.|++++|.+.+.++...+ ...
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~-------------------------~~~ 224 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL-------------------------YGL 224 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTT-------------------------TTC
T ss_pred hHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccc-------------------------cCc
Confidence 8899999999999999999988888899999999999999887655544332 233
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
+|+.|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|+
T Consensus 225 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 304 (477)
T 2id5_A 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVS 304 (477)
T ss_dssp CCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECC
T ss_pred cccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECC
Confidence 56666666666664433567777888888888888887777778888888888888888887778888888888999999
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCc
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGR 592 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 592 (1119)
+|+|++..+..|.++++|+.|+|++|.+...
T Consensus 305 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~ 335 (477)
T 2id5_A 305 GNQLTTLEESVFHSVGNLETLILDSNPLACD 335 (477)
T ss_dssp SSCCSCCCGGGBSCGGGCCEEECCSSCEECS
T ss_pred CCcCceeCHhHcCCCcccCEEEccCCCccCc
Confidence 9988877777788888999999999988743
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=338.59 Aligned_cols=248 Identities=29% Similarity=0.460 Sum_probs=190.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..+.||+|+||.||+|.+. ++.||||+++.. ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5667789999999999999975 789999998532 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--------CCceEEEecc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS--------ELEPKIGDFG 978 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--------~~~vkl~DfG 978 (1119)
||+++++|.+++... .+++..+..++.|+++|++|||+....+|+||||||+||+++. ++.+|++|||
T Consensus 86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 999999999998643 4899999999999999999999992122999999999999986 6789999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
.++...... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||....... ..... .
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~-~------ 227 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---VAYGV-A------ 227 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHH-H------
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHhh-h------
Confidence 998654322 224568999999999988889999999999999999999999996431110 00000 0
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
...... ..+...+..+.+++.+||+.||++|||++|++++|+++
T Consensus 228 -----~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 -----MNKLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----TSCCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----cCCCCC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000000 00112235688999999999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=353.18 Aligned_cols=253 Identities=16% Similarity=0.177 Sum_probs=205.2
Q ss_pred HhhCCceeeecCCccEEEEE-----eCCCceEEEEEecccc-cccHHHHHHHHhhcC---CCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTL-----SNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVR---HRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV 905 (1119)
+|+..++||+|+||+||+|. +..+++.||||+++.. ..++.+|+.++++++ |+||+++++++..++..|+|
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 46667899999999999994 5667899999999653 456788999988887 99999999999999999999
Q ss_pred EeccCCCCHHHhhccCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-----------CCce
Q 001226 906 TEYMPGGTLFNVLHQNE--PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-----------ELEP 972 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----------~~~v 972 (1119)
|||+++|+|.+++.... ....+++..+..++.||++||+|||+. +||||||||+||+++. ++.+
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCE
Confidence 99999999999997532 133599999999999999999999998 9999999999999998 8999
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK 1052 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 1052 (1119)
||+|||+|+...............||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------- 294 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-------- 294 (365)
T ss_dssp EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--------
T ss_pred EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--------
Confidence 999999998665333334445567999999999999999999999999999999999999998542111000
Q ss_pred hcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHcccccC
Q 001226 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMR-PSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~ell~~L~~~~~~~ 1113 (1119)
....+... .....+.+++..|++.+|.+| |+++++.+.|+++.++.
T Consensus 295 ----------~~~~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 ----------PEGLFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ----------ECSCCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------echhcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 01111111 113456789999999999988 68899999998877654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=348.88 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=208.7
Q ss_pred HHhhCCceeeecCCccEEEEEe-----CCCceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC-c
Q 001226 834 IRATEGRIIGKGKHGTVYRTLS-----NNSRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE-H 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~ 901 (1119)
.+|+..+.||+|+||.||+|.+ ..+++.||||+++... ..+.+|+.+++.+ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 3677789999999999999984 4567899999986532 3477899999999 7999999999987654 5
Q ss_pred eEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS 968 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~ 968 (1119)
.++||||+++++|.+++..... ...+++..+..++.|+++|+.|||+. +|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 8999999999999999987543 12378999999999999999999999 9999999999999999
Q ss_pred CCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceee
Q 001226 969 ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 969 ~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 1047 (1119)
++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||........ .
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~-- 260 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F-- 260 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-H--
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-H--
Confidence 99999999999987655433334445678899999999988899999999999999999998 9999865321111 0
Q ss_pred hhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
........ ..... ...+..+.+++.+||+.||++|||++|++++|+++.++..
T Consensus 261 ~~~~~~~~--------~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 261 CRRLKEGT--------RMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp HHHHHHTC--------CCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHhccCc--------cCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 00000000 00000 1123467899999999999999999999999999887654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.12 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=204.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 3678889999999999999999999999999988532 345889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----ceEEEeccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL----EPKIGDFGM 979 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~DfGl 979 (1119)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++ .+||+|||.
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997654 489999999999999999999999 999999999999999877 899999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
+....... ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ........
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~------ 225 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----ETLTNISA------ 225 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHT------
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----HHHHHhHh------
Confidence 98764422 223456899999999999899999999999999999999999998643110 00000000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccccC
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLNDKN 1113 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~~~ 1113 (1119)
.............+..+.+++.+||+.||++|||++|++++ ++.++.+.
T Consensus 226 -----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 226 -----VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp -----TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred -----cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 00000000011224567899999999999999999999984 55555443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=366.00 Aligned_cols=249 Identities=25% Similarity=0.307 Sum_probs=203.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|...++||+|+||.||+|.++.+++.||+|++.. ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 264 (576)
T 2acx_A 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264 (576)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 46667899999999999999999999999999843 22447789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|++||+|.+++.... ...+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 265 y~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 265 LMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 999999999998654 23489999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
......||+.|+|||++.+..++.++||||+||++|||++|+.||......... ........... ..+
T Consensus 341 ---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~~~~--------~~~ 408 (576)
T 2acx_A 341 ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVP--------EEY 408 (576)
T ss_dssp ---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHHHCC--------CCC
T ss_pred ---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhhccc--------ccC
Confidence 233457999999999999989999999999999999999999999753221110 00111000000 001
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
. ...+.++.+++.+||+.||++|| +++|+++|
T Consensus 409 p------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 409 S------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp C------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred C------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 11235678999999999999999 78999876
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=339.98 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=195.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|...+.||+|+||.||+|.++.++..||+|++.... ..+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888899999999999999999999999999985432 4578999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCceEEEecccccccc
Q 001226 909 MPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~DfGla~~~~ 984 (1119)
+++|+|.+++.... ....+++..+..++.|+++|++|||+. +|+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986532 123589999999999999999999999 99999999999999 456889999999998664
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.. .......+|+.|+|||.+. +.++.++||||+|+++|||++|+.||...... ... ...... .
T Consensus 179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~---~~~~~~--------~ 241 (285)
T 3is5_A 179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQ---QKATYK--------E 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH---HHHHHC--------C
T ss_pred Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHH---hhhccC--------C
Confidence 32 2233457899999999775 56899999999999999999999999643111 000 000000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.... ......+..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYA---VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCC---C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccc---cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0001123467899999999999999999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=344.07 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=199.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc-------eEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR-------KHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+..+.||+|+||.||+|.+..++ ..||+|+++.. ...+.+|+.+++.++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 35677799999999999999988765 57999998543 24578899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc--------eEE
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE--------PKI 974 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------vkl 974 (1119)
++||||+++++|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++. +|+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999987543 489999999999999999999999 9999999999999998887 999
Q ss_pred EeccccccccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 975 GDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 975 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
+|||.+..... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|..|+........ ... ..
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----~~~-~~ 231 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----KLQ-FY 231 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHH-HH
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH----HHH-Hh
Confidence 99999875432 233467899999998877 6789999999999999999996655432211100 000 00
Q ss_pred cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1054 QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
..... ... ..+..+.+++.+||+.||++|||++|++++|+++......
T Consensus 232 ~~~~~--------~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 232 EDRHQ--------LPA------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HTTCC--------CCC------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred hccCC--------CCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 00000 000 0123567999999999999999999999999999876544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=337.35 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=206.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+.. ++.||+|+++.. .+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecC-CCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 356677899999999999999874 788999998643 3568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++..... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.+|++|||.+....... ..
T Consensus 87 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 9999999987543 488999999999999999999999 99999999999999999999999999998654321 11
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ...... ... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~i-~~~------~~~~--- 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI-STG------FRLY--- 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHH-HTT------CCCC---
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHHHH-hcC------CcCC---
Confidence 2223456789999999988889999999999999999999 89998643110 000000 000 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+...+..+.+++.+||+.||++|||+++++++|+++.++
T Consensus 226 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 226 ---KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0111234678999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.14 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=195.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCC---CceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCC----
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN---SRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDE---- 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 900 (1119)
.+|+..+.||+|+||.||+|.+.. +++.||+|+++... ..+.+|+.+++.++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 467778999999999999998764 46689999986332 34778999999999999999999987754
Q ss_pred -ceEEEEeccCCCCHHHhhccCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 901 -HGFIVTEYMPGGTLFNVLHQNE---PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 901 -~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
..++||||+++++|.+++.... ....+++..++.++.|+++|+.|||+. +|+||||||+||+++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence 3499999999999999985432 234589999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...............+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... .. .......
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~---~~~~~~~ 265 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EM---YDYLLHG 265 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GH---HHHHHTT
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HH---HHHHHcC
Confidence 999987654433333445567889999999999999999999999999999999 88888643211 10 0000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
. ... .+...+..+.+++.+||+.||++|||+++++++|+++.++.
T Consensus 266 -~------~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 -H------RLK------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp -C------CCC------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -C------CCC------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000 01122346889999999999999999999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.84 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=193.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCce----E
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHG----F 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~ 903 (1119)
+|+..+.||+|+||.||+|++..+++.||||+++... ..+.+|+.+++.++||||+++++++...... |
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 5777899999999999999999999999999986432 2467899999999999999999998765543 9
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.++++..+ .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 9999999999999998755 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
...... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ..+ ........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~--~~~~~~~~---- 237 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAY--QHVREDPI---- 237 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH--HHHHCCCC----
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHH--HHhcCCCC----
Confidence 543221 22334578999999999999999999999999999999999999996431110 000 00000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHHcccc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMRE-VVGFLIKLND 1111 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e-ll~~L~~~~~ 1111 (1119)
... ......+.++.+++.+||+.||++||++.+ +...+.+...
T Consensus 238 -~~~-----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 238 -PPS-----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp -CHH-----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred -Ccc-----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 000 000113456889999999999999996555 5555655543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=352.12 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=207.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce-----EEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK-----HWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~-----~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 903 (1119)
+|+..+.||+|+||.||+|.+..+++ .||+|+++.. ...+.+|+.+++.+ +||||+++++++.+++..+
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 126 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL 126 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence 56667899999999999999876554 7999998643 24578899999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCce
Q 001226 904 IVTEYMPGGTLFNVLHQNEP-----------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 972 (1119)
+||||+++|+|.+++..... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 203 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA 203 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence 99999999999999976421 22478999999999999999999999 99999999999999999999
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhh
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRW 1051 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 1051 (1119)
||+|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |..||........ .......
T Consensus 204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~ 282 (333)
T 2i1m_A 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVKD 282 (333)
T ss_dssp EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHHHH
T ss_pred EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHHhc
Confidence 9999999987654433333445567889999999888889999999999999999998 9999865321110 0000000
Q ss_pred hhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1052 KLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
. ..... +...+..+.+++.+||+.||++|||++|++++|+++.++
T Consensus 283 ----~------~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 283 ----G------YQMAQ------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----T------CCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----C------CCCCC------CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 0 00000 011234678999999999999999999999999987654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=358.86 Aligned_cols=259 Identities=24% Similarity=0.271 Sum_probs=193.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------Cc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------EH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 901 (1119)
.+|+..++||+|+||+||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 4677889999999999999999999999999998542 24567899999999999999999998654 35
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.|+||||+++ ++.+.+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 142 ~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred EEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 6999999975 46666643 388999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh-----------
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR----------- 1050 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~----------- 1050 (1119)
..... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. ......
T Consensus 213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHT
T ss_pred ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 76432 233456899999999999999999999999999999999999999965321000 000000
Q ss_pred -------hhhcc-----ccccccccccc-ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1051 -------WKLQE-----NHECICFLDRE-ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1051 -------~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..... .......+... ...........+.++.+++.+||+.||++|||++|+++|
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000 011111223346678999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.86 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=204.0
Q ss_pred HhhCCceeeecCCccEEEEE----eCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceE
Q 001226 835 RATEGRIIGKGKHGTVYRTL----SNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 903 (1119)
+|+..+.||+|+||.||+|+ +..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.++ ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 46777999999999999998 5667899999998633 24578999999999999999999999876 6689
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 102 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999976543 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
...... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.|+................. .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 255 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTRLVNT 255 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG-GHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc-cCHHHHHHH
Confidence 543221 223445688899999999888899999999999999999999988643210000000000000 000000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
+...... ..+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 256 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 256 LKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCCC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000 011123457889999999999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=364.37 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=195.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..++||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 3577789999999999999999999999999998532 234667999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++....
T Consensus 228 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 228 EYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred eeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999998754 48999999999999999999998 7 999999999999999999999999999985432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... . ....... ..
T Consensus 302 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~---~~~~~i~----------~~ 364 (446)
T 4ejn_A 302 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E---KLFELIL----------ME 364 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHH----------HC
T ss_pred C--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--H---HHHHHHH----------hC
Confidence 2 2223456799999999999999999999999999999999999999964311 0 0001000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.... +...+..+.+++.+||+.||++|| +++|+++|
T Consensus 365 ~~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 EIRF----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCC----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1110 111234678999999999999999 99999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=352.34 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=190.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHH-HhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRT-LSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|+++.+++.||||++++.. ..+.+|..+ ++.++||||+++++++.+++..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46777899999999999999999999999999985432 234556555 4678999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++...+ .+++..++.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999998754 488999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... ++..
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~----------i~~~ 254 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN----------ILNK 254 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHH----------HHHS
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH----------HHhc
Confidence 2 1233456799999999999999999999999999999999999999964211 000000 1111
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMR 1100 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 1100 (1119)
..... ...+..+.+++.+||+.||++||++.
T Consensus 255 ~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 PLQLK----PNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp CCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ccCCC----CCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 11110 11234678999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=338.68 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=204.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCc---eEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCce-EEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSR---KHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHG-FIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 905 (1119)
.|..+++||+|+||+||+|.+..++ ..||+|+++... ..+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3445688999999999999865543 479999986432 4577899999999999999999999876655 999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999987442 588999999999999999999999 999999999999999999999999999986644
Q ss_pred CC--CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 986 SH--SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 986 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.. .........+|+.|+|||...+..++.++||||+|+++|||++|..|+....... .. ........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~---~~~~~~~~------- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DL---THFLAQGR------- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GH---HHHHHTTC-------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HH---HHHhhcCC-------
Confidence 32 1223334567899999999999999999999999999999999766654321111 11 11000000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
.. ..+...+..+.+++.+||+.||++|||++++++.|+++..+..+.
T Consensus 246 --~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 246 --RL----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp --CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred --CC----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 00 001112346789999999999999999999999999998876554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=352.51 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=193.4
Q ss_pred hhCCceeeecCCccEEEEEeCCC---ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeec-CCceEEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTK-DEHGFIVT 906 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~ 906 (1119)
|...+.||+|+||.||+|.+..+ +..||+|.++.. ...+.+|+.+++.++||||+++++++.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 44557899999999999987533 356899988642 2457889999999999999999998654 56789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.++++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999976543 478999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCC--CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 987 HSS--STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 987 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... .......+|+.|+|||.+.+..++.++||||+||++|||++ |..||...... +... ..... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~~~~---~~~~~-~------ 313 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV---YLLQG-R------ 313 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--CHHH---HHHTT-C------
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--HHHH---HHHcC-C------
Confidence 211 12234567889999999988899999999999999999999 66666533111 1111 00000 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
... .+...+..+.+++.+||+.||++|||++|++++|+++.....++
T Consensus 314 --~~~----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 314 --RLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp --CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 000 01112346789999999999999999999999999998776654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.71 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=200.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCC---CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN---SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+.. ++..||+|+++.. ...+.+|+.+++.++||||+++++++.+ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 357777999999999999998653 3457999998653 3457889999999999999999999865 456899
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++...+. .+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999987543 488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.. ........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ........ ..
T Consensus 166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~----~~------- 231 (281)
T 3cc6_A 166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEK----GD------- 231 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHH----TC-------
T ss_pred cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhc----CC-------
Confidence 22 122334457889999999988889999999999999999998 99998643211 11100000 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
... .+...+..+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 232 -~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 232 -RLP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 000 0011234678999999999999999999999999988654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.33 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=200.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+. ++.||||+++.. ...+.+|+.+++.++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 46677799999999999999986 788999998643 23578899999999999999999999876 778999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
|||+++|+|.+++..... ..+++..+..++.|+++|++|||+. + ++||||||+||+++.++.++++|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999987542 3589999999999999999999998 7 999999999999999999999999987643
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCC---cchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTE---KSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
.. ....+|+.|+|||.+.+..++. ++||||+|+++|||++|+.||........ ... ....
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~-~~~~----- 226 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMK-VALE----- 226 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----HHH-HHHS-----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----HHH-HHhc-----
Confidence 22 2346799999999887765544 79999999999999999999964311100 000 0000
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
...... +...+..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 227 -~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~~ 271 (271)
T 3kmu_A 227 -GLRPTI------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271 (271)
T ss_dssp -CCCCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred -CCCCCC------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 000011 112244688999999999999999999999999998763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=350.83 Aligned_cols=269 Identities=16% Similarity=0.194 Sum_probs=208.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCC--------CceEEEEEecccccccHHHHHHHHhhcCCCCEEE--------------
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN--------SRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILR-------------- 891 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~-------------- 891 (1119)
.+|+..+.||+|+||.||+|++.. .++.||+|++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 367778999999999999999987 3789999998754 57899999999999999887
Q ss_pred -Eeeeeec-CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 001226 892 -IVGSCTK-DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969 (1119)
Q Consensus 892 -l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 969 (1119)
+++++.. ++..++||||+ +++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||+++.+
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETT
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCC
Confidence 5666655 67789999999 999999998753 23599999999999999999999999 99999999999999999
Q ss_pred C--ceEEEeccccccccCCCCC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCC
Q 001226 970 L--EPKIGDFGMSKLISDSHSS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGED 1042 (1119)
Q Consensus 970 ~--~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~ 1042 (1119)
+ .+||+|||+++........ .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 8 8999999999876543211 12234579999999999999899999999999999999999999997542221
Q ss_pred CceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
............. .....+.... ....+..+.+++.+||+.||++|||++++++.|+++.++.+..
T Consensus 276 ~~~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 276 EDIMKQKQKFVDK---PGPFVGPCGH-----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHHHHHS---CCCEECTTSC-----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhccCC---hhhhhhhccc-----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 1111111100000 0111110000 0012356889999999999999999999999999998776543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.18 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=198.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCC----ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS----RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~----~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|+..+.||+|+||.||+|.+..+ +..||||+++.. ...+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 455668999999999999987654 346999998643 23477899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 125 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 125 TEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999987533 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 986 SHS-SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 986 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... ........+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...... .. .... ....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--~~---~~~~-~~~~------ 267 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EV---MKAI-NDGF------ 267 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---HHHH-HTTC------
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--HH---HHHH-HCCC------
Confidence 321 112223456789999999988899999999999999999998 99998643110 00 0000 0000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
... .+...+..+.+++.+||+.+|++||++++++++|+++....
T Consensus 268 --~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 268 --RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp --CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 000 01122456789999999999999999999999999886543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=345.64 Aligned_cols=261 Identities=21% Similarity=0.231 Sum_probs=196.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..+.||+|+||+||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 5677799999999999999999999999999885432 3466899999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 84 CDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 99999999887654 489999999999999999999999 99999999999999999999999999998765322
Q ss_pred CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc-----------c
Q 001226 989 SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE-----------N 1056 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 1056 (1119)
.......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.. ......... .
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL--YLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHHHTC
T ss_pred -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhcccccccccccccc
Confidence 22234578999999998875 67899999999999999999999999653211110 000000000 0
Q ss_pred ccccccccccccCCCchH---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREISFWDSDD---QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+......... ...+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 1234567899999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=349.39 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=194.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||+||+|.+..+++.||+|+++... ..+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 5677789999999999999999999999999885332 24557999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
+ |+|.+++...+. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 83 ~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~ 154 (324)
T 3mtl_A 83 D-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 154 (324)
T ss_dssp S-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred c-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence 7 599999887643 489999999999999999999999 9999999999999999999999999999865432 1
Q ss_pred CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh--ccccccccccc--
Q 001226 990 STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL--QENHECICFLD-- 1064 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-- 1064 (1119)
.......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ........ ...........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHhchhhhcch
Confidence 22334578999999998876 5689999999999999999999999975321110 00000000 00000000000
Q ss_pred ----ccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 ----REISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ----~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....... ......+.++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000 0001224567899999999999999999999885
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=354.97 Aligned_cols=248 Identities=27% Similarity=0.341 Sum_probs=191.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------------cccHHHHHHHHhhcCCCCEEEEeeeeecCCc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 901 (1119)
.+|...+.||+|+||.||+|.+..+++.||||++... ...+.+|+.++++++||||+++++++.. +.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 4678889999999999999999999999999998532 1247899999999999999999999854 45
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceEEEecc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPKIGDFG 978 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vkl~DfG 978 (1119)
.|+||||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred eEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecc
Confidence 799999999999999987654 489999999999999999999999 999999999999997654 59999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ . ......
T Consensus 288 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~---~~~i~~- 359 (419)
T 3i6u_A 288 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-L---KDQITS- 359 (419)
T ss_dssp TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-H---HHHHHT-
T ss_pred cceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-H---HHHHhc-
Confidence 99876542 22334679999999998753 5678899999999999999999999975321111 0 000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+..+.+++.+||+.||++|||++|+++|
T Consensus 360 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 ---------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000111234578899999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=357.95 Aligned_cols=269 Identities=23% Similarity=0.302 Sum_probs=191.3
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcC-CCCEEEEeeeeecC--CceE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVR-HRNILRIVGSCTKD--EHGF 903 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~ 903 (1119)
+.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.+. ||||+++++++..+ ...|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 45788889999999999999999999999999988432 234668999999997 99999999998754 3689
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++ ++|.++++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+|+..
T Consensus 88 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 6899998764 488999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCC-------------------CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001226 984 SDSH-------------------SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043 (1119)
Q Consensus 984 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~ 1043 (1119)
.... ........+||++|+|||++.+ ..++.++||||+||++|||++|+.||......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 4311 1112234579999999998876 6789999999999999999999999975321100
Q ss_pred ceeehhhh-hhcccccc-------c-ccc----------cccccCCCch----------HHHHHHHHHHHHHHccccCCC
Q 001226 1044 DIVTWTRW-KLQENHEC-------I-CFL----------DREISFWDSD----------DQLKALRLLELALECTRQVAD 1094 (1119)
Q Consensus 1044 ~~~~~~~~-~~~~~~~~-------~-~~~----------~~~~~~~~~~----------~~~~~~~l~~l~~~cl~~dP~ 1094 (1119)
....... ..+..... . ..+ .......... ....+.++.+++.+||+.||+
T Consensus 240 -~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 240 -LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp -HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred -HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 0000000 00000000 0 000 0000000000 001234688999999999999
Q ss_pred CCCCHHHHHHH--HHccc
Q 001226 1095 MRPSMREVVGF--LIKLN 1110 (1119)
Q Consensus 1095 ~RPs~~ell~~--L~~~~ 1110 (1119)
+|||++|+++| ++.+.
T Consensus 319 ~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFH 336 (388)
T ss_dssp GSCCHHHHTTSTTTTTTC
T ss_pred cCCCHHHHhCCHHHHHhc
Confidence 99999999998 55443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=338.41 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=200.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCC---ceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeee-ecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSC-TKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV 905 (1119)
+|...++||+|+||.||+|.+..+ ...||+|.++... ..+.+|+.++++++||||+++++++ ..++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 456668999999999999986543 3468999886422 4577899999999999999999985 455678999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 106 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999976442 478999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC--CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 986 SHS--SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK-MPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 986 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
... ........+|+.|+|||.+.+..++.++||||+|+++|||++|. .||... .... ... .......
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-~~~~-~~~---~~~~~~~----- 250 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFD-ITV---YLLQGRR----- 250 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS-CTTT-HHH---HHHTTCC-----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC-CHHH-HHH---HHhcCCC-----
Confidence 321 12233456788999999998889999999999999999999955 454332 1111 110 0000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
.. .+...+..+.+++.+||+.||++|||++|+++.|+++.....++
T Consensus 251 --~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 251 --LL------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp --CC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred --CC------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 00 00112346789999999999999999999999999998887664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=348.36 Aligned_cols=264 Identities=18% Similarity=0.226 Sum_probs=198.4
Q ss_pred HhhCCceeeecCCccEEEEEeCC---CceEEEEEecccccc---------------cHHHHHHHHhhcCCCCEEEEeeee
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN---SRKHWAVKKLNRSET---------------NFDVEIRTLSLVRHRNILRIVGSC 896 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~~~---------------~~~~E~~~l~~l~h~niv~l~~~~ 896 (1119)
+|+..+.||+|+||.||+|.+.. ++..||+|+...... .+.+|+..++.++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 57777999999999999999987 788999999865432 244567777788999999999998
Q ss_pred ec----CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC--
Q 001226 897 TK----DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-- 970 (1119)
Q Consensus 897 ~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 970 (1119)
.. +...|+||||+ +++|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||+++.++
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 87 67889999999 999999998765 489999999999999999999999 999999999999999887
Q ss_pred ceEEEeccccccccCCCCC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce
Q 001226 971 EPKIGDFGMSKLISDSHSS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 1045 (1119)
.+||+|||+++........ .......||+.|+|||.+.+..++.++||||+||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999876432211 11244579999999999998899999999999999999999999996321111111
Q ss_pred eehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1046 VTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..... . ........+..... ....+..+.+++.+||+.||++||++++|++.|+++.-..
T Consensus 271 ~~~~~-~--~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 271 QTAKT-N--LLDELPQSVLKWAP-----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp HHHHH-H--HHHTTTHHHHHHSC-----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred HHHHH-h--hcccccHHHHhhcc-----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 00000 0 00000000000000 0023457899999999999999999999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.18 Aligned_cols=265 Identities=21% Similarity=0.325 Sum_probs=200.8
Q ss_pred HHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCce
Q 001226 830 YEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 830 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 902 (1119)
+..+.+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 33456788889999999999999999988999999988531 23577899999999999999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
++||||+++++|.+++.... ....+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 99999999999999987532 123589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
...... .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ........... ..
T Consensus 185 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~-- 255 (310)
T 2wqm_A 185 FFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEQC--DY-- 255 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHHHHHHTT--CS--
T ss_pred eecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHHHHhhcc--cC--
Confidence 664321 1223456899999999999999999999999999999999999998643111 11111100000 00
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
+... ....+..+.+++.+||+.||++|||+++++++|+++...+.
T Consensus 256 ---~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 256 ---PPLP-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp ---CCCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---CCCc-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 0000 01223467899999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=347.54 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=172.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcC-----CCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVR-----HRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|...++||+|+||+||+|++..+++.||||+++.. ...+..|+.+++.++ ||||+++++++...+..++||
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~ 115 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence 677789999999999999999999999999998643 345677999999986 999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC------------------
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS------------------ 968 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~------------------ 968 (1119)
||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 116 e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 116 EPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp CCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred cCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccccc
Confidence 999 9999999987653 2489999999999999999999999 9999999999999975
Q ss_pred -------CCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 969 -------ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 969 -------~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
++.+||+|||+++.... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 78899999999986543 223457899999999999999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=361.09 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=200.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..++||+|+||+||+|.++.+++.||||++.. ....+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 578889999999999999999999999999999842 33467899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCceEEEecccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD---SELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~DfGla~~~~ 984 (1119)
|+++|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++ .++.+||+|||+++...
T Consensus 102 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999987754 489999999999999999999999 999999999999995 45679999999998664
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.. .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ... .... ..
T Consensus 176 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i----------~~ 236 (486)
T 3mwu_A 176 QN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDI---LKRV----------ET 236 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHH----------HH
T ss_pred CC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHH----------Hh
Confidence 42 22334579999999998865 589999999999999999999999964311 000 0000 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00111111112234567899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.39 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=205.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||.||+|.+.. +..||+|+++.. .+.+.+|+.+++.++||||+++++++.+ +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 356777999999999999999764 678999998643 3568899999999999999999999864 56899999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+++|.+++.... ...+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||.+....... ..
T Consensus 91 ~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (279)
T ss_dssp TCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence 999999997643 12489999999999999999999999 99999999999999999999999999998765422 12
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......++..|+|||.+.+..++.++||||+|+++|||++ |+.||...... .. .... ... ....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~---~~~~-~~~------~~~~--- 230 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EV---IQNL-ERG------YRMV--- 230 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH---HHHH-HTT------CCCC---
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HH---HHHH-hcc------cCCC---
Confidence 2233456889999999988889999999999999999999 89998643111 00 0000 000 0000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
.+...+..+.+++.+|++.||++|||++++++.|+++....++.+
T Consensus 231 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 275 (279)
T 1qpc_A 231 ---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY 275 (279)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred ---CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence 011223578899999999999999999999999999988776554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=360.31 Aligned_cols=191 Identities=24% Similarity=0.338 Sum_probs=152.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec-----CCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK-----DEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~ 902 (1119)
.+|+..+.||+|+||+||+|.++.+++.||||++... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 3678889999999999999999999999999988542 2457789999999999999999999843 3568
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 578999987654 489999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCC-------------------------CcccccccCCCccccccc-CCCCCCCcchHHHHHHHHHHHHhC
Q 001226 983 ISDSHSS-------------------------STRSAIVGSLGYIAPENA-YSTRLTEKSDVYSYGVILFELLFR 1031 (1119)
Q Consensus 983 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg 1031 (1119)
....... ......+||++|+|||++ .+..++.++||||+||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432211 123345789999999976 566799999999999999999994
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=360.63 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=202.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|...++||+|+||.||+|+++.+++.||+|++++. ...+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE 265 (543)
T 3c4z_A 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT 265 (543)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence 455668899999999999999999999999998532 2457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|++||+|.+++..... ...+++..+..++.||+.|+.|||+. +|+||||||+||+++.+|.+||+|||+++.....
T Consensus 266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999999999876532 33589999999999999999999999 9999999999999999999999999999876542
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ......... ...
T Consensus 343 ~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~----------~~~ 409 (543)
T 3c4z_A 343 Q--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVL----------EQA 409 (543)
T ss_dssp C--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHH----------HCC
T ss_pred C--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHh----------hcc
Confidence 2 122345799999999999999999999999999999999999999975422111 111111111 111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSM-----REVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ell~~ 1105 (1119)
... +...+..+.+++.+||+.||++||++ +++++|
T Consensus 410 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 VTY----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCC----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cCC----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 110 11224567899999999999999965 677653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=369.58 Aligned_cols=259 Identities=26% Similarity=0.424 Sum_probs=209.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..++||+|+||.||+|.+.. +..||||+++.. .+++.+|+++++.++||||+++++++.+ +..|+||||+++
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 56677899999999999999886 567999998643 3568899999999999999999999876 678999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.++++.... ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 346 gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~ 420 (535)
T 2h8h_A 346 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA 420 (535)
T ss_dssp EEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHT
T ss_pred CcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eec
Confidence 999999985421 2488999999999999999999999 99999999999999999999999999998664321 112
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... +... ...... ...
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~----~i~~~~--------~~~-- 484 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD----QVERGY--------RMP-- 484 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHH----HHHTTC--------CCC--
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----HHHcCC--------CCC--
Confidence 223456789999999988899999999999999999999 99998643111 1000 000000 000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGMR 1118 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~ 1118 (1119)
.+...+..+.+++.+||+.||++|||+++|++.|+++....+..|+
T Consensus 485 --~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~ 530 (535)
T 2h8h_A 485 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530 (535)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence 0112245678999999999999999999999999999988887764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=335.32 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=202.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|...+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4677789999999999999999999999999998432 345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++...+ .+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999998764 389999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... . ..... ....
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~----------~~~~ 228 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--E---THRRI----------VNVD 228 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHH----------HTTC
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--H---HHHHH----------hccc
Confidence 223457899999999999989999999999999999999999999643110 0 00000 0000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... +...+..+.+++.+|++.||++|||++|++++
T Consensus 229 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 100 01123467899999999999999999999974
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.23 Aligned_cols=274 Identities=26% Similarity=0.336 Sum_probs=206.0
Q ss_pred HHhhCCceeeecCCccEEEEE----eCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeee--cCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTL----SNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCT--KDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|+ +..+++.||||++.... ..+.+|+.++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 466777999999999999998 46678999999986432 34789999999999999999999886 455689
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999987542 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
...... .......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||.....+......... ...........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER-DVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc-ccccHHHHHHH
Confidence 543221 1233456888899999998888999999999999999999999998642110000000000 00000000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
+...... ..+...+..+.+++.+||+.||++|||++|++++|+++.....+
T Consensus 257 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 257 LEEGQRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp HHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred hhcccCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 1111000 11122345788999999999999999999999999998776543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=345.88 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=207.3
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEE--EEEeccc-----ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceE
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHW--AVKKLNR-----SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~v--avK~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 903 (1119)
+..+|+..+.||+|+||.||+|++..++..+ |+|+++. ....+.+|+.+++++ +||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 3356778899999999999999998878755 9998853 234588999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC
Q 001226 904 IVTEYMPGGTLFNVLHQNE-------------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL 970 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~ 970 (1119)
+||||+++++|.+++.... ....+++..++.++.|+++|++|||+. +|+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999998653 123589999999999999999999999 999999999999999999
Q ss_pred ceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehh
Q 001226 971 EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWT 1049 (1119)
Q Consensus 971 ~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 1049 (1119)
.+||+|||+++..... .......+++.|+|||.+.+..++.++||||+||++|||++ |+.||...... ...
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~ 251 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELY 251 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHH
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----HHH
Confidence 9999999998744321 12233457889999999988888999999999999999998 99998643110 000
Q ss_pred hhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
. ..... .... .+...+..+.+++.+||+.||++|||++|++++|+++.++...
T Consensus 252 ~-~~~~~------~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 252 E-KLPQG------YRLE------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp H-HGGGT------CCCC------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred H-HhhcC------CCCC------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 0 00000 0000 0112235678999999999999999999999999998876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=338.35 Aligned_cols=247 Identities=21% Similarity=0.340 Sum_probs=201.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|...+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 4788889999999999999999999999999998643 345789999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCceEEEeccccccccCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~DfGla~~~~~~ 986 (1119)
++++|.+++...+ .+++..+..++.|++.|+.|||+. +|+||||||+||++ +.++.+|++|||++......
T Consensus 89 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 9999999997654 489999999999999999999999 99999999999999 78899999999998754331
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
......||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ... .... . ...
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~--~~~i-~----------~~~ 223 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKL--FEKI-K----------EGY 223 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHH--HHHH-H----------HCC
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHH--HHHH-H----------cCC
Confidence 22345689999999999999999999999999999999999999864311 000 0000 0 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...........+..+.+++.+|++.||++|||++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000000011224567899999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=346.86 Aligned_cols=248 Identities=24% Similarity=0.393 Sum_probs=200.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------------ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------------TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|...+.||+|+||.||+|.+..+|+.||||+++... ..+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 35777899999999999999999889999999885322 3467899999999 7999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..|+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.+|++|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999999998654 489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAY------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
....... ......||+.|+|||++. ...++.++||||+||++|||++|+.||.... ... ......
T Consensus 248 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~~-~~~~i~- 318 (365)
T 2y7j_A 248 CHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QIL-MLRMIM- 318 (365)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHHH-
T ss_pred cccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HHH-HHHHHH-
Confidence 8765422 233467899999999775 3358899999999999999999999996421 100 000000
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..............+..+.+++.+||+.||++|||++|++++
T Consensus 319 ---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 ---------EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---------HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---------hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000000000001223467899999999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=352.68 Aligned_cols=264 Identities=17% Similarity=0.238 Sum_probs=208.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecc--cccccHHHHHHHHhhcCC-CCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN--RSETNFDVEIRTLSLVRH-RNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|...++||+|+||.||+|.+..+++.||||+++ ....++.+|+++++.++| +++..+..++.+.+..++||||+ +
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g 86 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-C
Confidence 5777899999999999999999999999999874 344678999999999986 55666666677788889999999 9
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCceEEEeccccccccCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
++|.+++..... .+++..++.++.||+.||+|||+. +||||||||+|||+ +.++.+||+|||+++.......
T Consensus 87 ~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 87 PSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred CCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999999986543 489999999999999999999999 99999999999999 5889999999999987755332
Q ss_pred C-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 989 S-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 989 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+...... .....+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~---~~~~~~ 237 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEK---KVATSI 237 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHHHHHH---HHHSCH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHHHhhc---cccccH
Confidence 1 2233567999999999999999999999999999999999999999764322111 000000000 000000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCC
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEG 1115 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1115 (1119)
.. .....+.++.+++.+||+.+|++||++++|++.|+++..+.+.
T Consensus 238 ~~-------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 238 EA-------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HH-------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH-------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 00 0011245789999999999999999999999999998766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.73 Aligned_cols=264 Identities=19% Similarity=0.252 Sum_probs=193.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+.+|+..+.||+|+||+||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 35788889999999999999999999999999998532 234678999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe-----CCCCceEEEeccccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL-----DSELEPKIGDFGMSK 981 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill-----~~~~~vkl~DfGla~ 981 (1119)
||++ |+|.+++.... .+++..++.++.|++.|++|||+. +|+||||||+||++ +..+.+||+|||+++
T Consensus 113 e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp ECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred ecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9997 59999998765 389999999999999999999999 99999999999999 455669999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
...... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......+..................
T Consensus 186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 764321 223345689999999988774 58999999999999999999999996532111000000000000000000
Q ss_pred c-----cccccccCCCch------HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 C-----FLDREISFWDSD------DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~-----~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ............ ....+.++.+++.+||+.||++|||++|+++|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 000000000000 01124577899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=360.56 Aligned_cols=247 Identities=26% Similarity=0.353 Sum_probs=197.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||+||+|+++.++..||+|+++.. ...+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4788889999999999999999999999999998532 3457899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEecccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGDFGMSKLIS 984 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~DfGla~~~~ 984 (1119)
|+++|+|.+++.... .+++..+..++.||++|++|||+. +|+||||||+||+++.. +.+||+|||+++...
T Consensus 117 ~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 999999999887654 489999999999999999999999 99999999999999764 459999999998765
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.. .......||+.|+|||++. +.++.++||||+||++|+|++|+.||..... ... ..... .
T Consensus 191 ~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i~----------~ 251 (494)
T 3lij_A 191 NQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEI---LRKVE----------K 251 (494)
T ss_dssp TT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHH----------H
T ss_pred CC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHHH----------h
Confidence 42 2234457999999999875 5689999999999999999999999964311 110 00000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+..+.+++.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00000001111234567899999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.72 Aligned_cols=245 Identities=26% Similarity=0.409 Sum_probs=202.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... .+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 3577789999999999999999999999999988532 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++.... .+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999987654 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .......+|+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ..+.... ...
T Consensus 169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~-----------~~~ 231 (294)
T 2rku_A 169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIK-----------KNE 231 (294)
T ss_dssp T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH-----------TTC
T ss_pred c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh-----------hcc
Confidence 2 2233457899999999998888999999999999999999999999643111 0000000 000
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... +...+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 YSI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 01123467899999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=363.32 Aligned_cols=247 Identities=27% Similarity=0.374 Sum_probs=202.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..++||+|+||.||+|.++.+++.||||++.. ....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 478888999999999999999999999999999842 2345789999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe---CCCCceEEEeccccccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL---DSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill---~~~~~vkl~DfGla~~~ 983 (1119)
||+++|+|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 106 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp CCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 9999999999997654 489999999999999999999999 99999999999999 56789999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... .......||+.|+|||.+.+ .++.++||||+||++|||++|+.||..... .... ....
T Consensus 180 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~---~~i~---------- 240 (484)
T 3nyv_A 180 EAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDIL---KKVE---------- 240 (484)
T ss_dssp CCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH---HHHH----------
T ss_pred ccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHH---HHHH----------
Confidence 442 22344579999999998765 689999999999999999999999974311 0000 0000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..............+..+.+++.+||+.||++|||++|+++|
T Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000111111112234567899999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=353.68 Aligned_cols=246 Identities=22% Similarity=0.346 Sum_probs=191.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcC--CCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVR--HRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..+.||+|+||.||+|.+.. ++.||||++... ...+.+|+.+++.++ ||||+++++++..++..|+||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 47777999999999999999876 889999988532 245788999999996 599999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
| +.+++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999998765 488999999999999999999999 999999999999995 589999999999877543
Q ss_pred CCCCcccccccCCCcccccccCC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-----------TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
..........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~------- 277 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKL------- 277 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHH-------
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHH-------
Confidence 33333445679999999998754 46889999999999999999999999643111 0000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...++....... +...+..+.+++.+||+.||++|||++|++++
T Consensus 278 ----~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 ----HAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----HHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHhCccccCCC--CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011111110000 00013467899999999999999999999976
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=349.63 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=189.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCC--CCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRH--RNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..+.||+|+||.||+|.+.. ++.||||++.... ..+.+|+.+++.++| |||+++++++.+++..++||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 46667899999999999998854 8899999885322 457789999999986 99999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|+ .+++|.+++.... .+++..+..++.|+++|+.|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 89 e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp CC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred eC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 94 5889999998765 489999999999999999999999 999999999999997 678999999999877554
Q ss_pred CCCCcccccccCCCcccccccCC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-----------TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
..........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~------ 231 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLH------ 231 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHH------
Confidence 33333445679999999998753 67889999999999999999999999643111 00000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
..+++..... .+...+..+.+++.+||+.||++|||++|++++-
T Consensus 232 -----~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 232 -----AIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp -----HHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HHhcCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 0111111000 0001124678999999999999999999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.23 Aligned_cols=245 Identities=26% Similarity=0.380 Sum_probs=197.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|++..+++.||||++.... ..+.+|+++++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45777799999999999999999999999999985321 35778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++ |++.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 688888865432 489999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.....||+.|+|||.+. ...++.++||||+||++|||++|+.||...... ..........
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~~~~~~~-------- 269 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNE-------- 269 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHSC--------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcC--------
Confidence 22357899999999874 567899999999999999999999998643110 0000000000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
.+... ....+..+.+++.+||+.||++|||+++++++--
T Consensus 270 ~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 270 SPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp CCCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCCCC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 00000 0112346789999999999999999999987643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.62 Aligned_cols=258 Identities=27% Similarity=0.388 Sum_probs=200.9
Q ss_pred HHhhCCceeeecCCccEEEEE-----eCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTL-----SNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~-----~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|. ...+++.||||++... ...+.+|+.+++.++||||+++++++.+++..|
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 467778999999999999998 4456789999998532 245778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNEP----RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~D 976 (1119)
+||||+++++|.+++..... ...+++..++.++.|++.|+.|||+. +|+||||||+||+++.+ ..+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999987542 13588999999999999999999999 99999999999999944 4699999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ... .......
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~---~~~~~~~ 261 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEV---LEFVTSG 261 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH---HHHHHTT
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHH---HHHHhcC
Confidence 999986654433334445578999999999988889999999999999999998 9999864311 010 0000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
. ... .+...+..+.+++.+||+.||++||++++++++++.+.+.
T Consensus 262 -~------~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 262 -G------RMD------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -C------CCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -C------CCC------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 0 000 0112234678999999999999999999999999988654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=351.00 Aligned_cols=195 Identities=28% Similarity=0.370 Sum_probs=165.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 903 (1119)
+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+++++.++||||+++++++... ...|
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 577789999999999999999999999999998642 23577899999999999999999999766 5689
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++ ++|.++++... .+++..+..++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999996 69999998654 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC--------------------CcccccccCCCccccccc-CCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 001226 984 SDSHSS--------------------STRSAIVGSLGYIAPENA-YSTRLTEKSDVYSYGVILFELLFRKMPVD 1036 (1119)
Q Consensus 984 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslG~vl~elltg~~p~~ 1036 (1119)
...... ......+||++|+|||.+ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 543211 123456899999999985 56679999999999999999998766654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=336.42 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=203.5
Q ss_pred ceeeecCCccEEEEEeC--CCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSN--NSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.||+|+||.||+|.+. .++..||||+++.. ...+.+|+.+++.++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999864 45788999998653 24577899999999999999999999 556789999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC-Cc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-ST 991 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~-~~ 991 (1119)
+|.+++..... .+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 95 ~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 95 PLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp EHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred CHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 99999975432 489999999999999999999999 9999999999999999999999999999876543221 22
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ... ...... . ....
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~---~~i~~~-~------~~~~--- 234 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVM---AFIEQG-K------RMEC--- 234 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHH---HHHHTT-C------CCCC---
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHH---HHHhcC-C------cCCC---
Confidence 233456889999999888889999999999999999998 99998653211 111 000000 0 0000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
+...+..+.+++.+||+.||++||++++++++|+++..+.+.+.
T Consensus 235 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 235 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ---CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 11234578899999999999999999999999999987766553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=341.82 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=197.2
Q ss_pred HhhCC-ceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEG-RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|... +.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++ ||||+++++++.+++..++||
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 44444 8899999999999999999999999988532 245788999999985 699999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccc
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLI 983 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~ 983 (1119)
||+++|+|.+++.... ...+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 109 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp ECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999999999986543 23589999999999999999999999 9999999999999998 789999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ........ .
T Consensus 185 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~~-~-------- 248 (327)
T 3lm5_A 185 GHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETYLNISQ-V-------- 248 (327)
T ss_dssp ------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH-T--------
T ss_pred CCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHHHh-c--------
Confidence 5422 223457899999999999999999999999999999999999999643111 00000000 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+..+.+++.+||+.||++|||++|++++
T Consensus 249 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 --NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0000000111234567899999999999999999999886
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=335.59 Aligned_cols=243 Identities=28% Similarity=0.401 Sum_probs=193.9
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec----CCceEEE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK----DEHGFIV 905 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV 905 (1119)
|...+.||+|+||.||+|.+..++..||+|++... ...+.+|+.+++.++||||+++++++.. +...++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 44557899999999999999999999999988532 2347789999999999999999998865 3567999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeC-CCCceEEEecccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLD-SELEPKIGDFGMSKL 982 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~vkl~DfGla~~ 982 (1119)
|||+++++|.+++.... .+++..+..++.|++.|+.|||+. + |+||||||+||+++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999998754 488999999999999999999998 7 99999999999998 789999999999975
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.... ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||....... ......... ..
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~-~~---- 247 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRVTSG-VK---- 247 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHHTTT-CC----
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHHHHHhcc-CC----
Confidence 4332 223456899999999776 458999999999999999999999996432111 110000000 00
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .+...+..+.+++.+||+.||++|||++|++++
T Consensus 248 -~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 -PAS------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CGG------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccc------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 011112467899999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=337.60 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=201.4
Q ss_pred HHhhCCc-eeeecCCccEEEEEe--CCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 834 IRATEGR-IIGKGKHGTVYRTLS--NNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~-~lG~G~fg~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
.+|+..+ .||+|+||.||+|.+ ..+++.||||+++.. ...+.+|+.+++.++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 3556555 899999999999954 566789999998643 34578899999999999999999999 5677899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999998754 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ... .... ...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~---~~~~-~~~----- 237 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVT---AMLE-KGE----- 237 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHH---HHHH-TTC-----
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHH---HHHH-cCC-----
Confidence 43221 12223456789999999988888999999999999999999 99998653211 100 0000 000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
... .+...+..+.+++.+||+.||++||+++++++.|+++...
T Consensus 238 -~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 238 -RMG------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -CCC------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CCC------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 000 0112345788999999999999999999999999988654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=347.90 Aligned_cols=251 Identities=23% Similarity=0.296 Sum_probs=199.7
Q ss_pred HHhhCCceeeecCCccEEEEEeC---CCceEEEEEecccc--------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN---NSRKHWAVKKLNRS--------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~---~~~~~vavK~~~~~--------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 901 (1119)
.+|+..+.||+|+||.||+|++. .+++.||||+++.. ...+.+|+.+++.+ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 56788899999999999999984 47899999998532 24467799999999 69999999999999999
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.++||||+++++|.+++.... .+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999998754 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
...... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ............
T Consensus 208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--- 282 (355)
T ss_dssp ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC---
T ss_pred ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC---
Confidence 654322 122334579999999999875 3478999999999999999999999975322111 111111110000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGFL 1106 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~L 1106 (1119)
+.. +...+..+.+++.+||+.||++|| +++|++++.
T Consensus 283 -----~~~------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -----PPY------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCC------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCC------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 001 112234678999999999999999 999998864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=357.58 Aligned_cols=263 Identities=24% Similarity=0.272 Sum_probs=195.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecC------CceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKD------EHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lV~e~ 908 (1119)
+|+..+.||+|+||.||+|++..+++.||||++........+|+.+++.++||||+++++++... ...++||||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 46677999999999999999999999999999977666677899999999999999999988532 235799999
Q ss_pred cCCCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEeccccccccCC
Q 001226 909 MPGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 909 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla~~~~~~ 986 (1119)
+++ ++.+.+... .....+++..+..++.||++||+|||+. +|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 975 666665431 1123589999999999999999999999 99999999999999965 56899999999876442
Q ss_pred CCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh--------cccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL--------QENH 1057 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 1057 (1119)
. ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+........ ....
T Consensus 211 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 211 E---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp C---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHHHHCS
T ss_pred C---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhhCh
Confidence 2 22345789999999988764 78999999999999999999999997532111 1111000000 0000
Q ss_pred cccccccccccCCCc---hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECICFLDREISFWDS---DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~~~---~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....+.-+.+....- .....+.++.+++.+||+.||++|||+.|+++|
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000000000 001224578899999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=343.93 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=202.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|...+.||+|+||.||++.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3677789999999999999999999999999998533 245778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++++|.+++.... .+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp CCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 9999999999987654 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ..+..... ... .
T Consensus 195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~-~~~--------~ 259 (335)
T 2owb_A 195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK----ETYLRIKK-NEY--------S 259 (335)
T ss_dssp T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHH-TCC--------C
T ss_pred c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHhc-CCC--------C
Confidence 2 2233457899999999998888999999999999999999999999643110 00000000 000 0
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+. ......+.+++.+||+.||++|||++|++++
T Consensus 260 ~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 IP------KHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CC------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CC------ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 1123467899999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=361.28 Aligned_cols=247 Identities=29% Similarity=0.355 Sum_probs=199.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----------------cccHHHHHHHHhhcCCCCEEEEeeee
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----------------ETNFDVEIRTLSLVRHRNILRIVGSC 896 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~~~~ 896 (1119)
.+|+..++||+|+||+||+|.++.+++.||+|+++.. ...+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3677789999999999999999999999999998532 23577899999999999999999999
Q ss_pred ecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC---ceE
Q 001226 897 TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL---EPK 973 (1119)
Q Consensus 897 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~---~vk 973 (1119)
.+++..|+||||+++|+|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999997754 489999999999999999999999 999999999999998876 699
Q ss_pred EEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 974 IGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 974 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
|+|||+++..... .......||+.|+|||.+. +.++.++||||+||++|+|++|+.||..... ... ....
T Consensus 190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i- 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDI---IKKV- 259 (504)
T ss_dssp ECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHH-
T ss_pred EEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHH-
Confidence 9999999876542 2233457999999999876 5689999999999999999999999975311 110 0000
Q ss_pred cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...............+..+.+++.+||+.||.+|||++|++++
T Consensus 260 ---------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 ---------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---------HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000000111234578899999999999999999999876
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=367.74 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=198.4
Q ss_pred eeeecCCccEEEEEeC--CCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 841 IIGKGKHGTVYRTLSN--NSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
.||+|+||.||+|.++ .++..||||+++.. ..++.+|+++++.++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 34678999998642 3468899999999999999999999976 56899999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC-CCcc
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS-SSTR 992 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~-~~~~ 992 (1119)
|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus 422 L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 999997653 2589999999999999999999999 999999999999999999999999999987654322 1122
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +..... .... ...
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i----~~~~--------~~~--- 559 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFI----EQGK--------RME--- 559 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHH----HTTC--------CCC---
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCC--------CCC---
Confidence 23346789999999988899999999999999999998 99999754221 111100 0000 000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
.+...+..+.+++.+||+.+|++||++++|++.|+.+....+.+
T Consensus 560 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 560 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 01123457889999999999999999999999999876655443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.55 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=204.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeec----CCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTK----DEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++.. ....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 3577779999999999999999999999999988432 3457889999999999999999999863 3467999
Q ss_pred EeccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 906 TEYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
|||+++|+|.+++.... ....+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999997631 123589999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCCC-------cccccccCCCcccccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc
Q 001226 985 DSHSSS-------TRSAIVGSLGYIAPENAYSTR---LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 985 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
...... ......||+.|+|||.+.+.. ++.++||||+|+++|||++|+.||...............
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---- 261 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---- 261 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH----
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh----
Confidence 211110 112345799999999887554 689999999999999999999998532111111110000
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
..... ......+..+.+++.+||+.||++|||+++++++|+++.+...+.
T Consensus 262 ----------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 262 ----------NQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ----------CC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ----------ccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00000 001122356889999999999999999999999999998776554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=347.47 Aligned_cols=268 Identities=25% Similarity=0.400 Sum_probs=204.2
Q ss_pred hCCceeeecCCccEEEEEe----CCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecC--CceEEE
Q 001226 837 TEGRIIGKGKHGTVYRTLS----NNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKD--EHGFIV 905 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~----~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 905 (1119)
+..+.||+|+||.||++.+ ..+++.||||+++... ..+.+|+++++.++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 6779999999999988754 3468899999996542 3478999999999999999999999874 567999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++++|.+++.... +++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999997653 89999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||............+..... ........+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-TVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH-HHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch-hHHHHHHHHh
Confidence 3221 2233456788999999998888999999999999999999999998642111000000000000 0000011111
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
..... ..+...+..+.+++.+||+.||++|||++|+++.|+++.++..
T Consensus 266 ~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 266 RGERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cccCC--CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 11110 1112234578899999999999999999999999999877654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=343.24 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=187.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcC-CCCEEEEeeeee--------cCCc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVR-HRNILRIVGSCT--------KDEH 901 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~~ 901 (1119)
+|+..++||+|+||.||+|.+..+++.||||++... ...+.+|+.+++++. ||||+++++++. ....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 567779999999999999999999999999988432 245778999999996 999999999983 3445
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeCCCCceEEEeccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
.++||||++ |+|.+++........+++..++.++.|++.|++|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 799999995 79999987644344699999999999999999999998 8 99999999999999999999999999
Q ss_pred cccccCCCCCC----------cccccccCCCccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee
Q 001226 980 SKLISDSHSSS----------TRSAIVGSLGYIAPENA---YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 980 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~ 1046 (1119)
++......... ......+|+.|+|||.+ .+..++.++||||+||++|||++|+.||...... ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~ 262 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--RIV 262 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--Hhh
Confidence 98765432211 11244689999999988 5667889999999999999999999998643111 000
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
.... .... .......+.+++.+||+.||++|||++|++++|+++.....
T Consensus 263 ---~~~~----------~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 263 ---NGKY----------SIPP------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ------C----------CCCT------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---cCcc----------cCCc------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0000 0000 00011246789999999999999999999999999876544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=343.01 Aligned_cols=271 Identities=22% Similarity=0.318 Sum_probs=201.9
Q ss_pred CCCCHHHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecC
Q 001226 826 RDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKD 899 (1119)
Q Consensus 826 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~ 899 (1119)
..+.+..+.+|+..+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++.++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 17 ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp --CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred chhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 3455566778999999999999999999999999999999884322 2366899999999999999999999999
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
+..++||||++++++.++..... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 170 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCC
Confidence 99999999999999988876544 389999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh-------
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW------- 1051 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~------- 1051 (1119)
++...... .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......+. .......
T Consensus 171 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 171 ARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPR 247 (331)
T ss_dssp C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHH
T ss_pred ceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChh
Confidence 98664322 223345789999999988765 789999999999999999999999965321110 0000000
Q ss_pred ---hhcccccccccccccccCCCchH---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1052 ---KLQENHECICFLDREISFWDSDD---QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1052 ---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+......... ...+..+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000001111000000 1234578999999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=343.70 Aligned_cols=265 Identities=23% Similarity=0.263 Sum_probs=197.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
..+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 35788889999999999999999999999999998532 235778999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++ +|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 89 lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999975 89888876542 478889999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc-----
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH----- 1057 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 1057 (1119)
.... .......+|+.|+|||.+.+. .++.++||||+||++|||++|..||......+.....+.........
T Consensus 163 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 4322 223345789999999988654 58899999999999999999999986432110000000000000000
Q ss_pred -ccccccc-ccccCCC--chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 -ECICFLD-REISFWD--SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 -~~~~~~~-~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
....... ....... ......+.++.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 0000000 0001224578999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=348.42 Aligned_cols=249 Identities=10% Similarity=0.032 Sum_probs=178.1
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhc--CCCCEEEEee-------eeecC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLV--RHRNILRIVG-------SCTKD 899 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l--~h~niv~l~~-------~~~~~ 899 (1119)
|+..+.||+|+||.||+|.+..+++.||||+++... ..+.+|+.+++.+ +||||++++. ++..+
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 566789999999999999999999999999986532 3456775545444 6999888653 33322
Q ss_pred -----------------CceEEEEeccCCCCHHHhhccCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEe
Q 001226 900 -----------------EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTR------YHIALGIAQGLSYLHYDCVPQIIH 956 (1119)
Q Consensus 900 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ivH 956 (1119)
...|+||||++ |+|.+++...+. .+++..+ ..++.||++|++|||+. +|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCcc
Confidence 23799999998 899999987532 2344455 67789999999999999 9999
Q ss_pred cCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCC
Q 001226 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMP 1034 (1119)
Q Consensus 957 ~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p 1034 (1119)
|||||+||+++.++.+||+|||+++.... ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.|
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999986643 1114457799999999987 6799999999999999999999999
Q ss_pred CCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1035 VDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
|............ .... .......... ......+..+.+++.+||+.||++|||++|++++
T Consensus 293 f~~~~~~~~~~~~--~~~~------~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 293 FGLVTPGIKGSWK--RPSL------RVPGTDSLAF--GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TTBCCTTCTTCCC--BCCT------TSCCCCSCCC--TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCcCcccccchh--hhhh------hhccccccch--hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9765332221111 0000 0000001000 0011224577899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=338.80 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=201.6
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-ccccHHHHHHHHhhcC-CCCEEEEeeeeec--CCceEEEEe
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-SETNFDVEIRTLSLVR-HRNILRIVGSCTK--DEHGFIVTE 907 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~e 907 (1119)
...+|+..+.||+|+||.||+|.+..+++.||||+++. ....+.+|+.+++.++ ||||+++++++.+ ....++|||
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 33577888999999999999999999999999999864 3466889999999997 9999999999987 567899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~ 986 (1119)
|+++++|.+++.. +++..+..++.|++.|++|||+. +|+||||||+||+++.++ .+||+|||+++.....
T Consensus 114 ~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 114 HVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999999998853 78889999999999999999999 999999999999999777 8999999999876543
Q ss_pred CCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh------------
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL------------ 1053 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------------ 1053 (1119)
. ......+|..|+|||.+.+ ..++.++||||+||++|||++|+.||..................
T Consensus 185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 2 2334578999999998877 67899999999999999999999999643222111111000000
Q ss_pred -cccccccccccc----ccc--CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 -QENHECICFLDR----EIS--FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 -~~~~~~~~~~~~----~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............ ... .........+.++.+++.+||+.||++|||++|+++|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000000 000 0000111235678999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=331.69 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=192.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+..++.++||||+++++++.+++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 567779999999999999999988999999998532 2357889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++.... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+|++|||.+.......
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999998764 389999999999999999999999 99999999999999999999999999998764422
Q ss_pred CCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
......+++.|+|||.+.+..+ +.++||||+|+++|||++|+.||..... .......... .
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~----------~ 227 (276)
T 2h6d_A 166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKIRGG----------V 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHC----------C
T ss_pred ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcC----------c
Confidence 2234568999999999887765 6899999999999999999999864211 0000000000 0
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. .+...+..+.+++.+|++.||++|||++|++++
T Consensus 228 ~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 FY----IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cc----CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 001123467899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.51 Aligned_cols=252 Identities=24% Similarity=0.392 Sum_probs=197.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecC-CceEEEEecc
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKD-EHGFIVTEYM 909 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 909 (1119)
..+|+..+.||+|+||.||+|.+. ++.||||+++.. ...+.+|+.+++.++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 356788899999999999999875 789999999653 35678999999999999999999987554 5789999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++..... ..+++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 99999999976532 2378899999999999999999999 9999999999999999999999999998765432
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... +. .... ... .....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~---~~~~-~~~------~~~~~- 235 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DV---VPRV-EKG------YKMDA- 235 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GH---HHHH-TTT------CCCCC-
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHH-hcC------CCCCC-
Confidence 223357889999999988889999999999999999998 99998643211 10 0000 000 00000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+...+..+.+++.+||+.||++|||++|+++.|+++++..
T Consensus 236 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 236 -----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1122456889999999999999999999999999987654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=343.23 Aligned_cols=266 Identities=20% Similarity=0.282 Sum_probs=199.1
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec--------
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK-------- 898 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 898 (1119)
+.+|+..+.||+|+||.||+|++..+++.||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 45788889999999999999999999999999988432 2356789999999999999999999876
Q ss_pred CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
.+..++||||+++ ++.+.+..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 3467999999975 77777765543 489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC--CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh-----
Q 001226 979 MSKLISDSHS--SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR----- 1050 (1119)
Q Consensus 979 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~----- 1050 (1119)
+++....... ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ......
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~ 248 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSI 248 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 9987653221 223345678999999998876 5589999999999999999999999975321100 000000
Q ss_pred ----hhhcccccccccccccccCCCchHH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1051 ----WKLQENHECICFLDREISFWDSDDQ-----LKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1051 ----~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+...........+............ .....+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000000000010 113458899999999999999999999986
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=338.99 Aligned_cols=319 Identities=18% Similarity=0.135 Sum_probs=253.5
Q ss_pred cCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCccccccccccee
Q 001226 94 KNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESI 173 (1119)
Q Consensus 94 ~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L 173 (1119)
.++++++|++++|.++...+..+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..|..++++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 56899999999999985444457999999999999999998878899999999999999999998888889999999999
Q ss_pred eecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCC
Q 001226 174 GFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGG 253 (1119)
Q Consensus 174 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~ 253 (1119)
++++|.++...+..|+.+++|++|++++|++++.. |..+.++++|++|++++|++++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~-----------------------~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE-----------------------DDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC-----------------------TTTTSSCTTCCEEECCSSCCSB
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC-----------------------hhhccCCCCCCEEECCCCcCCc
Confidence 99999999766666789999999999999887543 3457788889999999998874
Q ss_pred ccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccC
Q 001226 254 AISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVG 333 (1119)
Q Consensus 254 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 333 (1119)
. .+..+++|++|++++|.+++. ...++|++|++++|.++..... ..++|++|++++|.+++. ..+.
T Consensus 180 ~----~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 180 V----DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp C----CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGG
T ss_pred c----ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHc
Confidence 3 256678888888888887742 3446788888888888765332 246788888888888753 4677
Q ss_pred CCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEE
Q 001226 334 NLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVEL 413 (1119)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 413 (1119)
.+++|++|++++|.+++..|..|..+++|++|++++|++++ +|..+..+++|++|++++|+++ .+|..+..+++|++|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 88888888888888887777788888888888888888874 4556667788888888888887 455567778888888
Q ss_pred EeecccccccCCccccCCCCcCEEEccCccCcccchhhhhc
Q 001226 414 ALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK 454 (1119)
Q Consensus 414 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 454 (1119)
++++|+++.. + +..+++|+.|++++|++++.....++.
T Consensus 324 ~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~ 361 (390)
T 3o6n_A 324 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFR 361 (390)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred ECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHH
Confidence 8888888743 3 667778888888888887654444443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=337.12 Aligned_cols=248 Identities=27% Similarity=0.345 Sum_probs=197.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------------cccHHHHHHHHhhcCCCCEEEEeeeeecCCc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 901 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 4788889999999999999999999999999988532 134789999999999999999999987654
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc---eEEEecc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFG 978 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~DfG 978 (1119)
.|+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++. +||+|||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999997654 489999999999999999999999 9999999999999987664 9999999
Q ss_pred ccccccCCCCCCcccccccCCCccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENA---YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
+++..... .......||+.|+|||.+ ....++.++||||+||++|||++|+.||........ .. ......
T Consensus 163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~---~~~~~~ 235 (322)
T 2ycf_A 163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LK---DQITSG 235 (322)
T ss_dssp TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HH---HHHHHT
T ss_pred cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HH---HHHHhC
Confidence 99876432 122345689999999986 356789999999999999999999999975322111 10 000000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+..+.+++.+||+.||++||+++|++++
T Consensus 236 ----------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 236 ----------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp ----------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----------ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000000011234578899999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=348.38 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=200.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 567778999999999999999999999999998643 245788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++...+ .+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 114 ~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 114 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 9999999998764 3889999999999999999999842 8999999999999999999999999999765432
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee------------ehhhhh-----
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV------------TWTRWK----- 1052 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~------------~~~~~~----- 1052 (1119)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||........... .+....
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 12345789999999999999999999999999999999999999975321110000 000000
Q ss_pred ------hcccccccccccccccC--CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1053 ------LQENHECICFLDREISF--WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1053 ------~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...........+..... ........+..+.+++.+||+.||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000000000 000011124468899999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=334.82 Aligned_cols=248 Identities=24% Similarity=0.298 Sum_probs=196.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--------cccHHHHHHHHhhcCCCCEEEEeeee--ecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRHRNILRIVGSC--TKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~ 903 (1119)
.+|...+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+.+++.++||||+++++++ .+....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 3677889999999999999999999999999998532 24578999999999999999999998 4456789
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++++ +.+++..... ..+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+|++|||.+...
T Consensus 85 lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999876 7777766542 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTR--LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
.............||+.|+|||...+.. ++.++||||+|+++|||++|+.||.... ..........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~------- 227 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGK------- 227 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH-------
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhc-------
Confidence 5433333344567899999999887644 3779999999999999999999986421 1000000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..... +...+..+.+++.+||+.||++|||++|++++
T Consensus 228 ---~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 ---GSYAI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCCCC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCCCC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 01123467899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=351.08 Aligned_cols=263 Identities=23% Similarity=0.269 Sum_probs=196.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecC---------------
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKD--------------- 899 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------------- 899 (1119)
+|+..+.||+|+||+||+|.+..+++.||||++..+.....+|+.+++.++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 57778999999999999999999999999999987777777899999999999999999998432
Q ss_pred -----------------------CceEEEEeccCCCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 001226 900 -----------------------EHGFIVTEYMPGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955 (1119)
Q Consensus 900 -----------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 955 (1119)
...++||||++ |+|.+.+... .....+++..+..++.|+++|++|||+. +|+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~ 163 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GIC 163 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEE
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCc
Confidence 34789999997 5877777642 1123589999999999999999999999 999
Q ss_pred ecCCCCCCeEeC-CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCC
Q 001226 956 HRDIKSDNILLD-SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKM 1033 (1119)
Q Consensus 956 H~Dlkp~Nill~-~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~ 1033 (1119)
||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999997 68899999999998764432 23345789999999988764 58999999999999999999999
Q ss_pred CCCCCCCCCCceeehhhhhhc--------ccccccccccccccCCC---chHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 001226 1034 PVDPSFGEDTDIVTWTRWKLQ--------ENHECICFLDREISFWD---SDDQLKALRLLELALECTRQVADMRPSMREV 1102 (1119)
Q Consensus 1034 p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPs~~el 1102 (1119)
||......+. .......... .........-+...... ..+...+..+.+++.+||+.||++|||++|+
T Consensus 241 pf~~~~~~~~-~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 241 LFSGETSIDQ-LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp SSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCChHHH-HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 9975321110 0000000000 00000000000000000 0011134568899999999999999999999
Q ss_pred HHH
Q 001226 1103 VGF 1105 (1119)
Q Consensus 1103 l~~ 1105 (1119)
++|
T Consensus 320 l~h 322 (383)
T 3eb0_A 320 MAH 322 (383)
T ss_dssp HTS
T ss_pred hcC
Confidence 864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=334.60 Aligned_cols=246 Identities=28% Similarity=0.403 Sum_probs=202.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 3467779999999999999999999999999998532 25678999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++++|.+++... .+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||.+.......
T Consensus 102 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 9999999998753 489999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... . ........ ..+.+.
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~~~-------~~~~~~ 240 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--K---VLFLIPKN-------NPPTLE 240 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H---HHHHHHHS-------CCCCCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--H---HHHHhhcC-------CCCCCc
Confidence 2233457899999999999999999999999999999999999998643110 0 00000000 000111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L 1106 (1119)
...+..+.+++.+||+.||++|||++|++++.
T Consensus 241 ------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 241 ------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ------cccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 11234678999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=353.26 Aligned_cols=269 Identities=21% Similarity=0.271 Sum_probs=196.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecCC------ceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKDE------HGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e~ 908 (1119)
+|+..++||+|+||+||+|++..+++ ||+|++........+|+.+++.++||||+++++++...+ ..++||||
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 57778999999999999999988655 899988666666678999999999999999999985543 27899999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~DfGla~~~~~~~ 987 (1119)
++++.+............+++..++.++.|+++|++|||+. +|+||||||+||+++ .++.+||+|||+++......
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 98754443333222233589999999999999999999999 999999999999998 78999999999998764422
Q ss_pred CCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc-----ccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE-----CIC 1061 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 1061 (1119)
......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||......+. .....+........ ...
T Consensus 197 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~p~~~~~~~~~~~ 272 (394)
T 4e7w_A 197 ---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEIIKVLGTPSREQIKTMNPN 272 (394)
T ss_dssp ---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHCGG
T ss_pred ---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhhChh
Confidence 22345789999999988764 589999999999999999999999975321110 00000000000000 000
Q ss_pred cccccccCCCch------HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccc
Q 001226 1062 FLDREISFWDSD------DQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLND 1111 (1119)
Q Consensus 1062 ~~~~~~~~~~~~------~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~ 1111 (1119)
+....+...... ....+.++.+++.+||+.||++|||++|+++| ++.++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011111000000 01134578999999999999999999999987 554433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=336.29 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=199.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence 4577779999999999999999999999999998543 45688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
++|.+++..... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+....... ..
T Consensus 109 ~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (314)
T 3com_A 109 GSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AK 181 (314)
T ss_dssp EEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SC
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cc
Confidence 999999974432 489999999999999999999999 99999999999999999999999999998765422 22
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....+|+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ..... .... .....
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~--~~~~------~~~~~---- 245 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIFM--IPTN------PPPTF---- 245 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH--HHHS------CCCCC----
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHH--HhcC------CCccc----
Confidence 33457899999999999889999999999999999999999998643110 00000 0000 00000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.||++|||+++++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111224567899999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=333.46 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=200.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------------cccHHHHHHHHhhcC-CCCEEEEeeeeecC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------------ETNFDVEIRTLSLVR-HRNILRIVGSCTKD 899 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 899 (1119)
.+|+..+.||+|+||.||+|.++.+++.||||+++.. ...+.+|+.++++++ ||||+++++++.++
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 96 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC
Confidence 4677789999999999999999999999999998532 234678999999996 99999999999999
Q ss_pred CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccc
Q 001226 900 EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
+..++||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.
T Consensus 97 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 97 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999998754 489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAY------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL 1053 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 1053 (1119)
+....... ......+++.|+|||.+. ...++.++||||+|+++|||++|+.||..... .. ......
T Consensus 171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~---~~~~~~ 242 (298)
T 1phk_A 171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--ML---MLRMIM 242 (298)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHH
T ss_pred hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HH---HHHHHh
Confidence 98765422 233456899999999764 45688999999999999999999999864311 00 000000
Q ss_pred cccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 QENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..............+..+.+++.+||+.||++|||++|++++
T Consensus 243 ----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 243 ----------SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ----------HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----------cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 000000001112234578899999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=335.51 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=196.7
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
...+||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 346899999999999999999999999988543 3457889999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-CCceEEEeccccccccCCCCCCcc
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-ELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
|.+++.........++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||.+....... ...
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~ 180 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCT 180 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC--Ccc
Confidence 999998765444578899999999999999999999 9999999999999987 8999999999998664322 122
Q ss_pred cccccCCCcccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 993 SAIVGSLGYIAPENAYST--RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
....||+.|+|||.+.+. .++.++||||+|+++|||++|+.||........ ..+...... ..+.+
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~--------~~~~~--- 247 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFKVGMFK--------VHPEI--- 247 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHHHHHHC--------CCCCC---
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHhhcccc--------ccccc---
Confidence 345689999999988654 378999999999999999999999863211100 000000000 00111
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+...+..+.+++.+||+.||++||+++|++++
T Consensus 248 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 248 ---PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11223467899999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=342.84 Aligned_cols=254 Identities=24% Similarity=0.309 Sum_probs=190.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC------ce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------HG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 902 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++||||+++++++..++ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 566778999999999999999999999999998532 234678999999999999999999987653 45
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+||||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 88999999763 388999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc---
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE--- 1058 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 1058 (1119)
... ......+|++|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ..............
T Consensus 178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred ccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence 543 2234578999999998876 6799999999999999999999999975321100 00000000000000
Q ss_pred -------------ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1059 -------------CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1059 -------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+. ......+..+.+++.+|++.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFA---SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG---GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHH---HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 0011224567899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=340.71 Aligned_cols=256 Identities=25% Similarity=0.290 Sum_probs=190.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCC------c
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDE------H 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 901 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 4677789999999999999999999999999998542 234678999999999999999999987654 6
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.|+||||++ ++|.+++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 799999996 578888752 388999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccc----
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH---- 1057 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 1057 (1119)
..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+.........
T Consensus 176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQLGTPCPE 248 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHC-CCCCCHH
T ss_pred ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHH
Confidence 66432 1233457899999999999999999999999999999999999999753211 000000000000
Q ss_pred ----------------------ccccccccc-ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ----------------------ECICFLDRE-ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ----------------------~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....+... ...........+..+.+++.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 011111223346688999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=352.34 Aligned_cols=194 Identities=28% Similarity=0.340 Sum_probs=171.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhc------CCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLV------RHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|+..++||+|+||+||+|.+..+++.||||+++... .++.+|+++++.+ .|+||+++++++...+..++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 5777899999999999999999999999999996543 4567788888877 577999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc--eEEEeccccccc
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE--PKIGDFGMSKLI 983 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~--vkl~DfGla~~~ 983 (1119)
|||++ ++|.+++..... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++. +||+|||+++..
T Consensus 178 ~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp ECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 99995 699999987653 2489999999999999999999999 9999999999999999987 999999999765
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 253 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 253 HQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 43 223457899999999999999999999999999999999999999653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=367.98 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=195.8
Q ss_pred ceeeecCCccEEEEEe--CCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLS--NNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~--~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||.||+|.+ +.+++.||||+++.. ..++.+|+.+++.++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 5799999999999954 456789999998642 2468899999999999999999999964 568899999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC-CC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS-SS 990 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~-~~ 990 (1119)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999998654 489999999999999999999999 999999999999999999999999999987654322 22
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... ..... ..... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~----i~~~~--------~~-- 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAM----LEKGE--------RM-- 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH----HHTTC--------CC--
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHcCC--------CC--
Confidence 2334457889999999988899999999999999999998 99999753211 10000 00000 00
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
..+...+.++.+++.+||+.||++||++++|++.|+++..
T Consensus 592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0011234578899999999999999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=367.16 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=201.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..++||+|+||.||+|+++.+++.||||++++. ...+..|..++..+ +||+|+++++++.+.+..|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 4567778999999999999999999999999998532 23467788888887 799999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 421 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999998764 489999999999999999999999 999999999999999999999999999985432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ........||+.|+|||++.+..|+.++||||+||++|||++|+.||..... . ...... +..
T Consensus 495 ~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~---~~~~~i----------~~~ 557 (674)
T 3pfq_A 495 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--D---ELFQSI----------MEH 557 (674)
T ss_dssp T--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHH----------HSS
T ss_pred C--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--H---HHHHHH----------HhC
Confidence 2 2234456899999999999999999999999999999999999999974311 0 111111 111
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSM-----REVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~ell~~ 1105 (1119)
.... +...+.++.+++.+||+.||++||++ +||++|
T Consensus 558 ~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 NVAY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCCC----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCCC----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1111 11234567899999999999999997 777764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=332.74 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=195.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.. ...+.+|+..+..+ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788889999999999999999999999999998542 24567788888888 8999999999999999999999
Q ss_pred eccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC----------------
Q 001226 907 EYMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---------------- 969 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---------------- 969 (1119)
||+++++|.+++..... ...+++..+..++.|+++|++|||+. +|+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999999999986532 13589999999999999999999999 99999999999999844
Q ss_pred ---CceEEEeccccccccCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce
Q 001226 970 ---LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045 (1119)
Q Consensus 970 ---~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 1045 (1119)
..+|++|||.+...... ....||+.|+|||.+.+. .++.++||||+||++|||++|..|+... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~- 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQ- 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HH-
T ss_pred CCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hH-
Confidence 47999999999876432 223589999999988765 5668999999999999999998775321 10
Q ss_pred eehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1046 VTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+...... . .+.+. ...+..+.+++.+||+.||++|||++|++++
T Consensus 237 --~~~~~~~---~-----~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 --WHEIRQG---R-----LPRIP------QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HHHHHTT---C-----CCCCS------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --HHHHHcC---C-----CCCCC------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111000 0 00111 1123467899999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=344.75 Aligned_cols=268 Identities=26% Similarity=0.400 Sum_probs=204.9
Q ss_pred HhhCCceeeecCCccEEEEE----eCCCceEEEEEeccccc----ccHHHHHHHHhhcCCCCEEEEeeeeecCC--ceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTL----SNNSRKHWAVKKLNRSE----TNFDVEIRTLSLVRHRNILRIVGSCTKDE--HGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~----~~~~~~~vavK~~~~~~----~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 904 (1119)
+|+..+.||+|+||.||+|. ...+++.||||++.... ..+.+|+.+++.++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 56677999999999999998 45678999999986432 35789999999999999999999886644 7799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++..... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 122 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999987643 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc---cccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ---ENHECI 1060 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~ 1060 (1119)
..... .......++..|+|||.+.+..++.++||||+|+++|||++|..|+.....+ .......... ......
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence 43221 1223345778899999988888899999999999999999999987532100 0000000000 000000
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
..+...... ..+...+..+.+++.+||+.||++|||++|+++.|++++++
T Consensus 274 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 274 ELLKNNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHTTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhhcCCCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111110000 01112345788999999999999999999999999998765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=338.72 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=176.7
Q ss_pred HHhhC-CceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeec----CCceEEEEec
Q 001226 834 IRATE-GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTK----DEHGFIVTEY 908 (1119)
Q Consensus 834 ~~~~~-~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 908 (1119)
.+|.. .++||+|+||.||+|.++.+++.||||++........+....++.++||||+++++++.. +...++||||
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 45666 357999999999999999999999999997655444444555677899999999999876 4457999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~DfGla~~~~~ 985 (1119)
+++|+|.+++..... ..+++..++.++.|++.|++|||+. +|+||||||+||+++.+ +.+||+|||+++....
T Consensus 108 ~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~ 183 (336)
T 3fhr_A 108 MEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183 (336)
T ss_dssp CTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence 999999999987643 3589999999999999999999999 99999999999999864 5599999999986543
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||............... . ...
T Consensus 184 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~----------~~~ 248 (336)
T 3fhr_A 184 N----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR-I----------RLG 248 (336)
T ss_dssp ------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------
T ss_pred c----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh-h----------hcc
Confidence 2 223456899999999998888999999999999999999999999754322110000000 0 000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+..+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000011234567899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=333.11 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=202.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeee--cCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCT--KDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++. .+...++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 4677789999999999999999999999999998532 235778999999999999999999874 35678999
Q ss_pred EeccCCCCHHHhhccCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeEeCCCCceEEEeccc
Q 001226 906 TEYMPGGTLFNVLHQNEP-RLVLDWNTRYHIALGIAQGLSYLHYDCVPQ-----IIHRDIKSDNILLDSELEPKIGDFGM 979 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~vkl~DfGl 979 (1119)
|||+++++|.+++..... ...+++..++.++.|++.|++|||+. + |+||||||+||+++.++.+||+|||.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999976432 23489999999999999999999998 7 99999999999999999999999999
Q ss_pred cccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 980 SKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 980 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
++...... .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||..... .. ........ .
T Consensus 163 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~i~~~--~- 232 (279)
T 2w5a_A 163 ARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KE---LAGKIREG--K- 232 (279)
T ss_dssp HHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH---HHHHHHHT--C-
T ss_pred heeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HH---HHHHHhhc--c-
Confidence 98664321 112335689999999999888899999999999999999999999864311 00 00000000 0
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
.+.+. ...+..+.+++.+||+.||++|||++|+++++....+..
T Consensus 233 ----~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 233 ----FRRIP------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp ----CCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred ----cccCC------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 00011 122456789999999999999999999999876655443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=343.20 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=197.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 904 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++.... ..+.+|+++++.++||||+++++++... ...|+
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 5777899999999999999999999999999986422 4577899999999999999999998654 46799
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++ ++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999996 5899998764 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCC-CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh-cccccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-QENHECIC 1061 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1061 (1119)
..... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ......... ........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNC 258 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHHT
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHH
Confidence 43221 12344579999999997654 5589999999999999999999999965321111 000000000 00000000
Q ss_pred c------------ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 F------------LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~------------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ..+....+.......+.++.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000000001124568899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.15 Aligned_cols=238 Identities=13% Similarity=0.151 Sum_probs=183.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHH---HHhhcCCCCEEEEe-------eeee
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIR---TLSLVRHRNILRIV-------GSCT 897 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~---~l~~l~h~niv~l~-------~~~~ 897 (1119)
+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+. .++.++|||||+++ +++.
T Consensus 74 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~ 153 (377)
T 3byv_A 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153 (377)
T ss_dssp EEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred eEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence 456678999999999999999988999999998522 245778994 45555799999998 5554
Q ss_pred cCC-----------------ceEEEEeccCCCCHHHhhccCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 001226 898 KDE-----------------HGFIVTEYMPGGTLFNVLHQNEP----RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIH 956 (1119)
Q Consensus 898 ~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 956 (1119)
+++ ..|+||||+ +|+|.+++...+. ...+++..+..++.||++||+|||+. +|+|
T Consensus 154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 229 (377)
T 3byv_A 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 229 (377)
T ss_dssp CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 443 278999999 6899999986431 11244688889999999999999999 9999
Q ss_pred cCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCC-----------CCCCcchHHHHHHHH
Q 001226 957 RDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-----------RLTEKSDVYSYGVIL 1025 (1119)
Q Consensus 957 ~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslG~vl 1025 (1119)
|||||+||+++.++.+||+|||+++.... ......| +.|+|||.+.+. .++.++||||+||++
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 99999999999999999999999985432 2334567 999999998877 799999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1026 FELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1026 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
|||++|+.||........ .. . ... ... ..+..+.+++.+||+.||++|||++|++++
T Consensus 304 ~elltg~~Pf~~~~~~~~--~~---~----------~~~-~~~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 304 YWIWCADLPITKDAALGG--SE---W----------IFR-SCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHSSCCC------CC--SG---G----------GGS-SCC-------CCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHCCCCCcccccccc--hh---h----------hhh-hcc-------CCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999964321111 00 0 000 000 113467899999999999999999999873
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=341.20 Aligned_cols=262 Identities=19% Similarity=0.291 Sum_probs=200.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---------------------ccHHHHHHHHhhcCCCCEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------------------TNFDVEIRTLSLVRHRNILRI 892 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------------~~~~~E~~~l~~l~h~niv~l 892 (1119)
.+|+..+.||+|+||.||+|.+ +++.||||++.... ..+.+|+.+++.++||||+++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 3677789999999999999998 68999999984321 668899999999999999999
Q ss_pred eeeeecCCceEEEEeccCCCCHHHh------hccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeE
Q 001226 893 VGSCTKDEHGFIVTEYMPGGTLFNV------LHQNEPRLVLDWNTRYHIALGIAQGLSYLHY-DCVPQIIHRDIKSDNIL 965 (1119)
Q Consensus 893 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlkp~Nil 965 (1119)
++++.+++..++||||+++++|.++ +.... ...+++..+..++.|++.|+.|||+ . +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 55432 3358999999999999999999998 7 9999999999999
Q ss_pred eCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCC-CCCC-cchHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 001226 966 LDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-RLTE-KSDVYSYGVILFELLFRKMPVDPSFGEDT 1043 (1119)
Q Consensus 966 l~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslG~vl~elltg~~p~~~~~~~~~ 1043 (1119)
++.++.+||+|||.+...... ......+|+.|+|||.+.+. .++. ++||||+|+++|||++|+.||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876442 23445789999999998877 5666 99999999999999999999975422111
Q ss_pred ceeehhhhhhcccccccccccccccC-CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1044 DIVTWTRWKLQENHECICFLDREISF-WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....................+.... ........+..+.+++.+||+.||++|||++|++++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000000000000000000000 000012234578899999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=333.18 Aligned_cols=250 Identities=21% Similarity=0.281 Sum_probs=183.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccc------cHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET------NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|+++.... .+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 356777999999999999999999999999999864321 23344555778899999999999999999999999
Q ss_pred ccCCCCHHHhhccC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQN-EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
|++ |+|.+++... .....+++..+..++.|++.|++|||+.+ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 997 5888777642 11235899999999999999999999853 8999999999999999999999999999876442
Q ss_pred CCCCcccccccCCCccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENA----YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. ......||+.|+|||.+ .+..++.++||||+||++|||++|+.||........ .........
T Consensus 164 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~------- 230 (290)
T 3fme_A 164 V---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQVVEEP------- 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH---HHHHHHHSC-------
T ss_pred c---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH---HHHHHhccC-------
Confidence 2 22334689999999985 566789999999999999999999999964211111 111100000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+... ....+.++.+++.+||+.||++|||++|++++
T Consensus 231 -~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 231 -SPQLP-----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -CCCCC-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CCCcc-----cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 00000 11224467899999999999999999999884
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=335.12 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=183.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 566778999999999999999888999999988532 345778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 910 PGGTLFNVLHQN-----EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 910 ~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
++++|.+++... .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 999999998742 1123589999999999999999999999 99999999999999999999999999987664
Q ss_pred CCCC---CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 985 DSHS---SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 985 ~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
.... ........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........ . ............
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~--~~~~~~~~~~~~ 248 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--L--MLTLQNDPPSLE 248 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H--HHHHTSSCCCTT
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--H--HHHhccCCCccc
Confidence 3211 112234578999999998765 5689999999999999999999999975321110 0 000000000000
Q ss_pred c-cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 C-FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ..+.... ...+..+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 249 TGVQDKEML------KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C-----CCC------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccchhh------hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0000000 1123467899999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=345.35 Aligned_cols=257 Identities=23% Similarity=0.306 Sum_probs=179.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecC------Cc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKD------EH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 901 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 3677779999999999999999999999999998542 23567899999999999999999998654 56
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.|+|+|++ +++|.+++... .+++..+..++.||++|++|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred EEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 79999999 78999888753 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc----
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN---- 1056 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 1056 (1119)
.... ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .............
T Consensus 181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 6543 1234578999999998876 678999999999999999999999996532110 0000000000000
Q ss_pred -----ccccccccccccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 -----HECICFLDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 -----~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.....++. .+...... ....+..+.+++.+||+.||++|||++|+++|
T Consensus 255 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00000000 01123567899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=333.89 Aligned_cols=249 Identities=21% Similarity=0.326 Sum_probs=196.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 4577779999999999999999999999999998532 345788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++++|.+++..... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 99 PGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred CCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 99999999876432 489999999999999999999999 99999999999999999999999999876432211
Q ss_pred CcccccccCCCccccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENA-----YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
.......||+.|+|||.+ .+..++.++||||+|+++|||++|+.||....... ......... .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~--------~ 239 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR----VLLKIAKSD--------P 239 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSC--------C
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH----HHHHHhccC--------C
Confidence 112234689999999987 46778999999999999999999999986431100 000000000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+.. ..+...+..+.+++.+||+.||++|||+++++++
T Consensus 240 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 PTL----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CCC----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ccc----CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 0111224567899999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=348.12 Aligned_cols=196 Identities=24% Similarity=0.409 Sum_probs=153.1
Q ss_pred CceeeecCCccEEEEEeC--CCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeee--cCCceEEEEeccCCC
Q 001226 839 GRIIGKGKHGTVYRTLSN--NSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCT--KDEHGFIVTEYMPGG 912 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lV~e~~~~g 912 (1119)
+++||+|+||+||+|+++ .+++.||||+++.. ...+.+|+.+++.++||||+++++++. .+...|+||||++ +
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~ 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-E
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-C
Confidence 678999999999999966 46789999999643 346789999999999999999999995 4678899999996 5
Q ss_pred CHHHhhccCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe----CCCCceEEEecccccc
Q 001226 913 TLFNVLHQNE------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL----DSELEPKIGDFGMSKL 982 (1119)
Q Consensus 913 sL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----~~~~~vkl~DfGla~~ 982 (1119)
+|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 8888776422 122489999999999999999999999 99999999999999 6778999999999987
Q ss_pred ccCCCC-CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 983 ISDSHS-SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 983 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 654211 123345678999999998877 45899999999999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=339.63 Aligned_cols=273 Identities=21% Similarity=0.237 Sum_probs=188.6
Q ss_pred HHHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCc------
Q 001226 831 EDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH------ 901 (1119)
Q Consensus 831 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 901 (1119)
..+.+|+..+.||+|+||.||+|.+..+++.||||++... .....+|++.++.++||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 4566888999999999999999999999999999988543 2346677777888899999999999865333
Q ss_pred -eEEEEeccCCCCHHHhhcc-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeEeCC-CCceEEEe
Q 001226 902 -GFIVTEYMPGGTLFNVLHQ-NEPRLVLDWNTRYHIALGIAQGLSYLH--YDCVPQIIHRDIKSDNILLDS-ELEPKIGD 976 (1119)
Q Consensus 902 -~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlkp~Nill~~-~~~vkl~D 976 (1119)
.++||||+++ ++.+.+.. ......+++..+..++.|++.|+.||| +. +|+||||||+||+++. ++.+||+|
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEee
Confidence 7899999976 45444332 222335889999999999999999999 77 9999999999999997 89999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+++...... ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... ............
T Consensus 176 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~ 251 (360)
T 3e3p_A 176 FGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLGCP 251 (360)
T ss_dssp CTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred CCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcCCC
Confidence 99998765432 22345689999999988655 48999999999999999999999997532110 000000000000
Q ss_pred c----------ccccccccccccC----CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccc
Q 001226 1056 N----------HECICFLDREISF----WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLND 1111 (1119)
Q Consensus 1056 ~----------~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~ 1111 (1119)
. .......+..... ........+..+.+++.+||+.||++|||++|+++| ++++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0 0000000000000 000011135678999999999999999999999986 444433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=343.59 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=200.2
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcC--------CCCEEEEeeeee----c
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVR--------HRNILRIVGSCT----K 898 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~--------h~niv~l~~~~~----~ 898 (1119)
.+|+..++||+|+||+||+|++..+++.||||+++... ..+.+|+++++.++ |+||+++++++. .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~ 116 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN 116 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence 36777899999999999999999999999999997543 45778999999885 788999999987 5
Q ss_pred CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC--------
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-------- 970 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-------- 970 (1119)
+...++||||+ ++++.+++.... ...+++..++.++.||++||+|||+++ +|+||||||+||+++.++
T Consensus 117 ~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 117 GTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 56789999999 667766666543 235899999999999999999999864 899999999999999775
Q ss_pred -----------------------------------------ceEEEeccccccccCCCCCCcccccccCCCcccccccCC
Q 001226 971 -----------------------------------------EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS 1009 (1119)
Q Consensus 971 -----------------------------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 1009 (1119)
.+||+|||.++..... .....||+.|+|||.+.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHT
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcC
Confidence 7999999999876432 234578999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee--e---hhhhhhcc-------ccccccccccc--------ccC
Q 001226 1010 TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV--T---WTRWKLQE-------NHECICFLDRE--------ISF 1069 (1119)
Q Consensus 1010 ~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~--~---~~~~~~~~-------~~~~~~~~~~~--------~~~ 1069 (1119)
..++.++||||+||++|||++|+.||........... . ........ ......++... ...
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 8999999999999999999999999976533321100 0 00000000 00000000000 000
Q ss_pred ---------CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1070 ---------WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1070 ---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+..+.+++.+||+.||++|||++|+++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 001134556788999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.64 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=199.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 5788889999999999999999988999999998432 3457889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC---CceEEEecccccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE---LEPKIGDFGMSKLIS 984 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~---~~vkl~DfGla~~~~ 984 (1119)
|+++++|.+++.... .+++..+..++.|++.|+.|||+. +++||||||+||+++.+ +.+||+|||++....
T Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999987654 489999999999999999999999 99999999999999764 469999999998664
Q ss_pred CCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... ......+|+.|+|||.+.+ .++.++||||+|+++|||++|+.||...... . ...... .
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~---~~~~~~----------~ 236 (287)
T 2wei_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--D---ILKRVE----------T 236 (287)
T ss_dssp CCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H---HHHHHH----------H
T ss_pred CCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--H---HHHHHH----------c
Confidence 422 2233468899999998765 4899999999999999999999998643110 0 000000 0
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+..+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00000001111234567899999999999999999999984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=335.47 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=199.7
Q ss_pred HhhCCceeeecCCccEEEEEe-CCCceEEEEEeccccc---ccHHHHHHHHhhcCCC------CEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLS-NNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHR------NILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~~l 904 (1119)
+|+..+.||+|+||.||+|.+ ..+++.||||+++... ..+.+|+.+++.++|+ +++++++++.+++..++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 577779999999999999998 5678999999986533 4577899999888655 59999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC----------------
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---------------- 968 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---------------- 968 (1119)
||||+ +++|.+++..... ..+++..+..++.|+++|++|||+. +|+||||||+||+++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 99999 8999999987652 3588999999999999999999999 9999999999999987
Q ss_pred ---CCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce
Q 001226 969 ---ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI 1045 (1119)
Q Consensus 969 ---~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~ 1045 (1119)
++.+||+|||+++.... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+. .
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~ 243 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-L 243 (339)
T ss_dssp EESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-H
T ss_pred cccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-H
Confidence 66899999999986543 22345789999999999999999999999999999999999999975321110 0
Q ss_pred eehhhhhhccccc------cccccc--------------------ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCH
Q 001226 1046 VTWTRWKLQENHE------CICFLD--------------------REISFWDSDDQLKALRLLELALECTRQVADMRPSM 1099 (1119)
Q Consensus 1046 ~~~~~~~~~~~~~------~~~~~~--------------------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 1099 (1119)
............. ...... +............+.++.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 0000000000000 000000 00000001122345678999999999999999999
Q ss_pred HHHHHH
Q 001226 1100 REVVGF 1105 (1119)
Q Consensus 1100 ~ell~~ 1105 (1119)
+|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999976
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=350.78 Aligned_cols=317 Identities=19% Similarity=0.145 Sum_probs=238.7
Q ss_pred cCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCccccccccccee
Q 001226 94 KNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESI 173 (1119)
Q Consensus 94 ~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L 173 (1119)
.+.+++.|++++|.+++..+..++.+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46789999999999986556668999999999999999998888899999999999999999998888888999999999
Q ss_pred eecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCC
Q 001226 174 GFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGG 253 (1119)
Q Consensus 174 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~ 253 (1119)
+|++|.+++..+..|+.+++|++|+|++|++++.+ |..++++++|++|++++|.+++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~-----------------------~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE-----------------------DDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC-----------------------TTTTTTCTTCCEEECTTSCCSB
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCC-----------------------hhhhhcCCcCcEEECcCCCCCC
Confidence 99999999777777899999999999999887543 3457778888888888888875
Q ss_pred ccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccC
Q 001226 254 AISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVG 333 (1119)
Q Consensus 254 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 333 (1119)
. .+..+++|+.|++++|.+++ +...++|++|++++|.++...+.. .++|+.|+|++|.+++ +..+.
T Consensus 186 ~----~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 186 V----DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp C----CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGG
T ss_pred c----ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--Chhhc
Confidence 3 24556778888888887764 234457778888888777544332 2567777777777764 35667
Q ss_pred CCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEE
Q 001226 334 NLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVEL 413 (1119)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 413 (1119)
.+++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L 329 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEE
Confidence 77777777777777776667777777777777777777764 4555566677777777777776 455556667777777
Q ss_pred EeecccccccCCccccCCCCcCEEEccCccCcccchhhh
Q 001226 414 ALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALEL 452 (1119)
Q Consensus 414 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 452 (1119)
+|++|++++. + +..+++|+.|++++|++++.....+
T Consensus 330 ~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~ 365 (597)
T 3oja_B 330 YLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRAL 365 (597)
T ss_dssp ECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHH
T ss_pred ECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHH
Confidence 7777777643 2 5556677777777777665443333
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=334.29 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=192.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc---ccccHHHHHHHHhhc-CCCCEEEEeeeeec------CCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLV-RHRNILRIVGSCTK------DEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~~~~l 904 (1119)
+|+..+.||+|+||.||+|.+..+++.||||++.. ....+.+|+.+++++ +||||+++++++.. ++..++
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 56677999999999999999998899999999853 345688999999998 79999999999976 467899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 999999999999998754 23588999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
... .......||+.|+|||.+. +..++.++||||+||++|||++|+.||...... ..... .... .
T Consensus 181 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~--~- 250 (326)
T 2x7f_A 181 RTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFL-IPRN--P- 250 (326)
T ss_dssp ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-HHHS--C-
T ss_pred cCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHH-hhcC--c-
Confidence 321 1223457899999999886 567899999999999999999999998643110 00000 0000 0
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+... ....+..+.+++.+||+.||++||++++++++
T Consensus 251 ----~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 251 ----APRLK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ----CCCCS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----cccCC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 01123467899999999999999999999885
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=330.26 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=197.9
Q ss_pred HHhhCCceeeecCCccEEEEEeC-CCceEEEEEecccc------cccHHHHHHHHhhc---CCCCEEEEeeeee-----c
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-NSRKHWAVKKLNRS------ETNFDVEIRTLSLV---RHRNILRIVGSCT-----K 898 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~~vavK~~~~~------~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 898 (1119)
.+|+..+.||+|+||.||+|.+. .+++.||+|+++.. ...+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 35777899999999999999985 67899999988532 23577888888777 8999999999987 4
Q ss_pred CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
....++||||++ |+|.+++..... ..+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence 567899999997 699999987653 2489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh-hhcccc
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW-KLQENH 1057 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~ 1057 (1119)
+++..... .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ....... ......
T Consensus 166 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 166 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE 241 (326)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred ccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcc
Confidence 99866432 123345789999999999999999999999999999999999999975321100 0000000 000000
Q ss_pred ccc--------ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1058 ECI--------CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1058 ~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .+...............+..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000000000000001224567899999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=331.33 Aligned_cols=309 Identities=19% Similarity=0.170 Sum_probs=147.4
Q ss_pred CCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEE
Q 001226 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLL 342 (1119)
Q Consensus 263 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 342 (1119)
+.++++|++++|.++...+..|..+++|++|++++|.++++.+..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 34555555655555544444455555555555555555555555555555555555555555544444455555555555
Q ss_pred ccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccc
Q 001226 343 LFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG 422 (1119)
Q Consensus 343 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 422 (1119)
+++|+++...+..|.++++|++|++++|.+++..+..+..+++|++|++++|++++.
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------- 180 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----------------------- 180 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-----------------------
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-----------------------
Confidence 555555533333344555555555555555444444444444455555544444432
Q ss_pred cCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcccc
Q 001226 423 RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502 (1119)
Q Consensus 423 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 502 (1119)
.+..+++|+.|++++|.+++. ...+.|++|++++|.++.. |.. ..++|+.|++++|++++. ..+.
T Consensus 181 ----~~~~l~~L~~L~l~~n~l~~~------~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~ 245 (390)
T 3o6n_A 181 ----DLSLIPSLFHANVSYNLLSTL------AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLL 245 (390)
T ss_dssp ----CGGGCTTCSEEECCSSCCSEE------ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGG
T ss_pred ----ccccccccceeeccccccccc------CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHc
Confidence 133344444445554444421 0122344444444444322 111 123455555555555532 3455
Q ss_pred ccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEE
Q 001226 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQIL 582 (1119)
Q Consensus 503 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 582 (1119)
.+++|++|++++|.+++..|..+..+++|+.|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L 323 (390)
T 3o6n_A 246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323 (390)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEE
Confidence 55555555555555555445555555555555555544442 3333344444445555555444 334444444444444
Q ss_pred EcccCcccCcCCcccccCCCCcEEeccCcccc
Q 001226 583 RLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 583 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
+|++|++.. +| +..+++|+.|++++|+++
T Consensus 324 ~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 324 YLDHNSIVT-LK--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp ECCSSCCCC-CC--CCTTCCCSEEECCSSCEE
T ss_pred ECCCCccce-eC--chhhccCCEEEcCCCCcc
Confidence 444444442 22 333444444444444444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=328.05 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=189.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeec------------
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTK------------ 898 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~------------ 898 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||+++... ..+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 46788899999999999999999899999999986432 457789999999999999999998754
Q ss_pred -CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEec
Q 001226 899 -DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977 (1119)
Q Consensus 899 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~Df 977 (1119)
.+..|+||||+++++|.+++..... .+++..++.++.|+++|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeC
Confidence 3567999999999999999986542 478889999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCC------------CCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 001226 978 GMSKLISDSHS------------SSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044 (1119)
Q Consensus 978 Gla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 1044 (1119)
|.++....... ........||+.|+|||.+.+. .++.++||||+||++|||++ ||.... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~----~ 233 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM----E 233 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----h
Confidence 99986643210 1122345689999999988754 78999999999999999998 543210 0
Q ss_pred eeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1045 IVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........... ...+. .......+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLRSV--------SIEFP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHST--------TCCCC--TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcccc--------ccccC--ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00000000000 00000 00111223457899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=339.81 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=192.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCce------
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHG------ 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~------ 902 (1119)
+|...+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 566778999999999999999999999999998643 24567899999999999999999999877654
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++||||++ ++|.+++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 688887743 388999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
... ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .................
T Consensus 194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHT
T ss_pred ccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCcHHHHH
Confidence 543 2234568999999998877 6789999999999999999999999975321100 00000000000000000
Q ss_pred cc--------cccccCCC-----chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FL--------DREISFWD-----SDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~--------~~~~~~~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+ ........ ......+..+.+++.+||+.||++|||++|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000000 0001224578999999999999999999999986
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=352.49 Aligned_cols=334 Identities=19% Similarity=0.193 Sum_probs=209.6
Q ss_pred CCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEE
Q 001226 359 CGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438 (1119)
Q Consensus 359 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 438 (1119)
+.+++.|++++|.++...+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 45677777777777755555566777777777777777766666777777777777777777766666667777777777
Q ss_pred ccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccc
Q 001226 439 LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQ 518 (1119)
Q Consensus 439 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 518 (1119)
|++|.|+ .+|...+..+++|+.|+| ++|.+++..|..++++++|+.|+|++|.++
T Consensus 130 L~~n~l~-~l~~~~~~~l~~L~~L~L------------------------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 130 LERNDLS-SLPRGIFHNTPKLTTLSM------------------------SNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEEC------------------------CSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eeCCCCC-CCCHHHhccCCCCCEEEe------------------------eCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 7777666 333333333444444444 444444444444444555555555555544
Q ss_pred cCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccc
Q 001226 519 GSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELG 598 (1119)
Q Consensus 519 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 598 (1119)
+.. +..+++|+.|++++|.+++ +....+|+.|++++|.++. +|..+. ++|+.|+|++|.+++ +..+.
T Consensus 185 ~~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~~--~~L~~L~L~~n~l~~--~~~l~ 251 (597)
T 3oja_B 185 HVD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPVN--VELTILKLQHNNLTD--TAWLL 251 (597)
T ss_dssp BCC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCE-EECSCC--SCCCEEECCSSCCCC--CGGGG
T ss_pred CcC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccc-cccccC--CCCCEEECCCCCCCC--Chhhc
Confidence 321 2334445555555554442 1223456666666666653 333222 466777777777764 35566
Q ss_pred cCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccce
Q 001226 599 KCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSI 678 (1119)
Q Consensus 599 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~ 678 (1119)
.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~----------------------- 307 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD----------------------- 307 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE-----------------------
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE-----------------------
Confidence 67777777777777776666667777777777777777764 455556666666644
Q ss_pred eeeccccccCCcccccccccccceeeccCceecccCCccccccccceEEecccccccccCCCccccccccCCccccCCcc
Q 001226 679 LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMVSYPGSFLGNSE 758 (1119)
Q Consensus 679 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~~~~~~~~~~~~~~~~n~~ 758 (1119)
|++|+++ .+|..++.+++|+.|+|++|+|++. | +..+++|+.|++++|++++..+.. -+......++.++..
T Consensus 308 --Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~--~~~~~~~~~~~~~~~ 379 (597)
T 3oja_B 308 --LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRA--LFRNVARPAVDDADQ 379 (597)
T ss_dssp --CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHH--HTTTCCTTTBCCCCC
T ss_pred --CCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHH--HHHHHhhhccccccc
Confidence 4455555 5677778888888888988888753 3 667788888999999988865432 233345667788888
Q ss_pred cccC
Q 001226 759 LCRQ 762 (1119)
Q Consensus 759 ~c~~ 762 (1119)
.|+.
T Consensus 380 ~C~~ 383 (597)
T 3oja_B 380 HCKI 383 (597)
T ss_dssp CCCT
T ss_pred cCCc
Confidence 8875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=330.53 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=193.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-C--ceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-S--RKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-~--~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+.. + +..||||+++.. ...+.+|+++++.++||||+++++++.++. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 367778999999999999998643 2 346999988532 245778999999999999999999998765 88
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++..... .+++..+..++.|+++|+.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999986532 488999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 984 SDSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 984 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
...... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ...........
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~---- 242 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGE---- 242 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCC----
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCC----
Confidence 543221 12234567889999999888888999999999999999999 99998643111 00000000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
... .....+..+.+++.+||+.||++|||+++++++|+++.+..
T Consensus 243 ----~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 243 ----RLP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ----CCC----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 000 01123457889999999999999999999999999887654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=336.86 Aligned_cols=197 Identities=25% Similarity=0.308 Sum_probs=169.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcC-CC-----CEEEEeeeeecCCceEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVR-HR-----NILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~l 904 (1119)
.+|+..+.||+|+||+||+|.+..+++.||||+++... .++.+|+++++.++ |+ +++++++++..++..++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 46777899999999999999999999999999997543 45667888888875 44 49999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCCceEEEecccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD--SELEPKIGDFGMSKL 982 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~DfGla~~ 982 (1119)
||||++ ++|.+++..... ..+++..+..++.|++.|+.|||++ ..+|+||||||+||+++ .++.+||+|||+++.
T Consensus 134 v~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999996 599999987642 2489999999999999999999952 22899999999999995 478899999999987
Q ss_pred ccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~ 1038 (1119)
.... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 211 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 211 LGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 6432 23457899999999999999999999999999999999999999753
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=334.77 Aligned_cols=236 Identities=22% Similarity=0.364 Sum_probs=196.0
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcC--CCCEEEEeeeeecCCce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVR--HRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 902 (1119)
+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++ ||||+++++++.+++..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 577779999999999999999999999999998532 245778999999996 59999999999999999
Q ss_pred EEEEeccCC-CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCceEEEecccc
Q 001226 903 FIVTEYMPG-GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIGDFGMS 980 (1119)
Q Consensus 903 ~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~DfGla 980 (1119)
++|||++.+ ++|.+++.... .+++..+..++.|+++|++|||+. +|+||||||+||+++ .++.+||+|||++
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999976 89999998754 489999999999999999999999 999999999999999 7899999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
+..... ......||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||.... . ... ...
T Consensus 198 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~---~~~----~~~-- 260 (320)
T 3a99_A 198 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E---IIR----GQV-- 260 (320)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H---HHH----CCC--
T ss_pred cccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----h---hhc----ccc--
Confidence 876542 2233568999999998876665 688999999999999999999986320 0 000 000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ...+.++.+++.+||+.||++|||++|++++
T Consensus 261 --~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 --FFR----------QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCS----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccc----------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0123467899999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=360.50 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=200.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC---ceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..+.||+|+||.||+|.+..+ +..||||+++... ..+.+|+.+++.++||||+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 3577789999999999999998643 4679999986432 45788999999999999999999985 4568999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++...+. .+++..+..++.|+++|+.|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 469 ~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999986542 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... .......+|+.|+|||.+.+..++.++||||+||++|||++ |..||...... +... ... ...
T Consensus 544 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~~~~---~i~-~~~------- 609 (656)
T 2j0j_A 544 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIG---RIE-NGE------- 609 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---HHH-HTC-------
T ss_pred Ccc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--HHHH---HHH-cCC-------
Confidence 322 22234467889999999988899999999999999999997 99998643111 1000 000 000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
... .+...+..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 610 -~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 -RLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 000 0112235678999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=331.83 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=188.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeee-------------
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCT------------- 897 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~------------- 897 (1119)
+|+..+.||+|+||.||+|.+..+++.||+|++... ...+.+|+.+++.++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 566778999999999999999999999999988533 245778999999999999999998873
Q ss_pred -cCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCceEEE
Q 001226 898 -KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIG 975 (1119)
Q Consensus 898 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~ 975 (1119)
+....++||||++ |+|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++ +++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467799999997 6999998753 488999999999999999999999 999999999999997 56799999
Q ss_pred eccccccccCCCC-CCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-
Q 001226 976 DFGMSKLISDSHS-SSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK- 1052 (1119)
Q Consensus 976 DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~- 1052 (1119)
|||+++....... ........+|..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ........
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence 9999987643211 122334567999999998765 6789999999999999999999999975321100 00000000
Q ss_pred hcc-------cccccccccccccCCCc----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1053 LQE-------NHECICFLDREISFWDS----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1053 ~~~-------~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... .......+......... .....+.++.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 00000000000000000 001234578999999999999999999999985
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.40 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=184.5
Q ss_pred cccceeeccCccccC--CCCccccccccccEEEecc-CccccCCCccccCCCCcceeeccCcccCCCCCccccccccceE
Q 001226 481 TNLFVLVLGNNRFNG--SFPIEIGKCSSLRRVILSN-NLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTM 557 (1119)
Q Consensus 481 ~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 557 (1119)
.+++.|+|++|++++ .+|..++++++|++|++++ |.+.+.+|..+..+++|++|++++|++++.+|..+..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356777777777777 6777777788888888874 7777777777777888888888888887777777888888888
Q ss_pred EeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCC-CCcEEeccCccccccCChhhhhcccCCeeEccCcc
Q 001226 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCT-KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENN 636 (1119)
Q Consensus 558 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 636 (1119)
|+|++|++++.+|..|.++++|++|+|++|++++.+|..++.++ +|++|+|++|++++.+|..+..++ |+.|+|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 88888888878888888888888888888888878888888887 888888888888878888888776 8888888888
Q ss_pred CccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCc
Q 001226 637 LSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPT 716 (1119)
Q Consensus 637 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 716 (1119)
+++.+|..|..+++|+.|+|++|.+++.+|. +..++.+ +.|++++|+++|.+|..++.+++|+.|+|++|+|+|.+|.
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L-~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTC-CEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCC-CEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 8888888888888888877777777655544 3333332 2355566666555666666666666666666666666655
Q ss_pred cccccccceEEeccccc-ccc
Q 001226 717 EVNNMVSLYFVNISFNH-FSG 736 (1119)
Q Consensus 717 ~~~~~~~l~~l~ls~N~-~~g 736 (1119)
. ..+++|+.+++++|+ ++|
T Consensus 287 ~-~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp S-TTGGGSCGGGTCSSSEEES
T ss_pred C-ccccccChHHhcCCCCccC
Confidence 4 555566666666665 444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=349.29 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=197.8
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeec------CCc
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTK------DEH 901 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 901 (1119)
+.+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 35788999999999999999999999999999998643 3457789999999999999999998765 667
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc---eEEEecc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE---PKIGDFG 978 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~---vkl~DfG 978 (1119)
.++||||+++|+|.+++........+++..++.++.|++.|++|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 799999999999999998766545688899999999999999999999 9999999999999997765 8999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc---c
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ---E 1055 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~ 1055 (1119)
.+....... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..|...... .
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC-----
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccch
Confidence 998765432 233457899999999999999999999999999999999999999653110 000000000 0
Q ss_pred cccccccc------cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 001226 1056 NHECICFL------DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102 (1119)
Q Consensus 1056 ~~~~~~~~------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~el 1102 (1119)
........ ..............+..+.+++.+||+.||++|||++|+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000 011111111123356678999999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=331.99 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=194.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecC-----CceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKD-----EHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 904 (1119)
+|+..+.||+|+||.||+|.+..+++.||||+++... ..+.+|+.+++.++||||+++++++..+ ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 5677799999999999999999999999999986432 3466899999999999999999987654 67899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||++ ++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 92 v~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999996 6899998763 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCC--------cccccccCCCcccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhh-c
Q 001226 985 DSHSSS--------TRSAIVGSLGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKL-Q 1054 (1119)
Q Consensus 985 ~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-~ 1054 (1119)
...... ......||+.|+|||.+. +..++.++||||+||++|||++|+.||........ ......... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 242 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTP 242 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCC
Confidence 322111 122347899999999765 47789999999999999999999999975321000 000000000 0
Q ss_pred c---------cccccccccccccCCCc-----hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 E---------NHECICFLDREISFWDS-----DDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ~---------~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ......... ....... .....+.++.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHH-TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhh-cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000000000 0000000 001234567899999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=328.70 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=194.5
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
.+|+..+.||+|+||.||+|.+.. .||+|+++.. ...+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 356778999999999999998864 4899988532 2457789999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++++|.+++...+. .+++..+..++.|+++|++|||+. +|+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999987542 488999999999999999999999 999999999999998 6799999999987653221
Q ss_pred ---CCCcccccccCCCcccccccCC---------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 988 ---SSSTRSAIVGSLGYIAPENAYS---------TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 988 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
.........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||...... . .. .....
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~-~~---~~~~~ 257 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--A-II---WQMGT 257 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--H-HH---HHHHT
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-HH---HHhcc
Confidence 1122334568999999998764 45788999999999999999999998643111 0 00 00000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
. ..+.... ...+..+.+++.+||+.||++|||++++++.|+++.++.
T Consensus 258 ~------~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 G------MKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp T------CCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred C------CCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 0000000 011235789999999999999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=338.38 Aligned_cols=260 Identities=23% Similarity=0.263 Sum_probs=187.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---------------ccHHHHHHHHhhcCCCCEEEEeeeeec-
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---------------TNFDVEIRTLSLVRHRNILRIVGSCTK- 898 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~E~~~l~~l~h~niv~l~~~~~~- 898 (1119)
+|+..+.||+|+||.||+|.+.. ++.||||++.... ..+.+|+++++.++||||+++++++..
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred ceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 46667899999999999999876 8999999884311 457899999999999999999999843
Q ss_pred ----CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEE
Q 001226 899 ----DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI 974 (1119)
Q Consensus 899 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 974 (1119)
....|+||||++ |+|.+++.... ..+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEE
Confidence 335799999997 68888887553 2589999999999999999999999 9999999999999999999999
Q ss_pred EeccccccccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhh---
Q 001226 975 GDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR--- 1050 (1119)
Q Consensus 975 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~--- 1050 (1119)
+|||+++..... .......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ......
T Consensus 176 ~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~ 251 (362)
T 3pg1_A 176 CDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-LNKIVEVVG 251 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred EecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcC
Confidence 999999754332 22334578999999998876 6789999999999999999999999975321100 000000
Q ss_pred ------hhhcccccccccccccccC-----CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1051 ------WKLQENHECICFLDREISF-----WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1051 ------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+...... +.......+..+.+++.+||+.||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000000000000000000 000011224568899999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=334.05 Aligned_cols=256 Identities=20% Similarity=0.273 Sum_probs=191.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCc------e
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEH------G 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~ 902 (1119)
+|...+.||+|+||.||+|.+..+++.||||++... ...+.+|+.+++.++||||+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 466678999999999999999999999999998542 2346789999999999999999999987654 4
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+||||++ ++|.+++.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp EEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 99999997 688877643 388999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc-
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI- 1060 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 1060 (1119)
.... .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ................
T Consensus 176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH-HHHHHHHHCBCCHHHHT
T ss_pred CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence 5431 234578999999998876 6789999999999999999999999975321100 0000000000000000
Q ss_pred --------cc---cccc-ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 --------CF---LDRE-ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 --------~~---~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. +... ...+.......+..+.+++.+|++.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 0000 000001112235578899999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=329.28 Aligned_cols=237 Identities=24% Similarity=0.375 Sum_probs=191.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhc----CCCCEEEEeeeeecC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLV----RHRNILRIVGSCTKD 899 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l----~h~niv~l~~~~~~~ 899 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||+++.. ...+.+|+.+++++ +||||+++++++.++
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 3688889999999999999999999999999998532 23456799999998 899999999999999
Q ss_pred CceEEEEec-cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC-CCCceEEEec
Q 001226 900 EHGFIVTEY-MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD-SELEPKIGDF 977 (1119)
Q Consensus 900 ~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~-~~~~vkl~Df 977 (1119)
+..++|||+ +++++|.+++.... .+++..++.++.|+++|++|||+. +|+||||||+||+++ .++.+||+||
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999 78999999998754 489999999999999999999999 999999999999999 8899999999
Q ss_pred cccccccCCCCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccc
Q 001226 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQEN 1056 (1119)
Q Consensus 978 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1056 (1119)
|+++...... .....++..|+|||.+.+..+ +.++||||+|+++|||++|+.||.... . ..
T Consensus 185 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~-------~~--- 246 (312)
T 2iwi_A 185 GSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----E-------IL--- 246 (312)
T ss_dssp SSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H-------HH---
T ss_pred chhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----H-------Hh---
Confidence 9998765422 234568999999998876665 458999999999999999999986320 0 00
Q ss_pred ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1057 HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1057 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... ....+..+.+++.+||+.||++|||++|++++
T Consensus 247 -------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 -------EAELHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------HTCCCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------hhccCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 01123467899999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=329.19 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=188.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcC--CCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVR--HRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..+.||+|+||.||+|.+.. ++.||||++... ...+.+|+.+++.++ ||||+++++++.+++..++||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 46677899999999999999865 889999998532 245788999999997 599999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
| +.+++|.+++.... .+++..+..++.|+++|+.|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 108 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 108 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp C-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred e-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9 56889999998754 489999999999999999999999 999999999999996 489999999999876543
Q ss_pred CCCCcccccccCCCcccccccCC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS-----------TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
..........||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........ ...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~------ 250 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLH------ 250 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHH------
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHH------
Confidence 33333345578999999998765 4688899999999999999999999964321100 000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...+...... .+...+..+.+++.+||+.||++||+++|++++
T Consensus 251 -----~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 -----AIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -----HHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHhcccccC--CcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0011110000 000113467899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=335.95 Aligned_cols=263 Identities=20% Similarity=0.252 Sum_probs=197.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcC-----------CCCEEEEeeeeecC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVR-----------HRNILRIVGSCTKD 899 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 899 (1119)
.+|+..+.||+|+||.||+|.+..+++.||||++... ...+.+|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 3677789999999999999999999999999999754 345778999998876 89999999998765
Q ss_pred C----ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC------CC
Q 001226 900 E----HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD------SE 969 (1119)
Q Consensus 900 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~------~~ 969 (1119)
+ ..++||||+ +++|.+++..... ..+++..+..++.||+.|++|||+.+ +|+||||||+||+++ ..
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 4 679999999 8999999987543 24899999999999999999999853 899999999999994 44
Q ss_pred CceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCce----
Q 001226 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDI---- 1045 (1119)
Q Consensus 970 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~---- 1045 (1119)
+.+||+|||+++..... .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||..........
T Consensus 175 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 58999999999866432 233478999999999999999999999999999999999999997543221100
Q ss_pred -eehhhhhh-----------------ccccccccccc-------ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHH
Q 001226 1046 -VTWTRWKL-----------------QENHECICFLD-------REISFWDSDDQLKALRLLELALECTRQVADMRPSMR 1100 (1119)
Q Consensus 1046 -~~~~~~~~-----------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 1100 (1119)
........ ........... .........+...+..+.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 00000000 00000000000 000000112345677889999999999999999999
Q ss_pred HHHHH
Q 001226 1101 EVVGF 1105 (1119)
Q Consensus 1101 ell~~ 1105 (1119)
|++++
T Consensus 330 ell~h 334 (373)
T 1q8y_A 330 GLVNH 334 (373)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=329.29 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=174.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHH-HHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIR-TLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|...+.||+|+||.||+|.+..+++.||||+++... .++..|+. +++.++||||+++++++.+++..++||||
T Consensus 23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3aln_A 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102 (327)
T ss_dssp SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEee
Confidence 5667789999999999999999999999999985432 23444555 66778999999999999999999999999
Q ss_pred cCCCCHHHhhccC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 909 MPGGTLFNVLHQN--EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 909 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
+++ +|.+++... .....+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 975 787777631 11235899999999999999999999853 8999999999999999999999999999876432
Q ss_pred CCCCcccccccCCCccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENA----YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. ......||+.|+|||.+ .+..++.++||||+||++|||++|+.||................ .
T Consensus 180 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------~---- 246 (327)
T 3aln_A 180 I---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG------D---- 246 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS------C----
T ss_pred c---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC------C----
Confidence 2 22334689999999988 45678999999999999999999999997532111111100000 0
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.+.. ......+..+.+++.+||+.||++|||++|++++
T Consensus 247 -~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 247 -PPQLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCCCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CCCCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000000 0001123467899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=331.85 Aligned_cols=261 Identities=21% Similarity=0.282 Sum_probs=197.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc-eEEEEEecccc---cccHHHHHHHHhhcCCCC------EEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR-KHWAVKKLNRS---ETNFDVEIRTLSLVRHRN------ILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-~~vavK~~~~~---~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~ 903 (1119)
.+|+..+.||+|+||.||+|.+..++ +.||+|+++.. ...+.+|+.+++.++|++ ++.+.+++...+..+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 36777899999999999999998766 78999999643 345778999999987655 999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEe-----------------
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILL----------------- 966 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill----------------- 966 (1119)
+||||+ ++++.+++..... ..+++..+..++.||+.|++|||+. +|+||||||+||++
T Consensus 99 lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 999999 6777777766542 3589999999999999999999999 99999999999999
Q ss_pred --CCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 001226 967 --DSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044 (1119)
Q Consensus 967 --~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~ 1044 (1119)
+.++.+||+|||+++.... ......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 247 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-H 247 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred cccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 5678999999999986543 2234578999999999999999999999999999999999999997532111 0
Q ss_pred eeehhhhhhcccc-------cccccccc-------------------cccCCCchHHHHHHHHHHHHHHccccCCCCCCC
Q 001226 1045 IVTWTRWKLQENH-------ECICFLDR-------------------EISFWDSDDQLKALRLLELALECTRQVADMRPS 1098 (1119)
Q Consensus 1045 ~~~~~~~~~~~~~-------~~~~~~~~-------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs 1098 (1119)
............. ....+... ............+..+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 0000000000000 00000000 000000111233557889999999999999999
Q ss_pred HHHHHHH
Q 001226 1099 MREVVGF 1105 (1119)
Q Consensus 1099 ~~ell~~ 1105 (1119)
++|++++
T Consensus 328 ~~e~l~h 334 (355)
T 2eu9_A 328 LAEALLH 334 (355)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=336.47 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=183.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+|...++||+|+||+||.. ...+++.||||++.. ....+.+|+.+++.+ +|||||++++++.++...|+||||++ |
T Consensus 25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g 102 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-A 102 (432)
T ss_dssp EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-C
Confidence 4556689999999997643 334588999999854 345678999999999 79999999999999999999999996 6
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-----CCceEEEeccccccccCCC
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-----ELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl~DfGla~~~~~~~ 987 (1119)
+|.+++..... ..++..+..++.||++|++|||+. +|+||||||+||+++. ...+||+|||+++......
T Consensus 103 ~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 103 TLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp EHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99999986643 244446678999999999999999 9999999999999953 2358899999998765432
Q ss_pred C-CCcccccccCCCcccccccC---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 988 S-SSTRSAIVGSLGYIAPENAY---STRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 988 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
. ........||+.|+|||++. ...++.++||||+||++|||++ |..||........ .. .....
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~------~~-~~~~~----- 245 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA------NI-LLGAC----- 245 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH------HH-HTTCC-----
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH------HH-HhccC-----
Confidence 1 12334567999999999887 4567889999999999999999 8999853211100 00 00000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ...........+.+++.+||+.||++|||++|+++|
T Consensus 246 ---~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 246 ---SLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ---CCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---Ccc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 001112334567899999999999999999999954
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=316.41 Aligned_cols=307 Identities=20% Similarity=0.309 Sum_probs=206.8
Q ss_pred ccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccc
Q 001226 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLE 387 (1119)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~ 387 (1119)
+..+++|++|++++|.+.. ++ .+..+++|++|++++|++++..+ +..+++|++|++++|.+++. +.+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCS
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCC
Confidence 4567778888888888773 33 37778888888888888774433 77778888888888877642 3577777788
Q ss_pred eeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccc
Q 001226 388 VLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGN 467 (1119)
Q Consensus 388 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N 467 (1119)
+|++++|.+++..+ +..+++|++|++++|..... +..+..+++|++|++++|.+++..+ +..+++|++|++++|
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~---~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYN 187 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCSEEECTTS
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh---hccCCCCCEEEccCC
Confidence 88888777775433 67777777777777755433 3346777777777777777664322 233444555544444
Q ss_pred eeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCc
Q 001226 468 SFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP 547 (1119)
Q Consensus 468 ~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 547 (1119)
. +.+. +. +..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+
T Consensus 188 ~------------------------l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~- 238 (347)
T 4fmz_A 188 Q------------------------IEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238 (347)
T ss_dssp C------------------------CCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred c------------------------cccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-
Confidence 4 4422 21 4555666666666666654333 5566666666666666664333
Q ss_pred cccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccC
Q 001226 548 VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKM 627 (1119)
Q Consensus 548 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 627 (1119)
+..+++|++|++++|++++ + ..+..+++|+.|++++|++.+ + ..+..+++|+.|++++|++++..|..+..+++|
T Consensus 239 -~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 -LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 6667777777777777764 2 457777788888888888774 3 357778888888888888877777778888888
Q ss_pred CeeEccCccCccCCCccccccccccEeecCCcccC
Q 001226 628 QSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 628 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
++|+|++|++++..| +..+++|++|++++|.++
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888888886655 777888888887777664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=317.03 Aligned_cols=309 Identities=26% Similarity=0.323 Sum_probs=223.2
Q ss_pred hhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCC
Q 001226 282 ETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGS 361 (1119)
Q Consensus 282 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 361 (1119)
..+..+++|++|++++|.+.... .+..+++|++|++++|++++..+ +..+++|++|++++|.++.. +.+..+++
T Consensus 38 ~~~~~l~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~ 111 (347)
T 4fmz_A 38 VTQEELESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTN 111 (347)
T ss_dssp ECHHHHTTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred ccchhcccccEEEEeCCccccch--hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCc
Confidence 34568899999999999998653 48899999999999999995443 99999999999999999853 46999999
Q ss_pred CcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccC
Q 001226 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441 (1119)
Q Consensus 362 L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 441 (1119)
|++|++++|.+++. +. +..+++|+.|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|+.|++++
T Consensus 112 L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~ 186 (347)
T 4fmz_A 112 LRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186 (347)
T ss_dssp CSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTT
T ss_pred CCEEECcCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccC
Confidence 99999999999854 33 8899999999999997664544 48999999999999999985433 88999999999999
Q ss_pred ccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCC
Q 001226 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSL 521 (1119)
Q Consensus 442 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 521 (1119)
|++++..+ +..++.|+.|++++|.+++..+ +..+++|+.|++++|+++ +..
T Consensus 187 n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~------------------------~~~ 237 (347)
T 4fmz_A 187 NQIEDISP---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT------------------------DLS 237 (347)
T ss_dssp SCCCCCGG---GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC------------------------CCG
T ss_pred Cccccccc---ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccC------------------------CCc
Confidence 99985433 4456677777777776664433 444455555555555554 322
Q ss_pred CccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCC
Q 001226 522 PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCT 601 (1119)
Q Consensus 522 p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 601 (1119)
+ +..+++|+.|++++|++++. +.+..+++|++|++++|++++. ..+..+++|+.|++++|++.+..|..+..++
T Consensus 238 ~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~ 311 (347)
T 4fmz_A 238 P--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311 (347)
T ss_dssp G--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCT
T ss_pred c--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccc
Confidence 2 44444555555555554432 2355566666666666666642 3466666777777777777666666666677
Q ss_pred CCcEEeccCccccccCChhhhhcccCCeeEccCccCc
Q 001226 602 KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLS 638 (1119)
Q Consensus 602 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 638 (1119)
+|++|+|++|++++..| +..+++|+.|++++|.|+
T Consensus 312 ~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp TCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 77777777777765444 666677777777777664
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=336.41 Aligned_cols=250 Identities=26% Similarity=0.322 Sum_probs=183.3
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEEeccCCCCH
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
...++||+|+||+||.+. ..+|+.||||++... .+.+.+|+.+++++ +||||+++++++.+++..|+||||++ |+|
T Consensus 18 ~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred eccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 345789999999998754 445899999998654 34567899999876 89999999999999999999999995 699
Q ss_pred HHhhccCCCCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-------------CceEEEec
Q 001226 915 FNVLHQNEPRL----VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-------------LEPKIGDF 977 (1119)
Q Consensus 915 ~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-------------~~vkl~Df 977 (1119)
.+++....... ..++..++.++.||+.|++|||+. +|+||||||+||+++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99998654211 112334578999999999999999 99999999999999754 48999999
Q ss_pred cccccccCCCCC--CcccccccCCCcccccccCC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceee
Q 001226 978 GMSKLISDSHSS--STRSAIVGSLGYIAPENAYS-------TRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 978 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~ 1047 (1119)
|+++........ .......||+.|+|||++.+ ..++.++||||+||++|||++ |+.||........ .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~ 249 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES---N 249 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH---H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH---H
Confidence 999877543221 12234579999999998865 678999999999999999998 9999864321110 0
Q ss_pred hhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ..... +... .......+.++.+++.+||+.||++|||++|+++|
T Consensus 250 i~~----~~~~~-----~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 250 IIR----GIFSL-----DEMK--CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHH----TCCCC-----CCCT--TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Hhc----CCCCc-----cccc--ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 000 00000 0000 01123456688999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=320.95 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=177.5
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccccc------cHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET------NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+.+|+..+.||+|+||.||+|.+..+++.||||++..... .+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 4567778999999999999999999999999999854321 2334445677889999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+ ++.+..+..... ..+++..+..++.|+++|+.|||+.+ +|+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 555655554432 24899999999999999999999832 8999999999999999999999999999766442
Q ss_pred CCCCcccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
. ......+|+.|+|||.+. ...++.++||||+||++|||++|+.||...... ...+.......
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~------ 246 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD---FEVLTKVLQEE------ 246 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHHHHHHSC------
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc---HHHHHHHhccC------
Confidence 2 223456899999999884 556889999999999999999999999743111 11111100000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.... ....+..+.+++.+||+.||++||+++|++++
T Consensus 247 --~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 --PPLLPG----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCCCCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCCCCc----cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000110 01123467899999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=310.83 Aligned_cols=230 Identities=11% Similarity=0.090 Sum_probs=182.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||.||+|++..+++.||||+++... ..+.+|+..++.++||||+++++++.+++..|+|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 5777899999999999999999999999999996432 457889999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|++|++|.++++.. ....++.+++.|++.|++|||+. ||+||||||+||+++.++.+||+++|
T Consensus 112 ~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred ecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 99999999999542 34557889999999999999999 99999999999999999999998543
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
|++ .++.++||||+||++|||++|+.||............... .....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~------------~~~~~ 222 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD------------TAGQP 222 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC------------TTSCB
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH------------hccCC
Confidence 333 3688999999999999999999999764322111000000 00000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
..........+..+.+++.+||+.||++| |++|+++.|+++.....
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00000001224568899999999999999 99999999999876654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=310.48 Aligned_cols=231 Identities=22% Similarity=0.306 Sum_probs=180.2
Q ss_pred HhhCC-ceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHH-hhcCCCCEEEEeeeeec----CCceEEEEec
Q 001226 835 RATEG-RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTL-SLVRHRNILRIVGSCTK----DEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~lV~e~ 908 (1119)
+|... +.||+|+||.||+|.+..+++.||+|+++. ...+.+|+.++ +..+||||+++++++.. +...++||||
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 34444 779999999999999999999999999865 34577888888 56689999999999876 6778999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~~~ 985 (1119)
+++|+|.+++..... ..+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||++....
T Consensus 97 ~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 97 LDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred cCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999999987643 3589999999999999999999999 9999999999999998 7889999999986432
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
+..++.++||||+||++|||++|+.||............. ......
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-----------~~~~~~ 217 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-----------TRIRMG 217 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-----------CSSCTT
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-----------HHHhhc
Confidence 2346789999999999999999999996542211100000 000000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+..+.+++.+||+.||++|||++|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000011234578899999999999999999999985
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-32 Score=306.43 Aligned_cols=289 Identities=23% Similarity=0.281 Sum_probs=169.4
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEee
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 416 (1119)
+++.+++++|.++ .+|..+. ++|++|++++|.+++..|..|.++++|++|++++|++++..|..|..+++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 6778888888777 5555543 577777777777776666677777777777777777777667777777777777777
Q ss_pred cccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCC
Q 001226 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGS 496 (1119)
Q Consensus 417 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~ 496 (1119)
+|+++ .+|..+. ++|++|++++|+++ .++...+..+++|+.|++++|.++. .+.
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~~ 164 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLEN----------------------SGF 164 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBG----------------------GGS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCcccc----------------------CCC
Confidence 77776 4454443 56666666666665 2333333445555555555555532 012
Q ss_pred CCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCc
Q 001226 497 FPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNL 576 (1119)
Q Consensus 497 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 576 (1119)
.|..+..+ +|+.|++++|++++ +|..+. ++|+.|++++|++++..|..+..+++|++|+|++|++++..|..|..+
T Consensus 165 ~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (332)
T 2ft3_A 165 EPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240 (332)
T ss_dssp CTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred CcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence 33333333 44444444444443 222222 445555555555555555555555566666666666655555556666
Q ss_pred ccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhh------cccCCeeEccCccCc--cCCCcccccc
Q 001226 577 ENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS------LEKMQSLSLQENNLS--GAIPDAFSSV 648 (1119)
Q Consensus 577 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l 648 (1119)
++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..+.. ...|+.|++++|.+. +..|.+|..+
T Consensus 241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l 319 (332)
T 2ft3_A 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319 (332)
T ss_dssp TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccccc
Confidence 66666666666665 55555666666666666666665444444433 244666666666665 4556666666
Q ss_pred ccccEeecCCc
Q 001226 649 QSLFELQLGSN 659 (1119)
Q Consensus 649 ~~L~~L~L~~N 659 (1119)
++|+.|++++|
T Consensus 320 ~~L~~l~l~~n 330 (332)
T 2ft3_A 320 TDRLAIQFGNY 330 (332)
T ss_dssp CCSTTEEC---
T ss_pred chhhhhhcccc
Confidence 66666666655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-31 Score=302.83 Aligned_cols=290 Identities=21% Similarity=0.266 Sum_probs=216.2
Q ss_pred CCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeec
Q 001226 312 NQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL 391 (1119)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L 391 (1119)
.+++.+++++|.++ .+|..+. ++|+.|++++|.+++..+..|.++++|++|++++|++++..|..|.++++|++|++
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 37999999999998 6776664 79999999999999888889999999999999999999888999999999999999
Q ss_pred cCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCccc-chhhhhccCCccceeccccceee
Q 001226 392 FNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGE-VALELGKHFPYLSRLDLTGNSFY 470 (1119)
Q Consensus 392 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~ 470 (1119)
++|+++. +|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++.. .....+..+ +|+.|++++|.++
T Consensus 110 ~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~ 185 (332)
T 2ft3_A 110 SKNHLVE-IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT 185 (332)
T ss_dssp CSSCCCS-CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred CCCcCCc-cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence 9999995 454444 8999999999999977777799999999999999999731 222222223 5555555555554
Q ss_pred CccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCcccc
Q 001226 471 GPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFG 550 (1119)
Q Consensus 471 ~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 550 (1119)
+ +|..+. ++|++|++++|.+++..+..+..+++|+.|++++|++++..+..+.
T Consensus 186 ~-------------------------l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 238 (332)
T 2ft3_A 186 G-------------------------IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238 (332)
T ss_dssp S-------------------------CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGG
T ss_pred c-------------------------cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhh
Confidence 3 333322 4566666666666665556666666666666666666666666677
Q ss_pred ccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCccccc------CCCCcEEeccCcccc--ccCChhhh
Q 001226 551 FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGK------CTKMIKLDLSDNYLA--GSIPSEVI 622 (1119)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~ 622 (1119)
.+++|++|+|++|+++ .+|..+.++++|+.|++++|++++..+..|.. ..+|+.|++++|.+. +..|..+.
T Consensus 239 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~ 317 (332)
T 2ft3_A 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317 (332)
T ss_dssp GCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccc
Confidence 7777777777777776 66777777777777777777777554555543 356788888888876 56677778
Q ss_pred hcccCCeeEccCcc
Q 001226 623 SLEKMQSLSLQENN 636 (1119)
Q Consensus 623 ~l~~L~~L~L~~N~ 636 (1119)
.+++|+.+++++|+
T Consensus 318 ~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 318 CVTDRLAIQFGNYK 331 (332)
T ss_dssp TBCCSTTEEC----
T ss_pred ccchhhhhhccccc
Confidence 88888888888774
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=310.42 Aligned_cols=281 Identities=18% Similarity=0.231 Sum_probs=177.8
Q ss_pred ccCCCcHHHHHHHHhcCCCCCC-CCCCCCCC-CCCCCCceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcc
Q 001226 21 VSSPPSAISLVQFLDSLPKQSQ-SHLPWNQS-VSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHL 98 (1119)
Q Consensus 21 ~~~~~~~~~ll~~~~~~~~~~~-~~~~w~~~-~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l 98 (1119)
.+..++++||++||+++..++. .+.+|..+ ....++|.|.|++|..... .+. -...+++
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~------------------~l~-~~~~~~l 83 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD------------------LLE-DATQPGR 83 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHH------------------HHH-HHTSTTC
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHH------------------HHh-cccccce
Confidence 3467889999999998854432 34578411 1246789999999963110 000 1134677
Q ss_pred cEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeeccc
Q 001226 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN 178 (1119)
Q Consensus 99 ~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n 178 (1119)
++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|++++|
T Consensus 84 ~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n 160 (328)
T 4fcg_A 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRAC 160 (328)
T ss_dssp CEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEE
T ss_pred eEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCC
Confidence 77888888777 67777777888888888888877 77777788888888888888777 66777777777777777777
Q ss_pred ccccccCccCCC---------cccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCC
Q 001226 179 FLNGELPNDICS---------LPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSN 249 (1119)
Q Consensus 179 ~l~~~~~~~l~~---------l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n 249 (1119)
++.+.+|..++. +++|++|++++|+++ .+|..+++
T Consensus 161 ~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~------------------------~lp~~l~~------------ 204 (328)
T 4fcg_A 161 PELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR------------------------SLPASIAN------------ 204 (328)
T ss_dssp TTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC------------------------CCCGGGGG------------
T ss_pred CCccccChhHhhccchhhhccCCCCCEEECcCCCcC------------------------cchHhhcC------------
Confidence 666666665543 566666666665554 23333444
Q ss_pred ccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccC
Q 001226 250 NFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIP 329 (1119)
Q Consensus 250 ~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 329 (1119)
+++|++|+|++|++++ +|..+..+++|++|+|++|.+.+.+|..|..+++|++|+|++|.+.+.+|
T Consensus 205 -------------l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p 270 (328)
T 4fcg_A 205 -------------LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270 (328)
T ss_dssp -------------CTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCC
T ss_pred -------------CCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcc
Confidence 4445555555555552 33345555555555555555555555555555555666665555555566
Q ss_pred cccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCc
Q 001226 330 RSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIG 373 (1119)
Q Consensus 330 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~ 373 (1119)
..+.++++|++|++++|++.+.+|..++++++|+.+++..+.+.
T Consensus 271 ~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred hhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 56666666666666666666566666666666666666655443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-33 Score=324.07 Aligned_cols=237 Identities=15% Similarity=0.152 Sum_probs=176.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCC-CCE---------------E--
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRH-RNI---------------L-- 890 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h-~ni---------------v-- 890 (1119)
+..+++||+|+||+||+|.+..+++.||||+++.. .+.+.+|+.+++.++| ++. +
T Consensus 80 ~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 159 (413)
T 3dzo_A 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 159 (413)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEEC
T ss_pred EEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhccc
Confidence 45568899999999999999999999999998621 3457899999999976 211 1
Q ss_pred ----EEeeeeec-----CCceEEEEeccCCCCHHHhhccC----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001226 891 ----RIVGSCTK-----DEHGFIVTEYMPGGTLFNVLHQN----EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHR 957 (1119)
Q Consensus 891 ----~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 957 (1119)
.+..++.. ....+++|+++ +++|.+++... .....+++..+..++.|+++||+|||+. +|+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHr 235 (413)
T 3dzo_A 160 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT 235 (413)
T ss_dssp CC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 11111121 12356777765 78999988521 1123578889999999999999999999 99999
Q ss_pred CCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccccCCCccccccc----------CCCCCCCcchHHHHHHHHHH
Q 001226 958 DIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA----------YSTRLTEKSDVYSYGVILFE 1027 (1119)
Q Consensus 958 Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslG~vl~e 1027 (1119)
||||+||+++.++.+||+|||+++..... .....| +.|+|||.+ ....++.++||||+||++||
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999998865432 334466 999999988 55668889999999999999
Q ss_pred HHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1028 LLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1028 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
|++|+.||........ . ...+..+. ..+..+.+++.+||+.||++||++.|++++
T Consensus 310 lltg~~Pf~~~~~~~~--~-----------------~~~~~~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALGG--S-----------------EWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGSC--S-----------------GGGGSSCC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhhh--H-----------------HHHHhhcc----cCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999965321110 0 00011000 113468899999999999999997777543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=303.30 Aligned_cols=291 Identities=23% Similarity=0.275 Sum_probs=172.9
Q ss_pred CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEe
Q 001226 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELAL 415 (1119)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 415 (1119)
.+++.++++++.++ .+|..+. ++|+.|++++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 36788888888887 4555543 57888888888888766667788888888888888888777777777888888888
Q ss_pred ecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccC
Q 001226 416 YNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG 495 (1119)
Q Consensus 416 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~ 495 (1119)
++|+++ .+|..+. ++|+.|++++|++++ ++...+..+++|+.|++++|.++. .+
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~----------------------~~ 161 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKS----------------------SG 161 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCG----------------------GG
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccc-cCHhHhcCCccccEEECCCCcCCc----------------------cC
Confidence 888777 4554443 577777777777763 333334445556666665555532 01
Q ss_pred CCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCC
Q 001226 496 SFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGN 575 (1119)
Q Consensus 496 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 575 (1119)
..+..+.++++|+.|++++|.++. +|..+. ++|+.|++++|++++..|..+..+++|++|+|++|++++..+..|.+
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 233344444444444444444442 222221 44555555555555444455555555555555555555544455555
Q ss_pred cccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhh------cccCCeeEccCccCcc--CCCccccc
Q 001226 576 LENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS------LEKMQSLSLQENNLSG--AIPDAFSS 647 (1119)
Q Consensus 576 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~p~~~~~ 647 (1119)
+++|++|+|++|++. .+|..+..+++|++|+|++|++++..+..|.. ...++.|++++|.+.. ..|..|..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 555566666665555 45555555556666666666655444444322 2455666666666642 44566666
Q ss_pred cccccEeecCCc
Q 001226 648 VQSLFELQLGSN 659 (1119)
Q Consensus 648 l~~L~~L~L~~N 659 (1119)
+.+++.++|++|
T Consensus 318 ~~~l~~l~L~~N 329 (330)
T 1xku_A 318 VYVRAAVQLGNY 329 (330)
T ss_dssp CCCGGGEEC---
T ss_pred ccceeEEEeccc
Confidence 666666666665
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=341.64 Aligned_cols=234 Identities=24% Similarity=0.269 Sum_probs=189.0
Q ss_pred HhhCCceeeecCCccEEEEEeCC-CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCc-----eE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEH-----GF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~ 903 (1119)
+|+..+.||+|+||+||+|.+.. +++.||||++.... ..+.+|+.+++.++||||+++++++.+.+. .|
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 67778999999999999999976 68999999885332 346789999999999999999999987665 69
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||+++++|.+++.. .+++..+..++.||++||.|||+. +|+||||||+||+++.+ .+||+|||+++..
T Consensus 161 lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 99999999999987754 489999999999999999999999 99999999999999986 8999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
... ....||+.|+|||++.+.. +.++||||+||++|||++|..||........
T Consensus 232 ~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------- 284 (681)
T 2pzi_A 232 NSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------- 284 (681)
T ss_dssp TCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------------
T ss_pred ccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------------
Confidence 432 3457899999999876554 8899999999999999999888753210000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHcc
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRP-SMREVVGFLIKL 1109 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ell~~L~~~ 1109 (1119)
. ...........+.+++.+||+.||++|| +++++.+.+..+
T Consensus 285 ----~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ----P-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ----C-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----c-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0011222345788999999999999999 466676666654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-31 Score=298.39 Aligned_cols=291 Identities=21% Similarity=0.241 Sum_probs=208.1
Q ss_pred CCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeec
Q 001226 312 NQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYL 391 (1119)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L 391 (1119)
.+++.++++++.++ .+|..+. ++|+.|++++|++++..+..|+++++|++|++++|.+++..|..|.++++|++|++
T Consensus 31 c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 31 CHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp EETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 47899999999998 5676554 68999999999999887789999999999999999999888999999999999999
Q ss_pred cCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCccc-chhhhhccCCccceeccccceee
Q 001226 392 FNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGE-VALELGKHFPYLSRLDLTGNSFY 470 (1119)
Q Consensus 392 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~ 470 (1119)
++|+++. +|..+. ++|++|++++|++++..+..+.++++|+.|++++|+++.. .....+..+++|+.|++++|.++
T Consensus 108 s~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 108 SKNQLKE-LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184 (330)
T ss_dssp CSSCCSB-CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCCcCCc-cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence 9999995 454443 7999999999999988778899999999999999999731 22333445666666666666665
Q ss_pred CccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCcccc
Q 001226 471 GPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFG 550 (1119)
Q Consensus 471 ~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 550 (1119)
. +|..+ . ++|++|++++|++++..|..+..+++|+.|++++|++++..+..+.
T Consensus 185 ~-l~~~~------------------------~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 237 (330)
T 1xku_A 185 T-IPQGL------------------------P--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237 (330)
T ss_dssp S-CCSSC------------------------C--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred c-CCccc------------------------c--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhcc
Confidence 3 33322 1 4455555555555555555555555555555555555554555556
Q ss_pred ccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCccccc------CCCCcEEeccCccccc--cCChhhh
Q 001226 551 FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGK------CTKMIKLDLSDNYLAG--SIPSEVI 622 (1119)
Q Consensus 551 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~ 622 (1119)
.+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|.. .+.|+.|++++|.+.. ..|..+.
T Consensus 238 ~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~ 316 (330)
T 1xku_A 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316 (330)
T ss_dssp GSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccc
Confidence 6666666666666666 56666666666666666666666544444432 3567777777777642 4556677
Q ss_pred hcccCCeeEccCcc
Q 001226 623 SLEKMQSLSLQENN 636 (1119)
Q Consensus 623 ~l~~L~~L~L~~N~ 636 (1119)
.+..++.++|++|+
T Consensus 317 ~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 317 CVYVRAAVQLGNYK 330 (330)
T ss_dssp TCCCGGGEEC----
T ss_pred cccceeEEEecccC
Confidence 77777777777774
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-35 Score=350.40 Aligned_cols=386 Identities=20% Similarity=0.148 Sum_probs=243.3
Q ss_pred CCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCC----CcchhhcCCCCCceeeeccccccccCcccc-cCCC-
Q 001226 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG----QIPETLWGLENLQKLVLSANKLNGTISGQI-SHCN- 312 (1119)
Q Consensus 239 ~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~- 312 (1119)
++|++|++++|++++......+..+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4678888888888755555557888888888888888874 346667777888888888888876444333 3344
Q ss_pred ---CCcEEEcccccccc----ccCcccCCCCCCCeEEccCCcccCCCCCCC-----CCCCCCcEEEcccCcCcccC----
Q 001226 313 ---QLQVIALSRNNLVG----QIPRSVGNLSSLNSLLLFNNRLQGTLPPEL-----GNCGSLVDLRLQHNFIGGTI---- 376 (1119)
Q Consensus 313 ---~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~i~~~~---- 376 (1119)
+|++|+|++|.+++ .++..+..+++|++|++++|.+++..+..+ ...++|++|++++|.+++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 68888888888774 446777788888888888887764333222 23456888888888777533
Q ss_pred chhhhcccccceeeccCccccCCCCccccc-----cCcceEEEeeccccccc----CCccccCCCCcCEEEccCccCccc
Q 001226 377 PPEICNLAKLEVLYLFNNRIEGAIPHQIGR-----MSKLVELALYNNRLTGR----IPPDITRLRNLQFLSLAHNHLTGE 447 (1119)
Q Consensus 377 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 447 (1119)
+..+..+++|+.|++++|.+++..+..+.. .++|++|++++|.+++. ++..+..+++|+.|++++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 445556677777777777776544443332 45777777777777643 355566667777777777776643
Q ss_pred chhh----hhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCc
Q 001226 448 VALE----LGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPA 523 (1119)
Q Consensus 448 ~~~~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 523 (1119)
.... +...++.|++|++++|.+++.... .++..+..+++|++|++++|.+.+..+.
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCG--------------------DLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--------------------HHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHH--------------------HHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 2222 222345555555555555432000 0334444455555555555555433222
Q ss_pred cccC-----CCCcceeeccCcccCCC----CCccccccccceEEeccCCcccCCCCCccCC-----cccccEEEcccCcc
Q 001226 524 TLER-----NPGVSFLDVRGNLLQGS----IPPVFGFWSNLTMLDFSENRLSGSIPSELGN-----LENLQILRLSANKL 589 (1119)
Q Consensus 524 ~~~~-----l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l 589 (1119)
.+.. .++|+.|++++|.+++. ++..+..+++|++|+|++|++++..+..+.. .++|++|+|++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 2221 24666666666666543 3455556677888888888777554444432 56788888888888
Q ss_pred cC----cCCcccccCCCCcEEeccCccccccCChhhh-----hcccCCeeEccCccCccCCCcc
Q 001226 590 DG----RIPYELGKCTKMIKLDLSDNYLAGSIPSEVI-----SLEKMQSLSLQENNLSGAIPDA 644 (1119)
Q Consensus 590 ~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~p~~ 644 (1119)
++ .+|..+..+++|++|||++|++++.-...+. ....|+.|++.++.+....++.
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~ 446 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 446 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHH
Confidence 75 6777777888888888888888753222222 1235778888777776544443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-33 Score=314.85 Aligned_cols=240 Identities=16% Similarity=0.153 Sum_probs=182.5
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------------ccHHHHHHHHhhcC---------CCCEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------------TNFDVEIRTLSLVR---------HRNILR 891 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------------~~~~~E~~~l~~l~---------h~niv~ 891 (1119)
..+|+..+.||+|+||+||+|++ +++.||||+++... ..+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46889999999999999999998 47999999986432 45788999998886 666666
Q ss_pred Eeee-----------------eec-------------CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHH
Q 001226 892 IVGS-----------------CTK-------------DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941 (1119)
Q Consensus 892 l~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~ 941 (1119)
+.++ +.+ ++..|+||||+++|++.+.+.+ ..+++..++.++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 6654 332 6788999999999987776644 24899999999999999
Q ss_pred HHHHHH-hCCCCCeEecCCCCCCeEeCCCC--------------------ceEEEeccccccccCCCCCCcccccccCCC
Q 001226 942 GLSYLH-YDCVPQIIHRDIKSDNILLDSEL--------------------EPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000 (1119)
Q Consensus 942 ~l~~LH-~~~~~~ivH~Dlkp~Nill~~~~--------------------~vkl~DfGla~~~~~~~~~~~~~~~~gt~~ 1000 (1119)
|++||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 88 999999999999999887 8999999999876531 3479999
Q ss_pred cccccccCCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCchHHHHHH
Q 001226 1001 YIAPENAYSTRLTEKSDVYSYGVI-LFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKAL 1079 (1119)
Q Consensus 1001 y~aPE~~~~~~~~~~sDvwslG~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1079 (1119)
|+|||.+.+.. +.++||||+|++ .+++++|..||... .|..... .....................+.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT---DKMLKQMTFKTKCNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH---HHHHHTCCCSSCCCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH---HhhhhhhccCcccchhhhhhcCH
Confidence 99999988666 889999998777 77788899887421 0100000 00000000000111122345677
Q ss_pred HHHHHHHHccccCCCCCCCHHHHH-HH
Q 001226 1080 RLLELALECTRQVADMRPSMREVV-GF 1105 (1119)
Q Consensus 1080 ~l~~l~~~cl~~dP~~RPs~~ell-~~ 1105 (1119)
++.+++.+||+.| |++|++ +|
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHHHHhccC-----CHHHHHhcC
Confidence 8999999999976 999998 54
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-35 Score=348.70 Aligned_cols=340 Identities=22% Similarity=0.165 Sum_probs=177.9
Q ss_pred cccccCCCCCcEEEccCCccCCccChhhhhcCC----CccEEEcCCCccCC----CcchhhcCCCCCceeeecccccccc
Q 001226 232 PTSLSNCRNLVEFSASSNNFGGAISPWIFKGLL----QLEVLYLDDNNLEG----QIPETLWGLENLQKLVLSANKLNGT 303 (1119)
Q Consensus 232 p~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~----~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~ 303 (1119)
+..+..+++|++|++++|.+++......+..+. +|++|+|++|++++ .++..+..+++|++|+|++|.+++.
T Consensus 49 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 128 (461)
T 1z7x_W 49 SSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA 128 (461)
T ss_dssp HHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHH
T ss_pred HHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchH
Confidence 344555555555555555554333333334444 46666666666663 3466666666777777777766543
Q ss_pred Ccccc-----cCCCCCcEEEcccccccccc----CcccCCCCCCCeEEccCCcccCCCCCCCC-----CCCCCcEEEccc
Q 001226 304 ISGQI-----SHCNQLQVIALSRNNLVGQI----PRSVGNLSSLNSLLLFNNRLQGTLPPELG-----NCGSLVDLRLQH 369 (1119)
Q Consensus 304 ~~~~~-----~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-----~l~~L~~L~L~~ 369 (1119)
.+..+ ...++|++|+|++|.+++.. +..+..+++|++|++++|.+++..+..+. ..++|++|++++
T Consensus 129 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 208 (461)
T 1z7x_W 129 GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLES 208 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTT
T ss_pred HHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccC
Confidence 33222 22445666666666665432 34445556666666666665533222222 234666666666
Q ss_pred CcCccc----CchhhhcccccceeeccCccccCCC-----CccccccCcceEEEeeccccccc----CCccccCCCCcCE
Q 001226 370 NFIGGT----IPPEICNLAKLEVLYLFNNRIEGAI-----PHQIGRMSKLVELALYNNRLTGR----IPPDITRLRNLQF 436 (1119)
Q Consensus 370 N~i~~~----~~~~l~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~ 436 (1119)
|.+++. ++..+..+++|+.|++++|++++.. +..+..+++|++|++++|++++. ++..+..+++|+.
T Consensus 209 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 288 (461)
T 1z7x_W 209 CGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288 (461)
T ss_dssp SCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCE
T ss_pred CCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcce
Confidence 666542 3445555666666666666655422 11222355666666666666542 3444555666666
Q ss_pred EEccCccCcccchhhhhcc----CCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEe
Q 001226 437 LSLAHNHLTGEVALELGKH----FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVIL 512 (1119)
Q Consensus 437 L~L~~N~l~~~~~~~~~~~----l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 512 (1119)
|++++|.+++..+..+... .+.|++|++++|.+++.... .++..+..+++|++|++
T Consensus 289 L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 289 LSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCS--------------------HFSSVLAQNRFLLELQI 348 (461)
T ss_dssp EECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--------------------HHHHHHHHCSSCCEEEC
T ss_pred EECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHH--------------------HHHHHHhhCCCccEEEc
Confidence 6666666654333332221 13444444444444432100 13334445555666666
Q ss_pred ccCccccCCCccccC-----CCCcceeeccCcccCC----CCCccccccccceEEeccCCcccCCCCCccC-----Cccc
Q 001226 513 SNNLLQGSLPATLER-----NPGVSFLDVRGNLLQG----SIPPVFGFWSNLTMLDFSENRLSGSIPSELG-----NLEN 578 (1119)
Q Consensus 513 s~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~ 578 (1119)
++|.+++..+..+.. .++|+.|++++|++++ .+|..+..+++|++|+|++|++++.-...+. ...+
T Consensus 349 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~ 428 (461)
T 1z7x_W 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 428 (461)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCC
T ss_pred cCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcc
Confidence 666555433333322 4566666666666654 5566666667777777777776643111111 1234
Q ss_pred ccEEEcccCcccC
Q 001226 579 LQILRLSANKLDG 591 (1119)
Q Consensus 579 L~~L~Ls~N~l~~ 591 (1119)
|+.|++.++.+..
T Consensus 429 L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 429 LEQLVLYDIYWSE 441 (461)
T ss_dssp CCEEECTTCCCCH
T ss_pred hhheeecccccCH
Confidence 6666666666553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-31 Score=329.79 Aligned_cols=412 Identities=15% Similarity=0.081 Sum_probs=201.5
Q ss_pred CCccccccCccCEEEccCccc---cCCCCcccc------------cccccceeeecccccccccCccCCCc-c-cccEEE
Q 001226 136 IPPEIFKLKRLSWLDLGYNSL---SGKIPPQVS------------LCYSLESIGFHNNFLNGELPNDICSL-P-KLKSLY 198 (1119)
Q Consensus 136 ~p~~l~~l~~L~~L~Ls~n~l---~~~~p~~l~------------~l~~L~~L~L~~n~l~~~~~~~l~~l-~-~L~~L~ 198 (1119)
.+..+..+++|++|+|+++.. .+.+|...+ .+++|++|+|++|.+++..+..+... + +|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 344566788999999987532 133443333 55666666666666665555555543 2 366666
Q ss_pred ecccc-ccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCcc---ChhhhhcCCCccEEEcCCC
Q 001226 199 LNTNN-LTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI---SPWIFKGLLQLEVLYLDDN 274 (1119)
Q Consensus 199 L~~n~-l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~---~~~~~~~l~~L~~L~L~~n 274 (1119)
+++|. ++. ..++....++++|++|++++|.+++.. ....+..+++|++|++++|
T Consensus 145 L~~~~~~~~----------------------~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n 202 (592)
T 3ogk_B 145 LDKCSGFTT----------------------DGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT 202 (592)
T ss_dssp EESCEEEEH----------------------HHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTC
T ss_pred CcCCCCcCH----------------------HHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeecc
Confidence 66654 110 012222234555555555555544332 1223344455555555555
Q ss_pred ccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCccc---CC
Q 001226 275 NLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ---GT 351 (1119)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~ 351 (1119)
.+++..+. ..+..+..+++|++|++++|.+.+ +|..+.++++|+.|+++.+... +.
T Consensus 203 ~~~~~~~~--------------------~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~ 261 (592)
T 3ogk_B 203 EFAKISPK--------------------DLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPE 261 (592)
T ss_dssp CCSSCCHH--------------------HHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTT
T ss_pred CCCccCHH--------------------HHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHH
Confidence 54421111 122223344444444444444442 3344444555555555432211 12
Q ss_pred CCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCC-ccccccCcceEEEeecccccc-cCCcccc
Q 001226 352 LPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP-HQIGRMSKLVELALYNNRLTG-RIPPDIT 429 (1119)
Q Consensus 352 ~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-~~~~~~~ 429 (1119)
.+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ |.+.+ .++..+.
T Consensus 262 ~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~ 339 (592)
T 3ogk_B 262 KYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQ 339 (592)
T ss_dssp SSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHH
T ss_pred HHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHH
Confidence 2334455566666666654332 445555566666666666666543322 224556666666666 33322 2222334
Q ss_pred CCCCcCEEEcc-----------CccCcccchhhhhccCCccceeccccceeeCccCCcccc-ccccceeecc----Cccc
Q 001226 430 RLRNLQFLSLA-----------HNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICV-GTNLFVLVLG----NNRF 493 (1119)
Q Consensus 430 ~l~~L~~L~L~-----------~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~~L~~L~L~----~N~l 493 (1119)
.+++|+.|+++ .|.+++.....+...+++|++|+++.|.+++..+..+.. +++|+.|+++ .|++
T Consensus 340 ~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l 419 (592)
T 3ogk_B 340 YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERI 419 (592)
T ss_dssp HCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCC
T ss_pred hCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccc
Confidence 55666666666 345554444444445566666666656555544444433 4455555553 4444
Q ss_pred cCC-----CCccccccccccEEEeccCc--cccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCccc
Q 001226 494 NGS-----FPIEIGKCSSLRRVILSNNL--LQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS 566 (1119)
Q Consensus 494 ~~~-----~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (1119)
++. ++..+.++++|++|++++|. +++..+..+. ..+++|++|+|++|+++
T Consensus 420 ~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~-----------------------~~~~~L~~L~L~~n~l~ 476 (592)
T 3ogk_B 420 TDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIG-----------------------QYSPNVRWMLLGYVGES 476 (592)
T ss_dssp SSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHH-----------------------HSCTTCCEEEECSCCSS
T ss_pred cCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHH-----------------------HhCccceEeeccCCCCC
Confidence 432 22224445566666665322 3322222221 12344555555555554
Q ss_pred C-CCCCccCCcccccEEEcccCcccCc-CCcccccCCCCcEEeccCccccc
Q 001226 567 G-SIPSELGNLENLQILRLSANKLDGR-IPYELGKCTKMIKLDLSDNYLAG 615 (1119)
Q Consensus 567 ~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ 615 (1119)
+ .++..+.++++|+.|+|++|.+++. ++..+..+++|++|+|++|++++
T Consensus 477 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 477 DEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp HHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred HHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 3 2233344555555555555555432 23333445556666666666553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-31 Score=330.04 Aligned_cols=416 Identities=16% Similarity=0.096 Sum_probs=251.7
Q ss_pred ccCCCCcccccCCCccEEEcccccc---cccCCcccc------------ccCccCEEEccCccccCCCCcccccc--ccc
Q 001226 108 FTGSIPKQLGNCGQLKTLLLNDNRF---QGSIPPEIF------------KLKRLSWLDLGYNSLSGKIPPQVSLC--YSL 170 (1119)
Q Consensus 108 ~~~~~~~~l~~l~~L~~L~L~~n~i---~~~~p~~l~------------~l~~L~~L~Ls~n~l~~~~p~~l~~l--~~L 170 (1119)
+....+..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..++.. .+|
T Consensus 61 ~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L 140 (592)
T 3ogk_B 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140 (592)
T ss_dssp GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGC
T ss_pred cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccC
Confidence 3434555678899999999988632 134444443 68999999999999987777777764 459
Q ss_pred ceeeecccc-cccc-cCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccC
Q 001226 171 ESIGFHNNF-LNGE-LPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248 (1119)
Q Consensus 171 ~~L~L~~n~-l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~ 248 (1119)
++|+|++|. ++.. .+.....+++|++|+|++|.+++.... .++..+.++++|++|++++
T Consensus 141 ~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~-------------------~l~~~~~~~~~L~~L~L~~ 201 (592)
T 3ogk_B 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGK-------------------WLHELAQHNTSLEVLNFYM 201 (592)
T ss_dssp CEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSH-------------------HHHHHHHHCCCCCEEECTT
T ss_pred cEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchh-------------------HHHHHHhcCCCccEEEeec
Confidence 999999986 3322 222334789999999999988754221 1344556789999999999
Q ss_pred CccCCc---cChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeecccccc---ccCcccccCCCCCcEEEcccc
Q 001226 249 NNFGGA---ISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN---GTISGQISHCNQLQVIALSRN 322 (1119)
Q Consensus 249 n~i~~~---~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N 322 (1119)
|.+++. ..+..+..+++|++|++++|.+.+ +|..+.++++|++|+++.+... ......+..+++|+.|+++++
T Consensus 202 n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 280 (592)
T 3ogk_B 202 TEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM 280 (592)
T ss_dssp CCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred cCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence 998732 224456788999999999999885 7788999999999999864332 223345666777777777765
Q ss_pred ccccccCcccCCCCCCCeEEccCCcccCCCC-CCCCCCCCCcEEEcccCcCcc-cCchhhhcccccceeeccC-------
Q 001226 323 NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLP-PELGNCGSLVDLRLQHNFIGG-TIPPEICNLAKLEVLYLFN------- 393 (1119)
Q Consensus 323 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~i~~-~~~~~l~~l~~L~~L~L~~------- 393 (1119)
... .+|..+..+++|++|++++|.+++... ..+..+++|++|+++ +.+.+ .++..+..+++|++|++++
T Consensus 281 ~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~ 358 (592)
T 3ogk_B 281 GPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGM 358 (592)
T ss_dssp CTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTT
T ss_pred chh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcccccc
Confidence 333 556666777777777777777653322 234666777777777 33332 2233334566677777762
Q ss_pred ----ccccCCCC-ccccccCcceEEEeecccccccCCccccC-CCCcCEEEcc----CccCccc----chhhhhccCCcc
Q 001226 394 ----NRIEGAIP-HQIGRMSKLVELALYNNRLTGRIPPDITR-LRNLQFLSLA----HNHLTGE----VALELGKHFPYL 459 (1119)
Q Consensus 394 ----N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~----~~~~~~~~l~~L 459 (1119)
|.+++... .....+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ....+...+++|
T Consensus 359 ~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L 438 (592)
T 3ogk_B 359 EDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438 (592)
T ss_dssp SSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTC
T ss_pred ccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCC
Confidence 44443211 11234566666666666666554444443 5666666664 4555542 111223345555
Q ss_pred ceeccccceeeCccCCccccccccceeeccCccccCCCCccccc-cccccEEEeccCcccc-CCCccccCCCCcceeecc
Q 001226 460 SRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGK-CSSLRRVILSNNLLQG-SLPATLERNPGVSFLDVR 537 (1119)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~ 537 (1119)
++|++++|. +.+++..+..++. +++|++|++++|.+++ .++..+..+++|+.|+++
T Consensus 439 ~~L~L~~~~----------------------~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~ 496 (592)
T 3ogk_B 439 RRFAFYLRQ----------------------GGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMR 496 (592)
T ss_dssp CEEEEECCG----------------------GGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEE
T ss_pred CEEEEecCC----------------------CCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeecc
Confidence 555554321 1133222222222 4455555555555443 223333444555555555
Q ss_pred CcccCCC-CCccccccccceEEeccCCcccC
Q 001226 538 GNLLQGS-IPPVFGFWSNLTMLDFSENRLSG 567 (1119)
Q Consensus 538 ~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~ 567 (1119)
+|.+++. ++..+..+++|++|+|++|+++.
T Consensus 497 ~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~ 527 (592)
T 3ogk_B 497 GCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527 (592)
T ss_dssp SCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred CCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence 5554322 22223345556666666666553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=292.74 Aligned_cols=256 Identities=20% Similarity=0.225 Sum_probs=157.6
Q ss_pred ccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeecc
Q 001226 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVR 537 (1119)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 537 (1119)
.|++|++++|.+++..+..+..+++|++|++++|++++..|..++++++|++|++++|++++..+..+..+++|++|+++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 34444444444443333345555555555555555555555555566666666666666654444445556666666666
Q ss_pred CcccCCCCC-ccccccccceEEeccCC-cccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccc
Q 001226 538 GNLLQGSIP-PVFGFWSNLTMLDFSEN-RLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615 (1119)
Q Consensus 538 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 615 (1119)
+|++++..+ ..+..+++|++|++++| .+.+..|..|.++++|++|++++|++.+..|..+..+++|++|++++|+++.
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 666653222 25566666666666666 3554445566666666666666666666666666666666666666666653
Q ss_pred cCChh-hhhcccCCeeEccCccCccCCCccccc---cccccEeecCCcccCCCccccchhhccccceeeeccccccC---
Q 001226 616 SIPSE-VISLEKMQSLSLQENNLSGAIPDAFSS---VQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSG--- 688 (1119)
Q Consensus 616 ~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~--- 688 (1119)
+|.. +..+++|+.|+|++|++++..+..+.. ...++. +++++|.+++
T Consensus 213 -~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~-------------------------l~L~~~~l~~~~l 266 (353)
T 2z80_A 213 -LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK-------------------------FTFRNVKITDESL 266 (353)
T ss_dssp -HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE-------------------------EEEESCBCCHHHH
T ss_pred -chhhhhhhcccccEEECCCCccccccccccccccccchhhc-------------------------cccccccccCcch
Confidence 3333 334566666666666666544443332 223333 4444444443
Q ss_pred -CcccccccccccceeeccCceecccCCccc-cccccceEEecccccccccCCC
Q 001226 689 -KIPECLGNLDKLQILDLSSNSFSGEIPTEV-NNMVSLYFVNISFNHFSGKLPA 740 (1119)
Q Consensus 689 -~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~-~~~~~l~~l~ls~N~~~g~~p~ 740 (1119)
.+|+.++++++|+.|||++|+|+ .+|+.+ ..+++|+.+++++|+++|..|.
T Consensus 267 ~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 267 FQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp HHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred hhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 57888999999999999999998 778775 8899999999999999998874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=278.18 Aligned_cols=224 Identities=20% Similarity=0.270 Sum_probs=132.8
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
+++.|+|++|+++ .+|..++++++|++|+|++|.++ .+|..+..+++|++|++++|+++ .+|..++.+++|++|+|+
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 3444444444444 34444444444555555544444 44444444444444444444444 344444445555555555
Q ss_pred CCcccCCCCCccC---------CcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEc
Q 001226 562 ENRLSGSIPSELG---------NLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSL 632 (1119)
Q Consensus 562 ~N~l~~~~p~~~~---------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 632 (1119)
+|++.+.+|..++ ++++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|+.|+|
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDL 236 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEEC
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEEC
Confidence 5444444444443 3666666666666665 566666666666666666666663 4555666666666666
Q ss_pred cCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecc
Q 001226 633 QENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712 (1119)
Q Consensus 633 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 712 (1119)
++|++.+.+|..|+.+++|+. |++++|++.+.+|..++++++|+.|||++|++.|
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~-------------------------L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKR-------------------------LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCE-------------------------EECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred cCCcchhhhHHHhcCCCCCCE-------------------------EECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 666666666666666666655 4555555556677777777888888888888888
Q ss_pred cCCccccccccceEEeccccccc
Q 001226 713 EIPTEVNNMVSLYFVNISFNHFS 735 (1119)
Q Consensus 713 ~ip~~~~~~~~l~~l~ls~N~~~ 735 (1119)
.+|+++..+++|+.++++.|.+.
T Consensus 292 ~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 292 RLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp CCCGGGGGSCTTCEEECCGGGSC
T ss_pred hccHHHhhccCceEEeCCHHHHH
Confidence 88888888888888888776554
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-29 Score=277.50 Aligned_cols=249 Identities=20% Similarity=0.191 Sum_probs=171.4
Q ss_pred ceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccc--hhhhhccCCccceecc
Q 001226 387 EVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEV--ALELGKHFPYLSRLDL 464 (1119)
Q Consensus 387 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~~l~~L~~L~L 464 (1119)
+.++.+++.++. +|..+. ++|++|++++|+++...+..|.++++|+.|+|++|+++... +..+. .+++|++|++
T Consensus 10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~-~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDF-GTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHH-SCSCCCEEEC
T ss_pred CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccc-cccccCEEEC
Confidence 467777777773 444332 57778888888877444445677777888888777776321 22222 2444444444
Q ss_pred ccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCC-ccccCCCCcceeeccCcccCC
Q 001226 465 TGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLP-ATLERNPGVSFLDVRGNLLQG 543 (1119)
Q Consensus 465 ~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 543 (1119)
++ |.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++.+
T Consensus 86 s~------------------------n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~ 140 (306)
T 2z66_A 86 SF------------------------NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 140 (306)
T ss_dssp CS------------------------CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE
T ss_pred CC------------------------Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc
Confidence 44 4444 344455666666666666666665444 456666777777777777766
Q ss_pred CCCccccccccceEEeccCCcccC-CCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhh
Q 001226 544 SIPPVFGFWSNLTMLDFSENRLSG-SIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI 622 (1119)
Q Consensus 544 ~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 622 (1119)
..|..+..+++|++|+|++|++++ .+|..+.++++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+.
T Consensus 141 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 220 (306)
T 2z66_A 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220 (306)
T ss_dssp CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence 666777777778888888887775 4677788888888888888888776677788888888888888888776666777
Q ss_pred hcccCCeeEccCccCccCCCccccccc-cccEeecCCcccCCC
Q 001226 623 SLEKMQSLSLQENNLSGAIPDAFSSVQ-SLFELQLGSNIFDGS 664 (1119)
Q Consensus 623 ~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~ 664 (1119)
.+++|+.|+|++|++++..|..+..++ +|+.|+|++|.+++.
T Consensus 221 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp TCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred CcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 788888888888888887888887774 788877777777643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=278.75 Aligned_cols=258 Identities=20% Similarity=0.202 Sum_probs=155.7
Q ss_pred ccceeccccceeeCccCCccccccccceeeccCccccC--CCCccccccccccEEEeccCccccCCCccccCCCCcceee
Q 001226 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNG--SFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535 (1119)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (1119)
.|++|++++|.++...+..+..+++|++|+|++|+++. ..|..+..+++|++|++++|.+.+ +|..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEE
Confidence 34444444444443222334455555555555555542 224555567777777777777763 455566677777777
Q ss_pred ccCcccCCCCC-ccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccC-cCCcccccCCCCcEEeccCccc
Q 001226 536 VRGNLLQGSIP-PVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG-RIPYELGKCTKMIKLDLSDNYL 613 (1119)
Q Consensus 536 l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l 613 (1119)
+++|++++..+ ..+..+++|++|++++|++++..|..|.++++|++|+|++|++.+ .+|..+..+++|++|+|++|++
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l 187 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCc
Confidence 77777765444 456666677777777777766666666666777777777777664 4566666667777777777776
Q ss_pred cccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccc
Q 001226 614 AGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693 (1119)
Q Consensus 614 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~ 693 (1119)
++..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++| ++++..|..
T Consensus 188 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-------------------------~l~~~~~~~ 242 (306)
T 2z66_A 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN-------------------------HIMTSKKQE 242 (306)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTS-------------------------CCCBCSSSS
T ss_pred CCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCC-------------------------CCcccCHHH
Confidence 6656666666666777777777666655556666666666555555 455555555
Q ss_pred cccc-cccceeeccCceecccCC--ccccccccceEEecccccccccCCCc
Q 001226 694 LGNL-DKLQILDLSSNSFSGEIP--TEVNNMVSLYFVNISFNHFSGKLPAS 741 (1119)
Q Consensus 694 ~~~l-~~L~~L~Ls~N~l~g~ip--~~~~~~~~l~~l~ls~N~~~g~~p~~ 741 (1119)
+..+ ++|+.|+|++|+|++..+ .....+...+.+.+..|.+.+..|+.
T Consensus 243 ~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 243 LQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred HHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 6655 367777777777765422 11222333334455666666666654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=282.56 Aligned_cols=278 Identities=19% Similarity=0.167 Sum_probs=173.5
Q ss_pred ccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccC
Q 001226 266 LEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN 345 (1119)
Q Consensus 266 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 345 (1119)
....++++++++ .+|..+. ++|++|++++|+++++.+..|..+++|++|+|++|++++..|..|.++++|++|++++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 344566666666 3454443 3667777777777666666667777777777777777666666677777777777777
Q ss_pred CcccCCCCCCCCCCCCCcEEEcccCcCcccCc-hhhhcccccceeeccCc-cccCCCCccccccCcceEEEeeccccccc
Q 001226 346 NRLQGTLPPELGNCGSLVDLRLQHNFIGGTIP-PEICNLAKLEVLYLFNN-RIEGAIPHQIGRMSKLVELALYNNRLTGR 423 (1119)
Q Consensus 346 N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~-~~l~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 423 (1119)
|++++..+..+.++++|++|++++|++++..+ ..+.++++|++|++++| .++...+..|..+++|++|++++|++++.
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 189 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEE
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCcc
Confidence 77764444446667777777777777764333 35667777777777777 46656666777777777777777777777
Q ss_pred CCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccc
Q 001226 424 IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGK 503 (1119)
Q Consensus 424 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 503 (1119)
.|..+..+++|++|++++|+++ .++..++..+++|+.|++++|.+++..+..+.. ...
T Consensus 190 ~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~---------------------~~~ 247 (353)
T 2z80_A 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELST---------------------GET 247 (353)
T ss_dssp CTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC---------------------------C
T ss_pred CHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccccccccccc---------------------ccc
Confidence 7777777777888888877775 455555556777777777777776654433321 011
Q ss_pred cccccEEEeccCcccc----CCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCC
Q 001226 504 CSSLRRVILSNNLLQG----SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGS 568 (1119)
Q Consensus 504 l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 568 (1119)
.+.++.+++++|.+++ .+|..+..+++|+.|++++|+++...+..|..+++|++|+|++|.+.+.
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 2233444444444433 2445555666666666666666632222346666677777777766643
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=268.30 Aligned_cols=208 Identities=24% Similarity=0.215 Sum_probs=150.4
Q ss_pred CccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCc-cccCCCccccCCCCcceee
Q 001226 457 PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNL-LQGSLPATLERNPGVSFLD 535 (1119)
Q Consensus 457 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~ 535 (1119)
+.|++|++++|.+++..+..+..+++|++|++++|++++..|..+.++++|++|++++|+ +....|..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555555555556666666777777777666666677777777777777776 6655567777777777777
Q ss_pred ccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccc
Q 001226 536 VRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615 (1119)
Q Consensus 536 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 615 (1119)
+++|++++..|..+..+++|++|+|++|++++..+..|+++++|++|+|++|++++..+..+..+++|++|+|++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 77777777667777777778888888888776666667777888888888888875555567777888888888888877
Q ss_pred cCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCC
Q 001226 616 SIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664 (1119)
Q Consensus 616 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 664 (1119)
..|..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++...
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 7777777778888888888888876667777888888877777777643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-29 Score=283.26 Aligned_cols=248 Identities=20% Similarity=0.181 Sum_probs=167.8
Q ss_pred ccCCccceeccccceeeCccCCccccccccceeeccCccc-cCCCCcccc-------ccccccEEEeccCccccCCCccc
Q 001226 454 KHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRF-NGSFPIEIG-------KCSSLRRVILSNNLLQGSLPATL 525 (1119)
Q Consensus 454 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~ 525 (1119)
...++|+.|++++|.+ .+|..+... |+.|+|++|++ ...+|..+. ++++|++|+|++|.+++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3456778888888887 566655443 77888888887 345665554 67778888888888877777765
Q ss_pred --cCCCCcceeeccCcccCCCCCcccccc-----ccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCc--CCcc
Q 001226 526 --ERNPGVSFLDVRGNLLQGSIPPVFGFW-----SNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR--IPYE 596 (1119)
Q Consensus 526 --~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~ 596 (1119)
..+++|++|++++|++++. |..++.+ ++|++|+|++|++++..|..|+++++|++|+|++|++.+. +|..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 7777777777777777765 6666665 7777777777777766667777777777777777776654 2223
Q ss_pred c--ccCCCCcEEeccCccccc--cCC-hhhhhcccCCeeEccCccCccCCC-ccccccccccEeecCCcccCCCccccch
Q 001226 597 L--GKCTKMIKLDLSDNYLAG--SIP-SEVISLEKMQSLSLQENNLSGAIP-DAFSSVQSLFELQLGSNIFDGSIPCSLS 670 (1119)
Q Consensus 597 ~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 670 (1119)
+ ..+++|++|+|++|++++ .++ ..+..+++|++|+|++|++++.+| ..+..+++|+.|+|++|.+
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l--------- 265 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL--------- 265 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCC---------
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCcc---------
Confidence 3 667777777777777762 122 223455677777777777776654 4455566666655555554
Q ss_pred hhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccccccceEEecccccccc
Q 001226 671 KLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSG 736 (1119)
Q Consensus 671 ~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g 736 (1119)
+ .+|..+. ++|++|||++|+|++. |. +..+++|+.+++++|++++
T Consensus 266 ----------------~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 266 ----------------K-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp ----------------S-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred ----------------C-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 4 4555554 6677777777777754 55 6777777777777777765
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=283.07 Aligned_cols=250 Identities=22% Similarity=0.223 Sum_probs=210.9
Q ss_pred cccCCCCcCEEEccCccCcccchhhhhccCCccceecccccee-eCccCCccc-------cccccceeeccCccccCCCC
Q 001226 427 DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF-YGPIPANIC-------VGTNLFVLVLGNNRFNGSFP 498 (1119)
Q Consensus 427 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l-~~~~p~~~~-------~~~~L~~L~L~~N~l~~~~p 498 (1119)
.++..++|+.|++++|.+ .+|..+... |+.|+|++|.+ ...+|..+. .+++|++|+|++|++++.+|
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 112 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP 112 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhH
Confidence 456678899999999999 677766654 89999999999 456776665 68999999999999999999
Q ss_pred ccc--cccccccEEEeccCccccCCCccccCC-----CCcceeeccCcccCCCCCccccccccceEEeccCCcccCC--C
Q 001226 499 IEI--GKCSSLRRVILSNNLLQGSLPATLERN-----PGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGS--I 569 (1119)
Q Consensus 499 ~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~ 569 (1119)
..+ +.+++|++|+|++|++++. |..+..+ ++|++|++++|++++..|..|+.+++|++|+|++|++.+. .
T Consensus 113 ~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 191 (312)
T 1wwl_A 113 PPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191 (312)
T ss_dssp CCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHH
T ss_pred HHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHH
Confidence 987 8999999999999999987 8888887 9999999999999998889999999999999999998765 3
Q ss_pred CCcc--CCcccccEEEcccCcccC--cCC-cccccCCCCcEEeccCccccccCC-hhhhhcccCCeeEccCccCccCCCc
Q 001226 570 PSEL--GNLENLQILRLSANKLDG--RIP-YELGKCTKMIKLDLSDNYLAGSIP-SEVISLEKMQSLSLQENNLSGAIPD 643 (1119)
Q Consensus 570 p~~~--~~l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~ 643 (1119)
|..+ .++++|++|+|++|++++ .++ ..+..+++|++|||++|++++.+| ..+..+++|++|+|++|+|+ .+|.
T Consensus 192 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp HHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCS
T ss_pred HHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhh
Confidence 4444 899999999999999983 222 345678999999999999998775 45667899999999999999 7888
Q ss_pred cccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecc
Q 001226 644 AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712 (1119)
Q Consensus 644 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 712 (1119)
.+. ++|++|+|++|+ |++. |. +..+++|+.|+|++|+|++
T Consensus 271 ~~~--~~L~~L~Ls~N~-------------------------l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 271 GLP--AKLSVLDLSYNR-------------------------LDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SCC--SEEEEEECCSSC-------------------------CCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hcc--CCceEEECCCCC-------------------------CCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 776 777775555554 4433 55 7788889999999998875
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-29 Score=282.04 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=149.3
Q ss_pred EEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccC
Q 001226 436 FLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515 (1119)
Q Consensus 436 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 515 (1119)
.++++.+.+. ..+..++..+++|++|+|++|.+++..|..+..+++|++|+|++|++++..+ +..+++|++|++++|
T Consensus 14 i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred Eeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 4455555554 3333444445556666666666655555555555566666666666554333 555666666666666
Q ss_pred ccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCc
Q 001226 516 LLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPY 595 (1119)
Q Consensus 516 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 595 (1119)
++++.. ..++|+.|++++|++++..+.. +++|++|+|++|++++..|..++++++|++|+|++|++.+..|.
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 655322 2245555555555554433222 34455555555555544444555555555555555555544444
Q ss_pred cc-ccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhcc
Q 001226 596 EL-GKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHH 674 (1119)
Q Consensus 596 ~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 674 (1119)
.+ ..+++|++|+|++|++++. |.. ..+++|+.|+|++|++++ +|..|..+++|+.
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~-~~~-~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~--------------------- 218 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDV-KGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTW--------------------- 218 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEE-ECC-CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSE---------------------
T ss_pred HHhhccCcCCEEECCCCcCccc-ccc-cccccCCEEECCCCcCCc-chhhhcccCcccE---------------------
Confidence 33 2455555555555555432 211 124555555555555553 2233444555544
Q ss_pred ccceeeeccccccCCcccccccccccceeeccCceec-ccCCccccccccceEEecc-cccccccCCC
Q 001226 675 FSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS-GEIPTEVNNMVSLYFVNIS-FNHFSGKLPA 740 (1119)
Q Consensus 675 ~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~~~~l~~l~ls-~N~~~g~~p~ 740 (1119)
|++++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..++.|+.++++ .+.++|..|.
T Consensus 219 ----L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 219 ----ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp ----EECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred ----EECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence 555555555 46777778888888888888887 7788888888888888888 5577777664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=263.79 Aligned_cols=253 Identities=22% Similarity=0.225 Sum_probs=136.2
Q ss_pred ceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCc
Q 001226 460 SRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGN 539 (1119)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 539 (1119)
..++.+++.++. +|..+ .++|+.|++++|++++..+..+.++++|++|++++|.+++..|..|..+++|++|++++|
T Consensus 14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 345555555542 23322 245555555555555444444555555555555555555544555555555555555555
Q ss_pred c-cCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCC
Q 001226 540 L-LQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618 (1119)
Q Consensus 540 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 618 (1119)
+ +....|..+..+++|++|+|++|++++..|..|.++++|++|++++|++.+..+..+..+++|++|+|++|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 4 443334445555555555555555554444445555555555555555543333344455555555555555544333
Q ss_pred hhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCccccccccc
Q 001226 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLD 698 (1119)
Q Consensus 619 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~ 698 (1119)
..+..+++|+.|+|++|++++..|..|..+++|+. |++++|++++..|+.+..++
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-------------------------L~l~~n~l~~~~~~~~~~l~ 225 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT-------------------------LYLFANNLSALPTEALAPLR 225 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE-------------------------EECCSSCCSCCCHHHHTTCT
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccE-------------------------eeCCCCcCCcCCHHHcccCc
Confidence 34444555555555555555444555554444444 55666666655566677888
Q ss_pred ccceeeccCceecccCCccccccccceEEecccccccccCCCc
Q 001226 699 KLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPAS 741 (1119)
Q Consensus 699 ~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p~~ 741 (1119)
+|+.|+|++|+++...+.. .....++.+..+.|.+.+..|..
T Consensus 226 ~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 226 ALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp TCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGG
T ss_pred ccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchH
Confidence 8888888888887654432 12234555667778888877764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.1e-29 Score=278.68 Aligned_cols=255 Identities=19% Similarity=0.183 Sum_probs=123.7
Q ss_pred EEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCcc
Q 001226 364 DLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNH 443 (1119)
Q Consensus 364 ~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 443 (1119)
.++++.+.+.......+..+++|++|+|++|++++..|..|..+++|++|++++|++++..+ +..+++|++|++++|+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~ 91 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence 33444444443333334445556666666666655555555556666666666666554332 5556666666666665
Q ss_pred CcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCc
Q 001226 444 LTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPA 523 (1119)
Q Consensus 444 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 523 (1119)
+++.. ..+.|++|++++|++++..+.. +++|+.|++++|++++..+..++.+++|++|++++|.+++..+.
T Consensus 92 l~~l~------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 162 (317)
T 3o53_A 92 VQELL------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162 (317)
T ss_dssp EEEEE------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred ccccc------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence 55321 1245555555555554433322 23455555555555544444555555555555555555544443
Q ss_pred cc-cCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCC
Q 001226 524 TL-ERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTK 602 (1119)
Q Consensus 524 ~~-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 602 (1119)
.+ ..+++|++|++++|++++. |. ...+++|++|+|++|+|++ +|..+..+++|+.|+|++|+++ .+|..+..+++
T Consensus 163 ~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~ 238 (317)
T 3o53_A 163 ELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238 (317)
T ss_dssp GGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred HHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence 33 2344444444444444432 11 1124445555555555542 2333444445555555555554 34444444445
Q ss_pred CcEEeccCcccc-ccCChhhhhcccCCeeEcc
Q 001226 603 MIKLDLSDNYLA-GSIPSEVISLEKMQSLSLQ 633 (1119)
Q Consensus 603 L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~ 633 (1119)
|+.|+|++|+++ +.+|..+..++.|+.|+++
T Consensus 239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred CCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 555555555444 3444444444444444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-26 Score=282.26 Aligned_cols=268 Identities=27% Similarity=0.358 Sum_probs=140.1
Q ss_pred ccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceecc
Q 001226 385 KLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDL 464 (1119)
Q Consensus 385 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 464 (1119)
+++.|++++|.++ .+|..+. ++|++|++++|+++ .+|. .+++|++|+|++|+|++ +|. .+++|++|++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~L 108 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV----LPPGLLELSI 108 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC----CCTTCCEEEE
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC----CCCCCCEEEC
Confidence 4566666666665 3343333 45666666666665 3443 34556666666665552 222 2344444444
Q ss_pred ccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCC
Q 001226 465 TGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS 544 (1119)
Q Consensus 465 ~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 544 (1119)
++|++++ +|. .+++|+.|++++|++++ +|.. +++|++|++++|++++
T Consensus 109 s~N~l~~-------------------------l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~- 155 (622)
T 3g06_A 109 FSNPLTH-------------------------LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS- 155 (622)
T ss_dssp CSCCCCC-------------------------CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-
T ss_pred cCCcCCC-------------------------CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-
Confidence 4444442 121 23344444444444442 2221 2445555555555543
Q ss_pred CCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhc
Q 001226 545 IPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISL 624 (1119)
Q Consensus 545 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 624 (1119)
+|. .+++|+.|++++|+|++ +| ..+++|+.|+|++|++++ +|.. +++|+.|++++|+++ .+|.. +
T Consensus 156 l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~ 220 (622)
T 3g06_A 156 LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---P 220 (622)
T ss_dssp CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---C
T ss_pred cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---C
Confidence 232 22456666666666653 44 334566666666666663 4432 356666666666665 34432 3
Q ss_pred ccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceee
Q 001226 625 EKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILD 704 (1119)
Q Consensus 625 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 704 (1119)
++|+.|+|++|+|++ +| ..+++|+.|+|++|.++ .+|..+.+ +..|++++|+|+ .+|..++++++|+.|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~~~~~----L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPMLPSG----LLSLSVYRNQLT-RLPESLIHLSSETTVN 290 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCCCCTT----CCEEECCSSCCC-SCCGGGGGSCTTCEEE
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCccccc----CcEEeCCCCCCC-cCCHHHhhccccCEEE
Confidence 556666666666664 44 33455666666666555 34432111 123556666666 5666667777777777
Q ss_pred ccCceecccCCccccccc
Q 001226 705 LSSNSFSGEIPTEVNNMV 722 (1119)
Q Consensus 705 Ls~N~l~g~ip~~~~~~~ 722 (1119)
|++|+|+|.+|..+..+.
T Consensus 291 L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 291 LEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCSCCCCHHHHHHHHHHH
T ss_pred ecCCCCCCcCHHHHHhcc
Confidence 777777776666655543
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=273.48 Aligned_cols=229 Identities=22% Similarity=0.178 Sum_probs=152.7
Q ss_pred CcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeee
Q 001226 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGF 175 (1119)
Q Consensus 96 ~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 175 (1119)
+++++|+|++|++++..|..|+++++|++|+|++|+|++..|..+.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 57778888888877777777777888888888888777776777777777777777777777555555666666666666
Q ss_pred cccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCcc
Q 001226 176 HNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI 255 (1119)
Q Consensus 176 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~ 255 (1119)
++|.++...+..|.++++|++|++++| +..+.+
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~-----------------------------------------------~~l~~i 187 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGEL-----------------------------------------------KKLEYI 187 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCC-----------------------------------------------TTCCEE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCC-----------------------------------------------CCcccc
Confidence 666666555555555666666655553 222233
Q ss_pred ChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCC
Q 001226 256 SPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNL 335 (1119)
Q Consensus 256 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 335 (1119)
+...|.++++|++|+|++|++++. | .+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++
T Consensus 188 ~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 265 (452)
T 3zyi_A 188 SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL 265 (452)
T ss_dssp CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC
Confidence 444555666666666666666643 3 35666677777777777776666666667777777777776666666666666
Q ss_pred CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCc
Q 001226 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIG 373 (1119)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~ 373 (1119)
++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 266 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 266 ASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 77777777777666555556666666666666666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=271.99 Aligned_cols=245 Identities=23% Similarity=0.169 Sum_probs=160.1
Q ss_pred EecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccC
Q 001226 74 LNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGY 153 (1119)
Q Consensus 74 l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~ 153 (1119)
+++++.+++.++... .+++++|+|++|++++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++
T Consensus 48 v~c~~~~l~~iP~~~------~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 48 VICVRKNLREVPDGI------STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp EECCSCCCSSCCSCC------CTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred EEeCCCCcCcCCCCC------CCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 344445565544321 25777888888888777777788888888888888888776667777778888888887
Q ss_pred ccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccc
Q 001226 154 NSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPT 233 (1119)
Q Consensus 154 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~ 233 (1119)
|++++..+..|..+++|++|+|++|.++...+..|..+++|++|++++|+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~------------------------------ 171 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK------------------------------ 171 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT------------------------------
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC------------------------------
Confidence 77775555566666666666666666665555556666666666665532
Q ss_pred cccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCC
Q 001226 234 SLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQ 313 (1119)
Q Consensus 234 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 313 (1119)
..+.+.+..|.++++|++|+|++|+++. +| .+..+++|++|+|++|++++..+..|..+++
T Consensus 172 -----------------~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 232 (440)
T 3zyj_A 172 -----------------RLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232 (440)
T ss_dssp -----------------TCCEECTTTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTT
T ss_pred -----------------CcceeCcchhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCcc
Confidence 2223334455556666666666666663 33 3566667777777777776666666666666
Q ss_pred CcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCc
Q 001226 314 LQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIG 373 (1119)
Q Consensus 314 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~ 373 (1119)
|++|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus 233 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp CCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 666666666666666666666666666777666666555556666666666666666654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=272.89 Aligned_cols=247 Identities=22% Similarity=0.197 Sum_probs=158.6
Q ss_pred cEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCc
Q 001226 315 QVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNN 394 (1119)
Q Consensus 315 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N 394 (1119)
..++.+++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34444444444 3443332 45666666666666555666666666666666666666555566666666666666666
Q ss_pred cccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccC
Q 001226 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIP 474 (1119)
Q Consensus 395 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 474 (1119)
++++..+..|..+++|++|+|++|+++...+..|.++++|+.|++++|...+.++...+..+
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l------------------ 195 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGL------------------ 195 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC------------------
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCC------------------
Confidence 66655555566666666666666666655555566666666666666433333333333333
Q ss_pred CccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCcccccccc
Q 001226 475 ANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554 (1119)
Q Consensus 475 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 554 (1119)
++|+.|+|++|++++ +| .+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..|..|..+++
T Consensus 196 ------~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 267 (452)
T 3zyi_A 196 ------FNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267 (452)
T ss_dssp ------TTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred ------CCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence 444444444444442 22 3556667777777777777777777777777777777777777777777888888
Q ss_pred ceEEeccCCcccCCCCCccCCcccccEEEcccCccc
Q 001226 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590 (1119)
Q Consensus 555 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 590 (1119)
|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 888888888888777777888888999999998886
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.4e-26 Score=277.87 Aligned_cols=128 Identities=28% Similarity=0.360 Sum_probs=80.4
Q ss_pred CCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEec
Q 001226 529 PGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDL 608 (1119)
Q Consensus 529 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 608 (1119)
++|+.|++++|++++ +|.. +++|+.|++++|.++ .+|.. +++|+.|+|++|++++ +| ..+++|+.|+|
T Consensus 181 ~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~L 248 (622)
T 3g06_A 181 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMV 248 (622)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEEC
T ss_pred CCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEEC
Confidence 444444444444443 3322 245666666666666 34432 3567777777777763 55 34566777777
Q ss_pred cCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhc
Q 001226 609 SDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLH 673 (1119)
Q Consensus 609 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 673 (1119)
++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|++++.+|..+..+.
T Consensus 249 s~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 249 SGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 777776 3554 4566777777777777 5677777777777777777777777777666655
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-30 Score=313.75 Aligned_cols=454 Identities=15% Similarity=0.105 Sum_probs=206.7
Q ss_pred CceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccC---CCCc------------ccccCC
Q 001226 56 PCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTG---SIPK------------QLGNCG 120 (1119)
Q Consensus 56 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~---~~~~------------~l~~l~ 120 (1119)
|++|.++... ....++++++. +..+ ...+..+++|++|+|+++.... ..|. ....++
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~--~~~~--~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~ 105 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCY--AVSP--ATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYT 105 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTT--SSCH--HHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCT
T ss_pred HHHHHHhhhh----hceEEeecccc--ccCH--HHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCC
Confidence 6679988322 23455665542 2222 1335567888888888875321 1111 123455
Q ss_pred CccEEEcccccccccCCcccc-ccCccCEEEccCc-cccCC-CCcccccccccceeeecccccccccCccCCCcccccEE
Q 001226 121 QLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYN-SLSGK-IPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSL 197 (1119)
Q Consensus 121 ~L~~L~L~~n~i~~~~p~~l~-~l~~L~~L~Ls~n-~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 197 (1119)
+|++|+|++|.+++..+..+. .+++|++|+|++| .+++. ++..+.++++|++|++++|.+++..+..+.
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~-------- 177 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLS-------- 177 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGG--------
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHH--------
Confidence 666666666666655555554 4566666666665 33322 112222444444444444444433222222
Q ss_pred EeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCc--cCCccChhhhhcCCCccEEEcCCC-
Q 001226 198 YLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNN--FGGAISPWIFKGLLQLEVLYLDDN- 274 (1119)
Q Consensus 198 ~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~--i~~~~~~~~~~~l~~L~~L~L~~n- 274 (1119)
.....+++|++|++++|. ++.......+..+++|++|++++|
T Consensus 178 -----------------------------------~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~ 222 (594)
T 2p1m_B 178 -----------------------------------HFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222 (594)
T ss_dssp -----------------------------------GSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTS
T ss_pred -----------------------------------HHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCC
Confidence 222344455555555554 111111222233466666666666
Q ss_pred ccCCCcchhhcCCCCCceeeecc-------ccccccCcccccCCCCCcEE-EccccccccccCcccCCCCCCCeEEccCC
Q 001226 275 NLEGQIPETLWGLENLQKLVLSA-------NKLNGTISGQISHCNQLQVI-ALSRNNLVGQIPRSVGNLSSLNSLLLFNN 346 (1119)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~-------N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 346 (1119)
.+++ +|..+..+++|++|+++. |.+.+. +..+.++++|+.| .+.+... +.++..+..+++|++|++++|
T Consensus 223 ~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l-~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~ 299 (594)
T 2p1m_B 223 PLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGL-SVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYA 299 (594)
T ss_dssp CHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHH-HHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTC
T ss_pred cHHH-HHHHHhcCCcceEcccccccCccchhhHHHH-HHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCC
Confidence 3333 555566666666666433 233332 2245566666666 2332221 123333345556666666666
Q ss_pred cccCCCC-CCCCCCCCCcEEEcccCcCcccCchh-hhcccccceeeccC---------ccccCCCCcccc-ccCcceEEE
Q 001226 347 RLQGTLP-PELGNCGSLVDLRLQHNFIGGTIPPE-ICNLAKLEVLYLFN---------NRIEGAIPHQIG-RMSKLVELA 414 (1119)
Q Consensus 347 ~l~~~~~-~~l~~l~~L~~L~L~~N~i~~~~~~~-l~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~ 414 (1119)
.+++... ..+..+++|++|++++| +++..... ...+++|+.|++++ +.+++.....+. .+++|+.|.
T Consensus 300 ~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~ 378 (594)
T 2p1m_B 300 TVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVL 378 (594)
T ss_dssp CCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEE
T ss_pred CCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHH
Confidence 5443211 12345556666666655 33221111 22355566665522 233322111121 244555555
Q ss_pred eecccccccCCcccc-CCCCcCEEEcc--C----ccCccc----chhhhhccCCccceeccccceeeCccCCcccccccc
Q 001226 415 LYNNRLTGRIPPDIT-RLRNLQFLSLA--H----NHLTGE----VALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNL 483 (1119)
Q Consensus 415 L~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L 483 (1119)
++.|.+++..+..+. .+++|+.|+++ + |.+++. ....+...+++ |
T Consensus 379 ~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~------------------------L 434 (594)
T 2p1m_B 379 YFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKD------------------------L 434 (594)
T ss_dssp EEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTT------------------------C
T ss_pred HhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCC------------------------c
Confidence 555555443333332 24455555554 2 333311 01111223344 4
Q ss_pred ceeeccCccccCCCCccccc-cccccEEEeccCccccCCCccc-cCCCCcceeeccCcccCCCCCc-cccccccceEEec
Q 001226 484 FVLVLGNNRFNGSFPIEIGK-CSSLRRVILSNNLLQGSLPATL-ERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTMLDF 560 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~L 560 (1119)
+.|++++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++..+. ....+++|++|++
T Consensus 435 ~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l 513 (594)
T 2p1m_B 435 RRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513 (594)
T ss_dssp CEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEE
T ss_pred cEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEee
Confidence 4444433 333322233332 4455555555555443322222 3455555555555555322221 2334566777777
Q ss_pred cCCcccCCCCCcc-CCcccccEEEcccCcc
Q 001226 561 SENRLSGSIPSEL-GNLENLQILRLSANKL 589 (1119)
Q Consensus 561 s~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l 589 (1119)
++|+++..-...+ ..+++|+...+..+.-
T Consensus 514 ~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~ 543 (594)
T 2p1m_B 514 SSCSVSFGACKLLGQKMPKLNVEVIDERGA 543 (594)
T ss_dssp ESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred eCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence 7776643222223 3455666666555543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-26 Score=270.00 Aligned_cols=248 Identities=22% Similarity=0.204 Sum_probs=175.9
Q ss_pred CcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccC
Q 001226 314 LQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN 393 (1119)
Q Consensus 314 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~ 393 (1119)
.+.++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 345555555555 4554443 5677777777777766667777777777777777777766666777777777777777
Q ss_pred ccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCcc
Q 001226 394 NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPI 473 (1119)
Q Consensus 394 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1119)
|+++...+..|..+++|++|+|++|+++...+..|.++++|+.|+|++|...+.++...+..+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l----------------- 184 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL----------------- 184 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTC-----------------
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcc-----------------
Confidence 777766666677777777777777777766666677777777777777543334443333334
Q ss_pred CCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccc
Q 001226 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWS 553 (1119)
Q Consensus 474 p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 553 (1119)
++|+.|+|++|+++ .+| .+..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..|..++
T Consensus 185 -------~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 255 (440)
T 3zyj_A 185 -------SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ 255 (440)
T ss_dssp -------SSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT
T ss_pred -------cccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC
Confidence 44444444444444 233 356677777777777777777777788888888888888888877777888888
Q ss_pred cceEEeccCCcccCCCCCccCCcccccEEEcccCccc
Q 001226 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590 (1119)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 590 (1119)
+|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 256 SLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred CCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 8999999999998777778888999999999999886
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-27 Score=282.54 Aligned_cols=234 Identities=22% Similarity=0.199 Sum_probs=128.5
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
+|+.|+|++|.+++..|..|+.+++|+.|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|++|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 44444444444444444445555555555555555544333 4455555555555555543211 2455556666
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhh-hcccCCeeEccCccCccC
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI-SLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~ 640 (1119)
+|+|++..+.. +++|+.|+|++|++++..|..++.+++|+.|+|++|++++.+|..+. .+++|+.|+|++|.|++.
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 66555443332 34556666666666555555555566666666666666655555554 455666666666666544
Q ss_pred CCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceec-ccCCcccc
Q 001226 641 IPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS-GEIPTEVN 719 (1119)
Q Consensus 641 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~ 719 (1119)
.+ +..+++|+.|+|++|.+++ +|..+..++.+ ..|++++|+|++ +|..++.+++|+.|++++|+++ +.+|..+.
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L-~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGV-TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTC-SEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred cc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCc-cEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 22 2235555555555555553 22234444333 235566666663 5666777777777777777776 66777777
Q ss_pred ccccceEEecc
Q 001226 720 NMVSLYFVNIS 730 (1119)
Q Consensus 720 ~~~~l~~l~ls 730 (1119)
.++.|..++++
T Consensus 260 ~l~~L~~l~~~ 270 (487)
T 3oja_A 260 KNQRVQTVAKQ 270 (487)
T ss_dssp TCHHHHHHHHH
T ss_pred hCCCCcEEecc
Confidence 77777776665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-29 Score=306.79 Aligned_cols=300 Identities=15% Similarity=0.143 Sum_probs=184.1
Q ss_pred cccCCCCCcEEEccCCccCCccC--------------hhhhhcCCCccEEEcCCCccCCCcchhhc-CCCCCceeeeccc
Q 001226 234 SLSNCRNLVEFSASSNNFGGAIS--------------PWIFKGLLQLEVLYLDDNNLEGQIPETLW-GLENLQKLVLSAN 298 (1119)
Q Consensus 234 ~l~~l~~L~~L~l~~n~i~~~~~--------------~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N 298 (1119)
.+..+++|++|+++++.....+. ...+..+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 61 ~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~ 140 (594)
T 2p1m_B 61 VIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140 (594)
T ss_dssp HHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESC
T ss_pred HHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCc
Confidence 35567778888888865322111 23345678888888888888877777775 6888888888888
Q ss_pred -ccccc-CcccccCCCCCcEEEccccccccccCcccC----CCCCCCeEEccCCc--ccCC-CCCCCCCCCCCcEEEccc
Q 001226 299 -KLNGT-ISGQISHCNQLQVIALSRNNLVGQIPRSVG----NLSSLNSLLLFNNR--LQGT-LPPELGNCGSLVDLRLQH 369 (1119)
Q Consensus 299 -~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~~L~~L~L~~N~--l~~~-~~~~l~~l~~L~~L~L~~ 369 (1119)
.++.. .+..+..+++|++|+|++|.+++..+..+. .+++|+.|++++|. ++.. ++..+..+++|++|++++
T Consensus 141 ~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~ 220 (594)
T 2p1m_B 141 EGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR 220 (594)
T ss_dssp EEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred CCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence 55532 344455788888888888887765444443 56688888888886 2211 111123468888888888
Q ss_pred C-cCcccCchhhhcccccceeeccCc-------cccCCCCccccccCcceEE-EeecccccccCCccccCCCCcCEEEcc
Q 001226 370 N-FIGGTIPPEICNLAKLEVLYLFNN-------RIEGAIPHQIGRMSKLVEL-ALYNNRLTGRIPPDITRLRNLQFLSLA 440 (1119)
Q Consensus 370 N-~i~~~~~~~l~~l~~L~~L~L~~N-------~l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~L~L~ 440 (1119)
| .++ .++..+..+++|+.|+++.+ .+.+ ++..+.++++|+.| .+.+... +.++..+..+++|+.|+|+
T Consensus 221 ~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~ 297 (594)
T 2p1m_B 221 AVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLS 297 (594)
T ss_dssp TSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECT
T ss_pred CCcHH-HHHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEcc
Confidence 7 344 36677778888888885443 3443 23356777778777 3333322 2344445567788888888
Q ss_pred CccCcccchhhhhccCCccceeccccceeeCccCCcc-ccccccceeecc---------CccccCCCCcccc-ccccccE
Q 001226 441 HNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANI-CVGTNLFVLVLG---------NNRFNGSFPIEIG-KCSSLRR 509 (1119)
Q Consensus 441 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~~~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~ 509 (1119)
+|.+++.....+...+++|++|++++| +++.....+ ..+++|+.|+++ .+.+++.....+. .+++|+.
T Consensus 298 ~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~ 376 (594)
T 2p1m_B 298 YATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLES 376 (594)
T ss_dssp TCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCE
T ss_pred CCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHH
Confidence 888776555555666778888888777 432211112 235667777662 3344432222222 3566666
Q ss_pred EEeccCccccCCCcccc-CCCCcceeecc
Q 001226 510 VILSNNLLQGSLPATLE-RNPGVSFLDVR 537 (1119)
Q Consensus 510 L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~ 537 (1119)
|.++.|.+++..+..+. .+++|+.|+++
T Consensus 377 L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 377 VLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp EEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred HHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 66666666544333332 35555555555
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.1e-27 Score=278.57 Aligned_cols=234 Identities=20% Similarity=0.195 Sum_probs=121.1
Q ss_pred ccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceecc
Q 001226 385 KLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDL 464 (1119)
Q Consensus 385 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 464 (1119)
+|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+ .+.|+.|++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~------~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV------GPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE------CTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC------CCCcCEEEC
Confidence 45555555555555445555555555555555555554332 5555555555555555543211 134444444
Q ss_pred ccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCC
Q 001226 465 TGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS 544 (1119)
Q Consensus 465 ~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 544 (1119)
++|.+++..+.. +++|+.|+|++|.+++..|..+..+++|+.|+|++|++++.
T Consensus 107 ~~N~l~~~~~~~---------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (487)
T 3oja_A 107 ANNNISRVSCSR---------------------------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV 159 (487)
T ss_dssp CSSCCCCEEECC---------------------------CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred cCCcCCCCCccc---------------------------cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCc
Confidence 444444333321 23344444444444444444444444444444444444444
Q ss_pred CCcccc-ccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhh
Q 001226 545 IPPVFG-FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVIS 623 (1119)
Q Consensus 545 ~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 623 (1119)
+|..+. .+++|++|+|++|.|++. |. +..+++|+.|+|++|++++ +|..+..+++|+.|||++|+|++ +|..+..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~ 235 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred ChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhcc
Confidence 444443 455555555555555533 21 2235566666666666654 33335566666666666666653 5555666
Q ss_pred cccCCeeEccCccCc-cCCCccccccccccEeecC
Q 001226 624 LEKMQSLSLQENNLS-GAIPDAFSSVQSLFELQLG 657 (1119)
Q Consensus 624 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~ 657 (1119)
+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus 236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 666666666666665 5556666666666666664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=241.57 Aligned_cols=145 Identities=27% Similarity=0.273 Sum_probs=82.3
Q ss_pred CCCceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEccccccc
Q 001226 54 SAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQ 133 (1119)
Q Consensus 54 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~ 133 (1119)
.++|.|.|+.|.- .+.++.+++++.+++.++.. + .+++++|+|++|.+++..+..|+++++|++|+|++|+++
T Consensus 2 ~~~C~~~~~~C~c-~~~~~~l~~~~~~l~~ip~~-~-----~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 74 (270)
T 2o6q_A 2 EALCKKDGGVCSC-NNNKNSVDCSSKKLTAIPSN-I-----PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74 (270)
T ss_dssp CCCBGGGTCSBEE-ETTTTEEECTTSCCSSCCSC-C-----CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS
T ss_pred CccCCCCCCCCEe-CCCCCEEEccCCCCCccCCC-C-----CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC
Confidence 3689999999973 33456677777777654321 1 145666666666666555556666666666666666666
Q ss_pred ccCCccccccCccCEEEccCccccCCCCcccccccccceeeecccccccccCccCCCcccccEEEecccccc
Q 001226 134 GSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLT 205 (1119)
Q Consensus 134 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 205 (1119)
...+..+..+++|++|+|++|.+++..+..+..+++|++|++++|.+++..+..|+.+++|++|++++|+++
T Consensus 75 ~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 146 (270)
T 2o6q_A 75 TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146 (270)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC
Confidence 433334455666666666666665444444444444444444444444444444444444444444444433
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.3e-25 Score=241.71 Aligned_cols=229 Identities=18% Similarity=0.203 Sum_probs=154.7
Q ss_pred eccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCccc
Q 001226 487 VLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLS 566 (1119)
Q Consensus 487 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 566 (1119)
+..+..++ .+|..+. ++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+++
T Consensus 13 ~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 89 (276)
T 2z62_A 13 QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89 (276)
T ss_dssp ECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred EecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccC
Confidence 33344444 3444433 35777777777777666666667777777777777776655566777777777777777777
Q ss_pred CCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccccc-CChhhhhcccCCeeEccCccCccCCCccc
Q 001226 567 GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS-IPSEVISLEKMQSLSLQENNLSGAIPDAF 645 (1119)
Q Consensus 567 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 645 (1119)
+..|..|.++++|++|++++|++.+..+..+..+++|++|+|++|++++. +|..+..+++|++|+|++|++++..+..|
T Consensus 90 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 169 (276)
T 2z62_A 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169 (276)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred ccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence 66667777777777777777777765555677777777777777777653 47777777777777777777776666666
Q ss_pred cccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccccccce
Q 001226 646 SSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLY 725 (1119)
Q Consensus 646 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~ 725 (1119)
..+++|+.|++ .|++++|++++..+..+ ...+|+.|+|++|+|++..|..+..+++|+
T Consensus 170 ~~l~~L~~l~l---------------------~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 227 (276)
T 2z62_A 170 RVLHQMPLLNL---------------------SLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQ 227 (276)
T ss_dssp HHHHTCTTCCE---------------------EEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCC
T ss_pred hhhhhccccce---------------------eeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhccccccc
Confidence 66666653221 26666666664434333 344788888888888855555567788888
Q ss_pred EEecccccccccCCC
Q 001226 726 FVNISFNHFSGKLPA 740 (1119)
Q Consensus 726 ~l~ls~N~~~g~~p~ 740 (1119)
.+++++|++++..|.
T Consensus 228 ~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 228 KIWLHTNPWDCSCPR 242 (276)
T ss_dssp EEECCSSCBCCCTTT
T ss_pred EEEccCCcccccCCc
Confidence 888888888887764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.8e-27 Score=281.37 Aligned_cols=181 Identities=18% Similarity=0.153 Sum_probs=129.8
Q ss_pred eeecCCccEEEEEeCCCceEEEEEecccc--------------cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEEE
Q 001226 842 IGKGKHGTVYRTLSNNSRKHWAVKKLNRS--------------ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 842 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--------------~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+.|++|.+..++....|+.||+|++... ..++.+|+++|+++ .|+||+++++++++++..|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56667777776666666889999998532 13588999999999 6999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++|++|.+++.+.++ ++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999987653 5543 5899999999999999 9999999999999999999999999999876542
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p 1034 (1119)
. ......+||+.|+|||.+.+ .+..++|+||+|++.+++.++..|
T Consensus 393 ~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 23345689999999998765 567889999999998887665443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=243.52 Aligned_cols=225 Identities=23% Similarity=0.282 Sum_probs=146.3
Q ss_pred cceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccC
Q 001226 483 LFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562 (1119)
Q Consensus 483 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (1119)
+..+++..+.+.+. .....+++|+.|++++|.+... ..+..+++|++|++++|++++ + ..+..+++|++|+|++
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTT
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCC
Confidence 33444444444432 2244566666666666666532 235566666666666666654 2 3566667777777777
Q ss_pred CcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCC
Q 001226 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIP 642 (1119)
Q Consensus 563 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 642 (1119)
|++++..+..|+++++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..|
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 77776666666777777777777777776555566777777777777777776555556667777777777777776666
Q ss_pred ccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccccc
Q 001226 643 DAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMV 722 (1119)
Q Consensus 643 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~ 722 (1119)
..|+.+++|+.|+|+ +|++++..|..++.+++|+.|+|++|+++|..|
T Consensus 175 ~~~~~l~~L~~L~L~-------------------------~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------- 222 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLY-------------------------QNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------- 222 (272)
T ss_dssp TTTTTCTTCCEEECC-------------------------SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-------
T ss_pred HHhcCCccCCEEECC-------------------------CCcCCccCHHHHhCCcCCCEEEccCCCccccCc-------
Confidence 666777766664444 444444555667777888888888888876544
Q ss_pred cceEEecccccccccCCCccccc
Q 001226 723 SLYFVNISFNHFSGKLPASWTTL 745 (1119)
Q Consensus 723 ~l~~l~ls~N~~~g~~p~~~~~~ 745 (1119)
.|++++++.|.++|.+|..++..
T Consensus 223 ~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 223 GIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp TTHHHHHHHHHTGGGBBCTTSCB
T ss_pred HHHHHHHHHHhCCCcccCccccc
Confidence 46777888888888888765544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=239.09 Aligned_cols=209 Identities=24% Similarity=0.214 Sum_probs=174.4
Q ss_pred cccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEec
Q 001226 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDF 560 (1119)
Q Consensus 481 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 560 (1119)
.+|++|++++|++++..+..+.++++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46788888888888766668888888999999999888877788888999999999999998877788999999999999
Q ss_pred cCCcccCCCCCccCCcccccEEEcccCcccCc-CCcccccCCCCcEEeccCccccccCChhhhhcccCC----eeEccCc
Q 001226 561 SENRLSGSIPSELGNLENLQILRLSANKLDGR-IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQ----SLSLQEN 635 (1119)
Q Consensus 561 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N 635 (1119)
++|++++..+..++++++|++|++++|++.+. +|..+..+++|++|+|++|++++..+..+..+.+|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99999977777899999999999999999863 689999999999999999999988788888888888 8899999
Q ss_pred cCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCC
Q 001226 636 NLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIP 715 (1119)
Q Consensus 636 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip 715 (1119)
++++..+..+.. .+|++|+ +++|++++..+..|+.+++|+.|+|++|++++..|
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~-------------------------L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELA-------------------------LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEE-------------------------CCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccCC-CcccEEE-------------------------CCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 998766555544 3666655 45555554555567889999999999999997654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-25 Score=240.85 Aligned_cols=229 Identities=23% Similarity=0.245 Sum_probs=184.1
Q ss_pred CccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeec
Q 001226 457 PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDV 536 (1119)
Q Consensus 457 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 536 (1119)
..+..+++.++.+.+.. ....+++|+.|++++|.++. + ..+..+++|++|++++|.+++. ..+..+++|++|++
T Consensus 19 ~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence 34555666666554432 34566778888888888773 3 3578889999999999998863 47888999999999
Q ss_pred cCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccccc
Q 001226 537 RGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS 616 (1119)
Q Consensus 537 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 616 (1119)
++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|+.|+|++|++++.
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 172 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL 172 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCcc
Confidence 99999987777889999999999999999987778899999999999999999977777789999999999999999987
Q ss_pred CChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCccccccc
Q 001226 617 IPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGN 696 (1119)
Q Consensus 617 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~ 696 (1119)
.|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|.+.+..
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~------------------------------- 221 (272)
T 3rfs_A 173 PEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC------------------------------- 221 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT-------------------------------
T ss_pred CHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC-------------------------------
Confidence 7777889999999999999999988888999999999888777665432
Q ss_pred ccccceeeccCceecccCCcccccccc
Q 001226 697 LDKLQILDLSSNSFSGEIPTEVNNMVS 723 (1119)
Q Consensus 697 l~~L~~L~Ls~N~l~g~ip~~~~~~~~ 723 (1119)
++|+.|+++.|+++|.+|.+++.+..
T Consensus 222 -~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 222 -PGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp -TTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred -cHHHHHHHHHHhCCCcccCcccccCC
Confidence 34566666667777777766665543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-23 Score=228.11 Aligned_cols=203 Identities=26% Similarity=0.279 Sum_probs=153.7
Q ss_pred cceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccC
Q 001226 459 LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRG 538 (1119)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 538 (1119)
.+.+++++|.++ .+|..+. ++++.|++++|++++..+..+.++++|++|++++|.++...+..|..+++|++|++++
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 344555555554 2343332 4677777777777766566777788888888888888766666677788888888888
Q ss_pred cccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCC
Q 001226 539 NLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618 (1119)
Q Consensus 539 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 618 (1119)
|++++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++.+..+..|..+++|++|+|++|++++..|
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 174 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPE 174 (270)
T ss_dssp SCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeCh
Confidence 88887666677788888888888888887777778888888888888888886555667888888888888888887666
Q ss_pred hhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCC
Q 001226 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664 (1119)
Q Consensus 619 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 664 (1119)
..+..+++|++|+|++|++++..+..|..+++|+.|+|++|++...
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred hHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 6778888888888888888877777788888888888888887643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=231.31 Aligned_cols=177 Identities=25% Similarity=0.273 Sum_probs=79.6
Q ss_pred CcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEecc
Q 001226 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLS 609 (1119)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 609 (1119)
+++.|++++|++++..|..|..+++|++|+|++|+|++. |.. +.+++|++|+|++|++. .+|..+..+++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 334444444444333333444444444444444444422 111 34444444444444444 344444444444444444
Q ss_pred CccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCC
Q 001226 610 DNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGK 689 (1119)
Q Consensus 610 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~ 689 (1119)
+|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++ ++.
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------~~l 163 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL-------------------------TEL 163 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC-------------------------SCC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC-------------------------Ccc
Confidence 4444443334444444444555555544444444444444444433333333 322
Q ss_pred cccccccccccceeeccCceecccCCccccccccceEEeccccccc
Q 001226 690 IPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735 (1119)
Q Consensus 690 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~ 735 (1119)
.+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.+++++|++.
T Consensus 164 ~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 2233344455555555555554 44555555555555555555544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=229.84 Aligned_cols=153 Identities=27% Similarity=0.236 Sum_probs=82.3
Q ss_pred cccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcc
Q 001226 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLS 585 (1119)
Q Consensus 506 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 585 (1119)
+++.|+|++|.+++..|..|..+++|++|++++|++++..+ . +.+++|++|+|++|+|+ .+|..+.++++|++|+|+
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 44444555554444444444455555555555555443222 1 44555566666666555 455555556666666666
Q ss_pred cCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCccc
Q 001226 586 ANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIF 661 (1119)
Q Consensus 586 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 661 (1119)
+|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcC
Confidence 6666544445555666666666666666554444455556666666666666654444555555555544444443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-25 Score=255.05 Aligned_cols=260 Identities=17% Similarity=0.146 Sum_probs=123.6
Q ss_pred EEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCc----hhhhccc-ccceeeccCccccCCCCcccccc-----Ccc
Q 001226 341 LLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIP----PEICNLA-KLEVLYLFNNRIEGAIPHQIGRM-----SKL 410 (1119)
Q Consensus 341 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~----~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L 410 (1119)
+.++.|.+++.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4455555555555444444455566666555554444 4444555 55555555555555544444443 555
Q ss_pred eEEEeecccccccCCccc----cCC-CCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCcccc-ccccc
Q 001226 411 VELALYNNRLTGRIPPDI----TRL-RNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICV-GTNLF 484 (1119)
Q Consensus 411 ~~L~L~~N~l~~~~~~~~----~~l-~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~~L~ 484 (1119)
++|+|++|++++..+..+ ..+ ++|+.|+|++|++++..+..+... +.. .++|+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~---------------------l~~~~~~L~ 141 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQA---------------------FSNLPASIT 141 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH---------------------HTTSCTTCC
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHH---------------------HHhCCCcee
Confidence 555555555554433322 222 455555555555543333222211 001 13444
Q ss_pred eeeccCccccCCCC----ccccccc-cccEEEeccCccccCCCcccc----CC-CCcceeeccCcccCCC----CCcccc
Q 001226 485 VLVLGNNRFNGSFP----IEIGKCS-SLRRVILSNNLLQGSLPATLE----RN-PGVSFLDVRGNLLQGS----IPPVFG 550 (1119)
Q Consensus 485 ~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~l~~N~l~~~----~p~~~~ 550 (1119)
+|+|++|++++..+ ..+..++ +|++|+|++|++++..+..+. .. ++|+.|||++|++++. ++..+.
T Consensus 142 ~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred EEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 44444444443222 2222333 555555555555544433222 22 3555555555555431 233333
Q ss_pred c-cccceEEeccCCcccCCCC----CccCCcccccEEEcccCcccCc-------CCcccccCCCCcEEeccCccccccCC
Q 001226 551 F-WSNLTMLDFSENRLSGSIP----SELGNLENLQILRLSANKLDGR-------IPYELGKCTKMIKLDLSDNYLAGSIP 618 (1119)
Q Consensus 551 ~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p 618 (1119)
. .++|++|||++|++++..+ ..+..+++|+.|+|++|++.+. ++..+..+++|+.|||++|++.+..|
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3 2356666666666654322 2334556666666666664321 22344555666666666666655444
Q ss_pred hhh
Q 001226 619 SEV 621 (1119)
Q Consensus 619 ~~~ 621 (1119)
..+
T Consensus 302 ~~~ 304 (362)
T 3goz_A 302 IPI 304 (362)
T ss_dssp HHH
T ss_pred HHH
Confidence 333
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=247.55 Aligned_cols=236 Identities=15% Similarity=0.136 Sum_probs=138.7
Q ss_pred CceeeeeeeecCCCceEEEecCCCcccccCccchhhhccC--CcccEEEcCCCcccCCCCcccccCCCccEEEccccccc
Q 001226 56 PCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKN--QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQ 133 (1119)
Q Consensus 56 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l--~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~ 133 (1119)
|.+|.++.|+. ..++.++++++.+.. ..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.++
T Consensus 36 c~~W~~~~~~~--~~~~~l~l~~~~~~~------~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 36 CKRWYRLASDE--SLWQTLDLTGKNLHP------DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp CHHHHHHHTCS--TTSSEEECTTCBCCH------HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEEC
T ss_pred HHHHHHHhcCc--hhheeeccccccCCH------HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcC
Confidence 66899998864 357788888776652 123344 6778888888887765554 556777888888887777
Q ss_pred cc-CCccccccCccCEEEccCccccCCCCcccccccccceeeeccc-ccccc-cCccCCCcccccEEEeccc-cccccCC
Q 001226 134 GS-IPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN-FLNGE-LPNDICSLPKLKSLYLNTN-NLTGLLP 209 (1119)
Q Consensus 134 ~~-~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~n-~l~~~~~ 209 (1119)
+. +|..+..+++|++|+|++|.+++..|..++.+++|++|++++| .+++. .+..+..+++|++|++++| ++++.
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-- 184 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-- 184 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH--
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH--
Confidence 65 6667777777777777777777666666666666777766666 45542 4444555666666666666 55421
Q ss_pred CCCccccceeeeeeccccccCccccccCCC-CCcEEEccCC--ccCCccChhhhhcCCCccEEEcCCCc-cCCCcchhhc
Q 001226 210 EFPNSCAILHLLIHENDFVGSLPTSLSNCR-NLVEFSASSN--NFGGAISPWIFKGLLQLEVLYLDDNN-LEGQIPETLW 285 (1119)
Q Consensus 210 ~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~-~L~~L~l~~n--~i~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~p~~l~ 285 (1119)
.++..+.+++ +|++|++++| .+++...+..+..+++|++|++++|. +++..+..+.
T Consensus 185 --------------------~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~ 244 (336)
T 2ast_B 185 --------------------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 244 (336)
T ss_dssp --------------------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred --------------------HHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh
Confidence 1233444555 5555555555 33322223344455555555555555 4444444555
Q ss_pred CCCCCceeeecccc-ccccCcccccCCCCCcEEEcccc
Q 001226 286 GLENLQKLVLSANK-LNGTISGQISHCNQLQVIALSRN 322 (1119)
Q Consensus 286 ~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~N 322 (1119)
.+++|++|++++|. +.......+..+++|++|++++|
T Consensus 245 ~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 245 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp GCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 55555555555552 22111123444444444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-24 Score=248.96 Aligned_cols=258 Identities=20% Similarity=0.183 Sum_probs=128.1
Q ss_pred eccccceeeCccCCccccccccceeeccCccccCCCC----ccccccc-cccEEEeccCccccCCCccccCC-----CCc
Q 001226 462 LDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFP----IEIGKCS-SLRRVILSNNLLQGSLPATLERN-----PGV 531 (1119)
Q Consensus 462 L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~L 531 (1119)
++++.|.+++.+|..+....+|++|+|++|++++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4556666666666555555556666666666654444 4445555 56666666666655544444443 555
Q ss_pred ceeeccCcccCCCCCcccccc-----ccceEEeccCCcccCCCCCccCC-----cccccEEEcccCcccCcC----Cccc
Q 001226 532 SFLDVRGNLLQGSIPPVFGFW-----SNLTMLDFSENRLSGSIPSELGN-----LENLQILRLSANKLDGRI----PYEL 597 (1119)
Q Consensus 532 ~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~~~----p~~~ 597 (1119)
++|++++|++++..+..+... ++|++|+|++|+|++..+..+.. .++|++|+|++|++.+.. +..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 555555555554443322222 45555555555554433333221 134555555555554221 1222
Q ss_pred ccCC-CCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcccccc-ccccEeecCCcccCCC----ccccchh
Q 001226 598 GKCT-KMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSV-QSLFELQLGSNIFDGS----IPCSLSK 671 (1119)
Q Consensus 598 ~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~ 671 (1119)
..++ +|++|+|++|++++..+..+... +..+ ++|++|+|++|.+++. ++..+..
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKF--------------------LASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHH--------------------HHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 2332 45555555555544444333322 1111 3444444444444431 2222322
Q ss_pred hccccceeeeccccccCCcc----cccccccccceeeccCceecc-------cCCccccccccceEEecccccccccCC
Q 001226 672 LHHFSSILNVSNNKLSGKIP----ECLGNLDKLQILDLSSNSFSG-------EIPTEVNNMVSLYFVNISFNHFSGKLP 739 (1119)
Q Consensus 672 l~~~~~~L~ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~g-------~ip~~~~~~~~l~~l~ls~N~~~g~~p 739 (1119)
...-++.|++++|++++..+ ..+..+++|+.|+|++|++++ .++..+..+++|+.+|+++|++.+..|
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 22223345555555554333 234556777777887777442 233345667778888888887776644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=233.90 Aligned_cols=224 Identities=18% Similarity=0.203 Sum_probs=161.0
Q ss_pred CcCEEEccCccCcccchhhhh--ccCCccceeccccceeeCccCCcc--ccccccceeeccCccccCCCC----cccccc
Q 001226 433 NLQFLSLAHNHLTGEVALELG--KHFPYLSRLDLTGNSFYGPIPANI--CVGTNLFVLVLGNNRFNGSFP----IEIGKC 504 (1119)
Q Consensus 433 ~L~~L~L~~N~l~~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~--~~~~~L~~L~L~~N~l~~~~p----~~~~~l 504 (1119)
.++.+.+.++.++......+. ..++.|++|++++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 456666766666532222111 124568888888888887777777 777888888888888876555 344567
Q ss_pred ccccEEEeccCccccCCCccccCCCCcceeeccCcccCCC--C--CccccccccceEEeccCCcccCCCCC----ccCCc
Q 001226 505 SSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS--I--PPVFGFWSNLTMLDFSENRLSGSIPS----ELGNL 576 (1119)
Q Consensus 505 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l 576 (1119)
++|++|+|++|++.+..|..+..+++|++|++++|++.+. + +..++.+++|++|+|++|+++ .+|. .++++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 8888888888888877778888888888888888887642 2 223467778888888888886 3333 24677
Q ss_pred ccccEEEcccCcccCcCCcccccC---CCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccE
Q 001226 577 ENLQILRLSANKLDGRIPYELGKC---TKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFE 653 (1119)
Q Consensus 577 ~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 653 (1119)
++|++|+|++|++.+..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 888888888888887767777666 58888888888887 5676664 6888888888888853 43 677788888
Q ss_pred eecCCcccC
Q 001226 654 LQLGSNIFD 662 (1119)
Q Consensus 654 L~L~~N~l~ 662 (1119)
|+|++|+++
T Consensus 299 L~L~~N~l~ 307 (310)
T 4glp_A 299 LTLDGNPFL 307 (310)
T ss_dssp EECSSTTTS
T ss_pred EECcCCCCC
Confidence 787777775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.7e-25 Score=255.17 Aligned_cols=240 Identities=19% Similarity=0.252 Sum_probs=144.8
Q ss_pred ccccccccccEEEeccCccccCCC----ccccCCCCcceeeccCc---ccCCCCCccc-------cccccceEEeccCCc
Q 001226 499 IEIGKCSSLRRVILSNNLLQGSLP----ATLERNPGVSFLDVRGN---LLQGSIPPVF-------GFWSNLTMLDFSENR 564 (1119)
Q Consensus 499 ~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~l~~N---~l~~~~p~~~-------~~l~~L~~L~Ls~N~ 564 (1119)
..+..+++|+.|+|++|.+.+..+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|+
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~ 105 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 105 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCc
Confidence 334444444444444444443211 22334444444444443 2223333332 455666666666666
Q ss_pred ccC----CCCCccCCcccccEEEcccCcccCcCCcc----cccC---------CCCcEEeccCcccc-ccCC---hhhhh
Q 001226 565 LSG----SIPSELGNLENLQILRLSANKLDGRIPYE----LGKC---------TKMIKLDLSDNYLA-GSIP---SEVIS 623 (1119)
Q Consensus 565 l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l---------~~L~~L~Ls~N~l~-~~~p---~~~~~ 623 (1119)
+++ .+|..+.++++|++|+|++|++.+..+.. +..+ ++|++|+|++|+++ +.+| ..+..
T Consensus 106 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~ 185 (386)
T 2ca6_A 106 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185 (386)
T ss_dssp CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHh
Confidence 654 35555566666666666666664322222 2222 66666666666665 2334 34555
Q ss_pred cccCCeeEccCccCc--c---CCCccccccccccEeecCCcccC----CCccccchhhccccceeeeccccccCC----c
Q 001226 624 LEKMQSLSLQENNLS--G---AIPDAFSSVQSLFELQLGSNIFD----GSIPCSLSKLHHFSSILNVSNNKLSGK----I 690 (1119)
Q Consensus 624 l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~~~~~L~ls~N~l~~~----~ 690 (1119)
+++|++|+|++|+++ | .+|..+..+++|+.|+|++|.++ +.+|..+..++.+. .|+|++|++++. +
T Consensus 186 ~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~-~L~L~~n~i~~~~~~~l 264 (386)
T 2ca6_A 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR-ELGLNDCLLSARGAAAV 264 (386)
T ss_dssp CTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC-EEECTTCCCCHHHHHHH
T ss_pred CCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC-EEECCCCCCchhhHHHH
Confidence 666666666666665 2 34446666666777777776664 45566555555543 477777777655 5
Q ss_pred cccc--ccccccceeeccCceecc----cCCccc-cccccceEEecccccccccCC
Q 001226 691 PECL--GNLDKLQILDLSSNSFSG----EIPTEV-NNMVSLYFVNISFNHFSGKLP 739 (1119)
Q Consensus 691 p~~~--~~l~~L~~L~Ls~N~l~g----~ip~~~-~~~~~l~~l~ls~N~~~g~~p 739 (1119)
|..+ +.+++|+.|+|++|+|++ .+|..+ .++++|+.|++++|++++..|
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 6677 448999999999999998 589888 668999999999999997665
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=232.15 Aligned_cols=201 Identities=20% Similarity=0.219 Sum_probs=140.1
Q ss_pred cccccEEEeccCccccCCCccc--cCCCCcceeeccCcccCCCCC----ccccccccceEEeccCCcccCCCCCccCCcc
Q 001226 504 CSSLRRVILSNNLLQGSLPATL--ERNPGVSFLDVRGNLLQGSIP----PVFGFWSNLTMLDFSENRLSGSIPSELGNLE 577 (1119)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 577 (1119)
+++|++|++++|.+.+..|..+ ..+++|++|++++|++++..+ ..+..+++|++|+|++|++++..|..|++++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 4567777777777777777766 777777777777777776554 3345678888888888888877778888888
Q ss_pred cccEEEcccCcccCc--C--CcccccCCCCcEEeccCccccccCCh----hhhhcccCCeeEccCccCccCCCcccccc-
Q 001226 578 NLQILRLSANKLDGR--I--PYELGKCTKMIKLDLSDNYLAGSIPS----EVISLEKMQSLSLQENNLSGAIPDAFSSV- 648 (1119)
Q Consensus 578 ~L~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~l- 648 (1119)
+|++|+|++|++.+. + +..+..+++|++|+|++|+++. +|. .+..+++|++|+|++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 888888888887642 2 2344678888888888888863 343 24677888888888888888778777776
Q ss_pred --ccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccccccccceE
Q 001226 649 --QSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYF 726 (1119)
Q Consensus 649 --~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~ 726 (1119)
++|++|+|++|+++ .+ |..+. ++|+.|||++|+|++. |. +..+++|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~l-------------------------p~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QV-------------------------PKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCTTCCCEECCSSCCC-SC-------------------------CSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CcCcCCEEECCCCCCC-ch-------------------------hhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 47777666666655 33 43332 4566666666666542 22 345556666
Q ss_pred Eeccccccc
Q 001226 727 VNISFNHFS 735 (1119)
Q Consensus 727 l~ls~N~~~ 735 (1119)
|++++|+++
T Consensus 299 L~L~~N~l~ 307 (310)
T 4glp_A 299 LTLDGNPFL 307 (310)
T ss_dssp EECSSTTTS
T ss_pred EECcCCCCC
Confidence 666666654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=218.36 Aligned_cols=94 Identities=21% Similarity=0.203 Sum_probs=49.0
Q ss_pred CCceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEcccccccc
Q 001226 55 APCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQG 134 (1119)
Q Consensus 55 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~ 134 (1119)
+||.|.|++|.. ..+.+++++.+++..+... .+++++|+|++|.+++..+..++++++|++|+|++|++++
T Consensus 3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~~~p~~~------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 73 (251)
T 3m19_A 3 TCETVTGCTCNE---GKKEVDCQGKSLDSVPSGI------PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT 73 (251)
T ss_dssp -CHHHHSSEEEG---GGTEEECTTCCCSSCCSCC------CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC
T ss_pred cCCCCCceEcCC---CCeEEecCCCCccccCCCC------CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc
Confidence 589999999964 2335666666665443211 1345555555555554444445555555555555555444
Q ss_pred cCCccccccCccCEEEccCcccc
Q 001226 135 SIPPEIFKLKRLSWLDLGYNSLS 157 (1119)
Q Consensus 135 ~~p~~l~~l~~L~~L~Ls~n~l~ 157 (1119)
..|..+..+++|++|+|++|.++
T Consensus 74 ~~~~~~~~l~~L~~L~L~~n~l~ 96 (251)
T 3m19_A 74 LSAGVFDDLTELGTLGLANNQLA 96 (251)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCC
T ss_pred cCHhHhccCCcCCEEECCCCccc
Confidence 44444444444444444444444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-22 Score=217.12 Aligned_cols=180 Identities=24% Similarity=0.247 Sum_probs=147.2
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
+.+.++++++.++ .+|..+. ++|+.|+|++|.+++..+..|..+++|++|++++|++++..|..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 4556666777666 5555554 577888888888887777778888888888888888887777778888888888888
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCC
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 641 (1119)
+|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..+..+++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 88888777778888889999999999988666667788899999999999998766667888889999999999999888
Q ss_pred CccccccccccEeecCCcccCCC
Q 001226 642 PDAFSSVQSLFELQLGSNIFDGS 664 (1119)
Q Consensus 642 p~~~~~l~~L~~L~L~~N~l~~~ 664 (1119)
|..|..+++|+.|+|++|++++.
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTT
T ss_pred HHHHhCCCCCCEEEeeCCceeCC
Confidence 88888999999999999988765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-24 Score=257.34 Aligned_cols=181 Identities=20% Similarity=0.220 Sum_probs=141.7
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEecccc------------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
...++||+|+||.||+|... ++.+++|+.... ...+.+|++++++++||||+++..++..++..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34578999999999999443 678889875321 1236899999999999999966555567777899
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++++|.+++.. +..++.|+++|++|||++ +|+||||||+||+++. .+||+|||+++...
T Consensus 417 VmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999999876 457999999999999999 9999999999999999 99999999998775
Q ss_pred CCCCCC-----cccccccCCCcccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCC
Q 001226 985 DSHSSS-----TRSAIVGSLGYIAPENAYS--TRLTEKSDVYSYGVILFELLFRKMPV 1035 (1119)
Q Consensus 985 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslG~vl~elltg~~p~ 1035 (1119)
...... ......||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 422111 1235679999999998876 56778889999999998888877665
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=226.32 Aligned_cols=173 Identities=23% Similarity=0.368 Sum_probs=104.7
Q ss_pred cccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccce
Q 001226 477 ICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLT 556 (1119)
Q Consensus 477 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 556 (1119)
+..+++|+.|++++|++++..+ +..+++|++|++++|++++. ..+..+++|+.|++++|++++. +. +..+++|+
T Consensus 59 ~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~ 132 (308)
T 1h6u_A 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQ 132 (308)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCC
T ss_pred hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCC
Confidence 4445555555555555553222 55566666666666665542 2455666666666666666542 22 56666677
Q ss_pred EEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCcc
Q 001226 557 MLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENN 636 (1119)
Q Consensus 557 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 636 (1119)
+|+|++|++++..+ +.++++|+.|+|++|++++ ++. +..+++|+.|+|++|++++..| +..+++|++|+|++|+
T Consensus 133 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~ 206 (308)
T 1h6u_A 133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206 (308)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred EEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence 77777776664332 6666677777777777664 333 6666777777777777764322 6666777777777777
Q ss_pred CccCCCccccccccccEeecCCcccCC
Q 001226 637 LSGAIPDAFSSVQSLFELQLGSNIFDG 663 (1119)
Q Consensus 637 l~~~~p~~~~~l~~L~~L~L~~N~l~~ 663 (1119)
+++..| +..+++|+.|+|++|.+++
T Consensus 207 l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 207 ISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCcccc--ccCCCCCCEEEccCCeeec
Confidence 765432 6667777777777776653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-24 Score=251.80 Aligned_cols=277 Identities=19% Similarity=0.188 Sum_probs=157.2
Q ss_pred EEccCccccCCCCcccccccccceeeecccccccccCc----cCCCcccccEEEeccccccccCCCCCccccceeeeeec
Q 001226 149 LDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPN----DICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHE 224 (1119)
Q Consensus 149 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~----~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~ 224 (1119)
..++...+. .++..+..+++|++|+|++|.+++..+. .+..+++|++|+|++|.+..
T Consensus 14 ~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~------------------ 74 (386)
T 2ca6_A 14 DAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGR------------------ 74 (386)
T ss_dssp SSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTS------------------
T ss_pred CCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCc------------------
Confidence 333433433 4556667777777777777777765433 35567777777777764431
Q ss_pred cccccCccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCC----CcchhhcCCCCCceeeeccccc
Q 001226 225 NDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG----QIPETLWGLENLQKLVLSANKL 300 (1119)
Q Consensus 225 n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l 300 (1119)
+.+.+|..+.. ....+..+++|++|+|++|++++ .+|..+..+++|++|+|++|.+
T Consensus 75 --l~~~~~~~~~~------------------l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l 134 (386)
T 2ca6_A 75 --VKDEIPEALRL------------------LLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 134 (386)
T ss_dssp --CGGGSHHHHHH------------------HHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred --cccchhHHHHH------------------HHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCC
Confidence 11122222210 01123344455555555555544 2444555555555555555555
Q ss_pred cccCccccc----CC---------CCCcEEEccccccc-cccC---cccCCCCCCCeEEccCCcccC-----CCCCCCCC
Q 001226 301 NGTISGQIS----HC---------NQLQVIALSRNNLV-GQIP---RSVGNLSSLNSLLLFNNRLQG-----TLPPELGN 358 (1119)
Q Consensus 301 ~~~~~~~~~----~l---------~~L~~L~Ls~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~-----~~~~~l~~ 358 (1119)
++..+..+. .+ ++|++|+|++|+++ +.++ ..+..+++|++|++++|+++. ..+..+..
T Consensus 135 ~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~ 214 (386)
T 2ca6_A 135 GPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY 214 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG
T ss_pred CHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhc
Confidence 433222222 22 56666666666665 2233 345566677777777776652 23336667
Q ss_pred CCCCcEEEcccCcCc----ccCchhhhcccccceeeccCccccCC----CCccc--cccCcceEEEeecccccc----cC
Q 001226 359 CGSLVDLRLQHNFIG----GTIPPEICNLAKLEVLYLFNNRIEGA----IPHQI--GRMSKLVELALYNNRLTG----RI 424 (1119)
Q Consensus 359 l~~L~~L~L~~N~i~----~~~~~~l~~l~~L~~L~L~~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~ 424 (1119)
+++|++|+|++|.++ ..+|..+..+++|+.|+|++|++++. ++..+ +.+++|+.|+|++|++++ .+
T Consensus 215 ~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l 294 (386)
T 2ca6_A 215 CQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 294 (386)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHH
T ss_pred CCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHH
Confidence 777777777777775 45566677777777777777777654 34444 236777777777777765 35
Q ss_pred Cccc-cCCCCcCEEEccCccCcccch--hhhhccCCccceecc
Q 001226 425 PPDI-TRLRNLQFLSLAHNHLTGEVA--LELGKHFPYLSRLDL 464 (1119)
Q Consensus 425 ~~~~-~~l~~L~~L~L~~N~l~~~~~--~~~~~~l~~L~~L~L 464 (1119)
|..+ .++++|++|++++|++++..+ ..+...++.++.+++
T Consensus 295 ~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l 337 (386)
T 2ca6_A 295 KTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGEL 337 (386)
T ss_dssp HHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEE
T ss_pred HHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchh
Confidence 5555 456777777777777776553 444444555544444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=219.29 Aligned_cols=196 Identities=17% Similarity=0.168 Sum_probs=118.3
Q ss_pred CcceeeccCcccCCCCCccccccccceEEeccCCc-ccCCCCCccCCcccccEEEccc-CcccCcCCcccccCCCCcEEe
Q 001226 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENR-LSGSIPSELGNLENLQILRLSA-NKLDGRIPYELGKCTKMIKLD 607 (1119)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~ 607 (1119)
+++.|++++|++++..+..|..+++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 44444444444444334445555555555555554 5444444555555666666655 555544445555566666666
Q ss_pred ccCccccccCChhhhhcccCC---eeEccCc-cCccCCCcccccccccc-EeecCCcccCCCccccchhhccccceeeec
Q 001226 608 LSDNYLAGSIPSEVISLEKMQ---SLSLQEN-NLSGAIPDAFSSVQSLF-ELQLGSNIFDGSIPCSLSKLHHFSSILNVS 682 (1119)
Q Consensus 608 Ls~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls 682 (1119)
+++|++++ +|. +..+++|+ +|++++| ++++..+..|..+++|+ +|++++|.++ .+|...+.... ++.|+++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~-L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK-LDAVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCE-EEEEECT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCC-CCEEEcC
Confidence 66666654 444 55555555 6666666 66655555566666666 6666666665 55554444432 3457777
Q ss_pred ccc-ccCCcccccccc-cccceeeccCceecccCCccccccccceEEecccc
Q 001226 683 NNK-LSGKIPECLGNL-DKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFN 732 (1119)
Q Consensus 683 ~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N 732 (1119)
+|+ +++..+..|..+ ++|+.|||++|+|+ .+|+. .+.+|+.|+++++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTTC
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccCc
Confidence 774 775556778888 89999999999998 56655 6778888888776
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-23 Score=239.72 Aligned_cols=256 Identities=18% Similarity=0.209 Sum_probs=151.9
Q ss_pred cccEEEcCCCcccCCCCcccccC--CCccEEEcccccccccCCccccccCccCEEEccCccccCC-CCccccccccccee
Q 001226 97 HLLSLDLSGNEFTGSIPKQLGNC--GQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGK-IPPQVSLCYSLESI 173 (1119)
Q Consensus 97 ~l~~L~Ls~n~~~~~~~~~l~~l--~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L 173 (1119)
.++.||++++.+. +..+..+ +++++|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3566777766655 4455555 6666777776666654433 45566666666666666543 45555555556666
Q ss_pred eecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCC
Q 001226 174 GFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGG 253 (1119)
Q Consensus 174 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~ 253 (1119)
++++|.+++..+..++.+++|++|++++|. .+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~----------------------------------------------~l~~ 157 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCS----------------------------------------------GFSE 157 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCB----------------------------------------------SCCH
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCC----------------------------------------------CCCH
Confidence 665555555555555555555555555551 2332
Q ss_pred ccChhhhhcCCCccEEEcCCC-ccCCC-cchhhcCCC-CCceeeeccc--ccc-ccCcccccCCCCCcEEEccccc-ccc
Q 001226 254 AISPWIFKGLLQLEVLYLDDN-NLEGQ-IPETLWGLE-NLQKLVLSAN--KLN-GTISGQISHCNQLQVIALSRNN-LVG 326 (1119)
Q Consensus 254 ~~~~~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~l~-~L~~L~Ls~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~ 326 (1119)
...+..+.++++|++|++++| .+++. ++..+..++ +|++|++++| .++ +..+..+..+++|++|++++|. +++
T Consensus 158 ~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~ 237 (336)
T 2ast_B 158 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKN 237 (336)
T ss_dssp HHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCG
T ss_pred HHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCH
Confidence 222334455555666666665 55543 345555666 6666666666 333 2344455666667777777666 555
Q ss_pred ccCcccCCCCCCCeEEccCCc-ccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcc-cccceeeccCccccCCCCccc
Q 001226 327 QIPRSVGNLSSLNSLLLFNNR-LQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNL-AKLEVLYLFNNRIEGAIPHQI 404 (1119)
Q Consensus 327 ~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~ 404 (1119)
..+..+..+++|++|++++|. ++......++++++|++|++++| ++. ..+..+ ..|+.|++++|++++..|..+
T Consensus 238 ~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 238 DCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred HHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcc
Confidence 556667777777777777774 33222235667788888888877 432 234444 347777788888888888766
Q ss_pred cc
Q 001226 405 GR 406 (1119)
Q Consensus 405 ~~ 406 (1119)
+.
T Consensus 314 ~~ 315 (336)
T 2ast_B 314 GN 315 (336)
T ss_dssp SS
T ss_pred cc
Confidence 64
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=6.4e-22 Score=221.39 Aligned_cols=192 Identities=19% Similarity=0.321 Sum_probs=89.5
Q ss_pred cccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEE
Q 001226 504 CSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILR 583 (1119)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 583 (1119)
+++|++|++++|.+.. +| .+..+++|+.|++++|++++..+ +..+++|++|+|++|++++ +| .+.++++|+.|+
T Consensus 40 l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~ 113 (308)
T 1h6u_A 40 LDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLD 113 (308)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEE
T ss_pred cCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEE
Confidence 3444444444444432 12 23444444444444444443222 4444444455555444442 22 344445555555
Q ss_pred cccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCC
Q 001226 584 LSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663 (1119)
Q Consensus 584 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 663 (1119)
|++|++++ +|. +..+++|++|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|.+++
T Consensus 114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence 55555542 222 4445555555555555543222 4444555555555555543222 4455555555555554443
Q ss_pred CccccchhhccccceeeeccccccCCcccccccccccceeeccCceecc
Q 001226 664 SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712 (1119)
Q Consensus 664 ~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 712 (1119)
..| +..++.+ +.|++++|++++..| +..+++|+.|+|++|++++
T Consensus 188 ~~~--l~~l~~L-~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 188 ISP--LASLPNL-IEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CGG--GGGCTTC-CEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred Chh--hcCCCCC-CEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 222 3333332 235555555554332 6667777777777777764
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.1e-22 Score=211.81 Aligned_cols=194 Identities=15% Similarity=0.114 Sum_probs=113.8
Q ss_pred ceeccccceeeCccCCccccccccceeeccCcc-ccCCCCccccccccccEEEecc-CccccCCCccccCCCCcceeecc
Q 001226 460 SRLDLTGNSFYGPIPANICVGTNLFVLVLGNNR-FNGSFPIEIGKCSSLRRVILSN-NLLQGSLPATLERNPGVSFLDVR 537 (1119)
Q Consensus 460 ~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~ 537 (1119)
++|++++|++++..+..+..+++|++|++++|+ +++..+..|.++++|++|++++ |++++..+..|..+++|++|+++
T Consensus 34 ~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~ 113 (239)
T 2xwt_C 34 QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113 (239)
T ss_dssp CEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEE
T ss_pred cEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCC
Confidence 333333333333333344445555555555554 5444444556666666666665 66665555566666666666666
Q ss_pred CcccCCCCCccccccccce---EEeccCC-cccCCCCCccCCccccc-EEEcccCcccCcCCcccccCCCCcEEeccCcc
Q 001226 538 GNLLQGSIPPVFGFWSNLT---MLDFSEN-RLSGSIPSELGNLENLQ-ILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612 (1119)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 612 (1119)
+|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ .|++++|+++ .+|......++|+.|+|++|+
T Consensus 114 ~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 114 NTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred CCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 666664 444 55566665 7777777 66655555667777777 7777777776 444433333677777777774
Q ss_pred -ccccCChhhhhc-ccCCeeEccCccCccCCCccccccccccEeecCCc
Q 001226 613 -LAGSIPSEVISL-EKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659 (1119)
Q Consensus 613 -l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 659 (1119)
+++..+..+..+ ++|+.|+|++|++++. |.. .+++|+.|+++++
T Consensus 191 ~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp TCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 665555566666 6777777777777643 332 4555666666554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-21 Score=233.58 Aligned_cols=192 Identities=26% Similarity=0.424 Sum_probs=105.7
Q ss_pred cccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcc
Q 001226 506 SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLS 585 (1119)
Q Consensus 506 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 585 (1119)
+|+.|+|++|.+++ +|..+ .++|++|+|++|+++ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 44444444444443 33322 144555555555554 344 234555666666666654 444 443 56666666
Q ss_pred cCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCc
Q 001226 586 ANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665 (1119)
Q Consensus 586 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 665 (1119)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|.++ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 666654 444 35566666666666654 443 34556666666666664 444 44 56666666666555 44
Q ss_pred cccchh-h---ccccceeeeccccccCCcccccccccccceeeccCceecccCCcccccccc
Q 001226 666 PCSLSK-L---HHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVS 723 (1119)
Q Consensus 666 p~~~~~-l---~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~ 723 (1119)
|. +.. + ...+..|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|..+..+..
T Consensus 196 p~-~~~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC--------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHHhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 44 222 0 000144667777776 56777777777777777777777777777766544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-21 Score=219.29 Aligned_cols=243 Identities=18% Similarity=0.181 Sum_probs=138.7
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCc-cccccccceE-Eecc
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPP-VFGFWSNLTM-LDFS 561 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~-L~Ls 561 (1119)
+.++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|..++++.+ ++++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34555556665 455444 24566666666666655455666666666666666666554443 4555655443 5555
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccC-ccccccCChhhhhcc-cCCeeEccCccCcc
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD-NYLAGSIPSEVISLE-KMQSLSLQENNLSG 639 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~ 639 (1119)
.|+|++..|..|.++++|++|++++|++.+..+..+....++..|++++ |++....+..+..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 6666655566666666777777777776655555555666666666654 455544444455443 46666777777664
Q ss_pred CCCccccccccccEeecCCcccCCCccccc-hhhccccceeeeccccccCCcccccccccccceeeccCceecccCCccc
Q 001226 640 AIPDAFSSVQSLFELQLGSNIFDGSIPCSL-SKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEV 718 (1119)
Q Consensus 640 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 718 (1119)
+|.......+|++|++++|+..+.+|... ..+..+ +.|++++|+|+...+..|.+|++|+.+++ ++++ .+|+ +
T Consensus 169 -i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L-~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~lP~-l 242 (350)
T 4ay9_X 169 -IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP-VILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT-L 242 (350)
T ss_dssp -ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECC-SEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CCCC-T
T ss_pred -CChhhccccchhHHhhccCCcccCCCHHHhccCccc-chhhcCCCCcCccChhhhccchHhhhccC--CCcC-cCCC-c
Confidence 33333344566666666544444555433 334433 34667777776433344555555544433 3343 6663 6
Q ss_pred cccccceEEeccccccc
Q 001226 719 NNMVSLYFVNISFNHFS 735 (1119)
Q Consensus 719 ~~~~~l~~l~ls~N~~~ 735 (1119)
.++++|+.++++++.-.
T Consensus 243 ~~l~~L~~l~l~~~~~c 259 (350)
T 4ay9_X 243 EKLVALMEASLTYPSHC 259 (350)
T ss_dssp TTCCSCCEEECSCHHHH
T ss_pred hhCcChhhCcCCCCccc
Confidence 77777777777766544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.5e-21 Score=217.04 Aligned_cols=239 Identities=16% Similarity=0.178 Sum_probs=115.5
Q ss_pred eeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccce-ecccc
Q 001226 388 VLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR-LDLTG 466 (1119)
Q Consensus 388 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~-L~L~~ 466 (1119)
+++.++++++ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.++...+..++++.+ +.+++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4455555555 333333 2355666666666664334456666666666666666554455444444444332 33333
Q ss_pred ceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccC-cccCCCC
Q 001226 467 NSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRG-NLLQGSI 545 (1119)
Q Consensus 467 N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~ 545 (1119)
|+++...|..|.. +++|++|++++|++++..+..+....++..+++.+ |++....
T Consensus 90 N~l~~l~~~~f~~------------------------l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 90 NNLLYINPEAFQN------------------------LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TTCCEECTTSBCC------------------------CTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred CcccccCchhhhh------------------------ccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 4444333444444 44444444444444433333333444444444433 2333222
Q ss_pred Ccccccc-ccceEEeccCCcccCCCCCccCCcccccEEEccc-CcccCcCC-cccccCCCCcEEeccCccccccCChhhh
Q 001226 546 PPVFGFW-SNLTMLDFSENRLSGSIPSELGNLENLQILRLSA-NKLDGRIP-YELGKCTKMIKLDLSDNYLAGSIPSEVI 622 (1119)
Q Consensus 546 p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 622 (1119)
+..|..+ ..++.|+|++|+|+ .+|.......+|++|++++ |.+. .+| ..|..+++|++|||++|+|+...+..+
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~- 222 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGL- 222 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCCCCCSSSC-
T ss_pred ccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcCccChhhh-
Confidence 3333333 24566666666665 3343333445566666653 4444 333 345666666666666666663222223
Q ss_pred hcccCCeeEccCccCccCCCccccccccccEeecCCc
Q 001226 623 SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659 (1119)
Q Consensus 623 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 659 (1119)
.+|+.|.+.++.--..+| .+.++++|+.+++.++
T Consensus 223 --~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 223 --ENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp --TTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred --ccchHhhhccCCCcCcCC-CchhCcChhhCcCCCC
Confidence 333444433322222455 3666666666666544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.5e-21 Score=199.46 Aligned_cols=133 Identities=26% Similarity=0.299 Sum_probs=69.7
Q ss_pred CcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEecc
Q 001226 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLS 609 (1119)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 609 (1119)
+|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|+
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 34444444444443333344455555555555555554444445555555555555555554434445555555555555
Q ss_pred CccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccC
Q 001226 610 DNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 610 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
+|++++..+..+..+++|++|+|++|++++..+..|..+++|+.|++++|.+.
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 55555444444555555556666666555544445555566655555555444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=9.8e-21 Score=198.99 Aligned_cols=181 Identities=22% Similarity=0.175 Sum_probs=132.7
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCC
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSEN 563 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (1119)
+.++.+++.++ .+|..+ .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 34555666655 344433 346777777777777666667777788888888888887666666777888888888888
Q ss_pred cccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCc
Q 001226 564 RLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPD 643 (1119)
Q Consensus 564 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 643 (1119)
++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|.+.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 163 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 163 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC---
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC---
Confidence 88866666678888888888888888866666678888888888888888866666677888888888888877753
Q ss_pred cccccccccEeecCCcccCCCccccchhhcc
Q 001226 644 AFSSVQSLFELQLGSNIFDGSIPCSLSKLHH 674 (1119)
Q Consensus 644 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 674 (1119)
+++|+.|+++.|.++|.+|.+++.+..
T Consensus 164 ----~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 ----CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ----TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ----CCCHHHHHHHHHhCCceeeccCccccC
Confidence 446777777777777777766665543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.8e-21 Score=228.33 Aligned_cols=189 Identities=28% Similarity=0.373 Sum_probs=123.7
Q ss_pred ccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeecc
Q 001226 458 YLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVR 537 (1119)
Q Consensus 458 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 537 (1119)
+++.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.. +|+.|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 45555555555554 444332 55666666666666 455 345667777777777765 454 443 67777777
Q ss_pred CcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccC
Q 001226 538 GNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617 (1119)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 617 (1119)
+|++++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 777765 454 46677777777777774 555 45677777777777775 665 54 77777777777777 45
Q ss_pred ChhhhhcccC-------CeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhcc
Q 001226 618 PSEVISLEKM-------QSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHH 674 (1119)
Q Consensus 618 p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 674 (1119)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 65 443 55 77777777777 56777777777777777777777777777666553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.1e-21 Score=208.37 Aligned_cols=137 Identities=20% Similarity=0.169 Sum_probs=112.1
Q ss_pred CCceeeecCCccEEEEEeCCCceEEEEEecccc----------------------cccHHHHHHHHhhcCCCCEEEEeee
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------------------ETNFDVEIRTLSLVRHRNILRIVGS 895 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------------------~~~~~~E~~~l~~l~h~niv~l~~~ 895 (1119)
.++.||+|+||.||+|.+ .+++.||+|+++.. ...+.+|+.++++++ | +++.++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~ 169 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKV 169 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCE
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeE
Confidence 448999999999999999 77999999998532 234779999999998 4 555555
Q ss_pred eecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEE
Q 001226 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975 (1119)
Q Consensus 896 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~ 975 (1119)
+.. +..|+||||++|++|.+ +... ....++.|+++|+.|||+. +|+||||||+||+++ ++.+||+
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~~---------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRVE---------NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCCS---------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred Eec-cceEEEEEecCCCcHHH-cchh---------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence 433 56699999999999988 4321 2346999999999999999 999999999999999 9999999
Q ss_pred eccccccccCCCCCCcccccccCCCcccccccC
Q 001226 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAY 1008 (1119)
Q Consensus 976 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 1008 (1119)
|||+|+. +..|.|||++.
T Consensus 235 DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CCTTCEE---------------TTSTTHHHHHH
T ss_pred ECCCCeE---------------CCCCCHHHHHH
Confidence 9999863 33478888654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.4e-20 Score=205.45 Aligned_cols=171 Identities=23% Similarity=0.301 Sum_probs=103.3
Q ss_pred cccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEE
Q 001226 479 VGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTML 558 (1119)
Q Consensus 479 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 558 (1119)
.+++|+.|++++|.+.+ ++ .+..+++|++|++++|++++..+ +..+++|++|++++|++++ +| .+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 44555555666555553 22 35556666666666666665433 5666666666666666654 22 35666666666
Q ss_pred eccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCc
Q 001226 559 DFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLS 638 (1119)
Q Consensus 559 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 638 (1119)
+|++|++++. ..+.++++|+.|++++|++++. ..+..+++|+.|+|++|++++..| +..+++|+.|+|++|+++
T Consensus 118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~ 191 (291)
T 1h6t_A 118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 191 (291)
T ss_dssp ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence 6666666642 3566666666666666666643 456666667777777776665333 666666677777777666
Q ss_pred cCCCccccccccccEeecCCcccCC
Q 001226 639 GAIPDAFSSVQSLFELQLGSNIFDG 663 (1119)
Q Consensus 639 ~~~p~~~~~l~~L~~L~L~~N~l~~ 663 (1119)
+ +| .+..+++|+.|++++|+++.
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccC
Confidence 4 33 36666666666666666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=220.15 Aligned_cols=237 Identities=21% Similarity=0.233 Sum_probs=145.7
Q ss_pred cceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccC
Q 001226 459 LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRG 538 (1119)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 538 (1119)
+..+.++.+.+.+..+ +..+.+|+.|++++|.+.. +| .+..+++|+.|+|++|++++..| +..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3444455554443322 3445566666666666653 33 46667777777777777765444 66777777777777
Q ss_pred cccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCC
Q 001226 539 NLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP 618 (1119)
Q Consensus 539 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 618 (1119)
|++++ +| .+..+++|++|+|++|+|++ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+|++..|
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 77764 33 56677777777777777764 2 3577777777777777777743 567777777777777777776544
Q ss_pred hhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCccccccccc
Q 001226 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLD 698 (1119)
Q Consensus 619 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~ 698 (1119)
+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.....+..+..+...-++ .+...
T Consensus 171 --l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~l~~l------------~g~~~ 234 (605)
T 1m9s_A 171 --LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT------------DGSLV 234 (605)
T ss_dssp --GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCEEECCCBCS------------SSCBC
T ss_pred --hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEEeccccccc------------CCCCc
Confidence 77777777777777777753 357777777777777777765433333322221110011 12222
Q ss_pred ccceeeccCceecccCCcccccccc
Q 001226 699 KLQILDLSSNSFSGEIPTEVNNMVS 723 (1119)
Q Consensus 699 ~L~~L~Ls~N~l~g~ip~~~~~~~~ 723 (1119)
..+.+...++-..|.+|..+..+..
T Consensus 235 ~~~~i~~~g~~~~~~i~~~l~~~~~ 259 (605)
T 1m9s_A 235 TPEIISDDGDYEKPNVKWHLPEFTN 259 (605)
T ss_dssp CCSEESTTCEEETTEEECCCSSCCS
T ss_pred CchhcccCCcccCCcceeccccccc
Confidence 3345556666667766666665544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-20 Score=232.04 Aligned_cols=195 Identities=19% Similarity=0.219 Sum_probs=124.9
Q ss_pred eeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccc
Q 001226 534 LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613 (1119)
Q Consensus 534 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 613 (1119)
++++.|.+. ..|..+..+++|+.|+|++|++. .+|..+.++++|++|+|++|+|+ .+|..|+++++|++|||++|+|
T Consensus 206 ~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp -----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 345556655 56777888888999999999887 77777778899999999999998 7888889999999999999999
Q ss_pred cccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccc
Q 001226 614 AGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPEC 693 (1119)
Q Consensus 614 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~ 693 (1119)
+ .+|..++.|++|++|+|++|.|+ .+|..|+.+++|+.|+|++|.+++.+|..+..+......++|++|.++|.+|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 8 67888999999999999999987 778889999999999999999999888888776544445889999999998864
Q ss_pred cccccccceeeccCc--------eecccCCccccccccceEEecccccccccCC
Q 001226 694 LGNLDKLQILDLSSN--------SFSGEIPTEVNNMVSLYFVNISFNHFSGKLP 739 (1119)
Q Consensus 694 ~~~l~~L~~L~Ls~N--------~l~g~ip~~~~~~~~l~~l~ls~N~~~g~~p 739 (1119)
|+.|++++| .|++.++..+.++..+....+++|-+.+...
T Consensus 361 ------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~ 408 (727)
T 4b8c_D 361 ------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA 408 (727)
T ss_dssp -----------------------------------------------CCCGGGC
T ss_pred ------cceeEeecccccccccCCccccccchhhcccccceeeeeccccccccC
Confidence 456677777 5555556666777788888999998876544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=218.91 Aligned_cols=193 Identities=23% Similarity=0.337 Sum_probs=139.2
Q ss_pred ccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEe
Q 001226 480 GTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLD 559 (1119)
Q Consensus 480 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 559 (1119)
+..+..+.++.+.+.+..+ +..+++|+.|++++|.+... | .+..+++|+.|+|++|++++..| +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 4456677888888775443 56788888889998888743 3 47788888888888888876544 77788888888
Q ss_pred ccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCcc
Q 001226 560 FSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 560 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
|++|+|++ +| .+..+++|+.|+|++|++.+ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+|++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 88888874 33 67778888888888888874 3 3577788888888888888753 567777788888888888876
Q ss_pred CCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceeccc
Q 001226 640 AIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713 (1119)
Q Consensus 640 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 713 (1119)
..| +..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~--------------------------l~-~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISD--------------------------LR-ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCB--------------------------CG-GGTTCTTCSEEECCSEEEECC
T ss_pred chh--hccCCCCCEEECcCCCCCC--------------------------Ch-HHccCCCCCEEEccCCcCcCC
Confidence 655 7777777776666666553 22 355566666666666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.4e-19 Score=198.53 Aligned_cols=190 Identities=24% Similarity=0.349 Sum_probs=126.3
Q ss_pred ccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEecc
Q 001226 482 NLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 561 (1119)
.+..+.++.+.+++.. .+..+++|+.|++++|.+... + .+..+++|+.|++++|++++..+ +..+++|++|+|+
T Consensus 25 ~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECC
Confidence 4445566666665432 245788888888888888754 3 36777777777777777775443 6777777777777
Q ss_pred CCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCC
Q 001226 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641 (1119)
Q Consensus 562 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 641 (1119)
+|++++ +| .+.++++|+.|+|++|++.+ + ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..
T Consensus 99 ~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV 172 (291)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred CCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccch
Confidence 777764 33 36777777777777777764 3 3566677777777777777643 45666777777777777776544
Q ss_pred CccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecc
Q 001226 642 PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712 (1119)
Q Consensus 642 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 712 (1119)
| +..+++|+.|+|++|.++ + +| .+..+++|+.|++++|+++.
T Consensus 173 ~--l~~l~~L~~L~L~~N~i~-------------------------~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSKNHIS-------------------------D-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp G--GTTCTTCCEEECCSSCCC-------------------------B-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred h--hcCCCccCEEECCCCcCC-------------------------C-Ch-hhccCCCCCEEECcCCcccC
Confidence 3 666666666555555443 2 33 26677778888888887774
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=197.92 Aligned_cols=170 Identities=18% Similarity=0.179 Sum_probs=98.6
Q ss_pred ccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEe
Q 001226 480 GTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLD 559 (1119)
Q Consensus 480 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 559 (1119)
+.++..+++++|.+++. + .+..+++|+.|++++|.++. +| .+..+++|+.|++++|++++..+ +..+++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 34444555555555522 2 34555566666666665553 23 45556666666666666654333 55666666666
Q ss_pred ccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCcc
Q 001226 560 FSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 560 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
|++|++++ +|.... ++|+.|+|++|++++ +| .+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++
T Consensus 92 L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcc
Confidence 66666653 333222 666666666666663 33 46666666666666666664 33 46666666666666666665
Q ss_pred CCCccccccccccEeecCCcccCCC
Q 001226 640 AIPDAFSSVQSLFELQLGSNIFDGS 664 (1119)
Q Consensus 640 ~~p~~~~~l~~L~~L~L~~N~l~~~ 664 (1119)
. ..+..+++|+.|++++|.+++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 4 5566666666666666666544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.1e-19 Score=186.15 Aligned_cols=153 Identities=22% Similarity=0.289 Sum_probs=70.1
Q ss_pred EEeccCCcccCCCCCccCCcccccEEEcccCcccCcCC-cccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCc
Q 001226 557 MLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIP-YELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635 (1119)
Q Consensus 557 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 635 (1119)
.+++++|.++ .+|..+. ..++.|+|++|++++..| ..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4555555554 3444443 234555555555554333 23455555555555555555444445555555555555555
Q ss_pred cCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceeccc
Q 001226 636 NLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713 (1119)
Q Consensus 636 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 713 (1119)
+|++..|..|..+++|++|+|++|.+++..|..+..+..+ +.|+|++|+|++..|..|..+++|+.|+|++|++++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV-RLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTC-SEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccC-CEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 5555555555555555554433333332111111111111 0133333333333344455555555555555555443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=184.51 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=96.1
Q ss_pred cceeeccCcccCCCCC-ccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEecc
Q 001226 531 VSFLDVRGNLLQGSIP-PVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLS 609 (1119)
Q Consensus 531 L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 609 (1119)
++.|++++|++++..| ..|..+++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3455555555554433 345667777777777777776666677777777777777777776666667777777777777
Q ss_pred CccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCc
Q 001226 610 DNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665 (1119)
Q Consensus 610 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 665 (1119)
+|+|++..|..+..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+..
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 77777766777777777778888888887777777888888888777777776543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.9e-19 Score=201.10 Aligned_cols=176 Identities=22% Similarity=0.149 Sum_probs=123.7
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCccccCCCcccc-CCCCcceeeccCcccCCCCCccccccccceEEeccC
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLE-RNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (1119)
+.+++++|+++ .+|..+. +.++.|+|++|+|++..+..+. .+++|+.|+|++|++++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45666777666 4555443 3467777777777776666666 777777777777777766666777777777777777
Q ss_pred CcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhh---hhcccCCeeEccCccCcc
Q 001226 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEV---ISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 563 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~ 639 (1119)
|+|++..+..|.++++|+.|+|++|++.+..|..|..+++|+.|+|++|+|++..+..+ ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77776666677777778888888888776667777777888888888888775333333 457777778888887776
Q ss_pred CCCccccccccc--cEeecCCcccC
Q 001226 640 AIPDAFSSVQSL--FELQLGSNIFD 662 (1119)
Q Consensus 640 ~~p~~~~~l~~L--~~L~L~~N~l~ 662 (1119)
..+..|..++.+ +.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 655667777663 66777777665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=5e-21 Score=230.99 Aligned_cols=215 Identities=20% Similarity=0.173 Sum_probs=107.9
Q ss_pred CCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceee
Q 001226 456 FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535 (1119)
Q Consensus 456 l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (1119)
.+.|+.|+|++|.++ .+|..++.+++|+.|++++|......|.. +..+.+.+.+|..+..+++|+.|+
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~L~ 415 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKAVD 415 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHHHC
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcccCc
Confidence 455566666666654 45555555555555555444311000000 001112334444444445555554
Q ss_pred -ccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccc
Q 001226 536 -VRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 536 -l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
++.|.+ .+|..+.+++|.+++..+ ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|+|+
T Consensus 416 ~l~~n~~-----------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~ 476 (567)
T 1dce_A 416 PMRAAYL-----------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR 476 (567)
T ss_dssp GGGHHHH-----------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC
T ss_pred chhhccc-----------chhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc
Confidence 333322 234444455555542211 125555555555553 444 555555555555555555
Q ss_pred ccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCc-ccc
Q 001226 615 GSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKI-PEC 693 (1119)
Q Consensus 615 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~-p~~ 693 (1119)
.+|..++.+++|+.|+|++|+|++ +| .|+.+++|+. |+|++|+|++.+ |..
T Consensus 477 -~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~-------------------------L~Ls~N~l~~~~~p~~ 528 (567)
T 1dce_A 477 -ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQE-------------------------LLLCNNRLQQSAAIQP 528 (567)
T ss_dssp -CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCE-------------------------EECCSSCCCSSSTTGG
T ss_pred -ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcE-------------------------EECCCCCCCCCCCcHH
Confidence 455555555555555555555554 44 5555555555 444444444444 666
Q ss_pred cccccccceeeccCceecccCCcc---ccccccceEEec
Q 001226 694 LGNLDKLQILDLSSNSFSGEIPTE---VNNMVSLYFVNI 729 (1119)
Q Consensus 694 ~~~l~~L~~L~Ls~N~l~g~ip~~---~~~~~~l~~l~l 729 (1119)
++.+++|+.|+|++|+|++.+|.. +..+++|+.||+
T Consensus 529 l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 529 LVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp GGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred HhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 677777777777777777554422 122556666653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.8e-21 Score=229.33 Aligned_cols=202 Identities=20% Similarity=0.129 Sum_probs=145.7
Q ss_pred cCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcccccccccc
Q 001226 429 TRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLR 508 (1119)
Q Consensus 429 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 508 (1119)
..+++|+.|+|++|+|+ .+|..+. .++.|+.|++++|......|. .+..+.+.+..|..++.+++|+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~-~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~ 412 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELE-SCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLK 412 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHH-HHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHH-HHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhcc
Confidence 67899999999999997 7777765 588999999977752111110 1112233445666777777777
Q ss_pred EEE-eccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccC
Q 001226 509 RVI-LSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSAN 587 (1119)
Q Consensus 509 ~L~-Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 587 (1119)
.|+ ++.|.+. .|..+.+++|.++...+ ..|+.|+|++|+|++ +|. |+++++|+.|+|++|
T Consensus 413 ~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 413 AVDPMRAAYLD-----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp HHCGGGHHHHH-----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred cCcchhhcccc-----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 777 6666543 35556666676653221 247788888888874 565 888888888888888
Q ss_pred cccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCC-CccccccccccEeecCCcccCCCc
Q 001226 588 KLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI-PDAFSSVQSLFELQLGSNIFDGSI 665 (1119)
Q Consensus 588 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~ 665 (1119)
+|+ .+|..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..|+.+++|+.|+|++|++++.+
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 887 778888888888888888888875 66 7788888888888888888776 888888888888777777776443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=182.60 Aligned_cols=133 Identities=22% Similarity=0.267 Sum_probs=86.8
Q ss_pred CcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEecc
Q 001226 530 GVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLS 609 (1119)
Q Consensus 530 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 609 (1119)
+++.|++++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 112 (220)
T 2v9t_B 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN 112 (220)
T ss_dssp TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence 44455555555554444455666666666666666666566666666677777777777664444455667777777777
Q ss_pred CccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccC
Q 001226 610 DNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 610 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
+|++++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 77776666666777777777777777777666666777777777777777665
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.4e-18 Score=182.11 Aligned_cols=153 Identities=19% Similarity=0.225 Sum_probs=116.7
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCC
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSEN 563 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (1119)
+.+++++|.++ .+|..+. ++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 45666666666 4555443 56777777777777766677777778888888888877777777888888888888888
Q ss_pred cccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCcc
Q 001226 564 RLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 564 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
+|++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.+..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 8876555567788888888888888887777788888888888888888887666677788888888888888764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.1e-20 Score=227.10 Aligned_cols=266 Identities=18% Similarity=0.181 Sum_probs=106.6
Q ss_pred CCCcHHHHHHHHhcCCCCCC-CCCCCCCCCCCCCCceeeeeeeecCCCceEEEecCCCcccccCccchhhhccCCcccEE
Q 001226 23 SPPSAISLVQFLDSLPKQSQ-SHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSL 101 (1119)
Q Consensus 23 ~~~~~~~ll~~~~~~~~~~~-~~~~w~~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~~~~~l~~l~~L 101 (1119)
...++++|+++.......+. .-.+|... .+..+.|.+++++. ++++.|+|.++++..... ..++.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~---------~~l~~l 196 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGD--STPSGTATNSAVST--PLTPKIELFANGKDEANQ---------ALLQHK 196 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCC--CCccccCCCceecC--CccceEEeeCCCCCcchh---------hHhhcC
Confidence 45678999999987643321 22356432 23457899999975 589999999988877432 234445
Q ss_pred EcCCCcccC---------CCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccce
Q 001226 102 DLSGNEFTG---------SIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLES 172 (1119)
Q Consensus 102 ~Ls~n~~~~---------~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 172 (1119)
+|+.|.+.+ ..|..+..++.|++|+|++|++. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++
T Consensus 197 ~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~ 274 (727)
T 4b8c_D 197 KLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRV 274 (727)
T ss_dssp -------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCE
T ss_pred ccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCE
Confidence 555554443 34666777788888888888777 67777777888888888888777 67777777777777
Q ss_pred eeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccC
Q 001226 173 IGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFG 252 (1119)
Q Consensus 173 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~ 252 (1119)
|+|++|.++ .+|..|+.+++|++|+|++|.|+ .+|..|+++++|++|+|++|.++
T Consensus 275 L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~------------------------~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 275 LDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT------------------------TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp EECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC------------------------CCCSSTTSCTTCCCEECTTSCCC
T ss_pred EeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC------------------------ccChhhhcCCCccEEeCCCCccC
Confidence 777777777 56777777777777777777765 34445666666666666666665
Q ss_pred CccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCccc
Q 001226 253 GAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV 332 (1119)
Q Consensus 253 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 332 (1119)
+.++.........+..|+|++|.+++.+|.. |+.|+++.|... .. ..+.+.+..+..+
T Consensus 330 ~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~---~~-------------~~~~l~~~~~~~~ 387 (727)
T 4b8c_D 330 KQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEP---QR-------------EYDSLQQSTEHLA 387 (727)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------------------------------------
T ss_pred CCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccc---cc-------------ccCCccccccchh
Confidence 4433222111111223455555555555432 233444444100 00 0113333344445
Q ss_pred CCCCCCCeEEccCCcccC
Q 001226 333 GNLSSLNSLLLFNNRLQG 350 (1119)
Q Consensus 333 ~~l~~L~~L~L~~N~l~~ 350 (1119)
.++..++...++.|-+.+
T Consensus 388 ~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 388 TDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp --------------CCCG
T ss_pred hcccccceeeeecccccc
Confidence 566666777777777653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.6e-18 Score=179.96 Aligned_cols=154 Identities=23% Similarity=0.266 Sum_probs=104.1
Q ss_pred cEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccC
Q 001226 508 RRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSAN 587 (1119)
Q Consensus 508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 587 (1119)
+.++.+++.+. .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 34455555544 2333222 55666666666666666666666777777777777776555556677777777777777
Q ss_pred cccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCc
Q 001226 588 KLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665 (1119)
Q Consensus 588 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 665 (1119)
+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+..
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 777555556677777777777777777 56777777777777777777777666667777788888777777776443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=189.35 Aligned_cols=170 Identities=22% Similarity=0.255 Sum_probs=130.3
Q ss_pred CCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceee
Q 001226 456 FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLD 535 (1119)
Q Consensus 456 l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 535 (1119)
+..+..+++++|.+++.. .+..+++|+.|++++|+++ .+| .+..+++|++|+|++|++++..+ +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344556666666665433 4566777777777777777 445 67778888888888888886554 78888888888
Q ss_pred ccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccc
Q 001226 536 VRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAG 615 (1119)
Q Consensus 536 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 615 (1119)
+++|++++ +|.... ++|++|+|++|++++ +| .+.++++|+.|+|++|++++ +| .+..+++|+.|+|++|++++
T Consensus 92 L~~N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCC-cCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcc
Confidence 88888875 443333 889999999999985 33 58888999999999999985 44 68889999999999999986
Q ss_pred cCChhhhhcccCCeeEccCccCccC
Q 001226 616 SIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 616 ~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
. ..+..+++|+.|++++|++++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 5 6788888999999999999865
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.5e-18 Score=179.53 Aligned_cols=155 Identities=21% Similarity=0.217 Sum_probs=127.9
Q ss_pred cceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccC
Q 001226 483 LFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562 (1119)
Q Consensus 483 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (1119)
-+.++.++++++ .+|..+. ++|+.|+|++|.+++..|..|..+++|+.|+|++|+++...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345777777776 5665543 7888888888888888888888888888888888888766667778888999999999
Q ss_pred CcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCC
Q 001226 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAI 641 (1119)
Q Consensus 563 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 641 (1119)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..+..+++|+.|+|++|.+.+..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9998777777888999999999999998 78888889999999999999998766677888899999999999988654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-18 Score=196.95 Aligned_cols=176 Identities=23% Similarity=0.188 Sum_probs=98.9
Q ss_pred cEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCcccc-ccccceEEeccCCcccCCCCCccCCcccccEEEccc
Q 001226 508 RRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFG-FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSA 586 (1119)
Q Consensus 508 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 586 (1119)
+.+++++|.++. +|..+. +.++.|+|++|++++..+..|. .+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 466777777663 444332 2355666666666655555554 556666666666666655555566666666666666
Q ss_pred CcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccc---cccccccEeecCCcccCC
Q 001226 587 NKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAF---SSVQSLFELQLGSNIFDG 663 (1119)
Q Consensus 587 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~ 663 (1119)
|+|.+..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~------ 171 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS------ 171 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECC------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECC------
Confidence 66655444555666666666666666665555556666666666666666664333333 345555555554
Q ss_pred CccccchhhccccceeeeccccccCCcccccccccc--cceeeccCceec
Q 001226 664 SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDK--LQILDLSSNSFS 711 (1119)
Q Consensus 664 ~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~ 711 (1119)
+|+|++..+..+..++. |+.|+|++|+++
T Consensus 172 -------------------~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 172 -------------------SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp -------------------SSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred -------------------CCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 45554333344555554 366677777665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=172.65 Aligned_cols=154 Identities=20% Similarity=0.200 Sum_probs=106.7
Q ss_pred ccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCccccc
Q 001226 501 IGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQ 580 (1119)
Q Consensus 501 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 580 (1119)
.+.+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..|+++++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 355666667777776666 334 4666666777777766554 233566677777777777777766777777777788
Q ss_pred EEEcccCcccCcCCcccccCCCCcEEeccCcc-ccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCc
Q 001226 581 ILRLSANKLDGRIPYELGKCTKMIKLDLSDNY-LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659 (1119)
Q Consensus 581 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 659 (1119)
+|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCc
Confidence 88888887776667777777788888888877 54 455 57777778888888888775 33 6777777777777777
Q ss_pred ccC
Q 001226 660 IFD 662 (1119)
Q Consensus 660 ~l~ 662 (1119)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 664
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=171.41 Aligned_cols=155 Identities=16% Similarity=0.186 Sum_probs=119.8
Q ss_pred ccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceE
Q 001226 478 CVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTM 557 (1119)
Q Consensus 478 ~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 557 (1119)
..+++|+.|++++|+++ .+| .+..+++|++|++++|.++ .+..+..+++|++|++++|++++..|..+..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45567777777777777 555 5777888888888888664 3346778888888888888888777788888888888
Q ss_pred EeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccC
Q 001226 558 LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNL 637 (1119)
Q Consensus 558 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 637 (1119)
|+|++|++++..|..++++++|++|+|++|++.+.+| .+..+++|+.|++++|++++ ++ .+..+++|++|++++|++
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 8888888887778888888888888888888333566 68888889999999998875 44 778888899999998887
Q ss_pred cc
Q 001226 638 SG 639 (1119)
Q Consensus 638 ~~ 639 (1119)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=169.72 Aligned_cols=132 Identities=27% Similarity=0.393 Sum_probs=102.3
Q ss_pred ceeeccCcccCCCCCccccccccceEEeccCCcccCCCCC-ccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccC
Q 001226 532 SFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPS-ELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD 610 (1119)
Q Consensus 532 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 610 (1119)
+.+++++|+++ .+|..+. .+|++|+|++|+|++..+. .|+++++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 4555443 2788888888888765554 478888888888888888877788888888888888888
Q ss_pred ccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCcc
Q 001226 611 NYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP 666 (1119)
Q Consensus 611 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 666 (1119)
|+|++..|..+..+++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 88887777778888888888888888888888888888888888888888876654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=4.1e-17 Score=168.62 Aligned_cols=133 Identities=27% Similarity=0.363 Sum_probs=107.6
Q ss_pred ceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCc-ccccCCCCcEEeccCccccccCChhhhhcccCCeeEcc
Q 001226 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPY-ELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQ 633 (1119)
Q Consensus 555 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 633 (1119)
-+.+++++|+++ .+|..+.. +|++|+|++|++.+..+. .+..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 378999999996 77877764 899999999999866654 48889999999999999998888889999999999999
Q ss_pred CccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceeccc
Q 001226 634 ENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGE 713 (1119)
Q Consensus 634 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 713 (1119)
+|+|++..|..|..+++|+.|+|++|++ ++.+|..|+.+++|++|+|++|+|++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQI-------------------------SCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCC-------------------------CEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcC-------------------------CeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 9999988888888888888765555544 445566777778888888888888876
Q ss_pred CC
Q 001226 714 IP 715 (1119)
Q Consensus 714 ip 715 (1119)
.|
T Consensus 142 c~ 143 (192)
T 1w8a_A 142 CH 143 (192)
T ss_dssp GG
T ss_pred Cc
Confidence 65
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=2e-17 Score=186.88 Aligned_cols=201 Identities=14% Similarity=0.059 Sum_probs=115.9
Q ss_pred cccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeecccc----ccccCccccc
Q 001226 234 SLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK----LNGTISGQIS 309 (1119)
Q Consensus 234 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~----l~~~~~~~~~ 309 (1119)
.+.+|++|+++++.. +++ .|...+|.++++|+.|++++|.++...+.+|.++.++..+.+..+. ...+....|.
T Consensus 96 ~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~ 173 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFI 173 (329)
T ss_dssp EEEECTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEE
T ss_pred cccccCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccc
Confidence 333488888888888 665 6778888888888888888888887778888887777777766532 2334455666
Q ss_pred CCCCCc-EEEcccccc-ccccCccc------------------------CCCCCCCeEEccCCcccCCCCCCCCCCCCCc
Q 001226 310 HCNQLQ-VIALSRNNL-VGQIPRSV------------------------GNLSSLNSLLLFNNRLQGTLPPELGNCGSLV 363 (1119)
Q Consensus 310 ~l~~L~-~L~Ls~N~l-~~~~~~~~------------------------~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 363 (1119)
++..|+ .+++....- ...+...- ..+++|+.|+|++|+++...+.+|.++++|+
T Consensus 174 ~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 174 EGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL 253 (329)
T ss_dssp ESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred cccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence 666666 444432210 00000000 0245555555555555544444555555555
Q ss_pred EEEcccCcCcccCchhhhcccccc-eeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEE
Q 001226 364 DLRLQHNFIGGTIPPEICNLAKLE-VLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438 (1119)
Q Consensus 364 ~L~L~~N~i~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 438 (1119)
.|++++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|+++...+.+|.++++|+.++
T Consensus 254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 5555555 4444444555555555 555555 44444455555555555555555555544444555555555554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-17 Score=185.82 Aligned_cols=102 Identities=13% Similarity=0.058 Sum_probs=52.4
Q ss_pred cccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccce-EEeccCCcccCCCCCccCCcccccEE
Q 001226 504 CSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLT-MLDFSENRLSGSIPSELGNLENLQIL 582 (1119)
Q Consensus 504 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 582 (1119)
+++|+.|+|++|.++...+..|..+++|+.+++.+| ++...+..|..+++|+ .+++.+ +++..-+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 344444444444444444444444444444444444 3333334455555555 555555 4443444556666666666
Q ss_pred EcccCcccCcCCcccccCCCCcEEe
Q 001226 583 RLSANKLDGRIPYELGKCTKMIKLD 607 (1119)
Q Consensus 583 ~Ls~N~l~~~~p~~~~~l~~L~~L~ 607 (1119)
+++.|++...-+..|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 6666666544445566666666554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=4.4e-17 Score=176.82 Aligned_cols=131 Identities=18% Similarity=0.194 Sum_probs=102.9
Q ss_pred CCceeeecCCccEEEEEeCCCceE--EEEEeccccc----------------------------ccHHHHHHHHhhcCCC
Q 001226 838 EGRIIGKGKHGTVYRTLSNNSRKH--WAVKKLNRSE----------------------------TNFDVEIRTLSLVRHR 887 (1119)
Q Consensus 838 ~~~~lG~G~fg~Vy~~~~~~~~~~--vavK~~~~~~----------------------------~~~~~E~~~l~~l~h~ 887 (1119)
..+.||+|+||.||+|.+..+|+. ||||+++... ..+.+|+..+++++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999998666888 9999864321 1467899999999877
Q ss_pred CE--EEEeeeeecCCceEEEEeccCC-C----CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCC
Q 001226 888 NI--LRIVGSCTKDEHGFIVTEYMPG-G----TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH-YDCVPQIIHRDI 959 (1119)
Q Consensus 888 ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dl 959 (1119)
++ ...+++ ...++||||+++ | +|.++... .++..+..++.|++.|+.||| +. +|+||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 53 333332 356899999942 3 67666432 123456789999999999999 88 9999999
Q ss_pred CCCCeEeCCCCceEEEeccccccc
Q 001226 960 KSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 960 kp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.4e-16 Score=156.01 Aligned_cols=136 Identities=23% Similarity=0.233 Sum_probs=91.3
Q ss_pred ccceEEeccCCccc-CCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeE
Q 001226 553 SNLTMLDFSENRLS-GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLS 631 (1119)
Q Consensus 553 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 631 (1119)
++|++|+|++|+++ +.+|..+..+++|+.|+|++|++++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 66777777777788888888877754 6677777788888888887766777777777777777
Q ss_pred ccCccCccCC-CccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcc---cccccccccceeeccC
Q 001226 632 LQENNLSGAI-PDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIP---ECLGNLDKLQILDLSS 707 (1119)
Q Consensus 632 L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p---~~~~~l~~L~~L~Ls~ 707 (1119)
|++|++++.. +..|..+++|+.|++++|.++ +..+ ..+..+++|+.||+++
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-------------------------~~~~~~~~~~~~l~~L~~L~l~~ 156 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-------------------------NLNDYRESVFKLLPQLTYLDGYD 156 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-------------------------TSTTHHHHHHTTCSSCCEETTEE
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-------------------------chHHHHHHHHHhCccCcEecCCC
Confidence 7777777532 256666666666554444433 2222 2556666666777776
Q ss_pred ceecccCCc
Q 001226 708 NSFSGEIPT 716 (1119)
Q Consensus 708 N~l~g~ip~ 716 (1119)
|.++ ++|.
T Consensus 157 n~~~-~~~~ 164 (168)
T 2ell_A 157 REDQ-EAPD 164 (168)
T ss_dssp TTSC-BCCS
T ss_pred CChh-hccc
Confidence 6665 4444
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=6.1e-16 Score=156.17 Aligned_cols=132 Identities=23% Similarity=0.207 Sum_probs=77.4
Q ss_pred CCcceeeccCcccC-CCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEe
Q 001226 529 PGVSFLDVRGNLLQ-GSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLD 607 (1119)
Q Consensus 529 ~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 607 (1119)
++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++.+.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 33444444444444 34555555566666666666666543 5566666666666666666655565555566666666
Q ss_pred ccCccccccC-ChhhhhcccCCeeEccCccCccCCC---ccccccccccEeecCCcccC
Q 001226 608 LSDNYLAGSI-PSEVISLEKMQSLSLQENNLSGAIP---DAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 608 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 662 (1119)
|++|++++.. +..+..+++|++|++++|++++..+ ..|..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 6666666421 1556666666666666666664443 35666666666666666554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-14 Score=168.08 Aligned_cols=266 Identities=11% Similarity=0.081 Sum_probs=146.6
Q ss_pred CCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeeecccccccccCccCCCcccccEEE
Q 001226 119 CGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLY 198 (1119)
Q Consensus 119 l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 198 (1119)
+..++.+.+.+ .++.....+|.+. +|+.++|..+ ++.....+|.++ +|+.+.+.+ .++.+...+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 34555555543 2332333444443 4555655544 443344444443 455555553 44444455555555555555
Q ss_pred eccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCC
Q 001226 199 LNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEG 278 (1119)
Q Consensus 199 L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~ 278 (1119)
+..|+++ .++...|. ..+|+.+.|.++ ++.
T Consensus 187 l~~n~l~------------------------------------------------~I~~~aF~-~~~L~~l~lp~~-l~~ 216 (401)
T 4fdw_A 187 LSKTKIT------------------------------------------------KLPASTFV-YAGIEEVLLPVT-LKE 216 (401)
T ss_dssp CTTSCCS------------------------------------------------EECTTTTT-TCCCSEEECCTT-CCE
T ss_pred cCCCcce------------------------------------------------EechhhEe-ecccCEEEeCCc-hhe
Confidence 5555444 23333343 244455555422 443
Q ss_pred CcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCccc-----CCCC
Q 001226 279 QIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ-----GTLP 353 (1119)
Q Consensus 279 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~ 353 (1119)
....+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.....+|.++++|+.+++.+|.+. ...+
T Consensus 217 I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~ 293 (401)
T 4fdw_A 217 IGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHP 293 (401)
T ss_dssp ECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECT
T ss_pred ehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECH
Confidence 44445555555555555443 34444445554 45555555 23344344455555556666655555443 3445
Q ss_pred CCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCC-
Q 001226 354 PELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLR- 432 (1119)
Q Consensus 354 ~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~- 432 (1119)
.+|.+|++|+.+++.+ .++.+...+|.++++|+.+.|..| ++.+...+|.++ +|+.+++++|.+....+..|..++
T Consensus 294 ~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~ 370 (401)
T 4fdw_A 294 YCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPD 370 (401)
T ss_dssp TTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCT
T ss_pred HHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCC
Confidence 5677777777777773 465555667777777777777544 555666777777 788888877777655666677764
Q ss_pred CcCEEEccCccCc
Q 001226 433 NLQFLSLAHNHLT 445 (1119)
Q Consensus 433 ~L~~L~L~~N~l~ 445 (1119)
+++.|++..+.+.
T Consensus 371 ~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 371 DITVIRVPAESVE 383 (401)
T ss_dssp TCCEEEECGGGHH
T ss_pred CccEEEeCHHHHH
Confidence 6778888777654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=154.86 Aligned_cols=127 Identities=25% Similarity=0.346 Sum_probs=94.8
Q ss_pred eeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcc
Q 001226 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612 (1119)
Q Consensus 533 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 612 (1119)
.+++++|+++ .+|..+ .++|++|+|++|+|+ .+|..|.++++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus 14 ~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4555555555 344433 246778888888887 667778888888888888888886666778888888888888888
Q ss_pred ccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCC
Q 001226 613 LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663 (1119)
Q Consensus 613 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 663 (1119)
|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 887777778888888888888888886666678888888888888887753
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=7.4e-16 Score=152.14 Aligned_cols=111 Identities=23% Similarity=0.296 Sum_probs=52.6
Q ss_pred CCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccccc-CChhhhh
Q 001226 545 IPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGS-IPSEVIS 623 (1119)
Q Consensus 545 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~ 623 (1119)
+|..+..+++|++|+|++|++++. ..++++++|++|+|++|++.+.+|..+..+++|++|++++|++++. .|..+..
T Consensus 34 ~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~ 111 (149)
T 2je0_A 34 LEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK 111 (149)
T ss_dssp CCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGG
T ss_pred HHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhh
Confidence 333344444444444444444432 4444445555555555555444444444455555555555555431 2244455
Q ss_pred cccCCeeEccCccCccCCC---ccccccccccEeecC
Q 001226 624 LEKMQSLSLQENNLSGAIP---DAFSSVQSLFELQLG 657 (1119)
Q Consensus 624 l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~ 657 (1119)
+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 112 l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 112 LENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555555555555554333 345555555555443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=151.15 Aligned_cols=131 Identities=26% Similarity=0.281 Sum_probs=94.8
Q ss_pred eeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcc
Q 001226 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612 (1119)
Q Consensus 533 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 612 (1119)
.+++++|+++ .+|..+ .++|++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|+
T Consensus 11 ~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 87 (177)
T 2o6r_A 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87 (177)
T ss_dssp EEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence 4445555554 234322 2577788888888876666667778888888888888876555667788888888888888
Q ss_pred ccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCcc
Q 001226 613 LAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIP 666 (1119)
Q Consensus 613 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 666 (1119)
+++..+..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+++..|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 88 LQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 886666667778888888888888886666667788888888888888876554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.4e-15 Score=150.15 Aligned_cols=128 Identities=23% Similarity=0.238 Sum_probs=85.8
Q ss_pred ccccEEEeccCccc-cCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEE
Q 001226 505 SSLRRVILSNNLLQ-GSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILR 583 (1119)
Q Consensus 505 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 583 (1119)
++|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..++.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555555555555 45555555666666666666666544 5566677777777777777766677666777777777
Q ss_pred cccCcccCc-CCcccccCCCCcEEeccCccccccCC---hhhhhcccCCeeEccC
Q 001226 584 LSANKLDGR-IPYELGKCTKMIKLDLSDNYLAGSIP---SEVISLEKMQSLSLQE 634 (1119)
Q Consensus 584 Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~ 634 (1119)
+++|++++. .|..++.+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777752 23667777778888888887776544 4677777788777753
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4e-14 Score=163.21 Aligned_cols=264 Identities=11% Similarity=0.140 Sum_probs=152.2
Q ss_pred CCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEE
Q 001226 239 RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318 (1119)
Q Consensus 239 ~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (1119)
..++++.+..+ ++ .|...+|.+. +|+.+.+.++ ++.....+|.+. +|+.+.+.. .++.+...+|.+|++|+.++
T Consensus 113 ~~l~~i~ip~~-i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPNS-VK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCTT-CC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEECCc-cC-EehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 44555555432 22 4556667664 6777777665 665666667663 577777764 56666667777777777777
Q ss_pred ccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccC
Q 001226 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEG 398 (1119)
Q Consensus 319 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 398 (1119)
+++|+++.....+|. .++|+.+.+.++ ++.....+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++.
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence 777777644444454 467777777644 55455666777777777777654 44344455555 56666666 344554
Q ss_pred CCCccccccCcceEEEeeccccc-----ccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCcc
Q 001226 399 AIPHQIGRMSKLVELALYNNRLT-----GRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPI 473 (1119)
Q Consensus 399 ~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1119)
+...+|.++++|+.+++.+|.+. ...+..|.++++|+.++|.+ .++ .++..
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~---------------------- 317 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQG---------------------- 317 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTT----------------------
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhh----------------------
Confidence 55566666666666666666553 23344555555555555552 233 33333
Q ss_pred CCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCC-CcceeeccCccc
Q 001226 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNP-GVSFLDVRGNLL 541 (1119)
Q Consensus 474 p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l 541 (1119)
.|..+++|+.+.+..| ++..-+.+|.++ +|+.+++++|.+....+..|..++ .++.|.+..+.+
T Consensus 318 --aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 318 --LLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp --TTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred --hhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 4444445555555333 333334455555 566666666655544455555553 455565555443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.1e-14 Score=150.16 Aligned_cols=94 Identities=24% Similarity=0.318 Sum_probs=46.4
Q ss_pred CCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhc
Q 001226 545 IPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISL 624 (1119)
Q Consensus 545 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 624 (1119)
+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|+|++|+|++..+..|..+
T Consensus 46 ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l 125 (193)
T 2wfh_A 46 VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL 125 (193)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTC
T ss_pred hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcC
Confidence 33444444445555555555544444445555555555555555554444445555555555555555554333344455
Q ss_pred ccCCeeEccCccCc
Q 001226 625 EKMQSLSLQENNLS 638 (1119)
Q Consensus 625 ~~L~~L~L~~N~l~ 638 (1119)
++|+.|+|++|.+.
T Consensus 126 ~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 126 SALSHLAIGANPLY 139 (193)
T ss_dssp TTCCEEECCSSCEE
T ss_pred ccccEEEeCCCCee
Confidence 55555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-14 Score=148.02 Aligned_cols=128 Identities=24% Similarity=0.240 Sum_probs=57.7
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCC
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSEN 563 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (1119)
+.+++++|+++ .+|..+. ++|++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34555555554 3333222 45555555555555444444444444444444444444333333444444444444444
Q ss_pred cccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccc
Q 001226 564 RLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 564 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
+|++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 444333333444444444444444444322223344444444444444444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=5.4e-14 Score=162.94 Aligned_cols=154 Identities=17% Similarity=0.205 Sum_probs=74.3
Q ss_pred ccccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCC
Q 001226 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCN 312 (1119)
Q Consensus 233 ~~l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 312 (1119)
.+|.+|++|+++.+..+ ++ .|...+|.++++|+.+++.++ ++.....+|.++++|+.+.+..+ +..+...+|.++.
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHhhCCCCceEEEeCCC-cc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 34556666666666432 32 445556666666666666543 44344455555666665555433 3334444555554
Q ss_pred CCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeecc
Q 001226 313 QLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLF 392 (1119)
Q Consensus 313 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~ 392 (1119)
.++......... ....+|.++++|+.+.+.++..+ .....|.++.+|+.+++..| ++.+....|.++..|+.+.+.
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~ 216 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFP 216 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCC
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecC
Confidence 333322222211 22344555555555555443222 33444555555555555544 332333445555555555544
Q ss_pred Cc
Q 001226 393 NN 394 (1119)
Q Consensus 393 ~N 394 (1119)
.+
T Consensus 217 ~~ 218 (394)
T 4fs7_A 217 NS 218 (394)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.56 E-value=7e-14 Score=161.98 Aligned_cols=196 Identities=14% Similarity=0.095 Sum_probs=94.9
Q ss_pred hhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCC
Q 001226 257 PWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLS 336 (1119)
Q Consensus 257 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 336 (1119)
..+|.++.+|+.+.+.++- ......+|.++.+|+.+++..+ ++.+...+|.++..|+.+.+..+... +...+....
T Consensus 155 ~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~ 230 (394)
T 4fs7_A 155 DEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKT 230 (394)
T ss_dssp TTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTC
T ss_pred hhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccC
Confidence 3345555555555554332 2234445555555555555544 44444555555555555555444322 222333345
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEee
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 416 (1119)
+|+.+.+..+. +......|.++..|+.+.+..+... .....|..+..++.+....+.+. ...|..+.+|+.+.+.
T Consensus 231 ~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 231 GVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEEC
T ss_pred CCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccc
Confidence 55555554332 2233445555666666666555433 44445555566665555544332 2345555666666654
Q ss_pred cccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceecc
Q 001226 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDL 464 (1119)
Q Consensus 417 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 464 (1119)
++ ++.....+|.++++|+.+++..+ ++ .+....+..+.+|+.+++
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~l 350 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINF 350 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECC
T ss_pred cc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEE
Confidence 43 44344455556666666655433 33 233333333444444443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-16 Score=165.54 Aligned_cols=151 Identities=21% Similarity=0.266 Sum_probs=90.5
Q ss_pred ccceEEeccCCcccCCCCC------ccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhccc
Q 001226 553 SNLTMLDFSENRLSGSIPS------ELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEK 626 (1119)
Q Consensus 553 ~~L~~L~Ls~N~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 626 (1119)
..++.++++.|.++|.+|. .|.++++|++|+|++|++.+ +| .+..+++|+.|+|++|+++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3444444444444444443 66666666666666666664 55 6666666666666666666 45666666666
Q ss_pred CCeeEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcc-cccccccccceeec
Q 001226 627 MQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIP-ECLGNLDKLQILDL 705 (1119)
Q Consensus 627 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L 705 (1119)
|++|+|++|++++ +| .+..+++|+.|+|++|.++ +..+ ..+..+++|++|++
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~-------------------------~~~~~~~l~~l~~L~~L~l 147 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-------------------------NWGEIDKLAALDKLEDLLL 147 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC-------------------------CHHHHHHHTTTTTCSEEEE
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC-------------------------chhHHHHHhcCCCCCEEEe
Confidence 6666666666664 33 4556666665554444443 2111 35666777777777
Q ss_pred cCceecccCCcc----------ccccccceEEeccccccc
Q 001226 706 SSNSFSGEIPTE----------VNNMVSLYFVNISFNHFS 735 (1119)
Q Consensus 706 s~N~l~g~ip~~----------~~~~~~l~~l~ls~N~~~ 735 (1119)
++|++++.+|.. +..+++|+.+| +|.++
T Consensus 148 ~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 148 AGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred cCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 777777666553 66677777766 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.6e-16 Score=165.16 Aligned_cols=92 Identities=21% Similarity=0.256 Sum_probs=39.3
Q ss_pred cccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCC-hhhhhccc
Q 001226 548 VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP-SEVISLEK 626 (1119)
Q Consensus 548 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~ 626 (1119)
.+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++
T Consensus 65 ~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~ 141 (198)
T 1ds9_A 65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141 (198)
T ss_dssp CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCC
Confidence 3344444444444444444 334444444444444444444442 22 34444444444444444442111 23444444
Q ss_pred CCeeEccCccCccCCC
Q 001226 627 MQSLSLQENNLSGAIP 642 (1119)
Q Consensus 627 L~~L~L~~N~l~~~~p 642 (1119)
|++|++++|++++.+|
T Consensus 142 L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 142 LEDLLLAGNPLYNDYK 157 (198)
T ss_dssp CSEEEECSCHHHHHHH
T ss_pred CCEEEecCCccccccc
Confidence 4444444444444333
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=1.1e-14 Score=163.47 Aligned_cols=131 Identities=17% Similarity=0.130 Sum_probs=95.7
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccccc------------------c--------HHHHHHHHhhcCCCCE
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET------------------N--------FDVEIRTLSLVRHRNI 889 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~------------------~--------~~~E~~~l~~l~h~ni 889 (1119)
|..+++||+|+||.||+|.+.. |+.||||+++.... . ..+|...+.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~-G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEK-GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTT-CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECCC-CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 5567899999999999999865 89999998742210 0 1235555666544333
Q ss_pred E--EEeeeeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 890 L--RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 890 v--~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
. ..++. ...++||||++|+++.++... .....++.|++.++.|+|+. |||||||||.|||++
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 1 12221 234799999999888665432 12356889999999999998 999999999999998
Q ss_pred CCC----------ceEEEeccccccc
Q 001226 968 SEL----------EPKIGDFGMSKLI 983 (1119)
Q Consensus 968 ~~~----------~vkl~DfGla~~~ 983 (1119)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 876 3899999977644
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.9e-14 Score=146.27 Aligned_cols=104 Identities=17% Similarity=0.190 Sum_probs=48.4
Q ss_pred cceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCCh--hhhhcccCCeeE
Q 001226 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPS--EVISLEKMQSLS 631 (1119)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~ 631 (1119)
+|++|+|++|+|++. ..|.++++|++|+|++|++++..|..+..+++|++|+|++|+++ .+|. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence 444444444444432 34444445555555555554322233344555555555555553 2333 444455555555
Q ss_pred ccCccCccCCCcc----ccccccccEeecCCccc
Q 001226 632 LQENNLSGAIPDA----FSSVQSLFELQLGSNIF 661 (1119)
Q Consensus 632 L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l 661 (1119)
+++|.++ .+|.. +..+++|+.||+++|..
T Consensus 120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 5555554 23332 45555555555555543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=2.6e-14 Score=145.34 Aligned_cols=134 Identities=16% Similarity=0.109 Sum_probs=98.5
Q ss_pred cccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccc
Q 001226 500 EIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENL 579 (1119)
Q Consensus 500 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 579 (1119)
.+.++++|+.|++++|.++. +|......++|++|++++|++++. ..+..+++|++|+|++|+|++..|..|.++++|
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hcCCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 35667788888888888874 354333344888888888888754 567778888888888888875444445778888
Q ss_pred cEEEcccCcccCcCCc--ccccCCCCcEEeccCccccccCChh----hhhcccCCeeEccCccCc
Q 001226 580 QILRLSANKLDGRIPY--ELGKCTKMIKLDLSDNYLAGSIPSE----VISLEKMQSLSLQENNLS 638 (1119)
Q Consensus 580 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~ 638 (1119)
+.|+|++|++. .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 88888888885 5665 6777888888888888887 45654 777888888888888776
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.44 E-value=2.8e-13 Score=136.56 Aligned_cols=107 Identities=28% Similarity=0.356 Sum_probs=79.3
Q ss_pred ceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccC
Q 001226 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634 (1119)
Q Consensus 555 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 634 (1119)
.+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456777777776 4666554 6777777777777766677777777888888888887766666667777888888888
Q ss_pred ccCccCCCccccccccccEeecCCcccCCC
Q 001226 635 NNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664 (1119)
Q Consensus 635 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 664 (1119)
|+|++..|..|..+++|+.|+|++|.++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 888876666788888888888877777643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.2e-13 Score=135.77 Aligned_cols=104 Identities=24% Similarity=0.335 Sum_probs=68.8
Q ss_pred eEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCc
Q 001226 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635 (1119)
Q Consensus 556 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 635 (1119)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45666666664 5555554 56666777777776655666666777777777777776544445566777777777777
Q ss_pred cCccCCCccccccccccEeecCCcccC
Q 001226 636 NLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 636 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 777555555777777777777777665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=6.3e-13 Score=133.97 Aligned_cols=105 Identities=23% Similarity=0.265 Sum_probs=68.3
Q ss_pred eeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcc
Q 001226 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNY 612 (1119)
Q Consensus 533 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 612 (1119)
.+++++|+++. +|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 13 ~l~~s~n~l~~-ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 13 TVDCSGKSLAS-VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp EEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcCc-cCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 44444444442 44333 2566777777777776666677777777777777777775555556677777777777777
Q ss_pred ccccCChhhhhcccCCeeEccCccCccC
Q 001226 613 LAGSIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 613 l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
|++..|..+..+++|+.|+|++|.+++.
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 7765555667777777777777777643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=7.8e-13 Score=133.77 Aligned_cols=105 Identities=24% Similarity=0.291 Sum_probs=72.5
Q ss_pred ceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCc
Q 001226 532 SFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611 (1119)
Q Consensus 532 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 611 (1119)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|||++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34555555554 3454443 66777777777777666777777777777777777777554555677777777777777
Q ss_pred cccccCChhhhhcccCCeeEccCccCcc
Q 001226 612 YLAGSIPSEVISLEKMQSLSLQENNLSG 639 (1119)
Q Consensus 612 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 639 (1119)
+|++..+..+..+++|++|+|++|.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccc
Confidence 7775555557777777777777777774
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=3.7e-11 Score=138.98 Aligned_cols=113 Identities=13% Similarity=0.206 Sum_probs=61.6
Q ss_pred ccChhhhhcCC-CccEEEcCCCccCCCcchhhcCCCCCceeeecccc---ccccCcccccCCCCCcEEEccccccccccC
Q 001226 254 AISPWIFKGLL-QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANK---LNGTISGQISHCNQLQVIALSRNNLVGQIP 329 (1119)
Q Consensus 254 ~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 329 (1119)
.|...+|.++. .|+.+.+-++ ++.....+|.++++|+.+.+..|. ++.+...+|..+.+|+.+.+..+ ++....
T Consensus 53 ~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~ 130 (394)
T 4gt6_A 53 KIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDS 130 (394)
T ss_dssp EECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECT
T ss_pred EcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehh
Confidence 34556666653 4777777543 555556667777777777766653 44455556666666665555433 332334
Q ss_pred cccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEccc
Q 001226 330 RSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQH 369 (1119)
Q Consensus 330 ~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 369 (1119)
.+|.++.+|+.+.+..+. +......|..+.+|+.+.+..
T Consensus 131 ~aF~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~ 169 (394)
T 4gt6_A 131 EAFHHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPD 169 (394)
T ss_dssp TTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCT
T ss_pred hhhhhhccccccccccee-eeecccceecccccccccccc
Confidence 455555555555554332 223344455555555555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.32 E-value=8.4e-11 Score=136.02 Aligned_cols=330 Identities=11% Similarity=0.130 Sum_probs=154.1
Q ss_pred cccCCC-CCcEEEccCCccCCccChhhhhcCCCccEEEcCCCc---cCCCcchhhcCCCCCceeeeccccccccCccccc
Q 001226 234 SLSNCR-NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN---LEGQIPETLWGLENLQKLVLSANKLNGTISGQIS 309 (1119)
Q Consensus 234 ~l~~l~-~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 309 (1119)
+|.+++ .|+++.+..+ ++ .|...+|.++.+|+.+.+.+|. ++.....+|.++.+|+.+.+..+ ++.+...+|.
T Consensus 58 aF~~~~~~L~sI~iP~s-vt-~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VT-EIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CC-EECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hccCCCCcCEEEEECCC-ee-EEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 455553 3666666543 32 4556666666666666666542 44445556666666666665543 4445556666
Q ss_pred CCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhccccccee
Q 001226 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVL 389 (1119)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L 389 (1119)
.+.+|+.+.+..+ +.......|.++.+|+.+.+.++ ++.....+|.+ .+|+.+.+..+-.. ....+|..+.+++..
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence 6666666666543 23244455666666666666544 33233344433 45666655544322 333444555555544
Q ss_pred eccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceecccccee
Q 001226 390 YLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469 (1119)
Q Consensus 390 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 469 (1119)
....+.........+........-. ..+.....+..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~-------------------------------- 247 (394)
T 4gt6_A 211 TSDSESYPAIDNVLYEKSANGDYAL-----------IRYPSQREDPAF-------------------------------- 247 (394)
T ss_dssp EECCSSSCBSSSCEEEECTTSCEEE-----------EECCTTCCCSEE--------------------------------
T ss_pred cccccccccccceeecccccccccc-----------cccccccccceE--------------------------------
Confidence 4433332211100000000000000 000000111111
Q ss_pred eCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccc
Q 001226 470 YGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVF 549 (1119)
Q Consensus 470 ~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 549 (1119)
.+. +.++..-..+|.++++|+.+.+.++... .....|..+++|+.+.+. +.++..-...|
T Consensus 248 -----------------~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF 307 (394)
T 4gt6_A 248 -----------------KIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVF 307 (394)
T ss_dssp -----------------ECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTT
T ss_pred -----------------EcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceee
Confidence 111 0111111223444444444444433222 333444555555555553 23333333456
Q ss_pred cccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCe
Q 001226 550 GFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQS 629 (1119)
Q Consensus 550 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 629 (1119)
..+++|+.++|..+ ++..-..+|.++.+|+.+.|..+ ++..-..+|.++++|+.+++.+|.... ..+.....|+.
T Consensus 308 ~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~ 382 (394)
T 4gt6_A 308 AGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQN 382 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--
T ss_pred cCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCE
Confidence 66667777777654 44344556777777777777544 543334567777777777777765431 34555566777
Q ss_pred eEccCccCc
Q 001226 630 LSLQENNLS 638 (1119)
Q Consensus 630 L~L~~N~l~ 638 (1119)
+.+..|.+.
T Consensus 383 i~i~~~~~~ 391 (394)
T 4gt6_A 383 LPVAPGSID 391 (394)
T ss_dssp ---------
T ss_pred EEeCCCCEE
Confidence 776665543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.5e-14 Score=160.44 Aligned_cols=191 Identities=17% Similarity=0.110 Sum_probs=89.4
Q ss_pred CcccEEEcCCCcccCCCCccccc-----CCCccEEEcccccccccCCcccc-ccCccCEEEccCccccCCCCcccccccc
Q 001226 96 QHLLSLDLSGNEFTGSIPKQLGN-----CGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSLCYS 169 (1119)
Q Consensus 96 ~~l~~L~Ls~n~~~~~~~~~l~~-----l~~L~~L~L~~n~i~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 169 (1119)
++|++|+|++|.++......+.. .++|++|+|++|.+++.....+. .+++|++|||++|.+++.....++..
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~-- 149 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL-- 149 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHH--
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHH--
Confidence 45666666666665432222222 24566666666665543333332 24555566666665543322222110
Q ss_pred cceeeecccccccccCccC-CCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccC
Q 001226 170 LESIGFHNNFLNGELPNDI-CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248 (1119)
Q Consensus 170 L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~ 248 (1119)
+ ...++|++|+|++|.|+.... ..++..+..+++|++|+|++
T Consensus 150 ------------------L~~~~~~L~~L~Ls~n~l~~~~~-------------------~~l~~~L~~~~~L~~L~Ls~ 192 (372)
T 3un9_A 150 ------------------LLHDQCQITTLRLSNNPLTAAGV-------------------AVLMEGLAGNTSVTHLSLLH 192 (372)
T ss_dssp ------------------HHSTTCCCCEEECCSSCCHHHHH-------------------HHHHHHHHTCSSCCEEECTT
T ss_pred ------------------HHhcCCccceeeCCCCCCChHHH-------------------HHHHHHHhcCCCcCEEeCCC
Confidence 0 123455555555555542110 12233444555555555555
Q ss_pred CccCCcc---ChhhhhcCCCccEEEcCCCccCCCc----chhhcCCCCCceeeeccccccccCcccccCCC-----CCcE
Q 001226 249 NNFGGAI---SPWIFKGLLQLEVLYLDDNNLEGQI----PETLWGLENLQKLVLSANKLNGTISGQISHCN-----QLQV 316 (1119)
Q Consensus 249 n~i~~~~---~~~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~ 316 (1119)
|.+++.. ....+...++|++|+|++|.|++.. +.++...++|++|+|++|.|++.....+..+. .|+.
T Consensus 193 N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~ 272 (372)
T 3un9_A 193 TGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARV 272 (372)
T ss_dssp SSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEE
T ss_pred CCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchh
Confidence 5554221 1233444556666666666665432 23334456677777777766654444443321 1555
Q ss_pred EE--ccccccc
Q 001226 317 IA--LSRNNLV 325 (1119)
Q Consensus 317 L~--Ls~N~l~ 325 (1119)
+. +..|.+.
T Consensus 273 l~~ll~~~~~~ 283 (372)
T 3un9_A 273 VVSLTEGTAVS 283 (372)
T ss_dssp ECCCC----CH
T ss_pred hHhhhcCCccC
Confidence 55 5555544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.29 E-value=7e-14 Score=159.56 Aligned_cols=187 Identities=17% Similarity=0.097 Sum_probs=120.1
Q ss_pred CCccEEEcccccccccCCcccccc-----CccCEEEccCccccCCCCcccccccccceeeecccccccccCccCC-Cccc
Q 001226 120 GQLKTLLLNDNRFQGSIPPEIFKL-----KRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDIC-SLPK 193 (1119)
Q Consensus 120 ~~L~~L~L~~n~i~~~~p~~l~~l-----~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~ 193 (1119)
++|++|+|++|++++.....+... ++|++|||++|.++ +.....+. .+++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~------------------------~~~~~~l~~~L~~ 127 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD------------------------PAGLRTLLPVFLR 127 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCC------------------------HHHHHHTHHHHHT
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCC------------------------HHHHHHHHHHHHh
Confidence 456666666666654433333322 45555555555554 33222222 3567
Q ss_pred ccEEEeccccccccCCCCCccccceeeeeeccccccCccccc-cCCCCCcEEEccCCccCCcc---ChhhhhcCCCccEE
Q 001226 194 LKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSL-SNCRNLVEFSASSNNFGGAI---SPWIFKGLLQLEVL 269 (1119)
Q Consensus 194 L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l-~~l~~L~~L~l~~n~i~~~~---~~~~~~~l~~L~~L 269 (1119)
|++|+|++|+|+..... .+...+ ...++|++|++++|.+++.. ....+..+++|++|
T Consensus 128 L~~L~Ls~n~l~~~~~~-------------------~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L 188 (372)
T 3un9_A 128 ARKLGLQLNSLGPEACK-------------------DLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188 (372)
T ss_dssp EEEEECCSSCCCHHHHH-------------------HHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEE
T ss_pred ccHhhcCCCCCCHHHHH-------------------HHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEE
Confidence 88888888887643211 122233 34678999999999987432 23345778999999
Q ss_pred EcCCCccCCCc----chhhcCCCCCceeeeccccccccC----cccccCCCCCcEEEccccccccccCcccCCC---C--
Q 001226 270 YLDDNNLEGQI----PETLWGLENLQKLVLSANKLNGTI----SGQISHCNQLQVIALSRNNLVGQIPRSVGNL---S-- 336 (1119)
Q Consensus 270 ~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~-- 336 (1119)
+|++|+|++.. ++.+...++|++|+|++|.|++.. ...+..++.|++|+|++|.|++.....+..+ .
T Consensus 189 ~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~ 268 (372)
T 3un9_A 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEG 268 (372)
T ss_dssp ECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC-----
T ss_pred eCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCc
Confidence 99999998643 566778899999999999998643 3455678999999999999986555444333 2
Q ss_pred CCCeEE--ccCCccc
Q 001226 337 SLNSLL--LFNNRLQ 349 (1119)
Q Consensus 337 ~L~~L~--L~~N~l~ 349 (1119)
.|+.+. +..|.+.
T Consensus 269 ~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 269 GARVVVSLTEGTAVS 283 (372)
T ss_dssp -CEEECCCC----CH
T ss_pred cchhhHhhhcCCccC
Confidence 266776 6666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.8e-11 Score=137.58 Aligned_cols=102 Identities=22% Similarity=0.203 Sum_probs=60.0
Q ss_pred EeccCC-cccCCCCCccCCcccccEEEccc-CcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCc
Q 001226 558 LDFSEN-RLSGSIPSELGNLENLQILRLSA-NKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635 (1119)
Q Consensus 558 L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 635 (1119)
++++++ +|+ .+|. |..+++|+.|+|++ |+|.+..|..|..+++|+.|+|++|+|++.+|..|..|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3555 55566666666664 6665544555666666666666666666555556666666666666666
Q ss_pred cCccCCCccccccccccEeecCCcccC
Q 001226 636 NLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 636 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
+|++..|..|..++ |+.|+|++|.|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 66655455555444 666666666655
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.14 E-value=9.8e-11 Score=133.01 Aligned_cols=130 Identities=18% Similarity=0.156 Sum_probs=80.1
Q ss_pred eEEccCC-cccCCCCCCCCCCCCCcEEEccc-CcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeec
Q 001226 340 SLLLFNN-RLQGTLPPELGNCGSLVDLRLQH-NFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYN 417 (1119)
Q Consensus 340 ~L~L~~N-~l~~~~~~~l~~l~~L~~L~L~~-N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 417 (1119)
.++++++ +|+ .+|. +..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3566665 666 3555 66666777777764 777666666677777777777777777777777777777777777777
Q ss_pred ccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCc
Q 001226 418 NRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGP 472 (1119)
Q Consensus 418 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~ 472 (1119)
|+|++..+..|..++ |+.|+|++|++........+..+.......+..+.++..
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~ 143 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCH 143 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCC
Confidence 777754444455444 788888888777544433333332223333333444433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.06 E-value=6.6e-09 Score=119.40 Aligned_cols=135 Identities=16% Similarity=0.114 Sum_probs=74.6
Q ss_pred CcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcc
Q 001226 304 ISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNL 383 (1119)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l 383 (1119)
....+..+..|+.+.+..+ +.......|.++..|+.+.+..+ ++.....+|.++.+|+.+.+..+ +.......|.++
T Consensus 209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence 3444555555555555433 22233445555666666666544 33344455666666666666443 333444456666
Q ss_pred cccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCc
Q 001226 384 AKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442 (1119)
Q Consensus 384 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 442 (1119)
++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.....+|.++++|+.+.+..+
T Consensus 286 ~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 286 SNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp TTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred cccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 66666666666665555566666666666666543 44344556666666666666543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=3.1e-10 Score=123.33 Aligned_cols=137 Identities=12% Similarity=0.077 Sum_probs=107.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.|+.....+.|+.+.||++... ++.+++|+... ....+.+|+.+++.+. +..+.++++++.+.+..|+||||+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 4555566788888999998754 57899999853 3457899999999885 677888999988888899999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC--------------------------------------- 950 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 950 (1119)
+|.++.+.+... .....++.+++++++.||+..
T Consensus 93 ~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 93 DGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred CCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999998763211 123467889999999999811
Q ss_pred -----------------CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 951 -----------------VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 951 -----------------~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799999765
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.01 E-value=2.7e-08 Score=114.23 Aligned_cols=146 Identities=14% Similarity=0.125 Sum_probs=73.4
Q ss_pred chhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCC
Q 001226 281 PETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCG 360 (1119)
Q Consensus 281 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 360 (1119)
..++....+|+.+.+..+ +..+...+|..+..|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++......|.+++
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 334444555555555433 33344445555555555555443 33333445555555555555433 3323344555555
Q ss_pred CCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCccccCC
Q 001226 361 SLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRL 431 (1119)
Q Consensus 361 ~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 431 (1119)
+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.+.+..+ ++.....+|.+.
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 6666665555555444455555566666655433 44444455666666666555433 433334445444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=9.7e-10 Score=124.10 Aligned_cols=65 Identities=15% Similarity=0.122 Sum_probs=30.7
Q ss_pred CCCCcEEEccCCccCCccChhhhh--cCCCccEEEcCCCccCCCcch----hhcCCCCCceeeeccccccc
Q 001226 238 CRNLVEFSASSNNFGGAISPWIFK--GLLQLEVLYLDDNNLEGQIPE----TLWGLENLQKLVLSANKLNG 302 (1119)
Q Consensus 238 l~~L~~L~l~~n~i~~~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~ 302 (1119)
+++|+.|++.+|.+++......+. .+++|++|+|+.|.+++..+. .+..+++|+.|+|++|.|++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 455666666555554322222221 345555556655555543222 22334555555555555543
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=5.9e-10 Score=125.86 Aligned_cols=207 Identities=16% Similarity=0.111 Sum_probs=135.7
Q ss_pred CCceEEEecCCCcccc-cC----ccchhhhccCCcccEEEcCCCccc---------CCCCcccccCCCccEEEccccccc
Q 001226 68 SSSLKALNLSGFGLSG-VL----NNSISYICKNQHLLSLDLSGNEFT---------GSIPKQLGNCGQLKTLLLNDNRFQ 133 (1119)
Q Consensus 68 ~~~v~~l~l~~~~l~~-~~----~~~~~~~~~l~~l~~L~Ls~n~~~---------~~~~~~l~~l~~L~~L~L~~n~i~ 133 (1119)
..+|+.|.+...++.| .. +...+.+..+++|+.|.+..+.+. +.++..+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3468888888776653 21 122333556889999999765431 134455678899999999988311
Q ss_pred ccCCccccccCccCEEEccCccccCCCCcccc--cccccceeeecc--ccccccc-C----ccC--CCcccccEEEeccc
Q 001226 134 GSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVS--LCYSLESIGFHN--NFLNGEL-P----NDI--CSLPKLKSLYLNTN 202 (1119)
Q Consensus 134 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~--~l~~L~~L~L~~--n~l~~~~-~----~~l--~~l~~L~~L~L~~n 202 (1119)
.++. + .+++|++|+|..|.++......++ .+++|++|+|+. |...+.. . ..+ ..+++|++|+|++|
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 2333 4 388999999999888654444454 689999999863 2221110 1 122 24789999999999
Q ss_pred cccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCccChh---hhhcCCCccEEEcCCCccCCC
Q 001226 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW---IFKGLLQLEVLYLDDNNLEGQ 279 (1119)
Q Consensus 203 ~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~~~~---~~~~l~~L~~L~L~~n~l~~~ 279 (1119)
.+++..+. .+. ....+++|++|+|+.|.+++..... .+..+++|+.|+|++|.|++.
T Consensus 263 ~i~~~~~~-------------------~la-~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 263 EEQNVVVE-------------------MFL-ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp TTHHHHHH-------------------HHH-HCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred CCchHHHH-------------------HHH-hCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 87643211 011 1135789999999999987643222 235679999999999998866
Q ss_pred cchhhcC-CCCCceeeecccc
Q 001226 280 IPETLWG-LENLQKLVLSANK 299 (1119)
Q Consensus 280 ~p~~l~~-l~~L~~L~Ls~N~ 299 (1119)
.-..+.. + ...++++.++
T Consensus 323 ~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 323 MKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHHc--CCEEEecCCc
Confidence 5555554 3 3557777766
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.85 E-value=8e-09 Score=117.73 Aligned_cols=136 Identities=15% Similarity=0.301 Sum_probs=105.2
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecc--c-----ccccHHHHHHHHhhcC--CCCEEEEeeeeecC---CceEEEEe
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLN--R-----SETNFDVEIRTLSLVR--HRNILRIVGSCTKD---EHGFIVTE 907 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~e 907 (1119)
+.++.|.++.||+.... +..+++|+.. . ....+.+|+.+++.++ +..+.++++++.+. +..|+|||
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 67899999999998765 3678899876 2 2357889999999997 45578888888766 45799999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC------------------------------------- 950 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 950 (1119)
|++|..+.+... ..++...+..++.+++++++.||+..
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999887743211 13677788899999999999999731
Q ss_pred ------------------CCCeEecCCCCCCeEeCCCCc--eEEEecccccc
Q 001226 951 ------------------VPQIIHRDIKSDNILLDSELE--PKIGDFGMSKL 982 (1119)
Q Consensus 951 ------------------~~~ivH~Dlkp~Nill~~~~~--vkl~DfGla~~ 982 (1119)
.+.++|+|++|.||+++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999998753 68999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.83 E-value=6.4e-09 Score=112.70 Aligned_cols=130 Identities=17% Similarity=0.127 Sum_probs=96.4
Q ss_pred ceee-ecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhcCCCC--EEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIG-KGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVRHRN--ILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG-~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
+.++ .|..+.||++... +|+.+++|+.... ...+.+|+.+++.+++.+ +.+++++...++..++||||++|.++.
T Consensus 25 ~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 25 AQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp EECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EecccCCCCceEEEEecC-CCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 3454 5556999999653 4678999987543 356889999999986544 456888888778889999999998884
Q ss_pred HhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 001226 916 NVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC--------------------------------------------- 950 (1119)
Q Consensus 916 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------- 950 (1119)
... .+ ...++.++++.++.||+..
T Consensus 104 --~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 --SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp --TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred --cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 2256777888888888642
Q ss_pred ----------CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 951 ----------VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 951 ----------~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
...++|+|++|.||++++++.+.++|||.+.
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.77 E-value=4.2e-10 Score=120.27 Aligned_cols=141 Identities=18% Similarity=0.148 Sum_probs=84.0
Q ss_pred CceeeeeeeecCCCceEEEecCC---CcccccCcc-ch--------------------hhhccCCcccE--EEcCCCcc-
Q 001226 56 PCKWSGVSCYNNSSSLKALNLSG---FGLSGVLNN-SI--------------------SYICKNQHLLS--LDLSGNEF- 108 (1119)
Q Consensus 56 ~c~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~-~~--------------------~~~~~l~~l~~--L~Ls~n~~- 108 (1119)
.|+|.|+.|+....+|..+...+ .++.|.+++ .+ +.+...+.|.. ++++.|..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 48999999997655676655544 334443331 11 11222233333 44455522
Q ss_pred --cCCCCcccccCCCccEEEcccccccc--cCCccccccCccCEEEccCccccCCCCccccccc--ccceeeeccccccc
Q 001226 109 --TGSIPKQLGNCGQLKTLLLNDNRFQG--SIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCY--SLESIGFHNNFLNG 182 (1119)
Q Consensus 109 --~~~~~~~l~~l~~L~~L~L~~n~i~~--~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~--~L~~L~L~~n~l~~ 182 (1119)
.+.++....++++|++|+|++|+|++ .+|..+..+++|++|+|++|+|++. ..+..++ +|++|+|++|.+.+
T Consensus 157 ~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 157 CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 21222222467778888888888776 4556666788888888888887754 3444444 77777888777776
Q ss_pred ccCc-------cCCCcccccEEE
Q 001226 183 ELPN-------DICSLPKLKSLY 198 (1119)
Q Consensus 183 ~~~~-------~l~~l~~L~~L~ 198 (1119)
..|. .+..+++|+.||
T Consensus 235 ~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 235 TFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GCSSHHHHHHHHHHHCTTCCEES
T ss_pred ccCcchhHHHHHHHHCcccCeEC
Confidence 5542 355677777765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.65 E-value=7.4e-09 Score=114.96 Aligned_cols=180 Identities=23% Similarity=0.245 Sum_probs=118.8
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcC-CCC--EEEEeeeeecCC---ceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVR-HRN--ILRIVGSCTKDE---HGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~~~ 911 (1119)
+.++.|....||++. ..+++|+.... ...+.+|++.++.+. +.. +.+++.....++ ..|+|||+++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 569999999999863 46889987644 356889999998873 322 344454443332 34899999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD------------------------------------------ 949 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 949 (1119)
.++.+.... .++.+++..++.++++.++.||+.
T Consensus 101 ~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 887653321 256677778888888888888861
Q ss_pred -------------CCCCeEecCCCCCCeEeCC--CCceEEEeccccccccCCCCCCcccccccCCCc---cccccc----
Q 001226 950 -------------CVPQIIHRDIKSDNILLDS--ELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY---IAPENA---- 1007 (1119)
Q Consensus 950 -------------~~~~ivH~Dlkp~Nill~~--~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~---- 1007 (1119)
..+.++|+|++|.||++++ ...+.++||+.+..-..... .. ....+ ..|+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~---~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FI---SLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HH---TTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HH---HHHhhccccCHHHHHHHH
Confidence 1135899999999999998 45678999998865322100 00 00000 122210
Q ss_pred C--CC--------CCCCcchHHHHHHHHHHHHhCCCCC
Q 001226 1008 Y--ST--------RLTEKSDVYSYGVILFELLFRKMPV 1035 (1119)
Q Consensus 1008 ~--~~--------~~~~~sDvwslG~vl~elltg~~p~ 1035 (1119)
. +. ......+.|++|.++|++.+|+.+|
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00 0112268999999999999998775
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.43 E-value=1.6e-08 Score=102.93 Aligned_cols=115 Identities=12% Similarity=0.084 Sum_probs=88.3
Q ss_pred hhccCCcccEEEcCCC-cccC----CCCcccccCCCccEEEcccccccccC----CccccccCccCEEEccCccccCC--
Q 001226 91 YICKNQHLLSLDLSGN-EFTG----SIPKQLGNCGQLKTLLLNDNRFQGSI----PPEIFKLKRLSWLDLGYNSLSGK-- 159 (1119)
Q Consensus 91 ~~~~l~~l~~L~Ls~n-~~~~----~~~~~l~~l~~L~~L~L~~n~i~~~~----p~~l~~l~~L~~L~Ls~n~l~~~-- 159 (1119)
.+...+.|++|+|++| .+.. .+...+...++|++|+|++|+|.+.. ...+...++|++|+|++|.|++.
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3556788999999998 8864 24556677889999999999987643 34455568899999999998764
Q ss_pred --CCcccccccccceeee--cccccccccCc----cCCCcccccEEEecccccc
Q 001226 160 --IPPQVSLCYSLESIGF--HNNFLNGELPN----DICSLPKLKSLYLNTNNLT 205 (1119)
Q Consensus 160 --~p~~l~~l~~L~~L~L--~~n~l~~~~~~----~l~~l~~L~~L~L~~n~l~ 205 (1119)
+...+...++|++|+| ++|.+++.... .+...+.|++|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 3456677788999999 88998876544 3444588999999999876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.37 E-value=3.4e-08 Score=105.56 Aligned_cols=80 Identities=28% Similarity=0.348 Sum_probs=47.5
Q ss_pred CCcccccEEEcccCcccC--cCCcccccCCCCcEEeccCccccccCChhhhhcc--cCCeeEccCccCccCCCc------
Q 001226 574 GNLENLQILRLSANKLDG--RIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLE--KMQSLSLQENNLSGAIPD------ 643 (1119)
Q Consensus 574 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~------ 643 (1119)
.++++|+.|+|++|+|++ .+|..+..+++|+.|||++|+|++. ..+..+. +|+.|+|++|.+++.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 345667777777777765 3445556667777777777777643 3344444 666666666666665542
Q ss_pred -cccccccccEee
Q 001226 644 -AFSSVQSLFELQ 655 (1119)
Q Consensus 644 -~~~~l~~L~~L~ 655 (1119)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 245555555544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2e-06 Score=93.53 Aligned_cols=135 Identities=21% Similarity=0.238 Sum_probs=99.2
Q ss_pred ceeeecCCc-cEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEeccCCCCHHH
Q 001226 840 RIIGKGKHG-TVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 840 ~~lG~G~fg-~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 916 (1119)
+.+..|..| .||+......+..+++|+.... ...+.+|+..++.+. +--|.++++++.+++..++|||+++|.++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 456667766 5999888777788999987543 346788999998875 3346778888888889999999999988876
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 001226 917 VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC---------------------------------------------- 950 (1119)
Q Consensus 917 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------- 950 (1119)
...... .....++.+++..++.||+..
T Consensus 110 ~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 110 VLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 554321 122345556666666666431
Q ss_pred ---------CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 951 ---------VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 951 ---------~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899999875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.28 E-value=1.4e-07 Score=95.90 Aligned_cols=122 Identities=15% Similarity=0.099 Sum_probs=58.6
Q ss_pred cccccCCCCCcEEEccCC-ccCCccC---hhhhhcCCCccEEEcCCCccCCCc----chhhcCCCCCceeeecccccccc
Q 001226 232 PTSLSNCRNLVEFSASSN-NFGGAIS---PWIFKGLLQLEVLYLDDNNLEGQI----PETLWGLENLQKLVLSANKLNGT 303 (1119)
Q Consensus 232 p~~l~~l~~L~~L~l~~n-~i~~~~~---~~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~~~ 303 (1119)
...+...++|++|++++| .+++... ...+...++|++|+|++|+|.+.. .+.+...++|++|+|++|.|++.
T Consensus 29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~ 108 (185)
T 1io0_A 29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS 108 (185)
T ss_dssp HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence 344555666666666666 5543211 222333455555555555554322 22223334455555555544422
Q ss_pred CcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEc--cCCcccCC----CCCCCCCCCCCcEEEcccCcCc
Q 001226 304 ISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLL--FNNRLQGT----LPPELGNCGSLVDLRLQHNFIG 373 (1119)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L--~~N~l~~~----~~~~l~~l~~L~~L~L~~N~i~ 373 (1119)
... .+...+...++|++|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 109 g~~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 109 GIL--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHH--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHH--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 100 12334444555666666 55555532 1223344566777777777664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1e-05 Score=89.35 Aligned_cols=133 Identities=23% Similarity=0.273 Sum_probs=90.5
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCC---CEEEEeeeee-cCCceEEEEeccCCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHR---NILRIVGSCT-KDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~gs 913 (1119)
+.++.|....||+. ++.+++|+.... ...+.+|+++++.+.+. .+.+++.+.. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 56889999999987 467889986532 34678999999998742 3455566553 4566789999999988
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD-------------------------------------------- 949 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------------- 949 (1119)
+.+.... .++..+...++.++++.++.||+.
T Consensus 100 l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 100 LGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp CHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred Cchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 7653211 123333444444444444444432
Q ss_pred -------------CCCCeEecCCCCCCeEeCC---CCce-EEEecccccc
Q 001226 950 -------------CVPQIIHRDIKSDNILLDS---ELEP-KIGDFGMSKL 982 (1119)
Q Consensus 950 -------------~~~~ivH~Dlkp~Nill~~---~~~v-kl~DfGla~~ 982 (1119)
..+.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2236799999999999998 4554 8999998763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.09 E-value=6.5e-07 Score=88.52 Aligned_cols=83 Identities=11% Similarity=0.025 Sum_probs=47.1
Q ss_pred CccEEEcccccccccCCccccccCccCEEEccCc-cccCCCCcccccc----cccceeeeccc-ccccccCccCCCcccc
Q 001226 121 QLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYN-SLSGKIPPQVSLC----YSLESIGFHNN-FLNGELPNDICSLPKL 194 (1119)
Q Consensus 121 ~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n-~l~~~~p~~l~~l----~~L~~L~L~~n-~l~~~~~~~l~~l~~L 194 (1119)
+|++|||+++.|++.....+..+++|++|+|++| .|++..-..++.+ ++|++|+|++| ++|+.....+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 4555555555555544444555555555555555 2444333344432 35666666665 3666666666677777
Q ss_pred cEEEecccc
Q 001226 195 KSLYLNTNN 203 (1119)
Q Consensus 195 ~~L~L~~n~ 203 (1119)
++|++++|.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 777777773
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.94 E-value=1.4e-06 Score=86.23 Aligned_cols=87 Identities=7% Similarity=0.005 Sum_probs=68.1
Q ss_pred CcccEEEcCCCcccCCCCcccccCCCccEEEcccc-cccccCCcccccc----CccCEEEccCc-cccCCCCcccccccc
Q 001226 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDN-RFQGSIPPEIFKL----KRLSWLDLGYN-SLSGKIPPQVSLCYS 169 (1119)
Q Consensus 96 ~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n-~i~~~~p~~l~~l----~~L~~L~Ls~n-~l~~~~p~~l~~l~~ 169 (1119)
.+|++|||+++.+++.--..+..|++|++|+|++| +|++..-..++.+ ++|++|+|++| +|++..-..++.+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 36888888888887766666788889999999998 5887766667764 47999999987 488766677888889
Q ss_pred cceeeecccc-ccc
Q 001226 170 LESIGFHNNF-LNG 182 (1119)
Q Consensus 170 L~~L~L~~n~-l~~ 182 (1119)
|++|++++|. +++
T Consensus 141 L~~L~L~~c~~Itd 154 (176)
T 3e4g_A 141 LKYLFLSDLPGVKE 154 (176)
T ss_dssp CCEEEEESCTTCCC
T ss_pred CCEEECCCCCCCCc
Confidence 9999998873 554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=1.6e-05 Score=90.14 Aligned_cols=77 Identities=13% Similarity=0.153 Sum_probs=55.8
Q ss_pred cee-eecCCccEEEEEeC---C---CceEEEEEeccccc-------ccHHHHHHHHhhcC-C--CCEEEEeeeeecC---
Q 001226 840 RII-GKGKHGTVYRTLSN---N---SRKHWAVKKLNRSE-------TNFDVEIRTLSLVR-H--RNILRIVGSCTKD--- 899 (1119)
Q Consensus 840 ~~l-G~G~fg~Vy~~~~~---~---~~~~vavK~~~~~~-------~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 899 (1119)
+.| +.|....+|+.... + .++.+++|+..... ..+.+|+.+++.+. + -.+.++++++.++
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999987654 1 15678999875432 56889999998885 2 3566777776655
Q ss_pred CceEEEEeccCCCCHHH
Q 001226 900 EHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 900 ~~~~lV~e~~~~gsL~~ 916 (1119)
+..|+||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 45689999999876643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.67 E-value=5.2e-05 Score=85.28 Aligned_cols=140 Identities=16% Similarity=0.213 Sum_probs=81.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCC--CCEEEEeee------eecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRH--RNILRIVGS------CTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~------~~~~~~~~lV~e~~~~ 911 (1119)
+.++.|..+.||+....+ ..+++|+..........|+.+++.+.. -.+.+++.. ...++..++||||++|
T Consensus 38 ~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G 115 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS--GAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG 115 (346)
T ss_dssp EECC----CEEEEEEETT--EEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred eeccccccCcEEEEEeCC--CCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence 456667789999987653 458999987655556667777766631 123333331 1245667899999998
Q ss_pred CCHH--------------HhhccCC-----C-C-----CCCCHHHH-------------------------------HHH
Q 001226 912 GTLF--------------NVLHQNE-----P-R-----LVLDWNTR-------------------------------YHI 935 (1119)
Q Consensus 912 gsL~--------------~~l~~~~-----~-~-----~~l~~~~~-------------------------------~~i 935 (1119)
..+. ..+|... + . ....|... ..+
T Consensus 116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (346)
T 2q83_A 116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF 195 (346)
T ss_dssp BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence 6542 1122110 0 0 01123211 011
Q ss_pred HHHHHHHHHHHHh----------CCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 936 ALGIAQGLSYLHY----------DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 936 ~~~i~~~l~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
...+..++.+|+. .....++|+|+++.||+++.++.+.++||+.+.
T Consensus 196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1223345666653 123489999999999999888899999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00013 Score=83.96 Aligned_cols=71 Identities=17% Similarity=0.163 Sum_probs=47.4
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccc-----------ccccHHHHHHHHhhcCC--C-CEEEEeeeeecCCceEEE
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----------SETNFDVEIRTLSLVRH--R-NILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~lV 905 (1119)
+.+|.|..+.||++.....++.|+||.... ..+.+..|++.++.+.. | .+.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 579999999999997765678899997532 12345779888887742 3 33455543 34456899
Q ss_pred EeccCCC
Q 001226 906 TEYMPGG 912 (1119)
Q Consensus 906 ~e~~~~g 912 (1119)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00041 Score=76.19 Aligned_cols=136 Identities=19% Similarity=0.221 Sum_probs=90.6
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhcC---CCCEEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVR---HRNILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
+.++.|....+|+.... ++.+++|+.... ...+..|+..++.+. ...+.+++++...++..++||||+++..+.
T Consensus 42 ~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE--VQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EEECCSSSSEEEEEESS--SCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred EEeCCccceeeeEEEEC--CCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 57899999999998753 577889987543 345788999998884 356788888887778899999999987642
Q ss_pred -----------HhhccCCC--CC-----------------CCCHHHHH---HHHH----------------HHHHH-HHH
Q 001226 916 -----------NVLHQNEP--RL-----------------VLDWNTRY---HIAL----------------GIAQG-LSY 945 (1119)
Q Consensus 916 -----------~~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------~i~~~-l~~ 945 (1119)
..+|.... .. .-+|.+.. ++.. .++.. ...
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 12233221 00 12454321 1111 11111 223
Q ss_pred HHh-CCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 946 LHY-DCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 946 LH~-~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
|.. ...+.++|+|+.+.|++++.++ +.|+|++
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 321 2246899999999999999887 8899974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.24 E-value=3.9e-05 Score=77.28 Aligned_cols=114 Identities=12% Similarity=0.118 Sum_probs=82.4
Q ss_pred hccCCcccEEEcCCC-cccC----CCCcccccCCCccEEEcccccccccCCccc----cccCccCEEEccCccccCCCCc
Q 001226 92 ICKNQHLLSLDLSGN-EFTG----SIPKQLGNCGQLKTLLLNDNRFQGSIPPEI----FKLKRLSWLDLGYNSLSGKIPP 162 (1119)
Q Consensus 92 ~~~l~~l~~L~Ls~n-~~~~----~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l----~~l~~L~~L~Ls~n~l~~~~p~ 162 (1119)
+...+.|++|+|++| .|.. .+.+.+..-+.|++|+|++|+|.+.....| ..-+.|++|+|++|.|.+.+..
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 445678999999985 7754 355667777889999999999987644444 4568899999999999865433
Q ss_pred ----ccccccccceeeeccc---ccccc----cCccCCCcccccEEEecccccc
Q 001226 163 ----QVSLCYSLESIGFHNN---FLNGE----LPNDICSLPKLKSLYLNTNNLT 205 (1119)
Q Consensus 163 ----~l~~l~~L~~L~L~~n---~l~~~----~~~~l~~l~~L~~L~L~~n~l~ 205 (1119)
.+..-+.|++|+|++| .+... +.+.+..-+.|+.|+++.|.+.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 3445567999999865 44543 2344556688999999887654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00079 Score=77.86 Aligned_cols=76 Identities=14% Similarity=0.150 Sum_probs=47.3
Q ss_pred CCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcccccc--cCCCcccccccCCC---CCCCcchHHHHHHHHH
Q 001226 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV--GSLGYIAPENAYST---RLTEKSDVYSYGVILF 1026 (1119)
Q Consensus 952 ~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDvwslG~vl~ 1026 (1119)
+.++|+|++|.||+++.++ ++++||+.+..-.... ...... -...|.+|+..... ......++......+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4899999999999999876 9999999887432110 000000 11346666644311 1122355667888888
Q ss_pred HHHhC
Q 001226 1027 ELLFR 1031 (1119)
Q Consensus 1027 elltg 1031 (1119)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0018 Score=72.17 Aligned_cols=140 Identities=14% Similarity=0.113 Sum_probs=75.9
Q ss_pred ceeeecCCcc-EEEEEeCCCceEEEEEeccccc-ccHHHHHHHHhhcCC--CCEEEEeeeeecCCceEEEEeccCCCCHH
Q 001226 840 RIIGKGKHGT-VYRTLSNNSRKHWAVKKLNRSE-TNFDVEIRTLSLVRH--RNILRIVGSCTKDEHGFIVTEYMPGGTLF 915 (1119)
Q Consensus 840 ~~lG~G~fg~-Vy~~~~~~~~~~vavK~~~~~~-~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 915 (1119)
+.++.|+... +|+.... +++.+++|...... ..+..|+.+++.+.. -.+.+++.+..+.+ ++|||++++..+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 4465565544 6676543 25667788765544 677888888887742 23455666533333 7899999877765
Q ss_pred HhhccCC---------------------CC--CCCCHHHHH-------H-------------HHHHHHHHHHHHHh---C
Q 001226 916 NVLHQNE---------------------PR--LVLDWNTRY-------H-------------IALGIAQGLSYLHY---D 949 (1119)
Q Consensus 916 ~~l~~~~---------------------~~--~~l~~~~~~-------~-------------i~~~i~~~l~~LH~---~ 949 (1119)
+++.... .. ...+..... . ....+...+..+.. .
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 5443211 00 011111100 0 00111222233311 1
Q ss_pred CCCCeEecCCCCCCeEeCCC----CceEEEecccccc
Q 001226 950 CVPQIIHRDIKSDNILLDSE----LEPKIGDFGMSKL 982 (1119)
Q Consensus 950 ~~~~ivH~Dlkp~Nill~~~----~~vkl~DfGla~~ 982 (1119)
....++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 23479999999999999875 6789999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0018 Score=70.63 Aligned_cols=70 Identities=16% Similarity=0.161 Sum_probs=50.9
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCC---CCEEEEeeeeecCCceEEEEeccCCC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRH---RNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
+.+|.|..+.||+.+..+ |+.|++|+.... ...+..|++.|+.+.- --+.+++++. ..++||||++++
T Consensus 21 ~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 678999999999998765 789999987532 2357899999998842 1244455432 347899999876
Q ss_pred CH
Q 001226 913 TL 914 (1119)
Q Consensus 913 sL 914 (1119)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00058 Score=68.71 Aligned_cols=90 Identities=17% Similarity=0.186 Sum_probs=44.4
Q ss_pred hcCCCCCceeeeccccccccC----cccccCCCCCcEEEccccccccc----cCcccCCCCCCCeEEccCCc---ccCC-
Q 001226 284 LWGLENLQKLVLSANKLNGTI----SGQISHCNQLQVIALSRNNLVGQ----IPRSVGNLSSLNSLLLFNNR---LQGT- 351 (1119)
Q Consensus 284 l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~---l~~~- 351 (1119)
+..-+.|+.|+|++|+|.+.. ...+...+.|++|+|++|.|.+. +.+.+..-+.|++|+|++|. +...
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g 145 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 145 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHH
Confidence 333444555555555554322 22333445555555555555432 22334445556667766542 2211
Q ss_pred ---CCCCCCCCCCCcEEEcccCcCc
Q 001226 352 ---LPPELGNCGSLVDLRLQHNFIG 373 (1119)
Q Consensus 352 ---~~~~l~~l~~L~~L~L~~N~i~ 373 (1119)
+...+..-+.|+.|+++.|.+.
T Consensus 146 ~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 146 EMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHHhCCCcCeEeccCCCcc
Confidence 2233444567777777776654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0023 Score=70.18 Aligned_cols=135 Identities=16% Similarity=0.114 Sum_probs=76.4
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCE-EEEeeeeecCCceEEEEecc-CCCC
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNI-LRIVGSCTKDEHGFIVTEYM-PGGT 913 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gs 913 (1119)
.+.++.|....+|+. +.+++|+..... .+..+|+..++.+....+ .+++++. .+..++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 477999999999998 457899885432 345778888887742222 3555443 33457899999 6544
Q ss_pred HHH------------------hhccCCCCC--CCC-HHHHHHHHHH--------------HHHHH----HHHHh-CCCCC
Q 001226 914 LFN------------------VLHQNEPRL--VLD-WNTRYHIALG--------------IAQGL----SYLHY-DCVPQ 953 (1119)
Q Consensus 914 L~~------------------~l~~~~~~~--~l~-~~~~~~i~~~--------------i~~~l----~~LH~-~~~~~ 953 (1119)
+.. -+|...... ... +.....+... +.+.+ ..+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 011111100 011 1111111110 11111 11211 12235
Q ss_pred eEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 954 IIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 954 ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
++|+|+.|.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5667789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0017 Score=74.99 Aligned_cols=71 Identities=14% Similarity=0.191 Sum_probs=49.9
Q ss_pred ceeeecCCccEEEEEeCC-------CceEEEEEeccc-cc-ccHHHHHHHHhhcCCCC-EEEEeeeeecCCceEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNR-SE-TNFDVEIRTLSLVRHRN-ILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~-~~-~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+.|+.|....||++.... .++.|++|+... .. ..+..|..+++.+...+ ..++++.+.+ .+|+||+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l 154 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 154 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEe
Confidence 568889899999998653 257899999854 33 56678999988875323 3566665543 3899999
Q ss_pred CCCCH
Q 001226 910 PGGTL 914 (1119)
Q Consensus 910 ~~gsL 914 (1119)
+|.++
T Consensus 155 ~G~~l 159 (429)
T 1nw1_A 155 PSRPL 159 (429)
T ss_dssp CEEEC
T ss_pred CCccc
Confidence 86443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0032 Score=71.01 Aligned_cols=139 Identities=17% Similarity=0.159 Sum_probs=82.9
Q ss_pred ceeeecCCccEEEEEeCC-------CceEEEEEeccc---ccccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEec
Q 001226 840 RIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNR---SETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+.+..|....+|++.... .++.|++|+... ......+|.++++.+. +.-..++++++.+ .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 568888899999988642 357899998743 2345668999998874 3223566666554 289999
Q ss_pred cCCCCHHHh-----------------hccCCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHH--
Q 001226 909 MPGGTLFNV-----------------LHQNEP--RLVL--DWNTRYHIALGIAQ-------------------GLSYL-- 946 (1119)
Q Consensus 909 ~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~l~~L-- 946 (1119)
++|..+..- +|.... .... -+.++.++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 988654310 111111 1112 23455555444321 22333
Q ss_pred --HhC-CCCCeEecCCCCCCeEeCCC----CceEEEecccccc
Q 001226 947 --HYD-CVPQIIHRDIKSDNILLDSE----LEPKIGDFGMSKL 982 (1119)
Q Consensus 947 --H~~-~~~~ivH~Dlkp~Nill~~~----~~vkl~DfGla~~ 982 (1119)
... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 12368999999999999876 7899999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0047 Score=71.63 Aligned_cols=71 Identities=18% Similarity=0.254 Sum_probs=48.8
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccccc---cHHHHHHHHhhcCCCCE-EEEeeeeecCCceEEEEeccCCCCH
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET---NFDVEIRTLSLVRHRNI-LRIVGSCTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL 914 (1119)
+.|+.|....+|++.....+..|++|+...... +..+|..+++.+...++ .++++++.. ..||||++|.++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 578889999999998765457899998854322 23689999998864444 566666632 259999987544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0029 Score=70.08 Aligned_cols=140 Identities=13% Similarity=0.187 Sum_probs=80.6
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhcCCCC--EEEEeeee------ecCCceEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLVRHRN--ILRIVGSC------TKDEHGFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lV~e~~ 909 (1119)
+.++.|....+|+....+ ..+++|+... ....+..|+.+++.+.... +.+++... ...+..++||+|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK--DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESS--CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCC--ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 457778889999987653 3688998865 4566788888888774222 23333221 1235568999999
Q ss_pred CCCCHHH--------------hhccC----CCC-----CCCCHHHHHH------------HHHHHHHHHHHHHhC----C
Q 001226 910 PGGTLFN--------------VLHQN----EPR-----LVLDWNTRYH------------IALGIAQGLSYLHYD----C 950 (1119)
Q Consensus 910 ~~gsL~~--------------~l~~~----~~~-----~~l~~~~~~~------------i~~~i~~~l~~LH~~----~ 950 (1119)
+|..+.. .+|.. ... ....|..... +...+.+.+++++.. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865311 11211 000 0011222100 011134445555532 1
Q ss_pred CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 951 ~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
..+++|+|+.+.||++++++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2479999999999999887666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.24 E-value=0.015 Score=64.44 Aligned_cols=139 Identities=15% Similarity=0.157 Sum_probs=79.2
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccc---ccccHHHHHHHHhhcCCC--CEEEEeee-----eecCCceEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHR--NILRIVGS-----CTKDEHGFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~e~~ 909 (1119)
+.++ |....||+....+ |+.+++|+... ....+..|...++.+... .+++++.. ...++..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~-g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCC-CCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 8888999876543 56789999863 345677788888877422 23444443 11244567899999
Q ss_pred CCCCHH-----Hh---------hcc----CC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 001226 910 PGGTLF-----NV---------LHQ----NE--PRLVLDWNTR----YHI---------------ALGIAQGLSYLHYD- 949 (1119)
Q Consensus 910 ~~gsL~-----~~---------l~~----~~--~~~~l~~~~~----~~i---------------~~~i~~~l~~LH~~- 949 (1119)
+|..+. .+ +|. .. .....++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 00 111 00 0111222111 000 11111223333221
Q ss_pred ---CCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 950 ---CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 950 ---~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999987753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.006 Score=57.25 Aligned_cols=55 Identities=22% Similarity=0.269 Sum_probs=26.6
Q ss_pred EEeccCCccc-CCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccc
Q 001226 557 MLDFSENRLS-GSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613 (1119)
Q Consensus 557 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 613 (1119)
.++.+++.++ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4455555553 23443332 2355555555555533334445555555555555554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0061 Score=68.94 Aligned_cols=71 Identities=13% Similarity=0.177 Sum_probs=44.7
Q ss_pred ceeeecCCccEEEEEeCC--------CceEEEEEecccccc---cHHHHHHHHhhcCCCC-EEEEeeeeecCCceEEEEe
Q 001226 840 RIIGKGKHGTVYRTLSNN--------SRKHWAVKKLNRSET---NFDVEIRTLSLVRHRN-ILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~--------~~~~vavK~~~~~~~---~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e 907 (1119)
+.++.|....+|+..... .++.|++|+...... +...|..+++.+...+ +.++++.. . .++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 567888889999987653 126889998864332 3468888888875323 34555543 1 368999
Q ss_pred ccCCCCH
Q 001226 908 YMPGGTL 914 (1119)
Q Consensus 908 ~~~~gsL 914 (1119)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.005 Score=57.83 Aligned_cols=56 Identities=25% Similarity=0.358 Sum_probs=37.9
Q ss_pred EEeccCcccc-ccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccC
Q 001226 605 KLDLSDNYLA-GSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 605 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
.+|.+++.|+ ..+|..+. .+|+.|+|++|+|+...++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777775 23554432 35777777777777666667777777888777777664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.48 E-value=0.014 Score=64.95 Aligned_cols=66 Identities=9% Similarity=0.156 Sum_probs=42.5
Q ss_pred cCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcC---CCCEEEEeee------eecCCceEEEEeccCCCCH
Q 001226 845 GKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVR---HRNILRIVGS------CTKDEHGFIVTEYMPGGTL 914 (1119)
Q Consensus 845 G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lV~e~~~~gsL 914 (1119)
|....||+....+ | .+++|+..... ...|+..++.+. -|.+++.+.. ....+..++||||++|..+
T Consensus 34 g~~N~vy~v~~~~-g-~~vLK~~~~~~--~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~ 108 (339)
T 3i1a_A 34 DTNAFAYQADSES-K-SYFIKLKYGYH--DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG 108 (339)
T ss_dssp CSSCEEEEEECSS-C-EEEEEEEECSS--CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred ccccceEEEEeCC-C-CEEEEEecCcc--chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence 3367899987654 4 88999876543 246777776663 2224444432 1234667899999998755
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.26 E-value=0.052 Score=54.76 Aligned_cols=101 Identities=14% Similarity=0.124 Sum_probs=65.0
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
.+|.++|...+. +++++++|.++.|.+.++.-.-.... . ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 478999987754 69999999999999998877632111 1 1222346889999999887774 2111
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK 1032 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~ 1032 (1119)
.....+.|||... ...+.+.=|||+|+++|.-+--.
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0122466888653 34567888999999999998433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.11 Score=59.40 Aligned_cols=71 Identities=13% Similarity=0.153 Sum_probs=48.8
Q ss_pred ceeeecCCccEEEEEeCCC-------ceEEEEEeccccc---ccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEec
Q 001226 840 RIIGKGKHGTVYRTLSNNS-------RKHWAVKKLNRSE---TNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~-------~~~vavK~~~~~~---~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+.+..|....+|+...... ++.|++|+..... .+..+|.++++.+. +.-..++++.+. .+.||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 5677888899999886531 4778999875432 24578999998885 322345554332 3789999
Q ss_pred cCCCCH
Q 001226 909 MPGGTL 914 (1119)
Q Consensus 909 ~~~gsL 914 (1119)
++|..+
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=91.46 E-value=0.024 Score=39.56 Aligned_cols=30 Identities=37% Similarity=0.666 Sum_probs=23.3
Q ss_pred CCCcccceeeehhhHHHHHHHHHHHhheee
Q 001226 769 GRGHTRGRLAGIIIGVLLSVALLCALIYIM 798 (1119)
Q Consensus 769 ~~~~~~~~~~~ii~~~~~~v~~~~~~~~~~ 798 (1119)
+++.+.+.++||++|+++.+++++++++++
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 345667889999999999888877766544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.34 E-value=0.79 Score=51.99 Aligned_cols=30 Identities=30% Similarity=0.390 Sum_probs=25.2
Q ss_pred CeEecCCCCCCeEe------CCCCceEEEecccccc
Q 001226 953 QIIHRDIKSDNILL------DSELEPKIGDFGMSKL 982 (1119)
Q Consensus 953 ~ivH~Dlkp~Nill------~~~~~vkl~DfGla~~ 982 (1119)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998863
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1119 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-36 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.004 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-17 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.004 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 5e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 9e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-60
Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLSLVRHRNILRI 892
G+ IG G GTVY+ + AVK LN + F E+ L RH NIL
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDV---AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 893 VGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVP 952
+G T + IVT++ G +L++ LH E + + IA AQG+ YLH
Sbjct: 70 MGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 953 QIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE---NAYS 1009
IIHRD+KS+NI L +L KIGDFG++ + S S + GS+ ++APE
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 1010 TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069
+ +SDVY++G++L+EL+ ++P + + + + + +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
+ + L EC ++ D RP +++ + L
Sbjct: 239 PKA--------MKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 3e-56
Identities = 69/296 (23%), Positives = 127/296 (42%), Gaps = 29/296 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
IGKG+ G V+R + AVK + E + EI ++RH NIL + +
Sbjct: 8 QESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 896 CTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
KD ++V++Y G+LF+ L++ + +AL A GL++LH + V
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121
Query: 952 -----PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS--HSSSTRSAIVGSLGYIAP 1004
P I HRD+KS NIL+ I D G++ + + VG+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 1005 E------NAYSTRLTEKSDVYSYGVILFELLFRKMP--VDPSFGEDTDIVTWTRWKLQEN 1056
E N +++D+Y+ G++ +E+ R + + + + ++E
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 1057 HECICFLDREISFWDSDDQLKALRLL-ELALECTRQVADMRPSMREVVGFLIKLND 1111
+ +C + + +ALR++ ++ EC R + + L +L+
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-55
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVE 877
+L D +E + +G G G V++ S A K ++ E
Sbjct: 2 ELKDD-DFEKI------SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 878 IRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937
++ L I+ G+ D I E+M GG+L VL + + +++
Sbjct: 55 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSI 111
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
+ +GL+YL +I+HRD+K NIL++S E K+ DFG+S + DS ++S VG
Sbjct: 112 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVG 165
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046
+ Y++PE T + +SD++S G+ L E+ + P+ P ++ +++
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-54
Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIR 879
++PR+ + +G G+ G V+ N K AVK L + + F E
Sbjct: 9 EVPRE-TLK------LVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEAN 60
Query: 880 TLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
+ ++H+ ++R+ T++ +I+TEYM G+L + L L N +A I
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQI 118
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL 999
A+G++++ IHRD+++ NIL+ L KI DFG+++LI D+ + R +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPI 174
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
+ APE T KSDV+S+G++L E++ P N E
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG---------------MTNPEV 219
Query: 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
I L+R D+ + L +L C ++ + RP+ + L
Sbjct: 220 IQNLERGYRMVRPDNCPEELY--QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 9e-54
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 43/296 (14%)
Query: 819 SRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN----- 873
SR+ED YE IG G +G + + K K+L+
Sbjct: 1 SRAED------YE------VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ 48
Query: 874 -FDVEIRTLSLVRHRNILRIVGSCTKDEHG--FIVTEYMPGGTLFNVLHQN-EPRLVLDW 929
E+ L ++H NI+R + +IV EY GG L +V+ + + R LD
Sbjct: 49 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108
Query: 930 NTRYHIALGIAQGLSYLHY--DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987
+ + L H D ++HRD+K N+ LD + K+GDFG+++++ +H
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NH 166
Query: 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047
+S A VG+ Y++PE EKSD++S G +L+EL P
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP------------- 213
Query: 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103
+T + +E I + D+L E+ RPS+ E++
Sbjct: 214 FTAFSQKELAGKIREGKFRRIPYRYSDELN-----EIITRMLNLKDYHRPSVEEIL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 36/276 (13%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLSLVRHRNILRI 892
IG+G TVY+ L + A +L + F E L ++H NI+R
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 893 VGSCTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
S G +VTE M GTL L + + + I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHT 130
Query: 949 DCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENA 1007
P IIHRD+K DNI + KIGD G++ L S + + ++G+ ++APE
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPE-M 184
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067
Y + E DVY++G+ + E+ + P + + + +
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYS------------ECQNAAQIYRRVTSGVKPA 232
Query: 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103
SF + E+ C RQ D R S+++++
Sbjct: 233 SFDKVAIP----EVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-53
Identities = 76/272 (27%), Positives = 117/272 (43%), Gaps = 36/272 (13%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRNILR 891
GR +GKGK G VY S+ A+K L +++ E+ S +RH NILR
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ G +++ EY P GT++ L + D +A LSY H
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHS--- 124
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
++IHRDIK +N+LL S E KI DFG S S ++ + G+L Y+ PE
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGRM 180
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071
EK D++S GV+ +E L K P + QE ++ I ++ +
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPP-------------FEANTYQETYKRISRVEFTFPDFV 227
Query: 1072 SDDQLKALRLLELALECTRQVADMRPSMREVV 1103
++ +L + RP +REV+
Sbjct: 228 TEG------ARDLISRLLKHNPSQRPMLREVL 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 62/288 (21%), Positives = 121/288 (42%), Gaps = 35/288 (12%)
Query: 825 PRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTL 881
P+DL + + +G G+ G V A+K + SE F E + +
Sbjct: 3 PKDLTF--------LKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVM 53
Query: 882 SLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQ 941
+ H ++++ G CTK FI+TEYM G L N L + R + + +
Sbjct: 54 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCE 111
Query: 942 GLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGY 1001
+ YL +HRD+ + N L++ + K+ DFG+S+ + D +S+ + +
Sbjct: 112 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS-VGSKFPVRW 167
Query: 1002 IAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061
PE ++ + KSD++++GV+++E+ + R+ E E I
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM------------PYERFTNSETAEHIA 215
Query: 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
R L + ++ + C + AD RP+ + ++ ++ +
Sbjct: 216 QGLR-----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (468), Expect = 2e-52
Identities = 80/315 (25%), Positives = 138/315 (43%), Gaps = 36/315 (11%)
Query: 806 KCFSDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHW 862
K F DP +D + +++ V ++IG G+ G V L
Sbjct: 1 KIFIDPFTFEDPNEAVREFAKEIDISCV---KIEQVIGAGEFGEVCSGHLKLPGKREIFV 57
Query: 863 AVKKLNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNV 917
A+K L T +F E + H N++ + G TK I+TE+M G+L +
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 918 LHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
L QN+ + + GIA G+ YL +HRD+ + NIL++S L K+ DF
Sbjct: 118 LRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDF 172
Query: 978 GMSKLISDSHSSSTRSAIVG---SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
G+S+ + D S T ++ +G + + APE + T SDV+SYG++++E++
Sbjct: 173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232
Query: 1035 VDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVAD 1094
P + N + I ++++ D AL +L L+C ++ +
Sbjct: 233 --PYWDMT-------------NQDVINAIEQDYRLPPPMDCPSALH--QLMLDCWQKDRN 275
Query: 1095 MRPSMREVVGFLIKL 1109
RP ++V L K+
Sbjct: 276 HRPKFGQIVNTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-52
Identities = 55/274 (20%), Positives = 115/274 (41%), Gaps = 27/274 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGS 895
+ IG G+ G V+ N K A+K + E +F E + + H ++++ G
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
C + +V E+M G L + + R + T + L + +G + Y +I
Sbjct: 69 CLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLEEACVI 123
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRD+ + N L+ K+ DFGM++ + D +S+ + + +PE +R + K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSK 182
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQ 1075
SDV+S+GV+++E+ ++ + N E + + +
Sbjct: 183 SDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYKPRLA 227
Query: 1076 LKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
+ ++ C ++ + RP+ ++ L ++
Sbjct: 228 STHVY--QIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (464), Expect = 4e-52
Identities = 62/281 (22%), Positives = 121/281 (43%), Gaps = 25/281 (8%)
Query: 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIV 893
T +G G++G VY + AVK L F E + ++H N+++++
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G CT++ +I+TE+M G L + L + R + ++A I+ + YL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KN 135
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
IHRD+ + N L+ K+ DFG+S+L++ + + + + + APE+ + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073
KSDV+++GV+L+E+ M P + + L+++ +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI---------------DLSQVYELLEKDYRMERPE 239
Query: 1074 DQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
+ + EL C + RPS E+ + ++
Sbjct: 240 GCPEKVY--ELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-52
Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
+G+G G V+ N + + A+K L + F E + + +RH ++++
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+++ +IVTEYM G+L + + E L +A IA G++Y+ +
Sbjct: 81 VSEEPI-YIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YV 135
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRD+++ NIL+ L K+ DFG+++LI D+ ++ + + + APE A R T K
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIK 194
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQ 1075
SDV+S+G++L EL + P N E + ++R +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGM---------------VNREVLDQVERGYRMPCPPEC 239
Query: 1076 LKALRLLELALECTRQVADMRPSMREVVGFL 1106
++L +L +C R+ + RP+ + FL
Sbjct: 240 PESLH--DLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (460), Expect = 1e-51
Identities = 70/318 (22%), Positives = 123/318 (38%), Gaps = 58/318 (18%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRS-----ET 872
+ PR+ E R IG+G G V++ L AVK L +
Sbjct: 9 EYPRN-NIE------YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 873 NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV------ 926
+F E ++ + NI++++G C + ++ EYM G L L P V
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 927 ---------------LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE 971
L + IA +A G++YL +HRD+ + N L+ +
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMV 178
Query: 972 PKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFR 1031
KI DFG+S+ I + + ++ PE+ + R T +SDV++YGV+L+E+
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 1032 KMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQ 1091
+ P +G + + +++ + I L L L C +
Sbjct: 239 GLQ--PYYGMAHE---EVIYYVRDGN--ILACPENCP----------LELYNLMRLCWSK 281
Query: 1092 VADMRPSMREVVGFLIKL 1109
+ RPS + L ++
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 65/290 (22%), Positives = 122/290 (42%), Gaps = 34/290 (11%)
Query: 822 EDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET----NFDVE 877
E + RDL ED +G G G VY+ + + A K ++ ++ VE
Sbjct: 2 EHVTRDLNPED--FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 878 IRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937
I L+ H NI++++ + + + +I+ E+ GG + V+ + E L + +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL--TESQIQVVCK 117
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
L+YLH +IIHRD+K+ NIL + + K+ DFG+S + + + +G
Sbjct: 118 QTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIG 172
Query: 998 SLGYIAPE-----NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK 1052
+ ++APE + K+DV+S G+ L E+ + P E +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRV----- 223
Query: 1053 LQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
L + + + S W S+ + +C + D R + ++
Sbjct: 224 LLKIAKSEPPTLAQPSRWSSN-------FKDFLKKCLEKNVDARWTTSQL 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET--NFDVEIRTLSLVRHRNILRIVGSC 896
+ IGKG+ G V AVK + T F E ++ +RH N+++++G
Sbjct: 12 LQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 897 TKDEHG-FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+++ G +IVTEYM G+L + L + R VL + +L + + + YL +
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 125
Query: 956 HRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEK 1015
HRD+ + N+L+ + K+ DFG++K +SST+ + + APE + + K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTK 180
Query: 1016 SDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQ 1075
SDV+S+G++L+E+ + R + +
Sbjct: 181 SDVWSFGILLWEIYSFGR---VPYPRIPLKDVVPRVEKGYKMDAPDGCPPA--------- 228
Query: 1076 LKALRLLELALECTRQVADMRPSMREVVGFL 1106
+ E+ C A MRPS ++ L
Sbjct: 229 -----VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-51
Identities = 71/310 (22%), Positives = 126/310 (40%), Gaps = 46/310 (14%)
Query: 824 LPRDLRYE-DVIRATEGRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRSET----- 872
LP D ++E R + G+ +G G G V + +++ AVK L S
Sbjct: 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71
Query: 873 NFDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN---------- 921
E++ LS L H NI+ ++G+CT ++TEY G L N L +
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 922 -----EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976
+ L LD + +A+G+++L IHRD+ + NILL KI D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICD 188
Query: 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVD 1036
FG+++ I + + + + ++APE+ ++ T +SDV+SYG+ L+EL
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 1037 PSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMR 1096
P D+ + + + + ++ C R
Sbjct: 249 PGMPVDSKFYKMIKEGFR----------MLSPEHAPAE------MYDIMKTCWDADPLKR 292
Query: 1097 PSMREVVGFL 1106
P+ +++V +
Sbjct: 293 PTFKQIVQLI 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-51
Identities = 60/270 (22%), Positives = 110/270 (40%), Gaps = 28/270 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-----NFDVEIRTLSLVRHRNILRIV 893
+ +G+G +G V ++ + + AVK ++ N EI ++ H N+++
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 69
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
G + ++ EY GG LF+ + + + + G+ YLH
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IG 123
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL- 1012
I HRDIK +N+LLD KI DFG++ + ++ + + G+L Y+APE
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 1013 TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072
E DV+S G++L +L ++P D + W K ++ W
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------LNPWKK 231
Query: 1073 DDQLKALRLLELALECTRQVADMRPSMREV 1102
D L L + + R ++ ++
Sbjct: 232 IDS----APLALLHKILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-51
Identities = 66/322 (20%), Positives = 123/322 (38%), Gaps = 51/322 (15%)
Query: 817 VQSRSEDLPRDLRYE-DVIRATEGRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRS 870
+ DL++E G+++G G G V AVK L
Sbjct: 19 FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78
Query: 871 ETN-----FDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPR 924
+ E++ ++ L H NI+ ++G+CT +++ EY G L N L +
Sbjct: 79 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138
Query: 925 L--------------------VLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNI 964
VL + A +A+G+ +L + +HRD+ + N+
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 195
Query: 965 LLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVI 1024
L+ KI DFG+++ I + R + ++APE+ + T KSDV+SYG++
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
Query: 1025 LFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLEL 1084
L+E+ + P D + + + + F+ +++ + +
Sbjct: 256 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------DQPFYATEE------IYII 299
Query: 1085 ALECTRQVADMRPSMREVVGFL 1106
C + RPS + FL
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSFL 321
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (456), Expect = 7e-51
Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 49/304 (16%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR 869
DP + + +D P + D+ R IG G G VY + + A+KK++
Sbjct: 1 DPDVAELF---FKDDPEK-LFSDL------REIGHGSFGAVYFARDVRNSEVVAIKKMSY 50
Query: 870 SE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNE 922
S + E+R L +RH N ++ G ++ ++V EY G + +
Sbjct: 51 SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 110
Query: 923 PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982
P L + G QGL+YLH +IHRD+K+ NILL K+GDFG + +
Sbjct: 111 P---LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 983 ISDSHSSSTRSAIVGSLGYIAPE---NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSF 1039
++ ++S VG+ ++APE + K DV+S G+ EL RK P
Sbjct: 165 MAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----L 214
Query: 1040 GEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSM 1099
+ E S + R C +++ RP+
Sbjct: 215 FNMNAMSALYHI-----------AQNESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTS 261
Query: 1100 REVV 1103
++
Sbjct: 262 EVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 8e-51
Identities = 80/311 (25%), Positives = 131/311 (42%), Gaps = 40/311 (12%)
Query: 810 DPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVKK 866
+P L+Q VQ P L +IG+G G VY ++ + H AVK
Sbjct: 10 NPELVQAVQHVVIG-PSSLIVHF------NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 62
Query: 867 LNRSET-----NFDVEIRTLSLVRHRNILRIVGSCTKDE-HGFIVTEYMPGGTLFNVLHQ 920
LNR F E + H N+L ++G C + E +V YM G L N +
Sbjct: 63 LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 122
Query: 921 NEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980
L +A+G+ + + +HRD+ + N +LD + K+ DFG++
Sbjct: 123 ETHNP--TVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 981 KLISDS--HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPS 1038
+ + D S ++ + ++A E+ + + T KSDV+S+GV+L+EL+ R P
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP---- 233
Query: 1039 FGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPS 1098
D + T + LQ + D L E+ L+C A+MRPS
Sbjct: 234 PYPDVNTFDITVYLLQGRR-------LLQPEYCPDP------LYEVMLKCWHPKAEMRPS 280
Query: 1099 MREVVGFLIKL 1109
E+V + +
Sbjct: 281 FSELVSRISAI 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 9e-51
Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 35/289 (12%)
Query: 838 EGRIIGKGKHGTVYRTLSNNSR--KHWAVKKLNRSETN------FDVEIRTLSLVRHRNI 889
E + +G G GTV + + K AVK L + E + + + I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 890 LRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD 949
+R++G C + +V E G L L QN + + ++ G+ YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE- 125
Query: 950 CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-STRSAIVGSLGYIAPENAY 1008
+HRD+ + N+LL ++ KI DFG+SK + + ++ + + APE
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 1009 STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068
+ + KSDV+S+GV+++E + + E C RE
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYG---QKPYRGMKGSEVTAMLEKGERMGCPAGCPRE-- 238
Query: 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL--IKLNDKNEG 1115
+ +L C + RP V L + NEG
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-50
Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 32/283 (11%)
Query: 837 TEGRIIGKGKHGTVYR----TLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHR 887
T ++IG G+ G VY+ T S A+K L +F E + H
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
NI+R+ G +K + I+TEYM G L E + GIA G+
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGM---K 124
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI-SDSHSSSTRSAIVGSLGYIAPEN 1006
Y +HRD+ + NIL++S L K+ DFG+S+++ D ++ T S + + APE
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066
+ T SDV+S+G++++E++ NHE + ++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------------LSNHEVMKAINDG 229
Query: 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
D A+ +L ++C +Q RP ++V L KL
Sbjct: 230 FRLPTPMDCPSAIY--QLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-50
Identities = 70/299 (23%), Positives = 126/299 (42%), Gaps = 37/299 (12%)
Query: 809 SDPSLLQDVQSR-SEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKL 867
SD +L+ ++S S P+ +Y IG+G GTVY + + + A++++
Sbjct: 1 SDEEILEKLRSIVSVGDPKK-KYTRF------EKIGQGASGTVYTAMDVATGQEVAIRQM 53
Query: 868 NRSETN----FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEP 923
N + EI + ++ NI+ + S + ++V EY+ GG+L +V+ +
Sbjct: 54 NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM 113
Query: 924 RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983
D + Q L +LH + Q+IHRDIKSDNILL + K+ DFG I
Sbjct: 114 ----DEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
+ S RS +VG+ ++APE K D++S G++ E++ + P + +
Sbjct: 167 T--PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNEN 220
Query: 1044 DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
+ E+ + + + C + R S +E+
Sbjct: 221 PLRALYLIATNGT--------PELQNPEKLSAI----FRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-49
Identities = 67/286 (23%), Positives = 112/286 (39%), Gaps = 35/286 (12%)
Query: 842 IGKGKHGTVYRTLSNNSRKHW--AVKKLNRSETNFDV-----EIRTLSLVRHRNILRIVG 894
+G G G+V + + +K A+K L + D E + + + + I+R++G
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
C + E +V E GG L L + + + ++ G+ YL
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEE---KNF 130
Query: 955 IHRDIKSDNILLDSELEPKIGDFGMSKLI-SDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
+HRD+ + N+LL + KI DFG+SK + +D + RSA L + APE + +
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 190
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073
+SDV+SYGV ++E L + + + + EC E
Sbjct: 191 SRSDVWSYGVTMWEALSYG---QKPYKKMKGPEVMAFIEQGKRMECPPECPPE------- 240
Query: 1074 DQLKALRLLELALECTRQVADMRPSMREVVGFL----IKLNDKNEG 1115
L L +C + RP V + L K EG
Sbjct: 241 -------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-49
Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 825 PRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVE 877
PR R ED G+I+G+G TV + + +A+K L + E
Sbjct: 2 PRKKRPEDF---KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 58
Query: 878 IRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937
+S + H +++ + DE + Y G L + + D
Sbjct: 59 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDET---CTRF 112
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
A+ +S L Y IIHRD+K +NILL+ ++ +I DFG +K++S + ++ VG
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057
+ Y++PE + SD+++ G I+++L+ P F + + + +
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK------- 221
Query: 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110
+ E F + + +L + A R E+ G+
Sbjct: 222 ----IIKLEYDFPEKFFP----KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-48
Identities = 70/297 (23%), Positives = 122/297 (41%), Gaps = 44/297 (14%)
Query: 839 GRIIGKGKHGTVY--RTLSNNSRKHWAVKKLNRSET-----NFDVEIRTLS-LVRHRNIL 890
+IG+G G V R + R A+K++ + +F E+ L L H NI+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQ-------------NEPRLVLDWNTRYHIAL 937
++G+C + ++ EY P G L + L + N L H A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
+A+G+ Y Q IHRD+ + NIL+ KI DFG+S+ +
Sbjct: 135 DVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 188
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057
+ ++A E+ + T SDV+SYGV+L+E++ P G KL + +
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCA---ELYEKLPQGY 243
Query: 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114
E D+ + +L +C R+ RPS +++ L ++ ++ +
Sbjct: 244 ------RLEKPLNCDDE------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (441), Expect = 2e-48
Identities = 58/294 (19%), Positives = 118/294 (40%), Gaps = 30/294 (10%)
Query: 816 DVQSRSEDLPRDLRYEDVI-RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN- 873
D+ + P +++++ V+ +G G G V+R + ++A K + +
Sbjct: 7 DIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 874 ---FDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWN 930
EI+T+S++RH ++ + + D ++ E+M GG LF + + + +
Sbjct: 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSED 124
Query: 931 TRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL--EPKIGDFGMSKLISDSHS 988
+ +GL ++H + +H D+K +NI+ ++ E K+ DFG++ + S
Sbjct: 125 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181
Query: 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTW 1048
G+ + APE A + +D++S GV+ + LL P FG + D T
Sbjct: 182 VKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDETL 234
Query: 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
K D S D + + + R ++ +
Sbjct: 235 RNVK----SCDWNMDDSAFSGISED-------GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-47
Identities = 74/314 (23%), Positives = 131/314 (41%), Gaps = 47/314 (14%)
Query: 823 DLPRDLRYE-DVIRATEGRIIGKGKHGTVYR-------TLSNNSRKHWAVKKLNRSETNF 874
+LP D R+E R G+ +G+G G V N AVK L T
Sbjct: 1 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 875 DV-----EIRTLS-LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV-- 926
D+ E+ + + +H+NI+ ++G+CT+D +++ EY G L L P +
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 927 -----------LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIG 975
L A +A+G+ YL + IHRD+ + N+L+ + KI
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIA 177
Query: 976 DFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPV 1035
DFG+++ I + + ++APE + T +SDV+S+GV+L+E+
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS- 236
Query: 1036 DPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADM 1095
P G + L+E H + +++ L + +C V
Sbjct: 237 -PYPGVPVE---ELFKLLKEGHR------MDKPSNCTNE------LYMMMRDCWHAVPSQ 280
Query: 1096 RPSMREVVGFLIKL 1109
RP+ +++V L ++
Sbjct: 281 RPTFKQLVEDLDRI 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 7e-46
Identities = 61/289 (21%), Positives = 124/289 (42%), Gaps = 35/289 (12%)
Query: 833 VIRATE---GRIIGKGKHGTVYRTLSNNSRKHW----AVKKLN-----RSETNFDVEIRT 880
+++ TE +++G G GTVY+ L + A+K+L ++ E
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 881 LSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIA 940
++ V + ++ R++G C ++T+ MP G L + + +++ + + + IA
Sbjct: 65 MASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIA 121
Query: 941 QGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLG 1000
+G++YL +++HRD+ + N+L+ + KI DFG++KL+ +
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 1001 YIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060
++A E+ T +SDV+SYGV ++EL+ + E
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEIS 223
Query: 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
L++ + + ++C AD RP RE++ K+
Sbjct: 224 SILEKGERLPQPPICTIDVY--MIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 7e-46
Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 824 LPRDLRYEDVIRATEGRIIGKGKHGTVYR---TLSNNSRKHWAVKKLNRSETN-----FD 875
+ R+ R E GR IG+G+ G V++ N A+K ++ F
Sbjct: 4 IQRE-RIE------LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 56
Query: 876 VEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHI 935
E T+ H +I++++G T + +I+ E G L + L + L D +
Sbjct: 57 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSL--DLASLILY 113
Query: 936 ALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAI 995
A ++ L+YL + +HRDI + N+L+ S K+GDFG+S+ + DS S
Sbjct: 114 AYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKG 169
Query: 996 VGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055
+ ++APE+ R T SDV+ +GV ++E+L + + K +
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK------------PFQGVKNND 217
Query: 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
I +R + L L +C RP E+ L +
Sbjct: 218 VIGRIENGERLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-46
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 33/282 (11%)
Query: 839 GRIIGKGKHGTVYR---TLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRN 888
+G G G V R + AVK L + F E+ + + HRN
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
++R+ G +VTE P G+L + L +++ +L +RY A+ +A+G+ YL
Sbjct: 73 LIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLES 129
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRS-AIVGSLGYIAPENA 1007
IHRD+ + N+LL + KIGDFG+ + + + + APE+
Sbjct: 130 KR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067
+ + SD + +GV L+E+ P G + + K E ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEGERLPRPEDCPQD- 243
Query: 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
+ + ++C + RP+ + FL++
Sbjct: 244 -------------IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-45
Identities = 59/287 (20%), Positives = 114/287 (39%), Gaps = 37/287 (12%)
Query: 837 TEGRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRH 886
T R +G+G G VY + + A+K +N + F E +
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLV-------LDWNTRYHIALGI 939
+++R++G ++ + ++ E M G L + L P + + +A I
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSL 999
A G++YL+ + +HRD+ + N ++ + KIGDFGM++ I ++ + +
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 1000 GYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059
+++PE+ T SDV+S+GV+L+E+ + + L + +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDN 259
Query: 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
L EL C + MRPS E++ +
Sbjct: 260 C-----------------PDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (412), Expect = 2e-44
Identities = 49/296 (16%), Positives = 112/296 (37%), Gaps = 30/296 (10%)
Query: 814 LQDVQSRSEDLPRDLRYEDVI-RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-- 870
+D+ + P +++ V +G G G V+R + + + + K +N
Sbjct: 8 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 67
Query: 871 --ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLD 928
+ EI ++ + H ++ + + ++ E++ GG LF+ + + + +
Sbjct: 68 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--MS 125
Query: 929 WNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP--KIGDFGMSKLISDS 986
+ +GL ++H I+H DIK +NI+ +++ KI DFG++ ++
Sbjct: 126 EAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182
Query: 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV 1046
+ + APE + +D+++ GV+ + LL P F + D+
Sbjct: 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP----FAGEDDLE 235
Query: 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
T K F + S + + ++ R ++ +
Sbjct: 236 TLQNVK----RCDWEFDEDAFSSVSPE-------AKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 3e-44
Identities = 52/269 (19%), Positives = 105/269 (39%), Gaps = 28/269 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN---FDVEIRTLSLVRHRNILRIVGS 895
+G+G+ G V+R + +S+K + K + T+ EI L++ RHRNIL + S
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 896 CTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
E ++ E++ G +F ++ + L+ + + L +LH I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 956 HRDIKSDNILLDSELEP--KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLT 1013
H DI+ +NI+ + KI +FG ++ + + + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 1014 EKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDSD 1073
+D++S G +++ LL P F +T+ + F + +
Sbjct: 182 TATDMWSLGTLVYVLLSGINP----FLAETNQQIIENIM----NAEYTFDEEAFKEISIE 233
Query: 1074 DQLKALRLLELALECTRQVADMRPSMREV 1102
++ + R + E
Sbjct: 234 -------AMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 6e-44
Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 34/288 (11%)
Query: 820 RSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNF 874
++ED+ RD Y+ ++G G V ++K A+K + + E +
Sbjct: 3 QAEDI-RD-IYD------FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSM 54
Query: 875 DVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH 934
+ EI L ++H NI+ + H +++ + + GG LF+ + +
Sbjct: 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASR 111
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSA 994
+ + + YLH + + LD + + I DFG+SK+ ST
Sbjct: 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--- 168
Query: 995 IVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054
G+ GY+APE ++ D +S GVI + LL P F ++ D + +
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFEQILKA 224
Query: 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
E + + +WD + + + R + +
Sbjct: 225 E-------YEFDSPYWDDISD----SAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (399), Expect = 3e-43
Identities = 64/272 (23%), Positives = 124/272 (45%), Gaps = 34/272 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRNILR 891
R +G G G V+ S ++ +++A+K L + + E LS+V H I+R
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ G+ + F++ +Y+ GG LF++L ++ A+ L Y
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS 122
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
II+RD+K +NILLD KI DFG +K + D + + G+ YIAPE +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTKP 177
Query: 1012 LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071
+ D +S+G++++E+L P F + + T+ + L+ E+ F
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEK-----------ILNAELRFPP 222
Query: 1072 S-DDQLKALRLLELALECTRQVADMRPSMREV 1102
++ +K L + + ++++ +++ +V
Sbjct: 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 2e-42
Identities = 71/312 (22%), Positives = 119/312 (38%), Gaps = 51/312 (16%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYR-----TLSNNSRKHWAVKKLNRSETN---- 873
+ PRD R + G+ +G+G G V + + AVK L T+
Sbjct: 9 EFPRD-RLK------LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 874 -FDVEIRTLSLVRHR-NILRIVGSCTKDEHG-FIVTEYMPGGTLFNVLHQNE-------- 922
E++ L + H N++ ++G+CTK ++ E+ G L L
Sbjct: 62 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 121
Query: 923 -----PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDF 977
+ L + +A+G+ +L + IHRD+ + NILL + KI DF
Sbjct: 122 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDF 178
Query: 978 GMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDP 1037
G+++ I + L ++APE + T +SDV+S+GV+L+E+ P
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--P 236
Query: 1038 SFGEDTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRP 1097
G D R K + E + + L+C RP
Sbjct: 237 YPGVKIDEEFCRRLKEGTRMRAPDYTTPE--------------MYQTMLDCWHGEPSQRP 282
Query: 1098 SMREVVGFLIKL 1109
+ E+V L L
Sbjct: 283 TFSELVEHLGNL 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-42
Identities = 59/272 (21%), Positives = 107/272 (39%), Gaps = 27/272 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLS-LVRHRNILRIVGSC- 896
+++G G +G V + + +++ +A+K L E+ + +I+RIV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-KARREVELHWRASQCPHIVRIVDVYE 75
Query: 897 ---TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ IV E + GG LF+ + + I I + + YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLH---SIN 131
Query: 954 IIHRDIKSDNILLDSELEP---KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
I HRD+K +N+L S+ K+ DFG +K + +S +T + Y+APE
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP---CYTPYYVAPEVLGPE 188
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070
+ + D++S GVI++ LL P F + + K + F + E S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPP----FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244
Query: 1071 DSDDQLKALRLLELALECTRQVADMRPSMREV 1102
+ + L + R ++ E
Sbjct: 245 SEE-------VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 6e-42
Identities = 61/284 (21%), Positives = 104/284 (36%), Gaps = 44/284 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------------FDVEIRTLSLVR 885
I+G+G V R + + K +AVK ++ + E+ L V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 886 -HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
H NI+++ + + F+V + M G LF+ L + L I + + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 124
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
LH I+HRD+K +NILLD ++ K+ DFG S + + G+ Y+AP
Sbjct: 125 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYLAP 178
Query: 1005 E------NAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058
E N ++ D++S GVI++ LL P F ++
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLRMIM----SG 230
Query: 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
F E + + +L R + E
Sbjct: 231 NYQFGSPEWDDYSDT-------VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 9e-42
Identities = 67/284 (23%), Positives = 125/284 (44%), Gaps = 34/284 (11%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-------FDVEIRTLSLVRHRNILR 891
G I+G G V+ + AVK L F E + + + H I+
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 892 IVGSCTKDEHG----FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
+ + + +IV EY+ G TL +++H P + + IA L+
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEV---IADACQALN 125
Query: 948 YDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR-SAIVGSLGYIAPEN 1006
+ IIHRD+K NI++ + K+ DFG+++ I+DS +S T+ +A++G+ Y++PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 1007 AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066
A + +SDVYS G +L+E+L + P F D+ + + ++E+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ-HVREDPIPPSARHEG 240
Query: 1067 ISFWDSDDQLKALRLLELALECTRQVADMRP-SMREVVGFLIKL 1109
+S L + L+ + + R + E+ L+++
Sbjct: 241 LSAD----------LDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-41
Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 35/271 (12%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFD-------VEIRTLSLV-RHRNIL 890
+++GKG G V+ + + +A+K L + D VE R LSL H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
+ + E+ F V EY+ GG L + D + A I GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS-- 121
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
I++RD+K DNILLD + KI DFGM K + + G+ YIAPE
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQ 178
Query: 1011 RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070
+ D +S+GV+L+E+L + P + +E I + W
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSP-------------FHGQDEEELFHSIRMDNPFYPRW 225
Query: 1071 DSDDQLKALRLLELALECTRQVADMRPSMRE 1101
+ +L ++ + + R +R
Sbjct: 226 LEKE------AKDLLVKLFVREPEKRLGVRG 250
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 1e-39
Identities = 45/279 (16%), Positives = 84/279 (30%), Gaps = 28/279 (10%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSC 896
GR IG G G +Y + + A+K +E + +++ + + C
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 897 -TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQII 955
+ ++ +V E + + T +A + + Y+H I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 956 HRDIKSDNIL---LDSELEPKIGDFGMSKLISDSHSSS-----TRSAIVGSLGYIAPENA 1007
HRD+K DN L I DFG++K D+ + + G+ Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067
+ + D+ S G +L +P R K + E E+
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT------KRQKYERISEKKMSTPIEV 239
Query: 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFL 1106
+ C D +P +
Sbjct: 240 LCKGYPSEFA-----TYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 2e-39
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 21/225 (9%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET----------NFDVEIRTLSLVRHRN 888
RIIG+G G VY ++ K +A+K L++ N + + +S
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
I+ + + + + + M GG L L Q+ A I GL ++H
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMHN 125
Query: 949 DCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN-A 1007
+++RD+K NILLD +I D G++ S ++ G+ GY+APE
Sbjct: 126 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQ 178
Query: 1008 YSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK 1052
+D +S G +LF+LL P +D +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-39
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 819 SRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEI 878
+ D P+++ Y D ++IG G G VY+ +S + A+KK+ + + + E+
Sbjct: 11 GQGPDRPQEVSYTDT------KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 879 RTLSLVRHRNILRIVGSCT------KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTR 932
+ + + H NI+R+ + + +V +Y+P H + + L
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 933 YHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHSSST 991
+ + L+Y+H I HRDIK N+LLD + K+ DFG +K + + +
Sbjct: 125 KLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 992 RSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMP 1034
+ S Y APE + T DV+S G +L ELL +
Sbjct: 182 Y---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-39
Identities = 59/278 (21%), Positives = 103/278 (37%), Gaps = 38/278 (13%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----------SETNFDVEIRTLSLVRHRN 888
G +G G+ V + ++ +A K + + S + + E+ L ++H N
Sbjct: 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 889 ILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY 948
++ + ++ E + GG LF+ L + E L I G ++Y
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG---VYY 128
Query: 949 DCVPQIIHRDIKSDNILLDSELEP----KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAP 1004
QI H D+K +NI+L P KI DFG++ I + I G+ ++AP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAP 185
Query: 1005 ENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
E L ++D++S GVI + LL P F DT T F D
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVS----AVNYEFED 237
Query: 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
S + + + R ++++
Sbjct: 238 EYFSNTSAL-------AKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-38
Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 27/282 (9%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNIL 890
+G+G+ TVY+ N+ + A+KK+ EI+ L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 891 RIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDC 950
++ + + +V ++M ++ N L Y + L L Y
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAY-----MLMTLQGLEYLH 117
Query: 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYST 1010
I+HRD+K +N+LLD K+ DFG++K + + T V + Y APE +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--QVVTRWYRAPELLFGA 175
Query: 1011 RL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDT--DIVTWTRWKLQENHECICFLDREI 1067
R+ D+++ G IL ELL R + D I +E +C L +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 1068 SFWDSDDQLKALRLLELALECTRQVADM-------RPSMREV 1102
+F + + + R + +
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 9e-38
Identities = 46/292 (15%), Positives = 94/292 (32%), Gaps = 30/292 (10%)
Query: 832 DVI--RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHR 887
+V+ GR IG+G G ++ + + + A+K R E RT L+
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC 60
Query: 888 NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLH 947
+ V ++ ++ + G +L ++L + T A + + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF--SVKTVAMAAKQMLARVQSIH 118
Query: 948 YDCVPQIIHRDIKSDNILLDSELEP-----KIGDFGMSKLISDSHSSS-----TRSAIVG 997
+++RDIK DN L+ + DFGM K D + + + G
Sbjct: 119 E---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENH 1057
+ Y++ + + D+ + G + L +P ++ +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN----------KQKY 225
Query: 1058 ECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109
E I + + + D P + G K+
Sbjct: 226 ERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-36
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-------NFDVEIRTLSLVRHRNILR 891
+++GKG G V + +++A+K L + + E R L RH +
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 892 IVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCV 951
+ + + V EY GG LF L + T A+ +S L Y
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS 123
Query: 952 PQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR 1011
+++RDIK +N++LD + KI DFG+ K +T G+ Y+APE
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDND 181
Query: 1012 LTEKSDVYSYGVILFELLFRKMP 1034
D + GV+++E++ ++P
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-36
Identities = 66/307 (21%), Positives = 120/307 (39%), Gaps = 42/307 (13%)
Query: 819 SRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYR-TLSNNSRKHWAVKKLNRSETNFDV- 876
R++ +YE V IG+G +G V++ N + A+K++ +
Sbjct: 3 CRADQ-----QYECV------AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP 51
Query: 877 --------EIRTLSLVRHRNILRIVGSCT-----KDEHGFIVTEYMPGGTLFNVLHQNEP 923
+R L H N++R+ CT ++ +V E++ + EP
Sbjct: 52 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP 111
Query: 924 RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983
+ T + + +GL +LH ++HRD+K NIL+ S + K+ DFG++++
Sbjct: 112 GV--PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 166
Query: 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT 1043
S + ++ +V +L Y APE + D++S G I E+ RK S D
Sbjct: 167 SFQMALTS---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223
Query: 1044 --DIVTWTRWKLQENHECICFLDREISFWDSDDQLKALR------LLELALECTRQVADM 1095
I+ +E+ L R+ S ++ +L L+C
Sbjct: 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
Query: 1096 RPSMREV 1102
R S
Sbjct: 284 RISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-36
Identities = 54/292 (18%), Positives = 107/292 (36%), Gaps = 32/292 (10%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLS 882
+YE + IG+G +GTV++ + + + A+K++ + + EI L
Sbjct: 3 KYEKL------EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLK 56
Query: 883 LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQG 942
++H+NI+R+ D+ +V E+ N + + Q
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQL 110
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
L L + ++HRD+K N+L++ E K+ +FG+++ + V +L Y
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVVTLWYR 168
Query: 1003 APENAYSTR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061
P+ + + + D++S G I EL P+ P D + R E
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADM-----------RPSMREV 1102
+ + + L+ + + D+ R S E
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-36
Identities = 67/298 (22%), Positives = 116/298 (38%), Gaps = 38/298 (12%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET-----NFDVEIRTLSL 883
RY ++ IG+G +G V N ++ A+KK++ E EI+ L
Sbjct: 9 RYTNL------SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 884 VRHRNILRIVGSC----TKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGI 939
RH NI+ I + + ++ G L+ +L L + + I
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQI 118
Query: 940 AQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-STRSAIVGS 998
+GL Y+H ++HRD+K N+LL++ + KI DFG++++ H + V +
Sbjct: 119 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 999 LGYIAPENAY-STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT--DIVTWTRWKLQE 1055
Y APE S T+ D++S G IL E+L + D I+ QE
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADM-----------RPSMREV 1102
+ CI L + ++ S + L + D+ R + +
Sbjct: 236 DLNCIINL-KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 56/284 (19%), Positives = 108/284 (38%), Gaps = 32/284 (11%)
Query: 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIV 893
IG+G +G VY+ + + + A+KK+ + EI L + H NI++++
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 894 GSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ 953
+ ++V E++ + + L Y + Q L L + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLAFCHSHR 122
Query: 954 IIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTR-L 1012
++HRD+K N+L+++E K+ DFG+++ + T V +L Y APE +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYY 180
Query: 1013 TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTR---------WKLQENHECICFL 1063
+ D++S G I E++ R+ F D++I R + +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 1064 DREISFWDSDDQLKALR-----LLELALECTRQVADMRPSMREV 1102
W D K + L + + R S +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 6e-35
Identities = 52/278 (18%), Positives = 101/278 (36%), Gaps = 48/278 (17%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVR--H 886
G ++G G G+VY + + A+K + + T +E+ L V
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 887 RNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
++R++ + + ++ E L + + + +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHC 126
Query: 947 HYDCVPQIIHRDIKSDNILLD-SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPE 1005
H ++HRDIK +NIL+D + E K+ DFG L+ D+ + G+ Y PE
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPE 179
Query: 1006 N-AYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064
Y + V+S G++L++++ +P F D +I+ F
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEIIRGQV-----------FFR 224
Query: 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREV 1102
+ +S + + L C RP+ E+
Sbjct: 225 QRVS-----SECQ-----HLIRWCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 128 bits (323), Expect = 2e-33
Identities = 55/291 (18%), Positives = 113/291 (38%), Gaps = 32/291 (10%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLS 882
+Y + IG+G +G VY+ +N +A+KK+ + + EI L
Sbjct: 3 KYHGL------EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILK 55
Query: 883 LVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQG 942
++H NI+++ + +V E++ + L+ T L + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNG 112
Query: 943 LSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYI 1002
++Y H +++HRD+K N+L++ E E KI DFG+++ + + +L Y
Sbjct: 113 IAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYR 167
Query: 1003 APENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDT--DIVTWTRWKLQENHEC 1059
AP+ + + + D++S G I E++ D I +N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 1060 ICFLDREISFWDSDDQLKALRLL--------ELALECTRQVADMRPSMREV 1102
+ L + + + L L +L + + + R + ++
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 47/223 (21%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLS 882
+YE + IG+G G V++ + + A+KK+ EI+ L
Sbjct: 11 KYEKL------AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 883 LVRHRNILRIVGSCTKDEHG--------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYH 934
L++H N++ ++ C ++V ++ + + T
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF------TLSE 118
Query: 935 IALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS--STR 992
I + L+ L+Y +I+HRD+K+ N+L+ + K+ DFG+++ S + +S +
Sbjct: 119 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 993 SAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMP 1034
+ V +L Y PE R D++ G I+ E+ R
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (324), Expect = 6e-33
Identities = 61/301 (20%), Positives = 125/301 (41%), Gaps = 38/301 (12%)
Query: 809 SDPSLLQDVQSRSEDLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN 868
+ L+ ++ S++ + +++ + + +G G G V S H+A+K L+
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQFDRI------KTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 869 RSET-------NFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQN 921
+ + + E R L V ++++ S + + ++V EY+ GG +F+ L +
Sbjct: 76 KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI 135
Query: 922 EPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981
A I YLH +I+RD+K +N+L+D + ++ DFG +K
Sbjct: 136 GR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGE 1041
+ + + G+ +APE S + D ++ GV+++E+ P F
Sbjct: 190 RVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP----FFA 240
Query: 1042 DTDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMRE 1101
D I + E I S D LR L L ++ T++ +++ + +
Sbjct: 241 DQPIQIY---------EKIVSGKVRFPSHFSSDLKDLLRNL-LQVDLTKRFGNLKNGVND 290
Query: 1102 V 1102
+
Sbjct: 291 I 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-32
Identities = 62/299 (20%), Positives = 115/299 (38%), Gaps = 44/299 (14%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLS 882
Y D+ + +G G +G V + + A+KKL R + E+R L
Sbjct: 19 VYRDL------QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 72
Query: 883 LVRHRNILRIVGSCTKDEHG------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
+RH N++ ++ T DE ++V +M GT L ++E L + +
Sbjct: 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---LGEDRIQFLV 127
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
+ +GL Y+H IIHRD+K N+ ++ + E KI DFG+++ + S + V
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYV 179
Query: 997 GSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMP-VDPSFGEDTDIVTWTRWKLQ 1054
+ Y APE + R T+ D++S G I+ E++ K + +
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADM-----------RPSMREV 1102
D ++ +L+ + + ++ R + E
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-31
Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 839 GRIIGKGKHGTVYR---TLSNNSRKHWAVKKLNRSET--------NFDVEIRTLSLVRHR 887
+++G G +G V+ +++ K +A+K L ++ + E + L +R
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 888 -NILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYL 946
++ + + + ++ +Y+ GG LF L Q E T + + + + + + L
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF------TEHEVQIYVGEIVLAL 142
Query: 947 HYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPEN 1006
+ II+RDIK +NILLDS + DFG+SK + G++ Y+AP+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDI 201
Query: 1007 AYSTR--LTEKSDVYSYGVILFELLFRKMP 1034
+ D +S GV+++ELL P
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 120 bits (301), Expect = 4e-30
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 18/206 (8%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN-FDVEIRTLS-LVRHRNILRIVGSC 896
R +G+GK+ V+ ++ + + VK L + EI+ L L NI+ +
Sbjct: 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIV 99
Query: 897 TKDEHG--FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQI 954
+V E++ + L I + L Y H I
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---I 150
Query: 955 IHRDIKSDNILLDSE-LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRL- 1012
+HRD+K N+++D E + ++ D+G+++ H + V S + PE ++
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 1013 TEKSDVYSYGVILFELLFRKMPVDPS 1038
D++S G +L ++FRK P
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHG 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 5e-30
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLS 882
RY+++ + IG G G V ++ A+KKL+R N E+ +
Sbjct: 18 RYQNL------KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 883 LVRHRNILRIVGSCTKDEHG------FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIA 936
V H+NI+ ++ T + ++V E M + + D ++
Sbjct: 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLL 125
Query: 937 LGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIV 996
+ G+ +LH IIHRD+K NI++ S+ KI DFG+++ S + V
Sbjct: 126 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYV 179
Query: 997 GSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+ Y APE E D++S G I+ E++ K+
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 28/217 (12%)
Query: 829 RYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN------FDVEIRTLS 882
RY+++ +G G +G+V + AVKKL+R + E+R L
Sbjct: 19 RYQNL------SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 883 LVRHRNILRIVGSCT-----KDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIAL 937
++H N++ ++ T ++ + + ++ G L N++ + L + +
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIY 128
Query: 938 GIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVG 997
I +GL Y+H IIHRD+K N+ ++ + E KI DFG+++ D + +
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-- 183
Query: 998 SLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMP 1034
+ D++S G I+ ELL +
Sbjct: 184 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (269), Expect = 1e-25
Identities = 45/239 (18%), Positives = 83/239 (34%), Gaps = 25/239 (10%)
Query: 823 DLPRDLRYEDVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSET---NFDVEIR 879
+ +D RY V R +G G TV+ + H A+K + + + EI+
Sbjct: 8 EPYKDARYILV------RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK 61
Query: 880 TLSLVRHRNILRIVGSCTK-------------DEHGFIVTEYMPGGTLFNVLHQNEPRLV 926
L V + + +V + G L +
Sbjct: 62 LLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG 121
Query: 927 LDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP-KIGDFGMSKLISD 985
+ I+ + GL Y+H C IIH DIK +N+L++ P + ++ L +
Sbjct: 122 IPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 179
Query: 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTD 1044
+ + + Y +PE +D++S ++FEL+ +P G
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 9e-22
Identities = 74/383 (19%), Positives = 134/383 (34%), Gaps = 32/383 (8%)
Query: 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNS 155
+ L T ++ + + Q+ TL + + SI + L L+ ++ N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ 77
Query: 156 LSGKIPPQ-----VSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPE 210
L+ P + V + + I N + + NLT L
Sbjct: 78 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137
Query: 211 FPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISP------WIFKGLL 264
+S I + + + +L + + IS + L
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
LE L +N + P + NL +L L+ N+L G ++ L + L+ N +
Sbjct: 198 NLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQI 253
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA 384
P + L+ L L L N++ L +L +L L N + I NL
Sbjct: 254 SNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQL--EDISPISNLK 307
Query: 385 KLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHL 444
L L L+ N I P + ++KL L NN+++ + L N+ +LS HN +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 445 TGEVALELGKHFPYLSRLDLTGN 467
+ L + +++L L
Sbjct: 364 SDLTPLA---NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.4 bits (228), Expect = 3e-20
Identities = 69/382 (18%), Positives = 129/382 (33%), Gaps = 33/382 (8%)
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
+ L + T+ +L ++ L I+ + ++ L ++ NN+LT
Sbjct: 24 KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT 79
Query: 422 GRIP-PDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVG 480
P ++T+L ++ + +T L + + N
Sbjct: 80 DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 481 TNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSF------- 533
++ + + S L+N L + + +S
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 534 --LDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG 591
L N + P G +NL L + N+L L +L NL L L+ N++
Sbjct: 200 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 592 RIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSL 651
P L TK+ +L L N ++ P ++ L+ + S++++L
Sbjct: 256 LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DISPISNLKNL 309
Query: 652 FELQLGSNIFDGSIP-CSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSF 710
L L N P SL+KL L +NNK+S L NL + L N
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQR----LFFANNKVSD--VSSLANLTNINWLSAGHNQI 363
Query: 711 SGEIPTEVNNMVSLYFVNISFN 732
S P + N+ + + ++
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 91.2 bits (225), Expect = 5e-20
Identities = 78/391 (19%), Positives = 137/391 (35%), Gaps = 41/391 (10%)
Query: 236 SNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVL 295
+ ++ N +S L Q+ L D ++ + + L NL ++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 73
Query: 296 SANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLP-- 353
S N+L + + +L I ++ N + P + + +L L
Sbjct: 74 SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131
Query: 354 -------------PELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAI 400
++ L L+ T + NL LE L + +N++
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS--D 189
Query: 401 PHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLS 460
+ +++ L L NN+++ P I NL LSL N L L L+
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGTL---ASLTNLT 244
Query: 461 RLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS 520
LDL N P + T L L LG N+ + P+ L N Q
Sbjct: 245 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL----AGLTALTNLELNENQLE 298
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQ 580
+ + +++L + N + P + L L F+ N++S S L NL N+
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 581 ILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611
L N++ P L T++ +L L+D
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.8 bits (224), Expect = 8e-20
Identities = 65/370 (17%), Positives = 117/370 (31%), Gaps = 50/370 (13%)
Query: 69 SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLN 128
+ L G+ SI + +L ++ S N+ T P L N +L +L+N
Sbjct: 44 DQVTTLQADRLGI-----KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96
Query: 129 DNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDI 188
+N+ P L + + + +
Sbjct: 97 NNQIADITPLANLTNLTGLTLF--------NNQITDIDPLKNLTNLNRLELSSNTISDIS 148
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
L+ N L N + L I N + NL A++
Sbjct: 149 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATN 206
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N I L+ L L+ N L+ TL L NL L L+ N+++ +
Sbjct: 207 NQISDITPLGILT---NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 309 SHCNQLQVIALSRNNLVGQIP--------------------RSVGNLSSLNSLLLFNNRL 348
S +L + L N + P + NL +L L L+ N +
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 349 QGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMS 408
P + + L L +N + + + NL + L +N+I P + ++
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLT 373
Query: 409 KLVELALYNN 418
++ +L L +
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.8 bits (211), Expect = 3e-18
Identities = 63/371 (16%), Positives = 118/371 (31%), Gaps = 35/371 (9%)
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
LA+ L + + + ++ L + + L NL ++ ++
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEI 501
N LT L K+ L + + N P L
Sbjct: 76 NQLTDITPL---KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTM---- 557
+++ S +L++ + + L + SN
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 558 ---------LDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDL 608
L + N++S P + NL L L+ N+L L T + LDL
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 609 SDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCS 668
++N ++ P + L K+ L L N +S P + L L + S
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDIS 301
Query: 669 LSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVN 728
+ L + N +S P + +L KLQ L ++N S + + N+ ++ +++
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 729 ISFNHFSGKLP 739
N S P
Sbjct: 358 AGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.1 bits (191), Expect = 9e-16
Identities = 63/397 (15%), Positives = 129/397 (32%), Gaps = 34/397 (8%)
Query: 143 LKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTN 202
L LG +++ + + + ++ + + + L L + + N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 203 NLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKG 262
LT + P N ++ +L++ N P + + + +
Sbjct: 77 QLTDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRN 322
L+L + D + + Q L T+ N+
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--------- 186
Query: 323 NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICN 382
+ L++L SL+ NN++ P +L +L L N + + +
Sbjct: 187 ---VSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLAS 239
Query: 383 LAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
L L L L NN+I P + ++KL EL L N+++ P L L L+
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-----LAGLTALTNLEL 292
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502
+ + + L+ L L N+ P + T L L NN+ + +
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL--TKLQRLFFANNKVSD--VSSLA 348
Query: 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGN 539
+++ + +N + P L ++ L +
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.3 bits (189), Expect = 2e-15
Identities = 59/384 (15%), Positives = 123/384 (32%), Gaps = 30/384 (7%)
Query: 190 SLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSN 249
+L + L N+T + + + L + + S+ + NL + + S+N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNN 76
Query: 250 NFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQIS 309
L+ + + ++ T L ++ ++
Sbjct: 77 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGN----------C 359
I+ + + + + L N N
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNR 419
+L L +N I P I L+ L L N+++ + ++ L +L L NN+
Sbjct: 197 TNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 420 LTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICV 479
++ P ++ L L L L N ++ L L+ L+L N P +
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPL---AGLTALTNLELNENQLEDISPISNL- 306
Query: 480 GTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGN 539
NL L L N + + + L+R+ +NN + ++L +++L N
Sbjct: 307 -KNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 540 LLQGSIPPVFGFWSNLTMLDFSEN 563
+ P + +T L ++
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 1e-12
Identities = 41/218 (18%), Positives = 73/218 (33%), Gaps = 41/218 (18%)
Query: 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQL 116
+ S ++ ++L L+L+G L I + +L LDL+ N+ + P L
Sbjct: 207 NQISDITPLGILTNLDELSLNGNQLKD-----IGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 117 GNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFH 176
+L L L N+ P N + +S +L + +
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISPISNLKNLTYLTLY 315
Query: 177 NNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLS 236
N ++ P + SL KL+ L+ N ++ +SL+
Sbjct: 316 FNNISDISP--VSSLTKLQRLFFANNKVSD-------------------------VSSLA 348
Query: 237 NCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDN 274
N N+ SA N L ++ L L+D
Sbjct: 349 NLTNINWLSAGHNQISDLTP---LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 6e-07
Identities = 23/135 (17%), Positives = 41/135 (30%), Gaps = 9/135 (6%)
Query: 20 SVSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGF 79
+S L + + S + + +S +N +L L L
Sbjct: 258 PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 80 GLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPE 139
+S IS + L L + N+ + L N + L N+ P
Sbjct: 318 NISD-----ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP-- 368
Query: 140 IFKLKRLSWLDLGYN 154
+ L R++ L L
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 0.001
Identities = 36/208 (17%), Positives = 73/208 (35%), Gaps = 18/208 (8%)
Query: 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSAN------------KLDGRIPYE 596
+ +NLT ++FS N+L+ P L NL L + ++ N L G +
Sbjct: 62 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 119
Query: 597 LGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQL 656
+L++ + + + + L+ + G + +L L+
Sbjct: 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLER 179
Query: 657 GSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPT 716
+ S+ L +NN++S P + L L L+ N
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IG 235
Query: 717 EVNNMVSLYFVNISFNHFSGKLPASWTT 744
+ ++ +L ++++ N S P S T
Sbjct: 236 TLASLTNLTDLDLANNQISNLAPLSGLT 263
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.0 bits (224), Expect = 2e-20
Identities = 61/279 (21%), Positives = 87/279 (31%), Gaps = 4/279 (1%)
Query: 189 CSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASS 248
C + L + P + + L H N S CRNL S
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRIFL--HGNRISHVPAASFRACRNLTILWLHS 65
Query: 249 NNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQI 308
N + L ++ D+ L P T GL L L L L G
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 309 SHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ 368
LQ + L N L + +L +L L L NR+ SL L L
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 369 HNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDI 428
N + P +L +L LYLF N + + + L L L +N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-R 244
Query: 429 TRLRNLQFLSLAHNHLTGEVALEL-GKHFPYLSRLDLTG 466
LQ + + + + L G+ L+ DL G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (189), Expect = 5e-16
Identities = 58/258 (22%), Positives = 98/258 (37%), Gaps = 6/258 (2%)
Query: 456 FPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNN 515
R+ L GN A+ NL +L L +N + L ++ LS+N
Sbjct: 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 516 LLQGSL-PATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELG 574
S+ PAT + L + LQ P +F + L L +N L
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 575 NLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634
+L NL L L N++ + +L L N +A P L ++ +L L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 635 NNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECL 694
NNLS +A + +++L L+L N + C L + S++++ +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCD--CRARPLWAWLQKFRGSSSEVPCSLPQRL 268
Query: 695 GNLDKLQILDLSSNSFSG 712
+ L++N G
Sbjct: 269 AG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (183), Expect = 4e-15
Identities = 56/265 (21%), Positives = 77/265 (29%), Gaps = 6/265 (2%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNL 434
+P I A + ++L NRI L L L++N L T L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 435 QFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN 494
+ L L+ N V L L L P L L L +N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 495 GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554
+L + L N + + L + N + P F
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614
L L N LS L L LQ LRL+ N + K S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261
Query: 615 GSIPSEVISLEKMQSLSLQENNLSG 639
S+P L L N+L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 6e-15
Identities = 53/265 (20%), Positives = 82/265 (30%), Gaps = 8/265 (3%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVS 532
+P I + L NR + C +L + L +N+L A +
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 533 FLDVRGNLLQGSIPP-VFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDG 591
LD+ N S+ P F L L L P L LQ L L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 592 RIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSL 651
+ L L N ++ L + L L +N ++ P AF + L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 652 FELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711
L L +N +L+ L L +++N LQ SS+
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261
Query: 712 GEIPTEVNNMVSLYFVNISFNHFSG 736
+P + ++ N G
Sbjct: 262 CSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (165), Expect = 6e-13
Identities = 54/297 (18%), Positives = 88/297 (29%), Gaps = 40/297 (13%)
Query: 56 PCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQ 115
PC CYN + GL V + L GN +
Sbjct: 1 PCP-GACVCYNEPK--VTTSCPQQGLQAVPVGI------PAASQRIFLHGNRISHVPAAS 51
Query: 116 LGNCGQLKTLLLNDNRFQGSI-------------------------PPEIFKLKRLSWLD 150
C L L L+ N P L RL L
Sbjct: 52 FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111
Query: 151 LGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPE 210
L L P +L+ + +N L + L L L+L+ N ++ +
Sbjct: 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171
Query: 211 FPNSCAILHL-LIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVL 269
L L+H+N P + + L+ N A+ L L+ L
Sbjct: 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY-LFANNLSALPTEALAPLRALQYL 230
Query: 270 YLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG 326
L+DN LQK S++++ ++ +++ + L+ N+L G
Sbjct: 231 RLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 31/212 (14%), Positives = 56/212 (26%), Gaps = 28/212 (13%)
Query: 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENN---------------- 636
+P + ++ ++ L N ++ + + + L L N
Sbjct: 26 VPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 637 ---------LSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLS 687
L P F + L L L + L + L + +N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 688 GKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLMV 747
+ +L L L L N S + SL + + N + P ++ L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 748 SYPGSFLGNSELCRQGNCGKNGRGHTRGRLAG 779
N+ R RL
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLND 234
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 23/137 (16%), Positives = 46/137 (33%), Gaps = 3/137 (2%)
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665
L ++P + + Q + L N +S +F + ++L L L SN+
Sbjct: 16 TSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 666 PCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLY 725
+ + L + N +L P L +L L L P + +L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 726 FVNISFNHFSGKLPASW 742
++ + N ++
Sbjct: 133 YLYLQDNALQALPDDTF 149
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.8 bits (216), Expect = 3e-19
Identities = 58/283 (20%), Positives = 98/283 (34%), Gaps = 35/283 (12%)
Query: 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNS 155
LDL N+ T N L TL+L +N+ P L +L L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
L +P + +L+ + H N + + L N
Sbjct: 91 LKE-LPE--KMPKTLQELRVHENEITKVRKSVFNGL---------------------NQM 126
Query: 216 AILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNN 275
++ L + G + + L + N I + L L+LD N
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPP---SLTELHLDGNK 182
Query: 276 LEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNL 335
+ +L GL NL KL LS N ++ +G +++ L+ + L+ N LV ++P + +
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241
Query: 336 SSLNSLLLFNNRLQG------TLPPELGNCGSLVDLRLQHNFI 372
+ + L NN + P S + L N +
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.3 bits (207), Expect = 4e-18
Identities = 67/292 (22%), Positives = 108/292 (36%), Gaps = 20/292 (6%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
L V+ D LE ++P+ L + L L NK+ G + L + L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA 384
P + L L L L N+L+ LP ++ LR+ N I L
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE--LRVHENEITKVRKSVFNGLN 124
Query: 385 KLEVLYLFN--NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
++ V+ L + G M KL + + + +T IP + +L L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 181
Query: 443 HLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502
+T A L K L++L L+ NS ++ +L L L NN+ P +
Sbjct: 182 KITKVDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239
Query: 503 KCSSLRRVILSNNLLQG------SLPATLERNPGVSFLDVRGNLLQ-GSIPP 547
++ V L NN + P + S + + N +Q I P
Sbjct: 240 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.9 bits (193), Expect = 3e-16
Identities = 48/240 (20%), Positives = 84/240 (35%), Gaps = 9/240 (3%)
Query: 504 CS-SLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562
C LR V S+ L+ +P L + + LD++ N + F NL L
Sbjct: 8 CQCHLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILIN 64
Query: 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVI 622
N++S P L L+ L LS N+L ++ + + S+ + +
Sbjct: 65 NKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNG-L 123
Query: 623 SLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVS 682
+ + L SG AF ++ L +++ L L++
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE----LHLD 179
Query: 683 NNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASW 742
NK++ L L+ L L LS NS S + N L ++++ N
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLA 239
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.9 bits (193), Expect = 3e-16
Identities = 55/291 (18%), Positives = 100/291 (34%), Gaps = 38/291 (13%)
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNL 434
+P ++ +L L NN+I + L L L NN+++ P L L
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 435 QFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN 494
+ L L+ N L E+ ++ K L + + + + L + +
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSS 139
Query: 495 GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554
G L + +++ + +IP G +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-------------------------TIPQ--GLPPS 172
Query: 555 LTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614
LT L N+++ + L L NL L LS N + L + +L L++N L
Sbjct: 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL- 231
Query: 615 GSIPSEVISLEKMQSLSLQENNLSGAIPDAF------SSVQSLFELQLGSN 659
+P + + +Q + L NN+S + F + S + L SN
Sbjct: 232 VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.2 bits (186), Expect = 2e-15
Identities = 51/260 (19%), Positives = 94/260 (36%), Gaps = 16/260 (6%)
Query: 457 PYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNL 516
P + LDL N + NL L+L NN+ + P L R+ LS N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 517 LQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDF--SENRLSGSIPSELG 574
L+ LP + + L V N + VF + + +++ + + SG
Sbjct: 91 LK-ELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 575 NLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634
++ L +R++ + G + +L L N + + + L + L L
Sbjct: 148 GMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 635 NNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSG------ 688
N++S + ++ L EL +N +P L+ + ++ + NN +S
Sbjct: 205 NSISAVDNGSLANTPHLRELH-LNNNKLVKVPGGLADHKYI-QVVYLHNNNISAIGSNDF 262
Query: 689 KIPECLGNLDKLQILDLSSN 708
P + L SN
Sbjct: 263 CPPGYNTKKASYSGVSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.5 bits (184), Expect = 4e-15
Identities = 46/269 (17%), Positives = 98/269 (36%), Gaps = 14/269 (5%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVS 532
+P ++ + +L L NN+ + +L +IL NN + P +
Sbjct: 25 VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR 592
L + N L+ + L + + ++ S+ + L + ++ L + K G
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLF 652
K+ + ++D + +IP + + L L N ++ + + +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 653 ELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSG 712
+L S ++ L+++NNKL K+P L + +Q++ L +N+ S
Sbjct: 199 KLG-LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
Query: 713 ------EIPTEVNNMVSLYFVNISFNHFS 735
P S V++ N
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.7 bits (213), Expect = 6e-19
Identities = 79/335 (23%), Positives = 129/335 (38%), Gaps = 36/335 (10%)
Query: 29 SLVQFLDSLPKQSQSHLP-WNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNN 87
+L+Q L + + L W + + W GV C ++ +
Sbjct: 10 ALLQIKKDL--GNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTY---------------- 50
Query: 88 SISYICKNQHLLSLDLSGNEFTG--SIPKQLGNCGQLKTLLLNDN-RFQGSIPPEIFKLK 144
+ +LDLSG IP L N L L + G IPP I KL
Sbjct: 51 ---------RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLT 101
Query: 145 RLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNL 204
+L +L + + ++SG IP +S +L ++ F N L+G LP I SLP L + + N +
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 205 TGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLL 264
+G +P+ S + L + + + + + F S N + +F
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGS-D 220
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
+ N + +NL L L N++ GT+ ++ L + +S NNL
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNC 359
G+IP GNL + NN+ P L C
Sbjct: 281 CGEIP-QGGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 6e-14
Identities = 71/294 (24%), Positives = 108/294 (36%), Gaps = 26/294 (8%)
Query: 186 NDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFS 245
+ ++ +L L+ NL P +P+SL+N L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYP---------------------IPSSLANLPYLNFLY 82
Query: 246 ASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTIS 305
N P L QL LY+ N+ G IP+ L ++ L L S N L+GT+
Sbjct: 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP 142
Query: 306 GQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNS-LLLFNNRLQGTLPPELGNCGSLVD 364
IS L I N + G IP S G+ S L + + + NRL G +PP N
Sbjct: 143 PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFV 202
Query: 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRI 424
++ G + K ++G L L L NNR+ G +
Sbjct: 203 DLSRNMLEGDASVLFGSD--KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260
Query: 425 PPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANIC 478
P +T+L+ L L+++ N+L GE+ G + N P C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIP--QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.7 bits (174), Expect = 6e-14
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 8/281 (2%)
Query: 463 DLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPI--EIGKCSSLRRVILSNNL-LQG 519
D ++ G + + L L +PI + L + + L G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 520 SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENL 579
+P + + + +L + + G+IP L LDFS N LSG++P + +L NL
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 580 QILRLSANKLDGRIPYELGKCTK-MIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLS 638
+ N++ G IP G +K + +S N L G IP +L +
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211
Query: 639 GAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLD 698
A S + +++ LSK + ++ NN++ G +P+ L L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL---DLRNNRIYGTLPQGLTQLK 268
Query: 699 KLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLP 739
L L++S N+ GEIP + N+ + N P
Sbjct: 269 FLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 68.6 bits (166), Expect = 7e-13
Identities = 62/265 (23%), Positives = 96/265 (36%), Gaps = 8/265 (3%)
Query: 262 GLLQLEVLYLDDNNLEG--QIPETLWGLENLQKLVLSAN-KLNGTISGQISHCNQLQVIA 318
++ L L NL IP +L L L L + L G I I+ QL +
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
++ N+ G IP + + +L +L N L GTLPP + + +LV + N I G IP
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 379 EICNLAKLEV-LYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFL 437
+ +KL + + NR+ G IP ++ N + +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML---EGDASVLFGSDKNTQ 224
Query: 438 SLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSF 497
+ + L L+ LDL N YG +P + L L + N G
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 498 PIEIGKCSSLRRVILSNNLLQGSLP 522
P + G +NN P
Sbjct: 285 P-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.8 bits (130), Expect = 2e-08
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 1/65 (1%)
Query: 126 LLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELP 185
L +NR G++P + +LK L L++ +N+L G+IP +L + + NN P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL-QRFDVSAYANNKCLCGSP 308
Query: 186 NDICS 190
C+
Sbjct: 309 LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.8 bits (130), Expect = 3e-08
Identities = 20/76 (26%), Positives = 33/76 (43%), Gaps = 2/76 (2%)
Query: 91 YICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLD 150
+ +++L LDL N G++P+ L L +L ++ N G I P+ L+R
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSA 297
Query: 151 LGYNS-LSGKIPPQVS 165
N L G P +
Sbjct: 298 YANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 5e-05
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 25/217 (11%)
Query: 554 NLTMLDFSENRLSG--SIPSELGNLENLQILRLSAN-KLDGRIPYELGKCTKMIKLDLSD 610
+ LD S L IPS L NL L L + L G IP + K T++ L ++
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 611 NYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLS 670
++G+IP + ++ + +L N LSG +P + SS+ +L + N G+IP S
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 671 KLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMV-------- 722
+ + +S N+L+GKIP NL+ + + ++
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 723 --------------SLYFVNISFNHFSGKLPASWTTL 745
+L +++ N G LP T L
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 38.2 bits (87), Expect = 0.004
Identities = 30/139 (21%), Positives = 57/139 (41%), Gaps = 2/139 (1%)
Query: 629 SLSLQENNLSGA--IPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKL 686
+L L NL IP + +++ L L +G L +++ +
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 687 SGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPASWTTLM 746
SG IP+ L + L LD S N+ SG +P ++++ +L + N SG +P S+ +
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
Query: 747 VSYPGSFLGNSELCRQGNC 765
+ + + L +
Sbjct: 174 KLFTSMTISRNRLTGKIPP 192
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 6e-17
Identities = 26/164 (15%), Positives = 54/164 (32%), Gaps = 25/164 (15%)
Query: 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETN--------------FDVEIRTLSLV 884
G+++G+GK V+ S + VK T+ F V +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 885 RHRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLS 944
R + ++ G + + G + L + + + I + ++
Sbjct: 64 EFRALQKLQGLAVPKVYAWE------GNAVLMELIDAKELYRVRVENPDEVLDMILEEVA 117
Query: 945 YLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988
++ I+H D+ N+L+ E I DF S + +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGW 157
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 6e-10
Identities = 39/275 (14%), Positives = 81/275 (29%), Gaps = 18/275 (6%)
Query: 100 SLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGK 159
+LDL+G + +L + G + + + E F R+ +DL + +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVS 61
Query: 160 IPPQV-SLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAIL 218
+ S C L+++ L+ + N + L L L+ + +
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-LQTLLSSC 120
Query: 219 HLLIHENDFVGSLPTSLSNCRNLVE----------FSASSNNFGGAISPWIFKGLLQLEV 268
L N T + N +S + + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 269 LYLDDNNLEGQIPETLWGLENLQKLVLS-ANKLNGTISGQISHCNQLQVIALSRNNLVGQ 327
D L+ + + L LQ L LS + ++ L+ + + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSL 362
+ L L + + P +GN +
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 41/270 (15%), Positives = 85/270 (31%), Gaps = 15/270 (5%)
Query: 291 QKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQG 350
Q L L+ L+ ++G++ + R+ + + + + + L N+ ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 351 -TLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLF--NNRIEGAIPHQIGRM 407
TL L C L +L L+ + I + + L L L + E A+ +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 408 SKLVELALYNNRLTG------RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSR 461
S+L EL L + + L N +++ + + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 462 LDLTGNSFYGPIPANICVGTNLFVLVL-GNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS 520
L L L +E+G+ +L+ + + + G+
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPPVFG 550
L E P L + + P G
Sbjct: 241 LQLLKEALPH---LQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 2e-07
Identities = 38/290 (13%), Positives = 89/290 (30%), Gaps = 37/290 (12%)
Query: 461 RLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGS 520
LDLTG + + + + + + + + E ++ + LSN+
Sbjct: 4 TLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNS----- 56
Query: 521 LPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQ 580
+ ++ + S L L RLS I + L NL
Sbjct: 57 ------------------VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
Query: 581 IL--------RLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSL 632
L A + L + D ++ ++ ++ ++ ++
Sbjct: 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 158
Query: 633 QENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSN-NKLSGKIP 691
++N + +L L L ++ + ++ L++S + +
Sbjct: 159 RKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218
Query: 692 ECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFSGKLPAS 741
LG + L+ L + G + + L I+ +HF+ +
Sbjct: 219 LELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPT 265
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 2e-06
Identities = 36/263 (13%), Positives = 66/263 (25%), Gaps = 18/263 (6%)
Query: 68 SSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTG-SIPKQLGNCGQLKTLL 126
S + A + L S + +DLS + ++ L C +L+ L
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHFS----PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 77
Query: 127 LNDNRFQGSIPPEIFKLKRLSWLDLG--YNSLSGKIPPQVSLCYSLESIGFHNNFLNGEL 184
L R I + K L L+L + +S C L+ + F E
Sbjct: 78 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK 137
Query: 185 PNDICSLP--------KLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLS 236
+ L N + L
Sbjct: 138 HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 197
Query: 237 NCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLS 296
L S S + + L+ L + +G + E L L ++
Sbjct: 198 QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQIN 254
Query: 297 ANKLNGTISGQISHCNQLQVIAL 319
+ I + ++ +
Sbjct: 255 CSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 3e-05
Identities = 37/274 (13%), Positives = 80/274 (29%), Gaps = 14/274 (5%)
Query: 172 SIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDF-VGS 230
++ L+ ++ + S + + + + L E + + H+ + + V +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 231 LPTSLSNCRNLVEFSASSNNFGGAISPWI--FKGLLQLEVLYLDDNNLEGQIPET----- 283
L LS C L S I + L++L + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 284 LWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVG-QIPRSVGNLSSLNSLL 342
L L + + ++ QL + +N + ++ L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 343 LFNNRLQGTLPPELGNCGSLVDLRLQH-NFIGGTIPPEICNLAKLEVLYLFNNRIEGAIP 401
+ L+ E L L L I E+ + L+ L +F +G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 402 HQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQ 435
+ L + + T P I +N +
Sbjct: 243 LLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 43/214 (20%), Positives = 63/214 (29%), Gaps = 12/214 (5%)
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438
E+ +A + + A+P + + L L N L + L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 439 LAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGP--IPANICVGTNLFVLVLGNNRFNGS 496
L LT + L L S +P L VL + NR
Sbjct: 62 LDRAELTKL------QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSL 115
Query: 497 FPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLT 556
+ L+ + L N L+ P L P + L + N L + NL
Sbjct: 116 PLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 557 MLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590
L EN L +IP L L N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.8 bits (138), Expect = 2e-09
Identities = 43/191 (22%), Positives = 67/191 (35%), Gaps = 7/191 (3%)
Query: 544 SIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM 603
++PP + T+L SEN L + L L L L +L +
Sbjct: 24 ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD---GTLPV 78
Query: 604 IKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663
+ + S+P +L + L + N L+ A + L EL L N
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK- 137
Query: 664 SIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVS 723
++P L L+++NN L+ L L+ L L L NS IP
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 724 LYFVNISFNHF 734
L F + N +
Sbjct: 197 LPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 49/209 (23%), Positives = 74/209 (35%), Gaps = 8/209 (3%)
Query: 234 SLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKL 293
+S + +E + N A+ P + K +L+L +N L TL L +L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDT---TILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 294 VLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLP 353
L + Q+ + +N + +P L +L L + NRL
Sbjct: 61 NLDRAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 354 PELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVEL 413
L G L +L L+ N + P + KLE L L NN + + + L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 414 ALYNNRLTGRIPPDITRLRNLQFLSLAHN 442
L N L IP L F L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 4e-08
Identities = 39/212 (18%), Positives = 60/212 (28%), Gaps = 12/212 (5%)
Query: 66 NNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTL 125
+ +S +N L+ + + + K+ L LS N L +L L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPD----LPKD--TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 126 LLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELP 185
L+ + L +P +L + N L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQ---SLPLLGQTLPALTVLDVSFNRLTSLPL 117
Query: 186 NDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHE-NDFVGSLPTSLSNCRNLVEF 244
+ L +L+ LYL N L L P L L N+ L+ NL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNL 276
N+ P F G L +L N
Sbjct: 178 LLQENSL--YTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 42/211 (19%), Positives = 72/211 (34%), Gaps = 7/211 (3%)
Query: 139 EIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLY 198
E+ K+ ++ +L+ +PP L + N L + +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 199 LNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258
L+ LT + + + + L + S N ++
Sbjct: 62 LDRAELT---KLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIA 318
+GL +L+ LYL N L+ P L L+KL L+ N L +G ++ L +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349
L N+L IP+ L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 48/203 (23%), Positives = 74/203 (36%), Gaps = 8/203 (3%)
Query: 473 IPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVS 532
+P ++ + +L L N + + L ++ L L
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVL--- 79
Query: 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR 592
+ S+P + LT+LD S NRL+ L L LQ L L N+L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLF 652
P L K+ KL L++N L + LE + +L LQEN+L IP F L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 653 ELQLGSNIFDGSIPCSLSKLHHF 675
L N + + C + +
Sbjct: 199 FAFLHGNPWLCN--CEILYFRRW 219
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 53/205 (25%), Positives = 78/205 (38%), Gaps = 9/205 (4%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324
LEV D NL +P L ++ L LS N L + +L + L R
Sbjct: 12 HLEV-NCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE- 66
Query: 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLA 384
+ G L L +L L +N+ +LP +L L + N + + L
Sbjct: 67 -LTKLQVDGTLPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 385 KLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHL 444
+L+ LYL N ++ P + KL +L+L NN LT + L NL L L N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 445 TGEVALELGKHFPYLSRLDLTGNSF 469
+ L L GN +
Sbjct: 185 Y-TIPKGFFG-SHLLPFAFLHGNPW 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 7e-09
Identities = 21/91 (23%), Positives = 36/91 (39%), Gaps = 5/91 (5%)
Query: 554 NLTMLDFSENRLSGSIPSEL-GNLENLQILRLSANKLDGR----IPYELGKCTKMIKLDL 608
++ LD LS + +EL L+ Q++RL L I L + +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 609 SDNYLAGSIPSEVISLEKMQSLSLQENNLSG 639
N L V+ + S +Q+ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 4e-07
Identities = 22/112 (19%), Positives = 41/112 (36%), Gaps = 6/112 (5%)
Query: 40 QSQSHLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISY-ICKNQHL 98
+ L + + A + S L+ L L+ +S +S++ + N L
Sbjct: 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399
Query: 99 LSLDLSGNEFTGSIPKQLG-----NCGQLKTLLLNDNRFQGSIPPEIFKLKR 145
LDLS N + QL L+ L+L D + + + L++
Sbjct: 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 9/87 (10%)
Query: 549 FGFWSNLTMLDFSENRLSG----SIPSELGNLENLQILRLSANKLDGRIPYELGK----- 599
S L +L ++ +S S+ + L +L+ L LS N L +L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 600 CTKMIKLDLSDNYLAGSIPSEVISLEK 626
+ +L L D Y + + + +LEK
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 17/89 (19%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKLVL 295
++ A + L Q +V+ LDD L I L L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 296 SANKLNGTISGQISHCNQLQVIALSRNNL 324
+N+L + Q + + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 9/96 (9%)
Query: 664 SIPCSLSKLHHFSSILNVSNNKLSGK----IPECLGNLDKLQILDLSSNSFSGEIPTEV- 718
+ L + +L +++ +S + L L+ LDLS+N ++
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 719 ----NNMVSLYFVNISFNHFSGKLPASWTTLMVSYP 750
L + + ++S ++ L P
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 454
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 7/89 (7%)
Query: 98 LLSLDLSGNEFTGS-IPKQLGNCGQLKTLLLNDNRFQG----SIPPEIFKLKRLSWLDLG 152
+ SLD+ E + + + L Q + + L+D I + L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 153 YNSLSGKIPPQVSLCYSLESIGFHNNFLN 181
N L + L++ L+
Sbjct: 64 SNELGDVGVH--CVLQGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 14/92 (15%), Positives = 28/92 (30%), Gaps = 9/92 (9%)
Query: 433 NLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF----YGPIPANICVGTNLFVLVL 488
++Q L + L+ EL + L I + + V L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 489 GNNRFNGSFPIEIGK-----CSSLRRVILSNN 515
+N + + ++++ L N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 16/112 (14%), Positives = 36/112 (32%), Gaps = 24/112 (21%)
Query: 169 SLESIGFHNNFLNGELPNDICS-LPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDF 227
++S+ L+ ++ L + + + L+ LT
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT-------------------EAR 43
Query: 228 VGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGL----LQLEVLYLDDNN 275
+ ++L L E + SN G + +GL +++ L L +
Sbjct: 44 CKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 9/91 (9%)
Query: 627 MQSLSLQENNLSGA-IPDAFSSVQSLFELQLGSNIFDGSIPCSLSK-LHHFSSI--LNVS 682
+QSL +Q LS A + +Q ++L + +S L ++ LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 683 NNKLSGKIPECLG-----NLDKLQILDLSSN 708
+N+L C+ K+Q L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 6e-04
Identities = 12/73 (16%), Positives = 25/73 (34%), Gaps = 4/73 (5%)
Query: 410 LVELALYNNRLTGRIPPDI-TRLRNLQFLSLAHNHLTGEVALELG---KHFPYLSRLDLT 465
+ L + L+ ++ L+ Q + L LT ++ + P L+ L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 466 GNSFYGPIPANIC 478
N +
Sbjct: 64 SNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 10/96 (10%)
Query: 211 FPNSCAILHLLIHENDF----VGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQ- 265
+ L + + D SL +L +L E S+N G A + + + Q
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 266 ---LEVLYLDDNNLEGQIPETLWGL-ENLQKL-VLS 296
LE L L D ++ + L L ++ L V+S
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 0.001
Identities = 14/84 (16%), Positives = 33/84 (39%), Gaps = 9/84 (10%)
Query: 575 NLENLQILRLSANKLDGR----IPYELGKCTKMIKLDLSDNYLAGSIPSEVIS-----LE 625
L++L L+ + + L + +LDLS+N L + +++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 626 KMQSLSLQENNLSGAIPDAFSSVQ 649
++ L L + S + D +++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 18/87 (20%), Positives = 31/87 (35%), Gaps = 9/87 (10%)
Query: 118 NCGQLKTLLLNDNRFQG----SIPPEIFKLKRLSWLDLGYNSLSGKIPPQVS-----LCY 168
L+ L L D S+ + L LDL N L Q+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 169 SLESIGFHNNFLNGELPNDICSLPKLK 195
LE + ++ + + E+ + + +L K K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 18/98 (18%), Positives = 34/98 (34%), Gaps = 9/98 (9%)
Query: 254 AISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKLVLSANKLNGTISGQIS 309
+ + + L VL+L D ++ + TL +L++L LS N L Q+
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 310 -----HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLL 342
L+ + L ++ + L L
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 11/90 (12%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 122 LKTLLLNDNRFQGSIPPEIFK-LKRLSWLDLGYNSLSGK----IPPQVSLCYSLESIGFH 176
+++L + + E+ L++ + L L+ I + + +L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 177 NNFLNGELPNDICSLPKLKSLYLNTNNLTG 206
+N L + + + S + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 13/94 (13%)
Query: 358 NCGSLVDLRLQHNFIGGT----IPPEICNLAKLEVLYLFNNRIEGAIPHQIGR-----MS 408
L L L + + + + L L L NN + A Q+
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 409 KLVELALYNNRLTGRIPPDITRLR----NLQFLS 438
L +L LY+ + + + L +L+ +S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.002
Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 10/91 (10%)
Query: 314 LQVIALSRNNLV-GQIPRSVGNLSSLNSLLLFNNRLQG----TLPPELGNCGSLVDLRLQ 368
+Q + + L + + L + L + L + L +L +L L+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 369 HNFIGGTIPPEIC-----NLAKLEVLYLFNN 394
N +G + K++ L L N
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 18/93 (19%), Positives = 29/93 (31%), Gaps = 14/93 (15%)
Query: 433 NLQFLSLAHNHLTGEVALELG---KHFPYLSRLDLTGNSFYGPIPANICVG-----TNLF 484
L+ L LA ++ L L LDL+ N + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 485 VLVLGNNRFNGSFPIEIG----KCSSLRRVILS 513
LVL + ++ + SLR ++S
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLR--VIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 21/92 (22%), Positives = 34/92 (36%), Gaps = 13/92 (14%)
Query: 504 CSSLRRVILSNNLLQG----SLPATLERNPGVSFLDVRGNLLQGSIPPVFG-----FWSN 554
S LR + L++ + SL ATL N + LD+ N L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 555 LTMLDFSENRLSGSIPSELGNLE----NLQIL 582
L L + S + L LE +L+++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.004
Identities = 14/79 (17%), Positives = 29/79 (36%), Gaps = 8/79 (10%)
Query: 407 MSKLVELALYNNRLTGR----IPPDITRLRNLQFLSLAHNHLTGEVALELGKHFP----Y 458
S L L L + ++ + + +L+ L L++N L L+L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 459 LSRLDLTGNSFYGPIPANI 477
L +L L + + +
Sbjct: 428 LEQLVLYDIYWSEEMEDRL 446
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.0 bits (131), Expect = 8e-09
Identities = 36/229 (15%), Positives = 69/229 (30%), Gaps = 19/229 (8%)
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
LA + + + + + + L+ + +T + L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEI 501
N + L L P + + +
Sbjct: 73 NQI---------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561
+L +L Q + + L + +L + Q S S LT L
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA--QVSDLTPLANLSKLTTLKAD 181
Query: 562 ENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD 610
+N++S P L +L NL + L N++ P L + + + L++
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 30/219 (13%), Positives = 63/219 (28%), Gaps = 23/219 (10%)
Query: 261 KGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALS 320
L + +N+ + + L+ + L + TI G + + N L + L
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 321 RNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI 380
N + P + L + + + + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 381 CNLAKLEVLYLFNNRIEGAIPH--------------QIGRMSKLVELALYNNRLTGRIPP 426
L + + G + +SKL L +N+++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 427 DITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLT 465
+ L NL + L +N ++ L + L + LT
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSPL---ANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 31/218 (14%), Positives = 56/218 (25%), Gaps = 28/218 (12%)
Query: 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNS 155
+ + + + T ++ + + TL +I + L L L+L N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQ 74
Query: 156 LSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSC 215
+ + + + N L K L L N
Sbjct: 75 I--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 216 AILHL-----------------LIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPW 258
+ + + S T L+N L A N
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 259 IFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLS 296
L L ++L +N + P L NL + L+
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 34/219 (15%), Positives = 68/219 (31%), Gaps = 23/219 (10%)
Query: 237 NCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLS 296
N ++ +A +N ++ L + L + E + L NL L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 297 ANKLNGTISG--------QISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFN--- 345
N++ N L+ ++ + + + L
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 346 ---NRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPH 402
+ G L + + NL+KL L +N+I P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 403 QIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
+ + L+E+ L NN+++ P + NL ++L +
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 38/228 (16%), Positives = 65/228 (28%), Gaps = 18/228 (7%)
Query: 190 SLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSN 249
+L + +N+T + + + L V ++ + NL+ N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDN 73
Query: 250 NFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQIS 309
I+ L N + + S + T +S
Sbjct: 74 Q----ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQH 369
+ L + QI N L Q + L N L L+
Sbjct: 130 NLQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 370 NFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYN 417
N I P + +L L ++L NN+I P + S L + L N
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 33/234 (14%), Positives = 71/234 (30%), Gaps = 21/234 (8%)
Query: 139 EIF---KLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLK 195
IF L + G ++++ + + + ++ + + + L L
Sbjct: 11 VIFPDPALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEG-VQYLNNLI 66
Query: 196 SLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI 255
L L N +T L P + L S L + + L S +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 256 SPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQ 315
+ L + + L G S + +++ ++L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYL----------SIGNAQVSDLTPLANLSKLT 176
Query: 316 VIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQH 369
+ N + P + +L +L + L NN++ L N +L + L +
Sbjct: 177 TLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTN 226
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 7e-08
Identities = 54/327 (16%), Positives = 91/327 (27%), Gaps = 24/327 (7%)
Query: 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN------GTISGQISHCNQLQVIA 318
Q L L++ L +PE +L+ LV S N L ++ + N L+ ++
Sbjct: 39 QAHELELNNLGLS-SLPELP---PHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALS 94
Query: 319 LSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPP 378
L + ++ L L + G
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL-EFIAAGNNQLE 153
Query: 379 EICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLS 438
E+ L L L +S +A N ++ L + +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 439 LAHNHLTGEVALELGKHFPYLSRLDLTG----NSFYGPIPANICVGTNLFVLVLGNNRFN 494
L + DL +F + L + N +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 495 GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554
SL + +SNN L LPA P + L N L +P + N
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQ---N 325
Query: 555 LTMLDFSENRLSGSIPSELGNLENLQI 581
L L N L P ++E+L++
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/90 (23%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 539 NLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELG 598
N I + +L L+ S N+L +P+ LE L S N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHL-AEVPELPQ 324
Query: 599 KCTKMIKLDLSDNYLAGSIPSEVISLEKMQ 628
+L + N L P S+E ++
Sbjct: 325 NLK---QLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 1e-05
Identities = 26/101 (25%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 551 FWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSD 610
S L + N S I S +L+ L +S NKL +P + +L S
Sbjct: 258 GLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASF 313
Query: 611 NYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSL 651
N+L +P + ++ L ++ N L PD SV+ L
Sbjct: 314 NHL-AEVPE---LPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 10/97 (10%)
Query: 632 LQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIP 691
N S I SL EL + +N +P +L L S N L+ ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFNHLA-EVP 320
Query: 692 ECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVN 728
E NL + L + N E P ++ L +
Sbjct: 321 ELPQNL---KQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 6e-05
Identities = 57/336 (16%), Positives = 93/336 (27%), Gaps = 30/336 (8%)
Query: 64 CYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLK 123
C + L L+ GLS L HL SL S N T +P+ + L
Sbjct: 35 CLDRQ--AHELELNNLGLSS-LPELPP------HLESLVASCNSLT-ELPELPQSLKSLL 84
Query: 124 TLLLNDNRFQGSIP-----------PEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLES 172
N P E + S + + + L SLE
Sbjct: 85 VDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 173 IGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLP 232
I NN L N+ LP S + ++ E + +LP
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204
Query: 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQK 292
+ + + + + L GL L
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 293 LVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTL 352
+ N + I L+ + +S N L+ ++P L L N L +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EV 319
Query: 353 PPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV 388
P N L L +++N + P ++ L +
Sbjct: 320 PELPQN---LKQLHVEYNPL-REFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 1e-04
Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 12/92 (13%)
Query: 86 NNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKR 145
N S L L++S N+ +P L+ L+ + N +P +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL---PQN 325
Query: 146 LSWLDLGYNSLSGKIPPQVSLCYSLESIGFHN 177
L L + YN L + P S+E + ++
Sbjct: 326 LKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 3e-04
Identities = 60/315 (19%), Positives = 95/315 (30%), Gaps = 25/315 (7%)
Query: 166 LCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHEN 225
L + +N L+ LP P L+SL + N+LT LPE P S L + +
Sbjct: 36 LDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNL 90
Query: 226 DFVGSLPTSLSNC---RNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPE 282
+ LP L N +E N + L+
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 283 TLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLL 342
L L LQ L S + L + ++ N + + + NL L ++
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 343 LFNNRLQGTLPPELGNCGSLVDLRLQHNFIGG--------TIPPEICNLAKLEVLYLFNN 394
NN L+ V + L++L + N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 395 RIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGK 454
I L EL + NN+L +P L+ L + NHL E+ +
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-----EVPE 321
Query: 455 HFPYLSRLDLTGNSF 469
L +L + N
Sbjct: 322 LPQNLKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 5e-04
Identities = 55/332 (16%), Positives = 95/332 (28%), Gaps = 31/332 (9%)
Query: 119 CGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNN 178
Q L LN+ S+P L+ L NSL+ ++P L SL+S+ NN
Sbjct: 37 DRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELP---ELPQSLKSLLVDNN 88
Query: 179 FLNG------ELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLP 232
L L S +L+ L N+ + + N+ + + +
Sbjct: 89 NLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAG 148
Query: 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQK 292
+ ++ + L L + + N + L L L
Sbjct: 149 NNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 208
Query: 293 LVLSANKLNGTISGQISHCNQLQVIAL--------SRNNLVGQIPRSVGNLSSLNSLLLF 344
+ N L S + LS L L +
Sbjct: 209 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYY 268
Query: 345 NNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI 404
N + SL +L + +N + +P LE L N + +P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLA-EVPELP 323
Query: 405 GRMSKLVELALYNNRLTGRIPPDITRLRNLQF 436
L +L + N L P + +L+
Sbjct: 324 Q---NLKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 2e-07
Identities = 22/109 (20%), Positives = 40/109 (36%), Gaps = 7/109 (6%)
Query: 606 LDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSI 665
L L+ L ++ + L + L L N L P ++ +L L++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56
Query: 666 PCSLSKLHHFSSILNVSNNKL-SGKIPECLGNLDKLQILDLSSNSFSGE 713
L + NN+L + L + +L +L+L NS E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 3e-07
Identities = 24/107 (22%), Positives = 41/107 (38%), Gaps = 4/107 (3%)
Query: 101 LDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKI 160
L L+ + T + L + L L+ NR + +PP + L+ L L N+ +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA-LENV 58
Query: 161 PPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGL 207
+L E + +N + S P+L L L N+L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 8e-07
Identities = 34/125 (27%), Positives = 49/125 (39%), Gaps = 8/125 (6%)
Query: 341 LLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAI 400
L L + L T+ L + L L HN + +PP + L LEVL +N +E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD 59
Query: 401 PHQIGRMSKLVELALYNNRLTGRIPPD-ITRLRNLQFLSLAHNHLTGEVAL--ELGKHFP 457
+ EL L NNRL + L L+L N L E + L + P
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 458 YLSRL 462
+S +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 7/106 (6%)
Query: 365 LRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRI 424
L L H + T+ + L + L L +NR+ P ++ L L +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56
Query: 425 -PPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSF 469
+ L LQ L L +N L A++ P L L+L GNS
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.0 bits (98), Expect = 4e-05
Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 8/122 (6%)
Query: 176 HNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSL 235
H + + + L + L L+ N L L P + L +N +
Sbjct: 7 HKDL---TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN--VDGV 61
Query: 236 SNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNL---EGQIPETLWGLENLQK 292
+N L E +N + + +L +L L N+L EG L ++
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 121
Query: 293 LV 294
++
Sbjct: 122 IL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 20/113 (17%), Positives = 35/113 (30%), Gaps = 6/113 (5%)
Query: 485 VLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGS 544
VL L + + + + + + LS+N L+ PA ++ +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALR---CLEVLQASDNALE 56
Query: 545 IPPVFGFWSNLTMLDFSENRL-SGSIPSELGNLENLQILRLSANKLDGRIPYE 596
L L NRL + L + L +L L N L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.7 bits (92), Expect = 3e-04
Identities = 37/120 (30%), Positives = 52/120 (43%), Gaps = 7/120 (5%)
Query: 268 VLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQ 327
VL+L +L + L L + L LS N+L ++ L+V+ S N +
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LE 56
Query: 328 IPRSVGNLSSLNSLLLFNNRLQGT-LPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKL 386
V NL L LLL NNRLQ + L +C LV L LQ N + LA++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 4e-04
Identities = 25/109 (22%), Positives = 39/109 (35%), Gaps = 9/109 (8%)
Query: 413 LALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLT-GNSFYG 471
L L + LT + + +L + L L+HN L L L++ +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDNAL 55
Query: 472 PIPANICVGTNLFVLVLGNNRFNGSFPIE-IGKCSSLRRVILSNNLLQG 519
+ L L+L NNR S I+ + C L + L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 8e-04
Identities = 26/109 (23%), Positives = 38/109 (34%), Gaps = 6/109 (5%)
Query: 195 KSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGA 254
+ L+L +LT L + HL + N P +L+ R L AS N
Sbjct: 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 255 ISPWIFKGLLQLEVLYLDDNNLEG-QIPETLWGLENLQKLVLSANKLNG 302
+L+ L L +N L+ + L L L L N L
Sbjct: 59 DGVANLP---RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 6e-06
Identities = 29/247 (11%), Positives = 60/247 (24%), Gaps = 22/247 (8%)
Query: 57 CKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQL 116
C C + + S + +N + L +
Sbjct: 8 CSNRVFLCQESK----------------VTEIPSDLPRN--AIELRFVLTKLRVIQKGAF 49
Query: 117 GNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFH 176
G L+ + ++ N I ++F + + +
Sbjct: 50 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109
Query: 177 NNFLN----GELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLP 232
+ ++ L + N N T F +L + + +
Sbjct: 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH 169
Query: 233 TSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQK 292
N L E + S NN + +F G +L + + L L+ L+
Sbjct: 170 NCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA 229
Query: 293 LVLSANK 299
K
Sbjct: 230 RSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 4e-04
Identities = 43/245 (17%), Positives = 77/245 (31%), Gaps = 9/245 (3%)
Query: 185 PNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEF 244
+ IC + + +T + + P + L + S +L +
Sbjct: 2 HHRICHC-SNRVFLCQESKVTEIPSDLPRNAIELRF--VLTKLRVIQKGAFSGFGDLEKI 58
Query: 245 SASSNNFGGAISPWIFKGLLQLEVLYLDD-NNLEGQIPETLWGLENLQKLVLSANKLNGT 303
S N+ I +F L +L + ++ NNL PE L NLQ L++S +
Sbjct: 59 EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118
Query: 304 I--SGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGS 361
S L I + N + VG L L N +Q
Sbjct: 119 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQL 178
Query: 362 LVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421
+N + + +L + RI + + + KL + YN +
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK-- 236
Query: 422 GRIPP 426
++P
Sbjct: 237 -KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 31/246 (12%), Positives = 71/246 (28%), Gaps = 11/246 (4%)
Query: 113 PKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLES 172
++ +C + L +++ IP ++ + L L S LE
Sbjct: 2 HHRICHC-SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 173 IGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVG--- 229
I N + + D+ S L + +L G
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 230 -SLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLE 288
+ + + ++ + N + +L+L+ N ++ G +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 289 NLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRL 348
+ + N L + + ++ +SR + + NL L + +N +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK- 236
Query: 349 QGTLPP 354
LP
Sbjct: 237 --KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 31/246 (12%), Positives = 71/246 (28%), Gaps = 10/246 (4%)
Query: 377 PPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQF 436
IC+ + +++ IP + R +EL +L + +L+
Sbjct: 2 HHRICHCSNRVF-LCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 437 LSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGS 496
+ ++ N + + ++ + P L + + + I +L +N
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 497 FPIE---IGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWS 553
P L + + N+ + + + L + N +Q F
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYL 613
+ N L IL +S ++ Y L K+ +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL-- 235
Query: 614 AGSIPS 619
+P+
Sbjct: 236 -KKLPT 240
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 35/174 (20%), Positives = 62/174 (35%), Gaps = 7/174 (4%)
Query: 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPAN 476
L IP DI + L L N L + L P+L +L+L N G P
Sbjct: 17 GRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 477 ICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDV 536
+++ L LG N+ L+ + L +N + +P + E ++ L++
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 537 RGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590
N + F L + PS+ + ++QI L ++
Sbjct: 134 ASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 5e-04
Identities = 38/180 (21%), Positives = 67/180 (37%), Gaps = 9/180 (5%)
Query: 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL-GKCTKMIKLDLSDNYLA 614
T +D + L IP ++ + L L+ N+L L G+ ++KL+L N L
Sbjct: 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 615 GSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHH 674
G P+ +Q L L EN + F + L L L N +P S L+
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 675 FSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHF 734
+S+ SN + L+ + P++V + + ++ + F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRK--KSLNGGAARCGAPSKVRD---VQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 32/192 (16%), Positives = 51/192 (26%), Gaps = 17/192 (8%)
Query: 57 CKWSGVSCYNNS---------SSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNE 107
C+ + V C L L+ L + ++ + L
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSD---GLFGRLPHLVKLELKRN 64
Query: 108 FTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIF-KLKRLSWLDLGYNSLSGKIPPQVSL 166
I L I ++F L +L L+L N +S +P
Sbjct: 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEH 124
Query: 167 CYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHEND 226
SL S+ +N N L+ LN P I L ++
Sbjct: 125 LNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAPSKVRDVQIKDL--PHSE 181
Query: 227 FVGSLPTSLSNC 238
F S + C
Sbjct: 182 FKCS-SENSEGC 192
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 1e-05
Identities = 22/154 (14%), Positives = 47/154 (30%)
Query: 138 PEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSL 197
P+ S L + + E + L D+ L +L++L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 198 YLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISP 257
+ + L + P+ + L L + + SL +L E S N + +
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
Query: 258 WIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQ 291
+ + + + + L+ L + N
Sbjct: 122 RWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 28/144 (19%), Positives = 43/144 (29%), Gaps = 2/144 (1%)
Query: 214 SCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDD 273
L D L NL E + + +GL +L L +
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 274 NNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLV-GQIPRSV 332
+ L P+ L +L LS N ++S + LQ + LS N L R +
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 333 GNLSSLNSLLLFNNRLQGTLPPEL 356
+ +LQ L
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 22/152 (14%), Positives = 38/152 (25%), Gaps = 5/152 (3%)
Query: 93 CKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFK-LKRLSWLDL 151
C L + + L L L + + + + + L L L +
Sbjct: 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 152 GYNSLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNL--TGLLP 209
+ L P L + N L L+ L L+ N L + L
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALR 122
Query: 210 EFPNSCAILHLLIHENDFVGSLPTSLSNCRNL 241
+ E L++ N
Sbjct: 123 WLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 43/333 (12%), Positives = 75/333 (22%), Gaps = 20/333 (6%)
Query: 99 LSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQG----SIPPEIFKLKRLSWLDLGYN 154
L LD E S+ L +K ++L+ N + I K L +
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 155 SLSGKIPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFP-- 212
L L+ +D P + ++ + L
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH 129
Query: 213 --NSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLY 270
I ++ N L N K +L+
Sbjct: 130 NNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189
Query: 271 LDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPR 330
G PE + L K+ +H + ++ +
Sbjct: 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 249
Query: 331 SVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEIC-----NLAK 385
L S + L LRLQ+N I + +
Sbjct: 250 LNDCLLSARGAAAVVDAF------SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 386 LEVLYLFNNRIEGAIPHQIGRMSKLVELALYNN 418
L L L NR + + ++
Sbjct: 304 LLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 3e-05
Identities = 46/336 (13%), Positives = 95/336 (28%), Gaps = 34/336 (10%)
Query: 141 FKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGFHNNFLNGE----LPNDICSLPKLKS 196
+ K L + + + S++ I N + E L +I S L+
Sbjct: 5 IEGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 197 LYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFS---ASSNNFGG 253
+ + E P + +L + + + ++ S + + S +
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 254 AISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLN----GTISGQIS 309
GL + E + + L+ ++ N+L +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 310 HCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ---------GTLPPELGNCG 360
L + + +N + + + L LQ L L +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 361 SLVDLRLQHNFIGGTIPPEI------CNLAKLEVLYLFNNRIEGAIPHQI-----GRMSK 409
+L +L L + + L+ L L N IE + +M
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 410 LVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLT 445
L+ L L NR + + +R + F + L
Sbjct: 304 LLFLELNGNRFSE-EDDVVDEIREV-FSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 3e-04
Identities = 21/108 (19%), Positives = 34/108 (31%), Gaps = 8/108 (7%)
Query: 44 HLPWNQSVSTSAPCKWSGVSCYNNSSSLKALNLSGFGLSGVLNNSISYICKNQHLLSLDL 103
+ +SA L LS G + V++ +N L +L L
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK--LENIGLQTLRL 280
Query: 104 SGNEFTGSIPKQL-----GNCGQLKTLLLNDNRFQGSIPPEIFKLKRL 146
NE + L L L LN NRF + +++ +
Sbjct: 281 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 45/324 (13%), Positives = 90/324 (27%), Gaps = 35/324 (10%)
Query: 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGG----TIPPEICNLAKLEVLYLF 392
SL + + ++ L S+ ++ L N IG + I + LE+
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 393 NNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPP---DITRLRNLQFLSLAHNHLTGEVA 449
+ + L++ L +L + L+ + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 450 LELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509
L P ++ N NGS S R
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 510 VILSNNLLQGSLPATLERNPGVSFLD------------VRGNLLQGSIPPVFGFWSNLTM 557
+ + G P +E +L ++ W NL
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 558 LDFSENRLSGSIPSELGN------LENLQILRLSANKLDGRIPYEL-----GKCTKMIKL 606
L ++ LS + + + LQ LRL N+++ L K ++ L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 607 DLSDNYLAGSIPSEVISLEKMQSL 630
+L+ N E +++++ +
Sbjct: 308 ELNGN----RFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 35/315 (11%), Positives = 77/315 (24%), Gaps = 19/315 (6%)
Query: 424 IPPDITRLRNLQFLSLAHNHLTGEVALELGKHF---PYLSRLDLTGNSFYGPIPANICVG 480
+ + +++ + L+ N + E A L ++ L + +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 481 TNLFVLVLGNNR---FNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVR 537
L +L + S LS + L + +
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 538 GNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYEL 597
L + ++ L + NRL E L + + I E
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 598 GKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLG 657
+ + L + + + L + L
Sbjct: 203 IEHLLLEGLAYCQEL------KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 658 SNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECL-----GNLDKLQILDLSSNSFS- 711
+ + + L + N++ L + L L+L+ N FS
Sbjct: 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316
Query: 712 -GEIPTEVNNMVSLY 725
++ E+ + S
Sbjct: 317 EDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 43/352 (12%), Positives = 95/352 (26%), Gaps = 46/352 (13%)
Query: 264 LQLEVLYLDDNNLEG--QIPETLWGLENLQKLVLSANKLNG----TISGQISHCNQLQVI 317
++ + L LD E + L ++++++VLS N + +S I+ L++
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 318 ALSRN---NLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGG 374
S + +IP ++ L + ++ + + L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 375 TIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNL 434
+ L + E A+ + L + NRL
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK-------- 176
Query: 435 QFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN 494
L K R + + + + + +
Sbjct: 177 ----EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 232
Query: 495 GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSN 554
+ I + +LR + L++ LL A +
Sbjct: 233 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS------------------KLENIG 274
Query: 555 LTMLDFSENRLSGSIPSEL-----GNLENLQILRLSANKL--DGRIPYELGK 599
L L N + L + +L L L+ N+ + + E+ +
Sbjct: 275 LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIRE 326
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 2e-05
Identities = 36/162 (22%), Positives = 58/162 (35%), Gaps = 7/162 (4%)
Query: 271 LDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPR 330
L +E Q+ + + + L L S + V+ R+++ +
Sbjct: 4 LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR---SDPDLVAQNIDVVLNRRSSMAATLRI 59
Query: 331 SVGNLSSLNSLLLFNNRLQGT--LPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEV 388
N+ L SL L NNRL + + +L L L N + + KLE
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 389 LYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGR-IPPDIT 429
L+L N + Q +S + E RL G +PP I
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 9e-04
Identities = 22/96 (22%), Positives = 41/96 (42%), Gaps = 2/96 (2%)
Query: 561 SENRLSGSIPSELGNLENLQILRLSANKLDGR--IPYELGKCTKMIKLDLSDNYLAGSIP 618
+ ++ ++ N+ L L LS N+L + + K + L+LS N L
Sbjct: 49 RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERE 108
Query: 619 SEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFEL 654
+ I K++ L L N+LS D + + ++ E
Sbjct: 109 LDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.002
Identities = 23/121 (19%), Positives = 40/121 (33%), Gaps = 7/121 (5%)
Query: 95 NQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYN 154
+ +LDL G L L + ++ + L L+L N
Sbjct: 21 DGSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNN 75
Query: 155 SLSGK--IPPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFP 212
L + V +L+ + N L E D KL+ L+L+ N+L+ +
Sbjct: 76 RLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS 135
Query: 213 N 213
Sbjct: 136 T 136
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 25/206 (12%), Positives = 61/206 (29%), Gaps = 17/206 (8%)
Query: 261 KGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALS 320
+ L ++ + T L ++ +++ + + + I + + + L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 321 RNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEI 380
N L L++L +L + + I +
Sbjct: 77 GNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 381 CNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLA 440
+ N + + ++ ++ L + + + L LQ L L+
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLS 186
Query: 441 HNHLTGEVALELGKHFPYLSRLDLTG 466
NH++ AL L L+L
Sbjct: 187 KNHISDLRALA---GLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 17/203 (8%)
Query: 407 MSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTG 466
++ ++ L +T + L ++ + ++ + ++ + P +++L L G
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLNG 77
Query: 467 NSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLE 526
N NL L N + K + + + + +
Sbjct: 78 NKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 527 RNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSA 586
S + ++ L++ D + + L L LQ L LS
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-----PLAGLTKLQNLYLSK 187
Query: 587 NKLDGRIPYELGKCTKMIKLDLS 609
N + + L + L+L
Sbjct: 188 NHISD-LR-ALAGLKNLDVLELF 208
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 32/201 (15%), Positives = 56/201 (27%), Gaps = 17/201 (8%)
Query: 382 NLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAH 441
LA+ L + + + ++ L + + L NL ++ ++
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 442 NHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEI 501
N LT L+ + G FN
Sbjct: 72 NQLTDITPLKNLTKLVD---------ILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 502 GKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFS 561
+ L + S + L + L+ N + P + L LD S
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 562 ENRLSGSIPSELGNLENLQIL 582
N++S S L L NL+ L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 28/188 (14%), Positives = 71/188 (37%), Gaps = 25/188 (13%)
Query: 553 SNLTMLDFSENRLSGSIP-SELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611
+ + ++ ++ ++L + LQ RL +DG + + +++ S+N
Sbjct: 18 AEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSNN 72
Query: 612 YLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSK 671
L P + ++ ++ + + + + ++I +L++
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 672 LHHFSSILNVS---------------NNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPT 716
L S+ ++ +N+++ P L NL L+ LD+SSN S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD--IS 188
Query: 717 EVNNMVSL 724
+ + +L
Sbjct: 189 VLAKLTNL 196
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 23/117 (19%), Positives = 39/117 (33%), Gaps = 3/117 (2%)
Query: 354 PELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVEL 413
+ N +L L+ I I L + + + +N I + +L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTL 68
Query: 414 ALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFY 470
+ NNR+ L +L L L +N L L+ L+ L + N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1119 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.81 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.65 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.6 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.58 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.34 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.23 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.97 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.65 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.39 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.96 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.7 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.44 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.0 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=416.28 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=205.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||+||+|+++.+++.||||+++.. .+.+.+|+.+++.++|||||++++++.+++..|+||||+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 577789999999999999999999999999998432 346889999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++|+|.+++.... .+++..++.++.||++|++|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 86 ~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 86 SGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp TTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999997654 499999999999999999999999 9999999999999999999999999999977554433
Q ss_pred CcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||........... ...... .
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~--~---------- 224 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKK--T---------- 224 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTC--T----------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCC--C----------
Confidence 44556789999999999887775 5789999999999999999999975322211111 111000 0
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........+.++.+++.+||+.||++|||++|+++|
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000111223467799999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-47 Score=408.89 Aligned_cols=243 Identities=33% Similarity=0.472 Sum_probs=204.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||+||+|+++.+++.||+|++.+ ....+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 468888999999999999999999999999998842 2345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++...+ .+++..+..++.||++|++|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998755 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+.. ... ..
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~-i~~----------~~ 220 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKR-ISR----------VE 220 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHH-HHT----------TC
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHH-HHc----------CC
Confidence 23345799999999999999999999999999999999999999964211 000110 000 01
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... +...+.++.+++.+||+.||++|||++|+++|
T Consensus 221 ~~~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCC----CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 110 11123567899999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=410.37 Aligned_cols=256 Identities=33% Similarity=0.489 Sum_probs=197.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+.++.||+|+||+||+|+.+. .||||+++.. ...+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 45667999999999999998653 5999998532 2457889999999999999999998764 568999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++|+|.++++..+. .+++..+..++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 85 CEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999976543 489999999999999999999999 999999999999999999999999999987765444
Q ss_pred CCcccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
........||+.|+|||++.+ ..|+.++|||||||++|||+||+.||........ ... ..... ...+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~----~~~~~-----~~~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIF----MVGRG-----YLSP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHH----HHHHT-----SCCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHH----HHhcC-----CCCC
Confidence 444456689999999998864 3588999999999999999999999975321111 000 00000 0011
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.... .....+..+.+++.+||+.||++||||+||+++|+.+.+.
T Consensus 230 ~~~~---~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLSK---VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CGGG---SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cchh---ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1100 0112245788999999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=407.53 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=204.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.||+|+||+||+|+++.+|+.||||+++.. .+.+.+|+.+++.++|||||++++++.+++..|+||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 577889999999999999999999999999998532 3457899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.+++... .+++..++.++.||+.|++|||++ |||||||||+|||++.++.+||+|||+|+...... .
T Consensus 101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 99999988754 389999999999999999999999 99999999999999999999999999998765432 2
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... . ......... .+.+
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~--~~~~~~~~~--------~~~~--- 236 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R--ALYLIATNG--------TPEL--- 236 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H--HHHHHHHHC--------SCCC---
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--H--HHHHHHhCC--------CCCC---
Confidence 334567999999999999999999999999999999999999999643110 0 000000000 0001
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..+...+..+.+++.+||+.||++|||++|+++|
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234567899999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=406.11 Aligned_cols=253 Identities=22% Similarity=0.379 Sum_probs=195.2
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
|+..+.||+|+||+||+|++++ ++.||||+++.. .+++.+|+++++.++|||||+++|++.+++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 4556889999999999999875 678999998643 356889999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
+|.+++..... .+++..+..++.|+++|++|+|+. +|+||||||+||++++++.+||+|||+++....... ...
T Consensus 86 ~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~ 159 (263)
T d1sm2a_ 86 CLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS 159 (263)
T ss_dssp BHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence 99999876543 588999999999999999999999 999999999999999999999999999987654322 223
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCCc
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWDS 1072 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1072 (1119)
....||+.|+|||.+.+..++.++|||||||++|||+|+..|+..... ......... .. ....
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~----~~------~~~~------ 222 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDIS----TG------FRLY------ 222 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHH----HT------CCCC------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHH----hc------CCCC------
Confidence 345789999999999999999999999999999999996555432211 111111000 00 0000
Q ss_pred hHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1073 DDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1073 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+...+.++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 0111234678999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-46 Score=410.56 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=212.1
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||+||+|.++.+++.||||+++.+ .+++.+|+++++.++|||||++++++.+++..++||||++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 3567778999999999999999999999999998643 3568899999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|+|.+++..... ..+++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 97 ~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~ 171 (287)
T d1opja_ 97 YGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT 171 (287)
T ss_dssp TCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-SE
T ss_pred CcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC-ce
Confidence 9999999976543 3589999999999999999999999 99999999999999999999999999998765432 22
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......||+.|+|||++.+..|+.++|||||||++|||++|..||...... ..... .+....+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~--------------~i~~~~~~- 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYE--------------LLEKDYRM- 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHH--------------HHHTTCCC-
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHH--------------HHhcCCCC-
Confidence 334456899999999999999999999999999999999988776532111 11000 00111000
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..+...+.++.+++.+||+.||++|||++||++.|+++.++.
T Consensus 236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 011122457889999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-46 Score=412.28 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=195.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce---EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK---HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~---~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..++||+|+||+||+|+++.+++ .||||++... ...+.+|+.++++++|||||+++|++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 45667899999999999999876554 6899987532 235889999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 107 Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999886543 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCC---cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 987 HSSS---TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 987 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.... ......+|+.|+|||.+.++.++.++|||||||++|||+| |+.||..... .+..... ...
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i----~~~------ 249 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAI----EQD------ 249 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTT------
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcC------
Confidence 2221 1223467899999999999999999999999999999998 8999864321 1111100 000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.+.. .+...+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 250 --~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 --YRLP----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --CCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCCC----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 0011 1112345688999999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=407.35 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=200.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 907 (1119)
+|+..+.||+|+||+||+|+++.+++.||||++++ ....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 57888999999999999999999999999999853 22457899999999999999999999999999999999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~ 987 (1119)
|+++|+|.+++...+ .+++..++.++.|++.|++|||+. +||||||||+||++++++.+||+|||+|+......
T Consensus 89 y~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999988765 489999999999999999999999 99999999999999999999999999998776543
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...... ... ....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~~~~-~i~----------~~~~ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN----EYLIFQ-KII----------KLEY 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS----HHHHHH-HHH----------TTCC
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC----HHHHHH-HHH----------cCCC
Confidence 3334445689999999999999999999999999999999999999997421 100010 000 0111
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.. +...+.++.+++.+||+.||++|||++|+.++
T Consensus 228 ~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11 01123467899999999999999999986543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=413.51 Aligned_cols=267 Identities=22% Similarity=0.333 Sum_probs=204.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..++||+|+||+||+|+++.+++.||+|+++.. ...+.+|+.+++.++|||||+++++|.+++..|+||||+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 567778999999999999999999999999998532 245788999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++|+|.+++.+.+ .+++..++.++.|+++|+.|||+++ +|+||||||+|||++.++.+||+|||+|+...+.
T Consensus 87 ~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 87 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp TTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 9999999998765 4899999999999999999999732 8999999999999999999999999999876542
Q ss_pred CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-----------hccccc
Q 001226 990 STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-----------LQENHE 1058 (1119)
Q Consensus 990 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~ 1058 (1119)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||................. ......
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 22346899999999999999999999999999999999999999975422111000000000 000000
Q ss_pred ccccccccccCC--------------CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHccc
Q 001226 1059 CICFLDREISFW--------------DSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLN 1110 (1119)
Q Consensus 1059 ~~~~~~~~~~~~--------------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~ 1110 (1119)
.....+...... .......+.++.+++.+||+.||++|||++|+++| +++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 000000000000 00000123467899999999999999999999986 55443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=402.83 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=201.4
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccc----ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR----SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
|+..+.||+|+||+||+|+++.+++.||||+++. ....+.+|+++++.++|||||++++++.+++..|+||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 5667899999999999999999999999999853 235688999999999999999999999999999999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.+... .+++..+..++.||++|+.|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 94 g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 94 GAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 999999876432 489999999999999999999999 99999999999999999999999999997654311 12
Q ss_pred ccccccCCCcccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 992 RSAIVGSLGYIAPENAY-----STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.....||+.|+|||++. +..|+.++||||+||++|||++|+.||......+ .......... +.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i~~~~~--------~~ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKIAKSEP--------PT 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHHHSCC--------CC
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCC--------CC
Confidence 33467999999999874 4568899999999999999999999996532111 1111000000 00
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
+ ..+...+.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 235 L----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp C----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C----CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1112234577899999999999999999999885
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=402.48 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=204.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||+||+|.++. ++.||||+++.. .+.+.+|+.++++++|||||++++++.+ +..++||||+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 56777899999999999999874 788999998643 3568899999999999999999998865 567999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... ...+++..+.+++.||++|+.|||++ +|+||||||+||++++++.+||+|||+|+...... ...
T Consensus 92 g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~ 166 (272)
T d1qpca_ 92 GSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA 166 (272)
T ss_dssp CBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred CcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc-ccc
Confidence 99999876543 23489999999999999999999999 99999999999999999999999999998775432 223
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
.....||+.|+|||++.++.++.++|||||||++|||+||..|+...... .... ... ... .....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~---~~i-~~~------~~~~~---- 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVI---QNL-ERG------YRMVR---- 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHH---HHH-HTT------CCCCC----
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHH---HHH-Hhc------CCCCC----
Confidence 34457899999999998889999999999999999999976665432111 1110 000 000 00000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+...+.++.+++.+||+.||++||||+||++.|+.+..+.
T Consensus 232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 1122346789999999999999999999999999887654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-45 Score=405.59 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=189.9
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+|+..+.||+|+||+||+|+++.+++.||||++... ...+.+|+.+++.++|||||++++++.+++..|+||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 377789999999999999999999999999998532 345678999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC---CCCceEEEeccccccccCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD---SELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~---~~~~vkl~DfGla~~~~~~ 986 (1119)
+||+|.+++...+ .+++..+..++.||+.|++|||+. +|+||||||+||++. +++.+||+|||+|+.....
T Consensus 90 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 90 SGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 9999999998654 499999999999999999999999 999999999999995 5789999999999866442
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... . .+ .... ...
T Consensus 164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~--~~-~~i~----------~~~ 225 (307)
T d1a06a_ 164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--K--LF-EQIL----------KAE 225 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H--HH-HHHH----------TTC
T ss_pred C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--H--HH-HHHh----------ccC
Confidence 2 233467999999999999999999999999999999999999999643111 0 00 0000 111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...........+.++.+++.+||+.||++|||++|+++|
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111101112234567899999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=396.71 Aligned_cols=240 Identities=28% Similarity=0.436 Sum_probs=192.2
Q ss_pred CceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec----CCceEEEEec
Q 001226 839 GRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK----DEHGFIVTEY 908 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 908 (1119)
.++||+|+||+||+|.++.+++.||+|++... ...+.+|++++++++|||||++++++.+ +...|+||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 46799999999999999999999999988532 2357899999999999999999999864 3457999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeEeC-CCCceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQ--IIHRDIKSDNILLD-SELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~vkl~DfGla~~~~~ 985 (1119)
+++|+|.+++.+.. .+++..+..++.||++|++|||++ + |+||||||+|||++ +++.+||+|||+|+....
T Consensus 94 ~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999998764 489999999999999999999998 6 99999999999996 578999999999986433
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
......+||+.|+|||++.+ .++.++||||+||++|||++|+.||...... ..... ....... ..
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~----~~~~~-~i~~~~~-----~~ 232 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYR-RVTSGVK-----PA 232 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHH-HHTTTCC-----CG
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH----HHHHH-HHHcCCC-----Cc
Confidence 22335689999999998765 5999999999999999999999999643111 00000 0000000 00
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+ +...+.++.+++.+||+.||++|||++|+++|
T Consensus 233 ~~------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 SF------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp GG------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc------CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 00 11123357899999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=400.90 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=190.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec--CCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK--DEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 906 (1119)
+|+..+.||+|+||+||+|+++.+|+.||||+++.. ...+.+|++++++++|||||++++++.+ ++..|+||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 467778999999999999999999999999998532 2347789999999999999999999865 45689999
Q ss_pred eccCCCCHHHhhccCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 907 EYMPGGTLFNVLHQNE-PRLVLDWNTRYHIALGIAQGLSYLHYDC--VPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
||+++|+|.+++.... ....+++..++.++.|+++|++|||+.. ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 9999999999987532 1335999999999999999999999872 124999999999999999999999999999876
Q ss_pred cCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .+. ... . .
T Consensus 165 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~---~~~-i---------~ 227 (269)
T d2java1 165 NHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KEL---AGK-I---------R 227 (269)
T ss_dssp -------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH---HHH-H---------H
T ss_pred ccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHH---HHH-H---------H
Confidence 5422 223346799999999999999999999999999999999999999964311 110 000 0 0
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
...... .+...+.++.+++.+||+.||++|||++|+++|
T Consensus 228 ~~~~~~---~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 228 EGKFRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 001100 011224468899999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=408.18 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=204.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCc-----eEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSR-----KHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~-----~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 903 (1119)
+|+.+++||+|+||+||+|++...+ ..||+|++... ...+.+|+.+++++ +|||||++++++.+.+..|
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 5677899999999999999986543 36999988432 34578899999988 8999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001226 904 IVTEYMPGGTLFNVLHQNEP--------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDN 963 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 963 (1119)
+||||+++|+|.++++.... ...+++..+..++.||++|++|||++ +||||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 99999999999999976532 13488999999999999999999999 99999999999
Q ss_pred eEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 001226 964 ILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGED 1042 (1119)
Q Consensus 964 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~ 1042 (1119)
|+++.++.+||+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||++ |+.||......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~- 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD- 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987765444444455678999999999999999999999999999999997 89998643211
Q ss_pred CceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 001226 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLI 1107 (1119)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~ 1107 (1119)
........ ... .... +...+.++.+++.+||+.||++|||++||+++|.
T Consensus 274 ~~~~~~~~----~~~------~~~~------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQ----NGF------KMDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHH----TTC------CCCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHh----cCC------CCCC------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11111100 000 0011 1122457889999999999999999999999995
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=390.65 Aligned_cols=249 Identities=23% Similarity=0.428 Sum_probs=205.3
Q ss_pred hhCCceeeecCCccEEEEEeCCCceEEEEEeccc---ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCC
Q 001226 836 ATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGG 912 (1119)
Q Consensus 836 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 912 (1119)
|+..++||+|+||+||+|+++ +++.||||+++. ..+++.+|+.++++++||||++++|++.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 456788999999999999986 578999999854 3467899999999999999999999999999999999999999
Q ss_pred CHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCcc
Q 001226 913 TLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSSTR 992 (1119)
Q Consensus 913 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~~ 992 (1119)
++.+++..... .+++..+.+++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++...... ....
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~ 158 (258)
T d1k2pa_ 85 CLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS 158 (258)
T ss_dssp EHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred cHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence 99999776543 488999999999999999999999 99999999999999999999999999998765532 2233
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +.. ....... +..
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~----~~i~~~~--------~~~--- 221 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA----EHIAQGL--------RLY--- 221 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHH----HHHHTTC--------CCC---
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHH----HHHHhCC--------CCC---
Confidence 44678999999999999999999999999999999998 89998654211 111 0110000 000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.+...+..+.+++.+||+.||++|||++||+++|..+
T Consensus 222 -~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 0112234688999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=397.40 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=197.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCc----eEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSR----KHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~----~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
.|+..++||+|+||+||+|.++.++ ..||||+++.. ..++.+|+.+++.++|||||+++|++.+.+..++|
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v 87 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 87 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence 3556789999999999999987644 57999998542 23578999999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||++++++.+++..... .+++.++..++.|++.|++|||+. +|+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999998876543 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHS-SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
... ........||+.|+|||++.++.++.++|||||||++|||++|..|+...... ...... +.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~--------------i~ 227 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKA--------------IN 227 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHH--------------HH
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHH--------------Hh
Confidence 322 22333456899999999999999999999999999999999977666432111 111100 00
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
...+. ..+...+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 228 ~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 DGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTCCC--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ccCCC--CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 00000 01112345688999999999999999999999999988764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=396.18 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=196.4
Q ss_pred ceeeecCCccEEEEEeC--CCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCC
Q 001226 840 RIIGKGKHGTVYRTLSN--NSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~--~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
++||+|+||+||+|.++ .+++.||||+++.. .+.+.+|++++++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 67999999999999864 34678999998532 2358899999999999999999999864 567899999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC-C
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS-S 990 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~-~ 990 (1119)
|+|.++++... .+++..+..++.||++|++|||+. +||||||||+||+++.++.+|++|||+|+........ .
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998765 489999999999999999999999 9999999999999999999999999999876543222 2
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISF 1069 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1119)
......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..... .+... ...... +..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~----~i~~~~--------~~~- 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTA----MLEKGE--------RMG- 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHH----HHHTTC--------CCC-
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHH----HHHcCC--------CCC-
Confidence 3344578999999999998999999999999999999997 8999875321 11110 000000 000
Q ss_pred CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccc
Q 001226 1070 WDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLN 1110 (1119)
Q Consensus 1070 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~ 1110 (1119)
.+...+.++.+++.+||+.||++|||+++|++.|+.+.
T Consensus 231 ---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 01122457789999999999999999999999887653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-44 Score=405.54 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=204.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEecc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
.+|+..+.||+|+||+||+|+++.+|+.||||++... .+.+.+|+.+++.++|||||++++++.+++..|+||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4788889999999999999999999999999998543 245778999999999999999999999999999999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC--CCceEEEeccccccccCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS--ELEPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~--~~~vkl~DfGla~~~~~~~ 987 (1119)
+||+|.+++..... .+++..+..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 106 SGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999999965432 489999999999999999999999 9999999999999964 578999999999876542
Q ss_pred CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+. + .... ....
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~--~-~~i~----------~~~~ 242 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DET--L-RNVK----------SCDW 242 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH--H-HHHH----------HTCC
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHH--H-HHHH----------hCCC
Confidence 233456799999999999999999999999999999999999999964311 110 0 0000 0000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..........+.++.+++.+||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011111234567899999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=394.57 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=198.8
Q ss_pred eeeecCCccEEEEEeCC--CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccCCCC
Q 001226 841 IIGKGKHGTVYRTLSNN--SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMPGGT 913 (1119)
Q Consensus 841 ~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 913 (1119)
+||+|+||+||+|.++. ++..||||+++.. ...+.+|++++++++|||||++++++.+ +..|+||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 49999999999998754 3568999998543 2458899999999999999999999865 56899999999999
Q ss_pred HHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC-CCcc
Q 001226 914 LFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS-SSTR 992 (1119)
Q Consensus 914 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~-~~~~ 992 (1119)
|.+++...+. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+....... ....
T Consensus 95 L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (285)
T d1u59a_ 95 LHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169 (285)
T ss_dssp HHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred HHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccc
Confidence 9999876543 589999999999999999999999 999999999999999999999999999987754322 2233
Q ss_pred cccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCCC
Q 001226 993 SAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFWD 1071 (1119)
Q Consensus 993 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1071 (1119)
....||+.|+|||++.++.++.++|||||||++|||+| |+.||..... .+..... .... +..
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i----~~~~--------~~~--- 232 (285)
T d1u59a_ 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI----EQGK--------RME--- 232 (285)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH----HTTC--------CCC---
T ss_pred cccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHH----HcCC--------CCC---
Confidence 34568999999999988899999999999999999998 8999975321 1111110 0000 000
Q ss_pred chHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1072 SDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1072 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
.+...+.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 233 -~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011234577899999999999999999999999886543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=396.68 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=203.8
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+.++.||+|+||+||+|+++.+|+.||||++++. .+.+.+|+.+++.++|||||++++++.+++..|+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 578889999999999999999999999999988421 2457899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC----ceEEEecccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL----EPKIGDFGMS 980 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~----~vkl~DfGla 980 (1119)
||||+++|+|.+++...+ .+++..++.++.|++.|++|||+. +||||||||+||+++.++ .+|++|||+|
T Consensus 91 v~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999998765 499999999999999999999999 999999999999998876 4999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECI 1060 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1119)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+.. ..
T Consensus 165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~-i~------- 229 (293)
T d1jksa_ 165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLAN-VS------- 229 (293)
T ss_dssp EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH-HH-------
T ss_pred hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----HHHHH-HH-------
Confidence 8765432 233457899999999999999999999999999999999999999743110 00000 00
Q ss_pred ccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
..............+..+.+++.+||+.||++|||++|+++|
T Consensus 230 ---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 230 ---AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000111001112234567899999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=399.00 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=198.7
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||+||+|++..+++.||||+++... ..+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35788899999999999999999999999999985322 34778999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|++..++.... .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987766544 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCcccccccCCCcccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYS---TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.....||+.|+|||++.+ +.|+.++||||+||++|||++|+.||..... ...........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~i~~~~-------- 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNE-------- 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSC--------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhCC--------
Confidence 234579999999998753 4689999999999999999999999864311 10010000000
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+... ....+..+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 231 SPALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCCS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCC-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 00000 01123467899999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=392.42 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=204.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc---cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+.++.||+|+||+||+|+++++ +.||||+++.. .+.+.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 4678889999999999999999874 67999999643 3568999999999999999999999864 56789999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
+|++.+++..... ..++|.++..++.||++|++|||+. +|+||||||+||+++.++.+||+|||+|+...... ..
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~ 169 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT 169 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence 9999999876432 2489999999999999999999999 99999999999999999999999999998765432 22
Q ss_pred cccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 991 TRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
......||+.|+|||++.++.++.++|||||||++|||++|..|+...... .......... . ....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~----~------~~~~--- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERG----Y------RMPC--- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTT----C------CCCC---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhc----C------CCCC---
Confidence 334467899999999999999999999999999999999987776542111 1111111000 0 0011
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCCC
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGMR 1118 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~ 1118 (1119)
+...+.++.+++.+||+.||++|||+++|++.|+.+....++.++
T Consensus 236 ---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 236 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred ---CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 112234678999999999999999999999999998877776653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.3e-44 Score=402.59 Aligned_cols=248 Identities=17% Similarity=0.252 Sum_probs=204.1
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
+|+..+.||+|+||+||+|+++.+|+.||||+++.. ...+.+|+.++++++|||||++++++.+++..|+||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 578889999999999999999999999999998543 2457789999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC--CCCceEEEeccccccccCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD--SELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~--~~~~vkl~DfGla~~~~~~~~ 988 (1119)
||+|.+++..... .+++.+++.++.||+.|++|||+. |||||||||+|||++ .++.+||+|||+|+.....
T Consensus 110 gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 110 GGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999998876542 489999999999999999999999 999999999999998 5789999999999877542
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... . .... .... ...
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~--~~~~-i~~~----------~~~ 246 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--E--TLQN-VKRC----------DWE 246 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--H--HHHH-HHHC----------CCC
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--H--HHHH-HHhC----------CCC
Confidence 2334467899999999999999999999999999999999999999643111 1 0000 0000 000
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.........+.++.+++.+||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000111234567899999999999999999999886
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=396.31 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=204.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|...+.||+|+||+||+|+++.+++.||||++++. ...+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 3577789999999999999999999999999998532 245788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++||+|.+++...+ .+++..++.++.|++.|++|||++ +|+||||||+||+++++|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998765 489999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... . ....... ...
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~---~~~~~i~----------~~~ 221 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--E---RLFELIL----------MEE 221 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHH----------HCC
T ss_pred --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--H---HHHHHHh----------cCC
Confidence 2233456899999999999999999999999999999999999999975311 0 0111111 011
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
.... ...+.++.+++.+||+.||++||+ ++|+++|
T Consensus 222 ~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1111 122346789999999999999994 8899875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-43 Score=394.04 Aligned_cols=242 Identities=27% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccc-------ccccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-------SETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
.+|+..+.||+|+||+||+|+++.+|+.||||++++ ....+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 457778999999999999999999999999999853 2345788999999999999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||++||++..++.... .+++..++.++.||+.|++|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999988765 378889999999999999999999 9999999999999999999999999999876542
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||..... . ...... ....
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~-~~~~~i----------~~~~ 217 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----M-KTYEKI----------LNAE 217 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H-HHHHHH----------HHCC
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----H-HHHHHH----------HcCC
Confidence 2346799999999999999999999999999999999999999964211 0 000000 0111
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
... +...+.++.+++.+|++.||++|| |++|+++|
T Consensus 218 ~~~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCC----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 110 111234678999999999999996 99999876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=392.12 Aligned_cols=276 Identities=24% Similarity=0.314 Sum_probs=203.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-ccH--HHHHHHHhhcCCCCEEEEeeeeecCC----ceEEEEe
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-TNF--DVEIRTLSLVRHRNILRIVGSCTKDE----HGFIVTE 907 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~--~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 907 (1119)
+|+..+.||+|+||+||+|++. |+.||||+++... ..+ +.|+..+..++|||||++++++.+++ ..|+|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4556688999999999999874 7899999986433 233 34555556789999999999997654 5689999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYD-----CVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+++|+|.+++++. .++|..+.+++.|++.|++|+|+. +.++||||||||+|||++.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 99999999999865 389999999999999999999974 134999999999999999999999999999987
Q ss_pred ccCCCCC--CcccccccCCCcccccccCCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc
Q 001226 983 ISDSHSS--STRSAIVGSLGYIAPENAYSTR------LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 983 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
....... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||...................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7543221 2334568999999999876543 5678999999999999999998875432211111100000000
Q ss_pred cc----ccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCCC
Q 001226 1055 EN----HECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGGM 1117 (1119)
Q Consensus 1055 ~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~ 1117 (1119)
.. ......+++.+.. ..........+.+++.+||+.||++|||+.||+++|+++.++.+.++
T Consensus 238 ~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~~ 303 (303)
T d1vjya_ 238 VEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 303 (303)
T ss_dssp HHHHHHHHTTSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCCC
T ss_pred HHHHHHHHhccccCCCCCc-ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCCC
Confidence 00 0000011111111 01123455678999999999999999999999999999998877654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=394.82 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=199.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCce----EEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRK----HWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+|+..++||+|+||+||+|.+..+|+ +||+|+++.. ..++.+|++++++++|||||+++++|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 36667899999999999999887665 6888887532 34688999999999999999999999864 56788
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
+||+.+|+|.+++..... .+++..+.+++.||++|++|||++ +||||||||+||+++.++.+||+|||+|+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999998887643 589999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLD 1064 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1119)
...........||+.|+|||.+.++.++.++|||||||++|||+| |+.||...... .+..... ...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~----~~~------- 230 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE----KGE------- 230 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHH----HTC-------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCC-------
Confidence 444444445678999999999999999999999999999999998 78887643211 1111110 000
Q ss_pred ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1065 REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1065 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
+.. .+...+..+.+++.+||+.||++|||++||+++|+++..
T Consensus 231 -~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 231 -RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCC----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 000 111224567899999999999999999999999988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=393.36 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=205.2
Q ss_pred HhhCCceeeecCCccEEEEEeCC-----CceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..+.||+|+||+||+|+++. +++.||||+++.. ..++.+|+.+++.++||||+++++++.+.+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 45667899999999999998753 5678999998643 2458899999999999999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 001226 905 VTEYMPGGTLFNVLHQNEP---------------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDN 963 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~N 963 (1119)
||||+++|+|.++++.... ...+++..+..++.|++.|++|||++ +||||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence 9999999999999975321 22488999999999999999999999 99999999999
Q ss_pred eEeCCCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCCCC
Q 001226 964 ILLDSELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKM-PVDPSFGED 1042 (1119)
Q Consensus 964 ill~~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~-p~~~~~~~~ 1042 (1119)
|+++.++.+||+|||+|+...............+|+.|+|||.+.+..++.++|||||||++|||++|.. ||.... .
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~--~ 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA--H 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--H
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC--H
Confidence 9999999999999999987655444444455678999999999999999999999999999999999864 554321 1
Q ss_pred CceeehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1043 TDIVTWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
.+... ... +..... .+...+.++.+++.+||+.+|++||||.||+++|+++.+
T Consensus 249 ~e~~~----~v~---------~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 EEVIY----YVR---------DGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHH----HHH---------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHH----HHH---------cCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 010 111000 011223468899999999999999999999999999863
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-43 Score=382.32 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=202.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------------ccHHHHHHHHhhcC-CCCEEEEeeeeecCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------------TNFDVEIRTLSLVR-HRNILRIVGSCTKDE 900 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 900 (1119)
+|+..+.||+|+||+||+|+++.+++.||||++++.. +.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 5777899999999999999999999999999985321 24778999999997 999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..|+||||+++|+|.++++..+ .+++..++.++.||++|++|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred ceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 9999999999999999998755 489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAY------STRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQ 1054 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1054 (1119)
+...... ......||+.|+|||.+. ...++.++||||+||++|||++|+.||...... . .. .....
T Consensus 158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~--~~-~~i~~ 229 (277)
T d1phka_ 158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--L--ML-RMIMS 229 (277)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--H--HH-HHHHH
T ss_pred eEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--H--HH-HHHHh
Confidence 8775432 234467999999999764 345788999999999999999999999753110 0 00 00010
Q ss_pred ccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1055 ENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1055 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............+.++.+++.+||+.||++|||++|+++|
T Consensus 230 ----------~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 ----------GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ----------TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ----------CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01100001112234578899999999999999999999876
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=385.07 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=193.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCC---ceEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|..++.||+|+||+||+|.+..+ +..||||+++.. ...+.+|+.++++++|||||++++++. ++..|+||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 567789999999999999998654 457999988532 235788999999999999999999986 46789999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|++.+++..... .+++..+..++.||++|+.|||+. +|+||||||+||++++++.+||+|||+|+.....
T Consensus 87 E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp ECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999998876543 589999999999999999999999 9999999999999999999999999999876542
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... +.... .....
T Consensus 162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~----i~~~~-------- 226 (273)
T d1mp8a_ 162 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGR----IENGE-------- 226 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHH----HHTTC--------
T ss_pred c-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHH----HHcCC--------
Confidence 2 223344578999999999999999999999999999999997 88888653211 11100 00000
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
.... +...+..+.+++.+||+.||++|||++||+++|+++.++
T Consensus 227 ~~~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0011 112345788999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=383.40 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=195.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc--cccHHHHHHHHhhcCCCCEEEEeeeeec-CCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS--ETNFDVEIRTLSLVRHRNILRIVGSCTK-DEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~~ 911 (1119)
+++..++||+|+||.||+|+++ |..||||+++.+ .+++.+|++++++++||||++++|++.+ .+..|+||||+++
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 8 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred HeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 4566788999999999999985 678999999654 3568899999999999999999999865 4568999999999
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCCc
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSST 991 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~~ 991 (1119)
|+|.+++.... ...+++..+.+++.||+.|+.|||+. +|+||||||+||+++.++.+|++|||+++.... .
T Consensus 86 g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~ 156 (262)
T d1byga_ 86 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----T 156 (262)
T ss_dssp EEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC-----C
Confidence 99999997653 22489999999999999999999999 999999999999999999999999999986543 2
Q ss_pred ccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhcccccccccccccccCC
Q 001226 992 RSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREISFW 1070 (1119)
Q Consensus 992 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1070 (1119)
.....+|..|+|||++.++.++.++|||||||++|||+| |+.||.... ..+...... .. ..+.+
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~----~~------~~~~~--- 221 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVE----KG------YKMDA--- 221 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHT----TT------CCCCC---
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH----cC------CCCCC---
Confidence 233467899999999998999999999999999999998 677765431 111111111 00 00111
Q ss_pred CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1071 DSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1071 ~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
+...+.++.+++.+||+.||++||||+|++++|+++++.
T Consensus 222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 112234678999999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=391.75 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=195.8
Q ss_pred HhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecC-Cce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKD-EHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~~ 902 (1119)
+|+.+++||+|+||.||+|.+.. +++.||||+++... ..+.+|...+.++ +|+||+.+++++.++ ...
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 57778999999999999999754 45789999986432 3456677777666 699999999987654 568
Q ss_pred EEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE 969 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~ 969 (1119)
++||||+++|+|.++++.... ...+++..+..++.||++|++|||++ +||||||||+|||++++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCC
Confidence 999999999999999976431 23588999999999999999999999 99999999999999999
Q ss_pred CceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCceeeh
Q 001226 970 LEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK-MPVDPSFGEDTDIVTW 1048 (1119)
Q Consensus 970 ~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~~~~~~ 1048 (1119)
+.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. .||..... ......
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~~~~~~- 248 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-DEEFCR- 248 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-SHHHHH-
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH-HHHHHH-
Confidence 999999999998776544444555678999999999999999999999999999999999875 56643211 111110
Q ss_pred hhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1049 TRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
....... ... +...+.++.+++.+||+.||++|||++||+++|+++.+.+
T Consensus 249 ---~~~~~~~------~~~------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 249 ---RLKEGTR------MRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp ---HHHHTCC------CCC------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHhcCCC------CCC------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 0000000 001 1112346789999999999999999999999999987653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=391.19 Aligned_cols=249 Identities=20% Similarity=0.297 Sum_probs=204.4
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
.+|+..+.||+|+||+||+|.++.+++.||||+++... ..+.+|+++++.++|||||++++++.+++..|+||||++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 36788899999999999999999999999999996533 347799999999999999999999999999999999999
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC--CceEEEeccccccccCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE--LEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~--~~vkl~DfGla~~~~~~~~ 988 (1119)
||+|.+++...+. .+++.+++.++.||++|++|||+. +|+||||||+||+++.+ ..+|++|||+++.....
T Consensus 85 gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-- 157 (321)
T d1tkia_ 85 GLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-- 157 (321)
T ss_dssp CCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence 9999999986542 489999999999999999999999 99999999999999854 57999999999876432
Q ss_pred CCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREIS 1068 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1068 (1119)
.......+|+.|+|||...+..++.++||||+||++|||++|+.||...... + .... +......
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~---~~~~----------i~~~~~~ 221 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--Q---IIEN----------IMNAEYT 221 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHH----------HHHTCCC
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--H---HHHH----------HHhCCCC
Confidence 2334467899999999999999999999999999999999999999643110 0 0000 0111111
Q ss_pred CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1069 FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1069 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.........+.++.+++.+|++.||++|||++|+++|
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1000111234567899999999999999999999985
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-42 Score=380.40 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=198.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-------ccHHHHHHHHhhcCCCCEEEEeeeeecCC----ceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-------TNFDVEIRTLSLVRHRNILRIVGSCTKDE----HGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 903 (1119)
+|+..+.||+|+||+||+|++..+++.||||+++... ..+.+|+++++.++|||||++++++..++ ..|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4777899999999999999999999999999985321 34788999999999999999999987654 378
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+||||++|++|.+++...+ .+++.++..++.||++|++|||+. +|+||||||+||+++.++.++++|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 9999999999999988765 489999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCC-CCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 984 SDSH-SSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 984 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
.... .........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ................
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~~ 236 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIPPSA 236 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCCGGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCCCCCch
Confidence 4322 222344568999999999999999999999999999999999999999642110 0000011110000000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHccc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRP-SMREVVGFLIKLN 1110 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~ell~~L~~~~ 1110 (1119)
. ....+..+.+++.+||+.||++|| |++++.+.|.++.
T Consensus 237 ~----------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 237 R----------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp T----------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred h----------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 011235678999999999999999 8999999998875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-43 Score=394.42 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=204.0
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEE
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 905 (1119)
+.+|+..+.||+|+||+||+|+++.+|+.||||++++. ...+.+|+++++.++|||||++++++.+....++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 45788889999999999999999999999999998532 23578899999999999999999999999999999
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
|||+++|+|.+++...+ .+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999998765 489999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.... ... ...... ..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~-~~~~i~----------~~ 253 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQ-IYEKIV----------SG 253 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH-HHHHHH----------HC
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HHH-HHHHHh----------cC
Confidence 2 234679999999999999999999999999999999999999996421 111 001000 01
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.... +...+.++.+++.+||+.||++|+ |++|+++|
T Consensus 254 ~~~~----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 254 KVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCC----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1111 112245678999999999999994 89999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-42 Score=394.40 Aligned_cols=245 Identities=27% Similarity=0.315 Sum_probs=197.7
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHH---HHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVE---IRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..++||+|+||.||+|+++.+|+.||||++.+. ...+.+| +.+++.++|||||++++++.+++..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 567779999999999999999999999999998432 1223344 566677789999999999999999999
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++|+|.+++.... .+++..++.++.||+.|++|||++ +||||||||+|||++.+|.+||+|||+|+...
T Consensus 85 vmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 999999999999998765 488999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccc
Q 001226 985 DSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFL 1063 (1119)
Q Consensus 985 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1119)
.. ......||+.|+|||++.. ..|+.++||||+||++|||++|+.||......+. .........
T Consensus 159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~~~--------- 223 (364)
T d1omwa3 159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT--------- 223 (364)
T ss_dssp SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHHHSSS---------
T ss_pred CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccc---------
Confidence 43 2334579999999999865 5689999999999999999999999975322211 111111100
Q ss_pred cccccCCCchHHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 001226 1064 DREISFWDSDDQLKALRLLELALECTRQVADMRPS-----MREVVGF 1105 (1119)
Q Consensus 1064 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~ell~~ 1105 (1119)
..... +...+.++.+++.+||+.||++||| ++|+++|
T Consensus 224 -~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 224 -MAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -CCCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -CCCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01111 1112346789999999999999999 7898875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=387.31 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=200.1
Q ss_pred HhhCC-ceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhh-cCCCCEEEEeeeeec----CCceEEEEec
Q 001226 835 RATEG-RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSL-VRHRNILRIVGSCTK----DEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~-~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~lV~e~ 908 (1119)
+|... +.||+|+||+||+|++..+++.||||+++. ...+.+|+.++.+ .+|||||++++++.+ +...|+||||
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEEC
Confidence 45543 569999999999999999999999999865 3467889988655 589999999999865 4568999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccccC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~~~ 985 (1119)
|+||+|.+++...+. ..+++.+++.++.||+.|++|||+. +|+||||||+||+++. .+.+|++|||+|+....
T Consensus 91 ~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 91 LDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence 999999999986542 3589999999999999999999999 9999999999999986 46799999999987654
Q ss_pred CCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccc
Q 001226 986 SHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDR 1065 (1119)
Q Consensus 986 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1119)
.. ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.......... .... .....
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-~~~~----------~i~~~ 232 (335)
T d2ozaa1 167 HN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKT----------RIRMG 232 (335)
T ss_dssp CC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCCSC
T ss_pred CC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-HHHH----------HHhcC
Confidence 32 2344679999999999999999999999999999999999999996432211100 0000 00011
Q ss_pred cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1066 EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1066 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
............+.++.+++.+||+.||++|||++|+++|
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111112223445678999999999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=389.05 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=210.7
Q ss_pred HHhhCCceeeecCCccEEEEEeC-----CCceEEEEEecccc-----cccHHHHHHHHhhc-CCCCEEEEeeeeecCCce
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSN-----NSRKHWAVKKLNRS-----ETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~-----~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 902 (1119)
.+|+.+++||+|+||.||+|++. .+++.||||+++.. ...+.+|+.+++.+ +|||||++++++.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 46777899999999999999863 45788999998643 23577899999998 699999999999999999
Q ss_pred EEEEeccCCCCHHHhhccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 903 FIVTEYMPGGTLFNVLHQNEP---------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
++||||+++|+|.++++.... ...+++..+..++.||++|++|||++ ++|||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 999999999999999976431 23588999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVT 1047 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~ 1047 (1119)
.++.+|++|||.++...............||+.|+|||.+.++.++.++|||||||++|||+|+..|+.........+..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999999876655555556678999999999999999999999999999999999955554432222211111
Q ss_pred hhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1048 WTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
..... .+.. .+...+..+.+++.+||+.||++||||+||+++|++...+.
T Consensus 260 ~i~~~--------------~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 260 MIKEG--------------FRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHT--------------CCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhcC--------------CCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 11110 1000 01112456889999999999999999999999999876653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=388.98 Aligned_cols=243 Identities=26% Similarity=0.392 Sum_probs=199.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-------cccHHHHHHHHh-hcCCCCEEEEeeeeecCCceEEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-------ETNFDVEIRTLS-LVRHRNILRIVGSCTKDEHGFIVT 906 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV~ 906 (1119)
+|+..++||+|+||+||+|+++.+++.||||++++. ...+.+|..++. .++|||||++++++.+++..|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 567789999999999999999999999999998532 223556766654 689999999999999999999999
Q ss_pred eccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCC
Q 001226 907 EYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 907 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~ 986 (1119)
||+++|+|.++++... .+++..+..++.||+.|++|||++ +|+||||||+|||+++++.+|++|||+++.....
T Consensus 83 Ey~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999998765 389999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccccccccccc
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDRE 1066 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1066 (1119)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... . ..+..... . ...
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~--~~~~~i~~-~--------~~~ 221 (320)
T d1xjda_ 157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--E--ELFHSIRM-D--------NPF 221 (320)
T ss_dssp --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H--HHHHHHHH-C--------CCC
T ss_pred --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--H--HHHHHHHc-C--------CCC
Confidence 2233456799999999999999999999999999999999999999974311 1 11111100 0 001
Q ss_pred ccCCCchHHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 001226 1067 ISFWDSDDQLKALRLLELALECTRQVADMRPSMR-EVVG 1104 (1119)
Q Consensus 1067 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-ell~ 1104 (1119)
+ +...+.++.+++.+||+.||++||+++ |+++
T Consensus 222 ~------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 Y------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 111234678999999999999999996 6765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=389.75 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=204.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCce--EEEEEeccc-----ccccHHHHHHHHhhc-CCCCEEEEeeeeecCCceEEE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRK--HWAVKKLNR-----SETNFDVEIRTLSLV-RHRNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~--~vavK~~~~-----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 905 (1119)
.+|+..++||+|+||+||+|.++.++. .||||+++. ..+.+.+|+++++++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 456677899999999999999988765 477887642 334688999999998 799999999999999999999
Q ss_pred EeccCCCCHHHhhccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCce
Q 001226 906 TEYMPGGTLFNVLHQNE-------------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEP 972 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~v 972 (1119)
|||+++|+|.++++... ....+++..+.+++.||++|+.|+|+. +|+||||||+||+++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997642 234699999999999999999999999 99999999999999999999
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCCCCCceeehhhh
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKM-PVDPSFGEDTDIVTWTRW 1051 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~-p~~~~~~~~~~~~~~~~~ 1051 (1119)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|.. ||.... ..... ..
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~---~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELY---EK 238 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHH---HH
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHH---HH
Confidence 99999999865432 22234568999999999999999999999999999999999765 554321 11111 00
Q ss_pred hhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCC
Q 001226 1052 KLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNE 1114 (1119)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1114 (1119)
..... +.. .+...+.++.+++.+||+.||++||||+||+++|+++.++..
T Consensus 239 -i~~~~--------~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 239 -LPQGY--------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp -GGGTC--------CCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -HHhcC--------CCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 00000 011 111234578899999999999999999999999999886553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-42 Score=381.84 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=203.3
Q ss_pred CceeeecCCccEEEEEeCCCc---eEEEEEecccc-----cccHHHHHHHHhhcCCCCEEEEeeeeec-CCceEEEEecc
Q 001226 839 GRIIGKGKHGTVYRTLSNNSR---KHWAVKKLNRS-----ETNFDVEIRTLSLVRHRNILRIVGSCTK-DEHGFIVTEYM 909 (1119)
Q Consensus 839 ~~~lG~G~fg~Vy~~~~~~~~---~~vavK~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 909 (1119)
+++||+|+||+||+|.+..++ ..||||+++.. ..++.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 368999999999999986543 46999988532 2458899999999999999999999865 56789999999
Q ss_pred CCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCC
Q 001226 910 PGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSS 989 (1119)
Q Consensus 910 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~ 989 (1119)
++|+|.++++.... ..++..+.+++.|+++|+.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999886543 477889999999999999999999 9999999999999999999999999999876543222
Q ss_pred --CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccccccccc
Q 001226 990 --STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECICFLDREI 1067 (1119)
Q Consensus 990 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1067 (1119)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .+... ..... .. ...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~---~i~~g-~~------~~~ 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITV---YLLQG-RR------LLQ 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHH---HHHTT-CC------CCC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHH---HHHcC-CC------CCC
Confidence 2233457899999999999999999999999999999999988887643211 11111 11100 00 000
Q ss_pred cCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccCCCC
Q 001226 1068 SFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKNEGG 1116 (1119)
Q Consensus 1068 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~ 1116 (1119)
+...+..+.+++.+||+.||++||+|+||+++|+++......+
T Consensus 256 ------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 0112346789999999999999999999999999999886654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=382.31 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=204.0
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCc-------eEEEEEeccccc-----ccHHHHHHHHhhc-CCCCEEEEeeeeecCC
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSR-------KHWAVKKLNRSE-----TNFDVEIRTLSLV-RHRNILRIVGSCTKDE 900 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~-------~~vavK~~~~~~-----~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 900 (1119)
.+|+.++.||+|+||.||+|++..++ ..||||+++.+. .++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 36778899999999999999876543 479999986433 3466788888887 7999999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeC
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEP-------------RLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLD 967 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~ 967 (1119)
..++||||+++|+|.+++..... ...+++..+.+++.||++|++|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999976542 23589999999999999999999999 999999999999999
Q ss_pred CCCceEEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCcee
Q 001226 968 SELEPKIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIV 1046 (1119)
Q Consensus 968 ~~~~vkl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~ 1046 (1119)
.++.+||+|||+++...............+|+.|+|||.+.++.|+.++|||||||++|||++ |+.||..... ...
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~~- 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL- 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HHH-
Confidence 999999999999998876555555566789999999999999999999999999999999998 6777753211 111
Q ss_pred ehhhhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccc
Q 001226 1047 TWTRWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLND 1111 (1119)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~ 1111 (1119)
+.... ... ....+ ...+.++.+++.+||+.||++|||++||++.|+++..
T Consensus 247 -~~~i~--~~~------~~~~p------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 -FKLLK--EGH------RMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHHH--TTC------CCCCC------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHH--cCC------CCCCC------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11100 000 00111 1123468899999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=383.05 Aligned_cols=257 Identities=23% Similarity=0.250 Sum_probs=194.3
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEecccc---------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEeccC
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS---------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEYMP 910 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 910 (1119)
++||+|+||+||+|+++.+++.||||+++.. ...+.+|+.+++.++|||||++++++.+++..|+||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999999999999999998532 2347789999999999999999999999999999999998
Q ss_pred CCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCCCC
Q 001226 911 GGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHSSS 990 (1119)
Q Consensus 911 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~~~ 990 (1119)
++++..+..... .+++..+..++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+...... .
T Consensus 84 ~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~ 155 (299)
T d1ua2a_ 84 TDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R 155 (299)
T ss_dssp EEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred chHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc--c
Confidence 887776655433 488889999999999999999999 99999999999999999999999999998765432 2
Q ss_pred cccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-hccccccccc----cc
Q 001226 991 TRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-LQENHECICF----LD 1064 (1119)
Q Consensus 991 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~ 1064 (1119)
.....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||......+. .....+.. .......... ..
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchh
Confidence 2334579999999998865 4679999999999999999999999864321100 00000000 0000000000 00
Q ss_pred ccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1065 REISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1065 ~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.........+ ...+.++.+++.+||+.||++|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000 1124568899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=378.96 Aligned_cols=236 Identities=21% Similarity=0.364 Sum_probs=195.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc----------cccHHHHHHHHhhcC--CCCEEEEeeeeecCCce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS----------ETNFDVEIRTLSLVR--HRNILRIVGSCTKDEHG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~ 902 (1119)
+|+.++.||+|+||+||+|++..+++.||||+++.. ...+.+|+.++++++ |||||++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 577789999999999999999999999999988532 234678999999987 89999999999999999
Q ss_pred EEEEeccCC-CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCC-CceEEEecccc
Q 001226 903 FIVTEYMPG-GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSE-LEPKIGDFGMS 980 (1119)
Q Consensus 903 ~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~-~~vkl~DfGla 980 (1119)
|+||||+.+ +++.+++.... .+++..++.++.|+++|++|||+. +|+||||||+||+++.+ +.+|++|||+|
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 67888887654 489999999999999999999999 99999999999999854 79999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYSTRL-TEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC 1059 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1119)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... .. ......
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~-------i~~~~~-- 221 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE-------IIRGQV-- 221 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH-------HHHCCC--
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hH-------Hhhccc--
Confidence 865432 2345679999999998876665 57799999999999999999998632 00 000000
Q ss_pred cccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 ICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.+.+ ..+.++.+++.+||+.||++|||++|+++|
T Consensus 222 --~~~~----------~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 --FFRQ----------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --CCSS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CCCC----------CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111 123467899999999999999999999886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=377.22 Aligned_cols=252 Identities=24% Similarity=0.369 Sum_probs=192.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCC---ceEEEEEecccc-------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNS---RKHWAVKKLNRS-------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFI 904 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~---~~~vavK~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 904 (1119)
+|+..+.||+|+||+||+|++... ...||||+++.. ..++.+|+.+++.++|||||+++|++.+ +..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 466678999999999999986432 357999988532 2458899999999999999999999975 46789
Q ss_pred EEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccccc
Q 001226 905 VTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLIS 984 (1119)
Q Consensus 905 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~ 984 (1119)
||||+++|++.+++..... .+++..+..++.|+++|+.|||++ +|+||||||+||+++.++.+|++|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999998876543 489999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCC-CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCCCCCceeehhhhhhccccccccc
Q 001226 985 DSHSS-STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLF-RKMPVDPSFGEDTDIVTWTRWKLQENHECICF 1062 (1119)
Q Consensus 985 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1119)
..... .......+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... +. ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~---~~~i~~~~~~---- 233 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QI---LHKIDKEGER---- 233 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HH---HHHHHTSCCC----
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--HH---HHHHHhCCCC----
Confidence 54322 22334567889999999999999999999999999999998 89998643111 11 1111111000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKL 1109 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~ 1109 (1119)
.. .+...+..+.+++.+||+.||++||||+||++.|++.
T Consensus 234 ----~~----~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 ----LP----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC----CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 0112235688999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-42 Score=381.25 Aligned_cols=259 Identities=23% Similarity=0.387 Sum_probs=208.9
Q ss_pred HHhhCCceeeecCCccEEEEEeCC-----CceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCCceE
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNN-----SRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDEHGF 903 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 903 (1119)
.+++.+++||+|+||+||+|.++. ++..||||+++... ..+.+|+.++++++|||||++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 466778999999999999998753 35789999996432 34789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHhhccCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEe
Q 001226 904 IVTEYMPGGTLFNVLHQNE-------PRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGD 976 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~D 976 (1119)
+||||+++|+|.+++.... ....+++..+.+++.|+++|+.|||++ +|+||||||+|||+++++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 9999999999999987532 223578999999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCCCCCceeehhhhhhcc
Q 001226 977 FGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRK-MPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 977 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
||+|+...............+|+.|+|||.+.+..++.++|||||||++|||+||. .||.... .... ...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~~~---~~~---- 247 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQV---LRF---- 247 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHH---HHH----
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--HHHH---HHH----
Confidence 99998776554444455567899999999999999999999999999999999985 5554321 0000 000
Q ss_pred cccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1056 NHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1056 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+.+.... ..+...+..+.+++.+||+.+|++|||+++|+++|++..+..
T Consensus 248 ------i~~~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 248 ------VMEGGLL---DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ------HHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ------HHhCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0111100 011122356899999999999999999999999999886643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-41 Score=374.51 Aligned_cols=267 Identities=20% Similarity=0.270 Sum_probs=200.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..++||+|+||+||+|.+..+++.||||+++.. ...+.+|+++++.++|||||++++++.+++..|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 567779999999999999999999999999998532 34578999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+.++ +.+++.... ...+++..+..++.|++.|++|||++ +||||||||+||+++.++.+|++|||.|+......
T Consensus 83 ~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 83 LHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred cCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9654 444544332 22589999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCcccccccCCCcccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhh-hhccccc---cc--c
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRW-KLQENHE---CI--C 1061 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~---~~--~ 1061 (1119)
.......||+.|+|||...... ++.++||||+||++|||++|+.||......+. ....... ....... .. .
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhcccccccc
Confidence 2344567999999999877655 57899999999999999999999974321100 0000000 0000000 00 0
Q ss_pred cccccccCCCchH-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcc
Q 001226 1062 FLDREISFWDSDD-----QLKALRLLELALECTRQVADMRPSMREVVGF--LIKL 1109 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~ 1109 (1119)
........+.... ...+.++.+++.+|++.||++|||++|+++| ++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000111111110 1123567899999999999999999999997 5544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-41 Score=373.09 Aligned_cols=269 Identities=22% Similarity=0.257 Sum_probs=197.3
Q ss_pred HHhhCCceeeecCCccEEEEEeCCC-ceEEEEEeccc------ccccHHHHHHHHhhc---CCCCEEEEeeeeec-----
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNS-RKHWAVKKLNR------SETNFDVEIRTLSLV---RHRNILRIVGSCTK----- 898 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~vavK~~~~------~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 898 (1119)
.+|+..++||+|+||+||+|++..+ ++.||||+++. ....+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 3677789999999999999998654 67899998842 233567888888776 79999999999853
Q ss_pred CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
....+++|||++++.+........ ..+++..++.++.|++.||+|||++ +||||||||+|||+++++.+|++|||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred CceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 346799999998877655444332 3589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehh---------
Q 001226 979 MSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT--------- 1049 (1119)
Q Consensus 979 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~--------- 1049 (1119)
.++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. .....
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchh
Confidence 98765432 234456899999999999999999999999999999999999999975321100 00000
Q ss_pred hhhhcccccccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccc
Q 001226 1050 RWKLQENHECICFLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLND 1111 (1119)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~ 1111 (1119)
.+..........................+..+.+++.+||+.||++|||++|+++| ++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 00000000000000000000000011123467889999999999999999999987 555543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=381.37 Aligned_cols=269 Identities=24% Similarity=0.266 Sum_probs=199.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccccccHHHHHHHHhhcCCCCEEEEeeeeecC------CceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSETNFDVEIRTLSLVRHRNILRIVGSCTKD------EHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lV~e~ 908 (1119)
+|+..++||+|+||+||+|+++.+++.||||+++.......+|++++++++||||++++++|... .+.|+||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 56677999999999999999999999999999987777778999999999999999999998542 346899999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDSH 987 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~~ 987 (1119)
++++.+..+.+.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 98765444433322334699999999999999999999998 999999999999999875 89999999998765432
Q ss_pred CCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeeh---------hhhhhcccc
Q 001226 988 SSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTW---------TRWKLQENH 1057 (1119)
Q Consensus 988 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~ 1057 (1119)
......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .... ..+.... .
T Consensus 178 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~~-~ 252 (350)
T d1q5ka_ 178 ---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMN-P 252 (350)
T ss_dssp ---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHHC-C
T ss_pred ---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhhc-c
Confidence 2334579999999998765 5789999999999999999999999964321110 0000 0000000 0
Q ss_pred cccccccccccCC---CchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccc
Q 001226 1058 ECICFLDREISFW---DSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLND 1111 (1119)
Q Consensus 1058 ~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~ 1111 (1119)
......-+..... .......+.++.+++.+||+.||++|||++|+++| ++++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000000000000 00011224467899999999999999999999986 555543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-40 Score=364.21 Aligned_cols=260 Identities=21% Similarity=0.260 Sum_probs=194.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|+..++||+|+||+||+|+++ +++.||||+++.. ...+.+|+.++++++|||||++++++.+++..+++||+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5677789999999999999987 5899999998542 34588999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+.++.+..+....+ .+++..+..++.||+.||+|||+. +||||||||+||+++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98777766655443 499999999999999999999999 99999999999999999999999999998765422
Q ss_pred CCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhh-------hccccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWK-------LQENHECI 1060 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 1060 (1119)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. ........ ........
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGST
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhh
Confidence 223345689999999988754 568999999999999999999999975321110 00000000 00000000
Q ss_pred cccccccc-----CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLDREIS-----FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
. ...... .+.......+..+.+++.+||+.||++|||++|+++|
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 K-YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp T-CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h-cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 0000011223567899999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-39 Score=359.80 Aligned_cols=260 Identities=18% Similarity=0.240 Sum_probs=199.6
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecc--cccccHHHHHHHHhhcCCCCE-EEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLN--RSETNFDVEIRTLSLVRHRNI-LRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~--~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..+.||+|+||+||+|++..+++.||||++. ....++.+|+++++.++|+++ +.+.+++.+++..++||||+ +
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~ 86 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 86 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-C
Confidence 5777899999999999999999999999999874 344678999999999987665 45555667778889999999 5
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC---CCceEEEeccccccccCCCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS---ELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~---~~~vkl~DfGla~~~~~~~~ 988 (1119)
+++.+.+..... .+++..+..++.|++.|++|||++ +|+||||||+||+++. +..+|++|||+|+.......
T Consensus 87 ~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 87 PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred CchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 667666655443 489999999999999999999999 9999999999999864 45799999999998754332
Q ss_pred C-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc-ccccccc
Q 001226 989 S-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE-NHECICF 1062 (1119)
Q Consensus 989 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1062 (1119)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ........ ....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~~~~~~--- 237 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPI--- 237 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSCH---
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhcccCCCCh---
Confidence 1 233456899999999999999999999999999999999999999976433222111 11110000 0000
Q ss_pred ccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHccccc
Q 001226 1063 LDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDK 1112 (1119)
Q Consensus 1063 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~ 1112 (1119)
+.. ....+.++.+++.+||+.+|++||+++++.+.|+.+..+
T Consensus 238 --~~~------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 --EVL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp --HHH------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred --hHh------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000 011235688999999999999999999999988876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-39 Score=355.33 Aligned_cols=262 Identities=18% Similarity=0.249 Sum_probs=208.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhcCC-CCEEEEeeeeecCCceEEEEeccCC
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLVRH-RNILRIVGSCTKDEHGFIVTEYMPG 911 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~ 911 (1119)
+|+..++||+|+||+||+|++..+++.||||+++. ....+.+|++.++.++| +|++.+++++.++...++||||+ +
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~ 84 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-G 84 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-C
Confidence 56778999999999999999999999999998743 44568899999999975 89999999999999999999999 7
Q ss_pred CCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCC-----CCceEEEeccccccccCC
Q 001226 912 GTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDS-----ELEPKIGDFGMSKLISDS 986 (1119)
Q Consensus 912 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~vkl~DfGla~~~~~~ 986 (1119)
++|.+++..... .+++.++..++.|++.|++|||+. ||+||||||+||+++. ++.+|++|||+|+...+.
T Consensus 85 ~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 85 PSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp CBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred CCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 899999877653 489999999999999999999999 9999999999999974 578999999999876543
Q ss_pred CCC-----CcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccccc
Q 001226 987 HSS-----STRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHECIC 1061 (1119)
Q Consensus 987 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1119)
... .......||+.|+|||.+.+..+++++||||+||++|||++|+.||.......... ..............
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~~~i~~~~~~~~~- 237 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTPL- 237 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHSCH-
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-HHHHHHhccCCCCh-
Confidence 221 23345679999999999999999999999999999999999999997542221110 00000000000000
Q ss_pred cccccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHcccccC
Q 001226 1062 FLDREISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGFLIKLNDKN 1113 (1119)
Q Consensus 1062 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1113 (1119)
+.+ ....+.++.+++..|++.+|++||+++.+.+.|+++.++.
T Consensus 238 ---~~l------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 238 ---REL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp ---HHH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHh------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 000 0112346889999999999999999999999988876544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=363.17 Aligned_cols=266 Identities=18% Similarity=0.227 Sum_probs=194.7
Q ss_pred HHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec--------
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK-------- 898 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 898 (1119)
+.+|...++||+|+||+||+|++..+|+.||||++... ..++.+|+.+++.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46788889999999999999999999999999998432 2357799999999999999999998855
Q ss_pred CCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecc
Q 001226 899 DEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFG 978 (1119)
Q Consensus 899 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfG 978 (1119)
++..|+||||++++.+..+..... .++...++.++.|+++|+.|||+. +|+||||||+||+++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 346799999998776665544433 488899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC--CCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc
Q 001226 979 MSKLISDSHS--SSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE 1055 (1119)
Q Consensus 979 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1055 (1119)
+++....... ........||+.|+|||.+.+. .+++++||||+||++|||++|+.||....... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~~~~~~~ 241 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSI 241 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence 9987654322 1223345799999999988754 68999999999999999999999996431100 000000000000
Q ss_pred ccc---------ccccccccccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1056 NHE---------CICFLDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1056 ~~~---------~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
... ............... .......+.+++.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 000000000000000 01123456789999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=368.25 Aligned_cols=268 Identities=24% Similarity=0.305 Sum_probs=195.4
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc-----ccHHHHHHHHhhcCCCCEEEEeeeeecCC----ceEEE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE-----TNFDVEIRTLSLVRHRNILRIVGSCTKDE----HGFIV 905 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 905 (1119)
+|+..++||+|+||+||+|.++.+++.||||+++... ..+.+|+.+++.++||||+++++++.... ..+++
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 4777799999999999999999999999999986432 35678999999999999999999986543 23455
Q ss_pred EeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccC
Q 001226 906 TEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISD 985 (1119)
Q Consensus 906 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~ 985 (1119)
++++.+|+|.+++... .+++..++.++.|+++|++|||++ +||||||||+||+++.++.+||+|||+|+....
T Consensus 89 ~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 5667799999999754 389999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-CcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc-----
Q 001226 986 SHSS-STRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE----- 1058 (1119)
Q Consensus 986 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 1058 (1119)
.... .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+. .............
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDLNC 239 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHT
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCChhhhhh
Confidence 3222 22345679999999998754 5678999999999999999999999965321100 0000000000000
Q ss_pred -----ccccc--cccccC--CCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccc
Q 001226 1059 -----CICFL--DREISF--WDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLND 1111 (1119)
Q Consensus 1059 -----~~~~~--~~~~~~--~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~ 1111 (1119)
..... .+.... +.......+.++.+++.+||+.||++|||++|+++| +++..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00000 000000 000000112467899999999999999999999987 554433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=3.5e-39 Score=360.94 Aligned_cols=297 Identities=29% Similarity=0.464 Sum_probs=244.2
Q ss_pred ccCCCcHHHHHHHHhcCCCCCCCCCCCCCCCCCCCCc--eeeeeeeecCC--CceEEEecCCCccccc--Cccchhhhcc
Q 001226 21 VSSPPSAISLVQFLDSLPKQSQSHLPWNQSVSTSAPC--KWSGVSCYNNS--SSLKALNLSGFGLSGV--LNNSISYICK 94 (1119)
Q Consensus 21 ~~~~~~~~~ll~~~~~~~~~~~~~~~w~~~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~~~--~~~~~~~~~~ 94 (1119)
.|.++|++||++||+++.+++ .+.+|+. ++||| .|+||+|+... +||++|+|++++++|. +|+ .+++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~---~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~---~l~~ 74 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP---TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS---SLAN 74 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT---TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG---GGGG
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCCCCCC---CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh---HHhc
Confidence 578999999999999998763 6789975 36899 59999998743 4899999999999985 443 4678
Q ss_pred CCcccEEEcCC-CcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCccccccccccee
Q 001226 95 NQHLLSLDLSG-NEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESI 173 (1119)
Q Consensus 95 l~~l~~L~Ls~-n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L 173 (1119)
+++|++|||++ |+++|.+|.+|+++++|++|+|++|++.+..|..+..+.+|+++++++|.+.+.+|..++++++|+++
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 99999999997 89999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecccccccccCccCCCcccc-cEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccC
Q 001226 174 GFHNNFLNGELPNDICSLPKL-KSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFG 252 (1119)
Q Consensus 174 ~L~~n~l~~~~~~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~ 252 (1119)
++++|.+++.+|..+..+.++ +.+++++|++++..|.. +.++..+ .++++.+.+.
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~-----------------------~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT-----------------------FANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG-----------------------GGGCCCS-EEECCSSEEE
T ss_pred ecccccccccccccccccccccccccccccccccccccc-----------------------ccccccc-cccccccccc
Confidence 999999999999999998886 88999999998765543 3333332 4666666555
Q ss_pred CccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCccc
Q 001226 253 GAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSV 332 (1119)
Q Consensus 253 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 332 (1119)
+.+ +..+..+++++.+++++|.+++.+| .+..+++|+.|+|++|++++.+|..|.++++|++|+|++|+++|.+|. +
T Consensus 211 ~~~-~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~ 287 (313)
T d1ogqa_ 211 GDA-SVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287 (313)
T ss_dssp ECC-GGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred ccc-ccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c
Confidence 433 3445566677777777777775544 567778888888888888877888888888888888888888887774 6
Q ss_pred CCCCCCCeEEccCCc-ccCC
Q 001226 333 GNLSSLNSLLLFNNR-LQGT 351 (1119)
Q Consensus 333 ~~l~~L~~L~L~~N~-l~~~ 351 (1119)
+++++|+.+++++|+ +.|.
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCCHHHhCCCccccCC
Confidence 788888888888886 5543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=369.30 Aligned_cols=263 Identities=25% Similarity=0.302 Sum_probs=192.3
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeecCC------ce
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTKDE------HG 902 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 902 (1119)
+|+..++||+|+||+||+|.++.+|+.||||+++... ..+.+|+.+++.++|||||+++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 5677789999999999999999999999999986432 34678999999999999999999997654 46
Q ss_pred EEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccccc
Q 001226 903 FIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKL 982 (1119)
Q Consensus 903 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~ 982 (1119)
|+||||+ +.++..+.+.. .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|+.
T Consensus 99 ~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 9999999 66787777643 389999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCCCCcccccccCCCcccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc--
Q 001226 983 ISDSHSSSTRSAIVGSLGYIAPENAYS-TRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC-- 1059 (1119)
Q Consensus 983 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 1059 (1119)
... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ...............
T Consensus 171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 171 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred cCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHh
Confidence 643 2344678999999998865 4578999999999999999999999965311100 000000000000000
Q ss_pred ----------cccccc-cccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHcccc
Q 001226 1060 ----------ICFLDR-EISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF--LIKLND 1111 (1119)
Q Consensus 1060 ----------~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~--L~~~~~ 1111 (1119)
.....+ ....+.......+..+.+++.+||+.||++|||++|+++| ++.+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 000000 0000000001123467899999999999999999999997 665543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=357.71 Aligned_cols=263 Identities=21% Similarity=0.224 Sum_probs=201.2
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeecCCceEEEEec
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTKDEHGFIVTEY 908 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 908 (1119)
+|...++||+|+||+||+|++..+++.||||+++.. ...+.+|+.+++.++||||+++++++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 577779999999999999999999999999998532 24578999999999999999999999999999999999
Q ss_pred cCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccccCCCC
Q 001226 909 MPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLISDSHS 988 (1119)
Q Consensus 909 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~~~~~~ 988 (1119)
+.++++..++...+ .+++..++.++.|+++||+|||++ +||||||||+||+++.++.+|++|||.++......
T Consensus 83 ~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~- 155 (292)
T d1unla_ 83 CDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-
T ss_pred cccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC-
Confidence 99999888877654 488999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCcccccccCCCcccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcc-------ccccc
Q 001226 989 SSTRSAIVGSLGYIAPENAYSTR-LTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQE-------NHECI 1060 (1119)
Q Consensus 989 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 1060 (1119)
.......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.................... .....
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2233446788999999887654 68999999999999999999999754322111110000000000 00000
Q ss_pred cccc----ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1061 CFLD----REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1061 ~~~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.... ................+.+++.+|++.||.+|||++|+++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000001112223467899999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-39 Score=361.42 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=198.8
Q ss_pred HHHHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhcC-CCCEEEEeeeeec--CCceEEEEe
Q 001226 832 DVIRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVR-HRNILRIVGSCTK--DEHGFIVTE 907 (1119)
Q Consensus 832 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~e 907 (1119)
+..+|+..++||+|+||+||+|++..+++.||||+++.. ...+.+|+.+++.++ ||||+++++++.. ....++|||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 335788889999999999999999999999999998654 456889999999995 9999999999874 456899999
Q ss_pred ccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCC-ceEEEeccccccccCC
Q 001226 908 YMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSEL-EPKIGDFGMSKLISDS 986 (1119)
Q Consensus 908 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~-~vkl~DfGla~~~~~~ 986 (1119)
|+++++|..+.+ .+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+|++|||+|+.....
T Consensus 113 ~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 113 HVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 999999977642 388999999999999999999999 999999999999998765 5899999999876543
Q ss_pred CCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehh---------hh----h
Q 001226 987 HSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWT---------RW----K 1052 (1119)
Q Consensus 987 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~---------~~----~ 1052 (1119)
. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.............. .+ .
T Consensus 184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2 23456789999999987765 479999999999999999999999975422111000000 00 0
Q ss_pred hccccccccccccccc------CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1053 LQENHECICFLDREIS------FWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1053 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
................ .........+.++.+++.+||+.||++|||++|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000000000 0001112234567899999999999999999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=362.03 Aligned_cols=251 Identities=24% Similarity=0.299 Sum_probs=200.2
Q ss_pred HHHhhCCceeeecCCccEEEEEe---CCCceEEEEEecccc--------cccHHHHHHHHhhcCC-CCEEEEeeeeecCC
Q 001226 833 VIRATEGRIIGKGKHGTVYRTLS---NNSRKHWAVKKLNRS--------ETNFDVEIRTLSLVRH-RNILRIVGSCTKDE 900 (1119)
Q Consensus 833 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~~~~vavK~~~~~--------~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 900 (1119)
+.+|...++||+|+||+||+|++ +.+|+.||||++++. .+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 45688889999999999999987 446899999988532 2457789999999976 89999999999999
Q ss_pred ceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEecccc
Q 001226 901 HGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMS 980 (1119)
Q Consensus 901 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla 980 (1119)
..++||||+.+|+|.+++...+. +++..+..++.|++.|++|+|+. +||||||||+||+++.++.+||+|||++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred ceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999987653 77889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccCCCcccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhccccc
Q 001226 981 KLISDSHSSSTRSAIVGSLGYIAPENAYST--RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHE 1058 (1119)
Q Consensus 981 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1119)
+...... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+........ ..
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~-~~----- 249 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-IL----- 249 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-HH-----
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cc-----
Confidence 8764422 2233456799999999988654 4688999999999999999999999754322211111110 00
Q ss_pred ccccccccccCCCchHHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 001226 1059 CICFLDREISFWDSDDQLKALRLLELALECTRQVADMRP-----SMREVVGF 1105 (1119)
Q Consensus 1059 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~ell~~ 1105 (1119)
.... ..+...+.++.+++.+||++||++|| |++|+++|
T Consensus 250 -----~~~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 -----KSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----HCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----cCCC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0000 01112345788999999999999999 58999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=358.28 Aligned_cols=260 Identities=23% Similarity=0.232 Sum_probs=188.6
Q ss_pred HHhhCCceeeecCCccEEEEEeCCCceEEEEEecccc------cccHHHHHHHHhhcCCCCEEEEeeeeec------CCc
Q 001226 834 IRATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRS------ETNFDVEIRTLSLVRHRNILRIVGSCTK------DEH 901 (1119)
Q Consensus 834 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 901 (1119)
.+|...++||+|+||+||+|+++.+|+.||||+++.. ...+.+|+.+++.++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 4577778999999999999999999999999998532 2347789999999999999999999864 357
Q ss_pred eEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 902 GFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 902 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
.|+||||+.++.+. .+.. .+++..++.++.|++.|+.|||+. ||+||||||+||+++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 79999999765444 4432 378999999999999999999999 99999999999999999999999999988
Q ss_pred cccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee--------ehhhhhh
Q 001226 982 LISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV--------TWTRWKL 1053 (1119)
Q Consensus 982 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~--------~~~~~~~ 1053 (1119)
..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||........... ....+..
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 66432 233455789999999999999999999999999999999999999964311000000 0000000
Q ss_pred --------------ccccccccccc-ccccCCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1054 --------------QENHECICFLD-REISFWDSDDQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1054 --------------~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
........... .............+.++.+++.+|++.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000010 11111222334556788999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=356.69 Aligned_cols=258 Identities=22% Similarity=0.251 Sum_probs=190.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc------ccHHHHHHHHhhcCCCCEEEEeeeeec-----CCceE
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE------TNFDVEIRTLSLVRHRNILRIVGSCTK-----DEHGF 903 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~------~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~ 903 (1119)
+|+..++||+|+||+||+|++..+++.||||+++... ..+.+|+.+++.++|||+|++++++.. +...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 5777799999999999999999999999999986432 346789999999999999999998853 33446
Q ss_pred EEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEEEeccccccc
Q 001226 904 IVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKIGDFGMSKLI 983 (1119)
Q Consensus 904 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~~~ 983 (1119)
+|++|+.+|+|.+++... .+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+|++|||.+...
T Consensus 99 ~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence 677788899999999653 389999999999999999999999 9999999999999999999999999999755
Q ss_pred cCCCCCCcccccccCCCcccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCceeehhhhhhcccccc---
Q 001226 984 SDSHSSSTRSAIVGSLGYIAPENAYST-RLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIVTWTRWKLQENHEC--- 1059 (1119)
Q Consensus 984 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 1059 (1119)
.. ......||+.|+|||...+. .++.++||||+||++|||++|+.||......... ..............
T Consensus 172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKK 245 (348)
T ss_dssp TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHHTT
T ss_pred Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChHHhhh
Confidence 43 23445789999999987665 4689999999999999999999999643111000 00000000000000
Q ss_pred -----cccccccccCCCch-----HHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 001226 1060 -----ICFLDREISFWDSD-----DQLKALRLLELALECTRQVADMRPSMREVVGF 1105 (1119)
Q Consensus 1060 -----~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPs~~ell~~ 1105 (1119)
.............. ....+..+.+++.+||+.||++|||++|+++|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000 01123467899999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-35 Score=332.05 Aligned_cols=270 Identities=20% Similarity=0.233 Sum_probs=192.5
Q ss_pred HhhCCceeeecCCccEEEEEeCCCceEEEEEeccccc---ccHHHHHHHHhhcC-----------CCCEEEEeeeeecC-
Q 001226 835 RATEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE---TNFDVEIRTLSLVR-----------HRNILRIVGSCTKD- 899 (1119)
Q Consensus 835 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~- 899 (1119)
||+..++||+|+||+||+|+++.+|+.||||+++... +.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 4788899999999999999999999999999997543 45678998888775 57899999988653
Q ss_pred -CceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCc------e
Q 001226 900 -EHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELE------P 972 (1119)
Q Consensus 900 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~------v 972 (1119)
...+++|+++..+...............++..++.++.||+.|++|||+.. +|+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCccccccee
Confidence 455667777655544333333333446889999999999999999999832 9999999999999987653 8
Q ss_pred EEEeccccccccCCCCCCcccccccCCCcccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCCCCCcee--ehhh
Q 001226 973 KIGDFGMSKLISDSHSSSTRSAIVGSLGYIAPENAYSTRLTEKSDVYSYGVILFELLFRKMPVDPSFGEDTDIV--TWTR 1050 (1119)
Q Consensus 973 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG~vl~elltg~~p~~~~~~~~~~~~--~~~~ 1050 (1119)
+++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||........... ....
T Consensus 172 kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999975543 23446799999999999999999999999999999999999999975432111000 0000
Q ss_pred --hhh--------ccccccccccc-----ccc---c---------CCCchHHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 001226 1051 --WKL--------QENHECICFLD-----REI---S---------FWDSDDQLKALRLLELALECTRQVADMRPSMREVV 1103 (1119)
Q Consensus 1051 --~~~--------~~~~~~~~~~~-----~~~---~---------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ell 1103 (1119)
... ..........+ ..+ . .........+.++.+++.+|++.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 00000000000 000 0 01111244567889999999999999999999999
Q ss_pred HH--HHcccc
Q 001226 1104 GF--LIKLND 1111 (1119)
Q Consensus 1104 ~~--L~~~~~ 1111 (1119)
+| ++....
T Consensus 327 ~Hp~f~~~~~ 336 (362)
T d1q8ya_ 327 NHPWLKDTLG 336 (362)
T ss_dssp TCGGGTTCTT
T ss_pred cCcccCCCCC
Confidence 87 554433
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=3.4e-32 Score=303.80 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=193.6
Q ss_pred ccceeeccCccccC--CCCccccccccccEEEecc-CccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEE
Q 001226 482 NLFVLVLGNNRFNG--SFPIEIGKCSSLRRVILSN-NLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTML 558 (1119)
Q Consensus 482 ~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L 558 (1119)
.++.|+|++|.++| .+|.+++++++|++|+|++ |.++|.+|..+.++++|++|+|++|++.+..|..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 57777788877776 4677888888888888876 78888888888888888888888888888777778888888888
Q ss_pred eccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCC-cEEeccCccccccCChhhhhcccCCeeEccCccC
Q 001226 559 DFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKM-IKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNL 637 (1119)
Q Consensus 559 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 637 (1119)
++++|++.+.+|.++++++.|+.+++++|.+.|.+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++|..
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 888888888888888888888888888888888888888877776 788888888888888887776544 688888888
Q ss_pred ccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceecccCCcc
Q 001226 638 SGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTE 717 (1119)
Q Consensus 638 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~ 717 (1119)
.|.+|..+..+++++.+++++|.+.+.+| .+..+..+ +.|+|++|+++|.+|++|+++++|++|||++|+|+|.||+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L-~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~- 286 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTC-CEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred ccccccccccccccccccccccccccccc-cccccccc-ccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence 88888888888888888888777776655 34444443 3477777777777777777777777777777777777764
Q ss_pred ccccccceEEeccccc-ccc
Q 001226 718 VNNMVSLYFVNISFNH-FSG 736 (1119)
Q Consensus 718 ~~~~~~l~~l~ls~N~-~~g 736 (1119)
+.++++|+.+++++|+ ++|
T Consensus 287 ~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp STTGGGSCGGGTCSSSEEES
T ss_pred cccCCCCCHHHhCCCccccC
Confidence 4666777777777775 555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=6.6e-28 Score=277.15 Aligned_cols=341 Identities=23% Similarity=0.295 Sum_probs=183.0
Q ss_pred CCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEE
Q 001226 263 LLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLL 342 (1119)
Q Consensus 263 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 342 (1119)
+.+|++|++++++|+.. +.+..+++|++|+|++|+|+++.+ ++++++|++|++++|.+.+.. .++++++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccccc--cccccccccccc
Confidence 34566666666666632 345566666666666666665432 566666666666666665332 255666666666
Q ss_pred ccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccc
Q 001226 343 LFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTG 422 (1119)
Q Consensus 343 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 422 (1119)
+++|.+++..+ ......+..+....|.+....+................. ....+...+.........|...
T Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~- 188 (384)
T d2omza2 117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNKVS- 188 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSCCC-
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccc-----hhhhhccccccccccccccccc-
Confidence 66665553322 233344555555555544222211111111111111111 1112333333333444444332
Q ss_pred cCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCcccc
Q 001226 423 RIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIG 502 (1119)
Q Consensus 423 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~ 502 (1119)
....+..+++++.+++++|.+++..+ .....+|+.|++++|++++ + ..+.
T Consensus 189 -~~~~~~~l~~~~~l~l~~n~i~~~~~---------------------------~~~~~~L~~L~l~~n~l~~-~-~~l~ 238 (384)
T d2omza2 189 -DISVLAKLTNLESLIATNNQISDITP---------------------------LGILTNLDELSLNGNQLKD-I-GTLA 238 (384)
T ss_dssp -CCGGGGGCTTCSEEECCSSCCCCCGG---------------------------GGGCTTCCEEECCSSCCCC-C-GGGG
T ss_pred -cccccccccccceeeccCCccCCCCc---------------------------ccccCCCCEEECCCCCCCC-c-chhh
Confidence 23334455555555555555543322 1223444455555555442 1 2345
Q ss_pred ccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEE
Q 001226 503 KCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQIL 582 (1119)
Q Consensus 503 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 582 (1119)
.+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+..++.+++++|++++ +..+..+++++.|
T Consensus 239 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L 312 (384)
T d2omza2 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL 312 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEE
T ss_pred cccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccccccccccc--ccccchhcccCeE
Confidence 55566666666666554332 5555666666666666654322 4456667777777777764 2346666777777
Q ss_pred EcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCc
Q 001226 583 RLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSN 659 (1119)
Q Consensus 583 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 659 (1119)
++++|++++. + .+..+++|++|++++|+|++ +| .+..+++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 313 ~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 313 TLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 7777777643 2 26667777777777777763 33 56777777777777777776544 677777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=6.5e-28 Score=277.22 Aligned_cols=356 Identities=24% Similarity=0.284 Sum_probs=238.3
Q ss_pred EcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCccc
Q 001226 270 YLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQ 349 (1119)
Q Consensus 270 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 349 (1119)
.++.+.+++.+. ...+.+|++|++++|.|+.. ..+..+++|++|+|++|+|++. + .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccc
Confidence 455555555433 24556777777777777643 2355666666666666666643 2 2666666666666666665
Q ss_pred CCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeecccccccCCcccc
Q 001226 350 GTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDIT 429 (1119)
Q Consensus 350 ~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 429 (1119)
+.. .++++++|+.|++++|.+++.. .......+..+....|.+....+... .
T Consensus 102 ~i~--~l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~------------------------~ 153 (384)
T d2omza2 102 DIT--PLANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSG------------------------L 153 (384)
T ss_dssp CCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTT------------------------C
T ss_pred ccc--cccccccccccccccccccccc--cccccccccccccccccccccccccc------------------------c
Confidence 332 2555556666666555554322 12233444444444444443222211 1
Q ss_pred CCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccE
Q 001226 430 RLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRR 509 (1119)
Q Consensus 430 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 509 (1119)
..............+. .....+.........|... .+.....++++..+++++|.+++..| +..+++|++
T Consensus 154 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~ 223 (384)
T d2omza2 154 TSLQQLSFGNQVTDLK------PLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 223 (384)
T ss_dssp TTCSEEEEEESCCCCG------GGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred ccccccccccccchhh------hhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCE
Confidence 1111111111111111 0111222233333333332 23445667788899999999986554 467889999
Q ss_pred EEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcc
Q 001226 510 VILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKL 589 (1119)
Q Consensus 510 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 589 (1119)
|++++|+++.. ..+..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+.+++.++.++++.|++
T Consensus 224 L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 224 LSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQL 297 (384)
T ss_dssp EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCC
T ss_pred EECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccc
Confidence 99999999853 468899999999999999997543 778899999999999998543 477899999999999999
Q ss_pred cCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCCccccc
Q 001226 590 DGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSL 669 (1119)
Q Consensus 590 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 669 (1119)
++ + ..+..+++++.|++++|++++.. .+..+++|+.|+|++|+|++ +| .|+++++|++|++++|++++..| +
T Consensus 298 ~~-~-~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l 369 (384)
T d2omza2 298 ED-I-SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--L 369 (384)
T ss_dssp SC-C-GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--G
T ss_pred cc-c-cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--h
Confidence 85 3 45888999999999999999743 38889999999999999985 44 69999999999999999997665 6
Q ss_pred hhhccccceeeeccc
Q 001226 670 SKLHHFSSILNVSNN 684 (1119)
Q Consensus 670 ~~l~~~~~~L~ls~N 684 (1119)
.+++++ +.|++++|
T Consensus 370 ~~l~~L-~~L~L~~N 383 (384)
T d2omza2 370 ANLTRI-TQLGLNDQ 383 (384)
T ss_dssp TTCTTC-SEEECCCE
T ss_pred ccCCCC-CEeeCCCC
Confidence 777765 45999998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=1.1e-24 Score=241.34 Aligned_cols=244 Identities=22% Similarity=0.264 Sum_probs=117.4
Q ss_pred CcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccC
Q 001226 314 LQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN 393 (1119)
Q Consensus 314 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~ 393 (1119)
++.+|-++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 344555555555 3444332 3455555555555533333455555555555555555544444555555555555555
Q ss_pred ccccCCCCccccccCcceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCcc
Q 001226 394 NRIEGAIPHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPI 473 (1119)
Q Consensus 394 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 473 (1119)
|+++.. |.. ....++.|++++|.+.+..+..+.....++.++...|... .....
T Consensus 89 n~l~~l-~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~-----------------------~~~~~ 142 (305)
T d1xkua_ 89 NQLKEL-PEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-----------------------SSGIE 142 (305)
T ss_dssp SCCSBC-CSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC-----------------------GGGBC
T ss_pred CccCcC-ccc--hhhhhhhhhccccchhhhhhhhhhcccccccccccccccc-----------------------ccCCC
Confidence 555432 211 1223444444444444333333333344444444433321 11122
Q ss_pred CCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccc
Q 001226 474 PANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWS 553 (1119)
Q Consensus 474 p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 553 (1119)
+..+..+++|+.+++++|.++ .+|..+ +++|+.|++++|...+..+..+..++.++.|++++|++++..+..+..++
T Consensus 143 ~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~ 219 (305)
T d1xkua_ 143 NGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219 (305)
T ss_dssp TTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred ccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccc
Confidence 333444455555555555554 233322 34556666666665555555555555555555555555544444555555
Q ss_pred cceEEeccCCcccCCCCCccCCcccccEEEcccCccc
Q 001226 554 NLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLD 590 (1119)
Q Consensus 554 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 590 (1119)
+|++|+|++|+|+ .+|.+|.++++|++|+|++|+|+
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence 5555555555554 34455555555555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.8e-25 Score=243.12 Aligned_cols=276 Identities=24% Similarity=0.263 Sum_probs=158.8
Q ss_pred CCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEee
Q 001226 337 SLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALY 416 (1119)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 416 (1119)
.++.++-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5667777777777 5565553 567788888887775555567777777777777777776667777777777777777
Q ss_pred cccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeeccCcccc--
Q 001226 417 NNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFN-- 494 (1119)
Q Consensus 417 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~-- 494 (1119)
+|+++ .+|..+ ...++.|++++|.+.+. +.. .+.....+..++...|...
T Consensus 88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l-~~~------------------------~~~~~~~~~~l~~~~n~~~~~ 139 (305)
T d1xkua_ 88 KNQLK-ELPEKM--PKTLQELRVHENEITKV-RKS------------------------VFNGLNQMIVVELGTNPLKSS 139 (305)
T ss_dssp SSCCS-BCCSSC--CTTCCEEECCSSCCCBB-CHH------------------------HHTTCTTCCEEECCSSCCCGG
T ss_pred CCccC-cCccch--hhhhhhhhccccchhhh-hhh------------------------hhhcccccccccccccccccc
Confidence 77776 344332 24566666666666532 211 1222233334444444322
Q ss_pred CCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccC
Q 001226 495 GSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELG 574 (1119)
Q Consensus 495 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 574 (1119)
...+..+..+++|+.+++++|.+.. +|..+ +++|+.|++++|.+++..+..|.
T Consensus 140 ~~~~~~~~~l~~L~~l~l~~n~l~~-------------------------l~~~~--~~~L~~L~l~~n~~~~~~~~~~~ 192 (305)
T d1xkua_ 140 GIENGAFQGMKKLSYIRIADTNITT-------------------------IPQGL--PPSLTELHLDGNKITKVDAASLK 192 (305)
T ss_dssp GBCTTGGGGCTTCCEEECCSSCCCS-------------------------CCSSC--CTTCSEEECTTSCCCEECTGGGT
T ss_pred CCCccccccccccCccccccCCccc-------------------------cCccc--CCccCEEECCCCcCCCCChhHhh
Confidence 2233445555566666666655542 22221 34555555665555555555555
Q ss_pred CcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcc------cccc
Q 001226 575 NLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDA------FSSV 648 (1119)
Q Consensus 575 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~------~~~l 648 (1119)
+++.++.|++++|++.+..|..+..+++|++|+|++|+|+ .+|+++..+++|++|+|++|+|+..-+.. +..+
T Consensus 193 ~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~ 271 (305)
T d1xkua_ 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271 (305)
T ss_dssp TCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTS
T ss_pred ccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhccc
Confidence 5556666666666665555555555666666666666665 34555555666666666666665332222 2345
Q ss_pred ccccEeecCCcccC-CCccccchh
Q 001226 649 QSLFELQLGSNIFD-GSIPCSLSK 671 (1119)
Q Consensus 649 ~~L~~L~L~~N~l~-~~~p~~~~~ 671 (1119)
.+|+.|+|++|++. ..++...+.
T Consensus 272 ~~L~~L~L~~N~~~~~~~~~~~f~ 295 (305)
T d1xkua_ 272 ASYSGVSLFSNPVQYWEIQPSTFR 295 (305)
T ss_dssp CCCSEEECCSSSSCGGGSCGGGGT
T ss_pred CCCCEEECCCCcCccCcCCHhHhc
Confidence 56667777777663 344444433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.1e-25 Score=243.01 Aligned_cols=205 Identities=24% Similarity=0.216 Sum_probs=148.7
Q ss_pred cceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEec-cCccccCCCccccCCCCcceeecc
Q 001226 459 LSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILS-NNLLQGSLPATLERNPGVSFLDVR 537 (1119)
Q Consensus 459 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~l~ 537 (1119)
+++|+|++|+|+...+..|..+++|++|++++|++.+..+..+..++.++.+... .|.++...|..|..+++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 3444444444444444455556666666666666665555666666666666543 455665666677777777777777
Q ss_pred CcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccC
Q 001226 538 GNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI 617 (1119)
Q Consensus 538 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 617 (1119)
+|.+....+..+...++|+.+++++|+|++..+..|..+++|+.|++++|++.+..|..|.++++|+.+++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 77777666667777778888888888887666677778888888888888888777777888888888888888888777
Q ss_pred ChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCC
Q 001226 618 PSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDG 663 (1119)
Q Consensus 618 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 663 (1119)
|..|..+++|++|++++|++++..|..|+.+++|+.|+|++|++.+
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 8888888888888888888888777888888888888888887764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.3e-24 Score=238.04 Aligned_cols=206 Identities=22% Similarity=0.170 Sum_probs=154.5
Q ss_pred cCEEEccCccCcccchhhhhccCCccceeccccceeeCccCCccccccccceeec-cCccccCCCCccccccccccEEEe
Q 001226 434 LQFLSLAHNHLTGEVALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVL-GNNRFNGSFPIEIGKCSSLRRVIL 512 (1119)
Q Consensus 434 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L 512 (1119)
+++|+|++|+|+ .++...+..++.|++|++++|++.+..+..+...+.+..+.. ..|.++...|..+.++++|++|++
T Consensus 34 ~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 34 SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp CSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 344444444443 233333334444444444444444444445555555666554 355566556777888888888888
Q ss_pred ccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCc
Q 001226 513 SNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR 592 (1119)
Q Consensus 513 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 592 (1119)
++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|+|++|++++..+..|.++++|+.+++++|++.+.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 88888777777788888888888888888877777888888999999999999887888889999999999999999988
Q ss_pred CCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccC
Q 001226 593 IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGA 640 (1119)
Q Consensus 593 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 640 (1119)
.|..|..+++|++||+++|++++..|..|..+++|++|+|++|.+.+.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 889999999999999999999887778888899999999999998864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.1e-22 Score=220.00 Aligned_cols=56 Identities=29% Similarity=0.302 Sum_probs=28.3
Q ss_pred eeeccccccCCcccccccccccceeeccCceecccCCccccccccceEEeccccccc
Q 001226 679 LNVSNNKLSGKIPECLGNLDKLQILDLSSNSFSGEIPTEVNNMVSLYFVNISFNHFS 735 (1119)
Q Consensus 679 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~l~~l~ls~N~~~ 735 (1119)
+++++|+|++..|+.|+.+++|++|||++|+|+ .||+.+..+.+|+.++|++|++.
T Consensus 153 l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 333444444344444555555555555555555 45555555555555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.3e-22 Score=217.40 Aligned_cols=196 Identities=25% Similarity=0.246 Sum_probs=101.8
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCC
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSEN 563 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 563 (1119)
..++.+++.++ .+|..+. +++++|+|++|+|++..+..|..+++|++|+|++|+|+. +| .++.+++|++|+|++|
T Consensus 13 ~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N 87 (266)
T d1p9ag_ 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHN 87 (266)
T ss_dssp CEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSS
T ss_pred eEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccccccc
Confidence 33444444444 3343332 245555555555554444445555555555555555542 22 2344555555555555
Q ss_pred cccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCc
Q 001226 564 RLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPD 643 (1119)
Q Consensus 564 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 643 (1119)
+++ ..+..+.++++|+.|++++|++.+..+..+..+.+++.|++++|.++...+..+..++.|+.|++++|+|++..|+
T Consensus 88 ~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~ 166 (266)
T d1p9ag_ 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166 (266)
T ss_dssp CCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTT
T ss_pred ccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCcc
Confidence 555 3444555555556666655555544455555555555566655555544444455555555555555555555555
Q ss_pred cccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCceec
Q 001226 644 AFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNSFS 711 (1119)
Q Consensus 644 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 711 (1119)
.|..+++|++|+|++|++ + .+|+.+..+++|+.|+|++|++.
T Consensus 167 ~~~~l~~L~~L~Ls~N~L-------------------------~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 167 LLNGLENLDTLLLQENSL-------------------------Y-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TTTTCTTCCEEECCSSCC-------------------------C-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccccccccceeecccCCC-------------------------c-ccChhHCCCCCCCEEEecCCCCC
Confidence 555555555544433333 3 44444455555666666666553
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=8.3e-19 Score=197.64 Aligned_cols=137 Identities=27% Similarity=0.301 Sum_probs=71.7
Q ss_pred CccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCCCCCCeEEcc
Q 001226 265 QLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLF 344 (1119)
Q Consensus 265 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 344 (1119)
++++|+|++|+++ .+|+. .++|++|+|++|+|+.+ |.. ..+|+.|++++|+++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc---hhhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5778888888877 45643 35677777777777733 332 345666666666665 22211 1346666666
Q ss_pred CCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEEeeccccc
Q 001226 345 NNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELALYNNRLT 421 (1119)
Q Consensus 345 ~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 421 (1119)
+|.++ .+|. ++.+++|++|++++|.+... +.. ...+..+.+..+.... +..+..++.++.+++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhccccccc--cccccccccceeccccccccc
Confidence 66665 3332 45556666666666555422 211 2333444444433321 222344444455555544443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.81 E-value=2e-18 Score=194.54 Aligned_cols=143 Identities=24% Similarity=0.295 Sum_probs=65.2
Q ss_pred cccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCe
Q 001226 550 GFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQS 629 (1119)
Q Consensus 550 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 629 (1119)
..++.|+.+++++|... .+|.. ..++..+.+.+|++.. .+.. ...+...++..|.+.+. +.. ......
T Consensus 201 ~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l-~~l---~~~~~~ 268 (353)
T d1jl5a_ 201 QNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYY 268 (353)
T ss_dssp TTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCE
T ss_pred ccccccccccccccccc-ccccc---cccccccccccccccc-cccc---ccccccccccccccccc-ccc---cchhcc
Confidence 34455555555555544 23322 2334555555555542 2221 23444455544444321 110 012334
Q ss_pred eEccCccCccCCCccccccccccEeecCCcccCCCccccchhhccccceeeeccccccCCcccccccccccceeeccCce
Q 001226 630 LSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIPECLGNLDKLQILDLSSNS 709 (1119)
Q Consensus 630 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 709 (1119)
.++..|.+.+. ...+++|++|+|++|+++ .+|..+.++. .|++++|+|+ .+|+. +++|++|+|++|+
T Consensus 269 ~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp~~~~~L~----~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~ 335 (353)
T d1jl5a_ 269 LNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVPEL---PQNLKQLHVEYNP 335 (353)
T ss_dssp EECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCCCCCTTCC----EEECCSSCCS-CCCCC---CTTCCEEECCSSC
T ss_pred cccccCccccc----cccCCCCCEEECCCCccC-ccccccCCCC----EEECCCCcCC-ccccc---cCCCCEEECcCCc
Confidence 44555544421 122345555555555554 3443333222 2555555555 45543 3456677777777
Q ss_pred ecccCCccc
Q 001226 710 FSGEIPTEV 718 (1119)
Q Consensus 710 l~g~ip~~~ 718 (1119)
|+ .+|...
T Consensus 336 L~-~lp~~~ 343 (353)
T d1jl5a_ 336 LR-EFPDIP 343 (353)
T ss_dssp CS-SCCCCC
T ss_pred CC-CCCccc
Confidence 66 556543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.81 E-value=6.1e-21 Score=194.76 Aligned_cols=159 Identities=17% Similarity=0.192 Sum_probs=116.7
Q ss_pred hCCceeeecCCccEEEEEeCCCceEEEEEeccccc----------------------ccHHHHHHHHhhcCCCCEEEEee
Q 001226 837 TEGRIIGKGKHGTVYRTLSNNSRKHWAVKKLNRSE----------------------TNFDVEIRTLSLVRHRNILRIVG 894 (1119)
Q Consensus 837 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----------------------~~~~~E~~~l~~l~h~niv~l~~ 894 (1119)
..+++||+|+||+||+|.+.+ |+.||||+++... ....+|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 357899999999999999864 8899999864211 12345788889999999988876
Q ss_pred eeecCCceEEEEeccCCCCHHHhhccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeEeCCCCceEE
Q 001226 895 SCTKDEHGFIVTEYMPGGTLFNVLHQNEPRLVLDWNTRYHIALGIAQGLSYLHYDCVPQIIHRDIKSDNILLDSELEPKI 974 (1119)
Q Consensus 895 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlkp~Nill~~~~~vkl 974 (1119)
+. ..++||||+++..+.+ ++...+..++.|++++++|||+. +|+||||||+|||++++ .+++
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 53 2379999998765432 33345568999999999999999 99999999999999865 5899
Q ss_pred EeccccccccCCCCCCcccccccCCCcccc--c---ccCCCCCCCcchHHHHHHH
Q 001226 975 GDFGMSKLISDSHSSSTRSAIVGSLGYIAP--E---NAYSTRLTEKSDVYSYGVI 1024 (1119)
Q Consensus 975 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~sDvwslG~v 1024 (1119)
+|||.|........ ..|... + ....+.|+.++|+||..--
T Consensus 144 iDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 144 IDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred EECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 99999976543211 011111 0 0123567889999997543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.9e-22 Score=232.46 Aligned_cols=110 Identities=24% Similarity=0.285 Sum_probs=57.1
Q ss_pred cccEEEcCCCcccCC-CCcccccCCCccEEEccccccccc----CCccccccCccCEEEccCccccCCCCccc----c-c
Q 001226 97 HLLSLDLSGNEFTGS-IPKQLGNCGQLKTLLLNDNRFQGS----IPPEIFKLKRLSWLDLGYNSLSGKIPPQV----S-L 166 (1119)
Q Consensus 97 ~l~~L~Ls~n~~~~~-~~~~l~~l~~L~~L~L~~n~i~~~----~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l----~-~ 166 (1119)
+|++||+++|++++. +.+-+..++++++|+|++|+|++. ++..+..+++|++|||++|.|++.....+ . .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 455566666655542 123344555666666666655532 23334455666666666665543211111 1 1
Q ss_pred ccccceeeecccccccc----cCccCCCcccccEEEeccccccc
Q 001226 167 CYSLESIGFHNNFLNGE----LPNDICSLPKLKSLYLNTNNLTG 206 (1119)
Q Consensus 167 l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~ 206 (1119)
..+|++|+|++|++++. ++..+..+++|++|++++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 23566666666666543 23445556667777776666553
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=9.7e-22 Score=230.62 Aligned_cols=386 Identities=20% Similarity=0.156 Sum_probs=201.0
Q ss_pred CCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCC----cchhhcCCCCCceeeeccccccccC----ccccc-C
Q 001226 240 NLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQ----IPETLWGLENLQKLVLSANKLNGTI----SGQIS-H 310 (1119)
Q Consensus 240 ~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~-~ 310 (1119)
+|++|++++|++++..-...+..++++++|+|++|+|+.. ++.++..+++|++|+|++|+|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5778888888887655566677788888888888887732 3455667788888888888876322 12222 2
Q ss_pred CCCCcEEEccccccccc----cCcccCCCCCCCeEEccCCcccCCCCCCC-----CCCCCCcEEEcccCcCcccC----c
Q 001226 311 CNQLQVIALSRNNLVGQ----IPRSVGNLSSLNSLLLFNNRLQGTLPPEL-----GNCGSLVDLRLQHNFIGGTI----P 377 (1119)
Q Consensus 311 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~l-----~~l~~L~~L~L~~N~i~~~~----~ 377 (1119)
..+|++|+|++|++++. ++..+..+++|++|++++|.++......+ ...............+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 34677777777777643 34456667777777777777653211111 11122333344333332111 1
Q ss_pred hhhhcccccceeeccCccccCCCCc----cc-cccCcceEEEeeccccccc----CCccccCCCCcCEEEccCccCcccc
Q 001226 378 PEICNLAKLEVLYLFNNRIEGAIPH----QI-GRMSKLVELALYNNRLTGR----IPPDITRLRNLQFLSLAHNHLTGEV 448 (1119)
Q Consensus 378 ~~l~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~ 448 (1119)
..+.....++.++++++.+...... .+ ........+++..+.+... ....+...+.++.+++++|++....
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 1223345555666655544321100 01 1112334455544443311 1112234455555555555543211
Q ss_pred ----hhhhhccCCccceeccccceeeCccCCccccccccceeeccCccccCCCCccccccccccEEEeccCccccCCCcc
Q 001226 449 ----ALELGKHFPYLSRLDLTGNSFYGPIPANICVGTNLFVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPAT 524 (1119)
Q Consensus 449 ----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 524 (1119)
........+.++.+++++|.+...... .....+...+.++.+++++|.+.......
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~--------------------~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCG--------------------DLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHH--------------------HHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cchhhcccccccccccccccccccccccccc--------------------cccccccccccccccccccccccccccch
Confidence 111112233444444444443321100 01112233445555555555543211111
Q ss_pred -----ccCCCCcceeeccCcccCCCCCc----cccccccceEEeccCCcccCC----CCCccC-CcccccEEEcccCccc
Q 001226 525 -----LERNPGVSFLDVRGNLLQGSIPP----VFGFWSNLTMLDFSENRLSGS----IPSELG-NLENLQILRLSANKLD 590 (1119)
Q Consensus 525 -----~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N~l~ 590 (1119)
......|+.+++++|.++..... .+....+|++|||++|+|+.. +++.+. ..+.|++|+|++|.|+
T Consensus 303 l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~ 382 (460)
T d1z7xw1 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 382 (460)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred hhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence 11234566666666655533222 223445688888888887632 333333 3566888888888886
Q ss_pred C----cCCcccccCCCCcEEeccCccccccCChhhh-----hcccCCeeEccCccCccCCCccc
Q 001226 591 G----RIPYELGKCTKMIKLDLSDNYLAGSIPSEVI-----SLEKMQSLSLQENNLSGAIPDAF 645 (1119)
Q Consensus 591 ~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~p~~~ 645 (1119)
. .++..+..+++|++|||++|+|+..-...+. +...|+.|++.+|.+....+..+
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred hHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence 3 2445566778888888888888743333332 23368888888888875444433
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=2.7e-18 Score=180.38 Aligned_cols=207 Identities=21% Similarity=0.296 Sum_probs=113.5
Q ss_pred CcccEEEcCCCcccCCCCcccccCCCccEEEcccccccccCCccccccCccCEEEccCccccCCCCcccccccccceeee
Q 001226 96 QHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKIPPQVSLCYSLESIGF 175 (1119)
Q Consensus 96 ~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 175 (1119)
.++..++++.+.+++.+ .++.+.+|++|++++|+|++ + +.+..+++|++|++++|.+++.. .+..+++|+++++
T Consensus 19 ~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~ 92 (227)
T d1h6ua2 19 ANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELEL 92 (227)
T ss_dssp HHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEEC
T ss_pred HHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--ccccccccccccc
Confidence 34455667777666533 45667777777777777764 3 35777777777777777776432 2556666666666
Q ss_pred cccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccCccccccCCCCCcEEEccCCccCCcc
Q 001226 176 HNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGSLPTSLSNCRNLVEFSASSNNFGGAI 255 (1119)
Q Consensus 176 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~lp~~l~~l~~L~~L~l~~n~i~~~~ 255 (1119)
++|.++.. ..++++++|+++++++|...+.
T Consensus 93 ~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~------------------------------------------------ 122 (227)
T d1h6ua2 93 SGNPLKNV--SAIAGLQSIKTLDLTSTQITDV------------------------------------------------ 122 (227)
T ss_dssp CSCCCSCC--GGGTTCTTCCEEECTTSCCCCC------------------------------------------------
T ss_pred cccccccc--cccccccccccccccccccccc------------------------------------------------
Confidence 66655532 2355566666666665544321
Q ss_pred ChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEccccccccccCcccCCC
Q 001226 256 SPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNLVGQIPRSVGNL 335 (1119)
Q Consensus 256 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 335 (1119)
..+...+.++.+.++++.+... ..+.++++|++|++++|.+.+.. .+.++++|++|+|++|++++. + .++++
T Consensus 123 --~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l 194 (227)
T d1h6ua2 123 --TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASL 194 (227)
T ss_dssp --GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGC
T ss_pred --chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCC
Confidence 1122333444444444444422 22444455555555555544322 245555555555555555532 2 25555
Q ss_pred CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcc
Q 001226 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQ 368 (1119)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 368 (1119)
++|++|+|++|++++.. .++++++|++|+++
T Consensus 195 ~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 195 PNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp TTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred CCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 66666666666665332 25566666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3.4e-18 Score=179.55 Aligned_cols=146 Identities=24% Similarity=0.371 Sum_probs=115.0
Q ss_pred ccCCCCCcEEEccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCC
Q 001226 235 LSNCRNLVEFSASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQL 314 (1119)
Q Consensus 235 l~~l~~L~~L~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 314 (1119)
+.++++|+++++++|.++. + ..+.++++|+.++++++...+. ..+...+.++.+.++.+.+... ..+..+++|
T Consensus 81 l~~l~~l~~l~~~~n~~~~-i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L 153 (227)
T d1h6ua2 81 LKNLTKITELELSGNPLKN-V--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNL 153 (227)
T ss_dssp GTTCCSCCEEECCSCCCSC-C--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTC
T ss_pred ccccccccccccccccccc-c--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccc
Confidence 4445555555555555542 1 2356788899999999888754 4467789999999999998754 347889999
Q ss_pred cEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccC
Q 001226 315 QVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFN 393 (1119)
Q Consensus 315 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~ 393 (1119)
++|++++|.+.+. ..++++++|++|+|++|++++. + .++++++|++|++++|++++. + .+.++++|+.|++++
T Consensus 154 ~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 154 QYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred ccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 9999999999744 3489999999999999999853 3 489999999999999999954 3 488999999999974
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=3.6e-18 Score=174.07 Aligned_cols=129 Identities=27% Similarity=0.392 Sum_probs=105.7
Q ss_pred eeeccCcccCCCCCccccccccceEEeccCCcccCCC-CCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCc
Q 001226 533 FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSI-PSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDN 611 (1119)
Q Consensus 533 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 611 (1119)
.++.++++++ .+|..+ .+++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCC--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCC--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4566666666 455544 267888999999987644 566788999999999999998888888888999999999999
Q ss_pred cccccCChhhhhcccCCeeEccCccCccCCCccccccccccEeecCCcccCCC
Q 001226 612 YLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSSVQSLFELQLGSNIFDGS 664 (1119)
Q Consensus 612 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 664 (1119)
+|+...|..|.++++|++|+|++|+|++..|++|..+++|++|+|++|.+...
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 99877778888899999999999999988888899999999999988888643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=5e-18 Score=172.96 Aligned_cols=172 Identities=19% Similarity=0.218 Sum_probs=115.7
Q ss_pred ceeeccCccccCCCCccccccccccEEEeccCcccc-CCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccC
Q 001226 484 FVLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQG-SLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSE 562 (1119)
Q Consensus 484 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~ 562 (1119)
+.++.++|+++ .+|..+. +++++|+|++|+|++ ..+..|..+++|+.|++++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 45667777776 5666553 567778888887765 3355667777777777777777777777777777788888888
Q ss_pred CcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCC
Q 001226 563 NRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIP 642 (1119)
Q Consensus 563 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 642 (1119)
|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+ ...-...++.+.+..|.++...|
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSS
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCC
Confidence 88876667777778888888888888876667777777888888888887764322 22222335556666676666555
Q ss_pred ccccccccccEeecCCcccC
Q 001226 643 DAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 643 ~~~~~l~~L~~L~L~~N~l~ 662 (1119)
..+. .++.++|+.|.|.
T Consensus 167 ~~l~---~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 167 SKVR---DVQIKDLPHSEFK 183 (192)
T ss_dssp TTTT---TSBGGGSCTTTCC
T ss_pred hhhc---CCEeeecCHhhCc
Confidence 4433 3444555555553
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.5e-17 Score=174.78 Aligned_cols=79 Identities=20% Similarity=0.113 Sum_probs=41.4
Q ss_pred cccEEEeccCccccCCCccccCCCCcc-eeeccCcccCCCCCccccccccceEEeccCCcccCCCCCccCCcccccEEEc
Q 001226 506 SLRRVILSNNLLQGSLPATLERNPGVS-FLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRL 584 (1119)
Q Consensus 506 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 584 (1119)
.++.|++++|+++...+..+ ..+++. .+++++|+++...+..|..+++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 154 ~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 154 ESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp SCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 44455555555553333222 233332 2344555555433445666677777777777776444445666666666555
Q ss_pred c
Q 001226 585 S 585 (1119)
Q Consensus 585 s 585 (1119)
.
T Consensus 233 ~ 233 (242)
T d1xwdc1 233 Y 233 (242)
T ss_dssp E
T ss_pred C
Confidence 3
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.7e-17 Score=174.53 Aligned_cols=134 Identities=14% Similarity=0.121 Sum_probs=60.2
Q ss_pred cceEEEeecccccccCCccccCCCCcCEEEccCccCcccchhhhhccCCccceeccc-cceeeCccCCccccccccceee
Q 001226 409 KLVELALYNNRLTGRIPPDITRLRNLQFLSLAHNHLTGEVALELGKHFPYLSRLDLT-GNSFYGPIPANICVGTNLFVLV 487 (1119)
Q Consensus 409 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~~~~L~~L~ 487 (1119)
++++|++++|+|+...+..|.++++|++|++++|.+...++...+..++.++++++. .|++....+..+..+++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 445555555555433333455555555555555554443443333444444444433 2333333444444455555555
Q ss_pred ccCccccCCCCc-cccccccccEEEeccCccccCCCccccCCC-CcceeeccCcccC
Q 001226 488 LGNNRFNGSFPI-EIGKCSSLRRVILSNNLLQGSLPATLERNP-GVSFLDVRGNLLQ 542 (1119)
Q Consensus 488 L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~ 542 (1119)
+++|++....+. .+..+..++.+...++.+....+..|..++ .++.|++++|+++
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 555555422111 223344444555555555544334443332 3444444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.7e-17 Score=171.48 Aligned_cols=162 Identities=23% Similarity=0.304 Sum_probs=89.4
Q ss_pred eeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCcc
Q 001226 486 LVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENRL 565 (1119)
Q Consensus 486 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 565 (1119)
.+++.+.+++.++. ..+.+|++|++++|.++... .+..+++|+.|++++|++++. + .++.+++|++|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccc
Confidence 34444444433332 23555666666666665321 245556666666666666542 2 245566666666666666
Q ss_pred cCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccc
Q 001226 566 SGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAF 645 (1119)
Q Consensus 566 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 645 (1119)
++ +| .+.++++|+.|++++|.+. .+ ..+..+++++.+++++|.+++ +..+..+++|+.+++++|++++. + .+
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l 174 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PL 174 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GG
T ss_pred cc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cc
Confidence 53 33 3566666666666666665 22 245566666666666666653 33455566666666666666642 2 25
Q ss_pred cccccccEeecCCccc
Q 001226 646 SSVQSLFELQLGSNIF 661 (1119)
Q Consensus 646 ~~l~~L~~L~L~~N~l 661 (1119)
+++++|++|+|++|++
T Consensus 175 ~~l~~L~~L~Ls~N~i 190 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHI 190 (210)
T ss_dssp TTCTTCCEEECCSSCC
T ss_pred cCCCCCCEEECCCCCC
Confidence 5666666644444433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=4.8e-17 Score=166.61 Aligned_cols=163 Identities=21% Similarity=0.298 Sum_probs=88.9
Q ss_pred eeeccCccccCCCCccccccccccEEEeccCccccCCCccccCCCCcceeeccCcccCCCCCccccccccceEEeccCCc
Q 001226 485 VLVLGNNRFNGSFPIEIGKCSSLRRVILSNNLLQGSLPATLERNPGVSFLDVRGNLLQGSIPPVFGFWSNLTMLDFSENR 564 (1119)
Q Consensus 485 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 564 (1119)
.+.++.+.+++.++ ...+++++.|++++|.+... +.++.+++|++|++++|++++..| ++.+++|++|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34455555554322 23455666666666666532 234555666666666666654322 5566666666666666
Q ss_pred ccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCcc
Q 001226 565 LSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDA 644 (1119)
Q Consensus 565 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 644 (1119)
+.. ++ .+.++++|+.|++++|.+.. + ..+..+++|+.|++++|++.. +| .+..+++|+.|++++|++++. + .
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~-~ 167 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K-P 167 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G-G
T ss_pred ccc-cc-cccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC-c-c
Confidence 652 22 35566666666666666653 2 235556666666666666652 22 455566666666666666642 2 3
Q ss_pred ccccccccEeecCCccc
Q 001226 645 FSSVQSLFELQLGSNIF 661 (1119)
Q Consensus 645 ~~~l~~L~~L~L~~N~l 661 (1119)
|+++++|++|++++|++
T Consensus 168 l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 168 LANLTTLERLDISSNKV 184 (199)
T ss_dssp GTTCTTCCEEECCSSCC
T ss_pred ccCCCCCCEEECCCCCC
Confidence 55666665555444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=3.1e-16 Score=161.89 Aligned_cols=179 Identities=24% Similarity=0.330 Sum_probs=103.5
Q ss_pred EccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEcccccc
Q 001226 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324 (1119)
Q Consensus 245 ~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 324 (1119)
.+..+.+++.+... .+.+|++|++++|++++.. .+..+++|++|+|++|+|++.. .++.+++|++|++++|++
T Consensus 30 ~l~~~~~~~~~~~~---~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 30 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HTTCSCTTSEECHH---HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred HhCcCccCCccCHH---HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence 44445555444332 2345666777777766432 3566677777777777666543 245666666666666666
Q ss_pred ccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccc
Q 001226 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI 404 (1119)
Q Consensus 325 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 404 (1119)
++ +| .+.++++|+.|++++|.+.. ...+..+++++.+++++|.+++ +..+..+++|+.+++++|++++.. .+
T Consensus 103 ~~-l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 103 KD-LS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred cc-cc-cccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cc
Confidence 63 33 36666666666666666552 2345566666666666666653 234555666666666666665432 25
Q ss_pred cccCcceEEEeecccccccCCccccCCCCcCEEEcc
Q 001226 405 GRMSKLVELALYNNRLTGRIPPDITRLRNLQFLSLA 440 (1119)
Q Consensus 405 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 440 (1119)
.++++|++|++++|++++ ++ .+.++++|++|+|+
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 566666666666666653 33 45666666666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.65 E-value=5.9e-16 Score=158.37 Aligned_cols=176 Identities=25% Similarity=0.376 Sum_probs=94.3
Q ss_pred EccCCccCCccChhhhhcCCCccEEEcCCCccCCCcchhhcCCCCCceeeeccccccccCcccccCCCCCcEEEcccccc
Q 001226 245 SASSNNFGGAISPWIFKGLLQLEVLYLDDNNLEGQIPETLWGLENLQKLVLSANKLNGTISGQISHCNQLQVIALSRNNL 324 (1119)
Q Consensus 245 ~l~~n~i~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 324 (1119)
.++.+++++.+.. ..+.++++|++++|+|+.. +.+..+++|++|++++|++++..+ +.++++|++|++++|.+
T Consensus 24 ~l~~~~~~~~~~~---~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 24 VLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HTTCSSTTSEECH---HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HhCCCCCCCccCH---HHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 4444555443322 2345566666666666632 335566666666666666664432 55666666666666665
Q ss_pred ccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCCCccc
Q 001226 325 VGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQI 404 (1119)
Q Consensus 325 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 404 (1119)
.. ++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|++++.. .+
T Consensus 97 ~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l 168 (199)
T d2omxa2 97 AD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PL 168 (199)
T ss_dssp CC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GG
T ss_pred cc-cc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cc
Confidence 52 22 355566666666666655432 235555566666666665542 2 24555555666666666555432 25
Q ss_pred cccCcceEEEeecccccccCCccccCCCCcCEE
Q 001226 405 GRMSKLVELALYNNRLTGRIPPDITRLRNLQFL 437 (1119)
Q Consensus 405 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 437 (1119)
+++++|++|++++|++++ ++ .++++++|+.|
T Consensus 169 ~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 555555555555555553 22 34555555543
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=1.2e-16 Score=173.39 Aligned_cols=80 Identities=16% Similarity=0.189 Sum_probs=41.5
Q ss_pred ccEEEcccccccccCCccccccCccCEEEccCccccCCC-CcccccccccceeeecccccccccCccCCCcccccEEEec
Q 001226 122 LKTLLLNDNRFQGSIPPEIFKLKRLSWLDLGYNSLSGKI-PPQVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLN 200 (1119)
Q Consensus 122 L~~L~L~~n~i~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 200 (1119)
+..+.++...+... ........+|++|||++|.+++.. +..+.++++|++|++++|.+++..+..++++++|++|+++
T Consensus 25 ~~~lrl~~~~~~~~-~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSC-CCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccc-hhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 34444544444322 122333455666666666554322 2234555566666666665555555556666666666666
Q ss_pred cc
Q 001226 201 TN 202 (1119)
Q Consensus 201 ~n 202 (1119)
+|
T Consensus 104 ~c 105 (284)
T d2astb2 104 GC 105 (284)
T ss_dssp TC
T ss_pred cc
Confidence 54
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=3e-16 Score=170.22 Aligned_cols=223 Identities=15% Similarity=0.123 Sum_probs=149.3
Q ss_pred EEecCCCcccccCccchhhhccCCcccEEEcCCCcccCCCCcccccCCCccEEEccccccccc-CCccccccCccCEEEc
Q 001226 73 ALNLSGFGLSGVLNNSISYICKNQHLLSLDLSGNEFTGSIPKQLGNCGQLKTLLLNDNRFQGS-IPPEIFKLKRLSWLDL 151 (1119)
Q Consensus 73 ~l~l~~~~l~~~~~~~~~~~~~l~~l~~L~Ls~n~~~~~~~~~l~~l~~L~~L~L~~n~i~~~-~p~~l~~l~~L~~L~L 151 (1119)
.|||++..+... .+..+.. ..+..+.++...+...+. ......+|++|||+++.+++. ++..+.++++|++|+|
T Consensus 4 ~lDLs~~~l~~~---~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 4 TLDLTGKNLHPD---VTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp EEECTTCBCCHH---HHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred EEECCCCCCCch---HHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccc
Confidence 577877666432 1222221 245677777766653332 344556899999999888754 3445677899999999
Q ss_pred cCccccCCCCcccccccccceeeeccc-ccccccCcc-CCCcccccEEEeccc-cccccCCCCCccccceeeeeeccccc
Q 001226 152 GYNSLSGKIPPQVSLCYSLESIGFHNN-FLNGELPND-ICSLPKLKSLYLNTN-NLTGLLPEFPNSCAILHLLIHENDFV 228 (1119)
Q Consensus 152 s~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~~~~-l~~l~~L~~L~L~~n-~l~~~~~~~~~~~~l~~l~l~~n~~~ 228 (1119)
++|.+++..+..++.+++|++|++++| .+++..... +..+++|++|++++| .+++.
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~--------------------- 137 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK--------------------- 137 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH---------------------
T ss_pred cccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccc---------------------
Confidence 999888777788888899999999985 666543332 345789999999886 34321
Q ss_pred cCcccccc-CCCCCcEEEccCC--ccCCccChhhhhcCCCccEEEcCCC-ccCCCcchhhcCCCCCceeeeccc-ccccc
Q 001226 229 GSLPTSLS-NCRNLVEFSASSN--NFGGAISPWIFKGLLQLEVLYLDDN-NLEGQIPETLWGLENLQKLVLSAN-KLNGT 303 (1119)
Q Consensus 229 ~~lp~~l~-~l~~L~~L~l~~n--~i~~~~~~~~~~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~ 303 (1119)
.+...+. .+++|+.|+++++ .+++......+..+++|++|++++| .+++..+..+.++++|++|+|++| .+++.
T Consensus 138 -~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~ 216 (284)
T d2astb2 138 -HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE 216 (284)
T ss_dssp -HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGG
T ss_pred -cchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChH
Confidence 1222232 3467888888864 3443333445566788888888875 577677777778888888888874 56655
Q ss_pred CcccccCCCCCcEEEcccc
Q 001226 304 ISGQISHCNQLQVIALSRN 322 (1119)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N 322 (1119)
....++.+++|++|+++++
T Consensus 217 ~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 217 TLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGGGCTTCCEEECTTS
T ss_pred HHHHHhcCCCCCEEeeeCC
Confidence 5556667777777777665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.52 E-value=8.6e-16 Score=172.03 Aligned_cols=251 Identities=17% Similarity=0.169 Sum_probs=131.7
Q ss_pred hhhhccCCcccEEEcCCCcccC----CCCcccccCCCccEEEcccccccc---c-------CCccccccCccCEEEccCc
Q 001226 89 ISYICKNQHLLSLDLSGNEFTG----SIPKQLGNCGQLKTLLLNDNRFQG---S-------IPPEIFKLKRLSWLDLGYN 154 (1119)
Q Consensus 89 ~~~~~~l~~l~~L~Ls~n~~~~----~~~~~l~~l~~L~~L~L~~n~i~~---~-------~p~~l~~l~~L~~L~Ls~n 154 (1119)
.+.+.....|++|+|++|.+.. .+...+...++|+.|+++++.+.. . +.+.+..+++|++|||++|
T Consensus 24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n 103 (344)
T d2ca6a1 24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDN 103 (344)
T ss_dssp SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSC
T ss_pred HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccc
Confidence 3445567778888888887754 234456667778888887664321 1 1223344566777777777
Q ss_pred cccCCCCc----ccccccccceeeecccccccccCccCCCcccccEEEeccccccccCCCCCccccceeeeeeccccccC
Q 001226 155 SLSGKIPP----QVSLCYSLESIGFHNNFLNGELPNDICSLPKLKSLYLNTNNLTGLLPEFPNSCAILHLLIHENDFVGS 230 (1119)
Q Consensus 155 ~l~~~~p~----~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~l~l~~n~~~~~ 230 (1119)
.++..... .+..+++|++|++++|.++......++.. |..+ .
T Consensus 104 ~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~--l~~~--------------------------------~ 149 (344)
T d2ca6a1 104 AFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL--------------------------------A 149 (344)
T ss_dssp CCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH--------------------------------H
T ss_pred ccccccccchhhhhcccccchheeccccccccccccccccc--cccc--------------------------------c
Confidence 76653222 22334555555555555432221111000 0000 0
Q ss_pred ccccccCCCCCcEEEccCCccCCcc---ChhhhhcCCCccEEEcCCCccCCC-----cchhhcCCCCCceeeeccccccc
Q 001226 231 LPTSLSNCRNLVEFSASSNNFGGAI---SPWIFKGLLQLEVLYLDDNNLEGQ-----IPETLWGLENLQKLVLSANKLNG 302 (1119)
Q Consensus 231 lp~~l~~l~~L~~L~l~~n~i~~~~---~~~~~~~l~~L~~L~L~~n~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~ 302 (1119)
........+.|+.+.+++|+++... ....+...+.|++|+|++|+|+.. +...+..+++|+.|+|++|.++.
T Consensus 150 ~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 229 (344)
T d2ca6a1 150 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 229 (344)
T ss_dssp HHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHH
T ss_pred cccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccc
Confidence 0001123344555555555544221 122234455666666666665432 22334556666667776666653
Q ss_pred c----CcccccCCCCCcEEEccccccccccCcc----cC--CCCCCCeEEccCCcccCCC----CCCCC-CCCCCcEEEc
Q 001226 303 T----ISGQISHCNQLQVIALSRNNLVGQIPRS----VG--NLSSLNSLLLFNNRLQGTL----PPELG-NCGSLVDLRL 367 (1119)
Q Consensus 303 ~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~--~l~~L~~L~L~~N~l~~~~----~~~l~-~l~~L~~L~L 367 (1119)
. +...+..+++|++|+|++|.|++..... +. ..+.|++|++++|+|+... ...+. ++++|++|++
T Consensus 230 ~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l 309 (344)
T d2ca6a1 230 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309 (344)
T ss_dssp HHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEEC
T ss_pred cccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEEC
Confidence 2 2334556667777777777765432222 22 2356777888877776321 22222 4667888888
Q ss_pred ccCcCc
Q 001226 368 QHNFIG 373 (1119)
Q Consensus 368 ~~N~i~ 373 (1119)
++|++.
T Consensus 310 ~~N~~~ 315 (344)
T d2ca6a1 310 NGNRFS 315 (344)
T ss_dssp TTSBSC
T ss_pred CCCcCC
Confidence 888876
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.49 E-value=1.8e-15 Score=169.43 Aligned_cols=245 Identities=21% Similarity=0.163 Sum_probs=120.2
Q ss_pred CccccccCCCCCcEEEccCCccCCccC---hhhhhcCCCccEEEcCCCccCCC----------cchhhcCCCCCceeeec
Q 001226 230 SLPTSLSNCRNLVEFSASSNNFGGAIS---PWIFKGLLQLEVLYLDDNNLEGQ----------IPETLWGLENLQKLVLS 296 (1119)
Q Consensus 230 ~lp~~l~~l~~L~~L~l~~n~i~~~~~---~~~~~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~Ls 296 (1119)
.+...+.+..+|++|++++|.++.... ...+...++|+.|+++++..... +.+.+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 344567777888888888887754321 22345567788888877654321 12233455667777777
Q ss_pred cccccccC----cccccCCCCCcEEEccccccccccCccc-------------CCCCCCCeEEccCCcccCCCCCCCCCC
Q 001226 297 ANKLNGTI----SGQISHCNQLQVIALSRNNLVGQIPRSV-------------GNLSSLNSLLLFNNRLQGTLPPELGNC 359 (1119)
Q Consensus 297 ~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-------------~~l~~L~~L~L~~N~l~~~~~~~l~~l 359 (1119)
+|.++... ...+..+++|++|++++|.+.......+ ...+.|+.+++++|.++.....
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~----- 176 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK----- 176 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH-----
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccc-----
Confidence 77665432 2234455666677776666542111111 1233445555555444321111
Q ss_pred CCCcEEEcccCcCcccCchhhhcccccceeeccCccccCC-----CCccccccCcceEEEeeccccccc----CCccccC
Q 001226 360 GSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGA-----IPHQIGRMSKLVELALYNNRLTGR----IPPDITR 430 (1119)
Q Consensus 360 ~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~ 430 (1119)
.+...+...+.|+.|+|++|+|+.. +...+..+++|+.|++++|.++.. +...+..
T Consensus 177 ---------------~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~ 241 (344)
T d2ca6a1 177 ---------------EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241 (344)
T ss_dssp ---------------HHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred ---------------cccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccc
Confidence 1111223344455555555544321 122234445555555555554321 2233445
Q ss_pred CCCcCEEEccCccCcccchhhhhc-----cCCccceeccccceeeCcc----CCccc-cccccceeeccCcccc
Q 001226 431 LRNLQFLSLAHNHLTGEVALELGK-----HFPYLSRLDLTGNSFYGPI----PANIC-VGTNLFVLVLGNNRFN 494 (1119)
Q Consensus 431 l~~L~~L~L~~N~l~~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----p~~~~-~~~~L~~L~L~~N~l~ 494 (1119)
+++|++|+|++|.|++.....+.. ..+.|++|++++|+++... ...+. ..++|+.|+|++|++.
T Consensus 242 ~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 555555555555555433322221 1234555555555554321 11121 3455666666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=7.2e-14 Score=129.90 Aligned_cols=87 Identities=30% Similarity=0.422 Sum_probs=40.9
Q ss_pred ccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccC-ChhhhhcccC
Q 001226 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSI-PSEVISLEKM 627 (1119)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L 627 (1119)
+..+++|++||+++|+|+ .+|..|+.+++|+.|++++|+++ .+| .+..+++|++|++++|+++... +..+..+++|
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L 92 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 92 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence 444445555555555554 34444555555555555555554 232 2444555555555555554221 1234444445
Q ss_pred CeeEccCccCc
Q 001226 628 QSLSLQENNLS 638 (1119)
Q Consensus 628 ~~L~L~~N~l~ 638 (1119)
+.|++++|+++
T Consensus 93 ~~L~l~~N~i~ 103 (124)
T d1dcea3 93 VLLNLQGNSLC 103 (124)
T ss_dssp CEEECTTSGGG
T ss_pred CEEECCCCcCC
Confidence 55555555444
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.1e-13 Score=128.68 Aligned_cols=102 Identities=27% Similarity=0.319 Sum_probs=88.1
Q ss_pred eEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCc
Q 001226 556 TMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQEN 635 (1119)
Q Consensus 556 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 635 (1119)
+.|||++|+|+ .++ .+.++++|++|++++|+|+ .+|..++.+++|+.|++++|+|++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57899999998 555 4899999999999999998 688889999999999999999984 55 5889999999999999
Q ss_pred cCccCC-CccccccccccEeecCCcccC
Q 001226 636 NLSGAI-PDAFSSVQSLFELQLGSNIFD 662 (1119)
Q Consensus 636 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 662 (1119)
+++... +..+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 998543 257889999999999988876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=7.5e-14 Score=136.62 Aligned_cols=106 Identities=17% Similarity=0.195 Sum_probs=51.5
Q ss_pred CccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCC--hhhhh
Q 001226 546 PPVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP--SEVIS 623 (1119)
Q Consensus 546 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~ 623 (1119)
|..+..+++|+.|||++|+|+ .+ +.|..+++|++|++++|+++...+..+..+++|+.|+|++|+++. ++ ..+..
T Consensus 34 ~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~ 110 (162)
T d1a9na_ 34 ENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLAS 110 (162)
T ss_dssp CCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGG
T ss_pred CccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccccccceeccccccc-ccccccccc
Confidence 333344445555555555554 22 234555555555555555553333334445555555555555542 22 23445
Q ss_pred cccCCeeEccCccCccCCCc----cccccccccEee
Q 001226 624 LEKMQSLSLQENNLSGAIPD----AFSSVQSLFELQ 655 (1119)
Q Consensus 624 l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 655 (1119)
+++|++|++++|.++. .|. .+..+++|+.||
T Consensus 111 l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 111 LKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred ccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 5555555555555542 222 344555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.4e-13 Score=134.69 Aligned_cols=111 Identities=17% Similarity=0.135 Sum_probs=58.6
Q ss_pred ccCCCCCcEEEccccccccccCcccCCCCCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccCcCcccCchhhhcccccc
Q 001226 308 ISHCNQLQVIALSRNNLVGQIPRSVGNLSSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHNFIGGTIPPEICNLAKLE 387 (1119)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~i~~~~~~~l~~l~~L~ 387 (1119)
|.++.++++|+|++|+|+ .++..+..+++|+.|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 334445555555555555 234444555556666666665552 2 2355566666666666666544444445566666
Q ss_pred eeeccCccccCCCC-ccccccCcceEEEeeccccc
Q 001226 388 VLYLFNNRIEGAIP-HQIGRMSKLVELALYNNRLT 421 (1119)
Q Consensus 388 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 421 (1119)
.|++++|+|+.... ..+..+++|++|++++|+++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666666553211 23445555555555555554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=5.9e-14 Score=142.47 Aligned_cols=130 Identities=21% Similarity=0.305 Sum_probs=72.9
Q ss_pred CCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccCccCccCCCccccc
Q 001226 568 SIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQENNLSGAIPDAFSS 647 (1119)
Q Consensus 568 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 647 (1119)
.+|.++..+++|+.|+|++|+++ .++ .+..+++|+.|+|++|+|+ .+|.....++.|++|++++|+++. + +.+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 34455566666666666666665 343 3566666666666666665 345444445566666666666653 2 23555
Q ss_pred cccccEeecCCcccCCCccccchhhccccceeeeccccccCCcc--cccccccccceeeccCceecccCCcc--------
Q 001226 648 VQSLFELQLGSNIFDGSIPCSLSKLHHFSSILNVSNNKLSGKIP--ECLGNLDKLQILDLSSNSFSGEIPTE-------- 717 (1119)
Q Consensus 648 l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~L~ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~g~ip~~-------- 717 (1119)
+++|+.|++++|+++ .++ ..+..+++|+.|+|++|+++...+..
T Consensus 114 l~~L~~L~L~~N~i~--------------------------~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~ 167 (198)
T d1m9la_ 114 LVNLRVLYMSNNKIT--------------------------NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167 (198)
T ss_dssp HHHSSEEEESEEECC--------------------------CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHH
T ss_pred cccccccccccchhc--------------------------cccccccccCCCccceeecCCCccccCcccccchhhHHH
Confidence 555555444444332 122 24556667777777777766544332
Q ss_pred --ccccccceEEe
Q 001226 718 --VNNMVSLYFVN 728 (1119)
Q Consensus 718 --~~~~~~l~~l~ 728 (1119)
+..+++|+.||
T Consensus 168 ~vi~~lp~L~~LD 180 (198)
T d1m9la_ 168 EVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHCSSCCEES
T ss_pred HHHHHCCCcCEeC
Confidence 34556666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=1e-13 Score=140.66 Aligned_cols=86 Identities=22% Similarity=0.302 Sum_probs=35.6
Q ss_pred ccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCccccccCC--hhhhhccc
Q 001226 549 FGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLAGSIP--SEVISLEK 626 (1119)
Q Consensus 549 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~ 626 (1119)
+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|+++. ++ .+..+++|+.|+|++|+++. ++ ..+..+++
T Consensus 66 l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~ 141 (198)
T d1m9la_ 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDK 141 (198)
T ss_dssp HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTT
T ss_pred ccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccccccchhcc-ccccccccCCCc
Confidence 334444444444444443 233333333344444444444442 21 23344444444444444432 22 23344444
Q ss_pred CCeeEccCccCc
Q 001226 627 MQSLSLQENNLS 638 (1119)
Q Consensus 627 L~~L~L~~N~l~ 638 (1119)
|+.|+|++|++.
T Consensus 142 L~~L~L~~N~l~ 153 (198)
T d1m9la_ 142 LEDLLLAGNPLY 153 (198)
T ss_dssp CSEEEECSSHHH
T ss_pred cceeecCCCccc
Confidence 444444444444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=2.4e-11 Score=117.56 Aligned_cols=109 Identities=17% Similarity=0.141 Sum_probs=75.9
Q ss_pred CCCCeEEccCCcccCCCCCCCCCCCCCcEEEcccC-cCcccCchhhhcccccceeeccCccccCCCCccccccCcceEEE
Q 001226 336 SSLNSLLLFNNRLQGTLPPELGNCGSLVDLRLQHN-FIGGTIPPEICNLAKLEVLYLFNNRIEGAIPHQIGRMSKLVELA 414 (1119)
Q Consensus 336 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N-~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 414 (1119)
...+.++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34455666666666 45666677777777777655 47666666777777788888888877777777777788888888
Q ss_pred eecccccccCCccccCCCCcCEEEccCccCcc
Q 001226 415 LYNNRLTGRIPPDITRLRNLQFLSLAHNHLTG 446 (1119)
Q Consensus 415 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 446 (1119)
|++|+|+. +|.......+|+.|+|++|++.-
T Consensus 87 Ls~N~l~~-l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 87 LSFNALES-LSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp CCSSCCSC-CCSTTTCSCCCCEEECCSSCCCC
T ss_pred ccCCCCcc-cChhhhccccccccccCCCcccC
Confidence 88888873 44443344468888888888753
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=1.9e-11 Score=118.30 Aligned_cols=67 Identities=22% Similarity=0.180 Sum_probs=36.2
Q ss_pred ccccccccceEEeccCCcccCCCCCccCCcccccEEEcccCcccCcCCcccccCCCCcEEeccCcccc
Q 001226 547 PVFGFWSNLTMLDFSENRLSGSIPSELGNLENLQILRLSANKLDGRIPYELGKCTKMIKLDLSDNYLA 614 (1119)
Q Consensus 547 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 614 (1119)
..|..+++|+.|+|++|+|++..|.+|.++++|++|+|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus 50 ~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 50 RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp GGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred hhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 34555555555555555555444555555566666666666665 33333333335666666666553
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.34 E-value=1.7e-08 Score=97.90 Aligned_cols=98 Identities=24% Similarity=0.244 Sum_probs=53.0
Q ss_pred EEeccCCcccCCCCCccCCcccccEEEcccCcccCc--CCcccccCCCCcEEeccCccccccCChhhhhcccCCeeEccC
Q 001226 557 MLDFSENRLSGSIPSELGNLENLQILRLSANKLDGR--IPYELGKCTKMIKLDLSDNYLAGSIPSEVISLEKMQSLSLQE 634 (1119)
Q Consensus 557 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 634 (1119)
.++..+|... .++..+.++++|++|+|++|+|+.. ++..+..+++|+.|||++|+++...+-.......|+.|++++
T Consensus 46 ~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~ 124 (162)
T d1koha1 46 VLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124 (162)
T ss_dssp CTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTT
T ss_pred hcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCC
Confidence 3344443332 3333344566666667777766632 123455667777777777777643222333334567777777
Q ss_pred ccCccCCCcc-------ccccccccEee
Q 001226 635 NNLSGAIPDA-------FSSVQSLFELQ 655 (1119)
Q Consensus 635 N~l~~~~p~~-------~~~l~~L~~L~ 655 (1119)
|.++....+. +..+++|+.||
T Consensus 125 Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 125 NSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp STTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 7776544322 44566666544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=5.3e-08 Score=94.22 Aligned_cols=104 Identities=26% Similarity=0.210 Sum_probs=60.3
Q ss_pred CCCCcEEEcccCcCcccCchhhhcccccceeeccCccccCCC--CccccccCcceEEEeecccccccCCccccCCCCcCE
Q 001226 359 CGSLVDLRLQHNFIGGTIPPEICNLAKLEVLYLFNNRIEGAI--PHQIGRMSKLVELALYNNRLTGRIPPDITRLRNLQF 436 (1119)
Q Consensus 359 l~~L~~L~L~~N~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 436 (1119)
+..+..++..++.+. .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+...+-.+.+..+|+.
T Consensus 41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~ 119 (162)
T d1koha1 41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119 (162)
T ss_dssp TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence 333444444444333 33344456777777777777777543 234556777777777777776433323344556777
Q ss_pred EEccCccCcccch------hhhhccCCccceec
Q 001226 437 LSLAHNHLTGEVA------LELGKHFPYLSRLD 463 (1119)
Q Consensus 437 L~L~~N~l~~~~~------~~~~~~l~~L~~L~ 463 (1119)
|++++|+++.... ..+...+|+|+.||
T Consensus 120 L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 120 LWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred eecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 7777777764322 12345567777665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.97 E-value=8.6e-06 Score=85.27 Aligned_cols=127 Identities=13% Similarity=0.106 Sum_probs=87.6
Q ss_pred cCCccEEEEEeCCCceEEEEEecccc----cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEeccCCCCHHHhhc
Q 001226 845 GKHGTVYRTLSNNSRKHWAVKKLNRS----ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYMPGGTLFNVLH 919 (1119)
Q Consensus 845 G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~ 919 (1119)
++.+.||+.... ++.+++|+.... ...+.+|...++.+. +--+.+++++..+++..++||++++|.++.+...
T Consensus 25 ~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 25 MSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 334689987543 556778877432 345788999888774 4346677788888888999999999988765432
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 001226 920 QNEPRLVLDWNTRYHIALGIAQGLSYLHYDC------------------------------------------------- 950 (1119)
Q Consensus 920 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------------- 950 (1119)
... ....++.++++.++.||+..
T Consensus 103 ~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 103 DEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp TCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 211 12234555555566666431
Q ss_pred -------CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 951 -------VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 951 -------~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
...++|+|+.|.||++++++.+.++||+.+.
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987667799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.65 E-value=3.9e-05 Score=79.62 Aligned_cols=129 Identities=18% Similarity=0.129 Sum_probs=84.1
Q ss_pred eeeecCC-ccEEEEEeCCCceEEEEEecccc-cccHHHHHHHHhhcCC--CCEEEEeeeeecCCceEEEEeccCCCCHHH
Q 001226 841 IIGKGKH-GTVYRTLSNNSRKHWAVKKLNRS-ETNFDVEIRTLSLVRH--RNILRIVGSCTKDEHGFIVTEYMPGGTLFN 916 (1119)
Q Consensus 841 ~lG~G~f-g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 916 (1119)
.+..|.. +.||+..... +..+++|..... ...+..|+..++.+.. -.+.+++++..+++..++|||+++|.++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 4555554 5789887654 667888987543 3457889999887743 335677787788888899999998865532
Q ss_pred hhccCCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 001226 917 VLHQNEPRLVLDWNTRYHIALGIAQGLSYLHY------------------------------------------------ 948 (1119)
Q Consensus 917 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------------ 948 (1119)
.. ... ...+.++.+.++-||+
T Consensus 96 ~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 96 SH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp SC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 10 000 0111222223333332
Q ss_pred ---C----CCCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 949 ---D----CVPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 949 ---~----~~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
. ..+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11248999999999999987667899999765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=1.4e-05 Score=77.09 Aligned_cols=11 Identities=9% Similarity=0.045 Sum_probs=6.2
Q ss_pred cCccCEEEccC
Q 001226 143 LKRLSWLDLGY 153 (1119)
Q Consensus 143 l~~L~~L~Ls~ 153 (1119)
.++|++|+|++
T Consensus 14 ~~~L~~L~L~~ 24 (167)
T d1pgva_ 14 DTDLKEVNINN 24 (167)
T ss_dssp CSSCCEEECTT
T ss_pred CCCCcEEEeCC
Confidence 35566666654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.39 E-value=4.2e-05 Score=73.59 Aligned_cols=66 Identities=14% Similarity=0.041 Sum_probs=31.8
Q ss_pred cCCCCCcEEEccCC-ccCCccC---hhhhhcCCCccEEEcCCCccCCCc----chhhcCCCCCceeeecccccc
Q 001226 236 SNCRNLVEFSASSN-NFGGAIS---PWIFKGLLQLEVLYLDDNNLEGQI----PETLWGLENLQKLVLSANKLN 301 (1119)
Q Consensus 236 ~~l~~L~~L~l~~n-~i~~~~~---~~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~Ls~N~l~ 301 (1119)
.+.++|++|+|+++ .++.... ...+...+.|++|+|++|.++... .+.+...+.|++|+|++|.++
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 34566777777653 3443221 112334455666666666554322 222333445555555555554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00019 Score=79.31 Aligned_cols=72 Identities=18% Similarity=0.194 Sum_probs=47.0
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccc-----------ccccHHHHHHHHhhcC-C--CCEEEEeeeeecCCceEEE
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR-----------SETNFDVEIRTLSLVR-H--RNILRIVGSCTKDEHGFIV 905 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-----------~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV 905 (1119)
+.||.|....||++....+++.|+||.... ..+....|++.++.+. + ..+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 568999999999998887788899996421 1123456888887663 2 335555554 34456799
Q ss_pred EeccCCCC
Q 001226 906 TEYMPGGT 913 (1119)
Q Consensus 906 ~e~~~~gs 913 (1119)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.96 E-value=4.3e-05 Score=73.51 Aligned_cols=111 Identities=14% Similarity=0.104 Sum_probs=71.5
Q ss_pred cCCcccEEEcCC-CcccC----CCCcccccCCCccEEEcccccccccCC----ccccccCccCEEEccCccccCCC----
Q 001226 94 KNQHLLSLDLSG-NEFTG----SIPKQLGNCGQLKTLLLNDNRFQGSIP----PEIFKLKRLSWLDLGYNSLSGKI---- 160 (1119)
Q Consensus 94 ~l~~l~~L~Ls~-n~~~~----~~~~~l~~l~~L~~L~L~~n~i~~~~p----~~l~~l~~L~~L~Ls~n~l~~~~---- 160 (1119)
..+.|++|+|++ +.++. .+..++...++|++|+|++|.++.... ..+...+.|+.+++++|.+....
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 347788888876 34543 234455677788888888887765433 33445677888888888776432
Q ss_pred Ccccccccccceeee--ccccccccc----CccCCCcccccEEEeccccc
Q 001226 161 PPQVSLCYSLESIGF--HNNFLNGEL----PNDICSLPKLKSLYLNTNNL 204 (1119)
Q Consensus 161 p~~l~~l~~L~~L~L--~~n~l~~~~----~~~l~~l~~L~~L~L~~n~l 204 (1119)
...+...++|+.++| ++|.+++.. ...+...++|++|+++.++.
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 245566677776444 456666533 33455678899998877654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.70 E-value=0.00023 Score=68.12 Aligned_cols=67 Identities=13% Similarity=0.038 Sum_probs=33.6
Q ss_pred ccCCCCCcEEEccC-CccCCccC---hhhhhcCCCccEEEcCCCccCCCcch----hhcCCCCCceeeecccccc
Q 001226 235 LSNCRNLVEFSASS-NNFGGAIS---PWIFKGLLQLEVLYLDDNNLEGQIPE----TLWGLENLQKLVLSANKLN 301 (1119)
Q Consensus 235 l~~l~~L~~L~l~~-n~i~~~~~---~~~~~~l~~L~~L~L~~n~l~~~~p~----~l~~l~~L~~L~Ls~N~l~ 301 (1119)
..+.++|++|++++ +.++.... ...+...++|++|+|++|.++..... .+...+.++.+++++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 34556777777776 34543221 22233455666666666665533222 2233455555555555544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.56 E-value=0.011 Score=62.88 Aligned_cols=132 Identities=16% Similarity=0.178 Sum_probs=74.4
Q ss_pred CccEEEEEeCCCceEEEEEeccc---ccccHHHHHHHHhhcCCCCE--EEEee-----eeecCCceEEEEeccCCCCHH-
Q 001226 847 HGTVYRTLSNNSRKHWAVKKLNR---SETNFDVEIRTLSLVRHRNI--LRIVG-----SCTKDEHGFIVTEYMPGGTLF- 915 (1119)
Q Consensus 847 fg~Vy~~~~~~~~~~vavK~~~~---~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lV~e~~~~gsL~- 915 (1119)
--.||++...+ |..|++|+.+. ..+++..|...+..+....+ +..+. .+..++..+.|+++++|..+.
T Consensus 35 EN~vy~v~~~d-g~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCC-CCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 45799997765 78899999864 34567889888887752222 11111 123355678899999764321
Q ss_pred ----Hh---------hcc----CC--CCCCCCH-------------------HHHHHHHHHHHHHHHHHHh----CCCCC
Q 001226 916 ----NV---------LHQ----NE--PRLVLDW-------------------NTRYHIALGIAQGLSYLHY----DCVPQ 953 (1119)
Q Consensus 916 ----~~---------l~~----~~--~~~~l~~-------------------~~~~~i~~~i~~~l~~LH~----~~~~~ 953 (1119)
.+ +|. .. .+...++ .....+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 111 00 0111111 1111122222333333332 22347
Q ss_pred eEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 954 IIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 954 ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
+||+|+.|.||+++++ ..++||+-++
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eecCCCCcccEEEeCC--ceEEechhcc
Confidence 8999999999999743 4589999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.44 E-value=0.012 Score=64.27 Aligned_cols=71 Identities=14% Similarity=0.171 Sum_probs=49.6
Q ss_pred ceeeecCCccEEEEEeCC-------CceEEEEEecccc--cccHHHHHHHHhhcC-CCCEEEEeeeeecCCceEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNN-------SRKHWAVKKLNRS--ETNFDVEIRTLSLVR-HRNILRIVGSCTKDEHGFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~-------~~~~vavK~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 909 (1119)
+.|+.|-.-.+|++.... ..+.|++++.... ..+..+|..+++.+. +.-..++++++.+ ..|+||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence 678889999999988653 2456788877532 234567888888875 4334577777653 5899999
Q ss_pred CCCCH
Q 001226 910 PGGTL 914 (1119)
Q Consensus 910 ~~gsL 914 (1119)
+|..+
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.00 E-value=0.063 Score=56.28 Aligned_cols=140 Identities=11% Similarity=0.081 Sum_probs=72.4
Q ss_pred ceeeecCCccEEEEEeCCCceEEEEEeccc--ccccHHHHHHHHhhcCCCCE--EEEeee------eecCCceEEEEecc
Q 001226 840 RIIGKGKHGTVYRTLSNNSRKHWAVKKLNR--SETNFDVEIRTLSLVRHRNI--LRIVGS------CTKDEHGFIVTEYM 909 (1119)
Q Consensus 840 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~--~~~~~~~E~~~l~~l~h~ni--v~l~~~------~~~~~~~~lV~e~~ 909 (1119)
+.|..|.--+.|+..... | .+++|++.. ..+++..|+..+..+...++ ...+.. ....+..+.++.+.
T Consensus 24 ~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 24 KGIAEGVENSNFLLHTTK-D-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EEECC---EEEEEEEESS-C-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ecCCCCcccCeEEEEECC-C-cEEEEEcCCCCCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 345567667889987654 3 578999854 34567778888877743222 111111 11233445667776
Q ss_pred CCCCHHH--------------hhccC----C--CCCCCC------------------HHHHHHHHHHHHHHHHHHHh-CC
Q 001226 910 PGGTLFN--------------VLHQN----E--PRLVLD------------------WNTRYHIALGIAQGLSYLHY-DC 950 (1119)
Q Consensus 910 ~~gsL~~--------------~l~~~----~--~~~~l~------------------~~~~~~i~~~i~~~l~~LH~-~~ 950 (1119)
.+..... .++.. . ...... .......+......+...+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 5543211 01100 0 000000 00111122222222222221 12
Q ss_pred CCCeEecCCCCCCeEeCCCCceEEEeccccc
Q 001226 951 VPQIIHRDIKSDNILLDSELEPKIGDFGMSK 981 (1119)
Q Consensus 951 ~~~ivH~Dlkp~Nill~~~~~vkl~DfGla~ 981 (1119)
..|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3489999999999999988777899999875
|